data_6ved_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6ved _Structure_validation_residue.Date_analyzed 2020-06-12 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 134' ' ' LEU . 1.4 mm? -100.37 -12.25 19.58 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.397 0.679 . . . . 0.0 111.419 -171.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.87 138.78 33.02 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.45 176.24 6.45 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 118.532 0.605 . . . . 0.0 112.226 -174.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.68 -14.96 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 124.578 1.151 . . . . 0.0 111.694 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.446 ' HA ' ' NE2' ' A' ' 155' ' ' GLN . 35.2 m-80 -113.01 24.96 11.83 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.34 0.656 . . . . 0.0 111.636 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.488 ' HG3' HG13 ' A' ' 141' ' ' VAL . 8.9 tp10 -98.98 79.77 2.4 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.632 0.73 . . . . 0.0 111.496 -173.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 9.5 p90 -73.55 98.37 2.8 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.172 173.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.488 HG13 ' HG3' ' A' ' 139' ' ' GLU . 15.7 m -114.87 171.56 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.771 0.828 . . . . 0.0 109.196 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 7.1 t0 -90.91 107.74 19.39 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -172.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.74 99.74 12.57 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.956 0.902 . . . . 0.0 109.756 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -76.06 98.91 4.45 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.9 123.68 20.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 170.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.1 t -79.9 -28.15 39.87 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.741 0.816 . . . . 0.0 110.837 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -68.85 -51.49 39.91 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.065 0.946 . . . . 0.0 111.124 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 43.8 ttp -94.72 -14.1 25.1 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.343 0.657 . . . . 0.0 109.883 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.88 7.08 86.17 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 113.668 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.52 134.52 43.36 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.733 0.413 . . . . 0.0 111.871 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -75.31 135.85 40.89 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.386 1.074 . . . . 0.0 109.34 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -143.14 118.4 10.19 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 41.5 mt-10 -59.21 98.58 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.996 0.518 . . . . 0.0 109.889 176.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -103.04 138.82 39.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.432 1.093 . . . . 0.0 112.374 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.4 tp60 -87.2 104.47 16.41 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.921 1.688 . . . . 0.0 110.546 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.591 HG22 HG13 ' A' ' 186' ' ' VAL . 59.2 t -61.99 115.43 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.64 -12.77 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.89 0.876 . . . . 0.0 111.265 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -161.17 144.98 13.16 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.539 0.736 . . . . 0.0 109.549 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.22 137.33 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 166.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.42 ' HG1' ' HB ' ' A' ' 183' ' ' ILE . 31.6 p -132.65 150.62 52.13 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -87.37 161.09 18.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.998 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 79.9 tttt . . . . . 0 CA--C 1.551 0.991 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.324 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 . . . . . 0 C--O 1.247 0.948 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.435 ' HB3' HG21 ' A' ' 182' ' ' VAL . 2.3 mp0 -68.61 105.31 2.21 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.484 -172.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.31 50.23 0.5 Allowed 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 122.234 1.016 . . . . 0.0 110.283 166.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.435 HG21 ' HB3' ' A' ' 180' ' ' GLU . 13.2 m -122.64 160.85 24.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 174.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.487 HG22 ' HB2' ' A' ' 198' ' ' GLN . 3.3 mp -95.56 110.83 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -166.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -92.59 109.2 20.61 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -78.56 98.68 6.21 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.591 HG13 HG22 ' A' ' 156' ' ' VAL . 14.7 m -107.98 165.43 4.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.358 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -130.43 116.49 18.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -54.21 110.26 0.59 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.635 0.652 . . . . 0.0 109.26 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.03 -22.42 62.14 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.738 0.78 . . . . 0.0 109.217 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.616 ' HA ' ' HA ' ' A' ' 297' ' ' LYS . 0.9 OUTLIER -69.3 -28.37 66.21 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.837 1.255 . . . . 0.0 111.899 171.278 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -142.2 78.82 16.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 123.75 0.82 . . . . 0.0 109.862 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.09 -22.33 55.41 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.322 2.682 . . . . 0.0 113.814 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -66.27 -18.85 65.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.178 0.991 . . . . 0.0 112.074 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.11 -21.65 58.76 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.987 0.515 . . . . 0.0 111.241 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 67.24 -148.0 49.63 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.67 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 18.8 t -84.56 114.7 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.3 m -112.2 151.01 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.657 1.183 . . . . 0.0 109.39 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.487 ' HB2' HG22 ' A' ' 183' ' ' ILE . 16.6 pt20 -94.66 123.45 38.1 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.061 0.544 . . . . 0.0 110.568 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.539 ' HE1' ' HB3' ' A' ' 203' ' ' ASP . 87.8 mmm -139.17 135.6 34.19 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -88.11 176.46 7.27 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 14.0 t -64.96 -39.81 94.05 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.074 0.397 . . . . 0.0 111.188 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -50.97 -29.12 11.41 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.68 0.792 . . . . 0.0 112.388 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.539 ' HB3' ' HE1' ' A' ' 199' ' ' MET . 20.3 m-20 -92.92 -39.17 11.3 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.738 0.815 . . . . 0.0 111.34 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.414 HG12 HG11 ' A' ' 186' ' ' VAL . 27.8 m -98.77 114.84 37.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 CA-C-O 121.991 0.9 . . . . 0.0 110.132 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -110.81 165.91 11.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.673 1.189 . . . . 0.0 108.704 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -78.88 124.82 28.61 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 102.41 0.22 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.548 0.739 . . . . 0.0 110.33 172.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 281' ' ' GLU . . . -68.6 99.36 0.98 Allowed 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.704 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -77.06 75.02 3.63 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.752 0.657 . . . . 0.0 110.223 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 92.5 m -147.34 108.54 4.26 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 28.8 mt -82.86 116.5 27.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.584 HD12 ' HB3' ' A' ' 279' ' ' LYS . 41.5 mm -79.25 120.41 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.516 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -76.96 164.99 25.26 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . 0.493 ' HA ' HD12 ' A' ' 217' ' ' LEU . 90.3 t90 -56.04 -43.65 78.06 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.686 0.794 . . . . 0.0 111.029 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -69.48 -18.61 63.72 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.846 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.63 -19.12 22.21 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.769 0.427 . . . . 0.0 110.086 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 214' ' ' TRP . 88.2 mt -69.05 129.22 39.28 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . 0.453 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 7.9 pt-20 -147.89 160.59 42.62 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.215 1.006 . . . . 0.0 109.573 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 35.0 m -59.4 134.66 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 123.631 0.582 . . . . 0.0 111.958 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.13 -22.26 30.22 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.835 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -74.62 121.47 21.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.201 0.6 . . . . 0.0 110.912 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.63 130.0 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.414 0.686 . . . . 0.0 109.275 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.1 m -140.87 147.21 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.674 1.19 . . . . 0.0 109.584 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 20.8 ptm -98.64 127.93 44.75 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.343 0.657 . . . . 0.0 111.257 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.513 HD11 HG22 ' A' ' 271' ' ' ILE . 2.2 pt? -134.58 155.58 50.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.267 1.027 . . . . 0.0 110.602 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -71.7 106.78 4.23 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -132.68 128.11 36.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.505 0.722 . . . . 0.0 109.964 -169.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -89.44 113.07 55.11 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.95 -5.26 16.73 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.645 2.23 . . . . 0.0 112.582 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.86 -32.34 23.28 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.22 0.608 . . . . 0.0 110.176 171.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -151.52 105.16 2.91 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 123.923 0.889 . . . . 0.0 109.576 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.55 -18.39 63.27 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.27 2.647 . . . . 0.0 113.322 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -84.88 -5.96 59.34 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.049 0.94 . . . . 0.0 110.952 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -126.88 153.35 45.84 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.583 0.753 . . . . 0.0 110.054 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -75.27 162.59 28.3 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.537 0.735 . . . . 0.0 112.002 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -169.47 -124.21 0.72 Allowed Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.11 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -82.84 146.75 28.74 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.89 0.876 . . . . 0.0 109.559 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . 0.435 ' CE2' ' HD2' ' A' ' 296' ' ' ARG . 43.5 m95 -74.92 111.76 10.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.869 0.366 . . . . 0.0 111.673 -175.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -119.12 166.24 13.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.377 1.071 . . . . 0.0 110.193 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . 0.507 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 3.8 m-20 -82.45 158.62 23.17 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.931 0.892 . . . . 0.0 109.512 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -151.51 132.26 14.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.904 0.482 . . . . 0.0 109.774 169.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -95.95 117.28 30.32 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 174.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.571 HD12 HD13 ' A' ' 255' ' ' LEU . 25.3 mm -65.4 124.23 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.649 0.593 . . . . 0.0 109.424 -175.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.0 t -108.29 -43.51 4.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.575 0.75 . . . . 0.0 109.58 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.495 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 63.0 mtt180 -139.34 157.48 45.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.457 1.103 . . . . 0.0 110.0 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -154.37 120.22 5.24 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.06 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 45.7 ttt-85 -144.1 115.68 8.14 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -93.65 133.61 36.81 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.366 0.603 . . . . 0.0 110.0 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 39.2 p -107.97 166.71 10.51 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 167.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -71.33 -10.4 59.69 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.5 p -94.04 -28.71 15.59 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.192 0.597 . . . . 0.0 111.515 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -171.27 145.97 2.26 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -80.46 102.68 9.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.168 0.987 . . . . 0.0 109.482 172.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -95.47 140.16 30.71 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.35 0.66 . . . . 0.0 111.674 -173.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.604 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.6 OUTLIER -132.57 142.4 49.14 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -176.229 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . 0.495 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 92.1 m-85 -132.11 122.55 25.56 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.95 46.23 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.176 0.512 . . . . 0.0 111.778 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 39.9 t30 -78.64 95.58 5.29 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.73 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 59.9 t -76.19 107.17 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.26 0.553 . . . . 0.0 110.313 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 39.4 t -86.12 115.17 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.081 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.23 -152.56 0.12 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.013 1.325 . . . . 0.0 110.208 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -48.25 -65.23 2.63 Favored Glycine 0 C--N 1.363 2.056 0 C-N-CA 124.092 0.853 . . . . 0.0 114.266 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -123.09 -22.41 5.19 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.546 0.738 . . . . 0.0 109.575 165.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -76.17 177.35 7.24 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.166 0.987 . . . . 0.0 112.077 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 35.6 p -153.17 154.41 34.69 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.679 0.792 . . . . 0.0 110.44 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 69.8 mt -128.77 89.71 2.93 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.441 1.096 . . . . 0.0 108.783 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 61.6 t30 -71.87 136.55 46.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.759 0.424 . . . . 0.0 111.431 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 14.6 t70 60.35 68.58 0.75 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.24 1.416 . . . . 0.0 111.078 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 79.9 m -113.72 135.39 53.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.919 0.888 . . . . 0.0 109.553 169.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -66.51 116.7 7.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.926 0.49 . . . . 0.0 110.714 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 43.1 mm -92.49 96.28 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.981 0.912 . . . . 0.0 108.88 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 62.6 mt -76.23 -23.48 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.217 1.007 . . . . 0.0 110.713 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.436 ' HD2' HD12 ' A' ' 225' ' ' LEU . 24.5 m-85 -93.21 32.0 1.39 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.458 1.103 . . . . 0.0 111.214 -166.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.07 -21.45 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.273 1.029 . . . . 0.0 112.003 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.65 -21.72 44.46 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.914 0.886 . . . . 0.0 111.827 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.63 9.42 3.37 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.134 0.574 . . . . 0.0 112.278 -168.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.4 129.16 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 122.985 0.514 . . . . 0.0 110.263 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -92.52 161.33 14.65 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.749 0.82 . . . . 0.0 110.652 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.584 ' HB3' HD12 ' A' ' 212' ' ' ILE . 18.2 ptmt -82.32 158.12 23.54 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.446 0.698 . . . . 0.0 111.087 176.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 42.2 mm -87.65 131.39 35.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 166.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 0.0 OUTLIER -72.44 104.79 3.9 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.427 -175.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.697 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 84.6 mtt180 -87.36 159.49 50.26 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 123.466 0.707 . . . . 0.0 111.125 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -55.25 94.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.426 2.751 . . . . 0.0 113.513 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.38 -46.44 1.24 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.294 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.697 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 21.6 tt0 -73.59 -17.88 61.12 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.3 0.64 . . . . 0.0 111.452 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -74.78 98.9 1.09 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.622 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.1 p -75.32 126.15 88.1 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.403 0.681 . . . . 0.0 111.124 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.24 167.1 26.5 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 123.193 2.595 . . . . 0.0 112.379 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' MET . . . . . 0.576 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 55.1 ttm -86.26 81.39 8.41 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.4 p -96.21 -28.55 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.35 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -81.88 -172.71 4.06 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.373 1.069 . . . . 0.0 109.143 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -45.14 117.42 3.31 Favored Pre-proline 0 N--CA 1.489 1.49 0 C-N-CA 124.912 1.285 . . . . 0.0 112.742 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.576 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 64.9 Cg_exo -55.96 141.75 85.76 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.656 2.238 . . . . 0.0 113.36 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 24.5 mmt -84.06 -69.57 0.63 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 49.47 62.32 2.69 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 122.006 0.908 . . . . 0.0 109.15 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.485 ' NH1' ' HG3' ' A' ' 153' ' ' GLU . 12.5 ptt180 -58.48 -29.16 66.02 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.092 -166.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 190' ' ' ASP . 38.6 mtmm 54.1 58.04 5.38 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.952 0.901 . . . . 0.0 111.974 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' SER . . . . . 0.432 ' HG ' ' HG3' ' A' ' 296' ' ' ARG . 6.6 m . . . . . 0 CA--C 1.538 0.508 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.037 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.379 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.19 2.72 8.56 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.674 0.79 . . . . 0.0 110.808 173.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -127.54 137.6 52.66 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.455 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 2.1 mptp? -89.65 175.25 7.34 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.535 1.134 . . . . 0.0 110.256 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.7 m -75.9 8.07 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.035 0.934 . . . . 0.0 112.811 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -124.96 -1.17 7.83 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.622 0.769 . . . . 0.0 110.236 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.455 ' HG2' ' HB2' ' A' ' 136' ' ' LYS . 22.3 mm-40 -91.21 89.98 7.57 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.677 0.751 . . . . 0.0 111.652 -170.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 6.8 p90 -63.48 111.5 2.36 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.346 164.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.2 m -120.89 166.69 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.189 0.995 . . . . 0.0 109.32 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -93.05 104.95 17.12 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.442 ' HB3' HG11 ' A' ' 204' ' ' VAL . . . -109.65 117.56 34.25 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.753 1.221 . . . . 0.0 109.93 -176.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -73.93 112.74 10.35 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.79 127.49 32.68 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.6 m -69.58 -27.8 65.43 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.845 0.858 . . . . 0.0 111.38 -173.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.47 -44.12 13.0 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.459 0.704 . . . . 0.0 110.968 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 51.0 tpp -75.71 -37.62 59.31 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.75 0.82 . . . . 0.0 110.611 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.3 7.79 88.2 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.133 -0.939 . . . . 0.0 113.215 -172.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -107.03 152.54 23.85 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.607 0.763 . . . . 0.0 110.858 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 238' ' ' TRP . 67.2 m95 -77.65 132.29 38.15 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.496 1.118 . . . . 0.0 109.919 171.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -136.54 130.97 33.23 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.235 1.014 . . . . 0.0 108.702 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.35 96.78 0.51 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.598 0.713 . . . . 0.0 109.218 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.72 128.15 45.83 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.928 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.648 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 56.7 tt0 -84.91 105.69 15.87 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.743 0.817 . . . . 0.0 110.647 -173.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.71 107.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.6 m -107.64 -3.13 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.651 0.781 . . . . 0.0 111.234 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.519 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 79.2 ttt180 -171.28 146.44 2.33 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.157 0.911 . . . . 0.0 108.986 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.0 m -125.78 144.39 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.4 p -131.85 130.44 41.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -73.32 147.99 43.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.668 0.787 . . . . 0.0 109.407 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 61.1 mttm . . . . . 0 N--CA 1.496 1.859 0 C-N-CA 123.179 0.592 . . . . 0.0 111.402 -176.409 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 201' ' ' SER . 1.0 OUTLIER -80.75 67.89 6.79 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.404 1.097 . . . . 0.0 110.67 -178.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.501 ' HA ' ' H ' ' A' ' 201' ' ' SER . 67.9 m-20 -82.89 44.74 0.94 Allowed 'General case' 0 C--O 1.243 0.727 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.537 174.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.1 m -69.58 176.49 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.881 0 C-N-CA 124.472 1.109 . . . . 0.0 108.507 174.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 183' ' ' ILE . 2.6 mp -92.35 106.37 17.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -172.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -89.01 104.03 16.6 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 7.0 m170 -79.7 92.84 5.44 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.31 158.17 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.609 0.764 . . . . 0.0 110.615 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -123.98 119.49 29.71 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -57.83 125.83 24.74 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.74 -31.37 72.52 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.271 0.558 . . . . 0.0 109.974 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.46 -28.94 62.22 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.247 175.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -139.32 71.89 38.84 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.14 0.576 . . . . 0.0 112.022 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.05 -15.86 28.99 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.527 2.151 . . . . 0.0 111.184 165.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.33 -22.89 66.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.315 1.046 . . . . 0.0 111.587 173.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -78.77 -5.37 53.14 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.791 0.836 . . . . 0.0 111.356 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.4 -161.95 53.13 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.555 0.534 . . . . 0.0 111.817 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 25.5 t -86.53 124.09 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 29.2 m -107.49 154.58 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.928 0.891 . . . . 0.0 110.09 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -92.93 131.16 38.18 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.542 0.737 . . . . 0.0 109.472 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.502 ' HE1' ' HB3' ' A' ' 203' ' ' ASP . 92.9 mmm -131.88 153.58 50.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.514 0.726 . . . . 0.0 109.299 177.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . 0.529 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 36.9 m-80 -98.96 172.21 7.55 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.574 0.75 . . . . 0.0 109.163 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.501 ' H ' ' HA ' ' A' ' 181' ' ' ASP . 10.9 t -67.64 -29.34 68.63 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.139 0.427 . . . . 0.0 110.84 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.529 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 17.2 ptp180 -62.19 -25.56 67.85 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.474 0.71 . . . . 0.0 111.638 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.502 ' HB3' ' HE1' ' A' ' 199' ' ' MET . 21.9 m-20 -92.23 -39.87 11.3 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.87 0.868 . . . . 0.0 111.0 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.484 HG22 ' HA ' ' A' ' 201' ' ' SER . 26.8 m -93.85 117.35 37.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 CA-C-O 122.462 1.125 . . . . 0.0 109.292 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 170.82 7.67 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.906 174.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.82 148.78 27.56 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 167.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -72.37 109.91 6.42 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.38 113.75 3.84 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.83 0.452 . . . . 0.0 110.638 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 289' ' ' MET . 5.8 ptm180 -82.09 9.36 8.66 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.007 0.923 . . . . 0.0 112.23 -177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.9 m -100.91 112.32 24.73 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.028 0.931 . . . . 0.0 110.088 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.1 mt -85.54 130.75 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.523 HD11 ' HB2' ' A' ' 279' ' ' LYS . 30.1 mm -96.77 148.08 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.504 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 1.5 ptpp? -129.52 171.22 12.8 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.97 0.908 . . . . 0.0 109.96 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . 0.416 ' HE3' ' HB ' ' A' ' 274' ' ' VAL . 72.1 t-105 -53.78 -44.83 70.4 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.535 1.134 . . . . 0.0 112.103 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -71.24 -11.28 60.84 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.668 0.787 . . . . 0.0 112.442 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -109.33 -7.96 15.15 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.221 1.008 . . . . 0.0 110.704 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 213' ' ' LYS . 92.2 mt -72.17 124.11 24.33 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -134.03 146.73 50.64 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 31.6 m -67.44 126.89 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 123.54 0.525 . . . . 0.0 111.322 -174.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 106.1 -16.86 41.99 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.681 -0.511 . . . . 0.0 113.011 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.419 ' HG2' HG12 ' A' ' 223' ' ' VAL . 8.6 tt0 -80.4 122.24 26.72 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.21 0.604 . . . . 0.0 110.472 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 50.8 t -91.39 129.78 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.962 0.905 . . . . 0.0 108.935 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.419 HG12 ' HG2' ' A' ' 221' ' ' GLN . 2.8 m -145.73 149.65 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.676 1.19 . . . . 0.0 110.586 -172.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.495 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 20.0 ptm -100.34 125.51 46.58 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.643 0.777 . . . . 0.0 111.357 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.431 ' HG ' HG12 ' A' ' 277' ' ' VAL . 1.4 mp -127.11 158.7 36.32 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.971 0.908 . . . . 0.0 108.798 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -89.66 106.12 18.25 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.363 0.601 . . . . 0.0 110.232 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -167.4 148.09 5.45 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.749 1.22 . . . . 0.0 108.602 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -90.76 144.82 30.91 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.414 ' HB3' HD23 ' A' ' 261' ' ' LEU . 33.9 Cg_endo -62.29 -37.17 63.4 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.137 2.558 . . . . 0.0 112.373 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -71.03 -19.41 62.51 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.012 0.925 . . . . 0.0 111.721 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -144.23 82.97 10.38 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 122.746 0.419 . . . . 0.0 110.104 174.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.06 -4.48 15.49 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.534 2.156 . . . . 0.0 112.833 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -72.73 -27.51 62.09 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.106 0.963 . . . . 0.0 110.958 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -138.38 161.6 36.55 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.46 0.704 . . . . 0.0 110.376 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -52.81 156.34 2.02 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.575 1.55 . . . . 0.0 112.711 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -161.98 -93.42 0.09 OUTLIER Glycine 0 C--N 1.335 0.515 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.644 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -129.08 167.78 17.03 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.596 0.758 . . . . 0.0 109.354 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 89.9 m95 -79.4 105.75 10.94 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -121.65 154.74 36.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.092 0.957 . . . . 0.0 109.726 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . 0.727 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 0.8 OUTLIER -82.07 154.12 25.76 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.555 -177.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -152.19 134.23 14.97 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -100.11 118.45 36.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 26.5 mm -59.09 110.01 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.9 m -100.25 -25.77 14.14 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.235 0.614 . . . . 0.0 110.352 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 59.8 ttt180 -172.02 149.95 2.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.174 0.99 . . . . 0.0 108.642 -174.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -154.85 147.95 24.77 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -148.49 119.06 7.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.709 0.804 . . . . 0.0 108.873 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -96.89 124.53 40.89 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 54.1 p -124.62 162.61 23.74 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 167.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -60.69 -18.58 54.9 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.693 0.797 . . . . 0.0 112.612 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 53.6 p -93.85 -32.92 13.74 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.45 0.7 . . . . 0.0 112.151 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -174.08 164.54 4.11 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.298 0.57 . . . . 0.0 111.225 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -107.47 114.91 29.22 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.388 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -94.78 97.44 10.05 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 270' ' ' ARG . 1.7 tt -102.83 125.58 49.63 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . 0.482 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 43.4 m-85 -118.46 116.98 27.8 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -136.92 143.56 42.98 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.237 0.615 . . . . 0.0 111.095 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -78.13 99.37 6.15 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 94.9 t -64.93 106.64 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.494 0.718 . . . . 0.0 109.37 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.727 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 58.6 t -87.52 98.89 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' A' ' 229' ' ' PRO . 31.9 mt -84.14 -177.94 6.8 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.416 176.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -76.65 -45.05 13.94 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.387 -0.37 . . . . 0.0 112.612 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -107.52 -5.47 17.57 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.959 0.904 . . . . 0.0 111.726 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -155.46 176.12 13.01 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.49 0.716 . . . . 0.0 110.25 -172.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 27.7 p -145.63 115.86 7.49 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.478 0.711 . . . . 0.0 110.404 171.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 66.1 mt -82.53 95.05 7.61 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.688 0.795 . . . . 0.0 109.911 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -70.93 136.28 48.44 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.346 0.258 . . . . 0.0 110.689 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 14.6 t70 60.08 75.7 0.39 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.957 1.303 . . . . 0.0 111.347 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 42.9 t -111.6 129.2 56.15 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.917 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 71.4 ttt-85 -74.73 107.88 7.12 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.422 ' HB ' HD12 ' A' ' 255' ' ' LEU . 43.2 mm -90.81 128.3 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.773 0.829 . . . . 0.0 109.572 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 67.2 mt -96.12 -21.33 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.194 0.998 . . . . 0.0 110.694 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -86.44 45.13 1.21 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.207 1.003 . . . . 0.0 111.471 -173.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . 0.496 HG11 HD13 ' A' ' 255' ' ' LEU . 24.7 m -64.74 -21.84 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 125.11 1.364 . . . . 0.0 113.437 -169.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -110.87 -24.87 10.17 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.157 0.983 . . . . 0.0 110.115 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -89.0 44.26 1.2 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.879 0.872 . . . . 0.0 110.2 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.431 HG12 ' HG ' ' A' ' 225' ' ' LEU . 4.1 t -103.14 150.19 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.026 0.93 . . . . 0.0 109.279 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.495 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 72.9 m-85 -124.91 154.85 40.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 167.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.523 ' HB2' HD11 ' A' ' 212' ' ' ILE . 22.9 ttmm -77.42 144.85 37.54 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 45.9 mm -69.88 127.16 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.96 105.5 2.03 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 174.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -115.03 147.66 38.84 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 124.574 1.15 . . . . 0.0 109.888 -171.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.79 102.03 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.588 2.192 . . . . 0.0 111.407 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.51 -4.58 54.31 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-O 119.109 -0.828 . . . . 0.0 114.364 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -128.27 -25.14 3.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.157 0.979 . . . . 0.0 112.426 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -75.13 112.14 3.56 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.8 m -64.75 131.44 95.15 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 117.091 0.445 . . . . 0.0 111.186 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.68 135.41 19.69 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.306 2.67 . . . . 0.0 111.341 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' MET . . . . . 0.52 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 38.5 ttm -78.97 82.3 5.16 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.836 0.826 . . . . 0.0 109.767 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.2 p -108.68 -23.12 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.293 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -99.52 -153.84 0.45 Allowed 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -57.5 127.16 77.14 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-N 119.116 0.871 . . . . 0.0 111.87 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.52 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 12.0 Cg_exo -72.57 111.9 3.34 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.373 2.715 . . . . 0.0 113.673 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 91.7 mmm -77.14 115.96 17.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.143 0.577 . . . . 0.0 110.207 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -100.01 171.7 7.67 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.309 1.044 . . . . 0.0 109.158 171.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.65 -29.06 2.67 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.687 0.795 . . . . 0.0 108.936 164.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -169.64 121.61 0.71 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.777 1.231 . . . . 0.0 109.013 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.544 0.716 0 C-N-CA 123.688 0.795 . . . . 0.0 109.255 178.816 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.226 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.81 -13.31 31.67 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.848 0.859 . . . . 0.0 111.207 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.4 ' O ' HG11 ' A' ' 159' ' ' VAL . 25.6 m-85 -94.91 162.64 13.66 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.548 0.739 . . . . 0.0 109.542 171.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.468 ' HB2' ' HZ1' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -124.75 -177.41 3.82 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.04 0.936 . . . . 0.0 109.043 171.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.5 m -68.22 2.47 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -173.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -112.94 -9.97 13.57 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.637 0.775 . . . . 0.0 111.377 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.87 84.87 3.44 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.459 0.703 . . . . 0.0 111.562 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 3.9 p90 -71.93 99.61 2.27 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.079 168.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.98 -178.97 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.476 1.11 . . . . 0.0 109.13 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 5.3 t0 -94.75 163.21 13.45 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.651 0.78 . . . . 0.0 108.922 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.07 125.35 8.74 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 120.872 0.368 . . . . 0.0 111.833 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -74.83 109.73 8.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.786 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.488 ' HB3' ' SD ' ' A' ' 148' ' ' MET . 9.2 t70 -80.01 117.99 21.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.8 m -66.86 -28.49 68.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.839 0.856 . . . . 0.0 112.333 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -58.05 -54.74 43.49 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.6 0.76 . . . . 0.0 111.948 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.488 ' SD ' ' HB3' ' A' ' 145' ' ' ASP . 1.7 pmm? -103.35 -8.86 19.93 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.575 0.35 . . . . 0.0 111.006 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.12 18.27 80.14 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 123.215 0.322 . . . . 0.0 113.518 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.413 ' HB1' ' CE2' ' A' ' 239' ' ' TYR . . . -93.29 150.14 20.7 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.45 0.643 . . . . 0.0 111.899 -175.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -76.11 139.0 41.14 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.468 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -145.52 124.35 12.67 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 45.4 mt-10 -65.78 93.94 0.19 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.444 0.698 . . . . 0.0 110.993 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.44 120.06 39.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.095 0.558 . . . . 0.0 110.894 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.656 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 53.4 tt0 -87.39 114.56 24.12 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.833 0.853 . . . . 0.0 110.664 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.413 ' HA ' HG13 ' A' ' 186' ' ' VAL . 50.1 t -59.88 114.74 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.1 m -115.35 -4.41 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.372 0.669 . . . . 0.0 111.264 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.519 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 76.7 ttt180 -164.56 138.86 5.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.836 0.854 . . . . 0.0 109.564 173.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 135' ' ' TYR . 34.4 m -117.19 137.64 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.511 0.724 . . . . 0.0 109.554 173.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.4 m -145.69 137.86 25.49 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.907 0.883 . . . . 0.0 108.857 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.95 135.11 36.33 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.612 ' HB2' HG13 ' A' ' 183' ' ' ILE . 55.3 tttm . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 124.158 0.983 . . . . 0.0 111.132 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 C--O 1.238 0.486 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.24 87.81 0.82 Allowed 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.979 0.895 . . . . 0.0 110.82 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.4 ' HA ' ' HB3' ' A' ' 200' ' ' ASN . 15.3 t70 -80.51 73.13 7.44 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.145 176.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 18.0 m -125.73 172.59 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.338 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.612 HG13 ' HB2' ' A' ' 162' ' ' LYS . 97.5 mt -94.86 110.13 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.619 0.768 . . . . 0.0 110.045 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -103.1 106.93 17.55 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 43.3 m-70 -77.31 92.47 3.91 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.466 HG11 HG11 ' A' ' 204' ' ' VAL . 35.0 m -108.38 151.02 10.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.336 -175.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.449 ' HD3' HG23 ' A' ' 196' ' ' VAL . 31.6 mmmt -110.92 113.12 25.45 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.217 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -57.43 105.6 0.26 Allowed 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 168.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.7 -24.02 64.45 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.211 0.529 . . . . 0.0 109.814 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -68.91 -31.86 71.07 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.201 1.0 . . . . 0.0 110.733 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -143.8 67.45 15.83 Favored Pre-proline 0 N--CA 1.487 1.381 0 C-N-CA 124.12 0.968 . . . . 0.0 110.667 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.3 -15.82 28.2 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.211 1.94 . . . . 0.0 113.177 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.36 -17.1 61.86 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.483 0.713 . . . . 0.0 111.024 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -87.63 25.17 1.53 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.119 0.967 . . . . 0.0 111.893 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 83.13 174.81 50.65 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.175 0.297 . . . . 0.0 113.84 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.449 HG23 ' HD3' ' A' ' 187' ' ' LYS . 3.1 t -92.2 118.32 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 172.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.32 143.62 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 122.903 0.481 . . . . 0.0 110.019 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.575 ' HB2' HG21 ' A' ' 183' ' ' ILE . 15.3 pt20 -106.92 114.36 28.41 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.31 0.576 . . . . 0.0 110.128 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.547 ' HE1' ' HB3' ' A' ' 203' ' ' ASP . 55.4 mtp -125.66 162.95 23.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.002 0.921 . . . . 0.0 109.701 -172.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . 0.442 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 6.7 m-80 -98.98 170.02 9.02 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.221 0.609 . . . . 0.0 109.55 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 50.9 m -56.42 -39.59 73.29 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.135 0.574 . . . . 0.0 111.634 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.442 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 34.1 ptt180 -54.66 -34.95 62.98 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.204 1.002 . . . . 0.0 112.222 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.547 ' HB3' ' HE1' ' A' ' 199' ' ' MET . 23.5 m-20 -86.82 -45.07 11.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.753 0.821 . . . . 0.0 110.534 -174.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.466 HG11 HG11 ' A' ' 186' ' ' VAL . 13.6 m -96.11 115.08 34.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 CA-C-O 121.797 0.808 . . . . 0.0 109.811 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -118.43 129.23 55.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.786 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.09 126.61 29.73 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -66.03 107.34 1.86 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.268 0.485 . . . . 0.0 111.789 -172.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.61 107.47 0.51 Allowed 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.175 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.433 ' HG2' ' HG3' ' A' ' 294' ' ' MET . 0.1 OUTLIER -75.28 81.04 2.38 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -173.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.5 m -145.54 108.44 4.53 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 54.0 mt -85.19 119.27 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.506 ' HB ' HG13 ' A' ' 277' ' ' VAL . 31.7 mm -91.45 152.86 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 123.911 0.884 . . . . 0.0 109.363 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -127.45 171.68 11.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.578 0.351 . . . . 0.0 110.681 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -48.93 -42.85 38.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.239 1.416 . . . . 0.0 111.874 -177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -62.06 -39.14 91.38 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.044 0.937 . . . . 0.0 111.93 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.42 ' HB2' HG21 ' A' ' 212' ' ' ILE . 61.2 m-20 -77.64 -22.31 50.89 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.077 0.551 . . . . 0.0 110.749 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.488 HD13 HG12 ' A' ' 277' ' ' VAL . 94.8 mt -72.41 109.98 6.49 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -114.14 154.14 28.32 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.161 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 32.0 m -67.97 130.35 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-O 120.754 0.312 . . . . 0.0 111.065 -175.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.05 -6.96 64.34 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.412 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.43 ' NE2' ' HA ' ' A' ' 217' ' ' LEU . 28.4 tt0 -88.55 121.22 30.69 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.236 0.615 . . . . 0.0 111.161 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.5 t -91.83 127.66 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.022 0.929 . . . . 0.0 109.3 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 280' ' ' ILE . 3.5 m -142.77 151.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.974 1.31 . . . . 0.0 110.298 -172.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.471 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 16.1 ptm -101.06 128.14 47.26 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.932 0.493 . . . . 0.0 111.378 -177.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.56 ' HB3' HG23 ' A' ' 277' ' ' VAL . 2.3 pt? -145.72 174.72 10.96 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.273 1.029 . . . . 0.0 110.393 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.493 ' HB3' ' CZ3' ' A' ' 238' ' ' TRP . 8.1 p30 -79.03 131.22 36.2 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 167.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -168.91 142.43 2.92 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.462 HD22 ' HB3' ' A' ' 231' ' ' ASN . 6.0 p-10 -136.64 133.56 19.09 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.305 0.642 . . . . 0.0 109.959 172.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.12 -20.92 67.94 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.365 2.043 . . . . 0.0 112.303 170.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.45 -47.74 84.32 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.513 0.725 . . . . 0.0 110.824 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.462 ' HB3' HD22 ' A' ' 228' ' ' ASN . 53.2 t30 -145.35 82.21 9.85 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.668 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.9 -16.51 54.37 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.078 2.519 . . . . 0.0 112.958 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -76.47 -27.7 56.24 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.581 0.753 . . . . 0.0 111.843 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -121.95 165.71 15.55 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.706 0.402 . . . . 0.0 110.389 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -60.58 131.19 49.96 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.929 1.292 . . . . 0.0 112.0 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -127.2 -139.24 4.9 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.088 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -82.23 159.96 23.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.12 0.568 . . . . 0.0 109.912 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . 0.493 ' CZ3' ' HB3' ' A' ' 226' ' ' ASN . 22.9 m95 -82.93 100.4 10.38 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.413 ' CE2' ' HB1' ' A' ' 150' ' ' ALA . 40.8 m-85 -114.87 163.04 16.09 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.834 0.854 . . . . 0.0 111.032 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.35 148.83 27.1 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.512 171.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -147.46 134.7 20.57 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.583 0.753 . . . . 0.0 109.154 172.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.15 119.09 34.99 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.455 HD13 HD23 ' A' ' 255' ' ' LEU . 26.6 mm -61.9 107.92 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.0 t -79.62 -50.68 10.31 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.394 0.616 . . . . 0.0 109.801 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.493 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 20.3 mtp180 -151.36 163.24 39.39 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.726 1.61 . . . . 0.0 108.09 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -155.83 143.15 19.3 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.987 0.358 . . . . 0.0 111.025 166.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -149.92 128.23 12.12 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.204 1.002 . . . . 0.0 109.03 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -100.83 125.33 47.33 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 31.4 p -96.02 -175.13 3.3 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 170.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -76.75 -23.09 53.0 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 120.679 0.276 . . . . 0.0 110.849 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 22.8 p -97.76 -29.24 13.48 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.393 0.677 . . . . 0.0 112.7 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -167.39 146.05 4.91 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.773 0.429 . . . . 0.0 111.955 -173.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -90.43 102.02 14.75 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -92.37 99.2 12.0 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.455 HD23 HD13 ' A' ' 243' ' ' ILE . 9.4 tt -100.47 131.39 46.41 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 174.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . 0.493 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 65.0 m-85 -106.51 127.05 53.01 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.253 1.021 . . . . 0.0 108.308 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -142.79 141.16 31.62 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.939 0.336 . . . . 0.0 111.009 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -79.75 96.62 6.32 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 39.7 t -77.54 102.8 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 13.8 m -92.11 111.03 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.655 0.74 . . . . 0.0 110.065 -171.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 264' ' ' ASP . 12.4 mt -87.48 -165.78 1.4 Allowed 'General case' 0 CA--C 1.557 1.237 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.857 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.06 -35.29 88.85 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 122.395 -0.19 . . . . 0.0 113.34 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -123.2 -51.76 1.87 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.097 0.959 . . . . 0.0 109.482 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.555 ' HB2' HD11 ' A' ' 261' ' ' LEU . 4.7 m-20 -76.26 164.43 26.06 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.317 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 55.9 m -143.46 136.97 28.24 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.648 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 73.7 mt -113.7 82.07 1.63 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.754 0.822 . . . . 0.0 109.394 -171.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.1 125.63 26.11 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.847 0.859 . . . . 0.0 112.737 -170.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 61.46 26.94 16.6 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.855 1.262 . . . . 0.0 112.896 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 96.5 m -68.31 128.18 35.64 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 122.698 0.399 . . . . 0.0 110.061 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 52.3 ttp180 -69.77 111.44 5.53 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 121.645 0.736 . . . . 0.0 110.532 -174.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.47 HD12 HD11 ' A' ' 225' ' ' LEU . 48.7 mm -82.29 123.88 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.427 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 49.9 mt -90.51 -27.37 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.076 0.951 . . . . 0.0 109.243 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -96.15 36.71 1.3 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.032 1.333 . . . . 0.0 110.06 -166.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 29.0 m -65.82 -20.57 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.794 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -95.27 -27.51 15.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.056 0.943 . . . . 0.0 110.617 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -91.59 4.26 53.06 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.743 0.817 . . . . 0.0 111.807 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.56 HG23 ' HB3' ' A' ' 225' ' ' LEU . 13.3 p -78.92 154.81 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 C-N-CA 123.238 0.615 . . . . 0.0 110.499 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.471 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 54.6 m-85 -128.89 161.07 30.7 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.502 1.121 . . . . 0.0 110.45 -173.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -73.93 140.54 45.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.128 0.971 . . . . 0.0 111.081 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.465 HG12 ' HA ' ' A' ' 223' ' ' VAL . 31.3 mm -77.12 122.3 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.817 0.847 . . . . 0.0 109.421 169.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.94 119.78 28.63 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 97.5 mtt180 -101.73 127.52 31.05 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.271 1.028 . . . . 0.0 109.817 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -37.36 131.91 0.59 Allowed 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 123.746 2.964 . . . . 0.0 114.326 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 105.27 -46.67 1.14 Allowed Glycine 0 C--N 1.341 0.823 0 CA-C-O 119.937 -0.368 . . . . 0.0 112.716 -171.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 9.5 pt-20 -84.69 -9.25 58.41 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 117.562 0.681 . . . . 0.0 110.793 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -35.82 83.62 0.0 OUTLIER Glycine 0 C--N 1.351 1.377 0 N-CA-C 117.558 1.783 . . . . 0.0 117.558 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 2.6 m -92.62 138.07 23.98 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 171.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.62 177.67 5.25 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.87 2.38 . . . . 0.0 111.476 -175.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' MET . . . . . 0.551 ' HA ' ' HE3' ' A' ' 289' ' ' MET . 2.8 tpt -75.1 80.91 2.26 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.92 -37.18 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.082 -173.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.04 179.0 6.5 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -43.82 123.83 3.96 Favored Pre-proline 0 CA--C 1.561 1.388 0 C-N-CA 125.159 1.384 . . . . 0.0 113.319 -168.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.11 109.25 0.25 Allowed 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 123.949 3.099 . . . . 0.0 114.479 -173.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' MET . . . . . 0.433 ' HG3' ' HG2' ' A' ' 209' ' ' ARG . 90.2 mtp -74.17 104.0 4.81 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 168.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.72 81.24 1.96 Allowed 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -74.88 -71.34 0.36 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.422 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? 57.26 115.62 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.224 1.81 . . . . 0.0 112.368 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 124.233 1.013 . . . . 0.0 109.193 172.621 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.065 0 N-CA-C 112.222 -0.351 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.85 0.1 37.93 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.212 0.605 . . . . 0.0 111.668 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -115.86 160.95 19.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.853 0.861 . . . . 0.0 108.782 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.12 -178.24 4.24 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.745 0.818 . . . . 0.0 110.115 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 157' ' ' VAL . 13.0 m -55.35 -19.23 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 124.683 1.193 . . . . 0.0 113.869 -175.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -94.86 -31.37 13.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.132 0.973 . . . . 0.0 111.413 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.55 105.97 5.92 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.69 0.757 . . . . 0.0 111.652 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.562 ' HD1' ' HD3' ' A' ' 207' ' ' ARG . 15.3 t80 -70.32 138.11 51.21 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.547 164.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 28.7 m -127.9 179.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.559 1.144 . . . . 0.0 111.311 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -119.46 108.17 14.22 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.51 118.58 33.57 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.59 0.756 . . . . 0.0 110.11 -169.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -69.44 133.27 47.54 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -68.02 127.49 33.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -67.29 -26.61 66.62 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 123.845 0.716 . . . . 0.0 111.602 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -80.36 -52.87 7.18 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.994 0.518 . . . . 0.0 111.095 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 43.0 ttm -83.18 -24.67 32.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.353 0.661 . . . . 0.0 111.05 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.42 -15.92 32.51 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.474 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.449 ' HB3' ' CE2' ' A' ' 239' ' ' TYR . . . -73.68 153.54 40.05 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.98 0.912 . . . . 0.0 111.305 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 238' ' ' TRP . 40.7 m95 -73.74 136.14 43.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -140.27 110.57 6.63 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.4 ' HG3' ' NH2' ' A' ' 296' ' ' ARG . 19.4 mt-10 -48.3 137.92 10.48 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.89 0.876 . . . . 0.0 109.908 172.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.12 154.48 32.42 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.086 0.554 . . . . 0.0 110.613 -169.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -105.18 119.66 39.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.843 0.457 . . . . 0.0 110.041 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.6 t -68.25 114.23 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 168.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.451 ' O ' HG11 ' A' ' 137' ' ' VAL . 24.6 m -107.52 -10.36 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.157 0.583 . . . . 0.0 111.113 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -171.51 146.3 2.2 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.536 0.523 . . . . 0.0 110.892 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.59 133.4 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.433 0.693 . . . . 0.0 109.661 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.4 p -142.14 166.39 24.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.93 1.292 . . . . 0.0 108.621 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -119.44 155.19 32.5 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt . . . . . 0 N--CA 1.5 2.047 0 C-N-CA 123.813 0.845 . . . . 0.0 110.396 178.688 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.714 ' HB3' HG21 ' A' ' 182' ' ' VAL . 3.8 mp0 -70.01 101.02 1.7 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.568 -166.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -83.99 16.18 3.0 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.155 164.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.714 HG21 ' HB3' ' A' ' 180' ' ' GLU . 15.3 m -72.5 166.92 2.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-O 121.394 0.616 . . . . 0.0 110.411 172.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.494 HG22 ' HB2' ' A' ' 198' ' ' GLN . 2.5 mp -95.44 115.87 35.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.178 -172.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -97.52 104.54 16.58 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -79.11 94.66 5.39 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.53 151.06 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.49 ' HG2' HG21 ' A' ' 196' ' ' VAL . 43.2 mtmt -106.37 118.79 37.57 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 170.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -56.53 116.01 2.85 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.35 -36.84 66.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.753 0.821 . . . . 0.0 110.312 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -72.29 -32.07 66.27 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.808 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.536 ' HB3' ' ND2' ' A' ' 194' ' ' ASN . 68.0 m-85 -140.04 61.0 16.35 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 123.58 0.752 . . . . 0.0 111.744 -173.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.59 -20.02 9.65 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.033 1.822 . . . . 0.0 112.905 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.04 -20.21 66.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.933 0.893 . . . . 0.0 111.723 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.536 ' ND2' ' HB3' ' A' ' 191' ' ' TYR . 29.1 m-80 -81.51 -20.17 40.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.64 0.776 . . . . 0.0 111.155 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 110.42 -179.36 20.3 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 116.521 -0.309 . . . . 0.0 113.068 174.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.49 HG21 ' HG2' ' A' ' 187' ' ' LYS . 20.3 t -79.63 122.77 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.857 0.863 . . . . 0.0 109.433 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 33.9 m -104.73 144.13 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.637 0.775 . . . . 0.0 110.634 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.494 ' HB2' HG22 ' A' ' 183' ' ' ILE . 8.7 pt20 -99.62 121.79 41.71 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.631 0.772 . . . . 0.0 110.327 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.433 ' HE3' ' HB3' ' A' ' 203' ' ' ASP . 67.4 mmm -120.11 170.14 9.58 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.547 1.139 . . . . 0.0 110.554 -169.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -105.86 176.61 5.11 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.707 0.803 . . . . 0.0 109.66 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.709 ' HB3' ' HB2' ' A' ' 180' ' ' GLU . 61.1 p -59.64 -42.81 93.59 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.031 0.932 . . . . 0.0 110.999 174.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? -70.11 -5.12 24.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.958 0.903 . . . . 0.0 113.283 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.433 ' HB3' ' HE3' ' A' ' 199' ' ' MET . 53.9 m-20 -105.36 -34.91 7.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.811 0.444 . . . . 0.0 111.351 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.49 126.98 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.735 0.778 . . . . 0.0 110.312 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.454 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 2.1 mpt_? -120.26 172.24 7.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.502 1.121 . . . . 0.0 109.09 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.63 167.24 18.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.999 0.428 . . . . 0.0 109.903 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.562 ' HD3' ' HD1' ' A' ' 140' ' ' TYR . 77.6 mtm180 -78.65 90.24 4.57 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.614 0.766 . . . . 0.0 110.419 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.75 96.59 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.536 0.684 . . . . 0.0 109.545 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.525 ' HG2' ' HE3' ' A' ' 294' ' ' MET . 0.0 OUTLIER -80.65 -1.78 43.81 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.061 1.344 . . . . 0.0 111.344 -174.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 44.9 m -84.19 112.79 20.59 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 121.681 -0.637 . . . . 0.0 109.339 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.432 HD11 ' SD ' ' A' ' 294' ' ' MET . 41.4 mt -82.21 123.32 38.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 175.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.611 HG21 ' HB2' ' A' ' 216' ' ' ASP . 49.1 mm -97.27 128.09 48.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.364 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.52 176.92 4.94 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . 0.435 ' HA ' HD21 ' A' ' 217' ' ' LEU . 69.7 t90 -46.94 -41.63 16.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.578 0.751 . . . . 0.0 111.553 -170.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -53.67 -43.03 68.52 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.002 1.321 . . . . 0.0 111.913 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.611 ' HB2' HG21 ' A' ' 212' ' ' ILE . 20.0 m-20 -77.97 -25.86 48.37 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.084 0.953 . . . . 0.0 112.416 -175.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.435 HD21 ' HA ' ' A' ' 214' ' ' TRP . 1.4 mm? -67.7 112.63 4.91 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -115.35 152.2 33.25 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.9 m -67.05 115.76 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-O 121.114 0.483 . . . . 0.0 110.524 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 110.15 -5.09 30.22 Favored Glycine 0 C--N 1.346 1.128 0 C-N-CA 123.412 0.53 . . . . 0.0 112.846 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -86.69 128.72 35.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.614 0.766 . . . . 0.0 110.677 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.63 130.7 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.531 ' HA ' HG12 ' A' ' 280' ' ' ILE . 3.0 m -145.9 164.2 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.98 1.312 . . . . 0.0 109.74 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.641 ' SD ' ' HB3' ' A' ' 238' ' ' TRP . 9.0 tmm? -105.31 129.84 53.56 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.568 ' HG ' HG11 ' A' ' 277' ' ' VAL . 2.1 mp -129.12 160.41 32.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.24 0.616 . . . . 0.0 110.354 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -90.01 108.42 19.71 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.784 0.834 . . . . 0.0 110.899 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.647 ' HE1' ' HB2' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -168.1 158.6 10.43 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.304 1.041 . . . . 0.0 110.413 177.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.551 HD22 ' HB3' ' A' ' 231' ' ' ASN . 6.6 p30 -111.14 148.61 39.06 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -58.28 -33.17 97.4 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.926 2.417 . . . . 0.0 113.115 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.44 -39.95 77.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.425 0.69 . . . . 0.0 111.025 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.551 ' HB3' HD22 ' A' ' 228' ' ' ASN . 41.6 t-20 -128.64 99.49 23.17 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.273 0.629 . . . . 0.0 109.69 -172.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -84.16 -0.0 9.37 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.941 2.427 . . . . 0.0 112.824 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -92.44 -29.27 16.36 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.379 0.672 . . . . 0.0 110.318 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -124.46 152.74 42.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.673 0.789 . . . . 0.0 109.732 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -55.39 170.19 0.25 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.334 1.453 . . . . 0.0 113.699 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 228' ' ' ASN . . . -171.27 -110.79 0.24 Allowed Glycine 0 C--N 1.337 0.631 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.138 174.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.467 ' HB2' ' CE1' ' A' ' 239' ' ' TYR . 17.8 m-85 -91.85 177.51 6.17 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.757 0.823 . . . . 0.0 109.454 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . 0.641 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 6.8 m95 -99.5 106.46 18.48 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.647 ' HB2' ' HE1' ' A' ' 227' ' ' TYR . 90.3 m-85 -121.84 166.89 13.68 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 118.927 0.785 . . . . 0.0 110.993 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . 0.551 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 3.4 m-20 -83.42 160.61 21.55 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.627 1.171 . . . . 0.0 110.329 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -162.51 138.9 7.61 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.07 0.948 . . . . 0.0 110.77 170.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -103.05 120.14 40.12 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.533 HD13 HD11 ' A' ' 255' ' ' LEU . 25.0 mm -63.89 117.47 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.924 0.89 . . . . 0.0 110.937 -171.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 33.3 t -88.24 -53.07 4.88 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.593 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.401 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 95.9 mtt180 -140.6 164.83 29.13 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.282 1.033 . . . . 0.0 109.873 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -155.95 147.89 23.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.493 0.717 . . . . 0.0 110.05 170.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -146.23 116.21 7.34 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.516 0.727 . . . . 0.0 109.599 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.651 ' HG2' ' HG2' ' A' ' 253' ' ' ARG . 6.0 tm-20 -92.85 123.6 36.23 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 30.6 p -133.47 148.45 51.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 168.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -63.81 -10.58 20.91 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.382 0.673 . . . . 0.0 112.801 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 47.2 p -91.73 -28.98 17.07 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.84 0.856 . . . . 0.0 111.058 175.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.84 130.2 0.8 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.301 0.64 . . . . 0.0 111.409 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.651 ' HG2' ' HG2' ' A' ' 248' ' ' GLU . 53.6 mtm180 -83.63 98.55 9.68 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -92.71 150.42 20.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.341 1.056 . . . . 0.0 110.213 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.799 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.5 OUTLIER -145.87 146.41 31.1 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -174.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . 0.401 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 78.9 m-85 -134.06 127.77 32.89 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.206 1.002 . . . . 0.0 108.662 174.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -143.64 141.67 30.68 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.515 0.726 . . . . 0.0 109.805 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -78.64 94.94 5.13 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 92.9 t -67.54 105.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.608 0.567 . . . . 0.0 110.371 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 45.1 t -85.79 99.3 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 30.6 mt -84.99 176.78 8.23 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.365 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -56.78 -36.46 72.48 Favored Glycine 0 N--CA 1.475 1.264 0 N-CA-C 114.349 0.5 . . . . 0.0 114.349 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -123.26 -47.75 2.0 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.707 0.803 . . . . 0.0 109.774 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -80.11 166.35 21.58 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.781 -175.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 30.7 p -146.84 110.3 4.86 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.573 0.749 . . . . 0.0 109.187 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 61.9 mt -87.12 87.39 7.44 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.973 0.909 . . . . 0.0 109.439 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -64.38 139.4 58.76 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.792 0.437 . . . . 0.0 110.763 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.92 29.81 19.36 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.065 0.946 . . . . 0.0 112.199 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.47 ' HB3' HG21 ' A' ' 259' ' ' VAL . 38.3 t -72.96 126.97 31.19 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.76 0.424 . . . . 0.0 110.58 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -63.57 133.41 53.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.105 0.562 . . . . 0.0 110.894 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.799 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 46.9 mm -111.97 124.5 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.404 1.081 . . . . 0.0 109.251 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 41.3 mt -106.02 2.04 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.181 0.992 . . . . 0.0 109.312 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -102.87 29.98 5.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.048 1.339 . . . . 0.0 109.712 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 24.0 m -57.82 -29.46 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -165.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -97.13 -23.72 16.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.283 0.633 . . . . 0.0 111.72 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -81.84 6.5 15.49 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.869 0.868 . . . . 0.0 112.208 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.568 HG11 ' HG ' ' A' ' 225' ' ' LEU . 19.4 t -73.94 148.62 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.325 0.65 . . . . 0.0 109.432 178.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -128.18 160.28 32.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.576 1.151 . . . . 0.0 108.313 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.514 ' HZ3' ' HG2' ' A' ' 285' ' ' GLU . 65.4 tttm -76.16 153.62 36.05 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.105 0.562 . . . . 0.0 111.481 -176.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.531 HG12 ' HA ' ' A' ' 223' ' ' VAL . 46.8 mm -75.6 122.71 30.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 167.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.535 ' HG2' ' HA3' ' A' ' 286' ' ' GLY . 0.1 OUTLIER -84.16 106.11 15.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 165.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -107.81 108.22 61.21 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -11.26 88.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 1 C-N-CA 126.883 5.055 . . . . 0.0 116.687 -158.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 99.69 1.12 56.42 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 115.102 -0.954 . . . . 0.0 114.923 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.514 ' HG2' ' HZ3' ' A' ' 279' ' ' LYS . 23.5 tt0 -93.52 -23.44 18.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.003 0.902 . . . . 0.0 110.801 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . 0.535 ' HA3' ' HG2' ' A' ' 281' ' ' GLU . . . -93.84 -165.94 37.19 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.579 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 38.2 p -117.64 163.98 21.59 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 123.681 0.792 . . . . 0.0 111.438 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -86.62 -154.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.142 2.561 . . . . 0.0 111.308 164.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 23.3 mmt -115.32 80.51 1.44 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 168.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.91 -35.25 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 168.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -84.11 -168.7 2.26 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.479 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -49.89 115.95 5.74 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.499 1.12 . . . . 0.0 111.849 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.525 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 12.4 Cg_exo -70.81 80.89 1.14 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.267 2.645 . . . . 0.0 111.148 175.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' MET . . . . . 0.525 ' HE3' ' HG2' ' A' ' 209' ' ' ARG . 49.3 mtm -63.26 -55.63 23.21 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.589 -172.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 66.6 144.74 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.858 1.263 . . . . 0.0 111.245 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.4 ' NH2' ' HG3' ' A' ' 153' ' ' GLU . 14.2 mtm180 -91.93 -30.95 15.85 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 173.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.436 ' HB2' ' HZ2' ' A' ' 238' ' ' TRP . 77.1 tttt -141.63 153.04 44.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.248 1.019 . . . . 0.0 108.978 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.0 p . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 123.444 0.697 . . . . 0.0 110.535 -176.451 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.87 8.69 9.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.208 0.603 . . . . 0.0 112.317 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -116.1 161.74 18.46 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.258 0.552 . . . . 0.0 110.938 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.12 161.65 15.72 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.994 1.317 . . . . 0.0 109.153 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' A' ' 158' ' ' ARG . 92.1 t -70.17 80.38 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 124.188 0.995 . . . . 0.0 110.058 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.3 m120 175.2 -38.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 126.641 1.976 . . . . 0.0 109.18 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -72.17 91.82 1.31 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -159.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 10.5 p90 -72.49 99.88 2.59 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.917 0.865 . . . . 0.0 109.616 168.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.87 -176.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.937 1.295 . . . . 0.0 109.255 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.416 ' HB3' ' HE3' ' A' ' 151' ' ' TRP . 0.5 OUTLIER -92.18 104.15 16.56 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.392 0.615 . . . . 0.0 110.239 -179.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -95.79 102.28 14.06 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 26.2 ttt180 -72.08 109.7 6.06 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.36 109.39 0.99 Allowed 'General case' 0 C--O 1.217 -0.625 0 O-C-N 124.506 1.129 . . . . 0.0 108.07 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.81 -10.94 59.85 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 124.033 0.833 . . . . 0.0 111.282 -170.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -74.03 -56.01 5.44 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.444 0.698 . . . . 0.0 110.258 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 50.5 ttp -92.53 -37.16 12.64 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.902 0.481 . . . . 0.0 109.955 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.422 ' HA3' ' CA ' ' A' ' 262' ' ' GLY . . . 101.44 20.73 12.7 Favored Glycine 0 N--CA 1.469 0.87 0 CA-C-N 115.45 -0.795 . . . . 0.0 113.518 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -101.79 140.31 36.26 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.085 0.554 . . . . 0.0 110.405 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 76.5 m95 -74.76 134.86 41.78 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.811 0.845 . . . . 0.0 109.581 174.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -135.78 136.36 40.66 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.687 ' HB3' HH12 ' A' ' 207' ' ' ARG . 19.9 pt-20 -68.62 103.76 1.8 Allowed 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -108.64 131.27 55.05 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.681 0.792 . . . . 0.0 110.287 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 60.8 tt0 -87.11 109.09 19.2 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.298 0.639 . . . . 0.0 110.444 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.44 ' HA ' HG13 ' A' ' 186' ' ' VAL . 70.1 t -61.68 103.87 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 124.197 0.936 . . . . 0.0 109.381 171.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.0 m -106.12 -0.37 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.758 0.423 . . . . 0.0 111.613 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.413 ' HA ' HG21 ' A' ' 137' ' ' VAL . 52.4 ttm-85 -172.73 149.92 2.08 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.617 0.573 . . . . 0.0 110.674 169.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.11 142.47 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.754 0.822 . . . . 0.0 108.955 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.448 ' OG1' ' HB ' ' A' ' 183' ' ' ILE . 8.1 p -145.69 161.95 38.68 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.882 1.273 . . . . 0.0 108.907 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -114.88 178.36 4.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.829 0.852 . . . . 0.0 110.78 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 N--CA 1.485 1.322 0 C-N-CA 123.685 0.794 . . . . 0.0 110.417 -179.807 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 CA--C 1.541 0.603 0 CA-C-O 122.3 1.048 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -88.49 67.37 8.54 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.049 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -85.07 40.31 0.81 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 121.889 0.852 . . . . 0.0 109.707 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 34.9 m -88.61 175.93 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.823 0.849 . . . . 0.0 111.085 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.448 ' HB ' ' OG1' ' A' ' 160' ' ' THR . 20.6 mt -96.72 112.35 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.683 0.793 . . . . 0.0 110.594 -168.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -102.05 109.38 21.09 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.418 1.087 . . . . 0.0 108.961 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -79.26 89.38 4.91 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 156' ' ' VAL . 26.7 m -110.58 161.16 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.762 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.497 ' HG2' HG22 ' A' ' 196' ' ' VAL . 32.0 mtmt -124.97 117.75 24.72 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 173.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -57.52 97.03 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -62.73 -23.92 67.41 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.202 1.001 . . . . 0.0 111.593 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 297' ' ' LYS . 19.9 m-20 -63.34 -30.81 71.88 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.715 0.406 . . . . 0.0 111.711 173.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -146.88 78.04 10.8 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 124.14 0.976 . . . . 0.0 108.89 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.15 -21.2 55.88 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.925 2.417 . . . . 0.0 112.563 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -67.14 -8.19 29.12 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.648 1.179 . . . . 0.0 112.788 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -79.33 -12.76 59.93 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.443 0.697 . . . . 0.0 111.333 173.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 93.88 -178.7 37.88 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.713 0.633 . . . . 0.0 112.915 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 187' ' ' LYS . 24.6 t -83.95 116.6 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.55 153.64 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.036 0.934 . . . . 0.0 109.663 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -108.32 122.21 46.51 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.437 0.695 . . . . 0.0 109.536 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.484 ' HE2' ' HB3' ' A' ' 203' ' ' ASP . 84.7 mmm -125.28 164.88 19.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.696 1.198 . . . . 0.0 109.265 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -110.53 172.77 6.67 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.49 ' HA ' HG22 ' A' ' 204' ' ' VAL . 41.7 m -66.29 -30.23 70.61 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 118.159 0.436 . . . . 0.0 111.258 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -10.4 58.86 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.862 176.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.484 ' HB3' ' HE2' ' A' ' 199' ' ' MET . 55.7 m-20 -104.25 -39.93 6.31 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.452 1.101 . . . . 0.0 111.014 175.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 201' ' ' SER . 32.0 m -95.79 143.47 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -174.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.96 163.47 32.79 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.321 0.648 . . . . 0.0 109.774 -168.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.97 166.64 23.01 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.186 0.594 . . . . 0.0 109.804 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.687 HH12 ' HB3' ' A' ' 153' ' ' GLU . 10.8 ptm180 -136.75 134.11 36.76 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.0 148.32 40.02 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.744 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.627 ' HG3' ' HB3' ' A' ' 291' ' ' ASP . 3.3 tmt_? -75.79 -9.47 58.62 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.942 168.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.8 m -86.94 109.33 19.27 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.869 0.868 . . . . 0.0 111.023 -171.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.4 mt -84.02 136.36 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.654 HD13 ' HB2' ' A' ' 279' ' ' LYS . 39.0 mm -110.98 153.52 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.637 0.775 . . . . 0.0 111.419 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -125.1 171.29 10.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.988 1.315 . . . . 0.0 109.929 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . 0.482 ' HD1' HG12 ' A' ' 274' ' ' VAL . 88.7 t90 -50.01 -49.05 52.05 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.378 1.071 . . . . 0.0 111.662 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -61.23 -35.76 78.12 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.618 -175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.463 ' HB3' HG23 ' A' ' 212' ' ' ILE . 14.6 t70 -78.78 -23.98 44.94 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.279 0.632 . . . . 0.0 110.978 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.443 HD22 HG21 ' A' ' 223' ' ' VAL . 96.0 mt -72.37 113.18 9.12 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.051 0.54 . . . . 0.0 109.928 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . 0.4 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 9.3 pt-20 -119.71 154.06 34.68 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.993 0.917 . . . . 0.0 109.961 -176.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.3 m -63.68 123.63 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 120.844 0.354 . . . . 0.0 110.945 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.76 -14.05 56.26 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.177 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.475 ' HG2' HG11 ' A' ' 223' ' ' VAL . 30.5 tt0 -81.29 122.69 27.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.346 0.658 . . . . 0.0 110.767 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 74.1 t -93.58 130.74 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.475 HG11 ' HG2' ' A' ' 221' ' ' GLN . 3.0 m -150.34 147.02 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.268 1.027 . . . . 0.0 110.297 -172.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.527 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 26.1 ttp -102.76 130.41 49.71 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.896 0.478 . . . . 0.0 110.986 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.485 HD11 HD12 ' A' ' 271' ' ' ILE . 1.9 pt? -142.43 167.89 21.02 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.283 1.033 . . . . 0.0 110.917 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.478 HD22 ' HB3' ' A' ' 276' ' ' GLU . 4.8 p30 -81.37 126.52 31.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.328 0.651 . . . . 0.0 109.655 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -166.08 152.28 9.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.956 0.902 . . . . 0.0 109.384 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.553 HD22 ' HB3' ' A' ' 231' ' ' ASN . 3.7 p30 -131.34 133.0 23.97 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.451 ' HB3' HD13 ' A' ' 266' ' ' LEU . 27.0 Cg_endo -61.52 -26.02 80.29 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.809 2.339 . . . . 0.0 113.943 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.41 -33.32 71.22 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.114 0.566 . . . . 0.0 111.699 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.553 ' HB3' HD22 ' A' ' 228' ' ' ASN . 35.5 t-20 -133.23 104.33 12.46 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 123.48 0.712 . . . . 0.0 109.116 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.33 -19.48 49.75 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.767 2.311 . . . . 0.0 113.019 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.26 -10.82 40.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.331 0.652 . . . . 0.0 110.944 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -123.81 159.13 30.23 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.484 0.659 . . . . 0.0 111.179 -171.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -80.28 172.24 14.02 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.688 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 228' ' ' ASN . . . -161.55 -101.98 0.17 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.291 172.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -103.46 168.9 8.86 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.77 0.828 . . . . 0.0 109.503 -177.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -83.87 114.73 21.86 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -126.8 141.29 51.87 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.214 1.006 . . . . 0.0 108.387 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.4 p-10 -81.18 152.81 27.54 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -151.09 136.85 18.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.791 0.836 . . . . 0.0 109.058 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -94.54 118.27 31.41 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.499 HG22 HD23 ' A' ' 255' ' ' LEU . 32.3 mm -61.57 116.27 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 124.041 0.838 . . . . 0.0 108.952 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.6 t -97.08 -25.04 15.48 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.332 0.653 . . . . 0.0 110.633 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -170.13 157.34 6.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.859 0.864 . . . . 0.0 110.195 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.419 ' HB3' ' HG ' ' A' ' 255' ' ' LEU . 26.0 pttm -153.13 149.1 27.72 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.659 0.784 . . . . 0.0 109.32 163.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -154.52 120.45 5.24 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.305 0.642 . . . . 0.0 109.449 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 40.0 tt0 -111.24 125.49 53.87 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.179 0.992 . . . . 0.0 109.151 177.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.7 p -83.59 178.78 7.84 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.943 0.897 . . . . 0.0 109.565 171.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -71.62 -0.78 11.56 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.366 0.666 . . . . 0.0 112.634 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 25.4 p -123.4 -29.68 3.77 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.29 0.636 . . . . 0.0 112.607 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.86 166.76 27.96 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.882 0.31 . . . . 0.0 111.457 -172.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 33.1 ptt180 -121.14 140.76 51.55 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.454 0.701 . . . . 0.0 110.661 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.22 154.31 47.7 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.71 0.804 . . . . 0.0 108.876 172.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.499 HD23 HG22 ' A' ' 243' ' ' ILE . 7.1 tt -147.16 143.89 28.57 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -130.21 121.82 26.93 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -131.97 166.72 21.05 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.377 0.671 . . . . 0.0 110.431 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -102.19 98.14 8.33 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.787 HG23 ' SG ' ' A' ' 269' ' ' CYS . 96.6 t -66.57 112.36 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 123.783 0.677 . . . . 0.0 110.374 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.48 101.79 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 73.4 mt -82.81 -158.02 0.25 Allowed 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.642 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.422 ' CA ' ' HA3' ' A' ' 149' ' ' GLY . . . -70.29 -56.61 7.58 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-O 121.088 0.271 . . . . 0.0 113.418 177.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -112.87 -37.32 4.87 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.171 0.988 . . . . 0.0 109.929 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -94.39 176.39 6.32 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.125 0.97 . . . . 0.0 111.713 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 77.0 p -142.89 153.12 42.81 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.28 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 92.8 mt -125.31 92.15 3.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.359 0.663 . . . . 0.0 109.458 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -69.2 140.02 54.56 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 123.606 0.566 . . . . 0.0 110.284 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 12.6 t70 67.08 31.64 6.72 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.452 1.101 . . . . 0.0 111.705 171.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.787 ' SG ' HG23 ' A' ' 259' ' ' VAL . 27.2 p -65.05 124.92 23.35 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 37.6 ttp-105 -76.91 102.46 6.38 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.548 HD13 ' SG ' ' A' ' 269' ' ' CYS . 47.7 mm -77.87 108.29 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.886 -172.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 44.5 mt -82.1 -34.5 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.424 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.433 ' O ' HG21 ' A' ' 277' ' ' VAL . 46.0 m-85 -90.26 37.42 0.9 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.336 1.054 . . . . 0.0 111.14 -168.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . 0.482 HG12 ' HD1' ' A' ' 214' ' ' TRP . 21.0 m -56.75 -34.27 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.799 1.239 . . . . 0.0 112.433 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -92.78 -10.59 36.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.676 1.19 . . . . 0.0 111.983 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.478 ' HB3' HD22 ' A' ' 226' ' ' ASN . 59.4 mm-40 -102.6 21.26 15.64 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.215 1.006 . . . . 0.0 111.148 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 225' ' ' LEU . 84.2 t -90.44 153.44 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.038 0.935 . . . . 0.0 110.587 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.43 148.66 44.85 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.874 1.27 . . . . 0.0 107.808 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.654 ' HB2' HD13 ' A' ' 212' ' ' ILE . 24.0 ttmt -83.28 141.01 32.15 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 120.841 0.353 . . . . 0.0 111.126 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 36.5 mm -79.13 138.19 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 168.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.501 ' HA ' ' HA3' ' A' ' 286' ' ' GLY . 1.1 mp0 -66.11 103.46 0.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.283 0.563 . . . . 0.0 110.08 -167.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -85.7 155.0 59.14 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.31 1.044 . . . . 0.0 109.524 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.98 94.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 123.402 2.735 . . . . 0.0 112.075 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.9 -48.09 2.49 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.994 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -73.12 -25.61 60.91 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.996 0.519 . . . . 0.0 112.085 -172.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -84.68 82.19 1.7 Allowed Glycine 0 C--N 1.342 0.915 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 174.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 14.8 m -62.8 144.37 96.6 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.418 0.687 . . . . 0.0 111.989 -168.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.15 152.85 79.12 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.103 2.535 . . . . 0.0 111.875 -175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 16.7 ttt -79.76 80.77 6.11 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.26 -28.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.338 1.055 . . . . 0.0 109.963 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.627 ' HB3' ' HG3' ' A' ' 209' ' ' ARG . 10.3 t70 -84.26 -151.68 0.13 Allowed 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.303 1.041 . . . . 0.0 109.135 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.442 HD21 ' H ' ' A' ' 292' ' ' ASN . 0.8 OUTLIER -50.81 115.98 6.51 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.99 0.916 . . . . 0.0 110.533 177.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.75 102.97 0.44 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.218 1.946 . . . . 0.0 111.534 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 25.7 mmt -65.84 136.7 56.51 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.273 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -144.46 148.78 34.99 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.497 ' NH1' ' HE3' ' A' ' 224' ' ' MET . 18.8 ptt180 -148.0 -175.92 5.08 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.29 0.236 . . . . 0.0 110.847 -167.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 2.1 tppt? -161.02 134.0 6.36 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 111.541 0.201 . . . . 0.0 111.541 173.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 123.579 0.752 . . . . 0.0 110.064 175.292 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.979 -0.449 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.31 -34.2 32.06 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.178 0.513 . . . . 0.0 110.414 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -90.16 152.42 21.11 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.778 -165.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -99.35 162.93 12.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.128 -167.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.1 m -71.91 -2.28 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 124.161 0.984 . . . . 0.0 113.116 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -118.34 -21.04 8.27 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.89 0.876 . . . . 0.0 110.425 171.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -82.12 89.67 6.49 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.77 0.828 . . . . 0.0 110.116 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.671 ' HB3' ' HG2' ' A' ' 155' ' ' GLN . 26.8 p90 -68.16 139.12 56.11 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.202 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.0 m -119.5 178.96 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.998 0.919 . . . . 0.0 109.662 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.733 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 54.1 t0 -95.01 158.79 15.31 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 166.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.17 110.06 4.52 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 119.436 1.016 . . . . 0.0 111.213 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 151' ' ' TRP . 3.0 tmm_? -73.01 113.69 10.33 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.878 0.871 . . . . 0.0 110.593 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -87.16 114.62 23.93 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.6 m -70.79 -26.57 63.39 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.736 0.814 . . . . 0.0 111.546 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -59.99 -49.93 75.75 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.616 0.766 . . . . 0.0 110.683 -175.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.415 ' HG3' ' H ' ' A' ' 150' ' ' ALA . 23.9 ptm -101.79 -18.99 15.52 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.526 0.331 . . . . 0.0 111.394 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 93.32 -21.56 39.83 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-O 120.021 -0.321 . . . . 0.0 113.141 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.415 ' H ' ' HG3' ' A' ' 148' ' ' MET . . . -72.47 131.18 42.22 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.197 0.599 . . . . 0.0 110.818 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.42 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 0.1 OUTLIER -97.65 124.72 42.06 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.18 175.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -113.64 137.3 51.8 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.017 0.927 . . . . 0.0 109.464 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.733 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 48.3 mt-10 -64.43 102.21 0.52 Allowed 'General case' 0 C--N 1.346 0.435 0 O-C-N 123.653 0.596 . . . . 0.0 110.802 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.481 ' HB3' ' HB ' ' A' ' 186' ' ' VAL . . . -96.61 119.13 34.53 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.78 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.671 ' HG2' ' HB3' ' A' ' 140' ' ' TYR . 15.4 tm0? -84.94 107.91 17.31 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -173.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.505 ' HA ' HG13 ' A' ' 186' ' ' VAL . 47.0 t -61.47 119.61 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 124.229 0.955 . . . . 0.0 109.207 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 m -115.63 -6.03 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.574 0.749 . . . . 0.0 111.179 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.534 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 44.9 ttt85 -172.23 142.12 1.33 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.966 0.506 . . . . 0.0 110.511 175.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.3 m -126.05 132.09 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.282 1.033 . . . . 0.0 108.832 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.7 p -142.96 145.2 32.77 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.39 0.676 . . . . 0.0 110.099 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -74.93 150.13 39.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.868 0.867 . . . . 0.0 109.053 168.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.0 mttt . . . . . 0 N--CA 1.478 0.964 0 C-N-CA 123.601 0.76 . . . . 0.0 109.951 173.24 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.509 ' HB3' HG22 ' A' ' 182' ' ' VAL . 5.9 mm-40 -70.68 90.76 0.78 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.33 -169.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -85.88 8.85 18.61 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.648 167.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 180' ' ' GLU . 28.6 m -65.69 173.98 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.039 1.336 . . . . 0.0 112.02 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 198' ' ' GLN . 59.0 mt -94.95 110.81 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.549 0.74 . . . . 0.0 110.417 -169.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -93.95 106.48 18.45 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.887 1.275 . . . . 0.0 109.543 173.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 30.5 m-70 -80.54 101.95 9.45 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 156' ' ' VAL . 29.6 m -129.68 165.47 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.832 1.253 . . . . 0.0 110.5 -172.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -133.56 116.33 15.79 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.384 0.674 . . . . 0.0 109.375 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.641 ' HB2' ' HB2' ' A' ' 191' ' ' TYR . 47.0 m-85 -57.2 151.23 16.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 123.167 0.292 . . . . 0.0 111.347 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -60.11 -44.41 94.9 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.062 0.545 . . . . 0.0 110.875 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.47 -13.42 40.38 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.646 0.778 . . . . 0.0 111.268 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.641 ' HB2' ' HB2' ' A' ' 188' ' ' TYR . 58.3 m-85 -129.11 58.65 38.71 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -174.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.38 -23.78 8.38 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 121.71 1.607 . . . . 0.0 110.442 163.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.31 -20.55 62.18 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.687 1.195 . . . . 0.0 111.914 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -81.19 -0.42 40.4 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.057 0.543 . . . . 0.0 110.872 175.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 89.12 -177.48 44.44 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.161 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 23.6 t -82.86 116.89 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.12 153.21 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.027 0.931 . . . . 0.0 110.029 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.4 ' HB2' HG21 ' A' ' 183' ' ' ILE . 12.8 pt20 -103.78 113.88 27.73 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.731 0.777 . . . . 0.0 109.851 178.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.546 ' HE3' ' HB3' ' A' ' 203' ' ' ASP . 77.9 mmm -117.27 169.75 9.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.318 1.447 . . . . 0.0 108.785 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -110.92 173.07 6.51 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.585 ' HA ' HG22 ' A' ' 204' ' ' VAL . 9.7 t -70.56 -26.2 63.43 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 118.369 0.531 . . . . 0.0 110.63 177.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -12.24 60.88 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.745 0.418 . . . . 0.0 111.786 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.546 ' HB3' ' HE3' ' A' ' 199' ' ' MET . 16.3 m-20 -94.68 -44.47 7.79 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.51 0.724 . . . . 0.0 110.082 171.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 201' ' ' SER . 15.3 m -95.76 143.24 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.433 0.635 . . . . 0.0 110.996 -170.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 21.2 tpt180 -150.97 126.64 10.22 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.2 125.48 25.67 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 168.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.68 152.02 40.57 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.429 ' N ' ' HB2' ' A' ' 281' ' ' GLU . . . -64.39 135.11 55.8 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.835 0.709 . . . . 0.0 109.398 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.515 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 5.3 ppt_? -78.21 23.06 0.29 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.876 0.87 . . . . 0.0 112.803 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 79.5 m -113.6 119.41 37.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.892 1.277 . . . . 0.0 109.082 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.63 129.03 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.038 0.535 . . . . 0.0 109.77 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.473 HD13 ' HB2' ' A' ' 279' ' ' LYS . 28.2 mm -87.37 144.48 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.41 170.14 9.65 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.901 0.881 . . . . 0.0 109.727 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . 0.401 ' CZ3' ' HB2' ' A' ' 255' ' ' LEU . 38.2 t-105 -52.3 -47.78 65.75 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.979 0.912 . . . . 0.0 111.302 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -69.11 -23.03 63.94 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.278 0.631 . . . . 0.0 111.979 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -92.12 -16.57 26.16 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.115 0.566 . . . . 0.0 110.513 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.406 ' HA ' ' NE2' ' A' ' 221' ' ' GLN . 79.5 mt -75.62 141.21 42.88 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -147.79 155.08 41.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.586 0.755 . . . . 0.0 109.419 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.93 123.39 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-O 121.26 0.552 . . . . 0.0 110.947 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.1 -4.0 48.46 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.744 -174.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.5 ' HG2' HG13 ' A' ' 223' ' ' VAL . 30.1 tt0 -87.21 121.72 30.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.235 0.614 . . . . 0.0 110.233 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 92.9 t -87.15 115.58 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.779 0.832 . . . . 0.0 108.863 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.5 HG13 ' HG2' ' A' ' 221' ' ' GLN . 6.3 m -137.91 157.37 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.311 1.044 . . . . 0.0 110.642 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.694 ' SD ' ' HD3' ' A' ' 296' ' ' ARG . 1.5 ttp -88.24 129.71 35.28 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.572 ' HB3' HG22 ' A' ' 277' ' ' VAL . 2.0 pp -143.79 168.21 20.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.826 0.85 . . . . 0.0 110.304 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.459 HD22 ' HA ' ' A' ' 235' ' ' ARG . 8.8 t30 -90.92 143.13 27.04 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -167.18 144.02 4.5 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 124.227 0.955 . . . . 0.0 109.051 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -109.84 119.09 48.55 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -56.24 -44.87 42.39 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.067 2.512 . . . . 0.0 113.082 172.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.1 -27.74 59.98 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.046 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 234' ' ' GLU . 16.7 m120 -120.37 86.32 38.6 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 123.407 0.683 . . . . 0.0 109.194 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.37 -20.43 70.18 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.984 2.456 . . . . 0.0 113.366 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.547 ' HA ' HD12 ' A' ' 272' ' ' ILE . 61.7 tttm -97.47 -29.5 13.44 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.668 0.787 . . . . 0.0 111.26 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 231' ' ' ASN . 44.0 mt-10 -111.46 172.15 7.06 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.825 0.821 . . . . 0.0 112.665 -170.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.459 ' HA ' HD22 ' A' ' 226' ' ' ASN . 24.3 ptt180 -76.94 164.25 25.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.724 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -171.47 -79.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.694 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.404 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 11.5 m-85 -127.79 173.96 9.52 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.841 0.456 . . . . 0.0 110.268 -170.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -110.51 127.97 55.42 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 94.0 m-85 -133.54 158.34 43.39 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.415 0.686 . . . . 0.0 110.155 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -86.14 147.08 26.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 162.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.466 ' HB1' HD23 ' A' ' 225' ' ' LEU . . . -153.48 139.76 18.51 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 122.957 0.503 . . . . 0.0 110.04 -176.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -95.53 120.11 35.22 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.473 HD13 HD21 ' A' ' 255' ' ' LEU . 35.6 mm -58.3 111.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 123.658 0.599 . . . . 0.0 109.968 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.1 m -83.77 -49.47 9.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.688 0.795 . . . . 0.0 110.303 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.532 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 4.8 mmp_? -142.43 159.21 42.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.955 1.302 . . . . 0.0 109.07 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -154.89 116.81 4.16 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.33 0.652 . . . . 0.0 109.373 168.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -123.86 117.85 25.78 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.498 1.119 . . . . 0.0 108.542 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.54 135.48 49.74 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.465 0.706 . . . . 0.0 109.604 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.9 p -133.6 175.0 9.82 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.886 0.875 . . . . 0.0 109.284 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -69.12 -38.16 78.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.815 0.446 . . . . 0.0 110.757 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 46.1 p -88.66 -27.32 21.34 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.489 0.716 . . . . 0.0 112.859 -171.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.57 172.98 17.36 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.084 0.469 . . . . 0.0 111.829 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -128.54 130.36 47.31 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.943 0.897 . . . . 0.0 108.665 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -133.03 98.6 4.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.592 0.757 . . . . 0.0 109.314 -175.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.473 HD21 HD13 ' A' ' 243' ' ' ILE . 8.4 tt -107.72 147.01 31.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 64.2 m-85 -129.14 141.35 51.21 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.886 1.274 . . . . 0.0 107.599 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.96 151.02 35.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.718 0.407 . . . . 0.0 111.091 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -79.8 96.68 6.37 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 39.4 t -79.68 108.98 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.98 0.912 . . . . 0.0 109.96 -173.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 83.2 t -87.03 114.35 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.514 0.673 . . . . 0.0 110.796 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 13.4 mt -90.44 -161.6 0.81 Allowed 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.62 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.3 -42.5 57.1 Favored Glycine 0 C--N 1.35 1.32 0 O-C-N 122.16 -0.337 . . . . 0.0 113.907 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -122.3 -27.07 4.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.213 1.005 . . . . 0.0 111.039 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -114.19 167.17 10.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.924 0.889 . . . . 0.0 110.605 -172.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 67.8 p -137.45 133.22 34.43 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.022 0.929 . . . . 0.0 108.767 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.683 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 75.4 mt -81.56 93.8 6.77 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.061 0.944 . . . . 0.0 108.514 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -59.39 110.67 1.14 Allowed 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.413 1.071 . . . . 0.0 112.151 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 30.1 t70 67.26 29.44 7.62 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.766 0.827 . . . . 0.0 111.636 167.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.683 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 98.9 m -75.45 131.42 40.13 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.807 -0.558 . . . . 0.0 111.078 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -65.47 117.04 7.4 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.534 0.734 . . . . 0.0 112.126 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.444 HG21 HD22 ' A' ' 225' ' ' LEU . 36.5 mm -89.64 112.44 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.925 0.89 . . . . 0.0 109.126 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 233' ' ' LYS . 49.0 mt -97.93 22.98 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 CA-C-O 122.519 1.152 . . . . 0.0 109.061 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.408 ' H ' HG23 ' A' ' 271' ' ' ILE . 83.8 m-85 -135.6 34.86 2.94 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.622 1.169 . . . . 0.0 109.989 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 34.3 m -71.03 -12.5 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.057 -174.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -87.15 -29.01 22.11 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.547 0.739 . . . . 0.0 111.325 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -102.08 22.1 13.71 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.341 0.656 . . . . 0.0 111.356 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' ' 225' ' ' LEU . 85.2 t -73.14 131.34 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.946 0.898 . . . . 0.0 110.406 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -109.07 160.39 16.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.617 0.767 . . . . 0.0 109.886 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.473 ' HB2' HD13 ' A' ' 212' ' ' ILE . 85.3 tttt -75.44 143.35 42.71 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.132 174.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.1 mm -72.2 116.06 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.429 ' HB2' ' N ' ' A' ' 208' ' ' ALA . 0.5 OUTLIER -83.39 105.95 14.76 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -106.47 151.53 40.37 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.512 0.725 . . . . 0.0 110.111 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.11 121.14 9.47 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.009 2.472 . . . . 0.0 113.531 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.16 -49.09 1.08 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.974 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -91.31 -24.27 19.87 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -171.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -83.23 137.15 16.0 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.04 0.212 . . . . 0.0 113.027 -170.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 6.5 m -84.36 146.48 47.74 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.144 0.578 . . . . 0.0 111.789 -173.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.28 -173.61 1.8 Allowed 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 123.731 2.954 . . . . 0.0 111.617 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' MET . . . . . 0.515 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 25.5 mmt -82.04 78.83 8.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.102 0.477 . . . . 0.0 109.906 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 13.7 p -87.33 -25.46 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 121.779 0.8 . . . . 0.0 109.022 169.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.66 -166.4 1.57 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.405 1.482 . . . . 0.0 108.22 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.35 154.96 94.41 Favored Pre-proline 0 N--CA 1.483 1.198 0 CA-C-N 118.933 0.788 . . . . 0.0 109.701 172.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.56 102.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.586 2.19 . . . . 0.0 112.292 173.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 89.7 mmm -95.37 135.52 36.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.582 0.753 . . . . 0.0 110.108 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.558 ' HB3' ' HH ' ' A' ' 140' ' ' TYR . 11.4 ptm180 -155.93 165.44 36.47 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.479 0.657 . . . . 0.0 111.397 -172.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.694 ' HD3' ' SD ' ' A' ' 224' ' ' MET . 17.1 mtm180 -88.88 153.07 21.34 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.939 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 82.5 tttt 71.24 166.73 0.3 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.274 1.029 . . . . 0.0 112.397 167.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 CA--C 1.541 0.633 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 159.559 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.487 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.72 10.27 10.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.347 0.659 . . . . 0.0 111.898 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -114.92 149.36 37.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 170.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -102.94 170.25 8.09 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.019 0.528 . . . . 0.0 111.312 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -68.95 -6.23 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.489 1.116 . . . . 0.0 112.996 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.78 -22.97 9.92 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.139 0.976 . . . . 0.0 110.974 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -80.88 88.26 5.88 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.377 0.671 . . . . 0.0 110.212 -173.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.422 ' HB3' ' OE1' ' A' ' 155' ' ' GLN . 48.5 p90 -78.56 139.42 38.62 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.121 176.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.9 m -130.98 -166.74 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 126.158 1.783 . . . . 0.0 108.386 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -93.89 159.46 15.17 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 154' ' ' ALA . . . -128.94 101.95 6.3 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 124.338 1.055 . . . . 0.0 108.452 172.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -69.8 96.37 0.98 Allowed 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.652 174.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -78.4 111.02 13.98 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.1 m -71.96 -29.52 64.35 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.76 0.824 . . . . 0.0 111.694 -172.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -65.53 -42.97 91.38 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.819 0.847 . . . . 0.0 110.633 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.4 tpp -82.06 -37.9 25.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.191 0.996 . . . . 0.0 109.664 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.52 18.18 66.85 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.397 -170.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -107.4 161.13 15.09 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 122.029 0.918 . . . . 0.0 112.564 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -91.0 126.26 36.03 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.457 -1.701 . . . . 0.0 107.644 169.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -129.13 123.78 33.05 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.451 ' HB2' ' N ' ' A' ' 190' ' ' ASP . 14.6 mm-40 -43.7 137.78 2.89 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.192 0.933 . . . . 0.0 110.192 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 187' ' ' LYS . . . -134.73 116.07 14.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 122.32 0.248 . . . . 0.0 110.4 -176.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.422 ' OE1' ' HB3' ' A' ' 140' ' ' TYR . 60.6 tp60 -90.35 101.35 14.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.4 t -61.18 117.08 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -116.66 -10.02 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.785 0.434 . . . . 0.0 111.838 -176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 -171.33 148.53 2.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.747 0.819 . . . . 0.0 109.245 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 6.1 m -117.4 142.36 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.511 0.724 . . . . 0.0 109.4 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.515 ' HG1' ' HB ' ' A' ' 183' ' ' ILE . 69.6 p -144.24 159.99 41.74 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.79 1.236 . . . . 0.0 108.099 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -97.35 -179.21 4.42 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.213 0.605 . . . . 0.0 109.732 174.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.51 ' HZ3' HG12 ' A' ' 183' ' ' ILE . 74.5 mmtt . . . . . 0 N--CA 1.491 1.587 0 C-N-CA 124.002 0.921 . . . . 0.0 110.402 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 CA--C 1.544 0.742 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.19 95.22 0.56 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.442 0.639 . . . . 0.0 109.845 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -75.96 76.72 2.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.073 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.08 152.87 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.39 1.476 . . . . 0.0 107.792 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.515 ' HB ' ' HG1' ' A' ' 160' ' ' THR . 39.3 mt -95.19 110.15 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.02 0.528 . . . . 0.0 110.654 -170.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -92.48 112.44 24.38 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 170.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -79.34 93.95 5.41 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 6.0 m -108.2 163.84 5.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 114.404 -1.271 . . . . 0.0 107.773 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.461 ' HG2' HG22 ' A' ' 196' ' ' VAL . 35.4 mtmt -106.48 135.02 48.71 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 165.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -63.61 89.88 0.05 OUTLIER 'General case' 0 C--O 1.207 -1.148 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 164.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.46 -20.28 65.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.079 0.952 . . . . 0.0 110.639 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.451 ' N ' ' HB2' ' A' ' 153' ' ' GLU . 2.1 t70 -64.52 -32.48 74.14 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.871 0.869 . . . . 0.0 110.078 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -144.6 72.24 15.54 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.11 -16.61 55.94 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.285 2.657 . . . . 0.0 115.582 -165.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.53 -11.22 59.84 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.568 0.347 . . . . 0.0 111.59 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -72.61 -15.71 61.73 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.308 0.643 . . . . 0.0 111.226 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 93.25 -175.47 36.29 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.661 0.624 . . . . 0.0 114.661 167.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 187' ' ' LYS . 17.9 t -79.16 115.33 21.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.53 154.92 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.643 1.177 . . . . 0.0 110.214 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.491 ' HB2' HG21 ' A' ' 183' ' ' ILE . 10.8 pt20 -98.24 127.41 44.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.072 0.549 . . . . 0.0 110.103 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.579 ' HE3' ' HB3' ' A' ' 203' ' ' ASP . 82.7 mmm -137.13 142.01 42.26 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.327 1.051 . . . . 0.0 108.968 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . 0.416 ' O ' HG21 ' A' ' 204' ' ' VAL . 27.5 m-80 -86.24 173.6 9.65 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 118.294 0.497 . . . . 0.0 110.228 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 51.6 m -61.0 -37.88 84.07 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.858 0.299 . . . . 0.0 111.488 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -58.88 -27.9 65.63 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.788 0.835 . . . . 0.0 112.158 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.579 ' HB3' ' HE3' ' A' ' 199' ' ' MET . 28.4 m-20 -87.96 -41.55 13.07 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.359 0.664 . . . . 0.0 111.309 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 200' ' ' ASN . 4.7 m -93.28 116.66 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.82 0.819 . . . . 0.0 109.233 -175.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -113.43 148.77 35.25 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.59 -165.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.09 153.93 20.55 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.272 0.629 . . . . 0.0 110.275 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.424 ' HG3' ' SD ' ' A' ' 289' ' ' MET . 9.6 ptm85 -117.64 127.17 53.69 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.371 0.668 . . . . 0.0 111.006 -169.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -85.26 136.47 33.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.828 0.851 . . . . 0.0 109.837 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.69 ' HB3' ' HG2' ' A' ' 289' ' ' MET . 6.7 ppt_? -92.77 15.61 14.21 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.125 0.57 . . . . 0.0 110.65 175.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 279' ' ' LYS . 23.0 m -86.62 108.89 18.82 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.391 0.677 . . . . 0.0 110.01 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 mt -86.51 121.98 38.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 172.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 216' ' ' ASP . 38.5 mm -94.29 142.33 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.502 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 1.3 ptpp? -128.2 -179.73 5.16 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.609 1.164 . . . . 0.0 109.699 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . 0.427 ' CH2' ' HB2' ' A' ' 248' ' ' GLU . 10.5 t90 -56.16 -40.47 73.93 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.064 0.546 . . . . 0.0 110.454 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -59.3 -33.12 70.71 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.718 0.807 . . . . 0.0 111.604 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.551 ' HB2' HG23 ' A' ' 212' ' ' ILE . 66.0 m-20 -80.34 -34.7 36.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.279 0.632 . . . . 0.0 110.536 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.533 HD22 HD13 ' A' ' 243' ' ' ILE . 89.0 mt -67.18 112.86 4.7 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-O 120.99 0.424 . . . . 0.0 110.479 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.51 154.83 51.24 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.519 1.127 . . . . 0.0 108.353 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 36.0 m -64.42 124.15 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.008 0.432 . . . . 0.0 110.49 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.25 -18.88 47.56 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.561 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -79.64 124.36 28.48 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.526 0.663 . . . . 0.0 109.859 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 14.0 p -91.94 141.23 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.535 0.683 . . . . 0.0 109.165 173.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.463 HG12 HG22 ' A' ' 212' ' ' ILE . 11.4 m -139.1 -177.1 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.978 1.311 . . . . 0.0 109.266 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.429 ' HE1' ' HB3' ' A' ' 224' ' ' MET . 3.8 ttp -136.63 125.27 23.75 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.115 0.566 . . . . 0.0 109.609 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.21 151.62 37.89 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.408 1.083 . . . . 0.0 110.29 -169.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -88.8 108.79 19.7 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.935 0.494 . . . . 0.0 111.064 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.418 ' HH ' HG21 ' A' ' 271' ' ' ILE . 93.5 m-85 -140.61 139.77 34.96 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.913 0.885 . . . . 0.0 108.836 171.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.484 HD21 ' HB2' ' A' ' 230' ' ' ASP . 14.0 p-10 -87.26 134.62 36.07 Favored Pre-proline 0 N--CA 1.474 0.729 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.49 -13.12 36.78 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.116 1.878 . . . . 0.0 112.469 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.484 ' HB2' HD21 ' A' ' 228' ' ' ASN . 6.5 m-20 -67.69 -40.31 84.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.867 0.867 . . . . 0.0 110.133 173.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 234' ' ' GLU . 48.1 t-20 -141.31 104.19 6.04 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.78 -16.96 47.12 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.655 2.236 . . . . 0.0 112.688 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.457 ' HG3' HD13 ' A' ' 272' ' ' ILE . 83.0 tttt -95.55 8.3 43.75 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.989 0.916 . . . . 0.0 110.358 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 231' ' ' ASN . 38.3 tt0 -132.95 148.76 52.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.334 0.654 . . . . 0.0 110.964 -175.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -60.14 150.34 29.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.626 1.17 . . . . 0.0 112.386 172.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -169.6 -115.36 0.33 Allowed Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.493 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -95.62 150.06 20.77 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.347 0.659 . . . . 0.0 110.439 -176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -77.97 107.45 10.52 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.403 0.681 . . . . 0.0 110.042 -174.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -119.63 164.97 15.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.331 0.652 . . . . 0.0 109.263 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.55 144.23 30.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 174.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.73 133.95 21.68 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 222' ' ' VAL . 34.6 tt0 -105.49 127.06 52.8 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.533 HD13 HD22 ' A' ' 217' ' ' LEU . 14.7 mm -64.95 103.8 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 123.993 0.808 . . . . 0.0 109.666 -172.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.8 p -79.31 -45.57 19.4 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.144 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -143.82 163.6 32.91 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.284 1.034 . . . . 0.0 110.102 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -155.03 149.05 25.8 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.761 0.824 . . . . 0.0 109.427 172.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -146.57 118.87 8.36 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.484 0.659 . . . . 0.0 110.565 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.427 ' HB2' ' CH2' ' A' ' 214' ' ' TRP . 5.0 tm-20 -93.17 124.19 36.97 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 63.6 p -125.61 157.51 37.01 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.415 ' HG3' HG21 ' A' ' 251' ' ' THR . 27.5 ptt180 -60.82 -24.76 66.11 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.349 1.06 . . . . 0.0 112.703 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.415 HG21 ' HG3' ' A' ' 250' ' ' ARG . 55.9 p -97.93 -28.59 13.74 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.828 0.851 . . . . 0.0 112.566 -172.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -166.1 169.24 14.7 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.68 0.392 . . . . 0.0 111.026 -173.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -95.85 155.56 16.7 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.081 0.553 . . . . 0.0 109.747 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -146.28 140.56 26.58 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.529 HD11 HD12 ' A' ' 243' ' ' ILE . 0.3 OUTLIER -148.17 144.35 27.69 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -135.68 134.04 38.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.998 0.919 . . . . 0.0 109.82 176.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.84 143.98 27.82 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.223 0.609 . . . . 0.0 111.087 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -79.52 98.43 6.84 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.022 0.529 . . . . 0.0 109.583 172.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 91.8 t -76.42 103.51 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.273 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.66 122.53 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.966 0.889 . . . . 0.0 110.104 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 32.5 mt -88.17 -151.57 0.2 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.173 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -59.89 -77.04 0.19 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 117.852 0.296 . . . . 0.0 112.579 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -100.49 -25.15 14.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.378 0.671 . . . . 0.0 110.944 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -90.61 173.21 8.17 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.826 0.85 . . . . 0.0 111.435 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 32.8 p -155.56 120.54 4.8 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.553 0.741 . . . . 0.0 110.054 174.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.19 97.51 7.64 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.364 1.066 . . . . 0.0 109.033 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.7 132.92 46.89 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.564 0.746 . . . . 0.0 111.36 -172.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 55.3 35.87 25.85 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.644 1.215 . . . . 0.0 111.818 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 36.8 t -64.0 124.43 21.57 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -70.63 117.18 11.83 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.788 0.435 . . . . 0.0 110.229 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 34.8 mm -80.36 110.91 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.219 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.457 HD13 ' HG3' ' A' ' 233' ' ' LYS . 25.0 mm -78.12 -66.36 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.796 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -83.63 65.84 8.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.817 1.247 . . . . 0.0 109.948 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.7 m -64.4 -32.53 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.603 0.761 . . . . 0.0 111.999 -173.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 5.3 p-10 -86.05 -13.98 45.76 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.645 1.178 . . . . 0.0 111.917 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -97.65 -0.64 45.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.453 0.701 . . . . 0.0 111.471 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.81 153.87 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.704 0.801 . . . . 0.0 110.637 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -117.4 161.56 19.35 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.899 0.879 . . . . 0.0 108.869 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.417 ' HB3' ' HB ' ' A' ' 210' ' ' THR . 80.1 tttt -91.03 153.09 20.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.867 0.467 . . . . 0.0 112.008 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.2 mm -67.23 120.26 14.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 123.947 0.899 . . . . 0.0 108.802 168.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.36 112.2 8.22 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 96.1 mtt180 -128.2 141.59 41.79 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 123.883 0.873 . . . . 0.0 109.436 172.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -46.16 108.03 0.14 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.815 3.01 . . . . 0.0 113.265 170.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.36 -39.78 2.9 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.817 -0.628 . . . . 0.0 113.435 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 32.5 tt0 -79.35 -29.19 42.09 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.961 0.381 . . . . 0.0 111.766 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -117.57 151.43 18.07 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 12.5 p -88.91 109.95 34.15 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-N 117.788 0.794 . . . . 0.0 110.114 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.25 155.69 60.31 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 123.198 2.599 . . . . 0.0 110.166 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' MET . . . . . 0.69 ' HG2' ' HB3' ' A' ' 209' ' ' ARG . 63.8 mtt -74.78 80.5 2.08 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.61 0.719 . . . . 0.0 112.559 -172.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.02 -28.11 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 165.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.78 -164.42 0.79 Allowed 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.254 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -57.24 111.75 3.78 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 118.774 0.715 . . . . 0.0 111.566 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.526 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 11.9 Cg_exo -72.61 93.89 0.77 Allowed 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.432 2.088 . . . . 0.0 111.094 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.2 mtm -73.36 125.73 28.52 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.02 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.23 121.34 22.77 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -64.59 -30.08 71.1 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.06 0.944 . . . . 0.0 111.179 -175.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -57.06 122.08 11.52 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.383 167.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 50.2 p . . . . . 0 CA--C 1.55 0.948 0 C-N-CA 123.366 0.666 . . . . 0.0 110.804 -177.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.417 0 CA-C-O 119.744 -0.476 . . . . 0.0 111.967 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.31 7.37 4.97 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -79.6 128.47 33.42 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.755 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 58.1 pttt -72.18 174.66 6.88 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.004 0.922 . . . . 0.0 111.657 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -74.51 -2.67 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.206 0.602 . . . . 0.0 111.948 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.435 ' H ' ' HG3' ' A' ' 136' ' ' LYS . 92.0 m-20 -120.99 30.3 6.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.244 1.018 . . . . 0.0 110.96 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.755 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 6.3 mm-40 -88.86 71.21 8.64 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.253 1.025 . . . . 0.0 110.859 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -63.76 99.4 0.23 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.288 169.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 30.1 m -121.77 169.32 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.972 0.909 . . . . 0.0 109.703 -176.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 207' ' ' ARG . 1.6 t0 -101.6 110.34 22.32 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -92.75 92.98 8.21 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 122.932 0.493 . . . . 0.0 110.497 -171.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 2.8 tmt_? -72.27 106.13 4.32 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 174.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.62 114.8 3.78 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.482 ' HA ' ' NH1' ' A' ' 144' ' ' ARG . 13.8 t -60.25 -23.89 64.46 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -171.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -83.7 -38.69 21.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.447 0.699 . . . . 0.0 110.174 -174.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 41.9 ttm -92.96 -22.89 18.93 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.491 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.42 12.93 73.66 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.063 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.56 129.98 53.71 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.622 0.769 . . . . 0.0 111.147 -174.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 52.1 m95 -81.89 121.93 27.09 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.077 0.951 . . . . 0.0 110.617 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -131.03 115.18 16.12 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 27.1 mt-10 -58.45 144.86 40.72 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.311 0.505 . . . . 0.0 111.139 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' A' ' 186' ' ' VAL . . . -158.42 124.78 4.69 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 124.31 1.006 . . . . 0.0 109.613 -176.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -92.48 118.88 31.42 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 63.7 t -61.66 111.72 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 C-N-CA 123.484 0.713 . . . . 0.0 109.315 172.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.7 m -104.48 -6.89 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.138 0.575 . . . . 0.0 111.8 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -170.14 141.28 2.08 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.199 0.599 . . . . 0.0 110.24 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.6 m -119.41 142.09 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.59 0.756 . . . . 0.0 110.672 172.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.2 t -147.14 160.86 41.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.032 0.933 . . . . 0.0 108.833 169.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.2 ptt-85 -101.73 176.39 5.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.061 0.544 . . . . 0.0 110.217 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 N--CA 1.477 0.909 0 C-N-CA 123.474 0.71 . . . . 0.0 110.042 177.039 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.407 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 10.0 mm-40 52.11 29.21 6.15 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 173.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -71.41 63.35 0.38 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.54 168.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.31 -175.51 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.821 1.648 . . . . 0.0 108.645 -170.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.58 HG21 ' HB2' ' A' ' 198' ' ' GLN . 3.7 mp -97.5 110.71 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.407 ' OH ' ' HB3' ' A' ' 180' ' ' GLU . 99.6 m-85 -98.61 106.61 18.91 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.193 0.997 . . . . 0.0 108.411 170.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -79.09 97.7 6.23 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 35.1 m -109.97 163.65 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.241 1.017 . . . . 0.0 111.019 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.548 ' HZ3' ' HB3' ' A' ' 187' ' ' LYS . 1.8 mmmp? -121.54 114.01 20.61 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -63.16 115.03 4.12 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.303 0.377 . . . . 0.0 110.254 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.69 -34.77 72.33 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.968 0.413 . . . . 0.0 110.408 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.64 -28.72 61.93 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.898 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -142.17 68.13 22.0 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 122.762 0.425 . . . . 0.0 111.342 -170.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.34 -11.41 24.75 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.264 2.643 . . . . 0.0 113.629 -174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.44 -17.87 62.36 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.558 0.743 . . . . 0.0 111.17 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -72.5 -10.5 59.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.389 0.675 . . . . 0.0 111.54 173.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.63 -151.78 45.16 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.401 0.438 . . . . 0.0 112.342 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.75 117.88 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 18.5 m -116.6 152.62 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.833 0.853 . . . . 0.0 109.466 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.58 ' HB2' HG21 ' A' ' 183' ' ' ILE . 5.4 pm0 -107.57 123.97 49.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.976 0.51 . . . . 0.0 109.716 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.604 ' HE3' ' HB3' ' A' ' 203' ' ' ASP . 74.9 mtp -131.16 170.13 14.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.58 0.752 . . . . 0.0 110.045 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -109.41 175.4 5.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.922 0.889 . . . . 0.0 109.904 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 45.8 t -63.73 -40.02 95.72 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.884 0.474 . . . . 0.0 110.687 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -65.46 -7.32 13.59 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.604 ' HB3' ' HE3' ' A' ' 199' ' ' MET . 56.9 m-20 -101.87 -54.64 2.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.027 0.931 . . . . 0.0 111.345 172.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 32.6 m -91.72 119.94 39.94 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -168.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.426 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 16.0 mmt180 -123.12 141.4 52.01 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.937 -169.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.81 132.18 51.55 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 168.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.639 ' HB3' ' HB2' ' A' ' 142' ' ' ASP . 4.2 ptm180 -111.71 158.35 19.43 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.772 0.429 . . . . 0.0 111.119 -173.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.64 140.64 29.33 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.858 0.463 . . . . 0.0 109.882 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.513 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 10.9 ptm180 -93.43 18.11 10.32 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.378 0.609 . . . . 0.0 110.537 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 87.8 m -98.91 113.99 26.39 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.304 1.042 . . . . 0.0 109.996 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 30.6 mt -86.94 124.49 40.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 169.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.613 ' HB ' ' HB ' ' A' ' 277' ' ' VAL . 47.9 mm -86.37 127.3 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.755 1.222 . . . . 0.0 109.917 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.87 -178.91 3.6 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.208 1.003 . . . . 0.0 108.625 171.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . 0.4 ' HA ' HD23 ' A' ' 217' ' ' LEU . 64.4 t-105 -54.29 -32.92 57.54 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.128 0.571 . . . . 0.0 112.269 -172.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -61.77 -39.17 90.73 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.529 0.731 . . . . 0.0 111.487 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.535 ' HB2' HG21 ' A' ' 212' ' ' ILE . 7.1 m-20 -84.6 -14.52 48.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.85 0.86 . . . . 0.0 111.67 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.429 HD21 HG22 ' A' ' 212' ' ' ILE . 3.2 mm? -66.7 113.41 4.81 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.7 140.94 34.99 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.129 0.971 . . . . 0.0 108.438 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.1 m -70.0 138.49 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 120.966 0.412 . . . . 0.0 110.899 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 94.06 -13.78 66.66 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.324 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.47 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.1 tt0 -81.68 122.77 28.05 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.344 0.572 . . . . 0.0 110.837 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.83 119.66 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.55 ' HA ' HG12 ' A' ' 280' ' ' ILE . 1.9 m -135.27 172.58 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.587 1.155 . . . . 0.0 110.265 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.535 ' HE1' ' HB2' ' A' ' 278' ' ' PHE . 48.4 ttp -110.32 113.98 27.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.257 0.623 . . . . 0.0 110.08 -174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.511 ' HG ' HG12 ' A' ' 277' ' ' VAL . 0.2 OUTLIER -121.97 147.16 46.41 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.281 0.632 . . . . 0.0 109.502 -173.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -87.44 124.09 33.06 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.575 0.75 . . . . 0.0 110.143 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' A' ' 225' ' ' LEU . 7.3 p90 -169.07 154.2 5.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.061 0.944 . . . . 0.0 109.357 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -82.11 127.83 70.23 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 162.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.77 -38.89 77.57 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.304 2.003 . . . . 0.0 111.939 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -75.59 -30.1 59.51 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.021 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -132.9 79.87 62.21 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 123.3 0.64 . . . . 0.0 110.643 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.95 -11.96 32.18 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.135 2.557 . . . . 0.0 113.389 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.466 ' HA ' HD12 ' A' ' 272' ' ' ILE . 22.3 tptm -70.99 -24.23 62.35 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.35 0.66 . . . . 0.0 110.931 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.68 164.56 24.75 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.0 0.52 . . . . 0.0 111.033 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -51.49 160.08 0.65 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.335 1.454 . . . . 0.0 112.804 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -166.02 -107.32 0.2 Allowed Glycine 0 C--N 1.344 1.018 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -128.18 173.18 10.33 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.773 0.829 . . . . 0.0 109.11 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -96.65 127.16 42.37 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.452 0.701 . . . . 0.0 110.049 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -138.95 164.54 29.45 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.371 0.668 . . . . 0.0 110.051 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.4 140.44 34.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -150.95 137.38 18.62 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -95.42 126.42 40.7 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.475 HD12 HD12 ' A' ' 255' ' ' LEU . 19.0 mm -67.65 110.39 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.052 0.453 . . . . 0.0 109.801 -175.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 17.1 m -79.3 -39.66 32.35 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.823 0.849 . . . . 0.0 110.666 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -161.97 156.08 21.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.79 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -141.69 148.29 38.84 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.511 ' HB3' ' HG3' ' A' ' 254' ' ' GLU . 28.1 tpt180 -149.87 122.15 8.39 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -115.32 123.69 49.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.113 0.565 . . . . 0.0 109.873 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 62.2 p -121.6 162.95 19.73 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -67.18 -22.31 65.75 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 120.759 0.314 . . . . 0.0 111.401 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.2 p -86.41 -28.99 23.22 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.375 0.67 . . . . 0.0 111.414 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -165.67 141.41 5.1 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.431 ' O ' ' HD2' ' A' ' 253' ' ' ARG . 4.2 ppt_? -111.18 102.52 10.94 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.675 0.79 . . . . 0.0 109.569 173.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.511 ' HG3' ' HB3' ' A' ' 247' ' ' ARG . 7.6 pt-20 -95.71 122.85 38.92 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.634 0.774 . . . . 0.0 110.722 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.475 HD12 HD12 ' A' ' 243' ' ' ILE . 1.7 tm? -108.77 147.85 31.41 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . 0.425 ' N ' HD13 ' A' ' 255' ' ' LEU . 99.3 m-85 -135.04 132.31 38.1 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.264 1.026 . . . . 0.0 108.516 175.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.46 139.94 28.62 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 43.5 t30 -75.66 95.54 3.41 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 172.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 34.3 t -68.79 112.16 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.372 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.79 117.92 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 264' ' ' ASP . 59.8 mt -94.5 -165.78 1.37 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.497 0.719 . . . . 0.0 109.423 173.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -62.85 -45.3 95.99 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.01 0.194 . . . . 0.0 113.341 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -123.06 -35.98 2.92 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.546 0.738 . . . . 0.0 110.646 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.556 ' HB2' HD13 ' A' ' 261' ' ' LEU . 8.2 m-20 -91.79 176.55 6.49 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.83 0.852 . . . . 0.0 111.574 -172.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 35.1 t -156.59 118.08 3.82 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.514 0.726 . . . . 0.0 110.201 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 2.0 mm? -96.15 92.11 6.25 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 3.2 p-10 -68.7 138.61 55.07 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.353 0.261 . . . . 0.0 111.289 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 57.88 32.53 22.05 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.291 1.036 . . . . 0.0 111.786 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 44.0 t -65.27 127.27 31.05 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.41 0.684 . . . . 0.0 110.411 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 45.0 ttp180 -70.51 110.49 5.42 Favored 'General case' 0 C--N 1.346 0.456 0 O-C-N 123.436 0.46 . . . . 0.0 110.343 -178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.1 mm -89.43 132.78 33.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.774 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 233' ' ' LYS . 65.0 mt -102.09 -26.31 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.082 1.353 . . . . 0.0 109.932 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -92.38 42.62 1.11 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.124 1.37 . . . . 0.0 111.336 -168.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 16.7 m -69.59 -22.84 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -168.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.85 -25.22 19.07 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.96 9.12 17.9 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.762 0.825 . . . . 0.0 112.332 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.613 ' HB ' ' HB ' ' A' ' 212' ' ' ILE . 32.7 t -80.56 147.05 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.391 0.676 . . . . 0.0 110.836 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.535 ' HB2' ' HE1' ' A' ' 224' ' ' MET . 62.7 m-85 -105.8 156.26 18.49 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 162.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.539 ' HA ' HG11 ' A' ' 223' ' ' VAL . 36.5 ttmt -80.57 146.58 31.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.666 0.386 . . . . 0.0 110.417 173.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.55 HG12 ' HA ' ' A' ' 223' ' ' VAL . 35.1 mm -73.48 114.91 13.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 168.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -76.6 134.06 39.47 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.631 173.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 61.5 mtp180 -108.38 94.2 13.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 168.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -20.17 97.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.386 2.551 1 C-N-CA 126.263 4.642 . . . . 0.0 117.246 -162.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 103.53 -30.84 9.5 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 115.347 -0.842 . . . . 0.0 115.189 169.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 11.6 pt-20 -79.51 -20.21 47.77 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.859 1.33 . . . . 0.0 112.004 -173.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -87.46 -100.57 0.87 Allowed Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' SER . . . . . 0.421 ' HB2' ' HG2' ' A' ' 209' ' ' ARG . 14.6 p -127.23 128.52 24.08 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.535 1.134 . . . . 0.0 110.791 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.52 133.66 17.65 Favored 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 123.29 2.66 . . . . 0.0 112.921 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 98.3 mmm -86.45 82.49 7.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 168.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 11.2 p -128.58 -15.03 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.757 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -103.42 -153.18 0.47 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.701 1.2 . . . . 0.0 108.625 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -55.17 120.19 28.28 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.566 0.747 . . . . 0.0 111.575 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.33 85.12 0.45 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.817 2.345 . . . . 0.0 111.336 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 18.7 ptm -71.05 82.39 0.68 Allowed 'General case' 0 C--O 1.244 0.767 0 CA-C-O 123.037 1.399 . . . . 0.0 109.895 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -94.73 160.03 14.8 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.77 -172.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.434 ' NH2' ' H ' ' A' ' 153' ' ' GLU . 30.6 mtm-85 -87.3 118.79 26.96 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.108 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.6 mttt 64.81 -170.89 0.19 Allowed 'General case' 0 CA--C 1.551 1.002 0 O-C-N 124.565 1.166 . . . . 0.0 111.078 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 C--O 1.24 0.562 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 160.272 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.428 ' N ' HD12 ' A' ' 134' ' ' LEU . . . . . . . . 0 N--CA 1.485 1.955 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -127.29 5.67 6.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.488 0.715 . . . . 0.0 112.323 -173.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.486 ' HB2' HG13 ' A' ' 156' ' ' VAL . 43.0 m-85 -96.93 143.08 28.14 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.475 0.31 . . . . 0.0 110.433 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.517 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 22.6 pttp -86.14 176.8 7.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.037 0.535 . . . . 0.0 111.055 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.65 -10.27 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -173.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -127.44 21.59 6.59 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.747 0.419 . . . . 0.0 110.44 -171.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.517 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 17.9 mm-40 -99.65 88.62 3.88 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 122.038 -0.414 . . . . 0.0 110.798 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.685 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 25.6 p90 -76.75 122.87 25.35 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.339 171.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.26 167.42 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.617 0.767 . . . . 0.0 108.968 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -90.72 115.12 27.57 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.79 120.37 36.33 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.588 -167.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.54 128.37 35.39 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.85 112.45 5.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 t -68.02 -14.35 62.9 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.464 0.705 . . . . 0.0 112.702 -172.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -86.76 -54.12 4.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.343 0.657 . . . . 0.0 111.107 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 37.8 ttp -96.34 -27.83 14.77 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.411 0.685 . . . . 0.0 112.084 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.72 18.85 46.35 Favored Glycine 0 N--CA 1.475 1.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.946 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.75 129.37 53.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.119 0.568 . . . . 0.0 111.062 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.658 ' HH2' ' HD2' ' A' ' 205' ' ' ARG . 81.4 m95 -75.22 128.09 34.66 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.64 0.776 . . . . 0.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -131.8 137.66 48.22 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.283 1.033 . . . . 0.0 108.925 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -59.32 114.43 2.65 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -125.54 120.67 31.5 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.199 0.6 . . . . 0.0 109.796 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.685 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 51.6 tt0 -87.19 114.75 24.07 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.605 0.762 . . . . 0.0 110.554 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.486 HG13 ' HB2' ' A' ' 135' ' ' TYR . 92.5 t -62.28 98.41 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.7 m -94.88 -10.02 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.912 0.485 . . . . 0.0 111.076 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 27.8 ttt180 -170.25 146.7 2.97 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.975 0.797 . . . . 0.0 109.92 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.0 m -117.17 142.9 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 169.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.644 ' HG1' ' HB ' ' A' ' 183' ' ' ILE . 31.3 p -135.21 121.49 20.3 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 172.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -82.18 176.47 9.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.029 0.532 . . . . 0.0 111.051 -175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.77 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 . . . . . 0 C--O 1.241 0.621 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.23 97.43 1.55 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.025 -171.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -76.66 53.14 0.87 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.823 0.82 . . . . 0.0 110.435 169.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 31.6 m -83.85 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 124.603 1.161 . . . . 0.0 109.624 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.644 ' HB ' ' HG1' ' A' ' 160' ' ' THR . 3.5 mp -97.3 106.21 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -93.54 111.17 22.78 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 14.5 m-70 -80.01 90.28 5.38 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 35.0 m -108.97 140.2 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.32 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -105.74 123.45 47.97 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -57.04 96.3 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -62.96 -29.63 70.96 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.006 0.922 . . . . 0.0 109.076 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 298' ' ' SER . 2.0 t0 -61.83 -30.96 71.18 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.086 1.354 . . . . 0.0 111.031 176.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -145.75 81.27 10.1 Favored Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 124.549 1.14 . . . . 0.0 108.624 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -65.05 -16.86 57.36 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.076 2.517 . . . . 0.0 114.618 -170.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.53 -18.7 65.13 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -74.67 -20.9 59.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.206 0.602 . . . . 0.0 111.626 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.41 -144.6 41.04 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.511 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 6.8 t -87.66 129.55 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.217 0.607 . . . . 0.0 110.424 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.7 153.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.045 1.338 . . . . 0.0 108.52 170.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.536 ' HB2' HG22 ' A' ' 183' ' ' ILE . 16.2 pt20 -102.88 128.74 49.54 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.124 0.488 . . . . 0.0 110.305 177.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 84.2 mtp -137.61 159.82 40.9 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.33 1.052 . . . . 0.0 108.73 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -97.81 174.23 6.7 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.6 t -64.21 -34.79 78.89 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 120.827 0.346 . . . . 0.0 110.746 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.46 -14.86 63.3 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -96.5 -45.29 6.81 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.716 0.807 . . . . 0.0 110.344 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 32.6 m -95.41 117.29 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.658 ' HD2' ' HH2' ' A' ' 151' ' ' TRP . 92.7 mtt180 -128.55 171.42 12.15 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.77 -0.582 . . . . 0.0 111.193 -168.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.58 129.4 40.43 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.374 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.581 ' HG3' ' SD ' ' A' ' 289' ' ' MET . 26.4 ptt180 -81.1 142.11 33.64 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.357 1.063 . . . . 0.0 111.229 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 281' ' ' GLU . . . -99.92 145.41 27.84 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.395 0.678 . . . . 0.0 110.339 175.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -2.38 34.81 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.657 0.783 . . . . 0.0 110.558 173.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.5 m -89.49 117.71 28.6 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.473 0.709 . . . . 0.0 111.332 -165.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.3 mt -92.4 136.26 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 166.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.656 HG23 HD12 ' A' ' 217' ' ' LEU . 19.9 mm -107.46 153.55 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.951 0.9 . . . . 0.0 110.372 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -128.26 168.52 15.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.549 0.74 . . . . 0.0 109.066 167.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 35.9 t90 -46.32 -41.86 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.344 1.058 . . . . 0.0 112.096 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -57.68 -46.3 84.48 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.85 0.86 . . . . 0.0 112.637 -173.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -103.65 6.3 36.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.504 0.722 . . . . 0.0 111.023 -175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.656 HD12 HG23 ' A' ' 212' ' ' ILE . 8.0 tp -86.63 110.96 20.2 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 175.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.7 153.35 25.39 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.947 0.34 . . . . 0.0 110.861 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.421 ' HA ' ' HB ' ' A' ' 243' ' ' ILE . 28.0 m -66.13 136.99 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.701 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.0 -23.62 34.89 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.622 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.523 ' HG2' HG11 ' A' ' 223' ' ' VAL . 9.5 tt0 -74.69 123.39 24.81 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.119 0.567 . . . . 0.0 110.373 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 84.5 t -85.8 119.91 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.523 HG11 ' HG2' ' A' ' 221' ' ' GLN . 3.5 m -132.69 164.54 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.226 1.41 . . . . 0.0 109.856 -177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.546 ' HB3' HD13 ' A' ' 280' ' ' ILE . 15.0 ptm -112.28 139.11 48.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.635 0.774 . . . . 0.0 110.353 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.537 HD12 HG23 ' A' ' 271' ' ' ILE . 0.6 OUTLIER -142.69 157.28 44.83 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -89.37 112.23 23.29 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.195 0.598 . . . . 0.0 109.65 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.482 ' HH ' ' HB2' ' A' ' 239' ' ' TYR . 0.5 OUTLIER -159.89 149.69 18.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.692 0.797 . . . . 0.0 109.321 178.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -92.76 137.37 24.14 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 171.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.82 2.53 5.83 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.733 2.289 . . . . 0.0 113.66 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -96.77 -15.93 21.1 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.869 0.868 . . . . 0.0 110.726 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -160.08 90.48 1.79 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.606 0.762 . . . . 0.0 109.025 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.05 -5.19 15.8 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.067 2.511 . . . . 0.0 112.33 175.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.547 ' HA ' HD13 ' A' ' 272' ' ' ILE . 88.6 tttt -73.45 -28.29 61.88 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.772 0.829 . . . . 0.0 111.171 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -123.84 155.18 38.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.09 0.556 . . . . 0.0 110.263 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -68.75 174.3 4.45 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.263 1.025 . . . . 0.0 112.76 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -178.8 -105.03 0.19 Allowed Glycine 0 C--N 1.338 0.67 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.932 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -110.04 153.03 25.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 0.0 109.408 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . 0.428 ' HA ' ' O ' ' A' ' 225' ' ' LEU . 67.2 m95 -83.58 106.38 15.27 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 122.796 0.438 . . . . 0.0 110.074 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.482 ' HB2' ' HH ' ' A' ' 227' ' ' TYR . 84.3 m-85 -112.62 166.08 11.67 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . 0.482 ' HB2' HG12 ' A' ' 260' ' ' VAL . 3.8 m-20 -81.32 146.21 30.48 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.223 176.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -146.47 134.51 21.5 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -102.39 117.28 34.38 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 219' ' ' VAL . 31.8 mm -61.98 114.8 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 123.352 0.407 . . . . 0.0 110.377 -171.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 20.1 m -98.86 -25.01 14.76 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.463 0.705 . . . . 0.0 110.449 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 23.9 ttm180 -166.89 151.71 7.42 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.726 0.811 . . . . 0.0 109.381 -174.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -156.42 134.3 11.09 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.963 0.505 . . . . 0.0 110.388 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -146.51 116.38 7.27 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 8.9 pt-20 -100.16 152.18 20.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.194 0.521 . . . . 0.0 109.824 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 69.5 p -131.96 168.03 18.62 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -67.93 -15.98 63.86 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 117.829 0.286 . . . . 0.0 111.32 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.6 p -94.01 -29.87 15.0 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.843 0.857 . . . . 0.0 112.027 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -168.62 134.73 1.82 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 122.917 0.487 . . . . 0.0 111.528 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 46.9 mtt180 -90.79 106.88 18.82 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -95.95 143.55 27.03 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.301 0.64 . . . . 0.0 109.643 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 5.6 tt -150.0 149.84 30.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . 0.48 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 82.4 m-85 -134.72 124.84 25.89 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -134.54 147.88 50.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.11 0.564 . . . . 0.0 110.459 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 35.0 t30 -76.01 92.49 3.16 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 15.7 t -67.96 130.42 33.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.649 174.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 240' ' ' ASP . 4.3 p -122.47 114.26 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 40.4 mt -89.35 -155.63 0.36 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.221 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -81.3 -49.25 5.6 Favored Glycine 0 C--N 1.344 1.0 0 C-N-CA 121.932 -0.175 . . . . 0.0 112.722 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -104.99 -24.22 12.85 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.259 0.624 . . . . 0.0 111.988 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -139.57 175.66 9.38 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.97 0.508 . . . . 0.0 109.899 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 17.6 p -144.76 131.47 20.05 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.158 0.583 . . . . 0.0 111.315 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 14.7 mt -97.87 89.83 4.73 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.699 1.2 . . . . 0.0 109.38 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 18.4 t-20 -69.98 135.15 49.09 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.14 0.576 . . . . 0.0 111.44 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 57.18 29.7 17.1 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.532 1.133 . . . . 0.0 112.825 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 39.3 t -66.43 130.39 43.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.005 0.522 . . . . 0.0 109.968 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -69.58 131.22 44.33 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.032 0.444 . . . . 0.0 111.361 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.537 HG23 HD12 ' A' ' 225' ' ' LEU . 48.8 mm -108.24 114.44 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.838 1.255 . . . . 0.0 109.335 -175.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.547 HD13 ' HA ' ' A' ' 233' ' ' LYS . 11.9 mt -87.94 -21.96 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.579 0.752 . . . . 0.0 109.893 173.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.79 38.54 0.84 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.262 1.025 . . . . 0.0 111.461 -173.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 26.8 m -63.19 -21.33 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.543 0.737 . . . . 0.0 111.861 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.92 -27.62 14.19 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.895 1.278 . . . . 0.0 110.543 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -106.17 10.82 31.81 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.198 0.999 . . . . 0.0 111.434 -170.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.528 HG12 ' HB ' ' A' ' 212' ' ' ILE . 7.4 p -86.17 131.14 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.527 0.731 . . . . 0.0 109.515 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -101.27 164.21 11.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.478 1.111 . . . . 0.0 109.41 172.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.608 ' HB2' HD13 ' A' ' 212' ' ' ILE . 40.4 ttmt -83.76 142.32 30.77 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.153 0.581 . . . . 0.0 110.994 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 224' ' ' MET . 21.0 mm -84.04 117.47 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 165.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 208' ' ' ALA . 0.3 OUTLIER -83.63 106.34 15.27 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -97.65 92.35 1.3 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -15.33 90.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.474 1 C-N-CA 126.621 4.881 . . . . 0.0 117.037 -161.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.26 6.05 51.7 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.441 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -121.11 -23.06 5.9 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.438 0.695 . . . . 0.0 110.704 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -83.79 -126.88 1.31 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 174.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 23.0 m -127.81 142.36 44.02 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-N 117.62 0.71 . . . . 0.0 110.654 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.71 114.81 4.12 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.81 2.34 . . . . 0.0 111.036 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' MET . . . . . 0.581 ' SD ' ' HG3' ' A' ' 207' ' ' ARG . 26.5 ttt -73.94 92.76 2.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.564 0.697 . . . . 0.0 110.055 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 11.1 p -123.19 24.19 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 125.057 1.343 . . . . 0.0 108.687 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.09 -171.28 2.84 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.191 -165.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -47.2 141.71 6.06 Favored Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 125.048 1.339 . . . . 0.0 113.663 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.42 146.84 86.39 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.069 2.512 . . . . 0.0 112.582 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.4 mmt -82.39 -88.03 0.09 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.147 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 56.25 50.6 13.08 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -165.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -59.07 104.03 0.21 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.948 -1.933 . . . . 0.0 111.623 -170.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.575 ' HB3' ' HZ2' ' A' ' 297' ' ' LYS . 0.0 OUTLIER 58.54 26.28 14.15 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.13 0.972 . . . . 0.0 110.544 176.026 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 190' ' ' ASP . 78.4 p . . . . . 0 C--O 1.244 0.767 0 C-N-CA 123.204 0.601 . . . . 0.0 111.446 -172.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.791 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 135' ' ' TYR . 0.0 OUTLIER -59.09 -32.78 70.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.351 0.66 . . . . 0.0 112.475 -177.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.444 ' N ' HD22 ' A' ' 134' ' ' LEU . 48.8 m-85 -79.62 152.16 30.18 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -114.94 176.83 4.89 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 109.134 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.0 m -71.67 -2.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.479 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -117.66 7.68 12.63 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.877 0.871 . . . . 0.0 111.38 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -86.48 90.92 8.38 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.898 0.479 . . . . 0.0 111.211 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 50.4 p90 -63.81 123.36 18.71 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.612 167.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.19 -170.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.597 0.759 . . . . 0.0 110.154 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.458 ' HB3' ' HB2' ' A' ' 205' ' ' ARG . 47.0 t0 -106.1 158.39 16.85 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 165.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -140.27 111.45 7.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.36 0.527 . . . . 0.0 109.586 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -70.77 93.71 0.98 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -62.03 132.48 53.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.696 1.198 . . . . 0.0 112.1 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.3 p -86.8 -14.11 43.16 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.092 0.957 . . . . 0.0 111.36 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.92 -53.82 7.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.064 0.546 . . . . 0.0 110.479 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 53.8 ttm -100.68 -36.25 9.19 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.437 0.695 . . . . 0.0 111.239 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.61 16.68 48.11 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.443 -172.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -103.96 150.58 24.09 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.768 0.827 . . . . 0.0 110.283 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.451 ' HZ3' ' HG3' ' A' ' 205' ' ' ARG . 18.5 m95 -83.05 118.61 23.65 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -124.06 112.35 17.04 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.127 0.571 . . . . 0.0 109.648 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.635 ' HB2' ' HD2' ' A' ' 295' ' ' ARG . 5.6 pt-20 -58.48 128.96 39.78 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.701 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.437 ' HA ' ' H ' ' A' ' 189' ' ' ASP . . . -144.1 -175.72 4.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.218 1.007 . . . . 0.0 111.136 -168.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.6 tt0 -140.25 125.49 18.76 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.038 0.535 . . . . 0.0 109.906 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.9 t -62.13 115.48 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 124.026 0.93 . . . . 0.0 108.921 169.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.532 HG13 ' HE2' ' A' ' 187' ' ' LYS . 35.5 m -116.99 -3.48 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.238 0.615 . . . . 0.0 112.007 -178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 29.2 ttm180 -162.4 139.39 8.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.186 0.594 . . . . 0.0 109.488 173.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.436 HG11 ' O ' ' A' ' 135' ' ' TYR . 11.6 m -119.2 134.4 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.419 0.688 . . . . 0.0 109.693 176.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.541 HG21 ' HB ' ' A' ' 183' ' ' ILE . 3.2 t -147.09 161.51 40.71 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.885 0.874 . . . . 0.0 109.907 175.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -115.97 149.96 37.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.949 0.9 . . . . 0.0 110.145 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 N--CA 1.483 1.194 0 C-N-CA 123.758 0.823 . . . . 0.0 109.358 173.643 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.96 83.49 2.85 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.195 0.598 . . . . 0.0 109.6 -173.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 200' ' ' ASN . 5.9 m-20 -80.34 63.19 4.73 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.118 0.961 . . . . 0.0 109.364 171.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 34.7 m -105.54 159.27 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.641 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.541 ' HB ' HG21 ' A' ' 160' ' ' THR . 2.3 mp -93.18 108.97 21.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.979 0.895 . . . . 0.0 108.99 -173.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -92.54 108.3 19.87 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.518 167.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 33.2 m-70 -77.05 100.09 5.55 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.93 142.81 20.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 123.811 0.694 . . . . 0.0 109.223 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.57 ' HG2' HG21 ' A' ' 196' ' ' VAL . 42.9 mtmt -103.59 121.62 43.29 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 170.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -60.7 108.51 0.85 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.437 ' H ' ' HA ' ' A' ' 154' ' ' ALA . 20.9 t70 -57.75 -42.13 83.33 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.905 0.882 . . . . 0.0 110.737 -173.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.94 -19.0 32.84 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.98 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -133.77 64.72 68.52 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 122.907 0.483 . . . . 0.0 110.607 -177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.0 -11.77 32.68 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.635 2.223 . . . . 0.0 112.559 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.85 -30.64 70.08 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.899 0.88 . . . . 0.0 111.229 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -72.24 -16.76 61.94 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.376 0.67 . . . . 0.0 110.512 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 87.31 -166.33 36.46 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.811 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.57 HG21 ' HG2' ' A' ' 187' ' ' LYS . 6.5 t -93.04 125.24 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.65 157.01 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.782 0.833 . . . . 0.0 110.68 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.55 114.59 28.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.582 1.153 . . . . 0.0 109.192 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.516 ' HE1' ' HB3' ' A' ' 203' ' ' ASP . 77.3 mmm -126.94 138.89 53.35 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.449 0.7 . . . . 0.0 110.065 -173.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 20.6 m-80 -83.18 173.41 11.69 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.307 0.643 . . . . 0.0 109.865 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 29.8 t -56.15 -43.99 78.81 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.567 0.747 . . . . 0.0 111.813 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -54.04 -33.83 58.39 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.548 1.139 . . . . 0.0 111.947 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.516 ' HB3' ' HE1' ' A' ' 199' ' ' MET . 50.3 m-20 -88.28 -33.26 18.11 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.998 0.919 . . . . 0.0 111.661 -172.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 10.3 m -92.72 117.1 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 122.275 1.036 . . . . 0.0 108.483 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.458 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 22.3 mmm180 -109.66 168.65 9.25 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.836 -165.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.579 ' HA ' ' NH2' ' A' ' 207' ' ' ARG . . . -88.93 144.73 25.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.907 172.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.579 ' NH2' ' HA ' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -80.06 93.25 5.74 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.9 97.08 0.21 Allowed 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.437 ' H ' ' NE ' ' A' ' 209' ' ' ARG . 0.0 OUTLIER -76.75 71.13 3.3 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.639 1.209 . . . . 0.0 110.141 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.9 m -146.09 110.38 5.03 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.937 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 28.7 mt -83.35 134.23 27.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.453 HD13 ' HB2' ' A' ' 279' ' ' LYS . 42.6 mm -82.51 139.41 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.308 0.575 . . . . 0.0 110.951 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -124.41 160.03 29.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.12 1.368 . . . . 0.0 109.392 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . 0.565 ' HA ' HD23 ' A' ' 217' ' ' LEU . 31.9 t90 -56.2 -40.48 74.08 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.756 0.823 . . . . 0.0 112.323 -169.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -56.79 -41.77 78.29 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.663 0.785 . . . . 0.0 110.98 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.98 -21.27 51.18 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.881 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.565 HD23 ' HA ' ' A' ' 214' ' ' TRP . 2.4 mm? -63.02 115.37 4.36 Favored 'General case' 0 C--N 1.364 1.205 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -143.98 148.93 35.98 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.49 0.716 . . . . 0.0 109.556 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.38 135.02 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 122.781 0.433 . . . . 0.0 110.726 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.64 -9.44 77.0 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.633 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.467 ' HG2' HG12 ' A' ' 223' ' ' VAL . 29.7 tt0 -85.77 122.48 29.91 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.975 0.51 . . . . 0.0 110.445 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 72.8 t -93.66 114.47 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.467 HG12 ' HG2' ' A' ' 221' ' ' GLN . 13.1 m -126.91 160.27 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.957 0.903 . . . . 0.0 109.237 176.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 238' ' ' TRP . 44.0 ttp -95.16 111.56 23.37 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.869 0.467 . . . . 0.0 110.604 -176.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.545 HD22 HG13 ' A' ' 271' ' ' ILE . 0.8 OUTLIER -111.24 155.62 22.69 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.62 0.768 . . . . 0.0 109.143 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.459 HD21 ' NE ' ' A' ' 235' ' ' ARG . 9.1 p-10 -97.57 121.27 39.28 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.219 1.008 . . . . 0.0 111.009 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.554 ' HB2' ' HA ' ' A' ' 232' ' ' PRO . 6.9 p90 -168.15 155.89 8.37 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.334 1.053 . . . . 0.0 109.801 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -83.27 137.09 42.67 Favored Pre-proline 0 CA--C 1.555 1.157 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 171.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.75 -28.43 68.41 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.0 1.8 . . . . 0.0 111.917 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.64 -30.27 36.65 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.553 0.741 . . . . 0.0 110.918 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -140.81 90.34 9.66 Favored Pre-proline 0 N--CA 1.489 1.51 0 C-N-CA 123.692 0.797 . . . . 0.0 110.174 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . 0.554 ' HA ' ' HB2' ' A' ' 227' ' ' TYR . 38.8 Cg_endo -66.05 -8.24 19.47 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.453 2.102 . . . . 0.0 112.16 170.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.402 ' O ' HD13 ' A' ' 272' ' ' ILE . 21.3 tptm -74.18 -26.78 60.48 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.607 1.163 . . . . 0.0 110.967 173.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -117.19 147.14 42.74 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.332 0.653 . . . . 0.0 110.877 -172.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.459 ' NE ' HD21 ' A' ' 226' ' ' ASN . 3.3 tmt_? -69.0 117.29 10.47 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.656 1.582 . . . . 0.0 109.764 -176.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -134.26 -130.66 3.03 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 123.31 0.381 . . . . 0.0 112.427 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.419 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 42.0 m-85 -83.92 171.23 13.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.675 0.79 . . . . 0.0 110.819 -173.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . 0.538 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 97.6 m95 -91.38 112.38 24.26 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.254 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 68.3 m-85 -126.09 149.12 49.14 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 174.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.5 p-10 -82.44 157.11 23.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.488 ' HA ' HG21 ' A' ' 260' ' ' VAL . . . -162.93 140.76 8.07 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.216 0.606 . . . . 0.0 110.663 -176.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -90.51 118.6 30.1 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.144 0.578 . . . . 0.0 109.885 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.443 HD11 HD13 ' A' ' 255' ' ' LEU . 32.1 mm -62.8 126.36 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.38 0.672 . . . . 0.0 110.413 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.6 t -105.62 -38.47 6.41 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.466 1.106 . . . . 0.0 111.214 -174.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.55 143.25 11.53 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -135.71 143.48 45.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -155.33 114.94 3.67 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -100.13 121.6 41.67 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.8 p -84.64 -170.97 3.37 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 170.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -67.12 -34.63 78.01 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.01 23.79 3.89 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 120.696 0.284 . . . . 0.0 111.232 -171.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -159.35 129.07 5.52 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.261 0.625 . . . . 0.0 110.658 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.469 ' HD2' HG21 ' A' ' 274' ' ' VAL . 36.5 ttm180 -99.58 102.27 13.73 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.2 139.79 30.27 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.443 HD13 HD11 ' A' ' 243' ' ' ILE . 3.3 tm? -147.41 140.31 24.99 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -176.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -122.3 119.69 31.87 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.315 1.046 . . . . 0.0 108.538 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.77 137.15 54.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.81 0.844 . . . . 0.0 110.254 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -81.63 98.29 8.29 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.704 1.202 . . . . 0.0 108.34 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 58.9 t -63.31 134.16 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.857 0.863 . . . . 0.0 110.915 -173.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.488 HG21 ' HA ' ' A' ' 241' ' ' ALA . 38.4 t -117.26 107.05 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.33 -151.45 0.26 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.235 1.014 . . . . 0.0 110.078 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -55.11 -71.83 0.66 Allowed Glycine 0 C--N 1.355 1.629 0 C-N-CA 123.066 0.365 . . . . 0.0 113.779 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -123.34 -16.66 6.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.477 0.711 . . . . 0.0 110.302 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -87.59 174.49 8.42 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.782 0.833 . . . . 0.0 111.006 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 65.8 p -153.43 138.3 17.13 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.181 0.593 . . . . 0.0 110.666 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 20.9 mt -108.72 90.91 3.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.991 0.916 . . . . 0.0 108.636 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -67.32 143.69 56.27 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 117.945 0.338 . . . . 0.0 111.113 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 33.1 t70 58.75 75.8 0.38 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.513 1.125 . . . . 0.0 111.748 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 68.8 m -113.48 126.32 55.2 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.413 0.685 . . . . 0.0 109.298 170.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -71.43 113.27 8.29 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.545 HG13 HD22 ' A' ' 225' ' ' LEU . 39.9 mm -94.3 123.58 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.962 0.505 . . . . 0.0 109.844 -174.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.402 HD13 ' O ' ' A' ' 233' ' ' LYS . 59.4 mt -83.76 -36.38 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.221 1.008 . . . . 0.0 110.5 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -96.14 51.15 1.2 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 122.262 1.03 . . . . 0.0 110.574 -167.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . 0.469 HG21 ' HD2' ' A' ' 253' ' ' ARG . 23.9 m -72.14 -16.69 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.696 -1.593 . . . . 0.0 113.292 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.72 -15.07 33.32 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.936 0.494 . . . . 0.0 110.982 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -96.93 4.55 51.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.369 0.668 . . . . 0.0 111.634 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.409 HG12 ' HG ' ' A' ' 225' ' ' LEU . 43.4 t -76.4 146.15 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.36 0.664 . . . . 0.0 111.455 -175.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -126.65 160.16 31.52 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.045 0.938 . . . . 0.0 109.859 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.453 ' HB2' HD13 ' A' ' 212' ' ' ILE . 22.4 ttmm -84.87 149.21 25.84 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.306 0.643 . . . . 0.0 111.77 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.44 HD13 ' HB2' ' A' ' 224' ' ' MET . 50.2 mm -92.29 126.78 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 169.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 105.36 13.55 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.334 0.653 . . . . 0.0 110.559 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -93.18 146.06 31.22 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 123.777 0.831 . . . . 0.0 111.153 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -41.94 119.17 1.11 Allowed 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 124.525 3.484 . . . . 0.0 115.005 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 97.0 -51.88 1.44 Allowed Glycine 0 C--N 1.352 1.425 0 O-C-N 123.333 0.396 . . . . 0.0 112.205 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -71.73 -22.85 61.57 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.663 1.185 . . . . 0.0 110.47 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -77.38 78.39 1.46 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.9 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 14.8 m -71.24 146.97 92.92 Favored Pre-proline 0 C--O 1.246 0.896 0 C-N-CA 123.424 0.69 . . . . 0.0 109.911 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.25 157.03 62.89 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.744 2.296 . . . . 0.0 111.245 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' MET . . . . . 0.523 ' HE2' ' HA ' ' A' ' 293' ' ' PRO . 21.0 ttt -83.25 78.18 9.66 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.724 0.774 . . . . 0.0 109.393 -175.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 10.6 p -92.83 -28.43 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.372 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -74.81 162.33 28.76 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.012 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.45 140.5 13.5 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 124.703 1.201 . . . . 0.0 113.539 -167.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.523 ' HA ' ' HE2' ' A' ' 289' ' ' MET . 26.7 Cg_exo -62.12 109.63 0.86 Allowed 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.257 2.638 . . . . 0.0 112.922 -176.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -140.04 143.42 36.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.707 0.803 . . . . 0.0 109.891 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.635 ' HD2' ' HB2' ' A' ' 153' ' ' GLU . 49.4 mtm180 -129.91 -163.43 1.3 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -18.5 26.93 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.247 0.476 . . . . 0.0 110.738 -173.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -131.33 48.44 2.42 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 122.481 1.134 . . . . 0.0 109.398 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.7 p . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 164.924 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.4 ' HA3' ' CE1' ' A' ' 184' ' ' TYR . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 112.238 -0.345 . . . . 0.0 112.238 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.18 -10.04 14.66 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.262 1.025 . . . . 0.0 111.153 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -79.27 121.12 24.69 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -82.08 178.94 8.0 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.93 0.892 . . . . 0.0 111.407 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.14 29.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.708 1.203 . . . . 0.0 112.985 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -140.18 -50.39 0.47 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.528 1.131 . . . . 0.0 109.176 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -68.99 88.91 0.41 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.742 0.417 . . . . 0.0 111.268 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.4 ' HB3' ' OE1' ' A' ' 155' ' ' GLN . 22.1 p90 -75.35 138.35 41.7 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.341 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 206' ' ' ALA . 17.4 m -123.89 158.87 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.172 1.389 . . . . 0.0 109.854 -172.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -93.04 109.78 21.24 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.519 ' HB1' ' HE1' ' A' ' 199' ' ' MET . . . -93.74 120.46 34.03 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.69 0.796 . . . . 0.0 111.396 -168.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -72.78 98.86 2.49 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.658 0.783 . . . . 0.0 110.085 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.78 110.34 10.13 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.4 m -66.04 -27.53 68.17 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.032 0.933 . . . . 0.0 112.049 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -62.12 -50.68 70.94 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.973 0.509 . . . . 0.0 111.688 -171.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -102.27 -18.76 15.32 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 122.304 0.242 . . . . 0.0 111.64 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.44 50.63 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.237 0.336 . . . . 0.0 113.628 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.66 152.06 20.9 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.531 0.681 . . . . 0.0 112.554 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -80.06 120.89 24.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.159 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -127.3 115.84 19.62 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -62.27 137.71 58.3 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.621 0.575 . . . . 0.0 109.678 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -148.31 129.17 14.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.037 0.535 . . . . 0.0 111.384 -165.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.4 ' OE1' ' HB3' ' A' ' 140' ' ' TYR . 49.7 tp60 -87.29 114.54 23.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.492 0.717 . . . . 0.0 109.705 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.459 ' HA ' HG11 ' A' ' 186' ' ' VAL . 58.6 t -66.96 116.06 5.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.537 HG11 ' HE2' ' A' ' 187' ' ' LYS . 33.5 m -117.73 -9.4 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.171 0.588 . . . . 0.0 111.534 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.566 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 2.5 tpm_? -166.82 147.03 5.74 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.46 136.89 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 124.113 0.965 . . . . 0.0 109.655 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 10.2 t -148.77 163.33 37.68 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.323 1.049 . . . . 0.0 109.68 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 59.6 mtt-85 -122.77 170.4 10.11 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -172.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 94.1 mttt . . . . . 0 N--CA 1.479 0.993 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.002 173.653 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -67.61 85.76 0.19 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.815 0.697 . . . . 0.0 109.909 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -79.56 65.41 4.72 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 122.677 1.227 . . . . 0.0 108.202 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.64 177.35 3.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.838 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.547 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.3 mp -95.58 108.63 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.599 0.714 . . . . 0.0 109.342 -171.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.4 ' CE1' ' HA3' ' A' ' 133' ' ' GLY . 95.1 m-85 -97.59 107.2 19.65 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.857 1.263 . . . . 0.0 107.834 170.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 89.0 m-70 -78.77 102.5 8.16 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' A' ' 156' ' ' VAL . 20.9 m -114.92 150.9 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.125 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.537 ' HE2' HG11 ' A' ' 157' ' ' VAL . 45.0 mtmt -117.87 122.83 44.36 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -61.61 109.5 1.22 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.104 0.562 . . . . 0.0 111.329 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.3 -35.58 74.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -63.36 -34.73 78.35 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.815 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -155.02 82.07 4.07 Favored Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 124.655 1.182 . . . . 0.0 109.287 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -65.29 -27.34 55.8 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.807 3.005 . . . . 0.0 114.133 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.52 -1.96 17.89 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -75.13 -14.77 60.59 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.837 0.855 . . . . 0.0 111.436 171.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.86 -175.81 54.22 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.439 -0.346 . . . . 0.0 112.571 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.48 116.54 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.95 144.41 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.746 0.818 . . . . 0.0 109.144 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.547 ' HB2' HG23 ' A' ' 183' ' ' ILE . 28.9 pt20 -96.16 132.46 41.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.519 ' HE1' ' HB1' ' A' ' 143' ' ' ALA . 86.3 mmm -132.71 160.76 35.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.858 0.863 . . . . 0.0 109.193 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -110.88 175.1 5.55 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.882 0.473 . . . . 0.0 109.751 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 70.1 p -57.58 -45.87 84.69 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.673 0.789 . . . . 0.0 111.04 176.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -66.93 -8.49 29.91 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.082 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.494 ' HB3' ' HE3' ' A' ' 199' ' ' MET . 41.8 m-20 -97.31 -41.06 8.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.661 0.785 . . . . 0.0 110.87 173.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.59 132.91 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 112.773 0.656 . . . . 0.0 112.773 -169.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.601 ' HB3' ' HB3' ' A' ' 281' ' ' GLU . 39.5 mmt180 -112.29 155.72 23.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.827 1.251 . . . . 0.0 107.861 167.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.403 ' HA ' HG13 ' A' ' 141' ' ' VAL . . . -63.76 167.33 6.05 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.251 0.478 . . . . 0.0 110.87 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.67 95.82 6.7 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.25 97.86 0.13 Allowed 'General case' 0 C--N 1.36 1.023 0 C-N-CA 123.164 0.586 . . . . 0.0 109.841 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.449 ' NH2' ' HB2' ' A' ' 292' ' ' ASN . 3.5 tmt_? -84.45 76.52 10.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -172.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 73.1 m -147.19 119.06 8.11 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.062 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.508 HD12 ' HE1' ' A' ' 294' ' ' MET . 58.8 mt -85.05 126.75 40.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.546 HD13 ' HB2' ' A' ' 279' ' ' LYS . 38.4 mm -96.12 127.91 47.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 124.015 0.926 . . . . 0.0 108.636 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.443 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 0.0 OUTLIER -111.71 179.14 4.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.119 0.967 . . . . 0.0 109.168 -177.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . 0.495 ' HZ3' HG11 ' A' ' 274' ' ' VAL . 59.6 t-105 -60.42 -43.15 97.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.284 0.634 . . . . 0.0 110.899 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . 0.45 ' HA ' HE21 ' A' ' 215' ' ' GLN . 0.0 OUTLIER -62.1 -27.38 68.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.042 0.937 . . . . 0.0 111.888 177.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -90.03 -22.48 21.84 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.898 0.479 . . . . 0.0 110.894 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 214' ' ' TRP . 85.7 mt -67.77 112.6 4.94 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -138.29 151.1 47.28 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.607 0.763 . . . . 0.0 109.632 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.9 m -68.87 123.98 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.045 0.538 . . . . 0.0 111.565 -171.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.56 -15.75 49.1 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.732 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.418 ' HG2' HG11 ' A' ' 223' ' ' VAL . 29.5 tt0 -79.67 121.39 25.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.941 0.496 . . . . 0.0 109.979 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 45.8 t -93.07 120.21 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.418 HG11 ' HG2' ' A' ' 221' ' ' GLN . 13.2 m -141.01 148.66 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.32 1.048 . . . . 0.0 110.541 -175.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 20.5 ptm -89.82 136.22 33.16 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.273 0.629 . . . . 0.0 110.847 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.53 ' HB3' HG21 ' A' ' 277' ' ' VAL . 0.7 OUTLIER -144.7 144.1 31.05 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.046 0.939 . . . . 0.0 110.4 -174.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.402 ' HB3' ' CE2' ' A' ' 238' ' ' TRP . 10.5 p-10 -71.17 106.01 3.62 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.349 0.66 . . . . 0.0 109.837 174.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -135.31 132.13 37.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.467 HD21 ' HB2' ' A' ' 231' ' ' ASN . 61.1 t30 -105.41 114.89 62.8 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -62.92 -33.77 73.78 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.82 2.347 . . . . 0.0 111.756 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.26 -36.38 82.85 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.053 0.941 . . . . 0.0 111.213 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.467 ' HB2' HD21 ' A' ' 228' ' ' ASN . 38.4 m-80 -143.97 87.32 8.07 Favored Pre-proline 0 N--CA 1.487 1.413 0 C-N-CA 123.793 0.837 . . . . 0.0 109.382 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.86 -9.87 27.52 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.399 2.733 . . . . 0.0 115.104 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -82.83 -27.7 30.69 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.031 0.532 . . . . 0.0 110.984 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -120.95 154.63 35.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.512 0.725 . . . . 0.0 110.257 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -49.14 154.15 0.84 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.006 1.322 . . . . 0.0 113.053 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.61 -148.17 4.9 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.16 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -83.86 148.82 26.76 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.259 1.023 . . . . 0.0 109.699 -174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . 0.453 ' CE2' ' HD2' ' A' ' 296' ' ' ARG . 67.1 m95 -84.3 107.24 16.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.013 0.525 . . . . 0.0 110.54 -171.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -114.52 151.9 32.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.3 p-10 -83.93 146.2 28.16 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 172.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -146.26 137.17 24.33 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.581 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -91.11 119.48 31.28 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 29.8 mm -60.41 107.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 124.051 0.844 . . . . 0.0 109.388 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.6 t -82.89 -47.66 11.58 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.45 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 65.9 mtt85 -152.86 164.76 37.26 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 125.345 1.458 . . . . 0.0 109.649 -172.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -151.27 136.78 17.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.804 0.441 . . . . 0.0 110.745 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -150.82 115.49 5.2 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.812 0.845 . . . . 0.0 109.439 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -91.74 153.77 19.4 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 68.7 p -130.15 174.88 9.39 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.948 0.899 . . . . 0.0 108.871 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -65.62 -18.65 65.48 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.528 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 26.5 p -103.99 -31.54 9.67 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 123.426 0.691 . . . . 0.0 112.788 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.23 157.28 6.2 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.23 0.538 . . . . 0.0 112.292 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 253' ' ' ARG . 4.3 mpt_? -94.91 101.68 13.48 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -97.81 102.21 13.91 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.124 0.57 . . . . 0.0 110.736 -173.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 270' ' ' ARG . 3.4 tm? -95.18 143.65 26.43 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . 0.45 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 81.2 m-85 -123.03 116.42 23.5 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.23 144.8 31.68 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.984 0.513 . . . . 0.0 110.421 -174.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -81.55 96.87 7.58 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 92.6 t -81.06 107.23 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.699 1.2 . . . . 0.0 109.619 -176.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 16.9 m -89.11 129.8 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.52 0.676 . . . . 0.0 110.361 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 63.9 mt -93.95 -154.87 0.43 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.814 1.246 . . . . 0.0 108.888 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -64.68 -54.45 28.6 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 122.959 0.162 . . . . 0.0 113.122 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -115.95 -46.27 2.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.463 0.705 . . . . 0.0 110.283 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.68 151.01 37.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.819 0.848 . . . . 0.0 111.424 -173.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 15.5 p -120.3 113.63 20.67 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.863 0.865 . . . . 0.0 109.319 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.647 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 81.5 mt -82.27 102.45 11.18 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.232 1.013 . . . . 0.0 109.86 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -75.02 123.8 25.83 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.102 0.561 . . . . 0.0 112.073 -173.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 54.8 46.59 24.21 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.755 1.222 . . . . 0.0 113.128 169.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 81.6 m -67.96 133.1 48.5 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 122.396 0.278 . . . . 0.0 111.184 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 45.1 ttp180 -70.26 107.29 3.67 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.722 0.638 . . . . 0.0 109.8 173.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 40.7 mm -95.86 111.3 25.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 82.9 mt -84.76 -13.5 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 124.623 1.169 . . . . 0.0 109.884 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -99.86 39.52 1.32 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.352 1.461 . . . . 0.0 110.072 -161.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . 0.495 HG11 ' HZ3' ' A' ' 214' ' ' TRP . 28.8 m -71.74 -13.74 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 114.553 -1.203 . . . . 0.0 113.29 -167.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -86.87 -27.52 23.39 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.295 0.638 . . . . 0.0 110.996 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -93.26 1.26 57.1 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.694 0.797 . . . . 0.0 112.128 -174.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.53 HG21 ' HB3' ' A' ' 225' ' ' LEU . 59.2 t -71.12 139.35 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.198 0.599 . . . . 0.0 110.397 -174.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -120.37 160.92 22.08 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.216 1.007 . . . . 0.0 109.93 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.546 ' HB2' HD13 ' A' ' 212' ' ' ILE . 35.8 ttmt -79.66 151.34 30.58 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.715 0.406 . . . . 0.0 111.184 176.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.9 mm -77.54 132.79 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.8 0.84 . . . . 0.0 109.676 172.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 205' ' ' ARG . 1.0 OUTLIER -79.99 105.85 11.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 59.4 mtp85 -120.19 149.76 50.01 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.907 1.283 . . . . 0.0 109.445 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.93 98.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.413 2.742 . . . . 0.0 113.856 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 86.74 -3.96 86.61 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.494 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -119.4 -23.14 6.77 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.734 0.767 . . . . 0.0 111.827 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -92.89 100.6 2.68 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 175.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 11.6 p -64.45 130.29 94.6 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.003 0.521 . . . . 0.0 111.919 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.37 164.47 34.02 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.104 2.536 . . . . 0.0 111.676 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' MET . . . . . 0.485 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 44.1 ttm -80.31 85.44 5.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.669 0.747 . . . . 0.0 109.968 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.85 -29.41 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.9 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -85.89 -158.5 0.4 Allowed 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.828 0.851 . . . . 0.0 109.431 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.449 ' HB2' ' NH2' ' A' ' 209' ' ' ARG . 13.3 m120 -58.93 116.87 17.19 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.851 0.86 . . . . 0.0 110.866 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.485 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 25.1 Cg_exo -64.28 112.33 1.87 Allowed 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 123.263 2.642 . . . . 0.0 112.568 -175.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' MET . . . . . 0.508 ' HE1' HD12 ' A' ' 211' ' ' ILE . 22.2 ptm -117.63 129.87 56.02 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.729 0.812 . . . . 0.0 110.105 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -97.27 174.5 6.68 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.319 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.453 ' HD2' ' CE2' ' A' ' 238' ' ' TRP . 0.3 OUTLIER -60.37 -50.57 73.08 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.096 173.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.64 -161.69 1.4 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.469 1.508 . . . . 0.0 108.221 173.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 C--O 1.243 0.727 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.699 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.986 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.28 4.05 4.34 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.433 0.693 . . . . 0.0 111.683 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -78.94 159.32 27.76 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.253 0.549 . . . . 0.0 110.289 172.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.448 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -86.19 172.55 10.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.151 0.98 . . . . 0.0 110.814 -174.46 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.5 m -83.62 6.26 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.272 1.029 . . . . 0.0 112.257 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -127.84 8.4 6.27 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.581 0.753 . . . . 0.0 111.175 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 156' ' ' VAL . 19.6 mm-40 -80.9 74.13 7.89 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.888 0.475 . . . . 0.0 111.864 -173.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 8.7 p90 -77.69 98.8 5.6 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.524 0.678 . . . . 0.0 109.434 168.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.521 ' HA ' ' HD2' ' A' ' 207' ' ' ARG . 27.4 m -115.98 179.51 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.141 1.376 . . . . 0.0 108.772 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.16 109.72 21.22 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -92.9 122.95 35.79 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.805 0.842 . . . . 0.0 110.057 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -71.3 110.42 5.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.69 136.06 57.85 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.064 0.946 . . . . 0.0 110.249 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.5 p -74.26 -28.69 61.33 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.685 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.8 -55.5 4.77 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 120.926 0.393 . . . . 0.0 111.502 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.5 ttp -104.5 -18.16 14.47 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.71 0.804 . . . . 0.0 112.472 -170.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.95 18.24 70.36 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 113.981 0.352 . . . . 0.0 113.981 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -94.08 140.66 29.46 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.993 0.517 . . . . 0.0 111.172 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -75.31 119.94 20.1 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -115.22 148.65 38.84 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.47 ' HG2' HH22 ' A' ' 207' ' ' ARG . 8.1 mt-10 -76.84 89.03 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.97 116.95 30.09 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.626 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 53.8 tt0 -89.57 102.67 15.35 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.084 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 59.8 t -57.88 96.35 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 167.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.2 m -95.41 -13.85 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.443 0.697 . . . . 0.0 110.864 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.538 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 50.3 ttt85 -163.53 135.62 5.06 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.62 139.66 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.0 p -133.43 159.3 40.76 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 123.827 0.851 . . . . 0.0 108.713 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -96.43 175.57 6.36 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.622 0.769 . . . . 0.0 110.222 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.512 ' HG3' HG13 ' A' ' 182' ' ' VAL . 7.7 mtpm? . . . . . 0 CA--C 1.55 0.964 0 CA-C-O 121.979 0.895 . . . . 0.0 109.847 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 . . . . . 0 C--O 1.243 0.753 0 CA-C-O 121.694 0.759 . . . . 0.0 108.955 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.664 ' HB3' HG21 ' A' ' 182' ' ' VAL . 2.8 mp0 -69.12 99.01 1.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.688 -162.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.06 20.71 1.49 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.26 165.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.664 HG21 ' HB3' ' A' ' 180' ' ' GLU . 12.5 m -73.6 175.0 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 164.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 183' ' ' ILE . 3.1 mp -95.56 110.93 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 O-C-N 121.882 -0.512 . . . . 0.0 110.22 -165.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -95.62 106.49 18.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.003 0.921 . . . . 0.0 108.65 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 14.0 m-70 -79.79 96.55 6.32 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 13.3 m -109.01 157.73 9.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.475 0.71 . . . . 0.0 109.55 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -130.16 117.82 20.5 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -67.38 116.22 7.9 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.903 0.481 . . . . 0.0 110.638 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 153' ' ' GLU . 34.3 t70 -67.04 -27.1 67.12 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.368 1.067 . . . . 0.0 109.876 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.12 -29.54 62.97 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.929 0.892 . . . . 0.0 111.566 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -141.57 75.31 22.35 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.775 0.83 . . . . 0.0 110.494 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.42 -15.43 49.74 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.942 2.428 . . . . 0.0 112.455 171.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.5 -26.56 67.23 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.997 0.919 . . . . 0.0 111.282 174.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -77.37 -16.43 58.87 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.332 0.653 . . . . 0.0 110.985 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.83 -130.13 22.24 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.86 0.725 . . . . 0.0 112.503 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 6.2 t -101.17 118.25 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.521 0.729 . . . . 0.0 109.112 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 24.5 m -113.6 155.21 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.422 0.689 . . . . 0.0 109.258 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -97.93 130.13 44.81 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.232 0.613 . . . . 0.0 110.043 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.527 ' HE1' ' HB3' ' A' ' 203' ' ' ASP . 92.1 mmm -131.63 160.61 34.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.445 1.098 . . . . 0.0 108.891 179.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -95.69 167.2 11.43 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 180' ' ' GLU . 61.6 m -63.93 -39.47 94.22 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.866 0.466 . . . . 0.0 111.537 176.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -63.15 -23.51 67.47 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.703 0.801 . . . . 0.0 112.031 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.527 ' HB3' ' HE1' ' A' ' 199' ' ' MET . 56.2 m-20 -83.78 -37.72 22.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.521 0.728 . . . . 0.0 110.649 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 33.1 m -94.56 144.71 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.444 ' HA ' ' HE ' ' A' ' 205' ' ' ARG . 0.0 OUTLIER -140.69 142.92 34.83 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.8 155.49 7.72 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.024 0.93 . . . . 0.0 111.11 177.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.521 ' HD2' ' HA ' ' A' ' 141' ' ' VAL . 0.8 OUTLIER -128.85 138.42 52.03 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.078 0.466 . . . . 0.0 110.218 -172.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.09 152.74 18.55 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.11 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.404 ' HG3' ' SD ' ' A' ' 294' ' ' MET . 2.6 ttp180 -86.58 6.29 31.55 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 168.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.2 m -83.5 105.1 14.16 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.708 0.803 . . . . 0.0 108.91 -168.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 19.7 mt -85.69 132.73 31.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 279' ' ' LYS . 10.0 mm -105.48 139.07 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 0.0 OUTLIER -109.81 168.28 9.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.535 0.734 . . . . 0.0 109.757 176.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 55.3 t90 -45.38 -46.38 13.18 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.857 1.263 . . . . 0.0 111.936 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -57.52 -34.61 69.29 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.804 1.242 . . . . 0.0 111.961 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.48 -11.44 32.04 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.133 0.973 . . . . 0.0 113.06 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.458 HD13 HG13 ' A' ' 243' ' ' ILE . 1.5 mm? -73.84 114.41 12.1 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 169.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 12.6 pt-20 -115.77 165.03 13.52 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.621 0.768 . . . . 0.0 109.053 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.9 m -69.0 119.24 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 121.26 0.552 . . . . 0.0 110.361 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.91 -4.45 49.53 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.738 -0.664 . . . . 0.0 113.246 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -70.67 118.42 13.44 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.537 0.735 . . . . 0.0 110.581 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.78 113.39 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.73 150.13 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.938 1.295 . . . . 0.0 109.403 -172.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.645 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 16.0 ptm -97.95 124.69 42.52 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 120.838 0.351 . . . . 0.0 111.34 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.463 ' HB3' HG11 ' A' ' 277' ' ' VAL . 1.3 pt? -144.53 167.53 22.3 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.9 0.88 . . . . 0.0 110.149 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -80.84 135.38 35.93 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.865 0.364 . . . . 0.0 110.759 -169.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.482 ' HD1' ' HB2' ' A' ' 239' ' ' TYR . 58.0 m-85 -144.66 157.42 44.21 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.815 1.246 . . . . 0.0 110.167 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 42.5 t-20 -129.9 110.93 17.17 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 166.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -71.73 -17.91 29.04 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.431 2.088 . . . . 0.0 112.787 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -87.03 -39.66 15.42 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.261 0.624 . . . . 0.0 110.447 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 10.0 m120 -124.35 81.33 58.91 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.213 1.005 . . . . 0.0 108.482 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.91 -11.34 31.78 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.746 2.297 . . . . 0.0 114.317 -170.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -88.9 -4.17 58.54 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.28 0.632 . . . . 0.0 111.267 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -131.51 163.83 27.12 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.635 -0.665 . . . . 0.0 110.275 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 162.46 29.44 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.801 0.84 . . . . 0.0 111.639 174.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.03 -88.66 0.07 OUTLIER Glycine 0 C--O 1.238 0.361 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.376 171.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -130.23 167.57 18.23 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.495 1.118 . . . . 0.0 109.118 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -87.68 113.61 23.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.771 0.428 . . . . 0.0 110.574 -170.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.482 ' HB2' ' HD1' ' A' ' 227' ' ' TYR . 64.0 m-85 -117.51 142.84 46.69 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 8.3 p-10 -84.27 158.08 21.34 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -153.54 148.02 26.08 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.882 -173.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -96.01 118.26 32.28 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.458 HG13 HD13 ' A' ' 217' ' ' LEU . 36.1 mm -66.94 107.41 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.356 0.662 . . . . 0.0 109.328 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.2 t -81.16 -45.28 16.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.562 0.745 . . . . 0.0 110.267 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -154.11 167.54 29.5 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.626 1.171 . . . . 0.0 109.978 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.45 146.81 23.91 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.714 0.806 . . . . 0.0 109.898 167.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -142.65 115.93 8.97 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.15 0.98 . . . . 0.0 109.17 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.83 144.05 25.67 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 175.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.6 p -126.9 169.93 12.77 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 169.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -61.26 -34.07 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.883 0.473 . . . . 0.0 110.448 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 75.0 p -87.22 -29.67 21.53 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.449 -171.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -166.66 153.9 9.32 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.891 0.477 . . . . 0.0 111.616 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -104.06 105.78 16.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.738 0.815 . . . . 0.0 109.883 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.03 144.95 25.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.552 0.741 . . . . 0.0 110.099 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.787 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.3 OUTLIER -135.87 146.74 47.75 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -175.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -135.03 120.66 19.39 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.49 ' HB1' HD13 ' A' ' 271' ' ' ILE . . . -136.01 161.27 36.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.497 0.665 . . . . 0.0 111.653 -175.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -100.67 94.12 5.93 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 46.4 t -77.34 106.19 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.02 0.928 . . . . 0.0 110.068 -171.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 34.7 m -89.54 118.43 34.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 122.245 1.022 . . . . 0.0 110.201 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 31.2 mt -96.57 -153.08 0.4 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 113.888 -1.505 . . . . 0.0 108.173 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.5 -52.07 32.82 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 117.708 0.231 . . . . 0.0 113.278 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -122.23 -36.21 3.0 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.022 0.929 . . . . 0.0 110.611 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.11 157.92 18.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.264 1.025 . . . . 0.0 110.858 -174.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 67.2 p -135.2 113.83 11.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.542 0.737 . . . . 0.0 109.124 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.55 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 23.9 mt -81.73 86.68 6.39 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.773 0.829 . . . . 0.0 108.888 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -69.34 142.4 54.03 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.237 0.615 . . . . 0.0 111.659 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 57.41 17.69 3.95 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.569 1.148 . . . . 0.0 113.823 170.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 94.5 m -66.73 142.9 57.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.326 0.65 . . . . 0.0 111.04 -176.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -70.03 133.79 47.59 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.948 0.78 . . . . 0.0 110.821 -176.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.787 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 10.3 mm -107.02 128.46 61.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 46.3 mt -98.3 -24.51 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 123.862 0.865 . . . . 0.0 109.025 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.549 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 67.7 m-85 -91.69 47.91 1.41 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.69 1.196 . . . . 0.0 110.14 -176.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 27.5 m -65.35 -26.37 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.518 1.127 . . . . 0.0 112.92 -171.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 52.7 m-20 -110.27 -7.98 14.78 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.174 0.589 . . . . 0.0 110.984 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 15.5 mm-40 -94.09 24.69 4.16 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.907 0.883 . . . . 0.0 110.734 -175.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.543 ' HB ' ' HB ' ' A' ' 212' ' ' ILE . 19.4 t -89.61 153.63 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.155 0.982 . . . . 0.0 110.001 -174.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -129.21 156.19 44.34 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.123 0.969 . . . . 0.0 108.79 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.554 ' HB2' HD13 ' A' ' 212' ' ' ILE . 54.2 tttm -89.76 146.2 24.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.112 0.565 . . . . 0.0 110.925 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 44.3 mm -72.49 122.78 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 168.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -106.17 112.8 25.98 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 285' ' ' GLU . 59.8 mtt85 -103.3 107.26 55.1 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -25.41 94.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.38 2.227 1 C-N-CA 125.307 4.005 . . . . 0.0 117.196 -156.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 104.72 6.99 39.94 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 118.231 -1.316 . . . . 0.0 116.275 172.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 282' ' ' ARG . 0.2 OUTLIER -103.26 -25.04 13.48 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 120.236 2.018 . . . . 0.0 111.452 173.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -106.64 -177.66 23.12 Favored Glycine 0 C--O 1.245 0.821 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 172.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 13.5 m -76.26 144.44 74.84 Favored Pre-proline 0 CA--C 1.554 1.129 0 CA-C-N 116.991 0.396 . . . . 0.0 111.208 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.13 175.93 6.21 Favored 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 123.356 2.704 . . . . 0.0 112.337 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 43.5 ttm -82.8 95.43 7.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 170.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 14.4 p -125.83 19.29 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.944 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -154.42 -167.04 2.5 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.61 -169.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -44.27 121.38 3.99 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 125.597 1.559 . . . . 0.0 113.073 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -45.53 113.0 0.46 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 124.596 3.53 . . . . 0.0 114.784 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' MET . . . . . 0.404 ' SD ' ' HG3' ' A' ' 209' ' ' ARG . 88.0 mmm -78.04 97.34 5.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.207 0.603 . . . . 0.0 110.579 -176.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -128.07 113.13 15.39 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 172.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.77 123.09 11.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.336 1.454 . . . . 0.0 110.531 -169.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -101.59 -31.29 10.91 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.9 0.88 . . . . 0.0 109.112 167.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 33.5 p . . . . . 0 CA--C 1.543 0.686 0 C-N-CA 124.247 1.019 . . . . 0.0 110.196 -178.523 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.472 ' HA3' HG23 ' A' ' 159' ' ' VAL . . . . . . . . 0 N--CA 1.476 1.332 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 6.96 0.5 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.655 0.782 . . . . 0.0 112.092 -176.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.567 ' HB2' ' CE1' ' A' ' 184' ' ' TYR . 34.7 m-85 -126.21 149.92 48.71 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.128 0.49 . . . . 0.0 110.924 172.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -94.03 172.69 8.07 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.871 1.268 . . . . 0.0 110.12 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.52 4.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.235 1.014 . . . . 0.0 113.124 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -106.09 -18.04 14.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.1 0.96 . . . . 0.0 110.908 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -75.33 92.63 2.8 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-O 121.579 0.704 . . . . 0.0 111.726 -166.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 8.1 p90 -55.13 105.17 0.15 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.8 165.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 28.0 m -116.01 -174.79 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.903 0.881 . . . . 0.0 109.931 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.723 ' HB3' ' HB3' ' A' ' 205' ' ' ARG . 33.9 t0 -110.73 160.49 16.67 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 171.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.463 ' HB1' ' HE1' ' A' ' 199' ' ' MET . . . -140.72 105.86 5.0 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.638 0.775 . . . . 0.0 109.536 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.97 116.58 11.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.027 1.331 . . . . 0.0 109.33 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -85.59 116.69 24.03 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.7 0.8 . . . . 0.0 110.937 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.4 p -74.14 -33.48 63.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.556 1.142 . . . . 0.0 111.201 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.43 -52.59 57.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.318 0.647 . . . . 0.0 112.008 -171.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.405 ' HG2' ' HE1' ' A' ' 239' ' ' TYR . 38.1 ttp -102.75 -8.32 20.94 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.924 0.49 . . . . 0.0 111.1 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.15 18.86 70.93 Favored Glycine 0 C--N 1.358 1.756 0 CA-C-O 121.385 0.436 . . . . 0.0 112.246 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -96.32 174.7 6.74 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.057 0.943 . . . . 0.0 111.458 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -126.47 119.2 26.6 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -109.81 119.18 38.54 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.69 152.12 31.85 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.413 ' HA ' ' H ' ' A' ' 189' ' ' ASP . . . -153.95 -177.47 6.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.199 0.6 . . . . 0.0 111.57 -167.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 64.8 tt0 -151.64 120.72 6.7 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.152 172.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.49 126.02 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.769 0.828 . . . . 0.0 110.149 171.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.414 HG12 ' HE2' ' A' ' 187' ' ' LYS . 12.8 m -120.74 -6.08 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.121 0.568 . . . . 0.0 110.69 173.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 37.4 ttm180 -169.9 156.2 6.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.775 0.83 . . . . 0.0 110.639 174.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.472 HG23 ' HA3' ' A' ' 133' ' ' GLY . 1.7 p -132.96 127.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.22 1.008 . . . . 0.0 109.862 173.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.3 p -125.86 162.6 24.8 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.345 1.458 . . . . 0.0 109.319 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -107.38 177.21 4.91 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.45 0.7 . . . . 0.0 109.179 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.547 ' HD3' HD11 ' A' ' 183' ' ' ILE . 73.7 mmtt . . . . . 0 N--CA 1.5 2.07 0 C-N-CA 123.31 0.644 . . . . 0.0 112.599 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 C--O 1.237 0.441 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 201' ' ' SER . 26.9 mp0 -76.23 79.69 3.01 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 175.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -110.51 11.93 22.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.507 0.723 . . . . 0.0 109.724 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.27 149.09 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.328 0.651 . . . . 0.0 110.224 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.547 HD11 ' HD3' ' A' ' 162' ' ' LYS . 3.7 mp -95.75 109.59 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.003 0.521 . . . . 0.0 110.119 -167.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.567 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 58.3 m-85 -88.76 132.18 34.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.182 0.993 . . . . 0.0 111.033 173.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 30.6 m-70 -92.16 97.0 10.64 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.72 145.5 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.517 0.727 . . . . 0.0 110.447 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.414 ' HE2' HG12 ' A' ' 157' ' ' VAL . 45.2 mtmt -104.64 128.58 52.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -67.62 117.99 10.3 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.175 0.512 . . . . 0.0 111.088 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.413 ' H ' ' HA ' ' A' ' 154' ' ' ALA . 27.6 t70 -60.03 -30.2 69.01 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.846 1.258 . . . . 0.0 110.656 173.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.759 ' HA ' ' HD2' ' A' ' 297' ' ' LYS . 5.6 t70 -81.82 -30.18 32.3 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.209 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -138.48 81.17 25.14 Favored Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 123.082 0.553 . . . . 0.0 110.098 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.33 -21.9 46.78 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.593 2.195 . . . . 0.0 111.589 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.35 -26.48 68.77 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.411 1.084 . . . . 0.0 111.79 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -77.27 -20.11 55.55 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.821 0.449 . . . . 0.0 110.325 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 72.21 -154.23 50.43 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.58 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.3 t -79.46 117.39 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.564 0.746 . . . . 0.0 109.381 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.38 151.87 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.276 1.03 . . . . 0.0 109.38 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -88.48 129.29 35.48 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.463 ' HE1' ' HB1' ' A' ' 143' ' ' ALA . 90.8 mmm -147.23 126.8 13.28 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.699 1.2 . . . . 0.0 108.383 -174.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -68.18 160.8 28.39 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.591 ' HA ' HG21 ' A' ' 204' ' ' VAL . 20.6 t -69.32 -28.23 66.06 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.969 0.414 . . . . 0.0 111.048 -173.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -67.62 -32.22 72.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.038 0.935 . . . . 0.0 110.022 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.59 -19.84 32.41 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.078 0.951 . . . . 0.0 111.211 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.591 HG21 ' HA ' ' A' ' 201' ' ' SER . 7.8 m -96.68 157.87 3.21 Favored 'Isoleucine or valine' 0 C--N 1.356 0.882 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.723 ' HB3' ' HB3' ' A' ' 142' ' ' ASP . 0.5 OUTLIER -145.66 -178.63 6.19 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -165.295 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.436 ' HB2' ' HG3' ' A' ' 281' ' ' GLU . . . -98.51 143.82 28.52 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 166.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -70.32 96.56 1.14 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.164 0.585 . . . . 0.0 109.817 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.44 103.36 0.15 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.72 0.808 . . . . 0.0 110.955 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -82.86 -1.88 53.19 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.813 1.245 . . . . 0.0 111.632 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.0 m -94.46 119.93 33.93 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.843 0.857 . . . . 0.0 110.918 -176.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.4 mt -86.84 130.76 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.308 0.643 . . . . 0.0 109.284 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 39.7 mm -92.32 98.07 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.05 156.52 9.29 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.151 0.98 . . . . 0.0 111.439 174.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . 0.411 ' CZ2' ' HB2' ' A' ' 246' ' ' LYS . 79.9 t90 -57.26 -40.34 77.49 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.714 -167.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -65.39 -29.83 70.58 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.871 0.468 . . . . 0.0 111.297 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.35 -15.49 49.75 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.043 0.937 . . . . 0.0 111.723 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.1 mt -65.84 114.31 4.99 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 169.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . 0.43 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 11.1 pt-20 -119.0 168.03 11.2 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.219 1.007 . . . . 0.0 109.354 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.87 115.95 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-O 121.3 0.571 . . . . 0.0 109.541 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.19 -1.4 56.19 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.585 -174.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.532 ' HG3' HG12 ' A' ' 223' ' ' VAL . 6.2 tp-100 -67.55 120.58 14.21 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.969 0.508 . . . . 0.0 110.856 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.523 HG13 HG13 ' A' ' 280' ' ' ILE . 97.1 t -97.55 111.89 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.532 HG12 ' HG3' ' A' ' 221' ' ' GLN . 12.9 m -132.1 -174.76 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.219 1.408 . . . . 0.0 109.505 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 20.3 ptm -135.15 143.92 46.77 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.46 0.704 . . . . 0.0 109.447 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.51 159.89 42.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.779 0.832 . . . . 0.0 111.336 -169.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -90.31 106.94 18.83 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 173.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -145.48 138.73 26.34 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -172.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 46.4 t-20 -89.16 121.22 69.7 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.6 -19.74 21.19 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.562 2.175 . . . . 0.0 112.394 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -88.88 -39.16 14.01 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.468 0.707 . . . . 0.0 110.282 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.432 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 29.4 m-80 -119.97 101.93 47.11 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.443 0.697 . . . . 0.0 110.027 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -61.28 -26.57 82.12 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.803 2.336 . . . . 0.0 113.231 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -78.44 -27.05 46.44 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.764 0.825 . . . . 0.0 111.385 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -107.05 151.52 25.23 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.252 0.621 . . . . 0.0 111.144 -170.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -76.26 152.34 36.54 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.572 0.749 . . . . 0.0 109.192 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -139.04 -106.86 0.72 Allowed Glycine 0 N--CA 1.47 0.907 0 C-N-CA 121.674 -0.298 . . . . 0.0 112.77 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -128.35 170.52 12.99 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . 0.432 ' CE2' ' HB3' ' A' ' 296' ' ' ARG . 81.8 m95 -80.2 105.81 11.75 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.36 0.664 . . . . 0.0 110.917 -175.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.405 ' HE1' ' HG2' ' A' ' 148' ' ' MET . 76.1 m-85 -118.42 165.04 14.37 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.64 1.176 . . . . 0.0 108.449 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -97.34 142.92 28.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.0 0.52 . . . . 0.0 110.121 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -137.09 155.07 50.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.328 1.051 . . . . 0.0 111.12 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -110.91 117.53 33.63 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.583 HD12 HD13 ' A' ' 255' ' ' LEU . 33.0 mm -69.86 107.82 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.678 0.791 . . . . 0.0 109.012 -173.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.3 p -84.33 -32.71 24.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.468 0.707 . . . . 0.0 111.944 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -160.33 158.35 29.56 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.692 0.397 . . . . 0.0 110.914 -176.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.411 ' HB2' ' CZ2' ' A' ' 214' ' ' TRP . 60.8 pttt -154.62 148.78 25.9 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.36 0.664 . . . . 0.0 112.076 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -155.8 149.93 25.57 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.483 1.113 . . . . 0.0 108.671 173.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -129.72 139.87 51.23 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 119.564 1.075 . . . . 0.0 112.26 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.4 p -119.67 170.28 9.34 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 165.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -67.92 -32.88 73.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.824 0.449 . . . . 0.0 110.606 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 73.5 p -90.99 -19.71 22.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.246 1.019 . . . . 0.0 112.581 -172.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.69 155.44 21.66 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -171.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -108.53 132.96 53.31 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 173.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -102.25 128.82 48.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.274 1.03 . . . . 0.0 108.427 172.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.583 HD13 HD12 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -149.87 137.08 19.69 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -127.05 136.36 52.08 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.24 140.8 25.55 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.197 0.599 . . . . 0.0 110.697 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.456 HD21 ' N ' ' A' ' 258' ' ' ASN . 0.8 OUTLIER -79.51 94.98 5.7 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 49.0 t -78.24 105.66 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 28.8 t -86.35 124.02 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 264' ' ' ASP . 54.9 mt -103.16 -171.4 1.94 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.031 0.932 . . . . 0.0 109.032 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.08 -39.81 92.93 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 113.953 0.341 . . . . 0.0 113.953 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -121.77 -40.9 2.5 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.984 0.913 . . . . 0.0 109.255 173.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.475 ' HB2' HD12 ' A' ' 261' ' ' LEU . 21.5 m-20 -83.53 167.54 17.28 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.93 -173.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 54.7 p -145.53 114.21 6.81 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.611 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 61.9 mt -78.73 78.21 5.18 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -70.72 124.61 24.7 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.791 -170.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 36.8 t70 61.66 26.11 15.85 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.07 1.348 . . . . 0.0 111.603 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.611 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 94.9 m -73.47 133.62 43.71 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.709 -177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 -65.7 130.28 42.75 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.641 0.588 . . . . 0.0 110.493 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.9 mm -103.29 116.9 47.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.318 0.647 . . . . 0.0 109.555 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 61.9 mt -82.5 -45.45 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.685 173.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -89.58 64.44 6.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.951 0.9 . . . . 0.0 110.215 -168.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 30.5 m -78.84 -14.96 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.393 -174.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -90.63 -14.75 31.77 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.551 0.74 . . . . 0.0 111.047 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -96.98 43.6 1.07 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.098 0.959 . . . . 0.0 109.428 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.92 113.45 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.093 0.957 . . . . 0.0 109.737 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.414 ' HE2' ' HG3' ' A' ' 294' ' ' MET . 51.8 m-85 -94.61 164.92 12.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.014 0.926 . . . . 0.0 110.826 170.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -78.26 144.74 35.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.238 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.523 HG13 HG13 ' A' ' 222' ' ' VAL . 31.6 mm -73.42 113.57 11.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 164.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.436 ' HG3' ' HB2' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -78.97 125.52 29.48 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 170.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -109.16 104.92 56.34 Favored Pre-proline 0 N--CA 1.477 0.887 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -23.57 98.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.03 1 C-N-CA 125.751 4.3 . . . . 0.0 116.496 -151.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.23 60.21 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.577 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -78.2 -26.13 47.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.245 0.618 . . . . 0.0 110.24 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -134.79 160.44 24.27 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.838 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 12.4 m -91.04 159.01 40.79 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.552 0.741 . . . . 0.0 110.339 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.91 -155.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.62 2.214 . . . . 0.0 110.632 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' MET . . . . . 0.531 ' HB3' ' HB3' ' A' ' 293' ' ' PRO . 24.6 mmt -76.87 78.37 3.46 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 121.538 0.685 . . . . 0.0 109.534 177.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 13.6 p -106.78 -8.87 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.015 0.926 . . . . 0.0 109.933 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -122.32 -153.13 0.54 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.74 112.02 3.57 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.464 1.029 . . . . 0.0 109.709 167.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.531 ' HB3' ' HB3' ' A' ' 289' ' ' MET . 84.6 Cg_endo -76.17 137.21 18.95 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.051 1.834 . . . . 0.0 111.221 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' MET . . . . . 0.414 ' HG3' ' HE2' ' A' ' 278' ' ' PHE . 21.0 mmt -80.85 -49.45 11.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.148 0.579 . . . . 0.0 109.661 174.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 55.57 106.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.288 1.435 . . . . 0.0 110.627 -166.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.432 ' HB3' ' CE2' ' A' ' 238' ' ' TRP . 16.9 mtm180 -62.36 -33.41 74.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.989 0.915 . . . . 0.0 111.061 -177.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.759 ' HD2' ' HA ' ' A' ' 190' ' ' ASP . 51.5 tttp -64.26 92.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 37.2 t . . . . . 0 CA--C 1.541 0.625 0 C-N-CA 123.411 0.684 . . . . 0.0 110.48 -172.524 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.39 9.78 25.54 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.555 0.742 . . . . 0.0 112.104 -170.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.473 ' HH ' ' HA ' ' A' ' 205' ' ' ARG . 24.6 m-85 -125.91 144.87 50.5 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.391 0.676 . . . . 0.0 109.623 174.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.45 -177.6 3.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.635 0.774 . . . . 0.0 110.317 176.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.5 m -60.13 -6.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 125.205 1.402 . . . . 0.0 114.712 -173.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -110.63 -3.69 15.77 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.776 0.83 . . . . 0.0 112.032 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -86.39 88.52 7.65 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.352 0.596 . . . . 0.0 112.42 -171.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.64 ' HB3' ' HG2' ' A' ' 155' ' ' GLN . 31.0 p90 -75.86 102.1 5.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.052 0.929 . . . . 0.0 109.325 165.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.1 m -114.07 -165.84 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.526 1.53 . . . . 0.0 107.751 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.21 123.26 42.81 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.345 0.52 . . . . 0.0 111.825 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.536 ' HB1' ' HE1' ' A' ' 199' ' ' MET . . . -90.23 103.36 16.05 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.555 171.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.8 108.25 8.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -82.38 115.8 21.58 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.5 m -81.54 -15.43 54.88 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.81 0.844 . . . . 0.0 111.846 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -67.71 -51.91 43.9 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 23.1 ptp -96.65 -25.49 15.55 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.917 0.487 . . . . 0.0 110.934 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.55 18.22 33.63 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-O 119.991 -0.339 . . . . 0.0 113.836 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -99.68 168.51 9.89 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.669 0.747 . . . . 0.0 112.491 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -116.01 120.75 40.15 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 125.284 1.434 . . . . 0.0 107.63 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.9 127.18 54.0 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.19 103.5 0.39 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.477 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -101.95 117.42 34.79 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.828 0.851 . . . . 0.0 110.265 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.64 ' HG2' ' HB3' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -87.42 104.92 16.91 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.028 0.931 . . . . 0.0 109.165 -178.162 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 82.6 t -62.89 102.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.653 0.781 . . . . 0.0 109.501 172.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.0 -10.07 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 122.848 0.459 . . . . 0.0 110.983 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -170.5 143.29 2.23 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.839 0.856 . . . . 0.0 109.269 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 6.8 p -115.09 139.26 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 166.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.468 ' HG1' ' HB ' ' A' ' 183' ' ' ILE . 20.5 p -131.96 150.68 52.09 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.398 1.079 . . . . 0.0 108.583 172.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -66.97 147.21 53.52 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 171.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.424 ' HA ' HG13 ' A' ' 183' ' ' ILE . 87.5 tttt . . . . . 0 N--CA 1.485 1.31 0 C-N-CA 123.541 0.736 . . . . 0.0 112.74 -171.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 C--O 1.24 0.566 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -86.5 67.93 10.04 Favored 'General case' 0 C--O 1.248 1.015 0 CA-C-O 121.698 0.761 . . . . 0.0 109.235 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -84.37 61.05 6.36 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.2 m -115.45 173.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.449 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.468 ' HB ' ' HG1' ' A' ' 160' ' ' THR . 45.2 mt -96.26 108.29 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.218 0.532 . . . . 0.0 109.99 -170.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -93.36 112.08 23.9 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.978 0.911 . . . . 0.0 108.631 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -78.25 89.97 4.32 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 175.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.477 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 29.3 m -110.46 151.68 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.288 -177.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -120.41 148.83 43.27 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 170.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -68.36 107.82 2.99 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -58.38 -34.55 70.83 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.406 0.682 . . . . 0.0 110.635 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -78.15 -23.77 47.61 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.379 0.672 . . . . 0.0 111.525 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -137.22 67.43 54.51 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.758 -0.589 . . . . 0.0 109.957 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.7 -17.57 42.51 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.969 2.446 . . . . 0.0 112.269 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.79 -13.78 62.41 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.58 1.552 . . . . 0.0 112.667 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -85.03 -21.21 29.52 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.748 0.419 . . . . 0.0 111.11 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 90.31 -157.19 25.62 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.545 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.8 t -92.17 118.67 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.894 0.878 . . . . 0.0 110.634 -172.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.6 m -109.41 156.38 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.368 1.067 . . . . 0.0 109.703 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -103.91 134.04 47.87 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.153 0.581 . . . . 0.0 110.919 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.607 ' HE3' ' HB3' ' A' ' 203' ' ' ASP . 82.7 mmm -136.83 167.05 22.19 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.575 1.15 . . . . 0.0 109.305 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . 0.41 ' O ' HG22 ' A' ' 204' ' ' VAL . 21.1 m-80 -109.83 171.41 7.46 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.722 0.809 . . . . 0.0 109.639 174.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 43.4 m -61.32 -37.03 81.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 118.64 0.655 . . . . 0.0 111.566 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -16.59 61.57 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.453 176.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.607 ' HB3' ' HE3' ' A' ' 199' ' ' MET . 34.3 m-20 -96.66 -50.1 4.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.826 0.85 . . . . 0.0 110.681 174.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 200' ' ' ASN . 7.9 m -96.34 115.77 36.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 CA-C-O 122.004 0.907 . . . . 0.0 109.917 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.473 ' HA ' ' HH ' ' A' ' 135' ' ' TYR . 21.8 ttt180 -125.9 139.22 53.65 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.799 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.4 126.3 26.69 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.493 ' NH1' ' HB2' ' A' ' 296' ' ' ARG . 4.0 ptm180 -74.19 161.53 29.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.561 0.744 . . . . 0.0 112.215 -174.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 287' ' ' SER . . . -83.1 125.56 31.62 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.383 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.36 66.38 4.69 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 164.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.6 m -145.42 109.18 4.74 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.803 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.416 HD11 ' HE3' ' A' ' 294' ' ' MET . 46.9 mt -85.93 129.07 38.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 123.077 0.551 . . . . 0.0 110.014 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 279' ' ' LYS . 26.3 mm -101.51 148.12 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.791 1.237 . . . . 0.0 108.603 174.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 175.72 8.57 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.286 0.634 . . . . 0.0 110.27 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -54.28 -51.92 63.06 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -166.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -72.68 -19.56 61.4 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.24 -21.48 29.05 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.942 0.897 . . . . 0.0 109.954 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.44 HD23 HD13 ' A' ' 243' ' ' ILE . 90.5 mt -71.37 128.76 36.94 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -143.55 158.17 43.86 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.785 0.434 . . . . 0.0 110.572 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.0 127.28 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 123.912 0.757 . . . . 0.0 111.428 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.23 -25.7 25.95 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.013 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -72.95 122.12 21.16 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.32 0.648 . . . . 0.0 110.159 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.494 HG12 ' NH2' ' A' ' 282' ' ' ARG . 1.8 p -108.72 125.15 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.326 0.651 . . . . 0.0 110.308 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 280' ' ' ILE . 3.8 m -135.31 177.27 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 125.422 1.489 . . . . 0.0 109.912 -175.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 16.8 ptm -108.19 120.76 43.28 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.185 0.594 . . . . 0.0 110.702 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.664 ' HG ' HG11 ' A' ' 277' ' ' VAL . 0.4 OUTLIER -127.86 148.88 50.48 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.704 0.802 . . . . 0.0 108.91 -176.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -88.51 116.85 27.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.803 0.841 . . . . 0.0 111.734 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.516 ' HE1' ' HB2' ' A' ' 225' ' ' LEU . 4.9 p90 -163.69 142.45 7.88 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.156 0.982 . . . . 0.0 108.648 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -85.92 131.12 47.93 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 168.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.18 -19.77 66.36 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.25 1.967 . . . . 0.0 113.253 -171.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -66.57 -42.89 86.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.245 0.618 . . . . 0.0 110.154 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -130.06 89.1 46.44 Favored Pre-proline 0 N--CA 1.47 0.548 0 C-N-CA 123.608 0.763 . . . . 0.0 109.181 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.21 -6.97 17.51 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.616 2.211 . . . . 0.0 113.072 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.52 -29.35 46.48 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.243 0.617 . . . . 0.0 111.595 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.82 151.62 44.98 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.869 0.467 . . . . 0.0 110.237 -176.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 227' ' ' TYR . 7.0 ppt_? -66.72 161.79 22.74 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.814 0.846 . . . . 0.0 112.639 -175.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -165.57 -84.4 0.05 OUTLIER Glycine 0 C--N 1.338 0.684 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.388 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.445 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 30.1 m-85 -119.27 149.15 42.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.72 0.808 . . . . 0.0 109.224 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -88.36 104.43 16.76 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 95.5 m-85 -108.38 160.85 15.55 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.145 0.578 . . . . 0.0 110.367 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -81.48 119.23 23.48 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.676 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.447 ' HB3' HD13 ' A' ' 225' ' ' LEU . . . -126.82 136.56 52.53 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -99.36 123.17 43.41 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.565 HD12 HD12 ' A' ' 255' ' ' LEU . 19.5 mm -64.84 110.37 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.9 t -78.93 -36.42 41.79 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.278 -177.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -170.22 158.79 6.98 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.782 0.833 . . . . 0.0 109.52 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -143.43 136.21 27.52 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.455 ' HG3' ' HB2' ' A' ' 254' ' ' GLU . 4.0 ptm180 -145.61 125.41 13.44 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -92.15 137.67 32.17 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.9 p -116.0 176.62 5.01 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 170.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -58.7 -39.71 81.52 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.7 p -127.84 13.5 6.86 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.6 159.98 37.62 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.244 0.474 . . . . 0.0 111.314 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -122.35 108.76 13.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.106 0.962 . . . . 0.0 108.825 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.455 ' HB2' ' HG3' ' A' ' 247' ' ' ARG . 3.7 mp0 -90.88 99.1 12.19 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.565 HD12 HD12 ' A' ' 243' ' ' ILE . 2.1 tm? -100.23 121.34 41.31 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 176.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -107.23 132.14 53.4 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.05 122.32 12.28 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.28 0.632 . . . . 0.0 109.948 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -76.35 99.93 4.98 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 94.4 t -69.26 107.12 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.734 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 9.2 m -87.4 104.46 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 36.4 mt -81.93 -160.04 0.33 Allowed 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.684 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.43 -47.8 33.52 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-O 120.994 0.219 . . . . 0.0 112.979 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -122.3 -32.29 3.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.126 0.971 . . . . 0.0 111.044 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -101.44 171.56 7.5 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.666 0.787 . . . . 0.0 110.567 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 58.7 m -144.61 121.97 11.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.779 0.832 . . . . 0.0 109.816 171.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 72.2 mt -80.97 113.18 19.0 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.858 0.863 . . . . 0.0 109.562 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.69 109.47 4.38 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.513 0.725 . . . . 0.0 111.423 -173.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.79 57.69 4.56 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.735 1.214 . . . . 0.0 112.873 171.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 42.7 t -65.03 125.24 24.3 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 36.6 ttt180 -71.82 123.33 22.42 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.6 mm -100.03 122.4 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.32 0.648 . . . . 0.0 109.804 -175.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 65.4 mt -92.06 -14.29 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 124.451 1.1 . . . . 0.0 109.649 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -89.09 20.63 3.56 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.239 1.416 . . . . 0.0 111.494 -168.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 28.9 m -69.09 -4.51 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.757 1.223 . . . . 0.0 114.101 -166.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -94.19 -33.49 13.28 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.687 0.395 . . . . 0.0 111.228 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -128.72 48.62 2.3 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.77 0.795 . . . . 0.0 110.193 -173.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.664 HG11 ' HG ' ' A' ' 225' ' ' LEU . 59.4 t -74.7 154.01 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.426 169.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -119.92 149.8 41.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.539 ' HB2' HD13 ' A' ' 212' ' ' ILE . 26.4 ttmt -80.14 151.4 29.79 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.662 174.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 223' ' ' VAL . 36.1 mm -76.93 126.41 37.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 168.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.636 ' HA ' ' HA3' ' A' ' 286' ' ' GLY . 0.6 OUTLIER -71.26 108.57 4.81 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.666 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 90.2 mtt-85 -123.06 153.69 64.46 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.783 1.233 . . . . 0.0 108.566 -176.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.16 96.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.091 2.527 . . . . 0.0 113.557 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.28 -34.91 5.26 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.229 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.666 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 10.5 tp10 -85.97 -27.37 24.92 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.677 0.391 . . . . 0.0 111.902 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . 0.636 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -108.93 136.59 13.65 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -175.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 208' ' ' ALA . 3.3 m -96.24 144.98 28.77 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 117.259 0.53 . . . . 0.0 110.093 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -88.23 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.033 2.489 . . . . 0.0 111.765 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 17.4 mmt -80.66 78.92 7.37 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.1 -26.77 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.334 1.054 . . . . 0.0 110.146 -175.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -125.89 -160.08 0.95 Allowed 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -44.73 106.51 0.54 Allowed Pre-proline 0 N--CA 1.489 1.496 0 CA-C-N 119.743 1.156 . . . . 0.0 112.293 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.82 84.52 1.44 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.164 2.576 . . . . 0.0 111.252 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' MET . . . . . 0.416 ' HE3' HD11 ' A' ' 211' ' ' ILE . 25.0 ptm -66.2 140.97 58.21 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.14 176.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -85.16 159.64 20.09 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.493 ' HB2' ' NH1' ' A' ' 207' ' ' ARG . 23.1 ttp-105 -128.12 10.57 6.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.567 0.747 . . . . 0.0 109.837 -175.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -51.8 131.94 31.05 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.791 1.636 . . . . 0.0 111.139 172.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.548 0.871 0 C-N-CA 123.081 0.552 . . . . 0.0 109.902 -177.402 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.18 -18.57 8.01 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.258 0.623 . . . . 0.0 111.397 175.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -99.78 143.45 29.99 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 136' ' ' LYS . 6.3 mptt -97.87 179.32 4.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.494 1.117 . . . . 0.0 110.472 -170.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -68.74 -17.81 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 124.767 1.227 . . . . 0.0 112.161 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -116.41 16.29 15.68 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.253 0.621 . . . . 0.0 110.976 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.428 ' HG3' HG11 ' A' ' 141' ' ' VAL . 11.3 tp10 -97.21 89.43 4.76 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.341 0.591 . . . . 0.0 110.17 -173.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 22.8 p90 -82.18 100.23 9.72 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.69 0.757 . . . . 0.0 111.179 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.428 HG11 ' HG3' ' A' ' 139' ' ' GLU . 34.1 m -114.88 169.14 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.721 0.808 . . . . 0.0 109.221 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -87.93 113.88 24.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.136 0.493 . . . . 0.0 111.296 -169.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.38 109.41 19.54 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 170.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.531 HH22 HG11 ' A' ' 260' ' ' VAL . 26.3 ttt180 -74.9 113.68 12.49 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.497 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.89 134.89 35.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.431 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.6 p -77.04 -36.51 56.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.472 0.709 . . . . 0.0 111.494 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -65.03 -45.1 86.84 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.189 0.595 . . . . 0.0 110.847 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 54.0 tpp -85.54 -38.49 18.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.59 0.756 . . . . 0.0 110.127 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.68 9.89 80.35 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.867 -171.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.99 168.42 9.13 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 121.791 0.805 . . . . 0.0 112.243 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.431 ' HZ2' HD12 ' A' ' 280' ' ' ILE . 8.5 m0 -89.35 122.41 32.54 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.512 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.72 111.15 17.25 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 173.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -57.32 98.28 0.03 OUTLIER 'General case' 0 C--N 1.363 1.168 0 O-C-N 124.163 0.915 . . . . 0.0 109.963 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -103.73 133.1 49.29 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.437 1.095 . . . . 0.0 109.818 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.613 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 43.6 tt0 -84.01 106.75 15.91 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 122.684 0.394 . . . . 0.0 110.667 -173.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.1 t -58.56 109.23 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.521 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 167.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 m -108.37 -26.2 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 122.861 0.464 . . . . 0.0 111.028 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 56.5 ttt85 -146.5 122.63 10.81 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 110.788 -0.078 . . . . 0.0 110.788 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.16 117.82 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 123.335 0.654 . . . . 0.0 109.369 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.7 p -127.87 117.63 22.17 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.711 0.804 . . . . 0.0 109.289 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.414 ' HG3' HG11 ' A' ' 182' ' ' VAL . 27.1 ttt180 -76.14 138.19 40.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.376 0.67 . . . . 0.0 109.473 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 N--CA 1.486 1.337 0 C-N-CA 123.201 0.6 . . . . 0.0 111.144 177.734 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.243 0.75 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.89 96.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.367 1.079 . . . . 0.0 111.603 -172.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -88.81 19.71 3.91 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.209 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.414 HG11 ' HG3' ' A' ' 161' ' ' ARG . 6.4 m -78.17 163.4 3.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 124.007 0.923 . . . . 0.0 110.046 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.49 HG22 ' HB2' ' A' ' 198' ' ' GLN . 61.3 mt -97.16 110.31 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.41 0.684 . . . . 0.0 110.117 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -90.6 108.43 19.8 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 169.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 56.0 m-70 -77.14 97.77 4.86 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.49 143.32 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.533 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.522 ' HG2' HG23 ' A' ' 196' ' ' VAL . 25.3 mtmt -104.83 116.81 32.64 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -53.99 111.01 0.67 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.88 -22.99 67.1 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -80.34 -29.12 38.0 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.597 0.759 . . . . 0.0 111.404 173.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.485 ' HB3' ' ND2' ' A' ' 194' ' ' ASN . 79.8 m-85 -129.27 55.05 16.19 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 123.499 0.72 . . . . 0.0 111.321 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.38 -13.58 20.6 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 121.719 1.613 . . . . 0.0 112.73 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -71.83 -27.93 63.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.864 0.866 . . . . 0.0 110.697 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' ' 191' ' ' TYR . 30.4 m-80 -75.82 -1.42 25.1 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.548 0.739 . . . . 0.0 111.905 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 92.48 -172.05 34.14 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-O 121.11 0.283 . . . . 0.0 113.279 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.522 HG23 ' HG2' ' A' ' 187' ' ' LYS . 8.8 t -90.51 116.9 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.11 152.56 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.837 0.855 . . . . 0.0 110.015 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.49 ' HB2' HG22 ' A' ' 183' ' ' ILE . 16.7 pm0 -92.27 126.48 37.37 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.423 ' HE1' ' HB3' ' A' ' 203' ' ' ASP . 97.0 mmm -141.38 136.44 31.43 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.742 1.217 . . . . 0.0 107.973 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . 0.438 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 20.8 m-80 -89.45 173.12 8.52 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.167 0.44 . . . . 0.0 110.071 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.513 ' HA ' HG21 ' A' ' 204' ' ' VAL . 18.9 t -66.82 -30.0 70.08 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 120.806 0.336 . . . . 0.0 110.496 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.438 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 15.4 ptm180 -67.24 -18.11 65.08 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.585 0.754 . . . . 0.0 111.935 175.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.423 ' HB3' ' HE1' ' A' ' 199' ' ' MET . 59.9 m-20 -102.38 -29.32 11.71 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.93 0.892 . . . . 0.0 111.085 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.513 HG21 ' HA ' ' A' ' 201' ' ' SER . 31.9 m -99.21 148.78 5.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 CA-C-O 121.599 0.714 . . . . 0.0 110.374 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -128.85 146.14 51.01 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.873 1.269 . . . . 0.0 108.111 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.69 128.93 38.29 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -63.4 137.35 58.13 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.362 0.665 . . . . 0.0 110.814 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 281' ' ' GLU . . . -69.89 113.86 7.52 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -172.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.566 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 1.2 ptm180 -82.24 -31.94 29.96 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.686 169.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.7 m -90.04 123.51 33.98 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.554 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.4 mt -86.29 136.31 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.41 ' HB ' HG11 ' A' ' 277' ' ' VAL . 48.4 mm -107.51 144.2 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.673 0.789 . . . . 0.0 109.619 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.42 168.78 14.4 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.197 0.999 . . . . 0.0 109.296 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -52.22 -38.63 58.55 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.351 1.06 . . . . 0.0 112.953 -170.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.6 -44.31 93.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.358 0.663 . . . . 0.0 112.186 -173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.88 -1.46 32.07 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.609 0.764 . . . . 0.0 110.736 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.491 HD11 HG22 ' A' ' 223' ' ' VAL . 21.0 tp -79.19 121.0 24.49 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -130.69 156.72 44.44 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.496 0.589 . . . . 0.0 111.509 -172.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.4 m -67.93 132.34 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.971 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.8 -11.87 70.31 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.971 -176.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.401 ' HG2' HG11 ' A' ' 223' ' ' VAL . 29.0 tt0 -86.05 123.99 31.98 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.506 0.722 . . . . 0.0 109.47 177.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.96 133.16 29.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 173.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.491 HG22 HD11 ' A' ' 217' ' ' LEU . 3.3 m -145.19 145.76 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.6 1.16 . . . . 0.0 109.369 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.551 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 12.0 ptm -97.28 131.21 44.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.994 0.518 . . . . 0.0 109.692 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.501 ' HB3' ' HA ' ' A' ' 277' ' ' VAL . 0.8 OUTLIER -143.92 158.54 43.63 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.926 0.491 . . . . 0.0 110.834 -175.225 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 235' ' ' ARG . 16.5 p30 -77.04 117.87 19.04 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -156.6 143.16 18.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.726 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -108.53 120.47 46.29 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 168.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.66 -36.14 11.64 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.62 2.213 . . . . 0.0 111.873 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.31 -29.13 62.49 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.408 0.683 . . . . 0.0 110.774 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -131.18 90.13 39.64 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.41 -17.77 49.29 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.923 2.415 . . . . 0.0 113.473 -176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -76.03 -27.75 57.44 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.069 0.547 . . . . 0.0 111.176 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.09 153.64 37.17 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 226' ' ' ASN . 0.0 OUTLIER -75.4 173.34 11.06 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.933 0.493 . . . . 0.0 111.732 176.506 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -159.83 -117.53 0.47 Allowed Glycine 0 C--O 1.24 0.522 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.278 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -82.56 171.42 14.1 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.199 0.6 . . . . 0.0 110.102 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -89.01 105.5 17.82 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -114.02 135.3 54.16 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -82.67 129.0 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -136.65 137.04 39.64 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.205 1.002 . . . . 0.0 109.309 -173.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -94.64 118.93 32.48 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.572 HD12 HD13 ' A' ' 255' ' ' LEU . 37.3 mm -62.44 112.79 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.195 0.598 . . . . 0.0 111.192 -173.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.4 t -82.53 -41.62 19.43 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.901 0.88 . . . . 0.0 110.088 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -157.05 155.73 31.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.735 0.814 . . . . 0.0 109.53 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -142.85 144.28 32.45 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.15 0.58 . . . . 0.0 109.893 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 254' ' ' GLU . 33.3 ttm180 -156.54 148.85 23.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.96 0.904 . . . . 0.0 109.786 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.21 139.82 35.72 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 165.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.0 p -114.31 177.65 4.57 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 172.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -78.98 -23.4 44.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 118.434 0.561 . . . . 0.0 110.434 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.1 p -95.16 -21.04 18.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.702 0.801 . . . . 0.0 112.5 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.91 173.86 16.13 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.191 0.596 . . . . 0.0 111.006 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -126.4 151.1 48.12 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 247' ' ' ARG . 10.1 tp10 -138.73 137.1 36.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.11 0.481 . . . . 0.0 110.894 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.642 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.4 OUTLIER -149.96 139.1 21.18 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.242 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -130.75 129.88 43.06 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.79 138.58 24.5 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.238 0.615 . . . . 0.0 109.919 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -76.69 99.22 4.99 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.49 106.14 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.531 HG11 HH22 ' A' ' 144' ' ' ARG . 48.4 t -89.0 114.56 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.225 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' A' ' 264' ' ' ASP . 87.8 mt -92.28 -170.17 2.44 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.965 0.906 . . . . 0.0 109.907 173.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -61.41 -54.55 35.15 Favored Glycine 0 C--N 1.352 1.438 0 O-C-N 123.156 0.285 . . . . 0.0 112.591 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.05 -49.56 3.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.212 1.005 . . . . 0.0 109.905 172.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.426 ' HB2' HD11 ' A' ' 261' ' ' LEU . 7.4 m-20 -76.18 167.35 22.03 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.703 -171.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 38.0 p -153.95 112.89 3.69 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.409 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 2.6 mm? -81.41 95.86 7.18 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.508 0.723 . . . . 0.0 109.659 -177.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -58.6 111.73 1.36 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.229 0.956 . . . . 0.0 110.662 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 16.0 t70 64.01 83.75 0.16 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.889 1.275 . . . . 0.0 111.783 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 71.4 m -106.9 140.32 39.89 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.051 0.94 . . . . 0.0 109.554 172.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -82.2 107.97 15.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.106 0.562 . . . . 0.0 110.13 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 42.4 mm -91.76 124.06 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.947 0.899 . . . . 0.0 108.734 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 52.6 mt -88.17 -26.73 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.304 0.642 . . . . 0.0 110.499 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.463 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 38.0 m-85 -95.56 60.91 2.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.876 0.87 . . . . 0.0 111.038 -166.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 255' ' ' LEU . 9.8 m -66.69 -17.15 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.369 1.067 . . . . 0.0 112.246 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -98.65 -24.26 15.14 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.003 0.921 . . . . 0.0 110.98 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 36.5 mt-10 -98.24 28.05 4.29 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.564 0.697 . . . . 0.0 110.799 -176.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.501 ' HA ' ' HB3' ' A' ' 225' ' ' LEU . 72.6 t -82.95 146.36 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.586 1.155 . . . . 0.0 108.88 172.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.551 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 73.0 m-85 -130.78 160.89 33.01 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.179 0.991 . . . . 0.0 109.531 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -82.04 154.78 25.47 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.34 1.056 . . . . 0.0 111.858 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.431 HD12 ' HZ2' ' A' ' 151' ' ' TRP . 15.9 mm -88.54 111.08 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 164.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 208' ' ' ALA . 46.0 mm-40 -83.97 103.81 13.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -90.06 142.35 28.67 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.72 1.208 . . . . 0.0 109.52 -173.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.88 99.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.441 2.761 . . . . 0.0 113.544 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.28 -49.72 1.9 Allowed Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.906 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -73.36 -24.61 60.35 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.331 0.653 . . . . 0.0 111.728 -174.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -91.13 -159.81 35.94 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 25.2 p -126.99 135.11 26.89 Favored Pre-proline 0 N--CA 1.468 0.435 0 CA-C-N 117.142 0.471 . . . . 0.0 110.895 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.02 -174.67 1.63 Allowed 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.01 2.473 . . . . 0.0 110.616 163.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' MET . . . . . 0.566 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 24.6 mmt -74.72 81.33 2.06 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.429 0.633 . . . . 0.0 110.479 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 12.3 p -100.77 -17.36 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.843 1.257 . . . . 0.0 109.627 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -122.75 -160.68 0.9 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -45.87 117.65 3.93 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.56 1.144 . . . . 0.0 112.422 177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.554 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 85.1 Cg_endo -78.36 144.08 20.14 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.585 2.19 . . . . 0.0 111.994 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 97.5 mmm -115.1 145.18 42.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.963 0.905 . . . . 0.0 110.693 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -143.3 91.53 2.28 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 169.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.448 ' CZ ' ' HE1' ' A' ' 224' ' ' MET . 40.6 mtm-85 -72.57 -17.24 61.73 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.378 -170.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -67.74 98.71 0.73 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 162.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 23.5 p . . . . . 0 CA--C 1.543 0.688 0 C-N-CA 123.944 0.898 . . . . 0.0 110.935 -177.111 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.355 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.83 -21.07 14.08 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.585 0.754 . . . . 0.0 110.673 -175.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -108.02 132.56 53.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 169.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -130.24 -175.74 3.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.944 0.898 . . . . 0.0 110.742 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.8 m -35.47 -32.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -167.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -109.39 -22.18 12.16 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.208 0.603 . . . . 0.0 111.983 -173.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -77.13 78.83 3.66 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.371 1.068 . . . . 0.0 110.612 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -76.52 130.81 38.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.545 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.2 m -132.69 169.01 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.491 1.516 . . . . 0.0 107.219 172.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.42 ' HB2' ' CE3' ' A' ' 151' ' ' TRP . 4.5 m-20 -92.24 139.51 30.54 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.664 0.665 . . . . 0.0 110.878 -174.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.569 ' HB3' ' HE1' ' A' ' 199' ' ' MET . . . -89.1 99.4 12.4 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.888 174.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.424 ' HG2' ' NE1' ' A' ' 151' ' ' TRP . 0.0 OUTLIER -70.8 91.03 0.81 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.129 -1.396 . . . . 0.0 107.407 177.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.69 128.92 37.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.143 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.5 m -81.88 -19.15 41.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.563 0.345 . . . . 0.0 111.722 -172.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -76.69 -52.88 8.81 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.9 ttm -90.26 -39.99 12.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.693 0.797 . . . . 0.0 110.552 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.76 -7.67 59.38 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.199 -173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.3 153.38 35.94 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.598 0.759 . . . . 0.0 111.676 -174.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.491 ' CH2' HD12 ' A' ' 280' ' ' ILE . 12.9 m95 -101.51 116.07 31.93 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -109.0 123.28 48.88 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.03 101.66 0.23 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.757 0.66 . . . . 0.0 110.447 -173.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.9 114.84 26.49 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -85.52 97.6 10.15 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.401 ' HA ' HG11 ' A' ' 186' ' ' VAL . 44.7 t -65.51 97.84 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -92.14 -12.56 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.012 0.525 . . . . 0.0 111.851 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.477 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 21.1 ttm180 -168.72 154.05 6.34 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.525 0.73 . . . . 0.0 110.809 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.0 m -131.43 143.44 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.194 0.998 . . . . 0.0 110.14 172.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.535 HG21 ' HB ' ' A' ' 183' ' ' ILE . 4.5 t -141.69 150.4 41.82 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.896 0.878 . . . . 0.0 109.781 176.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -120.04 158.26 27.19 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.961 0.904 . . . . 0.0 110.791 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.569 ' HZ1' ' HB3' ' A' ' 162' ' ' LYS . 9.0 mtpm? . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 123.372 0.669 . . . . 0.0 110.378 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 71.59 -15.36 0.44 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.245 1.418 . . . . 0.0 112.346 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.509 ' HA ' ' H ' ' A' ' 201' ' ' SER . 28.7 m-20 -87.62 51.14 2.14 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.641 0.734 . . . . 0.0 110.147 174.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.429 ' HB ' ' O ' ' A' ' 160' ' ' THR . 35.3 m -81.59 179.56 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.771 169.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.535 ' HB ' HG21 ' A' ' 160' ' ' THR . 3.6 mp -94.04 107.31 19.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -176.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -85.49 108.92 18.13 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.498 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 22.5 m-70 -78.29 100.71 6.82 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' A' ' 156' ' ' VAL . 12.0 m -118.35 164.0 15.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.237 -176.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -122.18 116.13 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -57.99 111.18 1.09 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 169.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.98 -23.99 61.51 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.653 0.739 . . . . 0.0 110.334 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.596 ' HB3' ' HB2' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -82.3 -30.4 30.56 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.29 172.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -137.73 70.31 51.47 Favored Pre-proline 0 N--CA 1.487 1.381 0 C-N-CA 123.101 0.56 . . . . 0.0 110.985 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.83 -18.21 57.48 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.801 2.334 . . . . 0.0 112.173 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.19 -17.12 57.21 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.871 1.268 . . . . 0.0 112.573 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.411 HD21 ' N ' ' A' ' 194' ' ' ASN . 0.8 OUTLIER -75.91 -7.21 54.01 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.751 0.82 . . . . 0.0 112.263 177.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.77 -167.11 52.61 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 40.5 t -81.3 117.02 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 171.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 29.0 m -108.38 141.9 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 122.82 0.448 . . . . 0.0 110.047 -175.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.483 ' HB2' HG21 ' A' ' 183' ' ' ILE . 18.4 pt20 -87.51 130.48 34.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.448 0.699 . . . . 0.0 110.156 -176.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.569 ' HE1' ' HB3' ' A' ' 143' ' ' ALA . 60.1 mmm -133.3 161.5 34.32 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.335 0.654 . . . . 0.0 109.739 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -111.55 -179.5 3.73 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.099 0.959 . . . . 0.0 109.275 172.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.509 ' H ' ' HA ' ' A' ' 181' ' ' ASP . 42.3 t -62.37 -41.43 98.61 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 118.168 0.44 . . . . 0.0 110.367 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -15.19 62.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.868 0.467 . . . . 0.0 112.157 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.474 ' HB3' ' HE3' ' A' ' 199' ' ' MET . 12.6 m-20 -89.19 -57.79 2.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.445 0.698 . . . . 0.0 110.008 173.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -94.24 117.97 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.69 0.757 . . . . 0.0 109.77 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.404 ' HD2' ' HH2' ' A' ' 151' ' ' TRP . 25.8 ttm180 -111.66 149.89 30.91 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.08 -176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.18 127.72 32.66 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 123.907 0.754 . . . . 0.0 111.625 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -101.27 136.53 40.96 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.191 0.996 . . . . 0.0 109.417 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.75 157.55 15.89 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.037 0.922 . . . . 0.0 110.433 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.435 ' HD3' ' N ' ' A' ' 209' ' ' ARG . 0.0 OUTLIER -114.61 42.89 2.03 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.462 177.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 21.3 m -127.12 118.73 24.95 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.583 -178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 50.4 mt -84.08 127.74 39.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 216' ' ' ASP . 46.6 mm -92.37 138.96 18.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.379 -178.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -128.31 -178.49 4.58 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.867 1.267 . . . . 0.0 109.415 175.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . 0.487 ' CH2' ' HB2' ' A' ' 246' ' ' LYS . 49.7 t-105 -60.99 -28.64 69.17 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.812 0.445 . . . . 0.0 111.87 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -61.91 -41.98 98.55 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.301 0.641 . . . . 0.0 110.564 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.543 ' HB2' HG22 ' A' ' 212' ' ' ILE . 58.8 m-20 -80.58 -14.55 58.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.733 0.813 . . . . 0.0 111.58 -177.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.5 ' HB3' ' HD3' ' A' ' 246' ' ' LYS . 0.5 OUTLIER -63.06 113.49 3.15 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.634 0.773 . . . . 0.0 111.222 -172.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.85 139.53 22.72 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.736 0.814 . . . . 0.0 110.005 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -67.31 139.64 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.161 0.584 . . . . 0.0 110.876 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 96.88 -21.74 44.4 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.696 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.412 ' HG2' HG13 ' A' ' 223' ' ' VAL . 8.0 tt0 -77.83 122.15 25.06 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.937 0.495 . . . . 0.0 109.968 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 10.5 p -91.84 131.45 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 225' ' ' LEU . 15.6 m -135.64 156.73 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.741 1.216 . . . . 0.0 110.095 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' A' ' 238' ' ' TRP . 39.4 ttp -107.29 127.0 53.16 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.871 0.469 . . . . 0.0 109.988 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.494 ' HG ' HG11 ' A' ' 277' ' ' VAL . 0.1 OUTLIER -131.17 144.98 51.77 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.064 0.946 . . . . 0.0 108.558 -175.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -75.0 106.24 6.41 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -139.94 154.96 47.36 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.672 -169.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 32.6 t-20 -120.44 120.71 29.68 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.18 -29.75 32.36 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.42 2.08 . . . . 0.0 112.688 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -71.48 -53.8 12.72 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.88 0.472 . . . . 0.0 110.281 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 1.0 OUTLIER -117.0 88.59 26.96 Favored Pre-proline 0 N--CA 1.484 1.237 0 C-N-CA 123.823 0.849 . . . . 0.0 109.2 176.232 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.31 -9.85 23.72 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.014 2.476 . . . . 0.0 114.137 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.406 ' HD2' HD13 ' A' ' 272' ' ' ILE . 21.7 tptm -77.61 -15.5 59.18 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.989 0.915 . . . . 0.0 110.916 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -134.66 165.52 25.04 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.52 0.728 . . . . 0.0 110.463 -172.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.7 ppt_? -71.91 163.65 27.47 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.922 0.889 . . . . 0.0 111.023 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -145.52 -84.44 0.06 OUTLIER Glycine 0 C--O 1.239 0.456 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 175.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -128.53 178.09 6.55 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.33 1.052 . . . . 0.0 108.549 173.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . 0.486 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 97.4 m95 -83.21 110.03 17.72 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 122.744 0.418 . . . . 0.0 109.905 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.29 141.29 49.1 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.795 0.838 . . . . 0.0 109.656 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -83.53 123.06 29.37 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.265 0.555 . . . . 0.0 109.709 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -128.62 137.35 51.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.408 1.083 . . . . 0.0 109.59 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 222' ' ' VAL . 33.0 tt0 -94.98 136.43 35.3 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.501 HD11 HD22 ' A' ' 255' ' ' LEU . 33.9 mm -63.96 108.29 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 O-C-N 123.83 0.706 . . . . 0.0 109.46 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.4 t -93.9 -29.16 15.43 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.476 0.711 . . . . 0.0 110.198 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 77.0 ttt180 -167.98 156.26 8.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.355 0.662 . . . . 0.0 109.563 -175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 217' ' ' LEU . 23.8 pttm -148.03 139.84 23.92 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 167.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -134.01 114.84 13.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.791 1.236 . . . . 0.0 107.68 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 9.1 pt-20 -100.23 134.07 43.71 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.014 0.435 . . . . 0.0 109.924 175.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.3 p -118.55 161.76 19.5 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -64.44 -15.08 60.03 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 52.6 p -94.75 -32.06 13.5 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.549 0.74 . . . . 0.0 111.473 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.4 141.38 1.97 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.229 0.612 . . . . 0.0 110.986 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 0.0 OUTLIER -98.18 102.81 14.66 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 121.8 0.81 . . . . 0.0 111.174 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -87.92 116.73 26.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.186 0.994 . . . . 0.0 111.161 -169.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.628 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 3.9 tt -97.84 138.27 35.44 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . 0.509 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 53.2 m-85 -128.44 115.04 17.58 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -132.41 140.0 48.28 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.991 0.516 . . . . 0.0 110.083 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 3.4 p-10 -79.85 96.93 6.47 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.415 0.626 . . . . 0.0 109.551 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 49.6 t -72.83 100.49 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.053 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.2 p -93.74 110.91 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.609 0.718 . . . . 0.0 109.228 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 5.2 mp -83.6 -172.51 4.19 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.247 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.08 -31.45 66.61 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 121.885 -0.197 . . . . 0.0 112.824 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -121.81 -48.62 2.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.141 0.976 . . . . 0.0 109.677 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.74 168.81 18.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.511 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 51.7 p -158.43 112.63 2.5 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.605 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 55.3 mt -94.3 96.9 9.86 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.37 1.068 . . . . 0.0 110.044 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 4.1 p-10 -74.87 137.6 41.9 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.896 0.479 . . . . 0.0 111.439 -174.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 63.58 26.04 14.56 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.835 1.254 . . . . 0.0 113.634 171.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 72.0 m -64.83 133.2 51.44 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.628 0.371 . . . . 0.0 111.296 177.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -68.86 116.46 9.36 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.93 0.768 . . . . 0.0 110.058 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.628 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 45.8 mm -88.74 133.31 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.018 0.527 . . . . 0.0 109.726 177.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.406 HD13 ' HD2' ' A' ' 233' ' ' LYS . 62.3 mt -104.91 -22.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.342 1.057 . . . . 0.0 110.044 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -90.61 41.54 1.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.184 0.993 . . . . 0.0 110.794 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 26.2 m -70.04 -26.07 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.678 1.191 . . . . 0.0 112.686 -169.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -91.92 -3.57 55.79 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.372 0.669 . . . . 0.0 111.724 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.7 25.9 3.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.111 0.564 . . . . 0.0 111.331 -170.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.494 HG11 ' HG ' ' A' ' 225' ' ' LEU . 46.5 t -73.59 153.7 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.885 0.874 . . . . 0.0 110.267 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -116.71 150.26 38.49 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.457 0.703 . . . . 0.0 109.6 169.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.443 ' HE2' HD13 ' A' ' 212' ' ' ILE . 22.2 ttmm -82.97 149.48 26.98 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.227 1.011 . . . . 0.0 110.653 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.491 HD12 ' CH2' ' A' ' 151' ' ' TRP . 32.7 mm -87.1 125.03 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 165.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.52 104.4 6.06 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -173.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 98.0 mtt180 -94.4 103.7 11.75 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 168.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -27.98 118.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 125.25 3.967 . . . . 0.0 116.617 -165.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 106.96 -41.69 2.12 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.922 -0.932 . . . . 0.0 114.612 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 10.5 pt-20 -79.99 -25.23 40.39 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 119.088 1.444 . . . . 0.0 113.338 -170.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -76.84 117.88 5.01 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 17.8 p -63.57 129.8 93.91 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 117.508 0.654 . . . . 0.0 109.65 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.58 153.05 74.23 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.451 2.767 . . . . 0.0 112.85 -172.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' MET . . . . . 0.542 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 57.0 ttm -76.91 79.57 3.48 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-O 121.852 0.834 . . . . 0.0 110.167 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.9 -28.9 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -74.33 178.45 5.17 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.748 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -54.02 141.12 50.29 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.131 0.972 . . . . 0.0 111.964 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.542 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 16.0 Cg_exo -67.68 84.82 0.39 Allowed 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.758 2.305 . . . . 0.0 111.679 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.7 mtm -68.11 109.55 3.57 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.692 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -123.37 137.55 54.8 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.105 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 50.25 0.6 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.793 0.837 . . . . 0.0 110.697 -159.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 190' ' ' ASP . 16.8 ptpt -55.68 149.71 13.78 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.411 1.084 . . . . 0.0 113.872 -173.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.681 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.437 ' HA3' ' HB ' ' A' ' 159' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.61 10.81 15.65 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -169.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -91.74 159.45 15.83 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 166.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 60.0 mttp -79.18 178.64 7.91 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.99 0.516 . . . . 0.0 111.564 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -91.39 17.45 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 123.903 0.881 . . . . 0.0 110.929 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -151.8 9.11 0.51 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.422 0.689 . . . . 0.0 109.715 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 136' ' ' LYS . 9.2 tp10 -75.2 87.56 2.46 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 123.7 0.8 . . . . 0.0 110.133 -170.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 46.2 p90 -74.71 120.92 20.92 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.071 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.42 -170.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.424 1.09 . . . . 0.0 109.55 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -92.61 147.9 22.5 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -140.01 104.22 4.8 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -70.03 103.61 2.32 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 173.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.34 115.07 3.87 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.457 0.703 . . . . 0.0 109.843 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t -68.8 -16.67 63.86 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.163 0.985 . . . . 0.0 112.849 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -82.46 -49.34 10.05 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 122.914 0.486 . . . . 0.0 110.978 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 22.6 ptm -101.4 -13.61 17.91 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.568 0.747 . . . . 0.0 111.441 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.616 ' HA3' ' HA3' ' A' ' 262' ' ' GLY . . . 79.19 20.55 69.56 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 174.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -106.19 153.42 22.15 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.25 0.62 . . . . 0.0 111.278 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.425 ' HZ3' ' HG3' ' A' ' 205' ' ' ARG . 57.2 m95 -78.26 144.67 35.98 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 171.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.419 ' HA ' ' HD1' ' A' ' 238' ' ' TRP . 59.2 m-85 -145.56 145.78 31.14 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.397 0.544 . . . . 0.0 111.146 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 189' ' ' ASP . 75.2 mm-40 -63.51 138.07 58.37 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 167.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -146.82 166.69 25.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.408 0.683 . . . . 0.0 110.269 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.666 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 63.1 tt0 -137.08 105.13 5.65 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.346 0.659 . . . . 0.0 110.1 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.583 HG22 HG13 ' A' ' 186' ' ' VAL . 42.3 t -67.52 100.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.51 -3.02 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.217 0.607 . . . . 0.0 112.453 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.542 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 72.4 ttt180 -166.41 135.06 2.93 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.437 ' HB ' ' HA3' ' A' ' 133' ' ' GLY . 27.6 m -118.25 127.62 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.301 0.64 . . . . 0.0 109.48 173.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.3 p -136.26 145.65 45.82 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.835 0.854 . . . . 0.0 109.264 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.521 ' HA ' ' HB ' ' A' ' 182' ' ' VAL . 13.5 ptt180 -94.27 165.85 12.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.304 0.642 . . . . 0.0 110.474 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt . . . . . 0 N--CA 1.477 0.881 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.266 175.777 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.496 ' HB3' HG22 ' A' ' 182' ' ' VAL . 3.6 mp0 -71.86 92.02 1.21 Allowed 'General case' 0 C--O 1.243 0.726 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -80.11 70.29 6.69 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 160.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 161' ' ' ARG . 18.2 m -126.78 173.94 11.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.507 177.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 183' ' ' ILE . 3.1 mp -96.8 108.87 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.427 0.632 . . . . 0.0 109.748 -166.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -99.77 105.97 17.81 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 17.7 m-70 -78.88 92.88 4.93 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.583 HG13 HG22 ' A' ' 156' ' ' VAL . 2.4 m -108.93 153.55 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.508 ' HB2' ' HZ3' ' A' ' 187' ' ' LYS . 8.1 mtmp? -119.19 118.15 30.57 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -64.72 127.25 30.75 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.453 0.471 . . . . 0.0 110.378 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 153' ' ' GLU . 13.4 t70 -65.85 -37.53 86.45 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.72 -20.32 65.25 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.696 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -139.37 66.87 37.76 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 123.568 0.747 . . . . 0.0 109.11 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -71.2 -40.03 3.51 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.331 2.021 . . . . 0.0 112.883 -169.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.68 -2.57 58.7 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.782 0.833 . . . . 0.0 111.982 -176.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.04 -16.4 59.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.205 0.602 . . . . 0.0 110.56 172.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 100.02 -161.13 19.29 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.206 -0.452 . . . . 0.0 113.16 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 7.6 t -96.3 116.96 39.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 22.4 m -101.88 155.2 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.878 0.871 . . . . 0.0 110.204 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 15.1 pm0 -99.4 128.54 45.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.654 0.782 . . . . 0.0 109.563 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.494 ' HE3' ' HB3' ' A' ' 203' ' ' ASP . 86.3 mmm -130.05 165.05 23.02 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.636 1.175 . . . . 0.0 108.788 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -110.74 172.11 7.06 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 180' ' ' GLU . 56.9 m -58.32 -43.86 88.39 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.137 0.575 . . . . 0.0 111.593 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -22.62 67.0 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.83 0.852 . . . . 0.0 112.219 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.494 ' HB3' ' HE3' ' A' ' 199' ' ' MET . 33.5 m-20 -84.16 -40.68 17.89 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.624 0.77 . . . . 0.0 110.423 175.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 31.3 m -93.38 117.73 37.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 CA-C-O 122.216 1.008 . . . . 0.0 110.011 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.425 ' HG3' ' HZ3' ' A' ' 151' ' ' TRP . 2.0 mmp_? -122.08 -170.27 2.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.971 1.308 . . . . 0.0 109.085 -175.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -101.98 128.58 48.35 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 169.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.588 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -73.95 118.51 16.98 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 167.223 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -69.14 121.93 17.74 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 122.855 0.462 . . . . 0.0 110.446 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -74.41 4.39 6.0 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.217 0.607 . . . . 0.0 111.913 174.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 52.4 m -84.11 105.91 15.34 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.64 114.74 25.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 279' ' ' LYS . 30.8 mm -76.49 133.65 30.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.509 177.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.91 178.04 5.05 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . 0.516 ' HA ' HD13 ' A' ' 217' ' ' LEU . 75.3 t-105 -49.5 -41.87 41.93 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.957 0.903 . . . . 0.0 111.908 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -53.93 -44.18 70.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.466 1.106 . . . . 0.0 112.788 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -115.18 17.15 16.81 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.597 0.759 . . . . 0.0 112.34 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' A' ' 214' ' ' TRP . 53.1 mt -76.2 113.22 13.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 163.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -126.69 152.71 46.42 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.733 0.413 . . . . 0.0 110.274 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.33 140.58 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.219 0.608 . . . . 0.0 110.798 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.45 -1.39 82.12 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.5 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.512 ' HG2' HG11 ' A' ' 223' ' ' VAL . 29.5 tt0 -85.57 120.49 27.08 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.496 0.648 . . . . 0.0 109.818 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 64.8 t -90.05 114.29 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.512 HG11 ' HG2' ' A' ' 221' ' ' GLN . 3.5 m -126.89 163.44 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.501 1.12 . . . . 0.0 109.346 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.403 ' HB3' HD13 ' A' ' 280' ' ' ILE . 0.0 OUTLIER -100.88 139.46 36.53 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.62 ' HG ' HG13 ' A' ' 277' ' ' VAL . 1.1 mp -131.35 167.67 18.86 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -101.36 105.64 16.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.997 0.919 . . . . 0.0 110.434 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -167.71 159.16 11.62 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.485 0.714 . . . . 0.0 110.196 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -103.31 129.15 26.04 Favored Pre-proline 0 C--O 1.217 -0.644 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.82 -7.36 20.97 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 122.405 2.07 . . . . 0.0 113.366 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -70.5 -30.27 67.0 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.116 0.566 . . . . 0.0 109.53 170.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.536 HD21 ' HB2' ' A' ' 234' ' ' GLU . 5.1 t30 -152.45 82.82 5.1 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.754 1.222 . . . . 0.0 107.77 177.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -60.88 -10.9 15.87 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.345 2.696 . . . . 0.0 114.381 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -72.31 -31.34 65.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.458 0.703 . . . . 0.0 110.826 173.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.536 ' HB2' HD21 ' A' ' 231' ' ' ASN . 0.4 OUTLIER -108.01 156.52 19.15 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.822 0.849 . . . . 0.0 111.149 -173.073 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -65.81 161.37 21.09 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.284 -1.325 . . . . 0.0 112.033 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -171.25 -122.92 0.67 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -104.86 -177.32 3.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.179 0.592 . . . . 0.0 110.645 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . 0.419 ' HD1' ' HA ' ' A' ' 152' ' ' PHE . 14.5 m95 -90.59 105.77 18.04 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -173.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -126.63 157.57 38.58 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.77 0.828 . . . . 0.0 111.033 -176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -88.07 146.77 25.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.3 0.64 . . . . 0.0 110.6 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -155.89 138.5 15.06 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.254 1.022 . . . . 0.0 108.529 170.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.6 125.12 39.05 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.55 HD13 HD12 ' A' ' 255' ' ' LEU . 28.5 mm -64.72 108.94 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.548 0.739 . . . . 0.0 109.218 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.3 m -79.92 -48.43 13.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.667 0.787 . . . . 0.0 110.798 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.96 128.44 2.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -170.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -114.23 145.53 41.6 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -141.29 121.02 13.43 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -104.56 126.54 51.74 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 77.7 p -125.23 172.31 9.65 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.182 0.993 . . . . 0.0 108.869 170.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -78.99 -12.41 60.04 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.971 0.508 . . . . 0.0 111.366 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 65.4 p -96.69 -29.14 13.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.37 0.668 . . . . 0.0 111.085 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.54 163.24 38.58 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.031 0.532 . . . . 0.0 111.336 -173.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -116.6 99.89 7.46 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 165.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.37 100.54 13.09 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.181 0.593 . . . . 0.0 110.439 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.55 HD12 HD13 ' A' ' 243' ' ' ILE . 1.7 tm? -96.24 136.09 37.19 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 175.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -125.17 127.61 47.08 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -142.57 140.31 31.69 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.13 0.572 . . . . 0.0 110.575 -176.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.79 102.54 10.05 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 170.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 49.6 t -65.88 121.85 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.794 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.5 p -121.78 107.82 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 121.976 0.893 . . . . 0.0 109.166 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.568 HD12 ' HB3' ' A' ' 264' ' ' ASP . 25.4 mt -88.15 -160.01 0.59 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.437 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.616 ' HA3' ' HA3' ' A' ' 149' ' ' GLY . . . -89.23 -25.47 28.6 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -123.04 -43.72 2.21 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.534 0.734 . . . . 0.0 111.084 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.568 ' HB3' HD12 ' A' ' 261' ' ' LEU . 30.1 t70 -113.37 177.08 4.76 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.572 1.149 . . . . 0.0 110.442 -170.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 57.6 p -148.6 143.4 26.55 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.009 0.924 . . . . 0.0 110.159 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.501 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 2.8 mm? -114.58 106.37 14.17 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -78.59 125.24 29.09 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.57 0.748 . . . . 0.0 110.493 -177.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 62.39 81.56 0.2 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.854 1.261 . . . . 0.0 112.208 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 61.3 m -111.02 127.4 55.52 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 19.4 ttp180 -80.56 104.14 10.89 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 43.1 mm -74.3 120.19 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.247 1.019 . . . . 0.0 110.335 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 54.1 mt -83.52 -20.2 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 125.2 1.4 . . . . 0.0 110.177 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -93.71 37.55 1.07 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.289 1.436 . . . . 0.0 111.902 -167.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 32.9 m -66.9 -28.59 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -169.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -95.77 0.07 51.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.657 0.783 . . . . 0.0 112.293 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -134.72 25.88 3.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.119 0.568 . . . . 0.0 111.3 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.62 HG13 ' HG ' ' A' ' 225' ' ' LEU . 55.5 t -76.11 148.74 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.835 0.854 . . . . 0.0 108.844 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -117.66 150.69 38.63 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.5 ' HB2' HD13 ' A' ' 212' ' ' ILE . 38.8 ttmt -79.45 145.55 33.23 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.952 0.501 . . . . 0.0 111.091 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' A' ' 223' ' ' VAL . 37.0 mm -84.74 139.14 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 166.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.24 147.06 51.92 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 173.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -127.35 144.35 50.45 Favored Pre-proline 0 N--CA 1.473 0.704 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.88 125.48 13.08 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.061 2.508 . . . . 0.0 113.293 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.55 -58.95 0.56 Allowed Glycine 0 C--N 1.345 1.062 0 C-N-CA 123.156 0.408 . . . . 0.0 113.317 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.02 -23.14 26.93 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.249 0.524 . . . . 0.0 111.495 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -125.46 136.51 9.8 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 16.5 m -71.5 148.83 93.38 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 123.314 0.646 . . . . 0.0 110.858 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.8 176.63 9.87 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.133 2.555 . . . . 0.0 111.574 176.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 9.5 ttt -95.12 81.14 3.64 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 14.6 p -100.38 -26.73 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.286 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.31 -177.51 4.66 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.138 0.975 . . . . 0.0 109.912 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -47.62 109.63 1.15 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.508 1.123 . . . . 0.0 111.085 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.77 108.53 1.47 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.565 2.177 . . . . 0.0 111.639 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 58.4 ttp -105.69 91.26 3.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.128 0.971 . . . . 0.0 108.639 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -66.49 142.23 57.61 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.144 0.577 . . . . 0.0 110.631 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -59.99 -32.37 70.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.696 0.798 . . . . 0.0 112.138 -173.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.96 -24.34 66.94 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.268 1.027 . . . . 0.0 111.713 -176.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.8 m . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 172.063 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.109 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.35 -6.33 50.4 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.178 0.591 . . . . 0.0 112.167 -176.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -98.65 150.07 22.15 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.159 0.504 . . . . 0.0 111.106 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.618 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 48.4 mtpt -84.69 168.83 14.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.564 1.146 . . . . 0.0 110.998 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.2 m -78.75 14.47 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 C-N-CA 124.211 1.004 . . . . 0.0 112.735 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -132.2 0.22 3.75 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.974 0.91 . . . . 0.0 111.412 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.618 ' HG2' ' HB2' ' A' ' 136' ' ' LYS . 27.9 mm-40 -79.9 92.17 5.49 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.62 0.724 . . . . 0.0 112.29 -168.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 12.8 p90 -65.29 100.11 0.44 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.74 165.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.88 -172.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.983 1.313 . . . . 0.0 109.191 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.614 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 15.3 t70 -104.53 157.94 16.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 168.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -133.86 96.07 3.58 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.481 0.312 . . . . 0.0 110.465 169.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -73.41 97.95 2.64 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 169.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.82 128.0 34.11 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.121 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.6 m -68.5 -30.15 68.92 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.22 0.608 . . . . 0.0 111.222 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -74.03 -42.26 60.58 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.347 0.659 . . . . 0.0 111.649 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 54.4 ttm -102.02 -22.8 14.19 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.09 0.556 . . . . 0.0 112.378 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 77.45 0.75 73.58 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-N 116.663 -0.244 . . . . 0.0 113.431 -174.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -93.16 164.83 13.1 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 123.422 0.689 . . . . 0.0 111.342 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.563 ' HB3' ' HB2' ' A' ' 238' ' ' TRP . 2.3 p-90 -77.41 139.59 39.73 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.85 174.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -147.22 77.26 1.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 171.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 50.9 mt-10 -55.99 134.96 52.68 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.572 ' HB3' ' HB ' ' A' ' 186' ' ' VAL . . . -149.15 135.11 18.96 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.655 0.597 . . . . 0.0 111.796 -164.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.3 tt0 -91.44 109.63 20.92 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.51 113.77 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.524 0.73 . . . . 0.0 109.261 170.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.89 -8.7 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 122.967 0.507 . . . . 0.0 111.497 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 36.3 ttm180 -169.93 143.83 2.64 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.639 0.776 . . . . 0.0 109.412 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.34 143.47 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.7 0.8 . . . . 0.0 108.866 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.437 HG23 ' HB ' ' A' ' 183' ' ' ILE . 9.5 t -148.79 163.8 36.3 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.122 0.569 . . . . 0.0 111.207 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -87.28 171.78 10.37 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.381 1.072 . . . . 0.0 112.162 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 124.473 1.109 . . . . 0.0 110.086 173.441 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 201' ' ' SER . 7.3 mp0 -77.29 89.05 3.72 Favored 'General case' 0 C--O 1.249 1.026 0 CA-C-O 121.19 0.519 . . . . 0.0 110.764 -172.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.06 79.35 9.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 163.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 16.7 m -129.68 157.24 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.955 0.902 . . . . 0.0 108.768 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.457 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.2 mp -95.38 109.39 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -166.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.43 ' HB3' HG13 ' A' ' 186' ' ' VAL . 78.7 m-85 -92.35 111.4 22.95 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.519 1.127 . . . . 0.0 108.973 172.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 17.5 m-70 -77.29 91.59 3.81 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 168.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 34.9 m -109.02 157.92 9.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.477 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.444 ' HZ1' ' HB3' ' A' ' 187' ' ' LYS . 8.0 mtpm? -127.88 115.14 18.14 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -60.43 117.51 5.34 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.698 0.624 . . . . 0.0 111.755 -171.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -56.09 -42.7 77.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.034 1.334 . . . . 0.0 111.554 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -86.14 -16.63 37.32 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.263 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -138.61 68.14 44.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 123.115 0.566 . . . . 0.0 110.836 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.14 -17.67 53.67 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.565 2.177 . . . . 0.0 113.514 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.66 -23.08 66.71 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.743 0.817 . . . . 0.0 112.067 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -74.83 -13.34 60.55 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.151 0.58 . . . . 0.0 111.61 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.99 -141.35 34.33 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.81 0.694 . . . . 0.0 112.308 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 25.9 t -93.19 119.25 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 20.2 m -123.59 155.71 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.964 1.306 . . . . 0.0 109.54 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.457 ' HB2' HG23 ' A' ' 183' ' ' ILE . 20.8 pt20 -98.62 132.29 44.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.866 0.467 . . . . 0.0 110.812 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.58 ' HE1' ' HB3' ' A' ' 203' ' ' ASP . 83.5 mmm -135.24 164.49 27.6 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.998 0.919 . . . . 0.0 108.68 173.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . 0.416 ' O ' HG22 ' A' ' 204' ' ' VAL . 21.4 m-80 -109.71 172.03 7.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' A' ' 180' ' ' GLU . 40.7 m -61.59 -30.25 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.127 0.421 . . . . 0.0 111.134 175.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.403 ' H ' ' HG3' ' A' ' 202' ' ' ARG . 11.8 mtm180 -55.94 -42.59 76.4 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.428 1.091 . . . . 0.0 109.246 175.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.58 ' HB3' ' HE1' ' A' ' 199' ' ' MET . 6.0 m-20 -84.68 -40.44 17.38 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.366 -175.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 18.8 m -91.85 116.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 CA-C-O 122.703 1.24 . . . . 0.0 108.33 -173.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -106.96 137.7 44.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.479 -1.691 . . . . 0.0 107.895 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.541 ' HB2' ' HG2' ' A' ' 281' ' ' GLU . . . -62.37 126.31 26.9 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.711 ' HD3' ' H ' ' A' ' 295' ' ' ARG . 42.2 ttm180 -63.38 95.82 0.1 Allowed 'General case' 0 C--O 1.241 0.634 0 O-C-N 123.972 0.795 . . . . 0.0 109.854 -175.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.06 121.52 10.83 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.891 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -91.93 1.92 56.87 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.216 172.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.0 m -97.92 113.94 25.9 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.747 0.819 . . . . 0.0 110.67 -176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.76 136.8 22.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.759 0.824 . . . . 0.0 108.954 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.455 ' HB ' HG12 ' A' ' 277' ' ' VAL . 37.1 mm -90.25 133.79 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -97.92 172.43 7.65 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.21 0.604 . . . . 0.0 110.688 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . 0.408 ' HA ' HD12 ' A' ' 217' ' ' LEU . 73.1 t-105 -56.01 -43.36 77.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.904 0.882 . . . . 0.0 111.47 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -58.22 -37.96 75.89 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.012 0.925 . . . . 0.0 111.645 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -82.62 -20.91 35.45 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.137 0.575 . . . . 0.0 111.282 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 214' ' ' TRP . 96.0 mt -63.22 118.98 8.73 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . 0.406 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 10.6 pt-20 -144.97 155.56 43.47 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.724 0.809 . . . . 0.0 109.729 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 35.9 m -65.4 131.27 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.149 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.71 -12.58 69.01 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 115.782 -0.645 . . . . 0.0 113.641 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -72.76 123.02 22.47 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.255 0.527 . . . . 0.0 110.535 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 51.7 t -91.62 115.72 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.57 -170.12 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.564 1.546 . . . . 0.0 109.56 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.419 ' HB2' HD11 ' A' ' 280' ' ' ILE . 40.1 ttp -141.59 130.45 23.04 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.949 0.5 . . . . 0.0 109.953 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.29 147.19 34.38 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.857 0.863 . . . . 0.0 109.991 -175.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.41 ' OD1' ' HB2' ' A' ' 235' ' ' ARG . 6.9 p30 -90.92 114.24 26.66 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.392 0.615 . . . . 0.0 111.347 -175.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -137.64 144.54 41.93 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.348 1.059 . . . . 0.0 110.641 174.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -86.11 123.01 72.36 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.77 -9.63 26.13 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.468 2.112 . . . . 0.0 112.703 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.55 -43.57 14.37 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.31 0.644 . . . . 0.0 109.967 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -130.55 89.15 44.76 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.645 0.778 . . . . 0.0 109.967 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.18 -12.23 33.49 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.761 2.308 . . . . 0.0 112.615 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -66.51 -28.65 68.72 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.11 0.564 . . . . 0.0 110.544 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -120.24 161.12 21.63 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.31 0.644 . . . . 0.0 110.068 -173.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.41 ' HB2' ' OD1' ' A' ' 226' ' ' ASN . 1.4 ppt_? -60.47 166.85 2.86 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 124.397 1.079 . . . . 0.0 111.394 175.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -177.37 -113.33 0.35 Allowed Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.302 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -96.73 139.68 32.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.137 0.975 . . . . 0.0 110.178 -172.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 151' ' ' TRP . 79.7 m95 -70.91 123.59 22.37 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.208 0.528 . . . . 0.0 110.548 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -130.92 151.48 51.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.52 137.22 35.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 258' ' ' ASN . . . -134.83 137.71 43.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.804 0.442 . . . . 0.0 110.512 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -96.23 118.56 33.04 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.533 HD13 HD11 ' A' ' 255' ' ' LEU . 44.0 mm -59.64 107.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 123.813 0.696 . . . . 0.0 109.294 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 10.0 m -78.38 -44.19 25.63 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.855 0.862 . . . . 0.0 110.623 -176.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -155.49 155.79 34.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.973 -168.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -149.7 145.58 26.77 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.596 0.56 . . . . 0.0 110.18 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -155.53 117.35 4.05 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.002 0.921 . . . . 0.0 108.535 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -102.98 124.33 48.28 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.1 p -133.25 162.26 32.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.681 0.793 . . . . 0.0 109.598 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.31 -26.73 68.0 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.203 1.001 . . . . 0.0 112.71 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 26.9 p -88.69 -30.24 19.27 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.198 0.599 . . . . 0.0 111.342 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -172.06 151.96 2.8 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.428 0.455 . . . . 0.0 111.462 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -105.86 110.46 22.76 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.901 0.48 . . . . 0.0 109.768 172.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -89.87 129.43 36.23 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.694 1.197 . . . . 0.0 110.825 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.533 HD11 HD13 ' A' ' 243' ' ' ILE . 1.5 tm? -137.34 129.84 29.83 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -118.64 144.26 46.28 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.59 146.04 29.23 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.525 0.73 . . . . 0.0 110.611 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 241' ' ' ALA . 7.3 m-20 -78.19 96.3 5.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.746 0.818 . . . . 0.0 109.233 172.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 51.0 t -76.54 107.57 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 95.8 t -87.52 119.36 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.799 0.84 . . . . 0.0 110.786 -167.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 43.2 mt -107.81 -176.88 3.18 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.356 1.062 . . . . 0.0 108.816 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -76.75 -49.94 7.48 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-O 120.957 0.198 . . . . 0.0 113.247 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.17 -30.73 12.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.445 0.698 . . . . 0.0 109.885 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -112.14 175.34 5.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.571 0.749 . . . . 0.0 111.65 -175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 14.0 p -155.73 113.24 3.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.504 1.122 . . . . 0.0 108.103 170.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.439 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 31.9 mt -80.87 81.7 7.05 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.239 1.015 . . . . 0.0 108.57 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 4.2 p-10 -76.46 135.81 39.39 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.533 -171.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 13.6 t70 56.89 47.45 17.81 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.399 1.08 . . . . 0.0 110.597 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 91.9 m -99.66 132.67 44.85 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.826 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 24.8 ttp180 -62.93 117.9 7.05 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.598 0.759 . . . . 0.0 112.128 -174.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.51 105.56 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.666 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 34.3 mt -70.74 -36.31 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 125.443 1.497 . . . . 0.0 110.507 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -109.26 69.41 0.7 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.7 0.8 . . . . 0.0 109.881 -171.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 18.3 m -71.4 -14.39 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.516 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.19 -28.78 48.21 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.265 1.026 . . . . 0.0 110.87 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -90.6 26.0 2.14 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.332 0.587 . . . . 0.0 111.289 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.455 HG12 ' HB ' ' A' ' 212' ' ' ILE . 71.5 t -96.36 126.12 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.469 1.108 . . . . 0.0 109.602 175.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -112.28 160.88 17.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.181 0.992 . . . . 0.0 109.985 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.66 ' HD3' ' HA2' ' A' ' 286' ' ' GLY . 17.2 ttmm -78.31 136.61 37.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.488 1.115 . . . . 0.0 111.013 177.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 224' ' ' MET . 41.2 mm -83.05 117.15 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 163.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.541 ' HG2' ' HB2' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -68.25 105.36 2.1 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.458 0.647 . . . . 0.0 110.564 -178.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -122.02 142.52 36.66 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 123.654 0.781 . . . . 0.0 108.956 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.15 120.4 6.72 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.477 2.784 . . . . 0.0 113.817 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.26 -25.75 26.63 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-N 116.063 -0.517 . . . . 0.0 114.038 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.04 -12.9 4.61 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 117.855 0.828 . . . . 0.0 112.543 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . 0.66 ' HA2' ' HD3' ' A' ' 279' ' ' LYS . . . -98.11 120.46 6.8 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 123.448 0.546 . . . . 0.0 111.785 -173.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.3 m -75.52 142.3 74.13 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 117.092 0.446 . . . . 0.0 111.604 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.09 148.81 24.88 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.828 2.352 . . . . 0.0 111.993 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' MET . . . . . 0.55 ' SD ' ' HB3' ' A' ' 207' ' ' ARG . 23.5 ttt -77.81 85.1 4.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.242 0.544 . . . . 0.0 109.609 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 10.8 p -123.14 3.64 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.426 1.091 . . . . 0.0 109.668 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -120.36 -167.81 1.52 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.762 1.225 . . . . 0.0 108.341 -171.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -43.54 115.27 1.91 Allowed Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 124.902 1.281 . . . . 0.0 112.961 -177.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.86 115.18 2.94 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.368 2.046 . . . . 0.0 110.915 173.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 22.8 mmt -72.24 -77.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.475 0.71 . . . . 0.0 110.77 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.711 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 6.7 ttt180 66.43 106.58 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.411 1.484 . . . . 0.0 109.752 -176.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.464 ' NH2' ' HB2' ' A' ' 151' ' ' TRP . 7.3 mtm-85 -101.25 22.09 12.98 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.133 1.373 . . . . 0.0 109.688 -167.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -56.44 108.16 0.45 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 125.343 1.457 . . . . 0.0 110.063 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.242 0.699 0 C-N-CA 123.638 0.775 . . . . 0.0 110.028 -176.078 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 CA-C-O 119.807 -0.44 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.67 -58.77 2.25 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.278 0.631 . . . . 0.0 110.087 -172.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -80.92 159.47 24.96 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.754 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -100.04 177.24 5.15 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.73 0.812 . . . . 0.0 111.022 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.7 m -72.4 0.51 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.688 1.195 . . . . 0.0 113.298 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -119.98 6.0 10.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.656 0.782 . . . . 0.0 112.264 -173.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 156' ' ' VAL . 8.2 mm-40 -82.28 94.8 7.41 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.263 0.554 . . . . 0.0 111.588 -171.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -79.21 101.47 8.0 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.938 171.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 35.9 m -120.08 -166.29 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 125.974 1.71 . . . . 0.0 108.995 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -122.12 165.13 16.58 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.419 ' HB2' ' HB3' ' A' ' 154' ' ' ALA . . . -129.42 140.64 51.26 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.353 0.524 . . . . 0.0 111.418 -175.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.53 HH11 ' HA ' ' A' ' 146' ' ' THR . 1.1 tmt_? -90.74 102.3 15.05 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.25 110.82 2.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.53 ' HA ' HH11 ' A' ' 144' ' ' ARG . 13.1 t -72.58 -26.39 61.69 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 122.97 0.508 . . . . 0.0 111.965 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -80.82 -41.26 23.56 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.695 0.798 . . . . 0.0 111.19 -173.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.5 ttm -94.57 -33.78 12.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.434 0.694 . . . . 0.0 110.767 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.51 14.95 67.14 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.279 -171.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.4 175.23 5.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.133 0.973 . . . . 0.0 110.614 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -115.92 129.79 56.55 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -131.9 135.71 46.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 188' ' ' TYR . 23.9 mt-10 -60.52 142.85 54.79 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.748 0.655 . . . . 0.0 109.309 -178.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 143' ' ' ALA . . . -133.49 117.23 16.92 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.818 0.736 . . . . 0.0 111.267 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -94.24 101.88 13.88 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 55.1 t -63.68 108.55 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 172.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.412 HG13 ' HE2' ' A' ' 187' ' ' LYS . 29.0 m -108.45 -10.52 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.331 0.652 . . . . 0.0 111.97 -177.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 34.6 ttm-85 -168.85 148.2 4.19 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.384 0.674 . . . . 0.0 109.892 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.07 130.2 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.213 1.005 . . . . 0.0 109.484 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.478 ' HG1' ' HB ' ' A' ' 183' ' ' ILE . 38.7 p -130.94 151.84 50.91 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -103.19 178.75 4.47 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp . . . . . 0 N--CA 1.483 1.191 0 C-N-CA 123.099 0.56 . . . . 0.0 110.944 172.77 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 C--O 1.241 0.629 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.0 97.43 2.31 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.287 -172.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.63 19.64 0.48 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.463 171.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.5 m -66.97 162.14 3.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 124.537 1.135 . . . . 0.0 110.382 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 198' ' ' GLN . 3.9 mp -94.4 109.7 22.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -174.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -88.41 109.09 19.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.996 0.919 . . . . 0.0 109.165 172.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -80.31 88.94 5.51 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.9 m -114.0 155.21 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.53 ' HG2' HG22 ' A' ' 196' ' ' VAL . 43.8 mtmt -115.06 131.81 56.8 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 153' ' ' GLU . 19.7 m-30 -60.82 97.62 0.06 Allowed 'General case' 0 C--O 1.209 -1.038 0 O-C-N 123.586 0.554 . . . . 0.0 110.031 170.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -68.05 -21.18 65.01 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.687 0.795 . . . . 0.0 111.652 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 25.6 p30 -85.54 -28.77 24.69 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.67 0.788 . . . . 0.0 111.827 173.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -135.13 69.17 69.99 Favored Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 123.364 0.665 . . . . 0.0 109.818 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.61 -7.3 20.59 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.476 2.118 . . . . 0.0 112.902 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.79 -9.67 59.15 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.634 0.773 . . . . 0.0 110.88 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.49 -19.54 52.81 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.749 0.82 . . . . 0.0 110.443 169.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 84.78 -165.45 40.21 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.911 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.53 HG22 ' HG2' ' A' ' 187' ' ' LYS . 42.2 t -79.24 129.6 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 32.1 m -114.67 155.12 15.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 124.328 1.051 . . . . 0.0 109.541 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.516 ' HB2' HG21 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -102.45 117.08 33.95 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.597 0.759 . . . . 0.0 109.574 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' MET . . . . . 0.584 ' HE1' ' HB3' ' A' ' 203' ' ' ASP . 79.8 mmm -120.79 169.67 10.2 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.033 0.933 . . . . 0.0 109.702 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -109.92 178.58 4.37 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.334 0.654 . . . . 0.0 109.611 172.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 22.7 t -65.36 -39.82 92.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.419 0.688 . . . . 0.0 110.545 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -65.31 -22.87 66.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.546 0.738 . . . . 0.0 111.847 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.584 ' HB3' ' HE1' ' A' ' 199' ' ' MET . 33.9 m-20 -97.85 2.1 48.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.646 0.779 . . . . 0.0 112.339 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.9 m -121.55 134.74 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 171.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.51 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 7.2 ptm180 -120.58 166.4 13.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.012 1.325 . . . . 0.0 109.777 -177.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.02 167.62 21.15 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 163.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.618 ' H ' ' HA ' ' A' ' 288' ' ' PRO . 37.8 ttp180 -143.61 125.98 15.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.39 0.541 . . . . 0.0 110.405 169.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -81.82 158.91 23.9 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.671 1.188 . . . . 0.0 111.782 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.51 23.97 1.51 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.584 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 99.3 m -108.05 113.57 26.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.737 0.815 . . . . 0.0 110.473 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 14.8 mt -85.62 125.98 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 162.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.489 HG22 HG11 ' A' ' 223' ' ' VAL . 46.0 mm -75.7 147.03 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 123.297 0.639 . . . . 0.0 110.79 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.03 179.75 5.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.431 1.092 . . . . 0.0 109.54 176.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -59.89 -32.09 70.41 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.865 0.866 . . . . 0.0 111.037 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -68.92 -25.21 64.47 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.467 ' HB2' HG23 ' A' ' 212' ' ' ILE . 26.3 m-20 -77.21 -26.01 52.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.549 0.34 . . . . 0.0 110.937 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.531 HD21 HG13 ' A' ' 243' ' ' ILE . 50.4 mt -73.43 144.01 46.5 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.614 0.721 . . . . 0.0 112.848 -165.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.27 169.94 20.16 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.033 -1.439 . . . . 0.0 107.987 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.9 117.87 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.91 -6.76 57.01 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 116.024 -0.534 . . . . 0.0 113.171 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.48 ' HG2' ' HA ' ' A' ' 217' ' ' LEU . 4.0 tp-100 -64.49 120.64 12.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.547 0.739 . . . . 0.0 109.644 174.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.7 p -102.88 130.08 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 109.9 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.489 HG11 HG22 ' A' ' 212' ' ' ILE . 15.0 m -141.34 179.8 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 124.532 1.133 . . . . 0.0 110.232 -171.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.585 ' HE3' HH11 ' A' ' 296' ' ' ARG . 21.0 ttp -141.72 124.33 15.9 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 118.033 0.378 . . . . 0.0 111.877 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 273' ' ' PHE . 2.2 pt? -138.69 167.13 22.64 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.143 0.977 . . . . 0.0 110.404 -174.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.81 121.15 26.07 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 170.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -142.98 146.9 34.33 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -122.95 116.06 29.0 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.12 -24.13 66.42 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.229 1.953 . . . . 0.0 112.395 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.57 -44.11 21.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.265 0.626 . . . . 0.0 110.549 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -122.24 80.45 44.62 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.761 0.825 . . . . 0.0 109.798 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.89 -19.92 64.48 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.137 2.558 . . . . 0.0 114.408 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.474 ' HD3' HD11 ' A' ' 272' ' ' ILE . 5.0 tppp? -82.72 -27.14 31.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.943 0.497 . . . . 0.0 111.424 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.499 ' HG2' ' HG2' ' A' ' 235' ' ' ARG . 34.6 tt0 -118.38 160.46 21.63 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 120.913 0.387 . . . . 0.0 110.849 -173.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.499 ' HG2' ' HG2' ' A' ' 234' ' ' GLU . 24.4 ptt-85 -49.09 149.5 1.94 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.442 1.497 . . . . 0.0 113.587 175.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -141.49 -110.53 0.82 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 171.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -117.23 165.17 13.75 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.857 0.863 . . . . 0.0 109.161 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 296' ' ' ARG . 54.0 m95 -80.32 115.01 19.63 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -127.1 166.6 17.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . 0.438 ' HB2' HG23 ' A' ' 260' ' ' VAL . 5.2 m-20 -82.8 156.62 23.58 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -143.49 138.45 29.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 167.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -111.17 118.54 36.25 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.549 HD12 HD23 ' A' ' 255' ' ' LEU . 29.1 mm -63.9 104.56 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 124.459 1.099 . . . . 0.0 110.364 -169.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.43 ' H ' ' HA ' ' A' ' 257' ' ' ALA . 18.8 m -79.82 -32.36 40.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.8 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.583 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 36.5 ttm180 -164.01 156.19 17.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.05 0.94 . . . . 0.0 109.559 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -155.81 148.78 24.34 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -150.5 135.18 17.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.872 0.469 . . . . 0.0 109.904 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -91.93 122.72 34.72 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 58.4 p -122.64 154.44 38.02 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -62.01 -20.59 64.07 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.6 p -97.94 -29.75 13.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.992 0.517 . . . . 0.0 112.164 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.45 165.09 31.64 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.24 0.543 . . . . 0.0 112.384 -169.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -97.79 103.41 15.35 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -92.23 141.32 28.7 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.962 0.905 . . . . 0.0 110.601 -171.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.549 HD23 HD12 ' A' ' 243' ' ' ILE . 1.2 tt -149.66 138.93 21.35 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.668 0.787 . . . . 0.0 108.985 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . 0.583 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 95.5 m-85 -132.09 131.86 42.77 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.921 0.889 . . . . 0.0 108.602 169.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.43 ' HA ' ' H ' ' A' ' 244' ' ' SER . . . -145.97 148.98 33.33 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.001 0.429 . . . . 0.0 111.223 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 43.9 t30 -79.61 97.02 6.34 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.406 171.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.57 103.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 240' ' ' ASP . 30.9 m -96.44 120.24 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.744 0.783 . . . . 0.0 110.56 -171.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 264' ' ' ASP . 19.6 mt -92.26 -159.64 0.68 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.816 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.89 -40.62 89.22 Favored Glycine 0 C--N 1.352 1.423 0 N-CA-C 113.524 0.169 . . . . 0.0 113.524 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -123.5 -49.55 1.9 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.82 0.848 . . . . 0.0 109.675 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.478 ' HB2' HD11 ' A' ' 261' ' ' LEU . 3.3 m-20 -75.16 172.39 12.47 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.481 1.112 . . . . 0.0 111.932 -176.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 15.3 p -159.28 114.47 2.47 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.952 0.901 . . . . 0.0 109.37 175.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -82.06 88.93 6.41 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 25.8 t-20 -76.98 139.47 40.12 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.017 -175.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 38.5 t70 68.07 20.0 9.13 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.696 1.198 . . . . 0.0 111.276 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 48.9 t -71.71 122.84 21.33 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 255' ' ' LEU . 41.7 ttp180 -71.04 119.67 15.5 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.47 ' HB ' HD13 ' A' ' 255' ' ' LEU . 51.0 mm -78.71 95.98 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.615 0 CA-C-O 122.018 0.913 . . . . 0.0 110.163 -173.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.474 HD11 ' HD3' ' A' ' 233' ' ' LYS . 73.4 mt -67.5 -29.74 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 113.263 -1.79 . . . . 0.0 110.337 173.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.58 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 15.0 m-85 -95.65 45.47 1.09 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.678 1.191 . . . . 0.0 109.585 -173.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . 0.464 HG23 HD11 ' A' ' 255' ' ' LEU . 7.3 p -67.01 -20.52 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 124.576 1.15 . . . . 0.0 112.45 -175.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.38 -17.86 19.46 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.4 0.68 . . . . 0.0 111.135 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 65.2 mm-40 -93.59 16.63 13.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.408 1.083 . . . . 0.0 112.045 -174.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.81 138.01 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.303 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.521 ' HB2' ' HE2' ' A' ' 224' ' ' MET . 88.3 m-85 -125.78 163.89 21.89 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.493 1.517 . . . . 0.0 110.049 -168.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.463 ' HA ' ' HE3' ' A' ' 279' ' ' LYS . 0.6 OUTLIER -63.35 136.39 57.62 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.353 178.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 18.3 mm -98.8 116.77 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 162.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.18 134.77 40.48 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.473 1.109 . . . . 0.0 108.948 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -82.19 134.99 48.07 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.179 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.12 124.28 15.58 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.852 2.368 . . . . 0.0 111.794 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.98 -46.87 1.21 Allowed Glycine 0 C--N 1.344 0.98 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -75.87 -23.55 55.63 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.616 0.767 . . . . 0.0 110.925 175.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -130.84 159.13 22.88 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 53.5 p -97.32 150.12 36.45 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.217 0.607 . . . . 0.0 110.712 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.618 ' HA ' ' H ' ' A' ' 207' ' ' ARG . 86.3 Cg_endo -74.14 -171.76 0.98 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.856 2.371 . . . . 0.0 111.897 175.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 16.1 mmt -75.21 79.65 2.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.667 0.746 . . . . 0.0 110.285 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 6.8 p -92.7 -29.94 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.869 1.268 . . . . 0.0 108.619 173.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -81.34 161.29 23.88 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.945 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -46.58 99.41 0.21 Allowed Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 124.987 1.315 . . . . 0.0 111.995 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.31 99.85 0.17 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.608 2.872 . . . . 0.0 114.236 -164.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 55.7 mtm -78.21 92.09 4.43 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -83.28 170.14 14.95 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.072 0.463 . . . . 0.0 110.594 -178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.585 HH11 ' HE3' ' A' ' 224' ' ' MET . 20.9 mtm180 -89.08 91.05 8.66 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.57 0.748 . . . . 0.0 109.21 -169.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 70.17 -107.58 0.06 Allowed 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.27 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--O 1.24 0.561 0 C-N-CA 122.691 0.396 . . . . 0.0 110.13 -169.11 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.85 11.15 9.63 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.528 0.731 . . . . 0.0 111.202 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.447 ' O ' HG11 ' A' ' 159' ' ' VAL . 30.5 m-85 -124.4 163.4 21.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.235 1.014 . . . . 0.0 109.315 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.684 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 10.1 ptpp? -123.62 -179.57 4.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.275 1.03 . . . . 0.0 109.358 176.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.33 11.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.498 ' H ' ' HG3' ' A' ' 136' ' ' LYS . 6.9 t-20 -131.32 -6.64 3.79 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.247 0.619 . . . . 0.0 111.105 -174.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.684 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 29.8 mm-40 -78.22 87.15 4.31 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.59 0.71 . . . . 0.0 110.879 -177.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 11.4 p90 -68.91 100.49 1.2 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.289 169.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.38 177.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.456 0.702 . . . . 0.0 109.814 -177.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.636 ' HB2' ' HB3' ' A' ' 207' ' ' ARG . 16.9 t0 -94.25 152.06 18.97 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -146.89 115.65 6.81 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.401 0.68 . . . . 0.0 110.412 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -72.42 115.02 11.18 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.518 ' HB3' ' SD ' ' A' ' 148' ' ' MET . 9.8 t70 -66.68 110.41 3.21 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.4 p -64.74 -7.68 11.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.415 1.086 . . . . 0.0 113.775 -167.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -75.58 -57.14 4.06 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 117.898 0.317 . . . . 0.0 111.113 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.518 ' SD ' ' HB3' ' A' ' 145' ' ' ASP . 1.8 pmm? -104.5 -19.85 13.89 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.131 0.572 . . . . 0.0 111.38 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.44 9.57 61.51 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.911 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.01 128.62 34.16 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.591 0.357 . . . . 0.0 110.856 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.435 ' O ' ' HB2' ' A' ' 238' ' ' TRP . 97.1 m95 -73.09 133.19 44.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.578 0.751 . . . . 0.0 109.283 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -139.59 133.19 30.39 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 207' ' ' ARG . 33.2 tt0 -70.26 90.12 0.68 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.272 0.558 . . . . 0.0 110.427 -175.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.5 ' HB2' ' HB ' ' A' ' 186' ' ' VAL . . . -96.87 118.69 33.86 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.363 0.665 . . . . 0.0 110.007 -172.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.633 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 65.0 tt0 -86.38 116.09 24.32 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.495 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.422 ' HA ' HG12 ' A' ' 186' ' ' VAL . 61.8 t -61.56 109.04 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 124.359 1.037 . . . . 0.0 108.807 172.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.491 HG11 ' HE2' ' A' ' 187' ' ' LYS . 16.1 m -114.58 -0.98 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.993 0.917 . . . . 0.0 112.012 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.608 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 51.1 ttt85 -167.1 138.04 3.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.271 1.028 . . . . 0.0 108.549 173.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 135' ' ' TYR . 26.0 m -116.19 134.19 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.9 p -142.5 150.82 41.0 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.454 0.702 . . . . 0.0 109.738 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -76.91 164.03 26.18 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.699 0.8 . . . . 0.0 110.424 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.872 0.367 . . . . 0.0 110.39 172.569 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 74.6 -6.48 1.9 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.201 1.401 . . . . 0.0 112.824 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -108.38 23.03 15.11 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 m -81.74 175.71 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 123.657 0.783 . . . . 0.0 109.417 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.511 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.4 mp -97.5 109.39 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.75 0.786 . . . . 0.0 109.964 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 201' ' ' SER . 93.2 m-85 -96.77 113.35 24.9 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.757 1.223 . . . . 0.0 108.211 168.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' HIS . . . . . 0.608 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 12.7 m-70 -78.67 103.87 8.91 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 154' ' ' ALA . 35.5 m -117.36 157.31 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.468 1.107 . . . . 0.0 110.776 -172.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.491 ' HE2' HG11 ' A' ' 157' ' ' VAL . 50.6 mtmt -129.15 123.83 33.12 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -64.48 133.56 52.7 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.386 0.674 . . . . 0.0 110.339 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.37 -31.52 62.41 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -66.11 -30.75 71.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.089 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -145.69 71.74 13.93 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.046 0.538 . . . . 0.0 110.465 -174.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.87 -26.73 15.3 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.658 2.239 . . . . 0.0 112.047 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -76.42 -10.9 59.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.089 0.956 . . . . 0.0 110.885 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.73 6.09 19.2 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.259 0.624 . . . . 0.0 110.89 170.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.0 -154.14 49.35 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.393 0.433 . . . . 0.0 113.796 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.24 119.18 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.614 0.766 . . . . 0.0 109.57 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.7 m -109.13 153.55 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.992 0.917 . . . . 0.0 109.098 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.511 ' HB2' HG23 ' A' ' 183' ' ' ILE . 5.1 pm0 -91.1 137.3 32.47 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 80.4 mmm -148.51 158.52 44.17 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.049 0.94 . . . . 0.0 110.706 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -112.36 149.85 31.89 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.274 1.43 . . . . 0.0 110.477 -178.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.616 ' HA ' HG22 ' A' ' 204' ' ' VAL . 33.0 t -64.14 -30.32 71.39 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.071 0.949 . . . . 0.0 112.611 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -67.68 -20.63 65.32 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 122.519 -0.113 . . . . 0.0 111.131 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -115.15 -1.8 12.9 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.652 0.781 . . . . 0.0 111.838 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.616 HG22 ' HA ' ' A' ' 201' ' ' SER . 6.0 m -115.71 118.94 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.962 0.887 . . . . 0.0 109.37 169.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -106.07 158.7 16.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -175.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.25 128.12 34.39 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 169.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.636 ' HB3' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -76.28 138.26 40.43 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.127 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -88.57 139.79 30.12 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -90.7 -0.36 57.67 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.479 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 28.0 m -84.29 112.93 20.75 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.51 121.91 37.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.092 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.1 mm -93.41 148.66 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.141 0.977 . . . . 0.0 109.95 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 16.2 ptpt -123.9 169.02 12.01 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.541 0.736 . . . . 0.0 110.226 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -51.37 -44.12 62.02 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.112 0.965 . . . . 0.0 111.562 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -60.78 -35.21 75.87 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.171 -177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.11 -7.87 57.6 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.944 0.897 . . . . 0.0 111.372 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.491 ' O ' ' HD3' ' A' ' 246' ' ' LYS . 97.4 mt -84.67 137.55 33.19 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.736 0.814 . . . . 0.0 110.077 175.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . 0.474 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 9.6 pt-20 -151.78 171.64 17.4 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.773 0.829 . . . . 0.0 110.578 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 29.2 m -67.56 116.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 122.834 0.454 . . . . 0.0 111.745 -175.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.07 -15.12 33.64 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.345 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -71.92 122.42 20.77 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.57 1.148 . . . . 0.0 110.981 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.423 ' HB ' ' NH2' ' A' ' 282' ' ' ARG . 60.7 t -103.73 123.69 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 174.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.88 148.95 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 125.105 1.362 . . . . 0.0 109.927 -176.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 15.7 ptm -98.03 122.7 41.49 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.351 0.596 . . . . 0.0 111.22 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.89 141.85 40.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.742 1.217 . . . . 0.0 109.595 -171.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -96.34 107.35 19.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.017 0.913 . . . . 0.0 111.869 -173.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.564 ' HE2' ' HB2' ' A' ' 239' ' ' TYR . 20.4 p90 -136.33 156.83 48.08 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -87.62 125.07 66.38 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.56 -31.75 95.0 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.366 2.044 . . . . 0.0 112.707 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -81.47 -24.63 36.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.538 0.735 . . . . 0.0 110.982 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -134.62 81.81 46.79 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 123.716 0.807 . . . . 0.0 109.636 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.1 -27.14 73.3 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.602 2.201 . . . . 0.0 112.3 -175.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -85.42 15.07 4.71 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.357 1.063 . . . . 0.0 110.649 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -140.4 146.33 38.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.835 0.854 . . . . 0.0 110.061 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -71.37 138.45 49.2 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.437 0.695 . . . . 0.0 109.42 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.27 -114.36 0.52 Allowed Glycine 0 C--N 1.339 0.738 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -100.17 143.4 30.41 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.476 1.111 . . . . 0.0 109.694 -170.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' TRP . . . . . 0.435 ' HB2' ' O ' ' A' ' 151' ' ' TRP . 60.7 m95 -74.34 124.01 25.67 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.77 0.428 . . . . 0.0 110.049 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.564 ' HB2' ' HE2' ' A' ' 227' ' ' TYR . 96.3 m-85 -131.59 147.29 52.51 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -81.67 142.75 32.44 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.447 ' HB1' HG13 ' A' ' 259' ' ' VAL . . . -142.83 135.95 28.27 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 123.461 0.705 . . . . 0.0 110.029 -170.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -95.98 115.72 27.86 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.57 HD12 HD12 ' A' ' 255' ' ' LEU . 20.0 mm -65.1 113.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 123.803 0.841 . . . . 0.0 108.911 -175.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.4 p -90.97 -20.43 22.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.806 0.842 . . . . 0.0 110.954 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -161.81 142.15 10.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.1 0.56 . . . . 0.0 110.859 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 217' ' ' LEU . 23.5 pttm -122.55 129.5 52.01 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 167.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -155.27 150.54 27.02 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.923 0.889 . . . . 0.0 108.772 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -142.79 137.69 29.89 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.279 0.632 . . . . 0.0 109.761 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 32.7 p -99.04 178.04 5.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 161.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -68.14 -26.7 65.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.203 0.601 . . . . 0.0 110.929 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.7 p -86.5 -30.3 22.07 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.096 0.558 . . . . 0.0 112.132 -174.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -167.21 173.29 9.14 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.983 0.513 . . . . 0.0 110.941 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -109.73 113.53 26.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.105 0.962 . . . . 0.0 109.887 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -91.34 92.45 8.6 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.57 HD12 HD12 ' A' ' 243' ' ' ILE . 1.8 tm? -109.51 129.46 55.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.0 130.79 53.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.52 135.34 22.33 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.069 0.948 . . . . 0.0 109.736 -175.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.405 ' N ' HD21 ' A' ' 258' ' ' ASN . 0.8 OUTLIER -76.42 97.96 4.43 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 176.326 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 266' ' ' LEU . 18.8 m -81.86 107.3 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.488 -175.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.0 p -93.33 131.65 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.377 -175.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.37 -171.6 2.56 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.841 1.256 . . . . 0.0 109.491 174.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -85.9 -17.46 61.42 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-N 116.88 -0.146 . . . . 0.0 113.397 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -122.56 -34.18 3.29 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.368 1.067 . . . . 0.0 110.083 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.46 177.69 5.11 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.758 0.823 . . . . 0.0 109.77 -173.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 33.3 t -150.52 112.96 4.67 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.479 ' HB2' HG23 ' A' ' 259' ' ' VAL . 66.3 mt -80.49 105.83 12.04 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -64.5 122.61 17.19 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.455 0.702 . . . . 0.0 110.952 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 15.1 t70 54.63 74.37 0.35 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.724 1.209 . . . . 0.0 112.325 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 43.6 t -102.2 139.78 37.36 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.495 0.718 . . . . 0.0 109.651 173.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -69.51 134.8 49.31 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.096 0.558 . . . . 0.0 109.639 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 33.1 mm -107.55 130.74 59.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 48.7 mt -98.07 -29.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.39 1.076 . . . . 0.0 110.365 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -95.03 38.03 1.14 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.235 1.014 . . . . 0.0 110.242 -167.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.9 -29.77 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.131 1.372 . . . . 0.0 113.534 -166.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ASP . . . . . 0.646 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 45.6 m-20 -100.05 -0.37 39.27 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.392 0.677 . . . . 0.0 111.674 -175.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.539 ' HB2' ' HE3' ' A' ' 297' ' ' LYS . 11.8 pt-20 -125.07 22.59 7.91 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.567 0.698 . . . . 0.0 110.845 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.76 154.24 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.5 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -108.84 160.36 16.05 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.508 0.671 . . . . 0.0 110.336 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -79.11 145.48 33.73 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.508 1.123 . . . . 0.0 111.239 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.401 HG22 ' HG3' ' A' ' 282' ' ' ARG . 40.2 mm -79.67 114.18 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -76.45 115.51 16.26 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.423 ' NH2' ' HB ' ' A' ' 222' ' ' VAL . 95.2 mtt180 -118.8 148.95 45.56 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.008 0.923 . . . . 0.0 109.836 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -55.66 122.22 11.34 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.12 2.546 . . . . 0.0 112.884 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 98.87 -52.03 1.14 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.368 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.35 -22.47 18.31 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.081 0.552 . . . . 0.0 112.139 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -90.29 98.69 2.48 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 8.4 m -64.52 144.56 98.65 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 122.821 0.448 . . . . 0.0 110.613 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.44 140.43 43.86 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.629 2.22 . . . . 0.0 111.447 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' MET . . . . . 0.538 ' HE2' ' HA ' ' A' ' 293' ' ' PRO . 27.6 ttt -76.39 84.36 3.13 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.819 0.819 . . . . 0.0 110.232 -177.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.65 -27.38 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.321 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.28 178.29 8.38 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.253 1.021 . . . . 0.0 109.935 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -42.92 129.02 3.19 Favored Pre-proline 0 N--CA 1.489 1.481 0 C-N-CA 125.4 1.48 . . . . 0.0 113.304 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.538 ' HA ' ' HE2' ' A' ' 289' ' ' MET . 41.0 Cg_exo -58.73 84.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 123.337 2.691 . . . . 0.0 113.702 178.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.5 mmm -74.56 78.02 1.97 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.799 1.24 . . . . 0.0 108.292 168.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -56.9 170.65 0.41 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.013 0.925 . . . . 0.0 113.313 -175.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.416 ' HD3' ' HB2' ' A' ' 153' ' ' GLU . 3.4 tpt180 -57.35 155.94 8.41 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.08 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.539 ' HE3' ' HB2' ' A' ' 276' ' ' GLU . 65.3 mttm -82.99 64.71 7.75 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 165.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.5 p . . . . . 0 C--O 1.241 0.655 0 CA-C-N 112.912 -1.949 . . . . 0.0 110.384 -171.702 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.586 HD12 ' HB3' ' A' ' 176' ' ' PRO . 1.4 mm? -100.37 -12.25 19.58 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.397 0.679 . . . . 0.0 111.419 -171.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.87 138.78 33.02 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.45 176.24 6.45 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 118.532 0.605 . . . . 0.0 112.226 -174.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.68 -14.96 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 124.578 1.151 . . . . 0.0 111.694 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.446 ' HA ' ' NE2' ' A' ' 155' ' ' GLN . 35.2 m-80 -113.01 24.96 11.83 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.34 0.656 . . . . 0.0 111.636 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.488 ' HG3' HG13 ' A' ' 141' ' ' VAL . 8.9 tp10 -98.98 79.77 2.4 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.632 0.73 . . . . 0.0 111.496 -173.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 9.5 p90 -73.55 98.37 2.8 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.172 173.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.488 HG13 ' HG3' ' A' ' 139' ' ' GLU . 15.7 m -114.87 171.56 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.771 0.828 . . . . 0.0 109.196 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 7.1 t0 -90.91 107.74 19.39 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -172.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.74 99.74 12.57 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.956 0.902 . . . . 0.0 109.756 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -76.06 98.91 4.45 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.9 123.68 20.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 170.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.1 t -79.9 -28.15 39.87 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.741 0.816 . . . . 0.0 110.837 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -68.85 -51.49 39.91 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.065 0.946 . . . . 0.0 111.124 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 43.8 ttp -94.72 -14.1 25.1 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.343 0.657 . . . . 0.0 109.883 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.88 7.08 86.17 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 113.668 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.52 134.52 43.36 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.733 0.413 . . . . 0.0 111.871 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -75.31 135.85 40.89 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.386 1.074 . . . . 0.0 109.34 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -143.14 118.4 10.19 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 41.5 mt-10 -59.21 98.58 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.996 0.518 . . . . 0.0 109.889 176.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -103.04 138.82 39.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.432 1.093 . . . . 0.0 112.374 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.4 tp60 -87.2 104.47 16.41 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.921 1.688 . . . . 0.0 110.546 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.591 HG22 HG13 ' A' ' 186' ' ' VAL . 59.2 t -61.99 115.43 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.64 -12.77 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.89 0.876 . . . . 0.0 111.265 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -161.17 144.98 13.16 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.539 0.736 . . . . 0.0 109.549 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.22 137.33 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 166.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.42 ' HG1' ' HB ' ' A' ' 183' ' ' ILE . 31.6 p -132.65 150.62 52.13 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.6 HH21 ' HB3' ' A' ' 165' ' ' SER . 77.0 mtm180 -87.37 161.09 18.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.998 176.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -76.12 -16.5 59.88 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.87 159.63 81.61 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 124.521 1.128 . . . . 0.0 110.296 164.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.63 91.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.446 2.764 . . . . 0.0 113.631 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.6 ' HB3' HH21 ' A' ' 161' ' ' ARG . 19.9 p -157.46 98.9 1.72 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.07 1.348 . . . . 0.0 108.348 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -103.9 -21.18 13.68 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.837 0.855 . . . . 0.0 110.781 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -103.74 -165.94 1.21 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.959 0.904 . . . . 0.0 110.371 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -52.99 127.6 45.74 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 123.558 0.743 . . . . 0.0 110.907 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.85 134.86 45.43 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.746 2.297 . . . . 0.0 113.042 -169.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 28.4 p -158.14 -177.06 6.28 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.889 0.876 . . . . 0.0 109.761 -173.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 30.9 m 58.72 58.03 3.45 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.163 0.985 . . . . 0.0 110.938 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.3 m 55.4 77.02 0.24 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.499 1.119 . . . . 0.0 110.787 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 14.4 t -90.24 7.94 35.67 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.938 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 70.1 m -62.29 97.13 0.08 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 123.342 0.657 . . . . 0.0 110.446 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -140.1 78.26 24.16 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.886 0.874 . . . . 0.0 110.269 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.586 ' HB3' HD12 ' A' ' 134' ' ' LEU . 68.2 Cg_endo -89.52 174.26 3.54 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.419 2.746 . . . . 0.0 112.336 169.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -169.12 -171.33 1.28 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.717 0.807 . . . . 0.0 110.954 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.12 -58.75 2.93 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -120.96 105.51 10.73 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 163.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.435 ' HB3' HG21 ' A' ' 182' ' ' VAL . 2.3 mp0 -68.61 105.31 2.21 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.484 -172.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.31 50.23 0.5 Allowed 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 122.234 1.016 . . . . 0.0 110.283 166.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.435 HG21 ' HB3' ' A' ' 180' ' ' GLU . 13.2 m -122.64 160.85 24.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 174.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.487 HG22 ' HB2' ' A' ' 198' ' ' GLN . 3.3 mp -95.56 110.83 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -166.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -92.59 109.2 20.61 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -78.56 98.68 6.21 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.591 HG13 HG22 ' A' ' 156' ' ' VAL . 14.7 m -107.98 165.43 4.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.358 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -130.43 116.49 18.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -54.21 110.26 0.59 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.635 0.652 . . . . 0.0 109.26 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.03 -22.42 62.14 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.738 0.78 . . . . 0.0 109.217 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.616 ' HA ' ' HA ' ' A' ' 297' ' ' LYS . 0.9 OUTLIER -69.3 -28.37 66.21 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.837 1.255 . . . . 0.0 111.899 171.278 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -142.2 78.82 16.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 123.75 0.82 . . . . 0.0 109.862 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.09 -22.33 55.41 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.322 2.682 . . . . 0.0 113.814 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -66.27 -18.85 65.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.178 0.991 . . . . 0.0 112.074 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.11 -21.65 58.76 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.987 0.515 . . . . 0.0 111.241 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 67.24 -148.0 49.63 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.67 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 18.8 t -84.56 114.7 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.3 m -112.2 151.01 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.657 1.183 . . . . 0.0 109.39 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.487 ' HB2' HG22 ' A' ' 183' ' ' ILE . 16.6 pt20 -94.66 123.45 38.1 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.061 0.544 . . . . 0.0 110.568 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.539 ' HE1' ' HB3' ' A' ' 203' ' ' ASP . 87.8 mmm -139.17 135.6 34.19 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -88.11 176.46 7.27 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 14.0 t -64.96 -39.81 94.05 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.074 0.397 . . . . 0.0 111.188 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -50.97 -29.12 11.41 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.68 0.792 . . . . 0.0 112.388 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.539 ' HB3' ' HE1' ' A' ' 199' ' ' MET . 20.3 m-20 -92.92 -39.17 11.3 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.738 0.815 . . . . 0.0 111.34 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.414 HG12 HG11 ' A' ' 186' ' ' VAL . 27.8 m -98.77 114.84 37.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 CA-C-O 121.991 0.9 . . . . 0.0 110.132 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -110.81 165.91 11.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.673 1.189 . . . . 0.0 108.704 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -78.88 124.82 28.61 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 102.41 0.22 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.548 0.739 . . . . 0.0 110.33 172.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 281' ' ' GLU . . . -68.6 99.36 0.98 Allowed 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.704 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -77.06 75.02 3.63 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.752 0.657 . . . . 0.0 110.223 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 92.5 m -147.34 108.54 4.26 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 28.8 mt -82.86 116.5 27.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.584 HD12 ' HB3' ' A' ' 279' ' ' LYS . 41.5 mm -79.25 120.41 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.516 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -76.96 164.99 25.26 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.493 ' HA ' HD12 ' A' ' 217' ' ' LEU . 90.3 t90 -56.04 -43.65 78.06 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.686 0.794 . . . . 0.0 111.029 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -69.48 -18.61 63.72 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.846 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.63 -19.12 22.21 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.769 0.427 . . . . 0.0 110.086 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 214' ' ' TRP . 88.2 mt -69.05 129.22 39.28 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.453 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 7.9 pt-20 -147.89 160.59 42.62 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.215 1.006 . . . . 0.0 109.573 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 35.0 m -59.4 134.66 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 123.631 0.582 . . . . 0.0 111.958 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.13 -22.26 30.22 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.835 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -74.62 121.47 21.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.201 0.6 . . . . 0.0 110.912 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.63 130.0 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.414 0.686 . . . . 0.0 109.275 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.1 m -140.87 147.21 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.674 1.19 . . . . 0.0 109.584 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 20.8 ptm -98.64 127.93 44.75 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.343 0.657 . . . . 0.0 111.257 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.513 HD11 HG22 ' A' ' 271' ' ' ILE . 2.2 pt? -134.58 155.58 50.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.267 1.027 . . . . 0.0 110.602 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -71.7 106.78 4.23 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -132.68 128.11 36.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.505 0.722 . . . . 0.0 109.964 -169.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -89.44 113.07 55.11 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.95 -5.26 16.73 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.645 2.23 . . . . 0.0 112.582 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.86 -32.34 23.28 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.22 0.608 . . . . 0.0 110.176 171.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -151.52 105.16 2.91 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 123.923 0.889 . . . . 0.0 109.576 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.55 -18.39 63.27 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.27 2.647 . . . . 0.0 113.322 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -84.88 -5.96 59.34 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.049 0.94 . . . . 0.0 110.952 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -126.88 153.35 45.84 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.583 0.753 . . . . 0.0 110.054 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -75.27 162.59 28.3 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.537 0.735 . . . . 0.0 112.002 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -169.47 -124.21 0.72 Allowed Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.11 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -82.84 146.75 28.74 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.89 0.876 . . . . 0.0 109.559 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . 0.435 ' CE2' ' HD2' ' A' ' 296' ' ' ARG . 43.5 m95 -74.92 111.76 10.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.869 0.366 . . . . 0.0 111.673 -175.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -119.12 166.24 13.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.377 1.071 . . . . 0.0 110.193 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . 0.507 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 3.8 m-20 -82.45 158.62 23.17 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.931 0.892 . . . . 0.0 109.512 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -151.51 132.26 14.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.904 0.482 . . . . 0.0 109.774 169.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -95.95 117.28 30.32 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 174.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.571 HD12 HD13 ' A' ' 255' ' ' LEU . 25.3 mm -65.4 124.23 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.649 0.593 . . . . 0.0 109.424 -175.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.0 t -108.29 -43.51 4.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.575 0.75 . . . . 0.0 109.58 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.495 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 63.0 mtt180 -139.34 157.48 45.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.457 1.103 . . . . 0.0 110.0 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -154.37 120.22 5.24 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.06 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 45.7 ttt-85 -144.1 115.68 8.14 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -93.65 133.61 36.81 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.366 0.603 . . . . 0.0 110.0 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 39.2 p -107.97 166.71 10.51 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 167.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -71.33 -10.4 59.69 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.5 p -94.04 -28.71 15.59 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.192 0.597 . . . . 0.0 111.515 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -171.27 145.97 2.26 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -80.46 102.68 9.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.168 0.987 . . . . 0.0 109.482 172.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -95.47 140.16 30.71 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.35 0.66 . . . . 0.0 111.674 -173.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.604 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.6 OUTLIER -132.57 142.4 49.14 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -176.229 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . 0.495 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 92.1 m-85 -132.11 122.55 25.56 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.95 46.23 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.176 0.512 . . . . 0.0 111.778 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 39.9 t30 -78.64 95.58 5.29 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.73 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 59.9 t -76.19 107.17 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.26 0.553 . . . . 0.0 110.313 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 39.4 t -86.12 115.17 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.081 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.23 -152.56 0.12 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.013 1.325 . . . . 0.0 110.208 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -48.25 -65.23 2.63 Favored Glycine 0 C--N 1.363 2.056 0 C-N-CA 124.092 0.853 . . . . 0.0 114.266 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -123.09 -22.41 5.19 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.546 0.738 . . . . 0.0 109.575 165.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -76.17 177.35 7.24 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.166 0.987 . . . . 0.0 112.077 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 35.6 p -153.17 154.41 34.69 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.679 0.792 . . . . 0.0 110.44 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 69.8 mt -128.77 89.71 2.93 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.441 1.096 . . . . 0.0 108.783 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 61.6 t30 -71.87 136.55 46.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.759 0.424 . . . . 0.0 111.431 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 14.6 t70 60.35 68.58 0.75 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.24 1.416 . . . . 0.0 111.078 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 79.9 m -113.72 135.39 53.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.919 0.888 . . . . 0.0 109.553 169.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -66.51 116.7 7.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.926 0.49 . . . . 0.0 110.714 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 43.1 mm -92.49 96.28 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.981 0.912 . . . . 0.0 108.88 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 62.6 mt -76.23 -23.48 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.217 1.007 . . . . 0.0 110.713 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.436 ' HD2' HD12 ' A' ' 225' ' ' LEU . 24.5 m-85 -93.21 32.0 1.39 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.458 1.103 . . . . 0.0 111.214 -166.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.07 -21.45 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.273 1.029 . . . . 0.0 112.003 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.65 -21.72 44.46 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.914 0.886 . . . . 0.0 111.827 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.63 9.42 3.37 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.134 0.574 . . . . 0.0 112.278 -168.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.4 129.16 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 122.985 0.514 . . . . 0.0 110.263 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -92.52 161.33 14.65 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.749 0.82 . . . . 0.0 110.652 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.584 ' HB3' HD12 ' A' ' 212' ' ' ILE . 18.2 ptmt -82.32 158.12 23.54 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.446 0.698 . . . . 0.0 111.087 176.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 42.2 mm -87.65 131.39 35.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 166.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 0.0 OUTLIER -72.44 104.79 3.9 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.427 -175.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.697 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 84.6 mtt180 -87.36 159.49 50.26 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 123.466 0.707 . . . . 0.0 111.125 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -55.25 94.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.426 2.751 . . . . 0.0 113.513 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.38 -46.44 1.24 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.294 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.697 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 21.6 tt0 -73.59 -17.88 61.12 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.3 0.64 . . . . 0.0 111.452 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -74.78 98.9 1.09 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.622 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.1 p -75.32 126.15 88.1 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.403 0.681 . . . . 0.0 111.124 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.24 167.1 26.5 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 123.193 2.595 . . . . 0.0 112.379 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' MET . . . . . 0.576 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 55.1 ttm -86.26 81.39 8.41 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.4 p -96.21 -28.55 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.35 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -81.88 -172.71 4.06 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.373 1.069 . . . . 0.0 109.143 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -45.14 117.42 3.31 Favored Pre-proline 0 N--CA 1.489 1.49 0 C-N-CA 124.912 1.285 . . . . 0.0 112.742 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.576 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 64.9 Cg_exo -55.96 141.75 85.76 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.656 2.238 . . . . 0.0 113.36 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 24.5 mmt -84.06 -69.57 0.63 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 49.47 62.32 2.69 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 122.006 0.908 . . . . 0.0 109.15 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.485 ' NH1' ' HG3' ' A' ' 153' ' ' GLU . 12.5 ptt180 -58.48 -29.16 66.02 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.092 -166.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 190' ' ' ASP . 38.6 mtmm 54.1 58.04 5.38 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.952 0.901 . . . . 0.0 111.974 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' SER . . . . . 0.432 ' HG ' ' HG3' ' A' ' 296' ' ' ARG . 6.6 m -78.3 83.69 4.53 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.037 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -143.97 75.1 0.31 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 176.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--N 1.387 2.578 0 C-N-CA 123.904 3.069 . . . . 0.0 112.936 -176.595 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.379 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.19 2.72 8.56 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.674 0.79 . . . . 0.0 110.808 173.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -127.54 137.6 52.66 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.455 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 2.1 mptp? -89.65 175.25 7.34 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.535 1.134 . . . . 0.0 110.256 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.7 m -75.9 8.07 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.035 0.934 . . . . 0.0 112.811 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -124.96 -1.17 7.83 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.622 0.769 . . . . 0.0 110.236 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.455 ' HG2' ' HB2' ' A' ' 136' ' ' LYS . 22.3 mm-40 -91.21 89.98 7.57 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.677 0.751 . . . . 0.0 111.652 -170.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 6.8 p90 -63.48 111.5 2.36 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.346 164.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.2 m -120.89 166.69 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.189 0.995 . . . . 0.0 109.32 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -93.05 104.95 17.12 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.442 ' HB3' HG11 ' A' ' 204' ' ' VAL . . . -109.65 117.56 34.25 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.753 1.221 . . . . 0.0 109.93 -176.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -73.93 112.74 10.35 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.79 127.49 32.68 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.6 m -69.58 -27.8 65.43 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.845 0.858 . . . . 0.0 111.38 -173.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.47 -44.12 13.0 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.459 0.704 . . . . 0.0 110.968 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 51.0 tpp -75.71 -37.62 59.31 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.75 0.82 . . . . 0.0 110.611 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.3 7.79 88.2 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.133 -0.939 . . . . 0.0 113.215 -172.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -107.03 152.54 23.85 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.607 0.763 . . . . 0.0 110.858 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 238' ' ' TRP . 67.2 m95 -77.65 132.29 38.15 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.496 1.118 . . . . 0.0 109.919 171.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -136.54 130.97 33.23 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.235 1.014 . . . . 0.0 108.702 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.35 96.78 0.51 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.598 0.713 . . . . 0.0 109.218 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.72 128.15 45.83 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.928 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.648 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 56.7 tt0 -84.91 105.69 15.87 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.743 0.817 . . . . 0.0 110.647 -173.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.71 107.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.6 m -107.64 -3.13 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.651 0.781 . . . . 0.0 111.234 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.519 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 79.2 ttt180 -171.28 146.44 2.33 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.157 0.911 . . . . 0.0 108.986 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.0 m -125.78 144.39 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.4 p -131.85 130.44 41.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -73.32 147.99 43.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.668 0.787 . . . . 0.0 109.407 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -52.63 -56.28 16.53 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.179 0.592 . . . . 0.0 111.402 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.69 146.26 93.34 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.419 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -54.54 144.98 60.63 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.312 2.675 . . . . 0.0 113.613 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.9 m -70.12 -67.36 0.5 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.416 0.686 . . . . 0.0 110.136 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -177.28 158.8 1.51 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.712 1.205 . . . . 0.0 108.481 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -50.51 -47.66 57.3 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.081 0.952 . . . . 0.0 111.638 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -91.96 146.65 33.27 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.02 164.01 15.23 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 122.979 2.452 . . . . 0.0 113.097 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 77.9 m 73.03 -171.48 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.032 1.333 . . . . 0.0 111.033 -168.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.0 m 74.37 16.84 3.28 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.849 1.659 . . . . 0.0 112.815 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 30.4 p -76.64 91.9 3.46 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 173.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 37.1 p -86.49 145.8 26.65 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.875 0.87 . . . . 0.0 110.792 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.0 m -92.64 113.06 25.23 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.201 1.0 . . . . 0.0 110.244 -172.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -111.99 107.52 55.97 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 123.68 0.792 . . . . 0.0 109.72 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -70.33 83.98 0.77 Allowed 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.469 2.113 . . . . 0.0 110.945 169.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.82 -71.43 0.47 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.029 0.932 . . . . 0.0 111.199 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 43.3 mt -147.88 -74.83 0.19 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -119.18 102.41 8.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 201' ' ' SER . 1.0 OUTLIER -80.75 67.89 6.79 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.404 1.097 . . . . 0.0 110.67 -178.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.501 ' HA ' ' H ' ' A' ' 201' ' ' SER . 67.9 m-20 -82.89 44.74 0.94 Allowed 'General case' 0 C--O 1.243 0.727 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.537 174.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.1 m -69.58 176.49 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.881 0 C-N-CA 124.472 1.109 . . . . 0.0 108.507 174.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 183' ' ' ILE . 2.6 mp -92.35 106.37 17.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -172.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -89.01 104.03 16.6 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 7.0 m170 -79.7 92.84 5.44 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.31 158.17 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.609 0.764 . . . . 0.0 110.615 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -123.98 119.49 29.71 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -57.83 125.83 24.74 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.74 -31.37 72.52 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.271 0.558 . . . . 0.0 109.974 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.46 -28.94 62.22 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.247 175.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -139.32 71.89 38.84 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.14 0.576 . . . . 0.0 112.022 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.05 -15.86 28.99 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.527 2.151 . . . . 0.0 111.184 165.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.33 -22.89 66.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.315 1.046 . . . . 0.0 111.587 173.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -78.77 -5.37 53.14 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.791 0.836 . . . . 0.0 111.356 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.4 -161.95 53.13 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.555 0.534 . . . . 0.0 111.817 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 25.5 t -86.53 124.09 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 29.2 m -107.49 154.58 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.928 0.891 . . . . 0.0 110.09 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -92.93 131.16 38.18 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.542 0.737 . . . . 0.0 109.472 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.502 ' HE1' ' HB3' ' A' ' 203' ' ' ASP . 92.9 mmm -131.88 153.58 50.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.514 0.726 . . . . 0.0 109.299 177.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . 0.529 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 36.9 m-80 -98.96 172.21 7.55 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.574 0.75 . . . . 0.0 109.163 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.501 ' H ' ' HA ' ' A' ' 181' ' ' ASP . 10.9 t -67.64 -29.34 68.63 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.139 0.427 . . . . 0.0 110.84 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.529 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 17.2 ptp180 -62.19 -25.56 67.85 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.474 0.71 . . . . 0.0 111.638 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.502 ' HB3' ' HE1' ' A' ' 199' ' ' MET . 21.9 m-20 -92.23 -39.87 11.3 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.87 0.868 . . . . 0.0 111.0 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.484 HG22 ' HA ' ' A' ' 201' ' ' SER . 26.8 m -93.85 117.35 37.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 CA-C-O 122.462 1.125 . . . . 0.0 109.292 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 170.82 7.67 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.906 174.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.82 148.78 27.56 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 167.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -72.37 109.91 6.42 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.38 113.75 3.84 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.83 0.452 . . . . 0.0 110.638 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 289' ' ' MET . 5.8 ptm180 -82.09 9.36 8.66 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.007 0.923 . . . . 0.0 112.23 -177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.9 m -100.91 112.32 24.73 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.028 0.931 . . . . 0.0 110.088 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.1 mt -85.54 130.75 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.523 HD11 ' HB2' ' A' ' 279' ' ' LYS . 30.1 mm -96.77 148.08 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.504 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 1.5 ptpp? -129.52 171.22 12.8 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.97 0.908 . . . . 0.0 109.96 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.416 ' HE3' ' HB ' ' A' ' 274' ' ' VAL . 72.1 t-105 -53.78 -44.83 70.4 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.535 1.134 . . . . 0.0 112.103 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -71.24 -11.28 60.84 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.668 0.787 . . . . 0.0 112.442 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -109.33 -7.96 15.15 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.221 1.008 . . . . 0.0 110.704 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 213' ' ' LYS . 92.2 mt -72.17 124.11 24.33 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -134.03 146.73 50.64 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 31.6 m -67.44 126.89 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 123.54 0.525 . . . . 0.0 111.322 -174.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 106.1 -16.86 41.99 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.681 -0.511 . . . . 0.0 113.011 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.419 ' HG2' HG12 ' A' ' 223' ' ' VAL . 8.6 tt0 -80.4 122.24 26.72 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.21 0.604 . . . . 0.0 110.472 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 50.8 t -91.39 129.78 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.962 0.905 . . . . 0.0 108.935 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.419 HG12 ' HG2' ' A' ' 221' ' ' GLN . 2.8 m -145.73 149.65 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.676 1.19 . . . . 0.0 110.586 -172.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.495 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 20.0 ptm -100.34 125.51 46.58 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.643 0.777 . . . . 0.0 111.357 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.431 ' HG ' HG12 ' A' ' 277' ' ' VAL . 1.4 mp -127.11 158.7 36.32 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.971 0.908 . . . . 0.0 108.798 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -89.66 106.12 18.25 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.363 0.601 . . . . 0.0 110.232 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -167.4 148.09 5.45 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.749 1.22 . . . . 0.0 108.602 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -90.76 144.82 30.91 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.414 ' HB3' HD23 ' A' ' 261' ' ' LEU . 33.9 Cg_endo -62.29 -37.17 63.4 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.137 2.558 . . . . 0.0 112.373 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -71.03 -19.41 62.51 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.012 0.925 . . . . 0.0 111.721 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -144.23 82.97 10.38 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 122.746 0.419 . . . . 0.0 110.104 174.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.06 -4.48 15.49 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.534 2.156 . . . . 0.0 112.833 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -72.73 -27.51 62.09 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.106 0.963 . . . . 0.0 110.958 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -138.38 161.6 36.55 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.46 0.704 . . . . 0.0 110.376 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -52.81 156.34 2.02 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.575 1.55 . . . . 0.0 112.711 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -161.98 -93.42 0.09 OUTLIER Glycine 0 C--N 1.335 0.515 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.644 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -129.08 167.78 17.03 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.596 0.758 . . . . 0.0 109.354 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 89.9 m95 -79.4 105.75 10.94 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -121.65 154.74 36.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.092 0.957 . . . . 0.0 109.726 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . 0.727 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 0.8 OUTLIER -82.07 154.12 25.76 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.555 -177.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -152.19 134.23 14.97 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -100.11 118.45 36.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 26.5 mm -59.09 110.01 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.9 m -100.25 -25.77 14.14 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.235 0.614 . . . . 0.0 110.352 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 59.8 ttt180 -172.02 149.95 2.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.174 0.99 . . . . 0.0 108.642 -174.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -154.85 147.95 24.77 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -148.49 119.06 7.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.709 0.804 . . . . 0.0 108.873 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -96.89 124.53 40.89 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 54.1 p -124.62 162.61 23.74 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 167.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -60.69 -18.58 54.9 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.693 0.797 . . . . 0.0 112.612 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 53.6 p -93.85 -32.92 13.74 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.45 0.7 . . . . 0.0 112.151 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -174.08 164.54 4.11 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.298 0.57 . . . . 0.0 111.225 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -107.47 114.91 29.22 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.388 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -94.78 97.44 10.05 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 270' ' ' ARG . 1.7 tt -102.83 125.58 49.63 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . 0.482 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 43.4 m-85 -118.46 116.98 27.8 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -136.92 143.56 42.98 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.237 0.615 . . . . 0.0 111.095 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -78.13 99.37 6.15 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 94.9 t -64.93 106.64 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.494 0.718 . . . . 0.0 109.37 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.727 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 58.6 t -87.52 98.89 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' A' ' 229' ' ' PRO . 31.9 mt -84.14 -177.94 6.8 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.416 176.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -76.65 -45.05 13.94 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.387 -0.37 . . . . 0.0 112.612 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -107.52 -5.47 17.57 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.959 0.904 . . . . 0.0 111.726 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -155.46 176.12 13.01 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.49 0.716 . . . . 0.0 110.25 -172.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 27.7 p -145.63 115.86 7.49 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.478 0.711 . . . . 0.0 110.404 171.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 66.1 mt -82.53 95.05 7.61 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.688 0.795 . . . . 0.0 109.911 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -70.93 136.28 48.44 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.346 0.258 . . . . 0.0 110.689 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 14.6 t70 60.08 75.7 0.39 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.957 1.303 . . . . 0.0 111.347 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 42.9 t -111.6 129.2 56.15 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.917 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 71.4 ttt-85 -74.73 107.88 7.12 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.422 ' HB ' HD12 ' A' ' 255' ' ' LEU . 43.2 mm -90.81 128.3 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.773 0.829 . . . . 0.0 109.572 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 67.2 mt -96.12 -21.33 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.194 0.998 . . . . 0.0 110.694 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -86.44 45.13 1.21 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.207 1.003 . . . . 0.0 111.471 -173.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . 0.496 HG11 HD13 ' A' ' 255' ' ' LEU . 24.7 m -64.74 -21.84 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 125.11 1.364 . . . . 0.0 113.437 -169.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -110.87 -24.87 10.17 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.157 0.983 . . . . 0.0 110.115 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -89.0 44.26 1.2 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.879 0.872 . . . . 0.0 110.2 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.431 HG12 ' HG ' ' A' ' 225' ' ' LEU . 4.1 t -103.14 150.19 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.026 0.93 . . . . 0.0 109.279 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.495 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 72.9 m-85 -124.91 154.85 40.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 167.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.523 ' HB2' HD11 ' A' ' 212' ' ' ILE . 22.9 ttmm -77.42 144.85 37.54 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 45.9 mm -69.88 127.16 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.96 105.5 2.03 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 174.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -115.03 147.66 38.84 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 124.574 1.15 . . . . 0.0 109.888 -171.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.79 102.03 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.588 2.192 . . . . 0.0 111.407 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.51 -4.58 54.31 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-O 119.109 -0.828 . . . . 0.0 114.364 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -128.27 -25.14 3.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.157 0.979 . . . . 0.0 112.426 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -75.13 112.14 3.56 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.8 m -64.75 131.44 95.15 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 117.091 0.445 . . . . 0.0 111.186 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.68 135.41 19.69 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.306 2.67 . . . . 0.0 111.341 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' MET . . . . . 0.52 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 38.5 ttm -78.97 82.3 5.16 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.836 0.826 . . . . 0.0 109.767 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.2 p -108.68 -23.12 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.293 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -99.52 -153.84 0.45 Allowed 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -57.5 127.16 77.14 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-N 119.116 0.871 . . . . 0.0 111.87 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.52 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 12.0 Cg_exo -72.57 111.9 3.34 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.373 2.715 . . . . 0.0 113.673 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 91.7 mmm -77.14 115.96 17.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.143 0.577 . . . . 0.0 110.207 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -100.01 171.7 7.67 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.309 1.044 . . . . 0.0 109.158 171.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.65 -29.06 2.67 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.687 0.795 . . . . 0.0 108.936 164.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -169.64 121.61 0.71 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.777 1.231 . . . . 0.0 109.013 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 22.9 t -159.16 122.73 3.78 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.688 0.795 . . . . 0.0 109.255 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -151.3 -65.67 0.01 OUTLIER Glycine 0 CA--C 1.543 1.783 0 CA-C-O 118.633 -1.093 . . . . 0.0 113.482 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo . . . . . 0 C--N 1.385 2.466 0 C-N-CA 125.218 3.946 . . . . 0.0 115.038 174.705 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.226 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.81 -13.31 31.67 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.848 0.859 . . . . 0.0 111.207 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.4 ' O ' HG11 ' A' ' 159' ' ' VAL . 25.6 m-85 -94.91 162.64 13.66 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.548 0.739 . . . . 0.0 109.542 171.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.468 ' HB2' ' HZ1' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -124.75 -177.41 3.82 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.04 0.936 . . . . 0.0 109.043 171.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.5 m -68.22 2.47 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -173.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -112.94 -9.97 13.57 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.637 0.775 . . . . 0.0 111.377 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.87 84.87 3.44 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.459 0.703 . . . . 0.0 111.562 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 3.9 p90 -71.93 99.61 2.27 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.079 168.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.98 -178.97 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.476 1.11 . . . . 0.0 109.13 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 5.3 t0 -94.75 163.21 13.45 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.651 0.78 . . . . 0.0 108.922 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.07 125.35 8.74 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 120.872 0.368 . . . . 0.0 111.833 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -74.83 109.73 8.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.786 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.488 ' HB3' ' SD ' ' A' ' 148' ' ' MET . 9.2 t70 -80.01 117.99 21.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.8 m -66.86 -28.49 68.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.839 0.856 . . . . 0.0 112.333 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -58.05 -54.74 43.49 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.6 0.76 . . . . 0.0 111.948 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.488 ' SD ' ' HB3' ' A' ' 145' ' ' ASP . 1.7 pmm? -103.35 -8.86 19.93 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.575 0.35 . . . . 0.0 111.006 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.12 18.27 80.14 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 123.215 0.322 . . . . 0.0 113.518 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.413 ' HB1' ' CE2' ' A' ' 239' ' ' TYR . . . -93.29 150.14 20.7 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.45 0.643 . . . . 0.0 111.899 -175.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -76.11 139.0 41.14 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.468 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -145.52 124.35 12.67 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 45.4 mt-10 -65.78 93.94 0.19 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.444 0.698 . . . . 0.0 110.993 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.44 120.06 39.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.095 0.558 . . . . 0.0 110.894 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.656 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 53.4 tt0 -87.39 114.56 24.12 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.833 0.853 . . . . 0.0 110.664 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.413 ' HA ' HG13 ' A' ' 186' ' ' VAL . 50.1 t -59.88 114.74 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.1 m -115.35 -4.41 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.372 0.669 . . . . 0.0 111.264 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.519 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 76.7 ttt180 -164.56 138.86 5.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.836 0.854 . . . . 0.0 109.564 173.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 135' ' ' TYR . 34.4 m -117.19 137.64 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.511 0.724 . . . . 0.0 109.554 173.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.4 m -145.69 137.86 25.49 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.907 0.883 . . . . 0.0 108.857 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.95 135.11 36.33 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.612 ' HB2' HG13 ' A' ' 183' ' ' ILE . 55.3 tttm -98.05 87.07 3.86 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.158 0.983 . . . . 0.0 111.132 -170.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -173.8 157.38 2.78 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.479 1.112 . . . . 0.0 109.919 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.21 105.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.002 2.468 . . . . 0.0 112.503 169.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 39.7 m -89.74 -28.68 19.23 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.296 1.038 . . . . 0.0 111.301 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? 63.48 43.81 5.72 Favored 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 124.344 1.058 . . . . 0.0 109.294 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 75.0 -48.99 0.65 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.202 1.801 . . . . 0.0 112.331 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -61.46 139.57 94.93 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.506 1.122 . . . . 0.0 112.393 -175.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.2 -162.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 123.457 2.772 . . . . 0.0 112.549 173.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 61.4 m 71.93 136.38 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.943 1.297 . . . . 0.0 111.677 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 39.3 m -79.47 67.39 5.2 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.655 0.782 . . . . 0.0 108.915 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.3 t -71.64 -41.09 69.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.27 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 80.8 p -111.08 161.5 15.85 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.609 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 34.7 t 52.78 86.09 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.807 1.243 . . . . 0.0 113.474 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 73.4 mtm-85 -112.13 97.72 39.92 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.94 -60.42 0.82 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.501 2.801 . . . . 0.0 114.162 -172.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 59.47 17.69 6.24 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.47 1.108 . . . . 0.0 112.96 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 85.2 mt -141.44 -58.46 0.49 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -175.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -148.22 110.08 4.51 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 173.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.24 87.81 0.82 Allowed 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.979 0.895 . . . . 0.0 110.82 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.4 ' HA ' ' HB3' ' A' ' 200' ' ' ASN . 15.3 t70 -80.51 73.13 7.44 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.145 176.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 18.0 m -125.73 172.59 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.338 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.612 HG13 ' HB2' ' A' ' 162' ' ' LYS . 97.5 mt -94.86 110.13 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.619 0.768 . . . . 0.0 110.045 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -103.1 106.93 17.55 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 43.3 m-70 -77.31 92.47 3.91 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.466 HG11 HG11 ' A' ' 204' ' ' VAL . 35.0 m -108.38 151.02 10.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.336 -175.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.449 ' HD3' HG23 ' A' ' 196' ' ' VAL . 31.6 mmmt -110.92 113.12 25.45 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.217 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -57.43 105.6 0.26 Allowed 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 168.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.7 -24.02 64.45 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.211 0.529 . . . . 0.0 109.814 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -68.91 -31.86 71.07 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.201 1.0 . . . . 0.0 110.733 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -143.8 67.45 15.83 Favored Pre-proline 0 N--CA 1.487 1.381 0 C-N-CA 124.12 0.968 . . . . 0.0 110.667 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.3 -15.82 28.2 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.211 1.94 . . . . 0.0 113.177 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.36 -17.1 61.86 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.483 0.713 . . . . 0.0 111.024 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -87.63 25.17 1.53 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.119 0.967 . . . . 0.0 111.893 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 83.13 174.81 50.65 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.175 0.297 . . . . 0.0 113.84 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.449 HG23 ' HD3' ' A' ' 187' ' ' LYS . 3.1 t -92.2 118.32 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 172.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.32 143.62 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 122.903 0.481 . . . . 0.0 110.019 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.575 ' HB2' HG21 ' A' ' 183' ' ' ILE . 15.3 pt20 -106.92 114.36 28.41 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.31 0.576 . . . . 0.0 110.128 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.547 ' HE1' ' HB3' ' A' ' 203' ' ' ASP . 55.4 mtp -125.66 162.95 23.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.002 0.921 . . . . 0.0 109.701 -172.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . 0.442 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 6.7 m-80 -98.98 170.02 9.02 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.221 0.609 . . . . 0.0 109.55 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 50.9 m -56.42 -39.59 73.29 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.135 0.574 . . . . 0.0 111.634 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.442 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 34.1 ptt180 -54.66 -34.95 62.98 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.204 1.002 . . . . 0.0 112.222 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.547 ' HB3' ' HE1' ' A' ' 199' ' ' MET . 23.5 m-20 -86.82 -45.07 11.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.753 0.821 . . . . 0.0 110.534 -174.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.466 HG11 HG11 ' A' ' 186' ' ' VAL . 13.6 m -96.11 115.08 34.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 CA-C-O 121.797 0.808 . . . . 0.0 109.811 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -118.43 129.23 55.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.786 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.09 126.61 29.73 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -66.03 107.34 1.86 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.268 0.485 . . . . 0.0 111.789 -172.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.61 107.47 0.51 Allowed 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.175 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.433 ' HG2' ' HG3' ' A' ' 294' ' ' MET . 0.1 OUTLIER -75.28 81.04 2.38 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -173.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.5 m -145.54 108.44 4.53 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 54.0 mt -85.19 119.27 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.506 ' HB ' HG13 ' A' ' 277' ' ' VAL . 31.7 mm -91.45 152.86 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 123.911 0.884 . . . . 0.0 109.363 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -127.45 171.68 11.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.578 0.351 . . . . 0.0 110.681 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -48.93 -42.85 38.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.239 1.416 . . . . 0.0 111.874 -177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -62.06 -39.14 91.38 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.044 0.937 . . . . 0.0 111.93 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.42 ' HB2' HG21 ' A' ' 212' ' ' ILE . 61.2 m-20 -77.64 -22.31 50.89 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.077 0.551 . . . . 0.0 110.749 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.488 HD13 HG12 ' A' ' 277' ' ' VAL . 94.8 mt -72.41 109.98 6.49 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -114.14 154.14 28.32 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.161 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 32.0 m -67.97 130.35 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-O 120.754 0.312 . . . . 0.0 111.065 -175.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.05 -6.96 64.34 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.412 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.43 ' NE2' ' HA ' ' A' ' 217' ' ' LEU . 28.4 tt0 -88.55 121.22 30.69 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.236 0.615 . . . . 0.0 111.161 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.5 t -91.83 127.66 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.022 0.929 . . . . 0.0 109.3 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 280' ' ' ILE . 3.5 m -142.77 151.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.974 1.31 . . . . 0.0 110.298 -172.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.471 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 16.1 ptm -101.06 128.14 47.26 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.932 0.493 . . . . 0.0 111.378 -177.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.56 ' HB3' HG23 ' A' ' 277' ' ' VAL . 2.3 pt? -145.72 174.72 10.96 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.273 1.029 . . . . 0.0 110.393 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.493 ' HB3' ' CZ3' ' A' ' 238' ' ' TRP . 8.1 p30 -79.03 131.22 36.2 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 167.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -168.91 142.43 2.92 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.462 HD22 ' HB3' ' A' ' 231' ' ' ASN . 6.0 p-10 -136.64 133.56 19.09 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.305 0.642 . . . . 0.0 109.959 172.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.12 -20.92 67.94 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.365 2.043 . . . . 0.0 112.303 170.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.45 -47.74 84.32 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.513 0.725 . . . . 0.0 110.824 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.462 ' HB3' HD22 ' A' ' 228' ' ' ASN . 53.2 t30 -145.35 82.21 9.85 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.668 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.9 -16.51 54.37 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.078 2.519 . . . . 0.0 112.958 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -76.47 -27.7 56.24 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.581 0.753 . . . . 0.0 111.843 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -121.95 165.71 15.55 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.706 0.402 . . . . 0.0 110.389 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -60.58 131.19 49.96 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.929 1.292 . . . . 0.0 112.0 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -127.2 -139.24 4.9 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.088 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -82.23 159.96 23.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.12 0.568 . . . . 0.0 109.912 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . 0.493 ' CZ3' ' HB3' ' A' ' 226' ' ' ASN . 22.9 m95 -82.93 100.4 10.38 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.413 ' CE2' ' HB1' ' A' ' 150' ' ' ALA . 40.8 m-85 -114.87 163.04 16.09 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.834 0.854 . . . . 0.0 111.032 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.35 148.83 27.1 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.512 171.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -147.46 134.7 20.57 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.583 0.753 . . . . 0.0 109.154 172.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.15 119.09 34.99 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.455 HD13 HD23 ' A' ' 255' ' ' LEU . 26.6 mm -61.9 107.92 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.0 t -79.62 -50.68 10.31 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.394 0.616 . . . . 0.0 109.801 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.493 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 20.3 mtp180 -151.36 163.24 39.39 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.726 1.61 . . . . 0.0 108.09 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -155.83 143.15 19.3 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.987 0.358 . . . . 0.0 111.025 166.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -149.92 128.23 12.12 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.204 1.002 . . . . 0.0 109.03 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -100.83 125.33 47.33 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 31.4 p -96.02 -175.13 3.3 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 170.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -76.75 -23.09 53.0 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 120.679 0.276 . . . . 0.0 110.849 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 22.8 p -97.76 -29.24 13.48 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.393 0.677 . . . . 0.0 112.7 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -167.39 146.05 4.91 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.773 0.429 . . . . 0.0 111.955 -173.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -90.43 102.02 14.75 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -92.37 99.2 12.0 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.455 HD23 HD13 ' A' ' 243' ' ' ILE . 9.4 tt -100.47 131.39 46.41 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 174.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . 0.493 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 65.0 m-85 -106.51 127.05 53.01 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.253 1.021 . . . . 0.0 108.308 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -142.79 141.16 31.62 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.939 0.336 . . . . 0.0 111.009 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -79.75 96.62 6.32 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 39.7 t -77.54 102.8 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 13.8 m -92.11 111.03 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.655 0.74 . . . . 0.0 110.065 -171.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 264' ' ' ASP . 12.4 mt -87.48 -165.78 1.4 Allowed 'General case' 0 CA--C 1.557 1.237 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.857 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.06 -35.29 88.85 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 122.395 -0.19 . . . . 0.0 113.34 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -123.2 -51.76 1.87 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.097 0.959 . . . . 0.0 109.482 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.555 ' HB2' HD11 ' A' ' 261' ' ' LEU . 4.7 m-20 -76.26 164.43 26.06 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.317 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 55.9 m -143.46 136.97 28.24 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.648 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 73.7 mt -113.7 82.07 1.63 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.754 0.822 . . . . 0.0 109.394 -171.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.1 125.63 26.11 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.847 0.859 . . . . 0.0 112.737 -170.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 61.46 26.94 16.6 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.855 1.262 . . . . 0.0 112.896 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 96.5 m -68.31 128.18 35.64 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 122.698 0.399 . . . . 0.0 110.061 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 52.3 ttp180 -69.77 111.44 5.53 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 121.645 0.736 . . . . 0.0 110.532 -174.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.47 HD12 HD11 ' A' ' 225' ' ' LEU . 48.7 mm -82.29 123.88 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.427 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 49.9 mt -90.51 -27.37 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.076 0.951 . . . . 0.0 109.243 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -96.15 36.71 1.3 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.032 1.333 . . . . 0.0 110.06 -166.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 29.0 m -65.82 -20.57 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.794 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -95.27 -27.51 15.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.056 0.943 . . . . 0.0 110.617 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -91.59 4.26 53.06 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.743 0.817 . . . . 0.0 111.807 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.56 HG23 ' HB3' ' A' ' 225' ' ' LEU . 13.3 p -78.92 154.81 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 C-N-CA 123.238 0.615 . . . . 0.0 110.499 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.471 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 54.6 m-85 -128.89 161.07 30.7 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.502 1.121 . . . . 0.0 110.45 -173.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -73.93 140.54 45.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.128 0.971 . . . . 0.0 111.081 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.465 HG12 ' HA ' ' A' ' 223' ' ' VAL . 31.3 mm -77.12 122.3 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.817 0.847 . . . . 0.0 109.421 169.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.94 119.78 28.63 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 97.5 mtt180 -101.73 127.52 31.05 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.271 1.028 . . . . 0.0 109.817 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -37.36 131.91 0.59 Allowed 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 123.746 2.964 . . . . 0.0 114.326 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 105.27 -46.67 1.14 Allowed Glycine 0 C--N 1.341 0.823 0 CA-C-O 119.937 -0.368 . . . . 0.0 112.716 -171.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 9.5 pt-20 -84.69 -9.25 58.41 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 117.562 0.681 . . . . 0.0 110.793 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -35.82 83.62 0.0 OUTLIER Glycine 0 C--N 1.351 1.377 0 N-CA-C 117.558 1.783 . . . . 0.0 117.558 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 2.6 m -92.62 138.07 23.98 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 171.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.62 177.67 5.25 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.87 2.38 . . . . 0.0 111.476 -175.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' MET . . . . . 0.551 ' HA ' ' HE3' ' A' ' 289' ' ' MET . 2.8 tpt -75.1 80.91 2.26 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.92 -37.18 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.082 -173.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.04 179.0 6.5 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -43.82 123.83 3.96 Favored Pre-proline 0 CA--C 1.561 1.388 0 C-N-CA 125.159 1.384 . . . . 0.0 113.319 -168.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.11 109.25 0.25 Allowed 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 123.949 3.099 . . . . 0.0 114.479 -173.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.433 ' HG3' ' HG2' ' A' ' 209' ' ' ARG . 90.2 mtp -74.17 104.0 4.81 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 168.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.72 81.24 1.96 Allowed 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -74.88 -71.34 0.36 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.422 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? 57.26 115.62 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.224 1.81 . . . . 0.0 112.368 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.4 m -143.31 114.98 8.14 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.233 1.013 . . . . 0.0 109.193 172.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -155.51 -108.67 0.3 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-O 118.511 -1.16 . . . . 0.0 111.64 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo . . . . . 0 C--N 1.382 2.294 0 C-N-CA 123.183 2.589 . . . . 0.0 112.395 178.629 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.065 0 N-CA-C 112.222 -0.351 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.85 0.1 37.93 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.212 0.605 . . . . 0.0 111.668 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -115.86 160.95 19.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.853 0.861 . . . . 0.0 108.782 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.12 -178.24 4.24 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.745 0.818 . . . . 0.0 110.115 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 157' ' ' VAL . 13.0 m -55.35 -19.23 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 124.683 1.193 . . . . 0.0 113.869 -175.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -94.86 -31.37 13.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.132 0.973 . . . . 0.0 111.413 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.55 105.97 5.92 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.69 0.757 . . . . 0.0 111.652 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.562 ' HD1' ' HD3' ' A' ' 207' ' ' ARG . 15.3 t80 -70.32 138.11 51.21 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.547 164.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 28.7 m -127.9 179.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.559 1.144 . . . . 0.0 111.311 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -119.46 108.17 14.22 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.51 118.58 33.57 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.59 0.756 . . . . 0.0 110.11 -169.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -69.44 133.27 47.54 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -68.02 127.49 33.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -67.29 -26.61 66.62 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 123.845 0.716 . . . . 0.0 111.602 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -80.36 -52.87 7.18 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.994 0.518 . . . . 0.0 111.095 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 43.0 ttm -83.18 -24.67 32.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.353 0.661 . . . . 0.0 111.05 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.42 -15.92 32.51 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.474 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.449 ' HB3' ' CE2' ' A' ' 239' ' ' TYR . . . -73.68 153.54 40.05 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.98 0.912 . . . . 0.0 111.305 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 238' ' ' TRP . 40.7 m95 -73.74 136.14 43.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -140.27 110.57 6.63 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.4 ' HG3' ' NH2' ' A' ' 296' ' ' ARG . 19.4 mt-10 -48.3 137.92 10.48 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.89 0.876 . . . . 0.0 109.908 172.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.12 154.48 32.42 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.086 0.554 . . . . 0.0 110.613 -169.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -105.18 119.66 39.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.843 0.457 . . . . 0.0 110.041 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.6 t -68.25 114.23 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 168.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.451 ' O ' HG11 ' A' ' 137' ' ' VAL . 24.6 m -107.52 -10.36 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.157 0.583 . . . . 0.0 111.113 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -171.51 146.3 2.2 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.536 0.523 . . . . 0.0 110.892 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.59 133.4 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.433 0.693 . . . . 0.0 109.661 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.4 p -142.14 166.39 24.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.93 1.292 . . . . 0.0 108.621 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -119.44 155.19 32.5 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -51.85 -43.91 63.42 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 123.813 0.845 . . . . 0.0 110.396 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.88 127.55 59.41 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 168.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.77 89.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.394 2.729 . . . . 0.0 113.719 -175.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 41.6 t -122.28 147.21 46.5 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 125.149 1.38 . . . . 0.0 107.95 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.72 36.7 19.35 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-O 122.919 1.342 . . . . 0.0 107.908 -166.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -50.8 -49.7 57.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.821 1.648 . . . . 0.0 112.207 -173.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.92 141.75 33.62 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.318 0.647 . . . . 0.0 109.285 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.81 80.16 1.2 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.871 2.381 . . . . 0.0 111.731 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 57.8 m -143.52 168.13 20.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.648 -173.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 37.0 t -67.05 103.82 1.26 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.647 0.779 . . . . 0.0 109.667 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 37.6 m -129.43 80.45 1.97 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.718 0.807 . . . . 0.0 109.778 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 51.4 p -99.35 177.65 5.13 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.61 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.4 t 64.65 19.44 11.82 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.137 0.975 . . . . 0.0 112.38 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -87.11 146.79 41.13 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.647 0.779 . . . . 0.0 110.292 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -52.01 97.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 124.021 3.148 . . . . 0.0 113.795 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -126.2 99.19 5.77 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.854 0.861 . . . . 0.0 109.283 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.9 tt -139.4 107.65 5.78 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 56.71 80.61 0.15 Allowed 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.507 1.13 . . . . 0.0 108.761 -171.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.714 ' HB3' HG21 ' A' ' 182' ' ' VAL . 3.8 mp0 -70.01 101.02 1.7 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.568 -166.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -83.99 16.18 3.0 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.155 164.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.714 HG21 ' HB3' ' A' ' 180' ' ' GLU . 15.3 m -72.5 166.92 2.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-O 121.394 0.616 . . . . 0.0 110.411 172.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.494 HG22 ' HB2' ' A' ' 198' ' ' GLN . 2.5 mp -95.44 115.87 35.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.178 -172.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -97.52 104.54 16.58 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -79.11 94.66 5.39 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.53 151.06 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.49 ' HG2' HG21 ' A' ' 196' ' ' VAL . 43.2 mtmt -106.37 118.79 37.57 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 170.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -56.53 116.01 2.85 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.35 -36.84 66.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.753 0.821 . . . . 0.0 110.312 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -72.29 -32.07 66.27 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.808 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.536 ' HB3' ' ND2' ' A' ' 194' ' ' ASN . 68.0 m-85 -140.04 61.0 16.35 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 123.58 0.752 . . . . 0.0 111.744 -173.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.59 -20.02 9.65 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.033 1.822 . . . . 0.0 112.905 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.04 -20.21 66.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.933 0.893 . . . . 0.0 111.723 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.536 ' ND2' ' HB3' ' A' ' 191' ' ' TYR . 29.1 m-80 -81.51 -20.17 40.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.64 0.776 . . . . 0.0 111.155 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 110.42 -179.36 20.3 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 116.521 -0.309 . . . . 0.0 113.068 174.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.49 HG21 ' HG2' ' A' ' 187' ' ' LYS . 20.3 t -79.63 122.77 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.857 0.863 . . . . 0.0 109.433 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 33.9 m -104.73 144.13 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.637 0.775 . . . . 0.0 110.634 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.494 ' HB2' HG22 ' A' ' 183' ' ' ILE . 8.7 pt20 -99.62 121.79 41.71 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.631 0.772 . . . . 0.0 110.327 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.433 ' HE3' ' HB3' ' A' ' 203' ' ' ASP . 67.4 mmm -120.11 170.14 9.58 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.547 1.139 . . . . 0.0 110.554 -169.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -105.86 176.61 5.11 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.707 0.803 . . . . 0.0 109.66 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.709 ' HB3' ' HB2' ' A' ' 180' ' ' GLU . 61.1 p -59.64 -42.81 93.59 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.031 0.932 . . . . 0.0 110.999 174.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? -70.11 -5.12 24.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.958 0.903 . . . . 0.0 113.283 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.433 ' HB3' ' HE3' ' A' ' 199' ' ' MET . 53.9 m-20 -105.36 -34.91 7.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.811 0.444 . . . . 0.0 111.351 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.49 126.98 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.735 0.778 . . . . 0.0 110.312 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.454 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 2.1 mpt_? -120.26 172.24 7.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.502 1.121 . . . . 0.0 109.09 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.63 167.24 18.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.999 0.428 . . . . 0.0 109.903 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.562 ' HD3' ' HD1' ' A' ' 140' ' ' TYR . 77.6 mtm180 -78.65 90.24 4.57 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.614 0.766 . . . . 0.0 110.419 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.75 96.59 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.536 0.684 . . . . 0.0 109.545 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.525 ' HG2' ' HE3' ' A' ' 294' ' ' MET . 0.0 OUTLIER -80.65 -1.78 43.81 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.061 1.344 . . . . 0.0 111.344 -174.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 44.9 m -84.19 112.79 20.59 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 121.681 -0.637 . . . . 0.0 109.339 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.432 HD11 ' SD ' ' A' ' 294' ' ' MET . 41.4 mt -82.21 123.32 38.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 175.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.611 HG21 ' HB2' ' A' ' 216' ' ' ASP . 49.1 mm -97.27 128.09 48.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.364 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.52 176.92 4.94 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.435 ' HA ' HD21 ' A' ' 217' ' ' LEU . 69.7 t90 -46.94 -41.63 16.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.578 0.751 . . . . 0.0 111.553 -170.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -53.67 -43.03 68.52 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.002 1.321 . . . . 0.0 111.913 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.611 ' HB2' HG21 ' A' ' 212' ' ' ILE . 20.0 m-20 -77.97 -25.86 48.37 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.084 0.953 . . . . 0.0 112.416 -175.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.435 HD21 ' HA ' ' A' ' 214' ' ' TRP . 1.4 mm? -67.7 112.63 4.91 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -115.35 152.2 33.25 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.9 m -67.05 115.76 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-O 121.114 0.483 . . . . 0.0 110.524 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 110.15 -5.09 30.22 Favored Glycine 0 C--N 1.346 1.128 0 C-N-CA 123.412 0.53 . . . . 0.0 112.846 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -86.69 128.72 35.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.614 0.766 . . . . 0.0 110.677 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.63 130.7 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.531 ' HA ' HG12 ' A' ' 280' ' ' ILE . 3.0 m -145.9 164.2 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.98 1.312 . . . . 0.0 109.74 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.641 ' SD ' ' HB3' ' A' ' 238' ' ' TRP . 9.0 tmm? -105.31 129.84 53.56 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.568 ' HG ' HG11 ' A' ' 277' ' ' VAL . 2.1 mp -129.12 160.41 32.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.24 0.616 . . . . 0.0 110.354 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -90.01 108.42 19.71 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.784 0.834 . . . . 0.0 110.899 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.647 ' HE1' ' HB2' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -168.1 158.6 10.43 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.304 1.041 . . . . 0.0 110.413 177.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.551 HD22 ' HB3' ' A' ' 231' ' ' ASN . 6.6 p30 -111.14 148.61 39.06 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -58.28 -33.17 97.4 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.926 2.417 . . . . 0.0 113.115 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.44 -39.95 77.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.425 0.69 . . . . 0.0 111.025 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.551 ' HB3' HD22 ' A' ' 228' ' ' ASN . 41.6 t-20 -128.64 99.49 23.17 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.273 0.629 . . . . 0.0 109.69 -172.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -84.16 -0.0 9.37 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.941 2.427 . . . . 0.0 112.824 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -92.44 -29.27 16.36 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.379 0.672 . . . . 0.0 110.318 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -124.46 152.74 42.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.673 0.789 . . . . 0.0 109.732 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -55.39 170.19 0.25 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.334 1.453 . . . . 0.0 113.699 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 228' ' ' ASN . . . -171.27 -110.79 0.24 Allowed Glycine 0 C--N 1.337 0.631 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.138 174.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.467 ' HB2' ' CE1' ' A' ' 239' ' ' TYR . 17.8 m-85 -91.85 177.51 6.17 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.757 0.823 . . . . 0.0 109.454 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . 0.641 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 6.8 m95 -99.5 106.46 18.48 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.647 ' HB2' ' HE1' ' A' ' 227' ' ' TYR . 90.3 m-85 -121.84 166.89 13.68 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 118.927 0.785 . . . . 0.0 110.993 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . 0.551 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 3.4 m-20 -83.42 160.61 21.55 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.627 1.171 . . . . 0.0 110.329 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -162.51 138.9 7.61 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.07 0.948 . . . . 0.0 110.77 170.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -103.05 120.14 40.12 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.533 HD13 HD11 ' A' ' 255' ' ' LEU . 25.0 mm -63.89 117.47 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.924 0.89 . . . . 0.0 110.937 -171.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 33.3 t -88.24 -53.07 4.88 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.593 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.401 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 95.9 mtt180 -140.6 164.83 29.13 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.282 1.033 . . . . 0.0 109.873 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -155.95 147.89 23.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.493 0.717 . . . . 0.0 110.05 170.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -146.23 116.21 7.34 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.516 0.727 . . . . 0.0 109.599 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.651 ' HG2' ' HG2' ' A' ' 253' ' ' ARG . 6.0 tm-20 -92.85 123.6 36.23 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 30.6 p -133.47 148.45 51.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 168.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -63.81 -10.58 20.91 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.382 0.673 . . . . 0.0 112.801 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 47.2 p -91.73 -28.98 17.07 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.84 0.856 . . . . 0.0 111.058 175.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.84 130.2 0.8 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.301 0.64 . . . . 0.0 111.409 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.651 ' HG2' ' HG2' ' A' ' 248' ' ' GLU . 53.6 mtm180 -83.63 98.55 9.68 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -92.71 150.42 20.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.341 1.056 . . . . 0.0 110.213 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.799 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.5 OUTLIER -145.87 146.41 31.1 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -174.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . 0.401 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 78.9 m-85 -134.06 127.77 32.89 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.206 1.002 . . . . 0.0 108.662 174.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -143.64 141.67 30.68 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.515 0.726 . . . . 0.0 109.805 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -78.64 94.94 5.13 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 92.9 t -67.54 105.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.608 0.567 . . . . 0.0 110.371 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 45.1 t -85.79 99.3 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 30.6 mt -84.99 176.78 8.23 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.365 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -56.78 -36.46 72.48 Favored Glycine 0 N--CA 1.475 1.264 0 N-CA-C 114.349 0.5 . . . . 0.0 114.349 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -123.26 -47.75 2.0 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.707 0.803 . . . . 0.0 109.774 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -80.11 166.35 21.58 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.781 -175.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 30.7 p -146.84 110.3 4.86 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.573 0.749 . . . . 0.0 109.187 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 61.9 mt -87.12 87.39 7.44 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.973 0.909 . . . . 0.0 109.439 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -64.38 139.4 58.76 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.792 0.437 . . . . 0.0 110.763 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.92 29.81 19.36 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.065 0.946 . . . . 0.0 112.199 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.47 ' HB3' HG21 ' A' ' 259' ' ' VAL . 38.3 t -72.96 126.97 31.19 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.76 0.424 . . . . 0.0 110.58 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -63.57 133.41 53.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.105 0.562 . . . . 0.0 110.894 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.799 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 46.9 mm -111.97 124.5 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.404 1.081 . . . . 0.0 109.251 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 41.3 mt -106.02 2.04 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.181 0.992 . . . . 0.0 109.312 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -102.87 29.98 5.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.048 1.339 . . . . 0.0 109.712 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 24.0 m -57.82 -29.46 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -165.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -97.13 -23.72 16.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.283 0.633 . . . . 0.0 111.72 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -81.84 6.5 15.49 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.869 0.868 . . . . 0.0 112.208 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.568 HG11 ' HG ' ' A' ' 225' ' ' LEU . 19.4 t -73.94 148.62 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.325 0.65 . . . . 0.0 109.432 178.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -128.18 160.28 32.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.576 1.151 . . . . 0.0 108.313 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.514 ' HZ3' ' HG2' ' A' ' 285' ' ' GLU . 65.4 tttm -76.16 153.62 36.05 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.105 0.562 . . . . 0.0 111.481 -176.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.531 HG12 ' HA ' ' A' ' 223' ' ' VAL . 46.8 mm -75.6 122.71 30.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 167.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.535 ' HG2' ' HA3' ' A' ' 286' ' ' GLY . 0.1 OUTLIER -84.16 106.11 15.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 165.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -107.81 108.22 61.21 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -11.26 88.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 1 C-N-CA 126.883 5.055 . . . . 0.0 116.687 -158.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 99.69 1.12 56.42 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 115.102 -0.954 . . . . 0.0 114.923 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.514 ' HG2' ' HZ3' ' A' ' 279' ' ' LYS . 23.5 tt0 -93.52 -23.44 18.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.003 0.902 . . . . 0.0 110.801 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . 0.535 ' HA3' ' HG2' ' A' ' 281' ' ' GLU . . . -93.84 -165.94 37.19 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.579 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 38.2 p -117.64 163.98 21.59 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 123.681 0.792 . . . . 0.0 111.438 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -86.62 -154.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.142 2.561 . . . . 0.0 111.308 164.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 23.3 mmt -115.32 80.51 1.44 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 168.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.91 -35.25 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 168.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -84.11 -168.7 2.26 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.479 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -49.89 115.95 5.74 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.499 1.12 . . . . 0.0 111.849 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.525 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 12.4 Cg_exo -70.81 80.89 1.14 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.267 2.645 . . . . 0.0 111.148 175.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.525 ' HE3' ' HG2' ' A' ' 209' ' ' ARG . 49.3 mtm -63.26 -55.63 23.21 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.589 -172.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 66.6 144.74 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.858 1.263 . . . . 0.0 111.245 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.4 ' NH2' ' HG3' ' A' ' 153' ' ' GLU . 14.2 mtm180 -91.93 -30.95 15.85 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 173.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.436 ' HB2' ' HZ2' ' A' ' 238' ' ' TRP . 77.1 tttt -141.63 153.04 44.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.248 1.019 . . . . 0.0 108.978 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.0 p -143.29 113.37 7.21 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.444 0.697 . . . . 0.0 110.535 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -123.3 -89.77 0.92 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 C--N 1.374 1.893 0 C-N-CA 123.627 2.885 . . . . 0.0 112.642 167.774 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.515 HD12 ' HB3' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -122.87 8.69 9.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.208 0.603 . . . . 0.0 112.317 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -116.1 161.74 18.46 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.258 0.552 . . . . 0.0 110.938 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.12 161.65 15.72 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.994 1.317 . . . . 0.0 109.153 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' A' ' 158' ' ' ARG . 92.1 t -70.17 80.38 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 124.188 0.995 . . . . 0.0 110.058 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.3 m120 175.2 -38.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 126.641 1.976 . . . . 0.0 109.18 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -72.17 91.82 1.31 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -159.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 10.5 p90 -72.49 99.88 2.59 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.917 0.865 . . . . 0.0 109.616 168.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.87 -176.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.937 1.295 . . . . 0.0 109.255 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.416 ' HB3' ' HE3' ' A' ' 151' ' ' TRP . 0.5 OUTLIER -92.18 104.15 16.56 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.392 0.615 . . . . 0.0 110.239 -179.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -95.79 102.28 14.06 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 26.2 ttt180 -72.08 109.7 6.06 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.36 109.39 0.99 Allowed 'General case' 0 C--O 1.217 -0.625 0 O-C-N 124.506 1.129 . . . . 0.0 108.07 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.81 -10.94 59.85 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 124.033 0.833 . . . . 0.0 111.282 -170.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -74.03 -56.01 5.44 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.444 0.698 . . . . 0.0 110.258 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 50.5 ttp -92.53 -37.16 12.64 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.902 0.481 . . . . 0.0 109.955 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.422 ' HA3' ' CA ' ' A' ' 262' ' ' GLY . . . 101.44 20.73 12.7 Favored Glycine 0 N--CA 1.469 0.87 0 CA-C-N 115.45 -0.795 . . . . 0.0 113.518 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -101.79 140.31 36.26 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.085 0.554 . . . . 0.0 110.405 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 76.5 m95 -74.76 134.86 41.78 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.811 0.845 . . . . 0.0 109.581 174.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -135.78 136.36 40.66 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.687 ' HB3' HH12 ' A' ' 207' ' ' ARG . 19.9 pt-20 -68.62 103.76 1.8 Allowed 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -108.64 131.27 55.05 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.681 0.792 . . . . 0.0 110.287 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 60.8 tt0 -87.11 109.09 19.2 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.298 0.639 . . . . 0.0 110.444 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.44 ' HA ' HG13 ' A' ' 186' ' ' VAL . 70.1 t -61.68 103.87 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 124.197 0.936 . . . . 0.0 109.381 171.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.0 m -106.12 -0.37 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.758 0.423 . . . . 0.0 111.613 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.457 HH11 ' HG2' ' A' ' 169' ' ' PRO . 52.4 ttm-85 -172.73 149.92 2.08 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.617 0.573 . . . . 0.0 110.674 169.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.11 142.47 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.754 0.822 . . . . 0.0 108.955 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.448 ' OG1' ' HB ' ' A' ' 183' ' ' ILE . 8.1 p -145.69 161.95 38.68 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.882 1.273 . . . . 0.0 108.907 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -114.88 178.36 4.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.829 0.852 . . . . 0.0 110.78 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -58.18 -56.98 15.11 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.685 0.794 . . . . 0.0 110.417 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -93.95 162.21 27.58 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.666 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -49.01 127.17 16.6 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.954 2.436 . . . . 0.0 112.066 168.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.4 m -69.96 -56.49 6.86 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.246 0.618 . . . . 0.0 112.599 -171.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -156.19 -40.39 0.08 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -175.12 -63.97 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.74 154.05 39.21 Favored Pre-proline 0 CA--C 1.551 1.007 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.725 170.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.457 ' HG2' HH11 ' A' ' 158' ' ' ARG . 19.2 Cg_endo -57.22 90.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.863 3.042 . . . . 0.0 113.206 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 78.0 m 62.08 175.45 0.13 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.504 1.521 . . . . 0.0 112.297 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.6 t -167.79 148.36 5.18 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 122.884 0.474 . . . . 0.0 110.339 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.8 m 60.78 -163.95 0.24 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 124.563 1.164 . . . . 0.0 111.752 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.1 t -89.33 84.77 6.47 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.057 0.932 . . . . 0.0 108.544 172.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 57.4 p -67.79 115.69 7.63 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.343 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -65.28 124.28 86.55 Favored Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.266 0.626 . . . . 0.0 110.854 -172.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.515 ' HB3' HD12 ' A' ' 134' ' ' LEU . 57.2 Cg_endo -67.99 148.97 77.03 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.881 2.387 . . . . 0.0 112.439 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -87.99 -96.24 0.09 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -135.99 -68.96 0.49 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.95 86.23 7.31 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-O 122.3 1.048 . . . . 0.0 110.286 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -88.49 67.37 8.54 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.049 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -85.07 40.31 0.81 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 121.889 0.852 . . . . 0.0 109.707 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 34.9 m -88.61 175.93 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.823 0.849 . . . . 0.0 111.085 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.448 ' HB ' ' OG1' ' A' ' 160' ' ' THR . 20.6 mt -96.72 112.35 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.683 0.793 . . . . 0.0 110.594 -168.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -102.05 109.38 21.09 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.418 1.087 . . . . 0.0 108.961 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -79.26 89.38 4.91 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 156' ' ' VAL . 26.7 m -110.58 161.16 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.762 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.497 ' HG2' HG22 ' A' ' 196' ' ' VAL . 32.0 mtmt -124.97 117.75 24.72 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 173.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -57.52 97.03 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -62.73 -23.92 67.41 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.202 1.001 . . . . 0.0 111.593 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 297' ' ' LYS . 19.9 m-20 -63.34 -30.81 71.88 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.715 0.406 . . . . 0.0 111.711 173.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -146.88 78.04 10.8 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 124.14 0.976 . . . . 0.0 108.89 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.15 -21.2 55.88 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.925 2.417 . . . . 0.0 112.563 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -67.14 -8.19 29.12 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.648 1.179 . . . . 0.0 112.788 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -79.33 -12.76 59.93 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.443 0.697 . . . . 0.0 111.333 173.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 93.88 -178.7 37.88 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.713 0.633 . . . . 0.0 112.915 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 187' ' ' LYS . 24.6 t -83.95 116.6 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.55 153.64 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.036 0.934 . . . . 0.0 109.663 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -108.32 122.21 46.51 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.437 0.695 . . . . 0.0 109.536 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.484 ' HE2' ' HB3' ' A' ' 203' ' ' ASP . 84.7 mmm -125.28 164.88 19.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.696 1.198 . . . . 0.0 109.265 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -110.53 172.77 6.67 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.49 ' HA ' HG22 ' A' ' 204' ' ' VAL . 41.7 m -66.29 -30.23 70.61 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 118.159 0.436 . . . . 0.0 111.258 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -10.4 58.86 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.862 176.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.484 ' HB3' ' HE2' ' A' ' 199' ' ' MET . 55.7 m-20 -104.25 -39.93 6.31 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.452 1.101 . . . . 0.0 111.014 175.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 201' ' ' SER . 32.0 m -95.79 143.47 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -174.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.96 163.47 32.79 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.321 0.648 . . . . 0.0 109.774 -168.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.97 166.64 23.01 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.186 0.594 . . . . 0.0 109.804 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.687 HH12 ' HB3' ' A' ' 153' ' ' GLU . 10.8 ptm180 -136.75 134.11 36.76 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.0 148.32 40.02 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.744 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.627 ' HG3' ' HB3' ' A' ' 291' ' ' ASP . 3.3 tmt_? -75.79 -9.47 58.62 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.942 168.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.8 m -86.94 109.33 19.27 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.869 0.868 . . . . 0.0 111.023 -171.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.4 mt -84.02 136.36 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.654 HD13 ' HB2' ' A' ' 279' ' ' LYS . 39.0 mm -110.98 153.52 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.637 0.775 . . . . 0.0 111.419 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -125.1 171.29 10.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.988 1.315 . . . . 0.0 109.929 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.482 ' HD1' HG12 ' A' ' 274' ' ' VAL . 88.7 t90 -50.01 -49.05 52.05 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.378 1.071 . . . . 0.0 111.662 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -61.23 -35.76 78.12 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.618 -175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.463 ' HB3' HG23 ' A' ' 212' ' ' ILE . 14.6 t70 -78.78 -23.98 44.94 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.279 0.632 . . . . 0.0 110.978 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.443 HD22 HG21 ' A' ' 223' ' ' VAL . 96.0 mt -72.37 113.18 9.12 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.051 0.54 . . . . 0.0 109.928 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.4 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 9.3 pt-20 -119.71 154.06 34.68 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.993 0.917 . . . . 0.0 109.961 -176.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.3 m -63.68 123.63 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 120.844 0.354 . . . . 0.0 110.945 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.76 -14.05 56.26 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.177 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.475 ' HG2' HG11 ' A' ' 223' ' ' VAL . 30.5 tt0 -81.29 122.69 27.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.346 0.658 . . . . 0.0 110.767 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 74.1 t -93.58 130.74 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.475 HG11 ' HG2' ' A' ' 221' ' ' GLN . 3.0 m -150.34 147.02 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.268 1.027 . . . . 0.0 110.297 -172.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.527 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 26.1 ttp -102.76 130.41 49.71 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.896 0.478 . . . . 0.0 110.986 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.485 HD11 HD12 ' A' ' 271' ' ' ILE . 1.9 pt? -142.43 167.89 21.02 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.283 1.033 . . . . 0.0 110.917 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.478 HD22 ' HB3' ' A' ' 276' ' ' GLU . 4.8 p30 -81.37 126.52 31.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.328 0.651 . . . . 0.0 109.655 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -166.08 152.28 9.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.956 0.902 . . . . 0.0 109.384 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.553 HD22 ' HB3' ' A' ' 231' ' ' ASN . 3.7 p30 -131.34 133.0 23.97 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.451 ' HB3' HD13 ' A' ' 266' ' ' LEU . 27.0 Cg_endo -61.52 -26.02 80.29 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.809 2.339 . . . . 0.0 113.943 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.41 -33.32 71.22 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.114 0.566 . . . . 0.0 111.699 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.553 ' HB3' HD22 ' A' ' 228' ' ' ASN . 35.5 t-20 -133.23 104.33 12.46 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 123.48 0.712 . . . . 0.0 109.116 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.33 -19.48 49.75 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.767 2.311 . . . . 0.0 113.019 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.26 -10.82 40.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.331 0.652 . . . . 0.0 110.944 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -123.81 159.13 30.23 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.484 0.659 . . . . 0.0 111.179 -171.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 300' ' ' PRO . 11.8 ptp180 -80.28 172.24 14.02 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.688 175.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 228' ' ' ASN . . . -161.55 -101.98 0.17 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.291 172.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -103.46 168.9 8.86 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.77 0.828 . . . . 0.0 109.503 -177.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -83.87 114.73 21.86 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -126.8 141.29 51.87 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.214 1.006 . . . . 0.0 108.387 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.4 p-10 -81.18 152.81 27.54 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -151.09 136.85 18.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.791 0.836 . . . . 0.0 109.058 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -94.54 118.27 31.41 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.499 HG22 HD23 ' A' ' 255' ' ' LEU . 32.3 mm -61.57 116.27 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 124.041 0.838 . . . . 0.0 108.952 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.6 t -97.08 -25.04 15.48 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.332 0.653 . . . . 0.0 110.633 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -170.13 157.34 6.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.859 0.864 . . . . 0.0 110.195 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.419 ' HB3' ' HG ' ' A' ' 255' ' ' LEU . 26.0 pttm -153.13 149.1 27.72 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.659 0.784 . . . . 0.0 109.32 163.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -154.52 120.45 5.24 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.305 0.642 . . . . 0.0 109.449 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 40.0 tt0 -111.24 125.49 53.87 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.179 0.992 . . . . 0.0 109.151 177.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.7 p -83.59 178.78 7.84 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.943 0.897 . . . . 0.0 109.565 171.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -71.62 -0.78 11.56 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.366 0.666 . . . . 0.0 112.634 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 25.4 p -123.4 -29.68 3.77 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.29 0.636 . . . . 0.0 112.607 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.86 166.76 27.96 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.882 0.31 . . . . 0.0 111.457 -172.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 33.1 ptt180 -121.14 140.76 51.55 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.454 0.701 . . . . 0.0 110.661 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.22 154.31 47.7 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.71 0.804 . . . . 0.0 108.876 172.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.499 HD23 HG22 ' A' ' 243' ' ' ILE . 7.1 tt -147.16 143.89 28.57 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -130.21 121.82 26.93 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -131.97 166.72 21.05 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.377 0.671 . . . . 0.0 110.431 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -102.19 98.14 8.33 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.787 HG23 ' SG ' ' A' ' 269' ' ' CYS . 96.6 t -66.57 112.36 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 123.783 0.677 . . . . 0.0 110.374 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.48 101.79 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 73.4 mt -82.81 -158.02 0.25 Allowed 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.642 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.422 ' CA ' ' HA3' ' A' ' 149' ' ' GLY . . . -70.29 -56.61 7.58 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-O 121.088 0.271 . . . . 0.0 113.418 177.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -112.87 -37.32 4.87 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.171 0.988 . . . . 0.0 109.929 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -94.39 176.39 6.32 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.125 0.97 . . . . 0.0 111.713 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 77.0 p -142.89 153.12 42.81 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.28 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 92.8 mt -125.31 92.15 3.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.359 0.663 . . . . 0.0 109.458 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -69.2 140.02 54.56 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 123.606 0.566 . . . . 0.0 110.284 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 12.6 t70 67.08 31.64 6.72 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.452 1.101 . . . . 0.0 111.705 171.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.787 ' SG ' HG23 ' A' ' 259' ' ' VAL . 27.2 p -65.05 124.92 23.35 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 37.6 ttp-105 -76.91 102.46 6.38 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.548 HD13 ' SG ' ' A' ' 269' ' ' CYS . 47.7 mm -77.87 108.29 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.886 -172.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 44.5 mt -82.1 -34.5 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.424 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.433 ' O ' HG21 ' A' ' 277' ' ' VAL . 46.0 m-85 -90.26 37.42 0.9 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.336 1.054 . . . . 0.0 111.14 -168.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . 0.482 HG12 ' HD1' ' A' ' 214' ' ' TRP . 21.0 m -56.75 -34.27 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.799 1.239 . . . . 0.0 112.433 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -92.78 -10.59 36.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.676 1.19 . . . . 0.0 111.983 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.478 ' HB3' HD22 ' A' ' 226' ' ' ASN . 59.4 mm-40 -102.6 21.26 15.64 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.215 1.006 . . . . 0.0 111.148 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 225' ' ' LEU . 84.2 t -90.44 153.44 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.038 0.935 . . . . 0.0 110.587 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.43 148.66 44.85 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.874 1.27 . . . . 0.0 107.808 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.654 ' HB2' HD13 ' A' ' 212' ' ' ILE . 24.0 ttmt -83.28 141.01 32.15 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 120.841 0.353 . . . . 0.0 111.126 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 36.5 mm -79.13 138.19 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 168.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.501 ' HA ' ' HA3' ' A' ' 286' ' ' GLY . 1.1 mp0 -66.11 103.46 0.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.283 0.563 . . . . 0.0 110.08 -167.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -85.7 155.0 59.14 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.31 1.044 . . . . 0.0 109.524 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.98 94.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 123.402 2.735 . . . . 0.0 112.075 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.9 -48.09 2.49 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.994 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -73.12 -25.61 60.91 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.996 0.519 . . . . 0.0 112.085 -172.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -84.68 82.19 1.7 Allowed Glycine 0 C--N 1.342 0.915 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 174.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 14.8 m -62.8 144.37 96.6 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.418 0.687 . . . . 0.0 111.989 -168.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.15 152.85 79.12 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.103 2.535 . . . . 0.0 111.875 -175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 16.7 ttt -79.76 80.77 6.11 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.26 -28.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.338 1.055 . . . . 0.0 109.963 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.627 ' HB3' ' HG3' ' A' ' 209' ' ' ARG . 10.3 t70 -84.26 -151.68 0.13 Allowed 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.303 1.041 . . . . 0.0 109.135 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.442 HD21 ' H ' ' A' ' 292' ' ' ASN . 0.8 OUTLIER -50.81 115.98 6.51 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.99 0.916 . . . . 0.0 110.533 177.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.75 102.97 0.44 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.218 1.946 . . . . 0.0 111.534 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 25.7 mmt -65.84 136.7 56.51 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.273 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -144.46 148.78 34.99 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.497 ' NH1' ' HE3' ' A' ' 224' ' ' MET . 18.8 ptt180 -148.0 -175.92 5.08 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.29 0.236 . . . . 0.0 110.847 -167.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 2.1 tppt? -161.02 134.0 6.36 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 111.541 0.201 . . . . 0.0 111.541 173.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 48.3 m -75.13 79.3 2.28 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.579 0.752 . . . . 0.0 110.064 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -172.08 157.36 27.23 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-O 118.92 -0.933 . . . . 0.0 112.116 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.435 ' HA ' ' HD2' ' A' ' 235' ' ' ARG . 14.0 Cg_exo . . . . . 0 C--N 1.375 1.924 0 C-N-CA 123.468 2.778 . . . . 0.0 111.909 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.979 -0.449 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.31 -34.2 32.06 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.178 0.513 . . . . 0.0 110.414 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -90.16 152.42 21.11 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.778 -165.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -99.35 162.93 12.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.128 -167.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.1 m -71.91 -2.28 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 124.161 0.984 . . . . 0.0 113.116 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -118.34 -21.04 8.27 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.89 0.876 . . . . 0.0 110.425 171.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -82.12 89.67 6.49 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.77 0.828 . . . . 0.0 110.116 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.671 ' HB3' ' HG2' ' A' ' 155' ' ' GLN . 26.8 p90 -68.16 139.12 56.11 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.202 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.0 m -119.5 178.96 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.998 0.919 . . . . 0.0 109.662 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.733 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 54.1 t0 -95.01 158.79 15.31 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 166.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.17 110.06 4.52 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 119.436 1.016 . . . . 0.0 111.213 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 151' ' ' TRP . 3.0 tmm_? -73.01 113.69 10.33 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.878 0.871 . . . . 0.0 110.593 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -87.16 114.62 23.93 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.6 m -70.79 -26.57 63.39 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.736 0.814 . . . . 0.0 111.546 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -59.99 -49.93 75.75 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.616 0.766 . . . . 0.0 110.683 -175.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.415 ' HG3' ' H ' ' A' ' 150' ' ' ALA . 23.9 ptm -101.79 -18.99 15.52 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.526 0.331 . . . . 0.0 111.394 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 93.32 -21.56 39.83 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-O 120.021 -0.321 . . . . 0.0 113.141 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.415 ' H ' ' HG3' ' A' ' 148' ' ' MET . . . -72.47 131.18 42.22 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.197 0.599 . . . . 0.0 110.818 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.42 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 0.1 OUTLIER -97.65 124.72 42.06 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.18 175.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -113.64 137.3 51.8 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.017 0.927 . . . . 0.0 109.464 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.733 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 48.3 mt-10 -64.43 102.21 0.52 Allowed 'General case' 0 C--N 1.346 0.435 0 O-C-N 123.653 0.596 . . . . 0.0 110.802 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.481 ' HB3' ' HB ' ' A' ' 186' ' ' VAL . . . -96.61 119.13 34.53 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.78 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.671 ' HG2' ' HB3' ' A' ' 140' ' ' TYR . 15.4 tm0? -84.94 107.91 17.31 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -173.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.505 ' HA ' HG13 ' A' ' 186' ' ' VAL . 47.0 t -61.47 119.61 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 124.229 0.955 . . . . 0.0 109.207 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 m -115.63 -6.03 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.574 0.749 . . . . 0.0 111.179 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.534 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 44.9 ttt85 -172.23 142.12 1.33 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.966 0.506 . . . . 0.0 110.511 175.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.3 m -126.05 132.09 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.282 1.033 . . . . 0.0 108.832 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.7 p -142.96 145.2 32.77 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.39 0.676 . . . . 0.0 110.099 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -74.93 150.13 39.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.868 0.867 . . . . 0.0 109.053 168.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -65.4 78.21 0.06 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.601 0.76 . . . . 0.0 109.951 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 165.88 100.69 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.715 2.006 . . . . 0.0 106.909 -172.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.4 -56.14 1.46 Allowed 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.659 2.24 . . . . 0.0 112.537 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 39.2 p -82.14 -31.0 30.77 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.419 0.688 . . . . 0.0 111.41 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 61.89 104.63 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.936 1.294 . . . . 0.0 110.773 -170.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -58.46 -45.25 88.98 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.21 0.604 . . . . 0.0 109.945 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -110.54 100.26 44.48 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.2 -90.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.424 2.083 . . . . 0.0 113.092 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 85.2 m -148.3 99.64 3.06 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 118.616 0.643 . . . . 0.0 111.287 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 27.1 p -87.41 85.33 7.13 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 39.8 m 68.86 8.93 7.1 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.201 1.401 . . . . 0.0 113.128 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 53.3 p -96.8 141.01 30.53 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.341 0.656 . . . . 0.0 111.116 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.2 m -85.35 -59.14 2.41 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.108 0.963 . . . . 0.0 110.453 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -95.86 152.06 38.78 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.424 0.689 . . . . 0.0 109.815 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.92 -24.51 74.16 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.846 2.364 . . . . 0.0 115.159 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -158.61 165.94 33.27 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.1 mp -93.83 127.2 39.44 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 62.05 90.3 0.07 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.466 1.106 . . . . 0.0 109.242 -169.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.509 ' HB3' HG22 ' A' ' 182' ' ' VAL . 5.9 mm-40 -70.68 90.76 0.78 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.33 -169.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -85.88 8.85 18.61 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.648 167.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 180' ' ' GLU . 28.6 m -65.69 173.98 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.039 1.336 . . . . 0.0 112.02 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 198' ' ' GLN . 59.0 mt -94.95 110.81 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.549 0.74 . . . . 0.0 110.417 -169.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -93.95 106.48 18.45 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.887 1.275 . . . . 0.0 109.543 173.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 30.5 m-70 -80.54 101.95 9.45 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 156' ' ' VAL . 29.6 m -129.68 165.47 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.832 1.253 . . . . 0.0 110.5 -172.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -133.56 116.33 15.79 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.384 0.674 . . . . 0.0 109.375 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.641 ' HB2' ' HB2' ' A' ' 191' ' ' TYR . 47.0 m-85 -57.2 151.23 16.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 123.167 0.292 . . . . 0.0 111.347 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -60.11 -44.41 94.9 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.062 0.545 . . . . 0.0 110.875 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.47 -13.42 40.38 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.646 0.778 . . . . 0.0 111.268 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.641 ' HB2' ' HB2' ' A' ' 188' ' ' TYR . 58.3 m-85 -129.11 58.65 38.71 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -174.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.38 -23.78 8.38 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 121.71 1.607 . . . . 0.0 110.442 163.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.31 -20.55 62.18 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.687 1.195 . . . . 0.0 111.914 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -81.19 -0.42 40.4 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.057 0.543 . . . . 0.0 110.872 175.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 89.12 -177.48 44.44 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.161 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 23.6 t -82.86 116.89 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.12 153.21 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.027 0.931 . . . . 0.0 110.029 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.4 ' HB2' HG21 ' A' ' 183' ' ' ILE . 12.8 pt20 -103.78 113.88 27.73 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.731 0.777 . . . . 0.0 109.851 178.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.546 ' HE3' ' HB3' ' A' ' 203' ' ' ASP . 77.9 mmm -117.27 169.75 9.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.318 1.447 . . . . 0.0 108.785 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -110.92 173.07 6.51 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.585 ' HA ' HG22 ' A' ' 204' ' ' VAL . 9.7 t -70.56 -26.2 63.43 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 118.369 0.531 . . . . 0.0 110.63 177.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -12.24 60.88 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.745 0.418 . . . . 0.0 111.786 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.546 ' HB3' ' HE3' ' A' ' 199' ' ' MET . 16.3 m-20 -94.68 -44.47 7.79 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.51 0.724 . . . . 0.0 110.082 171.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 201' ' ' SER . 15.3 m -95.76 143.24 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.433 0.635 . . . . 0.0 110.996 -170.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 21.2 tpt180 -150.97 126.64 10.22 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.2 125.48 25.67 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 168.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.68 152.02 40.57 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.429 ' N ' ' HB2' ' A' ' 281' ' ' GLU . . . -64.39 135.11 55.8 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.835 0.709 . . . . 0.0 109.398 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.515 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 5.3 ppt_? -78.21 23.06 0.29 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.876 0.87 . . . . 0.0 112.803 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 79.5 m -113.6 119.41 37.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.892 1.277 . . . . 0.0 109.082 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.63 129.03 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.038 0.535 . . . . 0.0 109.77 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.473 HD13 ' HB2' ' A' ' 279' ' ' LYS . 28.2 mm -87.37 144.48 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.41 170.14 9.65 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.901 0.881 . . . . 0.0 109.727 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.401 ' CZ3' ' HB2' ' A' ' 255' ' ' LEU . 38.2 t-105 -52.3 -47.78 65.75 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.979 0.912 . . . . 0.0 111.302 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -69.11 -23.03 63.94 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.278 0.631 . . . . 0.0 111.979 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -92.12 -16.57 26.16 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.115 0.566 . . . . 0.0 110.513 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.406 ' HA ' ' NE2' ' A' ' 221' ' ' GLN . 79.5 mt -75.62 141.21 42.88 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -147.79 155.08 41.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.586 0.755 . . . . 0.0 109.419 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.93 123.39 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-O 121.26 0.552 . . . . 0.0 110.947 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.1 -4.0 48.46 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.744 -174.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.5 ' HG2' HG13 ' A' ' 223' ' ' VAL . 30.1 tt0 -87.21 121.72 30.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.235 0.614 . . . . 0.0 110.233 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 92.9 t -87.15 115.58 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.779 0.832 . . . . 0.0 108.863 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.5 HG13 ' HG2' ' A' ' 221' ' ' GLN . 6.3 m -137.91 157.37 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.311 1.044 . . . . 0.0 110.642 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.694 ' SD ' ' HD3' ' A' ' 296' ' ' ARG . 1.5 ttp -88.24 129.71 35.28 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.572 ' HB3' HG22 ' A' ' 277' ' ' VAL . 2.0 pp -143.79 168.21 20.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.826 0.85 . . . . 0.0 110.304 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.459 HD22 ' HA ' ' A' ' 235' ' ' ARG . 8.8 t30 -90.92 143.13 27.04 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -167.18 144.02 4.5 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 124.227 0.955 . . . . 0.0 109.051 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -109.84 119.09 48.55 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -56.24 -44.87 42.39 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.067 2.512 . . . . 0.0 113.082 172.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.1 -27.74 59.98 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.046 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 234' ' ' GLU . 16.7 m120 -120.37 86.32 38.6 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 123.407 0.683 . . . . 0.0 109.194 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.37 -20.43 70.18 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.984 2.456 . . . . 0.0 113.366 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.547 ' HA ' HD12 ' A' ' 272' ' ' ILE . 61.7 tttm -97.47 -29.5 13.44 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.668 0.787 . . . . 0.0 111.26 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 231' ' ' ASN . 44.0 mt-10 -111.46 172.15 7.06 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.825 0.821 . . . . 0.0 112.665 -170.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.459 ' HA ' HD22 ' A' ' 226' ' ' ASN . 24.3 ptt180 -76.94 164.25 25.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.724 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -171.47 -79.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.694 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.404 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 11.5 m-85 -127.79 173.96 9.52 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.841 0.456 . . . . 0.0 110.268 -170.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -110.51 127.97 55.42 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 94.0 m-85 -133.54 158.34 43.39 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.415 0.686 . . . . 0.0 110.155 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -86.14 147.08 26.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 162.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.466 ' HB1' HD23 ' A' ' 225' ' ' LEU . . . -153.48 139.76 18.51 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 122.957 0.503 . . . . 0.0 110.04 -176.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -95.53 120.11 35.22 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.473 HD13 HD21 ' A' ' 255' ' ' LEU . 35.6 mm -58.3 111.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 123.658 0.599 . . . . 0.0 109.968 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.1 m -83.77 -49.47 9.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.688 0.795 . . . . 0.0 110.303 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.532 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 4.8 mmp_? -142.43 159.21 42.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.955 1.302 . . . . 0.0 109.07 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -154.89 116.81 4.16 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.33 0.652 . . . . 0.0 109.373 168.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -123.86 117.85 25.78 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.498 1.119 . . . . 0.0 108.542 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.54 135.48 49.74 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.465 0.706 . . . . 0.0 109.604 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.9 p -133.6 175.0 9.82 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.886 0.875 . . . . 0.0 109.284 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -69.12 -38.16 78.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.815 0.446 . . . . 0.0 110.757 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 46.1 p -88.66 -27.32 21.34 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.489 0.716 . . . . 0.0 112.859 -171.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.57 172.98 17.36 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.084 0.469 . . . . 0.0 111.829 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -128.54 130.36 47.31 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.943 0.897 . . . . 0.0 108.665 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -133.03 98.6 4.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.592 0.757 . . . . 0.0 109.314 -175.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.473 HD21 HD13 ' A' ' 243' ' ' ILE . 8.4 tt -107.72 147.01 31.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 64.2 m-85 -129.14 141.35 51.21 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.886 1.274 . . . . 0.0 107.599 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.96 151.02 35.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.718 0.407 . . . . 0.0 111.091 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -79.8 96.68 6.37 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 39.4 t -79.68 108.98 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.98 0.912 . . . . 0.0 109.96 -173.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 83.2 t -87.03 114.35 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.514 0.673 . . . . 0.0 110.796 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 13.4 mt -90.44 -161.6 0.81 Allowed 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.62 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.3 -42.5 57.1 Favored Glycine 0 C--N 1.35 1.32 0 O-C-N 122.16 -0.337 . . . . 0.0 113.907 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -122.3 -27.07 4.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.213 1.005 . . . . 0.0 111.039 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -114.19 167.17 10.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.924 0.889 . . . . 0.0 110.605 -172.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 67.8 p -137.45 133.22 34.43 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.022 0.929 . . . . 0.0 108.767 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.683 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 75.4 mt -81.56 93.8 6.77 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.061 0.944 . . . . 0.0 108.514 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -59.39 110.67 1.14 Allowed 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.413 1.071 . . . . 0.0 112.151 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 30.1 t70 67.26 29.44 7.62 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.766 0.827 . . . . 0.0 111.636 167.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.683 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 98.9 m -75.45 131.42 40.13 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.807 -0.558 . . . . 0.0 111.078 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -65.47 117.04 7.4 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.534 0.734 . . . . 0.0 112.126 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.444 HG21 HD22 ' A' ' 225' ' ' LEU . 36.5 mm -89.64 112.44 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.925 0.89 . . . . 0.0 109.126 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 233' ' ' LYS . 49.0 mt -97.93 22.98 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 CA-C-O 122.519 1.152 . . . . 0.0 109.061 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.408 ' H ' HG23 ' A' ' 271' ' ' ILE . 83.8 m-85 -135.6 34.86 2.94 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.622 1.169 . . . . 0.0 109.989 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 34.3 m -71.03 -12.5 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.057 -174.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -87.15 -29.01 22.11 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.547 0.739 . . . . 0.0 111.325 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -102.08 22.1 13.71 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.341 0.656 . . . . 0.0 111.356 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' ' 225' ' ' LEU . 85.2 t -73.14 131.34 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.946 0.898 . . . . 0.0 110.406 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -109.07 160.39 16.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.617 0.767 . . . . 0.0 109.886 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.473 ' HB2' HD13 ' A' ' 212' ' ' ILE . 85.3 tttt -75.44 143.35 42.71 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.132 174.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.1 mm -72.2 116.06 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.429 ' HB2' ' N ' ' A' ' 208' ' ' ALA . 0.5 OUTLIER -83.39 105.95 14.76 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -106.47 151.53 40.37 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.512 0.725 . . . . 0.0 110.111 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.11 121.14 9.47 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.009 2.472 . . . . 0.0 113.531 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.16 -49.09 1.08 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.974 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -91.31 -24.27 19.87 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -171.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -83.23 137.15 16.0 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.04 0.212 . . . . 0.0 113.027 -170.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 6.5 m -84.36 146.48 47.74 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.144 0.578 . . . . 0.0 111.789 -173.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.28 -173.61 1.8 Allowed 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 123.731 2.954 . . . . 0.0 111.617 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' MET . . . . . 0.515 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 25.5 mmt -82.04 78.83 8.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.102 0.477 . . . . 0.0 109.906 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 13.7 p -87.33 -25.46 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 121.779 0.8 . . . . 0.0 109.022 169.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.66 -166.4 1.57 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.405 1.482 . . . . 0.0 108.22 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.35 154.96 94.41 Favored Pre-proline 0 N--CA 1.483 1.198 0 CA-C-N 118.933 0.788 . . . . 0.0 109.701 172.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.56 102.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.586 2.19 . . . . 0.0 112.292 173.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 89.7 mmm -95.37 135.52 36.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.582 0.753 . . . . 0.0 110.108 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.558 ' HB3' ' HH ' ' A' ' 140' ' ' TYR . 11.4 ptm180 -155.93 165.44 36.47 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.479 0.657 . . . . 0.0 111.397 -172.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.694 ' HD3' ' SD ' ' A' ' 224' ' ' MET . 17.1 mtm180 -88.88 153.07 21.34 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.939 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 82.5 tttt 71.24 166.73 0.3 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.274 1.029 . . . . 0.0 112.397 167.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 40.3 m -74.52 76.9 1.96 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 159.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.42 156.86 29.71 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.451 -174.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo . . . . . 0 C--N 1.37 1.667 0 C-N-CA 123.088 2.525 . . . . 0.0 111.003 175.501 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.487 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.72 10.27 10.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.347 0.659 . . . . 0.0 111.898 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -114.92 149.36 37.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 170.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -102.94 170.25 8.09 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.019 0.528 . . . . 0.0 111.312 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -68.95 -6.23 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.489 1.116 . . . . 0.0 112.996 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.78 -22.97 9.92 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.139 0.976 . . . . 0.0 110.974 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -80.88 88.26 5.88 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.377 0.671 . . . . 0.0 110.212 -173.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.422 ' HB3' ' OE1' ' A' ' 155' ' ' GLN . 48.5 p90 -78.56 139.42 38.62 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.121 176.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.9 m -130.98 -166.74 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 126.158 1.783 . . . . 0.0 108.386 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -93.89 159.46 15.17 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 154' ' ' ALA . . . -128.94 101.95 6.3 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 124.338 1.055 . . . . 0.0 108.452 172.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -69.8 96.37 0.98 Allowed 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.652 174.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -78.4 111.02 13.98 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.1 m -71.96 -29.52 64.35 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.76 0.824 . . . . 0.0 111.694 -172.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -65.53 -42.97 91.38 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.819 0.847 . . . . 0.0 110.633 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.4 tpp -82.06 -37.9 25.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.191 0.996 . . . . 0.0 109.664 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.52 18.18 66.85 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.397 -170.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -107.4 161.13 15.09 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 122.029 0.918 . . . . 0.0 112.564 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -91.0 126.26 36.03 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.457 -1.701 . . . . 0.0 107.644 169.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -129.13 123.78 33.05 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.451 ' HB2' ' N ' ' A' ' 190' ' ' ASP . 14.6 mm-40 -43.7 137.78 2.89 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.192 0.933 . . . . 0.0 110.192 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 187' ' ' LYS . . . -134.73 116.07 14.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 122.32 0.248 . . . . 0.0 110.4 -176.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.422 ' OE1' ' HB3' ' A' ' 140' ' ' TYR . 60.6 tp60 -90.35 101.35 14.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.4 t -61.18 117.08 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -116.66 -10.02 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.785 0.434 . . . . 0.0 111.838 -176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 -171.33 148.53 2.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.747 0.819 . . . . 0.0 109.245 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 6.1 m -117.4 142.36 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.511 0.724 . . . . 0.0 109.4 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.515 ' HG1' ' HB ' ' A' ' 183' ' ' ILE . 69.6 p -144.24 159.99 41.74 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.79 1.236 . . . . 0.0 108.099 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -97.35 -179.21 4.42 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.213 0.605 . . . . 0.0 109.732 174.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.51 ' HZ3' HG12 ' A' ' 183' ' ' ILE . 74.5 mmtt -78.3 40.87 0.36 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.002 0.921 . . . . 0.0 110.402 169.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -141.53 160.23 57.51 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.784 1.634 . . . . 0.0 108.087 -167.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -52.05 151.06 17.21 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.092 2.528 . . . . 0.0 115.077 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.562 ' HB3' ' HD3' ' A' ' 166' ' ' ARG . 55.5 m 61.06 -105.58 0.21 Allowed 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 125.574 1.55 . . . . 0.0 113.608 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.562 ' HD3' ' HB3' ' A' ' 165' ' ' SER . 0.0 OUTLIER -152.62 -178.16 6.69 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 118.344 0.52 . . . . 0.0 112.285 -170.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -146.39 160.71 41.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.958 0.903 . . . . 0.0 110.335 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.425 ' HB2' ' HG ' ' A' ' 171' ' ' SER . 40.0 mt-10 -104.8 154.45 38.58 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.846 0.858 . . . . 0.0 110.652 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.32 152.6 79.12 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.16 1.907 . . . . 0.0 110.768 163.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 25.2 t 68.57 17.92 8.94 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.79 1.236 . . . . 0.0 111.804 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.425 ' HG ' ' HB2' ' A' ' 168' ' ' GLU . 23.4 m -109.0 13.83 24.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.808 0.843 . . . . 0.0 110.968 177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 18.8 m -135.35 21.7 3.42 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.955 0.902 . . . . 0.0 109.939 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 24.2 p -69.9 -57.35 5.15 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.067 0.947 . . . . 0.0 111.186 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.5 m -84.85 -9.71 57.86 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.538 0.735 . . . . 0.0 111.581 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -128.37 85.81 59.47 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.203 0.601 . . . . 0.0 111.283 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -89.8 -148.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 123.179 2.586 . . . . 0.0 110.298 165.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -151.23 -129.31 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 171.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.0 -52.87 4.21 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 165.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -127.31 130.58 49.77 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 165.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.19 95.22 0.56 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.442 0.639 . . . . 0.0 109.845 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -75.96 76.72 2.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.073 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.08 152.87 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.39 1.476 . . . . 0.0 107.792 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.515 ' HB ' ' HG1' ' A' ' 160' ' ' THR . 39.3 mt -95.19 110.15 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.02 0.528 . . . . 0.0 110.654 -170.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -92.48 112.44 24.38 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 170.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -79.34 93.95 5.41 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 6.0 m -108.2 163.84 5.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 114.404 -1.271 . . . . 0.0 107.773 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.461 ' HG2' HG22 ' A' ' 196' ' ' VAL . 35.4 mtmt -106.48 135.02 48.71 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 165.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -63.61 89.88 0.05 OUTLIER 'General case' 0 C--O 1.207 -1.148 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 164.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.46 -20.28 65.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.079 0.952 . . . . 0.0 110.639 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.451 ' N ' ' HB2' ' A' ' 153' ' ' GLU . 2.1 t70 -64.52 -32.48 74.14 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.871 0.869 . . . . 0.0 110.078 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -144.6 72.24 15.54 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.11 -16.61 55.94 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.285 2.657 . . . . 0.0 115.582 -165.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.53 -11.22 59.84 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.568 0.347 . . . . 0.0 111.59 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -72.61 -15.71 61.73 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.308 0.643 . . . . 0.0 111.226 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 93.25 -175.47 36.29 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.661 0.624 . . . . 0.0 114.661 167.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 187' ' ' LYS . 17.9 t -79.16 115.33 21.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.53 154.92 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.643 1.177 . . . . 0.0 110.214 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.491 ' HB2' HG21 ' A' ' 183' ' ' ILE . 10.8 pt20 -98.24 127.41 44.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.072 0.549 . . . . 0.0 110.103 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.579 ' HE3' ' HB3' ' A' ' 203' ' ' ASP . 82.7 mmm -137.13 142.01 42.26 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.327 1.051 . . . . 0.0 108.968 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . 0.416 ' O ' HG21 ' A' ' 204' ' ' VAL . 27.5 m-80 -86.24 173.6 9.65 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 118.294 0.497 . . . . 0.0 110.228 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 51.6 m -61.0 -37.88 84.07 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.858 0.299 . . . . 0.0 111.488 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -58.88 -27.9 65.63 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.788 0.835 . . . . 0.0 112.158 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.579 ' HB3' ' HE3' ' A' ' 199' ' ' MET . 28.4 m-20 -87.96 -41.55 13.07 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.359 0.664 . . . . 0.0 111.309 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 200' ' ' ASN . 4.7 m -93.28 116.66 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.82 0.819 . . . . 0.0 109.233 -175.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -113.43 148.77 35.25 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.59 -165.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.09 153.93 20.55 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.272 0.629 . . . . 0.0 110.275 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.424 ' HG3' ' SD ' ' A' ' 289' ' ' MET . 9.6 ptm85 -117.64 127.17 53.69 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.371 0.668 . . . . 0.0 111.006 -169.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -85.26 136.47 33.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.828 0.851 . . . . 0.0 109.837 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.69 ' HB3' ' HG2' ' A' ' 289' ' ' MET . 6.7 ppt_? -92.77 15.61 14.21 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.125 0.57 . . . . 0.0 110.65 175.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 279' ' ' LYS . 23.0 m -86.62 108.89 18.82 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.391 0.677 . . . . 0.0 110.01 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 mt -86.51 121.98 38.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 172.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 216' ' ' ASP . 38.5 mm -94.29 142.33 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.502 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 1.3 ptpp? -128.2 -179.73 5.16 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.609 1.164 . . . . 0.0 109.699 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.427 ' CH2' ' HB2' ' A' ' 248' ' ' GLU . 10.5 t90 -56.16 -40.47 73.93 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.064 0.546 . . . . 0.0 110.454 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -59.3 -33.12 70.71 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.718 0.807 . . . . 0.0 111.604 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.551 ' HB2' HG23 ' A' ' 212' ' ' ILE . 66.0 m-20 -80.34 -34.7 36.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.279 0.632 . . . . 0.0 110.536 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.533 HD22 HD13 ' A' ' 243' ' ' ILE . 89.0 mt -67.18 112.86 4.7 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-O 120.99 0.424 . . . . 0.0 110.479 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.51 154.83 51.24 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.519 1.127 . . . . 0.0 108.353 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 36.0 m -64.42 124.15 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.008 0.432 . . . . 0.0 110.49 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.25 -18.88 47.56 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.561 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -79.64 124.36 28.48 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.526 0.663 . . . . 0.0 109.859 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 14.0 p -91.94 141.23 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.535 0.683 . . . . 0.0 109.165 173.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.463 HG12 HG22 ' A' ' 212' ' ' ILE . 11.4 m -139.1 -177.1 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.978 1.311 . . . . 0.0 109.266 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.429 ' HE1' ' HB3' ' A' ' 224' ' ' MET . 3.8 ttp -136.63 125.27 23.75 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.115 0.566 . . . . 0.0 109.609 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.21 151.62 37.89 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.408 1.083 . . . . 0.0 110.29 -169.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -88.8 108.79 19.7 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.935 0.494 . . . . 0.0 111.064 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.418 ' HH ' HG21 ' A' ' 271' ' ' ILE . 93.5 m-85 -140.61 139.77 34.96 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.913 0.885 . . . . 0.0 108.836 171.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.484 HD21 ' HB2' ' A' ' 230' ' ' ASP . 14.0 p-10 -87.26 134.62 36.07 Favored Pre-proline 0 N--CA 1.474 0.729 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.49 -13.12 36.78 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.116 1.878 . . . . 0.0 112.469 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.484 ' HB2' HD21 ' A' ' 228' ' ' ASN . 6.5 m-20 -67.69 -40.31 84.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.867 0.867 . . . . 0.0 110.133 173.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 234' ' ' GLU . 48.1 t-20 -141.31 104.19 6.04 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.78 -16.96 47.12 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.655 2.236 . . . . 0.0 112.688 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.457 ' HG3' HD13 ' A' ' 272' ' ' ILE . 83.0 tttt -95.55 8.3 43.75 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.989 0.916 . . . . 0.0 110.358 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 231' ' ' ASN . 38.3 tt0 -132.95 148.76 52.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.334 0.654 . . . . 0.0 110.964 -175.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -60.14 150.34 29.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.626 1.17 . . . . 0.0 112.386 172.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -169.6 -115.36 0.33 Allowed Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.493 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -95.62 150.06 20.77 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.347 0.659 . . . . 0.0 110.439 -176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -77.97 107.45 10.52 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.403 0.681 . . . . 0.0 110.042 -174.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -119.63 164.97 15.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.331 0.652 . . . . 0.0 109.263 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.55 144.23 30.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 174.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.73 133.95 21.68 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 222' ' ' VAL . 34.6 tt0 -105.49 127.06 52.8 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.533 HD13 HD22 ' A' ' 217' ' ' LEU . 14.7 mm -64.95 103.8 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 123.993 0.808 . . . . 0.0 109.666 -172.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.8 p -79.31 -45.57 19.4 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.144 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -143.82 163.6 32.91 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.284 1.034 . . . . 0.0 110.102 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -155.03 149.05 25.8 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.761 0.824 . . . . 0.0 109.427 172.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -146.57 118.87 8.36 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.484 0.659 . . . . 0.0 110.565 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.427 ' HB2' ' CH2' ' A' ' 214' ' ' TRP . 5.0 tm-20 -93.17 124.19 36.97 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 63.6 p -125.61 157.51 37.01 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.415 ' HG3' HG21 ' A' ' 251' ' ' THR . 27.5 ptt180 -60.82 -24.76 66.11 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.349 1.06 . . . . 0.0 112.703 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.415 HG21 ' HG3' ' A' ' 250' ' ' ARG . 55.9 p -97.93 -28.59 13.74 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.828 0.851 . . . . 0.0 112.566 -172.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -166.1 169.24 14.7 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.68 0.392 . . . . 0.0 111.026 -173.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -95.85 155.56 16.7 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.081 0.553 . . . . 0.0 109.747 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -146.28 140.56 26.58 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.529 HD11 HD12 ' A' ' 243' ' ' ILE . 0.3 OUTLIER -148.17 144.35 27.69 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -135.68 134.04 38.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.998 0.919 . . . . 0.0 109.82 176.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.84 143.98 27.82 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.223 0.609 . . . . 0.0 111.087 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -79.52 98.43 6.84 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.022 0.529 . . . . 0.0 109.583 172.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 91.8 t -76.42 103.51 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.273 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.66 122.53 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.966 0.889 . . . . 0.0 110.104 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 32.5 mt -88.17 -151.57 0.2 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.173 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -59.89 -77.04 0.19 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 117.852 0.296 . . . . 0.0 112.579 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -100.49 -25.15 14.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.378 0.671 . . . . 0.0 110.944 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -90.61 173.21 8.17 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.826 0.85 . . . . 0.0 111.435 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 32.8 p -155.56 120.54 4.8 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.553 0.741 . . . . 0.0 110.054 174.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.19 97.51 7.64 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.364 1.066 . . . . 0.0 109.033 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.7 132.92 46.89 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.564 0.746 . . . . 0.0 111.36 -172.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 55.3 35.87 25.85 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.644 1.215 . . . . 0.0 111.818 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 36.8 t -64.0 124.43 21.57 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -70.63 117.18 11.83 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.788 0.435 . . . . 0.0 110.229 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 34.8 mm -80.36 110.91 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.219 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.457 HD13 ' HG3' ' A' ' 233' ' ' LYS . 25.0 mm -78.12 -66.36 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.796 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -83.63 65.84 8.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.817 1.247 . . . . 0.0 109.948 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.7 m -64.4 -32.53 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.603 0.761 . . . . 0.0 111.999 -173.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 5.3 p-10 -86.05 -13.98 45.76 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.645 1.178 . . . . 0.0 111.917 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -97.65 -0.64 45.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.453 0.701 . . . . 0.0 111.471 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.81 153.87 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.704 0.801 . . . . 0.0 110.637 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -117.4 161.56 19.35 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.899 0.879 . . . . 0.0 108.869 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.417 ' HB3' ' HB ' ' A' ' 210' ' ' THR . 80.1 tttt -91.03 153.09 20.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.867 0.467 . . . . 0.0 112.008 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.2 mm -67.23 120.26 14.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 123.947 0.899 . . . . 0.0 108.802 168.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.36 112.2 8.22 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 96.1 mtt180 -128.2 141.59 41.79 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 123.883 0.873 . . . . 0.0 109.436 172.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -46.16 108.03 0.14 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.815 3.01 . . . . 0.0 113.265 170.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.36 -39.78 2.9 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.817 -0.628 . . . . 0.0 113.435 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 32.5 tt0 -79.35 -29.19 42.09 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.961 0.381 . . . . 0.0 111.766 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -117.57 151.43 18.07 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 12.5 p -88.91 109.95 34.15 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-N 117.788 0.794 . . . . 0.0 110.114 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.25 155.69 60.31 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 123.198 2.599 . . . . 0.0 110.166 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' MET . . . . . 0.69 ' HG2' ' HB3' ' A' ' 209' ' ' ARG . 63.8 mtt -74.78 80.5 2.08 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.61 0.719 . . . . 0.0 112.559 -172.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.02 -28.11 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 165.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.78 -164.42 0.79 Allowed 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.254 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -57.24 111.75 3.78 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 118.774 0.715 . . . . 0.0 111.566 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.526 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 11.9 Cg_exo -72.61 93.89 0.77 Allowed 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.432 2.088 . . . . 0.0 111.094 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.2 mtm -73.36 125.73 28.52 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.02 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.23 121.34 22.77 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -64.59 -30.08 71.1 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.06 0.944 . . . . 0.0 111.179 -175.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -57.06 122.08 11.52 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.383 167.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 50.2 p -77.57 91.98 4.02 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.366 0.666 . . . . 0.0 110.804 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -92.25 167.54 30.35 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.564 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo . . . . . 0 C--N 1.38 2.203 0 C-N-CA 123.214 2.609 . . . . 0.0 111.917 176.472 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.417 0 CA-C-O 119.744 -0.476 . . . . 0.0 111.967 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.31 7.37 4.97 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -79.6 128.47 33.42 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.755 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 58.1 pttt -72.18 174.66 6.88 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.004 0.922 . . . . 0.0 111.657 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -74.51 -2.67 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.206 0.602 . . . . 0.0 111.948 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.435 ' H ' ' HG3' ' A' ' 136' ' ' LYS . 92.0 m-20 -120.99 30.3 6.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.244 1.018 . . . . 0.0 110.96 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.755 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 6.3 mm-40 -88.86 71.21 8.64 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.253 1.025 . . . . 0.0 110.859 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -63.76 99.4 0.23 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.288 169.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 30.1 m -121.77 169.32 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.972 0.909 . . . . 0.0 109.703 -176.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 207' ' ' ARG . 1.6 t0 -101.6 110.34 22.32 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -92.75 92.98 8.21 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 122.932 0.493 . . . . 0.0 110.497 -171.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 2.8 tmt_? -72.27 106.13 4.32 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 174.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.62 114.8 3.78 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.482 ' HA ' ' NH1' ' A' ' 144' ' ' ARG . 13.8 t -60.25 -23.89 64.46 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -171.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -83.7 -38.69 21.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.447 0.699 . . . . 0.0 110.174 -174.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 41.9 ttm -92.96 -22.89 18.93 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.491 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.42 12.93 73.66 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.063 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.56 129.98 53.71 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.622 0.769 . . . . 0.0 111.147 -174.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 52.1 m95 -81.89 121.93 27.09 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.077 0.951 . . . . 0.0 110.617 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -131.03 115.18 16.12 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 27.1 mt-10 -58.45 144.86 40.72 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.311 0.505 . . . . 0.0 111.139 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' A' ' 186' ' ' VAL . . . -158.42 124.78 4.69 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 124.31 1.006 . . . . 0.0 109.613 -176.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -92.48 118.88 31.42 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 63.7 t -61.66 111.72 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 C-N-CA 123.484 0.713 . . . . 0.0 109.315 172.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.7 m -104.48 -6.89 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.138 0.575 . . . . 0.0 111.8 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -170.14 141.28 2.08 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.199 0.599 . . . . 0.0 110.24 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.6 m -119.41 142.09 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.59 0.756 . . . . 0.0 110.672 172.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.2 t -147.14 160.86 41.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.032 0.933 . . . . 0.0 108.833 169.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.586 ' HE ' ' HB3' ' A' ' 163' ' ' ALA . 17.2 ptt-85 -101.73 176.39 5.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.061 0.544 . . . . 0.0 110.217 -177.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -85.78 58.58 5.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.474 0.71 . . . . 0.0 110.042 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.586 ' HB3' ' HE ' ' A' ' 161' ' ' ARG . . . -169.17 148.92 3.75 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.709 1.204 . . . . 0.0 109.224 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.533 ' HB2' ' HB2' ' A' ' 167' ' ' ASP . 42.2 Cg_endo -64.39 92.42 0.19 Allowed 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.95 2.433 . . . . 0.0 112.585 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 16.7 m -86.07 -42.89 13.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.789 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -68.65 -51.57 40.66 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.313 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 164' ' ' PRO . 10.1 m-20 -54.73 -45.67 74.13 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 123.591 0.557 . . . . 0.0 110.456 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.601 ' HG2' ' HB3' ' A' ' 171' ' ' SER . 0.6 OUTLIER 47.4 73.7 0.95 Allowed Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.227 1.411 . . . . 0.0 110.083 -177.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.02 -61.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.37 2.047 . . . . 0.0 110.598 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 85.9 m -134.51 33.04 3.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.501 1.121 . . . . 0.0 109.108 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.601 ' HB3' ' HG2' ' A' ' 168' ' ' GLU . 32.7 t -71.97 171.15 12.33 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.537 1.135 . . . . 0.0 111.071 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.2 m 72.12 8.16 5.86 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.936 1.294 . . . . 0.0 112.809 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.6 t -88.15 -25.77 22.79 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.061 0.545 . . . . 0.0 109.747 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 23.7 p -166.09 154.75 11.11 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 124.794 1.238 . . . . 0.0 109.334 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -146.32 91.74 5.37 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.081 0.553 . . . . 0.0 109.894 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.84 113.5 3.81 Favored 'Trans proline' 0 CA--C 1.554 1.509 0 C-N-CA 122.709 2.273 . . . . 0.0 112.405 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -129.66 -33.76 1.82 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.665 0.786 . . . . 0.0 110.299 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.587 ' HG ' ' HG3' ' A' ' 179' ' ' GLU . 43.5 tp 56.61 -83.13 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.117 1.767 . . . . 0.0 112.447 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.587 ' HG3' ' HG ' ' A' ' 178' ' ' LEU . 45.3 mt-10 -126.18 44.48 2.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.408 1.083 . . . . 0.0 109.078 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.407 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 10.0 mm-40 52.11 29.21 6.15 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 173.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -71.41 63.35 0.38 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.54 168.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.31 -175.51 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.821 1.648 . . . . 0.0 108.645 -170.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.58 HG21 ' HB2' ' A' ' 198' ' ' GLN . 3.7 mp -97.5 110.71 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.407 ' OH ' ' HB3' ' A' ' 180' ' ' GLU . 99.6 m-85 -98.61 106.61 18.91 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.193 0.997 . . . . 0.0 108.411 170.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -79.09 97.7 6.23 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 35.1 m -109.97 163.65 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.241 1.017 . . . . 0.0 111.019 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.548 ' HZ3' ' HB3' ' A' ' 187' ' ' LYS . 1.8 mmmp? -121.54 114.01 20.61 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -63.16 115.03 4.12 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.303 0.377 . . . . 0.0 110.254 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.69 -34.77 72.33 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.968 0.413 . . . . 0.0 110.408 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.64 -28.72 61.93 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.898 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -142.17 68.13 22.0 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 122.762 0.425 . . . . 0.0 111.342 -170.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.34 -11.41 24.75 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.264 2.643 . . . . 0.0 113.629 -174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.44 -17.87 62.36 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.558 0.743 . . . . 0.0 111.17 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -72.5 -10.5 59.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.389 0.675 . . . . 0.0 111.54 173.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.63 -151.78 45.16 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.401 0.438 . . . . 0.0 112.342 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.75 117.88 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 18.5 m -116.6 152.62 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.833 0.853 . . . . 0.0 109.466 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.58 ' HB2' HG21 ' A' ' 183' ' ' ILE . 5.4 pm0 -107.57 123.97 49.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.976 0.51 . . . . 0.0 109.716 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.604 ' HE3' ' HB3' ' A' ' 203' ' ' ASP . 74.9 mtp -131.16 170.13 14.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.58 0.752 . . . . 0.0 110.045 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -109.41 175.4 5.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.922 0.889 . . . . 0.0 109.904 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 45.8 t -63.73 -40.02 95.72 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.884 0.474 . . . . 0.0 110.687 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -65.46 -7.32 13.59 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.604 ' HB3' ' HE3' ' A' ' 199' ' ' MET . 56.9 m-20 -101.87 -54.64 2.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.027 0.931 . . . . 0.0 111.345 172.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 32.6 m -91.72 119.94 39.94 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -168.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.426 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 16.0 mmt180 -123.12 141.4 52.01 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.937 -169.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.81 132.18 51.55 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 168.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.639 ' HB3' ' HB2' ' A' ' 142' ' ' ASP . 4.2 ptm180 -111.71 158.35 19.43 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.772 0.429 . . . . 0.0 111.119 -173.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.64 140.64 29.33 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.858 0.463 . . . . 0.0 109.882 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.513 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 10.9 ptm180 -93.43 18.11 10.32 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.378 0.609 . . . . 0.0 110.537 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 87.8 m -98.91 113.99 26.39 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.304 1.042 . . . . 0.0 109.996 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 30.6 mt -86.94 124.49 40.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 169.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.613 ' HB ' ' HB ' ' A' ' 277' ' ' VAL . 47.9 mm -86.37 127.3 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.755 1.222 . . . . 0.0 109.917 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.87 -178.91 3.6 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.208 1.003 . . . . 0.0 108.625 171.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.4 ' HA ' HD23 ' A' ' 217' ' ' LEU . 64.4 t-105 -54.29 -32.92 57.54 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.128 0.571 . . . . 0.0 112.269 -172.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -61.77 -39.17 90.73 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.529 0.731 . . . . 0.0 111.487 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.535 ' HB2' HG21 ' A' ' 212' ' ' ILE . 7.1 m-20 -84.6 -14.52 48.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.85 0.86 . . . . 0.0 111.67 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.429 HD21 HG22 ' A' ' 212' ' ' ILE . 3.2 mm? -66.7 113.41 4.81 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.7 140.94 34.99 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.129 0.971 . . . . 0.0 108.438 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.1 m -70.0 138.49 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 120.966 0.412 . . . . 0.0 110.899 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 94.06 -13.78 66.66 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.324 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.47 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.1 tt0 -81.68 122.77 28.05 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.344 0.572 . . . . 0.0 110.837 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.83 119.66 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.55 ' HA ' HG12 ' A' ' 280' ' ' ILE . 1.9 m -135.27 172.58 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.587 1.155 . . . . 0.0 110.265 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.535 ' HE1' ' HB2' ' A' ' 278' ' ' PHE . 48.4 ttp -110.32 113.98 27.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.257 0.623 . . . . 0.0 110.08 -174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.511 ' HG ' HG12 ' A' ' 277' ' ' VAL . 0.2 OUTLIER -121.97 147.16 46.41 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.281 0.632 . . . . 0.0 109.502 -173.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -87.44 124.09 33.06 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.575 0.75 . . . . 0.0 110.143 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' A' ' 225' ' ' LEU . 7.3 p90 -169.07 154.2 5.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.061 0.944 . . . . 0.0 109.357 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -82.11 127.83 70.23 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 162.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.77 -38.89 77.57 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.304 2.003 . . . . 0.0 111.939 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -75.59 -30.1 59.51 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.021 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -132.9 79.87 62.21 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 123.3 0.64 . . . . 0.0 110.643 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.95 -11.96 32.18 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.135 2.557 . . . . 0.0 113.389 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.466 ' HA ' HD12 ' A' ' 272' ' ' ILE . 22.3 tptm -70.99 -24.23 62.35 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.35 0.66 . . . . 0.0 110.931 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.68 164.56 24.75 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.0 0.52 . . . . 0.0 111.033 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -51.49 160.08 0.65 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.335 1.454 . . . . 0.0 112.804 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -166.02 -107.32 0.2 Allowed Glycine 0 C--N 1.344 1.018 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -128.18 173.18 10.33 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.773 0.829 . . . . 0.0 109.11 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -96.65 127.16 42.37 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.452 0.701 . . . . 0.0 110.049 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -138.95 164.54 29.45 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.371 0.668 . . . . 0.0 110.051 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.4 140.44 34.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -150.95 137.38 18.62 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -95.42 126.42 40.7 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.475 HD12 HD12 ' A' ' 255' ' ' LEU . 19.0 mm -67.65 110.39 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.052 0.453 . . . . 0.0 109.801 -175.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 17.1 m -79.3 -39.66 32.35 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.823 0.849 . . . . 0.0 110.666 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -161.97 156.08 21.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.79 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -141.69 148.29 38.84 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.511 ' HB3' ' HG3' ' A' ' 254' ' ' GLU . 28.1 tpt180 -149.87 122.15 8.39 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -115.32 123.69 49.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.113 0.565 . . . . 0.0 109.873 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 62.2 p -121.6 162.95 19.73 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -67.18 -22.31 65.75 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 120.759 0.314 . . . . 0.0 111.401 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.2 p -86.41 -28.99 23.22 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.375 0.67 . . . . 0.0 111.414 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -165.67 141.41 5.1 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.431 ' O ' ' HD2' ' A' ' 253' ' ' ARG . 4.2 ppt_? -111.18 102.52 10.94 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.675 0.79 . . . . 0.0 109.569 173.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.511 ' HG3' ' HB3' ' A' ' 247' ' ' ARG . 7.6 pt-20 -95.71 122.85 38.92 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.634 0.774 . . . . 0.0 110.722 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.475 HD12 HD12 ' A' ' 243' ' ' ILE . 1.7 tm? -108.77 147.85 31.41 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . 0.425 ' N ' HD13 ' A' ' 255' ' ' LEU . 99.3 m-85 -135.04 132.31 38.1 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.264 1.026 . . . . 0.0 108.516 175.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.46 139.94 28.62 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 43.5 t30 -75.66 95.54 3.41 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 172.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 34.3 t -68.79 112.16 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.372 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.79 117.92 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 264' ' ' ASP . 59.8 mt -94.5 -165.78 1.37 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.497 0.719 . . . . 0.0 109.423 173.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -62.85 -45.3 95.99 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.01 0.194 . . . . 0.0 113.341 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -123.06 -35.98 2.92 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.546 0.738 . . . . 0.0 110.646 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.556 ' HB2' HD13 ' A' ' 261' ' ' LEU . 8.2 m-20 -91.79 176.55 6.49 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.83 0.852 . . . . 0.0 111.574 -172.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 35.1 t -156.59 118.08 3.82 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.514 0.726 . . . . 0.0 110.201 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 2.0 mm? -96.15 92.11 6.25 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 3.2 p-10 -68.7 138.61 55.07 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.353 0.261 . . . . 0.0 111.289 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 57.88 32.53 22.05 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.291 1.036 . . . . 0.0 111.786 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 44.0 t -65.27 127.27 31.05 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.41 0.684 . . . . 0.0 110.411 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 45.0 ttp180 -70.51 110.49 5.42 Favored 'General case' 0 C--N 1.346 0.456 0 O-C-N 123.436 0.46 . . . . 0.0 110.343 -178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.1 mm -89.43 132.78 33.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.774 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 233' ' ' LYS . 65.0 mt -102.09 -26.31 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.082 1.353 . . . . 0.0 109.932 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -92.38 42.62 1.11 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.124 1.37 . . . . 0.0 111.336 -168.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 16.7 m -69.59 -22.84 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -168.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.85 -25.22 19.07 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.96 9.12 17.9 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.762 0.825 . . . . 0.0 112.332 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.613 ' HB ' ' HB ' ' A' ' 212' ' ' ILE . 32.7 t -80.56 147.05 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.391 0.676 . . . . 0.0 110.836 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.535 ' HB2' ' HE1' ' A' ' 224' ' ' MET . 62.7 m-85 -105.8 156.26 18.49 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 162.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.539 ' HA ' HG11 ' A' ' 223' ' ' VAL . 36.5 ttmt -80.57 146.58 31.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.666 0.386 . . . . 0.0 110.417 173.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.55 HG12 ' HA ' ' A' ' 223' ' ' VAL . 35.1 mm -73.48 114.91 13.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 168.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -76.6 134.06 39.47 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.631 173.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 61.5 mtp180 -108.38 94.2 13.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 168.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -20.17 97.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.386 2.551 1 C-N-CA 126.263 4.642 . . . . 0.0 117.246 -162.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 103.53 -30.84 9.5 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 115.347 -0.842 . . . . 0.0 115.189 169.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 11.6 pt-20 -79.51 -20.21 47.77 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.859 1.33 . . . . 0.0 112.004 -173.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -87.46 -100.57 0.87 Allowed Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' SER . . . . . 0.421 ' HB2' ' HG2' ' A' ' 209' ' ' ARG . 14.6 p -127.23 128.52 24.08 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.535 1.134 . . . . 0.0 110.791 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.52 133.66 17.65 Favored 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 123.29 2.66 . . . . 0.0 112.921 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 98.3 mmm -86.45 82.49 7.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 168.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 11.2 p -128.58 -15.03 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.757 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -103.42 -153.18 0.47 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.701 1.2 . . . . 0.0 108.625 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -55.17 120.19 28.28 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.566 0.747 . . . . 0.0 111.575 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.33 85.12 0.45 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.817 2.345 . . . . 0.0 111.336 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 18.7 ptm -71.05 82.39 0.68 Allowed 'General case' 0 C--O 1.244 0.767 0 CA-C-O 123.037 1.399 . . . . 0.0 109.895 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -94.73 160.03 14.8 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.77 -172.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.434 ' NH2' ' H ' ' A' ' 153' ' ' GLU . 30.6 mtm-85 -87.3 118.79 26.96 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.108 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.6 mttt 64.81 -170.89 0.19 Allowed 'General case' 0 CA--C 1.551 1.002 0 O-C-N 124.565 1.166 . . . . 0.0 111.078 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.5 m -146.32 76.41 1.44 Allowed 'General case' 0 C--O 1.24 0.562 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 160.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 122.22 175.33 14.78 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.891 -171.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo . . . . . 0 C--N 1.375 1.966 0 C-N-CA 123.311 2.674 . . . . 0.0 111.274 178.135 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.428 ' N ' HD12 ' A' ' 134' ' ' LEU . . . . . . . . 0 N--CA 1.485 1.955 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -127.29 5.67 6.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.488 0.715 . . . . 0.0 112.323 -173.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.486 ' HB2' HG13 ' A' ' 156' ' ' VAL . 43.0 m-85 -96.93 143.08 28.14 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.475 0.31 . . . . 0.0 110.433 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.517 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 22.6 pttp -86.14 176.8 7.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.037 0.535 . . . . 0.0 111.055 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.65 -10.27 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -173.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -127.44 21.59 6.59 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.747 0.419 . . . . 0.0 110.44 -171.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.517 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 17.9 mm-40 -99.65 88.62 3.88 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 122.038 -0.414 . . . . 0.0 110.798 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.685 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 25.6 p90 -76.75 122.87 25.35 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.339 171.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.26 167.42 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.617 0.767 . . . . 0.0 108.968 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -90.72 115.12 27.57 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.79 120.37 36.33 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.588 -167.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.54 128.37 35.39 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.85 112.45 5.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 t -68.02 -14.35 62.9 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.464 0.705 . . . . 0.0 112.702 -172.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -86.76 -54.12 4.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.343 0.657 . . . . 0.0 111.107 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 37.8 ttp -96.34 -27.83 14.77 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.411 0.685 . . . . 0.0 112.084 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.72 18.85 46.35 Favored Glycine 0 N--CA 1.475 1.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.946 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.75 129.37 53.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.119 0.568 . . . . 0.0 111.062 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.658 ' HH2' ' HD2' ' A' ' 205' ' ' ARG . 81.4 m95 -75.22 128.09 34.66 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.64 0.776 . . . . 0.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -131.8 137.66 48.22 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.283 1.033 . . . . 0.0 108.925 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -59.32 114.43 2.65 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -125.54 120.67 31.5 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.199 0.6 . . . . 0.0 109.796 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.685 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 51.6 tt0 -87.19 114.75 24.07 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.605 0.762 . . . . 0.0 110.554 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.486 HG13 ' HB2' ' A' ' 135' ' ' TYR . 92.5 t -62.28 98.41 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.7 m -94.88 -10.02 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.912 0.485 . . . . 0.0 111.076 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 27.8 ttt180 -170.25 146.7 2.97 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.975 0.797 . . . . 0.0 109.92 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.0 m -117.17 142.9 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 169.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.644 ' HG1' ' HB ' ' A' ' 183' ' ' ILE . 31.3 p -135.21 121.49 20.3 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 172.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -82.18 176.47 9.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.029 0.532 . . . . 0.0 111.051 -175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -78.29 67.71 4.15 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -171.38 155.02 4.07 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.399 -169.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.54 88.26 0.17 Allowed 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.562 2.175 . . . . 0.0 112.044 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.7 m -81.14 -41.71 22.03 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.057 0.943 . . . . 0.0 110.364 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 73.51 150.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.794 1.638 . . . . 0.0 112.636 173.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -50.54 -55.72 14.86 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.333 1.053 . . . . 0.0 111.199 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -79.44 108.98 9.95 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 163.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.82 139.85 34.25 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.558 2.172 . . . . 0.0 112.601 -166.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 10.0 p -78.37 153.46 31.61 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.732 0.813 . . . . 0.0 109.562 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 31.3 t -58.37 137.15 57.44 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.632 0.773 . . . . 0.0 110.221 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 71.2 p -60.29 104.8 0.35 Allowed 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.997 0.81 . . . . 0.0 111.867 -169.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 19.3 p -75.81 157.78 32.98 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.546 -1.207 . . . . 0.0 111.322 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 10.6 p -88.65 59.26 5.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.159 0.984 . . . . 0.0 110.12 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 64.9 mtt-85 -96.48 105.29 21.76 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.416 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.39 163.54 24.59 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.591 2.194 . . . . 0.0 113.063 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -160.61 -179.18 7.42 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.949 0.9 . . . . 0.0 110.207 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -120.2 -112.21 0.33 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -74.77 78.22 2.08 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 119.152 0.887 . . . . 0.0 108.658 167.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.23 97.43 1.55 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.025 -171.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -76.66 53.14 0.87 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.823 0.82 . . . . 0.0 110.435 169.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 31.6 m -83.85 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 124.603 1.161 . . . . 0.0 109.624 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.644 ' HB ' ' HG1' ' A' ' 160' ' ' THR . 3.5 mp -97.3 106.21 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -93.54 111.17 22.78 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 14.5 m-70 -80.01 90.28 5.38 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 35.0 m -108.97 140.2 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.32 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -105.74 123.45 47.97 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -57.04 96.3 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -62.96 -29.63 70.96 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.006 0.922 . . . . 0.0 109.076 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 298' ' ' SER . 2.0 t0 -61.83 -30.96 71.18 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.086 1.354 . . . . 0.0 111.031 176.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -145.75 81.27 10.1 Favored Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 124.549 1.14 . . . . 0.0 108.624 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -65.05 -16.86 57.36 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.076 2.517 . . . . 0.0 114.618 -170.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.53 -18.7 65.13 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -74.67 -20.9 59.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.206 0.602 . . . . 0.0 111.626 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.41 -144.6 41.04 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.511 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 6.8 t -87.66 129.55 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.217 0.607 . . . . 0.0 110.424 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.7 153.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.045 1.338 . . . . 0.0 108.52 170.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.536 ' HB2' HG22 ' A' ' 183' ' ' ILE . 16.2 pt20 -102.88 128.74 49.54 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.124 0.488 . . . . 0.0 110.305 177.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 84.2 mtp -137.61 159.82 40.9 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.33 1.052 . . . . 0.0 108.73 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -97.81 174.23 6.7 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.6 t -64.21 -34.79 78.89 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 120.827 0.346 . . . . 0.0 110.746 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.46 -14.86 63.3 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -96.5 -45.29 6.81 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.716 0.807 . . . . 0.0 110.344 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 32.6 m -95.41 117.29 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.658 ' HD2' ' HH2' ' A' ' 151' ' ' TRP . 92.7 mtt180 -128.55 171.42 12.15 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.77 -0.582 . . . . 0.0 111.193 -168.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.58 129.4 40.43 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.374 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.581 ' HG3' ' SD ' ' A' ' 289' ' ' MET . 26.4 ptt180 -81.1 142.11 33.64 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.357 1.063 . . . . 0.0 111.229 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 281' ' ' GLU . . . -99.92 145.41 27.84 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.395 0.678 . . . . 0.0 110.339 175.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -2.38 34.81 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.657 0.783 . . . . 0.0 110.558 173.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.5 m -89.49 117.71 28.6 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.473 0.709 . . . . 0.0 111.332 -165.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.3 mt -92.4 136.26 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 166.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.656 HG23 HD12 ' A' ' 217' ' ' LEU . 19.9 mm -107.46 153.55 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.951 0.9 . . . . 0.0 110.372 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -128.26 168.52 15.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.549 0.74 . . . . 0.0 109.066 167.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 35.9 t90 -46.32 -41.86 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.344 1.058 . . . . 0.0 112.096 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -57.68 -46.3 84.48 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.85 0.86 . . . . 0.0 112.637 -173.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -103.65 6.3 36.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.504 0.722 . . . . 0.0 111.023 -175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.656 HD12 HG23 ' A' ' 212' ' ' ILE . 8.0 tp -86.63 110.96 20.2 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 175.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.7 153.35 25.39 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.947 0.34 . . . . 0.0 110.861 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.421 ' HA ' ' HB ' ' A' ' 243' ' ' ILE . 28.0 m -66.13 136.99 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.701 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.0 -23.62 34.89 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.622 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.523 ' HG2' HG11 ' A' ' 223' ' ' VAL . 9.5 tt0 -74.69 123.39 24.81 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.119 0.567 . . . . 0.0 110.373 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 84.5 t -85.8 119.91 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.523 HG11 ' HG2' ' A' ' 221' ' ' GLN . 3.5 m -132.69 164.54 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.226 1.41 . . . . 0.0 109.856 -177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.546 ' HB3' HD13 ' A' ' 280' ' ' ILE . 15.0 ptm -112.28 139.11 48.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.635 0.774 . . . . 0.0 110.353 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.537 HD12 HG23 ' A' ' 271' ' ' ILE . 0.6 OUTLIER -142.69 157.28 44.83 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -89.37 112.23 23.29 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.195 0.598 . . . . 0.0 109.65 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.482 ' HH ' ' HB2' ' A' ' 239' ' ' TYR . 0.5 OUTLIER -159.89 149.69 18.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.692 0.797 . . . . 0.0 109.321 178.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -92.76 137.37 24.14 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 171.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.82 2.53 5.83 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.733 2.289 . . . . 0.0 113.66 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -96.77 -15.93 21.1 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.869 0.868 . . . . 0.0 110.726 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -160.08 90.48 1.79 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.606 0.762 . . . . 0.0 109.025 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.05 -5.19 15.8 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.067 2.511 . . . . 0.0 112.33 175.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.547 ' HA ' HD13 ' A' ' 272' ' ' ILE . 88.6 tttt -73.45 -28.29 61.88 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.772 0.829 . . . . 0.0 111.171 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -123.84 155.18 38.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.09 0.556 . . . . 0.0 110.263 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -68.75 174.3 4.45 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.263 1.025 . . . . 0.0 112.76 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -178.8 -105.03 0.19 Allowed Glycine 0 C--N 1.338 0.67 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.932 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -110.04 153.03 25.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 0.0 109.408 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . 0.428 ' HA ' ' O ' ' A' ' 225' ' ' LEU . 67.2 m95 -83.58 106.38 15.27 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 122.796 0.438 . . . . 0.0 110.074 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.482 ' HB2' ' HH ' ' A' ' 227' ' ' TYR . 84.3 m-85 -112.62 166.08 11.67 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . 0.482 ' HB2' HG12 ' A' ' 260' ' ' VAL . 3.8 m-20 -81.32 146.21 30.48 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.223 176.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -146.47 134.51 21.5 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -102.39 117.28 34.38 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 219' ' ' VAL . 31.8 mm -61.98 114.8 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 123.352 0.407 . . . . 0.0 110.377 -171.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 20.1 m -98.86 -25.01 14.76 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.463 0.705 . . . . 0.0 110.449 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 23.9 ttm180 -166.89 151.71 7.42 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.726 0.811 . . . . 0.0 109.381 -174.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -156.42 134.3 11.09 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.963 0.505 . . . . 0.0 110.388 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -146.51 116.38 7.27 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 8.9 pt-20 -100.16 152.18 20.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.194 0.521 . . . . 0.0 109.824 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 69.5 p -131.96 168.03 18.62 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -67.93 -15.98 63.86 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 117.829 0.286 . . . . 0.0 111.32 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.6 p -94.01 -29.87 15.0 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.843 0.857 . . . . 0.0 112.027 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -168.62 134.73 1.82 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 122.917 0.487 . . . . 0.0 111.528 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 46.9 mtt180 -90.79 106.88 18.82 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -95.95 143.55 27.03 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.301 0.64 . . . . 0.0 109.643 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 5.6 tt -150.0 149.84 30.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . 0.48 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 82.4 m-85 -134.72 124.84 25.89 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -134.54 147.88 50.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.11 0.564 . . . . 0.0 110.459 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 35.0 t30 -76.01 92.49 3.16 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 15.7 t -67.96 130.42 33.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.649 174.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 240' ' ' ASP . 4.3 p -122.47 114.26 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 40.4 mt -89.35 -155.63 0.36 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.221 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -81.3 -49.25 5.6 Favored Glycine 0 C--N 1.344 1.0 0 C-N-CA 121.932 -0.175 . . . . 0.0 112.722 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -104.99 -24.22 12.85 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.259 0.624 . . . . 0.0 111.988 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -139.57 175.66 9.38 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.97 0.508 . . . . 0.0 109.899 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 17.6 p -144.76 131.47 20.05 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.158 0.583 . . . . 0.0 111.315 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 14.7 mt -97.87 89.83 4.73 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.699 1.2 . . . . 0.0 109.38 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 18.4 t-20 -69.98 135.15 49.09 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.14 0.576 . . . . 0.0 111.44 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 57.18 29.7 17.1 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.532 1.133 . . . . 0.0 112.825 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 39.3 t -66.43 130.39 43.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.005 0.522 . . . . 0.0 109.968 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -69.58 131.22 44.33 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.032 0.444 . . . . 0.0 111.361 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.537 HG23 HD12 ' A' ' 225' ' ' LEU . 48.8 mm -108.24 114.44 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.838 1.255 . . . . 0.0 109.335 -175.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.547 HD13 ' HA ' ' A' ' 233' ' ' LYS . 11.9 mt -87.94 -21.96 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.579 0.752 . . . . 0.0 109.893 173.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.79 38.54 0.84 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.262 1.025 . . . . 0.0 111.461 -173.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 26.8 m -63.19 -21.33 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.543 0.737 . . . . 0.0 111.861 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.92 -27.62 14.19 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.895 1.278 . . . . 0.0 110.543 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -106.17 10.82 31.81 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.198 0.999 . . . . 0.0 111.434 -170.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.528 HG12 ' HB ' ' A' ' 212' ' ' ILE . 7.4 p -86.17 131.14 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.527 0.731 . . . . 0.0 109.515 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -101.27 164.21 11.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.478 1.111 . . . . 0.0 109.41 172.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.608 ' HB2' HD13 ' A' ' 212' ' ' ILE . 40.4 ttmt -83.76 142.32 30.77 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.153 0.581 . . . . 0.0 110.994 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 224' ' ' MET . 21.0 mm -84.04 117.47 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 165.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 208' ' ' ALA . 0.3 OUTLIER -83.63 106.34 15.27 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -97.65 92.35 1.3 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -15.33 90.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.474 1 C-N-CA 126.621 4.881 . . . . 0.0 117.037 -161.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.26 6.05 51.7 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.441 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -121.11 -23.06 5.9 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.438 0.695 . . . . 0.0 110.704 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -83.79 -126.88 1.31 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 174.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 23.0 m -127.81 142.36 44.02 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-N 117.62 0.71 . . . . 0.0 110.654 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.71 114.81 4.12 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.81 2.34 . . . . 0.0 111.036 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' MET . . . . . 0.581 ' SD ' ' HG3' ' A' ' 207' ' ' ARG . 26.5 ttt -73.94 92.76 2.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.564 0.697 . . . . 0.0 110.055 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 11.1 p -123.19 24.19 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 125.057 1.343 . . . . 0.0 108.687 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.09 -171.28 2.84 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.191 -165.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -47.2 141.71 6.06 Favored Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 125.048 1.339 . . . . 0.0 113.663 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.42 146.84 86.39 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.069 2.512 . . . . 0.0 112.582 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.4 mmt -82.39 -88.03 0.09 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.147 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 56.25 50.6 13.08 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -165.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -59.07 104.03 0.21 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.948 -1.933 . . . . 0.0 111.623 -170.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.575 ' HB3' ' HZ2' ' A' ' 297' ' ' LYS . 0.0 OUTLIER 58.54 26.28 14.15 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.13 0.972 . . . . 0.0 110.544 176.026 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 190' ' ' ASP . 78.4 p -89.52 163.3 15.28 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.204 0.601 . . . . 0.0 111.446 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -78.36 -177.45 48.37 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.579 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 CA--C 1.563 1.947 0 C-N-CA 123.143 2.562 . . . . 0.0 112.15 178.013 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.791 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 135' ' ' TYR . 0.0 OUTLIER -59.09 -32.78 70.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.351 0.66 . . . . 0.0 112.475 -177.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.444 ' N ' HD22 ' A' ' 134' ' ' LEU . 48.8 m-85 -79.62 152.16 30.18 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -114.94 176.83 4.89 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 109.134 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.0 m -71.67 -2.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.479 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -117.66 7.68 12.63 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.877 0.871 . . . . 0.0 111.38 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -86.48 90.92 8.38 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.898 0.479 . . . . 0.0 111.211 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 50.4 p90 -63.81 123.36 18.71 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.612 167.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.19 -170.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.597 0.759 . . . . 0.0 110.154 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.458 ' HB3' ' HB2' ' A' ' 205' ' ' ARG . 47.0 t0 -106.1 158.39 16.85 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 165.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -140.27 111.45 7.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.36 0.527 . . . . 0.0 109.586 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -70.77 93.71 0.98 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -62.03 132.48 53.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.696 1.198 . . . . 0.0 112.1 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.3 p -86.8 -14.11 43.16 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.092 0.957 . . . . 0.0 111.36 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.92 -53.82 7.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.064 0.546 . . . . 0.0 110.479 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 53.8 ttm -100.68 -36.25 9.19 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.437 0.695 . . . . 0.0 111.239 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.61 16.68 48.11 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.443 -172.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -103.96 150.58 24.09 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.768 0.827 . . . . 0.0 110.283 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.451 ' HZ3' ' HG3' ' A' ' 205' ' ' ARG . 18.5 m95 -83.05 118.61 23.65 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -124.06 112.35 17.04 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.127 0.571 . . . . 0.0 109.648 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.635 ' HB2' ' HD2' ' A' ' 295' ' ' ARG . 5.6 pt-20 -58.48 128.96 39.78 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.701 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.437 ' HA ' ' H ' ' A' ' 189' ' ' ASP . . . -144.1 -175.72 4.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.218 1.007 . . . . 0.0 111.136 -168.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.6 tt0 -140.25 125.49 18.76 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.038 0.535 . . . . 0.0 109.906 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.9 t -62.13 115.48 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 124.026 0.93 . . . . 0.0 108.921 169.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.532 HG13 ' HE2' ' A' ' 187' ' ' LYS . 35.5 m -116.99 -3.48 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.238 0.615 . . . . 0.0 112.007 -178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 29.2 ttm180 -162.4 139.39 8.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.186 0.594 . . . . 0.0 109.488 173.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.436 HG11 ' O ' ' A' ' 135' ' ' TYR . 11.6 m -119.2 134.4 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.419 0.688 . . . . 0.0 109.693 176.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.541 HG21 ' HB ' ' A' ' 183' ' ' ILE . 3.2 t -147.09 161.51 40.71 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.885 0.874 . . . . 0.0 109.907 175.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -115.97 149.96 37.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.949 0.9 . . . . 0.0 110.145 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.44 81.15 0.56 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.758 0.823 . . . . 0.0 109.358 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -166.69 159.55 11.52 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 124.392 1.077 . . . . 0.0 109.014 -171.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -54.33 -31.76 68.84 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.333 2.022 . . . . 0.0 112.07 167.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.8 m -77.65 134.44 38.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.491 0.717 . . . . 0.0 110.144 169.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.17 53.62 2.72 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.467 0.707 . . . . 0.0 110.206 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.3 t70 63.06 86.25 0.12 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.86 1.264 . . . . 0.0 109.249 -169.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -133.52 144.84 53.86 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.414 1.086 . . . . 0.0 109.181 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -42.19 110.6 0.15 Allowed 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 124.236 3.291 . . . . 0.0 114.438 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 26.9 p -159.51 -27.89 0.07 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.045 0.938 . . . . 0.0 110.277 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.0 m -105.42 19.05 21.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.288 1.035 . . . . 0.0 111.147 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 37.8 m -63.48 -36.99 85.59 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.695 0.798 . . . . 0.0 112.029 -174.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 61.6 p -115.79 114.93 25.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.911 0.884 . . . . 0.0 108.749 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.2 t 71.85 167.16 0.31 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.67 1.588 . . . . 0.0 111.24 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 38.33 91.82 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 C-N-CA 126.254 1.822 . . . . 0.0 113.878 -172.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.2 0.88 9.29 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.122 2.548 . . . . 0.0 113.627 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 69.46 91.59 0.09 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 124.727 1.211 . . . . 0.0 110.73 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 63.8 mt -78.03 128.68 34.23 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 62.66 81.07 0.21 Allowed 'General case' 0 N--CA 1.48 1.07 0 O-C-N 124.652 1.22 . . . . 0.0 109.828 -169.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.96 83.49 2.85 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.195 0.598 . . . . 0.0 109.6 -173.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 200' ' ' ASN . 5.9 m-20 -80.34 63.19 4.73 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.118 0.961 . . . . 0.0 109.364 171.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 34.7 m -105.54 159.27 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.641 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.541 ' HB ' HG21 ' A' ' 160' ' ' THR . 2.3 mp -93.18 108.97 21.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.979 0.895 . . . . 0.0 108.99 -173.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -92.54 108.3 19.87 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.518 167.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 33.2 m-70 -77.05 100.09 5.55 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.93 142.81 20.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 123.811 0.694 . . . . 0.0 109.223 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.57 ' HG2' HG21 ' A' ' 196' ' ' VAL . 42.9 mtmt -103.59 121.62 43.29 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 170.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -60.7 108.51 0.85 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.437 ' H ' ' HA ' ' A' ' 154' ' ' ALA . 20.9 t70 -57.75 -42.13 83.33 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.905 0.882 . . . . 0.0 110.737 -173.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.94 -19.0 32.84 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.98 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -133.77 64.72 68.52 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 122.907 0.483 . . . . 0.0 110.607 -177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.0 -11.77 32.68 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.635 2.223 . . . . 0.0 112.559 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.85 -30.64 70.08 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.899 0.88 . . . . 0.0 111.229 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -72.24 -16.76 61.94 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.376 0.67 . . . . 0.0 110.512 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 87.31 -166.33 36.46 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.811 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.57 HG21 ' HG2' ' A' ' 187' ' ' LYS . 6.5 t -93.04 125.24 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.65 157.01 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.782 0.833 . . . . 0.0 110.68 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.55 114.59 28.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.582 1.153 . . . . 0.0 109.192 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.516 ' HE1' ' HB3' ' A' ' 203' ' ' ASP . 77.3 mmm -126.94 138.89 53.35 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.449 0.7 . . . . 0.0 110.065 -173.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 20.6 m-80 -83.18 173.41 11.69 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.307 0.643 . . . . 0.0 109.865 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 29.8 t -56.15 -43.99 78.81 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.567 0.747 . . . . 0.0 111.813 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -54.04 -33.83 58.39 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.548 1.139 . . . . 0.0 111.947 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.516 ' HB3' ' HE1' ' A' ' 199' ' ' MET . 50.3 m-20 -88.28 -33.26 18.11 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.998 0.919 . . . . 0.0 111.661 -172.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 10.3 m -92.72 117.1 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 122.275 1.036 . . . . 0.0 108.483 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.458 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 22.3 mmm180 -109.66 168.65 9.25 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.836 -165.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.579 ' HA ' ' NH2' ' A' ' 207' ' ' ARG . . . -88.93 144.73 25.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.907 172.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.579 ' NH2' ' HA ' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -80.06 93.25 5.74 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.9 97.08 0.21 Allowed 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.437 ' H ' ' NE ' ' A' ' 209' ' ' ARG . 0.0 OUTLIER -76.75 71.13 3.3 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.639 1.209 . . . . 0.0 110.141 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.9 m -146.09 110.38 5.03 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.937 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 28.7 mt -83.35 134.23 27.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.453 HD13 ' HB2' ' A' ' 279' ' ' LYS . 42.6 mm -82.51 139.41 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.308 0.575 . . . . 0.0 110.951 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -124.41 160.03 29.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.12 1.368 . . . . 0.0 109.392 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.565 ' HA ' HD23 ' A' ' 217' ' ' LEU . 31.9 t90 -56.2 -40.48 74.08 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.756 0.823 . . . . 0.0 112.323 -169.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -56.79 -41.77 78.29 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.663 0.785 . . . . 0.0 110.98 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.98 -21.27 51.18 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.881 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.565 HD23 ' HA ' ' A' ' 214' ' ' TRP . 2.4 mm? -63.02 115.37 4.36 Favored 'General case' 0 C--N 1.364 1.205 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -143.98 148.93 35.98 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.49 0.716 . . . . 0.0 109.556 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.38 135.02 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 122.781 0.433 . . . . 0.0 110.726 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.64 -9.44 77.0 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.633 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.467 ' HG2' HG12 ' A' ' 223' ' ' VAL . 29.7 tt0 -85.77 122.48 29.91 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.975 0.51 . . . . 0.0 110.445 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 72.8 t -93.66 114.47 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.467 HG12 ' HG2' ' A' ' 221' ' ' GLN . 13.1 m -126.91 160.27 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.957 0.903 . . . . 0.0 109.237 176.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 238' ' ' TRP . 44.0 ttp -95.16 111.56 23.37 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.869 0.467 . . . . 0.0 110.604 -176.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.545 HD22 HG13 ' A' ' 271' ' ' ILE . 0.8 OUTLIER -111.24 155.62 22.69 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.62 0.768 . . . . 0.0 109.143 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.459 HD21 ' NE ' ' A' ' 235' ' ' ARG . 9.1 p-10 -97.57 121.27 39.28 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.219 1.008 . . . . 0.0 111.009 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.554 ' HB2' ' HA ' ' A' ' 232' ' ' PRO . 6.9 p90 -168.15 155.89 8.37 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.334 1.053 . . . . 0.0 109.801 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -83.27 137.09 42.67 Favored Pre-proline 0 CA--C 1.555 1.157 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 171.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.75 -28.43 68.41 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.0 1.8 . . . . 0.0 111.917 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.64 -30.27 36.65 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.553 0.741 . . . . 0.0 110.918 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -140.81 90.34 9.66 Favored Pre-proline 0 N--CA 1.489 1.51 0 C-N-CA 123.692 0.797 . . . . 0.0 110.174 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . 0.554 ' HA ' ' HB2' ' A' ' 227' ' ' TYR . 38.8 Cg_endo -66.05 -8.24 19.47 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.453 2.102 . . . . 0.0 112.16 170.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.402 ' O ' HD13 ' A' ' 272' ' ' ILE . 21.3 tptm -74.18 -26.78 60.48 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.607 1.163 . . . . 0.0 110.967 173.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -117.19 147.14 42.74 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.332 0.653 . . . . 0.0 110.877 -172.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.459 ' NE ' HD21 ' A' ' 226' ' ' ASN . 3.3 tmt_? -69.0 117.29 10.47 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.656 1.582 . . . . 0.0 109.764 -176.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -134.26 -130.66 3.03 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 123.31 0.381 . . . . 0.0 112.427 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.419 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 42.0 m-85 -83.92 171.23 13.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.675 0.79 . . . . 0.0 110.819 -173.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . 0.538 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 97.6 m95 -91.38 112.38 24.26 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.254 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 68.3 m-85 -126.09 149.12 49.14 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 174.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.5 p-10 -82.44 157.11 23.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.488 ' HA ' HG21 ' A' ' 260' ' ' VAL . . . -162.93 140.76 8.07 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.216 0.606 . . . . 0.0 110.663 -176.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -90.51 118.6 30.1 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.144 0.578 . . . . 0.0 109.885 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.443 HD11 HD13 ' A' ' 255' ' ' LEU . 32.1 mm -62.8 126.36 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.38 0.672 . . . . 0.0 110.413 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.6 t -105.62 -38.47 6.41 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.466 1.106 . . . . 0.0 111.214 -174.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.55 143.25 11.53 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -135.71 143.48 45.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -155.33 114.94 3.67 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -100.13 121.6 41.67 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.8 p -84.64 -170.97 3.37 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 170.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -67.12 -34.63 78.01 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.01 23.79 3.89 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 120.696 0.284 . . . . 0.0 111.232 -171.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -159.35 129.07 5.52 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.261 0.625 . . . . 0.0 110.658 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.469 ' HD2' HG21 ' A' ' 274' ' ' VAL . 36.5 ttm180 -99.58 102.27 13.73 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.2 139.79 30.27 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.443 HD13 HD11 ' A' ' 243' ' ' ILE . 3.3 tm? -147.41 140.31 24.99 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -176.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -122.3 119.69 31.87 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.315 1.046 . . . . 0.0 108.538 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.77 137.15 54.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.81 0.844 . . . . 0.0 110.254 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -81.63 98.29 8.29 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.704 1.202 . . . . 0.0 108.34 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 58.9 t -63.31 134.16 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.857 0.863 . . . . 0.0 110.915 -173.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.488 HG21 ' HA ' ' A' ' 241' ' ' ALA . 38.4 t -117.26 107.05 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.33 -151.45 0.26 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.235 1.014 . . . . 0.0 110.078 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -55.11 -71.83 0.66 Allowed Glycine 0 C--N 1.355 1.629 0 C-N-CA 123.066 0.365 . . . . 0.0 113.779 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -123.34 -16.66 6.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.477 0.711 . . . . 0.0 110.302 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -87.59 174.49 8.42 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.782 0.833 . . . . 0.0 111.006 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 65.8 p -153.43 138.3 17.13 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.181 0.593 . . . . 0.0 110.666 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 20.9 mt -108.72 90.91 3.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.991 0.916 . . . . 0.0 108.636 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -67.32 143.69 56.27 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 117.945 0.338 . . . . 0.0 111.113 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 33.1 t70 58.75 75.8 0.38 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.513 1.125 . . . . 0.0 111.748 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 68.8 m -113.48 126.32 55.2 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.413 0.685 . . . . 0.0 109.298 170.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -71.43 113.27 8.29 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.545 HG13 HD22 ' A' ' 225' ' ' LEU . 39.9 mm -94.3 123.58 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.962 0.505 . . . . 0.0 109.844 -174.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.402 HD13 ' O ' ' A' ' 233' ' ' LYS . 59.4 mt -83.76 -36.38 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.221 1.008 . . . . 0.0 110.5 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -96.14 51.15 1.2 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 122.262 1.03 . . . . 0.0 110.574 -167.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . 0.469 HG21 ' HD2' ' A' ' 253' ' ' ARG . 23.9 m -72.14 -16.69 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.696 -1.593 . . . . 0.0 113.292 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.72 -15.07 33.32 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.936 0.494 . . . . 0.0 110.982 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -96.93 4.55 51.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.369 0.668 . . . . 0.0 111.634 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.409 HG12 ' HG ' ' A' ' 225' ' ' LEU . 43.4 t -76.4 146.15 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.36 0.664 . . . . 0.0 111.455 -175.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -126.65 160.16 31.52 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.045 0.938 . . . . 0.0 109.859 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.453 ' HB2' HD13 ' A' ' 212' ' ' ILE . 22.4 ttmm -84.87 149.21 25.84 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.306 0.643 . . . . 0.0 111.77 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.44 HD13 ' HB2' ' A' ' 224' ' ' MET . 50.2 mm -92.29 126.78 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 169.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 105.36 13.55 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.334 0.653 . . . . 0.0 110.559 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -93.18 146.06 31.22 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 123.777 0.831 . . . . 0.0 111.153 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -41.94 119.17 1.11 Allowed 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 124.525 3.484 . . . . 0.0 115.005 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 97.0 -51.88 1.44 Allowed Glycine 0 C--N 1.352 1.425 0 O-C-N 123.333 0.396 . . . . 0.0 112.205 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -71.73 -22.85 61.57 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.663 1.185 . . . . 0.0 110.47 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -77.38 78.39 1.46 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.9 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 14.8 m -71.24 146.97 92.92 Favored Pre-proline 0 C--O 1.246 0.896 0 C-N-CA 123.424 0.69 . . . . 0.0 109.911 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.25 157.03 62.89 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.744 2.296 . . . . 0.0 111.245 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' MET . . . . . 0.523 ' HE2' ' HA ' ' A' ' 293' ' ' PRO . 21.0 ttt -83.25 78.18 9.66 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.724 0.774 . . . . 0.0 109.393 -175.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 10.6 p -92.83 -28.43 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.372 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -74.81 162.33 28.76 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.012 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.45 140.5 13.5 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 124.703 1.201 . . . . 0.0 113.539 -167.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.523 ' HA ' ' HE2' ' A' ' 289' ' ' MET . 26.7 Cg_exo -62.12 109.63 0.86 Allowed 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.257 2.638 . . . . 0.0 112.922 -176.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -140.04 143.42 36.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.707 0.803 . . . . 0.0 109.891 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.635 ' HD2' ' HB2' ' A' ' 153' ' ' GLU . 49.4 mtm180 -129.91 -163.43 1.3 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -18.5 26.93 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.247 0.476 . . . . 0.0 110.738 -173.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -131.33 48.44 2.42 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 122.481 1.134 . . . . 0.0 109.398 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.7 p -76.32 96.3 3.95 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 164.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -76.07 -134.36 0.5 Allowed Glycine 0 CA--C 1.534 1.266 0 CA-C-O 119.043 -0.865 . . . . 0.0 113.711 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo . . . . . 0 C--N 1.374 1.875 0 C-N-CA 123.362 2.708 . . . . 0.0 112.63 177.154 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.4 ' HA3' ' CE1' ' A' ' 184' ' ' TYR . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 112.238 -0.345 . . . . 0.0 112.238 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.18 -10.04 14.66 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.262 1.025 . . . . 0.0 111.153 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -79.27 121.12 24.69 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -82.08 178.94 8.0 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.93 0.892 . . . . 0.0 111.407 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.14 29.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.708 1.203 . . . . 0.0 112.985 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -140.18 -50.39 0.47 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.528 1.131 . . . . 0.0 109.176 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -68.99 88.91 0.41 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.742 0.417 . . . . 0.0 111.268 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.4 ' HB3' ' OE1' ' A' ' 155' ' ' GLN . 22.1 p90 -75.35 138.35 41.7 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.341 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 206' ' ' ALA . 17.4 m -123.89 158.87 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.172 1.389 . . . . 0.0 109.854 -172.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -93.04 109.78 21.24 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.519 ' HB1' ' HE1' ' A' ' 199' ' ' MET . . . -93.74 120.46 34.03 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.69 0.796 . . . . 0.0 111.396 -168.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -72.78 98.86 2.49 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.658 0.783 . . . . 0.0 110.085 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.78 110.34 10.13 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.4 m -66.04 -27.53 68.17 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.032 0.933 . . . . 0.0 112.049 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -62.12 -50.68 70.94 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.973 0.509 . . . . 0.0 111.688 -171.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -102.27 -18.76 15.32 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 122.304 0.242 . . . . 0.0 111.64 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.44 50.63 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.237 0.336 . . . . 0.0 113.628 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.66 152.06 20.9 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.531 0.681 . . . . 0.0 112.554 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -80.06 120.89 24.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.159 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -127.3 115.84 19.62 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -62.27 137.71 58.3 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.621 0.575 . . . . 0.0 109.678 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -148.31 129.17 14.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.037 0.535 . . . . 0.0 111.384 -165.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.4 ' OE1' ' HB3' ' A' ' 140' ' ' TYR . 49.7 tp60 -87.29 114.54 23.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.492 0.717 . . . . 0.0 109.705 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.459 ' HA ' HG11 ' A' ' 186' ' ' VAL . 58.6 t -66.96 116.06 5.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.537 HG11 ' HE2' ' A' ' 187' ' ' LYS . 33.5 m -117.73 -9.4 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.171 0.588 . . . . 0.0 111.534 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.566 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 2.5 tpm_? -166.82 147.03 5.74 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.46 136.89 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 124.113 0.965 . . . . 0.0 109.655 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 10.2 t -148.77 163.33 37.68 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.323 1.049 . . . . 0.0 109.68 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.529 HH22 ' HG3' ' A' ' 176' ' ' PRO . 59.6 mtt-85 -122.77 170.4 10.11 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -172.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -82.03 -22.03 36.66 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.002 173.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.86 159.94 59.03 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.018 0.927 . . . . 0.0 110.257 167.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.96 81.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.212 2.608 . . . . 0.0 112.55 172.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 73.9 m -160.49 91.31 0.91 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.283 1.433 . . . . 0.0 108.246 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 23.3 tpp180 -68.81 -34.68 75.91 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.549 0.74 . . . . 0.0 110.039 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -133.6 112.62 11.61 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -88.8 115.73 64.32 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-O 119.004 -0.522 . . . . 0.0 109.688 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.25 -60.86 0.15 Allowed 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.223 1.948 . . . . 0.0 111.602 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 28.7 p -168.17 33.63 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.401 0.68 . . . . 0.0 110.489 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.1 m -63.8 -10.86 22.42 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.765 0.826 . . . . 0.0 113.117 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 41.1 m -81.2 2.11 29.16 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.619 0.768 . . . . 0.0 112.7 176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.0 t -73.75 106.53 5.53 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-O 121.017 0.437 . . . . 0.0 110.113 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.7 m 67.24 -2.71 1.16 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 169.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -86.57 -46.24 0.55 Allowed Pre-proline 0 N--CA 1.484 1.236 0 CA-C-N 119.076 0.853 . . . . 0.0 110.472 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.529 ' HG3' HH22 ' A' ' 161' ' ' ARG . 23.9 Cg_endo -95.97 174.99 0.9 Allowed 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.478 2.119 . . . . 0.0 111.297 159.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -174.88 24.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.114 0.565 . . . . 0.0 111.88 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.55 -86.6 0.52 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -175.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -143.73 98.47 3.24 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 173.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -67.61 85.76 0.19 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.815 0.697 . . . . 0.0 109.909 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -79.56 65.41 4.72 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 122.677 1.227 . . . . 0.0 108.202 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.64 177.35 3.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.838 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.547 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.3 mp -95.58 108.63 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.599 0.714 . . . . 0.0 109.342 -171.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.4 ' CE1' ' HA3' ' A' ' 133' ' ' GLY . 95.1 m-85 -97.59 107.2 19.65 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.857 1.263 . . . . 0.0 107.834 170.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.566 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 89.0 m-70 -78.77 102.5 8.16 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' A' ' 156' ' ' VAL . 20.9 m -114.92 150.9 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.125 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.537 ' HE2' HG11 ' A' ' 157' ' ' VAL . 45.0 mtmt -117.87 122.83 44.36 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -61.61 109.5 1.22 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.104 0.562 . . . . 0.0 111.329 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.3 -35.58 74.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -63.36 -34.73 78.35 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.815 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -155.02 82.07 4.07 Favored Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 124.655 1.182 . . . . 0.0 109.287 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.47 ' HG3' ' HD3' ' A' ' 300' ' ' PRO . 26.4 Cg_exo -65.29 -27.34 55.8 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.807 3.005 . . . . 0.0 114.133 -173.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.52 -1.96 17.89 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -75.13 -14.77 60.59 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.837 0.855 . . . . 0.0 111.436 171.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.86 -175.81 54.22 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.439 -0.346 . . . . 0.0 112.571 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.48 116.54 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.95 144.41 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.746 0.818 . . . . 0.0 109.144 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.547 ' HB2' HG23 ' A' ' 183' ' ' ILE . 28.9 pt20 -96.16 132.46 41.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.519 ' HE1' ' HB1' ' A' ' 143' ' ' ALA . 86.3 mmm -132.71 160.76 35.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.858 0.863 . . . . 0.0 109.193 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -110.88 175.1 5.55 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.882 0.473 . . . . 0.0 109.751 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 70.1 p -57.58 -45.87 84.69 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.673 0.789 . . . . 0.0 111.04 176.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -66.93 -8.49 29.91 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.082 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.494 ' HB3' ' HE3' ' A' ' 199' ' ' MET . 41.8 m-20 -97.31 -41.06 8.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.661 0.785 . . . . 0.0 110.87 173.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.59 132.91 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 112.773 0.656 . . . . 0.0 112.773 -169.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.601 ' HB3' ' HB3' ' A' ' 281' ' ' GLU . 39.5 mmt180 -112.29 155.72 23.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.827 1.251 . . . . 0.0 107.861 167.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.403 ' HA ' HG13 ' A' ' 141' ' ' VAL . . . -63.76 167.33 6.05 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.251 0.478 . . . . 0.0 110.87 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.67 95.82 6.7 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.25 97.86 0.13 Allowed 'General case' 0 C--N 1.36 1.023 0 C-N-CA 123.164 0.586 . . . . 0.0 109.841 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.449 ' NH2' ' HB2' ' A' ' 292' ' ' ASN . 3.5 tmt_? -84.45 76.52 10.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -172.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 73.1 m -147.19 119.06 8.11 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.062 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.508 HD12 ' HE1' ' A' ' 294' ' ' MET . 58.8 mt -85.05 126.75 40.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.546 HD13 ' HB2' ' A' ' 279' ' ' LYS . 38.4 mm -96.12 127.91 47.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 124.015 0.926 . . . . 0.0 108.636 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.443 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 0.0 OUTLIER -111.71 179.14 4.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.119 0.967 . . . . 0.0 109.168 -177.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.495 ' HZ3' HG11 ' A' ' 274' ' ' VAL . 59.6 t-105 -60.42 -43.15 97.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.284 0.634 . . . . 0.0 110.899 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . 0.45 ' HA ' HE21 ' A' ' 215' ' ' GLN . 0.0 OUTLIER -62.1 -27.38 68.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.042 0.937 . . . . 0.0 111.888 177.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -90.03 -22.48 21.84 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.898 0.479 . . . . 0.0 110.894 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 214' ' ' TRP . 85.7 mt -67.77 112.6 4.94 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -138.29 151.1 47.28 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.607 0.763 . . . . 0.0 109.632 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.9 m -68.87 123.98 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.045 0.538 . . . . 0.0 111.565 -171.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.56 -15.75 49.1 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.732 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.418 ' HG2' HG11 ' A' ' 223' ' ' VAL . 29.5 tt0 -79.67 121.39 25.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.941 0.496 . . . . 0.0 109.979 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 45.8 t -93.07 120.21 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.418 HG11 ' HG2' ' A' ' 221' ' ' GLN . 13.2 m -141.01 148.66 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.32 1.048 . . . . 0.0 110.541 -175.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 20.5 ptm -89.82 136.22 33.16 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.273 0.629 . . . . 0.0 110.847 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.53 ' HB3' HG21 ' A' ' 277' ' ' VAL . 0.7 OUTLIER -144.7 144.1 31.05 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.046 0.939 . . . . 0.0 110.4 -174.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.402 ' HB3' ' CE2' ' A' ' 238' ' ' TRP . 10.5 p-10 -71.17 106.01 3.62 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.349 0.66 . . . . 0.0 109.837 174.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -135.31 132.13 37.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.467 HD21 ' HB2' ' A' ' 231' ' ' ASN . 61.1 t30 -105.41 114.89 62.8 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -62.92 -33.77 73.78 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.82 2.347 . . . . 0.0 111.756 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.26 -36.38 82.85 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.053 0.941 . . . . 0.0 111.213 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.467 ' HB2' HD21 ' A' ' 228' ' ' ASN . 38.4 m-80 -143.97 87.32 8.07 Favored Pre-proline 0 N--CA 1.487 1.413 0 C-N-CA 123.793 0.837 . . . . 0.0 109.382 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.86 -9.87 27.52 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.399 2.733 . . . . 0.0 115.104 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -82.83 -27.7 30.69 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.031 0.532 . . . . 0.0 110.984 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -120.95 154.63 35.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.512 0.725 . . . . 0.0 110.257 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -49.14 154.15 0.84 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.006 1.322 . . . . 0.0 113.053 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.61 -148.17 4.9 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.16 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -83.86 148.82 26.76 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.259 1.023 . . . . 0.0 109.699 -174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . 0.453 ' CE2' ' HD2' ' A' ' 296' ' ' ARG . 67.1 m95 -84.3 107.24 16.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.013 0.525 . . . . 0.0 110.54 -171.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -114.52 151.9 32.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.3 p-10 -83.93 146.2 28.16 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 172.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -146.26 137.17 24.33 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.581 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -91.11 119.48 31.28 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 29.8 mm -60.41 107.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 124.051 0.844 . . . . 0.0 109.388 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.6 t -82.89 -47.66 11.58 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.45 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 65.9 mtt85 -152.86 164.76 37.26 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 125.345 1.458 . . . . 0.0 109.649 -172.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -151.27 136.78 17.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.804 0.441 . . . . 0.0 110.745 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -150.82 115.49 5.2 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.812 0.845 . . . . 0.0 109.439 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -91.74 153.77 19.4 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 68.7 p -130.15 174.88 9.39 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.948 0.899 . . . . 0.0 108.871 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -65.62 -18.65 65.48 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.528 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 26.5 p -103.99 -31.54 9.67 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 123.426 0.691 . . . . 0.0 112.788 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.23 157.28 6.2 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.23 0.538 . . . . 0.0 112.292 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 253' ' ' ARG . 4.3 mpt_? -94.91 101.68 13.48 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -97.81 102.21 13.91 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.124 0.57 . . . . 0.0 110.736 -173.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 270' ' ' ARG . 3.4 tm? -95.18 143.65 26.43 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . 0.45 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 81.2 m-85 -123.03 116.42 23.5 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.23 144.8 31.68 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.984 0.513 . . . . 0.0 110.421 -174.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -81.55 96.87 7.58 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 92.6 t -81.06 107.23 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.699 1.2 . . . . 0.0 109.619 -176.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 16.9 m -89.11 129.8 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.52 0.676 . . . . 0.0 110.361 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 63.9 mt -93.95 -154.87 0.43 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.814 1.246 . . . . 0.0 108.888 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -64.68 -54.45 28.6 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 122.959 0.162 . . . . 0.0 113.122 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -115.95 -46.27 2.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.463 0.705 . . . . 0.0 110.283 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.68 151.01 37.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.819 0.848 . . . . 0.0 111.424 -173.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 15.5 p -120.3 113.63 20.67 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.863 0.865 . . . . 0.0 109.319 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.647 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 81.5 mt -82.27 102.45 11.18 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.232 1.013 . . . . 0.0 109.86 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -75.02 123.8 25.83 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.102 0.561 . . . . 0.0 112.073 -173.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 54.8 46.59 24.21 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.755 1.222 . . . . 0.0 113.128 169.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 81.6 m -67.96 133.1 48.5 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 122.396 0.278 . . . . 0.0 111.184 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 45.1 ttp180 -70.26 107.29 3.67 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.722 0.638 . . . . 0.0 109.8 173.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 40.7 mm -95.86 111.3 25.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 82.9 mt -84.76 -13.5 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 124.623 1.169 . . . . 0.0 109.884 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -99.86 39.52 1.32 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.352 1.461 . . . . 0.0 110.072 -161.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . 0.495 HG11 ' HZ3' ' A' ' 214' ' ' TRP . 28.8 m -71.74 -13.74 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 114.553 -1.203 . . . . 0.0 113.29 -167.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -86.87 -27.52 23.39 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.295 0.638 . . . . 0.0 110.996 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -93.26 1.26 57.1 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.694 0.797 . . . . 0.0 112.128 -174.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.53 HG21 ' HB3' ' A' ' 225' ' ' LEU . 59.2 t -71.12 139.35 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.198 0.599 . . . . 0.0 110.397 -174.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -120.37 160.92 22.08 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.216 1.007 . . . . 0.0 109.93 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.546 ' HB2' HD13 ' A' ' 212' ' ' ILE . 35.8 ttmt -79.66 151.34 30.58 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.715 0.406 . . . . 0.0 111.184 176.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.9 mm -77.54 132.79 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.8 0.84 . . . . 0.0 109.676 172.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 205' ' ' ARG . 1.0 OUTLIER -79.99 105.85 11.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 59.4 mtp85 -120.19 149.76 50.01 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.907 1.283 . . . . 0.0 109.445 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.93 98.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.413 2.742 . . . . 0.0 113.856 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 86.74 -3.96 86.61 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.494 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -119.4 -23.14 6.77 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.734 0.767 . . . . 0.0 111.827 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -92.89 100.6 2.68 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 175.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 11.6 p -64.45 130.29 94.6 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.003 0.521 . . . . 0.0 111.919 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.37 164.47 34.02 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.104 2.536 . . . . 0.0 111.676 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' MET . . . . . 0.485 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 44.1 ttm -80.31 85.44 5.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.669 0.747 . . . . 0.0 109.968 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.85 -29.41 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.9 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -85.89 -158.5 0.4 Allowed 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.828 0.851 . . . . 0.0 109.431 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.449 ' HB2' ' NH2' ' A' ' 209' ' ' ARG . 13.3 m120 -58.93 116.87 17.19 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.851 0.86 . . . . 0.0 110.866 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.485 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 25.1 Cg_exo -64.28 112.33 1.87 Allowed 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 123.263 2.642 . . . . 0.0 112.568 -175.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.508 ' HE1' HD12 ' A' ' 211' ' ' ILE . 22.2 ptm -117.63 129.87 56.02 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.729 0.812 . . . . 0.0 110.105 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -97.27 174.5 6.68 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.319 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.453 ' HD2' ' CE2' ' A' ' 238' ' ' TRP . 0.3 OUTLIER -60.37 -50.57 73.08 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.096 173.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.64 -161.69 1.4 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.469 1.508 . . . . 0.0 108.221 173.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 41.1 m -110.14 79.67 1.23 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.0 -96.8 0.7 Allowed Glycine 0 CA--C 1.537 1.412 0 CA-C-N 115.216 -0.902 . . . . 0.0 113.022 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.47 ' HD3' ' HG3' ' A' ' 192' ' ' PRO . 58.9 Cg_endo . . . . . 0 C--N 1.374 1.896 0 C-N-CA 123.107 2.538 . . . . 0.0 112.182 -175.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.986 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.516 ' HB3' ' HD3' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -131.28 4.05 4.34 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.433 0.693 . . . . 0.0 111.683 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -78.94 159.32 27.76 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.253 0.549 . . . . 0.0 110.289 172.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.448 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -86.19 172.55 10.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.151 0.98 . . . . 0.0 110.814 -174.46 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.5 m -83.62 6.26 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.272 1.029 . . . . 0.0 112.257 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -127.84 8.4 6.27 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.581 0.753 . . . . 0.0 111.175 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 156' ' ' VAL . 19.6 mm-40 -80.9 74.13 7.89 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.888 0.475 . . . . 0.0 111.864 -173.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 8.7 p90 -77.69 98.8 5.6 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.524 0.678 . . . . 0.0 109.434 168.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.521 ' HA ' ' HD2' ' A' ' 207' ' ' ARG . 27.4 m -115.98 179.51 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.141 1.376 . . . . 0.0 108.772 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.16 109.72 21.22 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -92.9 122.95 35.79 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.805 0.842 . . . . 0.0 110.057 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -71.3 110.42 5.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.69 136.06 57.85 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.064 0.946 . . . . 0.0 110.249 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.5 p -74.26 -28.69 61.33 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.685 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.8 -55.5 4.77 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 120.926 0.393 . . . . 0.0 111.502 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.5 ttp -104.5 -18.16 14.47 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.71 0.804 . . . . 0.0 112.472 -170.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.95 18.24 70.36 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 113.981 0.352 . . . . 0.0 113.981 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -94.08 140.66 29.46 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.993 0.517 . . . . 0.0 111.172 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -75.31 119.94 20.1 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -115.22 148.65 38.84 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.47 ' HG2' HH22 ' A' ' 207' ' ' ARG . 8.1 mt-10 -76.84 89.03 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.97 116.95 30.09 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.626 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 53.8 tt0 -89.57 102.67 15.35 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.084 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 59.8 t -57.88 96.35 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 167.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.2 m -95.41 -13.85 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.443 0.697 . . . . 0.0 110.864 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.538 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 50.3 ttt85 -163.53 135.62 5.06 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.62 139.66 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.0 p -133.43 159.3 40.76 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 123.827 0.851 . . . . 0.0 108.713 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -96.43 175.57 6.36 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.622 0.769 . . . . 0.0 110.222 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.512 ' HG3' HG13 ' A' ' 182' ' ' VAL . 7.7 mtpm? -86.1 58.3 4.97 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.979 0.895 . . . . 0.0 109.847 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -157.88 139.55 9.93 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 124.469 1.108 . . . . 0.0 108.818 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -59.68 96.52 0.1 OUTLIER 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.977 2.452 . . . . 0.0 112.126 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.6 m -140.05 -55.13 0.54 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.082 0.953 . . . . 0.0 109.839 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 77.63 -32.38 0.17 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 126.049 1.74 . . . . 0.0 112.976 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.511 ' HA ' ' NH2' ' A' ' 158' ' ' ARG . 3.5 p30 -72.9 178.14 4.45 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.493 0.717 . . . . 0.0 111.223 171.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -77.22 144.91 72.0 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 122.774 0.43 . . . . 0.0 110.142 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.51 77.65 1.33 Allowed 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.03 2.486 . . . . 0.0 112.491 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 38.8 t -102.36 -30.25 11.16 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.121 0.568 . . . . 0.0 110.417 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 28.2 m -103.77 21.81 15.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.293 1.037 . . . . 0.0 110.421 175.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.1 t -77.32 -5.37 49.27 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.89 0.876 . . . . 0.0 112.618 -173.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.1 m 74.01 -65.79 0.33 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.638 1.575 . . . . 0.0 110.619 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 26.2 m -132.28 121.66 23.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.06 0.944 . . . . 0.0 109.26 175.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.516 ' HD3' ' HB3' ' A' ' 134' ' ' LEU . 91.8 mtt180 -79.06 119.23 76.46 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.16 86.24 1.56 Allowed 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.543 2.162 . . . . 0.0 112.014 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -74.61 82.13 2.02 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 168.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -152.2 48.12 0.77 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -167.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 62.11 75.04 0.42 Allowed 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.955 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.664 ' HB3' HG21 ' A' ' 182' ' ' VAL . 2.8 mp0 -69.12 99.01 1.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.688 -162.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.06 20.71 1.49 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.26 165.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.664 HG21 ' HB3' ' A' ' 180' ' ' GLU . 12.5 m -73.6 175.0 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 164.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 183' ' ' ILE . 3.1 mp -95.56 110.93 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 O-C-N 121.882 -0.512 . . . . 0.0 110.22 -165.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -95.62 106.49 18.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.003 0.921 . . . . 0.0 108.65 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 14.0 m-70 -79.79 96.55 6.32 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 13.3 m -109.01 157.73 9.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.475 0.71 . . . . 0.0 109.55 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -130.16 117.82 20.5 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -67.38 116.22 7.9 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.903 0.481 . . . . 0.0 110.638 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 153' ' ' GLU . 34.3 t70 -67.04 -27.1 67.12 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.368 1.067 . . . . 0.0 109.876 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.12 -29.54 62.97 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.929 0.892 . . . . 0.0 111.566 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -141.57 75.31 22.35 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.775 0.83 . . . . 0.0 110.494 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.42 -15.43 49.74 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.942 2.428 . . . . 0.0 112.455 171.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.5 -26.56 67.23 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.997 0.919 . . . . 0.0 111.282 174.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -77.37 -16.43 58.87 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.332 0.653 . . . . 0.0 110.985 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.83 -130.13 22.24 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.86 0.725 . . . . 0.0 112.503 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 6.2 t -101.17 118.25 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.521 0.729 . . . . 0.0 109.112 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 24.5 m -113.6 155.21 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.422 0.689 . . . . 0.0 109.258 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -97.93 130.13 44.81 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.232 0.613 . . . . 0.0 110.043 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.527 ' HE1' ' HB3' ' A' ' 203' ' ' ASP . 92.1 mmm -131.63 160.61 34.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.445 1.098 . . . . 0.0 108.891 179.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -95.69 167.2 11.43 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 180' ' ' GLU . 61.6 m -63.93 -39.47 94.22 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.866 0.466 . . . . 0.0 111.537 176.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -63.15 -23.51 67.47 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.703 0.801 . . . . 0.0 112.031 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.527 ' HB3' ' HE1' ' A' ' 199' ' ' MET . 56.2 m-20 -83.78 -37.72 22.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.521 0.728 . . . . 0.0 110.649 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 33.1 m -94.56 144.71 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.444 ' HA ' ' HE ' ' A' ' 205' ' ' ARG . 0.0 OUTLIER -140.69 142.92 34.83 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.8 155.49 7.72 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.024 0.93 . . . . 0.0 111.11 177.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.521 ' HD2' ' HA ' ' A' ' 141' ' ' VAL . 0.8 OUTLIER -128.85 138.42 52.03 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.078 0.466 . . . . 0.0 110.218 -172.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.09 152.74 18.55 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.11 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.404 ' HG3' ' SD ' ' A' ' 294' ' ' MET . 2.6 ttp180 -86.58 6.29 31.55 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 168.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.2 m -83.5 105.1 14.16 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.708 0.803 . . . . 0.0 108.91 -168.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 19.7 mt -85.69 132.73 31.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 279' ' ' LYS . 10.0 mm -105.48 139.07 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 0.0 OUTLIER -109.81 168.28 9.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.535 0.734 . . . . 0.0 109.757 176.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 55.3 t90 -45.38 -46.38 13.18 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.857 1.263 . . . . 0.0 111.936 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -57.52 -34.61 69.29 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.804 1.242 . . . . 0.0 111.961 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.48 -11.44 32.04 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.133 0.973 . . . . 0.0 113.06 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.458 HD13 HG13 ' A' ' 243' ' ' ILE . 1.5 mm? -73.84 114.41 12.1 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 169.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 12.6 pt-20 -115.77 165.03 13.52 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.621 0.768 . . . . 0.0 109.053 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.9 m -69.0 119.24 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 121.26 0.552 . . . . 0.0 110.361 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.91 -4.45 49.53 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.738 -0.664 . . . . 0.0 113.246 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -70.67 118.42 13.44 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.537 0.735 . . . . 0.0 110.581 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.78 113.39 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.73 150.13 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.938 1.295 . . . . 0.0 109.403 -172.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.645 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 16.0 ptm -97.95 124.69 42.52 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 120.838 0.351 . . . . 0.0 111.34 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.463 ' HB3' HG11 ' A' ' 277' ' ' VAL . 1.3 pt? -144.53 167.53 22.3 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.9 0.88 . . . . 0.0 110.149 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -80.84 135.38 35.93 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.865 0.364 . . . . 0.0 110.759 -169.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.482 ' HD1' ' HB2' ' A' ' 239' ' ' TYR . 58.0 m-85 -144.66 157.42 44.21 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.815 1.246 . . . . 0.0 110.167 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 42.5 t-20 -129.9 110.93 17.17 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 166.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -71.73 -17.91 29.04 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.431 2.088 . . . . 0.0 112.787 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -87.03 -39.66 15.42 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.261 0.624 . . . . 0.0 110.447 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 10.0 m120 -124.35 81.33 58.91 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.213 1.005 . . . . 0.0 108.482 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.91 -11.34 31.78 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.746 2.297 . . . . 0.0 114.317 -170.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -88.9 -4.17 58.54 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.28 0.632 . . . . 0.0 111.267 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -131.51 163.83 27.12 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.635 -0.665 . . . . 0.0 110.275 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 162.46 29.44 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.801 0.84 . . . . 0.0 111.639 174.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.03 -88.66 0.07 OUTLIER Glycine 0 C--O 1.238 0.361 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.376 171.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -130.23 167.57 18.23 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.495 1.118 . . . . 0.0 109.118 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -87.68 113.61 23.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.771 0.428 . . . . 0.0 110.574 -170.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.482 ' HB2' ' HD1' ' A' ' 227' ' ' TYR . 64.0 m-85 -117.51 142.84 46.69 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 8.3 p-10 -84.27 158.08 21.34 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -153.54 148.02 26.08 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.882 -173.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -96.01 118.26 32.28 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.458 HG13 HD13 ' A' ' 217' ' ' LEU . 36.1 mm -66.94 107.41 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.356 0.662 . . . . 0.0 109.328 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.2 t -81.16 -45.28 16.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.562 0.745 . . . . 0.0 110.267 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -154.11 167.54 29.5 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.626 1.171 . . . . 0.0 109.978 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.45 146.81 23.91 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.714 0.806 . . . . 0.0 109.898 167.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -142.65 115.93 8.97 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.15 0.98 . . . . 0.0 109.17 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.83 144.05 25.67 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 175.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.6 p -126.9 169.93 12.77 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 169.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -61.26 -34.07 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.883 0.473 . . . . 0.0 110.448 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 75.0 p -87.22 -29.67 21.53 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.449 -171.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -166.66 153.9 9.32 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.891 0.477 . . . . 0.0 111.616 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -104.06 105.78 16.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.738 0.815 . . . . 0.0 109.883 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.03 144.95 25.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.552 0.741 . . . . 0.0 110.099 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.787 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.3 OUTLIER -135.87 146.74 47.75 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -175.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -135.03 120.66 19.39 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.49 ' HB1' HD13 ' A' ' 271' ' ' ILE . . . -136.01 161.27 36.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.497 0.665 . . . . 0.0 111.653 -175.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -100.67 94.12 5.93 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 46.4 t -77.34 106.19 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.02 0.928 . . . . 0.0 110.068 -171.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 34.7 m -89.54 118.43 34.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 122.245 1.022 . . . . 0.0 110.201 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 31.2 mt -96.57 -153.08 0.4 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 113.888 -1.505 . . . . 0.0 108.173 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.5 -52.07 32.82 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 117.708 0.231 . . . . 0.0 113.278 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -122.23 -36.21 3.0 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.022 0.929 . . . . 0.0 110.611 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.11 157.92 18.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.264 1.025 . . . . 0.0 110.858 -174.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 67.2 p -135.2 113.83 11.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.542 0.737 . . . . 0.0 109.124 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.55 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 23.9 mt -81.73 86.68 6.39 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.773 0.829 . . . . 0.0 108.888 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -69.34 142.4 54.03 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.237 0.615 . . . . 0.0 111.659 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 57.41 17.69 3.95 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.569 1.148 . . . . 0.0 113.823 170.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 94.5 m -66.73 142.9 57.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.326 0.65 . . . . 0.0 111.04 -176.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -70.03 133.79 47.59 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.948 0.78 . . . . 0.0 110.821 -176.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.787 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 10.3 mm -107.02 128.46 61.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 46.3 mt -98.3 -24.51 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 123.862 0.865 . . . . 0.0 109.025 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.549 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 67.7 m-85 -91.69 47.91 1.41 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.69 1.196 . . . . 0.0 110.14 -176.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 27.5 m -65.35 -26.37 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.518 1.127 . . . . 0.0 112.92 -171.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 52.7 m-20 -110.27 -7.98 14.78 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.174 0.589 . . . . 0.0 110.984 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 15.5 mm-40 -94.09 24.69 4.16 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.907 0.883 . . . . 0.0 110.734 -175.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.543 ' HB ' ' HB ' ' A' ' 212' ' ' ILE . 19.4 t -89.61 153.63 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.155 0.982 . . . . 0.0 110.001 -174.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -129.21 156.19 44.34 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.123 0.969 . . . . 0.0 108.79 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.554 ' HB2' HD13 ' A' ' 212' ' ' ILE . 54.2 tttm -89.76 146.2 24.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.112 0.565 . . . . 0.0 110.925 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 44.3 mm -72.49 122.78 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 168.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -106.17 112.8 25.98 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 285' ' ' GLU . 59.8 mtt85 -103.3 107.26 55.1 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -25.41 94.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.38 2.227 1 C-N-CA 125.307 4.005 . . . . 0.0 117.196 -156.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 104.72 6.99 39.94 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 118.231 -1.316 . . . . 0.0 116.275 172.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 282' ' ' ARG . 0.2 OUTLIER -103.26 -25.04 13.48 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 120.236 2.018 . . . . 0.0 111.452 173.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -106.64 -177.66 23.12 Favored Glycine 0 C--O 1.245 0.821 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 172.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 13.5 m -76.26 144.44 74.84 Favored Pre-proline 0 CA--C 1.554 1.129 0 CA-C-N 116.991 0.396 . . . . 0.0 111.208 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.13 175.93 6.21 Favored 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 123.356 2.704 . . . . 0.0 112.337 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 43.5 ttm -82.8 95.43 7.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 170.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 14.4 p -125.83 19.29 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.944 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -154.42 -167.04 2.5 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.61 -169.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -44.27 121.38 3.99 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 125.597 1.559 . . . . 0.0 113.073 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -45.53 113.0 0.46 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 124.596 3.53 . . . . 0.0 114.784 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.404 ' SD ' ' HG3' ' A' ' 209' ' ' ARG . 88.0 mmm -78.04 97.34 5.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.207 0.603 . . . . 0.0 110.579 -176.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -128.07 113.13 15.39 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 172.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.77 123.09 11.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.336 1.454 . . . . 0.0 110.531 -169.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -101.59 -31.29 10.91 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.9 0.88 . . . . 0.0 109.112 167.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 33.5 p -161.31 -170.62 2.71 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.247 1.019 . . . . 0.0 110.196 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -59.8 -57.49 19.16 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-O 119.443 -0.643 . . . . 0.0 112.832 169.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo . . . . . 0 C--N 1.383 2.379 0 C-N-CA 123.084 2.523 . . . . 0.0 111.59 171.721 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.472 ' HA3' HG23 ' A' ' 159' ' ' VAL . . . . . . . . 0 N--CA 1.476 1.332 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 6.96 0.5 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.655 0.782 . . . . 0.0 112.092 -176.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.567 ' HB2' ' CE1' ' A' ' 184' ' ' TYR . 34.7 m-85 -126.21 149.92 48.71 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.128 0.49 . . . . 0.0 110.924 172.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -94.03 172.69 8.07 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.871 1.268 . . . . 0.0 110.12 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.52 4.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.235 1.014 . . . . 0.0 113.124 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -106.09 -18.04 14.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.1 0.96 . . . . 0.0 110.908 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -75.33 92.63 2.8 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-O 121.579 0.704 . . . . 0.0 111.726 -166.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 8.1 p90 -55.13 105.17 0.15 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.8 165.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 28.0 m -116.01 -174.79 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.903 0.881 . . . . 0.0 109.931 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.723 ' HB3' ' HB3' ' A' ' 205' ' ' ARG . 33.9 t0 -110.73 160.49 16.67 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 171.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.463 ' HB1' ' HE1' ' A' ' 199' ' ' MET . . . -140.72 105.86 5.0 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.638 0.775 . . . . 0.0 109.536 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.97 116.58 11.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.027 1.331 . . . . 0.0 109.33 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -85.59 116.69 24.03 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.7 0.8 . . . . 0.0 110.937 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.4 p -74.14 -33.48 63.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.556 1.142 . . . . 0.0 111.201 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.43 -52.59 57.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.318 0.647 . . . . 0.0 112.008 -171.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.405 ' HG2' ' HE1' ' A' ' 239' ' ' TYR . 38.1 ttp -102.75 -8.32 20.94 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.924 0.49 . . . . 0.0 111.1 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.15 18.86 70.93 Favored Glycine 0 C--N 1.358 1.756 0 CA-C-O 121.385 0.436 . . . . 0.0 112.246 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -96.32 174.7 6.74 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.057 0.943 . . . . 0.0 111.458 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -126.47 119.2 26.6 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -109.81 119.18 38.54 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.69 152.12 31.85 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.413 ' HA ' ' H ' ' A' ' 189' ' ' ASP . . . -153.95 -177.47 6.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.199 0.6 . . . . 0.0 111.57 -167.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 64.8 tt0 -151.64 120.72 6.7 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.152 172.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.49 126.02 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.769 0.828 . . . . 0.0 110.149 171.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.414 HG12 ' HE2' ' A' ' 187' ' ' LYS . 12.8 m -120.74 -6.08 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.121 0.568 . . . . 0.0 110.69 173.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 37.4 ttm180 -169.9 156.2 6.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.775 0.83 . . . . 0.0 110.639 174.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.472 HG23 ' HA3' ' A' ' 133' ' ' GLY . 1.7 p -132.96 127.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.22 1.008 . . . . 0.0 109.862 173.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.3 p -125.86 162.6 24.8 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.345 1.458 . . . . 0.0 109.319 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -107.38 177.21 4.91 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.45 0.7 . . . . 0.0 109.179 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.547 ' HD3' HD11 ' A' ' 183' ' ' ILE . 73.7 mmtt -54.57 -33.8 60.81 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 123.31 0.644 . . . . 0.0 112.599 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.41 121.68 49.68 Favored Pre-proline 0 CA--C 1.546 0.799 0 O-C-N 123.856 0.723 . . . . 0.0 109.84 172.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -54.83 -29.51 63.35 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.079 2.519 . . . . 0.0 111.866 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 61.7 m 62.81 84.84 0.14 Allowed 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.951 1.3 . . . . 0.0 111.633 172.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -68.77 -35.46 77.09 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.645 170.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -79.5 174.47 11.54 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.572 167.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -114.34 94.56 36.07 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.385 0.674 . . . . 0.0 109.324 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -71.52 100.62 1.05 Allowed 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.351 2.701 . . . . 0.0 111.372 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 56.1 m -88.44 -44.49 10.69 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.588 0.755 . . . . 0.0 111.574 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 54.0 m -141.97 25.49 1.94 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.035 0.534 . . . . 0.0 112.123 -174.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.3 m -125.43 13.96 8.21 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.188 0.595 . . . . 0.0 110.782 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 m -84.14 -20.79 31.88 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.623 0.769 . . . . 0.0 110.52 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 67.1 p -71.91 10.83 0.63 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.061 1.344 . . . . 0.0 114.242 -172.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -57.92 152.24 39.67 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.402 1.081 . . . . 0.0 111.525 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -54.02 127.88 27.5 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.177 2.584 . . . . 0.0 113.995 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -142.37 102.35 4.07 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.424 1.09 . . . . 0.0 108.276 175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 59.8 tp -57.72 -45.09 86.24 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.701 0.801 . . . . 0.0 110.473 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -103.4 131.95 50.06 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.963 0.905 . . . . 0.0 108.771 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 201' ' ' SER . 26.9 mp0 -76.23 79.69 3.01 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 175.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -110.51 11.93 22.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.507 0.723 . . . . 0.0 109.724 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.27 149.09 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.328 0.651 . . . . 0.0 110.224 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.547 HD11 ' HD3' ' A' ' 162' ' ' LYS . 3.7 mp -95.75 109.59 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.003 0.521 . . . . 0.0 110.119 -167.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.567 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 58.3 m-85 -88.76 132.18 34.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.182 0.993 . . . . 0.0 111.033 173.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 30.6 m-70 -92.16 97.0 10.64 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.72 145.5 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.517 0.727 . . . . 0.0 110.447 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.414 ' HE2' HG12 ' A' ' 157' ' ' VAL . 45.2 mtmt -104.64 128.58 52.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -67.62 117.99 10.3 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.175 0.512 . . . . 0.0 111.088 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.413 ' H ' ' HA ' ' A' ' 154' ' ' ALA . 27.6 t70 -60.03 -30.2 69.01 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.846 1.258 . . . . 0.0 110.656 173.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.759 ' HA ' ' HD2' ' A' ' 297' ' ' LYS . 5.6 t70 -81.82 -30.18 32.3 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.209 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -138.48 81.17 25.14 Favored Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 123.082 0.553 . . . . 0.0 110.098 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.33 -21.9 46.78 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.593 2.195 . . . . 0.0 111.589 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.35 -26.48 68.77 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.411 1.084 . . . . 0.0 111.79 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -77.27 -20.11 55.55 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.821 0.449 . . . . 0.0 110.325 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 72.21 -154.23 50.43 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.58 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.3 t -79.46 117.39 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.564 0.746 . . . . 0.0 109.381 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.38 151.87 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.276 1.03 . . . . 0.0 109.38 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -88.48 129.29 35.48 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.463 ' HE1' ' HB1' ' A' ' 143' ' ' ALA . 90.8 mmm -147.23 126.8 13.28 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.699 1.2 . . . . 0.0 108.383 -174.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -68.18 160.8 28.39 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.591 ' HA ' HG21 ' A' ' 204' ' ' VAL . 20.6 t -69.32 -28.23 66.06 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.969 0.414 . . . . 0.0 111.048 -173.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -67.62 -32.22 72.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.038 0.935 . . . . 0.0 110.022 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.59 -19.84 32.41 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.078 0.951 . . . . 0.0 111.211 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.591 HG21 ' HA ' ' A' ' 201' ' ' SER . 7.8 m -96.68 157.87 3.21 Favored 'Isoleucine or valine' 0 C--N 1.356 0.882 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.723 ' HB3' ' HB3' ' A' ' 142' ' ' ASP . 0.5 OUTLIER -145.66 -178.63 6.19 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -165.295 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.436 ' HB2' ' HG3' ' A' ' 281' ' ' GLU . . . -98.51 143.82 28.52 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 166.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -70.32 96.56 1.14 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.164 0.585 . . . . 0.0 109.817 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.44 103.36 0.15 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.72 0.808 . . . . 0.0 110.955 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -82.86 -1.88 53.19 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.813 1.245 . . . . 0.0 111.632 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.0 m -94.46 119.93 33.93 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.843 0.857 . . . . 0.0 110.918 -176.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.4 mt -86.84 130.76 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.308 0.643 . . . . 0.0 109.284 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 39.7 mm -92.32 98.07 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.05 156.52 9.29 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.151 0.98 . . . . 0.0 111.439 174.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.411 ' CZ2' ' HB2' ' A' ' 246' ' ' LYS . 79.9 t90 -57.26 -40.34 77.49 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.714 -167.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -65.39 -29.83 70.58 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.871 0.468 . . . . 0.0 111.297 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.35 -15.49 49.75 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.043 0.937 . . . . 0.0 111.723 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.1 mt -65.84 114.31 4.99 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 169.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.43 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 11.1 pt-20 -119.0 168.03 11.2 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.219 1.007 . . . . 0.0 109.354 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.87 115.95 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-O 121.3 0.571 . . . . 0.0 109.541 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.19 -1.4 56.19 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.585 -174.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.532 ' HG3' HG12 ' A' ' 223' ' ' VAL . 6.2 tp-100 -67.55 120.58 14.21 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.969 0.508 . . . . 0.0 110.856 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.523 HG13 HG13 ' A' ' 280' ' ' ILE . 97.1 t -97.55 111.89 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.532 HG12 ' HG3' ' A' ' 221' ' ' GLN . 12.9 m -132.1 -174.76 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.219 1.408 . . . . 0.0 109.505 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 20.3 ptm -135.15 143.92 46.77 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.46 0.704 . . . . 0.0 109.447 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.51 159.89 42.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.779 0.832 . . . . 0.0 111.336 -169.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -90.31 106.94 18.83 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 173.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -145.48 138.73 26.34 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -172.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 46.4 t-20 -89.16 121.22 69.7 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.6 -19.74 21.19 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.562 2.175 . . . . 0.0 112.394 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -88.88 -39.16 14.01 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.468 0.707 . . . . 0.0 110.282 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.432 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 29.4 m-80 -119.97 101.93 47.11 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.443 0.697 . . . . 0.0 110.027 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -61.28 -26.57 82.12 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.803 2.336 . . . . 0.0 113.231 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -78.44 -27.05 46.44 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.764 0.825 . . . . 0.0 111.385 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -107.05 151.52 25.23 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.252 0.621 . . . . 0.0 111.144 -170.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -76.26 152.34 36.54 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.572 0.749 . . . . 0.0 109.192 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -139.04 -106.86 0.72 Allowed Glycine 0 N--CA 1.47 0.907 0 C-N-CA 121.674 -0.298 . . . . 0.0 112.77 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -128.35 170.52 12.99 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . 0.432 ' CE2' ' HB3' ' A' ' 296' ' ' ARG . 81.8 m95 -80.2 105.81 11.75 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.36 0.664 . . . . 0.0 110.917 -175.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.405 ' HE1' ' HG2' ' A' ' 148' ' ' MET . 76.1 m-85 -118.42 165.04 14.37 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.64 1.176 . . . . 0.0 108.449 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -97.34 142.92 28.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.0 0.52 . . . . 0.0 110.121 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -137.09 155.07 50.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.328 1.051 . . . . 0.0 111.12 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -110.91 117.53 33.63 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.583 HD12 HD13 ' A' ' 255' ' ' LEU . 33.0 mm -69.86 107.82 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.678 0.791 . . . . 0.0 109.012 -173.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.3 p -84.33 -32.71 24.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.468 0.707 . . . . 0.0 111.944 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -160.33 158.35 29.56 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.692 0.397 . . . . 0.0 110.914 -176.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.411 ' HB2' ' CZ2' ' A' ' 214' ' ' TRP . 60.8 pttt -154.62 148.78 25.9 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.36 0.664 . . . . 0.0 112.076 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -155.8 149.93 25.57 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.483 1.113 . . . . 0.0 108.671 173.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -129.72 139.87 51.23 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 119.564 1.075 . . . . 0.0 112.26 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.4 p -119.67 170.28 9.34 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 165.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -67.92 -32.88 73.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.824 0.449 . . . . 0.0 110.606 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 73.5 p -90.99 -19.71 22.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.246 1.019 . . . . 0.0 112.581 -172.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.69 155.44 21.66 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -171.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -108.53 132.96 53.31 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 173.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -102.25 128.82 48.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.274 1.03 . . . . 0.0 108.427 172.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.583 HD13 HD12 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -149.87 137.08 19.69 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -127.05 136.36 52.08 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.24 140.8 25.55 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.197 0.599 . . . . 0.0 110.697 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.456 HD21 ' N ' ' A' ' 258' ' ' ASN . 0.8 OUTLIER -79.51 94.98 5.7 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 49.0 t -78.24 105.66 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 28.8 t -86.35 124.02 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 264' ' ' ASP . 54.9 mt -103.16 -171.4 1.94 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.031 0.932 . . . . 0.0 109.032 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.08 -39.81 92.93 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 113.953 0.341 . . . . 0.0 113.953 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -121.77 -40.9 2.5 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.984 0.913 . . . . 0.0 109.255 173.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.475 ' HB2' HD12 ' A' ' 261' ' ' LEU . 21.5 m-20 -83.53 167.54 17.28 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.93 -173.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 54.7 p -145.53 114.21 6.81 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.611 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 61.9 mt -78.73 78.21 5.18 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -70.72 124.61 24.7 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.791 -170.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 36.8 t70 61.66 26.11 15.85 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.07 1.348 . . . . 0.0 111.603 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.611 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 94.9 m -73.47 133.62 43.71 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.709 -177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 -65.7 130.28 42.75 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.641 0.588 . . . . 0.0 110.493 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.9 mm -103.29 116.9 47.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.318 0.647 . . . . 0.0 109.555 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 61.9 mt -82.5 -45.45 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.685 173.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -89.58 64.44 6.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.951 0.9 . . . . 0.0 110.215 -168.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 30.5 m -78.84 -14.96 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.393 -174.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -90.63 -14.75 31.77 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.551 0.74 . . . . 0.0 111.047 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -96.98 43.6 1.07 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.098 0.959 . . . . 0.0 109.428 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.92 113.45 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.093 0.957 . . . . 0.0 109.737 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.414 ' HE2' ' HG3' ' A' ' 294' ' ' MET . 51.8 m-85 -94.61 164.92 12.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.014 0.926 . . . . 0.0 110.826 170.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -78.26 144.74 35.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.238 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.523 HG13 HG13 ' A' ' 222' ' ' VAL . 31.6 mm -73.42 113.57 11.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 164.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.436 ' HG3' ' HB2' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -78.97 125.52 29.48 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 170.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -109.16 104.92 56.34 Favored Pre-proline 0 N--CA 1.477 0.887 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -23.57 98.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.03 1 C-N-CA 125.751 4.3 . . . . 0.0 116.496 -151.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.23 60.21 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.577 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -78.2 -26.13 47.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.245 0.618 . . . . 0.0 110.24 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -134.79 160.44 24.27 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.838 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 12.4 m -91.04 159.01 40.79 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.552 0.741 . . . . 0.0 110.339 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.91 -155.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.62 2.214 . . . . 0.0 110.632 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' MET . . . . . 0.531 ' HB3' ' HB3' ' A' ' 293' ' ' PRO . 24.6 mmt -76.87 78.37 3.46 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 121.538 0.685 . . . . 0.0 109.534 177.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 13.6 p -106.78 -8.87 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.015 0.926 . . . . 0.0 109.933 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -122.32 -153.13 0.54 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.74 112.02 3.57 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.464 1.029 . . . . 0.0 109.709 167.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.531 ' HB3' ' HB3' ' A' ' 289' ' ' MET . 84.6 Cg_endo -76.17 137.21 18.95 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.051 1.834 . . . . 0.0 111.221 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.414 ' HG3' ' HE2' ' A' ' 278' ' ' PHE . 21.0 mmt -80.85 -49.45 11.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.148 0.579 . . . . 0.0 109.661 174.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 55.57 106.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.288 1.435 . . . . 0.0 110.627 -166.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.432 ' HB3' ' CE2' ' A' ' 238' ' ' TRP . 16.9 mtm180 -62.36 -33.41 74.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.989 0.915 . . . . 0.0 111.061 -177.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.759 ' HD2' ' HA ' ' A' ' 190' ' ' ASP . 51.5 tttp -64.26 92.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 37.2 t -152.55 97.9 2.31 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.411 0.684 . . . . 0.0 110.48 -172.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.464 ' N ' ' HD3' ' A' ' 300' ' ' PRO . . . -165.39 54.79 0.26 Allowed Glycine 0 CA--C 1.539 1.569 0 CA-C-O 119.191 -0.783 . . . . 0.0 112.401 170.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 299' ' ' GLY . 19.5 Cg_endo . . . . . 0 C--N 1.389 2.682 0 C-N-CA 123.648 2.899 . . . . 0.0 111.496 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.39 9.78 25.54 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.555 0.742 . . . . 0.0 112.104 -170.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.473 ' HH ' ' HA ' ' A' ' 205' ' ' ARG . 24.6 m-85 -125.91 144.87 50.5 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.391 0.676 . . . . 0.0 109.623 174.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.45 -177.6 3.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.635 0.774 . . . . 0.0 110.317 176.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.5 m -60.13 -6.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 125.205 1.402 . . . . 0.0 114.712 -173.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -110.63 -3.69 15.77 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.776 0.83 . . . . 0.0 112.032 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -86.39 88.52 7.65 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.352 0.596 . . . . 0.0 112.42 -171.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.64 ' HB3' ' HG2' ' A' ' 155' ' ' GLN . 31.0 p90 -75.86 102.1 5.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.052 0.929 . . . . 0.0 109.325 165.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.1 m -114.07 -165.84 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.526 1.53 . . . . 0.0 107.751 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.21 123.26 42.81 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.345 0.52 . . . . 0.0 111.825 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.536 ' HB1' ' HE1' ' A' ' 199' ' ' MET . . . -90.23 103.36 16.05 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.555 171.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.8 108.25 8.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -82.38 115.8 21.58 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.5 m -81.54 -15.43 54.88 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.81 0.844 . . . . 0.0 111.846 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -67.71 -51.91 43.9 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 23.1 ptp -96.65 -25.49 15.55 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.917 0.487 . . . . 0.0 110.934 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.55 18.22 33.63 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-O 119.991 -0.339 . . . . 0.0 113.836 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -99.68 168.51 9.89 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.669 0.747 . . . . 0.0 112.491 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -116.01 120.75 40.15 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 125.284 1.434 . . . . 0.0 107.63 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.9 127.18 54.0 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.19 103.5 0.39 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.477 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -101.95 117.42 34.79 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.828 0.851 . . . . 0.0 110.265 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.64 ' HG2' ' HB3' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -87.42 104.92 16.91 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.028 0.931 . . . . 0.0 109.165 -178.162 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 82.6 t -62.89 102.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.653 0.781 . . . . 0.0 109.501 172.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.0 -10.07 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 122.848 0.459 . . . . 0.0 110.983 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -170.5 143.29 2.23 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.839 0.856 . . . . 0.0 109.269 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 6.8 p -115.09 139.26 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 166.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.468 ' HG1' ' HB ' ' A' ' 183' ' ' ILE . 20.5 p -131.96 150.68 52.09 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.398 1.079 . . . . 0.0 108.583 172.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.418 ' NE ' ' SG ' ' A' ' 170' ' ' CYS . 1.9 tmm_? -66.97 147.21 53.52 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 171.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.424 ' HA ' HG13 ' A' ' 183' ' ' ILE . 87.5 tttt -57.69 90.48 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.541 0.736 . . . . 0.0 112.74 -171.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 164.13 163.39 0.07 OUTLIER Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 127.982 2.513 . . . . 0.0 107.085 172.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.58 -22.6 36.08 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.098 1.865 . . . . 0.0 112.545 167.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 54.8 m 61.32 30.02 18.88 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 124.655 1.182 . . . . 0.0 110.622 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -75.38 -36.63 60.87 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.85 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -74.48 -61.75 1.76 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.989 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.425 ' HG2' ' HG ' ' A' ' 170' ' ' CYS . 0.3 OUTLIER -109.94 125.78 30.42 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 123.951 0.901 . . . . 0.0 109.654 -176.176 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.09 -30.59 89.49 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.069 2.513 . . . . 0.0 113.296 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . 0.425 ' HG ' ' HG2' ' A' ' 168' ' ' GLU . 50.9 m 64.64 28.33 13.19 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.556 1.16 . . . . 0.0 111.034 -176.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 32.6 p -64.06 87.84 0.05 OUTLIER 'General case' 0 C--O 1.244 0.798 0 C-N-CA 124.348 1.059 . . . . 0.0 110.757 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 16.1 m 60.81 32.43 20.13 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.671 1.189 . . . . 0.0 111.842 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -60.55 122.54 14.93 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.777 0.431 . . . . 0.0 110.173 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.1 p -70.7 82.07 0.61 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.75 0.82 . . . . 0.0 111.017 -175.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -136.45 102.35 9.71 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -69.3 114.81 3.75 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.565 2.177 . . . . 0.0 112.075 -171.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -74.82 105.27 5.8 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.692 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 43.2 mt -71.94 -41.19 68.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.876 0.87 . . . . 0.0 108.908 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -132.36 127.11 34.78 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 167.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -86.5 67.93 10.04 Favored 'General case' 0 C--O 1.248 1.015 0 CA-C-O 121.698 0.761 . . . . 0.0 109.235 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -84.37 61.05 6.36 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.2 m -115.45 173.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.449 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.468 ' HB ' ' HG1' ' A' ' 160' ' ' THR . 45.2 mt -96.26 108.29 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.218 0.532 . . . . 0.0 109.99 -170.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -93.36 112.08 23.9 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.978 0.911 . . . . 0.0 108.631 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -78.25 89.97 4.32 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 175.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.477 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 29.3 m -110.46 151.68 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.288 -177.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -120.41 148.83 43.27 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 170.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -68.36 107.82 2.99 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -58.38 -34.55 70.83 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.406 0.682 . . . . 0.0 110.635 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -78.15 -23.77 47.61 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.379 0.672 . . . . 0.0 111.525 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -137.22 67.43 54.51 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.758 -0.589 . . . . 0.0 109.957 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.7 -17.57 42.51 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.969 2.446 . . . . 0.0 112.269 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.79 -13.78 62.41 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.58 1.552 . . . . 0.0 112.667 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -85.03 -21.21 29.52 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.748 0.419 . . . . 0.0 111.11 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 90.31 -157.19 25.62 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.545 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.8 t -92.17 118.67 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.894 0.878 . . . . 0.0 110.634 -172.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.6 m -109.41 156.38 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.368 1.067 . . . . 0.0 109.703 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -103.91 134.04 47.87 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.153 0.581 . . . . 0.0 110.919 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.607 ' HE3' ' HB3' ' A' ' 203' ' ' ASP . 82.7 mmm -136.83 167.05 22.19 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.575 1.15 . . . . 0.0 109.305 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . 0.41 ' O ' HG22 ' A' ' 204' ' ' VAL . 21.1 m-80 -109.83 171.41 7.46 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.722 0.809 . . . . 0.0 109.639 174.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 43.4 m -61.32 -37.03 81.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 118.64 0.655 . . . . 0.0 111.566 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -16.59 61.57 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.453 176.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.607 ' HB3' ' HE3' ' A' ' 199' ' ' MET . 34.3 m-20 -96.66 -50.1 4.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.826 0.85 . . . . 0.0 110.681 174.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 200' ' ' ASN . 7.9 m -96.34 115.77 36.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 CA-C-O 122.004 0.907 . . . . 0.0 109.917 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.473 ' HA ' ' HH ' ' A' ' 135' ' ' TYR . 21.8 ttt180 -125.9 139.22 53.65 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.799 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.4 126.3 26.69 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.493 ' NH1' ' HB2' ' A' ' 296' ' ' ARG . 4.0 ptm180 -74.19 161.53 29.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.561 0.744 . . . . 0.0 112.215 -174.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 287' ' ' SER . . . -83.1 125.56 31.62 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.383 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.36 66.38 4.69 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 164.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.6 m -145.42 109.18 4.74 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.803 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.416 HD11 ' HE3' ' A' ' 294' ' ' MET . 46.9 mt -85.93 129.07 38.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 123.077 0.551 . . . . 0.0 110.014 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 279' ' ' LYS . 26.3 mm -101.51 148.12 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.791 1.237 . . . . 0.0 108.603 174.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 175.72 8.57 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.286 0.634 . . . . 0.0 110.27 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -54.28 -51.92 63.06 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -166.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -72.68 -19.56 61.4 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.24 -21.48 29.05 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.942 0.897 . . . . 0.0 109.954 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.44 HD23 HD13 ' A' ' 243' ' ' ILE . 90.5 mt -71.37 128.76 36.94 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -143.55 158.17 43.86 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.785 0.434 . . . . 0.0 110.572 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.0 127.28 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 123.912 0.757 . . . . 0.0 111.428 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.23 -25.7 25.95 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.013 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -72.95 122.12 21.16 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.32 0.648 . . . . 0.0 110.159 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.494 HG12 ' NH2' ' A' ' 282' ' ' ARG . 1.8 p -108.72 125.15 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.326 0.651 . . . . 0.0 110.308 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 280' ' ' ILE . 3.8 m -135.31 177.27 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 125.422 1.489 . . . . 0.0 109.912 -175.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 16.8 ptm -108.19 120.76 43.28 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.185 0.594 . . . . 0.0 110.702 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.664 ' HG ' HG11 ' A' ' 277' ' ' VAL . 0.4 OUTLIER -127.86 148.88 50.48 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.704 0.802 . . . . 0.0 108.91 -176.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -88.51 116.85 27.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.803 0.841 . . . . 0.0 111.734 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.516 ' HE1' ' HB2' ' A' ' 225' ' ' LEU . 4.9 p90 -163.69 142.45 7.88 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.156 0.982 . . . . 0.0 108.648 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -85.92 131.12 47.93 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 168.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.18 -19.77 66.36 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.25 1.967 . . . . 0.0 113.253 -171.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -66.57 -42.89 86.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.245 0.618 . . . . 0.0 110.154 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -130.06 89.1 46.44 Favored Pre-proline 0 N--CA 1.47 0.548 0 C-N-CA 123.608 0.763 . . . . 0.0 109.181 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.21 -6.97 17.51 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.616 2.211 . . . . 0.0 113.072 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.52 -29.35 46.48 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.243 0.617 . . . . 0.0 111.595 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.82 151.62 44.98 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.869 0.467 . . . . 0.0 110.237 -176.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 227' ' ' TYR . 7.0 ppt_? -66.72 161.79 22.74 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.814 0.846 . . . . 0.0 112.639 -175.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -165.57 -84.4 0.05 OUTLIER Glycine 0 C--N 1.338 0.684 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.388 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.445 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 30.1 m-85 -119.27 149.15 42.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.72 0.808 . . . . 0.0 109.224 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -88.36 104.43 16.76 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 95.5 m-85 -108.38 160.85 15.55 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.145 0.578 . . . . 0.0 110.367 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -81.48 119.23 23.48 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.676 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.447 ' HB3' HD13 ' A' ' 225' ' ' LEU . . . -126.82 136.56 52.53 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -99.36 123.17 43.41 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.565 HD12 HD12 ' A' ' 255' ' ' LEU . 19.5 mm -64.84 110.37 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.9 t -78.93 -36.42 41.79 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.278 -177.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -170.22 158.79 6.98 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.782 0.833 . . . . 0.0 109.52 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -143.43 136.21 27.52 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.455 ' HG3' ' HB2' ' A' ' 254' ' ' GLU . 4.0 ptm180 -145.61 125.41 13.44 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -92.15 137.67 32.17 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.9 p -116.0 176.62 5.01 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 170.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -58.7 -39.71 81.52 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.7 p -127.84 13.5 6.86 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.6 159.98 37.62 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.244 0.474 . . . . 0.0 111.314 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -122.35 108.76 13.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.106 0.962 . . . . 0.0 108.825 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.455 ' HB2' ' HG3' ' A' ' 247' ' ' ARG . 3.7 mp0 -90.88 99.1 12.19 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.565 HD12 HD12 ' A' ' 243' ' ' ILE . 2.1 tm? -100.23 121.34 41.31 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 176.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -107.23 132.14 53.4 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.05 122.32 12.28 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.28 0.632 . . . . 0.0 109.948 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -76.35 99.93 4.98 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 94.4 t -69.26 107.12 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.734 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 9.2 m -87.4 104.46 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 36.4 mt -81.93 -160.04 0.33 Allowed 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.684 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.43 -47.8 33.52 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-O 120.994 0.219 . . . . 0.0 112.979 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -122.3 -32.29 3.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.126 0.971 . . . . 0.0 111.044 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -101.44 171.56 7.5 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.666 0.787 . . . . 0.0 110.567 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 58.7 m -144.61 121.97 11.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.779 0.832 . . . . 0.0 109.816 171.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 72.2 mt -80.97 113.18 19.0 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.858 0.863 . . . . 0.0 109.562 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.69 109.47 4.38 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.513 0.725 . . . . 0.0 111.423 -173.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.79 57.69 4.56 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.735 1.214 . . . . 0.0 112.873 171.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 42.7 t -65.03 125.24 24.3 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 36.6 ttt180 -71.82 123.33 22.42 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.6 mm -100.03 122.4 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.32 0.648 . . . . 0.0 109.804 -175.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 65.4 mt -92.06 -14.29 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 124.451 1.1 . . . . 0.0 109.649 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -89.09 20.63 3.56 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.239 1.416 . . . . 0.0 111.494 -168.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 28.9 m -69.09 -4.51 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.757 1.223 . . . . 0.0 114.101 -166.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -94.19 -33.49 13.28 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.687 0.395 . . . . 0.0 111.228 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -128.72 48.62 2.3 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.77 0.795 . . . . 0.0 110.193 -173.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.664 HG11 ' HG ' ' A' ' 225' ' ' LEU . 59.4 t -74.7 154.01 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.426 169.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -119.92 149.8 41.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.539 ' HB2' HD13 ' A' ' 212' ' ' ILE . 26.4 ttmt -80.14 151.4 29.79 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.662 174.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 223' ' ' VAL . 36.1 mm -76.93 126.41 37.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 168.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.636 ' HA ' ' HA3' ' A' ' 286' ' ' GLY . 0.6 OUTLIER -71.26 108.57 4.81 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.666 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 90.2 mtt-85 -123.06 153.69 64.46 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.783 1.233 . . . . 0.0 108.566 -176.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.16 96.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.091 2.527 . . . . 0.0 113.557 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.28 -34.91 5.26 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.229 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.666 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 10.5 tp10 -85.97 -27.37 24.92 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.677 0.391 . . . . 0.0 111.902 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . 0.636 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -108.93 136.59 13.65 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -175.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 208' ' ' ALA . 3.3 m -96.24 144.98 28.77 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 117.259 0.53 . . . . 0.0 110.093 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -88.23 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.033 2.489 . . . . 0.0 111.765 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 17.4 mmt -80.66 78.92 7.37 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.1 -26.77 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.334 1.054 . . . . 0.0 110.146 -175.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -125.89 -160.08 0.95 Allowed 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -44.73 106.51 0.54 Allowed Pre-proline 0 N--CA 1.489 1.496 0 CA-C-N 119.743 1.156 . . . . 0.0 112.293 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.82 84.52 1.44 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.164 2.576 . . . . 0.0 111.252 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.416 ' HE3' HD11 ' A' ' 211' ' ' ILE . 25.0 ptm -66.2 140.97 58.21 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.14 176.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -85.16 159.64 20.09 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.493 ' HB2' ' NH1' ' A' ' 207' ' ' ARG . 23.1 ttp-105 -128.12 10.57 6.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.567 0.747 . . . . 0.0 109.837 -175.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -51.8 131.94 31.05 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.791 1.636 . . . . 0.0 111.139 172.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 19.7 m -76.66 89.37 3.35 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.081 0.552 . . . . 0.0 109.902 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -81.38 118.64 4.67 Favored Glycine 0 CA--C 1.537 1.466 0 CA-C-O 119.026 -0.874 . . . . 0.0 113.298 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo . . . . . 0 C--N 1.375 1.926 0 C-N-CA 123.21 2.607 . . . . 0.0 112.16 177.465 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.18 -18.57 8.01 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.258 0.623 . . . . 0.0 111.397 175.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -99.78 143.45 29.99 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 136' ' ' LYS . 6.3 mptt -97.87 179.32 4.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.494 1.117 . . . . 0.0 110.472 -170.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -68.74 -17.81 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 124.767 1.227 . . . . 0.0 112.161 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -116.41 16.29 15.68 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.253 0.621 . . . . 0.0 110.976 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.428 ' HG3' HG11 ' A' ' 141' ' ' VAL . 11.3 tp10 -97.21 89.43 4.76 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.341 0.591 . . . . 0.0 110.17 -173.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 22.8 p90 -82.18 100.23 9.72 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.69 0.757 . . . . 0.0 111.179 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.428 HG11 ' HG3' ' A' ' 139' ' ' GLU . 34.1 m -114.88 169.14 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.721 0.808 . . . . 0.0 109.221 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -87.93 113.88 24.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.136 0.493 . . . . 0.0 111.296 -169.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.38 109.41 19.54 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 170.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.531 HH22 HG11 ' A' ' 260' ' ' VAL . 26.3 ttt180 -74.9 113.68 12.49 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.497 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.89 134.89 35.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.431 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.6 p -77.04 -36.51 56.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.472 0.709 . . . . 0.0 111.494 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -65.03 -45.1 86.84 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.189 0.595 . . . . 0.0 110.847 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 54.0 tpp -85.54 -38.49 18.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.59 0.756 . . . . 0.0 110.127 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.68 9.89 80.35 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.867 -171.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.99 168.42 9.13 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 121.791 0.805 . . . . 0.0 112.243 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.431 ' HZ2' HD12 ' A' ' 280' ' ' ILE . 8.5 m0 -89.35 122.41 32.54 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.512 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.72 111.15 17.25 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 173.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -57.32 98.28 0.03 OUTLIER 'General case' 0 C--N 1.363 1.168 0 O-C-N 124.163 0.915 . . . . 0.0 109.963 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -103.73 133.1 49.29 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.437 1.095 . . . . 0.0 109.818 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.613 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 43.6 tt0 -84.01 106.75 15.91 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 122.684 0.394 . . . . 0.0 110.667 -173.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.1 t -58.56 109.23 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.521 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 167.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 m -108.37 -26.2 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 122.861 0.464 . . . . 0.0 111.028 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 56.5 ttt85 -146.5 122.63 10.81 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 110.788 -0.078 . . . . 0.0 110.788 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.16 117.82 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 123.335 0.654 . . . . 0.0 109.369 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.7 p -127.87 117.63 22.17 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.711 0.804 . . . . 0.0 109.289 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.414 ' HG3' HG11 ' A' ' 182' ' ' VAL . 27.1 ttt180 -76.14 138.19 40.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.376 0.67 . . . . 0.0 109.473 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -63.69 -21.62 66.48 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.201 0.6 . . . . 0.0 111.144 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.18 101.77 1.46 Allowed Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 161.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -63.63 127.01 18.69 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 122.757 2.305 . . . . 0.0 111.499 -174.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.5 m -104.45 28.14 7.22 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.826 0.85 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 65.95 175.27 0.23 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.771 1.228 . . . . 0.0 111.779 -175.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.6 -51.66 68.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.892 0.477 . . . . 0.0 110.155 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -96.58 107.5 36.69 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.01 59.46 6.96 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.584 2.856 . . . . 0.0 112.384 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 61.9 m -70.22 -37.93 75.14 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.868 0.867 . . . . 0.0 111.212 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 45.5 m -73.79 93.76 2.18 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 171.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 27.2 t -144.66 26.74 1.39 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.449 -173.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 41.7 p -67.91 89.86 0.29 Allowed 'General case' 0 C--N 1.358 0.971 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.1 t 65.56 -179.99 0.19 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.624 1.17 . . . . 0.0 111.173 -171.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.8 ptt-85 -158.6 134.27 5.99 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 123.989 0.916 . . . . 0.0 108.901 175.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.48 113.59 2.17 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 123.088 2.525 . . . . 0.0 112.911 -173.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.43 123.9 19.11 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.475 0.71 . . . . 0.0 110.564 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 30.7 tp -154.17 176.19 12.56 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -172.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -70.48 97.98 1.38 Allowed 'General case' 0 C--O 1.243 0.75 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 163.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.89 96.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.367 1.079 . . . . 0.0 111.603 -172.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -88.81 19.71 3.91 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.209 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.414 HG11 ' HG3' ' A' ' 161' ' ' ARG . 6.4 m -78.17 163.4 3.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 124.007 0.923 . . . . 0.0 110.046 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.49 HG22 ' HB2' ' A' ' 198' ' ' GLN . 61.3 mt -97.16 110.31 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.41 0.684 . . . . 0.0 110.117 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -90.6 108.43 19.8 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 169.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 56.0 m-70 -77.14 97.77 4.86 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.49 143.32 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.533 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.522 ' HG2' HG23 ' A' ' 196' ' ' VAL . 25.3 mtmt -104.83 116.81 32.64 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -53.99 111.01 0.67 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.88 -22.99 67.1 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -80.34 -29.12 38.0 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.597 0.759 . . . . 0.0 111.404 173.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.485 ' HB3' ' ND2' ' A' ' 194' ' ' ASN . 79.8 m-85 -129.27 55.05 16.19 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 123.499 0.72 . . . . 0.0 111.321 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.38 -13.58 20.6 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 121.719 1.613 . . . . 0.0 112.73 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -71.83 -27.93 63.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.864 0.866 . . . . 0.0 110.697 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' ' 191' ' ' TYR . 30.4 m-80 -75.82 -1.42 25.1 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.548 0.739 . . . . 0.0 111.905 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 92.48 -172.05 34.14 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-O 121.11 0.283 . . . . 0.0 113.279 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.522 HG23 ' HG2' ' A' ' 187' ' ' LYS . 8.8 t -90.51 116.9 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.11 152.56 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.837 0.855 . . . . 0.0 110.015 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.49 ' HB2' HG22 ' A' ' 183' ' ' ILE . 16.7 pm0 -92.27 126.48 37.37 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.423 ' HE1' ' HB3' ' A' ' 203' ' ' ASP . 97.0 mmm -141.38 136.44 31.43 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.742 1.217 . . . . 0.0 107.973 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . 0.438 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 20.8 m-80 -89.45 173.12 8.52 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.167 0.44 . . . . 0.0 110.071 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.513 ' HA ' HG21 ' A' ' 204' ' ' VAL . 18.9 t -66.82 -30.0 70.08 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 120.806 0.336 . . . . 0.0 110.496 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.438 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 15.4 ptm180 -67.24 -18.11 65.08 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.585 0.754 . . . . 0.0 111.935 175.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.423 ' HB3' ' HE1' ' A' ' 199' ' ' MET . 59.9 m-20 -102.38 -29.32 11.71 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.93 0.892 . . . . 0.0 111.085 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.513 HG21 ' HA ' ' A' ' 201' ' ' SER . 31.9 m -99.21 148.78 5.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 CA-C-O 121.599 0.714 . . . . 0.0 110.374 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -128.85 146.14 51.01 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.873 1.269 . . . . 0.0 108.111 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.69 128.93 38.29 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -63.4 137.35 58.13 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.362 0.665 . . . . 0.0 110.814 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 281' ' ' GLU . . . -69.89 113.86 7.52 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -172.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.566 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 1.2 ptm180 -82.24 -31.94 29.96 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.686 169.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.7 m -90.04 123.51 33.98 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.554 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.4 mt -86.29 136.31 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.41 ' HB ' HG11 ' A' ' 277' ' ' VAL . 48.4 mm -107.51 144.2 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.673 0.789 . . . . 0.0 109.619 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.42 168.78 14.4 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.197 0.999 . . . . 0.0 109.296 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -52.22 -38.63 58.55 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.351 1.06 . . . . 0.0 112.953 -170.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.6 -44.31 93.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.358 0.663 . . . . 0.0 112.186 -173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.88 -1.46 32.07 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.609 0.764 . . . . 0.0 110.736 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.491 HD11 HG22 ' A' ' 223' ' ' VAL . 21.0 tp -79.19 121.0 24.49 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -130.69 156.72 44.44 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.496 0.589 . . . . 0.0 111.509 -172.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.4 m -67.93 132.34 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.971 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.8 -11.87 70.31 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.971 -176.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.401 ' HG2' HG11 ' A' ' 223' ' ' VAL . 29.0 tt0 -86.05 123.99 31.98 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.506 0.722 . . . . 0.0 109.47 177.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.96 133.16 29.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 173.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.491 HG22 HD11 ' A' ' 217' ' ' LEU . 3.3 m -145.19 145.76 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.6 1.16 . . . . 0.0 109.369 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.551 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 12.0 ptm -97.28 131.21 44.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.994 0.518 . . . . 0.0 109.692 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.501 ' HB3' ' HA ' ' A' ' 277' ' ' VAL . 0.8 OUTLIER -143.92 158.54 43.63 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.926 0.491 . . . . 0.0 110.834 -175.225 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 235' ' ' ARG . 16.5 p30 -77.04 117.87 19.04 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -156.6 143.16 18.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.726 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -108.53 120.47 46.29 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 168.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.66 -36.14 11.64 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.62 2.213 . . . . 0.0 111.873 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.31 -29.13 62.49 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.408 0.683 . . . . 0.0 110.774 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -131.18 90.13 39.64 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.41 -17.77 49.29 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.923 2.415 . . . . 0.0 113.473 -176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -76.03 -27.75 57.44 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.069 0.547 . . . . 0.0 111.176 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.09 153.64 37.17 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 226' ' ' ASN . 0.0 OUTLIER -75.4 173.34 11.06 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.933 0.493 . . . . 0.0 111.732 176.506 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -159.83 -117.53 0.47 Allowed Glycine 0 C--O 1.24 0.522 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.278 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -82.56 171.42 14.1 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.199 0.6 . . . . 0.0 110.102 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -89.01 105.5 17.82 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -114.02 135.3 54.16 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -82.67 129.0 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -136.65 137.04 39.64 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.205 1.002 . . . . 0.0 109.309 -173.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -94.64 118.93 32.48 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.572 HD12 HD13 ' A' ' 255' ' ' LEU . 37.3 mm -62.44 112.79 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.195 0.598 . . . . 0.0 111.192 -173.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.4 t -82.53 -41.62 19.43 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.901 0.88 . . . . 0.0 110.088 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -157.05 155.73 31.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.735 0.814 . . . . 0.0 109.53 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -142.85 144.28 32.45 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.15 0.58 . . . . 0.0 109.893 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 254' ' ' GLU . 33.3 ttm180 -156.54 148.85 23.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.96 0.904 . . . . 0.0 109.786 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.21 139.82 35.72 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 165.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.0 p -114.31 177.65 4.57 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 172.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -78.98 -23.4 44.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 118.434 0.561 . . . . 0.0 110.434 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.1 p -95.16 -21.04 18.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.702 0.801 . . . . 0.0 112.5 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.91 173.86 16.13 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.191 0.596 . . . . 0.0 111.006 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -126.4 151.1 48.12 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 247' ' ' ARG . 10.1 tp10 -138.73 137.1 36.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.11 0.481 . . . . 0.0 110.894 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.642 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.4 OUTLIER -149.96 139.1 21.18 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.242 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -130.75 129.88 43.06 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.79 138.58 24.5 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.238 0.615 . . . . 0.0 109.919 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -76.69 99.22 4.99 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.49 106.14 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.531 HG11 HH22 ' A' ' 144' ' ' ARG . 48.4 t -89.0 114.56 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.225 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' A' ' 264' ' ' ASP . 87.8 mt -92.28 -170.17 2.44 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.965 0.906 . . . . 0.0 109.907 173.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -61.41 -54.55 35.15 Favored Glycine 0 C--N 1.352 1.438 0 O-C-N 123.156 0.285 . . . . 0.0 112.591 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.05 -49.56 3.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.212 1.005 . . . . 0.0 109.905 172.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.426 ' HB2' HD11 ' A' ' 261' ' ' LEU . 7.4 m-20 -76.18 167.35 22.03 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.703 -171.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 38.0 p -153.95 112.89 3.69 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.409 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 2.6 mm? -81.41 95.86 7.18 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.508 0.723 . . . . 0.0 109.659 -177.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -58.6 111.73 1.36 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.229 0.956 . . . . 0.0 110.662 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 16.0 t70 64.01 83.75 0.16 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.889 1.275 . . . . 0.0 111.783 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 71.4 m -106.9 140.32 39.89 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.051 0.94 . . . . 0.0 109.554 172.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -82.2 107.97 15.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.106 0.562 . . . . 0.0 110.13 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 42.4 mm -91.76 124.06 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.947 0.899 . . . . 0.0 108.734 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 52.6 mt -88.17 -26.73 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.304 0.642 . . . . 0.0 110.499 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.463 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 38.0 m-85 -95.56 60.91 2.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.876 0.87 . . . . 0.0 111.038 -166.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 255' ' ' LEU . 9.8 m -66.69 -17.15 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.369 1.067 . . . . 0.0 112.246 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -98.65 -24.26 15.14 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.003 0.921 . . . . 0.0 110.98 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 36.5 mt-10 -98.24 28.05 4.29 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.564 0.697 . . . . 0.0 110.799 -176.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.501 ' HA ' ' HB3' ' A' ' 225' ' ' LEU . 72.6 t -82.95 146.36 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.586 1.155 . . . . 0.0 108.88 172.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.551 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 73.0 m-85 -130.78 160.89 33.01 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.179 0.991 . . . . 0.0 109.531 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -82.04 154.78 25.47 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.34 1.056 . . . . 0.0 111.858 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.431 HD12 ' HZ2' ' A' ' 151' ' ' TRP . 15.9 mm -88.54 111.08 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 164.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 208' ' ' ALA . 46.0 mm-40 -83.97 103.81 13.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -90.06 142.35 28.67 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.72 1.208 . . . . 0.0 109.52 -173.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.88 99.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.441 2.761 . . . . 0.0 113.544 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.28 -49.72 1.9 Allowed Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.906 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -73.36 -24.61 60.35 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.331 0.653 . . . . 0.0 111.728 -174.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -91.13 -159.81 35.94 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 25.2 p -126.99 135.11 26.89 Favored Pre-proline 0 N--CA 1.468 0.435 0 CA-C-N 117.142 0.471 . . . . 0.0 110.895 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.02 -174.67 1.63 Allowed 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.01 2.473 . . . . 0.0 110.616 163.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' MET . . . . . 0.566 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 24.6 mmt -74.72 81.33 2.06 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.429 0.633 . . . . 0.0 110.479 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 12.3 p -100.77 -17.36 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.843 1.257 . . . . 0.0 109.627 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -122.75 -160.68 0.9 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -45.87 117.65 3.93 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.56 1.144 . . . . 0.0 112.422 177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.554 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 85.1 Cg_endo -78.36 144.08 20.14 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.585 2.19 . . . . 0.0 111.994 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 97.5 mmm -115.1 145.18 42.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.963 0.905 . . . . 0.0 110.693 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -143.3 91.53 2.28 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 169.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.448 ' CZ ' ' HE1' ' A' ' 224' ' ' MET . 40.6 mtm-85 -72.57 -17.24 61.73 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.378 -170.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -67.74 98.71 0.73 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 162.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 23.5 p -74.56 79.95 1.97 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.944 0.898 . . . . 0.0 110.935 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -172.67 76.23 0.09 OUTLIER Glycine 0 C--N 1.344 0.979 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.185 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 CA--C 1.565 2.05 0 C-N-CA 123.317 2.678 . . . . 0.0 111.82 176.168 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.355 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.83 -21.07 14.08 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.585 0.754 . . . . 0.0 110.673 -175.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -108.02 132.56 53.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 169.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -130.24 -175.74 3.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.944 0.898 . . . . 0.0 110.742 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.8 m -35.47 -32.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -167.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -109.39 -22.18 12.16 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.208 0.603 . . . . 0.0 111.983 -173.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -77.13 78.83 3.66 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.371 1.068 . . . . 0.0 110.612 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -76.52 130.81 38.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.545 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.2 m -132.69 169.01 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.491 1.516 . . . . 0.0 107.219 172.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.42 ' HB2' ' CE3' ' A' ' 151' ' ' TRP . 4.5 m-20 -92.24 139.51 30.54 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.664 0.665 . . . . 0.0 110.878 -174.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.569 ' HB3' ' HE1' ' A' ' 199' ' ' MET . . . -89.1 99.4 12.4 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.888 174.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.424 ' HG2' ' NE1' ' A' ' 151' ' ' TRP . 0.0 OUTLIER -70.8 91.03 0.81 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.129 -1.396 . . . . 0.0 107.407 177.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.69 128.92 37.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.143 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.5 m -81.88 -19.15 41.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.563 0.345 . . . . 0.0 111.722 -172.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -76.69 -52.88 8.81 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.9 ttm -90.26 -39.99 12.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.693 0.797 . . . . 0.0 110.552 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.76 -7.67 59.38 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.199 -173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.3 153.38 35.94 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.598 0.759 . . . . 0.0 111.676 -174.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.491 ' CH2' HD12 ' A' ' 280' ' ' ILE . 12.9 m95 -101.51 116.07 31.93 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -109.0 123.28 48.88 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.03 101.66 0.23 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.757 0.66 . . . . 0.0 110.447 -173.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.9 114.84 26.49 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -85.52 97.6 10.15 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.401 ' HA ' HG11 ' A' ' 186' ' ' VAL . 44.7 t -65.51 97.84 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -92.14 -12.56 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.012 0.525 . . . . 0.0 111.851 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.485 ' HG3' ' HA ' ' A' ' 170' ' ' CYS . 21.1 ttm180 -168.72 154.05 6.34 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.525 0.73 . . . . 0.0 110.809 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.0 m -131.43 143.44 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.194 0.998 . . . . 0.0 110.14 172.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.535 HG21 ' HB ' ' A' ' 183' ' ' ILE . 4.5 t -141.69 150.4 41.82 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.896 0.878 . . . . 0.0 109.781 176.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -120.04 158.26 27.19 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.961 0.904 . . . . 0.0 110.791 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.569 ' HZ1' ' HB3' ' A' ' 162' ' ' LYS . 9.0 mtpm? -95.69 86.56 4.44 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.372 0.669 . . . . 0.0 110.378 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -144.21 155.68 58.02 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.979 0.912 . . . . 0.0 109.809 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.94 -42.86 63.23 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.423 2.082 . . . . 0.0 112.335 168.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 46.7 m -87.57 91.17 8.65 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 172.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -144.75 23.06 1.59 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.872 0.869 . . . . 0.0 110.615 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -77.61 124.98 28.63 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 55.9 59.83 9.04 Favored Pre-proline 0 CA--C 1.563 1.477 0 C-N-CA 124.684 1.193 . . . . 0.0 111.856 -173.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -89.0 98.17 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.345 2.697 . . . . 0.0 112.328 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . 0.485 ' HA ' ' HG3' ' A' ' 158' ' ' ARG . 47.6 t -129.04 172.47 11.36 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.622 0.725 . . . . 0.0 111.935 -174.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.8 p -72.73 -22.75 60.83 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.23 173.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 17.7 p -74.37 126.18 30.13 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.3 m 56.92 54.95 6.55 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -167.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.2 t -54.08 101.28 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.246 -170.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -74.49 130.97 80.87 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.512 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.15 143.98 17.61 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.967 3.111 . . . . 0.0 114.54 -172.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.5 146.59 31.27 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.445 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 50.8 mt -73.0 -75.72 0.14 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.194 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -113.83 16.2 18.48 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.111 0.964 . . . . 0.0 109.797 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 71.59 -15.36 0.44 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.245 1.418 . . . . 0.0 112.346 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.509 ' HA ' ' H ' ' A' ' 201' ' ' SER . 28.7 m-20 -87.62 51.14 2.14 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.641 0.734 . . . . 0.0 110.147 174.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.429 ' HB ' ' O ' ' A' ' 160' ' ' THR . 35.3 m -81.59 179.56 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.771 169.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.535 ' HB ' HG21 ' A' ' 160' ' ' THR . 3.6 mp -94.04 107.31 19.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -176.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -85.49 108.92 18.13 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.498 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 22.5 m-70 -78.29 100.71 6.82 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' A' ' 156' ' ' VAL . 12.0 m -118.35 164.0 15.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.237 -176.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -122.18 116.13 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -57.99 111.18 1.09 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 169.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.98 -23.99 61.51 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.653 0.739 . . . . 0.0 110.334 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.596 ' HB3' ' HB2' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -82.3 -30.4 30.56 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.29 172.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -137.73 70.31 51.47 Favored Pre-proline 0 N--CA 1.487 1.381 0 C-N-CA 123.101 0.56 . . . . 0.0 110.985 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.83 -18.21 57.48 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.801 2.334 . . . . 0.0 112.173 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.19 -17.12 57.21 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.871 1.268 . . . . 0.0 112.573 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.411 HD21 ' N ' ' A' ' 194' ' ' ASN . 0.8 OUTLIER -75.91 -7.21 54.01 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.751 0.82 . . . . 0.0 112.263 177.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.77 -167.11 52.61 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 40.5 t -81.3 117.02 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 171.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 29.0 m -108.38 141.9 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 122.82 0.448 . . . . 0.0 110.047 -175.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.483 ' HB2' HG21 ' A' ' 183' ' ' ILE . 18.4 pt20 -87.51 130.48 34.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.448 0.699 . . . . 0.0 110.156 -176.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.569 ' HE1' ' HB3' ' A' ' 143' ' ' ALA . 60.1 mmm -133.3 161.5 34.32 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.335 0.654 . . . . 0.0 109.739 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -111.55 -179.5 3.73 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.099 0.959 . . . . 0.0 109.275 172.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.509 ' H ' ' HA ' ' A' ' 181' ' ' ASP . 42.3 t -62.37 -41.43 98.61 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 118.168 0.44 . . . . 0.0 110.367 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -15.19 62.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.868 0.467 . . . . 0.0 112.157 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.474 ' HB3' ' HE3' ' A' ' 199' ' ' MET . 12.6 m-20 -89.19 -57.79 2.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.445 0.698 . . . . 0.0 110.008 173.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -94.24 117.97 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.69 0.757 . . . . 0.0 109.77 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.404 ' HD2' ' HH2' ' A' ' 151' ' ' TRP . 25.8 ttm180 -111.66 149.89 30.91 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.08 -176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.18 127.72 32.66 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 123.907 0.754 . . . . 0.0 111.625 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -101.27 136.53 40.96 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.191 0.996 . . . . 0.0 109.417 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.75 157.55 15.89 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.037 0.922 . . . . 0.0 110.433 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.435 ' HD3' ' N ' ' A' ' 209' ' ' ARG . 0.0 OUTLIER -114.61 42.89 2.03 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.462 177.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 21.3 m -127.12 118.73 24.95 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.583 -178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 50.4 mt -84.08 127.74 39.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 216' ' ' ASP . 46.6 mm -92.37 138.96 18.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.379 -178.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -128.31 -178.49 4.58 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.867 1.267 . . . . 0.0 109.415 175.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.487 ' CH2' ' HB2' ' A' ' 246' ' ' LYS . 49.7 t-105 -60.99 -28.64 69.17 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.812 0.445 . . . . 0.0 111.87 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -61.91 -41.98 98.55 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.301 0.641 . . . . 0.0 110.564 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.543 ' HB2' HG22 ' A' ' 212' ' ' ILE . 58.8 m-20 -80.58 -14.55 58.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.733 0.813 . . . . 0.0 111.58 -177.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.5 ' HB3' ' HD3' ' A' ' 246' ' ' LYS . 0.5 OUTLIER -63.06 113.49 3.15 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.634 0.773 . . . . 0.0 111.222 -172.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.85 139.53 22.72 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.736 0.814 . . . . 0.0 110.005 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -67.31 139.64 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.161 0.584 . . . . 0.0 110.876 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 96.88 -21.74 44.4 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.696 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.412 ' HG2' HG13 ' A' ' 223' ' ' VAL . 8.0 tt0 -77.83 122.15 25.06 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.937 0.495 . . . . 0.0 109.968 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 10.5 p -91.84 131.45 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 225' ' ' LEU . 15.6 m -135.64 156.73 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.741 1.216 . . . . 0.0 110.095 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' A' ' 238' ' ' TRP . 39.4 ttp -107.29 127.0 53.16 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.871 0.469 . . . . 0.0 109.988 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.494 ' HG ' HG11 ' A' ' 277' ' ' VAL . 0.1 OUTLIER -131.17 144.98 51.77 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.064 0.946 . . . . 0.0 108.558 -175.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -75.0 106.24 6.41 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -139.94 154.96 47.36 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.672 -169.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 32.6 t-20 -120.44 120.71 29.68 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.18 -29.75 32.36 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.42 2.08 . . . . 0.0 112.688 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -71.48 -53.8 12.72 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.88 0.472 . . . . 0.0 110.281 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 1.0 OUTLIER -117.0 88.59 26.96 Favored Pre-proline 0 N--CA 1.484 1.237 0 C-N-CA 123.823 0.849 . . . . 0.0 109.2 176.232 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.31 -9.85 23.72 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.014 2.476 . . . . 0.0 114.137 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.406 ' HD2' HD13 ' A' ' 272' ' ' ILE . 21.7 tptm -77.61 -15.5 59.18 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.989 0.915 . . . . 0.0 110.916 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -134.66 165.52 25.04 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.52 0.728 . . . . 0.0 110.463 -172.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.7 ppt_? -71.91 163.65 27.47 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.922 0.889 . . . . 0.0 111.023 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -145.52 -84.44 0.06 OUTLIER Glycine 0 C--O 1.239 0.456 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 175.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -128.53 178.09 6.55 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.33 1.052 . . . . 0.0 108.549 173.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . 0.486 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 97.4 m95 -83.21 110.03 17.72 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 122.744 0.418 . . . . 0.0 109.905 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.29 141.29 49.1 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.795 0.838 . . . . 0.0 109.656 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -83.53 123.06 29.37 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.265 0.555 . . . . 0.0 109.709 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -128.62 137.35 51.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.408 1.083 . . . . 0.0 109.59 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 222' ' ' VAL . 33.0 tt0 -94.98 136.43 35.3 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.501 HD11 HD22 ' A' ' 255' ' ' LEU . 33.9 mm -63.96 108.29 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 O-C-N 123.83 0.706 . . . . 0.0 109.46 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.4 t -93.9 -29.16 15.43 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.476 0.711 . . . . 0.0 110.198 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 77.0 ttt180 -167.98 156.26 8.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.355 0.662 . . . . 0.0 109.563 -175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 217' ' ' LEU . 23.8 pttm -148.03 139.84 23.92 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 167.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -134.01 114.84 13.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.791 1.236 . . . . 0.0 107.68 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 9.1 pt-20 -100.23 134.07 43.71 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.014 0.435 . . . . 0.0 109.924 175.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.3 p -118.55 161.76 19.5 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -64.44 -15.08 60.03 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 52.6 p -94.75 -32.06 13.5 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.549 0.74 . . . . 0.0 111.473 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.4 141.38 1.97 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.229 0.612 . . . . 0.0 110.986 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 0.0 OUTLIER -98.18 102.81 14.66 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 121.8 0.81 . . . . 0.0 111.174 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -87.92 116.73 26.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.186 0.994 . . . . 0.0 111.161 -169.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.628 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 3.9 tt -97.84 138.27 35.44 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . 0.509 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 53.2 m-85 -128.44 115.04 17.58 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -132.41 140.0 48.28 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.991 0.516 . . . . 0.0 110.083 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 3.4 p-10 -79.85 96.93 6.47 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.415 0.626 . . . . 0.0 109.551 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 49.6 t -72.83 100.49 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.053 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.2 p -93.74 110.91 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.609 0.718 . . . . 0.0 109.228 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 5.2 mp -83.6 -172.51 4.19 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.247 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.08 -31.45 66.61 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 121.885 -0.197 . . . . 0.0 112.824 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -121.81 -48.62 2.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.141 0.976 . . . . 0.0 109.677 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.74 168.81 18.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.511 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 51.7 p -158.43 112.63 2.5 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.605 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 55.3 mt -94.3 96.9 9.86 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.37 1.068 . . . . 0.0 110.044 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 4.1 p-10 -74.87 137.6 41.9 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.896 0.479 . . . . 0.0 111.439 -174.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 63.58 26.04 14.56 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.835 1.254 . . . . 0.0 113.634 171.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 72.0 m -64.83 133.2 51.44 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.628 0.371 . . . . 0.0 111.296 177.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -68.86 116.46 9.36 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.93 0.768 . . . . 0.0 110.058 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.628 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 45.8 mm -88.74 133.31 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.018 0.527 . . . . 0.0 109.726 177.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.406 HD13 ' HD2' ' A' ' 233' ' ' LYS . 62.3 mt -104.91 -22.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.342 1.057 . . . . 0.0 110.044 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -90.61 41.54 1.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.184 0.993 . . . . 0.0 110.794 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 26.2 m -70.04 -26.07 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.678 1.191 . . . . 0.0 112.686 -169.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -91.92 -3.57 55.79 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.372 0.669 . . . . 0.0 111.724 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.7 25.9 3.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.111 0.564 . . . . 0.0 111.331 -170.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.494 HG11 ' HG ' ' A' ' 225' ' ' LEU . 46.5 t -73.59 153.7 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.885 0.874 . . . . 0.0 110.267 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -116.71 150.26 38.49 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.457 0.703 . . . . 0.0 109.6 169.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.443 ' HE2' HD13 ' A' ' 212' ' ' ILE . 22.2 ttmm -82.97 149.48 26.98 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.227 1.011 . . . . 0.0 110.653 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.491 HD12 ' CH2' ' A' ' 151' ' ' TRP . 32.7 mm -87.1 125.03 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 165.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.52 104.4 6.06 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -173.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 98.0 mtt180 -94.4 103.7 11.75 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 168.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -27.98 118.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 125.25 3.967 . . . . 0.0 116.617 -165.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 106.96 -41.69 2.12 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.922 -0.932 . . . . 0.0 114.612 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 10.5 pt-20 -79.99 -25.23 40.39 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 119.088 1.444 . . . . 0.0 113.338 -170.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -76.84 117.88 5.01 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 17.8 p -63.57 129.8 93.91 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 117.508 0.654 . . . . 0.0 109.65 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.58 153.05 74.23 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.451 2.767 . . . . 0.0 112.85 -172.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' MET . . . . . 0.542 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 57.0 ttm -76.91 79.57 3.48 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-O 121.852 0.834 . . . . 0.0 110.167 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.9 -28.9 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -74.33 178.45 5.17 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.748 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -54.02 141.12 50.29 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.131 0.972 . . . . 0.0 111.964 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.542 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 16.0 Cg_exo -67.68 84.82 0.39 Allowed 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.758 2.305 . . . . 0.0 111.679 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.7 mtm -68.11 109.55 3.57 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.692 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -123.37 137.55 54.8 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.105 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 50.25 0.6 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.793 0.837 . . . . 0.0 110.697 -159.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 190' ' ' ASP . 16.8 ptpt -55.68 149.71 13.78 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.411 1.084 . . . . 0.0 113.872 -173.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.8 m -84.99 76.19 10.3 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -124.59 75.0 0.4 Allowed Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.426 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--N 1.378 2.096 0 C-N-CA 123.153 2.569 . . . . 0.0 112.328 -176.083 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.437 ' HA3' ' HB ' ' A' ' 159' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.61 10.81 15.65 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -169.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -91.74 159.45 15.83 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 166.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 60.0 mttp -79.18 178.64 7.91 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.99 0.516 . . . . 0.0 111.564 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -91.39 17.45 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 123.903 0.881 . . . . 0.0 110.929 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -151.8 9.11 0.51 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.422 0.689 . . . . 0.0 109.715 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 136' ' ' LYS . 9.2 tp10 -75.2 87.56 2.46 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 123.7 0.8 . . . . 0.0 110.133 -170.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 46.2 p90 -74.71 120.92 20.92 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.071 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.42 -170.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.424 1.09 . . . . 0.0 109.55 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -92.61 147.9 22.5 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -140.01 104.22 4.8 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -70.03 103.61 2.32 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 173.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.34 115.07 3.87 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.457 0.703 . . . . 0.0 109.843 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t -68.8 -16.67 63.86 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.163 0.985 . . . . 0.0 112.849 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -82.46 -49.34 10.05 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 122.914 0.486 . . . . 0.0 110.978 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 22.6 ptm -101.4 -13.61 17.91 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.568 0.747 . . . . 0.0 111.441 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.616 ' HA3' ' HA3' ' A' ' 262' ' ' GLY . . . 79.19 20.55 69.56 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 174.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -106.19 153.42 22.15 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.25 0.62 . . . . 0.0 111.278 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.425 ' HZ3' ' HG3' ' A' ' 205' ' ' ARG . 57.2 m95 -78.26 144.67 35.98 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 171.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.419 ' HA ' ' HD1' ' A' ' 238' ' ' TRP . 59.2 m-85 -145.56 145.78 31.14 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.397 0.544 . . . . 0.0 111.146 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 189' ' ' ASP . 75.2 mm-40 -63.51 138.07 58.37 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 167.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -146.82 166.69 25.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.408 0.683 . . . . 0.0 110.269 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.666 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 63.1 tt0 -137.08 105.13 5.65 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.346 0.659 . . . . 0.0 110.1 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.583 HG22 HG13 ' A' ' 186' ' ' VAL . 42.3 t -67.52 100.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.51 -3.02 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.217 0.607 . . . . 0.0 112.453 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.542 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 72.4 ttt180 -166.41 135.06 2.93 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.437 ' HB ' ' HA3' ' A' ' 133' ' ' GLY . 27.6 m -118.25 127.62 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.301 0.64 . . . . 0.0 109.48 173.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.3 p -136.26 145.65 45.82 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.835 0.854 . . . . 0.0 109.264 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.551 ' HD2' ' HB2' ' A' ' 163' ' ' ALA . 13.5 ptt180 -94.27 165.85 12.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.304 0.642 . . . . 0.0 110.474 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -70.21 -35.53 73.97 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.266 175.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.551 ' HB2' ' HD2' ' A' ' 161' ' ' ARG . . . -65.75 142.0 97.98 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.323 0.649 . . . . 0.0 110.628 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.57 140.58 54.75 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.336 2.69 . . . . 0.0 112.807 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.7 m -76.19 115.77 16.23 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.336 0.655 . . . . 0.0 110.581 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -105.73 87.08 2.51 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 169.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.7 t70 67.98 -72.72 0.09 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.211 1.404 . . . . 0.0 109.3 -165.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -168.53 -55.87 0.0 OUTLIER Pre-proline 0 CA--C 1.57 1.722 0 C-N-CA 125.053 1.341 . . . . 0.0 108.828 177.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.89 -171.31 1.02 Allowed 'Trans proline' 0 C--N 1.405 3.527 0 C-N-CA 122.518 2.146 . . . . 0.0 113.116 -174.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 51.9 t 66.02 76.58 0.31 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 124.829 1.252 . . . . 0.0 109.585 -173.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.3 m -66.62 103.84 1.16 Allowed 'General case' 0 C--N 1.35 0.59 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.441 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 5.2 m -77.6 78.45 4.11 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.852 0.861 . . . . 0.0 110.353 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 77.0 p 48.15 51.52 14.65 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.4 1.48 . . . . 0.0 111.82 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.7 t -102.55 26.23 8.15 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.565 -166.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -117.65 86.87 24.56 Favored Pre-proline 0 N--CA 1.482 1.148 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 171.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.469 ' HG2' ' HB3' ' A' ' 181' ' ' ASP . 59.5 Cg_exo -54.8 105.63 0.15 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.004 2.47 . . . . 0.0 112.043 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 65.1 -74.79 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.045 1.338 . . . . 0.0 109.464 -165.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 64.0 tp -149.99 -42.14 0.13 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.621 1.168 . . . . 0.0 108.381 169.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -64.86 128.41 35.63 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.749 0.82 . . . . 0.0 110.083 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.496 ' HB3' HG22 ' A' ' 182' ' ' VAL . 3.6 mp0 -71.86 92.02 1.21 Allowed 'General case' 0 C--O 1.243 0.726 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.469 ' HB3' ' HG2' ' A' ' 176' ' ' PRO . 19.5 t70 -80.11 70.29 6.69 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 160.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 161' ' ' ARG . 18.2 m -126.78 173.94 11.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.507 177.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 183' ' ' ILE . 3.1 mp -96.8 108.87 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.427 0.632 . . . . 0.0 109.748 -166.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -99.77 105.97 17.81 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 17.7 m-70 -78.88 92.88 4.93 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.583 HG13 HG22 ' A' ' 156' ' ' VAL . 2.4 m -108.93 153.55 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.508 ' HB2' ' HZ3' ' A' ' 187' ' ' LYS . 8.1 mtmp? -119.19 118.15 30.57 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -64.72 127.25 30.75 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.453 0.471 . . . . 0.0 110.378 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 153' ' ' GLU . 13.4 t70 -65.85 -37.53 86.45 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.72 -20.32 65.25 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.696 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -139.37 66.87 37.76 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 123.568 0.747 . . . . 0.0 109.11 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -71.2 -40.03 3.51 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.331 2.021 . . . . 0.0 112.883 -169.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.68 -2.57 58.7 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.782 0.833 . . . . 0.0 111.982 -176.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.04 -16.4 59.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.205 0.602 . . . . 0.0 110.56 172.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 100.02 -161.13 19.29 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.206 -0.452 . . . . 0.0 113.16 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 7.6 t -96.3 116.96 39.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 22.4 m -101.88 155.2 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.878 0.871 . . . . 0.0 110.204 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 15.1 pm0 -99.4 128.54 45.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.654 0.782 . . . . 0.0 109.563 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.494 ' HE3' ' HB3' ' A' ' 203' ' ' ASP . 86.3 mmm -130.05 165.05 23.02 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.636 1.175 . . . . 0.0 108.788 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -110.74 172.11 7.06 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 180' ' ' GLU . 56.9 m -58.32 -43.86 88.39 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.137 0.575 . . . . 0.0 111.593 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -22.62 67.0 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.83 0.852 . . . . 0.0 112.219 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.494 ' HB3' ' HE3' ' A' ' 199' ' ' MET . 33.5 m-20 -84.16 -40.68 17.89 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.624 0.77 . . . . 0.0 110.423 175.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 31.3 m -93.38 117.73 37.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 CA-C-O 122.216 1.008 . . . . 0.0 110.011 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.425 ' HG3' ' HZ3' ' A' ' 151' ' ' TRP . 2.0 mmp_? -122.08 -170.27 2.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.971 1.308 . . . . 0.0 109.085 -175.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -101.98 128.58 48.35 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 169.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.588 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -73.95 118.51 16.98 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 167.223 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -69.14 121.93 17.74 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 122.855 0.462 . . . . 0.0 110.446 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -74.41 4.39 6.0 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.217 0.607 . . . . 0.0 111.913 174.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 52.4 m -84.11 105.91 15.34 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.64 114.74 25.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 279' ' ' LYS . 30.8 mm -76.49 133.65 30.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.509 177.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.91 178.04 5.05 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.516 ' HA ' HD13 ' A' ' 217' ' ' LEU . 75.3 t-105 -49.5 -41.87 41.93 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.957 0.903 . . . . 0.0 111.908 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -53.93 -44.18 70.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.466 1.106 . . . . 0.0 112.788 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -115.18 17.15 16.81 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.597 0.759 . . . . 0.0 112.34 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' A' ' 214' ' ' TRP . 53.1 mt -76.2 113.22 13.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 163.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -126.69 152.71 46.42 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.733 0.413 . . . . 0.0 110.274 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.33 140.58 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.219 0.608 . . . . 0.0 110.798 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.45 -1.39 82.12 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.5 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.512 ' HG2' HG11 ' A' ' 223' ' ' VAL . 29.5 tt0 -85.57 120.49 27.08 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.496 0.648 . . . . 0.0 109.818 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 64.8 t -90.05 114.29 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.512 HG11 ' HG2' ' A' ' 221' ' ' GLN . 3.5 m -126.89 163.44 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.501 1.12 . . . . 0.0 109.346 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.403 ' HB3' HD13 ' A' ' 280' ' ' ILE . 0.0 OUTLIER -100.88 139.46 36.53 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.62 ' HG ' HG13 ' A' ' 277' ' ' VAL . 1.1 mp -131.35 167.67 18.86 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -101.36 105.64 16.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.997 0.919 . . . . 0.0 110.434 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -167.71 159.16 11.62 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.485 0.714 . . . . 0.0 110.196 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -103.31 129.15 26.04 Favored Pre-proline 0 C--O 1.217 -0.644 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.82 -7.36 20.97 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 122.405 2.07 . . . . 0.0 113.366 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -70.5 -30.27 67.0 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.116 0.566 . . . . 0.0 109.53 170.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.536 HD21 ' HB2' ' A' ' 234' ' ' GLU . 5.1 t30 -152.45 82.82 5.1 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.754 1.222 . . . . 0.0 107.77 177.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -60.88 -10.9 15.87 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.345 2.696 . . . . 0.0 114.381 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -72.31 -31.34 65.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.458 0.703 . . . . 0.0 110.826 173.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.536 ' HB2' HD21 ' A' ' 231' ' ' ASN . 0.4 OUTLIER -108.01 156.52 19.15 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.822 0.849 . . . . 0.0 111.149 -173.073 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -65.81 161.37 21.09 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.284 -1.325 . . . . 0.0 112.033 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -171.25 -122.92 0.67 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -104.86 -177.32 3.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.179 0.592 . . . . 0.0 110.645 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . 0.419 ' HD1' ' HA ' ' A' ' 152' ' ' PHE . 14.5 m95 -90.59 105.77 18.04 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -173.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -126.63 157.57 38.58 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.77 0.828 . . . . 0.0 111.033 -176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -88.07 146.77 25.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.3 0.64 . . . . 0.0 110.6 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -155.89 138.5 15.06 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.254 1.022 . . . . 0.0 108.529 170.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.6 125.12 39.05 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.55 HD13 HD12 ' A' ' 255' ' ' LEU . 28.5 mm -64.72 108.94 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.548 0.739 . . . . 0.0 109.218 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.3 m -79.92 -48.43 13.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.667 0.787 . . . . 0.0 110.798 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.96 128.44 2.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -170.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -114.23 145.53 41.6 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -141.29 121.02 13.43 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -104.56 126.54 51.74 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 77.7 p -125.23 172.31 9.65 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.182 0.993 . . . . 0.0 108.869 170.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -78.99 -12.41 60.04 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.971 0.508 . . . . 0.0 111.366 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 65.4 p -96.69 -29.14 13.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.37 0.668 . . . . 0.0 111.085 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.54 163.24 38.58 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.031 0.532 . . . . 0.0 111.336 -173.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -116.6 99.89 7.46 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 165.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.37 100.54 13.09 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.181 0.593 . . . . 0.0 110.439 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.55 HD12 HD13 ' A' ' 243' ' ' ILE . 1.7 tm? -96.24 136.09 37.19 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 175.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -125.17 127.61 47.08 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -142.57 140.31 31.69 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.13 0.572 . . . . 0.0 110.575 -176.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.79 102.54 10.05 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 170.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 49.6 t -65.88 121.85 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.794 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.5 p -121.78 107.82 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 121.976 0.893 . . . . 0.0 109.166 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.568 HD12 ' HB3' ' A' ' 264' ' ' ASP . 25.4 mt -88.15 -160.01 0.59 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.437 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.616 ' HA3' ' HA3' ' A' ' 149' ' ' GLY . . . -89.23 -25.47 28.6 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -123.04 -43.72 2.21 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.534 0.734 . . . . 0.0 111.084 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.568 ' HB3' HD12 ' A' ' 261' ' ' LEU . 30.1 t70 -113.37 177.08 4.76 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.572 1.149 . . . . 0.0 110.442 -170.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 57.6 p -148.6 143.4 26.55 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.009 0.924 . . . . 0.0 110.159 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.501 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 2.8 mm? -114.58 106.37 14.17 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -78.59 125.24 29.09 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.57 0.748 . . . . 0.0 110.493 -177.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 62.39 81.56 0.2 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.854 1.261 . . . . 0.0 112.208 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 61.3 m -111.02 127.4 55.52 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 19.4 ttp180 -80.56 104.14 10.89 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 43.1 mm -74.3 120.19 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.247 1.019 . . . . 0.0 110.335 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 54.1 mt -83.52 -20.2 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 125.2 1.4 . . . . 0.0 110.177 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -93.71 37.55 1.07 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.289 1.436 . . . . 0.0 111.902 -167.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 32.9 m -66.9 -28.59 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -169.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -95.77 0.07 51.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.657 0.783 . . . . 0.0 112.293 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -134.72 25.88 3.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.119 0.568 . . . . 0.0 111.3 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.62 HG13 ' HG ' ' A' ' 225' ' ' LEU . 55.5 t -76.11 148.74 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.835 0.854 . . . . 0.0 108.844 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -117.66 150.69 38.63 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.5 ' HB2' HD13 ' A' ' 212' ' ' ILE . 38.8 ttmt -79.45 145.55 33.23 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.952 0.501 . . . . 0.0 111.091 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' A' ' 223' ' ' VAL . 37.0 mm -84.74 139.14 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 166.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.24 147.06 51.92 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 173.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -127.35 144.35 50.45 Favored Pre-proline 0 N--CA 1.473 0.704 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.88 125.48 13.08 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.061 2.508 . . . . 0.0 113.293 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.55 -58.95 0.56 Allowed Glycine 0 C--N 1.345 1.062 0 C-N-CA 123.156 0.408 . . . . 0.0 113.317 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.02 -23.14 26.93 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.249 0.524 . . . . 0.0 111.495 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -125.46 136.51 9.8 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 16.5 m -71.5 148.83 93.38 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 123.314 0.646 . . . . 0.0 110.858 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.8 176.63 9.87 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.133 2.555 . . . . 0.0 111.574 176.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 9.5 ttt -95.12 81.14 3.64 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 14.6 p -100.38 -26.73 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.286 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.31 -177.51 4.66 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.138 0.975 . . . . 0.0 109.912 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -47.62 109.63 1.15 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.508 1.123 . . . . 0.0 111.085 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.77 108.53 1.47 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.565 2.177 . . . . 0.0 111.639 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 58.4 ttp -105.69 91.26 3.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.128 0.971 . . . . 0.0 108.639 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -66.49 142.23 57.61 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.144 0.577 . . . . 0.0 110.631 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -59.99 -32.37 70.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.696 0.798 . . . . 0.0 112.138 -173.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.96 -24.34 66.94 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.268 1.027 . . . . 0.0 111.713 -176.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.8 m -138.81 91.32 2.52 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 172.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -150.08 -63.76 0.01 OUTLIER Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo . . . . . 0 C--N 1.376 2.004 0 C-N-CA 123.046 2.497 . . . . 0.0 111.242 168.889 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.109 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.35 -6.33 50.4 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.178 0.591 . . . . 0.0 112.167 -176.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -98.65 150.07 22.15 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.159 0.504 . . . . 0.0 111.106 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.618 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 48.4 mtpt -84.69 168.83 14.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.564 1.146 . . . . 0.0 110.998 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.2 m -78.75 14.47 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 C-N-CA 124.211 1.004 . . . . 0.0 112.735 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -132.2 0.22 3.75 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.974 0.91 . . . . 0.0 111.412 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.618 ' HG2' ' HB2' ' A' ' 136' ' ' LYS . 27.9 mm-40 -79.9 92.17 5.49 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.62 0.724 . . . . 0.0 112.29 -168.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 12.8 p90 -65.29 100.11 0.44 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.74 165.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.88 -172.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.983 1.313 . . . . 0.0 109.191 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.614 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 15.3 t70 -104.53 157.94 16.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 168.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -133.86 96.07 3.58 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.481 0.312 . . . . 0.0 110.465 169.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -73.41 97.95 2.64 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 169.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.82 128.0 34.11 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.121 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.6 m -68.5 -30.15 68.92 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.22 0.608 . . . . 0.0 111.222 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -74.03 -42.26 60.58 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.347 0.659 . . . . 0.0 111.649 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 54.4 ttm -102.02 -22.8 14.19 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.09 0.556 . . . . 0.0 112.378 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 77.45 0.75 73.58 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-N 116.663 -0.244 . . . . 0.0 113.431 -174.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -93.16 164.83 13.1 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 123.422 0.689 . . . . 0.0 111.342 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.563 ' HB3' ' HB2' ' A' ' 238' ' ' TRP . 2.3 p-90 -77.41 139.59 39.73 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.85 174.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -147.22 77.26 1.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 171.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 50.9 mt-10 -55.99 134.96 52.68 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.572 ' HB3' ' HB ' ' A' ' 186' ' ' VAL . . . -149.15 135.11 18.96 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.655 0.597 . . . . 0.0 111.796 -164.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.3 tt0 -91.44 109.63 20.92 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.51 113.77 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.524 0.73 . . . . 0.0 109.261 170.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.89 -8.7 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 122.967 0.507 . . . . 0.0 111.497 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 36.3 ttm180 -169.93 143.83 2.64 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.639 0.776 . . . . 0.0 109.412 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.455 ' O ' ' HD2' ' A' ' 169' ' ' PRO . 11.0 m -129.34 143.47 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.7 0.8 . . . . 0.0 108.866 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.437 HG23 ' HB ' ' A' ' 183' ' ' ILE . 9.5 t -148.79 163.8 36.3 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.122 0.569 . . . . 0.0 111.207 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.441 ' NH2' ' HA ' ' A' ' 174' ' ' SER . 17.4 mmt180 -87.28 171.78 10.37 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.381 1.072 . . . . 0.0 112.162 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -68.59 -36.91 79.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.473 1.109 . . . . 0.0 110.086 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.27 152.38 90.21 Favored Pre-proline 0 C--O 1.241 0.645 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.003 172.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.49 91.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.785 2.323 . . . . 0.0 111.377 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.4 m -143.03 40.16 1.49 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.427 1.491 . . . . 0.0 107.739 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -69.38 -27.01 64.94 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.938 -169.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -68.97 79.91 0.31 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.479 0.711 . . . . 0.0 112.319 -171.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 28.07 65.67 0.64 Allowed Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 127.263 2.225 . . . . 0.0 115.117 174.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.455 ' HD2' ' O ' ' A' ' 159' ' ' VAL . 36.8 Cg_exo -60.12 -32.29 94.45 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.057 2.504 . . . . 0.0 113.165 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 65.5 m 61.45 -161.05 0.3 Allowed 'General case' 0 CA--C 1.55 0.977 0 O-C-N 124.699 1.25 . . . . 0.0 110.017 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.0 m -64.04 84.74 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.443 0.639 . . . . 0.0 111.398 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 32.0 t -174.15 178.61 2.06 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 124.9 1.28 . . . . 0.0 109.403 -171.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 14.9 t 43.85 53.74 6.04 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 126.236 1.814 . . . . 0.0 113.213 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.441 ' HA ' ' NH2' ' A' ' 161' ' ' ARG . 58.0 m -155.28 22.17 0.42 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.764 0.825 . . . . 0.0 111.526 173.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -61.81 -53.95 55.69 Favored Pre-proline 0 N--CA 1.489 1.514 0 CA-C-O 118.643 -0.694 . . . . 0.0 110.826 172.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -74.9 97.6 1.08 Allowed 'Trans proline' 0 C--N 1.39 2.739 0 C-N-CA 121.722 1.615 . . . . 0.0 110.466 171.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.653 ' HB2' ' HG3' ' A' ' 180' ' ' GLU . . . -160.92 127.38 4.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.204 -173.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.58 -63.06 1.46 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 173.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -112.28 106.98 15.66 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 168.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.653 ' HG3' ' HB2' ' A' ' 177' ' ' ALA . 7.3 mp0 -77.29 89.05 3.72 Favored 'General case' 0 C--O 1.249 1.026 0 CA-C-O 121.19 0.519 . . . . 0.0 110.764 -172.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.06 79.35 9.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 163.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 16.7 m -129.68 157.24 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.955 0.902 . . . . 0.0 108.768 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.457 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.2 mp -95.38 109.39 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -166.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.43 ' HB3' HG13 ' A' ' 186' ' ' VAL . 78.7 m-85 -92.35 111.4 22.95 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.519 1.127 . . . . 0.0 108.973 172.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 17.5 m-70 -77.29 91.59 3.81 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 168.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 34.9 m -109.02 157.92 9.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.477 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.444 ' HZ1' ' HB3' ' A' ' 187' ' ' LYS . 8.0 mtpm? -127.88 115.14 18.14 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -60.43 117.51 5.34 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.698 0.624 . . . . 0.0 111.755 -171.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -56.09 -42.7 77.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.034 1.334 . . . . 0.0 111.554 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -86.14 -16.63 37.32 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.263 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -138.61 68.14 44.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 123.115 0.566 . . . . 0.0 110.836 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.14 -17.67 53.67 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.565 2.177 . . . . 0.0 113.514 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.66 -23.08 66.71 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.743 0.817 . . . . 0.0 112.067 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -74.83 -13.34 60.55 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.151 0.58 . . . . 0.0 111.61 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.99 -141.35 34.33 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.81 0.694 . . . . 0.0 112.308 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 25.9 t -93.19 119.25 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 20.2 m -123.59 155.71 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.964 1.306 . . . . 0.0 109.54 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.457 ' HB2' HG23 ' A' ' 183' ' ' ILE . 20.8 pt20 -98.62 132.29 44.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.866 0.467 . . . . 0.0 110.812 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.58 ' HE1' ' HB3' ' A' ' 203' ' ' ASP . 83.5 mmm -135.24 164.49 27.6 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.998 0.919 . . . . 0.0 108.68 173.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . 0.416 ' O ' HG22 ' A' ' 204' ' ' VAL . 21.4 m-80 -109.71 172.03 7.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' A' ' 180' ' ' GLU . 40.7 m -61.59 -30.25 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.127 0.421 . . . . 0.0 111.134 175.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.403 ' H ' ' HG3' ' A' ' 202' ' ' ARG . 11.8 mtm180 -55.94 -42.59 76.4 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.428 1.091 . . . . 0.0 109.246 175.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.58 ' HB3' ' HE1' ' A' ' 199' ' ' MET . 6.0 m-20 -84.68 -40.44 17.38 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.366 -175.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 18.8 m -91.85 116.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 CA-C-O 122.703 1.24 . . . . 0.0 108.33 -173.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -106.96 137.7 44.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.479 -1.691 . . . . 0.0 107.895 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.541 ' HB2' ' HG2' ' A' ' 281' ' ' GLU . . . -62.37 126.31 26.9 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.711 ' HD3' ' H ' ' A' ' 295' ' ' ARG . 42.2 ttm180 -63.38 95.82 0.1 Allowed 'General case' 0 C--O 1.241 0.634 0 O-C-N 123.972 0.795 . . . . 0.0 109.854 -175.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.06 121.52 10.83 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.891 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -91.93 1.92 56.87 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.216 172.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.0 m -97.92 113.94 25.9 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.747 0.819 . . . . 0.0 110.67 -176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.76 136.8 22.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.759 0.824 . . . . 0.0 108.954 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.455 ' HB ' HG12 ' A' ' 277' ' ' VAL . 37.1 mm -90.25 133.79 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -97.92 172.43 7.65 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.21 0.604 . . . . 0.0 110.688 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . 0.408 ' HA ' HD12 ' A' ' 217' ' ' LEU . 73.1 t-105 -56.01 -43.36 77.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.904 0.882 . . . . 0.0 111.47 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -58.22 -37.96 75.89 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.012 0.925 . . . . 0.0 111.645 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -82.62 -20.91 35.45 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.137 0.575 . . . . 0.0 111.282 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 214' ' ' TRP . 96.0 mt -63.22 118.98 8.73 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.406 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 10.6 pt-20 -144.97 155.56 43.47 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.724 0.809 . . . . 0.0 109.729 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 35.9 m -65.4 131.27 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.149 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.71 -12.58 69.01 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 115.782 -0.645 . . . . 0.0 113.641 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -72.76 123.02 22.47 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.255 0.527 . . . . 0.0 110.535 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 51.7 t -91.62 115.72 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.57 -170.12 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.564 1.546 . . . . 0.0 109.56 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.419 ' HB2' HD11 ' A' ' 280' ' ' ILE . 40.1 ttp -141.59 130.45 23.04 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.949 0.5 . . . . 0.0 109.953 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.29 147.19 34.38 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.857 0.863 . . . . 0.0 109.991 -175.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.41 ' OD1' ' HB2' ' A' ' 235' ' ' ARG . 6.9 p30 -90.92 114.24 26.66 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.392 0.615 . . . . 0.0 111.347 -175.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -137.64 144.54 41.93 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.348 1.059 . . . . 0.0 110.641 174.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -86.11 123.01 72.36 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.77 -9.63 26.13 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.468 2.112 . . . . 0.0 112.703 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.55 -43.57 14.37 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.31 0.644 . . . . 0.0 109.967 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -130.55 89.15 44.76 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.645 0.778 . . . . 0.0 109.967 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.18 -12.23 33.49 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.761 2.308 . . . . 0.0 112.615 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -66.51 -28.65 68.72 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.11 0.564 . . . . 0.0 110.544 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -120.24 161.12 21.63 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.31 0.644 . . . . 0.0 110.068 -173.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.41 ' HB2' ' OD1' ' A' ' 226' ' ' ASN . 1.4 ppt_? -60.47 166.85 2.86 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 124.397 1.079 . . . . 0.0 111.394 175.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -177.37 -113.33 0.35 Allowed Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.302 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -96.73 139.68 32.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.137 0.975 . . . . 0.0 110.178 -172.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 151' ' ' TRP . 79.7 m95 -70.91 123.59 22.37 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.208 0.528 . . . . 0.0 110.548 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -130.92 151.48 51.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.52 137.22 35.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 258' ' ' ASN . . . -134.83 137.71 43.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.804 0.442 . . . . 0.0 110.512 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -96.23 118.56 33.04 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.533 HD13 HD11 ' A' ' 255' ' ' LEU . 44.0 mm -59.64 107.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 123.813 0.696 . . . . 0.0 109.294 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 10.0 m -78.38 -44.19 25.63 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.855 0.862 . . . . 0.0 110.623 -176.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -155.49 155.79 34.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.973 -168.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -149.7 145.58 26.77 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.596 0.56 . . . . 0.0 110.18 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -155.53 117.35 4.05 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.002 0.921 . . . . 0.0 108.535 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -102.98 124.33 48.28 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.1 p -133.25 162.26 32.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.681 0.793 . . . . 0.0 109.598 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.31 -26.73 68.0 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.203 1.001 . . . . 0.0 112.71 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 26.9 p -88.69 -30.24 19.27 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.198 0.599 . . . . 0.0 111.342 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -172.06 151.96 2.8 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.428 0.455 . . . . 0.0 111.462 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -105.86 110.46 22.76 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.901 0.48 . . . . 0.0 109.768 172.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -89.87 129.43 36.23 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.694 1.197 . . . . 0.0 110.825 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.533 HD11 HD13 ' A' ' 243' ' ' ILE . 1.5 tm? -137.34 129.84 29.83 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -118.64 144.26 46.28 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.59 146.04 29.23 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.525 0.73 . . . . 0.0 110.611 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 241' ' ' ALA . 7.3 m-20 -78.19 96.3 5.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.746 0.818 . . . . 0.0 109.233 172.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 51.0 t -76.54 107.57 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 95.8 t -87.52 119.36 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.799 0.84 . . . . 0.0 110.786 -167.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 43.2 mt -107.81 -176.88 3.18 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.356 1.062 . . . . 0.0 108.816 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -76.75 -49.94 7.48 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-O 120.957 0.198 . . . . 0.0 113.247 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.17 -30.73 12.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.445 0.698 . . . . 0.0 109.885 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -112.14 175.34 5.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.571 0.749 . . . . 0.0 111.65 -175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 14.0 p -155.73 113.24 3.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.504 1.122 . . . . 0.0 108.103 170.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.439 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 31.9 mt -80.87 81.7 7.05 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.239 1.015 . . . . 0.0 108.57 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 4.2 p-10 -76.46 135.81 39.39 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.533 -171.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 13.6 t70 56.89 47.45 17.81 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.399 1.08 . . . . 0.0 110.597 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 91.9 m -99.66 132.67 44.85 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.826 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 24.8 ttp180 -62.93 117.9 7.05 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.598 0.759 . . . . 0.0 112.128 -174.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.51 105.56 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.666 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 34.3 mt -70.74 -36.31 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 125.443 1.497 . . . . 0.0 110.507 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -109.26 69.41 0.7 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.7 0.8 . . . . 0.0 109.881 -171.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 18.3 m -71.4 -14.39 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.516 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.19 -28.78 48.21 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.265 1.026 . . . . 0.0 110.87 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -90.6 26.0 2.14 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.332 0.587 . . . . 0.0 111.289 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.455 HG12 ' HB ' ' A' ' 212' ' ' ILE . 71.5 t -96.36 126.12 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.469 1.108 . . . . 0.0 109.602 175.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -112.28 160.88 17.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.181 0.992 . . . . 0.0 109.985 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.66 ' HD3' ' HA2' ' A' ' 286' ' ' GLY . 17.2 ttmm -78.31 136.61 37.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.488 1.115 . . . . 0.0 111.013 177.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 224' ' ' MET . 41.2 mm -83.05 117.15 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 163.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.541 ' HG2' ' HB2' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -68.25 105.36 2.1 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.458 0.647 . . . . 0.0 110.564 -178.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -122.02 142.52 36.66 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 123.654 0.781 . . . . 0.0 108.956 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.15 120.4 6.72 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.477 2.784 . . . . 0.0 113.817 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.26 -25.75 26.63 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-N 116.063 -0.517 . . . . 0.0 114.038 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.04 -12.9 4.61 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 117.855 0.828 . . . . 0.0 112.543 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . 0.66 ' HA2' ' HD3' ' A' ' 279' ' ' LYS . . . -98.11 120.46 6.8 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 123.448 0.546 . . . . 0.0 111.785 -173.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.3 m -75.52 142.3 74.13 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 117.092 0.446 . . . . 0.0 111.604 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.09 148.81 24.88 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.828 2.352 . . . . 0.0 111.993 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' MET . . . . . 0.55 ' SD ' ' HB3' ' A' ' 207' ' ' ARG . 23.5 ttt -77.81 85.1 4.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.242 0.544 . . . . 0.0 109.609 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 10.8 p -123.14 3.64 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.426 1.091 . . . . 0.0 109.668 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -120.36 -167.81 1.52 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.762 1.225 . . . . 0.0 108.341 -171.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -43.54 115.27 1.91 Allowed Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 124.902 1.281 . . . . 0.0 112.961 -177.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.86 115.18 2.94 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.368 2.046 . . . . 0.0 110.915 173.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 22.8 mmt -72.24 -77.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.475 0.71 . . . . 0.0 110.77 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.711 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 6.7 ttt180 66.43 106.58 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.411 1.484 . . . . 0.0 109.752 -176.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.464 ' NH2' ' HB2' ' A' ' 151' ' ' TRP . 7.3 mtm-85 -101.25 22.09 12.98 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.133 1.373 . . . . 0.0 109.688 -167.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -56.44 108.16 0.45 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 125.343 1.457 . . . . 0.0 110.063 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 19.6 m -90.35 118.44 29.84 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.638 0.775 . . . . 0.0 110.028 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -109.27 -118.89 4.14 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-O 118.195 -1.336 . . . . 0.0 111.265 175.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo . . . . . 0 C--N 1.38 2.217 0 C-N-CA 123.298 2.665 . . . . 0.0 112.226 177.704 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 CA-C-O 119.807 -0.44 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.67 -58.77 2.25 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.278 0.631 . . . . 0.0 110.087 -172.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -80.92 159.47 24.96 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.754 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -100.04 177.24 5.15 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.73 0.812 . . . . 0.0 111.022 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.7 m -72.4 0.51 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.688 1.195 . . . . 0.0 113.298 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -119.98 6.0 10.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.656 0.782 . . . . 0.0 112.264 -173.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 156' ' ' VAL . 8.2 mm-40 -82.28 94.8 7.41 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.263 0.554 . . . . 0.0 111.588 -171.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -79.21 101.47 8.0 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.938 171.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 35.9 m -120.08 -166.29 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 125.974 1.71 . . . . 0.0 108.995 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -122.12 165.13 16.58 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.419 ' HB2' ' HB3' ' A' ' 154' ' ' ALA . . . -129.42 140.64 51.26 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.353 0.524 . . . . 0.0 111.418 -175.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.53 HH11 ' HA ' ' A' ' 146' ' ' THR . 1.1 tmt_? -90.74 102.3 15.05 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.25 110.82 2.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.53 ' HA ' HH11 ' A' ' 144' ' ' ARG . 13.1 t -72.58 -26.39 61.69 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 122.97 0.508 . . . . 0.0 111.965 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -80.82 -41.26 23.56 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.695 0.798 . . . . 0.0 111.19 -173.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.5 ttm -94.57 -33.78 12.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.434 0.694 . . . . 0.0 110.767 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.51 14.95 67.14 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.279 -171.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.4 175.23 5.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.133 0.973 . . . . 0.0 110.614 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -115.92 129.79 56.55 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -131.9 135.71 46.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 188' ' ' TYR . 23.9 mt-10 -60.52 142.85 54.79 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.748 0.655 . . . . 0.0 109.309 -178.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 143' ' ' ALA . . . -133.49 117.23 16.92 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.818 0.736 . . . . 0.0 111.267 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -94.24 101.88 13.88 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 55.1 t -63.68 108.55 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 172.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.412 HG13 ' HE2' ' A' ' 187' ' ' LYS . 29.0 m -108.45 -10.52 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.331 0.652 . . . . 0.0 111.97 -177.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 34.6 ttm-85 -168.85 148.2 4.19 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.384 0.674 . . . . 0.0 109.892 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.07 130.2 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.213 1.005 . . . . 0.0 109.484 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.478 ' HG1' ' HB ' ' A' ' 183' ' ' ILE . 38.7 p -130.94 151.84 50.91 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 163' ' ' ALA . 53.0 mtp180 -103.19 178.75 4.47 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -61.55 -24.06 66.38 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.099 0.56 . . . . 0.0 110.944 172.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 161' ' ' ARG . . . -108.54 145.58 31.88 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.574 1.15 . . . . 0.0 108.104 163.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -42.7 -36.59 5.05 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 124.288 3.325 . . . . 0.0 115.409 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.2 m -138.05 -43.29 0.52 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.485 0.714 . . . . 0.0 110.419 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.585 HH11 ' HB2' ' A' ' 167' ' ' ASP . 0.5 OUTLIER 70.26 141.73 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.563 1.545 . . . . 0.0 110.011 -174.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.585 ' HB2' HH11 ' A' ' 166' ' ' ARG . 29.3 t70 70.81 -168.92 0.16 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.971 0.908 . . . . 0.0 109.688 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -49.05 122.86 11.99 Favored Pre-proline 0 CA--C 1.562 1.427 0 CA-C-N 119.093 0.86 . . . . 0.0 111.478 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.5 13.83 0.68 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.583 2.855 . . . . 0.0 114.902 -173.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 4.2 p -75.98 170.24 16.63 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.548 0.739 . . . . 0.0 111.089 173.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.0 m -70.98 85.0 0.69 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.787 0.835 . . . . 0.0 112.736 -171.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 35.7 m 56.29 93.33 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.441 1.496 . . . . 0.0 112.931 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 68.5 p -72.58 -68.06 0.51 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 122.832 0.453 . . . . 0.0 110.373 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 48.7 m -156.02 -69.92 0.11 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.05 0.94 . . . . 0.0 109.667 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 175' ' ' ARG . 1.1 mpt_? 65.14 131.16 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 125.212 1.405 . . . . 0.0 111.89 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.58 117.39 5.12 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.333 2.022 . . . . 0.0 111.89 -174.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.56 81.54 4.88 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.541 0.736 . . . . 0.0 110.212 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 70.7 mt -111.17 -89.73 0.5 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.84 0.856 . . . . 0.0 109.611 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -141.23 78.52 1.65 Allowed 'General case' 0 C--O 1.241 0.629 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.0 97.43 2.31 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.287 -172.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.63 19.64 0.48 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.463 171.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.5 m -66.97 162.14 3.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 124.537 1.135 . . . . 0.0 110.382 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 198' ' ' GLN . 3.9 mp -94.4 109.7 22.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -174.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -88.41 109.09 19.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.996 0.919 . . . . 0.0 109.165 172.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -80.31 88.94 5.51 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 9.9 m -114.0 155.21 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.53 ' HG2' HG22 ' A' ' 196' ' ' VAL . 43.8 mtmt -115.06 131.81 56.8 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 153' ' ' GLU . 19.7 m-30 -60.82 97.62 0.06 Allowed 'General case' 0 C--O 1.209 -1.038 0 O-C-N 123.586 0.554 . . . . 0.0 110.031 170.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.435 ' O ' ' HA3' ' A' ' 299' ' ' GLY . 37.3 t70 -68.05 -21.18 65.01 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.687 0.795 . . . . 0.0 111.652 -173.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 25.6 p30 -85.54 -28.77 24.69 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.67 0.788 . . . . 0.0 111.827 173.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -135.13 69.17 69.99 Favored Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 123.364 0.665 . . . . 0.0 109.818 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.591 ' HD2' ' HD2' ' A' ' 300' ' ' PRO . 74.0 Cg_endo -72.61 -7.3 20.59 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.476 2.118 . . . . 0.0 112.902 -176.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.79 -9.67 59.15 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.634 0.773 . . . . 0.0 110.88 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.49 -19.54 52.81 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.749 0.82 . . . . 0.0 110.443 169.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 84.78 -165.45 40.21 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.911 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.53 HG22 ' HG2' ' A' ' 187' ' ' LYS . 42.2 t -79.24 129.6 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 32.1 m -114.67 155.12 15.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 124.328 1.051 . . . . 0.0 109.541 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.516 ' HB2' HG21 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -102.45 117.08 33.95 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.597 0.759 . . . . 0.0 109.574 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' MET . . . . . 0.584 ' HE1' ' HB3' ' A' ' 203' ' ' ASP . 79.8 mmm -120.79 169.67 10.2 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.033 0.933 . . . . 0.0 109.702 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -109.92 178.58 4.37 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.334 0.654 . . . . 0.0 109.611 172.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 22.7 t -65.36 -39.82 92.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.419 0.688 . . . . 0.0 110.545 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -65.31 -22.87 66.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.546 0.738 . . . . 0.0 111.847 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.584 ' HB3' ' HE1' ' A' ' 199' ' ' MET . 33.9 m-20 -97.85 2.1 48.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.646 0.779 . . . . 0.0 112.339 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.9 m -121.55 134.74 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 171.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.51 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 7.2 ptm180 -120.58 166.4 13.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.012 1.325 . . . . 0.0 109.777 -177.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.02 167.62 21.15 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 163.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.618 ' H ' ' HA ' ' A' ' 288' ' ' PRO . 37.8 ttp180 -143.61 125.98 15.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.39 0.541 . . . . 0.0 110.405 169.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -81.82 158.91 23.9 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.671 1.188 . . . . 0.0 111.782 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.51 23.97 1.51 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.584 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 99.3 m -108.05 113.57 26.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.737 0.815 . . . . 0.0 110.473 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 14.8 mt -85.62 125.98 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 162.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.489 HG22 HG11 ' A' ' 223' ' ' VAL . 46.0 mm -75.7 147.03 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 123.297 0.639 . . . . 0.0 110.79 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.03 179.75 5.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.431 1.092 . . . . 0.0 109.54 176.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -59.89 -32.09 70.41 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.865 0.866 . . . . 0.0 111.037 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -68.92 -25.21 64.47 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.467 ' HB2' HG23 ' A' ' 212' ' ' ILE . 26.3 m-20 -77.21 -26.01 52.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.549 0.34 . . . . 0.0 110.937 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.531 HD21 HG13 ' A' ' 243' ' ' ILE . 50.4 mt -73.43 144.01 46.5 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.614 0.721 . . . . 0.0 112.848 -165.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.27 169.94 20.16 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.033 -1.439 . . . . 0.0 107.987 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.9 117.87 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.91 -6.76 57.01 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 116.024 -0.534 . . . . 0.0 113.171 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.48 ' HG2' ' HA ' ' A' ' 217' ' ' LEU . 4.0 tp-100 -64.49 120.64 12.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.547 0.739 . . . . 0.0 109.644 174.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.7 p -102.88 130.08 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 109.9 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.489 HG11 HG22 ' A' ' 212' ' ' ILE . 15.0 m -141.34 179.8 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 124.532 1.133 . . . . 0.0 110.232 -171.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.585 ' HE3' HH11 ' A' ' 296' ' ' ARG . 21.0 ttp -141.72 124.33 15.9 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 118.033 0.378 . . . . 0.0 111.877 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 273' ' ' PHE . 2.2 pt? -138.69 167.13 22.64 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.143 0.977 . . . . 0.0 110.404 -174.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.81 121.15 26.07 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 170.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -142.98 146.9 34.33 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -122.95 116.06 29.0 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.12 -24.13 66.42 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.229 1.953 . . . . 0.0 112.395 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.57 -44.11 21.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.265 0.626 . . . . 0.0 110.549 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -122.24 80.45 44.62 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.761 0.825 . . . . 0.0 109.798 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.89 -19.92 64.48 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.137 2.558 . . . . 0.0 114.408 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.474 ' HD3' HD11 ' A' ' 272' ' ' ILE . 5.0 tppp? -82.72 -27.14 31.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.943 0.497 . . . . 0.0 111.424 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.499 ' HG2' ' HG2' ' A' ' 235' ' ' ARG . 34.6 tt0 -118.38 160.46 21.63 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 120.913 0.387 . . . . 0.0 110.849 -173.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.499 ' HG2' ' HG2' ' A' ' 234' ' ' GLU . 24.4 ptt-85 -49.09 149.5 1.94 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.442 1.497 . . . . 0.0 113.587 175.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -141.49 -110.53 0.82 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 171.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -117.23 165.17 13.75 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.857 0.863 . . . . 0.0 109.161 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 296' ' ' ARG . 54.0 m95 -80.32 115.01 19.63 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -127.1 166.6 17.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . 0.438 ' HB2' HG23 ' A' ' 260' ' ' VAL . 5.2 m-20 -82.8 156.62 23.58 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -143.49 138.45 29.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 167.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -111.17 118.54 36.25 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.549 HD12 HD23 ' A' ' 255' ' ' LEU . 29.1 mm -63.9 104.56 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 124.459 1.099 . . . . 0.0 110.364 -169.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.43 ' H ' ' HA ' ' A' ' 257' ' ' ALA . 18.8 m -79.82 -32.36 40.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.8 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.583 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 36.5 ttm180 -164.01 156.19 17.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.05 0.94 . . . . 0.0 109.559 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -155.81 148.78 24.34 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -150.5 135.18 17.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.872 0.469 . . . . 0.0 109.904 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -91.93 122.72 34.72 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 58.4 p -122.64 154.44 38.02 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -62.01 -20.59 64.07 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.6 p -97.94 -29.75 13.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.992 0.517 . . . . 0.0 112.164 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.45 165.09 31.64 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.24 0.543 . . . . 0.0 112.384 -169.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -97.79 103.41 15.35 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -92.23 141.32 28.7 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.962 0.905 . . . . 0.0 110.601 -171.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.549 HD23 HD12 ' A' ' 243' ' ' ILE . 1.2 tt -149.66 138.93 21.35 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.668 0.787 . . . . 0.0 108.985 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . 0.583 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 95.5 m-85 -132.09 131.86 42.77 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.921 0.889 . . . . 0.0 108.602 169.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.43 ' HA ' ' H ' ' A' ' 244' ' ' SER . . . -145.97 148.98 33.33 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.001 0.429 . . . . 0.0 111.223 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 43.9 t30 -79.61 97.02 6.34 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.406 171.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.57 103.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 240' ' ' ASP . 30.9 m -96.44 120.24 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.744 0.783 . . . . 0.0 110.56 -171.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 264' ' ' ASP . 19.6 mt -92.26 -159.64 0.68 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.816 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.89 -40.62 89.22 Favored Glycine 0 C--N 1.352 1.423 0 N-CA-C 113.524 0.169 . . . . 0.0 113.524 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -123.5 -49.55 1.9 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.82 0.848 . . . . 0.0 109.675 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.478 ' HB2' HD11 ' A' ' 261' ' ' LEU . 3.3 m-20 -75.16 172.39 12.47 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.481 1.112 . . . . 0.0 111.932 -176.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 15.3 p -159.28 114.47 2.47 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.952 0.901 . . . . 0.0 109.37 175.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -82.06 88.93 6.41 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 25.8 t-20 -76.98 139.47 40.12 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.017 -175.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 38.5 t70 68.07 20.0 9.13 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.696 1.198 . . . . 0.0 111.276 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 48.9 t -71.71 122.84 21.33 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 255' ' ' LEU . 41.7 ttp180 -71.04 119.67 15.5 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.47 ' HB ' HD13 ' A' ' 255' ' ' LEU . 51.0 mm -78.71 95.98 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.615 0 CA-C-O 122.018 0.913 . . . . 0.0 110.163 -173.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.474 HD11 ' HD3' ' A' ' 233' ' ' LYS . 73.4 mt -67.5 -29.74 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 113.263 -1.79 . . . . 0.0 110.337 173.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.58 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 15.0 m-85 -95.65 45.47 1.09 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.678 1.191 . . . . 0.0 109.585 -173.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . 0.464 HG23 HD11 ' A' ' 255' ' ' LEU . 7.3 p -67.01 -20.52 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 124.576 1.15 . . . . 0.0 112.45 -175.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.38 -17.86 19.46 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.4 0.68 . . . . 0.0 111.135 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 65.2 mm-40 -93.59 16.63 13.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.408 1.083 . . . . 0.0 112.045 -174.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.81 138.01 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.303 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.521 ' HB2' ' HE2' ' A' ' 224' ' ' MET . 88.3 m-85 -125.78 163.89 21.89 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.493 1.517 . . . . 0.0 110.049 -168.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.463 ' HA ' ' HE3' ' A' ' 279' ' ' LYS . 0.6 OUTLIER -63.35 136.39 57.62 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.353 178.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 18.3 mm -98.8 116.77 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 162.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.18 134.77 40.48 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.473 1.109 . . . . 0.0 108.948 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -82.19 134.99 48.07 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.179 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.12 124.28 15.58 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.852 2.368 . . . . 0.0 111.794 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.98 -46.87 1.21 Allowed Glycine 0 C--N 1.344 0.98 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -75.87 -23.55 55.63 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.616 0.767 . . . . 0.0 110.925 175.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -130.84 159.13 22.88 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 53.5 p -97.32 150.12 36.45 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.217 0.607 . . . . 0.0 110.712 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.618 ' HA ' ' H ' ' A' ' 207' ' ' ARG . 86.3 Cg_endo -74.14 -171.76 0.98 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.856 2.371 . . . . 0.0 111.897 175.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 16.1 mmt -75.21 79.65 2.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.667 0.746 . . . . 0.0 110.285 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 6.8 p -92.7 -29.94 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.869 1.268 . . . . 0.0 108.619 173.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -81.34 161.29 23.88 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.945 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -46.58 99.41 0.21 Allowed Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 124.987 1.315 . . . . 0.0 111.995 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.31 99.85 0.17 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.608 2.872 . . . . 0.0 114.236 -164.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 55.7 mtm -78.21 92.09 4.43 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -83.28 170.14 14.95 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.072 0.463 . . . . 0.0 110.594 -178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.585 HH11 ' HE3' ' A' ' 224' ' ' MET . 20.9 mtm180 -89.08 91.05 8.66 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.57 0.748 . . . . 0.0 109.21 -169.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 70.17 -107.58 0.06 Allowed 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.27 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 66.5 m -158.75 108.27 1.98 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 122.691 0.396 . . . . 0.0 110.13 -169.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 189' ' ' ASP . . . -75.39 119.11 5.73 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 117.894 -1.503 . . . . 0.0 110.516 164.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . 0.591 ' HD2' ' HD2' ' A' ' 192' ' ' PRO . 85.0 Cg_exo . . . . . 0 C--N 1.381 2.241 0 C-N-CA 124.059 3.173 . . . . 0.0 114.116 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.85 11.15 9.63 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.528 0.731 . . . . 0.0 111.202 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.447 ' O ' HG11 ' A' ' 159' ' ' VAL . 30.5 m-85 -124.4 163.4 21.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.235 1.014 . . . . 0.0 109.315 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.684 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 10.1 ptpp? -123.62 -179.57 4.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.275 1.03 . . . . 0.0 109.358 176.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.33 11.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.498 ' H ' ' HG3' ' A' ' 136' ' ' LYS . 6.9 t-20 -131.32 -6.64 3.79 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.247 0.619 . . . . 0.0 111.105 -174.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.684 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 29.8 mm-40 -78.22 87.15 4.31 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.59 0.71 . . . . 0.0 110.879 -177.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 11.4 p90 -68.91 100.49 1.2 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.289 169.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.38 177.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.456 0.702 . . . . 0.0 109.814 -177.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.636 ' HB2' ' HB3' ' A' ' 207' ' ' ARG . 16.9 t0 -94.25 152.06 18.97 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -146.89 115.65 6.81 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.401 0.68 . . . . 0.0 110.412 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -72.42 115.02 11.18 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.518 ' HB3' ' SD ' ' A' ' 148' ' ' MET . 9.8 t70 -66.68 110.41 3.21 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.4 p -64.74 -7.68 11.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.415 1.086 . . . . 0.0 113.775 -167.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -75.58 -57.14 4.06 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 117.898 0.317 . . . . 0.0 111.113 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.518 ' SD ' ' HB3' ' A' ' 145' ' ' ASP . 1.8 pmm? -104.5 -19.85 13.89 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.131 0.572 . . . . 0.0 111.38 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.44 9.57 61.51 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.911 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.01 128.62 34.16 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.591 0.357 . . . . 0.0 110.856 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.435 ' O ' ' HB2' ' A' ' 238' ' ' TRP . 97.1 m95 -73.09 133.19 44.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.578 0.751 . . . . 0.0 109.283 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -139.59 133.19 30.39 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 207' ' ' ARG . 33.2 tt0 -70.26 90.12 0.68 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.272 0.558 . . . . 0.0 110.427 -175.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.5 ' HB2' ' HB ' ' A' ' 186' ' ' VAL . . . -96.87 118.69 33.86 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.363 0.665 . . . . 0.0 110.007 -172.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.633 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 65.0 tt0 -86.38 116.09 24.32 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.495 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.422 ' HA ' HG12 ' A' ' 186' ' ' VAL . 61.8 t -61.56 109.04 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 124.359 1.037 . . . . 0.0 108.807 172.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.491 HG11 ' HE2' ' A' ' 187' ' ' LYS . 16.1 m -114.58 -0.98 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.993 0.917 . . . . 0.0 112.012 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.608 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 51.1 ttt85 -167.1 138.04 3.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.271 1.028 . . . . 0.0 108.549 173.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 135' ' ' TYR . 26.0 m -116.19 134.19 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.9 p -142.5 150.82 41.0 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.454 0.702 . . . . 0.0 109.738 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.488 ' HB2' ' HG3' ' A' ' 176' ' ' PRO . 46.0 ttt85 -76.91 164.03 26.18 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.699 0.8 . . . . 0.0 110.424 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -63.46 -28.55 70.04 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 120.872 0.367 . . . . 0.0 110.39 172.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.458 ' H ' ' HG2' ' A' ' 161' ' ' ARG . . . -59.34 143.95 84.53 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 124.034 0.934 . . . . 0.0 110.254 170.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -61.49 87.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.804 3.002 . . . . 0.0 114.192 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 12.1 m -90.94 91.79 8.49 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -93.07 -22.61 19.02 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.376 0.67 . . . . 0.0 111.737 -169.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -151.05 162.16 41.38 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.096 0.558 . . . . 0.0 110.174 -172.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.472 ' HG3' ' NH1' ' A' ' 158' ' ' ARG . 3.2 mp0 -75.24 126.78 87.49 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 174.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.36 69.54 4.11 Favored 'Trans proline' 0 CA--C 1.56 1.792 0 C-N-CA 122.127 1.885 . . . . 0.0 111.935 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 80.7 m 59.63 -85.83 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.888 1.675 . . . . 0.0 112.335 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 m -137.09 11.83 3.07 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.343 1.057 . . . . 0.0 110.186 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 25.1 m -91.98 161.76 14.67 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.665 0.786 . . . . 0.0 110.203 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.0 t -165.81 100.49 0.67 Allowed 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 122.193 0.997 . . . . 0.0 109.103 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 80.1 p -94.55 156.38 16.47 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.82 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.79 101.11 31.12 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 123.932 0.893 . . . . 0.0 109.199 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.488 ' HG3' ' HB2' ' A' ' 161' ' ' ARG . 59.6 Cg_endo -67.88 168.24 19.25 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.365 2.043 . . . . 0.0 111.558 172.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.6 157.63 26.5 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.766 0.826 . . . . 0.0 111.489 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.4 pp -72.29 155.25 40.39 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.892 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -165.99 -36.43 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 74.6 -6.48 1.9 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.201 1.401 . . . . 0.0 112.824 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -108.38 23.03 15.11 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 m -81.74 175.71 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 123.657 0.783 . . . . 0.0 109.417 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.511 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.4 mp -97.5 109.39 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.75 0.786 . . . . 0.0 109.964 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 201' ' ' SER . 93.2 m-85 -96.77 113.35 24.9 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.757 1.223 . . . . 0.0 108.211 168.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.608 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 12.7 m-70 -78.67 103.87 8.91 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 154' ' ' ALA . 35.5 m -117.36 157.31 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.468 1.107 . . . . 0.0 110.776 -172.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.491 ' HE2' HG11 ' A' ' 157' ' ' VAL . 50.6 mtmt -129.15 123.83 33.12 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -64.48 133.56 52.7 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.386 0.674 . . . . 0.0 110.339 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.37 -31.52 62.41 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -66.11 -30.75 71.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.089 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -145.69 71.74 13.93 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.046 0.538 . . . . 0.0 110.465 -174.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.87 -26.73 15.3 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.658 2.239 . . . . 0.0 112.047 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -76.42 -10.9 59.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.089 0.956 . . . . 0.0 110.885 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.73 6.09 19.2 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.259 0.624 . . . . 0.0 110.89 170.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.0 -154.14 49.35 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.393 0.433 . . . . 0.0 113.796 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.24 119.18 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.614 0.766 . . . . 0.0 109.57 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.7 m -109.13 153.55 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.992 0.917 . . . . 0.0 109.098 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.511 ' HB2' HG23 ' A' ' 183' ' ' ILE . 5.1 pm0 -91.1 137.3 32.47 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 80.4 mmm -148.51 158.52 44.17 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.049 0.94 . . . . 0.0 110.706 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -112.36 149.85 31.89 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.274 1.43 . . . . 0.0 110.477 -178.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.616 ' HA ' HG22 ' A' ' 204' ' ' VAL . 33.0 t -64.14 -30.32 71.39 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.071 0.949 . . . . 0.0 112.611 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -67.68 -20.63 65.32 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 122.519 -0.113 . . . . 0.0 111.131 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -115.15 -1.8 12.9 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.652 0.781 . . . . 0.0 111.838 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.616 HG22 ' HA ' ' A' ' 201' ' ' SER . 6.0 m -115.71 118.94 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.962 0.887 . . . . 0.0 109.37 169.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -106.07 158.7 16.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -175.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.25 128.12 34.39 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 169.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.636 ' HB3' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -76.28 138.26 40.43 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.127 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -88.57 139.79 30.12 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -90.7 -0.36 57.67 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.479 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 28.0 m -84.29 112.93 20.75 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.51 121.91 37.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.092 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.1 mm -93.41 148.66 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.141 0.977 . . . . 0.0 109.95 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 16.2 ptpt -123.9 169.02 12.01 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.541 0.736 . . . . 0.0 110.226 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -51.37 -44.12 62.02 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.112 0.965 . . . . 0.0 111.562 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -60.78 -35.21 75.87 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.171 -177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.11 -7.87 57.6 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.944 0.897 . . . . 0.0 111.372 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.491 ' O ' ' HD3' ' A' ' 246' ' ' LYS . 97.4 mt -84.67 137.55 33.19 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.736 0.814 . . . . 0.0 110.077 175.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.474 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 9.6 pt-20 -151.78 171.64 17.4 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.773 0.829 . . . . 0.0 110.578 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 29.2 m -67.56 116.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 122.834 0.454 . . . . 0.0 111.745 -175.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.07 -15.12 33.64 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.345 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -71.92 122.42 20.77 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.57 1.148 . . . . 0.0 110.981 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.423 ' HB ' ' NH2' ' A' ' 282' ' ' ARG . 60.7 t -103.73 123.69 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 174.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.88 148.95 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 125.105 1.362 . . . . 0.0 109.927 -176.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 15.7 ptm -98.03 122.7 41.49 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.351 0.596 . . . . 0.0 111.22 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.89 141.85 40.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.742 1.217 . . . . 0.0 109.595 -171.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -96.34 107.35 19.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.017 0.913 . . . . 0.0 111.869 -173.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.564 ' HE2' ' HB2' ' A' ' 239' ' ' TYR . 20.4 p90 -136.33 156.83 48.08 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -87.62 125.07 66.38 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.56 -31.75 95.0 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.366 2.044 . . . . 0.0 112.707 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -81.47 -24.63 36.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.538 0.735 . . . . 0.0 110.982 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -134.62 81.81 46.79 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 123.716 0.807 . . . . 0.0 109.636 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.1 -27.14 73.3 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.602 2.201 . . . . 0.0 112.3 -175.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -85.42 15.07 4.71 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.357 1.063 . . . . 0.0 110.649 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -140.4 146.33 38.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.835 0.854 . . . . 0.0 110.061 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -71.37 138.45 49.2 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.437 0.695 . . . . 0.0 109.42 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.27 -114.36 0.52 Allowed Glycine 0 C--N 1.339 0.738 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -100.17 143.4 30.41 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.476 1.111 . . . . 0.0 109.694 -170.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' TRP . . . . . 0.435 ' HB2' ' O ' ' A' ' 151' ' ' TRP . 60.7 m95 -74.34 124.01 25.67 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.77 0.428 . . . . 0.0 110.049 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.564 ' HB2' ' HE2' ' A' ' 227' ' ' TYR . 96.3 m-85 -131.59 147.29 52.51 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -81.67 142.75 32.44 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.447 ' HB1' HG13 ' A' ' 259' ' ' VAL . . . -142.83 135.95 28.27 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 123.461 0.705 . . . . 0.0 110.029 -170.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -95.98 115.72 27.86 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.57 HD12 HD12 ' A' ' 255' ' ' LEU . 20.0 mm -65.1 113.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 123.803 0.841 . . . . 0.0 108.911 -175.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.4 p -90.97 -20.43 22.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.806 0.842 . . . . 0.0 110.954 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -161.81 142.15 10.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.1 0.56 . . . . 0.0 110.859 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 217' ' ' LEU . 23.5 pttm -122.55 129.5 52.01 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 167.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -155.27 150.54 27.02 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.923 0.889 . . . . 0.0 108.772 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -142.79 137.69 29.89 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.279 0.632 . . . . 0.0 109.761 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 32.7 p -99.04 178.04 5.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 161.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -68.14 -26.7 65.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.203 0.601 . . . . 0.0 110.929 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.7 p -86.5 -30.3 22.07 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.096 0.558 . . . . 0.0 112.132 -174.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -167.21 173.29 9.14 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.983 0.513 . . . . 0.0 110.941 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -109.73 113.53 26.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.105 0.962 . . . . 0.0 109.887 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -91.34 92.45 8.6 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.57 HD12 HD12 ' A' ' 243' ' ' ILE . 1.8 tm? -109.51 129.46 55.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.0 130.79 53.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.52 135.34 22.33 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.069 0.948 . . . . 0.0 109.736 -175.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.405 ' N ' HD21 ' A' ' 258' ' ' ASN . 0.8 OUTLIER -76.42 97.96 4.43 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 176.326 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 266' ' ' LEU . 18.8 m -81.86 107.3 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.488 -175.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.0 p -93.33 131.65 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.377 -175.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.37 -171.6 2.56 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.841 1.256 . . . . 0.0 109.491 174.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -85.9 -17.46 61.42 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-N 116.88 -0.146 . . . . 0.0 113.397 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -122.56 -34.18 3.29 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.368 1.067 . . . . 0.0 110.083 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.46 177.69 5.11 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.758 0.823 . . . . 0.0 109.77 -173.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 33.3 t -150.52 112.96 4.67 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.479 ' HB2' HG23 ' A' ' 259' ' ' VAL . 66.3 mt -80.49 105.83 12.04 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -64.5 122.61 17.19 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.455 0.702 . . . . 0.0 110.952 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 15.1 t70 54.63 74.37 0.35 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.724 1.209 . . . . 0.0 112.325 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 43.6 t -102.2 139.78 37.36 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.495 0.718 . . . . 0.0 109.651 173.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -69.51 134.8 49.31 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.096 0.558 . . . . 0.0 109.639 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 33.1 mm -107.55 130.74 59.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 48.7 mt -98.07 -29.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.39 1.076 . . . . 0.0 110.365 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -95.03 38.03 1.14 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.235 1.014 . . . . 0.0 110.242 -167.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.9 -29.77 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.131 1.372 . . . . 0.0 113.534 -166.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . 0.646 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 45.6 m-20 -100.05 -0.37 39.27 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.392 0.677 . . . . 0.0 111.674 -175.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.539 ' HB2' ' HE3' ' A' ' 297' ' ' LYS . 11.8 pt-20 -125.07 22.59 7.91 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.567 0.698 . . . . 0.0 110.845 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.76 154.24 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.5 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -108.84 160.36 16.05 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.508 0.671 . . . . 0.0 110.336 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -79.11 145.48 33.73 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.508 1.123 . . . . 0.0 111.239 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.401 HG22 ' HG3' ' A' ' 282' ' ' ARG . 40.2 mm -79.67 114.18 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -76.45 115.51 16.26 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.423 ' NH2' ' HB ' ' A' ' 222' ' ' VAL . 95.2 mtt180 -118.8 148.95 45.56 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.008 0.923 . . . . 0.0 109.836 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -55.66 122.22 11.34 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.12 2.546 . . . . 0.0 112.884 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 98.87 -52.03 1.14 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.368 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.35 -22.47 18.31 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.081 0.552 . . . . 0.0 112.139 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -90.29 98.69 2.48 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 8.4 m -64.52 144.56 98.65 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 122.821 0.448 . . . . 0.0 110.613 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.44 140.43 43.86 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.629 2.22 . . . . 0.0 111.447 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' MET . . . . . 0.538 ' HE2' ' HA ' ' A' ' 293' ' ' PRO . 27.6 ttt -76.39 84.36 3.13 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.819 0.819 . . . . 0.0 110.232 -177.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.65 -27.38 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.321 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.28 178.29 8.38 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.253 1.021 . . . . 0.0 109.935 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -42.92 129.02 3.19 Favored Pre-proline 0 N--CA 1.489 1.481 0 C-N-CA 125.4 1.48 . . . . 0.0 113.304 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.538 ' HA ' ' HE2' ' A' ' 289' ' ' MET . 41.0 Cg_exo -58.73 84.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 123.337 2.691 . . . . 0.0 113.702 178.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.5 mmm -74.56 78.02 1.97 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.799 1.24 . . . . 0.0 108.292 168.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -56.9 170.65 0.41 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.013 0.925 . . . . 0.0 113.313 -175.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.416 ' HD3' ' HB2' ' A' ' 153' ' ' GLU . 3.4 tpt180 -57.35 155.94 8.41 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.08 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.539 ' HE3' ' HB2' ' A' ' 276' ' ' GLU . 65.3 mttm -82.99 64.71 7.75 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 165.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.5 p -80.08 83.09 6.02 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 112.912 -1.949 . . . . 0.0 110.384 -171.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 163.05 81.12 0.04 OUTLIER Glycine 0 C--N 1.333 0.405 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 C--N 1.376 2.007 0 C-N-CA 123.164 2.576 . . . . 0.0 111.934 178.65 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 134' ' ' LEU . 1.4 mm? -100.37 -12.25 19.58 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.397 0.679 . . . . 0.0 111.419 -171.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.87 138.78 33.02 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.401 ' H ' ' HB2' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -93.45 176.24 6.45 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 118.532 0.605 . . . . 0.0 112.226 -174.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.68 -14.96 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 124.578 1.151 . . . . 0.0 111.694 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.448 ' HA ' ' NE2' ' A' ' 155' ' ' GLN . 35.2 m-80 -113.01 24.96 11.83 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.34 0.656 . . . . 0.0 111.636 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.503 ' HG3' HG13 ' A' ' 141' ' ' VAL . 8.9 tp10 -98.98 79.77 2.4 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.632 0.73 . . . . 0.0 111.496 -173.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 9.5 p90 -73.55 98.37 2.8 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.172 173.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.503 HG13 ' HG3' ' A' ' 139' ' ' GLU . 15.7 m -114.87 171.56 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.771 0.828 . . . . 0.0 109.196 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 7.1 t0 -90.91 107.74 19.39 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -172.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.74 99.74 12.57 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.956 0.902 . . . . 0.0 109.756 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -76.06 98.91 4.45 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.9 123.68 20.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 170.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.1 t -79.9 -28.15 39.87 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.741 0.816 . . . . 0.0 110.837 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -68.85 -51.49 39.91 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.065 0.946 . . . . 0.0 111.124 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 43.8 ttp -94.72 -14.1 25.1 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.343 0.657 . . . . 0.0 109.883 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.88 7.08 86.17 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 113.668 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.52 134.52 43.36 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.733 0.413 . . . . 0.0 111.871 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -75.31 135.85 40.89 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.386 1.074 . . . . 0.0 109.34 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -143.14 118.4 10.19 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.491 ' HG3' ' NH1' ' A' ' 296' ' ' ARG . 41.5 mt-10 -59.21 98.58 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.996 0.518 . . . . 0.0 109.889 176.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -103.04 138.82 39.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.432 1.093 . . . . 0.0 112.374 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.4 tp60 -87.2 104.47 16.41 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.921 1.688 . . . . 0.0 110.546 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.651 HG22 HG12 ' A' ' 186' ' ' VAL . 59.2 t -61.99 115.43 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.64 -12.77 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.89 0.876 . . . . 0.0 111.265 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -161.17 144.98 13.16 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.539 0.736 . . . . 0.0 109.549 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.22 137.33 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 166.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.6 p -132.65 150.62 52.13 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -87.37 161.09 18.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.998 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 79.9 tttt . . . . . 0 CA--C 1.551 0.991 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.324 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 . . . . . 0 C--O 1.247 0.948 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.462 ' HB3' HG22 ' A' ' 182' ' ' VAL . 2.3 mp0 -68.61 105.31 2.21 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.484 -172.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.31 50.23 0.5 Allowed 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 122.234 1.016 . . . . 0.0 110.283 166.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 180' ' ' GLU . 13.2 m -122.64 160.85 24.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 174.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.519 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.3 mp -95.56 110.83 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -166.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -92.59 109.2 20.61 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -78.56 98.68 6.21 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 156' ' ' VAL . 14.7 m -107.98 165.43 4.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.358 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -130.43 116.49 18.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -54.21 110.26 0.59 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.635 0.652 . . . . 0.0 109.26 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.03 -22.42 62.14 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.738 0.78 . . . . 0.0 109.217 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.622 ' HA ' ' HA ' ' A' ' 297' ' ' LYS . 0.9 OUTLIER -69.3 -28.37 66.21 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.837 1.255 . . . . 0.0 111.899 171.278 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -142.2 78.82 16.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 123.75 0.82 . . . . 0.0 109.862 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.09 -22.33 55.41 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.322 2.682 . . . . 0.0 113.814 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -66.27 -18.85 65.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.178 0.991 . . . . 0.0 112.074 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.11 -21.65 58.76 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.987 0.515 . . . . 0.0 111.241 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 67.24 -148.0 49.63 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.67 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 18.8 t -84.56 114.7 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.3 m -112.2 151.01 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.657 1.183 . . . . 0.0 109.39 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.519 ' HB2' HG23 ' A' ' 183' ' ' ILE . 16.6 pt20 -94.66 123.45 38.1 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.061 0.544 . . . . 0.0 110.568 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 87.8 mmm -139.17 135.6 34.19 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -88.11 176.46 7.27 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 14.0 t -64.96 -39.81 94.05 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.074 0.397 . . . . 0.0 111.188 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -50.97 -29.12 11.41 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.68 0.792 . . . . 0.0 112.388 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -92.92 -39.17 11.3 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.738 0.815 . . . . 0.0 111.34 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.429 HG11 HG11 ' A' ' 186' ' ' VAL . 27.8 m -98.77 114.84 37.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 CA-C-O 121.991 0.9 . . . . 0.0 110.132 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -110.81 165.91 11.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.673 1.189 . . . . 0.0 108.704 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -78.88 124.82 28.61 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 102.41 0.22 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.548 0.739 . . . . 0.0 110.33 172.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 281' ' ' GLU . . . -68.6 99.36 0.98 Allowed 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.704 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -77.06 75.02 3.63 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.752 0.657 . . . . 0.0 110.223 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 92.5 m -147.34 108.54 4.26 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 28.8 mt -82.86 116.5 27.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.611 HD11 ' HB3' ' A' ' 279' ' ' LYS . 41.5 mm -79.25 120.41 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.516 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -76.96 164.99 25.26 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' TRP . . . . . 0.519 ' HA ' HD12 ' A' ' 217' ' ' LEU . 90.3 t90 -56.04 -43.65 78.06 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.686 0.794 . . . . 0.0 111.029 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -69.48 -18.61 63.72 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.846 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.63 -19.12 22.21 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.769 0.427 . . . . 0.0 110.086 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 214' ' ' TRP . 88.2 mt -69.05 129.22 39.28 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLU . . . . . 0.456 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 7.9 pt-20 -147.89 160.59 42.62 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.215 1.006 . . . . 0.0 109.573 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 35.0 m -59.4 134.66 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 123.631 0.582 . . . . 0.0 111.958 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.13 -22.26 30.22 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.835 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -74.62 121.47 21.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.201 0.6 . . . . 0.0 110.912 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.63 130.0 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.414 0.686 . . . . 0.0 109.275 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.1 m -140.87 147.21 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.674 1.19 . . . . 0.0 109.584 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 20.8 ptm -98.64 127.93 44.75 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.343 0.657 . . . . 0.0 111.257 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.577 HD13 HG23 ' A' ' 271' ' ' ILE . 2.2 pt? -134.58 155.58 50.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.267 1.027 . . . . 0.0 110.602 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -71.7 106.78 4.23 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -132.68 128.11 36.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.505 0.722 . . . . 0.0 109.964 -169.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ASN . . . . . 0.452 HD22 ' HB3' ' A' ' 231' ' ' ASN . 49.3 t30 -89.44 113.07 55.11 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.95 -5.26 16.73 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.645 2.23 . . . . 0.0 112.582 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.86 -32.34 23.28 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.22 0.608 . . . . 0.0 110.176 171.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.452 ' HB3' HD22 ' A' ' 228' ' ' ASN . 33.8 t30 -151.52 105.16 2.91 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 123.923 0.889 . . . . 0.0 109.576 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.55 -18.39 63.27 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.27 2.647 . . . . 0.0 113.322 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -84.88 -5.96 59.34 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.049 0.94 . . . . 0.0 110.952 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -126.88 153.35 45.84 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.583 0.753 . . . . 0.0 110.054 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -75.27 162.59 28.3 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.537 0.735 . . . . 0.0 112.002 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -169.47 -124.21 0.72 Allowed Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.11 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -82.84 146.75 28.74 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.89 0.876 . . . . 0.0 109.559 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' TRP . . . . . 0.44 ' CE2' ' HD2' ' A' ' 296' ' ' ARG . 43.5 m95 -74.92 111.76 10.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.869 0.366 . . . . 0.0 111.673 -175.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -119.12 166.24 13.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.377 1.071 . . . . 0.0 110.193 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ASP . . . . . 0.525 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 3.8 m-20 -82.45 158.62 23.17 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.931 0.892 . . . . 0.0 109.512 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -151.51 132.26 14.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.904 0.482 . . . . 0.0 109.774 169.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -95.95 117.28 30.32 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 174.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.616 HD12 HD11 ' A' ' 255' ' ' LEU . 25.3 mm -65.4 124.23 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.649 0.593 . . . . 0.0 109.424 -175.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.0 t -108.29 -43.51 4.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.575 0.75 . . . . 0.0 109.58 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.505 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 63.0 mtt180 -139.34 157.48 45.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.457 1.103 . . . . 0.0 110.0 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -154.37 120.22 5.24 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.06 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 45.7 ttt-85 -144.1 115.68 8.14 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -93.65 133.61 36.81 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.366 0.603 . . . . 0.0 110.0 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 39.2 p -107.97 166.71 10.51 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 167.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -71.33 -10.4 59.69 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.5 p -94.04 -28.71 15.59 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.192 0.597 . . . . 0.0 111.515 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -171.27 145.97 2.26 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -80.46 102.68 9.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.168 0.987 . . . . 0.0 109.482 172.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -95.47 140.16 30.71 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.35 0.66 . . . . 0.0 111.674 -173.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.616 HD11 HD12 ' A' ' 243' ' ' ILE . 0.6 OUTLIER -132.57 142.4 49.14 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -176.229 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 256' ' ' TYR . . . . . 0.505 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 92.1 m-85 -132.11 122.55 25.56 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.95 46.23 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.176 0.512 . . . . 0.0 111.778 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 39.9 t30 -78.64 95.58 5.29 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.73 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 59.9 t -76.19 107.17 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.26 0.553 . . . . 0.0 110.313 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 39.4 t -86.12 115.17 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.081 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.23 -152.56 0.12 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.013 1.325 . . . . 0.0 110.208 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -48.25 -65.23 2.63 Favored Glycine 0 C--N 1.363 2.056 0 C-N-CA 124.092 0.853 . . . . 0.0 114.266 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -123.09 -22.41 5.19 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.546 0.738 . . . . 0.0 109.575 165.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -76.17 177.35 7.24 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.166 0.987 . . . . 0.0 112.077 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 35.6 p -153.17 154.41 34.69 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.679 0.792 . . . . 0.0 110.44 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 69.8 mt -128.77 89.71 2.93 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.441 1.096 . . . . 0.0 108.783 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 61.6 t30 -71.87 136.55 46.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.759 0.424 . . . . 0.0 111.431 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 14.6 t70 60.35 68.58 0.75 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.24 1.416 . . . . 0.0 111.078 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 79.9 m -113.72 135.39 53.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.919 0.888 . . . . 0.0 109.553 169.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -66.51 116.7 7.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.926 0.49 . . . . 0.0 110.714 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.613 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 43.1 mm -92.49 96.28 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.981 0.912 . . . . 0.0 108.88 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 62.6 mt -76.23 -23.48 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.217 1.007 . . . . 0.0 110.713 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.446 ' HD2' HD12 ' A' ' 225' ' ' LEU . 24.5 m-85 -93.21 32.0 1.39 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.458 1.103 . . . . 0.0 111.214 -166.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.07 -21.45 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.273 1.029 . . . . 0.0 112.003 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.65 -21.72 44.46 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.914 0.886 . . . . 0.0 111.827 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.63 9.42 3.37 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.134 0.574 . . . . 0.0 112.278 -168.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.4 129.16 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 122.985 0.514 . . . . 0.0 110.263 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -92.52 161.33 14.65 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.749 0.82 . . . . 0.0 110.652 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.611 ' HB3' HD11 ' A' ' 212' ' ' ILE . 18.2 ptmt -82.32 158.12 23.54 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.446 0.698 . . . . 0.0 111.087 176.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 42.2 mm -87.65 131.39 35.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 166.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 208' ' ' ALA . 0.0 OUTLIER -72.44 104.79 3.9 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.427 -175.53 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.706 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 84.6 mtt180 -87.36 159.49 50.26 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 123.466 0.707 . . . . 0.0 111.125 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -55.25 94.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.426 2.751 . . . . 0.0 113.513 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.38 -46.44 1.24 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.294 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.706 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 21.6 tt0 -73.59 -17.88 61.12 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.3 0.64 . . . . 0.0 111.452 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -74.78 98.9 1.09 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.622 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.1 p -75.32 126.15 88.1 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.403 0.681 . . . . 0.0 111.124 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.24 167.1 26.5 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 123.193 2.595 . . . . 0.0 112.379 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' MET . . . . . 0.569 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 55.1 ttm -86.26 81.39 8.41 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.4 p -96.21 -28.55 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.35 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -81.88 -172.71 4.06 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.373 1.069 . . . . 0.0 109.143 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -45.14 117.42 3.31 Favored Pre-proline 0 N--CA 1.489 1.49 0 C-N-CA 124.912 1.285 . . . . 0.0 112.742 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.569 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 64.9 Cg_exo -55.96 141.75 85.76 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.656 2.238 . . . . 0.0 113.36 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 24.5 mmt -84.06 -69.57 0.63 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 49.47 62.32 2.69 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 122.006 0.908 . . . . 0.0 109.15 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.491 ' NH1' ' HG3' ' A' ' 153' ' ' GLU . 12.5 ptt180 -58.48 -29.16 66.02 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.092 -166.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.622 ' HA ' ' HA ' ' A' ' 190' ' ' ASP . 38.6 mtmm 54.1 58.04 5.38 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.952 0.901 . . . . 0.0 111.974 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 CA--C 1.538 0.508 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.037 -178.795 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.379 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.19 2.72 8.56 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.674 0.79 . . . . 0.0 110.808 173.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -127.54 137.6 52.66 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.467 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 2.1 mptp? -89.65 175.25 7.34 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.535 1.134 . . . . 0.0 110.256 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.7 m -75.9 8.07 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.035 0.934 . . . . 0.0 112.811 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -124.96 -1.17 7.83 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.622 0.769 . . . . 0.0 110.236 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.467 ' HG2' ' HB2' ' A' ' 136' ' ' LYS . 22.3 mm-40 -91.21 89.98 7.57 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.677 0.751 . . . . 0.0 111.652 -170.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 6.8 p90 -63.48 111.5 2.36 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.346 164.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.2 m -120.89 166.69 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.189 0.995 . . . . 0.0 109.32 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -93.05 104.95 17.12 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.494 ' HB2' HG12 ' A' ' 204' ' ' VAL . . . -109.65 117.56 34.25 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.753 1.221 . . . . 0.0 109.93 -176.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -73.93 112.74 10.35 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.79 127.49 32.68 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.6 m -69.58 -27.8 65.43 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.845 0.858 . . . . 0.0 111.38 -173.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.47 -44.12 13.0 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.459 0.704 . . . . 0.0 110.968 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 51.0 tpp -75.71 -37.62 59.31 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.75 0.82 . . . . 0.0 110.611 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.3 7.79 88.2 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.133 -0.939 . . . . 0.0 113.215 -172.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 239' ' ' TYR . . . -107.03 152.54 23.85 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.607 0.763 . . . . 0.0 110.858 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 238' ' ' TRP . 67.2 m95 -77.65 132.29 38.15 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.496 1.118 . . . . 0.0 109.919 171.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -136.54 130.97 33.23 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.235 1.014 . . . . 0.0 108.702 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.35 96.78 0.51 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.598 0.713 . . . . 0.0 109.218 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.72 128.15 45.83 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.928 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.648 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 56.7 tt0 -84.91 105.69 15.87 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.743 0.817 . . . . 0.0 110.647 -173.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.71 107.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.6 m -107.64 -3.13 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.651 0.781 . . . . 0.0 111.234 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.518 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 79.2 ttt180 -171.28 146.44 2.33 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.157 0.911 . . . . 0.0 108.986 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.0 m -125.78 144.39 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.4 p -131.85 130.44 41.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -73.32 147.99 43.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.668 0.787 . . . . 0.0 109.407 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 61.1 mttm . . . . . 0 N--CA 1.496 1.859 0 C-N-CA 123.179 0.592 . . . . 0.0 111.402 -176.409 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 201' ' ' SER . 1.0 OUTLIER -80.75 67.89 6.79 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.404 1.097 . . . . 0.0 110.67 -178.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.504 ' HA ' ' H ' ' A' ' 201' ' ' SER . 67.9 m-20 -82.89 44.74 0.94 Allowed 'General case' 0 C--O 1.243 0.727 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.537 174.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.1 m -69.58 176.49 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.881 0 C-N-CA 124.472 1.109 . . . . 0.0 108.507 174.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 183' ' ' ILE . 2.6 mp -92.35 106.37 17.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -172.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -89.01 104.03 16.6 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 7.0 m170 -79.7 92.84 5.44 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.31 158.17 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.609 0.764 . . . . 0.0 110.615 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -123.98 119.49 29.71 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -57.83 125.83 24.74 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.74 -31.37 72.52 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.271 0.558 . . . . 0.0 109.974 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.46 -28.94 62.22 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.247 175.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -139.32 71.89 38.84 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.14 0.576 . . . . 0.0 112.022 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.05 -15.86 28.99 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.527 2.151 . . . . 0.0 111.184 165.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.33 -22.89 66.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.315 1.046 . . . . 0.0 111.587 173.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -78.77 -5.37 53.14 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.791 0.836 . . . . 0.0 111.356 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.4 -161.95 53.13 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.555 0.534 . . . . 0.0 111.817 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 25.5 t -86.53 124.09 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 29.2 m -107.49 154.58 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.928 0.891 . . . . 0.0 110.09 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -92.93 131.16 38.18 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.542 0.737 . . . . 0.0 109.472 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 92.9 mmm -131.88 153.58 50.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.514 0.726 . . . . 0.0 109.299 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASN . . . . . 0.551 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 36.9 m-80 -98.96 172.21 7.55 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.574 0.75 . . . . 0.0 109.163 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 10.9 t -67.64 -29.34 68.63 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.139 0.427 . . . . 0.0 110.84 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.551 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 17.2 ptp180 -62.19 -25.56 67.85 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.474 0.71 . . . . 0.0 111.638 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -92.23 -39.87 11.3 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.87 0.868 . . . . 0.0 111.0 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' A' ' 201' ' ' SER . 26.8 m -93.85 117.35 37.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 CA-C-O 122.462 1.125 . . . . 0.0 109.292 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 170.82 7.67 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.906 174.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.82 148.78 27.56 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 167.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.41 ' O ' ' HE3' ' A' ' 289' ' ' MET . 37.7 mtm105 -72.37 109.91 6.42 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.38 113.75 3.84 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.83 0.452 . . . . 0.0 110.638 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' A' ' 289' ' ' MET . 5.8 ptm180 -82.09 9.36 8.66 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.007 0.923 . . . . 0.0 112.23 -177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.9 m -100.91 112.32 24.73 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.028 0.931 . . . . 0.0 110.088 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 277' ' ' VAL . 38.1 mt -85.54 130.75 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 279' ' ' LYS . 30.1 mm -96.77 148.08 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.516 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 1.5 ptpp? -129.52 171.22 12.8 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.97 0.908 . . . . 0.0 109.96 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' TRP . . . . . 0.43 ' HA ' HD12 ' A' ' 217' ' ' LEU . 72.1 t-105 -53.78 -44.83 70.4 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.535 1.134 . . . . 0.0 112.103 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -71.24 -11.28 60.84 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.668 0.787 . . . . 0.0 112.442 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -109.33 -7.96 15.15 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.221 1.008 . . . . 0.0 110.704 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 213' ' ' LYS . 92.2 mt -72.17 124.11 24.33 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -134.03 146.73 50.64 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 31.6 m -67.44 126.89 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 123.54 0.525 . . . . 0.0 111.322 -174.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 106.1 -16.86 41.99 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.681 -0.511 . . . . 0.0 113.011 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.425 ' HG2' HG13 ' A' ' 223' ' ' VAL . 8.6 tt0 -80.4 122.24 26.72 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.21 0.604 . . . . 0.0 110.472 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 50.8 t -91.39 129.78 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.962 0.905 . . . . 0.0 108.935 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.425 HG13 ' HG2' ' A' ' 221' ' ' GLN . 2.8 m -145.73 149.65 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.676 1.19 . . . . 0.0 110.586 -172.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.523 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 20.0 ptm -100.34 125.51 46.58 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.643 0.777 . . . . 0.0 111.357 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.431 ' HG ' HG13 ' A' ' 277' ' ' VAL . 1.4 mp -127.11 158.7 36.32 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.971 0.908 . . . . 0.0 108.798 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -89.66 106.12 18.25 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.363 0.601 . . . . 0.0 110.232 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -167.4 148.09 5.45 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.749 1.22 . . . . 0.0 108.602 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -90.76 144.82 30.91 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.434 ' HB3' HD21 ' A' ' 261' ' ' LEU . 33.9 Cg_endo -62.29 -37.17 63.4 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.137 2.558 . . . . 0.0 112.373 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -71.03 -19.41 62.51 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.012 0.925 . . . . 0.0 111.721 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -144.23 82.97 10.38 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 122.746 0.419 . . . . 0.0 110.104 174.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.06 -4.48 15.49 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.534 2.156 . . . . 0.0 112.833 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -72.73 -27.51 62.09 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.106 0.963 . . . . 0.0 110.958 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -138.38 161.6 36.55 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.46 0.704 . . . . 0.0 110.376 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -52.81 156.34 2.02 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.575 1.55 . . . . 0.0 112.711 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -161.98 -93.42 0.09 OUTLIER Glycine 0 C--N 1.335 0.515 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.644 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -129.08 167.78 17.03 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.596 0.758 . . . . 0.0 109.354 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' TRP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 89.9 m95 -79.4 105.75 10.94 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 150' ' ' ALA . 46.6 m-85 -121.65 154.74 36.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.092 0.957 . . . . 0.0 109.726 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ASP . . . . . 0.748 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 0.8 OUTLIER -82.07 154.12 25.76 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.555 -177.247 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -152.19 134.23 14.97 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -100.11 118.45 36.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.466 HD12 HD21 ' A' ' 255' ' ' LEU . 26.5 mm -59.09 110.01 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.9 m -100.25 -25.77 14.14 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.235 0.614 . . . . 0.0 110.352 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 59.8 ttt180 -172.02 149.95 2.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.174 0.99 . . . . 0.0 108.642 -174.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -154.85 147.95 24.77 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -148.49 119.06 7.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.709 0.804 . . . . 0.0 108.873 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -96.89 124.53 40.89 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 54.1 p -124.62 162.61 23.74 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 167.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -60.69 -18.58 54.9 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.693 0.797 . . . . 0.0 112.612 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 53.6 p -93.85 -32.92 13.74 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.45 0.7 . . . . 0.0 112.151 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -174.08 164.54 4.11 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.298 0.57 . . . . 0.0 111.225 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -107.47 114.91 29.22 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.388 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -94.78 97.44 10.05 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.526 ' O ' ' HA ' ' A' ' 270' ' ' ARG . 1.7 tt -102.83 125.58 49.63 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' TYR . . . . . 0.488 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 43.4 m-85 -118.46 116.98 27.8 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -136.92 143.56 42.98 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.237 0.615 . . . . 0.0 111.095 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -78.13 99.37 6.15 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 94.9 t -64.93 106.64 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.494 0.718 . . . . 0.0 109.37 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.748 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 58.6 t -87.52 98.89 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' A' ' 229' ' ' PRO . 31.9 mt -84.14 -177.94 6.8 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.416 176.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -76.65 -45.05 13.94 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.387 -0.37 . . . . 0.0 112.612 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -107.52 -5.47 17.57 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.959 0.904 . . . . 0.0 111.726 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -155.46 176.12 13.01 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.49 0.716 . . . . 0.0 110.25 -172.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 27.7 p -145.63 115.86 7.49 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.478 0.711 . . . . 0.0 110.404 171.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 66.1 mt -82.53 95.05 7.61 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.688 0.795 . . . . 0.0 109.911 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -70.93 136.28 48.44 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.346 0.258 . . . . 0.0 110.689 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 14.6 t70 60.08 75.7 0.39 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.957 1.303 . . . . 0.0 111.347 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 42.9 t -111.6 129.2 56.15 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.917 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 71.4 ttt-85 -74.73 107.88 7.12 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.435 ' HB ' HD13 ' A' ' 255' ' ' LEU . 43.2 mm -90.81 128.3 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.773 0.829 . . . . 0.0 109.572 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 67.2 mt -96.12 -21.33 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.194 0.998 . . . . 0.0 110.694 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -86.44 45.13 1.21 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.207 1.003 . . . . 0.0 111.471 -173.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.513 HG12 HD12 ' A' ' 255' ' ' LEU . 24.7 m -64.74 -21.84 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 125.11 1.364 . . . . 0.0 113.437 -169.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -110.87 -24.87 10.17 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.157 0.983 . . . . 0.0 110.115 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -89.0 44.26 1.2 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.879 0.872 . . . . 0.0 110.2 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.431 HG13 ' HG ' ' A' ' 225' ' ' LEU . 4.1 t -103.14 150.19 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.026 0.93 . . . . 0.0 109.279 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.523 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 72.9 m-85 -124.91 154.85 40.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 167.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.537 ' HB2' HD11 ' A' ' 212' ' ' ILE . 22.9 ttmm -77.42 144.85 37.54 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 45.9 mm -69.88 127.16 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.96 105.5 2.03 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 174.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 78.8 mtp180 -115.03 147.66 38.84 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 124.574 1.15 . . . . 0.0 109.888 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.79 102.03 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.588 2.192 . . . . 0.0 111.407 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.51 -4.58 54.31 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-O 119.109 -0.828 . . . . 0.0 114.364 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 33.3 tt0 -128.27 -25.14 3.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.157 0.979 . . . . 0.0 112.426 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -75.13 112.14 3.56 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.8 m -64.75 131.44 95.15 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 117.091 0.445 . . . . 0.0 111.186 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.68 135.41 19.69 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.306 2.67 . . . . 0.0 111.341 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' MET . . . . . 0.485 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 38.5 ttm -78.97 82.3 5.16 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.836 0.826 . . . . 0.0 109.767 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.2 p -108.68 -23.12 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.293 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -99.52 -153.84 0.45 Allowed 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 293' ' ' PRO . 27.3 t-20 -57.5 127.16 77.14 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-N 119.116 0.871 . . . . 0.0 111.87 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.485 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 12.0 Cg_exo -72.57 111.9 3.34 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.373 2.715 . . . . 0.0 113.673 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 91.7 mmm -77.14 115.96 17.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.143 0.577 . . . . 0.0 110.207 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -100.01 171.7 7.67 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.309 1.044 . . . . 0.0 109.158 171.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.65 -29.06 2.67 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.687 0.795 . . . . 0.0 108.936 164.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -169.64 121.61 0.71 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.777 1.231 . . . . 0.0 109.013 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.544 0.716 0 C-N-CA 123.688 0.795 . . . . 0.0 109.255 178.816 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.226 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -91.81 -13.31 31.67 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.848 0.859 . . . . 0.0 111.207 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.434 ' O ' HG11 ' A' ' 159' ' ' VAL . 25.6 m-85 -94.91 162.64 13.66 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.548 0.739 . . . . 0.0 109.542 171.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.75 -177.41 3.82 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.04 0.936 . . . . 0.0 109.043 171.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.5 m -68.22 2.47 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -173.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -112.94 -9.97 13.57 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.637 0.775 . . . . 0.0 111.377 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.87 84.87 3.44 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.459 0.703 . . . . 0.0 111.562 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.671 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 3.9 p90 -71.93 99.61 2.27 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.079 168.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.98 -178.97 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.476 1.11 . . . . 0.0 109.13 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 5.3 t0 -94.75 163.21 13.45 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.651 0.78 . . . . 0.0 108.922 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.436 ' HB2' HG12 ' A' ' 204' ' ' VAL . . . -152.07 125.35 8.74 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 120.872 0.368 . . . . 0.0 111.833 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -74.83 109.73 8.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.786 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.479 ' HB3' ' SD ' ' A' ' 148' ' ' MET . 9.2 t70 -80.01 117.99 21.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.8 m -66.86 -28.49 68.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.839 0.856 . . . . 0.0 112.333 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -58.05 -54.74 43.49 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.6 0.76 . . . . 0.0 111.948 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.479 ' SD ' ' HB3' ' A' ' 145' ' ' ASP . 1.7 pmm? -103.35 -8.86 19.93 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.575 0.35 . . . . 0.0 111.006 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.12 18.27 80.14 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 123.215 0.322 . . . . 0.0 113.518 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.427 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . . . -93.29 150.14 20.7 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.45 0.643 . . . . 0.0 111.899 -175.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -76.11 139.0 41.14 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.468 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -145.52 124.35 12.67 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 45.4 mt-10 -65.78 93.94 0.19 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.444 0.698 . . . . 0.0 110.993 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -99.44 120.06 39.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.095 0.558 . . . . 0.0 110.894 -176.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 53.4 tt0 -87.39 114.56 24.12 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.833 0.853 . . . . 0.0 110.664 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.428 ' HA ' HG12 ' A' ' 186' ' ' VAL . 50.1 t -59.88 114.74 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.1 m -115.35 -4.41 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.372 0.669 . . . . 0.0 111.264 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.52 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 76.7 ttt180 -164.56 138.86 5.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.836 0.854 . . . . 0.0 109.564 173.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 135' ' ' TYR . 34.4 m -117.19 137.64 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.511 0.724 . . . . 0.0 109.554 173.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.4 m -145.69 137.86 25.49 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.907 0.883 . . . . 0.0 108.857 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.95 135.11 36.33 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.604 ' HB2' HG13 ' A' ' 183' ' ' ILE . 55.3 tttm . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 124.158 0.983 . . . . 0.0 111.132 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 C--O 1.238 0.486 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.24 87.81 0.82 Allowed 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.979 0.895 . . . . 0.0 110.82 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -80.51 73.13 7.44 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.145 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 18.0 m -125.73 172.59 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.338 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.607 HG23 ' HB2' ' A' ' 198' ' ' GLN . 97.5 mt -94.86 110.13 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.619 0.768 . . . . 0.0 110.045 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -103.1 106.93 17.55 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 43.3 m-70 -77.31 92.47 3.91 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 204' ' ' VAL . 35.0 m -108.38 151.02 10.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.336 -175.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.477 ' HD3' HG22 ' A' ' 196' ' ' VAL . 31.6 mmmt -110.92 113.12 25.45 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.217 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -57.43 105.6 0.26 Allowed 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 168.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.7 -24.02 64.45 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.211 0.529 . . . . 0.0 109.814 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -68.91 -31.86 71.07 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.201 1.0 . . . . 0.0 110.733 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -143.8 67.45 15.83 Favored Pre-proline 0 N--CA 1.487 1.381 0 C-N-CA 124.12 0.968 . . . . 0.0 110.667 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.3 -15.82 28.2 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.211 1.94 . . . . 0.0 113.177 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.36 -17.1 61.86 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.483 0.713 . . . . 0.0 111.024 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -87.63 25.17 1.53 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.119 0.967 . . . . 0.0 111.893 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 83.13 174.81 50.65 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.175 0.297 . . . . 0.0 113.84 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.477 HG22 ' HD3' ' A' ' 187' ' ' LYS . 3.1 t -92.2 118.32 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 172.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.32 143.62 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 122.903 0.481 . . . . 0.0 110.019 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.607 ' HB2' HG23 ' A' ' 183' ' ' ILE . 15.3 pt20 -106.92 114.36 28.41 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.31 0.576 . . . . 0.0 110.128 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 55.4 mtp -125.66 162.95 23.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.002 0.921 . . . . 0.0 109.701 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 6.7 m-80 -98.98 170.02 9.02 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.221 0.609 . . . . 0.0 109.55 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 50.9 m -56.42 -39.59 73.29 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.135 0.574 . . . . 0.0 111.634 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.46 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 34.1 ptt180 -54.66 -34.95 62.98 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.204 1.002 . . . . 0.0 112.222 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -86.82 -45.07 11.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.753 0.821 . . . . 0.0 110.534 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 186' ' ' VAL . 13.6 m -96.11 115.08 34.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 CA-C-O 121.797 0.808 . . . . 0.0 109.811 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -118.43 129.23 55.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.786 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.09 126.61 29.73 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.441 ' HE ' ' HB2' ' A' ' 294' ' ' MET . 91.1 mtm-85 -66.03 107.34 1.86 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.268 0.485 . . . . 0.0 111.789 -172.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.61 107.47 0.51 Allowed 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.175 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.441 ' HG2' ' HG3' ' A' ' 294' ' ' MET . 0.1 OUTLIER -75.28 81.04 2.38 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -173.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.5 m -145.54 108.44 4.53 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 54.0 mt -85.19 119.27 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.524 ' HB ' HG13 ' A' ' 277' ' ' VAL . 31.7 mm -91.45 152.86 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 123.911 0.884 . . . . 0.0 109.363 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -127.45 171.68 11.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.578 0.351 . . . . 0.0 110.681 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -48.93 -42.85 38.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.239 1.416 . . . . 0.0 111.874 -177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -62.06 -39.14 91.38 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.044 0.937 . . . . 0.0 111.93 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.438 ' HB2' HG23 ' A' ' 212' ' ' ILE . 61.2 m-20 -77.64 -22.31 50.89 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.077 0.551 . . . . 0.0 110.749 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.516 HD11 HG11 ' A' ' 277' ' ' VAL . 94.8 mt -72.41 109.98 6.49 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -114.14 154.14 28.32 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.161 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 32.0 m -67.97 130.35 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-O 120.754 0.312 . . . . 0.0 111.065 -175.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.05 -6.96 64.34 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.412 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -88.55 121.22 30.69 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.236 0.615 . . . . 0.0 111.161 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.5 t -91.83 127.66 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.022 0.929 . . . . 0.0 109.3 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' A' ' 280' ' ' ILE . 3.5 m -142.77 151.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.974 1.31 . . . . 0.0 110.298 -172.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.481 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 16.1 ptm -101.06 128.14 47.26 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.932 0.493 . . . . 0.0 111.378 -177.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.577 ' HB3' HG23 ' A' ' 277' ' ' VAL . 2.3 pt? -145.72 174.72 10.96 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.273 1.029 . . . . 0.0 110.393 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.501 ' HB3' ' CZ3' ' A' ' 238' ' ' TRP . 8.1 p30 -79.03 131.22 36.2 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 167.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -168.91 142.43 2.92 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ASN . . . . . 0.498 HD21 ' HB3' ' A' ' 231' ' ' ASN . 6.0 p-10 -136.64 133.56 19.09 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.305 0.642 . . . . 0.0 109.959 172.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.12 -20.92 67.94 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.365 2.043 . . . . 0.0 112.303 170.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.45 -47.74 84.32 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.513 0.725 . . . . 0.0 110.824 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.498 ' HB3' HD21 ' A' ' 228' ' ' ASN . 53.2 t30 -145.35 82.21 9.85 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.668 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.9 -16.51 54.37 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.078 2.519 . . . . 0.0 112.958 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -76.47 -27.7 56.24 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.581 0.753 . . . . 0.0 111.843 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -121.95 165.71 15.55 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.706 0.402 . . . . 0.0 110.389 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -60.58 131.19 49.96 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.929 1.292 . . . . 0.0 112.0 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -127.2 -139.24 4.9 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.088 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -82.23 159.96 23.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.12 0.568 . . . . 0.0 109.912 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' TRP . . . . . 0.501 ' CZ3' ' HB3' ' A' ' 226' ' ' ASN . 22.9 m95 -82.93 100.4 10.38 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 150' ' ' ALA . 40.8 m-85 -114.87 163.04 16.09 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.834 0.854 . . . . 0.0 111.032 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.35 148.83 27.1 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.512 171.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -147.46 134.7 20.57 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.583 0.753 . . . . 0.0 109.154 172.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.15 119.09 34.99 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.532 HD12 HD21 ' A' ' 255' ' ' LEU . 26.6 mm -61.9 107.92 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.0 t -79.62 -50.68 10.31 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.394 0.616 . . . . 0.0 109.801 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 20.3 mtp180 -151.36 163.24 39.39 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.726 1.61 . . . . 0.0 108.09 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -155.83 143.15 19.3 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.987 0.358 . . . . 0.0 111.025 166.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -149.92 128.23 12.12 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.204 1.002 . . . . 0.0 109.03 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -100.83 125.33 47.33 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 31.4 p -96.02 -175.13 3.3 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 170.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -76.75 -23.09 53.0 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 120.679 0.276 . . . . 0.0 110.849 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 22.8 p -97.76 -29.24 13.48 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.393 0.677 . . . . 0.0 112.7 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -167.39 146.05 4.91 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.773 0.429 . . . . 0.0 111.955 -173.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -90.43 102.02 14.75 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -92.37 99.2 12.0 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.532 HD21 HD12 ' A' ' 243' ' ' ILE . 9.4 tt -100.47 131.39 46.41 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 174.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' TYR . . . . . 0.488 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 65.0 m-85 -106.51 127.05 53.01 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.253 1.021 . . . . 0.0 108.308 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -142.79 141.16 31.62 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.939 0.336 . . . . 0.0 111.009 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -79.75 96.62 6.32 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 39.7 t -77.54 102.8 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 13.8 m -92.11 111.03 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.655 0.74 . . . . 0.0 110.065 -171.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.576 HD12 ' HB2' ' A' ' 264' ' ' ASP . 12.4 mt -87.48 -165.78 1.4 Allowed 'General case' 0 CA--C 1.557 1.237 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.857 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.06 -35.29 88.85 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 122.395 -0.19 . . . . 0.0 113.34 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -123.2 -51.76 1.87 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.097 0.959 . . . . 0.0 109.482 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.576 ' HB2' HD12 ' A' ' 261' ' ' LEU . 4.7 m-20 -76.26 164.43 26.06 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.317 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 55.9 m -143.46 136.97 28.24 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.654 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 73.7 mt -113.7 82.07 1.63 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.754 0.822 . . . . 0.0 109.394 -171.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.1 125.63 26.11 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.847 0.859 . . . . 0.0 112.737 -170.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 61.46 26.94 16.6 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.855 1.262 . . . . 0.0 112.896 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 96.5 m -68.31 128.18 35.64 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 122.698 0.399 . . . . 0.0 110.061 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 52.3 ttp180 -69.77 111.44 5.53 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 121.645 0.736 . . . . 0.0 110.532 -174.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 225' ' ' LEU . 48.7 mm -82.29 123.88 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.427 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 49.9 mt -90.51 -27.37 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.076 0.951 . . . . 0.0 109.243 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -96.15 36.71 1.3 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.032 1.333 . . . . 0.0 110.06 -166.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 29.0 m -65.82 -20.57 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.794 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -95.27 -27.51 15.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.056 0.943 . . . . 0.0 110.617 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -91.59 4.26 53.06 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.743 0.817 . . . . 0.0 111.807 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.577 HG23 ' HB3' ' A' ' 225' ' ' LEU . 13.3 p -78.92 154.81 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 C-N-CA 123.238 0.615 . . . . 0.0 110.499 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.481 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 54.6 m-85 -128.89 161.07 30.7 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.502 1.121 . . . . 0.0 110.45 -173.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -73.93 140.54 45.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.128 0.971 . . . . 0.0 111.081 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 223' ' ' VAL . 31.3 mm -77.12 122.3 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.817 0.847 . . . . 0.0 109.421 169.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.94 119.78 28.63 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 97.5 mtt180 -101.73 127.52 31.05 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.271 1.028 . . . . 0.0 109.817 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -37.36 131.91 0.59 Allowed 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 123.746 2.964 . . . . 0.0 114.326 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 105.27 -46.67 1.14 Allowed Glycine 0 C--N 1.341 0.823 0 CA-C-O 119.937 -0.368 . . . . 0.0 112.716 -171.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 9.5 pt-20 -84.69 -9.25 58.41 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 117.562 0.681 . . . . 0.0 110.793 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -35.82 83.62 0.0 OUTLIER Glycine 0 C--N 1.351 1.377 0 N-CA-C 117.558 1.783 . . . . 0.0 117.558 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 2.6 m -92.62 138.07 23.98 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 171.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.62 177.67 5.25 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.87 2.38 . . . . 0.0 111.476 -175.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 2.8 tpt -75.1 80.91 2.26 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.92 -37.18 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.082 -173.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.04 179.0 6.5 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -43.82 123.83 3.96 Favored Pre-proline 0 CA--C 1.561 1.388 0 C-N-CA 125.159 1.384 . . . . 0.0 113.319 -168.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.11 109.25 0.25 Allowed 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 123.949 3.099 . . . . 0.0 114.479 -173.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' MET . . . . . 0.441 ' HB2' ' HE ' ' A' ' 207' ' ' ARG . 90.2 mtp -74.17 104.0 4.81 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 168.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.72 81.24 1.96 Allowed 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -74.88 -71.34 0.36 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.422 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? 57.26 115.62 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.224 1.81 . . . . 0.0 112.368 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 124.233 1.013 . . . . 0.0 109.193 172.621 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.065 0 N-CA-C 112.222 -0.351 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.85 0.1 37.93 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.212 0.605 . . . . 0.0 111.668 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -115.86 160.95 19.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.853 0.861 . . . . 0.0 108.782 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.12 -178.24 4.24 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.745 0.818 . . . . 0.0 110.115 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 157' ' ' VAL . 13.0 m -55.35 -19.23 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 124.683 1.193 . . . . 0.0 113.869 -175.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -94.86 -31.37 13.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.132 0.973 . . . . 0.0 111.413 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.55 105.97 5.92 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.69 0.757 . . . . 0.0 111.652 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.558 ' HD1' ' HD3' ' A' ' 207' ' ' ARG . 15.3 t80 -70.32 138.11 51.21 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.547 164.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 28.7 m -127.9 179.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.559 1.144 . . . . 0.0 111.311 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -119.46 108.17 14.22 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.51 118.58 33.57 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.59 0.756 . . . . 0.0 110.11 -169.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -69.44 133.27 47.54 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -68.02 127.49 33.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -67.29 -26.61 66.62 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 123.845 0.716 . . . . 0.0 111.602 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -80.36 -52.87 7.18 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.994 0.518 . . . . 0.0 111.095 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 43.0 ttm -83.18 -24.67 32.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.353 0.661 . . . . 0.0 111.05 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.42 -15.92 32.51 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.474 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.481 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . . . -73.68 153.54 40.05 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.98 0.912 . . . . 0.0 111.305 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 238' ' ' TRP . 40.7 m95 -73.74 136.14 43.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -140.27 110.57 6.63 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' A' ' 296' ' ' ARG . 19.4 mt-10 -48.3 137.92 10.48 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.89 0.876 . . . . 0.0 109.908 172.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.12 154.48 32.42 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.086 0.554 . . . . 0.0 110.613 -169.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -105.18 119.66 39.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.843 0.457 . . . . 0.0 110.041 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.6 t -68.25 114.23 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 168.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 137' ' ' VAL . 24.6 m -107.52 -10.36 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.157 0.583 . . . . 0.0 111.113 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -171.51 146.3 2.2 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.536 0.523 . . . . 0.0 110.892 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.59 133.4 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.433 0.693 . . . . 0.0 109.661 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.4 p -142.14 166.39 24.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.93 1.292 . . . . 0.0 108.621 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -119.44 155.19 32.5 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt . . . . . 0 N--CA 1.5 2.047 0 C-N-CA 123.813 0.845 . . . . 0.0 110.396 178.688 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.733 ' HB3' HG22 ' A' ' 182' ' ' VAL . 3.8 mp0 -70.01 101.02 1.7 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.568 -166.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -83.99 16.18 3.0 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.155 164.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.733 HG22 ' HB3' ' A' ' 180' ' ' GLU . 15.3 m -72.5 166.92 2.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-O 121.394 0.616 . . . . 0.0 110.411 172.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' A' ' 198' ' ' GLN . 2.5 mp -95.44 115.87 35.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.178 -172.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -97.52 104.54 16.58 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -79.11 94.66 5.39 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.53 151.06 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.508 ' HG2' HG22 ' A' ' 196' ' ' VAL . 43.2 mtmt -106.37 118.79 37.57 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 170.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -56.53 116.01 2.85 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.35 -36.84 66.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.753 0.821 . . . . 0.0 110.312 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -72.29 -32.07 66.27 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.808 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -140.04 61.0 16.35 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 123.58 0.752 . . . . 0.0 111.744 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.59 -20.02 9.65 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.033 1.822 . . . . 0.0 112.905 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.04 -20.21 66.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.933 0.893 . . . . 0.0 111.723 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -81.51 -20.17 40.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.64 0.776 . . . . 0.0 111.155 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 110.42 -179.36 20.3 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 116.521 -0.309 . . . . 0.0 113.068 174.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.508 HG22 ' HG2' ' A' ' 187' ' ' LYS . 20.3 t -79.63 122.77 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.857 0.863 . . . . 0.0 109.433 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 33.9 m -104.73 144.13 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.637 0.775 . . . . 0.0 110.634 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.552 ' HB2' HG23 ' A' ' 183' ' ' ILE . 8.7 pt20 -99.62 121.79 41.71 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.631 0.772 . . . . 0.0 110.327 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 67.4 mmm -120.11 170.14 9.58 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.547 1.139 . . . . 0.0 110.554 -169.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -105.86 176.61 5.11 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.707 0.803 . . . . 0.0 109.66 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 180' ' ' GLU . 61.1 p -59.64 -42.81 93.59 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.031 0.932 . . . . 0.0 110.999 174.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? -70.11 -5.12 24.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.958 0.903 . . . . 0.0 113.283 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -105.36 -34.91 7.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.811 0.444 . . . . 0.0 111.351 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.49 126.98 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.735 0.778 . . . . 0.0 110.312 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.453 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 2.1 mpt_? -120.26 172.24 7.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.502 1.121 . . . . 0.0 109.09 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.63 167.24 18.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.999 0.428 . . . . 0.0 109.903 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.558 ' HD3' ' HD1' ' A' ' 140' ' ' TYR . 77.6 mtm180 -78.65 90.24 4.57 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.614 0.766 . . . . 0.0 110.419 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.75 96.59 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.536 0.684 . . . . 0.0 109.545 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -1.78 43.81 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.061 1.344 . . . . 0.0 111.344 -174.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 44.9 m -84.19 112.79 20.59 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 121.681 -0.637 . . . . 0.0 109.339 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.424 HD11 ' SD ' ' A' ' 294' ' ' MET . 41.4 mt -82.21 123.32 38.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 175.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.692 HG23 ' HB2' ' A' ' 216' ' ' ASP . 49.1 mm -97.27 128.09 48.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.364 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 0.0 OUTLIER -117.52 176.92 4.94 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.095 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 214' ' ' TRP . . . . . 0.433 ' HA ' HD23 ' A' ' 217' ' ' LEU . 69.7 t90 -46.94 -41.63 16.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.578 0.751 . . . . 0.0 111.553 -170.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -53.67 -43.03 68.52 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.002 1.321 . . . . 0.0 111.913 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.692 ' HB2' HG23 ' A' ' 212' ' ' ILE . 20.0 m-20 -77.97 -25.86 48.37 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.084 0.953 . . . . 0.0 112.416 -175.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 214' ' ' TRP . 1.4 mm? -67.7 112.63 4.91 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -115.35 152.2 33.25 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.9 m -67.05 115.76 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-O 121.114 0.483 . . . . 0.0 110.524 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 110.15 -5.09 30.22 Favored Glycine 0 C--N 1.346 1.128 0 C-N-CA 123.412 0.53 . . . . 0.0 112.846 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -86.69 128.72 35.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.614 0.766 . . . . 0.0 110.677 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.63 130.7 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.54 HG23 HD11 ' A' ' 225' ' ' LEU . 3.0 m -145.9 164.2 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.98 1.312 . . . . 0.0 109.74 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.653 ' SD ' ' HB3' ' A' ' 238' ' ' TRP . 9.0 tmm? -105.31 129.84 53.56 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.575 ' HG ' HG13 ' A' ' 277' ' ' VAL . 2.1 mp -129.12 160.41 32.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.24 0.616 . . . . 0.0 110.354 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -90.01 108.42 19.71 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.784 0.834 . . . . 0.0 110.899 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.659 ' HE1' ' HB2' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -168.1 158.6 10.43 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.304 1.041 . . . . 0.0 110.413 177.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ASN . . . . . 0.575 HD21 ' HB3' ' A' ' 231' ' ' ASN . 6.6 p30 -111.14 148.61 39.06 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -58.28 -33.17 97.4 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.926 2.417 . . . . 0.0 113.115 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.44 -39.95 77.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.425 0.69 . . . . 0.0 111.025 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.575 ' HB3' HD21 ' A' ' 228' ' ' ASN . 41.6 t-20 -128.64 99.49 23.17 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.273 0.629 . . . . 0.0 109.69 -172.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -84.16 -0.0 9.37 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.941 2.427 . . . . 0.0 112.824 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -92.44 -29.27 16.36 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.379 0.672 . . . . 0.0 110.318 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -124.46 152.74 42.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.673 0.789 . . . . 0.0 109.732 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -55.39 170.19 0.25 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.334 1.453 . . . . 0.0 113.699 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 228' ' ' ASN . . . -171.27 -110.79 0.24 Allowed Glycine 0 C--N 1.337 0.631 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.138 174.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.469 ' HB2' ' CE1' ' A' ' 239' ' ' TYR . 17.8 m-85 -91.85 177.51 6.17 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.757 0.823 . . . . 0.0 109.454 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' TRP . . . . . 0.653 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 6.8 m95 -99.5 106.46 18.48 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.659 ' HB2' ' HE1' ' A' ' 227' ' ' TYR . 90.3 m-85 -121.84 166.89 13.68 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 118.927 0.785 . . . . 0.0 110.993 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ASP . . . . . 0.572 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 3.4 m-20 -83.42 160.61 21.55 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.627 1.171 . . . . 0.0 110.329 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -162.51 138.9 7.61 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.07 0.948 . . . . 0.0 110.77 170.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -103.05 120.14 40.12 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.546 HD12 HD11 ' A' ' 255' ' ' LEU . 25.0 mm -63.89 117.47 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.924 0.89 . . . . 0.0 110.937 -171.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 33.3 t -88.24 -53.07 4.88 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.593 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.403 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 95.9 mtt180 -140.6 164.83 29.13 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.282 1.033 . . . . 0.0 109.873 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -155.95 147.89 23.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.493 0.717 . . . . 0.0 110.05 170.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -146.23 116.21 7.34 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.516 0.727 . . . . 0.0 109.599 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.665 ' HG2' ' HG2' ' A' ' 253' ' ' ARG . 6.0 tm-20 -92.85 123.6 36.23 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 30.6 p -133.47 148.45 51.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 168.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -63.81 -10.58 20.91 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.382 0.673 . . . . 0.0 112.801 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 47.2 p -91.73 -28.98 17.07 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.84 0.856 . . . . 0.0 111.058 175.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.84 130.2 0.8 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.301 0.64 . . . . 0.0 111.409 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.665 ' HG2' ' HG2' ' A' ' 248' ' ' GLU . 53.6 mtm180 -83.63 98.55 9.68 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -92.71 150.42 20.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.341 1.056 . . . . 0.0 110.213 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.811 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.5 OUTLIER -145.87 146.41 31.1 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -174.494 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 256' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 78.9 m-85 -134.06 127.77 32.89 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.206 1.002 . . . . 0.0 108.662 174.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -143.64 141.67 30.68 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.515 0.726 . . . . 0.0 109.805 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 19.4 m-20 -78.64 94.94 5.13 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 269' ' ' CYS . 92.9 t -67.54 105.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.608 0.567 . . . . 0.0 110.371 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 45.1 t -85.79 99.3 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 30.6 mt -84.99 176.78 8.23 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.365 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -56.78 -36.46 72.48 Favored Glycine 0 N--CA 1.475 1.264 0 N-CA-C 114.349 0.5 . . . . 0.0 114.349 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -123.26 -47.75 2.0 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.707 0.803 . . . . 0.0 109.774 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -80.11 166.35 21.58 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.781 -175.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 30.7 p -146.84 110.3 4.86 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.573 0.749 . . . . 0.0 109.187 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 61.9 mt -87.12 87.39 7.44 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.973 0.909 . . . . 0.0 109.439 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 3.2 p-10 -64.38 139.4 58.76 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.792 0.437 . . . . 0.0 110.763 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.92 29.81 19.36 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.065 0.946 . . . . 0.0 112.199 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.481 ' HB3' HG23 ' A' ' 259' ' ' VAL . 38.3 t -72.96 126.97 31.19 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.76 0.424 . . . . 0.0 110.58 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -63.57 133.41 53.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.105 0.562 . . . . 0.0 110.894 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.811 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 46.9 mm -111.97 124.5 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.404 1.081 . . . . 0.0 109.251 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 41.3 mt -106.02 2.04 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.181 0.992 . . . . 0.0 109.312 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -102.87 29.98 5.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.048 1.339 . . . . 0.0 109.712 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 24.0 m -57.82 -29.46 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -165.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 22.5 m-20 -97.13 -23.72 16.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.283 0.633 . . . . 0.0 111.72 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -81.84 6.5 15.49 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.869 0.868 . . . . 0.0 112.208 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.575 HG13 ' HG ' ' A' ' 225' ' ' LEU . 19.4 t -73.94 148.62 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.325 0.65 . . . . 0.0 109.432 178.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -128.18 160.28 32.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.576 1.151 . . . . 0.0 108.313 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -76.16 153.62 36.05 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.105 0.562 . . . . 0.0 111.481 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.525 HG12 ' HA ' ' A' ' 223' ' ' VAL . 46.8 mm -75.6 122.71 30.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 167.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.521 ' HG2' ' HA3' ' A' ' 286' ' ' GLY . 0.1 OUTLIER -84.16 106.11 15.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 165.322 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -107.81 108.22 61.21 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -11.26 88.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 1 C-N-CA 126.883 5.055 . . . . 0.0 116.687 -158.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 99.69 1.12 56.42 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 115.102 -0.954 . . . . 0.0 114.923 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -93.52 -23.44 18.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.003 0.902 . . . . 0.0 110.801 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' GLY . . . . . 0.521 ' HA3' ' HG2' ' A' ' 281' ' ' GLU . . . -93.84 -165.94 37.19 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.579 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 38.2 p -117.64 163.98 21.59 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 123.681 0.792 . . . . 0.0 111.438 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -86.62 -154.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.142 2.561 . . . . 0.0 111.308 164.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' MET . . . . . 0.517 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 23.3 mmt -115.32 80.51 1.44 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 168.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.91 -35.25 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 168.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -84.11 -168.7 2.26 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.479 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -49.89 115.95 5.74 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.499 1.12 . . . . 0.0 111.849 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.517 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 12.4 Cg_exo -70.81 80.89 1.14 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.267 2.645 . . . . 0.0 111.148 175.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' MET . . . . . 0.424 ' SD ' HD11 ' A' ' 211' ' ' ILE . 49.3 mtm -63.26 -55.63 23.21 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.589 -172.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 66.6 144.74 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.858 1.263 . . . . 0.0 111.245 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.404 ' NH2' ' HG3' ' A' ' 153' ' ' GLU . 14.2 mtm180 -91.93 -30.95 15.85 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 173.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.454 ' HB2' ' HZ2' ' A' ' 238' ' ' TRP . 77.1 tttt -141.63 153.04 44.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.248 1.019 . . . . 0.0 108.978 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.0 p . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 123.444 0.697 . . . . 0.0 110.535 -176.451 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.87 8.69 9.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.208 0.603 . . . . 0.0 112.317 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -116.1 161.74 18.46 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.258 0.552 . . . . 0.0 110.938 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.12 161.65 15.72 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.994 1.317 . . . . 0.0 109.153 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 158' ' ' ARG . 92.1 t -70.17 80.38 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 124.188 0.995 . . . . 0.0 110.058 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 175.2 -38.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 126.641 1.976 . . . . 0.0 109.18 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -72.17 91.82 1.31 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -159.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 10.5 p90 -72.49 99.88 2.59 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.917 0.865 . . . . 0.0 109.616 168.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.87 -176.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.937 1.295 . . . . 0.0 109.255 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.18 104.15 16.56 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.392 0.615 . . . . 0.0 110.239 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -95.79 102.28 14.06 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 26.2 ttt180 -72.08 109.7 6.06 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.36 109.39 0.99 Allowed 'General case' 0 C--O 1.217 -0.625 0 O-C-N 124.506 1.129 . . . . 0.0 108.07 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.81 -10.94 59.85 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 124.033 0.833 . . . . 0.0 111.282 -170.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -74.03 -56.01 5.44 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.444 0.698 . . . . 0.0 110.258 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 50.5 ttp -92.53 -37.16 12.64 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.902 0.481 . . . . 0.0 109.955 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.434 ' HA3' ' CA ' ' A' ' 262' ' ' GLY . . . 101.44 20.73 12.7 Favored Glycine 0 N--CA 1.469 0.87 0 CA-C-N 115.45 -0.795 . . . . 0.0 113.518 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -101.79 140.31 36.26 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.085 0.554 . . . . 0.0 110.405 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 76.5 m95 -74.76 134.86 41.78 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.811 0.845 . . . . 0.0 109.581 174.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -135.78 136.36 40.66 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.686 ' HB3' HH12 ' A' ' 207' ' ' ARG . 19.9 pt-20 -68.62 103.76 1.8 Allowed 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -108.64 131.27 55.05 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.681 0.792 . . . . 0.0 110.287 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 60.8 tt0 -87.11 109.09 19.2 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.298 0.639 . . . . 0.0 110.444 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 186' ' ' VAL . 70.1 t -61.68 103.87 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 124.197 0.936 . . . . 0.0 109.381 171.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.0 m -106.12 -0.37 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.758 0.423 . . . . 0.0 111.613 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.423 ' HA ' HG22 ' A' ' 137' ' ' VAL . 52.4 ttm-85 -172.73 149.92 2.08 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.617 0.573 . . . . 0.0 110.674 169.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.11 142.47 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.754 0.822 . . . . 0.0 108.955 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.45 ' OG1' ' HB ' ' A' ' 183' ' ' ILE . 8.1 p -145.69 161.95 38.68 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.882 1.273 . . . . 0.0 108.907 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -114.88 178.36 4.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.829 0.852 . . . . 0.0 110.78 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 N--CA 1.485 1.322 0 C-N-CA 123.685 0.794 . . . . 0.0 110.417 -179.807 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 CA--C 1.541 0.603 0 CA-C-O 122.3 1.048 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -88.49 67.37 8.54 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.049 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -85.07 40.31 0.81 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 121.889 0.852 . . . . 0.0 109.707 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 34.9 m -88.61 175.93 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.823 0.849 . . . . 0.0 111.085 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.45 ' HB ' ' OG1' ' A' ' 160' ' ' THR . 20.6 mt -96.72 112.35 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.683 0.793 . . . . 0.0 110.594 -168.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -102.05 109.38 21.09 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.418 1.087 . . . . 0.0 108.961 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -79.26 89.38 4.91 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 156' ' ' VAL . 26.7 m -110.58 161.16 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.762 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.52 ' HG2' HG22 ' A' ' 196' ' ' VAL . 32.0 mtmt -124.97 117.75 24.72 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 173.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -57.52 97.03 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -62.73 -23.92 67.41 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.202 1.001 . . . . 0.0 111.593 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 297' ' ' LYS . 19.9 m-20 -63.34 -30.81 71.88 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.715 0.406 . . . . 0.0 111.711 173.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -146.88 78.04 10.8 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 124.14 0.976 . . . . 0.0 108.89 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.15 -21.2 55.88 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.925 2.417 . . . . 0.0 112.563 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -67.14 -8.19 29.12 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.648 1.179 . . . . 0.0 112.788 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -79.33 -12.76 59.93 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.443 0.697 . . . . 0.0 111.333 173.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 93.88 -178.7 37.88 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.713 0.633 . . . . 0.0 112.915 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.52 HG22 ' HG2' ' A' ' 187' ' ' LYS . 24.6 t -83.95 116.6 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.55 153.64 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.036 0.934 . . . . 0.0 109.663 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -108.32 122.21 46.51 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.437 0.695 . . . . 0.0 109.536 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 84.7 mmm -125.28 164.88 19.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.696 1.198 . . . . 0.0 109.265 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -110.53 172.77 6.67 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.525 ' HA ' HG22 ' A' ' 204' ' ' VAL . 41.7 m -66.29 -30.23 70.61 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 118.159 0.436 . . . . 0.0 111.258 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -10.4 58.86 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.862 176.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -104.25 -39.93 6.31 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.452 1.101 . . . . 0.0 111.014 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.525 HG22 ' HA ' ' A' ' 201' ' ' SER . 32.0 m -95.79 143.47 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -174.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.96 163.47 32.79 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.321 0.648 . . . . 0.0 109.774 -168.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.97 166.64 23.01 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.186 0.594 . . . . 0.0 109.804 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.686 HH12 ' HB3' ' A' ' 153' ' ' GLU . 10.8 ptm180 -136.75 134.11 36.76 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.0 148.32 40.02 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.744 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.63 ' HG3' ' HB3' ' A' ' 291' ' ' ASP . 3.3 tmt_? -75.79 -9.47 58.62 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.942 168.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.8 m -86.94 109.33 19.27 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.869 0.868 . . . . 0.0 111.023 -171.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.4 mt -84.02 136.36 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.676 HD11 ' HB2' ' A' ' 279' ' ' LYS . 39.0 mm -110.98 153.52 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.637 0.775 . . . . 0.0 111.419 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -125.1 171.29 10.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.988 1.315 . . . . 0.0 109.929 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' TRP . . . . . 0.483 ' HD1' HG11 ' A' ' 274' ' ' VAL . 88.7 t90 -50.01 -49.05 52.05 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.378 1.071 . . . . 0.0 111.662 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -61.23 -35.76 78.12 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.618 -175.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.451 ' HB3' HG23 ' A' ' 212' ' ' ILE . 14.6 t70 -78.78 -23.98 44.94 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.279 0.632 . . . . 0.0 110.978 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.444 HD22 HG21 ' A' ' 223' ' ' VAL . 96.0 mt -72.37 113.18 9.12 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.051 0.54 . . . . 0.0 109.928 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 221' ' ' GLN . 9.3 pt-20 -119.71 154.06 34.68 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.993 0.917 . . . . 0.0 109.961 -176.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.3 m -63.68 123.63 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 120.844 0.354 . . . . 0.0 110.945 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.76 -14.05 56.26 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.177 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.478 ' HG2' HG13 ' A' ' 223' ' ' VAL . 30.5 tt0 -81.29 122.69 27.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.346 0.658 . . . . 0.0 110.767 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 74.1 t -93.58 130.74 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.478 HG13 ' HG2' ' A' ' 221' ' ' GLN . 3.0 m -150.34 147.02 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.268 1.027 . . . . 0.0 110.297 -172.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 26.1 ttp -102.76 130.41 49.71 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.896 0.478 . . . . 0.0 110.986 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.506 HD11 HD12 ' A' ' 271' ' ' ILE . 1.9 pt? -142.43 167.89 21.02 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.283 1.033 . . . . 0.0 110.917 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.545 HD21 ' HB3' ' A' ' 276' ' ' GLU . 4.8 p30 -81.37 126.52 31.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.328 0.651 . . . . 0.0 109.655 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -166.08 152.28 9.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.956 0.902 . . . . 0.0 109.384 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ASN . . . . . 0.59 HD21 ' HB3' ' A' ' 231' ' ' ASN . 3.7 p30 -131.34 133.0 23.97 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.442 ' HB3' HD11 ' A' ' 266' ' ' LEU . 27.0 Cg_endo -61.52 -26.02 80.29 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.809 2.339 . . . . 0.0 113.943 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.41 -33.32 71.22 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.114 0.566 . . . . 0.0 111.699 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.59 ' HB3' HD21 ' A' ' 228' ' ' ASN . 35.5 t-20 -133.23 104.33 12.46 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 123.48 0.712 . . . . 0.0 109.116 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.33 -19.48 49.75 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.767 2.311 . . . . 0.0 113.019 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.26 -10.82 40.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.331 0.652 . . . . 0.0 110.944 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -123.81 159.13 30.23 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.484 0.659 . . . . 0.0 111.179 -171.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -80.28 172.24 14.02 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.688 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 228' ' ' ASN . . . -161.55 -101.98 0.17 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.291 172.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -103.46 168.9 8.86 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.77 0.828 . . . . 0.0 109.503 -177.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -83.87 114.73 21.86 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -126.8 141.29 51.87 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.214 1.006 . . . . 0.0 108.387 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.4 p-10 -81.18 152.81 27.54 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -151.09 136.85 18.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.791 0.836 . . . . 0.0 109.058 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -94.54 118.27 31.41 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.558 HD12 HD21 ' A' ' 255' ' ' LEU . 32.3 mm -61.57 116.27 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 124.041 0.838 . . . . 0.0 108.952 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.6 t -97.08 -25.04 15.48 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.332 0.653 . . . . 0.0 110.633 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -170.13 157.34 6.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.859 0.864 . . . . 0.0 110.195 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.406 ' HB3' ' HG ' ' A' ' 255' ' ' LEU . 26.0 pttm -153.13 149.1 27.72 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.659 0.784 . . . . 0.0 109.32 163.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -154.52 120.45 5.24 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.305 0.642 . . . . 0.0 109.449 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 40.0 tt0 -111.24 125.49 53.87 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.179 0.992 . . . . 0.0 109.151 177.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.7 p -83.59 178.78 7.84 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.943 0.897 . . . . 0.0 109.565 171.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -71.62 -0.78 11.56 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.366 0.666 . . . . 0.0 112.634 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 25.4 p -123.4 -29.68 3.77 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.29 0.636 . . . . 0.0 112.607 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.86 166.76 27.96 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.882 0.31 . . . . 0.0 111.457 -172.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 33.1 ptt180 -121.14 140.76 51.55 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.454 0.701 . . . . 0.0 110.661 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.22 154.31 47.7 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.71 0.804 . . . . 0.0 108.876 172.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.558 HD21 HD12 ' A' ' 243' ' ' ILE . 7.1 tt -147.16 143.89 28.57 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -130.21 121.82 26.93 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -131.97 166.72 21.05 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.377 0.671 . . . . 0.0 110.431 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -102.19 98.14 8.33 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.795 HG23 ' SG ' ' A' ' 269' ' ' CYS . 96.6 t -66.57 112.36 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 123.783 0.677 . . . . 0.0 110.374 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.48 101.79 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 73.4 mt -82.81 -158.02 0.25 Allowed 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.642 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.434 ' CA ' ' HA3' ' A' ' 149' ' ' GLY . . . -70.29 -56.61 7.58 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-O 121.088 0.271 . . . . 0.0 113.418 177.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -112.87 -37.32 4.87 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.171 0.988 . . . . 0.0 109.929 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -94.39 176.39 6.32 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.125 0.97 . . . . 0.0 111.713 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 77.0 p -142.89 153.12 42.81 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.28 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 92.8 mt -125.31 92.15 3.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.359 0.663 . . . . 0.0 109.458 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -69.2 140.02 54.56 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 123.606 0.566 . . . . 0.0 110.284 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 12.6 t70 67.08 31.64 6.72 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.452 1.101 . . . . 0.0 111.705 171.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.795 ' SG ' HG23 ' A' ' 259' ' ' VAL . 27.2 p -65.05 124.92 23.35 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 37.6 ttp-105 -76.91 102.46 6.38 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.57 HD11 ' SG ' ' A' ' 269' ' ' CYS . 47.7 mm -77.87 108.29 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.886 -172.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 44.5 mt -82.1 -34.5 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.424 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.448 ' O ' HG23 ' A' ' 277' ' ' VAL . 46.0 m-85 -90.26 37.42 0.9 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.336 1.054 . . . . 0.0 111.14 -168.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.483 HG11 ' HD1' ' A' ' 214' ' ' TRP . 21.0 m -56.75 -34.27 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.799 1.239 . . . . 0.0 112.433 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -92.78 -10.59 36.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.676 1.19 . . . . 0.0 111.983 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.545 ' HB3' HD21 ' A' ' 226' ' ' ASN . 59.4 mm-40 -102.6 21.26 15.64 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.215 1.006 . . . . 0.0 111.148 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.492 HG22 ' HB3' ' A' ' 225' ' ' LEU . 84.2 t -90.44 153.44 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.038 0.935 . . . . 0.0 110.587 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.43 148.66 44.85 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.874 1.27 . . . . 0.0 107.808 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.676 ' HB2' HD11 ' A' ' 212' ' ' ILE . 24.0 ttmt -83.28 141.01 32.15 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 120.841 0.353 . . . . 0.0 111.126 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 36.5 mm -79.13 138.19 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 168.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.506 ' HA ' ' HA3' ' A' ' 286' ' ' GLY . 1.1 mp0 -66.11 103.46 0.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.283 0.563 . . . . 0.0 110.08 -167.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -85.7 155.0 59.14 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.31 1.044 . . . . 0.0 109.524 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.98 94.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 123.402 2.735 . . . . 0.0 112.075 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.9 -48.09 2.49 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.994 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -73.12 -25.61 60.91 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.996 0.519 . . . . 0.0 112.085 -172.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -84.68 82.19 1.7 Allowed Glycine 0 C--N 1.342 0.915 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 174.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 14.8 m -62.8 144.37 96.6 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.418 0.687 . . . . 0.0 111.989 -168.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.15 152.85 79.12 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.103 2.535 . . . . 0.0 111.875 -175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 16.7 ttt -79.76 80.77 6.11 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.26 -28.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.338 1.055 . . . . 0.0 109.963 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.63 ' HB3' ' HG3' ' A' ' 209' ' ' ARG . 10.3 t70 -84.26 -151.68 0.13 Allowed 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.303 1.041 . . . . 0.0 109.135 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -50.81 115.98 6.51 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.99 0.916 . . . . 0.0 110.533 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.75 102.97 0.44 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.218 1.946 . . . . 0.0 111.534 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 25.7 mmt -65.84 136.7 56.51 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.273 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -144.46 148.78 34.99 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -148.0 -175.92 5.08 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.29 0.236 . . . . 0.0 110.847 -167.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 2.1 tppt? -161.02 134.0 6.36 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 111.541 0.201 . . . . 0.0 111.541 173.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 123.579 0.752 . . . . 0.0 110.064 175.292 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.979 -0.449 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.412 HD22 ' OH ' ' A' ' 184' ' ' TYR . 0.5 OUTLIER -81.31 -34.2 32.06 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.178 0.513 . . . . 0.0 110.414 -178.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -90.16 152.42 21.11 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.778 -165.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 139' ' ' GLU . 45.0 mttp -99.35 162.93 12.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.128 -167.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.1 m -71.91 -2.28 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 124.161 0.984 . . . . 0.0 113.116 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -118.34 -21.04 8.27 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.89 0.876 . . . . 0.0 110.425 171.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.457 ' HB3' ' H ' ' A' ' 136' ' ' LYS . 43.6 tt0 -82.12 89.67 6.49 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.77 0.828 . . . . 0.0 110.116 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.702 ' HB3' ' HG2' ' A' ' 155' ' ' GLN . 26.8 p90 -68.16 139.12 56.11 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.202 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.404 HG21 ' HB ' ' A' ' 204' ' ' VAL . 29.0 m -119.5 178.96 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.998 0.919 . . . . 0.0 109.662 176.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.73 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 54.1 t0 -95.01 158.79 15.31 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 166.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.17 110.06 4.52 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 119.436 1.016 . . . . 0.0 111.213 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.411 ' HA ' ' HB3' ' A' ' 151' ' ' TRP . 3.0 tmm_? -73.01 113.69 10.33 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.878 0.871 . . . . 0.0 110.593 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -87.16 114.62 23.93 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.6 m -70.79 -26.57 63.39 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.736 0.814 . . . . 0.0 111.546 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -59.99 -49.93 75.75 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.616 0.766 . . . . 0.0 110.683 -175.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.503 ' HG3' ' H ' ' A' ' 150' ' ' ALA . 23.9 ptm -101.79 -18.99 15.52 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.526 0.331 . . . . 0.0 111.394 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 93.32 -21.56 39.83 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-O 120.021 -0.321 . . . . 0.0 113.141 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.503 ' H ' ' HG3' ' A' ' 148' ' ' MET . . . -72.47 131.18 42.22 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.197 0.599 . . . . 0.0 110.818 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 0.1 OUTLIER -97.65 124.72 42.06 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.18 175.231 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -113.64 137.3 51.8 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.017 0.927 . . . . 0.0 109.464 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.73 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 48.3 mt-10 -64.43 102.21 0.52 Allowed 'General case' 0 C--N 1.346 0.435 0 O-C-N 123.653 0.596 . . . . 0.0 110.802 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -96.61 119.13 34.53 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.78 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.702 ' HG2' ' HB3' ' A' ' 140' ' ' TYR . 15.4 tm0? -84.94 107.91 17.31 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -173.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.527 ' HA ' HG12 ' A' ' 186' ' ' VAL . 47.0 t -61.47 119.61 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 124.229 0.955 . . . . 0.0 109.207 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.408 HG13 ' OE1' ' A' ' 155' ' ' GLN . 1.9 m -115.63 -6.03 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.574 0.749 . . . . 0.0 111.179 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.54 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 44.9 ttt85 -172.23 142.12 1.33 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.966 0.506 . . . . 0.0 110.511 175.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.3 m -126.05 132.09 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.282 1.033 . . . . 0.0 108.832 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.7 p -142.96 145.2 32.77 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.39 0.676 . . . . 0.0 110.099 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -74.93 150.13 39.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.868 0.867 . . . . 0.0 109.053 168.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.0 mttt . . . . . 0 N--CA 1.478 0.964 0 C-N-CA 123.601 0.76 . . . . 0.0 109.951 173.24 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.519 ' HB3' HG22 ' A' ' 182' ' ' VAL . 5.9 mm-40 -70.68 90.76 0.78 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.33 -169.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -85.88 8.85 18.61 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.648 167.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 180' ' ' GLU . 28.6 m -65.69 173.98 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.039 1.336 . . . . 0.0 112.02 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 198' ' ' GLN . 59.0 mt -94.95 110.81 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.549 0.74 . . . . 0.0 110.417 -169.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.412 ' OH ' HD22 ' A' ' 134' ' ' LEU . 58.5 m-85 -93.95 106.48 18.45 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.887 1.275 . . . . 0.0 109.543 173.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 30.5 m-70 -80.54 101.95 9.45 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 156' ' ' VAL . 29.6 m -129.68 165.47 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.832 1.253 . . . . 0.0 110.5 -172.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -133.56 116.33 15.79 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.384 0.674 . . . . 0.0 109.375 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.646 ' HB2' ' HB2' ' A' ' 191' ' ' TYR . 47.0 m-85 -57.2 151.23 16.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 123.167 0.292 . . . . 0.0 111.347 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -60.11 -44.41 94.9 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.062 0.545 . . . . 0.0 110.875 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.47 -13.42 40.38 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.646 0.778 . . . . 0.0 111.268 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.646 ' HB2' ' HB2' ' A' ' 188' ' ' TYR . 58.3 m-85 -129.11 58.65 38.71 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -174.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.38 -23.78 8.38 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 121.71 1.607 . . . . 0.0 110.442 163.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.31 -20.55 62.18 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.687 1.195 . . . . 0.0 111.914 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -81.19 -0.42 40.4 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.057 0.543 . . . . 0.0 110.872 175.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 89.12 -177.48 44.44 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.161 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 23.6 t -82.86 116.89 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.12 153.21 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.027 0.931 . . . . 0.0 110.029 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.409 ' HB2' HG23 ' A' ' 183' ' ' ILE . 12.8 pt20 -103.78 113.88 27.73 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.731 0.777 . . . . 0.0 109.851 178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 77.9 mmm -117.27 169.75 9.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.318 1.447 . . . . 0.0 108.785 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -110.92 173.07 6.51 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.611 ' HA ' HG22 ' A' ' 204' ' ' VAL . 9.7 t -70.56 -26.2 63.43 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 118.369 0.531 . . . . 0.0 110.63 177.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -12.24 60.88 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.745 0.418 . . . . 0.0 111.786 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -94.68 -44.47 7.79 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.51 0.724 . . . . 0.0 110.082 171.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.611 HG22 ' HA ' ' A' ' 201' ' ' SER . 15.3 m -95.76 143.24 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.433 0.635 . . . . 0.0 110.996 -170.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 21.2 tpt180 -150.97 126.64 10.22 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.2 125.48 25.67 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 168.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.427 ' H ' ' NE ' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -73.68 152.02 40.57 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.587 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.428 ' N ' ' HB2' ' A' ' 281' ' ' GLU . . . -64.39 135.11 55.8 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.835 0.709 . . . . 0.0 109.398 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.522 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 5.3 ppt_? -78.21 23.06 0.29 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.876 0.87 . . . . 0.0 112.803 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 79.5 m -113.6 119.41 37.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.892 1.277 . . . . 0.0 109.082 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.63 129.03 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.038 0.535 . . . . 0.0 109.77 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 279' ' ' LYS . 28.2 mm -87.37 144.48 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.41 170.14 9.65 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.901 0.881 . . . . 0.0 109.727 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' TRP . . . . . 0.409 ' CZ3' ' HB2' ' A' ' 255' ' ' LEU . 38.2 t-105 -52.3 -47.78 65.75 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.979 0.912 . . . . 0.0 111.302 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -69.11 -23.03 63.94 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.278 0.631 . . . . 0.0 111.979 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -92.12 -16.57 26.16 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.115 0.566 . . . . 0.0 110.513 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.62 141.21 42.88 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -147.79 155.08 41.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.586 0.755 . . . . 0.0 109.419 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.93 123.39 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-O 121.26 0.552 . . . . 0.0 110.947 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.1 -4.0 48.46 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.744 -174.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.521 ' HG2' HG13 ' A' ' 223' ' ' VAL . 33.8 tt0 -87.21 121.72 30.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.235 0.614 . . . . 0.0 110.233 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 92.9 t -87.15 115.58 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.779 0.832 . . . . 0.0 108.863 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.521 HG13 ' HG2' ' A' ' 221' ' ' GLN . 6.3 m -137.91 157.37 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.311 1.044 . . . . 0.0 110.642 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.701 ' SD ' ' HD3' ' A' ' 296' ' ' ARG . 1.5 ttp -88.24 129.71 35.28 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.592 ' HB3' HG22 ' A' ' 277' ' ' VAL . 2.0 pp -143.79 168.21 20.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.826 0.85 . . . . 0.0 110.304 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -90.92 143.13 27.04 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -167.18 144.02 4.5 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 124.227 0.955 . . . . 0.0 109.051 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -109.84 119.09 48.55 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -56.24 -44.87 42.39 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.067 2.512 . . . . 0.0 113.082 172.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.1 -27.74 59.98 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.046 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.56 ' HB3' ' HB2' ' A' ' 234' ' ' GLU . 16.7 m120 -120.37 86.32 38.6 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 123.407 0.683 . . . . 0.0 109.194 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.37 -20.43 70.18 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.984 2.456 . . . . 0.0 113.366 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.589 ' HA ' HD12 ' A' ' 272' ' ' ILE . 61.7 tttm -97.47 -29.5 13.44 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.668 0.787 . . . . 0.0 111.26 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 231' ' ' ASN . 44.0 mt-10 -111.46 172.15 7.06 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.825 0.821 . . . . 0.0 112.665 -170.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -76.94 164.25 25.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.724 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -171.47 -79.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.694 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.412 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 11.5 m-85 -127.79 173.96 9.52 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.841 0.456 . . . . 0.0 110.268 -170.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -110.51 127.97 55.42 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 94.0 m-85 -133.54 158.34 43.39 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.415 0.686 . . . . 0.0 110.155 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ASP . . . . . 0.404 ' HB3' ' CZ2' ' A' ' 151' ' ' TRP . 8.6 p-10 -86.14 147.08 26.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 162.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.449 ' HB3' HD21 ' A' ' 225' ' ' LEU . . . -153.48 139.76 18.51 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 122.957 0.503 . . . . 0.0 110.04 -176.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -95.53 120.11 35.22 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.564 HD12 HD21 ' A' ' 255' ' ' LEU . 35.6 mm -58.3 111.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 123.658 0.599 . . . . 0.0 109.968 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.1 m -83.77 -49.47 9.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.688 0.795 . . . . 0.0 110.303 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 4.8 mmp_? -142.43 159.21 42.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.955 1.302 . . . . 0.0 109.07 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -154.89 116.81 4.16 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.33 0.652 . . . . 0.0 109.373 168.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -123.86 117.85 25.78 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.498 1.119 . . . . 0.0 108.542 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.54 135.48 49.74 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.465 0.706 . . . . 0.0 109.604 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.9 p -133.6 175.0 9.82 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.886 0.875 . . . . 0.0 109.284 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -69.12 -38.16 78.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.815 0.446 . . . . 0.0 110.757 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 46.1 p -88.66 -27.32 21.34 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.489 0.716 . . . . 0.0 112.859 -171.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.57 172.98 17.36 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.084 0.469 . . . . 0.0 111.829 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -128.54 130.36 47.31 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.943 0.897 . . . . 0.0 108.665 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -133.03 98.6 4.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.592 0.757 . . . . 0.0 109.314 -175.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.564 HD21 HD12 ' A' ' 243' ' ' ILE . 8.4 tt -107.72 147.01 31.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 64.2 m-85 -129.14 141.35 51.21 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.886 1.274 . . . . 0.0 107.599 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.96 151.02 35.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.718 0.407 . . . . 0.0 111.091 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -79.8 96.68 6.37 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 39.4 t -79.68 108.98 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.98 0.912 . . . . 0.0 109.96 -173.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 83.2 t -87.03 114.35 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.514 0.673 . . . . 0.0 110.796 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 13.4 mt -90.44 -161.6 0.81 Allowed 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.62 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.3 -42.5 57.1 Favored Glycine 0 C--N 1.35 1.32 0 O-C-N 122.16 -0.337 . . . . 0.0 113.907 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -122.3 -27.07 4.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.213 1.005 . . . . 0.0 111.039 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -114.19 167.17 10.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.924 0.889 . . . . 0.0 110.605 -172.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 67.8 p -137.45 133.22 34.43 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.022 0.929 . . . . 0.0 108.767 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.691 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 75.4 mt -81.56 93.8 6.77 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.061 0.944 . . . . 0.0 108.514 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -59.39 110.67 1.14 Allowed 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.413 1.071 . . . . 0.0 112.151 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 30.1 t70 67.26 29.44 7.62 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.766 0.827 . . . . 0.0 111.636 167.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 98.9 m -75.45 131.42 40.13 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.807 -0.558 . . . . 0.0 111.078 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -65.47 117.04 7.4 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.534 0.734 . . . . 0.0 112.126 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 273' ' ' PHE . 36.5 mm -89.64 112.44 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.925 0.89 . . . . 0.0 109.126 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 233' ' ' LYS . 49.0 mt -97.93 22.98 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 CA-C-O 122.519 1.152 . . . . 0.0 109.061 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.502 ' H ' HG22 ' A' ' 271' ' ' ILE . 83.8 m-85 -135.6 34.86 2.94 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.622 1.169 . . . . 0.0 109.989 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 34.3 m -71.03 -12.5 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.057 -174.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -87.15 -29.01 22.11 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.547 0.739 . . . . 0.0 111.325 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -102.08 22.1 13.71 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.341 0.656 . . . . 0.0 111.356 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.592 HG22 ' HB3' ' A' ' 225' ' ' LEU . 85.2 t -73.14 131.34 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.946 0.898 . . . . 0.0 110.406 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -109.07 160.39 16.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.617 0.767 . . . . 0.0 109.886 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 212' ' ' ILE . 85.3 tttt -75.44 143.35 42.71 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.132 174.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.1 mm -72.2 116.06 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.428 ' HB2' ' N ' ' A' ' 208' ' ' ALA . 0.5 OUTLIER -83.39 105.95 14.76 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -106.47 151.53 40.37 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.512 0.725 . . . . 0.0 110.111 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.11 121.14 9.47 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.009 2.472 . . . . 0.0 113.531 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.16 -49.09 1.08 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.974 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -91.31 -24.27 19.87 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -171.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -83.23 137.15 16.0 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.04 0.212 . . . . 0.0 113.027 -170.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 6.5 m -84.36 146.48 47.74 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.144 0.578 . . . . 0.0 111.789 -173.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.28 -173.61 1.8 Allowed 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 123.731 2.954 . . . . 0.0 111.617 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' MET . . . . . 0.522 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 25.5 mmt -82.04 78.83 8.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.102 0.477 . . . . 0.0 109.906 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 13.7 p -87.33 -25.46 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 121.779 0.8 . . . . 0.0 109.022 169.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.66 -166.4 1.57 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.405 1.482 . . . . 0.0 108.22 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.35 154.96 94.41 Favored Pre-proline 0 N--CA 1.483 1.198 0 CA-C-N 118.933 0.788 . . . . 0.0 109.701 172.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.56 102.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.586 2.19 . . . . 0.0 112.292 173.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 89.7 mmm -95.37 135.52 36.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.582 0.753 . . . . 0.0 110.108 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -155.93 165.44 36.47 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.479 0.657 . . . . 0.0 111.397 -172.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.701 ' HD3' ' SD ' ' A' ' 224' ' ' MET . 17.1 mtm180 -88.88 153.07 21.34 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.939 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 82.5 tttt 71.24 166.73 0.3 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.274 1.029 . . . . 0.0 112.397 167.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 CA--C 1.541 0.633 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 159.559 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.487 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.72 10.27 10.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.347 0.659 . . . . 0.0 111.898 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -114.92 149.36 37.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 170.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.452 ' H ' ' HB3' ' A' ' 139' ' ' GLU . 3.9 mppt? -102.94 170.25 8.09 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.019 0.528 . . . . 0.0 111.312 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -68.95 -6.23 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.489 1.116 . . . . 0.0 112.996 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.78 -22.97 9.92 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.139 0.976 . . . . 0.0 110.974 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.452 ' HB3' ' H ' ' A' ' 136' ' ' LYS . 38.3 tt0 -80.88 88.26 5.88 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.377 0.671 . . . . 0.0 110.212 -173.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.424 ' HB3' ' OE1' ' A' ' 155' ' ' GLN . 48.5 p90 -78.56 139.42 38.62 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.121 176.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.9 m -130.98 -166.74 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 126.158 1.783 . . . . 0.0 108.386 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -93.89 159.46 15.17 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 154' ' ' ALA . . . -128.94 101.95 6.3 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 124.338 1.055 . . . . 0.0 108.452 172.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -69.8 96.37 0.98 Allowed 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.652 174.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -78.4 111.02 13.98 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.1 m -71.96 -29.52 64.35 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.76 0.824 . . . . 0.0 111.694 -172.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -65.53 -42.97 91.38 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.819 0.847 . . . . 0.0 110.633 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.4 tpp -82.06 -37.9 25.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.191 0.996 . . . . 0.0 109.664 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.52 18.18 66.85 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.397 -170.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -107.4 161.13 15.09 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 122.029 0.918 . . . . 0.0 112.564 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -91.0 126.26 36.03 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.457 -1.701 . . . . 0.0 107.644 169.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -129.13 123.78 33.05 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.459 ' HB2' ' N ' ' A' ' 190' ' ' ASP . 14.6 mm-40 -43.7 137.78 2.89 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.192 0.933 . . . . 0.0 110.192 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 187' ' ' LYS . . . -134.73 116.07 14.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 122.32 0.248 . . . . 0.0 110.4 -176.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.424 ' OE1' ' HB3' ' A' ' 140' ' ' TYR . 60.6 tp60 -90.35 101.35 14.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.409 HG22 HG12 ' A' ' 186' ' ' VAL . 59.4 t -61.18 117.08 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -116.66 -10.02 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.785 0.434 . . . . 0.0 111.838 -176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 -171.33 148.53 2.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.747 0.819 . . . . 0.0 109.245 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 6.1 m -117.4 142.36 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.511 0.724 . . . . 0.0 109.4 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.473 ' OG1' ' HB ' ' A' ' 183' ' ' ILE . 69.6 p -144.24 159.99 41.74 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.79 1.236 . . . . 0.0 108.099 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -97.35 -179.21 4.42 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.213 0.605 . . . . 0.0 109.732 174.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt . . . . . 0 N--CA 1.491 1.587 0 C-N-CA 124.002 0.921 . . . . 0.0 110.402 169.778 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 CA--C 1.544 0.742 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.19 95.22 0.56 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.442 0.639 . . . . 0.0 109.845 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -75.96 76.72 2.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.073 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.08 152.87 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.39 1.476 . . . . 0.0 107.792 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.505 HG23 ' HB2' ' A' ' 198' ' ' GLN . 39.3 mt -95.19 110.15 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.02 0.528 . . . . 0.0 110.654 -170.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -92.48 112.44 24.38 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 170.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -79.34 93.95 5.41 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.409 HG12 HG22 ' A' ' 156' ' ' VAL . 6.0 m -108.2 163.84 5.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 114.404 -1.271 . . . . 0.0 107.773 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.496 ' HG2' HG22 ' A' ' 196' ' ' VAL . 35.4 mtmt -106.48 135.02 48.71 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 165.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -63.61 89.88 0.05 OUTLIER 'General case' 0 C--O 1.207 -1.148 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 164.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.46 -20.28 65.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.079 0.952 . . . . 0.0 110.639 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.459 ' N ' ' HB2' ' A' ' 153' ' ' GLU . 2.1 t70 -64.52 -32.48 74.14 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.871 0.869 . . . . 0.0 110.078 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -144.6 72.24 15.54 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.11 -16.61 55.94 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.285 2.657 . . . . 0.0 115.582 -165.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.53 -11.22 59.84 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.568 0.347 . . . . 0.0 111.59 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -72.61 -15.71 61.73 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.308 0.643 . . . . 0.0 111.226 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 93.25 -175.47 36.29 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.661 0.624 . . . . 0.0 114.661 167.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.496 HG22 ' HG2' ' A' ' 187' ' ' LYS . 17.9 t -79.16 115.33 21.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.53 154.92 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.643 1.177 . . . . 0.0 110.214 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.505 ' HB2' HG23 ' A' ' 183' ' ' ILE . 10.8 pt20 -98.24 127.41 44.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.072 0.549 . . . . 0.0 110.103 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 82.7 mmm -137.13 142.01 42.26 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.327 1.051 . . . . 0.0 108.968 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASN . . . . . 0.43 ' O ' HG22 ' A' ' 204' ' ' VAL . 27.5 m-80 -86.24 173.6 9.65 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 118.294 0.497 . . . . 0.0 110.228 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 51.6 m -61.0 -37.88 84.07 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.858 0.299 . . . . 0.0 111.488 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -58.88 -27.9 65.63 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.788 0.835 . . . . 0.0 112.158 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -87.96 -41.55 13.07 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.359 0.664 . . . . 0.0 111.309 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 200' ' ' ASN . 4.7 m -93.28 116.66 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.82 0.819 . . . . 0.0 109.233 -175.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -113.43 148.77 35.25 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.59 -165.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.09 153.93 20.55 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.272 0.629 . . . . 0.0 110.275 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.419 ' HG3' ' SD ' ' A' ' 289' ' ' MET . 9.6 ptm85 -117.64 127.17 53.69 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.371 0.668 . . . . 0.0 111.006 -169.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -85.26 136.47 33.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.828 0.851 . . . . 0.0 109.837 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.715 ' HB3' ' HG2' ' A' ' 289' ' ' MET . 6.7 ppt_? -92.77 15.61 14.21 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.125 0.57 . . . . 0.0 110.65 175.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 279' ' ' LYS . 23.0 m -86.62 108.89 18.82 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.391 0.677 . . . . 0.0 110.01 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 mt -86.51 121.98 38.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 172.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.568 HG23 ' HB2' ' A' ' 216' ' ' ASP . 38.5 mm -94.29 142.33 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.502 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 1.3 ptpp? -128.2 -179.73 5.16 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.609 1.164 . . . . 0.0 109.699 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' TRP . . . . . 0.428 ' CH2' ' HB2' ' A' ' 248' ' ' GLU . 10.5 t90 -56.16 -40.47 73.93 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.064 0.546 . . . . 0.0 110.454 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -59.3 -33.12 70.71 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.718 0.807 . . . . 0.0 111.604 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.568 ' HB2' HG23 ' A' ' 212' ' ' ILE . 66.0 m-20 -80.34 -34.7 36.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.279 0.632 . . . . 0.0 110.536 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.518 HD22 HD11 ' A' ' 243' ' ' ILE . 89.0 mt -67.18 112.86 4.7 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-O 120.99 0.424 . . . . 0.0 110.479 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.51 154.83 51.24 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.519 1.127 . . . . 0.0 108.353 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 36.0 m -64.42 124.15 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.008 0.432 . . . . 0.0 110.49 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.25 -18.88 47.56 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.561 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -79.64 124.36 28.48 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.526 0.663 . . . . 0.0 109.859 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 14.0 p -91.94 141.23 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.535 0.683 . . . . 0.0 109.165 173.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.463 HG11 HG21 ' A' ' 212' ' ' ILE . 11.4 m -139.1 -177.1 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.978 1.311 . . . . 0.0 109.266 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.45 ' HB3' ' HE2' ' A' ' 224' ' ' MET . 3.8 ttp -136.63 125.27 23.75 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.115 0.566 . . . . 0.0 109.609 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.432 HD13 ' HD1' ' A' ' 227' ' ' TYR . 0.4 OUTLIER -146.21 151.62 37.89 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.408 1.083 . . . . 0.0 110.29 -169.445 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -88.8 108.79 19.7 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.935 0.494 . . . . 0.0 111.064 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.432 ' HD1' HD13 ' A' ' 225' ' ' LEU . 93.5 m-85 -140.61 139.77 34.96 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.913 0.885 . . . . 0.0 108.836 171.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ASN . . . . . 0.493 HD22 ' HB2' ' A' ' 230' ' ' ASP . 14.0 p-10 -87.26 134.62 36.07 Favored Pre-proline 0 N--CA 1.474 0.729 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.49 -13.12 36.78 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.116 1.878 . . . . 0.0 112.469 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.493 ' HB2' HD22 ' A' ' 228' ' ' ASN . 6.5 m-20 -67.69 -40.31 84.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.867 0.867 . . . . 0.0 110.133 173.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 234' ' ' GLU . 48.1 t-20 -141.31 104.19 6.04 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.78 -16.96 47.12 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.655 2.236 . . . . 0.0 112.688 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.478 ' HG3' HD11 ' A' ' 272' ' ' ILE . 83.0 tttt -95.55 8.3 43.75 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.989 0.916 . . . . 0.0 110.358 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 231' ' ' ASN . 38.3 tt0 -132.95 148.76 52.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.334 0.654 . . . . 0.0 110.964 -175.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -60.14 150.34 29.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.626 1.17 . . . . 0.0 112.386 172.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -169.6 -115.36 0.33 Allowed Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.493 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -95.62 150.06 20.77 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.347 0.659 . . . . 0.0 110.439 -176.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -77.97 107.45 10.52 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.403 0.681 . . . . 0.0 110.042 -174.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -119.63 164.97 15.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.331 0.652 . . . . 0.0 109.263 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.55 144.23 30.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 174.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.73 133.95 21.68 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 222' ' ' VAL . 34.6 tt0 -105.49 127.06 52.8 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.552 HD12 HD11 ' A' ' 255' ' ' LEU . 14.7 mm -64.95 103.8 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 123.993 0.808 . . . . 0.0 109.666 -172.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.8 p -79.31 -45.57 19.4 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.144 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -143.82 163.6 32.91 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.284 1.034 . . . . 0.0 110.102 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -155.03 149.05 25.8 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.761 0.824 . . . . 0.0 109.427 172.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -146.57 118.87 8.36 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.484 0.659 . . . . 0.0 110.565 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.428 ' HB2' ' CH2' ' A' ' 214' ' ' TRP . 5.0 tm-20 -93.17 124.19 36.97 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 63.6 p -125.61 157.51 37.01 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.44 ' HG3' HG23 ' A' ' 251' ' ' THR . 27.5 ptt180 -60.82 -24.76 66.11 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.349 1.06 . . . . 0.0 112.703 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.44 HG23 ' HG3' ' A' ' 250' ' ' ARG . 55.9 p -97.93 -28.59 13.74 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.828 0.851 . . . . 0.0 112.566 -172.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -166.1 169.24 14.7 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.68 0.392 . . . . 0.0 111.026 -173.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -95.85 155.56 16.7 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.081 0.553 . . . . 0.0 109.747 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -146.28 140.56 26.58 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.552 HD11 HD12 ' A' ' 243' ' ' ILE . 0.3 OUTLIER -148.17 144.35 27.69 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.183 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -135.68 134.04 38.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.998 0.919 . . . . 0.0 109.82 176.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.84 143.98 27.82 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.223 0.609 . . . . 0.0 111.087 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -79.52 98.43 6.84 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.022 0.529 . . . . 0.0 109.583 172.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 91.8 t -76.42 103.51 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.273 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.66 122.53 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.966 0.889 . . . . 0.0 110.104 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 32.5 mt -88.17 -151.57 0.2 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.173 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -59.89 -77.04 0.19 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 117.852 0.296 . . . . 0.0 112.579 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -100.49 -25.15 14.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.378 0.671 . . . . 0.0 110.944 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -90.61 173.21 8.17 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.826 0.85 . . . . 0.0 111.435 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 32.8 p -155.56 120.54 4.8 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.553 0.741 . . . . 0.0 110.054 174.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.19 97.51 7.64 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.364 1.066 . . . . 0.0 109.033 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.7 132.92 46.89 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.564 0.746 . . . . 0.0 111.36 -172.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 55.3 35.87 25.85 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.644 1.215 . . . . 0.0 111.818 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 36.8 t -64.0 124.43 21.57 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 54.3 ttt180 -70.63 117.18 11.83 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.788 0.435 . . . . 0.0 110.229 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 34.8 mm -80.36 110.91 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.219 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.478 HD11 ' HG3' ' A' ' 233' ' ' LYS . 25.0 mm -78.12 -66.36 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.796 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -83.63 65.84 8.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.817 1.247 . . . . 0.0 109.948 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.7 m -64.4 -32.53 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.603 0.761 . . . . 0.0 111.999 -173.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 5.3 p-10 -86.05 -13.98 45.76 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.645 1.178 . . . . 0.0 111.917 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -97.65 -0.64 45.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.453 0.701 . . . . 0.0 111.471 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.81 153.87 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.704 0.801 . . . . 0.0 110.637 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -117.4 161.56 19.35 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.899 0.879 . . . . 0.0 108.869 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.417 ' HB3' ' HB ' ' A' ' 210' ' ' THR . 80.1 tttt -91.03 153.09 20.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.867 0.467 . . . . 0.0 112.008 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.2 mm -67.23 120.26 14.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 123.947 0.899 . . . . 0.0 108.802 168.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.36 112.2 8.22 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.527 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 96.1 mtt180 -128.2 141.59 41.79 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 123.883 0.873 . . . . 0.0 109.436 172.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -46.16 108.03 0.14 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.815 3.01 . . . . 0.0 113.265 170.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.36 -39.78 2.9 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.817 -0.628 . . . . 0.0 113.435 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 32.5 tt0 -79.35 -29.19 42.09 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.961 0.381 . . . . 0.0 111.766 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -117.57 151.43 18.07 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 12.5 p -88.91 109.95 34.15 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-N 117.788 0.794 . . . . 0.0 110.114 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.25 155.69 60.31 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 123.198 2.599 . . . . 0.0 110.166 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' MET . . . . . 0.715 ' HG2' ' HB3' ' A' ' 209' ' ' ARG . 63.8 mtt -74.78 80.5 2.08 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.61 0.719 . . . . 0.0 112.559 -172.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.02 -28.11 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 165.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.78 -164.42 0.79 Allowed 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.254 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -57.24 111.75 3.78 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 118.774 0.715 . . . . 0.0 111.566 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.544 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 11.9 Cg_exo -72.61 93.89 0.77 Allowed 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.432 2.088 . . . . 0.0 111.094 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.2 mtm -73.36 125.73 28.52 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.02 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.23 121.34 22.77 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -64.59 -30.08 71.1 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.06 0.944 . . . . 0.0 111.179 -175.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -57.06 122.08 11.52 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.383 167.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 50.2 p . . . . . 0 CA--C 1.55 0.948 0 C-N-CA 123.366 0.666 . . . . 0.0 110.804 -177.96 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.417 0 CA-C-O 119.744 -0.476 . . . . 0.0 111.967 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.31 7.37 4.97 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -79.6 128.47 33.42 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.776 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 58.1 pttt -72.18 174.66 6.88 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.004 0.922 . . . . 0.0 111.657 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -74.51 -2.67 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.206 0.602 . . . . 0.0 111.948 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.511 ' H ' ' HG3' ' A' ' 136' ' ' LYS . 92.0 m-20 -120.99 30.3 6.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.244 1.018 . . . . 0.0 110.96 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.776 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 6.3 mm-40 -88.86 71.21 8.64 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.253 1.025 . . . . 0.0 110.859 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -63.76 99.4 0.23 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.288 169.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 30.1 m -121.77 169.32 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.972 0.909 . . . . 0.0 109.703 -176.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' A' ' 207' ' ' ARG . 1.6 t0 -101.6 110.34 22.32 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -92.75 92.98 8.21 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 122.932 0.493 . . . . 0.0 110.497 -171.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 2.8 tmt_? -72.27 106.13 4.32 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 174.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.62 114.8 3.78 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.47 ' HA ' ' NH1' ' A' ' 144' ' ' ARG . 13.8 t -60.25 -23.89 64.46 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -171.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -83.7 -38.69 21.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.447 0.699 . . . . 0.0 110.174 -174.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 41.9 ttm -92.96 -22.89 18.93 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.491 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.42 12.93 73.66 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.063 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.56 129.98 53.71 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.622 0.769 . . . . 0.0 111.147 -174.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 52.1 m95 -81.89 121.93 27.09 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.077 0.951 . . . . 0.0 110.617 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -131.03 115.18 16.12 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 27.1 mt-10 -58.45 144.86 40.72 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.311 0.505 . . . . 0.0 111.139 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.494 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -158.42 124.78 4.69 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 124.31 1.006 . . . . 0.0 109.613 -176.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -92.48 118.88 31.42 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 63.7 t -61.66 111.72 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 C-N-CA 123.484 0.713 . . . . 0.0 109.315 172.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.7 m -104.48 -6.89 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.138 0.575 . . . . 0.0 111.8 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -170.14 141.28 2.08 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.199 0.599 . . . . 0.0 110.24 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.6 m -119.41 142.09 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.59 0.756 . . . . 0.0 110.672 172.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.2 t -147.14 160.86 41.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.032 0.933 . . . . 0.0 108.833 169.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.2 ptt-85 -101.73 176.39 5.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.061 0.544 . . . . 0.0 110.217 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 N--CA 1.477 0.909 0 C-N-CA 123.474 0.71 . . . . 0.0 110.042 177.039 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.402 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 10.0 mm-40 52.11 29.21 6.15 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 173.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -71.41 63.35 0.38 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.54 168.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.31 -175.51 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.821 1.648 . . . . 0.0 108.645 -170.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.611 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.7 mp -97.5 110.71 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.402 ' OH ' ' HB3' ' A' ' 180' ' ' GLU . 99.6 m-85 -98.61 106.61 18.91 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.193 0.997 . . . . 0.0 108.411 170.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -79.09 97.7 6.23 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.494 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 35.1 m -109.97 163.65 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.241 1.017 . . . . 0.0 111.019 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 154' ' ' ALA . 1.8 mmmp? -121.54 114.01 20.61 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -63.16 115.03 4.12 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.303 0.377 . . . . 0.0 110.254 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.69 -34.77 72.33 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.968 0.413 . . . . 0.0 110.408 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.64 -28.72 61.93 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.898 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -142.17 68.13 22.0 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 122.762 0.425 . . . . 0.0 111.342 -170.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.34 -11.41 24.75 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.264 2.643 . . . . 0.0 113.629 -174.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.44 -17.87 62.36 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.558 0.743 . . . . 0.0 111.17 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -72.5 -10.5 59.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.389 0.675 . . . . 0.0 111.54 173.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.63 -151.78 45.16 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.401 0.438 . . . . 0.0 112.342 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.75 117.88 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 18.5 m -116.6 152.62 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.833 0.853 . . . . 0.0 109.466 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.611 ' HB2' HG23 ' A' ' 183' ' ' ILE . 5.4 pm0 -107.57 123.97 49.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.976 0.51 . . . . 0.0 109.716 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' MET . . . . . 0.404 ' HE1' ' HB1' ' A' ' 143' ' ' ALA . 74.9 mtp -131.16 170.13 14.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.58 0.752 . . . . 0.0 110.045 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -109.41 175.4 5.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.922 0.889 . . . . 0.0 109.904 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 45.8 t -63.73 -40.02 95.72 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.884 0.474 . . . . 0.0 110.687 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -65.46 -7.32 13.59 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -101.87 -54.64 2.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.027 0.931 . . . . 0.0 111.345 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 32.6 m -91.72 119.94 39.94 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -168.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.428 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 16.0 mmt180 -123.12 141.4 52.01 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.937 -169.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.81 132.18 51.55 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 168.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.674 ' HB3' ' HB2' ' A' ' 142' ' ' ASP . 4.2 ptm180 -111.71 158.35 19.43 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.772 0.429 . . . . 0.0 111.119 -173.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.64 140.64 29.33 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.858 0.463 . . . . 0.0 109.882 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.515 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 10.9 ptm180 -93.43 18.11 10.32 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.378 0.609 . . . . 0.0 110.537 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 87.8 m -98.91 113.99 26.39 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.304 1.042 . . . . 0.0 109.996 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 30.6 mt -86.94 124.49 40.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 169.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.629 ' HB ' ' HB ' ' A' ' 277' ' ' VAL . 47.9 mm -86.37 127.3 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.755 1.222 . . . . 0.0 109.917 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.87 -178.91 3.6 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.208 1.003 . . . . 0.0 108.625 171.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' TRP . . . . . 0.401 ' HA ' HD23 ' A' ' 217' ' ' LEU . 64.4 t-105 -54.29 -32.92 57.54 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.128 0.571 . . . . 0.0 112.269 -172.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -61.77 -39.17 90.73 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.529 0.731 . . . . 0.0 111.487 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.593 ' HB2' HG23 ' A' ' 212' ' ' ILE . 7.1 m-20 -84.6 -14.52 48.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.85 0.86 . . . . 0.0 111.67 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.447 HD22 HG22 ' A' ' 212' ' ' ILE . 3.2 mm? -66.7 113.41 4.81 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.7 140.94 34.99 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.129 0.971 . . . . 0.0 108.438 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.1 m -70.0 138.49 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 120.966 0.412 . . . . 0.0 110.899 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 94.06 -13.78 66.66 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.324 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.474 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.1 tt0 -81.68 122.77 28.05 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.344 0.572 . . . . 0.0 110.837 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.83 119.66 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 279' ' ' LYS . 1.9 m -135.27 172.58 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.587 1.155 . . . . 0.0 110.265 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.531 ' HE2' ' HB2' ' A' ' 278' ' ' PHE . 48.4 ttp -110.32 113.98 27.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.257 0.623 . . . . 0.0 110.08 -174.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.527 ' HG ' HG13 ' A' ' 277' ' ' VAL . 0.2 OUTLIER -121.97 147.16 46.41 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.281 0.632 . . . . 0.0 109.502 -173.102 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -87.44 124.09 33.06 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.575 0.75 . . . . 0.0 110.143 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 225' ' ' LEU . 7.3 p90 -169.07 154.2 5.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.061 0.944 . . . . 0.0 109.357 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -82.11 127.83 70.23 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 162.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.77 -38.89 77.57 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.304 2.003 . . . . 0.0 111.939 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -75.59 -30.1 59.51 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.021 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -132.9 79.87 62.21 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 123.3 0.64 . . . . 0.0 110.643 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.95 -11.96 32.18 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.135 2.557 . . . . 0.0 113.389 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.51 ' HA ' HD12 ' A' ' 272' ' ' ILE . 22.3 tptm -70.99 -24.23 62.35 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.35 0.66 . . . . 0.0 110.931 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.68 164.56 24.75 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.0 0.52 . . . . 0.0 111.033 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -51.49 160.08 0.65 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.335 1.454 . . . . 0.0 112.804 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -166.02 -107.32 0.2 Allowed Glycine 0 C--N 1.344 1.018 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -128.18 173.18 10.33 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.773 0.829 . . . . 0.0 109.11 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -96.65 127.16 42.37 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.452 0.701 . . . . 0.0 110.049 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 224' ' ' MET . 93.7 m-85 -138.95 164.54 29.45 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.371 0.668 . . . . 0.0 110.051 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.4 140.44 34.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -150.95 137.38 18.62 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -95.42 126.42 40.7 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.475 HD12 HD11 ' A' ' 255' ' ' LEU . 19.0 mm -67.65 110.39 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.052 0.453 . . . . 0.0 109.801 -175.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.424 ' H ' ' HA ' ' A' ' 257' ' ' ALA . 17.1 m -79.3 -39.66 32.35 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.823 0.849 . . . . 0.0 110.666 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -161.97 156.08 21.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.79 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -141.69 148.29 38.84 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.524 ' HB3' ' HG3' ' A' ' 254' ' ' GLU . 28.1 tpt180 -149.87 122.15 8.39 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -115.32 123.69 49.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.113 0.565 . . . . 0.0 109.873 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 62.2 p -121.6 162.95 19.73 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' A' ' 250' ' ' ARG . 11.6 tpt180 -67.18 -22.31 65.75 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 120.759 0.314 . . . . 0.0 111.401 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.2 p -86.41 -28.99 23.22 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.375 0.67 . . . . 0.0 111.414 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -165.67 141.41 5.1 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.445 ' O ' ' HD2' ' A' ' 253' ' ' ARG . 4.2 ppt_? -111.18 102.52 10.94 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.675 0.79 . . . . 0.0 109.569 173.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 247' ' ' ARG . 7.6 pt-20 -95.71 122.85 38.92 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.634 0.774 . . . . 0.0 110.722 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 270' ' ' ARG . 1.7 tm? -108.77 147.85 31.41 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' TYR . . . . . 0.448 ' N ' HD13 ' A' ' 255' ' ' LEU . 99.3 m-85 -135.04 132.31 38.1 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.264 1.026 . . . . 0.0 108.516 175.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.424 ' HA ' ' H ' ' A' ' 244' ' ' SER . . . -144.46 139.94 28.62 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 -177.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 43.5 t30 -75.66 95.54 3.41 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 172.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 34.3 t -68.79 112.16 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.372 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.79 117.92 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 264' ' ' ASP . 59.8 mt -94.5 -165.78 1.37 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.497 0.719 . . . . 0.0 109.423 173.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -62.85 -45.3 95.99 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.01 0.194 . . . . 0.0 113.341 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -123.06 -35.98 2.92 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.546 0.738 . . . . 0.0 110.646 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.571 ' HB2' HD12 ' A' ' 261' ' ' LEU . 8.2 m-20 -91.79 176.55 6.49 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.83 0.852 . . . . 0.0 111.574 -172.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 35.1 t -156.59 118.08 3.82 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.514 0.726 . . . . 0.0 110.201 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 2.0 mm? -96.15 92.11 6.25 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 3.2 p-10 -68.7 138.61 55.07 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.353 0.261 . . . . 0.0 111.289 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 57.88 32.53 22.05 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.291 1.036 . . . . 0.0 111.786 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 44.0 t -65.27 127.27 31.05 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.41 0.684 . . . . 0.0 110.411 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 45.0 ttp180 -70.51 110.49 5.42 Favored 'General case' 0 C--N 1.346 0.456 0 O-C-N 123.436 0.46 . . . . 0.0 110.343 -178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.1 mm -89.43 132.78 33.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.774 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 233' ' ' LYS . 65.0 mt -102.09 -26.31 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.082 1.353 . . . . 0.0 109.932 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -92.38 42.62 1.11 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.124 1.37 . . . . 0.0 111.336 -168.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 16.7 m -69.59 -22.84 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -168.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.85 -25.22 19.07 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.96 9.12 17.9 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.762 0.825 . . . . 0.0 112.332 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.629 ' HB ' ' HB ' ' A' ' 212' ' ' ILE . 32.7 t -80.56 147.05 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.391 0.676 . . . . 0.0 110.836 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.531 ' HB2' ' HE2' ' A' ' 224' ' ' MET . 62.7 m-85 -105.8 156.26 18.49 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 162.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.552 ' HA ' HG12 ' A' ' 223' ' ' VAL . 36.5 ttmt -80.57 146.58 31.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.666 0.386 . . . . 0.0 110.417 173.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.542 HG12 ' HA ' ' A' ' 223' ' ' VAL . 35.1 mm -73.48 114.91 13.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 168.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -76.6 134.06 39.47 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.631 173.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 61.5 mtp180 -108.38 94.2 13.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 168.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -20.17 97.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.386 2.551 1 C-N-CA 126.263 4.642 . . . . 0.0 117.246 -162.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 103.53 -30.84 9.5 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 115.347 -0.842 . . . . 0.0 115.189 169.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 11.6 pt-20 -79.51 -20.21 47.77 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.859 1.33 . . . . 0.0 112.004 -173.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -87.46 -100.57 0.87 Allowed Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' SER . . . . . 0.422 ' HB2' ' HG2' ' A' ' 209' ' ' ARG . 14.6 p -127.23 128.52 24.08 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.535 1.134 . . . . 0.0 110.791 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.52 133.66 17.65 Favored 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 123.29 2.66 . . . . 0.0 112.921 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' MET . . . . . 0.515 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 98.3 mmm -86.45 82.49 7.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 168.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 11.2 p -128.58 -15.03 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.757 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -103.42 -153.18 0.47 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.701 1.2 . . . . 0.0 108.625 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -55.17 120.19 28.28 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.566 0.747 . . . . 0.0 111.575 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.33 85.12 0.45 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.817 2.345 . . . . 0.0 111.336 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 18.7 ptm -71.05 82.39 0.68 Allowed 'General case' 0 C--O 1.244 0.767 0 CA-C-O 123.037 1.399 . . . . 0.0 109.895 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -94.73 160.03 14.8 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.77 -172.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.455 ' NH2' ' H ' ' A' ' 153' ' ' GLU . 30.6 mtm-85 -87.3 118.79 26.96 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.108 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.6 mttt 64.81 -170.89 0.19 Allowed 'General case' 0 CA--C 1.551 1.002 0 O-C-N 124.565 1.166 . . . . 0.0 111.078 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 C--O 1.24 0.562 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 160.272 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.634 ' N ' ' HH ' ' A' ' 184' ' ' TYR . . . . . . . . 0 N--CA 1.485 1.955 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.432 HD13 ' N ' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -127.29 5.67 6.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.488 0.715 . . . . 0.0 112.323 -173.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.505 ' HB2' HG11 ' A' ' 156' ' ' VAL . 43.0 m-85 -96.93 143.08 28.14 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.475 0.31 . . . . 0.0 110.433 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.551 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 22.6 pttp -86.14 176.8 7.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.037 0.535 . . . . 0.0 111.055 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.65 -10.27 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -173.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -127.44 21.59 6.59 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.747 0.419 . . . . 0.0 110.44 -171.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.551 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 17.9 mm-40 -99.65 88.62 3.88 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 122.038 -0.414 . . . . 0.0 110.798 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 25.6 p90 -76.75 122.87 25.35 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.339 171.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.26 167.42 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.617 0.767 . . . . 0.0 108.968 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -90.72 115.12 27.57 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.79 120.37 36.33 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.588 -167.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.54 128.37 35.39 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.85 112.45 5.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 t -68.02 -14.35 62.9 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.464 0.705 . . . . 0.0 112.702 -172.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -86.76 -54.12 4.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.343 0.657 . . . . 0.0 111.107 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 37.8 ttp -96.34 -27.83 14.77 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.411 0.685 . . . . 0.0 112.084 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.72 18.85 46.35 Favored Glycine 0 N--CA 1.475 1.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.946 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.75 129.37 53.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.119 0.568 . . . . 0.0 111.062 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.673 ' HH2' ' HD2' ' A' ' 205' ' ' ARG . 81.4 m95 -75.22 128.09 34.66 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.64 0.776 . . . . 0.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -131.8 137.66 48.22 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.283 1.033 . . . . 0.0 108.925 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -59.32 114.43 2.65 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -125.54 120.67 31.5 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.199 0.6 . . . . 0.0 109.796 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.734 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 51.6 tt0 -87.19 114.75 24.07 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.605 0.762 . . . . 0.0 110.554 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 135' ' ' TYR . 92.5 t -62.28 98.41 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.7 m -94.88 -10.02 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.912 0.485 . . . . 0.0 111.076 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 27.8 ttt180 -170.25 146.7 2.97 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.975 0.797 . . . . 0.0 109.92 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.0 m -117.17 142.9 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 169.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.3 p -135.21 121.49 20.3 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 172.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -82.18 176.47 9.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.029 0.532 . . . . 0.0 111.051 -175.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.77 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 . . . . . 0 C--O 1.241 0.621 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.23 97.43 1.55 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.025 -171.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -76.66 53.14 0.87 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.823 0.82 . . . . 0.0 110.435 169.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 31.6 m -83.85 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 124.603 1.161 . . . . 0.0 109.624 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.595 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.5 mp -97.3 106.21 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.634 ' HH ' ' N ' ' A' ' 133' ' ' GLY . 36.2 m-85 -93.54 111.17 22.78 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 14.5 m-70 -80.01 90.28 5.38 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 35.0 m -108.97 140.2 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.32 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -105.74 123.45 47.97 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -57.04 96.3 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -62.96 -29.63 70.96 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.006 0.922 . . . . 0.0 109.076 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 298' ' ' SER . 2.0 t0 -61.83 -30.96 71.18 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.086 1.354 . . . . 0.0 111.031 176.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -145.75 81.27 10.1 Favored Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 124.549 1.14 . . . . 0.0 108.624 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -65.05 -16.86 57.36 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.076 2.517 . . . . 0.0 114.618 -170.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.53 -18.7 65.13 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -74.67 -20.9 59.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.206 0.602 . . . . 0.0 111.626 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.41 -144.6 41.04 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.511 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 6.8 t -87.66 129.55 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.217 0.607 . . . . 0.0 110.424 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.7 153.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.045 1.338 . . . . 0.0 108.52 170.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.595 ' HB2' HG23 ' A' ' 183' ' ' ILE . 16.2 pt20 -102.88 128.74 49.54 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.124 0.488 . . . . 0.0 110.305 177.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 84.2 mtp -137.61 159.82 40.9 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.33 1.052 . . . . 0.0 108.73 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -97.81 174.23 6.7 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.6 t -64.21 -34.79 78.89 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 120.827 0.346 . . . . 0.0 110.746 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.46 -14.86 63.3 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -96.5 -45.29 6.81 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.716 0.807 . . . . 0.0 110.344 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 32.6 m -95.41 117.29 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.673 ' HD2' ' HH2' ' A' ' 151' ' ' TRP . 92.7 mtt180 -128.55 171.42 12.15 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.77 -0.582 . . . . 0.0 111.193 -168.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.58 129.4 40.43 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.374 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.58 ' HG3' ' SD ' ' A' ' 289' ' ' MET . 26.4 ptt180 -81.1 142.11 33.64 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.357 1.063 . . . . 0.0 111.229 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.65 ' HB2' ' HB2' ' A' ' 281' ' ' GLU . . . -99.92 145.41 27.84 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.395 0.678 . . . . 0.0 110.339 175.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -2.38 34.81 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.657 0.783 . . . . 0.0 110.558 173.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.5 m -89.49 117.71 28.6 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.473 0.709 . . . . 0.0 111.332 -165.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.3 mt -92.4 136.26 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 166.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.686 HG21 HD13 ' A' ' 217' ' ' LEU . 19.9 mm -107.46 153.55 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.951 0.9 . . . . 0.0 110.372 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -128.26 168.52 15.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.549 0.74 . . . . 0.0 109.066 167.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 35.9 t90 -46.32 -41.86 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.344 1.058 . . . . 0.0 112.096 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -57.68 -46.3 84.48 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.85 0.86 . . . . 0.0 112.637 -173.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -103.65 6.3 36.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.504 0.722 . . . . 0.0 111.023 -175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.686 HD13 HG21 ' A' ' 212' ' ' ILE . 8.0 tp -86.63 110.96 20.2 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 175.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.7 153.35 25.39 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.947 0.34 . . . . 0.0 110.861 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.413 ' HA ' ' HB ' ' A' ' 243' ' ' ILE . 28.0 m -66.13 136.99 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.701 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.0 -23.62 34.89 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.622 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.524 ' HG2' HG13 ' A' ' 223' ' ' VAL . 62.5 tt0 -74.69 123.39 24.81 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.119 0.567 . . . . 0.0 110.373 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 84.5 t -85.8 119.91 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.524 HG13 ' HG2' ' A' ' 221' ' ' GLN . 3.5 m -132.69 164.54 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.226 1.41 . . . . 0.0 109.856 -177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.589 ' HB3' HD11 ' A' ' 280' ' ' ILE . 15.0 ptm -112.28 139.11 48.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.635 0.774 . . . . 0.0 110.353 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.578 HD13 HG23 ' A' ' 271' ' ' ILE . 0.6 OUTLIER -142.69 157.28 44.83 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.31 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -89.37 112.23 23.29 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.195 0.598 . . . . 0.0 109.65 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.429 ' OH ' HG13 ' A' ' 259' ' ' VAL . 0.5 OUTLIER -159.89 149.69 18.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.692 0.797 . . . . 0.0 109.321 178.65 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -92.76 137.37 24.14 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 171.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.82 2.53 5.83 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.733 2.289 . . . . 0.0 113.66 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -96.77 -15.93 21.1 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.869 0.868 . . . . 0.0 110.726 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -160.08 90.48 1.79 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.606 0.762 . . . . 0.0 109.025 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.05 -5.19 15.8 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.067 2.511 . . . . 0.0 112.33 175.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.664 ' HA ' HD12 ' A' ' 272' ' ' ILE . 88.6 tttt -73.45 -28.29 61.88 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.772 0.829 . . . . 0.0 111.171 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -123.84 155.18 38.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.09 0.556 . . . . 0.0 110.263 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -68.75 174.3 4.45 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.263 1.025 . . . . 0.0 112.76 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -178.8 -105.03 0.19 Allowed Glycine 0 C--N 1.338 0.67 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.932 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -110.04 153.03 25.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 0.0 109.408 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' TRP . . . . . 0.437 ' HA ' ' O ' ' A' ' 225' ' ' LEU . 67.2 m95 -83.58 106.38 15.27 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 122.796 0.438 . . . . 0.0 110.074 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -112.62 166.08 11.67 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ASP . . . . . 0.494 ' HB2' HG13 ' A' ' 260' ' ' VAL . 3.8 m-20 -81.32 146.21 30.48 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.223 176.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -146.47 134.51 21.5 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -102.39 117.28 34.38 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.414 HD12 HD21 ' A' ' 255' ' ' LEU . 31.8 mm -61.98 114.8 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 123.352 0.407 . . . . 0.0 110.377 -171.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 20.1 m -98.86 -25.01 14.76 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.463 0.705 . . . . 0.0 110.449 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 23.9 ttm180 -166.89 151.71 7.42 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.726 0.811 . . . . 0.0 109.381 -174.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -156.42 134.3 11.09 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.963 0.505 . . . . 0.0 110.388 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -146.51 116.38 7.27 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 8.9 pt-20 -100.16 152.18 20.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.194 0.521 . . . . 0.0 109.824 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 69.5 p -131.96 168.03 18.62 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -67.93 -15.98 63.86 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 117.829 0.286 . . . . 0.0 111.32 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.6 p -94.01 -29.87 15.0 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.843 0.857 . . . . 0.0 112.027 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -168.62 134.73 1.82 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 122.917 0.487 . . . . 0.0 111.528 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 46.9 mtt180 -90.79 106.88 18.82 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -95.95 143.55 27.03 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.301 0.64 . . . . 0.0 109.643 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.516 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 5.6 tt -150.0 149.84 30.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' TYR . . . . . 0.476 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 82.4 m-85 -134.72 124.84 25.89 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -134.54 147.88 50.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.11 0.564 . . . . 0.0 110.459 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 35.0 t30 -76.01 92.49 3.16 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 15.7 t -67.96 130.42 33.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.649 174.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 240' ' ' ASP . 4.3 p -122.47 114.26 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 40.4 mt -89.35 -155.63 0.36 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.221 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -81.3 -49.25 5.6 Favored Glycine 0 C--N 1.344 1.0 0 C-N-CA 121.932 -0.175 . . . . 0.0 112.722 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -104.99 -24.22 12.85 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.259 0.624 . . . . 0.0 111.988 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -139.57 175.66 9.38 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.97 0.508 . . . . 0.0 109.899 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 17.6 p -144.76 131.47 20.05 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.158 0.583 . . . . 0.0 111.315 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 14.7 mt -97.87 89.83 4.73 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.699 1.2 . . . . 0.0 109.38 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 18.4 t-20 -69.98 135.15 49.09 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.14 0.576 . . . . 0.0 111.44 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 57.18 29.7 17.1 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.532 1.133 . . . . 0.0 112.825 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 39.3 t -66.43 130.39 43.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.005 0.522 . . . . 0.0 109.968 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -69.58 131.22 44.33 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.032 0.444 . . . . 0.0 111.361 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.578 HG23 HD13 ' A' ' 225' ' ' LEU . 48.8 mm -108.24 114.44 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.838 1.255 . . . . 0.0 109.335 -175.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.664 HD12 ' HA ' ' A' ' 233' ' ' LYS . 11.9 mt -87.94 -21.96 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.579 0.752 . . . . 0.0 109.893 173.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.79 38.54 0.84 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.262 1.025 . . . . 0.0 111.461 -173.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 26.8 m -63.19 -21.33 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.543 0.737 . . . . 0.0 111.861 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.92 -27.62 14.19 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.895 1.278 . . . . 0.0 110.543 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -106.17 10.82 31.81 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.198 0.999 . . . . 0.0 111.434 -170.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.529 HG13 ' HB ' ' A' ' 212' ' ' ILE . 7.4 p -86.17 131.14 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.527 0.731 . . . . 0.0 109.515 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.4 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 7.0 m-30 -101.27 164.21 11.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.478 1.111 . . . . 0.0 109.41 172.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.623 ' HB2' HD11 ' A' ' 212' ' ' ILE . 40.4 ttmt -83.76 142.32 30.77 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.153 0.581 . . . . 0.0 110.994 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.589 HD11 ' HB3' ' A' ' 224' ' ' MET . 21.0 mm -84.04 117.47 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 165.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.65 ' HB2' ' HB2' ' A' ' 208' ' ' ALA . 0.3 OUTLIER -83.63 106.34 15.27 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.407 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 29.4 mtp180 -97.65 92.35 1.3 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -15.33 90.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.474 1 C-N-CA 126.621 4.881 . . . . 0.0 117.037 -161.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.26 6.05 51.7 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.441 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 34.7 tt0 -121.11 -23.06 5.9 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.438 0.695 . . . . 0.0 110.704 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -83.79 -126.88 1.31 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 174.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 23.0 m -127.81 142.36 44.02 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-N 117.62 0.71 . . . . 0.0 110.654 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.71 114.81 4.12 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.81 2.34 . . . . 0.0 111.036 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' MET . . . . . 0.58 ' SD ' ' HG3' ' A' ' 207' ' ' ARG . 26.5 ttt -73.94 92.76 2.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.564 0.697 . . . . 0.0 110.055 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 11.1 p -123.19 24.19 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 125.057 1.343 . . . . 0.0 108.687 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.09 -171.28 2.84 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.191 -165.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -47.2 141.71 6.06 Favored Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 125.048 1.339 . . . . 0.0 113.663 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.42 146.84 86.39 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.069 2.512 . . . . 0.0 112.582 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.4 mmt -82.39 -88.03 0.09 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.147 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 56.25 50.6 13.08 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -165.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -59.07 104.03 0.21 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.948 -1.933 . . . . 0.0 111.623 -170.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.54 26.28 14.15 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.13 0.972 . . . . 0.0 110.544 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 190' ' ' ASP . 78.4 p . . . . . 0 C--O 1.244 0.767 0 C-N-CA 123.204 0.601 . . . . 0.0 111.446 -172.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.791 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.607 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -59.09 -32.78 70.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.351 0.66 . . . . 0.0 112.475 -177.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.515 ' N ' HD22 ' A' ' 134' ' ' LEU . 48.8 m-85 -79.62 152.16 30.18 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -114.94 176.83 4.89 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 109.134 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.0 m -71.67 -2.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.479 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -117.66 7.68 12.63 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.877 0.871 . . . . 0.0 111.38 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -86.48 90.92 8.38 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.898 0.479 . . . . 0.0 111.211 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 50.4 p90 -63.81 123.36 18.71 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.612 167.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.19 -170.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.597 0.759 . . . . 0.0 110.154 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 205' ' ' ARG . 47.0 t0 -106.1 158.39 16.85 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 165.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -140.27 111.45 7.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.36 0.527 . . . . 0.0 109.586 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -70.77 93.71 0.98 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -62.03 132.48 53.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.696 1.198 . . . . 0.0 112.1 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.3 p -86.8 -14.11 43.16 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.092 0.957 . . . . 0.0 111.36 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.92 -53.82 7.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.064 0.546 . . . . 0.0 110.479 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 53.8 ttm -100.68 -36.25 9.19 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.437 0.695 . . . . 0.0 111.239 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.61 16.68 48.11 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.443 -172.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -103.96 150.58 24.09 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.768 0.827 . . . . 0.0 110.283 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.446 ' HZ3' ' HG3' ' A' ' 205' ' ' ARG . 18.5 m95 -83.05 118.61 23.65 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -124.06 112.35 17.04 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.127 0.571 . . . . 0.0 109.648 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.637 ' HB2' ' HD2' ' A' ' 295' ' ' ARG . 5.6 pt-20 -58.48 128.96 39.78 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.701 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.461 ' HA ' ' H ' ' A' ' 189' ' ' ASP . . . -144.1 -175.72 4.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.218 1.007 . . . . 0.0 111.136 -168.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.6 tt0 -140.25 125.49 18.76 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.038 0.535 . . . . 0.0 109.906 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.9 t -62.13 115.48 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 124.026 0.93 . . . . 0.0 108.921 169.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.556 HG11 ' HE2' ' A' ' 187' ' ' LYS . 35.5 m -116.99 -3.48 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.238 0.615 . . . . 0.0 112.007 -178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 29.2 ttm180 -162.4 139.39 8.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.186 0.594 . . . . 0.0 109.488 173.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 135' ' ' TYR . 11.6 m -119.2 134.4 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.419 0.688 . . . . 0.0 109.693 176.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.553 HG23 ' HB ' ' A' ' 183' ' ' ILE . 3.2 t -147.09 161.51 40.71 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.885 0.874 . . . . 0.0 109.907 175.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -115.97 149.96 37.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.949 0.9 . . . . 0.0 110.145 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 N--CA 1.483 1.194 0 C-N-CA 123.758 0.823 . . . . 0.0 109.358 173.643 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.96 83.49 2.85 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.195 0.598 . . . . 0.0 109.6 -173.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.418 ' HA ' ' HB3' ' A' ' 200' ' ' ASN . 5.9 m-20 -80.34 63.19 4.73 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.118 0.961 . . . . 0.0 109.364 171.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 160' ' ' THR . 34.7 m -105.54 159.27 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.641 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.553 ' HB ' HG23 ' A' ' 160' ' ' THR . 2.3 mp -93.18 108.97 21.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.979 0.895 . . . . 0.0 108.99 -173.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.42 ' HD2' HG12 ' A' ' 159' ' ' VAL . 68.7 m-85 -92.54 108.3 19.87 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.518 167.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 33.2 m-70 -77.05 100.09 5.55 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.93 142.81 20.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 123.811 0.694 . . . . 0.0 109.223 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.583 ' HG2' HG22 ' A' ' 196' ' ' VAL . 42.9 mtmt -103.59 121.62 43.29 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 170.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -60.7 108.51 0.85 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.461 ' H ' ' HA ' ' A' ' 154' ' ' ALA . 20.9 t70 -57.75 -42.13 83.33 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.905 0.882 . . . . 0.0 110.737 -173.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.94 -19.0 32.84 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.98 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -133.77 64.72 68.52 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 122.907 0.483 . . . . 0.0 110.607 -177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.0 -11.77 32.68 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.635 2.223 . . . . 0.0 112.559 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.85 -30.64 70.08 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.899 0.88 . . . . 0.0 111.229 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -72.24 -16.76 61.94 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.376 0.67 . . . . 0.0 110.512 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 87.31 -166.33 36.46 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.811 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.583 HG22 ' HG2' ' A' ' 187' ' ' LYS . 6.5 t -93.04 125.24 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.65 157.01 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.782 0.833 . . . . 0.0 110.68 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.55 114.59 28.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.582 1.153 . . . . 0.0 109.192 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 77.3 mmm -126.94 138.89 53.35 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.449 0.7 . . . . 0.0 110.065 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 20.6 m-80 -83.18 173.41 11.69 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.307 0.643 . . . . 0.0 109.865 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 29.8 t -56.15 -43.99 78.81 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.567 0.747 . . . . 0.0 111.813 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -54.04 -33.83 58.39 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.548 1.139 . . . . 0.0 111.947 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -88.28 -33.26 18.11 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.998 0.919 . . . . 0.0 111.661 -172.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 10.3 m -92.72 117.1 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 122.275 1.036 . . . . 0.0 108.483 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 22.3 mmm180 -109.66 168.65 9.25 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.836 -165.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.579 ' HA ' ' NH2' ' A' ' 207' ' ' ARG . . . -88.93 144.73 25.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.907 172.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.602 ' HG2' ' HG2' ' A' ' 295' ' ' ARG . 0.0 OUTLIER -80.06 93.25 5.74 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.9 97.08 0.21 Allowed 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.521 ' H ' ' NE ' ' A' ' 209' ' ' ARG . 0.0 OUTLIER -76.75 71.13 3.3 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.639 1.209 . . . . 0.0 110.141 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.9 m -146.09 110.38 5.03 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.937 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 28.7 mt -83.35 134.23 27.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 279' ' ' LYS . 42.6 mm -82.51 139.41 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.308 0.575 . . . . 0.0 110.951 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -124.41 160.03 29.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.12 1.368 . . . . 0.0 109.392 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' TRP . . . . . 0.583 ' HA ' HD23 ' A' ' 217' ' ' LEU . 31.9 t90 -56.2 -40.48 74.08 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.756 0.823 . . . . 0.0 112.323 -169.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -56.79 -41.77 78.29 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.663 0.785 . . . . 0.0 110.98 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.98 -21.27 51.18 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.881 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 214' ' ' TRP . 2.4 mm? -63.02 115.37 4.36 Favored 'General case' 0 C--N 1.364 1.205 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 221' ' ' GLN . 10.3 pt-20 -143.98 148.93 35.98 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.49 0.716 . . . . 0.0 109.556 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.38 135.02 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 122.781 0.433 . . . . 0.0 110.726 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.64 -9.44 77.0 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.633 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.482 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.7 tt0 -85.77 122.48 29.91 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.975 0.51 . . . . 0.0 110.445 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 72.8 t -93.66 114.47 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.482 HG13 ' HG2' ' A' ' 221' ' ' GLN . 13.1 m -126.91 160.27 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.957 0.903 . . . . 0.0 109.237 176.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.545 ' SD ' ' HB3' ' A' ' 238' ' ' TRP . 44.0 ttp -95.16 111.56 23.37 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.869 0.467 . . . . 0.0 110.604 -176.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.571 HD22 HG13 ' A' ' 271' ' ' ILE . 0.8 OUTLIER -111.24 155.62 22.69 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.62 0.768 . . . . 0.0 109.143 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.51 HD22 ' NE ' ' A' ' 235' ' ' ARG . 9.1 p-10 -97.57 121.27 39.28 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.219 1.008 . . . . 0.0 111.009 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.575 ' HB2' ' HA ' ' A' ' 232' ' ' PRO . 6.9 p90 -168.15 155.89 8.37 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.334 1.053 . . . . 0.0 109.801 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -83.27 137.09 42.67 Favored Pre-proline 0 CA--C 1.555 1.157 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 171.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.75 -28.43 68.41 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.0 1.8 . . . . 0.0 111.917 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.64 -30.27 36.65 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.553 0.741 . . . . 0.0 110.918 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -140.81 90.34 9.66 Favored Pre-proline 0 N--CA 1.489 1.51 0 C-N-CA 123.692 0.797 . . . . 0.0 110.174 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.575 ' HA ' ' HB2' ' A' ' 227' ' ' TYR . 38.8 Cg_endo -66.05 -8.24 19.47 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.453 2.102 . . . . 0.0 112.16 170.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.417 ' O ' HD12 ' A' ' 272' ' ' ILE . 21.3 tptm -74.18 -26.78 60.48 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.607 1.163 . . . . 0.0 110.967 173.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -117.19 147.14 42.74 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.332 0.653 . . . . 0.0 110.877 -172.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.51 ' NE ' HD22 ' A' ' 226' ' ' ASN . 3.3 tmt_? -69.0 117.29 10.47 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.656 1.582 . . . . 0.0 109.764 -176.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -134.26 -130.66 3.03 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 123.31 0.381 . . . . 0.0 112.427 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.427 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 42.0 m-85 -83.92 171.23 13.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.675 0.79 . . . . 0.0 110.819 -173.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' TRP . . . . . 0.545 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 97.6 m95 -91.38 112.38 24.26 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.254 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 68.3 m-85 -126.09 149.12 49.14 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 174.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.5 p-10 -82.44 157.11 23.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.5 ' HA ' HG23 ' A' ' 260' ' ' VAL . . . -162.93 140.76 8.07 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.216 0.606 . . . . 0.0 110.663 -176.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -90.51 118.6 30.1 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.144 0.578 . . . . 0.0 109.885 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.485 HD12 HD11 ' A' ' 255' ' ' LEU . 32.1 mm -62.8 126.36 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.38 0.672 . . . . 0.0 110.413 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.6 t -105.62 -38.47 6.41 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.466 1.106 . . . . 0.0 111.214 -174.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.55 143.25 11.53 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -135.71 143.48 45.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -155.33 114.94 3.67 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -100.13 121.6 41.67 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.8 p -84.64 -170.97 3.37 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 170.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -67.12 -34.63 78.01 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.01 23.79 3.89 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 120.696 0.284 . . . . 0.0 111.232 -171.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -159.35 129.07 5.52 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.261 0.625 . . . . 0.0 110.658 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.472 ' HD2' HG21 ' A' ' 274' ' ' VAL . 36.5 ttm180 -99.58 102.27 13.73 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.2 139.79 30.27 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.485 HD11 HD12 ' A' ' 243' ' ' ILE . 3.3 tm? -147.41 140.31 24.99 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -176.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -122.3 119.69 31.87 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.315 1.046 . . . . 0.0 108.538 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.77 137.15 54.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.81 0.844 . . . . 0.0 110.254 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -81.63 98.29 8.29 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.704 1.202 . . . . 0.0 108.34 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 58.9 t -63.31 134.16 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.857 0.863 . . . . 0.0 110.915 -173.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 241' ' ' ALA . 38.4 t -117.26 107.05 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.33 -151.45 0.26 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.235 1.014 . . . . 0.0 110.078 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -55.11 -71.83 0.66 Allowed Glycine 0 C--N 1.355 1.629 0 C-N-CA 123.066 0.365 . . . . 0.0 113.779 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -123.34 -16.66 6.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.477 0.711 . . . . 0.0 110.302 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -87.59 174.49 8.42 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.782 0.833 . . . . 0.0 111.006 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 65.8 p -153.43 138.3 17.13 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.181 0.593 . . . . 0.0 110.666 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 20.9 mt -108.72 90.91 3.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.991 0.916 . . . . 0.0 108.636 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -67.32 143.69 56.27 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 117.945 0.338 . . . . 0.0 111.113 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 33.1 t70 58.75 75.8 0.38 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.513 1.125 . . . . 0.0 111.748 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 68.8 m -113.48 126.32 55.2 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.413 0.685 . . . . 0.0 109.298 170.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -71.43 113.27 8.29 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.571 HG13 HD22 ' A' ' 225' ' ' LEU . 39.9 mm -94.3 123.58 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.962 0.505 . . . . 0.0 109.844 -174.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 233' ' ' LYS . 59.4 mt -83.76 -36.38 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.221 1.008 . . . . 0.0 110.5 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -96.14 51.15 1.2 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 122.262 1.03 . . . . 0.0 110.574 -167.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.472 HG21 ' HD2' ' A' ' 253' ' ' ARG . 23.9 m -72.14 -16.69 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.696 -1.593 . . . . 0.0 113.292 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.72 -15.07 33.32 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.936 0.494 . . . . 0.0 110.982 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -96.93 4.55 51.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.369 0.668 . . . . 0.0 111.634 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.418 HG13 ' HG ' ' A' ' 225' ' ' LEU . 43.4 t -76.4 146.15 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.36 0.664 . . . . 0.0 111.455 -175.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -126.65 160.16 31.52 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.045 0.938 . . . . 0.0 109.859 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.501 ' HB2' HD11 ' A' ' 212' ' ' ILE . 22.4 ttmm -84.87 149.21 25.84 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.306 0.643 . . . . 0.0 111.77 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 224' ' ' MET . 50.2 mm -92.29 126.78 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 169.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 105.36 13.55 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.334 0.653 . . . . 0.0 110.559 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -93.18 146.06 31.22 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 123.777 0.831 . . . . 0.0 111.153 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -41.94 119.17 1.11 Allowed 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 124.525 3.484 . . . . 0.0 115.005 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 97.0 -51.88 1.44 Allowed Glycine 0 C--N 1.352 1.425 0 O-C-N 123.333 0.396 . . . . 0.0 112.205 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -71.73 -22.85 61.57 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.663 1.185 . . . . 0.0 110.47 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -77.38 78.39 1.46 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.9 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 14.8 m -71.24 146.97 92.92 Favored Pre-proline 0 C--O 1.246 0.896 0 C-N-CA 123.424 0.69 . . . . 0.0 109.911 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.25 157.03 62.89 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.744 2.296 . . . . 0.0 111.245 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 21.0 ttt -83.25 78.18 9.66 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.724 0.774 . . . . 0.0 109.393 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 10.6 p -92.83 -28.43 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.372 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -74.81 162.33 28.76 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.012 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 293' ' ' PRO . 24.8 p-10 -49.45 140.5 13.5 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 124.703 1.201 . . . . 0.0 113.539 -167.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 292' ' ' ASN . 26.7 Cg_exo -62.12 109.63 0.86 Allowed 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.257 2.638 . . . . 0.0 112.922 -176.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -140.04 143.42 36.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.707 0.803 . . . . 0.0 109.891 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.637 ' HD2' ' HB2' ' A' ' 153' ' ' GLU . 49.4 mtm180 -129.91 -163.43 1.3 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -18.5 26.93 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.247 0.476 . . . . 0.0 110.738 -173.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -131.33 48.44 2.42 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 122.481 1.134 . . . . 0.0 109.398 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.7 p . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 164.924 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.419 ' HA3' ' CE1' ' A' ' 184' ' ' TYR . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 112.238 -0.345 . . . . 0.0 112.238 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.18 -10.04 14.66 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.262 1.025 . . . . 0.0 111.153 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -79.27 121.12 24.69 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -82.08 178.94 8.0 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.93 0.892 . . . . 0.0 111.407 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.14 29.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.708 1.203 . . . . 0.0 112.985 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -140.18 -50.39 0.47 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.528 1.131 . . . . 0.0 109.176 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -68.99 88.91 0.41 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.742 0.417 . . . . 0.0 111.268 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -75.35 138.35 41.7 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.341 172.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 206' ' ' ALA . 17.4 m -123.89 158.87 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.172 1.389 . . . . 0.0 109.854 -172.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -93.04 109.78 21.24 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.74 120.46 34.03 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.69 0.796 . . . . 0.0 111.396 -168.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -72.78 98.86 2.49 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.658 0.783 . . . . 0.0 110.085 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.78 110.34 10.13 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.4 m -66.04 -27.53 68.17 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.032 0.933 . . . . 0.0 112.049 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -62.12 -50.68 70.94 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.973 0.509 . . . . 0.0 111.688 -171.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -102.27 -18.76 15.32 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 122.304 0.242 . . . . 0.0 111.64 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.44 50.63 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.237 0.336 . . . . 0.0 113.628 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.66 152.06 20.9 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.531 0.681 . . . . 0.0 112.554 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -80.06 120.89 24.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.159 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -127.3 115.84 19.62 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -62.27 137.71 58.3 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.621 0.575 . . . . 0.0 109.678 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.487 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -148.31 129.17 14.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.037 0.535 . . . . 0.0 111.384 -165.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -87.29 114.54 23.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.492 0.717 . . . . 0.0 109.705 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 186' ' ' VAL . 58.6 t -66.96 116.06 5.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.558 HG11 ' HE2' ' A' ' 187' ' ' LYS . 33.5 m -117.73 -9.4 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.171 0.588 . . . . 0.0 111.534 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.588 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 2.5 tpm_? -166.82 147.03 5.74 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.46 136.89 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 124.113 0.965 . . . . 0.0 109.655 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.405 HG23 ' HB ' ' A' ' 183' ' ' ILE . 10.2 t -148.77 163.33 37.68 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.323 1.049 . . . . 0.0 109.68 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 59.6 mtt-85 -122.77 170.4 10.11 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -172.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 94.1 mttt . . . . . 0 N--CA 1.479 0.993 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.002 173.653 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -67.61 85.76 0.19 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.815 0.697 . . . . 0.0 109.909 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -79.56 65.41 4.72 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 122.677 1.227 . . . . 0.0 108.202 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.64 177.35 3.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.838 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.3 mp -95.58 108.63 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.599 0.714 . . . . 0.0 109.342 -171.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.419 ' CE1' ' HA3' ' A' ' 133' ' ' GLY . 95.1 m-85 -97.59 107.2 19.65 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.857 1.263 . . . . 0.0 107.834 170.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.588 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 89.0 m-70 -78.77 102.5 8.16 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.487 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 20.9 m -114.92 150.9 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.125 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.558 ' HE2' HG11 ' A' ' 157' ' ' VAL . 45.0 mtmt -117.87 122.83 44.36 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.455 ' HD2' ' HB2' ' A' ' 154' ' ' ALA . 17.1 m-85 -61.61 109.5 1.22 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.104 0.562 . . . . 0.0 111.329 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.3 -35.58 74.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -63.36 -34.73 78.35 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.815 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -155.02 82.07 4.07 Favored Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 124.655 1.182 . . . . 0.0 109.287 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -65.29 -27.34 55.8 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.807 3.005 . . . . 0.0 114.133 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.52 -1.96 17.89 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -75.13 -14.77 60.59 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.837 0.855 . . . . 0.0 111.436 171.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.86 -175.81 54.22 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.439 -0.346 . . . . 0.0 112.571 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.48 116.54 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.95 144.41 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.746 0.818 . . . . 0.0 109.144 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.563 ' HB2' HG23 ' A' ' 183' ' ' ILE . 28.9 pt20 -96.16 132.46 41.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 86.3 mmm -132.71 160.76 35.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.858 0.863 . . . . 0.0 109.193 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -110.88 175.1 5.55 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.882 0.473 . . . . 0.0 109.751 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 70.1 p -57.58 -45.87 84.69 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.673 0.789 . . . . 0.0 111.04 176.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -66.93 -8.49 29.91 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.082 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.31 -41.06 8.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.661 0.785 . . . . 0.0 110.87 173.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.59 132.91 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 112.773 0.656 . . . . 0.0 112.773 -169.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.609 ' HB3' ' HB3' ' A' ' 281' ' ' GLU . 39.5 mmt180 -112.29 155.72 23.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.827 1.251 . . . . 0.0 107.861 167.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.405 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -63.76 167.33 6.05 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.251 0.478 . . . . 0.0 110.87 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.67 95.82 6.7 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.25 97.86 0.13 Allowed 'General case' 0 C--N 1.36 1.023 0 C-N-CA 123.164 0.586 . . . . 0.0 109.841 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.456 ' NH2' ' HB2' ' A' ' 292' ' ' ASN . 3.5 tmt_? -84.45 76.52 10.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -172.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 73.1 m -147.19 119.06 8.11 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.062 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 58.8 mt -85.05 126.75 40.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 279' ' ' LYS . 38.4 mm -96.12 127.91 47.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 124.015 0.926 . . . . 0.0 108.636 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.456 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 0.0 OUTLIER -111.71 179.14 4.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.119 0.967 . . . . 0.0 109.168 -177.519 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 214' ' ' TRP . . . . . 0.509 ' HA ' HD12 ' A' ' 217' ' ' LEU . 59.6 t-105 -60.42 -43.15 97.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.284 0.634 . . . . 0.0 110.899 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -62.1 -27.38 68.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.042 0.937 . . . . 0.0 111.888 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -90.03 -22.48 21.84 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.898 0.479 . . . . 0.0 110.894 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 214' ' ' TRP . 85.7 mt -67.77 112.6 4.94 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -138.29 151.1 47.28 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.607 0.763 . . . . 0.0 109.632 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.9 m -68.87 123.98 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.045 0.538 . . . . 0.0 111.565 -171.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.56 -15.75 49.1 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.732 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.429 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.5 tt0 -79.67 121.39 25.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.941 0.496 . . . . 0.0 109.979 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 45.8 t -93.07 120.21 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.429 HG13 ' HG2' ' A' ' 221' ' ' GLN . 13.2 m -141.01 148.66 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.32 1.048 . . . . 0.0 110.541 -175.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 20.5 ptm -89.82 136.22 33.16 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.273 0.629 . . . . 0.0 110.847 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.54 ' HB3' HG22 ' A' ' 277' ' ' VAL . 0.7 OUTLIER -144.7 144.1 31.05 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.046 0.939 . . . . 0.0 110.4 -174.745 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.409 ' HB3' ' CE2' ' A' ' 238' ' ' TRP . 10.5 p-10 -71.17 106.01 3.62 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.349 0.66 . . . . 0.0 109.837 174.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -135.31 132.13 37.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ASN . . . . . 0.536 HD22 ' HB2' ' A' ' 231' ' ' ASN . 61.1 t30 -105.41 114.89 62.8 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -62.92 -33.77 73.78 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.82 2.347 . . . . 0.0 111.756 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.26 -36.38 82.85 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.053 0.941 . . . . 0.0 111.213 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.536 ' HB2' HD22 ' A' ' 228' ' ' ASN . 38.4 m-80 -143.97 87.32 8.07 Favored Pre-proline 0 N--CA 1.487 1.413 0 C-N-CA 123.793 0.837 . . . . 0.0 109.382 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.86 -9.87 27.52 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.399 2.733 . . . . 0.0 115.104 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -82.83 -27.7 30.69 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.031 0.532 . . . . 0.0 110.984 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -120.95 154.63 35.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.512 0.725 . . . . 0.0 110.257 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -49.14 154.15 0.84 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.006 1.322 . . . . 0.0 113.053 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.61 -148.17 4.9 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.16 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -83.86 148.82 26.76 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.259 1.023 . . . . 0.0 109.699 -174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' TRP . . . . . 0.437 ' CE2' ' HD2' ' A' ' 296' ' ' ARG . 67.1 m95 -84.3 107.24 16.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.013 0.525 . . . . 0.0 110.54 -171.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -114.52 151.9 32.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.3 p-10 -83.93 146.2 28.16 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 172.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -146.26 137.17 24.33 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.581 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -91.11 119.48 31.28 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.401 HD12 HD11 ' A' ' 255' ' ' LEU . 29.8 mm -60.41 107.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 124.051 0.844 . . . . 0.0 109.388 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.6 t -82.89 -47.66 11.58 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.452 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 65.9 mtt85 -152.86 164.76 37.26 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 125.345 1.458 . . . . 0.0 109.649 -172.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -151.27 136.78 17.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.804 0.441 . . . . 0.0 110.745 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -150.82 115.49 5.2 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.812 0.845 . . . . 0.0 109.439 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -91.74 153.77 19.4 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 68.7 p -130.15 174.88 9.39 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.948 0.899 . . . . 0.0 108.871 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -65.62 -18.65 65.48 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.528 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 26.5 p -103.99 -31.54 9.67 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 123.426 0.691 . . . . 0.0 112.788 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.23 157.28 6.2 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.23 0.538 . . . . 0.0 112.292 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 253' ' ' ARG . 4.3 mpt_? -94.91 101.68 13.48 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -97.81 102.21 13.91 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.124 0.57 . . . . 0.0 110.736 -173.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 3.4 tm? -95.18 143.65 26.43 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 81.2 m-85 -123.03 116.42 23.5 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.23 144.8 31.68 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.984 0.513 . . . . 0.0 110.421 -174.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -81.55 96.87 7.58 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 92.6 t -81.06 107.23 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.699 1.2 . . . . 0.0 109.619 -176.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 16.9 m -89.11 129.8 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.52 0.676 . . . . 0.0 110.361 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 63.9 mt -93.95 -154.87 0.43 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.814 1.246 . . . . 0.0 108.888 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -64.68 -54.45 28.6 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 122.959 0.162 . . . . 0.0 113.122 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -115.95 -46.27 2.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.463 0.705 . . . . 0.0 110.283 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.68 151.01 37.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.819 0.848 . . . . 0.0 111.424 -173.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 15.5 p -120.3 113.63 20.67 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.863 0.865 . . . . 0.0 109.319 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.654 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 81.5 mt -82.27 102.45 11.18 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.232 1.013 . . . . 0.0 109.86 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -75.02 123.8 25.83 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.102 0.561 . . . . 0.0 112.073 -173.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 54.8 46.59 24.21 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.755 1.222 . . . . 0.0 113.128 169.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 81.6 m -67.96 133.1 48.5 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 122.396 0.278 . . . . 0.0 111.184 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 45.1 ttp180 -70.26 107.29 3.67 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.722 0.638 . . . . 0.0 109.8 173.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.459 HG21 HD22 ' A' ' 225' ' ' LEU . 40.7 mm -95.86 111.3 25.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 82.9 mt -84.76 -13.5 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 124.623 1.169 . . . . 0.0 109.884 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -99.86 39.52 1.32 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.352 1.461 . . . . 0.0 110.072 -161.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.506 HG11 ' HZ3' ' A' ' 214' ' ' TRP . 28.8 m -71.74 -13.74 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 114.553 -1.203 . . . . 0.0 113.29 -167.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -86.87 -27.52 23.39 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.295 0.638 . . . . 0.0 110.996 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -93.26 1.26 57.1 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.694 0.797 . . . . 0.0 112.128 -174.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 225' ' ' LEU . 59.2 t -71.12 139.35 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.198 0.599 . . . . 0.0 110.397 -174.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -120.37 160.92 22.08 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.216 1.007 . . . . 0.0 109.93 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.559 ' HB2' HD11 ' A' ' 212' ' ' ILE . 35.8 ttmt -79.66 151.34 30.58 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.715 0.406 . . . . 0.0 111.184 176.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.9 mm -77.54 132.79 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.8 0.84 . . . . 0.0 109.676 172.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 205' ' ' ARG . 1.0 OUTLIER -79.99 105.85 11.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 59.4 mtp85 -120.19 149.76 50.01 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.907 1.283 . . . . 0.0 109.445 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.93 98.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.413 2.742 . . . . 0.0 113.856 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 86.74 -3.96 86.61 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.494 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -119.4 -23.14 6.77 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.734 0.767 . . . . 0.0 111.827 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -92.89 100.6 2.68 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 175.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 11.6 p -64.45 130.29 94.6 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.003 0.521 . . . . 0.0 111.919 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.37 164.47 34.02 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.104 2.536 . . . . 0.0 111.676 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' MET . . . . . 0.476 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 44.1 ttm -80.31 85.44 5.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.669 0.747 . . . . 0.0 109.968 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.85 -29.41 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.9 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -85.89 -158.5 0.4 Allowed 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.828 0.851 . . . . 0.0 109.431 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.456 ' HB2' ' NH2' ' A' ' 209' ' ' ARG . 13.3 m120 -58.93 116.87 17.19 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.851 0.86 . . . . 0.0 110.866 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.476 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 25.1 Cg_exo -64.28 112.33 1.87 Allowed 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 123.263 2.642 . . . . 0.0 112.568 -175.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 22.2 ptm -117.63 129.87 56.02 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.729 0.812 . . . . 0.0 110.105 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -97.27 174.5 6.68 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.319 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.437 ' HD2' ' CE2' ' A' ' 238' ' ' TRP . 0.3 OUTLIER -60.37 -50.57 73.08 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.096 173.564 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.64 -161.69 1.4 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.469 1.508 . . . . 0.0 108.221 173.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 C--O 1.243 0.727 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.699 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.986 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.28 4.05 4.34 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.433 0.693 . . . . 0.0 111.683 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -78.94 159.32 27.76 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.253 0.549 . . . . 0.0 110.289 172.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.465 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -86.19 172.55 10.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.151 0.98 . . . . 0.0 110.814 -174.46 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.5 m -83.62 6.26 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.272 1.029 . . . . 0.0 112.257 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -127.84 8.4 6.27 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.581 0.753 . . . . 0.0 111.175 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 156' ' ' VAL . 19.6 mm-40 -80.9 74.13 7.89 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.888 0.475 . . . . 0.0 111.864 -173.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 8.7 p90 -77.69 98.8 5.6 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.524 0.678 . . . . 0.0 109.434 168.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.497 ' HA ' ' HD2' ' A' ' 207' ' ' ARG . 27.4 m -115.98 179.51 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.141 1.376 . . . . 0.0 108.772 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.16 109.72 21.22 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -92.9 122.95 35.79 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.805 0.842 . . . . 0.0 110.057 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -71.3 110.42 5.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.69 136.06 57.85 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.064 0.946 . . . . 0.0 110.249 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.5 p -74.26 -28.69 61.33 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.685 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.8 -55.5 4.77 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 120.926 0.393 . . . . 0.0 111.502 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.5 ttp -104.5 -18.16 14.47 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.71 0.804 . . . . 0.0 112.472 -170.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.95 18.24 70.36 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 113.981 0.352 . . . . 0.0 113.981 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -94.08 140.66 29.46 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.993 0.517 . . . . 0.0 111.172 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -75.31 119.94 20.1 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -115.22 148.65 38.84 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.506 ' HG2' HH22 ' A' ' 207' ' ' ARG . 8.1 mt-10 -76.84 89.03 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.97 116.95 30.09 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.653 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 53.8 tt0 -89.57 102.67 15.35 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.084 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 59.8 t -57.88 96.35 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 167.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.2 m -95.41 -13.85 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.443 0.697 . . . . 0.0 110.864 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 50.3 ttt85 -163.53 135.62 5.06 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.62 139.66 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.0 p -133.43 159.3 40.76 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 123.827 0.851 . . . . 0.0 108.713 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -96.43 175.57 6.36 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.622 0.769 . . . . 0.0 110.222 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.503 ' HG3' HG12 ' A' ' 182' ' ' VAL . 7.7 mtpm? . . . . . 0 CA--C 1.55 0.964 0 CA-C-O 121.979 0.895 . . . . 0.0 109.847 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 . . . . . 0 C--O 1.243 0.753 0 CA-C-O 121.694 0.759 . . . . 0.0 108.955 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.711 ' HB3' HG22 ' A' ' 182' ' ' VAL . 2.8 mp0 -69.12 99.01 1.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.688 -162.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.06 20.71 1.49 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.26 165.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.711 HG22 ' HB3' ' A' ' 180' ' ' GLU . 12.5 m -73.6 175.0 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 164.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 183' ' ' ILE . 3.1 mp -95.56 110.93 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 O-C-N 121.882 -0.512 . . . . 0.0 110.22 -165.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -95.62 106.49 18.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.003 0.921 . . . . 0.0 108.65 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 14.0 m-70 -79.79 96.55 6.32 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.409 HG12 HG22 ' A' ' 156' ' ' VAL . 13.3 m -109.01 157.73 9.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.475 0.71 . . . . 0.0 109.55 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -130.16 117.82 20.5 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -67.38 116.22 7.9 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.903 0.481 . . . . 0.0 110.638 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 153' ' ' GLU . 34.3 t70 -67.04 -27.1 67.12 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.368 1.067 . . . . 0.0 109.876 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.12 -29.54 62.97 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.929 0.892 . . . . 0.0 111.566 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -141.57 75.31 22.35 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.775 0.83 . . . . 0.0 110.494 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.42 -15.43 49.74 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.942 2.428 . . . . 0.0 112.455 171.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.5 -26.56 67.23 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.997 0.919 . . . . 0.0 111.282 174.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -77.37 -16.43 58.87 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.332 0.653 . . . . 0.0 110.985 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.83 -130.13 22.24 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.86 0.725 . . . . 0.0 112.503 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 6.2 t -101.17 118.25 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.521 0.729 . . . . 0.0 109.112 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 24.5 m -113.6 155.21 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.422 0.689 . . . . 0.0 109.258 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -97.93 130.13 44.81 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.232 0.613 . . . . 0.0 110.043 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 92.1 mmm -131.63 160.61 34.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.445 1.098 . . . . 0.0 108.891 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -95.69 167.2 11.43 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.451 ' OG ' ' HB2' ' A' ' 180' ' ' GLU . 61.6 m -63.93 -39.47 94.22 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.866 0.466 . . . . 0.0 111.537 176.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -63.15 -23.51 67.47 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.703 0.801 . . . . 0.0 112.031 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -83.78 -37.72 22.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.521 0.728 . . . . 0.0 110.649 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 33.1 m -94.56 144.71 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.518 ' HA ' ' HE ' ' A' ' 205' ' ' ARG . 0.0 OUTLIER -140.69 142.92 34.83 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.8 155.49 7.72 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.024 0.93 . . . . 0.0 111.11 177.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.506 HH22 ' HG2' ' A' ' 153' ' ' GLU . 0.8 OUTLIER -128.85 138.42 52.03 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.078 0.466 . . . . 0.0 110.218 -172.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.09 152.74 18.55 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.11 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.411 ' HG3' ' SD ' ' A' ' 294' ' ' MET . 2.6 ttp180 -86.58 6.29 31.55 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 168.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.2 m -83.5 105.1 14.16 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.708 0.803 . . . . 0.0 108.91 -168.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 19.7 mt -85.69 132.73 31.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 279' ' ' LYS . 10.0 mm -105.48 139.07 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 0.0 OUTLIER -109.81 168.28 9.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.535 0.734 . . . . 0.0 109.757 176.106 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 214' ' ' TRP . . . . . 0.412 ' CD1' HD23 ' A' ' 255' ' ' LEU . 55.3 t90 -45.38 -46.38 13.18 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.857 1.263 . . . . 0.0 111.936 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -57.52 -34.61 69.29 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.804 1.242 . . . . 0.0 111.961 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.48 -11.44 32.04 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.133 0.973 . . . . 0.0 113.06 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 243' ' ' ILE . 1.5 mm? -73.84 114.41 12.1 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 169.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 12.6 pt-20 -115.77 165.03 13.52 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.621 0.768 . . . . 0.0 109.053 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.9 m -69.0 119.24 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 121.26 0.552 . . . . 0.0 110.361 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.91 -4.45 49.53 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.738 -0.664 . . . . 0.0 113.246 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -70.67 118.42 13.44 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.537 0.735 . . . . 0.0 110.581 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.78 113.39 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.73 150.13 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.938 1.295 . . . . 0.0 109.403 -172.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.666 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 16.0 ptm -97.95 124.69 42.52 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 120.838 0.351 . . . . 0.0 111.34 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.477 ' HB3' HG13 ' A' ' 277' ' ' VAL . 1.3 pt? -144.53 167.53 22.3 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.9 0.88 . . . . 0.0 110.149 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -80.84 135.38 35.93 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.865 0.364 . . . . 0.0 110.759 -169.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.486 ' HD1' ' HB2' ' A' ' 239' ' ' TYR . 58.0 m-85 -144.66 157.42 44.21 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.815 1.246 . . . . 0.0 110.167 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 42.5 t-20 -129.9 110.93 17.17 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 166.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -71.73 -17.91 29.04 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.431 2.088 . . . . 0.0 112.787 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -87.03 -39.66 15.42 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.261 0.624 . . . . 0.0 110.447 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 10.0 m120 -124.35 81.33 58.91 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.213 1.005 . . . . 0.0 108.482 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.91 -11.34 31.78 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.746 2.297 . . . . 0.0 114.317 -170.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -88.9 -4.17 58.54 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.28 0.632 . . . . 0.0 111.267 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -131.51 163.83 27.12 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.635 -0.665 . . . . 0.0 110.275 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 162.46 29.44 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.801 0.84 . . . . 0.0 111.639 174.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.03 -88.66 0.07 OUTLIER Glycine 0 C--O 1.238 0.361 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.376 171.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -130.23 167.57 18.23 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.495 1.118 . . . . 0.0 109.118 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -87.68 113.61 23.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.771 0.428 . . . . 0.0 110.574 -170.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.486 ' HB2' ' HD1' ' A' ' 227' ' ' TYR . 64.0 m-85 -117.51 142.84 46.69 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ASP . . . . . 0.666 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 8.3 p-10 -84.27 158.08 21.34 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -153.54 148.02 26.08 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.882 -173.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -96.01 118.26 32.28 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.464 HG13 HD12 ' A' ' 217' ' ' LEU . 36.1 mm -66.94 107.41 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.356 0.662 . . . . 0.0 109.328 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.2 t -81.16 -45.28 16.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.562 0.745 . . . . 0.0 110.267 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -154.11 167.54 29.5 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.626 1.171 . . . . 0.0 109.978 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.45 146.81 23.91 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.714 0.806 . . . . 0.0 109.898 167.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -142.65 115.93 8.97 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.15 0.98 . . . . 0.0 109.17 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.83 144.05 25.67 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 175.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.6 p -126.9 169.93 12.77 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 169.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -61.26 -34.07 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.883 0.473 . . . . 0.0 110.448 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 75.0 p -87.22 -29.67 21.53 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.449 -171.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -166.66 153.9 9.32 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.891 0.477 . . . . 0.0 111.616 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -104.06 105.78 16.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.738 0.815 . . . . 0.0 109.883 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.03 144.95 25.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.552 0.741 . . . . 0.0 110.099 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.802 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.3 OUTLIER -135.87 146.74 47.75 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -175.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -135.03 120.66 19.39 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.54 ' HB3' HD11 ' A' ' 271' ' ' ILE . . . -136.01 161.27 36.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.497 0.665 . . . . 0.0 111.653 -175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -100.67 94.12 5.93 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 46.4 t -77.34 106.19 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.02 0.928 . . . . 0.0 110.068 -171.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 34.7 m -89.54 118.43 34.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 122.245 1.022 . . . . 0.0 110.201 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.403 HD12 ' HB2' ' A' ' 264' ' ' ASP . 31.2 mt -96.57 -153.08 0.4 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 113.888 -1.505 . . . . 0.0 108.173 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.5 -52.07 32.82 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 117.708 0.231 . . . . 0.0 113.278 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -122.23 -36.21 3.0 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.022 0.929 . . . . 0.0 110.611 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.403 ' HB2' HD12 ' A' ' 261' ' ' LEU . 3.8 m-20 -89.11 157.92 18.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.264 1.025 . . . . 0.0 110.858 -174.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 67.2 p -135.2 113.83 11.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.542 0.737 . . . . 0.0 109.124 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.554 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 23.9 mt -81.73 86.68 6.39 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.773 0.829 . . . . 0.0 108.888 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -69.34 142.4 54.03 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.237 0.615 . . . . 0.0 111.659 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 57.41 17.69 3.95 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.569 1.148 . . . . 0.0 113.823 170.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.554 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 94.5 m -66.73 142.9 57.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.326 0.65 . . . . 0.0 111.04 -176.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -70.03 133.79 47.59 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.948 0.78 . . . . 0.0 110.821 -176.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.802 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 10.3 mm -107.02 128.46 61.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 46.3 mt -98.3 -24.51 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 123.862 0.865 . . . . 0.0 109.025 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.555 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 67.7 m-85 -91.69 47.91 1.41 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.69 1.196 . . . . 0.0 110.14 -176.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 27.5 m -65.35 -26.37 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.518 1.127 . . . . 0.0 112.92 -171.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 52.7 m-20 -110.27 -7.98 14.78 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.174 0.589 . . . . 0.0 110.984 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 15.5 mm-40 -94.09 24.69 4.16 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.907 0.883 . . . . 0.0 110.734 -175.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.56 ' HB ' ' HB ' ' A' ' 212' ' ' ILE . 19.4 t -89.61 153.63 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.155 0.982 . . . . 0.0 110.001 -174.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -129.21 156.19 44.34 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.123 0.969 . . . . 0.0 108.79 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.566 ' HB2' HD11 ' A' ' 212' ' ' ILE . 54.2 tttm -89.76 146.2 24.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.112 0.565 . . . . 0.0 110.925 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 44.3 mm -72.49 122.78 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 168.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -106.17 112.8 25.98 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 285' ' ' GLU . 59.8 mtt85 -103.3 107.26 55.1 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -25.41 94.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.38 2.227 1 C-N-CA 125.307 4.005 . . . . 0.0 117.196 -156.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 104.72 6.99 39.94 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 118.231 -1.316 . . . . 0.0 116.275 172.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 282' ' ' ARG . 0.2 OUTLIER -103.26 -25.04 13.48 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 120.236 2.018 . . . . 0.0 111.452 173.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -106.64 -177.66 23.12 Favored Glycine 0 C--O 1.245 0.821 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 172.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 13.5 m -76.26 144.44 74.84 Favored Pre-proline 0 CA--C 1.554 1.129 0 CA-C-N 116.991 0.396 . . . . 0.0 111.208 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.13 175.93 6.21 Favored 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 123.356 2.704 . . . . 0.0 112.337 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 43.5 ttm -82.8 95.43 7.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 170.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 14.4 p -125.83 19.29 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.944 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -154.42 -167.04 2.5 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.61 -169.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -44.27 121.38 3.99 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 125.597 1.559 . . . . 0.0 113.073 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -45.53 113.0 0.46 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 124.596 3.53 . . . . 0.0 114.784 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' MET . . . . . 0.411 ' SD ' ' HG3' ' A' ' 209' ' ' ARG . 88.0 mmm -78.04 97.34 5.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.207 0.603 . . . . 0.0 110.579 -176.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -128.07 113.13 15.39 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 172.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.77 123.09 11.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.336 1.454 . . . . 0.0 110.531 -169.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -101.59 -31.29 10.91 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.9 0.88 . . . . 0.0 109.112 167.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 33.5 p . . . . . 0 CA--C 1.543 0.686 0 C-N-CA 124.247 1.019 . . . . 0.0 110.196 -178.523 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.504 ' HA3' HG21 ' A' ' 159' ' ' VAL . . . . . . . . 0 N--CA 1.476 1.332 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 6.96 0.5 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.655 0.782 . . . . 0.0 112.092 -176.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.575 ' HB2' ' CE1' ' A' ' 184' ' ' TYR . 34.7 m-85 -126.21 149.92 48.71 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.128 0.49 . . . . 0.0 110.924 172.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -94.03 172.69 8.07 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.871 1.268 . . . . 0.0 110.12 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.52 4.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.235 1.014 . . . . 0.0 113.124 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -106.09 -18.04 14.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.1 0.96 . . . . 0.0 110.908 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -75.33 92.63 2.8 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-O 121.579 0.704 . . . . 0.0 111.726 -166.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 8.1 p90 -55.13 105.17 0.15 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.8 165.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 28.0 m -116.01 -174.79 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.903 0.881 . . . . 0.0 109.931 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.733 ' HB3' ' HB3' ' A' ' 205' ' ' ARG . 33.9 t0 -110.73 160.49 16.67 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 171.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -140.72 105.86 5.0 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.638 0.775 . . . . 0.0 109.536 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.97 116.58 11.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.027 1.331 . . . . 0.0 109.33 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -85.59 116.69 24.03 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.7 0.8 . . . . 0.0 110.937 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.4 p -74.14 -33.48 63.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.556 1.142 . . . . 0.0 111.201 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.43 -52.59 57.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.318 0.647 . . . . 0.0 112.008 -171.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.408 ' HG2' ' HE1' ' A' ' 239' ' ' TYR . 38.1 ttp -102.75 -8.32 20.94 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.924 0.49 . . . . 0.0 111.1 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.15 18.86 70.93 Favored Glycine 0 C--N 1.358 1.756 0 CA-C-O 121.385 0.436 . . . . 0.0 112.246 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -96.32 174.7 6.74 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.057 0.943 . . . . 0.0 111.458 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -126.47 119.2 26.6 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -109.81 119.18 38.54 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.69 152.12 31.85 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.427 ' HA ' ' H ' ' A' ' 189' ' ' ASP . . . -153.95 -177.47 6.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.199 0.6 . . . . 0.0 111.57 -167.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 64.8 tt0 -151.64 120.72 6.7 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.152 172.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.49 126.02 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.769 0.828 . . . . 0.0 110.149 171.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.414 HG11 ' HE2' ' A' ' 187' ' ' LYS . 12.8 m -120.74 -6.08 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.121 0.568 . . . . 0.0 110.69 173.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 37.4 ttm180 -169.9 156.2 6.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.775 0.83 . . . . 0.0 110.639 174.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.504 HG21 ' HA3' ' A' ' 133' ' ' GLY . 1.7 p -132.96 127.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.22 1.008 . . . . 0.0 109.862 173.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.3 p -125.86 162.6 24.8 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.345 1.458 . . . . 0.0 109.319 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -107.38 177.21 4.91 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.45 0.7 . . . . 0.0 109.179 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.562 ' HD3' HD11 ' A' ' 183' ' ' ILE . 73.7 mmtt . . . . . 0 N--CA 1.5 2.07 0 C-N-CA 123.31 0.644 . . . . 0.0 112.599 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 C--O 1.237 0.441 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 201' ' ' SER . 26.9 mp0 -76.23 79.69 3.01 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 175.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -110.51 11.93 22.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.507 0.723 . . . . 0.0 109.724 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.27 149.09 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.328 0.651 . . . . 0.0 110.224 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.562 HD11 ' HD3' ' A' ' 162' ' ' LYS . 3.7 mp -95.75 109.59 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.003 0.521 . . . . 0.0 110.119 -167.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 58.3 m-85 -88.76 132.18 34.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.182 0.993 . . . . 0.0 111.033 173.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 30.6 m-70 -92.16 97.0 10.64 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.72 145.5 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.517 0.727 . . . . 0.0 110.447 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.414 ' HE2' HG11 ' A' ' 157' ' ' VAL . 45.2 mtmt -104.64 128.58 52.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -67.62 117.99 10.3 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.175 0.512 . . . . 0.0 111.088 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.427 ' H ' ' HA ' ' A' ' 154' ' ' ALA . 27.6 t70 -60.03 -30.2 69.01 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.846 1.258 . . . . 0.0 110.656 173.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.748 ' HA ' ' HD2' ' A' ' 297' ' ' LYS . 5.6 t70 -81.82 -30.18 32.3 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.209 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -138.48 81.17 25.14 Favored Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 123.082 0.553 . . . . 0.0 110.098 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.33 -21.9 46.78 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.593 2.195 . . . . 0.0 111.589 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.35 -26.48 68.77 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.411 1.084 . . . . 0.0 111.79 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -77.27 -20.11 55.55 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.821 0.449 . . . . 0.0 110.325 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 72.21 -154.23 50.43 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.58 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.3 t -79.46 117.39 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.564 0.746 . . . . 0.0 109.381 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.38 151.87 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.276 1.03 . . . . 0.0 109.38 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -88.48 129.29 35.48 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 90.8 mmm -147.23 126.8 13.28 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.699 1.2 . . . . 0.0 108.383 -174.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -68.18 160.8 28.39 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.631 ' HA ' HG22 ' A' ' 204' ' ' VAL . 20.6 t -69.32 -28.23 66.06 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.969 0.414 . . . . 0.0 111.048 -173.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -67.62 -32.22 72.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.038 0.935 . . . . 0.0 110.022 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.59 -19.84 32.41 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.078 0.951 . . . . 0.0 111.211 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.631 HG22 ' HA ' ' A' ' 201' ' ' SER . 7.8 m -96.68 157.87 3.21 Favored 'Isoleucine or valine' 0 C--N 1.356 0.882 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.733 ' HB3' ' HB3' ' A' ' 142' ' ' ASP . 0.5 OUTLIER -145.66 -178.63 6.19 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -165.295 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.444 ' HB3' ' HG3' ' A' ' 281' ' ' GLU . . . -98.51 143.82 28.52 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 166.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.43 HH11 ' HB2' ' A' ' 140' ' ' TYR . 57.2 mtp180 -70.32 96.56 1.14 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.164 0.585 . . . . 0.0 109.817 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.44 103.36 0.15 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.72 0.808 . . . . 0.0 110.955 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -82.86 -1.88 53.19 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.813 1.245 . . . . 0.0 111.632 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.0 m -94.46 119.93 33.93 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.843 0.857 . . . . 0.0 110.918 -176.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.4 mt -86.84 130.76 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.308 0.643 . . . . 0.0 109.284 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 39.7 mm -92.32 98.07 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.462 ' HD3' ' H ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -58.05 156.52 9.29 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.151 0.98 . . . . 0.0 111.439 174.21 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 214' ' ' TRP . . . . . 0.415 ' CZ2' ' HB2' ' A' ' 246' ' ' LYS . 79.9 t90 -57.26 -40.34 77.49 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.714 -167.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -65.39 -29.83 70.58 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.871 0.468 . . . . 0.0 111.297 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.35 -15.49 49.75 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.043 0.937 . . . . 0.0 111.723 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.1 mt -65.84 114.31 4.99 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 169.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' GLU . . . . . 0.432 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 11.1 pt-20 -119.0 168.03 11.2 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.219 1.007 . . . . 0.0 109.354 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.87 115.95 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-O 121.3 0.571 . . . . 0.0 109.541 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.19 -1.4 56.19 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.585 -174.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.563 ' HG3' HG13 ' A' ' 223' ' ' VAL . 6.2 tp-100 -67.55 120.58 14.21 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.969 0.508 . . . . 0.0 110.856 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.534 HG12 HG13 ' A' ' 280' ' ' ILE . 97.1 t -97.55 111.89 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.563 HG13 ' HG3' ' A' ' 221' ' ' GLN . 12.9 m -132.1 -174.76 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.219 1.408 . . . . 0.0 109.505 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 20.3 ptm -135.15 143.92 46.77 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.46 0.704 . . . . 0.0 109.447 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.51 159.89 42.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.779 0.832 . . . . 0.0 111.336 -169.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -90.31 106.94 18.83 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 173.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -145.48 138.73 26.34 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -172.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 46.4 t-20 -89.16 121.22 69.7 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.6 -19.74 21.19 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.562 2.175 . . . . 0.0 112.394 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -88.88 -39.16 14.01 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.468 0.707 . . . . 0.0 110.282 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 15.3 m120 -119.97 101.93 47.11 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.443 0.697 . . . . 0.0 110.027 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -61.28 -26.57 82.12 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.803 2.336 . . . . 0.0 113.231 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -78.44 -27.05 46.44 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.764 0.825 . . . . 0.0 111.385 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 231' ' ' ASN . 8.6 tp10 -107.05 151.52 25.23 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.252 0.621 . . . . 0.0 111.144 -170.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -76.26 152.34 36.54 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.572 0.749 . . . . 0.0 109.192 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -139.04 -106.86 0.72 Allowed Glycine 0 N--CA 1.47 0.907 0 C-N-CA 121.674 -0.298 . . . . 0.0 112.77 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -128.35 170.52 12.99 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' TRP . . . . . 0.437 ' CE2' ' HB3' ' A' ' 296' ' ' ARG . 81.8 m95 -80.2 105.81 11.75 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.36 0.664 . . . . 0.0 110.917 -175.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.408 ' HE1' ' HG2' ' A' ' 148' ' ' MET . 76.1 m-85 -118.42 165.04 14.37 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.64 1.176 . . . . 0.0 108.449 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -97.34 142.92 28.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.0 0.52 . . . . 0.0 110.121 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' A' ' 257' ' ' ALA . . . -137.09 155.07 50.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.328 1.051 . . . . 0.0 111.12 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -110.91 117.53 33.63 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.632 HD12 HD11 ' A' ' 255' ' ' LEU . 33.0 mm -69.86 107.82 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.678 0.791 . . . . 0.0 109.012 -173.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.3 p -84.33 -32.71 24.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.468 0.707 . . . . 0.0 111.944 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -160.33 158.35 29.56 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.692 0.397 . . . . 0.0 110.914 -176.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.415 ' HB2' ' CZ2' ' A' ' 214' ' ' TRP . 60.8 pttt -154.62 148.78 25.9 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.36 0.664 . . . . 0.0 112.076 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -155.8 149.93 25.57 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.483 1.113 . . . . 0.0 108.671 173.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -129.72 139.87 51.23 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 119.564 1.075 . . . . 0.0 112.26 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.4 p -119.67 170.28 9.34 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 165.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -67.92 -32.88 73.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.824 0.449 . . . . 0.0 110.606 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 73.5 p -90.99 -19.71 22.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.246 1.019 . . . . 0.0 112.581 -172.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.69 155.44 21.66 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -171.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -108.53 132.96 53.31 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 173.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -102.25 128.82 48.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.274 1.03 . . . . 0.0 108.427 172.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -149.87 137.08 19.69 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -127.05 136.36 52.08 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' A' ' 241' ' ' ALA . . . -147.24 140.8 25.55 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.197 0.599 . . . . 0.0 110.697 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -79.51 94.98 5.7 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 49.0 t -78.24 105.66 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 28.8 t -86.35 124.02 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.48 HD12 ' HB2' ' A' ' 264' ' ' ASP . 54.9 mt -103.16 -171.4 1.94 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.031 0.932 . . . . 0.0 109.032 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.08 -39.81 92.93 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 113.953 0.341 . . . . 0.0 113.953 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -121.77 -40.9 2.5 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.984 0.913 . . . . 0.0 109.255 173.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.48 ' HB2' HD12 ' A' ' 261' ' ' LEU . 21.5 m-20 -83.53 167.54 17.28 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.93 -173.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 54.7 p -145.53 114.21 6.81 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.617 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 61.9 mt -78.73 78.21 5.18 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -70.72 124.61 24.7 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.791 -170.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 36.8 t70 61.66 26.11 15.85 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.07 1.348 . . . . 0.0 111.603 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 94.9 m -73.47 133.62 43.71 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.709 -177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 -65.7 130.28 42.75 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.641 0.588 . . . . 0.0 110.493 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.9 mm -103.29 116.9 47.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.318 0.647 . . . . 0.0 109.555 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 61.9 mt -82.5 -45.45 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.685 173.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -89.58 64.44 6.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.951 0.9 . . . . 0.0 110.215 -168.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 30.5 m -78.84 -14.96 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.393 -174.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -90.63 -14.75 31.77 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.551 0.74 . . . . 0.0 111.047 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -96.98 43.6 1.07 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.098 0.959 . . . . 0.0 109.428 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.92 113.45 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.093 0.957 . . . . 0.0 109.737 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.41 ' HE2' ' HG3' ' A' ' 294' ' ' MET . 51.8 m-85 -94.61 164.92 12.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.014 0.926 . . . . 0.0 110.826 170.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -78.26 144.74 35.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.238 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.534 HG13 HG12 ' A' ' 222' ' ' VAL . 31.6 mm -73.42 113.57 11.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 164.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.444 ' HG3' ' HB3' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -78.97 125.52 29.48 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 170.494 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -109.16 104.92 56.34 Favored Pre-proline 0 N--CA 1.477 0.887 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -23.57 98.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.03 1 C-N-CA 125.751 4.3 . . . . 0.0 116.496 -151.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.23 60.21 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.577 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -78.2 -26.13 47.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.245 0.618 . . . . 0.0 110.24 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -134.79 160.44 24.27 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.838 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 12.4 m -91.04 159.01 40.79 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.552 0.741 . . . . 0.0 110.339 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.91 -155.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.62 2.214 . . . . 0.0 110.632 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' MET . . . . . 0.532 ' HB3' ' HB3' ' A' ' 293' ' ' PRO . 24.6 mmt -76.87 78.37 3.46 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 121.538 0.685 . . . . 0.0 109.534 177.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 13.6 p -106.78 -8.87 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.015 0.926 . . . . 0.0 109.933 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -122.32 -153.13 0.54 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -54.74 112.02 3.57 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.464 1.029 . . . . 0.0 109.709 167.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.532 ' HB3' ' HB3' ' A' ' 289' ' ' MET . 84.6 Cg_endo -76.17 137.21 18.95 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.051 1.834 . . . . 0.0 111.221 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' MET . . . . . 0.41 ' HG3' ' HE2' ' A' ' 278' ' ' PHE . 21.0 mmt -80.85 -49.45 11.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.148 0.579 . . . . 0.0 109.661 174.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 55.57 106.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.288 1.435 . . . . 0.0 110.627 -166.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.437 ' HB3' ' CE2' ' A' ' 238' ' ' TRP . 16.9 mtm180 -62.36 -33.41 74.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.989 0.915 . . . . 0.0 111.061 -177.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.748 ' HD2' ' HA ' ' A' ' 190' ' ' ASP . 51.5 tttp -64.26 92.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 37.2 t . . . . . 0 CA--C 1.541 0.625 0 C-N-CA 123.411 0.684 . . . . 0.0 110.48 -172.524 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.443 ' HA3' HG21 ' A' ' 159' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.465 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -109.39 9.78 25.54 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.555 0.742 . . . . 0.0 112.104 -170.517 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -125.91 144.87 50.5 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.391 0.676 . . . . 0.0 109.623 174.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.45 -177.6 3.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.635 0.774 . . . . 0.0 110.317 176.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.5 m -60.13 -6.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 125.205 1.402 . . . . 0.0 114.712 -173.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -110.63 -3.69 15.77 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.776 0.83 . . . . 0.0 112.032 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -86.39 88.52 7.65 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.352 0.596 . . . . 0.0 112.42 -171.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.657 ' HB3' ' HG2' ' A' ' 155' ' ' GLN . 31.0 p90 -75.86 102.1 5.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.052 0.929 . . . . 0.0 109.325 165.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.1 m -114.07 -165.84 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.526 1.53 . . . . 0.0 107.751 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.21 123.26 42.81 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.345 0.52 . . . . 0.0 111.825 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.23 103.36 16.05 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.555 171.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.8 108.25 8.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -82.38 115.8 21.58 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.5 m -81.54 -15.43 54.88 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.81 0.844 . . . . 0.0 111.846 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -67.71 -51.91 43.9 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 23.1 ptp -96.65 -25.49 15.55 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.917 0.487 . . . . 0.0 110.934 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.55 18.22 33.63 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-O 119.991 -0.339 . . . . 0.0 113.836 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -99.68 168.51 9.89 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.669 0.747 . . . . 0.0 112.491 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -116.01 120.75 40.15 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 125.284 1.434 . . . . 0.0 107.63 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.9 127.18 54.0 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.19 103.5 0.39 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.484 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -101.95 117.42 34.79 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.828 0.851 . . . . 0.0 110.265 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.657 ' HG2' ' HB3' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -87.42 104.92 16.91 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.028 0.931 . . . . 0.0 109.165 -178.162 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.42 HG22 HG12 ' A' ' 186' ' ' VAL . 82.6 t -62.89 102.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.653 0.781 . . . . 0.0 109.501 172.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.0 -10.07 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 122.848 0.459 . . . . 0.0 110.983 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -170.5 143.29 2.23 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.839 0.856 . . . . 0.0 109.269 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.443 HG21 ' HA3' ' A' ' 133' ' ' GLY . 6.8 p -115.09 139.26 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 166.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 20.5 p -131.96 150.68 52.09 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.398 1.079 . . . . 0.0 108.583 172.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -66.97 147.21 53.52 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 171.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.41 ' HA ' HG13 ' A' ' 183' ' ' ILE . 87.5 tttt . . . . . 0 N--CA 1.485 1.31 0 C-N-CA 123.541 0.736 . . . . 0.0 112.74 -171.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 C--O 1.24 0.566 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -86.5 67.93 10.04 Favored 'General case' 0 C--O 1.248 1.015 0 CA-C-O 121.698 0.761 . . . . 0.0 109.235 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -84.37 61.05 6.36 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.2 m -115.45 173.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.449 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.41 HG13 ' HA ' ' A' ' 162' ' ' LYS . 45.2 mt -96.26 108.29 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.218 0.532 . . . . 0.0 109.99 -170.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -93.36 112.08 23.9 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.978 0.911 . . . . 0.0 108.631 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -78.25 89.97 4.32 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 175.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.484 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 29.3 m -110.46 151.68 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.288 -177.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -120.41 148.83 43.27 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 170.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -68.36 107.82 2.99 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -58.38 -34.55 70.83 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.406 0.682 . . . . 0.0 110.635 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -78.15 -23.77 47.61 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.379 0.672 . . . . 0.0 111.525 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -137.22 67.43 54.51 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.758 -0.589 . . . . 0.0 109.957 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.7 -17.57 42.51 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.969 2.446 . . . . 0.0 112.269 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.79 -13.78 62.41 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.58 1.552 . . . . 0.0 112.667 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -85.03 -21.21 29.52 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.748 0.419 . . . . 0.0 111.11 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 90.31 -157.19 25.62 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.545 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.8 t -92.17 118.67 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.894 0.878 . . . . 0.0 110.634 -172.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.6 m -109.41 156.38 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.368 1.067 . . . . 0.0 109.703 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -103.91 134.04 47.87 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.153 0.581 . . . . 0.0 110.919 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 82.7 mmm -136.83 167.05 22.19 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.575 1.15 . . . . 0.0 109.305 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ASN . . . . . 0.448 ' O ' HG22 ' A' ' 204' ' ' VAL . 21.1 m-80 -109.83 171.41 7.46 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.722 0.809 . . . . 0.0 109.639 174.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 43.4 m -61.32 -37.03 81.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 118.64 0.655 . . . . 0.0 111.566 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -16.59 61.57 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.453 176.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -96.66 -50.1 4.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.826 0.85 . . . . 0.0 110.681 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 200' ' ' ASN . 7.9 m -96.34 115.77 36.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 CA-C-O 122.004 0.907 . . . . 0.0 109.917 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -125.9 139.22 53.65 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.799 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.4 126.3 26.69 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.504 ' NH1' ' HB2' ' A' ' 296' ' ' ARG . 4.0 ptm180 -74.19 161.53 29.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.561 0.744 . . . . 0.0 112.215 -174.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 287' ' ' SER . . . -83.1 125.56 31.62 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.383 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.36 66.38 4.69 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 164.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.6 m -145.42 109.18 4.74 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.803 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.9 mt -85.93 129.07 38.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 123.077 0.551 . . . . 0.0 110.014 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.611 HD11 ' HE3' ' A' ' 279' ' ' LYS . 26.3 mm -101.51 148.12 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.791 1.237 . . . . 0.0 108.603 174.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 175.72 8.57 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.286 0.634 . . . . 0.0 110.27 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -54.28 -51.92 63.06 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -166.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -72.68 -19.56 61.4 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.24 -21.48 29.05 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.942 0.897 . . . . 0.0 109.954 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.463 HD22 HD11 ' A' ' 243' ' ' ILE . 90.5 mt -71.37 128.76 36.94 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -143.55 158.17 43.86 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.785 0.434 . . . . 0.0 110.572 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.0 127.28 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 123.912 0.757 . . . . 0.0 111.428 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.23 -25.7 25.95 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.013 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -72.95 122.12 21.16 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.32 0.648 . . . . 0.0 110.159 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.505 HG13 ' NH2' ' A' ' 282' ' ' ARG . 1.8 p -108.72 125.15 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.326 0.651 . . . . 0.0 110.308 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 280' ' ' ILE . 3.8 m -135.31 177.27 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 125.422 1.489 . . . . 0.0 109.912 -175.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 16.8 ptm -108.19 120.76 43.28 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.185 0.594 . . . . 0.0 110.702 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.676 ' HG ' HG13 ' A' ' 277' ' ' VAL . 0.4 OUTLIER -127.86 148.88 50.48 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.704 0.802 . . . . 0.0 108.91 -176.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -88.51 116.85 27.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.803 0.841 . . . . 0.0 111.734 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.523 ' HE1' ' HB2' ' A' ' 225' ' ' LEU . 4.9 p90 -163.69 142.45 7.88 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.156 0.982 . . . . 0.0 108.648 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ASN . . . . . 0.416 HD22 ' HB3' ' A' ' 231' ' ' ASN . 3.9 p30 -85.92 131.12 47.93 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 168.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.18 -19.77 66.36 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.25 1.967 . . . . 0.0 113.253 -171.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -66.57 -42.89 86.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.245 0.618 . . . . 0.0 110.154 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.416 ' HB3' HD22 ' A' ' 228' ' ' ASN . 63.2 t30 -130.06 89.1 46.44 Favored Pre-proline 0 N--CA 1.47 0.548 0 C-N-CA 123.608 0.763 . . . . 0.0 109.181 -176.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.21 -6.97 17.51 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.616 2.211 . . . . 0.0 113.072 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.52 -29.35 46.48 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.243 0.617 . . . . 0.0 111.595 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.82 151.62 44.98 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.869 0.467 . . . . 0.0 110.237 -176.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 227' ' ' TYR . 7.0 ppt_? -66.72 161.79 22.74 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.814 0.846 . . . . 0.0 112.639 -175.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -165.57 -84.4 0.05 OUTLIER Glycine 0 C--N 1.338 0.684 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.388 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.454 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 30.1 m-85 -119.27 149.15 42.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.72 0.808 . . . . 0.0 109.224 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -88.36 104.43 16.76 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 95.5 m-85 -108.38 160.85 15.55 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.145 0.578 . . . . 0.0 110.367 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -81.48 119.23 23.48 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.676 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.467 ' HB3' HD13 ' A' ' 225' ' ' LEU . . . -126.82 136.56 52.53 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -99.36 123.17 43.41 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.608 HD12 HD11 ' A' ' 255' ' ' LEU . 19.5 mm -64.84 110.37 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.9 t -78.93 -36.42 41.79 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.278 -177.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -170.22 158.79 6.98 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.782 0.833 . . . . 0.0 109.52 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -143.43 136.21 27.52 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 254' ' ' GLU . 4.0 ptm180 -145.61 125.41 13.44 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -92.15 137.67 32.17 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.9 p -116.0 176.62 5.01 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 170.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -58.7 -39.71 81.52 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.7 p -127.84 13.5 6.86 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.6 159.98 37.62 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.244 0.474 . . . . 0.0 111.314 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -122.35 108.76 13.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.106 0.962 . . . . 0.0 108.825 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' GLU . . . . . 0.475 ' HB2' ' HG3' ' A' ' 247' ' ' ARG . 3.7 mp0 -90.88 99.1 12.19 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.608 HD11 HD12 ' A' ' 243' ' ' ILE . 2.1 tm? -100.23 121.34 41.31 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 176.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -107.23 132.14 53.4 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.05 122.32 12.28 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.28 0.632 . . . . 0.0 109.948 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -76.35 99.93 4.98 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 94.4 t -69.26 107.12 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.734 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 9.2 m -87.4 104.46 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 36.4 mt -81.93 -160.04 0.33 Allowed 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.684 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.43 -47.8 33.52 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-O 120.994 0.219 . . . . 0.0 112.979 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -122.3 -32.29 3.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.126 0.971 . . . . 0.0 111.044 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -101.44 171.56 7.5 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.666 0.787 . . . . 0.0 110.567 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 58.7 m -144.61 121.97 11.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.779 0.832 . . . . 0.0 109.816 171.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 72.2 mt -80.97 113.18 19.0 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.858 0.863 . . . . 0.0 109.562 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.69 109.47 4.38 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.513 0.725 . . . . 0.0 111.423 -173.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.79 57.69 4.56 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.735 1.214 . . . . 0.0 112.873 171.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 42.7 t -65.03 125.24 24.3 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 36.6 ttt180 -71.82 123.33 22.42 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.6 mm -100.03 122.4 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.32 0.648 . . . . 0.0 109.804 -175.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 65.4 mt -92.06 -14.29 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 124.451 1.1 . . . . 0.0 109.649 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -89.09 20.63 3.56 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.239 1.416 . . . . 0.0 111.494 -168.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 28.9 m -69.09 -4.51 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.757 1.223 . . . . 0.0 114.101 -166.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -94.19 -33.49 13.28 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.687 0.395 . . . . 0.0 111.228 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -128.72 48.62 2.3 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.77 0.795 . . . . 0.0 110.193 -173.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.676 HG13 ' HG ' ' A' ' 225' ' ' LEU . 59.4 t -74.7 154.01 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.426 169.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -119.92 149.8 41.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.611 ' HE3' HD11 ' A' ' 212' ' ' ILE . 26.4 ttmt -80.14 151.4 29.79 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.662 174.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 223' ' ' VAL . 36.1 mm -76.93 126.41 37.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 168.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.669 ' HA ' ' HA3' ' A' ' 286' ' ' GLY . 0.6 OUTLIER -71.26 108.57 4.81 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.671 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 90.2 mtt-85 -123.06 153.69 64.46 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.783 1.233 . . . . 0.0 108.566 -176.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.16 96.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.091 2.527 . . . . 0.0 113.557 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.28 -34.91 5.26 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.229 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 10.5 tp10 -85.97 -27.37 24.92 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.677 0.391 . . . . 0.0 111.902 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -108.93 136.59 13.65 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -175.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 208' ' ' ALA . 3.3 m -96.24 144.98 28.77 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 117.259 0.53 . . . . 0.0 110.093 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -88.23 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.033 2.489 . . . . 0.0 111.765 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 17.4 mmt -80.66 78.92 7.37 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.1 -26.77 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.334 1.054 . . . . 0.0 110.146 -175.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -125.89 -160.08 0.95 Allowed 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -44.73 106.51 0.54 Allowed Pre-proline 0 N--CA 1.489 1.496 0 CA-C-N 119.743 1.156 . . . . 0.0 112.293 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.404 ' HB2' ' OH ' ' A' ' 140' ' ' TYR . 7.0 Cg_exo -73.82 84.52 1.44 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.164 2.576 . . . . 0.0 111.252 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 25.0 ptm -66.2 140.97 58.21 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.14 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -85.16 159.64 20.09 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.504 ' HB2' ' NH1' ' A' ' 207' ' ' ARG . 23.1 ttp-105 -128.12 10.57 6.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.567 0.747 . . . . 0.0 109.837 -175.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -51.8 131.94 31.05 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.791 1.636 . . . . 0.0 111.139 172.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.548 0.871 0 C-N-CA 123.081 0.552 . . . . 0.0 109.902 -177.402 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.401 HD13 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -120.18 -18.57 8.01 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.258 0.623 . . . . 0.0 111.397 175.024 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -99.78 143.45 29.99 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 136' ' ' LYS . 6.3 mptt -97.87 179.32 4.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.494 1.117 . . . . 0.0 110.472 -170.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -68.74 -17.81 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 124.767 1.227 . . . . 0.0 112.161 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -116.41 16.29 15.68 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.253 0.621 . . . . 0.0 110.976 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.43 ' HG3' HG13 ' A' ' 141' ' ' VAL . 11.3 tp10 -97.21 89.43 4.76 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.341 0.591 . . . . 0.0 110.17 -173.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.624 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 22.8 p90 -82.18 100.23 9.72 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.69 0.757 . . . . 0.0 111.179 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.43 HG13 ' HG3' ' A' ' 139' ' ' GLU . 34.1 m -114.88 169.14 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.721 0.808 . . . . 0.0 109.221 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -87.93 113.88 24.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.136 0.493 . . . . 0.0 111.296 -169.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.38 109.41 19.54 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 170.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.564 HH22 HG12 ' A' ' 260' ' ' VAL . 26.3 ttt180 -74.9 113.68 12.49 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.497 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.89 134.89 35.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.431 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.6 p -77.04 -36.51 56.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.472 0.709 . . . . 0.0 111.494 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -65.03 -45.1 86.84 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.189 0.595 . . . . 0.0 110.847 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 54.0 tpp -85.54 -38.49 18.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.59 0.756 . . . . 0.0 110.127 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.68 9.89 80.35 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.867 -171.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.99 168.42 9.13 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 121.791 0.805 . . . . 0.0 112.243 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.441 ' HZ2' HD12 ' A' ' 280' ' ' ILE . 8.5 m0 -89.35 122.41 32.54 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.512 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.72 111.15 17.25 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 173.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -57.32 98.28 0.03 OUTLIER 'General case' 0 C--N 1.363 1.168 0 O-C-N 124.163 0.915 . . . . 0.0 109.963 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -103.73 133.1 49.29 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.437 1.095 . . . . 0.0 109.818 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 43.6 tt0 -84.01 106.75 15.91 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 122.684 0.394 . . . . 0.0 110.667 -173.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.1 t -58.56 109.23 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.521 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 167.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 m -108.37 -26.2 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 122.861 0.464 . . . . 0.0 111.028 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.425 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 56.5 ttt85 -146.5 122.63 10.81 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 110.788 -0.078 . . . . 0.0 110.788 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.16 117.82 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 123.335 0.654 . . . . 0.0 109.369 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.7 p -127.87 117.63 22.17 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.711 0.804 . . . . 0.0 109.289 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.46 ' HG3' HG12 ' A' ' 182' ' ' VAL . 27.1 ttt180 -76.14 138.19 40.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.376 0.67 . . . . 0.0 109.473 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 N--CA 1.486 1.337 0 C-N-CA 123.201 0.6 . . . . 0.0 111.144 177.734 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.243 0.75 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.89 96.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.367 1.079 . . . . 0.0 111.603 -172.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -88.81 19.71 3.91 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.209 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.46 HG12 ' HG3' ' A' ' 161' ' ' ARG . 6.4 m -78.17 163.4 3.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 124.007 0.923 . . . . 0.0 110.046 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.497 HG23 ' HB2' ' A' ' 198' ' ' GLN . 61.3 mt -97.16 110.31 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.41 0.684 . . . . 0.0 110.117 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -90.6 108.43 19.8 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 169.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 56.0 m-70 -77.14 97.77 4.86 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.49 143.32 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.533 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.539 ' HG2' HG22 ' A' ' 196' ' ' VAL . 25.3 mtmt -104.83 116.81 32.64 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -53.99 111.01 0.67 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.88 -22.99 67.1 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -80.34 -29.12 38.0 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.597 0.759 . . . . 0.0 111.404 173.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -129.27 55.05 16.19 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 123.499 0.72 . . . . 0.0 111.321 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.38 -13.58 20.6 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 121.719 1.613 . . . . 0.0 112.73 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -71.83 -27.93 63.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.864 0.866 . . . . 0.0 110.697 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -75.82 -1.42 25.1 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.548 0.739 . . . . 0.0 111.905 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 92.48 -172.05 34.14 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-O 121.11 0.283 . . . . 0.0 113.279 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.539 HG22 ' HG2' ' A' ' 187' ' ' LYS . 8.8 t -90.51 116.9 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.11 152.56 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.837 0.855 . . . . 0.0 110.015 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.497 ' HB2' HG23 ' A' ' 183' ' ' ILE . 16.7 pm0 -92.27 126.48 37.37 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 97.0 mmm -141.38 136.44 31.43 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.742 1.217 . . . . 0.0 107.973 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ASN . . . . . 0.464 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 20.8 m-80 -89.45 173.12 8.52 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.167 0.44 . . . . 0.0 110.071 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.535 ' HA ' HG22 ' A' ' 204' ' ' VAL . 18.9 t -66.82 -30.0 70.08 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 120.806 0.336 . . . . 0.0 110.496 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.464 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 15.4 ptm180 -67.24 -18.11 65.08 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.585 0.754 . . . . 0.0 111.935 175.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -102.38 -29.32 11.71 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.93 0.892 . . . . 0.0 111.085 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 201' ' ' SER . 31.9 m -99.21 148.78 5.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 CA-C-O 121.599 0.714 . . . . 0.0 110.374 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -128.85 146.14 51.01 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.873 1.269 . . . . 0.0 108.111 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.69 128.93 38.29 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -63.4 137.35 58.13 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.362 0.665 . . . . 0.0 110.814 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 279' ' ' LYS . . . -69.89 113.86 7.52 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -172.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.576 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 1.2 ptm180 -82.24 -31.94 29.96 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.686 169.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.7 m -90.04 123.51 33.98 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.554 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.4 mt -86.29 136.31 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.425 ' HB ' HG12 ' A' ' 277' ' ' VAL . 48.4 mm -107.51 144.2 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.673 0.789 . . . . 0.0 109.619 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.42 168.78 14.4 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.197 0.999 . . . . 0.0 109.296 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -52.22 -38.63 58.55 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.351 1.06 . . . . 0.0 112.953 -170.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.6 -44.31 93.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.358 0.663 . . . . 0.0 112.186 -173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.88 -1.46 32.07 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.609 0.764 . . . . 0.0 110.736 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.522 HD11 HG21 ' A' ' 223' ' ' VAL . 21.0 tp -79.19 121.0 24.49 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -130.69 156.72 44.44 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.496 0.589 . . . . 0.0 111.509 -172.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.4 m -67.93 132.34 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.971 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.8 -11.87 70.31 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.971 -176.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.409 ' HG2' HG13 ' A' ' 223' ' ' VAL . 34.5 tt0 -86.05 123.99 31.98 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.506 0.722 . . . . 0.0 109.47 177.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.96 133.16 29.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 173.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.522 HG21 HD11 ' A' ' 217' ' ' LEU . 3.3 m -145.19 145.76 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.6 1.16 . . . . 0.0 109.369 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.568 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 12.0 ptm -97.28 131.21 44.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.994 0.518 . . . . 0.0 109.692 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.513 ' HB3' ' HA ' ' A' ' 277' ' ' VAL . 0.8 OUTLIER -143.92 158.54 43.63 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.926 0.491 . . . . 0.0 110.834 -175.225 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 235' ' ' ARG . 16.5 p30 -77.04 117.87 19.04 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -156.6 143.16 18.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.726 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -108.53 120.47 46.29 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 168.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.66 -36.14 11.64 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.62 2.213 . . . . 0.0 111.873 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.31 -29.13 62.49 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.408 0.683 . . . . 0.0 110.774 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -131.18 90.13 39.64 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.41 -17.77 49.29 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.923 2.415 . . . . 0.0 113.473 -176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -76.03 -27.75 57.44 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.069 0.547 . . . . 0.0 111.176 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.09 153.64 37.17 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.407 ' HB2' ' HB2' ' A' ' 226' ' ' ASN . 0.0 OUTLIER -75.4 173.34 11.06 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.933 0.493 . . . . 0.0 111.732 176.506 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -159.83 -117.53 0.47 Allowed Glycine 0 C--O 1.24 0.522 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.278 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -82.56 171.42 14.1 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.199 0.6 . . . . 0.0 110.102 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -89.01 105.5 17.82 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -114.02 135.3 54.16 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -82.67 129.0 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -136.65 137.04 39.64 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.205 1.002 . . . . 0.0 109.309 -173.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -94.64 118.93 32.48 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.601 HD12 HD11 ' A' ' 255' ' ' LEU . 37.3 mm -62.44 112.79 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.195 0.598 . . . . 0.0 111.192 -173.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.4 t -82.53 -41.62 19.43 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.901 0.88 . . . . 0.0 110.088 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -157.05 155.73 31.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.735 0.814 . . . . 0.0 109.53 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -142.85 144.28 32.45 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.15 0.58 . . . . 0.0 109.893 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 254' ' ' GLU . 33.3 ttm180 -156.54 148.85 23.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.96 0.904 . . . . 0.0 109.786 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.21 139.82 35.72 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 165.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.0 p -114.31 177.65 4.57 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 172.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -78.98 -23.4 44.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 118.434 0.561 . . . . 0.0 110.434 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.1 p -95.16 -21.04 18.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.702 0.801 . . . . 0.0 112.5 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.91 173.86 16.13 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.191 0.596 . . . . 0.0 111.006 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -126.4 151.1 48.12 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' GLU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 247' ' ' ARG . 10.1 tp10 -138.73 137.1 36.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.11 0.481 . . . . 0.0 110.894 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.648 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.4 OUTLIER -149.96 139.1 21.18 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.242 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -130.75 129.88 43.06 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.79 138.58 24.5 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.238 0.615 . . . . 0.0 109.919 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -76.69 99.22 4.99 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.49 106.14 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.564 HG12 HH22 ' A' ' 144' ' ' ARG . 48.4 t -89.0 114.56 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.225 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 264' ' ' ASP . 87.8 mt -92.28 -170.17 2.44 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.965 0.906 . . . . 0.0 109.907 173.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -61.41 -54.55 35.15 Favored Glycine 0 C--N 1.352 1.438 0 O-C-N 123.156 0.285 . . . . 0.0 112.591 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.05 -49.56 3.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.212 1.005 . . . . 0.0 109.905 172.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.431 ' HB2' HD12 ' A' ' 261' ' ' LEU . 7.4 m-20 -76.18 167.35 22.03 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.703 -171.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 38.0 p -153.95 112.89 3.69 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.422 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 2.6 mm? -81.41 95.86 7.18 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.508 0.723 . . . . 0.0 109.659 -177.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -58.6 111.73 1.36 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.229 0.956 . . . . 0.0 110.662 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 16.0 t70 64.01 83.75 0.16 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.889 1.275 . . . . 0.0 111.783 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 71.4 m -106.9 140.32 39.89 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.051 0.94 . . . . 0.0 109.554 172.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -82.2 107.97 15.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.106 0.562 . . . . 0.0 110.13 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.648 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 42.4 mm -91.76 124.06 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.947 0.899 . . . . 0.0 108.734 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 52.6 mt -88.17 -26.73 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.304 0.642 . . . . 0.0 110.499 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.476 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 38.0 m-85 -95.56 60.91 2.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.876 0.87 . . . . 0.0 111.038 -166.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 255' ' ' LEU . 9.8 m -66.69 -17.15 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.369 1.067 . . . . 0.0 112.246 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -98.65 -24.26 15.14 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.003 0.921 . . . . 0.0 110.98 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 36.5 mt-10 -98.24 28.05 4.29 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.564 0.697 . . . . 0.0 110.799 -176.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.513 ' HA ' ' HB3' ' A' ' 225' ' ' LEU . 72.6 t -82.95 146.36 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.586 1.155 . . . . 0.0 108.88 172.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.568 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 73.0 m-85 -130.78 160.89 33.01 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.179 0.991 . . . . 0.0 109.531 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 208' ' ' ALA . 75.1 tttt -82.04 154.78 25.47 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.34 1.056 . . . . 0.0 111.858 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.441 HD12 ' HZ2' ' A' ' 151' ' ' TRP . 15.9 mm -88.54 111.08 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 164.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' ' 208' ' ' ALA . 46.0 mm-40 -83.97 103.81 13.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -90.06 142.35 28.67 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.72 1.208 . . . . 0.0 109.52 -173.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.88 99.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.441 2.761 . . . . 0.0 113.544 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.28 -49.72 1.9 Allowed Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.906 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -73.36 -24.61 60.35 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.331 0.653 . . . . 0.0 111.728 -174.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -91.13 -159.81 35.94 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 25.2 p -126.99 135.11 26.89 Favored Pre-proline 0 N--CA 1.468 0.435 0 CA-C-N 117.142 0.471 . . . . 0.0 110.895 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.02 -174.67 1.63 Allowed 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.01 2.473 . . . . 0.0 110.616 163.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' MET . . . . . 0.576 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 24.6 mmt -74.72 81.33 2.06 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.429 0.633 . . . . 0.0 110.479 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 12.3 p -100.77 -17.36 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.843 1.257 . . . . 0.0 109.627 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -122.75 -160.68 0.9 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -45.87 117.65 3.93 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.56 1.144 . . . . 0.0 112.422 177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.555 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 85.1 Cg_endo -78.36 144.08 20.14 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.585 2.19 . . . . 0.0 111.994 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 97.5 mmm -115.1 145.18 42.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.963 0.905 . . . . 0.0 110.693 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -143.3 91.53 2.28 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 169.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 40.6 mtm-85 -72.57 -17.24 61.73 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.378 -170.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -67.74 98.71 0.73 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 162.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 23.5 p . . . . . 0 CA--C 1.543 0.688 0 C-N-CA 123.944 0.898 . . . . 0.0 110.935 -177.111 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.355 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -102.83 -21.07 14.08 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.585 0.754 . . . . 0.0 110.673 -175.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -108.02 132.56 53.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 169.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 139' ' ' GLU . 17.7 pttp -130.24 -175.74 3.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.944 0.898 . . . . 0.0 110.742 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.8 m -35.47 -32.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -167.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -109.39 -22.18 12.16 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.208 0.603 . . . . 0.0 111.983 -173.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.402 ' HB2' ' H ' ' A' ' 136' ' ' LYS . 5.1 mp0 -77.13 78.83 3.66 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.371 1.068 . . . . 0.0 110.612 -176.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -76.52 130.81 38.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.545 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.2 m -132.69 169.01 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.491 1.516 . . . . 0.0 107.219 172.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.434 ' HB2' ' CE3' ' A' ' 151' ' ' TRP . 4.5 m-20 -92.24 139.51 30.54 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.664 0.665 . . . . 0.0 110.878 -174.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.1 99.4 12.4 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.888 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.435 ' HG2' ' NE1' ' A' ' 151' ' ' TRP . 0.0 OUTLIER -70.8 91.03 0.81 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.129 -1.396 . . . . 0.0 107.407 177.687 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.69 128.92 37.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.143 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.5 m -81.88 -19.15 41.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.563 0.345 . . . . 0.0 111.722 -172.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -76.69 -52.88 8.81 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.9 ttm -90.26 -39.99 12.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.693 0.797 . . . . 0.0 110.552 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.76 -7.67 59.38 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.199 -173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.3 153.38 35.94 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.598 0.759 . . . . 0.0 111.676 -174.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.547 ' CH2' HD12 ' A' ' 280' ' ' ILE . 12.9 m95 -101.51 116.07 31.93 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -109.0 123.28 48.88 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.03 101.66 0.23 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.757 0.66 . . . . 0.0 110.447 -173.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.9 114.84 26.49 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -85.52 97.6 10.15 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.439 HG22 HG12 ' A' ' 186' ' ' VAL . 44.7 t -65.51 97.84 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -92.14 -12.56 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.012 0.525 . . . . 0.0 111.851 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 21.1 ttm180 -168.72 154.05 6.34 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.525 0.73 . . . . 0.0 110.809 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.0 m -131.43 143.44 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.194 0.998 . . . . 0.0 110.14 172.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.577 HG23 ' HB ' ' A' ' 183' ' ' ILE . 4.5 t -141.69 150.4 41.82 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.896 0.878 . . . . 0.0 109.781 176.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -120.04 158.26 27.19 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.961 0.904 . . . . 0.0 110.791 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 123.372 0.669 . . . . 0.0 110.378 177.03 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 71.59 -15.36 0.44 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.245 1.418 . . . . 0.0 112.346 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.547 ' HA ' ' H ' ' A' ' 201' ' ' SER . 28.7 m-20 -87.62 51.14 2.14 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.641 0.734 . . . . 0.0 110.147 174.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 160' ' ' THR . 35.3 m -81.59 179.56 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.771 169.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' A' ' 160' ' ' THR . 3.6 mp -94.04 107.31 19.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -176.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -85.49 108.92 18.13 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.498 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 22.5 m-70 -78.29 100.71 6.82 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.439 HG12 HG22 ' A' ' 156' ' ' VAL . 12.0 m -118.35 164.0 15.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.237 -176.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -122.18 116.13 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -57.99 111.18 1.09 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 169.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.98 -23.99 61.51 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.653 0.739 . . . . 0.0 110.334 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -82.3 -30.4 30.56 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.29 172.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -137.73 70.31 51.47 Favored Pre-proline 0 N--CA 1.487 1.381 0 C-N-CA 123.101 0.56 . . . . 0.0 110.985 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.83 -18.21 57.48 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.801 2.334 . . . . 0.0 112.173 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.19 -17.12 57.21 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.871 1.268 . . . . 0.0 112.573 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -75.91 -7.21 54.01 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.751 0.82 . . . . 0.0 112.263 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.77 -167.11 52.61 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 40.5 t -81.3 117.02 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 171.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 29.0 m -108.38 141.9 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 122.82 0.448 . . . . 0.0 110.047 -175.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.501 ' HB2' HG23 ' A' ' 183' ' ' ILE . 18.4 pt20 -87.51 130.48 34.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.448 0.699 . . . . 0.0 110.156 -176.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 60.1 mmm -133.3 161.5 34.32 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.335 0.654 . . . . 0.0 109.739 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -111.55 -179.5 3.73 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.099 0.959 . . . . 0.0 109.275 172.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.547 ' H ' ' HA ' ' A' ' 181' ' ' ASP . 42.3 t -62.37 -41.43 98.61 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 118.168 0.44 . . . . 0.0 110.367 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -15.19 62.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.868 0.467 . . . . 0.0 112.157 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -89.19 -57.79 2.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.445 0.698 . . . . 0.0 110.008 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -94.24 117.97 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.69 0.757 . . . . 0.0 109.77 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.428 ' HD2' ' HH2' ' A' ' 151' ' ' TRP . 25.8 ttm180 -111.66 149.89 30.91 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.08 -176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.18 127.72 32.66 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 123.907 0.754 . . . . 0.0 111.625 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -101.27 136.53 40.96 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.191 0.996 . . . . 0.0 109.417 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.75 157.55 15.89 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.037 0.922 . . . . 0.0 110.433 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.431 ' HD3' ' N ' ' A' ' 209' ' ' ARG . 0.0 OUTLIER -114.61 42.89 2.03 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.462 177.524 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 21.3 m -127.12 118.73 24.95 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.583 -178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 50.4 mt -84.08 127.74 39.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.574 HG23 ' HB2' ' A' ' 216' ' ' ASP . 46.6 mm -92.37 138.96 18.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.379 -178.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -128.31 -178.49 4.58 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.867 1.267 . . . . 0.0 109.415 175.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' A' ' 246' ' ' LYS . 49.7 t-105 -60.99 -28.64 69.17 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.812 0.445 . . . . 0.0 111.87 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -61.91 -41.98 98.55 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.301 0.641 . . . . 0.0 110.564 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.574 ' HB2' HG23 ' A' ' 212' ' ' ILE . 58.8 m-20 -80.58 -14.55 58.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.733 0.813 . . . . 0.0 111.58 -177.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.516 ' HB3' ' HD3' ' A' ' 246' ' ' LYS . 0.5 OUTLIER -63.06 113.49 3.15 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.634 0.773 . . . . 0.0 111.222 -172.81 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.85 139.53 22.72 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.736 0.814 . . . . 0.0 110.005 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -67.31 139.64 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.161 0.584 . . . . 0.0 110.876 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 96.88 -21.74 44.4 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.696 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.414 ' HG2' HG13 ' A' ' 223' ' ' VAL . 8.0 tt0 -77.83 122.15 25.06 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.937 0.495 . . . . 0.0 109.968 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 10.5 p -91.84 131.45 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.428 HG23 HD11 ' A' ' 225' ' ' LEU . 15.6 m -135.64 156.73 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.741 1.216 . . . . 0.0 110.095 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.505 ' HB2' HD11 ' A' ' 280' ' ' ILE . 39.4 ttp -107.29 127.0 53.16 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.871 0.469 . . . . 0.0 109.988 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.506 ' HG ' HG13 ' A' ' 277' ' ' VAL . 0.1 OUTLIER -131.17 144.98 51.77 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.064 0.946 . . . . 0.0 108.558 -175.021 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -75.0 106.24 6.41 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -139.94 154.96 47.36 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.672 -169.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 32.6 t-20 -120.44 120.71 29.68 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.18 -29.75 32.36 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.42 2.08 . . . . 0.0 112.688 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -71.48 -53.8 12.72 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.88 0.472 . . . . 0.0 110.281 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 4.1 m-20 -117.0 88.59 26.96 Favored Pre-proline 0 N--CA 1.484 1.237 0 C-N-CA 123.823 0.849 . . . . 0.0 109.2 176.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.31 -9.85 23.72 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.014 2.476 . . . . 0.0 114.137 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.424 ' HD2' HD11 ' A' ' 272' ' ' ILE . 21.7 tptm -77.61 -15.5 59.18 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.989 0.915 . . . . 0.0 110.916 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -134.66 165.52 25.04 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.52 0.728 . . . . 0.0 110.463 -172.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.7 ppt_? -71.91 163.65 27.47 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.922 0.889 . . . . 0.0 111.023 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -145.52 -84.44 0.06 OUTLIER Glycine 0 C--O 1.239 0.456 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 175.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -128.53 178.09 6.55 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.33 1.052 . . . . 0.0 108.549 173.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' TRP . . . . . 0.499 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 97.4 m95 -83.21 110.03 17.72 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 122.744 0.418 . . . . 0.0 109.905 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.29 141.29 49.1 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.795 0.838 . . . . 0.0 109.656 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -83.53 123.06 29.37 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.265 0.555 . . . . 0.0 109.709 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -128.62 137.35 51.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.408 1.083 . . . . 0.0 109.59 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 222' ' ' VAL . 33.0 tt0 -94.98 136.43 35.3 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.513 HD12 HD21 ' A' ' 255' ' ' LEU . 33.9 mm -63.96 108.29 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 O-C-N 123.83 0.706 . . . . 0.0 109.46 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.4 t -93.9 -29.16 15.43 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.476 0.711 . . . . 0.0 110.198 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 77.0 ttt180 -167.98 156.26 8.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.355 0.662 . . . . 0.0 109.563 -175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.516 ' HD3' ' HB3' ' A' ' 217' ' ' LEU . 23.8 pttm -148.03 139.84 23.92 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 167.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -134.01 114.84 13.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.791 1.236 . . . . 0.0 107.68 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 9.1 pt-20 -100.23 134.07 43.71 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.014 0.435 . . . . 0.0 109.924 175.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.3 p -118.55 161.76 19.5 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -64.44 -15.08 60.03 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 52.6 p -94.75 -32.06 13.5 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.549 0.74 . . . . 0.0 111.473 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.4 141.38 1.97 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.229 0.612 . . . . 0.0 110.986 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 0.0 OUTLIER -98.18 102.81 14.66 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 121.8 0.81 . . . . 0.0 111.174 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -87.92 116.73 26.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.186 0.994 . . . . 0.0 111.161 -169.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.632 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 3.9 tt -97.84 138.27 35.44 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' TYR . . . . . 0.513 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 53.2 m-85 -128.44 115.04 17.58 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -132.41 140.0 48.28 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.991 0.516 . . . . 0.0 110.083 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 3.4 p-10 -79.85 96.93 6.47 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.415 0.626 . . . . 0.0 109.551 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 49.6 t -72.83 100.49 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.053 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.2 p -93.74 110.91 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.609 0.718 . . . . 0.0 109.228 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 5.2 mp -83.6 -172.51 4.19 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.247 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.08 -31.45 66.61 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 121.885 -0.197 . . . . 0.0 112.824 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -121.81 -48.62 2.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.141 0.976 . . . . 0.0 109.677 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.74 168.81 18.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.511 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 51.7 p -158.43 112.63 2.5 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.61 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 55.3 mt -94.3 96.9 9.86 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.37 1.068 . . . . 0.0 110.044 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 4.1 p-10 -74.87 137.6 41.9 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.896 0.479 . . . . 0.0 111.439 -174.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 63.58 26.04 14.56 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.835 1.254 . . . . 0.0 113.634 171.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 72.0 m -64.83 133.2 51.44 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.628 0.371 . . . . 0.0 111.296 177.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -68.86 116.46 9.36 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.93 0.768 . . . . 0.0 110.058 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.632 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 45.8 mm -88.74 133.31 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.018 0.527 . . . . 0.0 109.726 177.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.424 HD11 ' HD2' ' A' ' 233' ' ' LYS . 62.3 mt -104.91 -22.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.342 1.057 . . . . 0.0 110.044 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -90.61 41.54 1.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.184 0.993 . . . . 0.0 110.794 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 26.2 m -70.04 -26.07 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.678 1.191 . . . . 0.0 112.686 -169.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -91.92 -3.57 55.79 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.372 0.669 . . . . 0.0 111.724 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.7 25.9 3.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.111 0.564 . . . . 0.0 111.331 -170.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.506 HG13 ' HG ' ' A' ' 225' ' ' LEU . 46.5 t -73.59 153.7 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.885 0.874 . . . . 0.0 110.267 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -116.71 150.26 38.49 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.457 0.703 . . . . 0.0 109.6 169.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.453 ' HE2' HD11 ' A' ' 212' ' ' ILE . 22.2 ttmm -82.97 149.48 26.98 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.227 1.011 . . . . 0.0 110.653 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.547 HD12 ' CH2' ' A' ' 151' ' ' TRP . 32.7 mm -87.1 125.03 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 165.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.52 104.4 6.06 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -173.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 98.0 mtt180 -94.4 103.7 11.75 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 168.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -27.98 118.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 125.25 3.967 . . . . 0.0 116.617 -165.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 106.96 -41.69 2.12 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.922 -0.932 . . . . 0.0 114.612 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 10.5 pt-20 -79.99 -25.23 40.39 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 119.088 1.444 . . . . 0.0 113.338 -170.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -76.84 117.88 5.01 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 17.8 p -63.57 129.8 93.91 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 117.508 0.654 . . . . 0.0 109.65 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.58 153.05 74.23 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.451 2.767 . . . . 0.0 112.85 -172.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' MET . . . . . 0.518 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 57.0 ttm -76.91 79.57 3.48 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-O 121.852 0.834 . . . . 0.0 110.167 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.9 -28.9 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -74.33 178.45 5.17 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.748 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -54.02 141.12 50.29 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.131 0.972 . . . . 0.0 111.964 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.518 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 16.0 Cg_exo -67.68 84.82 0.39 Allowed 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.758 2.305 . . . . 0.0 111.679 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.7 mtm -68.11 109.55 3.57 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.692 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -123.37 137.55 54.8 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.105 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 50.25 0.6 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.793 0.837 . . . . 0.0 110.697 -159.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 190' ' ' ASP . 16.8 ptpt -55.68 149.71 13.78 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.411 1.084 . . . . 0.0 113.872 -173.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.681 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.42 ' HA3' ' HB ' ' A' ' 159' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.411 ' N ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -115.61 10.81 15.65 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -169.843 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -91.74 159.45 15.83 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 166.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 60.0 mttp -79.18 178.64 7.91 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.99 0.516 . . . . 0.0 111.564 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -91.39 17.45 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 123.903 0.881 . . . . 0.0 110.929 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -151.8 9.11 0.51 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.422 0.689 . . . . 0.0 109.715 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 136' ' ' LYS . 9.2 tp10 -75.2 87.56 2.46 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 123.7 0.8 . . . . 0.0 110.133 -170.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.696 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 46.2 p90 -74.71 120.92 20.92 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.071 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.42 -170.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.424 1.09 . . . . 0.0 109.55 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -92.61 147.9 22.5 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -140.01 104.22 4.8 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -70.03 103.61 2.32 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 173.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.34 115.07 3.87 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.457 0.703 . . . . 0.0 109.843 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t -68.8 -16.67 63.86 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.163 0.985 . . . . 0.0 112.849 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -82.46 -49.34 10.05 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 122.914 0.486 . . . . 0.0 110.978 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 22.6 ptm -101.4 -13.61 17.91 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.568 0.747 . . . . 0.0 111.441 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.647 ' HA3' ' HA3' ' A' ' 262' ' ' GLY . . . 79.19 20.55 69.56 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 174.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.429 ' HB2' ' CE1' ' A' ' 239' ' ' TYR . . . -106.19 153.42 22.15 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.25 0.62 . . . . 0.0 111.278 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.425 ' HZ3' ' HG3' ' A' ' 205' ' ' ARG . 57.2 m95 -78.26 144.67 35.98 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 171.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.434 ' HA ' ' HD1' ' A' ' 238' ' ' TRP . 59.2 m-85 -145.56 145.78 31.14 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.397 0.544 . . . . 0.0 111.146 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 189' ' ' ASP . 75.2 mm-40 -63.51 138.07 58.37 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 167.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -146.82 166.69 25.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.408 0.683 . . . . 0.0 110.269 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.696 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 63.1 tt0 -137.08 105.13 5.65 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.346 0.659 . . . . 0.0 110.1 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 186' ' ' VAL . 42.3 t -67.52 100.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.51 -3.02 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.217 0.607 . . . . 0.0 112.453 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 72.4 ttt180 -166.41 135.06 2.93 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.42 ' HB ' ' HA3' ' A' ' 133' ' ' GLY . 27.6 m -118.25 127.62 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.301 0.64 . . . . 0.0 109.48 173.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.3 p -136.26 145.65 45.82 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.835 0.854 . . . . 0.0 109.264 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.51 ' HA ' ' HB ' ' A' ' 182' ' ' VAL . 13.5 ptt180 -94.27 165.85 12.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.304 0.642 . . . . 0.0 110.474 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt . . . . . 0 N--CA 1.477 0.881 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.266 175.777 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.523 ' HB3' HG22 ' A' ' 182' ' ' VAL . 3.6 mp0 -71.86 92.02 1.21 Allowed 'General case' 0 C--O 1.243 0.726 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -80.11 70.29 6.69 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 160.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.523 HG22 ' HB3' ' A' ' 180' ' ' GLU . 18.2 m -126.78 173.94 11.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.507 177.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 183' ' ' ILE . 3.1 mp -96.8 108.87 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.427 0.632 . . . . 0.0 109.748 -166.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -99.77 105.97 17.81 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 17.7 m-70 -78.88 92.88 4.93 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.664 HG12 HG22 ' A' ' 156' ' ' VAL . 2.4 m -108.93 153.55 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -119.19 118.15 30.57 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 191' ' ' TYR . 24.2 m-85 -64.72 127.25 30.75 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.453 0.471 . . . . 0.0 110.378 177.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 153' ' ' GLU . 13.4 t70 -65.85 -37.53 86.45 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.72 -20.32 65.25 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.696 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 188' ' ' TYR . 89.5 m-85 -139.37 66.87 37.76 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 123.568 0.747 . . . . 0.0 109.11 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -71.2 -40.03 3.51 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.331 2.021 . . . . 0.0 112.883 -169.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.68 -2.57 58.7 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.782 0.833 . . . . 0.0 111.982 -176.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.04 -16.4 59.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.205 0.602 . . . . 0.0 110.56 172.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 100.02 -161.13 19.29 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.206 -0.452 . . . . 0.0 113.16 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 7.6 t -96.3 116.96 39.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 22.4 m -101.88 155.2 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.878 0.871 . . . . 0.0 110.204 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.404 ' HB2' HG23 ' A' ' 183' ' ' ILE . 15.1 pm0 -99.4 128.54 45.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.654 0.782 . . . . 0.0 109.563 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 86.3 mmm -130.05 165.05 23.02 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.636 1.175 . . . . 0.0 108.788 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -110.74 172.11 7.06 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 180' ' ' GLU . 56.9 m -58.32 -43.86 88.39 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.137 0.575 . . . . 0.0 111.593 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -22.62 67.0 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.83 0.852 . . . . 0.0 112.219 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -84.16 -40.68 17.89 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.624 0.77 . . . . 0.0 110.423 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 31.3 m -93.38 117.73 37.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 CA-C-O 122.216 1.008 . . . . 0.0 110.011 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.425 ' HG3' ' HZ3' ' A' ' 151' ' ' TRP . 2.0 mmp_? -122.08 -170.27 2.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.971 1.308 . . . . 0.0 109.085 -175.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 289' ' ' MET . . . -101.98 128.58 48.35 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 169.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.67 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -73.95 118.51 16.98 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 167.223 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -69.14 121.93 17.74 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 122.855 0.462 . . . . 0.0 110.446 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -74.41 4.39 6.0 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.217 0.607 . . . . 0.0 111.913 174.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 52.4 m -84.11 105.91 15.34 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.64 114.74 25.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 279' ' ' LYS . 30.8 mm -76.49 133.65 30.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.509 177.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.91 178.04 5.05 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' TRP . . . . . 0.52 ' HA ' HD12 ' A' ' 217' ' ' LEU . 75.3 t-105 -49.5 -41.87 41.93 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.957 0.903 . . . . 0.0 111.908 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -53.93 -44.18 70.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.466 1.106 . . . . 0.0 112.788 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -115.18 17.15 16.81 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.597 0.759 . . . . 0.0 112.34 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 214' ' ' TRP . 53.1 mt -76.2 113.22 13.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 163.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -126.69 152.71 46.42 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.733 0.413 . . . . 0.0 110.274 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.33 140.58 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.219 0.608 . . . . 0.0 110.798 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.45 -1.39 82.12 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.5 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.53 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.5 tt0 -85.57 120.49 27.08 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.496 0.648 . . . . 0.0 109.818 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 64.8 t -90.05 114.29 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.53 HG13 ' HG2' ' A' ' 221' ' ' GLN . 3.5 m -126.89 163.44 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.501 1.12 . . . . 0.0 109.346 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.434 ' HB3' HD11 ' A' ' 280' ' ' ILE . 0.0 OUTLIER -100.88 139.46 36.53 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.882 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.617 ' HG ' HG13 ' A' ' 277' ' ' VAL . 1.1 mp -131.35 167.67 18.86 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.409 ' HB3' ' HZ3' ' A' ' 238' ' ' TRP . 12.2 p-10 -101.36 105.64 16.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.997 0.919 . . . . 0.0 110.434 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -167.71 159.16 11.62 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.485 0.714 . . . . 0.0 110.196 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -103.31 129.15 26.04 Favored Pre-proline 0 C--O 1.217 -0.644 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.82 -7.36 20.97 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 122.405 2.07 . . . . 0.0 113.366 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -70.5 -30.27 67.0 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.116 0.566 . . . . 0.0 109.53 170.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -152.45 82.82 5.1 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.754 1.222 . . . . 0.0 107.77 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -60.88 -10.9 15.87 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.345 2.696 . . . . 0.0 114.381 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.404 ' O ' HD12 ' A' ' 272' ' ' ILE . 50.6 tttm -72.31 -31.34 65.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.458 0.703 . . . . 0.0 110.826 173.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.01 156.52 19.15 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.822 0.849 . . . . 0.0 111.149 -173.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -65.81 161.37 21.09 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.284 -1.325 . . . . 0.0 112.033 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -171.25 -122.92 0.67 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -104.86 -177.32 3.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.179 0.592 . . . . 0.0 110.645 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' TRP . . . . . 0.434 ' HD1' ' HA ' ' A' ' 152' ' ' PHE . 14.5 m95 -90.59 105.77 18.04 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -173.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 150' ' ' ALA . 84.5 m-85 -126.63 157.57 38.58 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.77 0.828 . . . . 0.0 111.033 -176.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -88.07 146.77 25.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.3 0.64 . . . . 0.0 110.6 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -155.89 138.5 15.06 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.254 1.022 . . . . 0.0 108.529 170.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.6 125.12 39.05 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.611 HD12 HD11 ' A' ' 255' ' ' LEU . 28.5 mm -64.72 108.94 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.548 0.739 . . . . 0.0 109.218 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.3 m -79.92 -48.43 13.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.667 0.787 . . . . 0.0 110.798 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.96 128.44 2.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -170.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -114.23 145.53 41.6 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -141.29 121.02 13.43 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -104.56 126.54 51.74 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 77.7 p -125.23 172.31 9.65 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.182 0.993 . . . . 0.0 108.869 170.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -78.99 -12.41 60.04 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.971 0.508 . . . . 0.0 111.366 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 65.4 p -96.69 -29.14 13.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.37 0.668 . . . . 0.0 111.085 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.54 163.24 38.58 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.031 0.532 . . . . 0.0 111.336 -173.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -116.6 99.89 7.46 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 165.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.37 100.54 13.09 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.181 0.593 . . . . 0.0 110.439 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.611 HD11 HD12 ' A' ' 243' ' ' ILE . 1.7 tm? -96.24 136.09 37.19 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 175.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -125.17 127.61 47.08 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -142.57 140.31 31.69 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.13 0.572 . . . . 0.0 110.575 -176.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -80.79 102.54 10.05 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 170.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 49.6 t -65.88 121.85 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.794 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.5 p -121.78 107.82 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 121.976 0.893 . . . . 0.0 109.166 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' A' ' 264' ' ' ASP . 25.4 mt -88.15 -160.01 0.59 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.437 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.647 ' HA3' ' HA3' ' A' ' 149' ' ' GLY . . . -89.23 -25.47 28.6 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -123.04 -43.72 2.21 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.534 0.734 . . . . 0.0 111.084 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.581 ' HB3' HD12 ' A' ' 261' ' ' LEU . 30.1 t70 -113.37 177.08 4.76 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.572 1.149 . . . . 0.0 110.442 -170.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 57.6 p -148.6 143.4 26.55 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.009 0.924 . . . . 0.0 110.159 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 2.8 mm? -114.58 106.37 14.17 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -78.59 125.24 29.09 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.57 0.748 . . . . 0.0 110.493 -177.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 62.39 81.56 0.2 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.854 1.261 . . . . 0.0 112.208 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 61.3 m -111.02 127.4 55.52 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 19.4 ttp180 -80.56 104.14 10.89 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 43.1 mm -74.3 120.19 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.247 1.019 . . . . 0.0 110.335 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 233' ' ' LYS . 54.1 mt -83.52 -20.2 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 125.2 1.4 . . . . 0.0 110.177 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -93.71 37.55 1.07 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.289 1.436 . . . . 0.0 111.902 -167.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 32.9 m -66.9 -28.59 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -169.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -95.77 0.07 51.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.657 0.783 . . . . 0.0 112.293 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -134.72 25.88 3.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.119 0.568 . . . . 0.0 111.3 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.617 HG13 ' HG ' ' A' ' 225' ' ' LEU . 55.5 t -76.11 148.74 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.835 0.854 . . . . 0.0 108.844 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -117.66 150.69 38.63 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.506 ' HB2' HD11 ' A' ' 212' ' ' ILE . 38.8 ttmt -79.45 145.55 33.23 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.952 0.501 . . . . 0.0 111.091 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 224' ' ' MET . 37.0 mm -84.74 139.14 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 166.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.24 147.06 51.92 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 173.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -127.35 144.35 50.45 Favored Pre-proline 0 N--CA 1.473 0.704 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.88 125.48 13.08 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.061 2.508 . . . . 0.0 113.293 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.55 -58.95 0.56 Allowed Glycine 0 C--N 1.345 1.062 0 C-N-CA 123.156 0.408 . . . . 0.0 113.317 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.02 -23.14 26.93 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.249 0.524 . . . . 0.0 111.495 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -125.46 136.51 9.8 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 16.5 m -71.5 148.83 93.38 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 123.314 0.646 . . . . 0.0 110.858 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.8 176.63 9.87 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.133 2.555 . . . . 0.0 111.574 176.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' MET . . . . . 0.424 ' HB2' ' HB1' ' A' ' 206' ' ' ALA . 9.5 ttt -95.12 81.14 3.64 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 14.6 p -100.38 -26.73 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.286 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.31 -177.51 4.66 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.138 0.975 . . . . 0.0 109.912 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -47.62 109.63 1.15 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.508 1.123 . . . . 0.0 111.085 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.77 108.53 1.47 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.565 2.177 . . . . 0.0 111.639 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 58.4 ttp -105.69 91.26 3.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.128 0.971 . . . . 0.0 108.639 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -66.49 142.23 57.61 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.144 0.577 . . . . 0.0 110.631 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -59.99 -32.37 70.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.696 0.798 . . . . 0.0 112.138 -173.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.96 -24.34 66.94 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.268 1.027 . . . . 0.0 111.713 -176.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.8 m . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 172.063 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.109 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.487 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -92.35 -6.33 50.4 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.178 0.591 . . . . 0.0 112.167 -176.068 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -98.65 150.07 22.15 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.159 0.504 . . . . 0.0 111.106 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.621 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 48.4 mtpt -84.69 168.83 14.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.564 1.146 . . . . 0.0 110.998 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.2 m -78.75 14.47 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 C-N-CA 124.211 1.004 . . . . 0.0 112.735 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -132.2 0.22 3.75 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.974 0.91 . . . . 0.0 111.412 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.621 ' HG2' ' HB2' ' A' ' 136' ' ' LYS . 27.9 mm-40 -79.9 92.17 5.49 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.62 0.724 . . . . 0.0 112.29 -168.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 12.8 p90 -65.29 100.11 0.44 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.74 165.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.88 -172.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.983 1.313 . . . . 0.0 109.191 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.631 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 15.3 t70 -104.53 157.94 16.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 168.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -133.86 96.07 3.58 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.481 0.312 . . . . 0.0 110.465 169.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -73.41 97.95 2.64 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 169.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.82 128.0 34.11 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.121 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.6 m -68.5 -30.15 68.92 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.22 0.608 . . . . 0.0 111.222 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -74.03 -42.26 60.58 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.347 0.659 . . . . 0.0 111.649 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 54.4 ttm -102.02 -22.8 14.19 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.09 0.556 . . . . 0.0 112.378 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 77.45 0.75 73.58 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-N 116.663 -0.244 . . . . 0.0 113.431 -174.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -93.16 164.83 13.1 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 123.422 0.689 . . . . 0.0 111.342 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.571 ' HB3' ' HB2' ' A' ' 238' ' ' TRP . 2.3 p-90 -77.41 139.59 39.73 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.85 174.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.414 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 89.6 m-85 -147.22 77.26 1.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 171.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 50.9 mt-10 -55.99 134.96 52.68 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.628 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -149.15 135.11 18.96 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.655 0.597 . . . . 0.0 111.796 -164.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.3 tt0 -91.44 109.63 20.92 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.51 113.77 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.524 0.73 . . . . 0.0 109.261 170.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.89 -8.7 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 122.967 0.507 . . . . 0.0 111.497 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.559 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 36.3 ttm180 -169.93 143.83 2.64 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.639 0.776 . . . . 0.0 109.412 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.34 143.47 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.7 0.8 . . . . 0.0 108.866 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.437 HG23 ' HB ' ' A' ' 183' ' ' ILE . 9.5 t -148.79 163.8 36.3 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.122 0.569 . . . . 0.0 111.207 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -87.28 171.78 10.37 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.381 1.072 . . . . 0.0 112.162 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 124.473 1.109 . . . . 0.0 110.086 173.441 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 201' ' ' SER . 7.3 mp0 -77.29 89.05 3.72 Favored 'General case' 0 C--O 1.249 1.026 0 CA-C-O 121.19 0.519 . . . . 0.0 110.764 -172.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.06 79.35 9.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 163.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 16.7 m -129.68 157.24 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.955 0.902 . . . . 0.0 108.768 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.2 mp -95.38 109.39 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -166.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.446 ' HB3' HG13 ' A' ' 186' ' ' VAL . 78.7 m-85 -92.35 111.4 22.95 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.519 1.127 . . . . 0.0 108.973 172.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 17.5 m-70 -77.29 91.59 3.81 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 168.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.628 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 34.9 m -109.02 157.92 9.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.477 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -127.88 115.14 18.14 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.423 ' HD2' ' HB2' ' A' ' 154' ' ' ALA . 17.6 m-30 -60.43 117.51 5.34 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.698 0.624 . . . . 0.0 111.755 -171.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -56.09 -42.7 77.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.034 1.334 . . . . 0.0 111.554 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -86.14 -16.63 37.32 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.263 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -138.61 68.14 44.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 123.115 0.566 . . . . 0.0 110.836 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.14 -17.67 53.67 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.565 2.177 . . . . 0.0 113.514 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.66 -23.08 66.71 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.743 0.817 . . . . 0.0 112.067 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -74.83 -13.34 60.55 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.151 0.58 . . . . 0.0 111.61 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.99 -141.35 34.33 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.81 0.694 . . . . 0.0 112.308 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 25.9 t -93.19 119.25 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 20.2 m -123.59 155.71 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.964 1.306 . . . . 0.0 109.54 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.47 ' HB2' HG23 ' A' ' 183' ' ' ILE . 20.8 pt20 -98.62 132.29 44.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.866 0.467 . . . . 0.0 110.812 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 83.5 mmm -135.24 164.49 27.6 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.998 0.919 . . . . 0.0 108.68 173.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ASN . . . . . 0.425 ' O ' HG22 ' A' ' 204' ' ' VAL . 21.4 m-80 -109.71 172.03 7.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 180' ' ' GLU . 40.7 m -61.59 -30.25 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.127 0.421 . . . . 0.0 111.134 175.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -55.94 -42.59 76.4 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.428 1.091 . . . . 0.0 109.246 175.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.68 -40.44 17.38 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.366 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 18.8 m -91.85 116.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 CA-C-O 122.703 1.24 . . . . 0.0 108.33 -173.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -106.96 137.7 44.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.479 -1.691 . . . . 0.0 107.895 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.55 ' HB3' ' HG2' ' A' ' 281' ' ' GLU . . . -62.37 126.31 26.9 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.772 ' HD3' ' H ' ' A' ' 295' ' ' ARG . 42.2 ttm180 -63.38 95.82 0.1 Allowed 'General case' 0 C--O 1.241 0.634 0 O-C-N 123.972 0.795 . . . . 0.0 109.854 -175.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.06 121.52 10.83 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.891 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -91.93 1.92 56.87 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.216 172.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.0 m -97.92 113.94 25.9 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.747 0.819 . . . . 0.0 110.67 -176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.76 136.8 22.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.759 0.824 . . . . 0.0 108.954 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.453 ' HB ' HG12 ' A' ' 277' ' ' VAL . 37.1 mm -90.25 133.79 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -97.92 172.43 7.65 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.21 0.604 . . . . 0.0 110.688 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' TRP . . . . . 0.433 ' HA ' HD12 ' A' ' 217' ' ' LEU . 73.1 t-105 -56.01 -43.36 77.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.904 0.882 . . . . 0.0 111.47 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -58.22 -37.96 75.89 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.012 0.925 . . . . 0.0 111.645 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -82.62 -20.91 35.45 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.137 0.575 . . . . 0.0 111.282 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 214' ' ' TRP . 96.0 mt -63.22 118.98 8.73 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' GLU . . . . . 0.408 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 10.6 pt-20 -144.97 155.56 43.47 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.724 0.809 . . . . 0.0 109.729 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 35.9 m -65.4 131.27 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.149 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.71 -12.58 69.01 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 115.782 -0.645 . . . . 0.0 113.641 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -72.76 123.02 22.47 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.255 0.527 . . . . 0.0 110.535 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 51.7 t -91.62 115.72 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.57 -170.12 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.564 1.546 . . . . 0.0 109.56 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.44 ' HB2' HD11 ' A' ' 280' ' ' ILE . 40.1 ttp -141.59 130.45 23.04 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.949 0.5 . . . . 0.0 109.953 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.408 HD13 ' HD1' ' A' ' 227' ' ' TYR . 0.8 OUTLIER -143.29 147.19 34.38 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.857 0.863 . . . . 0.0 109.991 -175.52 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 235' ' ' ARG . 6.9 p30 -90.92 114.24 26.66 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.392 0.615 . . . . 0.0 111.347 -175.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.408 ' HD1' HD13 ' A' ' 225' ' ' LEU . 26.7 m-85 -137.64 144.54 41.93 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.348 1.059 . . . . 0.0 110.641 174.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -86.11 123.01 72.36 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.77 -9.63 26.13 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.468 2.112 . . . . 0.0 112.703 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.55 -43.57 14.37 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.31 0.644 . . . . 0.0 109.967 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -130.55 89.15 44.76 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.645 0.778 . . . . 0.0 109.967 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.18 -12.23 33.49 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.761 2.308 . . . . 0.0 112.615 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -66.51 -28.65 68.72 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.11 0.564 . . . . 0.0 110.544 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -120.24 161.12 21.63 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.31 0.644 . . . . 0.0 110.068 -173.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.415 ' HB2' ' OD1' ' A' ' 226' ' ' ASN . 1.4 ppt_? -60.47 166.85 2.86 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 124.397 1.079 . . . . 0.0 111.394 175.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -177.37 -113.33 0.35 Allowed Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.302 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -96.73 139.68 32.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.137 0.975 . . . . 0.0 110.178 -172.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' TRP . . . . . 0.571 ' HB2' ' HB3' ' A' ' 151' ' ' TRP . 79.7 m95 -70.91 123.59 22.37 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.208 0.528 . . . . 0.0 110.548 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -130.92 151.48 51.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.52 137.22 35.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 258' ' ' ASN . . . -134.83 137.71 43.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.804 0.442 . . . . 0.0 110.512 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -96.23 118.56 33.04 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.551 HD12 HD11 ' A' ' 255' ' ' LEU . 44.0 mm -59.64 107.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 123.813 0.696 . . . . 0.0 109.294 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 10.0 m -78.38 -44.19 25.63 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.855 0.862 . . . . 0.0 110.623 -176.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -155.49 155.79 34.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.973 -168.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -149.7 145.58 26.77 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.596 0.56 . . . . 0.0 110.18 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -155.53 117.35 4.05 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.002 0.921 . . . . 0.0 108.535 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -102.98 124.33 48.28 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.1 p -133.25 162.26 32.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.681 0.793 . . . . 0.0 109.598 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.31 -26.73 68.0 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.203 1.001 . . . . 0.0 112.71 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 26.9 p -88.69 -30.24 19.27 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.198 0.599 . . . . 0.0 111.342 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -172.06 151.96 2.8 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.428 0.455 . . . . 0.0 111.462 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -105.86 110.46 22.76 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.901 0.48 . . . . 0.0 109.768 172.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -89.87 129.43 36.23 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.694 1.197 . . . . 0.0 110.825 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.551 HD11 HD12 ' A' ' 243' ' ' ILE . 1.5 tm? -137.34 129.84 29.83 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -118.64 144.26 46.28 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.59 146.04 29.23 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.525 0.73 . . . . 0.0 110.611 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 241' ' ' ALA . 7.3 m-20 -78.19 96.3 5.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.746 0.818 . . . . 0.0 109.233 172.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 51.0 t -76.54 107.57 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 95.8 t -87.52 119.36 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.799 0.84 . . . . 0.0 110.786 -167.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 43.2 mt -107.81 -176.88 3.18 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.356 1.062 . . . . 0.0 108.816 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -76.75 -49.94 7.48 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-O 120.957 0.198 . . . . 0.0 113.247 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.17 -30.73 12.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.445 0.698 . . . . 0.0 109.885 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -112.14 175.34 5.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.571 0.749 . . . . 0.0 111.65 -175.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 14.0 p -155.73 113.24 3.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.504 1.122 . . . . 0.0 108.103 170.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.445 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 31.9 mt -80.87 81.7 7.05 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.239 1.015 . . . . 0.0 108.57 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 4.2 p-10 -76.46 135.81 39.39 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.533 -171.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 13.6 t70 56.89 47.45 17.81 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.399 1.08 . . . . 0.0 110.597 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 91.9 m -99.66 132.67 44.85 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.826 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 24.8 ttp180 -62.93 117.9 7.05 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.598 0.759 . . . . 0.0 112.128 -174.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.51 105.56 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.666 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 34.3 mt -70.74 -36.31 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 125.443 1.497 . . . . 0.0 110.507 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -109.26 69.41 0.7 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.7 0.8 . . . . 0.0 109.881 -171.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 18.3 m -71.4 -14.39 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.516 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.19 -28.78 48.21 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.265 1.026 . . . . 0.0 110.87 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -90.6 26.0 2.14 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.332 0.587 . . . . 0.0 111.289 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.453 HG12 ' HB ' ' A' ' 212' ' ' ILE . 71.5 t -96.36 126.12 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.469 1.108 . . . . 0.0 109.602 175.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -112.28 160.88 17.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.181 0.992 . . . . 0.0 109.985 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.674 ' HD3' ' HA2' ' A' ' 286' ' ' GLY . 17.2 ttmm -78.31 136.61 37.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.488 1.115 . . . . 0.0 111.013 177.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 224' ' ' MET . 41.2 mm -83.05 117.15 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 163.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.55 ' HG2' ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -68.25 105.36 2.1 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.458 0.647 . . . . 0.0 110.564 -178.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -122.02 142.52 36.66 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 123.654 0.781 . . . . 0.0 108.956 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.15 120.4 6.72 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.477 2.784 . . . . 0.0 113.817 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.26 -25.75 26.63 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-N 116.063 -0.517 . . . . 0.0 114.038 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.04 -12.9 4.61 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 117.855 0.828 . . . . 0.0 112.543 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' GLY . . . . . 0.674 ' HA2' ' HD3' ' A' ' 279' ' ' LYS . . . -98.11 120.46 6.8 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 123.448 0.546 . . . . 0.0 111.785 -173.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.3 m -75.52 142.3 74.13 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 117.092 0.446 . . . . 0.0 111.604 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.09 148.81 24.88 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.828 2.352 . . . . 0.0 111.993 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' MET . . . . . 0.548 ' SD ' ' HB3' ' A' ' 207' ' ' ARG . 23.5 ttt -77.81 85.1 4.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.242 0.544 . . . . 0.0 109.609 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 10.8 p -123.14 3.64 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.426 1.091 . . . . 0.0 109.668 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -120.36 -167.81 1.52 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.762 1.225 . . . . 0.0 108.341 -171.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -43.54 115.27 1.91 Allowed Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 124.902 1.281 . . . . 0.0 112.961 -177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.86 115.18 2.94 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.368 2.046 . . . . 0.0 110.915 173.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 22.8 mmt -72.24 -77.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.475 0.71 . . . . 0.0 110.77 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.772 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 6.7 ttt180 66.43 106.58 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.411 1.484 . . . . 0.0 109.752 -176.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.472 ' NH2' ' HB2' ' A' ' 151' ' ' TRP . 7.3 mtm-85 -101.25 22.09 12.98 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.133 1.373 . . . . 0.0 109.688 -167.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -56.44 108.16 0.45 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 125.343 1.457 . . . . 0.0 110.063 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.242 0.699 0 C-N-CA 123.638 0.775 . . . . 0.0 110.028 -176.078 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 CA-C-O 119.807 -0.44 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.67 -58.77 2.25 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.278 0.631 . . . . 0.0 110.087 -172.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -80.92 159.47 24.96 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.754 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -100.04 177.24 5.15 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.73 0.812 . . . . 0.0 111.022 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.7 m -72.4 0.51 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.688 1.195 . . . . 0.0 113.298 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -119.98 6.0 10.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.656 0.782 . . . . 0.0 112.264 -173.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 156' ' ' VAL . 8.2 mm-40 -82.28 94.8 7.41 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.263 0.554 . . . . 0.0 111.588 -171.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -79.21 101.47 8.0 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.938 171.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 35.9 m -120.08 -166.29 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 125.974 1.71 . . . . 0.0 108.995 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 207' ' ' ARG . 1.8 t70 -122.12 165.13 16.58 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 154' ' ' ALA . . . -129.42 140.64 51.26 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.353 0.524 . . . . 0.0 111.418 -175.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.558 HH11 ' HA ' ' A' ' 146' ' ' THR . 1.1 tmt_? -90.74 102.3 15.05 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.401 ' HB2' ' HD1' ' A' ' 152' ' ' PHE . 9.3 t70 -65.25 110.82 2.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.558 ' HA ' HH11 ' A' ' 144' ' ' ARG . 13.1 t -72.58 -26.39 61.69 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 122.97 0.508 . . . . 0.0 111.965 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -80.82 -41.26 23.56 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.695 0.798 . . . . 0.0 111.19 -173.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.5 ttm -94.57 -33.78 12.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.434 0.694 . . . . 0.0 110.767 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.51 14.95 67.14 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.279 -171.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.4 175.23 5.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.133 0.973 . . . . 0.0 110.614 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -115.92 129.79 56.55 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.401 ' HD1' ' HB2' ' A' ' 145' ' ' ASP . 97.1 m-85 -131.9 135.71 46.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 188' ' ' TYR . 23.9 mt-10 -60.52 142.85 54.79 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.748 0.655 . . . . 0.0 109.309 -178.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 143' ' ' ALA . . . -133.49 117.23 16.92 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.818 0.736 . . . . 0.0 111.267 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -94.24 101.88 13.88 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 55.1 t -63.68 108.55 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 172.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.427 HG11 ' HE2' ' A' ' 187' ' ' LYS . 29.0 m -108.45 -10.52 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.331 0.652 . . . . 0.0 111.97 -177.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 34.6 ttm-85 -168.85 148.2 4.19 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.384 0.674 . . . . 0.0 109.892 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.07 130.2 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.213 1.005 . . . . 0.0 109.484 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 38.7 p -130.94 151.84 50.91 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -103.19 178.75 4.47 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp . . . . . 0 N--CA 1.483 1.191 0 C-N-CA 123.099 0.56 . . . . 0.0 110.944 172.77 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 C--O 1.241 0.629 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.0 97.43 2.31 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.287 -172.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.63 19.64 0.48 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.463 171.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.5 m -66.97 162.14 3.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 124.537 1.135 . . . . 0.0 110.382 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.9 mp -94.4 109.7 22.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -174.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.403 ' HB3' HG13 ' A' ' 186' ' ' VAL . 71.1 m-85 -88.41 109.09 19.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.996 0.919 . . . . 0.0 109.165 172.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -80.31 88.94 5.51 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 156' ' ' VAL . 9.9 m -114.0 155.21 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.555 ' HG2' HG22 ' A' ' 196' ' ' VAL . 43.8 mtmt -115.06 131.81 56.8 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' A' ' 153' ' ' GLU . 19.7 m-30 -60.82 97.62 0.06 Allowed 'General case' 0 C--O 1.209 -1.038 0 O-C-N 123.586 0.554 . . . . 0.0 110.031 170.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -68.05 -21.18 65.01 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.687 0.795 . . . . 0.0 111.652 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 25.6 p30 -85.54 -28.77 24.69 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.67 0.788 . . . . 0.0 111.827 173.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -135.13 69.17 69.99 Favored Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 123.364 0.665 . . . . 0.0 109.818 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.61 -7.3 20.59 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.476 2.118 . . . . 0.0 112.902 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.79 -9.67 59.15 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.634 0.773 . . . . 0.0 110.88 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.49 -19.54 52.81 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.749 0.82 . . . . 0.0 110.443 169.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 84.78 -165.45 40.21 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.911 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.555 HG22 ' HG2' ' A' ' 187' ' ' LYS . 42.2 t -79.24 129.6 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 32.1 m -114.67 155.12 15.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 124.328 1.051 . . . . 0.0 109.541 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.551 ' HB2' HG23 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -102.45 117.08 33.95 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.597 0.759 . . . . 0.0 109.574 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 79.8 mmm -120.79 169.67 10.2 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.033 0.933 . . . . 0.0 109.702 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ASN . . . . . 0.442 ' H ' ' HB2' ' A' ' 203' ' ' ASP . 19.4 m-80 -109.92 178.58 4.37 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.334 0.654 . . . . 0.0 109.611 172.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 22.7 t -65.36 -39.82 92.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.419 0.688 . . . . 0.0 110.545 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -65.31 -22.87 66.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.546 0.738 . . . . 0.0 111.847 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' A' ' 200' ' ' ASN . 33.9 m-20 -97.85 2.1 48.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.646 0.779 . . . . 0.0 112.339 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.9 m -121.55 134.74 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 171.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 7.2 ptm180 -120.58 166.4 13.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.012 1.325 . . . . 0.0 109.777 -177.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.02 167.62 21.15 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 163.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.66 ' H ' ' HA ' ' A' ' 288' ' ' PRO . 37.8 ttp180 -143.61 125.98 15.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.39 0.541 . . . . 0.0 110.405 169.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -81.82 158.91 23.9 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.671 1.188 . . . . 0.0 111.782 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.51 23.97 1.51 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.584 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 99.3 m -108.05 113.57 26.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.737 0.815 . . . . 0.0 110.473 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 14.8 mt -85.62 125.98 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 162.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.506 HG21 HG11 ' A' ' 223' ' ' VAL . 46.0 mm -75.7 147.03 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 123.297 0.639 . . . . 0.0 110.79 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.03 179.75 5.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.431 1.092 . . . . 0.0 109.54 176.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -59.89 -32.09 70.41 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.865 0.866 . . . . 0.0 111.037 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -68.92 -25.21 64.47 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.472 ' HB2' HG23 ' A' ' 212' ' ' ILE . 26.3 m-20 -77.21 -26.01 52.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.549 0.34 . . . . 0.0 110.937 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.551 HD22 HG13 ' A' ' 243' ' ' ILE . 50.4 mt -73.43 144.01 46.5 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.614 0.721 . . . . 0.0 112.848 -165.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.27 169.94 20.16 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.033 -1.439 . . . . 0.0 107.987 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.9 117.87 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.91 -6.76 57.01 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 116.024 -0.534 . . . . 0.0 113.171 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.474 ' HG2' ' HA ' ' A' ' 217' ' ' LEU . 4.0 tp-100 -64.49 120.64 12.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.547 0.739 . . . . 0.0 109.644 174.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.7 p -102.88 130.08 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 109.9 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.506 HG11 HG21 ' A' ' 212' ' ' ILE . 15.0 m -141.34 179.8 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 124.532 1.133 . . . . 0.0 110.232 -171.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.412 ' HB2' HD11 ' A' ' 280' ' ' ILE . 21.0 ttp -141.72 124.33 15.9 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 118.033 0.378 . . . . 0.0 111.877 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.566 HD12 ' HB2' ' A' ' 273' ' ' PHE . 2.2 pt? -138.69 167.13 22.64 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.143 0.977 . . . . 0.0 110.404 -174.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.81 121.15 26.07 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 170.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -142.98 146.9 34.33 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -122.95 116.06 29.0 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.12 -24.13 66.42 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.229 1.953 . . . . 0.0 112.395 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.57 -44.11 21.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.265 0.626 . . . . 0.0 110.549 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -122.24 80.45 44.62 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.761 0.825 . . . . 0.0 109.798 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.89 -19.92 64.48 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.137 2.558 . . . . 0.0 114.408 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.48 ' HD3' HD13 ' A' ' 272' ' ' ILE . 5.0 tppp? -82.72 -27.14 31.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.943 0.497 . . . . 0.0 111.424 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.526 ' HG2' ' HG2' ' A' ' 235' ' ' ARG . 34.6 tt0 -118.38 160.46 21.63 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 120.913 0.387 . . . . 0.0 110.849 -173.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.526 ' HG2' ' HG2' ' A' ' 234' ' ' GLU . 24.4 ptt-85 -49.09 149.5 1.94 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.442 1.497 . . . . 0.0 113.587 175.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -141.49 -110.53 0.82 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 171.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -117.23 165.17 13.75 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.857 0.863 . . . . 0.0 109.161 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' TRP . . . . . 0.474 ' CZ2' ' HB3' ' A' ' 296' ' ' ARG . 54.0 m95 -80.32 115.01 19.63 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -127.1 166.6 17.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ASP . . . . . 0.447 ' HB2' HG23 ' A' ' 260' ' ' VAL . 5.2 m-20 -82.8 156.62 23.58 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -143.49 138.45 29.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 167.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -111.17 118.54 36.25 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.635 HD12 HD21 ' A' ' 255' ' ' LEU . 29.1 mm -63.9 104.56 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 124.459 1.099 . . . . 0.0 110.364 -169.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.481 ' H ' ' HA ' ' A' ' 257' ' ' ALA . 18.8 m -79.82 -32.36 40.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.8 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.591 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 36.5 ttm180 -164.01 156.19 17.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.05 0.94 . . . . 0.0 109.559 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -155.81 148.78 24.34 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -150.5 135.18 17.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.872 0.469 . . . . 0.0 109.904 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -91.93 122.72 34.72 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 58.4 p -122.64 154.44 38.02 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -62.01 -20.59 64.07 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.6 p -97.94 -29.75 13.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.992 0.517 . . . . 0.0 112.164 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.45 165.09 31.64 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.24 0.543 . . . . 0.0 112.384 -169.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -97.79 103.41 15.35 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -92.23 141.32 28.7 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.962 0.905 . . . . 0.0 110.601 -171.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.635 HD21 HD12 ' A' ' 243' ' ' ILE . 1.2 tt -149.66 138.93 21.35 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.668 0.787 . . . . 0.0 108.985 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' TYR . . . . . 0.591 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 95.5 m-85 -132.09 131.86 42.77 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.921 0.889 . . . . 0.0 108.602 169.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.481 ' HA ' ' H ' ' A' ' 244' ' ' SER . . . -145.97 148.98 33.33 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.001 0.429 . . . . 0.0 111.223 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 43.9 t30 -79.61 97.02 6.34 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.406 171.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.57 103.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 240' ' ' ASP . 30.9 m -96.44 120.24 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.744 0.783 . . . . 0.0 110.56 -171.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.5 HD12 ' HB2' ' A' ' 264' ' ' ASP . 19.6 mt -92.26 -159.64 0.68 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.816 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.89 -40.62 89.22 Favored Glycine 0 C--N 1.352 1.423 0 N-CA-C 113.524 0.169 . . . . 0.0 113.524 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -123.5 -49.55 1.9 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.82 0.848 . . . . 0.0 109.675 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.5 ' HB2' HD12 ' A' ' 261' ' ' LEU . 3.3 m-20 -75.16 172.39 12.47 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.481 1.112 . . . . 0.0 111.932 -176.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 15.3 p -159.28 114.47 2.47 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.952 0.901 . . . . 0.0 109.37 175.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -82.06 88.93 6.41 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 25.8 t-20 -76.98 139.47 40.12 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.017 -175.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 38.5 t70 68.07 20.0 9.13 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.696 1.198 . . . . 0.0 111.276 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 48.9 t -71.71 122.84 21.33 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 255' ' ' LEU . 41.7 ttp180 -71.04 119.67 15.5 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.484 ' HB ' HD13 ' A' ' 255' ' ' LEU . 51.0 mm -78.71 95.98 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.615 0 CA-C-O 122.018 0.913 . . . . 0.0 110.163 -173.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.48 HD13 ' HD3' ' A' ' 233' ' ' LYS . 73.4 mt -67.5 -29.74 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 113.263 -1.79 . . . . 0.0 110.337 173.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.599 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 15.0 m-85 -95.65 45.47 1.09 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.678 1.191 . . . . 0.0 109.585 -173.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' VAL . . . . . 0.545 HG23 HD12 ' A' ' 255' ' ' LEU . 7.3 p -67.01 -20.52 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 124.576 1.15 . . . . 0.0 112.45 -175.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.38 -17.86 19.46 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.4 0.68 . . . . 0.0 111.135 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 65.2 mm-40 -93.59 16.63 13.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.408 1.083 . . . . 0.0 112.045 -174.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.81 138.01 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.303 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -125.78 163.89 21.89 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.493 1.517 . . . . 0.0 110.049 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 279' ' ' LYS . 0.6 OUTLIER -63.35 136.39 57.62 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.353 178.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 224' ' ' MET . 18.3 mm -98.8 116.77 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 162.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.18 134.77 40.48 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.473 1.109 . . . . 0.0 108.948 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -82.19 134.99 48.07 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.179 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.12 124.28 15.58 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.852 2.368 . . . . 0.0 111.794 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.98 -46.87 1.21 Allowed Glycine 0 C--N 1.344 0.98 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -75.87 -23.55 55.63 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.616 0.767 . . . . 0.0 110.925 175.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -130.84 159.13 22.88 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 53.5 p -97.32 150.12 36.45 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.217 0.607 . . . . 0.0 110.712 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.66 ' HA ' ' H ' ' A' ' 207' ' ' ARG . 86.3 Cg_endo -74.14 -171.76 0.98 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.856 2.371 . . . . 0.0 111.897 175.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 16.1 mmt -75.21 79.65 2.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.667 0.746 . . . . 0.0 110.285 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 6.8 p -92.7 -29.94 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.869 1.268 . . . . 0.0 108.619 173.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -81.34 161.29 23.88 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.945 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -46.58 99.41 0.21 Allowed Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 124.987 1.315 . . . . 0.0 111.995 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.31 99.85 0.17 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.608 2.872 . . . . 0.0 114.236 -164.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 55.7 mtm -78.21 92.09 4.43 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -83.28 170.14 14.95 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.072 0.463 . . . . 0.0 110.594 -178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.474 ' HB3' ' CZ2' ' A' ' 238' ' ' TRP . 20.9 mtm180 -89.08 91.05 8.66 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.57 0.748 . . . . 0.0 109.21 -169.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 70.17 -107.58 0.06 Allowed 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.27 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--O 1.24 0.561 0 C-N-CA 122.691 0.396 . . . . 0.0 110.13 -169.11 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.85 11.15 9.63 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.528 0.731 . . . . 0.0 111.202 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.464 ' O ' HG11 ' A' ' 159' ' ' VAL . 30.5 m-85 -124.4 163.4 21.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.235 1.014 . . . . 0.0 109.315 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.704 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 10.1 ptpp? -123.62 -179.57 4.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.275 1.03 . . . . 0.0 109.358 176.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.33 11.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.566 ' H ' ' HG3' ' A' ' 136' ' ' LYS . 6.9 t-20 -131.32 -6.64 3.79 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.247 0.619 . . . . 0.0 111.105 -174.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.704 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 29.8 mm-40 -78.22 87.15 4.31 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.59 0.71 . . . . 0.0 110.879 -177.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 11.4 p90 -68.91 100.49 1.2 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.289 169.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.38 177.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.456 0.702 . . . . 0.0 109.814 -177.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.635 ' HB2' ' HB3' ' A' ' 207' ' ' ARG . 16.9 t0 -94.25 152.06 18.97 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -146.89 115.65 6.81 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.401 0.68 . . . . 0.0 110.412 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -72.42 115.02 11.18 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.51 ' HB3' ' SD ' ' A' ' 148' ' ' MET . 9.8 t70 -66.68 110.41 3.21 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.4 p -64.74 -7.68 11.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.415 1.086 . . . . 0.0 113.775 -167.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -75.58 -57.14 4.06 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 117.898 0.317 . . . . 0.0 111.113 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.51 ' SD ' ' HB3' ' A' ' 145' ' ' ASP . 1.8 pmm? -104.5 -19.85 13.89 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.131 0.572 . . . . 0.0 111.38 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.44 9.57 61.51 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.911 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.01 128.62 34.16 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.591 0.357 . . . . 0.0 110.856 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.43 ' O ' ' HB2' ' A' ' 238' ' ' TRP . 97.1 m95 -73.09 133.19 44.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.578 0.751 . . . . 0.0 109.283 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -139.59 133.19 30.39 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.483 ' HG3' ' HG2' ' A' ' 207' ' ' ARG . 33.2 tt0 -70.26 90.12 0.68 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.272 0.558 . . . . 0.0 110.427 -175.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.588 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -96.87 118.69 33.86 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.363 0.665 . . . . 0.0 110.007 -172.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.635 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 65.0 tt0 -86.38 116.09 24.32 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.495 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.422 ' HA ' HG12 ' A' ' 186' ' ' VAL . 61.8 t -61.56 109.04 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 124.359 1.037 . . . . 0.0 108.807 172.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.532 HG11 ' HE2' ' A' ' 187' ' ' LYS . 16.1 m -114.58 -0.98 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.993 0.917 . . . . 0.0 112.012 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.618 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 51.1 ttt85 -167.1 138.04 3.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.271 1.028 . . . . 0.0 108.549 173.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 135' ' ' TYR . 26.0 m -116.19 134.19 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.9 p -142.5 150.82 41.0 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.454 0.702 . . . . 0.0 109.738 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -76.91 164.03 26.18 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.699 0.8 . . . . 0.0 110.424 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.872 0.367 . . . . 0.0 110.39 172.569 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 74.6 -6.48 1.9 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.201 1.401 . . . . 0.0 112.824 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -108.38 23.03 15.11 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 m -81.74 175.71 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 123.657 0.783 . . . . 0.0 109.417 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.526 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.4 mp -97.5 109.39 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.75 0.786 . . . . 0.0 109.964 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 201' ' ' SER . 93.2 m-85 -96.77 113.35 24.9 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.757 1.223 . . . . 0.0 108.211 168.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' HIS . . . . . 0.618 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 12.7 m-70 -78.67 103.87 8.91 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.588 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 35.5 m -117.36 157.31 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.468 1.107 . . . . 0.0 110.776 -172.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.532 ' HE2' HG11 ' A' ' 157' ' ' VAL . 50.6 mtmt -129.15 123.83 33.12 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -64.48 133.56 52.7 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.386 0.674 . . . . 0.0 110.339 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.37 -31.52 62.41 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -66.11 -30.75 71.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.089 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -145.69 71.74 13.93 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.046 0.538 . . . . 0.0 110.465 -174.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.87 -26.73 15.3 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.658 2.239 . . . . 0.0 112.047 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -76.42 -10.9 59.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.089 0.956 . . . . 0.0 110.885 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.73 6.09 19.2 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.259 0.624 . . . . 0.0 110.89 170.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.0 -154.14 49.35 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.393 0.433 . . . . 0.0 113.796 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.24 119.18 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.614 0.766 . . . . 0.0 109.57 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.7 m -109.13 153.55 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.992 0.917 . . . . 0.0 109.098 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.526 ' HB2' HG23 ' A' ' 183' ' ' ILE . 5.1 pm0 -91.1 137.3 32.47 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 80.4 mmm -148.51 158.52 44.17 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.049 0.94 . . . . 0.0 110.706 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -112.36 149.85 31.89 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.274 1.43 . . . . 0.0 110.477 -178.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.72 ' HA ' HG22 ' A' ' 204' ' ' VAL . 33.0 t -64.14 -30.32 71.39 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.071 0.949 . . . . 0.0 112.611 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -67.68 -20.63 65.32 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 122.519 -0.113 . . . . 0.0 111.131 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -115.15 -1.8 12.9 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.652 0.781 . . . . 0.0 111.838 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 201' ' ' SER . 6.0 m -115.71 118.94 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.962 0.887 . . . . 0.0 109.37 169.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -106.07 158.7 16.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -175.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.25 128.12 34.39 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 169.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.635 ' HB3' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -76.28 138.26 40.43 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.127 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -88.57 139.79 30.12 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -90.7 -0.36 57.67 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.479 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 28.0 m -84.29 112.93 20.75 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.51 121.91 37.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.092 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.1 mm -93.41 148.66 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.141 0.977 . . . . 0.0 109.95 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.669 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 16.2 ptpt -123.9 169.02 12.01 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.541 0.736 . . . . 0.0 110.226 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -51.37 -44.12 62.02 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.112 0.965 . . . . 0.0 111.562 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -60.78 -35.21 75.87 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.171 -177.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.11 -7.87 57.6 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.944 0.897 . . . . 0.0 111.372 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.509 ' O ' ' HD3' ' A' ' 246' ' ' LYS . 97.4 mt -84.67 137.55 33.19 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.736 0.814 . . . . 0.0 110.077 175.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' GLU . . . . . 0.478 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 9.6 pt-20 -151.78 171.64 17.4 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.773 0.829 . . . . 0.0 110.578 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 29.2 m -67.56 116.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 122.834 0.454 . . . . 0.0 111.745 -175.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.07 -15.12 33.64 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.345 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -71.92 122.42 20.77 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.57 1.148 . . . . 0.0 110.981 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.431 ' HB ' ' NH2' ' A' ' 282' ' ' ARG . 60.7 t -103.73 123.69 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 174.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.88 148.95 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 125.105 1.362 . . . . 0.0 109.927 -176.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 15.7 ptm -98.03 122.7 41.49 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.351 0.596 . . . . 0.0 111.22 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.89 141.85 40.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.742 1.217 . . . . 0.0 109.595 -171.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -96.34 107.35 19.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.017 0.913 . . . . 0.0 111.869 -173.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.559 ' HE2' ' HB2' ' A' ' 239' ' ' TYR . 20.4 p90 -136.33 156.83 48.08 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -87.62 125.07 66.38 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.56 -31.75 95.0 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.366 2.044 . . . . 0.0 112.707 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -81.47 -24.63 36.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.538 0.735 . . . . 0.0 110.982 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -134.62 81.81 46.79 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 123.716 0.807 . . . . 0.0 109.636 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.1 -27.14 73.3 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.602 2.201 . . . . 0.0 112.3 -175.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -85.42 15.07 4.71 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.357 1.063 . . . . 0.0 110.649 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -140.4 146.33 38.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.835 0.854 . . . . 0.0 110.061 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -71.37 138.45 49.2 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.437 0.695 . . . . 0.0 109.42 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.27 -114.36 0.52 Allowed Glycine 0 C--N 1.339 0.738 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -100.17 143.4 30.41 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.476 1.111 . . . . 0.0 109.694 -170.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' TRP . . . . . 0.43 ' HB2' ' O ' ' A' ' 151' ' ' TRP . 60.7 m95 -74.34 124.01 25.67 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.77 0.428 . . . . 0.0 110.049 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.559 ' HB2' ' HE2' ' A' ' 227' ' ' TYR . 96.3 m-85 -131.59 147.29 52.51 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -81.67 142.75 32.44 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.495 ' HB2' HG12 ' A' ' 259' ' ' VAL . . . -142.83 135.95 28.27 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 123.461 0.705 . . . . 0.0 110.029 -170.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -95.98 115.72 27.86 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.6 HD12 HD11 ' A' ' 255' ' ' LEU . 20.0 mm -65.1 113.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 123.803 0.841 . . . . 0.0 108.911 -175.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.4 p -90.97 -20.43 22.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.806 0.842 . . . . 0.0 110.954 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -161.81 142.15 10.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.1 0.56 . . . . 0.0 110.859 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 217' ' ' LEU . 23.5 pttm -122.55 129.5 52.01 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 167.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -155.27 150.54 27.02 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.923 0.889 . . . . 0.0 108.772 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -142.79 137.69 29.89 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.279 0.632 . . . . 0.0 109.761 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 32.7 p -99.04 178.04 5.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 161.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -68.14 -26.7 65.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.203 0.601 . . . . 0.0 110.929 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.7 p -86.5 -30.3 22.07 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.096 0.558 . . . . 0.0 112.132 -174.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -167.21 173.29 9.14 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.983 0.513 . . . . 0.0 110.941 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -109.73 113.53 26.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.105 0.962 . . . . 0.0 109.887 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -91.34 92.45 8.6 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.6 HD11 HD12 ' A' ' 243' ' ' ILE . 1.8 tm? -109.51 129.46 55.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.0 130.79 53.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.52 135.34 22.33 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.069 0.948 . . . . 0.0 109.736 -175.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -76.42 97.96 4.43 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 176.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 266' ' ' LEU . 18.8 m -81.86 107.3 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.488 -175.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.0 p -93.33 131.65 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.377 -175.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.37 -171.6 2.56 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.841 1.256 . . . . 0.0 109.491 174.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -85.9 -17.46 61.42 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-N 116.88 -0.146 . . . . 0.0 113.397 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -122.56 -34.18 3.29 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.368 1.067 . . . . 0.0 110.083 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.46 177.69 5.11 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.758 0.823 . . . . 0.0 109.77 -173.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 33.3 t -150.52 112.96 4.67 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.496 ' HB2' HG23 ' A' ' 259' ' ' VAL . 66.3 mt -80.49 105.83 12.04 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -64.5 122.61 17.19 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.455 0.702 . . . . 0.0 110.952 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 15.1 t70 54.63 74.37 0.35 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.724 1.209 . . . . 0.0 112.325 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 43.6 t -102.2 139.78 37.36 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.495 0.718 . . . . 0.0 109.651 173.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -69.51 134.8 49.31 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.096 0.558 . . . . 0.0 109.639 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 33.1 mm -107.55 130.74 59.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 48.7 mt -98.07 -29.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.39 1.076 . . . . 0.0 110.365 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -95.03 38.03 1.14 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.235 1.014 . . . . 0.0 110.242 -167.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.9 -29.77 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.131 1.372 . . . . 0.0 113.534 -166.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ASP . . . . . 0.669 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 45.6 m-20 -100.05 -0.37 39.27 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.392 0.677 . . . . 0.0 111.674 -175.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.541 ' HB2' ' HE3' ' A' ' 297' ' ' LYS . 11.8 pt-20 -125.07 22.59 7.91 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.567 0.698 . . . . 0.0 110.845 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.76 154.24 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.5 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -108.84 160.36 16.05 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.508 0.671 . . . . 0.0 110.336 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -79.11 145.48 33.73 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.508 1.123 . . . . 0.0 111.239 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.429 HG22 ' HG3' ' A' ' 282' ' ' ARG . 40.2 mm -79.67 114.18 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -76.45 115.51 16.26 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.431 ' NH2' ' HB ' ' A' ' 222' ' ' VAL . 95.2 mtt180 -118.8 148.95 45.56 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.008 0.923 . . . . 0.0 109.836 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -55.66 122.22 11.34 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.12 2.546 . . . . 0.0 112.884 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 98.87 -52.03 1.14 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.368 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.35 -22.47 18.31 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.081 0.552 . . . . 0.0 112.139 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -90.29 98.69 2.48 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 8.4 m -64.52 144.56 98.65 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 122.821 0.448 . . . . 0.0 110.613 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.44 140.43 43.86 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.629 2.22 . . . . 0.0 111.447 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 27.6 ttt -76.39 84.36 3.13 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.819 0.819 . . . . 0.0 110.232 -177.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.65 -27.38 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.321 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.28 178.29 8.38 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.253 1.021 . . . . 0.0 109.935 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -42.92 129.02 3.19 Favored Pre-proline 0 N--CA 1.489 1.481 0 C-N-CA 125.4 1.48 . . . . 0.0 113.304 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -58.73 84.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 123.337 2.691 . . . . 0.0 113.702 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.5 mmm -74.56 78.02 1.97 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.799 1.24 . . . . 0.0 108.292 168.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -56.9 170.65 0.41 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.013 0.925 . . . . 0.0 113.313 -175.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.414 ' HD3' ' HB2' ' A' ' 153' ' ' GLU . 3.4 tpt180 -57.35 155.94 8.41 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.08 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.541 ' HE3' ' HB2' ' A' ' 276' ' ' GLU . 65.3 mttm -82.99 64.71 7.75 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 165.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.5 p . . . . . 0 C--O 1.241 0.655 0 CA-C-N 112.912 -1.949 . . . . 0.0 110.384 -171.702 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 176' ' ' PRO . 1.4 mm? -100.37 -12.25 19.58 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.397 0.679 . . . . 0.0 111.419 -171.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.87 138.78 33.02 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.401 ' H ' ' HB2' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -93.45 176.24 6.45 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 118.532 0.605 . . . . 0.0 112.226 -174.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.68 -14.96 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 124.578 1.151 . . . . 0.0 111.694 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.448 ' HA ' ' NE2' ' A' ' 155' ' ' GLN . 35.2 m-80 -113.01 24.96 11.83 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.34 0.656 . . . . 0.0 111.636 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.503 ' HG3' HG13 ' A' ' 141' ' ' VAL . 8.9 tp10 -98.98 79.77 2.4 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.632 0.73 . . . . 0.0 111.496 -173.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 9.5 p90 -73.55 98.37 2.8 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.172 173.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.503 HG13 ' HG3' ' A' ' 139' ' ' GLU . 15.7 m -114.87 171.56 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.771 0.828 . . . . 0.0 109.196 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 7.1 t0 -90.91 107.74 19.39 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -172.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.74 99.74 12.57 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.956 0.902 . . . . 0.0 109.756 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -76.06 98.91 4.45 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.9 123.68 20.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 170.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.1 t -79.9 -28.15 39.87 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.741 0.816 . . . . 0.0 110.837 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -68.85 -51.49 39.91 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.065 0.946 . . . . 0.0 111.124 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 43.8 ttp -94.72 -14.1 25.1 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.343 0.657 . . . . 0.0 109.883 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.88 7.08 86.17 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 113.668 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.52 134.52 43.36 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.733 0.413 . . . . 0.0 111.871 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -75.31 135.85 40.89 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.386 1.074 . . . . 0.0 109.34 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -143.14 118.4 10.19 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.491 ' HG3' ' NH1' ' A' ' 296' ' ' ARG . 41.5 mt-10 -59.21 98.58 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.996 0.518 . . . . 0.0 109.889 176.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -103.04 138.82 39.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.432 1.093 . . . . 0.0 112.374 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.4 tp60 -87.2 104.47 16.41 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.921 1.688 . . . . 0.0 110.546 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.651 HG22 HG12 ' A' ' 186' ' ' VAL . 59.2 t -61.99 115.43 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.64 -12.77 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.89 0.876 . . . . 0.0 111.265 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -161.17 144.98 13.16 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.539 0.736 . . . . 0.0 109.549 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.22 137.33 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 166.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.6 p -132.65 150.62 52.13 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.632 HH21 ' HB3' ' A' ' 165' ' ' SER . 77.0 mtm180 -87.37 161.09 18.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.998 176.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -76.12 -16.5 59.88 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.87 159.63 81.61 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 124.521 1.128 . . . . 0.0 110.296 164.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.63 91.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.446 2.764 . . . . 0.0 113.631 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.632 ' HB3' HH21 ' A' ' 161' ' ' ARG . 19.9 p -157.46 98.9 1.72 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.07 1.348 . . . . 0.0 108.348 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -103.9 -21.18 13.68 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.837 0.855 . . . . 0.0 110.781 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -103.74 -165.94 1.21 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.959 0.904 . . . . 0.0 110.371 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -52.99 127.6 45.74 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 123.558 0.743 . . . . 0.0 110.907 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.85 134.86 45.43 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.746 2.297 . . . . 0.0 113.042 -169.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 28.4 p -158.14 -177.06 6.28 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.889 0.876 . . . . 0.0 109.761 -173.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 30.9 m 58.72 58.03 3.45 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.163 0.985 . . . . 0.0 110.938 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.3 m 55.4 77.02 0.24 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.499 1.119 . . . . 0.0 110.787 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 14.4 t -90.24 7.94 35.67 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.938 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 70.1 m -62.29 97.13 0.08 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 123.342 0.657 . . . . 0.0 110.446 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.407 ' HA ' ' HE ' ' A' ' 175' ' ' ARG . 2.3 tpm_? -140.1 78.26 24.16 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.886 0.874 . . . . 0.0 110.269 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.576 ' HB3' HD11 ' A' ' 134' ' ' LEU . 68.2 Cg_endo -89.52 174.26 3.54 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.419 2.746 . . . . 0.0 112.336 169.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -169.12 -171.33 1.28 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.717 0.807 . . . . 0.0 110.954 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.12 -58.75 2.93 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -120.96 105.51 10.73 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 163.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.462 ' HB3' HG22 ' A' ' 182' ' ' VAL . 2.3 mp0 -68.61 105.31 2.21 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.484 -172.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.31 50.23 0.5 Allowed 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 122.234 1.016 . . . . 0.0 110.283 166.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 180' ' ' GLU . 13.2 m -122.64 160.85 24.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 174.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.519 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.3 mp -95.56 110.83 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -166.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -92.59 109.2 20.61 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -78.56 98.68 6.21 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 156' ' ' VAL . 14.7 m -107.98 165.43 4.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.358 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -130.43 116.49 18.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -54.21 110.26 0.59 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.635 0.652 . . . . 0.0 109.26 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.03 -22.42 62.14 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.738 0.78 . . . . 0.0 109.217 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.622 ' HA ' ' HA ' ' A' ' 297' ' ' LYS . 0.9 OUTLIER -69.3 -28.37 66.21 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.837 1.255 . . . . 0.0 111.899 171.278 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -142.2 78.82 16.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 123.75 0.82 . . . . 0.0 109.862 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.09 -22.33 55.41 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.322 2.682 . . . . 0.0 113.814 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -66.27 -18.85 65.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.178 0.991 . . . . 0.0 112.074 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.11 -21.65 58.76 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.987 0.515 . . . . 0.0 111.241 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 67.24 -148.0 49.63 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.67 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 18.8 t -84.56 114.7 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.3 m -112.2 151.01 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.657 1.183 . . . . 0.0 109.39 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.519 ' HB2' HG23 ' A' ' 183' ' ' ILE . 16.6 pt20 -94.66 123.45 38.1 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.061 0.544 . . . . 0.0 110.568 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 87.8 mmm -139.17 135.6 34.19 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -88.11 176.46 7.27 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 14.0 t -64.96 -39.81 94.05 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.074 0.397 . . . . 0.0 111.188 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -50.97 -29.12 11.41 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.68 0.792 . . . . 0.0 112.388 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -92.92 -39.17 11.3 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.738 0.815 . . . . 0.0 111.34 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.429 HG11 HG11 ' A' ' 186' ' ' VAL . 27.8 m -98.77 114.84 37.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 CA-C-O 121.991 0.9 . . . . 0.0 110.132 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -110.81 165.91 11.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.673 1.189 . . . . 0.0 108.704 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -78.88 124.82 28.61 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 102.41 0.22 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.548 0.739 . . . . 0.0 110.33 172.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 281' ' ' GLU . . . -68.6 99.36 0.98 Allowed 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.704 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -77.06 75.02 3.63 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.752 0.657 . . . . 0.0 110.223 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 92.5 m -147.34 108.54 4.26 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 28.8 mt -82.86 116.5 27.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.611 HD11 ' HB3' ' A' ' 279' ' ' LYS . 41.5 mm -79.25 120.41 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.516 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -76.96 164.99 25.26 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.519 ' HA ' HD12 ' A' ' 217' ' ' LEU . 90.3 t90 -56.04 -43.65 78.06 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.686 0.794 . . . . 0.0 111.029 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -69.48 -18.61 63.72 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.846 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.63 -19.12 22.21 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.769 0.427 . . . . 0.0 110.086 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 214' ' ' TRP . 88.2 mt -69.05 129.22 39.28 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.456 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 7.9 pt-20 -147.89 160.59 42.62 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.215 1.006 . . . . 0.0 109.573 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 35.0 m -59.4 134.66 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 123.631 0.582 . . . . 0.0 111.958 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.13 -22.26 30.22 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.835 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -74.62 121.47 21.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.201 0.6 . . . . 0.0 110.912 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.63 130.0 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.414 0.686 . . . . 0.0 109.275 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.1 m -140.87 147.21 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.674 1.19 . . . . 0.0 109.584 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 20.8 ptm -98.64 127.93 44.75 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.343 0.657 . . . . 0.0 111.257 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.577 HD13 HG23 ' A' ' 271' ' ' ILE . 2.2 pt? -134.58 155.58 50.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.267 1.027 . . . . 0.0 110.602 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -71.7 106.78 4.23 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -132.68 128.11 36.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.505 0.722 . . . . 0.0 109.964 -169.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.452 HD22 ' HB3' ' A' ' 231' ' ' ASN . 49.3 t30 -89.44 113.07 55.11 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.95 -5.26 16.73 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.645 2.23 . . . . 0.0 112.582 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.86 -32.34 23.28 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.22 0.608 . . . . 0.0 110.176 171.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.452 ' HB3' HD22 ' A' ' 228' ' ' ASN . 33.8 t30 -151.52 105.16 2.91 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 123.923 0.889 . . . . 0.0 109.576 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.55 -18.39 63.27 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.27 2.647 . . . . 0.0 113.322 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -84.88 -5.96 59.34 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.049 0.94 . . . . 0.0 110.952 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -126.88 153.35 45.84 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.583 0.753 . . . . 0.0 110.054 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -75.27 162.59 28.3 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.537 0.735 . . . . 0.0 112.002 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -169.47 -124.21 0.72 Allowed Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.11 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -82.84 146.75 28.74 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.89 0.876 . . . . 0.0 109.559 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' TRP . . . . . 0.44 ' CE2' ' HD2' ' A' ' 296' ' ' ARG . 43.5 m95 -74.92 111.76 10.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.869 0.366 . . . . 0.0 111.673 -175.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -119.12 166.24 13.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.377 1.071 . . . . 0.0 110.193 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASP . . . . . 0.525 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 3.8 m-20 -82.45 158.62 23.17 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.931 0.892 . . . . 0.0 109.512 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -151.51 132.26 14.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.904 0.482 . . . . 0.0 109.774 169.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -95.95 117.28 30.32 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 174.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.616 HD12 HD11 ' A' ' 255' ' ' LEU . 25.3 mm -65.4 124.23 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.649 0.593 . . . . 0.0 109.424 -175.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.0 t -108.29 -43.51 4.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.575 0.75 . . . . 0.0 109.58 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.505 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 63.0 mtt180 -139.34 157.48 45.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.457 1.103 . . . . 0.0 110.0 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -154.37 120.22 5.24 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.06 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 45.7 ttt-85 -144.1 115.68 8.14 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -93.65 133.61 36.81 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.366 0.603 . . . . 0.0 110.0 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 39.2 p -107.97 166.71 10.51 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 167.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -71.33 -10.4 59.69 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.5 p -94.04 -28.71 15.59 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.192 0.597 . . . . 0.0 111.515 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -171.27 145.97 2.26 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -80.46 102.68 9.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.168 0.987 . . . . 0.0 109.482 172.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -95.47 140.16 30.71 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.35 0.66 . . . . 0.0 111.674 -173.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.616 HD11 HD12 ' A' ' 243' ' ' ILE . 0.6 OUTLIER -132.57 142.4 49.14 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -176.229 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 256' ' ' TYR . . . . . 0.505 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 92.1 m-85 -132.11 122.55 25.56 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.95 46.23 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.176 0.512 . . . . 0.0 111.778 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 39.9 t30 -78.64 95.58 5.29 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.73 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 59.9 t -76.19 107.17 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.26 0.553 . . . . 0.0 110.313 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 39.4 t -86.12 115.17 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.081 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.23 -152.56 0.12 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.013 1.325 . . . . 0.0 110.208 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -48.25 -65.23 2.63 Favored Glycine 0 C--N 1.363 2.056 0 C-N-CA 124.092 0.853 . . . . 0.0 114.266 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -123.09 -22.41 5.19 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.546 0.738 . . . . 0.0 109.575 165.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -76.17 177.35 7.24 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.166 0.987 . . . . 0.0 112.077 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 35.6 p -153.17 154.41 34.69 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.679 0.792 . . . . 0.0 110.44 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 69.8 mt -128.77 89.71 2.93 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.441 1.096 . . . . 0.0 108.783 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 61.6 t30 -71.87 136.55 46.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.759 0.424 . . . . 0.0 111.431 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 14.6 t70 60.35 68.58 0.75 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.24 1.416 . . . . 0.0 111.078 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 79.9 m -113.72 135.39 53.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.919 0.888 . . . . 0.0 109.553 169.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -66.51 116.7 7.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.926 0.49 . . . . 0.0 110.714 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.613 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 43.1 mm -92.49 96.28 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.981 0.912 . . . . 0.0 108.88 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 62.6 mt -76.23 -23.48 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.217 1.007 . . . . 0.0 110.713 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.446 ' HD2' HD12 ' A' ' 225' ' ' LEU . 24.5 m-85 -93.21 32.0 1.39 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.458 1.103 . . . . 0.0 111.214 -166.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.07 -21.45 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.273 1.029 . . . . 0.0 112.003 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.65 -21.72 44.46 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.914 0.886 . . . . 0.0 111.827 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.63 9.42 3.37 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.134 0.574 . . . . 0.0 112.278 -168.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.4 129.16 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 122.985 0.514 . . . . 0.0 110.263 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -92.52 161.33 14.65 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.749 0.82 . . . . 0.0 110.652 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.611 ' HB3' HD11 ' A' ' 212' ' ' ILE . 18.2 ptmt -82.32 158.12 23.54 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.446 0.698 . . . . 0.0 111.087 176.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 42.2 mm -87.65 131.39 35.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 166.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 208' ' ' ALA . 0.0 OUTLIER -72.44 104.79 3.9 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.427 -175.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.706 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 84.6 mtt180 -87.36 159.49 50.26 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 123.466 0.707 . . . . 0.0 111.125 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -55.25 94.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.426 2.751 . . . . 0.0 113.513 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.38 -46.44 1.24 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.294 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.706 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 21.6 tt0 -73.59 -17.88 61.12 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.3 0.64 . . . . 0.0 111.452 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -74.78 98.9 1.09 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.622 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.1 p -75.32 126.15 88.1 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.403 0.681 . . . . 0.0 111.124 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.24 167.1 26.5 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 123.193 2.595 . . . . 0.0 112.379 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' MET . . . . . 0.569 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 55.1 ttm -86.26 81.39 8.41 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.4 p -96.21 -28.55 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.35 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -81.88 -172.71 4.06 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.373 1.069 . . . . 0.0 109.143 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -45.14 117.42 3.31 Favored Pre-proline 0 N--CA 1.489 1.49 0 C-N-CA 124.912 1.285 . . . . 0.0 112.742 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.569 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 64.9 Cg_exo -55.96 141.75 85.76 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.656 2.238 . . . . 0.0 113.36 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 24.5 mmt -84.06 -69.57 0.63 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 49.47 62.32 2.69 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 122.006 0.908 . . . . 0.0 109.15 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.491 ' NH1' ' HG3' ' A' ' 153' ' ' GLU . 12.5 ptt180 -58.48 -29.16 66.02 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.092 -166.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.622 ' HA ' ' HA ' ' A' ' 190' ' ' ASP . 38.6 mtmm 54.1 58.04 5.38 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.952 0.901 . . . . 0.0 111.974 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 6.6 m -78.3 83.69 4.53 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.037 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -143.97 75.1 0.31 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 176.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--N 1.387 2.578 0 C-N-CA 123.904 3.069 . . . . 0.0 112.936 -176.595 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.599 ' N ' ' HG ' ' A' ' 174' ' ' SER . . . . . . . . 0 N--CA 1.477 1.379 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.19 2.72 8.56 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.674 0.79 . . . . 0.0 110.808 173.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -127.54 137.6 52.66 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.467 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 2.1 mptp? -89.65 175.25 7.34 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.535 1.134 . . . . 0.0 110.256 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.7 m -75.9 8.07 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.035 0.934 . . . . 0.0 112.811 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -124.96 -1.17 7.83 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.622 0.769 . . . . 0.0 110.236 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.467 ' HG2' ' HB2' ' A' ' 136' ' ' LYS . 22.3 mm-40 -91.21 89.98 7.57 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.677 0.751 . . . . 0.0 111.652 -170.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 6.8 p90 -63.48 111.5 2.36 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.346 164.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.2 m -120.89 166.69 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.189 0.995 . . . . 0.0 109.32 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -93.05 104.95 17.12 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.494 ' HB2' HG12 ' A' ' 204' ' ' VAL . . . -109.65 117.56 34.25 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.753 1.221 . . . . 0.0 109.93 -176.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -73.93 112.74 10.35 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.79 127.49 32.68 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.6 m -69.58 -27.8 65.43 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.845 0.858 . . . . 0.0 111.38 -173.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.47 -44.12 13.0 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.459 0.704 . . . . 0.0 110.968 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 51.0 tpp -75.71 -37.62 59.31 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.75 0.82 . . . . 0.0 110.611 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.3 7.79 88.2 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.133 -0.939 . . . . 0.0 113.215 -172.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 239' ' ' TYR . . . -107.03 152.54 23.85 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.607 0.763 . . . . 0.0 110.858 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 238' ' ' TRP . 67.2 m95 -77.65 132.29 38.15 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.496 1.118 . . . . 0.0 109.919 171.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -136.54 130.97 33.23 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.235 1.014 . . . . 0.0 108.702 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.35 96.78 0.51 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.598 0.713 . . . . 0.0 109.218 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.72 128.15 45.83 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.928 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.648 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 56.7 tt0 -84.91 105.69 15.87 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.743 0.817 . . . . 0.0 110.647 -173.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.71 107.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.6 m -107.64 -3.13 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.651 0.781 . . . . 0.0 111.234 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.518 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 79.2 ttt180 -171.28 146.44 2.33 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.157 0.911 . . . . 0.0 108.986 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.0 m -125.78 144.39 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.4 p -131.85 130.44 41.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -73.32 147.99 43.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.668 0.787 . . . . 0.0 109.407 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -52.63 -56.28 16.53 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.179 0.592 . . . . 0.0 111.402 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.69 146.26 93.34 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.419 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -54.54 144.98 60.63 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.312 2.675 . . . . 0.0 113.613 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.9 m -70.12 -67.36 0.5 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.416 0.686 . . . . 0.0 110.136 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -177.28 158.8 1.51 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.712 1.205 . . . . 0.0 108.481 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -50.51 -47.66 57.3 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.081 0.952 . . . . 0.0 111.638 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -91.96 146.65 33.27 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.02 164.01 15.23 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 122.979 2.452 . . . . 0.0 113.097 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 77.9 m 73.03 -171.48 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.032 1.333 . . . . 0.0 111.033 -168.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.0 m 74.37 16.84 3.28 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.849 1.659 . . . . 0.0 112.815 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 30.4 p -76.64 91.9 3.46 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 173.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 37.1 p -86.49 145.8 26.65 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.875 0.87 . . . . 0.0 110.792 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.599 ' HG ' ' N ' ' A' ' 133' ' ' GLY . 16.0 m -92.64 113.06 25.23 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.201 1.0 . . . . 0.0 110.244 -172.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -111.99 107.52 55.97 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 123.68 0.792 . . . . 0.0 109.72 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -70.33 83.98 0.77 Allowed 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.469 2.113 . . . . 0.0 110.945 169.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.82 -71.43 0.47 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.029 0.932 . . . . 0.0 111.199 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 43.3 mt -147.88 -74.83 0.19 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -119.18 102.41 8.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 201' ' ' SER . 1.0 OUTLIER -80.75 67.89 6.79 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.404 1.097 . . . . 0.0 110.67 -178.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.504 ' HA ' ' H ' ' A' ' 201' ' ' SER . 67.9 m-20 -82.89 44.74 0.94 Allowed 'General case' 0 C--O 1.243 0.727 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.537 174.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.1 m -69.58 176.49 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.881 0 C-N-CA 124.472 1.109 . . . . 0.0 108.507 174.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 183' ' ' ILE . 2.6 mp -92.35 106.37 17.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -172.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -89.01 104.03 16.6 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 7.0 m170 -79.7 92.84 5.44 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.31 158.17 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.609 0.764 . . . . 0.0 110.615 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -123.98 119.49 29.71 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -57.83 125.83 24.74 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.74 -31.37 72.52 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.271 0.558 . . . . 0.0 109.974 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.46 -28.94 62.22 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.247 175.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -139.32 71.89 38.84 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.14 0.576 . . . . 0.0 112.022 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.05 -15.86 28.99 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.527 2.151 . . . . 0.0 111.184 165.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.33 -22.89 66.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.315 1.046 . . . . 0.0 111.587 173.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -78.77 -5.37 53.14 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.791 0.836 . . . . 0.0 111.356 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.4 -161.95 53.13 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.555 0.534 . . . . 0.0 111.817 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 25.5 t -86.53 124.09 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 29.2 m -107.49 154.58 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.928 0.891 . . . . 0.0 110.09 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -92.93 131.16 38.18 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.542 0.737 . . . . 0.0 109.472 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 92.9 mmm -131.88 153.58 50.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.514 0.726 . . . . 0.0 109.299 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.551 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 36.9 m-80 -98.96 172.21 7.55 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.574 0.75 . . . . 0.0 109.163 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 10.9 t -67.64 -29.34 68.63 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.139 0.427 . . . . 0.0 110.84 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.551 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 17.2 ptp180 -62.19 -25.56 67.85 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.474 0.71 . . . . 0.0 111.638 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -92.23 -39.87 11.3 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.87 0.868 . . . . 0.0 111.0 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' A' ' 201' ' ' SER . 26.8 m -93.85 117.35 37.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 CA-C-O 122.462 1.125 . . . . 0.0 109.292 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 170.82 7.67 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.906 174.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.82 148.78 27.56 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 167.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.41 ' O ' ' HE3' ' A' ' 289' ' ' MET . 37.7 mtm105 -72.37 109.91 6.42 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.38 113.75 3.84 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.83 0.452 . . . . 0.0 110.638 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' A' ' 289' ' ' MET . 5.8 ptm180 -82.09 9.36 8.66 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.007 0.923 . . . . 0.0 112.23 -177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.9 m -100.91 112.32 24.73 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.028 0.931 . . . . 0.0 110.088 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 277' ' ' VAL . 38.1 mt -85.54 130.75 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 279' ' ' LYS . 30.1 mm -96.77 148.08 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.516 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 1.5 ptpp? -129.52 171.22 12.8 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.97 0.908 . . . . 0.0 109.96 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.43 ' HA ' HD12 ' A' ' 217' ' ' LEU . 72.1 t-105 -53.78 -44.83 70.4 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.535 1.134 . . . . 0.0 112.103 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -71.24 -11.28 60.84 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.668 0.787 . . . . 0.0 112.442 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -109.33 -7.96 15.15 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.221 1.008 . . . . 0.0 110.704 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 213' ' ' LYS . 92.2 mt -72.17 124.11 24.33 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -134.03 146.73 50.64 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 31.6 m -67.44 126.89 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 123.54 0.525 . . . . 0.0 111.322 -174.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 106.1 -16.86 41.99 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.681 -0.511 . . . . 0.0 113.011 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.425 ' HG2' HG13 ' A' ' 223' ' ' VAL . 8.6 tt0 -80.4 122.24 26.72 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.21 0.604 . . . . 0.0 110.472 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 50.8 t -91.39 129.78 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.962 0.905 . . . . 0.0 108.935 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.425 HG13 ' HG2' ' A' ' 221' ' ' GLN . 2.8 m -145.73 149.65 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.676 1.19 . . . . 0.0 110.586 -172.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.523 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 20.0 ptm -100.34 125.51 46.58 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.643 0.777 . . . . 0.0 111.357 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.431 ' HG ' HG13 ' A' ' 277' ' ' VAL . 1.4 mp -127.11 158.7 36.32 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.971 0.908 . . . . 0.0 108.798 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -89.66 106.12 18.25 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.363 0.601 . . . . 0.0 110.232 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -167.4 148.09 5.45 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.749 1.22 . . . . 0.0 108.602 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -90.76 144.82 30.91 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.434 ' HB3' HD21 ' A' ' 261' ' ' LEU . 33.9 Cg_endo -62.29 -37.17 63.4 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.137 2.558 . . . . 0.0 112.373 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -71.03 -19.41 62.51 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.012 0.925 . . . . 0.0 111.721 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -144.23 82.97 10.38 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 122.746 0.419 . . . . 0.0 110.104 174.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.06 -4.48 15.49 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.534 2.156 . . . . 0.0 112.833 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -72.73 -27.51 62.09 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.106 0.963 . . . . 0.0 110.958 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -138.38 161.6 36.55 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.46 0.704 . . . . 0.0 110.376 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -52.81 156.34 2.02 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.575 1.55 . . . . 0.0 112.711 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -161.98 -93.42 0.09 OUTLIER Glycine 0 C--N 1.335 0.515 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.644 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -129.08 167.78 17.03 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.596 0.758 . . . . 0.0 109.354 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' TRP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 89.9 m95 -79.4 105.75 10.94 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 150' ' ' ALA . 46.6 m-85 -121.65 154.74 36.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.092 0.957 . . . . 0.0 109.726 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ASP . . . . . 0.748 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 0.8 OUTLIER -82.07 154.12 25.76 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.555 -177.247 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -152.19 134.23 14.97 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -100.11 118.45 36.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.466 HD12 HD21 ' A' ' 255' ' ' LEU . 26.5 mm -59.09 110.01 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.9 m -100.25 -25.77 14.14 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.235 0.614 . . . . 0.0 110.352 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 59.8 ttt180 -172.02 149.95 2.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.174 0.99 . . . . 0.0 108.642 -174.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -154.85 147.95 24.77 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -148.49 119.06 7.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.709 0.804 . . . . 0.0 108.873 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -96.89 124.53 40.89 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 54.1 p -124.62 162.61 23.74 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 167.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -60.69 -18.58 54.9 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.693 0.797 . . . . 0.0 112.612 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 53.6 p -93.85 -32.92 13.74 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.45 0.7 . . . . 0.0 112.151 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -174.08 164.54 4.11 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.298 0.57 . . . . 0.0 111.225 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -107.47 114.91 29.22 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.388 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -94.78 97.44 10.05 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.526 ' O ' ' HA ' ' A' ' 270' ' ' ARG . 1.7 tt -102.83 125.58 49.63 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' TYR . . . . . 0.488 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 43.4 m-85 -118.46 116.98 27.8 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -136.92 143.56 42.98 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.237 0.615 . . . . 0.0 111.095 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -78.13 99.37 6.15 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 94.9 t -64.93 106.64 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.494 0.718 . . . . 0.0 109.37 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.748 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 58.6 t -87.52 98.89 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' A' ' 229' ' ' PRO . 31.9 mt -84.14 -177.94 6.8 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.416 176.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -76.65 -45.05 13.94 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.387 -0.37 . . . . 0.0 112.612 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -107.52 -5.47 17.57 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.959 0.904 . . . . 0.0 111.726 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -155.46 176.12 13.01 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.49 0.716 . . . . 0.0 110.25 -172.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 27.7 p -145.63 115.86 7.49 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.478 0.711 . . . . 0.0 110.404 171.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 66.1 mt -82.53 95.05 7.61 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.688 0.795 . . . . 0.0 109.911 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -70.93 136.28 48.44 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.346 0.258 . . . . 0.0 110.689 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 14.6 t70 60.08 75.7 0.39 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.957 1.303 . . . . 0.0 111.347 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 42.9 t -111.6 129.2 56.15 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.917 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 71.4 ttt-85 -74.73 107.88 7.12 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.435 ' HB ' HD13 ' A' ' 255' ' ' LEU . 43.2 mm -90.81 128.3 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.773 0.829 . . . . 0.0 109.572 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 67.2 mt -96.12 -21.33 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.194 0.998 . . . . 0.0 110.694 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -86.44 45.13 1.21 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.207 1.003 . . . . 0.0 111.471 -173.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.513 HG12 HD12 ' A' ' 255' ' ' LEU . 24.7 m -64.74 -21.84 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 125.11 1.364 . . . . 0.0 113.437 -169.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -110.87 -24.87 10.17 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.157 0.983 . . . . 0.0 110.115 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -89.0 44.26 1.2 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.879 0.872 . . . . 0.0 110.2 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.431 HG13 ' HG ' ' A' ' 225' ' ' LEU . 4.1 t -103.14 150.19 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.026 0.93 . . . . 0.0 109.279 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.523 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 72.9 m-85 -124.91 154.85 40.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 167.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.537 ' HB2' HD11 ' A' ' 212' ' ' ILE . 22.9 ttmm -77.42 144.85 37.54 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 45.9 mm -69.88 127.16 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.96 105.5 2.03 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 174.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 78.8 mtp180 -115.03 147.66 38.84 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 124.574 1.15 . . . . 0.0 109.888 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.79 102.03 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.588 2.192 . . . . 0.0 111.407 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.51 -4.58 54.31 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-O 119.109 -0.828 . . . . 0.0 114.364 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 33.3 tt0 -128.27 -25.14 3.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.157 0.979 . . . . 0.0 112.426 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -75.13 112.14 3.56 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.8 m -64.75 131.44 95.15 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 117.091 0.445 . . . . 0.0 111.186 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.68 135.41 19.69 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.306 2.67 . . . . 0.0 111.341 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' MET . . . . . 0.485 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 38.5 ttm -78.97 82.3 5.16 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.836 0.826 . . . . 0.0 109.767 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.2 p -108.68 -23.12 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.293 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -99.52 -153.84 0.45 Allowed 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 293' ' ' PRO . 27.3 t-20 -57.5 127.16 77.14 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-N 119.116 0.871 . . . . 0.0 111.87 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.485 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 12.0 Cg_exo -72.57 111.9 3.34 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.373 2.715 . . . . 0.0 113.673 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 91.7 mmm -77.14 115.96 17.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.143 0.577 . . . . 0.0 110.207 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -100.01 171.7 7.67 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.309 1.044 . . . . 0.0 109.158 171.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.65 -29.06 2.67 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.687 0.795 . . . . 0.0 108.936 164.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -169.64 121.61 0.71 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.777 1.231 . . . . 0.0 109.013 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 22.9 t -159.16 122.73 3.78 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.688 0.795 . . . . 0.0 109.255 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -151.3 -65.67 0.01 OUTLIER Glycine 0 CA--C 1.543 1.783 0 CA-C-O 118.633 -1.093 . . . . 0.0 113.482 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo . . . . . 0 C--N 1.385 2.466 0 C-N-CA 125.218 3.946 . . . . 0.0 115.038 174.705 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.226 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -91.81 -13.31 31.67 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.848 0.859 . . . . 0.0 111.207 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.434 ' O ' HG11 ' A' ' 159' ' ' VAL . 25.6 m-85 -94.91 162.64 13.66 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.548 0.739 . . . . 0.0 109.542 171.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.75 -177.41 3.82 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.04 0.936 . . . . 0.0 109.043 171.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.5 m -68.22 2.47 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -173.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -112.94 -9.97 13.57 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.637 0.775 . . . . 0.0 111.377 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.87 84.87 3.44 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.459 0.703 . . . . 0.0 111.562 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.671 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 3.9 p90 -71.93 99.61 2.27 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.079 168.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.98 -178.97 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.476 1.11 . . . . 0.0 109.13 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 5.3 t0 -94.75 163.21 13.45 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.651 0.78 . . . . 0.0 108.922 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.436 ' HB2' HG12 ' A' ' 204' ' ' VAL . . . -152.07 125.35 8.74 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 120.872 0.368 . . . . 0.0 111.833 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -74.83 109.73 8.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.786 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.479 ' HB3' ' SD ' ' A' ' 148' ' ' MET . 9.2 t70 -80.01 117.99 21.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.8 m -66.86 -28.49 68.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.839 0.856 . . . . 0.0 112.333 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -58.05 -54.74 43.49 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.6 0.76 . . . . 0.0 111.948 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.479 ' SD ' ' HB3' ' A' ' 145' ' ' ASP . 1.7 pmm? -103.35 -8.86 19.93 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.575 0.35 . . . . 0.0 111.006 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.12 18.27 80.14 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 123.215 0.322 . . . . 0.0 113.518 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.427 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . . . -93.29 150.14 20.7 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.45 0.643 . . . . 0.0 111.899 -175.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -76.11 139.0 41.14 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.468 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -145.52 124.35 12.67 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 45.4 mt-10 -65.78 93.94 0.19 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.444 0.698 . . . . 0.0 110.993 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -99.44 120.06 39.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.095 0.558 . . . . 0.0 110.894 -176.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 53.4 tt0 -87.39 114.56 24.12 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.833 0.853 . . . . 0.0 110.664 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.428 ' HA ' HG12 ' A' ' 186' ' ' VAL . 50.1 t -59.88 114.74 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.1 m -115.35 -4.41 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.372 0.669 . . . . 0.0 111.264 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.52 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 76.7 ttt180 -164.56 138.86 5.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.836 0.854 . . . . 0.0 109.564 173.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 135' ' ' TYR . 34.4 m -117.19 137.64 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.511 0.724 . . . . 0.0 109.554 173.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.4 m -145.69 137.86 25.49 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.907 0.883 . . . . 0.0 108.857 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.95 135.11 36.33 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.604 ' HB2' HG13 ' A' ' 183' ' ' ILE . 55.3 tttm -98.05 87.07 3.86 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.158 0.983 . . . . 0.0 111.132 -170.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -173.8 157.38 2.78 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.479 1.112 . . . . 0.0 109.919 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.21 105.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.002 2.468 . . . . 0.0 112.503 169.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 39.7 m -89.74 -28.68 19.23 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.296 1.038 . . . . 0.0 111.301 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? 63.48 43.81 5.72 Favored 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 124.344 1.058 . . . . 0.0 109.294 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 75.0 -48.99 0.65 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.202 1.801 . . . . 0.0 112.331 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 169' ' ' PRO . 27.7 mt-10 -61.46 139.57 94.93 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.506 1.122 . . . . 0.0 112.393 -175.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 168' ' ' GLU . 23.7 Cg_exo -67.2 -162.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 123.457 2.772 . . . . 0.0 112.549 173.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 61.4 m 71.93 136.38 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.943 1.297 . . . . 0.0 111.677 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 39.3 m -79.47 67.39 5.2 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.655 0.782 . . . . 0.0 108.915 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.3 t -71.64 -41.09 69.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.27 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 80.8 p -111.08 161.5 15.85 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.609 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 34.7 t 52.78 86.09 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.807 1.243 . . . . 0.0 113.474 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 73.4 mtm-85 -112.13 97.72 39.92 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.94 -60.42 0.82 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.501 2.801 . . . . 0.0 114.162 -172.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 59.47 17.69 6.24 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.47 1.108 . . . . 0.0 112.96 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 85.2 mt -141.44 -58.46 0.49 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -175.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -148.22 110.08 4.51 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 173.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.24 87.81 0.82 Allowed 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.979 0.895 . . . . 0.0 110.82 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -80.51 73.13 7.44 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.145 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 18.0 m -125.73 172.59 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.338 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.607 HG23 ' HB2' ' A' ' 198' ' ' GLN . 97.5 mt -94.86 110.13 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.619 0.768 . . . . 0.0 110.045 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -103.1 106.93 17.55 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 43.3 m-70 -77.31 92.47 3.91 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 204' ' ' VAL . 35.0 m -108.38 151.02 10.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.336 -175.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.477 ' HD3' HG22 ' A' ' 196' ' ' VAL . 31.6 mmmt -110.92 113.12 25.45 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.217 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -57.43 105.6 0.26 Allowed 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 168.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.7 -24.02 64.45 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.211 0.529 . . . . 0.0 109.814 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -68.91 -31.86 71.07 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.201 1.0 . . . . 0.0 110.733 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -143.8 67.45 15.83 Favored Pre-proline 0 N--CA 1.487 1.381 0 C-N-CA 124.12 0.968 . . . . 0.0 110.667 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.3 -15.82 28.2 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.211 1.94 . . . . 0.0 113.177 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.36 -17.1 61.86 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.483 0.713 . . . . 0.0 111.024 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -87.63 25.17 1.53 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.119 0.967 . . . . 0.0 111.893 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 83.13 174.81 50.65 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.175 0.297 . . . . 0.0 113.84 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.477 HG22 ' HD3' ' A' ' 187' ' ' LYS . 3.1 t -92.2 118.32 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 172.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.32 143.62 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 122.903 0.481 . . . . 0.0 110.019 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.607 ' HB2' HG23 ' A' ' 183' ' ' ILE . 15.3 pt20 -106.92 114.36 28.41 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.31 0.576 . . . . 0.0 110.128 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 55.4 mtp -125.66 162.95 23.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.002 0.921 . . . . 0.0 109.701 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 6.7 m-80 -98.98 170.02 9.02 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.221 0.609 . . . . 0.0 109.55 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 50.9 m -56.42 -39.59 73.29 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.135 0.574 . . . . 0.0 111.634 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.46 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 34.1 ptt180 -54.66 -34.95 62.98 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.204 1.002 . . . . 0.0 112.222 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -86.82 -45.07 11.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.753 0.821 . . . . 0.0 110.534 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 186' ' ' VAL . 13.6 m -96.11 115.08 34.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 CA-C-O 121.797 0.808 . . . . 0.0 109.811 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -118.43 129.23 55.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.786 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.09 126.61 29.73 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.441 ' HE ' ' HB2' ' A' ' 294' ' ' MET . 91.1 mtm-85 -66.03 107.34 1.86 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.268 0.485 . . . . 0.0 111.789 -172.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.61 107.47 0.51 Allowed 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.175 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.441 ' HG2' ' HG3' ' A' ' 294' ' ' MET . 0.1 OUTLIER -75.28 81.04 2.38 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -173.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.5 m -145.54 108.44 4.53 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 54.0 mt -85.19 119.27 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.524 ' HB ' HG13 ' A' ' 277' ' ' VAL . 31.7 mm -91.45 152.86 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 123.911 0.884 . . . . 0.0 109.363 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -127.45 171.68 11.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.578 0.351 . . . . 0.0 110.681 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -48.93 -42.85 38.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.239 1.416 . . . . 0.0 111.874 -177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -62.06 -39.14 91.38 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.044 0.937 . . . . 0.0 111.93 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.438 ' HB2' HG23 ' A' ' 212' ' ' ILE . 61.2 m-20 -77.64 -22.31 50.89 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.077 0.551 . . . . 0.0 110.749 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.516 HD11 HG11 ' A' ' 277' ' ' VAL . 94.8 mt -72.41 109.98 6.49 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -114.14 154.14 28.32 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.161 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 32.0 m -67.97 130.35 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-O 120.754 0.312 . . . . 0.0 111.065 -175.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.05 -6.96 64.34 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.412 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -88.55 121.22 30.69 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.236 0.615 . . . . 0.0 111.161 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.5 t -91.83 127.66 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.022 0.929 . . . . 0.0 109.3 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' A' ' 280' ' ' ILE . 3.5 m -142.77 151.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.974 1.31 . . . . 0.0 110.298 -172.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.481 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 16.1 ptm -101.06 128.14 47.26 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.932 0.493 . . . . 0.0 111.378 -177.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.577 ' HB3' HG23 ' A' ' 277' ' ' VAL . 2.3 pt? -145.72 174.72 10.96 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.273 1.029 . . . . 0.0 110.393 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.501 ' HB3' ' CZ3' ' A' ' 238' ' ' TRP . 8.1 p30 -79.03 131.22 36.2 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 167.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -168.91 142.43 2.92 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.498 HD21 ' HB3' ' A' ' 231' ' ' ASN . 6.0 p-10 -136.64 133.56 19.09 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.305 0.642 . . . . 0.0 109.959 172.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.12 -20.92 67.94 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.365 2.043 . . . . 0.0 112.303 170.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.45 -47.74 84.32 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.513 0.725 . . . . 0.0 110.824 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.498 ' HB3' HD21 ' A' ' 228' ' ' ASN . 53.2 t30 -145.35 82.21 9.85 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.668 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.9 -16.51 54.37 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.078 2.519 . . . . 0.0 112.958 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -76.47 -27.7 56.24 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.581 0.753 . . . . 0.0 111.843 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -121.95 165.71 15.55 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.706 0.402 . . . . 0.0 110.389 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -60.58 131.19 49.96 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.929 1.292 . . . . 0.0 112.0 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -127.2 -139.24 4.9 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.088 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -82.23 159.96 23.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.12 0.568 . . . . 0.0 109.912 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' TRP . . . . . 0.501 ' CZ3' ' HB3' ' A' ' 226' ' ' ASN . 22.9 m95 -82.93 100.4 10.38 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 150' ' ' ALA . 40.8 m-85 -114.87 163.04 16.09 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.834 0.854 . . . . 0.0 111.032 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.35 148.83 27.1 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.512 171.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -147.46 134.7 20.57 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.583 0.753 . . . . 0.0 109.154 172.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.15 119.09 34.99 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.532 HD12 HD21 ' A' ' 255' ' ' LEU . 26.6 mm -61.9 107.92 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.0 t -79.62 -50.68 10.31 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.394 0.616 . . . . 0.0 109.801 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 20.3 mtp180 -151.36 163.24 39.39 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.726 1.61 . . . . 0.0 108.09 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -155.83 143.15 19.3 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.987 0.358 . . . . 0.0 111.025 166.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -149.92 128.23 12.12 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.204 1.002 . . . . 0.0 109.03 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -100.83 125.33 47.33 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 31.4 p -96.02 -175.13 3.3 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 170.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -76.75 -23.09 53.0 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 120.679 0.276 . . . . 0.0 110.849 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 22.8 p -97.76 -29.24 13.48 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.393 0.677 . . . . 0.0 112.7 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -167.39 146.05 4.91 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.773 0.429 . . . . 0.0 111.955 -173.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -90.43 102.02 14.75 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -92.37 99.2 12.0 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.532 HD21 HD12 ' A' ' 243' ' ' ILE . 9.4 tt -100.47 131.39 46.41 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 174.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' TYR . . . . . 0.488 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 65.0 m-85 -106.51 127.05 53.01 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.253 1.021 . . . . 0.0 108.308 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -142.79 141.16 31.62 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.939 0.336 . . . . 0.0 111.009 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -79.75 96.62 6.32 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 39.7 t -77.54 102.8 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 13.8 m -92.11 111.03 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.655 0.74 . . . . 0.0 110.065 -171.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.576 HD12 ' HB2' ' A' ' 264' ' ' ASP . 12.4 mt -87.48 -165.78 1.4 Allowed 'General case' 0 CA--C 1.557 1.237 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.857 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.06 -35.29 88.85 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 122.395 -0.19 . . . . 0.0 113.34 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -123.2 -51.76 1.87 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.097 0.959 . . . . 0.0 109.482 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.576 ' HB2' HD12 ' A' ' 261' ' ' LEU . 4.7 m-20 -76.26 164.43 26.06 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.317 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 55.9 m -143.46 136.97 28.24 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.654 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 73.7 mt -113.7 82.07 1.63 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.754 0.822 . . . . 0.0 109.394 -171.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.1 125.63 26.11 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.847 0.859 . . . . 0.0 112.737 -170.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 61.46 26.94 16.6 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.855 1.262 . . . . 0.0 112.896 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 96.5 m -68.31 128.18 35.64 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 122.698 0.399 . . . . 0.0 110.061 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 52.3 ttp180 -69.77 111.44 5.53 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 121.645 0.736 . . . . 0.0 110.532 -174.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 225' ' ' LEU . 48.7 mm -82.29 123.88 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.427 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 49.9 mt -90.51 -27.37 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.076 0.951 . . . . 0.0 109.243 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -96.15 36.71 1.3 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.032 1.333 . . . . 0.0 110.06 -166.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 29.0 m -65.82 -20.57 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.794 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -95.27 -27.51 15.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.056 0.943 . . . . 0.0 110.617 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -91.59 4.26 53.06 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.743 0.817 . . . . 0.0 111.807 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.577 HG23 ' HB3' ' A' ' 225' ' ' LEU . 13.3 p -78.92 154.81 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 C-N-CA 123.238 0.615 . . . . 0.0 110.499 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.481 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 54.6 m-85 -128.89 161.07 30.7 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.502 1.121 . . . . 0.0 110.45 -173.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -73.93 140.54 45.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.128 0.971 . . . . 0.0 111.081 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 223' ' ' VAL . 31.3 mm -77.12 122.3 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.817 0.847 . . . . 0.0 109.421 169.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.94 119.78 28.63 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 97.5 mtt180 -101.73 127.52 31.05 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.271 1.028 . . . . 0.0 109.817 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -37.36 131.91 0.59 Allowed 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 123.746 2.964 . . . . 0.0 114.326 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 105.27 -46.67 1.14 Allowed Glycine 0 C--N 1.341 0.823 0 CA-C-O 119.937 -0.368 . . . . 0.0 112.716 -171.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 9.5 pt-20 -84.69 -9.25 58.41 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 117.562 0.681 . . . . 0.0 110.793 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -35.82 83.62 0.0 OUTLIER Glycine 0 C--N 1.351 1.377 0 N-CA-C 117.558 1.783 . . . . 0.0 117.558 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 2.6 m -92.62 138.07 23.98 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 171.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.62 177.67 5.25 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.87 2.38 . . . . 0.0 111.476 -175.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 2.8 tpt -75.1 80.91 2.26 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.92 -37.18 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.082 -173.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.04 179.0 6.5 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -43.82 123.83 3.96 Favored Pre-proline 0 CA--C 1.561 1.388 0 C-N-CA 125.159 1.384 . . . . 0.0 113.319 -168.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.11 109.25 0.25 Allowed 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 123.949 3.099 . . . . 0.0 114.479 -173.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.441 ' HB2' ' HE ' ' A' ' 207' ' ' ARG . 90.2 mtp -74.17 104.0 4.81 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 168.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.72 81.24 1.96 Allowed 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -74.88 -71.34 0.36 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.422 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? 57.26 115.62 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.224 1.81 . . . . 0.0 112.368 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.4 m -143.31 114.98 8.14 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.233 1.013 . . . . 0.0 109.193 172.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -155.51 -108.67 0.3 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-O 118.511 -1.16 . . . . 0.0 111.64 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo . . . . . 0 C--N 1.382 2.294 0 C-N-CA 123.183 2.589 . . . . 0.0 112.395 178.629 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.065 0 N-CA-C 112.222 -0.351 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.85 0.1 37.93 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.212 0.605 . . . . 0.0 111.668 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -115.86 160.95 19.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.853 0.861 . . . . 0.0 108.782 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.12 -178.24 4.24 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.745 0.818 . . . . 0.0 110.115 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 157' ' ' VAL . 13.0 m -55.35 -19.23 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 124.683 1.193 . . . . 0.0 113.869 -175.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -94.86 -31.37 13.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.132 0.973 . . . . 0.0 111.413 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.55 105.97 5.92 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.69 0.757 . . . . 0.0 111.652 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.558 ' HD1' ' HD3' ' A' ' 207' ' ' ARG . 15.3 t80 -70.32 138.11 51.21 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.547 164.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 28.7 m -127.9 179.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.559 1.144 . . . . 0.0 111.311 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -119.46 108.17 14.22 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.51 118.58 33.57 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.59 0.756 . . . . 0.0 110.11 -169.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -69.44 133.27 47.54 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -68.02 127.49 33.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -67.29 -26.61 66.62 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 123.845 0.716 . . . . 0.0 111.602 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -80.36 -52.87 7.18 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.994 0.518 . . . . 0.0 111.095 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 43.0 ttm -83.18 -24.67 32.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.353 0.661 . . . . 0.0 111.05 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.42 -15.92 32.51 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.474 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.481 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . . . -73.68 153.54 40.05 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.98 0.912 . . . . 0.0 111.305 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 238' ' ' TRP . 40.7 m95 -73.74 136.14 43.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -140.27 110.57 6.63 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' A' ' 296' ' ' ARG . 19.4 mt-10 -48.3 137.92 10.48 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.89 0.876 . . . . 0.0 109.908 172.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.12 154.48 32.42 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.086 0.554 . . . . 0.0 110.613 -169.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -105.18 119.66 39.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.843 0.457 . . . . 0.0 110.041 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.6 t -68.25 114.23 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 168.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 137' ' ' VAL . 24.6 m -107.52 -10.36 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.157 0.583 . . . . 0.0 111.113 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -171.51 146.3 2.2 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.536 0.523 . . . . 0.0 110.892 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.59 133.4 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.433 0.693 . . . . 0.0 109.661 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.4 p -142.14 166.39 24.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.93 1.292 . . . . 0.0 108.621 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -119.44 155.19 32.5 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -51.85 -43.91 63.42 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 123.813 0.845 . . . . 0.0 110.396 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.88 127.55 59.41 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 168.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.77 89.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.394 2.729 . . . . 0.0 113.719 -175.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 41.6 t -122.28 147.21 46.5 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 125.149 1.38 . . . . 0.0 107.95 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.72 36.7 19.35 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-O 122.919 1.342 . . . . 0.0 107.908 -166.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -50.8 -49.7 57.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.821 1.648 . . . . 0.0 112.207 -173.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.92 141.75 33.62 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.318 0.647 . . . . 0.0 109.285 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.81 80.16 1.2 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.871 2.381 . . . . 0.0 111.731 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 57.8 m -143.52 168.13 20.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.648 -173.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 37.0 t -67.05 103.82 1.26 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.647 0.779 . . . . 0.0 109.667 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 37.6 m -129.43 80.45 1.97 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.718 0.807 . . . . 0.0 109.778 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 51.4 p -99.35 177.65 5.13 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.61 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.4 t 64.65 19.44 11.82 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.137 0.975 . . . . 0.0 112.38 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -87.11 146.79 41.13 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.647 0.779 . . . . 0.0 110.292 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -52.01 97.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 124.021 3.148 . . . . 0.0 113.795 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -126.2 99.19 5.77 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.854 0.861 . . . . 0.0 109.283 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.9 tt -139.4 107.65 5.78 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 56.71 80.61 0.15 Allowed 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.507 1.13 . . . . 0.0 108.761 -171.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.733 ' HB3' HG22 ' A' ' 182' ' ' VAL . 3.8 mp0 -70.01 101.02 1.7 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.568 -166.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -83.99 16.18 3.0 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.155 164.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.733 HG22 ' HB3' ' A' ' 180' ' ' GLU . 15.3 m -72.5 166.92 2.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-O 121.394 0.616 . . . . 0.0 110.411 172.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' A' ' 198' ' ' GLN . 2.5 mp -95.44 115.87 35.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.178 -172.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -97.52 104.54 16.58 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -79.11 94.66 5.39 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.53 151.06 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.508 ' HG2' HG22 ' A' ' 196' ' ' VAL . 43.2 mtmt -106.37 118.79 37.57 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 170.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -56.53 116.01 2.85 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.35 -36.84 66.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.753 0.821 . . . . 0.0 110.312 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -72.29 -32.07 66.27 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.808 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -140.04 61.0 16.35 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 123.58 0.752 . . . . 0.0 111.744 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.59 -20.02 9.65 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.033 1.822 . . . . 0.0 112.905 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.04 -20.21 66.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.933 0.893 . . . . 0.0 111.723 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -81.51 -20.17 40.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.64 0.776 . . . . 0.0 111.155 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 110.42 -179.36 20.3 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 116.521 -0.309 . . . . 0.0 113.068 174.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.508 HG22 ' HG2' ' A' ' 187' ' ' LYS . 20.3 t -79.63 122.77 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.857 0.863 . . . . 0.0 109.433 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 33.9 m -104.73 144.13 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.637 0.775 . . . . 0.0 110.634 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.552 ' HB2' HG23 ' A' ' 183' ' ' ILE . 8.7 pt20 -99.62 121.79 41.71 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.631 0.772 . . . . 0.0 110.327 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 67.4 mmm -120.11 170.14 9.58 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.547 1.139 . . . . 0.0 110.554 -169.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -105.86 176.61 5.11 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.707 0.803 . . . . 0.0 109.66 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 180' ' ' GLU . 61.1 p -59.64 -42.81 93.59 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.031 0.932 . . . . 0.0 110.999 174.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? -70.11 -5.12 24.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.958 0.903 . . . . 0.0 113.283 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -105.36 -34.91 7.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.811 0.444 . . . . 0.0 111.351 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.49 126.98 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.735 0.778 . . . . 0.0 110.312 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.453 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 2.1 mpt_? -120.26 172.24 7.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.502 1.121 . . . . 0.0 109.09 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.63 167.24 18.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.999 0.428 . . . . 0.0 109.903 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.558 ' HD3' ' HD1' ' A' ' 140' ' ' TYR . 77.6 mtm180 -78.65 90.24 4.57 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.614 0.766 . . . . 0.0 110.419 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.75 96.59 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.536 0.684 . . . . 0.0 109.545 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -1.78 43.81 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.061 1.344 . . . . 0.0 111.344 -174.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 44.9 m -84.19 112.79 20.59 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 121.681 -0.637 . . . . 0.0 109.339 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.424 HD11 ' SD ' ' A' ' 294' ' ' MET . 41.4 mt -82.21 123.32 38.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 175.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.692 HG23 ' HB2' ' A' ' 216' ' ' ASP . 49.1 mm -97.27 128.09 48.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.364 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 0.0 OUTLIER -117.52 176.92 4.94 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.095 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.433 ' HA ' HD23 ' A' ' 217' ' ' LEU . 69.7 t90 -46.94 -41.63 16.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.578 0.751 . . . . 0.0 111.553 -170.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -53.67 -43.03 68.52 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.002 1.321 . . . . 0.0 111.913 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.692 ' HB2' HG23 ' A' ' 212' ' ' ILE . 20.0 m-20 -77.97 -25.86 48.37 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.084 0.953 . . . . 0.0 112.416 -175.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 214' ' ' TRP . 1.4 mm? -67.7 112.63 4.91 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -115.35 152.2 33.25 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.9 m -67.05 115.76 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-O 121.114 0.483 . . . . 0.0 110.524 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 110.15 -5.09 30.22 Favored Glycine 0 C--N 1.346 1.128 0 C-N-CA 123.412 0.53 . . . . 0.0 112.846 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -86.69 128.72 35.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.614 0.766 . . . . 0.0 110.677 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.63 130.7 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.54 HG23 HD11 ' A' ' 225' ' ' LEU . 3.0 m -145.9 164.2 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.98 1.312 . . . . 0.0 109.74 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.653 ' SD ' ' HB3' ' A' ' 238' ' ' TRP . 9.0 tmm? -105.31 129.84 53.56 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.575 ' HG ' HG13 ' A' ' 277' ' ' VAL . 2.1 mp -129.12 160.41 32.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.24 0.616 . . . . 0.0 110.354 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -90.01 108.42 19.71 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.784 0.834 . . . . 0.0 110.899 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.659 ' HE1' ' HB2' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -168.1 158.6 10.43 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.304 1.041 . . . . 0.0 110.413 177.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.575 HD21 ' HB3' ' A' ' 231' ' ' ASN . 6.6 p30 -111.14 148.61 39.06 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -58.28 -33.17 97.4 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.926 2.417 . . . . 0.0 113.115 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.44 -39.95 77.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.425 0.69 . . . . 0.0 111.025 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.575 ' HB3' HD21 ' A' ' 228' ' ' ASN . 41.6 t-20 -128.64 99.49 23.17 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.273 0.629 . . . . 0.0 109.69 -172.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -84.16 -0.0 9.37 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.941 2.427 . . . . 0.0 112.824 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -92.44 -29.27 16.36 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.379 0.672 . . . . 0.0 110.318 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -124.46 152.74 42.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.673 0.789 . . . . 0.0 109.732 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -55.39 170.19 0.25 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.334 1.453 . . . . 0.0 113.699 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 228' ' ' ASN . . . -171.27 -110.79 0.24 Allowed Glycine 0 C--N 1.337 0.631 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.138 174.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.469 ' HB2' ' CE1' ' A' ' 239' ' ' TYR . 17.8 m-85 -91.85 177.51 6.17 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.757 0.823 . . . . 0.0 109.454 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' TRP . . . . . 0.653 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 6.8 m95 -99.5 106.46 18.48 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.659 ' HB2' ' HE1' ' A' ' 227' ' ' TYR . 90.3 m-85 -121.84 166.89 13.68 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 118.927 0.785 . . . . 0.0 110.993 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ASP . . . . . 0.572 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 3.4 m-20 -83.42 160.61 21.55 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.627 1.171 . . . . 0.0 110.329 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -162.51 138.9 7.61 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.07 0.948 . . . . 0.0 110.77 170.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -103.05 120.14 40.12 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.546 HD12 HD11 ' A' ' 255' ' ' LEU . 25.0 mm -63.89 117.47 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.924 0.89 . . . . 0.0 110.937 -171.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 33.3 t -88.24 -53.07 4.88 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.593 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.403 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 95.9 mtt180 -140.6 164.83 29.13 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.282 1.033 . . . . 0.0 109.873 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -155.95 147.89 23.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.493 0.717 . . . . 0.0 110.05 170.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -146.23 116.21 7.34 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.516 0.727 . . . . 0.0 109.599 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.665 ' HG2' ' HG2' ' A' ' 253' ' ' ARG . 6.0 tm-20 -92.85 123.6 36.23 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 30.6 p -133.47 148.45 51.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 168.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -63.81 -10.58 20.91 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.382 0.673 . . . . 0.0 112.801 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 47.2 p -91.73 -28.98 17.07 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.84 0.856 . . . . 0.0 111.058 175.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.84 130.2 0.8 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.301 0.64 . . . . 0.0 111.409 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.665 ' HG2' ' HG2' ' A' ' 248' ' ' GLU . 53.6 mtm180 -83.63 98.55 9.68 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -92.71 150.42 20.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.341 1.056 . . . . 0.0 110.213 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.811 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.5 OUTLIER -145.87 146.41 31.1 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -174.494 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 256' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 78.9 m-85 -134.06 127.77 32.89 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.206 1.002 . . . . 0.0 108.662 174.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -143.64 141.67 30.68 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.515 0.726 . . . . 0.0 109.805 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 19.4 m-20 -78.64 94.94 5.13 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 269' ' ' CYS . 92.9 t -67.54 105.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.608 0.567 . . . . 0.0 110.371 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 45.1 t -85.79 99.3 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 30.6 mt -84.99 176.78 8.23 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.365 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -56.78 -36.46 72.48 Favored Glycine 0 N--CA 1.475 1.264 0 N-CA-C 114.349 0.5 . . . . 0.0 114.349 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -123.26 -47.75 2.0 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.707 0.803 . . . . 0.0 109.774 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -80.11 166.35 21.58 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.781 -175.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 30.7 p -146.84 110.3 4.86 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.573 0.749 . . . . 0.0 109.187 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 61.9 mt -87.12 87.39 7.44 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.973 0.909 . . . . 0.0 109.439 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 3.2 p-10 -64.38 139.4 58.76 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.792 0.437 . . . . 0.0 110.763 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.92 29.81 19.36 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.065 0.946 . . . . 0.0 112.199 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.481 ' HB3' HG23 ' A' ' 259' ' ' VAL . 38.3 t -72.96 126.97 31.19 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.76 0.424 . . . . 0.0 110.58 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -63.57 133.41 53.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.105 0.562 . . . . 0.0 110.894 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.811 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 46.9 mm -111.97 124.5 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.404 1.081 . . . . 0.0 109.251 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 41.3 mt -106.02 2.04 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.181 0.992 . . . . 0.0 109.312 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -102.87 29.98 5.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.048 1.339 . . . . 0.0 109.712 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 24.0 m -57.82 -29.46 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -165.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 22.5 m-20 -97.13 -23.72 16.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.283 0.633 . . . . 0.0 111.72 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -81.84 6.5 15.49 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.869 0.868 . . . . 0.0 112.208 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.575 HG13 ' HG ' ' A' ' 225' ' ' LEU . 19.4 t -73.94 148.62 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.325 0.65 . . . . 0.0 109.432 178.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -128.18 160.28 32.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.576 1.151 . . . . 0.0 108.313 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -76.16 153.62 36.05 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.105 0.562 . . . . 0.0 111.481 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.525 HG12 ' HA ' ' A' ' 223' ' ' VAL . 46.8 mm -75.6 122.71 30.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 167.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.521 ' HG2' ' HA3' ' A' ' 286' ' ' GLY . 0.1 OUTLIER -84.16 106.11 15.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 165.322 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -107.81 108.22 61.21 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -11.26 88.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 1 C-N-CA 126.883 5.055 . . . . 0.0 116.687 -158.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 99.69 1.12 56.42 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 115.102 -0.954 . . . . 0.0 114.923 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -93.52 -23.44 18.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.003 0.902 . . . . 0.0 110.801 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' GLY . . . . . 0.521 ' HA3' ' HG2' ' A' ' 281' ' ' GLU . . . -93.84 -165.94 37.19 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.579 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 38.2 p -117.64 163.98 21.59 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 123.681 0.792 . . . . 0.0 111.438 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -86.62 -154.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.142 2.561 . . . . 0.0 111.308 164.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' MET . . . . . 0.517 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 23.3 mmt -115.32 80.51 1.44 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 168.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.91 -35.25 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 168.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -84.11 -168.7 2.26 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.479 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -49.89 115.95 5.74 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.499 1.12 . . . . 0.0 111.849 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.517 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 12.4 Cg_exo -70.81 80.89 1.14 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.267 2.645 . . . . 0.0 111.148 175.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.424 ' SD ' HD11 ' A' ' 211' ' ' ILE . 49.3 mtm -63.26 -55.63 23.21 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.589 -172.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 66.6 144.74 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.858 1.263 . . . . 0.0 111.245 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.404 ' NH2' ' HG3' ' A' ' 153' ' ' GLU . 14.2 mtm180 -91.93 -30.95 15.85 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 173.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.454 ' HB2' ' HZ2' ' A' ' 238' ' ' TRP . 77.1 tttt -141.63 153.04 44.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.248 1.019 . . . . 0.0 108.978 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.0 p -143.29 113.37 7.21 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.444 0.697 . . . . 0.0 110.535 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -123.3 -89.77 0.92 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 C--N 1.374 1.893 0 C-N-CA 123.627 2.885 . . . . 0.0 112.642 167.774 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.535 HD12 ' HB3' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -122.87 8.69 9.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.208 0.603 . . . . 0.0 112.317 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -116.1 161.74 18.46 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.258 0.552 . . . . 0.0 110.938 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.12 161.65 15.72 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.994 1.317 . . . . 0.0 109.153 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 158' ' ' ARG . 92.1 t -70.17 80.38 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 124.188 0.995 . . . . 0.0 110.058 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 175.2 -38.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 126.641 1.976 . . . . 0.0 109.18 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -72.17 91.82 1.31 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -159.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 10.5 p90 -72.49 99.88 2.59 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.917 0.865 . . . . 0.0 109.616 168.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.87 -176.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.937 1.295 . . . . 0.0 109.255 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.18 104.15 16.56 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.392 0.615 . . . . 0.0 110.239 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -95.79 102.28 14.06 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 26.2 ttt180 -72.08 109.7 6.06 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.36 109.39 0.99 Allowed 'General case' 0 C--O 1.217 -0.625 0 O-C-N 124.506 1.129 . . . . 0.0 108.07 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.81 -10.94 59.85 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 124.033 0.833 . . . . 0.0 111.282 -170.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -74.03 -56.01 5.44 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.444 0.698 . . . . 0.0 110.258 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 50.5 ttp -92.53 -37.16 12.64 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.902 0.481 . . . . 0.0 109.955 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.434 ' HA3' ' CA ' ' A' ' 262' ' ' GLY . . . 101.44 20.73 12.7 Favored Glycine 0 N--CA 1.469 0.87 0 CA-C-N 115.45 -0.795 . . . . 0.0 113.518 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -101.79 140.31 36.26 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.085 0.554 . . . . 0.0 110.405 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 76.5 m95 -74.76 134.86 41.78 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.811 0.845 . . . . 0.0 109.581 174.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -135.78 136.36 40.66 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.686 ' HB3' HH12 ' A' ' 207' ' ' ARG . 19.9 pt-20 -68.62 103.76 1.8 Allowed 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -108.64 131.27 55.05 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.681 0.792 . . . . 0.0 110.287 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 60.8 tt0 -87.11 109.09 19.2 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.298 0.639 . . . . 0.0 110.444 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 186' ' ' VAL . 70.1 t -61.68 103.87 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 124.197 0.936 . . . . 0.0 109.381 171.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.0 m -106.12 -0.37 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.758 0.423 . . . . 0.0 111.613 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.485 HH11 ' HG2' ' A' ' 169' ' ' PRO . 52.4 ttm-85 -172.73 149.92 2.08 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.617 0.573 . . . . 0.0 110.674 169.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.11 142.47 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.754 0.822 . . . . 0.0 108.955 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.45 ' OG1' ' HB ' ' A' ' 183' ' ' ILE . 8.1 p -145.69 161.95 38.68 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.882 1.273 . . . . 0.0 108.907 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -114.88 178.36 4.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.829 0.852 . . . . 0.0 110.78 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -58.18 -56.98 15.11 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.685 0.794 . . . . 0.0 110.417 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -93.95 162.21 27.58 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.666 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -49.01 127.17 16.6 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.954 2.436 . . . . 0.0 112.066 168.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.4 m -69.96 -56.49 6.86 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.246 0.618 . . . . 0.0 112.599 -171.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -156.19 -40.39 0.08 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -175.12 -63.97 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.74 154.05 39.21 Favored Pre-proline 0 CA--C 1.551 1.007 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.725 170.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.485 ' HG2' HH11 ' A' ' 158' ' ' ARG . 19.2 Cg_endo -57.22 90.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.863 3.042 . . . . 0.0 113.206 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 78.0 m 62.08 175.45 0.13 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.504 1.521 . . . . 0.0 112.297 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.6 t -167.79 148.36 5.18 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 122.884 0.474 . . . . 0.0 110.339 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.8 m 60.78 -163.95 0.24 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 124.563 1.164 . . . . 0.0 111.752 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.1 t -89.33 84.77 6.47 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.057 0.932 . . . . 0.0 108.544 172.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 57.4 p -67.79 115.69 7.63 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.343 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -65.28 124.28 86.55 Favored Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.266 0.626 . . . . 0.0 110.854 -172.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.535 ' HB3' HD12 ' A' ' 134' ' ' LEU . 57.2 Cg_endo -67.99 148.97 77.03 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.881 2.387 . . . . 0.0 112.439 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -87.99 -96.24 0.09 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -135.99 -68.96 0.49 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.95 86.23 7.31 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-O 122.3 1.048 . . . . 0.0 110.286 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -88.49 67.37 8.54 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.049 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -85.07 40.31 0.81 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 121.889 0.852 . . . . 0.0 109.707 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 34.9 m -88.61 175.93 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.823 0.849 . . . . 0.0 111.085 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.45 ' HB ' ' OG1' ' A' ' 160' ' ' THR . 20.6 mt -96.72 112.35 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.683 0.793 . . . . 0.0 110.594 -168.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -102.05 109.38 21.09 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.418 1.087 . . . . 0.0 108.961 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -79.26 89.38 4.91 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 156' ' ' VAL . 26.7 m -110.58 161.16 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.762 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.52 ' HG2' HG22 ' A' ' 196' ' ' VAL . 32.0 mtmt -124.97 117.75 24.72 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 173.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -57.52 97.03 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -62.73 -23.92 67.41 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.202 1.001 . . . . 0.0 111.593 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 297' ' ' LYS . 19.9 m-20 -63.34 -30.81 71.88 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.715 0.406 . . . . 0.0 111.711 173.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -146.88 78.04 10.8 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 124.14 0.976 . . . . 0.0 108.89 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.15 -21.2 55.88 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.925 2.417 . . . . 0.0 112.563 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -67.14 -8.19 29.12 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.648 1.179 . . . . 0.0 112.788 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -79.33 -12.76 59.93 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.443 0.697 . . . . 0.0 111.333 173.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 93.88 -178.7 37.88 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.713 0.633 . . . . 0.0 112.915 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.52 HG22 ' HG2' ' A' ' 187' ' ' LYS . 24.6 t -83.95 116.6 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.55 153.64 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.036 0.934 . . . . 0.0 109.663 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -108.32 122.21 46.51 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.437 0.695 . . . . 0.0 109.536 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 84.7 mmm -125.28 164.88 19.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.696 1.198 . . . . 0.0 109.265 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -110.53 172.77 6.67 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.525 ' HA ' HG22 ' A' ' 204' ' ' VAL . 41.7 m -66.29 -30.23 70.61 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 118.159 0.436 . . . . 0.0 111.258 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -10.4 58.86 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.862 176.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -104.25 -39.93 6.31 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.452 1.101 . . . . 0.0 111.014 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.525 HG22 ' HA ' ' A' ' 201' ' ' SER . 32.0 m -95.79 143.47 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -174.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.96 163.47 32.79 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.321 0.648 . . . . 0.0 109.774 -168.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.97 166.64 23.01 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.186 0.594 . . . . 0.0 109.804 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.686 HH12 ' HB3' ' A' ' 153' ' ' GLU . 10.8 ptm180 -136.75 134.11 36.76 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.0 148.32 40.02 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.744 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.63 ' HG3' ' HB3' ' A' ' 291' ' ' ASP . 3.3 tmt_? -75.79 -9.47 58.62 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.942 168.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.8 m -86.94 109.33 19.27 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.869 0.868 . . . . 0.0 111.023 -171.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.4 mt -84.02 136.36 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.676 HD11 ' HB2' ' A' ' 279' ' ' LYS . 39.0 mm -110.98 153.52 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.637 0.775 . . . . 0.0 111.419 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -125.1 171.29 10.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.988 1.315 . . . . 0.0 109.929 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.483 ' HD1' HG11 ' A' ' 274' ' ' VAL . 88.7 t90 -50.01 -49.05 52.05 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.378 1.071 . . . . 0.0 111.662 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -61.23 -35.76 78.12 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.618 -175.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.451 ' HB3' HG23 ' A' ' 212' ' ' ILE . 14.6 t70 -78.78 -23.98 44.94 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.279 0.632 . . . . 0.0 110.978 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.444 HD22 HG21 ' A' ' 223' ' ' VAL . 96.0 mt -72.37 113.18 9.12 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.051 0.54 . . . . 0.0 109.928 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 221' ' ' GLN . 9.3 pt-20 -119.71 154.06 34.68 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.993 0.917 . . . . 0.0 109.961 -176.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.3 m -63.68 123.63 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 120.844 0.354 . . . . 0.0 110.945 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.76 -14.05 56.26 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.177 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.478 ' HG2' HG13 ' A' ' 223' ' ' VAL . 30.5 tt0 -81.29 122.69 27.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.346 0.658 . . . . 0.0 110.767 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 74.1 t -93.58 130.74 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.478 HG13 ' HG2' ' A' ' 221' ' ' GLN . 3.0 m -150.34 147.02 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.268 1.027 . . . . 0.0 110.297 -172.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 26.1 ttp -102.76 130.41 49.71 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.896 0.478 . . . . 0.0 110.986 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.506 HD11 HD12 ' A' ' 271' ' ' ILE . 1.9 pt? -142.43 167.89 21.02 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.283 1.033 . . . . 0.0 110.917 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.545 HD21 ' HB3' ' A' ' 276' ' ' GLU . 4.8 p30 -81.37 126.52 31.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.328 0.651 . . . . 0.0 109.655 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -166.08 152.28 9.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.956 0.902 . . . . 0.0 109.384 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.59 HD21 ' HB3' ' A' ' 231' ' ' ASN . 3.7 p30 -131.34 133.0 23.97 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.442 ' HB3' HD11 ' A' ' 266' ' ' LEU . 27.0 Cg_endo -61.52 -26.02 80.29 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.809 2.339 . . . . 0.0 113.943 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.41 -33.32 71.22 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.114 0.566 . . . . 0.0 111.699 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.59 ' HB3' HD21 ' A' ' 228' ' ' ASN . 35.5 t-20 -133.23 104.33 12.46 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 123.48 0.712 . . . . 0.0 109.116 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.33 -19.48 49.75 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.767 2.311 . . . . 0.0 113.019 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.26 -10.82 40.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.331 0.652 . . . . 0.0 110.944 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -123.81 159.13 30.23 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.484 0.659 . . . . 0.0 111.179 -171.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -80.28 172.24 14.02 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.688 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 228' ' ' ASN . . . -161.55 -101.98 0.17 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.291 172.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -103.46 168.9 8.86 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.77 0.828 . . . . 0.0 109.503 -177.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -83.87 114.73 21.86 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -126.8 141.29 51.87 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.214 1.006 . . . . 0.0 108.387 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.4 p-10 -81.18 152.81 27.54 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -151.09 136.85 18.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.791 0.836 . . . . 0.0 109.058 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -94.54 118.27 31.41 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.558 HD12 HD21 ' A' ' 255' ' ' LEU . 32.3 mm -61.57 116.27 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 124.041 0.838 . . . . 0.0 108.952 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.6 t -97.08 -25.04 15.48 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.332 0.653 . . . . 0.0 110.633 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -170.13 157.34 6.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.859 0.864 . . . . 0.0 110.195 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.406 ' HB3' ' HG ' ' A' ' 255' ' ' LEU . 26.0 pttm -153.13 149.1 27.72 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.659 0.784 . . . . 0.0 109.32 163.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -154.52 120.45 5.24 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.305 0.642 . . . . 0.0 109.449 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 40.0 tt0 -111.24 125.49 53.87 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.179 0.992 . . . . 0.0 109.151 177.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.7 p -83.59 178.78 7.84 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.943 0.897 . . . . 0.0 109.565 171.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -71.62 -0.78 11.56 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.366 0.666 . . . . 0.0 112.634 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 25.4 p -123.4 -29.68 3.77 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.29 0.636 . . . . 0.0 112.607 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.86 166.76 27.96 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.882 0.31 . . . . 0.0 111.457 -172.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 33.1 ptt180 -121.14 140.76 51.55 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.454 0.701 . . . . 0.0 110.661 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.22 154.31 47.7 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.71 0.804 . . . . 0.0 108.876 172.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.558 HD21 HD12 ' A' ' 243' ' ' ILE . 7.1 tt -147.16 143.89 28.57 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -130.21 121.82 26.93 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -131.97 166.72 21.05 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.377 0.671 . . . . 0.0 110.431 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -102.19 98.14 8.33 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.795 HG23 ' SG ' ' A' ' 269' ' ' CYS . 96.6 t -66.57 112.36 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 123.783 0.677 . . . . 0.0 110.374 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.48 101.79 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 73.4 mt -82.81 -158.02 0.25 Allowed 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.642 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.434 ' CA ' ' HA3' ' A' ' 149' ' ' GLY . . . -70.29 -56.61 7.58 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-O 121.088 0.271 . . . . 0.0 113.418 177.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -112.87 -37.32 4.87 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.171 0.988 . . . . 0.0 109.929 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -94.39 176.39 6.32 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.125 0.97 . . . . 0.0 111.713 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 77.0 p -142.89 153.12 42.81 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.28 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 92.8 mt -125.31 92.15 3.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.359 0.663 . . . . 0.0 109.458 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -69.2 140.02 54.56 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 123.606 0.566 . . . . 0.0 110.284 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 12.6 t70 67.08 31.64 6.72 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.452 1.101 . . . . 0.0 111.705 171.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.795 ' SG ' HG23 ' A' ' 259' ' ' VAL . 27.2 p -65.05 124.92 23.35 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 37.6 ttp-105 -76.91 102.46 6.38 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.57 HD11 ' SG ' ' A' ' 269' ' ' CYS . 47.7 mm -77.87 108.29 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.886 -172.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 44.5 mt -82.1 -34.5 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.424 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.448 ' O ' HG23 ' A' ' 277' ' ' VAL . 46.0 m-85 -90.26 37.42 0.9 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.336 1.054 . . . . 0.0 111.14 -168.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.483 HG11 ' HD1' ' A' ' 214' ' ' TRP . 21.0 m -56.75 -34.27 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.799 1.239 . . . . 0.0 112.433 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -92.78 -10.59 36.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.676 1.19 . . . . 0.0 111.983 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.545 ' HB3' HD21 ' A' ' 226' ' ' ASN . 59.4 mm-40 -102.6 21.26 15.64 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.215 1.006 . . . . 0.0 111.148 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.492 HG22 ' HB3' ' A' ' 225' ' ' LEU . 84.2 t -90.44 153.44 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.038 0.935 . . . . 0.0 110.587 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.43 148.66 44.85 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.874 1.27 . . . . 0.0 107.808 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.676 ' HB2' HD11 ' A' ' 212' ' ' ILE . 24.0 ttmt -83.28 141.01 32.15 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 120.841 0.353 . . . . 0.0 111.126 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 36.5 mm -79.13 138.19 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 168.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.506 ' HA ' ' HA3' ' A' ' 286' ' ' GLY . 1.1 mp0 -66.11 103.46 0.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.283 0.563 . . . . 0.0 110.08 -167.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -85.7 155.0 59.14 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.31 1.044 . . . . 0.0 109.524 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.98 94.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 123.402 2.735 . . . . 0.0 112.075 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.9 -48.09 2.49 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.994 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -73.12 -25.61 60.91 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.996 0.519 . . . . 0.0 112.085 -172.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -84.68 82.19 1.7 Allowed Glycine 0 C--N 1.342 0.915 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 174.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 14.8 m -62.8 144.37 96.6 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.418 0.687 . . . . 0.0 111.989 -168.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.15 152.85 79.12 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.103 2.535 . . . . 0.0 111.875 -175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 16.7 ttt -79.76 80.77 6.11 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.26 -28.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.338 1.055 . . . . 0.0 109.963 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.63 ' HB3' ' HG3' ' A' ' 209' ' ' ARG . 10.3 t70 -84.26 -151.68 0.13 Allowed 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.303 1.041 . . . . 0.0 109.135 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -50.81 115.98 6.51 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.99 0.916 . . . . 0.0 110.533 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.75 102.97 0.44 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.218 1.946 . . . . 0.0 111.534 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 25.7 mmt -65.84 136.7 56.51 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.273 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -144.46 148.78 34.99 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -148.0 -175.92 5.08 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.29 0.236 . . . . 0.0 110.847 -167.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 2.1 tppt? -161.02 134.0 6.36 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 111.541 0.201 . . . . 0.0 111.541 173.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 48.3 m -75.13 79.3 2.28 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.579 0.752 . . . . 0.0 110.064 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -172.08 157.36 27.23 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-O 118.92 -0.933 . . . . 0.0 112.116 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo . . . . . 0 C--N 1.375 1.924 0 C-N-CA 123.468 2.778 . . . . 0.0 111.909 175.03 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.979 -0.449 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.412 HD22 ' OH ' ' A' ' 184' ' ' TYR . 0.5 OUTLIER -81.31 -34.2 32.06 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.178 0.513 . . . . 0.0 110.414 -178.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -90.16 152.42 21.11 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.778 -165.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 139' ' ' GLU . 45.0 mttp -99.35 162.93 12.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.128 -167.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.1 m -71.91 -2.28 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 124.161 0.984 . . . . 0.0 113.116 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -118.34 -21.04 8.27 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.89 0.876 . . . . 0.0 110.425 171.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.457 ' HB3' ' H ' ' A' ' 136' ' ' LYS . 43.6 tt0 -82.12 89.67 6.49 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.77 0.828 . . . . 0.0 110.116 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.702 ' HB3' ' HG2' ' A' ' 155' ' ' GLN . 26.8 p90 -68.16 139.12 56.11 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.202 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.404 HG21 ' HB ' ' A' ' 204' ' ' VAL . 29.0 m -119.5 178.96 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.998 0.919 . . . . 0.0 109.662 176.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.73 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 54.1 t0 -95.01 158.79 15.31 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 166.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.17 110.06 4.52 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 119.436 1.016 . . . . 0.0 111.213 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.411 ' HA ' ' HB3' ' A' ' 151' ' ' TRP . 3.0 tmm_? -73.01 113.69 10.33 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.878 0.871 . . . . 0.0 110.593 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -87.16 114.62 23.93 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.6 m -70.79 -26.57 63.39 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.736 0.814 . . . . 0.0 111.546 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -59.99 -49.93 75.75 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.616 0.766 . . . . 0.0 110.683 -175.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.503 ' HG3' ' H ' ' A' ' 150' ' ' ALA . 23.9 ptm -101.79 -18.99 15.52 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.526 0.331 . . . . 0.0 111.394 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 93.32 -21.56 39.83 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-O 120.021 -0.321 . . . . 0.0 113.141 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.503 ' H ' ' HG3' ' A' ' 148' ' ' MET . . . -72.47 131.18 42.22 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.197 0.599 . . . . 0.0 110.818 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 0.1 OUTLIER -97.65 124.72 42.06 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.18 175.231 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -113.64 137.3 51.8 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.017 0.927 . . . . 0.0 109.464 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.73 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 48.3 mt-10 -64.43 102.21 0.52 Allowed 'General case' 0 C--N 1.346 0.435 0 O-C-N 123.653 0.596 . . . . 0.0 110.802 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -96.61 119.13 34.53 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.78 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.702 ' HG2' ' HB3' ' A' ' 140' ' ' TYR . 15.4 tm0? -84.94 107.91 17.31 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -173.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.527 ' HA ' HG12 ' A' ' 186' ' ' VAL . 47.0 t -61.47 119.61 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 124.229 0.955 . . . . 0.0 109.207 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.408 HG13 ' OE1' ' A' ' 155' ' ' GLN . 1.9 m -115.63 -6.03 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.574 0.749 . . . . 0.0 111.179 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.54 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 44.9 ttt85 -172.23 142.12 1.33 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.966 0.506 . . . . 0.0 110.511 175.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.3 m -126.05 132.09 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.282 1.033 . . . . 0.0 108.832 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.7 p -142.96 145.2 32.77 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.39 0.676 . . . . 0.0 110.099 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -74.93 150.13 39.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.868 0.867 . . . . 0.0 109.053 168.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -65.4 78.21 0.06 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.601 0.76 . . . . 0.0 109.951 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 165.88 100.69 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.715 2.006 . . . . 0.0 106.909 -172.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.4 -56.14 1.46 Allowed 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.659 2.24 . . . . 0.0 112.537 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 39.2 p -82.14 -31.0 30.77 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.419 0.688 . . . . 0.0 111.41 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 61.89 104.63 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.936 1.294 . . . . 0.0 110.773 -170.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -58.46 -45.25 88.98 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.21 0.604 . . . . 0.0 109.945 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -110.54 100.26 44.48 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.2 -90.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.424 2.083 . . . . 0.0 113.092 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 85.2 m -148.3 99.64 3.06 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 118.616 0.643 . . . . 0.0 111.287 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 27.1 p -87.41 85.33 7.13 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 39.8 m 68.86 8.93 7.1 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.201 1.401 . . . . 0.0 113.128 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 53.3 p -96.8 141.01 30.53 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.341 0.656 . . . . 0.0 111.116 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.2 m -85.35 -59.14 2.41 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.108 0.963 . . . . 0.0 110.453 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -95.86 152.06 38.78 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.424 0.689 . . . . 0.0 109.815 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.92 -24.51 74.16 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.846 2.364 . . . . 0.0 115.159 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -158.61 165.94 33.27 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.1 mp -93.83 127.2 39.44 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 62.05 90.3 0.07 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.466 1.106 . . . . 0.0 109.242 -169.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.519 ' HB3' HG22 ' A' ' 182' ' ' VAL . 5.9 mm-40 -70.68 90.76 0.78 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.33 -169.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -85.88 8.85 18.61 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.648 167.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 180' ' ' GLU . 28.6 m -65.69 173.98 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.039 1.336 . . . . 0.0 112.02 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 198' ' ' GLN . 59.0 mt -94.95 110.81 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.549 0.74 . . . . 0.0 110.417 -169.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.412 ' OH ' HD22 ' A' ' 134' ' ' LEU . 58.5 m-85 -93.95 106.48 18.45 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.887 1.275 . . . . 0.0 109.543 173.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 30.5 m-70 -80.54 101.95 9.45 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 156' ' ' VAL . 29.6 m -129.68 165.47 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.832 1.253 . . . . 0.0 110.5 -172.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -133.56 116.33 15.79 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.384 0.674 . . . . 0.0 109.375 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.646 ' HB2' ' HB2' ' A' ' 191' ' ' TYR . 47.0 m-85 -57.2 151.23 16.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 123.167 0.292 . . . . 0.0 111.347 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -60.11 -44.41 94.9 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.062 0.545 . . . . 0.0 110.875 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.47 -13.42 40.38 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.646 0.778 . . . . 0.0 111.268 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.646 ' HB2' ' HB2' ' A' ' 188' ' ' TYR . 58.3 m-85 -129.11 58.65 38.71 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -174.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.38 -23.78 8.38 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 121.71 1.607 . . . . 0.0 110.442 163.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.31 -20.55 62.18 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.687 1.195 . . . . 0.0 111.914 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -81.19 -0.42 40.4 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.057 0.543 . . . . 0.0 110.872 175.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 89.12 -177.48 44.44 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.161 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 23.6 t -82.86 116.89 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.12 153.21 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.027 0.931 . . . . 0.0 110.029 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.409 ' HB2' HG23 ' A' ' 183' ' ' ILE . 12.8 pt20 -103.78 113.88 27.73 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.731 0.777 . . . . 0.0 109.851 178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 77.9 mmm -117.27 169.75 9.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.318 1.447 . . . . 0.0 108.785 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -110.92 173.07 6.51 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.611 ' HA ' HG22 ' A' ' 204' ' ' VAL . 9.7 t -70.56 -26.2 63.43 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 118.369 0.531 . . . . 0.0 110.63 177.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -12.24 60.88 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.745 0.418 . . . . 0.0 111.786 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -94.68 -44.47 7.79 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.51 0.724 . . . . 0.0 110.082 171.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.611 HG22 ' HA ' ' A' ' 201' ' ' SER . 15.3 m -95.76 143.24 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.433 0.635 . . . . 0.0 110.996 -170.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 21.2 tpt180 -150.97 126.64 10.22 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.2 125.48 25.67 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 168.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.427 ' H ' ' NE ' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -73.68 152.02 40.57 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.587 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.428 ' N ' ' HB2' ' A' ' 281' ' ' GLU . . . -64.39 135.11 55.8 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.835 0.709 . . . . 0.0 109.398 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.522 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 5.3 ppt_? -78.21 23.06 0.29 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.876 0.87 . . . . 0.0 112.803 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 79.5 m -113.6 119.41 37.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.892 1.277 . . . . 0.0 109.082 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.63 129.03 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.038 0.535 . . . . 0.0 109.77 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 279' ' ' LYS . 28.2 mm -87.37 144.48 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.41 170.14 9.65 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.901 0.881 . . . . 0.0 109.727 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.409 ' CZ3' ' HB2' ' A' ' 255' ' ' LEU . 38.2 t-105 -52.3 -47.78 65.75 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.979 0.912 . . . . 0.0 111.302 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -69.11 -23.03 63.94 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.278 0.631 . . . . 0.0 111.979 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -92.12 -16.57 26.16 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.115 0.566 . . . . 0.0 110.513 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.62 141.21 42.88 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -147.79 155.08 41.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.586 0.755 . . . . 0.0 109.419 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.93 123.39 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-O 121.26 0.552 . . . . 0.0 110.947 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.1 -4.0 48.46 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.744 -174.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.521 ' HG2' HG13 ' A' ' 223' ' ' VAL . 33.8 tt0 -87.21 121.72 30.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.235 0.614 . . . . 0.0 110.233 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 92.9 t -87.15 115.58 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.779 0.832 . . . . 0.0 108.863 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.521 HG13 ' HG2' ' A' ' 221' ' ' GLN . 6.3 m -137.91 157.37 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.311 1.044 . . . . 0.0 110.642 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.701 ' SD ' ' HD3' ' A' ' 296' ' ' ARG . 1.5 ttp -88.24 129.71 35.28 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.592 ' HB3' HG22 ' A' ' 277' ' ' VAL . 2.0 pp -143.79 168.21 20.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.826 0.85 . . . . 0.0 110.304 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -90.92 143.13 27.04 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -167.18 144.02 4.5 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 124.227 0.955 . . . . 0.0 109.051 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -109.84 119.09 48.55 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -56.24 -44.87 42.39 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.067 2.512 . . . . 0.0 113.082 172.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.1 -27.74 59.98 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.046 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.56 ' HB3' ' HB2' ' A' ' 234' ' ' GLU . 16.7 m120 -120.37 86.32 38.6 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 123.407 0.683 . . . . 0.0 109.194 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.37 -20.43 70.18 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.984 2.456 . . . . 0.0 113.366 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.589 ' HA ' HD12 ' A' ' 272' ' ' ILE . 61.7 tttm -97.47 -29.5 13.44 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.668 0.787 . . . . 0.0 111.26 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 231' ' ' ASN . 44.0 mt-10 -111.46 172.15 7.06 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.825 0.821 . . . . 0.0 112.665 -170.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -76.94 164.25 25.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.724 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -171.47 -79.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.694 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.412 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 11.5 m-85 -127.79 173.96 9.52 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.841 0.456 . . . . 0.0 110.268 -170.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -110.51 127.97 55.42 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 94.0 m-85 -133.54 158.34 43.39 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.415 0.686 . . . . 0.0 110.155 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ASP . . . . . 0.404 ' HB3' ' CZ2' ' A' ' 151' ' ' TRP . 8.6 p-10 -86.14 147.08 26.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 162.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.449 ' HB3' HD21 ' A' ' 225' ' ' LEU . . . -153.48 139.76 18.51 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 122.957 0.503 . . . . 0.0 110.04 -176.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -95.53 120.11 35.22 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.564 HD12 HD21 ' A' ' 255' ' ' LEU . 35.6 mm -58.3 111.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 123.658 0.599 . . . . 0.0 109.968 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.1 m -83.77 -49.47 9.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.688 0.795 . . . . 0.0 110.303 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 4.8 mmp_? -142.43 159.21 42.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.955 1.302 . . . . 0.0 109.07 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -154.89 116.81 4.16 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.33 0.652 . . . . 0.0 109.373 168.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -123.86 117.85 25.78 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.498 1.119 . . . . 0.0 108.542 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.54 135.48 49.74 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.465 0.706 . . . . 0.0 109.604 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.9 p -133.6 175.0 9.82 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.886 0.875 . . . . 0.0 109.284 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -69.12 -38.16 78.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.815 0.446 . . . . 0.0 110.757 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 46.1 p -88.66 -27.32 21.34 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.489 0.716 . . . . 0.0 112.859 -171.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.57 172.98 17.36 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.084 0.469 . . . . 0.0 111.829 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -128.54 130.36 47.31 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.943 0.897 . . . . 0.0 108.665 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -133.03 98.6 4.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.592 0.757 . . . . 0.0 109.314 -175.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.564 HD21 HD12 ' A' ' 243' ' ' ILE . 8.4 tt -107.72 147.01 31.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 64.2 m-85 -129.14 141.35 51.21 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.886 1.274 . . . . 0.0 107.599 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.96 151.02 35.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.718 0.407 . . . . 0.0 111.091 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -79.8 96.68 6.37 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 39.4 t -79.68 108.98 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.98 0.912 . . . . 0.0 109.96 -173.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 83.2 t -87.03 114.35 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.514 0.673 . . . . 0.0 110.796 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 13.4 mt -90.44 -161.6 0.81 Allowed 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.62 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.3 -42.5 57.1 Favored Glycine 0 C--N 1.35 1.32 0 O-C-N 122.16 -0.337 . . . . 0.0 113.907 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -122.3 -27.07 4.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.213 1.005 . . . . 0.0 111.039 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -114.19 167.17 10.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.924 0.889 . . . . 0.0 110.605 -172.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 67.8 p -137.45 133.22 34.43 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.022 0.929 . . . . 0.0 108.767 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.691 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 75.4 mt -81.56 93.8 6.77 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.061 0.944 . . . . 0.0 108.514 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -59.39 110.67 1.14 Allowed 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.413 1.071 . . . . 0.0 112.151 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 30.1 t70 67.26 29.44 7.62 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.766 0.827 . . . . 0.0 111.636 167.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 98.9 m -75.45 131.42 40.13 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.807 -0.558 . . . . 0.0 111.078 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -65.47 117.04 7.4 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.534 0.734 . . . . 0.0 112.126 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 273' ' ' PHE . 36.5 mm -89.64 112.44 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.925 0.89 . . . . 0.0 109.126 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 233' ' ' LYS . 49.0 mt -97.93 22.98 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 CA-C-O 122.519 1.152 . . . . 0.0 109.061 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.502 ' H ' HG22 ' A' ' 271' ' ' ILE . 83.8 m-85 -135.6 34.86 2.94 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.622 1.169 . . . . 0.0 109.989 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 34.3 m -71.03 -12.5 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.057 -174.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -87.15 -29.01 22.11 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.547 0.739 . . . . 0.0 111.325 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -102.08 22.1 13.71 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.341 0.656 . . . . 0.0 111.356 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.592 HG22 ' HB3' ' A' ' 225' ' ' LEU . 85.2 t -73.14 131.34 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.946 0.898 . . . . 0.0 110.406 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -109.07 160.39 16.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.617 0.767 . . . . 0.0 109.886 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 212' ' ' ILE . 85.3 tttt -75.44 143.35 42.71 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.132 174.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.1 mm -72.2 116.06 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.428 ' HB2' ' N ' ' A' ' 208' ' ' ALA . 0.5 OUTLIER -83.39 105.95 14.76 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -106.47 151.53 40.37 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.512 0.725 . . . . 0.0 110.111 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.11 121.14 9.47 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.009 2.472 . . . . 0.0 113.531 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.16 -49.09 1.08 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.974 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -91.31 -24.27 19.87 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -171.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -83.23 137.15 16.0 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.04 0.212 . . . . 0.0 113.027 -170.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 6.5 m -84.36 146.48 47.74 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.144 0.578 . . . . 0.0 111.789 -173.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.28 -173.61 1.8 Allowed 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 123.731 2.954 . . . . 0.0 111.617 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' MET . . . . . 0.522 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 25.5 mmt -82.04 78.83 8.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.102 0.477 . . . . 0.0 109.906 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 13.7 p -87.33 -25.46 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 121.779 0.8 . . . . 0.0 109.022 169.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.66 -166.4 1.57 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.405 1.482 . . . . 0.0 108.22 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.35 154.96 94.41 Favored Pre-proline 0 N--CA 1.483 1.198 0 CA-C-N 118.933 0.788 . . . . 0.0 109.701 172.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.56 102.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.586 2.19 . . . . 0.0 112.292 173.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 89.7 mmm -95.37 135.52 36.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.582 0.753 . . . . 0.0 110.108 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -155.93 165.44 36.47 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.479 0.657 . . . . 0.0 111.397 -172.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.701 ' HD3' ' SD ' ' A' ' 224' ' ' MET . 17.1 mtm180 -88.88 153.07 21.34 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.939 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 82.5 tttt 71.24 166.73 0.3 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.274 1.029 . . . . 0.0 112.397 167.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 40.3 m -74.52 76.9 1.96 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 159.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.42 156.86 29.71 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.451 -174.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo . . . . . 0 C--N 1.37 1.667 0 C-N-CA 123.088 2.525 . . . . 0.0 111.003 175.501 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.491 ' N ' ' HG ' ' A' ' 172' ' ' SER . . . . . . . . 0 N--CA 1.478 1.487 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.72 10.27 10.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.347 0.659 . . . . 0.0 111.898 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -114.92 149.36 37.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 170.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.452 ' H ' ' HB3' ' A' ' 139' ' ' GLU . 3.9 mppt? -102.94 170.25 8.09 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.019 0.528 . . . . 0.0 111.312 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -68.95 -6.23 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.489 1.116 . . . . 0.0 112.996 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.78 -22.97 9.92 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.139 0.976 . . . . 0.0 110.974 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.452 ' HB3' ' H ' ' A' ' 136' ' ' LYS . 38.3 tt0 -80.88 88.26 5.88 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.377 0.671 . . . . 0.0 110.212 -173.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.424 ' HB3' ' OE1' ' A' ' 155' ' ' GLN . 48.5 p90 -78.56 139.42 38.62 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.121 176.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.9 m -130.98 -166.74 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 126.158 1.783 . . . . 0.0 108.386 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -93.89 159.46 15.17 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 154' ' ' ALA . . . -128.94 101.95 6.3 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 124.338 1.055 . . . . 0.0 108.452 172.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -69.8 96.37 0.98 Allowed 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.652 174.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -78.4 111.02 13.98 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.1 m -71.96 -29.52 64.35 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.76 0.824 . . . . 0.0 111.694 -172.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -65.53 -42.97 91.38 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.819 0.847 . . . . 0.0 110.633 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.4 tpp -82.06 -37.9 25.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.191 0.996 . . . . 0.0 109.664 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.52 18.18 66.85 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.397 -170.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -107.4 161.13 15.09 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 122.029 0.918 . . . . 0.0 112.564 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -91.0 126.26 36.03 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.457 -1.701 . . . . 0.0 107.644 169.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -129.13 123.78 33.05 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.459 ' HB2' ' N ' ' A' ' 190' ' ' ASP . 14.6 mm-40 -43.7 137.78 2.89 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.192 0.933 . . . . 0.0 110.192 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 187' ' ' LYS . . . -134.73 116.07 14.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 122.32 0.248 . . . . 0.0 110.4 -176.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.424 ' OE1' ' HB3' ' A' ' 140' ' ' TYR . 60.6 tp60 -90.35 101.35 14.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.409 HG22 HG12 ' A' ' 186' ' ' VAL . 59.4 t -61.18 117.08 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -116.66 -10.02 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.785 0.434 . . . . 0.0 111.838 -176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 -171.33 148.53 2.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.747 0.819 . . . . 0.0 109.245 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 6.1 m -117.4 142.36 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.511 0.724 . . . . 0.0 109.4 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 166' ' ' ARG . 69.6 p -144.24 159.99 41.74 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.79 1.236 . . . . 0.0 108.099 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.4 HH22 ' NH2' ' A' ' 175' ' ' ARG . 93.5 mtt180 -97.35 -179.21 4.42 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.213 0.605 . . . . 0.0 109.732 174.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -78.3 40.87 0.36 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.002 0.921 . . . . 0.0 110.402 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -141.53 160.23 57.51 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.784 1.634 . . . . 0.0 108.087 -167.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -52.05 151.06 17.21 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.092 2.528 . . . . 0.0 115.077 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.593 ' HB3' ' HD3' ' A' ' 166' ' ' ARG . 55.5 m 61.06 -105.58 0.21 Allowed 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 125.574 1.55 . . . . 0.0 113.608 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.593 ' HD3' ' HB3' ' A' ' 165' ' ' SER . 0.0 OUTLIER -152.62 -178.16 6.69 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 118.344 0.52 . . . . 0.0 112.285 -170.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -146.39 160.71 41.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.958 0.903 . . . . 0.0 110.335 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -104.8 154.45 38.58 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.846 0.858 . . . . 0.0 110.652 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.32 152.6 79.12 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.16 1.907 . . . . 0.0 110.768 163.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 25.2 t 68.57 17.92 8.94 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.79 1.236 . . . . 0.0 111.804 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.4 m -109.0 13.83 24.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.808 0.843 . . . . 0.0 110.968 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.491 ' HG ' ' N ' ' A' ' 133' ' ' GLY . 18.8 m -135.35 21.7 3.42 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.955 0.902 . . . . 0.0 109.939 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 24.2 p -69.9 -57.35 5.15 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.067 0.947 . . . . 0.0 111.186 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.5 m -84.85 -9.71 57.86 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.538 0.735 . . . . 0.0 111.581 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.4 ' NH2' HH22 ' A' ' 161' ' ' ARG . 19.7 ptt180 -128.37 85.81 59.47 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.203 0.601 . . . . 0.0 111.283 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -89.8 -148.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 123.179 2.586 . . . . 0.0 110.298 165.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -151.23 -129.31 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 171.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.0 -52.87 4.21 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 165.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -127.31 130.58 49.77 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 165.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.19 95.22 0.56 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.442 0.639 . . . . 0.0 109.845 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -75.96 76.72 2.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.073 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.08 152.87 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.39 1.476 . . . . 0.0 107.792 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.505 HG23 ' HB2' ' A' ' 198' ' ' GLN . 39.3 mt -95.19 110.15 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.02 0.528 . . . . 0.0 110.654 -170.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -92.48 112.44 24.38 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 170.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -79.34 93.95 5.41 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.409 HG12 HG22 ' A' ' 156' ' ' VAL . 6.0 m -108.2 163.84 5.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 114.404 -1.271 . . . . 0.0 107.773 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.496 ' HG2' HG22 ' A' ' 196' ' ' VAL . 35.4 mtmt -106.48 135.02 48.71 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 165.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -63.61 89.88 0.05 OUTLIER 'General case' 0 C--O 1.207 -1.148 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 164.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.46 -20.28 65.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.079 0.952 . . . . 0.0 110.639 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.459 ' N ' ' HB2' ' A' ' 153' ' ' GLU . 2.1 t70 -64.52 -32.48 74.14 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.871 0.869 . . . . 0.0 110.078 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -144.6 72.24 15.54 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.11 -16.61 55.94 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.285 2.657 . . . . 0.0 115.582 -165.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.53 -11.22 59.84 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.568 0.347 . . . . 0.0 111.59 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -72.61 -15.71 61.73 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.308 0.643 . . . . 0.0 111.226 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 93.25 -175.47 36.29 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.661 0.624 . . . . 0.0 114.661 167.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.496 HG22 ' HG2' ' A' ' 187' ' ' LYS . 17.9 t -79.16 115.33 21.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.53 154.92 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.643 1.177 . . . . 0.0 110.214 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.505 ' HB2' HG23 ' A' ' 183' ' ' ILE . 10.8 pt20 -98.24 127.41 44.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.072 0.549 . . . . 0.0 110.103 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 82.7 mmm -137.13 142.01 42.26 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.327 1.051 . . . . 0.0 108.968 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.43 ' O ' HG22 ' A' ' 204' ' ' VAL . 27.5 m-80 -86.24 173.6 9.65 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 118.294 0.497 . . . . 0.0 110.228 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 51.6 m -61.0 -37.88 84.07 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.858 0.299 . . . . 0.0 111.488 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -58.88 -27.9 65.63 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.788 0.835 . . . . 0.0 112.158 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -87.96 -41.55 13.07 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.359 0.664 . . . . 0.0 111.309 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 200' ' ' ASN . 4.7 m -93.28 116.66 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.82 0.819 . . . . 0.0 109.233 -175.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -113.43 148.77 35.25 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.59 -165.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.09 153.93 20.55 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.272 0.629 . . . . 0.0 110.275 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.419 ' HG3' ' SD ' ' A' ' 289' ' ' MET . 9.6 ptm85 -117.64 127.17 53.69 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.371 0.668 . . . . 0.0 111.006 -169.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -85.26 136.47 33.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.828 0.851 . . . . 0.0 109.837 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.715 ' HB3' ' HG2' ' A' ' 289' ' ' MET . 6.7 ppt_? -92.77 15.61 14.21 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.125 0.57 . . . . 0.0 110.65 175.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 279' ' ' LYS . 23.0 m -86.62 108.89 18.82 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.391 0.677 . . . . 0.0 110.01 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 mt -86.51 121.98 38.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 172.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.568 HG23 ' HB2' ' A' ' 216' ' ' ASP . 38.5 mm -94.29 142.33 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.502 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 1.3 ptpp? -128.2 -179.73 5.16 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.609 1.164 . . . . 0.0 109.699 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.428 ' CH2' ' HB2' ' A' ' 248' ' ' GLU . 10.5 t90 -56.16 -40.47 73.93 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.064 0.546 . . . . 0.0 110.454 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -59.3 -33.12 70.71 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.718 0.807 . . . . 0.0 111.604 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.568 ' HB2' HG23 ' A' ' 212' ' ' ILE . 66.0 m-20 -80.34 -34.7 36.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.279 0.632 . . . . 0.0 110.536 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.518 HD22 HD11 ' A' ' 243' ' ' ILE . 89.0 mt -67.18 112.86 4.7 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-O 120.99 0.424 . . . . 0.0 110.479 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.51 154.83 51.24 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.519 1.127 . . . . 0.0 108.353 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 36.0 m -64.42 124.15 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.008 0.432 . . . . 0.0 110.49 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.25 -18.88 47.56 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.561 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -79.64 124.36 28.48 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.526 0.663 . . . . 0.0 109.859 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 14.0 p -91.94 141.23 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.535 0.683 . . . . 0.0 109.165 173.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.463 HG11 HG21 ' A' ' 212' ' ' ILE . 11.4 m -139.1 -177.1 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.978 1.311 . . . . 0.0 109.266 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.45 ' HB3' ' HE2' ' A' ' 224' ' ' MET . 3.8 ttp -136.63 125.27 23.75 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.115 0.566 . . . . 0.0 109.609 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.432 HD13 ' HD1' ' A' ' 227' ' ' TYR . 0.4 OUTLIER -146.21 151.62 37.89 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.408 1.083 . . . . 0.0 110.29 -169.445 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -88.8 108.79 19.7 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.935 0.494 . . . . 0.0 111.064 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.432 ' HD1' HD13 ' A' ' 225' ' ' LEU . 93.5 m-85 -140.61 139.77 34.96 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.913 0.885 . . . . 0.0 108.836 171.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.493 HD22 ' HB2' ' A' ' 230' ' ' ASP . 14.0 p-10 -87.26 134.62 36.07 Favored Pre-proline 0 N--CA 1.474 0.729 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.49 -13.12 36.78 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.116 1.878 . . . . 0.0 112.469 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.493 ' HB2' HD22 ' A' ' 228' ' ' ASN . 6.5 m-20 -67.69 -40.31 84.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.867 0.867 . . . . 0.0 110.133 173.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 234' ' ' GLU . 48.1 t-20 -141.31 104.19 6.04 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.78 -16.96 47.12 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.655 2.236 . . . . 0.0 112.688 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.478 ' HG3' HD11 ' A' ' 272' ' ' ILE . 83.0 tttt -95.55 8.3 43.75 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.989 0.916 . . . . 0.0 110.358 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 231' ' ' ASN . 38.3 tt0 -132.95 148.76 52.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.334 0.654 . . . . 0.0 110.964 -175.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -60.14 150.34 29.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.626 1.17 . . . . 0.0 112.386 172.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -169.6 -115.36 0.33 Allowed Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.493 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -95.62 150.06 20.77 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.347 0.659 . . . . 0.0 110.439 -176.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -77.97 107.45 10.52 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.403 0.681 . . . . 0.0 110.042 -174.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -119.63 164.97 15.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.331 0.652 . . . . 0.0 109.263 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.55 144.23 30.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 174.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.73 133.95 21.68 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 222' ' ' VAL . 34.6 tt0 -105.49 127.06 52.8 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.552 HD12 HD11 ' A' ' 255' ' ' LEU . 14.7 mm -64.95 103.8 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 123.993 0.808 . . . . 0.0 109.666 -172.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.8 p -79.31 -45.57 19.4 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.144 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -143.82 163.6 32.91 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.284 1.034 . . . . 0.0 110.102 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -155.03 149.05 25.8 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.761 0.824 . . . . 0.0 109.427 172.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -146.57 118.87 8.36 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.484 0.659 . . . . 0.0 110.565 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.428 ' HB2' ' CH2' ' A' ' 214' ' ' TRP . 5.0 tm-20 -93.17 124.19 36.97 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 63.6 p -125.61 157.51 37.01 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.44 ' HG3' HG23 ' A' ' 251' ' ' THR . 27.5 ptt180 -60.82 -24.76 66.11 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.349 1.06 . . . . 0.0 112.703 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.44 HG23 ' HG3' ' A' ' 250' ' ' ARG . 55.9 p -97.93 -28.59 13.74 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.828 0.851 . . . . 0.0 112.566 -172.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -166.1 169.24 14.7 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.68 0.392 . . . . 0.0 111.026 -173.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -95.85 155.56 16.7 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.081 0.553 . . . . 0.0 109.747 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -146.28 140.56 26.58 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.552 HD11 HD12 ' A' ' 243' ' ' ILE . 0.3 OUTLIER -148.17 144.35 27.69 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.183 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -135.68 134.04 38.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.998 0.919 . . . . 0.0 109.82 176.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.84 143.98 27.82 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.223 0.609 . . . . 0.0 111.087 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -79.52 98.43 6.84 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.022 0.529 . . . . 0.0 109.583 172.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 91.8 t -76.42 103.51 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.273 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.66 122.53 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.966 0.889 . . . . 0.0 110.104 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 32.5 mt -88.17 -151.57 0.2 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.173 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -59.89 -77.04 0.19 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 117.852 0.296 . . . . 0.0 112.579 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -100.49 -25.15 14.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.378 0.671 . . . . 0.0 110.944 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -90.61 173.21 8.17 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.826 0.85 . . . . 0.0 111.435 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 32.8 p -155.56 120.54 4.8 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.553 0.741 . . . . 0.0 110.054 174.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.19 97.51 7.64 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.364 1.066 . . . . 0.0 109.033 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.7 132.92 46.89 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.564 0.746 . . . . 0.0 111.36 -172.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 55.3 35.87 25.85 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.644 1.215 . . . . 0.0 111.818 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 36.8 t -64.0 124.43 21.57 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 54.3 ttt180 -70.63 117.18 11.83 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.788 0.435 . . . . 0.0 110.229 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 34.8 mm -80.36 110.91 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.219 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.478 HD11 ' HG3' ' A' ' 233' ' ' LYS . 25.0 mm -78.12 -66.36 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.796 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -83.63 65.84 8.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.817 1.247 . . . . 0.0 109.948 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.7 m -64.4 -32.53 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.603 0.761 . . . . 0.0 111.999 -173.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 5.3 p-10 -86.05 -13.98 45.76 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.645 1.178 . . . . 0.0 111.917 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -97.65 -0.64 45.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.453 0.701 . . . . 0.0 111.471 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.81 153.87 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.704 0.801 . . . . 0.0 110.637 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -117.4 161.56 19.35 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.899 0.879 . . . . 0.0 108.869 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.417 ' HB3' ' HB ' ' A' ' 210' ' ' THR . 80.1 tttt -91.03 153.09 20.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.867 0.467 . . . . 0.0 112.008 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.2 mm -67.23 120.26 14.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 123.947 0.899 . . . . 0.0 108.802 168.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.36 112.2 8.22 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.527 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 96.1 mtt180 -128.2 141.59 41.79 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 123.883 0.873 . . . . 0.0 109.436 172.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -46.16 108.03 0.14 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.815 3.01 . . . . 0.0 113.265 170.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.36 -39.78 2.9 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.817 -0.628 . . . . 0.0 113.435 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 32.5 tt0 -79.35 -29.19 42.09 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.961 0.381 . . . . 0.0 111.766 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -117.57 151.43 18.07 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 12.5 p -88.91 109.95 34.15 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-N 117.788 0.794 . . . . 0.0 110.114 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.25 155.69 60.31 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 123.198 2.599 . . . . 0.0 110.166 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' MET . . . . . 0.715 ' HG2' ' HB3' ' A' ' 209' ' ' ARG . 63.8 mtt -74.78 80.5 2.08 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.61 0.719 . . . . 0.0 112.559 -172.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.02 -28.11 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 165.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.78 -164.42 0.79 Allowed 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.254 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -57.24 111.75 3.78 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 118.774 0.715 . . . . 0.0 111.566 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.544 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 11.9 Cg_exo -72.61 93.89 0.77 Allowed 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.432 2.088 . . . . 0.0 111.094 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.2 mtm -73.36 125.73 28.52 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.02 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.23 121.34 22.77 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -64.59 -30.08 71.1 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.06 0.944 . . . . 0.0 111.179 -175.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -57.06 122.08 11.52 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.383 167.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 50.2 p -77.57 91.98 4.02 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.366 0.666 . . . . 0.0 110.804 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -92.25 167.54 30.35 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.564 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo . . . . . 0 C--N 1.38 2.203 0 C-N-CA 123.214 2.609 . . . . 0.0 111.917 176.472 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.417 0 CA-C-O 119.744 -0.476 . . . . 0.0 111.967 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.31 7.37 4.97 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -79.6 128.47 33.42 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.776 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 58.1 pttt -72.18 174.66 6.88 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.004 0.922 . . . . 0.0 111.657 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -74.51 -2.67 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.206 0.602 . . . . 0.0 111.948 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.511 ' H ' ' HG3' ' A' ' 136' ' ' LYS . 92.0 m-20 -120.99 30.3 6.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.244 1.018 . . . . 0.0 110.96 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.776 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 6.3 mm-40 -88.86 71.21 8.64 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.253 1.025 . . . . 0.0 110.859 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -63.76 99.4 0.23 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.288 169.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 30.1 m -121.77 169.32 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.972 0.909 . . . . 0.0 109.703 -176.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' A' ' 207' ' ' ARG . 1.6 t0 -101.6 110.34 22.32 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -92.75 92.98 8.21 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 122.932 0.493 . . . . 0.0 110.497 -171.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 2.8 tmt_? -72.27 106.13 4.32 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 174.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.62 114.8 3.78 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.47 ' HA ' ' NH1' ' A' ' 144' ' ' ARG . 13.8 t -60.25 -23.89 64.46 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -171.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -83.7 -38.69 21.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.447 0.699 . . . . 0.0 110.174 -174.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 41.9 ttm -92.96 -22.89 18.93 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.491 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.42 12.93 73.66 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.063 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.56 129.98 53.71 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.622 0.769 . . . . 0.0 111.147 -174.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 52.1 m95 -81.89 121.93 27.09 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.077 0.951 . . . . 0.0 110.617 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -131.03 115.18 16.12 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 27.1 mt-10 -58.45 144.86 40.72 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.311 0.505 . . . . 0.0 111.139 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.494 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -158.42 124.78 4.69 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 124.31 1.006 . . . . 0.0 109.613 -176.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -92.48 118.88 31.42 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 63.7 t -61.66 111.72 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 C-N-CA 123.484 0.713 . . . . 0.0 109.315 172.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.7 m -104.48 -6.89 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.138 0.575 . . . . 0.0 111.8 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -170.14 141.28 2.08 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.199 0.599 . . . . 0.0 110.24 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.6 m -119.41 142.09 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.59 0.756 . . . . 0.0 110.672 172.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.2 t -147.14 160.86 41.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.032 0.933 . . . . 0.0 108.833 169.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.588 ' HE ' ' HB3' ' A' ' 163' ' ' ALA . 17.2 ptt-85 -101.73 176.39 5.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.061 0.544 . . . . 0.0 110.217 -177.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -85.78 58.58 5.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.474 0.71 . . . . 0.0 110.042 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.588 ' HB3' ' HE ' ' A' ' 161' ' ' ARG . . . -169.17 148.92 3.75 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.709 1.204 . . . . 0.0 109.224 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.538 ' HB2' ' HB2' ' A' ' 167' ' ' ASP . 42.2 Cg_endo -64.39 92.42 0.19 Allowed 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.95 2.433 . . . . 0.0 112.585 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 16.7 m -86.07 -42.89 13.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.789 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -68.65 -51.57 40.66 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.313 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.538 ' HB2' ' HB2' ' A' ' 164' ' ' PRO . 10.1 m-20 -54.73 -45.67 74.13 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 123.591 0.557 . . . . 0.0 110.456 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.607 ' HG2' ' HB3' ' A' ' 171' ' ' SER . 0.6 OUTLIER 47.4 73.7 0.95 Allowed Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.227 1.411 . . . . 0.0 110.083 -177.532 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.02 -61.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.37 2.047 . . . . 0.0 110.598 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 85.9 m -134.51 33.04 3.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.501 1.121 . . . . 0.0 109.108 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.607 ' HB3' ' HG2' ' A' ' 168' ' ' GLU . 32.7 t -71.97 171.15 12.33 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.537 1.135 . . . . 0.0 111.071 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.2 m 72.12 8.16 5.86 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.936 1.294 . . . . 0.0 112.809 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.6 t -88.15 -25.77 22.79 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.061 0.545 . . . . 0.0 109.747 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 23.7 p -166.09 154.75 11.11 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 124.794 1.238 . . . . 0.0 109.334 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -146.32 91.74 5.37 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.081 0.553 . . . . 0.0 109.894 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.84 113.5 3.81 Favored 'Trans proline' 0 CA--C 1.554 1.509 0 C-N-CA 122.709 2.273 . . . . 0.0 112.405 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -129.66 -33.76 1.82 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.665 0.786 . . . . 0.0 110.299 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.594 ' HG ' ' HG3' ' A' ' 179' ' ' GLU . 43.5 tp 56.61 -83.13 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.117 1.767 . . . . 0.0 112.447 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.594 ' HG3' ' HG ' ' A' ' 178' ' ' LEU . 45.3 mt-10 -126.18 44.48 2.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.408 1.083 . . . . 0.0 109.078 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.402 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 10.0 mm-40 52.11 29.21 6.15 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 173.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -71.41 63.35 0.38 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.54 168.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.31 -175.51 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.821 1.648 . . . . 0.0 108.645 -170.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.611 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.7 mp -97.5 110.71 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.402 ' OH ' ' HB3' ' A' ' 180' ' ' GLU . 99.6 m-85 -98.61 106.61 18.91 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.193 0.997 . . . . 0.0 108.411 170.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -79.09 97.7 6.23 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.494 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 35.1 m -109.97 163.65 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.241 1.017 . . . . 0.0 111.019 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 154' ' ' ALA . 1.8 mmmp? -121.54 114.01 20.61 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -63.16 115.03 4.12 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.303 0.377 . . . . 0.0 110.254 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.69 -34.77 72.33 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.968 0.413 . . . . 0.0 110.408 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.64 -28.72 61.93 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.898 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -142.17 68.13 22.0 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 122.762 0.425 . . . . 0.0 111.342 -170.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.34 -11.41 24.75 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.264 2.643 . . . . 0.0 113.629 -174.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.44 -17.87 62.36 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.558 0.743 . . . . 0.0 111.17 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -72.5 -10.5 59.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.389 0.675 . . . . 0.0 111.54 173.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.63 -151.78 45.16 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.401 0.438 . . . . 0.0 112.342 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.75 117.88 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 18.5 m -116.6 152.62 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.833 0.853 . . . . 0.0 109.466 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.611 ' HB2' HG23 ' A' ' 183' ' ' ILE . 5.4 pm0 -107.57 123.97 49.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.976 0.51 . . . . 0.0 109.716 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' MET . . . . . 0.404 ' HE1' ' HB1' ' A' ' 143' ' ' ALA . 74.9 mtp -131.16 170.13 14.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.58 0.752 . . . . 0.0 110.045 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -109.41 175.4 5.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.922 0.889 . . . . 0.0 109.904 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 45.8 t -63.73 -40.02 95.72 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.884 0.474 . . . . 0.0 110.687 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -65.46 -7.32 13.59 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -101.87 -54.64 2.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.027 0.931 . . . . 0.0 111.345 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 32.6 m -91.72 119.94 39.94 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -168.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.428 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 16.0 mmt180 -123.12 141.4 52.01 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.937 -169.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.81 132.18 51.55 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 168.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.674 ' HB3' ' HB2' ' A' ' 142' ' ' ASP . 4.2 ptm180 -111.71 158.35 19.43 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.772 0.429 . . . . 0.0 111.119 -173.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.64 140.64 29.33 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.858 0.463 . . . . 0.0 109.882 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.515 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 10.9 ptm180 -93.43 18.11 10.32 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.378 0.609 . . . . 0.0 110.537 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 87.8 m -98.91 113.99 26.39 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.304 1.042 . . . . 0.0 109.996 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 30.6 mt -86.94 124.49 40.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 169.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.629 ' HB ' ' HB ' ' A' ' 277' ' ' VAL . 47.9 mm -86.37 127.3 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.755 1.222 . . . . 0.0 109.917 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.87 -178.91 3.6 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.208 1.003 . . . . 0.0 108.625 171.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.401 ' HA ' HD23 ' A' ' 217' ' ' LEU . 64.4 t-105 -54.29 -32.92 57.54 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.128 0.571 . . . . 0.0 112.269 -172.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -61.77 -39.17 90.73 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.529 0.731 . . . . 0.0 111.487 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.593 ' HB2' HG23 ' A' ' 212' ' ' ILE . 7.1 m-20 -84.6 -14.52 48.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.85 0.86 . . . . 0.0 111.67 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.447 HD22 HG22 ' A' ' 212' ' ' ILE . 3.2 mm? -66.7 113.41 4.81 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.7 140.94 34.99 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.129 0.971 . . . . 0.0 108.438 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.1 m -70.0 138.49 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 120.966 0.412 . . . . 0.0 110.899 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 94.06 -13.78 66.66 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.324 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.474 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.1 tt0 -81.68 122.77 28.05 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.344 0.572 . . . . 0.0 110.837 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.83 119.66 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 279' ' ' LYS . 1.9 m -135.27 172.58 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.587 1.155 . . . . 0.0 110.265 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.531 ' HE2' ' HB2' ' A' ' 278' ' ' PHE . 48.4 ttp -110.32 113.98 27.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.257 0.623 . . . . 0.0 110.08 -174.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.527 ' HG ' HG13 ' A' ' 277' ' ' VAL . 0.2 OUTLIER -121.97 147.16 46.41 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.281 0.632 . . . . 0.0 109.502 -173.102 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -87.44 124.09 33.06 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.575 0.75 . . . . 0.0 110.143 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 225' ' ' LEU . 7.3 p90 -169.07 154.2 5.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.061 0.944 . . . . 0.0 109.357 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -82.11 127.83 70.23 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 162.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.77 -38.89 77.57 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.304 2.003 . . . . 0.0 111.939 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -75.59 -30.1 59.51 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.021 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -132.9 79.87 62.21 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 123.3 0.64 . . . . 0.0 110.643 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.95 -11.96 32.18 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.135 2.557 . . . . 0.0 113.389 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.51 ' HA ' HD12 ' A' ' 272' ' ' ILE . 22.3 tptm -70.99 -24.23 62.35 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.35 0.66 . . . . 0.0 110.931 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.68 164.56 24.75 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.0 0.52 . . . . 0.0 111.033 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -51.49 160.08 0.65 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.335 1.454 . . . . 0.0 112.804 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -166.02 -107.32 0.2 Allowed Glycine 0 C--N 1.344 1.018 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -128.18 173.18 10.33 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.773 0.829 . . . . 0.0 109.11 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -96.65 127.16 42.37 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.452 0.701 . . . . 0.0 110.049 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 224' ' ' MET . 93.7 m-85 -138.95 164.54 29.45 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.371 0.668 . . . . 0.0 110.051 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.4 140.44 34.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -150.95 137.38 18.62 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -95.42 126.42 40.7 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.475 HD12 HD11 ' A' ' 255' ' ' LEU . 19.0 mm -67.65 110.39 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.052 0.453 . . . . 0.0 109.801 -175.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.424 ' H ' ' HA ' ' A' ' 257' ' ' ALA . 17.1 m -79.3 -39.66 32.35 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.823 0.849 . . . . 0.0 110.666 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -161.97 156.08 21.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.79 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -141.69 148.29 38.84 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.524 ' HB3' ' HG3' ' A' ' 254' ' ' GLU . 28.1 tpt180 -149.87 122.15 8.39 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -115.32 123.69 49.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.113 0.565 . . . . 0.0 109.873 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 62.2 p -121.6 162.95 19.73 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' A' ' 250' ' ' ARG . 11.6 tpt180 -67.18 -22.31 65.75 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 120.759 0.314 . . . . 0.0 111.401 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.2 p -86.41 -28.99 23.22 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.375 0.67 . . . . 0.0 111.414 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -165.67 141.41 5.1 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.445 ' O ' ' HD2' ' A' ' 253' ' ' ARG . 4.2 ppt_? -111.18 102.52 10.94 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.675 0.79 . . . . 0.0 109.569 173.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 247' ' ' ARG . 7.6 pt-20 -95.71 122.85 38.92 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.634 0.774 . . . . 0.0 110.722 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 270' ' ' ARG . 1.7 tm? -108.77 147.85 31.41 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' TYR . . . . . 0.448 ' N ' HD13 ' A' ' 255' ' ' LEU . 99.3 m-85 -135.04 132.31 38.1 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.264 1.026 . . . . 0.0 108.516 175.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.424 ' HA ' ' H ' ' A' ' 244' ' ' SER . . . -144.46 139.94 28.62 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 -177.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 43.5 t30 -75.66 95.54 3.41 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 172.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 34.3 t -68.79 112.16 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.372 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.79 117.92 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 264' ' ' ASP . 59.8 mt -94.5 -165.78 1.37 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.497 0.719 . . . . 0.0 109.423 173.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -62.85 -45.3 95.99 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.01 0.194 . . . . 0.0 113.341 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -123.06 -35.98 2.92 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.546 0.738 . . . . 0.0 110.646 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.571 ' HB2' HD12 ' A' ' 261' ' ' LEU . 8.2 m-20 -91.79 176.55 6.49 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.83 0.852 . . . . 0.0 111.574 -172.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 35.1 t -156.59 118.08 3.82 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.514 0.726 . . . . 0.0 110.201 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 2.0 mm? -96.15 92.11 6.25 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 3.2 p-10 -68.7 138.61 55.07 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.353 0.261 . . . . 0.0 111.289 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 57.88 32.53 22.05 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.291 1.036 . . . . 0.0 111.786 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 44.0 t -65.27 127.27 31.05 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.41 0.684 . . . . 0.0 110.411 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 45.0 ttp180 -70.51 110.49 5.42 Favored 'General case' 0 C--N 1.346 0.456 0 O-C-N 123.436 0.46 . . . . 0.0 110.343 -178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.1 mm -89.43 132.78 33.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.774 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 233' ' ' LYS . 65.0 mt -102.09 -26.31 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.082 1.353 . . . . 0.0 109.932 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -92.38 42.62 1.11 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.124 1.37 . . . . 0.0 111.336 -168.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 16.7 m -69.59 -22.84 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -168.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.85 -25.22 19.07 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.96 9.12 17.9 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.762 0.825 . . . . 0.0 112.332 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.629 ' HB ' ' HB ' ' A' ' 212' ' ' ILE . 32.7 t -80.56 147.05 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.391 0.676 . . . . 0.0 110.836 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.531 ' HB2' ' HE2' ' A' ' 224' ' ' MET . 62.7 m-85 -105.8 156.26 18.49 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 162.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.552 ' HA ' HG12 ' A' ' 223' ' ' VAL . 36.5 ttmt -80.57 146.58 31.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.666 0.386 . . . . 0.0 110.417 173.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.542 HG12 ' HA ' ' A' ' 223' ' ' VAL . 35.1 mm -73.48 114.91 13.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 168.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -76.6 134.06 39.47 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.631 173.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 61.5 mtp180 -108.38 94.2 13.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 168.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -20.17 97.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.386 2.551 1 C-N-CA 126.263 4.642 . . . . 0.0 117.246 -162.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 103.53 -30.84 9.5 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 115.347 -0.842 . . . . 0.0 115.189 169.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 11.6 pt-20 -79.51 -20.21 47.77 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.859 1.33 . . . . 0.0 112.004 -173.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -87.46 -100.57 0.87 Allowed Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' SER . . . . . 0.422 ' HB2' ' HG2' ' A' ' 209' ' ' ARG . 14.6 p -127.23 128.52 24.08 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.535 1.134 . . . . 0.0 110.791 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.52 133.66 17.65 Favored 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 123.29 2.66 . . . . 0.0 112.921 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' MET . . . . . 0.515 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 98.3 mmm -86.45 82.49 7.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 168.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 11.2 p -128.58 -15.03 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.757 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -103.42 -153.18 0.47 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.701 1.2 . . . . 0.0 108.625 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -55.17 120.19 28.28 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.566 0.747 . . . . 0.0 111.575 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.33 85.12 0.45 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.817 2.345 . . . . 0.0 111.336 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 18.7 ptm -71.05 82.39 0.68 Allowed 'General case' 0 C--O 1.244 0.767 0 CA-C-O 123.037 1.399 . . . . 0.0 109.895 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -94.73 160.03 14.8 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.77 -172.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.455 ' NH2' ' H ' ' A' ' 153' ' ' GLU . 30.6 mtm-85 -87.3 118.79 26.96 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.108 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.6 mttt 64.81 -170.89 0.19 Allowed 'General case' 0 CA--C 1.551 1.002 0 O-C-N 124.565 1.166 . . . . 0.0 111.078 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.5 m -146.32 76.41 1.44 Allowed 'General case' 0 C--O 1.24 0.562 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 160.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 122.22 175.33 14.78 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.891 -171.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo . . . . . 0 C--N 1.375 1.966 0 C-N-CA 123.311 2.674 . . . . 0.0 111.274 178.135 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.634 ' N ' ' HH ' ' A' ' 184' ' ' TYR . . . . . . . . 0 N--CA 1.485 1.955 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.432 HD13 ' N ' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -127.29 5.67 6.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.488 0.715 . . . . 0.0 112.323 -173.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.505 ' HB2' HG11 ' A' ' 156' ' ' VAL . 43.0 m-85 -96.93 143.08 28.14 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.475 0.31 . . . . 0.0 110.433 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.551 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 22.6 pttp -86.14 176.8 7.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.037 0.535 . . . . 0.0 111.055 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.65 -10.27 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -173.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -127.44 21.59 6.59 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.747 0.419 . . . . 0.0 110.44 -171.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.551 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 17.9 mm-40 -99.65 88.62 3.88 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 122.038 -0.414 . . . . 0.0 110.798 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 25.6 p90 -76.75 122.87 25.35 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.339 171.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.26 167.42 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.617 0.767 . . . . 0.0 108.968 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -90.72 115.12 27.57 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.79 120.37 36.33 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.588 -167.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.54 128.37 35.39 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.85 112.45 5.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 t -68.02 -14.35 62.9 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.464 0.705 . . . . 0.0 112.702 -172.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -86.76 -54.12 4.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.343 0.657 . . . . 0.0 111.107 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 37.8 ttp -96.34 -27.83 14.77 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.411 0.685 . . . . 0.0 112.084 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.72 18.85 46.35 Favored Glycine 0 N--CA 1.475 1.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.946 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.75 129.37 53.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.119 0.568 . . . . 0.0 111.062 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.673 ' HH2' ' HD2' ' A' ' 205' ' ' ARG . 81.4 m95 -75.22 128.09 34.66 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.64 0.776 . . . . 0.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -131.8 137.66 48.22 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.283 1.033 . . . . 0.0 108.925 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -59.32 114.43 2.65 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -125.54 120.67 31.5 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.199 0.6 . . . . 0.0 109.796 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.734 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 51.6 tt0 -87.19 114.75 24.07 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.605 0.762 . . . . 0.0 110.554 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 135' ' ' TYR . 92.5 t -62.28 98.41 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.7 m -94.88 -10.02 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.912 0.485 . . . . 0.0 111.076 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 27.8 ttt180 -170.25 146.7 2.97 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.975 0.797 . . . . 0.0 109.92 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.0 m -117.17 142.9 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 169.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.3 p -135.21 121.49 20.3 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 172.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -82.18 176.47 9.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.029 0.532 . . . . 0.0 111.051 -175.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -78.29 67.71 4.15 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -171.38 155.02 4.07 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.399 -169.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.54 88.26 0.17 Allowed 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.562 2.175 . . . . 0.0 112.044 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.7 m -81.14 -41.71 22.03 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.057 0.943 . . . . 0.0 110.364 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 73.51 150.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.794 1.638 . . . . 0.0 112.636 173.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -50.54 -55.72 14.86 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.333 1.053 . . . . 0.0 111.199 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -79.44 108.98 9.95 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 163.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.82 139.85 34.25 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.558 2.172 . . . . 0.0 112.601 -166.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 10.0 p -78.37 153.46 31.61 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.732 0.813 . . . . 0.0 109.562 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 31.3 t -58.37 137.15 57.44 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.632 0.773 . . . . 0.0 110.221 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 71.2 p -60.29 104.8 0.35 Allowed 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.997 0.81 . . . . 0.0 111.867 -169.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 19.3 p -75.81 157.78 32.98 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.546 -1.207 . . . . 0.0 111.322 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 10.6 p -88.65 59.26 5.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.159 0.984 . . . . 0.0 110.12 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 64.9 mtt-85 -96.48 105.29 21.76 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.416 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.39 163.54 24.59 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.591 2.194 . . . . 0.0 113.063 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -160.61 -179.18 7.42 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.949 0.9 . . . . 0.0 110.207 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.41 ' H ' HD23 ' A' ' 178' ' ' LEU . 1.2 pt? -120.2 -112.21 0.33 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -74.77 78.22 2.08 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 119.152 0.887 . . . . 0.0 108.658 167.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.23 97.43 1.55 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.025 -171.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -76.66 53.14 0.87 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.823 0.82 . . . . 0.0 110.435 169.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 31.6 m -83.85 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 124.603 1.161 . . . . 0.0 109.624 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.595 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.5 mp -97.3 106.21 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.634 ' HH ' ' N ' ' A' ' 133' ' ' GLY . 36.2 m-85 -93.54 111.17 22.78 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 14.5 m-70 -80.01 90.28 5.38 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 35.0 m -108.97 140.2 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.32 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -105.74 123.45 47.97 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -57.04 96.3 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -62.96 -29.63 70.96 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.006 0.922 . . . . 0.0 109.076 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 298' ' ' SER . 2.0 t0 -61.83 -30.96 71.18 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.086 1.354 . . . . 0.0 111.031 176.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -145.75 81.27 10.1 Favored Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 124.549 1.14 . . . . 0.0 108.624 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -65.05 -16.86 57.36 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.076 2.517 . . . . 0.0 114.618 -170.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.53 -18.7 65.13 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -74.67 -20.9 59.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.206 0.602 . . . . 0.0 111.626 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.41 -144.6 41.04 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.511 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 6.8 t -87.66 129.55 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.217 0.607 . . . . 0.0 110.424 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.7 153.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.045 1.338 . . . . 0.0 108.52 170.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.595 ' HB2' HG23 ' A' ' 183' ' ' ILE . 16.2 pt20 -102.88 128.74 49.54 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.124 0.488 . . . . 0.0 110.305 177.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 84.2 mtp -137.61 159.82 40.9 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.33 1.052 . . . . 0.0 108.73 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -97.81 174.23 6.7 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.6 t -64.21 -34.79 78.89 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 120.827 0.346 . . . . 0.0 110.746 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.46 -14.86 63.3 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -96.5 -45.29 6.81 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.716 0.807 . . . . 0.0 110.344 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 32.6 m -95.41 117.29 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.673 ' HD2' ' HH2' ' A' ' 151' ' ' TRP . 92.7 mtt180 -128.55 171.42 12.15 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.77 -0.582 . . . . 0.0 111.193 -168.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.58 129.4 40.43 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.374 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.58 ' HG3' ' SD ' ' A' ' 289' ' ' MET . 26.4 ptt180 -81.1 142.11 33.64 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.357 1.063 . . . . 0.0 111.229 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.65 ' HB2' ' HB2' ' A' ' 281' ' ' GLU . . . -99.92 145.41 27.84 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.395 0.678 . . . . 0.0 110.339 175.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -2.38 34.81 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.657 0.783 . . . . 0.0 110.558 173.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.5 m -89.49 117.71 28.6 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.473 0.709 . . . . 0.0 111.332 -165.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.3 mt -92.4 136.26 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 166.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.686 HG21 HD13 ' A' ' 217' ' ' LEU . 19.9 mm -107.46 153.55 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.951 0.9 . . . . 0.0 110.372 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -128.26 168.52 15.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.549 0.74 . . . . 0.0 109.066 167.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 35.9 t90 -46.32 -41.86 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.344 1.058 . . . . 0.0 112.096 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -57.68 -46.3 84.48 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.85 0.86 . . . . 0.0 112.637 -173.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -103.65 6.3 36.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.504 0.722 . . . . 0.0 111.023 -175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.686 HD13 HG21 ' A' ' 212' ' ' ILE . 8.0 tp -86.63 110.96 20.2 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 175.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.7 153.35 25.39 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.947 0.34 . . . . 0.0 110.861 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.413 ' HA ' ' HB ' ' A' ' 243' ' ' ILE . 28.0 m -66.13 136.99 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.701 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.0 -23.62 34.89 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.622 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.524 ' HG2' HG13 ' A' ' 223' ' ' VAL . 62.5 tt0 -74.69 123.39 24.81 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.119 0.567 . . . . 0.0 110.373 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 84.5 t -85.8 119.91 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.524 HG13 ' HG2' ' A' ' 221' ' ' GLN . 3.5 m -132.69 164.54 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.226 1.41 . . . . 0.0 109.856 -177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.589 ' HB3' HD11 ' A' ' 280' ' ' ILE . 15.0 ptm -112.28 139.11 48.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.635 0.774 . . . . 0.0 110.353 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.578 HD13 HG23 ' A' ' 271' ' ' ILE . 0.6 OUTLIER -142.69 157.28 44.83 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.31 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -89.37 112.23 23.29 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.195 0.598 . . . . 0.0 109.65 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.429 ' OH ' HG13 ' A' ' 259' ' ' VAL . 0.5 OUTLIER -159.89 149.69 18.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.692 0.797 . . . . 0.0 109.321 178.65 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -92.76 137.37 24.14 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 171.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.82 2.53 5.83 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.733 2.289 . . . . 0.0 113.66 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -96.77 -15.93 21.1 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.869 0.868 . . . . 0.0 110.726 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -160.08 90.48 1.79 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.606 0.762 . . . . 0.0 109.025 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.05 -5.19 15.8 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.067 2.511 . . . . 0.0 112.33 175.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.664 ' HA ' HD12 ' A' ' 272' ' ' ILE . 88.6 tttt -73.45 -28.29 61.88 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.772 0.829 . . . . 0.0 111.171 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -123.84 155.18 38.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.09 0.556 . . . . 0.0 110.263 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -68.75 174.3 4.45 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.263 1.025 . . . . 0.0 112.76 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -178.8 -105.03 0.19 Allowed Glycine 0 C--N 1.338 0.67 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.932 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -110.04 153.03 25.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 0.0 109.408 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' TRP . . . . . 0.437 ' HA ' ' O ' ' A' ' 225' ' ' LEU . 67.2 m95 -83.58 106.38 15.27 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 122.796 0.438 . . . . 0.0 110.074 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -112.62 166.08 11.67 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ASP . . . . . 0.494 ' HB2' HG13 ' A' ' 260' ' ' VAL . 3.8 m-20 -81.32 146.21 30.48 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.223 176.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -146.47 134.51 21.5 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -102.39 117.28 34.38 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.414 HD12 HD21 ' A' ' 255' ' ' LEU . 31.8 mm -61.98 114.8 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 123.352 0.407 . . . . 0.0 110.377 -171.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 20.1 m -98.86 -25.01 14.76 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.463 0.705 . . . . 0.0 110.449 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 23.9 ttm180 -166.89 151.71 7.42 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.726 0.811 . . . . 0.0 109.381 -174.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -156.42 134.3 11.09 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.963 0.505 . . . . 0.0 110.388 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -146.51 116.38 7.27 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 8.9 pt-20 -100.16 152.18 20.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.194 0.521 . . . . 0.0 109.824 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 69.5 p -131.96 168.03 18.62 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -67.93 -15.98 63.86 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 117.829 0.286 . . . . 0.0 111.32 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.6 p -94.01 -29.87 15.0 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.843 0.857 . . . . 0.0 112.027 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -168.62 134.73 1.82 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 122.917 0.487 . . . . 0.0 111.528 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 46.9 mtt180 -90.79 106.88 18.82 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -95.95 143.55 27.03 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.301 0.64 . . . . 0.0 109.643 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.516 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 5.6 tt -150.0 149.84 30.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' TYR . . . . . 0.476 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 82.4 m-85 -134.72 124.84 25.89 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -134.54 147.88 50.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.11 0.564 . . . . 0.0 110.459 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 35.0 t30 -76.01 92.49 3.16 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 15.7 t -67.96 130.42 33.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.649 174.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 240' ' ' ASP . 4.3 p -122.47 114.26 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 40.4 mt -89.35 -155.63 0.36 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.221 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -81.3 -49.25 5.6 Favored Glycine 0 C--N 1.344 1.0 0 C-N-CA 121.932 -0.175 . . . . 0.0 112.722 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -104.99 -24.22 12.85 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.259 0.624 . . . . 0.0 111.988 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -139.57 175.66 9.38 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.97 0.508 . . . . 0.0 109.899 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 17.6 p -144.76 131.47 20.05 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.158 0.583 . . . . 0.0 111.315 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 14.7 mt -97.87 89.83 4.73 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.699 1.2 . . . . 0.0 109.38 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 18.4 t-20 -69.98 135.15 49.09 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.14 0.576 . . . . 0.0 111.44 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 57.18 29.7 17.1 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.532 1.133 . . . . 0.0 112.825 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 39.3 t -66.43 130.39 43.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.005 0.522 . . . . 0.0 109.968 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -69.58 131.22 44.33 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.032 0.444 . . . . 0.0 111.361 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.578 HG23 HD13 ' A' ' 225' ' ' LEU . 48.8 mm -108.24 114.44 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.838 1.255 . . . . 0.0 109.335 -175.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.664 HD12 ' HA ' ' A' ' 233' ' ' LYS . 11.9 mt -87.94 -21.96 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.579 0.752 . . . . 0.0 109.893 173.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.79 38.54 0.84 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.262 1.025 . . . . 0.0 111.461 -173.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 26.8 m -63.19 -21.33 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.543 0.737 . . . . 0.0 111.861 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.92 -27.62 14.19 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.895 1.278 . . . . 0.0 110.543 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -106.17 10.82 31.81 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.198 0.999 . . . . 0.0 111.434 -170.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.529 HG13 ' HB ' ' A' ' 212' ' ' ILE . 7.4 p -86.17 131.14 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.527 0.731 . . . . 0.0 109.515 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.4 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 7.0 m-30 -101.27 164.21 11.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.478 1.111 . . . . 0.0 109.41 172.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.623 ' HB2' HD11 ' A' ' 212' ' ' ILE . 40.4 ttmt -83.76 142.32 30.77 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.153 0.581 . . . . 0.0 110.994 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.589 HD11 ' HB3' ' A' ' 224' ' ' MET . 21.0 mm -84.04 117.47 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 165.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.65 ' HB2' ' HB2' ' A' ' 208' ' ' ALA . 0.3 OUTLIER -83.63 106.34 15.27 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.407 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 29.4 mtp180 -97.65 92.35 1.3 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -15.33 90.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.474 1 C-N-CA 126.621 4.881 . . . . 0.0 117.037 -161.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.26 6.05 51.7 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.441 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 34.7 tt0 -121.11 -23.06 5.9 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.438 0.695 . . . . 0.0 110.704 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -83.79 -126.88 1.31 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 174.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 23.0 m -127.81 142.36 44.02 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-N 117.62 0.71 . . . . 0.0 110.654 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.71 114.81 4.12 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.81 2.34 . . . . 0.0 111.036 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' MET . . . . . 0.58 ' SD ' ' HG3' ' A' ' 207' ' ' ARG . 26.5 ttt -73.94 92.76 2.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.564 0.697 . . . . 0.0 110.055 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 11.1 p -123.19 24.19 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 125.057 1.343 . . . . 0.0 108.687 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.09 -171.28 2.84 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.191 -165.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -47.2 141.71 6.06 Favored Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 125.048 1.339 . . . . 0.0 113.663 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.42 146.84 86.39 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.069 2.512 . . . . 0.0 112.582 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.4 mmt -82.39 -88.03 0.09 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.147 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 56.25 50.6 13.08 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -165.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -59.07 104.03 0.21 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.948 -1.933 . . . . 0.0 111.623 -170.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.54 26.28 14.15 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.13 0.972 . . . . 0.0 110.544 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 190' ' ' ASP . 78.4 p -89.52 163.3 15.28 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.204 0.601 . . . . 0.0 111.446 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -78.36 -177.45 48.37 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.579 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 CA--C 1.563 1.947 0 C-N-CA 123.143 2.562 . . . . 0.0 112.15 178.013 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.791 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.607 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -59.09 -32.78 70.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.351 0.66 . . . . 0.0 112.475 -177.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.515 ' N ' HD22 ' A' ' 134' ' ' LEU . 48.8 m-85 -79.62 152.16 30.18 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -114.94 176.83 4.89 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 109.134 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.0 m -71.67 -2.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.479 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -117.66 7.68 12.63 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.877 0.871 . . . . 0.0 111.38 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -86.48 90.92 8.38 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.898 0.479 . . . . 0.0 111.211 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 50.4 p90 -63.81 123.36 18.71 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.612 167.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.19 -170.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.597 0.759 . . . . 0.0 110.154 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 205' ' ' ARG . 47.0 t0 -106.1 158.39 16.85 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 165.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -140.27 111.45 7.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.36 0.527 . . . . 0.0 109.586 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -70.77 93.71 0.98 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -62.03 132.48 53.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.696 1.198 . . . . 0.0 112.1 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.3 p -86.8 -14.11 43.16 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.092 0.957 . . . . 0.0 111.36 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.92 -53.82 7.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.064 0.546 . . . . 0.0 110.479 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 53.8 ttm -100.68 -36.25 9.19 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.437 0.695 . . . . 0.0 111.239 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.61 16.68 48.11 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.443 -172.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -103.96 150.58 24.09 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.768 0.827 . . . . 0.0 110.283 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.446 ' HZ3' ' HG3' ' A' ' 205' ' ' ARG . 18.5 m95 -83.05 118.61 23.65 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -124.06 112.35 17.04 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.127 0.571 . . . . 0.0 109.648 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.637 ' HB2' ' HD2' ' A' ' 295' ' ' ARG . 5.6 pt-20 -58.48 128.96 39.78 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.701 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.461 ' HA ' ' H ' ' A' ' 189' ' ' ASP . . . -144.1 -175.72 4.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.218 1.007 . . . . 0.0 111.136 -168.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.6 tt0 -140.25 125.49 18.76 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.038 0.535 . . . . 0.0 109.906 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.9 t -62.13 115.48 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 124.026 0.93 . . . . 0.0 108.921 169.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.556 HG11 ' HE2' ' A' ' 187' ' ' LYS . 35.5 m -116.99 -3.48 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.238 0.615 . . . . 0.0 112.007 -178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 29.2 ttm180 -162.4 139.39 8.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.186 0.594 . . . . 0.0 109.488 173.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 135' ' ' TYR . 11.6 m -119.2 134.4 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.419 0.688 . . . . 0.0 109.693 176.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.553 HG23 ' HB ' ' A' ' 183' ' ' ILE . 3.2 t -147.09 161.51 40.71 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.885 0.874 . . . . 0.0 109.907 175.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -115.97 149.96 37.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.949 0.9 . . . . 0.0 110.145 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.44 81.15 0.56 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.758 0.823 . . . . 0.0 109.358 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -166.69 159.55 11.52 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 124.392 1.077 . . . . 0.0 109.014 -171.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -54.33 -31.76 68.84 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.333 2.022 . . . . 0.0 112.07 167.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.8 m -77.65 134.44 38.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.491 0.717 . . . . 0.0 110.144 169.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.445 ' H ' ' HG3' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -89.17 53.62 2.72 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.467 0.707 . . . . 0.0 110.206 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.3 t70 63.06 86.25 0.12 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.86 1.264 . . . . 0.0 109.249 -169.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -133.52 144.84 53.86 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.414 1.086 . . . . 0.0 109.181 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -42.19 110.6 0.15 Allowed 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 124.236 3.291 . . . . 0.0 114.438 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 26.9 p -159.51 -27.89 0.07 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.045 0.938 . . . . 0.0 110.277 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.0 m -105.42 19.05 21.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.288 1.035 . . . . 0.0 111.147 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 37.8 m -63.48 -36.99 85.59 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.695 0.798 . . . . 0.0 112.029 -174.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 61.6 p -115.79 114.93 25.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.911 0.884 . . . . 0.0 108.749 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.2 t 71.85 167.16 0.31 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.67 1.588 . . . . 0.0 111.24 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 38.33 91.82 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 C-N-CA 126.254 1.822 . . . . 0.0 113.878 -172.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.2 0.88 9.29 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.122 2.548 . . . . 0.0 113.627 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 69.46 91.59 0.09 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 124.727 1.211 . . . . 0.0 110.73 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 63.8 mt -78.03 128.68 34.23 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 62.66 81.07 0.21 Allowed 'General case' 0 N--CA 1.48 1.07 0 O-C-N 124.652 1.22 . . . . 0.0 109.828 -169.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.96 83.49 2.85 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.195 0.598 . . . . 0.0 109.6 -173.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.418 ' HA ' ' HB3' ' A' ' 200' ' ' ASN . 5.9 m-20 -80.34 63.19 4.73 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.118 0.961 . . . . 0.0 109.364 171.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 160' ' ' THR . 34.7 m -105.54 159.27 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.641 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.553 ' HB ' HG23 ' A' ' 160' ' ' THR . 2.3 mp -93.18 108.97 21.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.979 0.895 . . . . 0.0 108.99 -173.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.42 ' HD2' HG12 ' A' ' 159' ' ' VAL . 68.7 m-85 -92.54 108.3 19.87 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.518 167.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 33.2 m-70 -77.05 100.09 5.55 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.93 142.81 20.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 123.811 0.694 . . . . 0.0 109.223 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.583 ' HG2' HG22 ' A' ' 196' ' ' VAL . 42.9 mtmt -103.59 121.62 43.29 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 170.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -60.7 108.51 0.85 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.461 ' H ' ' HA ' ' A' ' 154' ' ' ALA . 20.9 t70 -57.75 -42.13 83.33 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.905 0.882 . . . . 0.0 110.737 -173.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.94 -19.0 32.84 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.98 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -133.77 64.72 68.52 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 122.907 0.483 . . . . 0.0 110.607 -177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.0 -11.77 32.68 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.635 2.223 . . . . 0.0 112.559 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.85 -30.64 70.08 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.899 0.88 . . . . 0.0 111.229 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -72.24 -16.76 61.94 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.376 0.67 . . . . 0.0 110.512 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 87.31 -166.33 36.46 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.811 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.583 HG22 ' HG2' ' A' ' 187' ' ' LYS . 6.5 t -93.04 125.24 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.65 157.01 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.782 0.833 . . . . 0.0 110.68 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.55 114.59 28.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.582 1.153 . . . . 0.0 109.192 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 77.3 mmm -126.94 138.89 53.35 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.449 0.7 . . . . 0.0 110.065 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 20.6 m-80 -83.18 173.41 11.69 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.307 0.643 . . . . 0.0 109.865 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 29.8 t -56.15 -43.99 78.81 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.567 0.747 . . . . 0.0 111.813 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -54.04 -33.83 58.39 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.548 1.139 . . . . 0.0 111.947 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -88.28 -33.26 18.11 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.998 0.919 . . . . 0.0 111.661 -172.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 10.3 m -92.72 117.1 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 122.275 1.036 . . . . 0.0 108.483 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 22.3 mmm180 -109.66 168.65 9.25 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.836 -165.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.579 ' HA ' ' NH2' ' A' ' 207' ' ' ARG . . . -88.93 144.73 25.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.907 172.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.602 ' HG2' ' HG2' ' A' ' 295' ' ' ARG . 0.0 OUTLIER -80.06 93.25 5.74 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.9 97.08 0.21 Allowed 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.521 ' H ' ' NE ' ' A' ' 209' ' ' ARG . 0.0 OUTLIER -76.75 71.13 3.3 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.639 1.209 . . . . 0.0 110.141 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.9 m -146.09 110.38 5.03 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.937 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 28.7 mt -83.35 134.23 27.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 279' ' ' LYS . 42.6 mm -82.51 139.41 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.308 0.575 . . . . 0.0 110.951 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -124.41 160.03 29.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.12 1.368 . . . . 0.0 109.392 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.583 ' HA ' HD23 ' A' ' 217' ' ' LEU . 31.9 t90 -56.2 -40.48 74.08 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.756 0.823 . . . . 0.0 112.323 -169.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -56.79 -41.77 78.29 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.663 0.785 . . . . 0.0 110.98 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.98 -21.27 51.18 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.881 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 214' ' ' TRP . 2.4 mm? -63.02 115.37 4.36 Favored 'General case' 0 C--N 1.364 1.205 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 221' ' ' GLN . 10.3 pt-20 -143.98 148.93 35.98 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.49 0.716 . . . . 0.0 109.556 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.38 135.02 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 122.781 0.433 . . . . 0.0 110.726 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.64 -9.44 77.0 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.633 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.482 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.7 tt0 -85.77 122.48 29.91 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.975 0.51 . . . . 0.0 110.445 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 72.8 t -93.66 114.47 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.482 HG13 ' HG2' ' A' ' 221' ' ' GLN . 13.1 m -126.91 160.27 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.957 0.903 . . . . 0.0 109.237 176.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.545 ' SD ' ' HB3' ' A' ' 238' ' ' TRP . 44.0 ttp -95.16 111.56 23.37 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.869 0.467 . . . . 0.0 110.604 -176.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.571 HD22 HG13 ' A' ' 271' ' ' ILE . 0.8 OUTLIER -111.24 155.62 22.69 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.62 0.768 . . . . 0.0 109.143 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.51 HD22 ' NE ' ' A' ' 235' ' ' ARG . 9.1 p-10 -97.57 121.27 39.28 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.219 1.008 . . . . 0.0 111.009 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.575 ' HB2' ' HA ' ' A' ' 232' ' ' PRO . 6.9 p90 -168.15 155.89 8.37 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.334 1.053 . . . . 0.0 109.801 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -83.27 137.09 42.67 Favored Pre-proline 0 CA--C 1.555 1.157 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 171.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.75 -28.43 68.41 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.0 1.8 . . . . 0.0 111.917 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.64 -30.27 36.65 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.553 0.741 . . . . 0.0 110.918 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -140.81 90.34 9.66 Favored Pre-proline 0 N--CA 1.489 1.51 0 C-N-CA 123.692 0.797 . . . . 0.0 110.174 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.575 ' HA ' ' HB2' ' A' ' 227' ' ' TYR . 38.8 Cg_endo -66.05 -8.24 19.47 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.453 2.102 . . . . 0.0 112.16 170.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.417 ' O ' HD12 ' A' ' 272' ' ' ILE . 21.3 tptm -74.18 -26.78 60.48 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.607 1.163 . . . . 0.0 110.967 173.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -117.19 147.14 42.74 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.332 0.653 . . . . 0.0 110.877 -172.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.51 ' NE ' HD22 ' A' ' 226' ' ' ASN . 3.3 tmt_? -69.0 117.29 10.47 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.656 1.582 . . . . 0.0 109.764 -176.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -134.26 -130.66 3.03 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 123.31 0.381 . . . . 0.0 112.427 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.427 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 42.0 m-85 -83.92 171.23 13.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.675 0.79 . . . . 0.0 110.819 -173.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' TRP . . . . . 0.545 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 97.6 m95 -91.38 112.38 24.26 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.254 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 68.3 m-85 -126.09 149.12 49.14 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 174.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.5 p-10 -82.44 157.11 23.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.5 ' HA ' HG23 ' A' ' 260' ' ' VAL . . . -162.93 140.76 8.07 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.216 0.606 . . . . 0.0 110.663 -176.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -90.51 118.6 30.1 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.144 0.578 . . . . 0.0 109.885 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.485 HD12 HD11 ' A' ' 255' ' ' LEU . 32.1 mm -62.8 126.36 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.38 0.672 . . . . 0.0 110.413 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.6 t -105.62 -38.47 6.41 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.466 1.106 . . . . 0.0 111.214 -174.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.55 143.25 11.53 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -135.71 143.48 45.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -155.33 114.94 3.67 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -100.13 121.6 41.67 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.8 p -84.64 -170.97 3.37 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 170.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -67.12 -34.63 78.01 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.01 23.79 3.89 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 120.696 0.284 . . . . 0.0 111.232 -171.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -159.35 129.07 5.52 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.261 0.625 . . . . 0.0 110.658 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.472 ' HD2' HG21 ' A' ' 274' ' ' VAL . 36.5 ttm180 -99.58 102.27 13.73 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.2 139.79 30.27 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.485 HD11 HD12 ' A' ' 243' ' ' ILE . 3.3 tm? -147.41 140.31 24.99 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -176.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -122.3 119.69 31.87 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.315 1.046 . . . . 0.0 108.538 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.77 137.15 54.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.81 0.844 . . . . 0.0 110.254 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -81.63 98.29 8.29 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.704 1.202 . . . . 0.0 108.34 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 58.9 t -63.31 134.16 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.857 0.863 . . . . 0.0 110.915 -173.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 241' ' ' ALA . 38.4 t -117.26 107.05 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.33 -151.45 0.26 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.235 1.014 . . . . 0.0 110.078 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -55.11 -71.83 0.66 Allowed Glycine 0 C--N 1.355 1.629 0 C-N-CA 123.066 0.365 . . . . 0.0 113.779 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -123.34 -16.66 6.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.477 0.711 . . . . 0.0 110.302 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -87.59 174.49 8.42 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.782 0.833 . . . . 0.0 111.006 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 65.8 p -153.43 138.3 17.13 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.181 0.593 . . . . 0.0 110.666 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 20.9 mt -108.72 90.91 3.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.991 0.916 . . . . 0.0 108.636 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -67.32 143.69 56.27 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 117.945 0.338 . . . . 0.0 111.113 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 33.1 t70 58.75 75.8 0.38 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.513 1.125 . . . . 0.0 111.748 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 68.8 m -113.48 126.32 55.2 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.413 0.685 . . . . 0.0 109.298 170.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -71.43 113.27 8.29 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.571 HG13 HD22 ' A' ' 225' ' ' LEU . 39.9 mm -94.3 123.58 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.962 0.505 . . . . 0.0 109.844 -174.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 233' ' ' LYS . 59.4 mt -83.76 -36.38 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.221 1.008 . . . . 0.0 110.5 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -96.14 51.15 1.2 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 122.262 1.03 . . . . 0.0 110.574 -167.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.472 HG21 ' HD2' ' A' ' 253' ' ' ARG . 23.9 m -72.14 -16.69 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.696 -1.593 . . . . 0.0 113.292 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.72 -15.07 33.32 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.936 0.494 . . . . 0.0 110.982 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -96.93 4.55 51.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.369 0.668 . . . . 0.0 111.634 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.418 HG13 ' HG ' ' A' ' 225' ' ' LEU . 43.4 t -76.4 146.15 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.36 0.664 . . . . 0.0 111.455 -175.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -126.65 160.16 31.52 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.045 0.938 . . . . 0.0 109.859 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.501 ' HB2' HD11 ' A' ' 212' ' ' ILE . 22.4 ttmm -84.87 149.21 25.84 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.306 0.643 . . . . 0.0 111.77 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 224' ' ' MET . 50.2 mm -92.29 126.78 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 169.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 105.36 13.55 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.334 0.653 . . . . 0.0 110.559 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -93.18 146.06 31.22 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 123.777 0.831 . . . . 0.0 111.153 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -41.94 119.17 1.11 Allowed 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 124.525 3.484 . . . . 0.0 115.005 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 97.0 -51.88 1.44 Allowed Glycine 0 C--N 1.352 1.425 0 O-C-N 123.333 0.396 . . . . 0.0 112.205 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -71.73 -22.85 61.57 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.663 1.185 . . . . 0.0 110.47 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -77.38 78.39 1.46 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.9 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 14.8 m -71.24 146.97 92.92 Favored Pre-proline 0 C--O 1.246 0.896 0 C-N-CA 123.424 0.69 . . . . 0.0 109.911 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.25 157.03 62.89 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.744 2.296 . . . . 0.0 111.245 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 21.0 ttt -83.25 78.18 9.66 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.724 0.774 . . . . 0.0 109.393 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 10.6 p -92.83 -28.43 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.372 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -74.81 162.33 28.76 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.012 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 293' ' ' PRO . 24.8 p-10 -49.45 140.5 13.5 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 124.703 1.201 . . . . 0.0 113.539 -167.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 292' ' ' ASN . 26.7 Cg_exo -62.12 109.63 0.86 Allowed 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.257 2.638 . . . . 0.0 112.922 -176.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -140.04 143.42 36.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.707 0.803 . . . . 0.0 109.891 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.637 ' HD2' ' HB2' ' A' ' 153' ' ' GLU . 49.4 mtm180 -129.91 -163.43 1.3 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -18.5 26.93 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.247 0.476 . . . . 0.0 110.738 -173.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -131.33 48.44 2.42 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 122.481 1.134 . . . . 0.0 109.398 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.7 p -76.32 96.3 3.95 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 164.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -76.07 -134.36 0.5 Allowed Glycine 0 CA--C 1.534 1.266 0 CA-C-O 119.043 -0.865 . . . . 0.0 113.711 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo . . . . . 0 C--N 1.374 1.875 0 C-N-CA 123.362 2.708 . . . . 0.0 112.63 177.154 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.64 ' N ' ' HG ' ' A' ' 172' ' ' SER . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 112.238 -0.345 . . . . 0.0 112.238 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.18 -10.04 14.66 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.262 1.025 . . . . 0.0 111.153 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -79.27 121.12 24.69 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -82.08 178.94 8.0 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.93 0.892 . . . . 0.0 111.407 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.14 29.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.708 1.203 . . . . 0.0 112.985 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -140.18 -50.39 0.47 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.528 1.131 . . . . 0.0 109.176 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -68.99 88.91 0.41 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.742 0.417 . . . . 0.0 111.268 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -75.35 138.35 41.7 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.341 172.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 206' ' ' ALA . 17.4 m -123.89 158.87 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.172 1.389 . . . . 0.0 109.854 -172.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -93.04 109.78 21.24 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.74 120.46 34.03 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.69 0.796 . . . . 0.0 111.396 -168.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -72.78 98.86 2.49 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.658 0.783 . . . . 0.0 110.085 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.78 110.34 10.13 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.4 m -66.04 -27.53 68.17 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.032 0.933 . . . . 0.0 112.049 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -62.12 -50.68 70.94 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.973 0.509 . . . . 0.0 111.688 -171.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -102.27 -18.76 15.32 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 122.304 0.242 . . . . 0.0 111.64 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.44 50.63 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.237 0.336 . . . . 0.0 113.628 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.66 152.06 20.9 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.531 0.681 . . . . 0.0 112.554 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -80.06 120.89 24.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.159 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -127.3 115.84 19.62 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -62.27 137.71 58.3 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.621 0.575 . . . . 0.0 109.678 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.487 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -148.31 129.17 14.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.037 0.535 . . . . 0.0 111.384 -165.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -87.29 114.54 23.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.492 0.717 . . . . 0.0 109.705 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 186' ' ' VAL . 58.6 t -66.96 116.06 5.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.558 HG11 ' HE2' ' A' ' 187' ' ' LYS . 33.5 m -117.73 -9.4 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.171 0.588 . . . . 0.0 111.534 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.588 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 2.5 tpm_? -166.82 147.03 5.74 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.46 136.89 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 124.113 0.965 . . . . 0.0 109.655 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.405 HG23 ' HB ' ' A' ' 183' ' ' ILE . 10.2 t -148.77 163.33 37.68 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.323 1.049 . . . . 0.0 109.68 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.553 HH22 ' HG3' ' A' ' 176' ' ' PRO . 59.6 mtt-85 -122.77 170.4 10.11 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -172.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -82.03 -22.03 36.66 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.002 173.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.86 159.94 59.03 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.018 0.927 . . . . 0.0 110.257 167.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.96 81.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.212 2.608 . . . . 0.0 112.55 172.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 73.9 m -160.49 91.31 0.91 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.283 1.433 . . . . 0.0 108.246 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 23.3 tpp180 -68.81 -34.68 75.91 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.549 0.74 . . . . 0.0 110.039 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -133.6 112.62 11.61 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -88.8 115.73 64.32 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-O 119.004 -0.522 . . . . 0.0 109.688 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.25 -60.86 0.15 Allowed 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.223 1.948 . . . . 0.0 111.602 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 28.7 p -168.17 33.63 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.401 0.68 . . . . 0.0 110.489 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.1 m -63.8 -10.86 22.42 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.765 0.826 . . . . 0.0 113.117 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.64 ' HG ' ' N ' ' A' ' 133' ' ' GLY . 41.1 m -81.2 2.11 29.16 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.619 0.768 . . . . 0.0 112.7 176.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.0 t -73.75 106.53 5.53 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-O 121.017 0.437 . . . . 0.0 110.113 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.7 m 67.24 -2.71 1.16 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 169.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -86.57 -46.24 0.55 Allowed Pre-proline 0 N--CA 1.484 1.236 0 CA-C-N 119.076 0.853 . . . . 0.0 110.472 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.553 ' HG3' HH22 ' A' ' 161' ' ' ARG . 23.9 Cg_endo -95.97 174.99 0.9 Allowed 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.478 2.119 . . . . 0.0 111.297 159.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -174.88 24.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.114 0.565 . . . . 0.0 111.88 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.55 -86.6 0.52 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -175.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -143.73 98.47 3.24 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 173.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -67.61 85.76 0.19 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.815 0.697 . . . . 0.0 109.909 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -79.56 65.41 4.72 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 122.677 1.227 . . . . 0.0 108.202 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.64 177.35 3.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.838 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.3 mp -95.58 108.63 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.599 0.714 . . . . 0.0 109.342 -171.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.419 ' CE1' ' HA3' ' A' ' 133' ' ' GLY . 95.1 m-85 -97.59 107.2 19.65 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.857 1.263 . . . . 0.0 107.834 170.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.588 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 89.0 m-70 -78.77 102.5 8.16 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.487 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 20.9 m -114.92 150.9 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.125 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.558 ' HE2' HG11 ' A' ' 157' ' ' VAL . 45.0 mtmt -117.87 122.83 44.36 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.455 ' HD2' ' HB2' ' A' ' 154' ' ' ALA . 17.1 m-85 -61.61 109.5 1.22 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.104 0.562 . . . . 0.0 111.329 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.3 -35.58 74.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -63.36 -34.73 78.35 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.815 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -155.02 82.07 4.07 Favored Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 124.655 1.182 . . . . 0.0 109.287 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.479 ' HG3' ' HD3' ' A' ' 300' ' ' PRO . 26.4 Cg_exo -65.29 -27.34 55.8 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.807 3.005 . . . . 0.0 114.133 -173.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.52 -1.96 17.89 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -75.13 -14.77 60.59 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.837 0.855 . . . . 0.0 111.436 171.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.86 -175.81 54.22 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.439 -0.346 . . . . 0.0 112.571 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.48 116.54 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.95 144.41 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.746 0.818 . . . . 0.0 109.144 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.563 ' HB2' HG23 ' A' ' 183' ' ' ILE . 28.9 pt20 -96.16 132.46 41.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 86.3 mmm -132.71 160.76 35.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.858 0.863 . . . . 0.0 109.193 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -110.88 175.1 5.55 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.882 0.473 . . . . 0.0 109.751 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 70.1 p -57.58 -45.87 84.69 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.673 0.789 . . . . 0.0 111.04 176.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -66.93 -8.49 29.91 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.082 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.31 -41.06 8.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.661 0.785 . . . . 0.0 110.87 173.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.59 132.91 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 112.773 0.656 . . . . 0.0 112.773 -169.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.609 ' HB3' ' HB3' ' A' ' 281' ' ' GLU . 39.5 mmt180 -112.29 155.72 23.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.827 1.251 . . . . 0.0 107.861 167.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.405 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -63.76 167.33 6.05 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.251 0.478 . . . . 0.0 110.87 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.67 95.82 6.7 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.25 97.86 0.13 Allowed 'General case' 0 C--N 1.36 1.023 0 C-N-CA 123.164 0.586 . . . . 0.0 109.841 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.456 ' NH2' ' HB2' ' A' ' 292' ' ' ASN . 3.5 tmt_? -84.45 76.52 10.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -172.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 73.1 m -147.19 119.06 8.11 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.062 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 58.8 mt -85.05 126.75 40.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 279' ' ' LYS . 38.4 mm -96.12 127.91 47.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 124.015 0.926 . . . . 0.0 108.636 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.456 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 0.0 OUTLIER -111.71 179.14 4.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.119 0.967 . . . . 0.0 109.168 -177.519 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.509 ' HA ' HD12 ' A' ' 217' ' ' LEU . 59.6 t-105 -60.42 -43.15 97.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.284 0.634 . . . . 0.0 110.899 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -62.1 -27.38 68.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.042 0.937 . . . . 0.0 111.888 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -90.03 -22.48 21.84 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.898 0.479 . . . . 0.0 110.894 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 214' ' ' TRP . 85.7 mt -67.77 112.6 4.94 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -138.29 151.1 47.28 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.607 0.763 . . . . 0.0 109.632 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.9 m -68.87 123.98 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.045 0.538 . . . . 0.0 111.565 -171.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.56 -15.75 49.1 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.732 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.429 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.5 tt0 -79.67 121.39 25.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.941 0.496 . . . . 0.0 109.979 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 45.8 t -93.07 120.21 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.429 HG13 ' HG2' ' A' ' 221' ' ' GLN . 13.2 m -141.01 148.66 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.32 1.048 . . . . 0.0 110.541 -175.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 20.5 ptm -89.82 136.22 33.16 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.273 0.629 . . . . 0.0 110.847 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.54 ' HB3' HG22 ' A' ' 277' ' ' VAL . 0.7 OUTLIER -144.7 144.1 31.05 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.046 0.939 . . . . 0.0 110.4 -174.745 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.409 ' HB3' ' CE2' ' A' ' 238' ' ' TRP . 10.5 p-10 -71.17 106.01 3.62 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.349 0.66 . . . . 0.0 109.837 174.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -135.31 132.13 37.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.536 HD22 ' HB2' ' A' ' 231' ' ' ASN . 61.1 t30 -105.41 114.89 62.8 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -62.92 -33.77 73.78 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.82 2.347 . . . . 0.0 111.756 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.26 -36.38 82.85 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.053 0.941 . . . . 0.0 111.213 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.536 ' HB2' HD22 ' A' ' 228' ' ' ASN . 38.4 m-80 -143.97 87.32 8.07 Favored Pre-proline 0 N--CA 1.487 1.413 0 C-N-CA 123.793 0.837 . . . . 0.0 109.382 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.86 -9.87 27.52 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.399 2.733 . . . . 0.0 115.104 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -82.83 -27.7 30.69 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.031 0.532 . . . . 0.0 110.984 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -120.95 154.63 35.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.512 0.725 . . . . 0.0 110.257 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -49.14 154.15 0.84 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.006 1.322 . . . . 0.0 113.053 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.61 -148.17 4.9 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.16 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -83.86 148.82 26.76 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.259 1.023 . . . . 0.0 109.699 -174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' TRP . . . . . 0.437 ' CE2' ' HD2' ' A' ' 296' ' ' ARG . 67.1 m95 -84.3 107.24 16.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.013 0.525 . . . . 0.0 110.54 -171.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -114.52 151.9 32.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.3 p-10 -83.93 146.2 28.16 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 172.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -146.26 137.17 24.33 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.581 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -91.11 119.48 31.28 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.401 HD12 HD11 ' A' ' 255' ' ' LEU . 29.8 mm -60.41 107.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 124.051 0.844 . . . . 0.0 109.388 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.6 t -82.89 -47.66 11.58 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.452 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 65.9 mtt85 -152.86 164.76 37.26 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 125.345 1.458 . . . . 0.0 109.649 -172.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -151.27 136.78 17.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.804 0.441 . . . . 0.0 110.745 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -150.82 115.49 5.2 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.812 0.845 . . . . 0.0 109.439 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -91.74 153.77 19.4 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 68.7 p -130.15 174.88 9.39 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.948 0.899 . . . . 0.0 108.871 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -65.62 -18.65 65.48 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.528 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 26.5 p -103.99 -31.54 9.67 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 123.426 0.691 . . . . 0.0 112.788 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.23 157.28 6.2 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.23 0.538 . . . . 0.0 112.292 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 253' ' ' ARG . 4.3 mpt_? -94.91 101.68 13.48 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -97.81 102.21 13.91 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.124 0.57 . . . . 0.0 110.736 -173.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 3.4 tm? -95.18 143.65 26.43 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 81.2 m-85 -123.03 116.42 23.5 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.23 144.8 31.68 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.984 0.513 . . . . 0.0 110.421 -174.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -81.55 96.87 7.58 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 92.6 t -81.06 107.23 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.699 1.2 . . . . 0.0 109.619 -176.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 16.9 m -89.11 129.8 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.52 0.676 . . . . 0.0 110.361 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 63.9 mt -93.95 -154.87 0.43 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.814 1.246 . . . . 0.0 108.888 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -64.68 -54.45 28.6 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 122.959 0.162 . . . . 0.0 113.122 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -115.95 -46.27 2.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.463 0.705 . . . . 0.0 110.283 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.68 151.01 37.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.819 0.848 . . . . 0.0 111.424 -173.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 15.5 p -120.3 113.63 20.67 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.863 0.865 . . . . 0.0 109.319 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.654 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 81.5 mt -82.27 102.45 11.18 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.232 1.013 . . . . 0.0 109.86 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -75.02 123.8 25.83 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.102 0.561 . . . . 0.0 112.073 -173.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 54.8 46.59 24.21 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.755 1.222 . . . . 0.0 113.128 169.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 81.6 m -67.96 133.1 48.5 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 122.396 0.278 . . . . 0.0 111.184 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 45.1 ttp180 -70.26 107.29 3.67 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.722 0.638 . . . . 0.0 109.8 173.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.459 HG21 HD22 ' A' ' 225' ' ' LEU . 40.7 mm -95.86 111.3 25.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 82.9 mt -84.76 -13.5 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 124.623 1.169 . . . . 0.0 109.884 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -99.86 39.52 1.32 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.352 1.461 . . . . 0.0 110.072 -161.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.506 HG11 ' HZ3' ' A' ' 214' ' ' TRP . 28.8 m -71.74 -13.74 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 114.553 -1.203 . . . . 0.0 113.29 -167.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -86.87 -27.52 23.39 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.295 0.638 . . . . 0.0 110.996 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -93.26 1.26 57.1 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.694 0.797 . . . . 0.0 112.128 -174.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 225' ' ' LEU . 59.2 t -71.12 139.35 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.198 0.599 . . . . 0.0 110.397 -174.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -120.37 160.92 22.08 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.216 1.007 . . . . 0.0 109.93 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.559 ' HB2' HD11 ' A' ' 212' ' ' ILE . 35.8 ttmt -79.66 151.34 30.58 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.715 0.406 . . . . 0.0 111.184 176.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.9 mm -77.54 132.79 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.8 0.84 . . . . 0.0 109.676 172.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 205' ' ' ARG . 1.0 OUTLIER -79.99 105.85 11.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 59.4 mtp85 -120.19 149.76 50.01 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.907 1.283 . . . . 0.0 109.445 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.93 98.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.413 2.742 . . . . 0.0 113.856 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 86.74 -3.96 86.61 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.494 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -119.4 -23.14 6.77 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.734 0.767 . . . . 0.0 111.827 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -92.89 100.6 2.68 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 175.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 11.6 p -64.45 130.29 94.6 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.003 0.521 . . . . 0.0 111.919 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.37 164.47 34.02 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.104 2.536 . . . . 0.0 111.676 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' MET . . . . . 0.476 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 44.1 ttm -80.31 85.44 5.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.669 0.747 . . . . 0.0 109.968 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.85 -29.41 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.9 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -85.89 -158.5 0.4 Allowed 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.828 0.851 . . . . 0.0 109.431 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.456 ' HB2' ' NH2' ' A' ' 209' ' ' ARG . 13.3 m120 -58.93 116.87 17.19 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.851 0.86 . . . . 0.0 110.866 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.476 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 25.1 Cg_exo -64.28 112.33 1.87 Allowed 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 123.263 2.642 . . . . 0.0 112.568 -175.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 22.2 ptm -117.63 129.87 56.02 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.729 0.812 . . . . 0.0 110.105 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -97.27 174.5 6.68 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.319 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.437 ' HD2' ' CE2' ' A' ' 238' ' ' TRP . 0.3 OUTLIER -60.37 -50.57 73.08 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.096 173.564 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.64 -161.69 1.4 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.469 1.508 . . . . 0.0 108.221 173.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 41.1 m -110.14 79.67 1.23 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.0 -96.8 0.7 Allowed Glycine 0 CA--C 1.537 1.412 0 CA-C-N 115.216 -0.902 . . . . 0.0 113.022 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.479 ' HD3' ' HG3' ' A' ' 192' ' ' PRO . 58.9 Cg_endo . . . . . 0 C--N 1.374 1.896 0 C-N-CA 123.107 2.538 . . . . 0.0 112.182 -175.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.986 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.529 ' HB3' ' HD3' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -131.28 4.05 4.34 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.433 0.693 . . . . 0.0 111.683 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -78.94 159.32 27.76 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.253 0.549 . . . . 0.0 110.289 172.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.465 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -86.19 172.55 10.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.151 0.98 . . . . 0.0 110.814 -174.46 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.5 m -83.62 6.26 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.272 1.029 . . . . 0.0 112.257 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -127.84 8.4 6.27 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.581 0.753 . . . . 0.0 111.175 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 156' ' ' VAL . 19.6 mm-40 -80.9 74.13 7.89 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.888 0.475 . . . . 0.0 111.864 -173.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 8.7 p90 -77.69 98.8 5.6 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.524 0.678 . . . . 0.0 109.434 168.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.497 ' HA ' ' HD2' ' A' ' 207' ' ' ARG . 27.4 m -115.98 179.51 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.141 1.376 . . . . 0.0 108.772 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.16 109.72 21.22 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -92.9 122.95 35.79 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.805 0.842 . . . . 0.0 110.057 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -71.3 110.42 5.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.69 136.06 57.85 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.064 0.946 . . . . 0.0 110.249 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.5 p -74.26 -28.69 61.33 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.685 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.8 -55.5 4.77 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 120.926 0.393 . . . . 0.0 111.502 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.5 ttp -104.5 -18.16 14.47 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.71 0.804 . . . . 0.0 112.472 -170.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.95 18.24 70.36 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 113.981 0.352 . . . . 0.0 113.981 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -94.08 140.66 29.46 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.993 0.517 . . . . 0.0 111.172 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -75.31 119.94 20.1 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -115.22 148.65 38.84 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.506 ' HG2' HH22 ' A' ' 207' ' ' ARG . 8.1 mt-10 -76.84 89.03 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.97 116.95 30.09 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.653 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 53.8 tt0 -89.57 102.67 15.35 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.084 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 59.8 t -57.88 96.35 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 167.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.2 m -95.41 -13.85 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.443 0.697 . . . . 0.0 110.864 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 50.3 ttt85 -163.53 135.62 5.06 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.62 139.66 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.0 p -133.43 159.3 40.76 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 123.827 0.851 . . . . 0.0 108.713 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -96.43 175.57 6.36 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.622 0.769 . . . . 0.0 110.222 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.503 ' HG3' HG12 ' A' ' 182' ' ' VAL . 7.7 mtpm? -86.1 58.3 4.97 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.979 0.895 . . . . 0.0 109.847 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -157.88 139.55 9.93 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 124.469 1.108 . . . . 0.0 108.818 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -59.68 96.52 0.1 OUTLIER 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.977 2.452 . . . . 0.0 112.126 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.6 m -140.05 -55.13 0.54 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.082 0.953 . . . . 0.0 109.839 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 77.63 -32.38 0.17 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 126.049 1.74 . . . . 0.0 112.976 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.512 ' HA ' ' NH2' ' A' ' 158' ' ' ARG . 3.5 p30 -72.9 178.14 4.45 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.493 0.717 . . . . 0.0 111.223 171.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -77.22 144.91 72.0 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 122.774 0.43 . . . . 0.0 110.142 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.51 77.65 1.33 Allowed 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.03 2.486 . . . . 0.0 112.491 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 38.8 t -102.36 -30.25 11.16 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.121 0.568 . . . . 0.0 110.417 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 28.2 m -103.77 21.81 15.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.293 1.037 . . . . 0.0 110.421 175.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.1 t -77.32 -5.37 49.27 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.89 0.876 . . . . 0.0 112.618 -173.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.1 m 74.01 -65.79 0.33 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.638 1.575 . . . . 0.0 110.619 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 26.2 m -132.28 121.66 23.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.06 0.944 . . . . 0.0 109.26 175.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.529 ' HD3' ' HB3' ' A' ' 134' ' ' LEU . 91.8 mtt180 -79.06 119.23 76.46 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.16 86.24 1.56 Allowed 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.543 2.162 . . . . 0.0 112.014 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -74.61 82.13 2.02 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 168.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -152.2 48.12 0.77 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -167.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 62.11 75.04 0.42 Allowed 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.955 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.711 ' HB3' HG22 ' A' ' 182' ' ' VAL . 2.8 mp0 -69.12 99.01 1.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.688 -162.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.06 20.71 1.49 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.26 165.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.711 HG22 ' HB3' ' A' ' 180' ' ' GLU . 12.5 m -73.6 175.0 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 164.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 183' ' ' ILE . 3.1 mp -95.56 110.93 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 O-C-N 121.882 -0.512 . . . . 0.0 110.22 -165.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -95.62 106.49 18.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.003 0.921 . . . . 0.0 108.65 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 14.0 m-70 -79.79 96.55 6.32 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.409 HG12 HG22 ' A' ' 156' ' ' VAL . 13.3 m -109.01 157.73 9.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.475 0.71 . . . . 0.0 109.55 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -130.16 117.82 20.5 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -67.38 116.22 7.9 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.903 0.481 . . . . 0.0 110.638 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 153' ' ' GLU . 34.3 t70 -67.04 -27.1 67.12 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.368 1.067 . . . . 0.0 109.876 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.12 -29.54 62.97 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.929 0.892 . . . . 0.0 111.566 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -141.57 75.31 22.35 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.775 0.83 . . . . 0.0 110.494 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.42 -15.43 49.74 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.942 2.428 . . . . 0.0 112.455 171.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.5 -26.56 67.23 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.997 0.919 . . . . 0.0 111.282 174.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -77.37 -16.43 58.87 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.332 0.653 . . . . 0.0 110.985 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.83 -130.13 22.24 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.86 0.725 . . . . 0.0 112.503 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 6.2 t -101.17 118.25 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.521 0.729 . . . . 0.0 109.112 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 24.5 m -113.6 155.21 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.422 0.689 . . . . 0.0 109.258 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -97.93 130.13 44.81 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.232 0.613 . . . . 0.0 110.043 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 92.1 mmm -131.63 160.61 34.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.445 1.098 . . . . 0.0 108.891 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -95.69 167.2 11.43 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.451 ' OG ' ' HB2' ' A' ' 180' ' ' GLU . 61.6 m -63.93 -39.47 94.22 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.866 0.466 . . . . 0.0 111.537 176.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -63.15 -23.51 67.47 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.703 0.801 . . . . 0.0 112.031 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -83.78 -37.72 22.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.521 0.728 . . . . 0.0 110.649 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 33.1 m -94.56 144.71 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.518 ' HA ' ' HE ' ' A' ' 205' ' ' ARG . 0.0 OUTLIER -140.69 142.92 34.83 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.8 155.49 7.72 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.024 0.93 . . . . 0.0 111.11 177.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.506 HH22 ' HG2' ' A' ' 153' ' ' GLU . 0.8 OUTLIER -128.85 138.42 52.03 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.078 0.466 . . . . 0.0 110.218 -172.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.09 152.74 18.55 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.11 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.411 ' HG3' ' SD ' ' A' ' 294' ' ' MET . 2.6 ttp180 -86.58 6.29 31.55 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 168.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.2 m -83.5 105.1 14.16 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.708 0.803 . . . . 0.0 108.91 -168.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 19.7 mt -85.69 132.73 31.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 279' ' ' LYS . 10.0 mm -105.48 139.07 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 0.0 OUTLIER -109.81 168.28 9.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.535 0.734 . . . . 0.0 109.757 176.106 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.412 ' CD1' HD23 ' A' ' 255' ' ' LEU . 55.3 t90 -45.38 -46.38 13.18 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.857 1.263 . . . . 0.0 111.936 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -57.52 -34.61 69.29 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.804 1.242 . . . . 0.0 111.961 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.48 -11.44 32.04 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.133 0.973 . . . . 0.0 113.06 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 243' ' ' ILE . 1.5 mm? -73.84 114.41 12.1 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 169.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 12.6 pt-20 -115.77 165.03 13.52 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.621 0.768 . . . . 0.0 109.053 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.9 m -69.0 119.24 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 121.26 0.552 . . . . 0.0 110.361 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.91 -4.45 49.53 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.738 -0.664 . . . . 0.0 113.246 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -70.67 118.42 13.44 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.537 0.735 . . . . 0.0 110.581 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.78 113.39 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.73 150.13 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.938 1.295 . . . . 0.0 109.403 -172.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.666 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 16.0 ptm -97.95 124.69 42.52 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 120.838 0.351 . . . . 0.0 111.34 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.477 ' HB3' HG13 ' A' ' 277' ' ' VAL . 1.3 pt? -144.53 167.53 22.3 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.9 0.88 . . . . 0.0 110.149 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -80.84 135.38 35.93 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.865 0.364 . . . . 0.0 110.759 -169.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.486 ' HD1' ' HB2' ' A' ' 239' ' ' TYR . 58.0 m-85 -144.66 157.42 44.21 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.815 1.246 . . . . 0.0 110.167 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 42.5 t-20 -129.9 110.93 17.17 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 166.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -71.73 -17.91 29.04 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.431 2.088 . . . . 0.0 112.787 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -87.03 -39.66 15.42 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.261 0.624 . . . . 0.0 110.447 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 10.0 m120 -124.35 81.33 58.91 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.213 1.005 . . . . 0.0 108.482 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.91 -11.34 31.78 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.746 2.297 . . . . 0.0 114.317 -170.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -88.9 -4.17 58.54 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.28 0.632 . . . . 0.0 111.267 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -131.51 163.83 27.12 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.635 -0.665 . . . . 0.0 110.275 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 162.46 29.44 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.801 0.84 . . . . 0.0 111.639 174.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.03 -88.66 0.07 OUTLIER Glycine 0 C--O 1.238 0.361 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.376 171.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -130.23 167.57 18.23 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.495 1.118 . . . . 0.0 109.118 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -87.68 113.61 23.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.771 0.428 . . . . 0.0 110.574 -170.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.486 ' HB2' ' HD1' ' A' ' 227' ' ' TYR . 64.0 m-85 -117.51 142.84 46.69 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ASP . . . . . 0.666 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 8.3 p-10 -84.27 158.08 21.34 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -153.54 148.02 26.08 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.882 -173.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -96.01 118.26 32.28 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.464 HG13 HD12 ' A' ' 217' ' ' LEU . 36.1 mm -66.94 107.41 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.356 0.662 . . . . 0.0 109.328 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.2 t -81.16 -45.28 16.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.562 0.745 . . . . 0.0 110.267 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -154.11 167.54 29.5 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.626 1.171 . . . . 0.0 109.978 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.45 146.81 23.91 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.714 0.806 . . . . 0.0 109.898 167.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -142.65 115.93 8.97 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.15 0.98 . . . . 0.0 109.17 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.83 144.05 25.67 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 175.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.6 p -126.9 169.93 12.77 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 169.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -61.26 -34.07 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.883 0.473 . . . . 0.0 110.448 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 75.0 p -87.22 -29.67 21.53 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.449 -171.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -166.66 153.9 9.32 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.891 0.477 . . . . 0.0 111.616 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -104.06 105.78 16.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.738 0.815 . . . . 0.0 109.883 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.03 144.95 25.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.552 0.741 . . . . 0.0 110.099 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.802 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.3 OUTLIER -135.87 146.74 47.75 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -175.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -135.03 120.66 19.39 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.54 ' HB3' HD11 ' A' ' 271' ' ' ILE . . . -136.01 161.27 36.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.497 0.665 . . . . 0.0 111.653 -175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -100.67 94.12 5.93 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 46.4 t -77.34 106.19 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.02 0.928 . . . . 0.0 110.068 -171.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 34.7 m -89.54 118.43 34.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 122.245 1.022 . . . . 0.0 110.201 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.403 HD12 ' HB2' ' A' ' 264' ' ' ASP . 31.2 mt -96.57 -153.08 0.4 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 113.888 -1.505 . . . . 0.0 108.173 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.5 -52.07 32.82 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 117.708 0.231 . . . . 0.0 113.278 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -122.23 -36.21 3.0 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.022 0.929 . . . . 0.0 110.611 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.403 ' HB2' HD12 ' A' ' 261' ' ' LEU . 3.8 m-20 -89.11 157.92 18.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.264 1.025 . . . . 0.0 110.858 -174.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 67.2 p -135.2 113.83 11.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.542 0.737 . . . . 0.0 109.124 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.554 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 23.9 mt -81.73 86.68 6.39 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.773 0.829 . . . . 0.0 108.888 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -69.34 142.4 54.03 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.237 0.615 . . . . 0.0 111.659 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 57.41 17.69 3.95 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.569 1.148 . . . . 0.0 113.823 170.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.554 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 94.5 m -66.73 142.9 57.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.326 0.65 . . . . 0.0 111.04 -176.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -70.03 133.79 47.59 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.948 0.78 . . . . 0.0 110.821 -176.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.802 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 10.3 mm -107.02 128.46 61.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 46.3 mt -98.3 -24.51 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 123.862 0.865 . . . . 0.0 109.025 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.555 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 67.7 m-85 -91.69 47.91 1.41 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.69 1.196 . . . . 0.0 110.14 -176.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 27.5 m -65.35 -26.37 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.518 1.127 . . . . 0.0 112.92 -171.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 52.7 m-20 -110.27 -7.98 14.78 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.174 0.589 . . . . 0.0 110.984 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 15.5 mm-40 -94.09 24.69 4.16 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.907 0.883 . . . . 0.0 110.734 -175.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.56 ' HB ' ' HB ' ' A' ' 212' ' ' ILE . 19.4 t -89.61 153.63 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.155 0.982 . . . . 0.0 110.001 -174.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -129.21 156.19 44.34 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.123 0.969 . . . . 0.0 108.79 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.566 ' HB2' HD11 ' A' ' 212' ' ' ILE . 54.2 tttm -89.76 146.2 24.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.112 0.565 . . . . 0.0 110.925 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 44.3 mm -72.49 122.78 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 168.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -106.17 112.8 25.98 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 285' ' ' GLU . 59.8 mtt85 -103.3 107.26 55.1 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -25.41 94.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.38 2.227 1 C-N-CA 125.307 4.005 . . . . 0.0 117.196 -156.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 104.72 6.99 39.94 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 118.231 -1.316 . . . . 0.0 116.275 172.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 282' ' ' ARG . 0.2 OUTLIER -103.26 -25.04 13.48 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 120.236 2.018 . . . . 0.0 111.452 173.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -106.64 -177.66 23.12 Favored Glycine 0 C--O 1.245 0.821 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 172.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 13.5 m -76.26 144.44 74.84 Favored Pre-proline 0 CA--C 1.554 1.129 0 CA-C-N 116.991 0.396 . . . . 0.0 111.208 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.13 175.93 6.21 Favored 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 123.356 2.704 . . . . 0.0 112.337 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 43.5 ttm -82.8 95.43 7.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 170.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 14.4 p -125.83 19.29 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.944 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -154.42 -167.04 2.5 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.61 -169.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -44.27 121.38 3.99 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 125.597 1.559 . . . . 0.0 113.073 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -45.53 113.0 0.46 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 124.596 3.53 . . . . 0.0 114.784 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.411 ' SD ' ' HG3' ' A' ' 209' ' ' ARG . 88.0 mmm -78.04 97.34 5.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.207 0.603 . . . . 0.0 110.579 -176.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -128.07 113.13 15.39 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 172.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.77 123.09 11.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.336 1.454 . . . . 0.0 110.531 -169.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -101.59 -31.29 10.91 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.9 0.88 . . . . 0.0 109.112 167.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 33.5 p -161.31 -170.62 2.71 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.247 1.019 . . . . 0.0 110.196 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -59.8 -57.49 19.16 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-O 119.443 -0.643 . . . . 0.0 112.832 169.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo . . . . . 0 C--N 1.383 2.379 0 C-N-CA 123.084 2.523 . . . . 0.0 111.59 171.721 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.504 ' HA3' HG21 ' A' ' 159' ' ' VAL . . . . . . . . 0 N--CA 1.476 1.332 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 6.96 0.5 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.655 0.782 . . . . 0.0 112.092 -176.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.575 ' HB2' ' CE1' ' A' ' 184' ' ' TYR . 34.7 m-85 -126.21 149.92 48.71 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.128 0.49 . . . . 0.0 110.924 172.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -94.03 172.69 8.07 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.871 1.268 . . . . 0.0 110.12 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.52 4.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.235 1.014 . . . . 0.0 113.124 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -106.09 -18.04 14.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.1 0.96 . . . . 0.0 110.908 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -75.33 92.63 2.8 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-O 121.579 0.704 . . . . 0.0 111.726 -166.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 8.1 p90 -55.13 105.17 0.15 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.8 165.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 28.0 m -116.01 -174.79 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.903 0.881 . . . . 0.0 109.931 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.733 ' HB3' ' HB3' ' A' ' 205' ' ' ARG . 33.9 t0 -110.73 160.49 16.67 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 171.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -140.72 105.86 5.0 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.638 0.775 . . . . 0.0 109.536 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.97 116.58 11.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.027 1.331 . . . . 0.0 109.33 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -85.59 116.69 24.03 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.7 0.8 . . . . 0.0 110.937 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.4 p -74.14 -33.48 63.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.556 1.142 . . . . 0.0 111.201 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.43 -52.59 57.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.318 0.647 . . . . 0.0 112.008 -171.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.408 ' HG2' ' HE1' ' A' ' 239' ' ' TYR . 38.1 ttp -102.75 -8.32 20.94 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.924 0.49 . . . . 0.0 111.1 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.15 18.86 70.93 Favored Glycine 0 C--N 1.358 1.756 0 CA-C-O 121.385 0.436 . . . . 0.0 112.246 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -96.32 174.7 6.74 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.057 0.943 . . . . 0.0 111.458 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -126.47 119.2 26.6 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -109.81 119.18 38.54 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.69 152.12 31.85 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.427 ' HA ' ' H ' ' A' ' 189' ' ' ASP . . . -153.95 -177.47 6.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.199 0.6 . . . . 0.0 111.57 -167.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 64.8 tt0 -151.64 120.72 6.7 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.152 172.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.49 126.02 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.769 0.828 . . . . 0.0 110.149 171.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.414 HG11 ' HE2' ' A' ' 187' ' ' LYS . 12.8 m -120.74 -6.08 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.121 0.568 . . . . 0.0 110.69 173.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 37.4 ttm180 -169.9 156.2 6.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.775 0.83 . . . . 0.0 110.639 174.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.504 HG21 ' HA3' ' A' ' 133' ' ' GLY . 1.7 p -132.96 127.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.22 1.008 . . . . 0.0 109.862 173.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.3 p -125.86 162.6 24.8 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.345 1.458 . . . . 0.0 109.319 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -107.38 177.21 4.91 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.45 0.7 . . . . 0.0 109.179 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.562 ' HD3' HD11 ' A' ' 183' ' ' ILE . 73.7 mmtt -54.57 -33.8 60.81 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 123.31 0.644 . . . . 0.0 112.599 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.41 121.68 49.68 Favored Pre-proline 0 CA--C 1.546 0.799 0 O-C-N 123.856 0.723 . . . . 0.0 109.84 172.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -54.83 -29.51 63.35 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.079 2.519 . . . . 0.0 111.866 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 61.7 m 62.81 84.84 0.14 Allowed 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.951 1.3 . . . . 0.0 111.633 172.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -68.77 -35.46 77.09 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.645 170.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -79.5 174.47 11.54 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.572 167.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -114.34 94.56 36.07 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.385 0.674 . . . . 0.0 109.324 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -71.52 100.62 1.05 Allowed 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.351 2.701 . . . . 0.0 111.372 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 56.1 m -88.44 -44.49 10.69 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.588 0.755 . . . . 0.0 111.574 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 54.0 m -141.97 25.49 1.94 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.035 0.534 . . . . 0.0 112.123 -174.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.3 m -125.43 13.96 8.21 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.188 0.595 . . . . 0.0 110.782 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 m -84.14 -20.79 31.88 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.623 0.769 . . . . 0.0 110.52 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 67.1 p -71.91 10.83 0.63 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.061 1.344 . . . . 0.0 114.242 -172.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -57.92 152.24 39.67 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.402 1.081 . . . . 0.0 111.525 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -54.02 127.88 27.5 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.177 2.584 . . . . 0.0 113.995 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -142.37 102.35 4.07 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.424 1.09 . . . . 0.0 108.276 175.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 59.8 tp -57.72 -45.09 86.24 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.701 0.801 . . . . 0.0 110.473 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -103.4 131.95 50.06 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.963 0.905 . . . . 0.0 108.771 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 201' ' ' SER . 26.9 mp0 -76.23 79.69 3.01 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 175.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -110.51 11.93 22.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.507 0.723 . . . . 0.0 109.724 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.27 149.09 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.328 0.651 . . . . 0.0 110.224 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.562 HD11 ' HD3' ' A' ' 162' ' ' LYS . 3.7 mp -95.75 109.59 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.003 0.521 . . . . 0.0 110.119 -167.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 58.3 m-85 -88.76 132.18 34.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.182 0.993 . . . . 0.0 111.033 173.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 30.6 m-70 -92.16 97.0 10.64 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.72 145.5 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.517 0.727 . . . . 0.0 110.447 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.414 ' HE2' HG11 ' A' ' 157' ' ' VAL . 45.2 mtmt -104.64 128.58 52.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -67.62 117.99 10.3 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.175 0.512 . . . . 0.0 111.088 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.427 ' H ' ' HA ' ' A' ' 154' ' ' ALA . 27.6 t70 -60.03 -30.2 69.01 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.846 1.258 . . . . 0.0 110.656 173.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.748 ' HA ' ' HD2' ' A' ' 297' ' ' LYS . 5.6 t70 -81.82 -30.18 32.3 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.209 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -138.48 81.17 25.14 Favored Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 123.082 0.553 . . . . 0.0 110.098 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.33 -21.9 46.78 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.593 2.195 . . . . 0.0 111.589 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.35 -26.48 68.77 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.411 1.084 . . . . 0.0 111.79 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -77.27 -20.11 55.55 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.821 0.449 . . . . 0.0 110.325 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 72.21 -154.23 50.43 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.58 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.3 t -79.46 117.39 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.564 0.746 . . . . 0.0 109.381 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.38 151.87 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.276 1.03 . . . . 0.0 109.38 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -88.48 129.29 35.48 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 90.8 mmm -147.23 126.8 13.28 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.699 1.2 . . . . 0.0 108.383 -174.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -68.18 160.8 28.39 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.631 ' HA ' HG22 ' A' ' 204' ' ' VAL . 20.6 t -69.32 -28.23 66.06 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.969 0.414 . . . . 0.0 111.048 -173.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -67.62 -32.22 72.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.038 0.935 . . . . 0.0 110.022 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.59 -19.84 32.41 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.078 0.951 . . . . 0.0 111.211 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.631 HG22 ' HA ' ' A' ' 201' ' ' SER . 7.8 m -96.68 157.87 3.21 Favored 'Isoleucine or valine' 0 C--N 1.356 0.882 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.733 ' HB3' ' HB3' ' A' ' 142' ' ' ASP . 0.5 OUTLIER -145.66 -178.63 6.19 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -165.295 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.444 ' HB3' ' HG3' ' A' ' 281' ' ' GLU . . . -98.51 143.82 28.52 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 166.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.43 HH11 ' HB2' ' A' ' 140' ' ' TYR . 57.2 mtp180 -70.32 96.56 1.14 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.164 0.585 . . . . 0.0 109.817 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.44 103.36 0.15 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.72 0.808 . . . . 0.0 110.955 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -82.86 -1.88 53.19 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.813 1.245 . . . . 0.0 111.632 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.0 m -94.46 119.93 33.93 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.843 0.857 . . . . 0.0 110.918 -176.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.4 mt -86.84 130.76 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.308 0.643 . . . . 0.0 109.284 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 39.7 mm -92.32 98.07 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.462 ' HD3' ' H ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -58.05 156.52 9.29 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.151 0.98 . . . . 0.0 111.439 174.21 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.415 ' CZ2' ' HB2' ' A' ' 246' ' ' LYS . 79.9 t90 -57.26 -40.34 77.49 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.714 -167.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -65.39 -29.83 70.58 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.871 0.468 . . . . 0.0 111.297 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.35 -15.49 49.75 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.043 0.937 . . . . 0.0 111.723 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.1 mt -65.84 114.31 4.99 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 169.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.432 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 11.1 pt-20 -119.0 168.03 11.2 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.219 1.007 . . . . 0.0 109.354 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.87 115.95 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-O 121.3 0.571 . . . . 0.0 109.541 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.19 -1.4 56.19 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.585 -174.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.563 ' HG3' HG13 ' A' ' 223' ' ' VAL . 6.2 tp-100 -67.55 120.58 14.21 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.969 0.508 . . . . 0.0 110.856 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.534 HG12 HG13 ' A' ' 280' ' ' ILE . 97.1 t -97.55 111.89 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.563 HG13 ' HG3' ' A' ' 221' ' ' GLN . 12.9 m -132.1 -174.76 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.219 1.408 . . . . 0.0 109.505 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 20.3 ptm -135.15 143.92 46.77 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.46 0.704 . . . . 0.0 109.447 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.51 159.89 42.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.779 0.832 . . . . 0.0 111.336 -169.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -90.31 106.94 18.83 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 173.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -145.48 138.73 26.34 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -172.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 46.4 t-20 -89.16 121.22 69.7 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.6 -19.74 21.19 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.562 2.175 . . . . 0.0 112.394 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -88.88 -39.16 14.01 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.468 0.707 . . . . 0.0 110.282 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 15.3 m120 -119.97 101.93 47.11 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.443 0.697 . . . . 0.0 110.027 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -61.28 -26.57 82.12 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.803 2.336 . . . . 0.0 113.231 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -78.44 -27.05 46.44 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.764 0.825 . . . . 0.0 111.385 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 231' ' ' ASN . 8.6 tp10 -107.05 151.52 25.23 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.252 0.621 . . . . 0.0 111.144 -170.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -76.26 152.34 36.54 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.572 0.749 . . . . 0.0 109.192 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -139.04 -106.86 0.72 Allowed Glycine 0 N--CA 1.47 0.907 0 C-N-CA 121.674 -0.298 . . . . 0.0 112.77 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -128.35 170.52 12.99 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' TRP . . . . . 0.437 ' CE2' ' HB3' ' A' ' 296' ' ' ARG . 81.8 m95 -80.2 105.81 11.75 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.36 0.664 . . . . 0.0 110.917 -175.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.408 ' HE1' ' HG2' ' A' ' 148' ' ' MET . 76.1 m-85 -118.42 165.04 14.37 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.64 1.176 . . . . 0.0 108.449 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -97.34 142.92 28.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.0 0.52 . . . . 0.0 110.121 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' A' ' 257' ' ' ALA . . . -137.09 155.07 50.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.328 1.051 . . . . 0.0 111.12 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -110.91 117.53 33.63 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.632 HD12 HD11 ' A' ' 255' ' ' LEU . 33.0 mm -69.86 107.82 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.678 0.791 . . . . 0.0 109.012 -173.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.3 p -84.33 -32.71 24.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.468 0.707 . . . . 0.0 111.944 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -160.33 158.35 29.56 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.692 0.397 . . . . 0.0 110.914 -176.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.415 ' HB2' ' CZ2' ' A' ' 214' ' ' TRP . 60.8 pttt -154.62 148.78 25.9 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.36 0.664 . . . . 0.0 112.076 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -155.8 149.93 25.57 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.483 1.113 . . . . 0.0 108.671 173.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -129.72 139.87 51.23 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 119.564 1.075 . . . . 0.0 112.26 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.4 p -119.67 170.28 9.34 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 165.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -67.92 -32.88 73.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.824 0.449 . . . . 0.0 110.606 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 73.5 p -90.99 -19.71 22.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.246 1.019 . . . . 0.0 112.581 -172.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.69 155.44 21.66 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -171.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -108.53 132.96 53.31 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 173.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -102.25 128.82 48.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.274 1.03 . . . . 0.0 108.427 172.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -149.87 137.08 19.69 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -127.05 136.36 52.08 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' A' ' 241' ' ' ALA . . . -147.24 140.8 25.55 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.197 0.599 . . . . 0.0 110.697 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -79.51 94.98 5.7 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 49.0 t -78.24 105.66 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 28.8 t -86.35 124.02 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.48 HD12 ' HB2' ' A' ' 264' ' ' ASP . 54.9 mt -103.16 -171.4 1.94 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.031 0.932 . . . . 0.0 109.032 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.08 -39.81 92.93 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 113.953 0.341 . . . . 0.0 113.953 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -121.77 -40.9 2.5 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.984 0.913 . . . . 0.0 109.255 173.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.48 ' HB2' HD12 ' A' ' 261' ' ' LEU . 21.5 m-20 -83.53 167.54 17.28 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.93 -173.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 54.7 p -145.53 114.21 6.81 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.617 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 61.9 mt -78.73 78.21 5.18 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -70.72 124.61 24.7 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.791 -170.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 36.8 t70 61.66 26.11 15.85 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.07 1.348 . . . . 0.0 111.603 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 94.9 m -73.47 133.62 43.71 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.709 -177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 -65.7 130.28 42.75 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.641 0.588 . . . . 0.0 110.493 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.9 mm -103.29 116.9 47.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.318 0.647 . . . . 0.0 109.555 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 61.9 mt -82.5 -45.45 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.685 173.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -89.58 64.44 6.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.951 0.9 . . . . 0.0 110.215 -168.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 30.5 m -78.84 -14.96 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.393 -174.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -90.63 -14.75 31.77 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.551 0.74 . . . . 0.0 111.047 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -96.98 43.6 1.07 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.098 0.959 . . . . 0.0 109.428 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.92 113.45 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.093 0.957 . . . . 0.0 109.737 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.41 ' HE2' ' HG3' ' A' ' 294' ' ' MET . 51.8 m-85 -94.61 164.92 12.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.014 0.926 . . . . 0.0 110.826 170.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -78.26 144.74 35.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.238 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.534 HG13 HG12 ' A' ' 222' ' ' VAL . 31.6 mm -73.42 113.57 11.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 164.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.444 ' HG3' ' HB3' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -78.97 125.52 29.48 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 170.494 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -109.16 104.92 56.34 Favored Pre-proline 0 N--CA 1.477 0.887 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -23.57 98.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.03 1 C-N-CA 125.751 4.3 . . . . 0.0 116.496 -151.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.23 60.21 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.577 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -78.2 -26.13 47.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.245 0.618 . . . . 0.0 110.24 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -134.79 160.44 24.27 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.838 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 12.4 m -91.04 159.01 40.79 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.552 0.741 . . . . 0.0 110.339 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.91 -155.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.62 2.214 . . . . 0.0 110.632 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' MET . . . . . 0.532 ' HB3' ' HB3' ' A' ' 293' ' ' PRO . 24.6 mmt -76.87 78.37 3.46 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 121.538 0.685 . . . . 0.0 109.534 177.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 13.6 p -106.78 -8.87 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.015 0.926 . . . . 0.0 109.933 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -122.32 -153.13 0.54 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -54.74 112.02 3.57 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.464 1.029 . . . . 0.0 109.709 167.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.532 ' HB3' ' HB3' ' A' ' 289' ' ' MET . 84.6 Cg_endo -76.17 137.21 18.95 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.051 1.834 . . . . 0.0 111.221 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.41 ' HG3' ' HE2' ' A' ' 278' ' ' PHE . 21.0 mmt -80.85 -49.45 11.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.148 0.579 . . . . 0.0 109.661 174.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 55.57 106.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.288 1.435 . . . . 0.0 110.627 -166.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.437 ' HB3' ' CE2' ' A' ' 238' ' ' TRP . 16.9 mtm180 -62.36 -33.41 74.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.989 0.915 . . . . 0.0 111.061 -177.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.748 ' HD2' ' HA ' ' A' ' 190' ' ' ASP . 51.5 tttp -64.26 92.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 37.2 t -152.55 97.9 2.31 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.411 0.684 . . . . 0.0 110.48 -172.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.461 ' N ' ' HD3' ' A' ' 300' ' ' PRO . . . -165.39 54.79 0.26 Allowed Glycine 0 CA--C 1.539 1.569 0 CA-C-O 119.191 -0.783 . . . . 0.0 112.401 170.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 299' ' ' GLY . 19.5 Cg_endo . . . . . 0 C--N 1.389 2.682 0 C-N-CA 123.648 2.899 . . . . 0.0 111.496 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.443 ' HA3' HG21 ' A' ' 159' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.465 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -109.39 9.78 25.54 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.555 0.742 . . . . 0.0 112.104 -170.517 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -125.91 144.87 50.5 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.391 0.676 . . . . 0.0 109.623 174.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.45 -177.6 3.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.635 0.774 . . . . 0.0 110.317 176.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.5 m -60.13 -6.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 125.205 1.402 . . . . 0.0 114.712 -173.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -110.63 -3.69 15.77 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.776 0.83 . . . . 0.0 112.032 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -86.39 88.52 7.65 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.352 0.596 . . . . 0.0 112.42 -171.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.657 ' HB3' ' HG2' ' A' ' 155' ' ' GLN . 31.0 p90 -75.86 102.1 5.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.052 0.929 . . . . 0.0 109.325 165.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.1 m -114.07 -165.84 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.526 1.53 . . . . 0.0 107.751 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.21 123.26 42.81 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.345 0.52 . . . . 0.0 111.825 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.23 103.36 16.05 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.555 171.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.8 108.25 8.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -82.38 115.8 21.58 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.5 m -81.54 -15.43 54.88 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.81 0.844 . . . . 0.0 111.846 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -67.71 -51.91 43.9 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 23.1 ptp -96.65 -25.49 15.55 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.917 0.487 . . . . 0.0 110.934 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.55 18.22 33.63 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-O 119.991 -0.339 . . . . 0.0 113.836 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -99.68 168.51 9.89 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.669 0.747 . . . . 0.0 112.491 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -116.01 120.75 40.15 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 125.284 1.434 . . . . 0.0 107.63 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.9 127.18 54.0 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.19 103.5 0.39 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.484 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -101.95 117.42 34.79 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.828 0.851 . . . . 0.0 110.265 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.657 ' HG2' ' HB3' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -87.42 104.92 16.91 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.028 0.931 . . . . 0.0 109.165 -178.162 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.42 HG22 HG12 ' A' ' 186' ' ' VAL . 82.6 t -62.89 102.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.653 0.781 . . . . 0.0 109.501 172.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.0 -10.07 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 122.848 0.459 . . . . 0.0 110.983 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -170.5 143.29 2.23 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.839 0.856 . . . . 0.0 109.269 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.443 HG21 ' HA3' ' A' ' 133' ' ' GLY . 6.8 p -115.09 139.26 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 166.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 20.5 p -131.96 150.68 52.09 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.398 1.079 . . . . 0.0 108.583 172.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.418 ' NE ' ' SG ' ' A' ' 170' ' ' CYS . 1.9 tmm_? -66.97 147.21 53.52 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 171.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.41 ' HA ' HG13 ' A' ' 183' ' ' ILE . 87.5 tttt -57.69 90.48 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.541 0.736 . . . . 0.0 112.74 -171.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 164.13 163.39 0.07 OUTLIER Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 127.982 2.513 . . . . 0.0 107.085 172.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.58 -22.6 36.08 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.098 1.865 . . . . 0.0 112.545 167.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 54.8 m 61.32 30.02 18.88 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 124.655 1.182 . . . . 0.0 110.622 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -75.38 -36.63 60.87 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.85 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -74.48 -61.75 1.76 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.989 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.417 ' HG2' ' SG ' ' A' ' 170' ' ' CYS . 0.3 OUTLIER -109.94 125.78 30.42 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 123.951 0.901 . . . . 0.0 109.654 -176.176 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.09 -30.59 89.49 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.069 2.513 . . . . 0.0 113.296 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.418 ' SG ' ' NE ' ' A' ' 161' ' ' ARG . 50.9 m 64.64 28.33 13.19 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.556 1.16 . . . . 0.0 111.034 -176.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 32.6 p -64.06 87.84 0.05 OUTLIER 'General case' 0 C--O 1.244 0.798 0 C-N-CA 124.348 1.059 . . . . 0.0 110.757 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 16.1 m 60.81 32.43 20.13 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.671 1.189 . . . . 0.0 111.842 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -60.55 122.54 14.93 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.777 0.431 . . . . 0.0 110.173 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.1 p -70.7 82.07 0.61 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.75 0.82 . . . . 0.0 111.017 -175.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -136.45 102.35 9.71 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -69.3 114.81 3.75 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.565 2.177 . . . . 0.0 112.075 -171.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -74.82 105.27 5.8 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.692 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 43.2 mt -71.94 -41.19 68.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.876 0.87 . . . . 0.0 108.908 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -132.36 127.11 34.78 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 167.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -86.5 67.93 10.04 Favored 'General case' 0 C--O 1.248 1.015 0 CA-C-O 121.698 0.761 . . . . 0.0 109.235 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -84.37 61.05 6.36 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.2 m -115.45 173.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.449 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.41 HG13 ' HA ' ' A' ' 162' ' ' LYS . 45.2 mt -96.26 108.29 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.218 0.532 . . . . 0.0 109.99 -170.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -93.36 112.08 23.9 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.978 0.911 . . . . 0.0 108.631 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -78.25 89.97 4.32 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 175.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.484 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 29.3 m -110.46 151.68 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.288 -177.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -120.41 148.83 43.27 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 170.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -68.36 107.82 2.99 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -58.38 -34.55 70.83 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.406 0.682 . . . . 0.0 110.635 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -78.15 -23.77 47.61 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.379 0.672 . . . . 0.0 111.525 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -137.22 67.43 54.51 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.758 -0.589 . . . . 0.0 109.957 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.7 -17.57 42.51 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.969 2.446 . . . . 0.0 112.269 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.79 -13.78 62.41 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.58 1.552 . . . . 0.0 112.667 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -85.03 -21.21 29.52 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.748 0.419 . . . . 0.0 111.11 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 90.31 -157.19 25.62 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.545 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.8 t -92.17 118.67 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.894 0.878 . . . . 0.0 110.634 -172.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.6 m -109.41 156.38 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.368 1.067 . . . . 0.0 109.703 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -103.91 134.04 47.87 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.153 0.581 . . . . 0.0 110.919 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 82.7 mmm -136.83 167.05 22.19 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.575 1.15 . . . . 0.0 109.305 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.448 ' O ' HG22 ' A' ' 204' ' ' VAL . 21.1 m-80 -109.83 171.41 7.46 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.722 0.809 . . . . 0.0 109.639 174.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 43.4 m -61.32 -37.03 81.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 118.64 0.655 . . . . 0.0 111.566 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -16.59 61.57 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.453 176.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -96.66 -50.1 4.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.826 0.85 . . . . 0.0 110.681 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 200' ' ' ASN . 7.9 m -96.34 115.77 36.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 CA-C-O 122.004 0.907 . . . . 0.0 109.917 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -125.9 139.22 53.65 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.799 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.4 126.3 26.69 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.504 ' NH1' ' HB2' ' A' ' 296' ' ' ARG . 4.0 ptm180 -74.19 161.53 29.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.561 0.744 . . . . 0.0 112.215 -174.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 287' ' ' SER . . . -83.1 125.56 31.62 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.383 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.36 66.38 4.69 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 164.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.6 m -145.42 109.18 4.74 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.803 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.9 mt -85.93 129.07 38.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 123.077 0.551 . . . . 0.0 110.014 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.611 HD11 ' HE3' ' A' ' 279' ' ' LYS . 26.3 mm -101.51 148.12 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.791 1.237 . . . . 0.0 108.603 174.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 175.72 8.57 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.286 0.634 . . . . 0.0 110.27 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -54.28 -51.92 63.06 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -166.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -72.68 -19.56 61.4 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.24 -21.48 29.05 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.942 0.897 . . . . 0.0 109.954 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.463 HD22 HD11 ' A' ' 243' ' ' ILE . 90.5 mt -71.37 128.76 36.94 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -143.55 158.17 43.86 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.785 0.434 . . . . 0.0 110.572 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.0 127.28 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 123.912 0.757 . . . . 0.0 111.428 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.23 -25.7 25.95 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.013 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -72.95 122.12 21.16 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.32 0.648 . . . . 0.0 110.159 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.505 HG13 ' NH2' ' A' ' 282' ' ' ARG . 1.8 p -108.72 125.15 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.326 0.651 . . . . 0.0 110.308 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 280' ' ' ILE . 3.8 m -135.31 177.27 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 125.422 1.489 . . . . 0.0 109.912 -175.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 16.8 ptm -108.19 120.76 43.28 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.185 0.594 . . . . 0.0 110.702 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.676 ' HG ' HG13 ' A' ' 277' ' ' VAL . 0.4 OUTLIER -127.86 148.88 50.48 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.704 0.802 . . . . 0.0 108.91 -176.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -88.51 116.85 27.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.803 0.841 . . . . 0.0 111.734 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.523 ' HE1' ' HB2' ' A' ' 225' ' ' LEU . 4.9 p90 -163.69 142.45 7.88 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.156 0.982 . . . . 0.0 108.648 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.416 HD22 ' HB3' ' A' ' 231' ' ' ASN . 3.9 p30 -85.92 131.12 47.93 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 168.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.18 -19.77 66.36 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.25 1.967 . . . . 0.0 113.253 -171.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -66.57 -42.89 86.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.245 0.618 . . . . 0.0 110.154 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.416 ' HB3' HD22 ' A' ' 228' ' ' ASN . 63.2 t30 -130.06 89.1 46.44 Favored Pre-proline 0 N--CA 1.47 0.548 0 C-N-CA 123.608 0.763 . . . . 0.0 109.181 -176.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.21 -6.97 17.51 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.616 2.211 . . . . 0.0 113.072 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.52 -29.35 46.48 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.243 0.617 . . . . 0.0 111.595 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.82 151.62 44.98 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.869 0.467 . . . . 0.0 110.237 -176.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 227' ' ' TYR . 7.0 ppt_? -66.72 161.79 22.74 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.814 0.846 . . . . 0.0 112.639 -175.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -165.57 -84.4 0.05 OUTLIER Glycine 0 C--N 1.338 0.684 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.388 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.454 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 30.1 m-85 -119.27 149.15 42.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.72 0.808 . . . . 0.0 109.224 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -88.36 104.43 16.76 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 95.5 m-85 -108.38 160.85 15.55 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.145 0.578 . . . . 0.0 110.367 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -81.48 119.23 23.48 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.676 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.467 ' HB3' HD13 ' A' ' 225' ' ' LEU . . . -126.82 136.56 52.53 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -99.36 123.17 43.41 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.608 HD12 HD11 ' A' ' 255' ' ' LEU . 19.5 mm -64.84 110.37 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.9 t -78.93 -36.42 41.79 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.278 -177.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -170.22 158.79 6.98 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.782 0.833 . . . . 0.0 109.52 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -143.43 136.21 27.52 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 254' ' ' GLU . 4.0 ptm180 -145.61 125.41 13.44 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -92.15 137.67 32.17 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.9 p -116.0 176.62 5.01 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 170.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -58.7 -39.71 81.52 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.7 p -127.84 13.5 6.86 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.6 159.98 37.62 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.244 0.474 . . . . 0.0 111.314 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -122.35 108.76 13.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.106 0.962 . . . . 0.0 108.825 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.475 ' HB2' ' HG3' ' A' ' 247' ' ' ARG . 3.7 mp0 -90.88 99.1 12.19 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.608 HD11 HD12 ' A' ' 243' ' ' ILE . 2.1 tm? -100.23 121.34 41.31 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 176.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -107.23 132.14 53.4 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.05 122.32 12.28 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.28 0.632 . . . . 0.0 109.948 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -76.35 99.93 4.98 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 94.4 t -69.26 107.12 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.734 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 9.2 m -87.4 104.46 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 36.4 mt -81.93 -160.04 0.33 Allowed 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.684 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.43 -47.8 33.52 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-O 120.994 0.219 . . . . 0.0 112.979 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -122.3 -32.29 3.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.126 0.971 . . . . 0.0 111.044 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -101.44 171.56 7.5 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.666 0.787 . . . . 0.0 110.567 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 58.7 m -144.61 121.97 11.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.779 0.832 . . . . 0.0 109.816 171.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 72.2 mt -80.97 113.18 19.0 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.858 0.863 . . . . 0.0 109.562 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.69 109.47 4.38 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.513 0.725 . . . . 0.0 111.423 -173.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.79 57.69 4.56 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.735 1.214 . . . . 0.0 112.873 171.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 42.7 t -65.03 125.24 24.3 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 36.6 ttt180 -71.82 123.33 22.42 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.6 mm -100.03 122.4 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.32 0.648 . . . . 0.0 109.804 -175.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 65.4 mt -92.06 -14.29 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 124.451 1.1 . . . . 0.0 109.649 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -89.09 20.63 3.56 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.239 1.416 . . . . 0.0 111.494 -168.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 28.9 m -69.09 -4.51 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.757 1.223 . . . . 0.0 114.101 -166.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -94.19 -33.49 13.28 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.687 0.395 . . . . 0.0 111.228 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -128.72 48.62 2.3 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.77 0.795 . . . . 0.0 110.193 -173.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.676 HG13 ' HG ' ' A' ' 225' ' ' LEU . 59.4 t -74.7 154.01 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.426 169.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -119.92 149.8 41.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.611 ' HE3' HD11 ' A' ' 212' ' ' ILE . 26.4 ttmt -80.14 151.4 29.79 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.662 174.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 223' ' ' VAL . 36.1 mm -76.93 126.41 37.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 168.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.669 ' HA ' ' HA3' ' A' ' 286' ' ' GLY . 0.6 OUTLIER -71.26 108.57 4.81 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.671 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 90.2 mtt-85 -123.06 153.69 64.46 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.783 1.233 . . . . 0.0 108.566 -176.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.16 96.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.091 2.527 . . . . 0.0 113.557 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.28 -34.91 5.26 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.229 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 10.5 tp10 -85.97 -27.37 24.92 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.677 0.391 . . . . 0.0 111.902 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -108.93 136.59 13.65 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -175.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 208' ' ' ALA . 3.3 m -96.24 144.98 28.77 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 117.259 0.53 . . . . 0.0 110.093 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -88.23 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.033 2.489 . . . . 0.0 111.765 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 17.4 mmt -80.66 78.92 7.37 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.1 -26.77 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.334 1.054 . . . . 0.0 110.146 -175.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -125.89 -160.08 0.95 Allowed 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -44.73 106.51 0.54 Allowed Pre-proline 0 N--CA 1.489 1.496 0 CA-C-N 119.743 1.156 . . . . 0.0 112.293 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.404 ' HB2' ' OH ' ' A' ' 140' ' ' TYR . 7.0 Cg_exo -73.82 84.52 1.44 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.164 2.576 . . . . 0.0 111.252 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 25.0 ptm -66.2 140.97 58.21 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.14 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -85.16 159.64 20.09 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.504 ' HB2' ' NH1' ' A' ' 207' ' ' ARG . 23.1 ttp-105 -128.12 10.57 6.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.567 0.747 . . . . 0.0 109.837 -175.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -51.8 131.94 31.05 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.791 1.636 . . . . 0.0 111.139 172.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 19.7 m -76.66 89.37 3.35 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.081 0.552 . . . . 0.0 109.902 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -81.38 118.64 4.67 Favored Glycine 0 CA--C 1.537 1.466 0 CA-C-O 119.026 -0.874 . . . . 0.0 113.298 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo . . . . . 0 C--N 1.375 1.926 0 C-N-CA 123.21 2.607 . . . . 0.0 112.16 177.465 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.401 HD13 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -120.18 -18.57 8.01 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.258 0.623 . . . . 0.0 111.397 175.024 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -99.78 143.45 29.99 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 136' ' ' LYS . 6.3 mptt -97.87 179.32 4.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.494 1.117 . . . . 0.0 110.472 -170.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -68.74 -17.81 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 124.767 1.227 . . . . 0.0 112.161 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -116.41 16.29 15.68 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.253 0.621 . . . . 0.0 110.976 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.43 ' HG3' HG13 ' A' ' 141' ' ' VAL . 11.3 tp10 -97.21 89.43 4.76 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.341 0.591 . . . . 0.0 110.17 -173.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.624 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 22.8 p90 -82.18 100.23 9.72 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.69 0.757 . . . . 0.0 111.179 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.43 HG13 ' HG3' ' A' ' 139' ' ' GLU . 34.1 m -114.88 169.14 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.721 0.808 . . . . 0.0 109.221 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -87.93 113.88 24.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.136 0.493 . . . . 0.0 111.296 -169.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.38 109.41 19.54 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 170.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.564 HH22 HG12 ' A' ' 260' ' ' VAL . 26.3 ttt180 -74.9 113.68 12.49 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.497 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.89 134.89 35.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.431 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.6 p -77.04 -36.51 56.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.472 0.709 . . . . 0.0 111.494 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -65.03 -45.1 86.84 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.189 0.595 . . . . 0.0 110.847 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 54.0 tpp -85.54 -38.49 18.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.59 0.756 . . . . 0.0 110.127 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.68 9.89 80.35 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.867 -171.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.99 168.42 9.13 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 121.791 0.805 . . . . 0.0 112.243 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.441 ' HZ2' HD12 ' A' ' 280' ' ' ILE . 8.5 m0 -89.35 122.41 32.54 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.512 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.72 111.15 17.25 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 173.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -57.32 98.28 0.03 OUTLIER 'General case' 0 C--N 1.363 1.168 0 O-C-N 124.163 0.915 . . . . 0.0 109.963 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -103.73 133.1 49.29 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.437 1.095 . . . . 0.0 109.818 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 43.6 tt0 -84.01 106.75 15.91 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 122.684 0.394 . . . . 0.0 110.667 -173.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.1 t -58.56 109.23 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.521 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 167.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 m -108.37 -26.2 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 122.861 0.464 . . . . 0.0 111.028 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.425 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 56.5 ttt85 -146.5 122.63 10.81 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 110.788 -0.078 . . . . 0.0 110.788 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.16 117.82 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 123.335 0.654 . . . . 0.0 109.369 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.7 p -127.87 117.63 22.17 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.711 0.804 . . . . 0.0 109.289 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.46 ' HG3' HG12 ' A' ' 182' ' ' VAL . 27.1 ttt180 -76.14 138.19 40.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.376 0.67 . . . . 0.0 109.473 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -63.69 -21.62 66.48 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.201 0.6 . . . . 0.0 111.144 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.18 101.77 1.46 Allowed Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 161.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -63.63 127.01 18.69 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 122.757 2.305 . . . . 0.0 111.499 -174.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.5 m -104.45 28.14 7.22 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.826 0.85 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 65.95 175.27 0.23 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.771 1.228 . . . . 0.0 111.779 -175.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.6 -51.66 68.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.892 0.477 . . . . 0.0 110.155 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -96.58 107.5 36.69 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.01 59.46 6.96 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.584 2.856 . . . . 0.0 112.384 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 61.9 m -70.22 -37.93 75.14 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.868 0.867 . . . . 0.0 111.212 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 45.5 m -73.79 93.76 2.18 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 171.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 27.2 t -144.66 26.74 1.39 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.449 -173.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 41.7 p -67.91 89.86 0.29 Allowed 'General case' 0 C--N 1.358 0.971 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.1 t 65.56 -179.99 0.19 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.624 1.17 . . . . 0.0 111.173 -171.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.8 ptt-85 -158.6 134.27 5.99 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 123.989 0.916 . . . . 0.0 108.901 175.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.48 113.59 2.17 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 123.088 2.525 . . . . 0.0 112.911 -173.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.43 123.9 19.11 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.475 0.71 . . . . 0.0 110.564 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 30.7 tp -154.17 176.19 12.56 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -172.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -70.48 97.98 1.38 Allowed 'General case' 0 C--O 1.243 0.75 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 163.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.89 96.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.367 1.079 . . . . 0.0 111.603 -172.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -88.81 19.71 3.91 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.209 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.46 HG12 ' HG3' ' A' ' 161' ' ' ARG . 6.4 m -78.17 163.4 3.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 124.007 0.923 . . . . 0.0 110.046 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.497 HG23 ' HB2' ' A' ' 198' ' ' GLN . 61.3 mt -97.16 110.31 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.41 0.684 . . . . 0.0 110.117 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -90.6 108.43 19.8 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 169.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 56.0 m-70 -77.14 97.77 4.86 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.49 143.32 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.533 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.539 ' HG2' HG22 ' A' ' 196' ' ' VAL . 25.3 mtmt -104.83 116.81 32.64 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -53.99 111.01 0.67 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.88 -22.99 67.1 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -80.34 -29.12 38.0 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.597 0.759 . . . . 0.0 111.404 173.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -129.27 55.05 16.19 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 123.499 0.72 . . . . 0.0 111.321 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.38 -13.58 20.6 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 121.719 1.613 . . . . 0.0 112.73 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -71.83 -27.93 63.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.864 0.866 . . . . 0.0 110.697 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -75.82 -1.42 25.1 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.548 0.739 . . . . 0.0 111.905 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 92.48 -172.05 34.14 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-O 121.11 0.283 . . . . 0.0 113.279 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.539 HG22 ' HG2' ' A' ' 187' ' ' LYS . 8.8 t -90.51 116.9 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.11 152.56 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.837 0.855 . . . . 0.0 110.015 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.497 ' HB2' HG23 ' A' ' 183' ' ' ILE . 16.7 pm0 -92.27 126.48 37.37 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 97.0 mmm -141.38 136.44 31.43 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.742 1.217 . . . . 0.0 107.973 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.464 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 20.8 m-80 -89.45 173.12 8.52 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.167 0.44 . . . . 0.0 110.071 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.535 ' HA ' HG22 ' A' ' 204' ' ' VAL . 18.9 t -66.82 -30.0 70.08 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 120.806 0.336 . . . . 0.0 110.496 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.464 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 15.4 ptm180 -67.24 -18.11 65.08 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.585 0.754 . . . . 0.0 111.935 175.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -102.38 -29.32 11.71 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.93 0.892 . . . . 0.0 111.085 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 201' ' ' SER . 31.9 m -99.21 148.78 5.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 CA-C-O 121.599 0.714 . . . . 0.0 110.374 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -128.85 146.14 51.01 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.873 1.269 . . . . 0.0 108.111 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.69 128.93 38.29 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -63.4 137.35 58.13 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.362 0.665 . . . . 0.0 110.814 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 279' ' ' LYS . . . -69.89 113.86 7.52 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -172.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.576 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 1.2 ptm180 -82.24 -31.94 29.96 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.686 169.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.7 m -90.04 123.51 33.98 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.554 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.4 mt -86.29 136.31 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.425 ' HB ' HG12 ' A' ' 277' ' ' VAL . 48.4 mm -107.51 144.2 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.673 0.789 . . . . 0.0 109.619 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.42 168.78 14.4 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.197 0.999 . . . . 0.0 109.296 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -52.22 -38.63 58.55 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.351 1.06 . . . . 0.0 112.953 -170.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.6 -44.31 93.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.358 0.663 . . . . 0.0 112.186 -173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.88 -1.46 32.07 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.609 0.764 . . . . 0.0 110.736 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.522 HD11 HG21 ' A' ' 223' ' ' VAL . 21.0 tp -79.19 121.0 24.49 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -130.69 156.72 44.44 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.496 0.589 . . . . 0.0 111.509 -172.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.4 m -67.93 132.34 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.971 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.8 -11.87 70.31 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.971 -176.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.409 ' HG2' HG13 ' A' ' 223' ' ' VAL . 34.5 tt0 -86.05 123.99 31.98 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.506 0.722 . . . . 0.0 109.47 177.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.96 133.16 29.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 173.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.522 HG21 HD11 ' A' ' 217' ' ' LEU . 3.3 m -145.19 145.76 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.6 1.16 . . . . 0.0 109.369 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.568 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 12.0 ptm -97.28 131.21 44.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.994 0.518 . . . . 0.0 109.692 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.513 ' HB3' ' HA ' ' A' ' 277' ' ' VAL . 0.8 OUTLIER -143.92 158.54 43.63 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.926 0.491 . . . . 0.0 110.834 -175.225 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 235' ' ' ARG . 16.5 p30 -77.04 117.87 19.04 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -156.6 143.16 18.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.726 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -108.53 120.47 46.29 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 168.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.66 -36.14 11.64 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.62 2.213 . . . . 0.0 111.873 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.31 -29.13 62.49 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.408 0.683 . . . . 0.0 110.774 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -131.18 90.13 39.64 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.41 -17.77 49.29 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.923 2.415 . . . . 0.0 113.473 -176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -76.03 -27.75 57.44 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.069 0.547 . . . . 0.0 111.176 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.09 153.64 37.17 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.407 ' HB2' ' HB2' ' A' ' 226' ' ' ASN . 0.0 OUTLIER -75.4 173.34 11.06 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.933 0.493 . . . . 0.0 111.732 176.506 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -159.83 -117.53 0.47 Allowed Glycine 0 C--O 1.24 0.522 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.278 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -82.56 171.42 14.1 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.199 0.6 . . . . 0.0 110.102 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -89.01 105.5 17.82 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -114.02 135.3 54.16 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -82.67 129.0 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -136.65 137.04 39.64 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.205 1.002 . . . . 0.0 109.309 -173.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -94.64 118.93 32.48 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.601 HD12 HD11 ' A' ' 255' ' ' LEU . 37.3 mm -62.44 112.79 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.195 0.598 . . . . 0.0 111.192 -173.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.4 t -82.53 -41.62 19.43 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.901 0.88 . . . . 0.0 110.088 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -157.05 155.73 31.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.735 0.814 . . . . 0.0 109.53 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -142.85 144.28 32.45 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.15 0.58 . . . . 0.0 109.893 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 254' ' ' GLU . 33.3 ttm180 -156.54 148.85 23.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.96 0.904 . . . . 0.0 109.786 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.21 139.82 35.72 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 165.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.0 p -114.31 177.65 4.57 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 172.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -78.98 -23.4 44.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 118.434 0.561 . . . . 0.0 110.434 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.1 p -95.16 -21.04 18.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.702 0.801 . . . . 0.0 112.5 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.91 173.86 16.13 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.191 0.596 . . . . 0.0 111.006 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -126.4 151.1 48.12 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 247' ' ' ARG . 10.1 tp10 -138.73 137.1 36.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.11 0.481 . . . . 0.0 110.894 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.648 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.4 OUTLIER -149.96 139.1 21.18 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.242 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -130.75 129.88 43.06 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.79 138.58 24.5 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.238 0.615 . . . . 0.0 109.919 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -76.69 99.22 4.99 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.49 106.14 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.564 HG12 HH22 ' A' ' 144' ' ' ARG . 48.4 t -89.0 114.56 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.225 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 264' ' ' ASP . 87.8 mt -92.28 -170.17 2.44 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.965 0.906 . . . . 0.0 109.907 173.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -61.41 -54.55 35.15 Favored Glycine 0 C--N 1.352 1.438 0 O-C-N 123.156 0.285 . . . . 0.0 112.591 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.05 -49.56 3.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.212 1.005 . . . . 0.0 109.905 172.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.431 ' HB2' HD12 ' A' ' 261' ' ' LEU . 7.4 m-20 -76.18 167.35 22.03 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.703 -171.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 38.0 p -153.95 112.89 3.69 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.422 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 2.6 mm? -81.41 95.86 7.18 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.508 0.723 . . . . 0.0 109.659 -177.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -58.6 111.73 1.36 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.229 0.956 . . . . 0.0 110.662 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 16.0 t70 64.01 83.75 0.16 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.889 1.275 . . . . 0.0 111.783 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 71.4 m -106.9 140.32 39.89 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.051 0.94 . . . . 0.0 109.554 172.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -82.2 107.97 15.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.106 0.562 . . . . 0.0 110.13 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.648 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 42.4 mm -91.76 124.06 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.947 0.899 . . . . 0.0 108.734 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 52.6 mt -88.17 -26.73 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.304 0.642 . . . . 0.0 110.499 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.476 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 38.0 m-85 -95.56 60.91 2.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.876 0.87 . . . . 0.0 111.038 -166.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 255' ' ' LEU . 9.8 m -66.69 -17.15 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.369 1.067 . . . . 0.0 112.246 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -98.65 -24.26 15.14 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.003 0.921 . . . . 0.0 110.98 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 36.5 mt-10 -98.24 28.05 4.29 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.564 0.697 . . . . 0.0 110.799 -176.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.513 ' HA ' ' HB3' ' A' ' 225' ' ' LEU . 72.6 t -82.95 146.36 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.586 1.155 . . . . 0.0 108.88 172.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.568 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 73.0 m-85 -130.78 160.89 33.01 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.179 0.991 . . . . 0.0 109.531 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 208' ' ' ALA . 75.1 tttt -82.04 154.78 25.47 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.34 1.056 . . . . 0.0 111.858 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.441 HD12 ' HZ2' ' A' ' 151' ' ' TRP . 15.9 mm -88.54 111.08 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 164.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' ' 208' ' ' ALA . 46.0 mm-40 -83.97 103.81 13.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -90.06 142.35 28.67 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.72 1.208 . . . . 0.0 109.52 -173.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.88 99.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.441 2.761 . . . . 0.0 113.544 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.28 -49.72 1.9 Allowed Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.906 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -73.36 -24.61 60.35 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.331 0.653 . . . . 0.0 111.728 -174.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -91.13 -159.81 35.94 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 25.2 p -126.99 135.11 26.89 Favored Pre-proline 0 N--CA 1.468 0.435 0 CA-C-N 117.142 0.471 . . . . 0.0 110.895 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.02 -174.67 1.63 Allowed 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.01 2.473 . . . . 0.0 110.616 163.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' MET . . . . . 0.576 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 24.6 mmt -74.72 81.33 2.06 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.429 0.633 . . . . 0.0 110.479 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 12.3 p -100.77 -17.36 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.843 1.257 . . . . 0.0 109.627 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -122.75 -160.68 0.9 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -45.87 117.65 3.93 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.56 1.144 . . . . 0.0 112.422 177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.555 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 85.1 Cg_endo -78.36 144.08 20.14 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.585 2.19 . . . . 0.0 111.994 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 97.5 mmm -115.1 145.18 42.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.963 0.905 . . . . 0.0 110.693 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -143.3 91.53 2.28 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 169.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 40.6 mtm-85 -72.57 -17.24 61.73 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.378 -170.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -67.74 98.71 0.73 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 162.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 23.5 p -74.56 79.95 1.97 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.944 0.898 . . . . 0.0 110.935 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -172.67 76.23 0.09 OUTLIER Glycine 0 C--N 1.344 0.979 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.185 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 CA--C 1.565 2.05 0 C-N-CA 123.317 2.678 . . . . 0.0 111.82 176.168 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.456 ' N ' ' HG ' ' A' ' 174' ' ' SER . . . . . . . . 0 N--CA 1.476 1.355 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -102.83 -21.07 14.08 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.585 0.754 . . . . 0.0 110.673 -175.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -108.02 132.56 53.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 169.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 139' ' ' GLU . 17.7 pttp -130.24 -175.74 3.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.944 0.898 . . . . 0.0 110.742 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.8 m -35.47 -32.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -167.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -109.39 -22.18 12.16 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.208 0.603 . . . . 0.0 111.983 -173.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.402 ' HB2' ' H ' ' A' ' 136' ' ' LYS . 5.1 mp0 -77.13 78.83 3.66 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.371 1.068 . . . . 0.0 110.612 -176.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -76.52 130.81 38.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.545 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.2 m -132.69 169.01 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.491 1.516 . . . . 0.0 107.219 172.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.434 ' HB2' ' CE3' ' A' ' 151' ' ' TRP . 4.5 m-20 -92.24 139.51 30.54 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.664 0.665 . . . . 0.0 110.878 -174.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.1 99.4 12.4 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.888 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.435 ' HG2' ' NE1' ' A' ' 151' ' ' TRP . 0.0 OUTLIER -70.8 91.03 0.81 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.129 -1.396 . . . . 0.0 107.407 177.687 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.69 128.92 37.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.143 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.5 m -81.88 -19.15 41.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.563 0.345 . . . . 0.0 111.722 -172.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -76.69 -52.88 8.81 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.9 ttm -90.26 -39.99 12.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.693 0.797 . . . . 0.0 110.552 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.76 -7.67 59.38 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.199 -173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.3 153.38 35.94 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.598 0.759 . . . . 0.0 111.676 -174.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.547 ' CH2' HD12 ' A' ' 280' ' ' ILE . 12.9 m95 -101.51 116.07 31.93 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -109.0 123.28 48.88 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.03 101.66 0.23 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.757 0.66 . . . . 0.0 110.447 -173.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.9 114.84 26.49 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -85.52 97.6 10.15 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.439 HG22 HG12 ' A' ' 186' ' ' VAL . 44.7 t -65.51 97.84 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -92.14 -12.56 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.012 0.525 . . . . 0.0 111.851 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 170' ' ' CYS . 21.1 ttm180 -168.72 154.05 6.34 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.525 0.73 . . . . 0.0 110.809 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.0 m -131.43 143.44 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.194 0.998 . . . . 0.0 110.14 172.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.577 HG23 ' HB ' ' A' ' 183' ' ' ILE . 4.5 t -141.69 150.4 41.82 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.896 0.878 . . . . 0.0 109.781 176.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -120.04 158.26 27.19 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.961 0.904 . . . . 0.0 110.791 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -95.69 86.56 4.44 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.372 0.669 . . . . 0.0 110.378 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -144.21 155.68 58.02 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.979 0.912 . . . . 0.0 109.809 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.94 -42.86 63.23 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.423 2.082 . . . . 0.0 112.335 168.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 46.7 m -87.57 91.17 8.65 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 172.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -144.75 23.06 1.59 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.872 0.869 . . . . 0.0 110.615 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -77.61 124.98 28.63 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 55.9 59.83 9.04 Favored Pre-proline 0 CA--C 1.563 1.477 0 C-N-CA 124.684 1.193 . . . . 0.0 111.856 -173.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -89.0 98.17 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.345 2.697 . . . . 0.0 112.328 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' CYS . . . . . 0.498 ' HA ' ' HG3' ' A' ' 158' ' ' ARG . 47.6 t -129.04 172.47 11.36 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.622 0.725 . . . . 0.0 111.935 -174.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.8 p -72.73 -22.75 60.83 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.23 173.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 17.7 p -74.37 126.18 30.13 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.3 m 56.92 54.95 6.55 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -167.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.456 ' HG ' ' N ' ' A' ' 133' ' ' GLY . 14.2 t -54.08 101.28 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.246 -170.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -74.49 130.97 80.87 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.512 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.15 143.98 17.61 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.967 3.111 . . . . 0.0 114.54 -172.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.5 146.59 31.27 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.445 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 50.8 mt -73.0 -75.72 0.14 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.194 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -113.83 16.2 18.48 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.111 0.964 . . . . 0.0 109.797 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 71.59 -15.36 0.44 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.245 1.418 . . . . 0.0 112.346 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.547 ' HA ' ' H ' ' A' ' 201' ' ' SER . 28.7 m-20 -87.62 51.14 2.14 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.641 0.734 . . . . 0.0 110.147 174.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 160' ' ' THR . 35.3 m -81.59 179.56 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.771 169.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' A' ' 160' ' ' THR . 3.6 mp -94.04 107.31 19.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -176.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -85.49 108.92 18.13 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.498 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 22.5 m-70 -78.29 100.71 6.82 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.439 HG12 HG22 ' A' ' 156' ' ' VAL . 12.0 m -118.35 164.0 15.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.237 -176.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -122.18 116.13 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -57.99 111.18 1.09 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 169.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.98 -23.99 61.51 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.653 0.739 . . . . 0.0 110.334 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -82.3 -30.4 30.56 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.29 172.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -137.73 70.31 51.47 Favored Pre-proline 0 N--CA 1.487 1.381 0 C-N-CA 123.101 0.56 . . . . 0.0 110.985 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.83 -18.21 57.48 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.801 2.334 . . . . 0.0 112.173 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.19 -17.12 57.21 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.871 1.268 . . . . 0.0 112.573 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -75.91 -7.21 54.01 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.751 0.82 . . . . 0.0 112.263 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.77 -167.11 52.61 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 40.5 t -81.3 117.02 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 171.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 29.0 m -108.38 141.9 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 122.82 0.448 . . . . 0.0 110.047 -175.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.501 ' HB2' HG23 ' A' ' 183' ' ' ILE . 18.4 pt20 -87.51 130.48 34.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.448 0.699 . . . . 0.0 110.156 -176.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 60.1 mmm -133.3 161.5 34.32 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.335 0.654 . . . . 0.0 109.739 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -111.55 -179.5 3.73 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.099 0.959 . . . . 0.0 109.275 172.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.547 ' H ' ' HA ' ' A' ' 181' ' ' ASP . 42.3 t -62.37 -41.43 98.61 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 118.168 0.44 . . . . 0.0 110.367 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -15.19 62.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.868 0.467 . . . . 0.0 112.157 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -89.19 -57.79 2.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.445 0.698 . . . . 0.0 110.008 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -94.24 117.97 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.69 0.757 . . . . 0.0 109.77 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.428 ' HD2' ' HH2' ' A' ' 151' ' ' TRP . 25.8 ttm180 -111.66 149.89 30.91 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.08 -176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.18 127.72 32.66 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 123.907 0.754 . . . . 0.0 111.625 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -101.27 136.53 40.96 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.191 0.996 . . . . 0.0 109.417 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.75 157.55 15.89 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.037 0.922 . . . . 0.0 110.433 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.431 ' HD3' ' N ' ' A' ' 209' ' ' ARG . 0.0 OUTLIER -114.61 42.89 2.03 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.462 177.524 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 21.3 m -127.12 118.73 24.95 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.583 -178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 50.4 mt -84.08 127.74 39.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.574 HG23 ' HB2' ' A' ' 216' ' ' ASP . 46.6 mm -92.37 138.96 18.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.379 -178.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -128.31 -178.49 4.58 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.867 1.267 . . . . 0.0 109.415 175.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' A' ' 246' ' ' LYS . 49.7 t-105 -60.99 -28.64 69.17 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.812 0.445 . . . . 0.0 111.87 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -61.91 -41.98 98.55 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.301 0.641 . . . . 0.0 110.564 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.574 ' HB2' HG23 ' A' ' 212' ' ' ILE . 58.8 m-20 -80.58 -14.55 58.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.733 0.813 . . . . 0.0 111.58 -177.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.516 ' HB3' ' HD3' ' A' ' 246' ' ' LYS . 0.5 OUTLIER -63.06 113.49 3.15 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.634 0.773 . . . . 0.0 111.222 -172.81 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.85 139.53 22.72 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.736 0.814 . . . . 0.0 110.005 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -67.31 139.64 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.161 0.584 . . . . 0.0 110.876 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 96.88 -21.74 44.4 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.696 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.414 ' HG2' HG13 ' A' ' 223' ' ' VAL . 8.0 tt0 -77.83 122.15 25.06 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.937 0.495 . . . . 0.0 109.968 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 10.5 p -91.84 131.45 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.428 HG23 HD11 ' A' ' 225' ' ' LEU . 15.6 m -135.64 156.73 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.741 1.216 . . . . 0.0 110.095 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.505 ' HB2' HD11 ' A' ' 280' ' ' ILE . 39.4 ttp -107.29 127.0 53.16 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.871 0.469 . . . . 0.0 109.988 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.506 ' HG ' HG13 ' A' ' 277' ' ' VAL . 0.1 OUTLIER -131.17 144.98 51.77 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.064 0.946 . . . . 0.0 108.558 -175.021 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -75.0 106.24 6.41 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -139.94 154.96 47.36 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.672 -169.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 32.6 t-20 -120.44 120.71 29.68 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.18 -29.75 32.36 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.42 2.08 . . . . 0.0 112.688 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -71.48 -53.8 12.72 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.88 0.472 . . . . 0.0 110.281 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 4.1 m-20 -117.0 88.59 26.96 Favored Pre-proline 0 N--CA 1.484 1.237 0 C-N-CA 123.823 0.849 . . . . 0.0 109.2 176.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.31 -9.85 23.72 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.014 2.476 . . . . 0.0 114.137 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.424 ' HD2' HD11 ' A' ' 272' ' ' ILE . 21.7 tptm -77.61 -15.5 59.18 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.989 0.915 . . . . 0.0 110.916 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -134.66 165.52 25.04 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.52 0.728 . . . . 0.0 110.463 -172.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.7 ppt_? -71.91 163.65 27.47 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.922 0.889 . . . . 0.0 111.023 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -145.52 -84.44 0.06 OUTLIER Glycine 0 C--O 1.239 0.456 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 175.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -128.53 178.09 6.55 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.33 1.052 . . . . 0.0 108.549 173.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' TRP . . . . . 0.499 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 97.4 m95 -83.21 110.03 17.72 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 122.744 0.418 . . . . 0.0 109.905 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.29 141.29 49.1 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.795 0.838 . . . . 0.0 109.656 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -83.53 123.06 29.37 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.265 0.555 . . . . 0.0 109.709 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -128.62 137.35 51.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.408 1.083 . . . . 0.0 109.59 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 222' ' ' VAL . 33.0 tt0 -94.98 136.43 35.3 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.513 HD12 HD21 ' A' ' 255' ' ' LEU . 33.9 mm -63.96 108.29 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 O-C-N 123.83 0.706 . . . . 0.0 109.46 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.4 t -93.9 -29.16 15.43 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.476 0.711 . . . . 0.0 110.198 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 77.0 ttt180 -167.98 156.26 8.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.355 0.662 . . . . 0.0 109.563 -175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.516 ' HD3' ' HB3' ' A' ' 217' ' ' LEU . 23.8 pttm -148.03 139.84 23.92 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 167.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -134.01 114.84 13.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.791 1.236 . . . . 0.0 107.68 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 9.1 pt-20 -100.23 134.07 43.71 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.014 0.435 . . . . 0.0 109.924 175.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.3 p -118.55 161.76 19.5 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -64.44 -15.08 60.03 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 52.6 p -94.75 -32.06 13.5 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.549 0.74 . . . . 0.0 111.473 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.4 141.38 1.97 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.229 0.612 . . . . 0.0 110.986 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 0.0 OUTLIER -98.18 102.81 14.66 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 121.8 0.81 . . . . 0.0 111.174 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -87.92 116.73 26.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.186 0.994 . . . . 0.0 111.161 -169.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.632 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 3.9 tt -97.84 138.27 35.44 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' TYR . . . . . 0.513 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 53.2 m-85 -128.44 115.04 17.58 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -132.41 140.0 48.28 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.991 0.516 . . . . 0.0 110.083 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 3.4 p-10 -79.85 96.93 6.47 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.415 0.626 . . . . 0.0 109.551 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 49.6 t -72.83 100.49 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.053 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.2 p -93.74 110.91 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.609 0.718 . . . . 0.0 109.228 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 5.2 mp -83.6 -172.51 4.19 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.247 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.08 -31.45 66.61 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 121.885 -0.197 . . . . 0.0 112.824 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -121.81 -48.62 2.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.141 0.976 . . . . 0.0 109.677 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.74 168.81 18.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.511 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 51.7 p -158.43 112.63 2.5 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.61 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 55.3 mt -94.3 96.9 9.86 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.37 1.068 . . . . 0.0 110.044 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 4.1 p-10 -74.87 137.6 41.9 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.896 0.479 . . . . 0.0 111.439 -174.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 63.58 26.04 14.56 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.835 1.254 . . . . 0.0 113.634 171.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 72.0 m -64.83 133.2 51.44 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.628 0.371 . . . . 0.0 111.296 177.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -68.86 116.46 9.36 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.93 0.768 . . . . 0.0 110.058 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.632 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 45.8 mm -88.74 133.31 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.018 0.527 . . . . 0.0 109.726 177.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.424 HD11 ' HD2' ' A' ' 233' ' ' LYS . 62.3 mt -104.91 -22.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.342 1.057 . . . . 0.0 110.044 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -90.61 41.54 1.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.184 0.993 . . . . 0.0 110.794 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 26.2 m -70.04 -26.07 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.678 1.191 . . . . 0.0 112.686 -169.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -91.92 -3.57 55.79 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.372 0.669 . . . . 0.0 111.724 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.7 25.9 3.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.111 0.564 . . . . 0.0 111.331 -170.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.506 HG13 ' HG ' ' A' ' 225' ' ' LEU . 46.5 t -73.59 153.7 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.885 0.874 . . . . 0.0 110.267 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -116.71 150.26 38.49 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.457 0.703 . . . . 0.0 109.6 169.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.453 ' HE2' HD11 ' A' ' 212' ' ' ILE . 22.2 ttmm -82.97 149.48 26.98 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.227 1.011 . . . . 0.0 110.653 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.547 HD12 ' CH2' ' A' ' 151' ' ' TRP . 32.7 mm -87.1 125.03 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 165.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.52 104.4 6.06 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -173.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 98.0 mtt180 -94.4 103.7 11.75 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 168.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -27.98 118.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 125.25 3.967 . . . . 0.0 116.617 -165.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 106.96 -41.69 2.12 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.922 -0.932 . . . . 0.0 114.612 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 10.5 pt-20 -79.99 -25.23 40.39 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 119.088 1.444 . . . . 0.0 113.338 -170.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -76.84 117.88 5.01 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 17.8 p -63.57 129.8 93.91 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 117.508 0.654 . . . . 0.0 109.65 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.58 153.05 74.23 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.451 2.767 . . . . 0.0 112.85 -172.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' MET . . . . . 0.518 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 57.0 ttm -76.91 79.57 3.48 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-O 121.852 0.834 . . . . 0.0 110.167 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.9 -28.9 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -74.33 178.45 5.17 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.748 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -54.02 141.12 50.29 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.131 0.972 . . . . 0.0 111.964 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.518 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 16.0 Cg_exo -67.68 84.82 0.39 Allowed 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.758 2.305 . . . . 0.0 111.679 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.7 mtm -68.11 109.55 3.57 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.692 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -123.37 137.55 54.8 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.105 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 50.25 0.6 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.793 0.837 . . . . 0.0 110.697 -159.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 190' ' ' ASP . 16.8 ptpt -55.68 149.71 13.78 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.411 1.084 . . . . 0.0 113.872 -173.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.8 m -84.99 76.19 10.3 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -124.59 75.0 0.4 Allowed Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.426 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--N 1.378 2.096 0 C-N-CA 123.153 2.569 . . . . 0.0 112.328 -176.083 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.42 ' HA3' ' HB ' ' A' ' 159' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.411 ' N ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -115.61 10.81 15.65 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -169.843 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -91.74 159.45 15.83 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 166.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 60.0 mttp -79.18 178.64 7.91 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.99 0.516 . . . . 0.0 111.564 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -91.39 17.45 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 123.903 0.881 . . . . 0.0 110.929 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -151.8 9.11 0.51 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.422 0.689 . . . . 0.0 109.715 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 136' ' ' LYS . 9.2 tp10 -75.2 87.56 2.46 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 123.7 0.8 . . . . 0.0 110.133 -170.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.696 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 46.2 p90 -74.71 120.92 20.92 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.071 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.42 -170.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.424 1.09 . . . . 0.0 109.55 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -92.61 147.9 22.5 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -140.01 104.22 4.8 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -70.03 103.61 2.32 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 173.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.34 115.07 3.87 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.457 0.703 . . . . 0.0 109.843 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t -68.8 -16.67 63.86 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.163 0.985 . . . . 0.0 112.849 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -82.46 -49.34 10.05 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 122.914 0.486 . . . . 0.0 110.978 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 22.6 ptm -101.4 -13.61 17.91 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.568 0.747 . . . . 0.0 111.441 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.647 ' HA3' ' HA3' ' A' ' 262' ' ' GLY . . . 79.19 20.55 69.56 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 174.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.429 ' HB2' ' CE1' ' A' ' 239' ' ' TYR . . . -106.19 153.42 22.15 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.25 0.62 . . . . 0.0 111.278 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.425 ' HZ3' ' HG3' ' A' ' 205' ' ' ARG . 57.2 m95 -78.26 144.67 35.98 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 171.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.434 ' HA ' ' HD1' ' A' ' 238' ' ' TRP . 59.2 m-85 -145.56 145.78 31.14 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.397 0.544 . . . . 0.0 111.146 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 189' ' ' ASP . 75.2 mm-40 -63.51 138.07 58.37 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 167.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -146.82 166.69 25.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.408 0.683 . . . . 0.0 110.269 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.696 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 63.1 tt0 -137.08 105.13 5.65 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.346 0.659 . . . . 0.0 110.1 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 186' ' ' VAL . 42.3 t -67.52 100.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.51 -3.02 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.217 0.607 . . . . 0.0 112.453 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 72.4 ttt180 -166.41 135.06 2.93 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.42 ' HB ' ' HA3' ' A' ' 133' ' ' GLY . 27.6 m -118.25 127.62 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.301 0.64 . . . . 0.0 109.48 173.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.3 p -136.26 145.65 45.82 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.835 0.854 . . . . 0.0 109.264 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.565 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 13.5 ptt180 -94.27 165.85 12.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.304 0.642 . . . . 0.0 110.474 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -70.21 -35.53 73.97 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.266 175.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.565 ' HB3' ' HD2' ' A' ' 161' ' ' ARG . . . -65.75 142.0 97.98 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.323 0.649 . . . . 0.0 110.628 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.57 140.58 54.75 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.336 2.69 . . . . 0.0 112.807 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.7 m -76.19 115.77 16.23 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.336 0.655 . . . . 0.0 110.581 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -105.73 87.08 2.51 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 169.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.7 t70 67.98 -72.72 0.09 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.211 1.404 . . . . 0.0 109.3 -165.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.445 ' H ' ' HD2' ' A' ' 169' ' ' PRO . 0.9 OUTLIER -168.53 -55.87 0.0 OUTLIER Pre-proline 0 CA--C 1.57 1.722 0 C-N-CA 125.053 1.341 . . . . 0.0 108.828 177.297 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 168' ' ' GLU . 66.0 Cg_endo -75.89 -171.31 1.02 Allowed 'Trans proline' 0 C--N 1.405 3.527 0 C-N-CA 122.518 2.146 . . . . 0.0 113.116 -174.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 51.9 t 66.02 76.58 0.31 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 124.829 1.252 . . . . 0.0 109.585 -173.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.3 m -66.62 103.84 1.16 Allowed 'General case' 0 C--N 1.35 0.59 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.441 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 5.2 m -77.6 78.45 4.11 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.852 0.861 . . . . 0.0 110.353 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 77.0 p 48.15 51.52 14.65 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.4 1.48 . . . . 0.0 111.82 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.7 t -102.55 26.23 8.15 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.565 -166.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -117.65 86.87 24.56 Favored Pre-proline 0 N--CA 1.482 1.148 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 171.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.466 ' HG2' ' HB3' ' A' ' 181' ' ' ASP . 59.5 Cg_exo -54.8 105.63 0.15 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.004 2.47 . . . . 0.0 112.043 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 65.1 -74.79 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.045 1.338 . . . . 0.0 109.464 -165.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 64.0 tp -149.99 -42.14 0.13 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.621 1.168 . . . . 0.0 108.381 169.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -64.86 128.41 35.63 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.749 0.82 . . . . 0.0 110.083 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.523 ' HB3' HG22 ' A' ' 182' ' ' VAL . 3.6 mp0 -71.86 92.02 1.21 Allowed 'General case' 0 C--O 1.243 0.726 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.466 ' HB3' ' HG2' ' A' ' 176' ' ' PRO . 19.5 t70 -80.11 70.29 6.69 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 160.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.523 HG22 ' HB3' ' A' ' 180' ' ' GLU . 18.2 m -126.78 173.94 11.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.507 177.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 183' ' ' ILE . 3.1 mp -96.8 108.87 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.427 0.632 . . . . 0.0 109.748 -166.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -99.77 105.97 17.81 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 17.7 m-70 -78.88 92.88 4.93 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.664 HG12 HG22 ' A' ' 156' ' ' VAL . 2.4 m -108.93 153.55 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -119.19 118.15 30.57 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 191' ' ' TYR . 24.2 m-85 -64.72 127.25 30.75 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.453 0.471 . . . . 0.0 110.378 177.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 153' ' ' GLU . 13.4 t70 -65.85 -37.53 86.45 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.72 -20.32 65.25 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.696 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 188' ' ' TYR . 89.5 m-85 -139.37 66.87 37.76 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 123.568 0.747 . . . . 0.0 109.11 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -71.2 -40.03 3.51 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.331 2.021 . . . . 0.0 112.883 -169.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.68 -2.57 58.7 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.782 0.833 . . . . 0.0 111.982 -176.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.04 -16.4 59.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.205 0.602 . . . . 0.0 110.56 172.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 100.02 -161.13 19.29 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.206 -0.452 . . . . 0.0 113.16 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 7.6 t -96.3 116.96 39.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 22.4 m -101.88 155.2 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.878 0.871 . . . . 0.0 110.204 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.404 ' HB2' HG23 ' A' ' 183' ' ' ILE . 15.1 pm0 -99.4 128.54 45.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.654 0.782 . . . . 0.0 109.563 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 86.3 mmm -130.05 165.05 23.02 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.636 1.175 . . . . 0.0 108.788 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -110.74 172.11 7.06 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 180' ' ' GLU . 56.9 m -58.32 -43.86 88.39 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.137 0.575 . . . . 0.0 111.593 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -22.62 67.0 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.83 0.852 . . . . 0.0 112.219 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -84.16 -40.68 17.89 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.624 0.77 . . . . 0.0 110.423 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 31.3 m -93.38 117.73 37.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 CA-C-O 122.216 1.008 . . . . 0.0 110.011 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.425 ' HG3' ' HZ3' ' A' ' 151' ' ' TRP . 2.0 mmp_? -122.08 -170.27 2.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.971 1.308 . . . . 0.0 109.085 -175.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 289' ' ' MET . . . -101.98 128.58 48.35 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 169.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.67 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -73.95 118.51 16.98 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 167.223 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -69.14 121.93 17.74 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 122.855 0.462 . . . . 0.0 110.446 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -74.41 4.39 6.0 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.217 0.607 . . . . 0.0 111.913 174.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 52.4 m -84.11 105.91 15.34 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.64 114.74 25.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 279' ' ' LYS . 30.8 mm -76.49 133.65 30.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.509 177.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.91 178.04 5.05 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.52 ' HA ' HD12 ' A' ' 217' ' ' LEU . 75.3 t-105 -49.5 -41.87 41.93 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.957 0.903 . . . . 0.0 111.908 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -53.93 -44.18 70.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.466 1.106 . . . . 0.0 112.788 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -115.18 17.15 16.81 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.597 0.759 . . . . 0.0 112.34 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 214' ' ' TRP . 53.1 mt -76.2 113.22 13.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 163.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -126.69 152.71 46.42 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.733 0.413 . . . . 0.0 110.274 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.33 140.58 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.219 0.608 . . . . 0.0 110.798 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.45 -1.39 82.12 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.5 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.53 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.5 tt0 -85.57 120.49 27.08 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.496 0.648 . . . . 0.0 109.818 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 64.8 t -90.05 114.29 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.53 HG13 ' HG2' ' A' ' 221' ' ' GLN . 3.5 m -126.89 163.44 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.501 1.12 . . . . 0.0 109.346 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.434 ' HB3' HD11 ' A' ' 280' ' ' ILE . 0.0 OUTLIER -100.88 139.46 36.53 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.617 ' HG ' HG13 ' A' ' 277' ' ' VAL . 1.1 mp -131.35 167.67 18.86 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.409 ' HB3' ' HZ3' ' A' ' 238' ' ' TRP . 12.2 p-10 -101.36 105.64 16.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.997 0.919 . . . . 0.0 110.434 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -167.71 159.16 11.62 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.485 0.714 . . . . 0.0 110.196 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -103.31 129.15 26.04 Favored Pre-proline 0 C--O 1.217 -0.644 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.82 -7.36 20.97 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 122.405 2.07 . . . . 0.0 113.366 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -70.5 -30.27 67.0 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.116 0.566 . . . . 0.0 109.53 170.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -152.45 82.82 5.1 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.754 1.222 . . . . 0.0 107.77 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -60.88 -10.9 15.87 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.345 2.696 . . . . 0.0 114.381 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.404 ' O ' HD12 ' A' ' 272' ' ' ILE . 50.6 tttm -72.31 -31.34 65.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.458 0.703 . . . . 0.0 110.826 173.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.01 156.52 19.15 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.822 0.849 . . . . 0.0 111.149 -173.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -65.81 161.37 21.09 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.284 -1.325 . . . . 0.0 112.033 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -171.25 -122.92 0.67 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -104.86 -177.32 3.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.179 0.592 . . . . 0.0 110.645 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' TRP . . . . . 0.434 ' HD1' ' HA ' ' A' ' 152' ' ' PHE . 14.5 m95 -90.59 105.77 18.04 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -173.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 150' ' ' ALA . 84.5 m-85 -126.63 157.57 38.58 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.77 0.828 . . . . 0.0 111.033 -176.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -88.07 146.77 25.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.3 0.64 . . . . 0.0 110.6 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -155.89 138.5 15.06 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.254 1.022 . . . . 0.0 108.529 170.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.6 125.12 39.05 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.611 HD12 HD11 ' A' ' 255' ' ' LEU . 28.5 mm -64.72 108.94 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.548 0.739 . . . . 0.0 109.218 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.3 m -79.92 -48.43 13.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.667 0.787 . . . . 0.0 110.798 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.96 128.44 2.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -170.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -114.23 145.53 41.6 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -141.29 121.02 13.43 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -104.56 126.54 51.74 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 77.7 p -125.23 172.31 9.65 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.182 0.993 . . . . 0.0 108.869 170.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -78.99 -12.41 60.04 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.971 0.508 . . . . 0.0 111.366 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 65.4 p -96.69 -29.14 13.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.37 0.668 . . . . 0.0 111.085 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.54 163.24 38.58 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.031 0.532 . . . . 0.0 111.336 -173.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -116.6 99.89 7.46 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 165.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.37 100.54 13.09 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.181 0.593 . . . . 0.0 110.439 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.611 HD11 HD12 ' A' ' 243' ' ' ILE . 1.7 tm? -96.24 136.09 37.19 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 175.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -125.17 127.61 47.08 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -142.57 140.31 31.69 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.13 0.572 . . . . 0.0 110.575 -176.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -80.79 102.54 10.05 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 170.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 49.6 t -65.88 121.85 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.794 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.5 p -121.78 107.82 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 121.976 0.893 . . . . 0.0 109.166 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' A' ' 264' ' ' ASP . 25.4 mt -88.15 -160.01 0.59 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.437 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.647 ' HA3' ' HA3' ' A' ' 149' ' ' GLY . . . -89.23 -25.47 28.6 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -123.04 -43.72 2.21 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.534 0.734 . . . . 0.0 111.084 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.581 ' HB3' HD12 ' A' ' 261' ' ' LEU . 30.1 t70 -113.37 177.08 4.76 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.572 1.149 . . . . 0.0 110.442 -170.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 57.6 p -148.6 143.4 26.55 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.009 0.924 . . . . 0.0 110.159 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 2.8 mm? -114.58 106.37 14.17 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -78.59 125.24 29.09 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.57 0.748 . . . . 0.0 110.493 -177.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 62.39 81.56 0.2 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.854 1.261 . . . . 0.0 112.208 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 61.3 m -111.02 127.4 55.52 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 19.4 ttp180 -80.56 104.14 10.89 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 43.1 mm -74.3 120.19 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.247 1.019 . . . . 0.0 110.335 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 233' ' ' LYS . 54.1 mt -83.52 -20.2 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 125.2 1.4 . . . . 0.0 110.177 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -93.71 37.55 1.07 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.289 1.436 . . . . 0.0 111.902 -167.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 32.9 m -66.9 -28.59 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -169.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -95.77 0.07 51.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.657 0.783 . . . . 0.0 112.293 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -134.72 25.88 3.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.119 0.568 . . . . 0.0 111.3 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.617 HG13 ' HG ' ' A' ' 225' ' ' LEU . 55.5 t -76.11 148.74 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.835 0.854 . . . . 0.0 108.844 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -117.66 150.69 38.63 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.506 ' HB2' HD11 ' A' ' 212' ' ' ILE . 38.8 ttmt -79.45 145.55 33.23 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.952 0.501 . . . . 0.0 111.091 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 224' ' ' MET . 37.0 mm -84.74 139.14 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 166.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.24 147.06 51.92 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 173.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -127.35 144.35 50.45 Favored Pre-proline 0 N--CA 1.473 0.704 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.88 125.48 13.08 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.061 2.508 . . . . 0.0 113.293 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.55 -58.95 0.56 Allowed Glycine 0 C--N 1.345 1.062 0 C-N-CA 123.156 0.408 . . . . 0.0 113.317 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.02 -23.14 26.93 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.249 0.524 . . . . 0.0 111.495 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -125.46 136.51 9.8 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 16.5 m -71.5 148.83 93.38 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 123.314 0.646 . . . . 0.0 110.858 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.8 176.63 9.87 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.133 2.555 . . . . 0.0 111.574 176.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' MET . . . . . 0.424 ' HB2' ' HB1' ' A' ' 206' ' ' ALA . 9.5 ttt -95.12 81.14 3.64 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 14.6 p -100.38 -26.73 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.286 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.31 -177.51 4.66 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.138 0.975 . . . . 0.0 109.912 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -47.62 109.63 1.15 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.508 1.123 . . . . 0.0 111.085 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.77 108.53 1.47 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.565 2.177 . . . . 0.0 111.639 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 58.4 ttp -105.69 91.26 3.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.128 0.971 . . . . 0.0 108.639 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -66.49 142.23 57.61 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.144 0.577 . . . . 0.0 110.631 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -59.99 -32.37 70.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.696 0.798 . . . . 0.0 112.138 -173.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.96 -24.34 66.94 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.268 1.027 . . . . 0.0 111.713 -176.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.8 m -138.81 91.32 2.52 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 172.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -150.08 -63.76 0.01 OUTLIER Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo . . . . . 0 C--N 1.376 2.004 0 C-N-CA 123.046 2.497 . . . . 0.0 111.242 168.889 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.657 ' N ' ' HG ' ' A' ' 174' ' ' SER . . . . . . . . 0 N--CA 1.488 2.109 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.487 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -92.35 -6.33 50.4 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.178 0.591 . . . . 0.0 112.167 -176.068 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -98.65 150.07 22.15 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.159 0.504 . . . . 0.0 111.106 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.621 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 48.4 mtpt -84.69 168.83 14.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.564 1.146 . . . . 0.0 110.998 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.2 m -78.75 14.47 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 C-N-CA 124.211 1.004 . . . . 0.0 112.735 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -132.2 0.22 3.75 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.974 0.91 . . . . 0.0 111.412 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.621 ' HG2' ' HB2' ' A' ' 136' ' ' LYS . 27.9 mm-40 -79.9 92.17 5.49 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.62 0.724 . . . . 0.0 112.29 -168.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 12.8 p90 -65.29 100.11 0.44 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.74 165.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.88 -172.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.983 1.313 . . . . 0.0 109.191 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.631 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 15.3 t70 -104.53 157.94 16.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 168.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -133.86 96.07 3.58 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.481 0.312 . . . . 0.0 110.465 169.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -73.41 97.95 2.64 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 169.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.82 128.0 34.11 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.121 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.6 m -68.5 -30.15 68.92 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.22 0.608 . . . . 0.0 111.222 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -74.03 -42.26 60.58 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.347 0.659 . . . . 0.0 111.649 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 54.4 ttm -102.02 -22.8 14.19 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.09 0.556 . . . . 0.0 112.378 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 77.45 0.75 73.58 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-N 116.663 -0.244 . . . . 0.0 113.431 -174.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -93.16 164.83 13.1 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 123.422 0.689 . . . . 0.0 111.342 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.571 ' HB3' ' HB2' ' A' ' 238' ' ' TRP . 2.3 p-90 -77.41 139.59 39.73 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.85 174.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.414 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 89.6 m-85 -147.22 77.26 1.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 171.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 50.9 mt-10 -55.99 134.96 52.68 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.628 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -149.15 135.11 18.96 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.655 0.597 . . . . 0.0 111.796 -164.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.3 tt0 -91.44 109.63 20.92 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.51 113.77 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.524 0.73 . . . . 0.0 109.261 170.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.89 -8.7 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 122.967 0.507 . . . . 0.0 111.497 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.559 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 36.3 ttm180 -169.93 143.83 2.64 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.639 0.776 . . . . 0.0 109.412 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.455 ' O ' ' HD2' ' A' ' 169' ' ' PRO . 11.0 m -129.34 143.47 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.7 0.8 . . . . 0.0 108.866 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.437 HG23 ' HB ' ' A' ' 183' ' ' ILE . 9.5 t -148.79 163.8 36.3 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.122 0.569 . . . . 0.0 111.207 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.446 ' NH2' ' HA ' ' A' ' 174' ' ' SER . 17.4 mmt180 -87.28 171.78 10.37 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.381 1.072 . . . . 0.0 112.162 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -68.59 -36.91 79.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.473 1.109 . . . . 0.0 110.086 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.27 152.38 90.21 Favored Pre-proline 0 C--O 1.241 0.645 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.003 172.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.49 91.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.785 2.323 . . . . 0.0 111.377 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.4 m -143.03 40.16 1.49 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.427 1.491 . . . . 0.0 107.739 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -69.38 -27.01 64.94 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.938 -169.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -68.97 79.91 0.31 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.479 0.711 . . . . 0.0 112.319 -171.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 28.07 65.67 0.64 Allowed Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 127.263 2.225 . . . . 0.0 115.117 174.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.455 ' HD2' ' O ' ' A' ' 159' ' ' VAL . 36.8 Cg_exo -60.12 -32.29 94.45 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.057 2.504 . . . . 0.0 113.165 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 65.5 m 61.45 -161.05 0.3 Allowed 'General case' 0 CA--C 1.55 0.977 0 O-C-N 124.699 1.25 . . . . 0.0 110.017 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.0 m -64.04 84.74 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.443 0.639 . . . . 0.0 111.398 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 32.0 t -174.15 178.61 2.06 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 124.9 1.28 . . . . 0.0 109.403 -171.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 14.9 t 43.85 53.74 6.04 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 126.236 1.814 . . . . 0.0 113.213 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.657 ' HG ' ' N ' ' A' ' 133' ' ' GLY . 58.0 m -155.28 22.17 0.42 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.764 0.825 . . . . 0.0 111.526 173.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -61.81 -53.95 55.69 Favored Pre-proline 0 N--CA 1.489 1.514 0 CA-C-O 118.643 -0.694 . . . . 0.0 110.826 172.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -74.9 97.6 1.08 Allowed 'Trans proline' 0 C--N 1.39 2.739 0 C-N-CA 121.722 1.615 . . . . 0.0 110.466 171.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.67 ' HB1' ' HG3' ' A' ' 180' ' ' GLU . . . -160.92 127.38 4.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.204 -173.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.58 -63.06 1.46 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 173.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -112.28 106.98 15.66 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 168.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.67 ' HG3' ' HB1' ' A' ' 177' ' ' ALA . 7.3 mp0 -77.29 89.05 3.72 Favored 'General case' 0 C--O 1.249 1.026 0 CA-C-O 121.19 0.519 . . . . 0.0 110.764 -172.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.06 79.35 9.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 163.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 16.7 m -129.68 157.24 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.955 0.902 . . . . 0.0 108.768 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.2 mp -95.38 109.39 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -166.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.446 ' HB3' HG13 ' A' ' 186' ' ' VAL . 78.7 m-85 -92.35 111.4 22.95 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.519 1.127 . . . . 0.0 108.973 172.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 17.5 m-70 -77.29 91.59 3.81 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 168.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.628 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 34.9 m -109.02 157.92 9.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.477 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -127.88 115.14 18.14 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.423 ' HD2' ' HB2' ' A' ' 154' ' ' ALA . 17.6 m-30 -60.43 117.51 5.34 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.698 0.624 . . . . 0.0 111.755 -171.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -56.09 -42.7 77.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.034 1.334 . . . . 0.0 111.554 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -86.14 -16.63 37.32 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.263 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -138.61 68.14 44.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 123.115 0.566 . . . . 0.0 110.836 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.14 -17.67 53.67 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.565 2.177 . . . . 0.0 113.514 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.66 -23.08 66.71 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.743 0.817 . . . . 0.0 112.067 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -74.83 -13.34 60.55 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.151 0.58 . . . . 0.0 111.61 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.99 -141.35 34.33 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.81 0.694 . . . . 0.0 112.308 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 25.9 t -93.19 119.25 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 20.2 m -123.59 155.71 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.964 1.306 . . . . 0.0 109.54 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.47 ' HB2' HG23 ' A' ' 183' ' ' ILE . 20.8 pt20 -98.62 132.29 44.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.866 0.467 . . . . 0.0 110.812 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 83.5 mmm -135.24 164.49 27.6 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.998 0.919 . . . . 0.0 108.68 173.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.425 ' O ' HG22 ' A' ' 204' ' ' VAL . 21.4 m-80 -109.71 172.03 7.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 180' ' ' GLU . 40.7 m -61.59 -30.25 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.127 0.421 . . . . 0.0 111.134 175.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -55.94 -42.59 76.4 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.428 1.091 . . . . 0.0 109.246 175.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.68 -40.44 17.38 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.366 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 18.8 m -91.85 116.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 CA-C-O 122.703 1.24 . . . . 0.0 108.33 -173.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -106.96 137.7 44.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.479 -1.691 . . . . 0.0 107.895 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.55 ' HB3' ' HG2' ' A' ' 281' ' ' GLU . . . -62.37 126.31 26.9 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.772 ' HD3' ' H ' ' A' ' 295' ' ' ARG . 42.2 ttm180 -63.38 95.82 0.1 Allowed 'General case' 0 C--O 1.241 0.634 0 O-C-N 123.972 0.795 . . . . 0.0 109.854 -175.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.06 121.52 10.83 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.891 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -91.93 1.92 56.87 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.216 172.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.0 m -97.92 113.94 25.9 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.747 0.819 . . . . 0.0 110.67 -176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.76 136.8 22.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.759 0.824 . . . . 0.0 108.954 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.453 ' HB ' HG12 ' A' ' 277' ' ' VAL . 37.1 mm -90.25 133.79 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -97.92 172.43 7.65 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.21 0.604 . . . . 0.0 110.688 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' TRP . . . . . 0.433 ' HA ' HD12 ' A' ' 217' ' ' LEU . 73.1 t-105 -56.01 -43.36 77.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.904 0.882 . . . . 0.0 111.47 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -58.22 -37.96 75.89 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.012 0.925 . . . . 0.0 111.645 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -82.62 -20.91 35.45 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.137 0.575 . . . . 0.0 111.282 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 214' ' ' TRP . 96.0 mt -63.22 118.98 8.73 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.408 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 10.6 pt-20 -144.97 155.56 43.47 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.724 0.809 . . . . 0.0 109.729 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 35.9 m -65.4 131.27 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.149 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.71 -12.58 69.01 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 115.782 -0.645 . . . . 0.0 113.641 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -72.76 123.02 22.47 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.255 0.527 . . . . 0.0 110.535 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 51.7 t -91.62 115.72 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.57 -170.12 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.564 1.546 . . . . 0.0 109.56 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.44 ' HB2' HD11 ' A' ' 280' ' ' ILE . 40.1 ttp -141.59 130.45 23.04 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.949 0.5 . . . . 0.0 109.953 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.408 HD13 ' HD1' ' A' ' 227' ' ' TYR . 0.8 OUTLIER -143.29 147.19 34.38 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.857 0.863 . . . . 0.0 109.991 -175.52 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 235' ' ' ARG . 6.9 p30 -90.92 114.24 26.66 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.392 0.615 . . . . 0.0 111.347 -175.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.408 ' HD1' HD13 ' A' ' 225' ' ' LEU . 26.7 m-85 -137.64 144.54 41.93 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.348 1.059 . . . . 0.0 110.641 174.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -86.11 123.01 72.36 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.77 -9.63 26.13 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.468 2.112 . . . . 0.0 112.703 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.55 -43.57 14.37 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.31 0.644 . . . . 0.0 109.967 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -130.55 89.15 44.76 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.645 0.778 . . . . 0.0 109.967 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.18 -12.23 33.49 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.761 2.308 . . . . 0.0 112.615 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -66.51 -28.65 68.72 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.11 0.564 . . . . 0.0 110.544 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -120.24 161.12 21.63 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.31 0.644 . . . . 0.0 110.068 -173.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.415 ' HB2' ' OD1' ' A' ' 226' ' ' ASN . 1.4 ppt_? -60.47 166.85 2.86 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 124.397 1.079 . . . . 0.0 111.394 175.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -177.37 -113.33 0.35 Allowed Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.302 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -96.73 139.68 32.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.137 0.975 . . . . 0.0 110.178 -172.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' TRP . . . . . 0.571 ' HB2' ' HB3' ' A' ' 151' ' ' TRP . 79.7 m95 -70.91 123.59 22.37 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.208 0.528 . . . . 0.0 110.548 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -130.92 151.48 51.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.52 137.22 35.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 258' ' ' ASN . . . -134.83 137.71 43.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.804 0.442 . . . . 0.0 110.512 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -96.23 118.56 33.04 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.551 HD12 HD11 ' A' ' 255' ' ' LEU . 44.0 mm -59.64 107.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 123.813 0.696 . . . . 0.0 109.294 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 10.0 m -78.38 -44.19 25.63 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.855 0.862 . . . . 0.0 110.623 -176.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -155.49 155.79 34.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.973 -168.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -149.7 145.58 26.77 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.596 0.56 . . . . 0.0 110.18 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -155.53 117.35 4.05 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.002 0.921 . . . . 0.0 108.535 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -102.98 124.33 48.28 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.1 p -133.25 162.26 32.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.681 0.793 . . . . 0.0 109.598 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.31 -26.73 68.0 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.203 1.001 . . . . 0.0 112.71 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 26.9 p -88.69 -30.24 19.27 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.198 0.599 . . . . 0.0 111.342 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -172.06 151.96 2.8 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.428 0.455 . . . . 0.0 111.462 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -105.86 110.46 22.76 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.901 0.48 . . . . 0.0 109.768 172.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -89.87 129.43 36.23 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.694 1.197 . . . . 0.0 110.825 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.551 HD11 HD12 ' A' ' 243' ' ' ILE . 1.5 tm? -137.34 129.84 29.83 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -118.64 144.26 46.28 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.59 146.04 29.23 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.525 0.73 . . . . 0.0 110.611 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 241' ' ' ALA . 7.3 m-20 -78.19 96.3 5.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.746 0.818 . . . . 0.0 109.233 172.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 51.0 t -76.54 107.57 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 95.8 t -87.52 119.36 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.799 0.84 . . . . 0.0 110.786 -167.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 43.2 mt -107.81 -176.88 3.18 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.356 1.062 . . . . 0.0 108.816 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -76.75 -49.94 7.48 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-O 120.957 0.198 . . . . 0.0 113.247 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.17 -30.73 12.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.445 0.698 . . . . 0.0 109.885 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -112.14 175.34 5.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.571 0.749 . . . . 0.0 111.65 -175.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 14.0 p -155.73 113.24 3.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.504 1.122 . . . . 0.0 108.103 170.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.445 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 31.9 mt -80.87 81.7 7.05 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.239 1.015 . . . . 0.0 108.57 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 4.2 p-10 -76.46 135.81 39.39 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.533 -171.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 13.6 t70 56.89 47.45 17.81 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.399 1.08 . . . . 0.0 110.597 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 91.9 m -99.66 132.67 44.85 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.826 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 24.8 ttp180 -62.93 117.9 7.05 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.598 0.759 . . . . 0.0 112.128 -174.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.51 105.56 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.666 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 34.3 mt -70.74 -36.31 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 125.443 1.497 . . . . 0.0 110.507 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -109.26 69.41 0.7 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.7 0.8 . . . . 0.0 109.881 -171.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 18.3 m -71.4 -14.39 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.516 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.19 -28.78 48.21 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.265 1.026 . . . . 0.0 110.87 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -90.6 26.0 2.14 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.332 0.587 . . . . 0.0 111.289 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.453 HG12 ' HB ' ' A' ' 212' ' ' ILE . 71.5 t -96.36 126.12 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.469 1.108 . . . . 0.0 109.602 175.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -112.28 160.88 17.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.181 0.992 . . . . 0.0 109.985 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.674 ' HD3' ' HA2' ' A' ' 286' ' ' GLY . 17.2 ttmm -78.31 136.61 37.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.488 1.115 . . . . 0.0 111.013 177.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 224' ' ' MET . 41.2 mm -83.05 117.15 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 163.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.55 ' HG2' ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -68.25 105.36 2.1 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.458 0.647 . . . . 0.0 110.564 -178.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -122.02 142.52 36.66 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 123.654 0.781 . . . . 0.0 108.956 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.15 120.4 6.72 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.477 2.784 . . . . 0.0 113.817 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.26 -25.75 26.63 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-N 116.063 -0.517 . . . . 0.0 114.038 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.04 -12.9 4.61 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 117.855 0.828 . . . . 0.0 112.543 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' GLY . . . . . 0.674 ' HA2' ' HD3' ' A' ' 279' ' ' LYS . . . -98.11 120.46 6.8 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 123.448 0.546 . . . . 0.0 111.785 -173.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.3 m -75.52 142.3 74.13 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 117.092 0.446 . . . . 0.0 111.604 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.09 148.81 24.88 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.828 2.352 . . . . 0.0 111.993 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' MET . . . . . 0.548 ' SD ' ' HB3' ' A' ' 207' ' ' ARG . 23.5 ttt -77.81 85.1 4.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.242 0.544 . . . . 0.0 109.609 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 10.8 p -123.14 3.64 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.426 1.091 . . . . 0.0 109.668 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -120.36 -167.81 1.52 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.762 1.225 . . . . 0.0 108.341 -171.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -43.54 115.27 1.91 Allowed Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 124.902 1.281 . . . . 0.0 112.961 -177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.86 115.18 2.94 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.368 2.046 . . . . 0.0 110.915 173.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 22.8 mmt -72.24 -77.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.475 0.71 . . . . 0.0 110.77 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.772 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 6.7 ttt180 66.43 106.58 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.411 1.484 . . . . 0.0 109.752 -176.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.472 ' NH2' ' HB2' ' A' ' 151' ' ' TRP . 7.3 mtm-85 -101.25 22.09 12.98 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.133 1.373 . . . . 0.0 109.688 -167.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -56.44 108.16 0.45 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 125.343 1.457 . . . . 0.0 110.063 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 19.6 m -90.35 118.44 29.84 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.638 0.775 . . . . 0.0 110.028 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -109.27 -118.89 4.14 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-O 118.195 -1.336 . . . . 0.0 111.265 175.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo . . . . . 0 C--N 1.38 2.217 0 C-N-CA 123.298 2.665 . . . . 0.0 112.226 177.704 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 CA-C-O 119.807 -0.44 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.67 -58.77 2.25 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.278 0.631 . . . . 0.0 110.087 -172.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -80.92 159.47 24.96 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.754 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -100.04 177.24 5.15 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.73 0.812 . . . . 0.0 111.022 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.7 m -72.4 0.51 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.688 1.195 . . . . 0.0 113.298 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -119.98 6.0 10.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.656 0.782 . . . . 0.0 112.264 -173.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 156' ' ' VAL . 8.2 mm-40 -82.28 94.8 7.41 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.263 0.554 . . . . 0.0 111.588 -171.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -79.21 101.47 8.0 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.938 171.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 35.9 m -120.08 -166.29 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 125.974 1.71 . . . . 0.0 108.995 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 207' ' ' ARG . 1.8 t70 -122.12 165.13 16.58 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 154' ' ' ALA . . . -129.42 140.64 51.26 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.353 0.524 . . . . 0.0 111.418 -175.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.558 HH11 ' HA ' ' A' ' 146' ' ' THR . 1.1 tmt_? -90.74 102.3 15.05 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.401 ' HB2' ' HD1' ' A' ' 152' ' ' PHE . 9.3 t70 -65.25 110.82 2.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.558 ' HA ' HH11 ' A' ' 144' ' ' ARG . 13.1 t -72.58 -26.39 61.69 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 122.97 0.508 . . . . 0.0 111.965 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -80.82 -41.26 23.56 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.695 0.798 . . . . 0.0 111.19 -173.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.5 ttm -94.57 -33.78 12.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.434 0.694 . . . . 0.0 110.767 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.51 14.95 67.14 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.279 -171.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.4 175.23 5.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.133 0.973 . . . . 0.0 110.614 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -115.92 129.79 56.55 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.401 ' HD1' ' HB2' ' A' ' 145' ' ' ASP . 97.1 m-85 -131.9 135.71 46.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 188' ' ' TYR . 23.9 mt-10 -60.52 142.85 54.79 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.748 0.655 . . . . 0.0 109.309 -178.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 143' ' ' ALA . . . -133.49 117.23 16.92 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.818 0.736 . . . . 0.0 111.267 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -94.24 101.88 13.88 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 55.1 t -63.68 108.55 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 172.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.427 HG11 ' HE2' ' A' ' 187' ' ' LYS . 29.0 m -108.45 -10.52 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.331 0.652 . . . . 0.0 111.97 -177.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 34.6 ttm-85 -168.85 148.2 4.19 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.384 0.674 . . . . 0.0 109.892 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.07 130.2 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.213 1.005 . . . . 0.0 109.484 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 38.7 p -130.94 151.84 50.91 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 163' ' ' ALA . 53.0 mtp180 -103.19 178.75 4.47 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -61.55 -24.06 66.38 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.099 0.56 . . . . 0.0 110.944 172.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 161' ' ' ARG . . . -108.54 145.58 31.88 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.574 1.15 . . . . 0.0 108.104 163.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -42.7 -36.59 5.05 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 124.288 3.325 . . . . 0.0 115.409 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.2 m -138.05 -43.29 0.52 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.485 0.714 . . . . 0.0 110.419 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.595 HH11 ' HB2' ' A' ' 167' ' ' ASP . 0.5 OUTLIER 70.26 141.73 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.563 1.545 . . . . 0.0 110.011 -174.236 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.595 ' HB2' HH11 ' A' ' 166' ' ' ARG . 29.3 t70 70.81 -168.92 0.16 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.971 0.908 . . . . 0.0 109.688 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -49.05 122.86 11.99 Favored Pre-proline 0 CA--C 1.562 1.427 0 CA-C-N 119.093 0.86 . . . . 0.0 111.478 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.5 13.83 0.68 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.583 2.855 . . . . 0.0 114.902 -173.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 4.2 p -75.98 170.24 16.63 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.548 0.739 . . . . 0.0 111.089 173.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.0 m -70.98 85.0 0.69 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.787 0.835 . . . . 0.0 112.736 -171.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 35.7 m 56.29 93.33 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.441 1.496 . . . . 0.0 112.931 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 68.5 p -72.58 -68.06 0.51 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 122.832 0.453 . . . . 0.0 110.373 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 48.7 m -156.02 -69.92 0.11 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.05 0.94 . . . . 0.0 109.667 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.421 ' HD2' ' N ' ' A' ' 175' ' ' ARG . 1.1 mpt_? 65.14 131.16 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 125.212 1.405 . . . . 0.0 111.89 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.58 117.39 5.12 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.333 2.022 . . . . 0.0 111.89 -174.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.56 81.54 4.88 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.541 0.736 . . . . 0.0 110.212 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 70.7 mt -111.17 -89.73 0.5 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.84 0.856 . . . . 0.0 109.611 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -141.23 78.52 1.65 Allowed 'General case' 0 C--O 1.241 0.629 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.0 97.43 2.31 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.287 -172.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.63 19.64 0.48 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.463 171.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.5 m -66.97 162.14 3.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 124.537 1.135 . . . . 0.0 110.382 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.9 mp -94.4 109.7 22.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -174.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.403 ' HB3' HG13 ' A' ' 186' ' ' VAL . 71.1 m-85 -88.41 109.09 19.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.996 0.919 . . . . 0.0 109.165 172.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -80.31 88.94 5.51 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 156' ' ' VAL . 9.9 m -114.0 155.21 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.555 ' HG2' HG22 ' A' ' 196' ' ' VAL . 43.8 mtmt -115.06 131.81 56.8 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' A' ' 153' ' ' GLU . 19.7 m-30 -60.82 97.62 0.06 Allowed 'General case' 0 C--O 1.209 -1.038 0 O-C-N 123.586 0.554 . . . . 0.0 110.031 170.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.45 ' O ' ' HA3' ' A' ' 299' ' ' GLY . 37.3 t70 -68.05 -21.18 65.01 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.687 0.795 . . . . 0.0 111.652 -173.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 25.6 p30 -85.54 -28.77 24.69 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.67 0.788 . . . . 0.0 111.827 173.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -135.13 69.17 69.99 Favored Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 123.364 0.665 . . . . 0.0 109.818 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.607 ' HD2' ' HD2' ' A' ' 300' ' ' PRO . 74.0 Cg_endo -72.61 -7.3 20.59 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.476 2.118 . . . . 0.0 112.902 -176.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.79 -9.67 59.15 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.634 0.773 . . . . 0.0 110.88 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.49 -19.54 52.81 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.749 0.82 . . . . 0.0 110.443 169.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 84.78 -165.45 40.21 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.911 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.555 HG22 ' HG2' ' A' ' 187' ' ' LYS . 42.2 t -79.24 129.6 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 32.1 m -114.67 155.12 15.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 124.328 1.051 . . . . 0.0 109.541 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.551 ' HB2' HG23 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -102.45 117.08 33.95 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.597 0.759 . . . . 0.0 109.574 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 79.8 mmm -120.79 169.67 10.2 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.033 0.933 . . . . 0.0 109.702 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.442 ' H ' ' HB2' ' A' ' 203' ' ' ASP . 19.4 m-80 -109.92 178.58 4.37 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.334 0.654 . . . . 0.0 109.611 172.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 22.7 t -65.36 -39.82 92.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.419 0.688 . . . . 0.0 110.545 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -65.31 -22.87 66.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.546 0.738 . . . . 0.0 111.847 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' A' ' 200' ' ' ASN . 33.9 m-20 -97.85 2.1 48.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.646 0.779 . . . . 0.0 112.339 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.9 m -121.55 134.74 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 171.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 7.2 ptm180 -120.58 166.4 13.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.012 1.325 . . . . 0.0 109.777 -177.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.02 167.62 21.15 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 163.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.66 ' H ' ' HA ' ' A' ' 288' ' ' PRO . 37.8 ttp180 -143.61 125.98 15.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.39 0.541 . . . . 0.0 110.405 169.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -81.82 158.91 23.9 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.671 1.188 . . . . 0.0 111.782 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.51 23.97 1.51 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.584 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 99.3 m -108.05 113.57 26.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.737 0.815 . . . . 0.0 110.473 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 14.8 mt -85.62 125.98 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 162.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.506 HG21 HG11 ' A' ' 223' ' ' VAL . 46.0 mm -75.7 147.03 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 123.297 0.639 . . . . 0.0 110.79 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.03 179.75 5.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.431 1.092 . . . . 0.0 109.54 176.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -59.89 -32.09 70.41 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.865 0.866 . . . . 0.0 111.037 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -68.92 -25.21 64.47 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.472 ' HB2' HG23 ' A' ' 212' ' ' ILE . 26.3 m-20 -77.21 -26.01 52.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.549 0.34 . . . . 0.0 110.937 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.551 HD22 HG13 ' A' ' 243' ' ' ILE . 50.4 mt -73.43 144.01 46.5 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.614 0.721 . . . . 0.0 112.848 -165.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.27 169.94 20.16 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.033 -1.439 . . . . 0.0 107.987 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.9 117.87 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.91 -6.76 57.01 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 116.024 -0.534 . . . . 0.0 113.171 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.474 ' HG2' ' HA ' ' A' ' 217' ' ' LEU . 4.0 tp-100 -64.49 120.64 12.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.547 0.739 . . . . 0.0 109.644 174.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.7 p -102.88 130.08 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 109.9 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.506 HG11 HG21 ' A' ' 212' ' ' ILE . 15.0 m -141.34 179.8 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 124.532 1.133 . . . . 0.0 110.232 -171.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.412 ' HB2' HD11 ' A' ' 280' ' ' ILE . 21.0 ttp -141.72 124.33 15.9 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 118.033 0.378 . . . . 0.0 111.877 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.566 HD12 ' HB2' ' A' ' 273' ' ' PHE . 2.2 pt? -138.69 167.13 22.64 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.143 0.977 . . . . 0.0 110.404 -174.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.81 121.15 26.07 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 170.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -142.98 146.9 34.33 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -122.95 116.06 29.0 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.12 -24.13 66.42 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.229 1.953 . . . . 0.0 112.395 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.57 -44.11 21.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.265 0.626 . . . . 0.0 110.549 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -122.24 80.45 44.62 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.761 0.825 . . . . 0.0 109.798 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.89 -19.92 64.48 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.137 2.558 . . . . 0.0 114.408 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.48 ' HD3' HD13 ' A' ' 272' ' ' ILE . 5.0 tppp? -82.72 -27.14 31.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.943 0.497 . . . . 0.0 111.424 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.526 ' HG2' ' HG2' ' A' ' 235' ' ' ARG . 34.6 tt0 -118.38 160.46 21.63 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 120.913 0.387 . . . . 0.0 110.849 -173.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.526 ' HG2' ' HG2' ' A' ' 234' ' ' GLU . 24.4 ptt-85 -49.09 149.5 1.94 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.442 1.497 . . . . 0.0 113.587 175.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -141.49 -110.53 0.82 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 171.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -117.23 165.17 13.75 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.857 0.863 . . . . 0.0 109.161 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' TRP . . . . . 0.474 ' CZ2' ' HB3' ' A' ' 296' ' ' ARG . 54.0 m95 -80.32 115.01 19.63 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -127.1 166.6 17.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ASP . . . . . 0.447 ' HB2' HG23 ' A' ' 260' ' ' VAL . 5.2 m-20 -82.8 156.62 23.58 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -143.49 138.45 29.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 167.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -111.17 118.54 36.25 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.635 HD12 HD21 ' A' ' 255' ' ' LEU . 29.1 mm -63.9 104.56 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 124.459 1.099 . . . . 0.0 110.364 -169.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.481 ' H ' ' HA ' ' A' ' 257' ' ' ALA . 18.8 m -79.82 -32.36 40.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.8 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.591 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 36.5 ttm180 -164.01 156.19 17.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.05 0.94 . . . . 0.0 109.559 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -155.81 148.78 24.34 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -150.5 135.18 17.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.872 0.469 . . . . 0.0 109.904 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -91.93 122.72 34.72 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 58.4 p -122.64 154.44 38.02 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -62.01 -20.59 64.07 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.6 p -97.94 -29.75 13.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.992 0.517 . . . . 0.0 112.164 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.45 165.09 31.64 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.24 0.543 . . . . 0.0 112.384 -169.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -97.79 103.41 15.35 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -92.23 141.32 28.7 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.962 0.905 . . . . 0.0 110.601 -171.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.635 HD21 HD12 ' A' ' 243' ' ' ILE . 1.2 tt -149.66 138.93 21.35 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.668 0.787 . . . . 0.0 108.985 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' TYR . . . . . 0.591 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 95.5 m-85 -132.09 131.86 42.77 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.921 0.889 . . . . 0.0 108.602 169.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.481 ' HA ' ' H ' ' A' ' 244' ' ' SER . . . -145.97 148.98 33.33 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.001 0.429 . . . . 0.0 111.223 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 43.9 t30 -79.61 97.02 6.34 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.406 171.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.57 103.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 240' ' ' ASP . 30.9 m -96.44 120.24 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.744 0.783 . . . . 0.0 110.56 -171.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.5 HD12 ' HB2' ' A' ' 264' ' ' ASP . 19.6 mt -92.26 -159.64 0.68 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.816 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.89 -40.62 89.22 Favored Glycine 0 C--N 1.352 1.423 0 N-CA-C 113.524 0.169 . . . . 0.0 113.524 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -123.5 -49.55 1.9 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.82 0.848 . . . . 0.0 109.675 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.5 ' HB2' HD12 ' A' ' 261' ' ' LEU . 3.3 m-20 -75.16 172.39 12.47 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.481 1.112 . . . . 0.0 111.932 -176.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 15.3 p -159.28 114.47 2.47 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.952 0.901 . . . . 0.0 109.37 175.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -82.06 88.93 6.41 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 25.8 t-20 -76.98 139.47 40.12 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.017 -175.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 38.5 t70 68.07 20.0 9.13 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.696 1.198 . . . . 0.0 111.276 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 48.9 t -71.71 122.84 21.33 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 255' ' ' LEU . 41.7 ttp180 -71.04 119.67 15.5 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.484 ' HB ' HD13 ' A' ' 255' ' ' LEU . 51.0 mm -78.71 95.98 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.615 0 CA-C-O 122.018 0.913 . . . . 0.0 110.163 -173.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.48 HD13 ' HD3' ' A' ' 233' ' ' LYS . 73.4 mt -67.5 -29.74 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 113.263 -1.79 . . . . 0.0 110.337 173.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.599 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 15.0 m-85 -95.65 45.47 1.09 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.678 1.191 . . . . 0.0 109.585 -173.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' VAL . . . . . 0.545 HG23 HD12 ' A' ' 255' ' ' LEU . 7.3 p -67.01 -20.52 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 124.576 1.15 . . . . 0.0 112.45 -175.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.38 -17.86 19.46 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.4 0.68 . . . . 0.0 111.135 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 65.2 mm-40 -93.59 16.63 13.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.408 1.083 . . . . 0.0 112.045 -174.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.81 138.01 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.303 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -125.78 163.89 21.89 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.493 1.517 . . . . 0.0 110.049 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 279' ' ' LYS . 0.6 OUTLIER -63.35 136.39 57.62 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.353 178.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 224' ' ' MET . 18.3 mm -98.8 116.77 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 162.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.18 134.77 40.48 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.473 1.109 . . . . 0.0 108.948 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -82.19 134.99 48.07 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.179 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.12 124.28 15.58 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.852 2.368 . . . . 0.0 111.794 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.98 -46.87 1.21 Allowed Glycine 0 C--N 1.344 0.98 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -75.87 -23.55 55.63 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.616 0.767 . . . . 0.0 110.925 175.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -130.84 159.13 22.88 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 53.5 p -97.32 150.12 36.45 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.217 0.607 . . . . 0.0 110.712 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.66 ' HA ' ' H ' ' A' ' 207' ' ' ARG . 86.3 Cg_endo -74.14 -171.76 0.98 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.856 2.371 . . . . 0.0 111.897 175.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 16.1 mmt -75.21 79.65 2.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.667 0.746 . . . . 0.0 110.285 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 6.8 p -92.7 -29.94 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.869 1.268 . . . . 0.0 108.619 173.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -81.34 161.29 23.88 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.945 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -46.58 99.41 0.21 Allowed Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 124.987 1.315 . . . . 0.0 111.995 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.31 99.85 0.17 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.608 2.872 . . . . 0.0 114.236 -164.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 55.7 mtm -78.21 92.09 4.43 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -83.28 170.14 14.95 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.072 0.463 . . . . 0.0 110.594 -178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.474 ' HB3' ' CZ2' ' A' ' 238' ' ' TRP . 20.9 mtm180 -89.08 91.05 8.66 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.57 0.748 . . . . 0.0 109.21 -169.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 70.17 -107.58 0.06 Allowed 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.27 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 66.5 m -158.75 108.27 1.98 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 122.691 0.396 . . . . 0.0 110.13 -169.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 189' ' ' ASP . . . -75.39 119.11 5.73 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 117.894 -1.503 . . . . 0.0 110.516 164.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' PRO . . . . . 0.607 ' HD2' ' HD2' ' A' ' 192' ' ' PRO . 85.0 Cg_exo . . . . . 0 C--N 1.381 2.241 0 C-N-CA 124.059 3.173 . . . . 0.0 114.116 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.85 11.15 9.63 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.528 0.731 . . . . 0.0 111.202 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.464 ' O ' HG11 ' A' ' 159' ' ' VAL . 30.5 m-85 -124.4 163.4 21.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.235 1.014 . . . . 0.0 109.315 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.704 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 10.1 ptpp? -123.62 -179.57 4.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.275 1.03 . . . . 0.0 109.358 176.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.33 11.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.566 ' H ' ' HG3' ' A' ' 136' ' ' LYS . 6.9 t-20 -131.32 -6.64 3.79 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.247 0.619 . . . . 0.0 111.105 -174.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.704 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 29.8 mm-40 -78.22 87.15 4.31 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.59 0.71 . . . . 0.0 110.879 -177.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 11.4 p90 -68.91 100.49 1.2 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.289 169.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.38 177.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.456 0.702 . . . . 0.0 109.814 -177.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.635 ' HB2' ' HB3' ' A' ' 207' ' ' ARG . 16.9 t0 -94.25 152.06 18.97 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -146.89 115.65 6.81 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.401 0.68 . . . . 0.0 110.412 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -72.42 115.02 11.18 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.51 ' HB3' ' SD ' ' A' ' 148' ' ' MET . 9.8 t70 -66.68 110.41 3.21 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.4 p -64.74 -7.68 11.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.415 1.086 . . . . 0.0 113.775 -167.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -75.58 -57.14 4.06 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 117.898 0.317 . . . . 0.0 111.113 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.51 ' SD ' ' HB3' ' A' ' 145' ' ' ASP . 1.8 pmm? -104.5 -19.85 13.89 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.131 0.572 . . . . 0.0 111.38 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.44 9.57 61.51 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.911 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.01 128.62 34.16 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.591 0.357 . . . . 0.0 110.856 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.43 ' O ' ' HB2' ' A' ' 238' ' ' TRP . 97.1 m95 -73.09 133.19 44.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.578 0.751 . . . . 0.0 109.283 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -139.59 133.19 30.39 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.483 ' HG3' ' HG2' ' A' ' 207' ' ' ARG . 33.2 tt0 -70.26 90.12 0.68 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.272 0.558 . . . . 0.0 110.427 -175.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.588 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -96.87 118.69 33.86 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.363 0.665 . . . . 0.0 110.007 -172.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.635 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 65.0 tt0 -86.38 116.09 24.32 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.495 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.422 ' HA ' HG12 ' A' ' 186' ' ' VAL . 61.8 t -61.56 109.04 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 124.359 1.037 . . . . 0.0 108.807 172.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.532 HG11 ' HE2' ' A' ' 187' ' ' LYS . 16.1 m -114.58 -0.98 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.993 0.917 . . . . 0.0 112.012 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.618 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 51.1 ttt85 -167.1 138.04 3.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.271 1.028 . . . . 0.0 108.549 173.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 135' ' ' TYR . 26.0 m -116.19 134.19 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.9 p -142.5 150.82 41.0 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.454 0.702 . . . . 0.0 109.738 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.498 ' HG2' ' H ' ' A' ' 163' ' ' ALA . 46.0 ttt85 -76.91 164.03 26.18 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.699 0.8 . . . . 0.0 110.424 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -63.46 -28.55 70.04 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 120.872 0.367 . . . . 0.0 110.39 172.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.498 ' H ' ' HG2' ' A' ' 161' ' ' ARG . . . -59.34 143.95 84.53 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 124.034 0.934 . . . . 0.0 110.254 170.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -61.49 87.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.804 3.002 . . . . 0.0 114.192 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 12.1 m -90.94 91.79 8.49 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -93.07 -22.61 19.02 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.376 0.67 . . . . 0.0 111.737 -169.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -151.05 162.16 41.38 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.096 0.558 . . . . 0.0 110.174 -172.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.476 ' HG3' ' NH1' ' A' ' 158' ' ' ARG . 3.2 mp0 -75.24 126.78 87.49 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 174.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.36 69.54 4.11 Favored 'Trans proline' 0 CA--C 1.56 1.792 0 C-N-CA 122.127 1.885 . . . . 0.0 111.935 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 80.7 m 59.63 -85.83 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.888 1.675 . . . . 0.0 112.335 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 m -137.09 11.83 3.07 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.343 1.057 . . . . 0.0 110.186 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 25.1 m -91.98 161.76 14.67 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.665 0.786 . . . . 0.0 110.203 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.0 t -165.81 100.49 0.67 Allowed 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 122.193 0.997 . . . . 0.0 109.103 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 80.1 p -94.55 156.38 16.47 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.82 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.79 101.11 31.12 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 123.932 0.893 . . . . 0.0 109.199 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.494 ' HG3' ' HB2' ' A' ' 161' ' ' ARG . 59.6 Cg_endo -67.88 168.24 19.25 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.365 2.043 . . . . 0.0 111.558 172.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.6 157.63 26.5 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.766 0.826 . . . . 0.0 111.489 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.4 pp -72.29 155.25 40.39 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.892 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -165.99 -36.43 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 74.6 -6.48 1.9 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.201 1.401 . . . . 0.0 112.824 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -108.38 23.03 15.11 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 m -81.74 175.71 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 123.657 0.783 . . . . 0.0 109.417 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.526 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.4 mp -97.5 109.39 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.75 0.786 . . . . 0.0 109.964 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 201' ' ' SER . 93.2 m-85 -96.77 113.35 24.9 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.757 1.223 . . . . 0.0 108.211 168.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.618 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 12.7 m-70 -78.67 103.87 8.91 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.588 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 35.5 m -117.36 157.31 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.468 1.107 . . . . 0.0 110.776 -172.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.532 ' HE2' HG11 ' A' ' 157' ' ' VAL . 50.6 mtmt -129.15 123.83 33.12 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -64.48 133.56 52.7 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.386 0.674 . . . . 0.0 110.339 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.37 -31.52 62.41 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -66.11 -30.75 71.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.089 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -145.69 71.74 13.93 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.046 0.538 . . . . 0.0 110.465 -174.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.87 -26.73 15.3 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.658 2.239 . . . . 0.0 112.047 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -76.42 -10.9 59.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.089 0.956 . . . . 0.0 110.885 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.73 6.09 19.2 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.259 0.624 . . . . 0.0 110.89 170.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.0 -154.14 49.35 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.393 0.433 . . . . 0.0 113.796 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.24 119.18 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.614 0.766 . . . . 0.0 109.57 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.7 m -109.13 153.55 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.992 0.917 . . . . 0.0 109.098 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.526 ' HB2' HG23 ' A' ' 183' ' ' ILE . 5.1 pm0 -91.1 137.3 32.47 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 80.4 mmm -148.51 158.52 44.17 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.049 0.94 . . . . 0.0 110.706 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -112.36 149.85 31.89 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.274 1.43 . . . . 0.0 110.477 -178.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.72 ' HA ' HG22 ' A' ' 204' ' ' VAL . 33.0 t -64.14 -30.32 71.39 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.071 0.949 . . . . 0.0 112.611 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -67.68 -20.63 65.32 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 122.519 -0.113 . . . . 0.0 111.131 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -115.15 -1.8 12.9 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.652 0.781 . . . . 0.0 111.838 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 201' ' ' SER . 6.0 m -115.71 118.94 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.962 0.887 . . . . 0.0 109.37 169.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -106.07 158.7 16.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -175.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.25 128.12 34.39 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 169.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.635 ' HB3' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -76.28 138.26 40.43 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.127 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -88.57 139.79 30.12 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -90.7 -0.36 57.67 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.479 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 28.0 m -84.29 112.93 20.75 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.51 121.91 37.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.092 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.1 mm -93.41 148.66 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.141 0.977 . . . . 0.0 109.95 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.669 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 16.2 ptpt -123.9 169.02 12.01 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.541 0.736 . . . . 0.0 110.226 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -51.37 -44.12 62.02 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.112 0.965 . . . . 0.0 111.562 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -60.78 -35.21 75.87 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.171 -177.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.11 -7.87 57.6 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.944 0.897 . . . . 0.0 111.372 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.509 ' O ' ' HD3' ' A' ' 246' ' ' LYS . 97.4 mt -84.67 137.55 33.19 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.736 0.814 . . . . 0.0 110.077 175.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.478 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 9.6 pt-20 -151.78 171.64 17.4 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.773 0.829 . . . . 0.0 110.578 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 29.2 m -67.56 116.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 122.834 0.454 . . . . 0.0 111.745 -175.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.07 -15.12 33.64 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.345 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -71.92 122.42 20.77 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.57 1.148 . . . . 0.0 110.981 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.431 ' HB ' ' NH2' ' A' ' 282' ' ' ARG . 60.7 t -103.73 123.69 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 174.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.88 148.95 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 125.105 1.362 . . . . 0.0 109.927 -176.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 15.7 ptm -98.03 122.7 41.49 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.351 0.596 . . . . 0.0 111.22 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.89 141.85 40.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.742 1.217 . . . . 0.0 109.595 -171.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -96.34 107.35 19.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.017 0.913 . . . . 0.0 111.869 -173.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.559 ' HE2' ' HB2' ' A' ' 239' ' ' TYR . 20.4 p90 -136.33 156.83 48.08 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -87.62 125.07 66.38 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.56 -31.75 95.0 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.366 2.044 . . . . 0.0 112.707 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -81.47 -24.63 36.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.538 0.735 . . . . 0.0 110.982 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -134.62 81.81 46.79 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 123.716 0.807 . . . . 0.0 109.636 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.1 -27.14 73.3 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.602 2.201 . . . . 0.0 112.3 -175.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -85.42 15.07 4.71 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.357 1.063 . . . . 0.0 110.649 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -140.4 146.33 38.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.835 0.854 . . . . 0.0 110.061 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -71.37 138.45 49.2 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.437 0.695 . . . . 0.0 109.42 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.27 -114.36 0.52 Allowed Glycine 0 C--N 1.339 0.738 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -100.17 143.4 30.41 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.476 1.111 . . . . 0.0 109.694 -170.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' TRP . . . . . 0.43 ' HB2' ' O ' ' A' ' 151' ' ' TRP . 60.7 m95 -74.34 124.01 25.67 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.77 0.428 . . . . 0.0 110.049 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.559 ' HB2' ' HE2' ' A' ' 227' ' ' TYR . 96.3 m-85 -131.59 147.29 52.51 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -81.67 142.75 32.44 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.495 ' HB2' HG12 ' A' ' 259' ' ' VAL . . . -142.83 135.95 28.27 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 123.461 0.705 . . . . 0.0 110.029 -170.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -95.98 115.72 27.86 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.6 HD12 HD11 ' A' ' 255' ' ' LEU . 20.0 mm -65.1 113.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 123.803 0.841 . . . . 0.0 108.911 -175.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.4 p -90.97 -20.43 22.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.806 0.842 . . . . 0.0 110.954 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -161.81 142.15 10.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.1 0.56 . . . . 0.0 110.859 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 217' ' ' LEU . 23.5 pttm -122.55 129.5 52.01 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 167.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -155.27 150.54 27.02 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.923 0.889 . . . . 0.0 108.772 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -142.79 137.69 29.89 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.279 0.632 . . . . 0.0 109.761 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 32.7 p -99.04 178.04 5.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 161.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -68.14 -26.7 65.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.203 0.601 . . . . 0.0 110.929 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.7 p -86.5 -30.3 22.07 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.096 0.558 . . . . 0.0 112.132 -174.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -167.21 173.29 9.14 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.983 0.513 . . . . 0.0 110.941 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -109.73 113.53 26.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.105 0.962 . . . . 0.0 109.887 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -91.34 92.45 8.6 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.6 HD11 HD12 ' A' ' 243' ' ' ILE . 1.8 tm? -109.51 129.46 55.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.0 130.79 53.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.52 135.34 22.33 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.069 0.948 . . . . 0.0 109.736 -175.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -76.42 97.96 4.43 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 176.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 266' ' ' LEU . 18.8 m -81.86 107.3 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.488 -175.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.0 p -93.33 131.65 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.377 -175.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.37 -171.6 2.56 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.841 1.256 . . . . 0.0 109.491 174.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -85.9 -17.46 61.42 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-N 116.88 -0.146 . . . . 0.0 113.397 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -122.56 -34.18 3.29 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.368 1.067 . . . . 0.0 110.083 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.46 177.69 5.11 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.758 0.823 . . . . 0.0 109.77 -173.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 33.3 t -150.52 112.96 4.67 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.496 ' HB2' HG23 ' A' ' 259' ' ' VAL . 66.3 mt -80.49 105.83 12.04 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -64.5 122.61 17.19 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.455 0.702 . . . . 0.0 110.952 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 15.1 t70 54.63 74.37 0.35 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.724 1.209 . . . . 0.0 112.325 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 43.6 t -102.2 139.78 37.36 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.495 0.718 . . . . 0.0 109.651 173.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -69.51 134.8 49.31 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.096 0.558 . . . . 0.0 109.639 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 33.1 mm -107.55 130.74 59.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 48.7 mt -98.07 -29.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.39 1.076 . . . . 0.0 110.365 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -95.03 38.03 1.14 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.235 1.014 . . . . 0.0 110.242 -167.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.9 -29.77 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.131 1.372 . . . . 0.0 113.534 -166.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.669 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 45.6 m-20 -100.05 -0.37 39.27 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.392 0.677 . . . . 0.0 111.674 -175.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.541 ' HB2' ' HE3' ' A' ' 297' ' ' LYS . 11.8 pt-20 -125.07 22.59 7.91 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.567 0.698 . . . . 0.0 110.845 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.76 154.24 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.5 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -108.84 160.36 16.05 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.508 0.671 . . . . 0.0 110.336 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -79.11 145.48 33.73 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.508 1.123 . . . . 0.0 111.239 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.429 HG22 ' HG3' ' A' ' 282' ' ' ARG . 40.2 mm -79.67 114.18 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -76.45 115.51 16.26 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.431 ' NH2' ' HB ' ' A' ' 222' ' ' VAL . 95.2 mtt180 -118.8 148.95 45.56 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.008 0.923 . . . . 0.0 109.836 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -55.66 122.22 11.34 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.12 2.546 . . . . 0.0 112.884 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 98.87 -52.03 1.14 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.368 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.35 -22.47 18.31 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.081 0.552 . . . . 0.0 112.139 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -90.29 98.69 2.48 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 8.4 m -64.52 144.56 98.65 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 122.821 0.448 . . . . 0.0 110.613 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.44 140.43 43.86 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.629 2.22 . . . . 0.0 111.447 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 27.6 ttt -76.39 84.36 3.13 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.819 0.819 . . . . 0.0 110.232 -177.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.65 -27.38 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.321 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.28 178.29 8.38 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.253 1.021 . . . . 0.0 109.935 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -42.92 129.02 3.19 Favored Pre-proline 0 N--CA 1.489 1.481 0 C-N-CA 125.4 1.48 . . . . 0.0 113.304 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -58.73 84.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 123.337 2.691 . . . . 0.0 113.702 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.5 mmm -74.56 78.02 1.97 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.799 1.24 . . . . 0.0 108.292 168.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -56.9 170.65 0.41 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.013 0.925 . . . . 0.0 113.313 -175.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.414 ' HD3' ' HB2' ' A' ' 153' ' ' GLU . 3.4 tpt180 -57.35 155.94 8.41 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.08 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.541 ' HE3' ' HB2' ' A' ' 276' ' ' GLU . 65.3 mttm -82.99 64.71 7.75 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 165.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.5 p -80.08 83.09 6.02 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 112.912 -1.949 . . . . 0.0 110.384 -171.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 163.05 81.12 0.04 OUTLIER Glycine 0 C--N 1.333 0.405 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 C--N 1.376 2.007 0 C-N-CA 123.164 2.576 . . . . 0.0 111.934 178.65 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 134' ' ' LEU . 1.4 mm? -100.37 -12.25 19.58 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.397 0.679 . . . . 0.0 111.419 -171.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.87 138.78 33.02 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.401 ' H ' ' HB2' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -93.45 176.24 6.45 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 118.532 0.605 . . . . 0.0 112.226 -174.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.68 -14.96 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 124.578 1.151 . . . . 0.0 111.694 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.448 ' HA ' ' NE2' ' A' ' 155' ' ' GLN . 35.2 m-80 -113.01 24.96 11.83 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.34 0.656 . . . . 0.0 111.636 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.503 ' HG3' HG13 ' A' ' 141' ' ' VAL . 8.9 tp10 -98.98 79.77 2.4 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.632 0.73 . . . . 0.0 111.496 -173.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 9.5 p90 -73.55 98.37 2.8 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.172 173.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.503 HG13 ' HG3' ' A' ' 139' ' ' GLU . 15.7 m -114.87 171.56 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.771 0.828 . . . . 0.0 109.196 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 7.1 t0 -90.91 107.74 19.39 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -172.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.74 99.74 12.57 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.956 0.902 . . . . 0.0 109.756 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -76.06 98.91 4.45 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.9 123.68 20.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 170.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.1 t -79.9 -28.15 39.87 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.741 0.816 . . . . 0.0 110.837 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -68.85 -51.49 39.91 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.065 0.946 . . . . 0.0 111.124 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 43.8 ttp -94.72 -14.1 25.1 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.343 0.657 . . . . 0.0 109.883 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.88 7.08 86.17 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 113.668 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.52 134.52 43.36 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.733 0.413 . . . . 0.0 111.871 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -75.31 135.85 40.89 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.386 1.074 . . . . 0.0 109.34 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -143.14 118.4 10.19 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.491 ' HG3' ' NH1' ' A' ' 296' ' ' ARG . 41.5 mt-10 -59.21 98.58 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.996 0.518 . . . . 0.0 109.889 176.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -103.04 138.82 39.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.432 1.093 . . . . 0.0 112.374 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.4 tp60 -87.2 104.47 16.41 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.921 1.688 . . . . 0.0 110.546 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.651 HG22 HG12 ' A' ' 186' ' ' VAL . 59.2 t -61.99 115.43 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.64 -12.77 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.89 0.876 . . . . 0.0 111.265 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -161.17 144.98 13.16 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.539 0.736 . . . . 0.0 109.549 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.22 137.33 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 166.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.6 p -132.65 150.62 52.13 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -87.37 161.09 18.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.998 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 79.9 tttt . . . . . 0 CA--C 1.551 0.991 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.324 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 . . . . . 0 C--O 1.247 0.948 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.462 ' HB3' HG22 ' A' ' 182' ' ' VAL . 2.3 mp0 -68.61 105.31 2.21 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.484 -172.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.31 50.23 0.5 Allowed 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 122.234 1.016 . . . . 0.0 110.283 166.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 180' ' ' GLU . 13.2 m -122.64 160.85 24.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 174.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.519 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.3 mp -95.56 110.83 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -166.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -92.59 109.2 20.61 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -78.56 98.68 6.21 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 156' ' ' VAL . 14.7 m -107.98 165.43 4.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.358 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -130.43 116.49 18.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -54.21 110.26 0.59 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.635 0.652 . . . . 0.0 109.26 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.03 -22.42 62.14 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.738 0.78 . . . . 0.0 109.217 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.622 ' HA ' ' HA ' ' A' ' 297' ' ' LYS . 0.9 OUTLIER -69.3 -28.37 66.21 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.837 1.255 . . . . 0.0 111.899 171.278 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -142.2 78.82 16.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 123.75 0.82 . . . . 0.0 109.862 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.09 -22.33 55.41 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.322 2.682 . . . . 0.0 113.814 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -66.27 -18.85 65.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.178 0.991 . . . . 0.0 112.074 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.11 -21.65 58.76 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.987 0.515 . . . . 0.0 111.241 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 67.24 -148.0 49.63 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.67 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 18.8 t -84.56 114.7 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.3 m -112.2 151.01 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.657 1.183 . . . . 0.0 109.39 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.519 ' HB2' HG23 ' A' ' 183' ' ' ILE . 16.6 pt20 -94.66 123.45 38.1 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.061 0.544 . . . . 0.0 110.568 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 87.8 mmm -139.17 135.6 34.19 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -88.11 176.46 7.27 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 14.0 t -64.96 -39.81 94.05 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.074 0.397 . . . . 0.0 111.188 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -50.97 -29.12 11.41 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.68 0.792 . . . . 0.0 112.388 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -92.92 -39.17 11.3 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.738 0.815 . . . . 0.0 111.34 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.429 HG11 HG11 ' A' ' 186' ' ' VAL . 27.8 m -98.77 114.84 37.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 CA-C-O 121.991 0.9 . . . . 0.0 110.132 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -110.81 165.91 11.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.673 1.189 . . . . 0.0 108.704 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -78.88 124.82 28.61 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 102.41 0.22 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.548 0.739 . . . . 0.0 110.33 172.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 281' ' ' GLU . . . -68.6 99.36 0.98 Allowed 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.704 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -77.06 75.02 3.63 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.752 0.657 . . . . 0.0 110.223 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 92.5 m -147.34 108.54 4.26 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 28.8 mt -82.86 116.5 27.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.611 HD11 ' HB3' ' A' ' 279' ' ' LYS . 41.5 mm -79.25 120.41 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.516 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -76.96 164.99 25.26 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . 0.519 ' HA ' HD12 ' A' ' 217' ' ' LEU . 90.3 t90 -56.04 -43.65 78.06 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.686 0.794 . . . . 0.0 111.029 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -69.48 -18.61 63.72 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.846 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.63 -19.12 22.21 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.769 0.427 . . . . 0.0 110.086 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 214' ' ' TRP . 88.2 mt -69.05 129.22 39.28 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . 0.456 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 7.9 pt-20 -147.89 160.59 42.62 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.215 1.006 . . . . 0.0 109.573 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 35.0 m -59.4 134.66 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 123.631 0.582 . . . . 0.0 111.958 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.13 -22.26 30.22 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.835 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -74.62 121.47 21.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.201 0.6 . . . . 0.0 110.912 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.63 130.0 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.414 0.686 . . . . 0.0 109.275 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.1 m -140.87 147.21 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.674 1.19 . . . . 0.0 109.584 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 20.8 ptm -98.64 127.93 44.75 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.343 0.657 . . . . 0.0 111.257 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.577 HD13 HG23 ' A' ' 271' ' ' ILE . 2.2 pt? -134.58 155.58 50.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.267 1.027 . . . . 0.0 110.602 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -71.7 106.78 4.23 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -132.68 128.11 36.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.505 0.722 . . . . 0.0 109.964 -169.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.452 HD22 ' HB3' ' A' ' 231' ' ' ASN . 49.3 t30 -89.44 113.07 55.11 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.95 -5.26 16.73 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.645 2.23 . . . . 0.0 112.582 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.86 -32.34 23.28 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.22 0.608 . . . . 0.0 110.176 171.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.452 ' HB3' HD22 ' A' ' 228' ' ' ASN . 33.8 t30 -151.52 105.16 2.91 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 123.923 0.889 . . . . 0.0 109.576 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.55 -18.39 63.27 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.27 2.647 . . . . 0.0 113.322 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -84.88 -5.96 59.34 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.049 0.94 . . . . 0.0 110.952 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -126.88 153.35 45.84 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.583 0.753 . . . . 0.0 110.054 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -75.27 162.59 28.3 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.537 0.735 . . . . 0.0 112.002 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -169.47 -124.21 0.72 Allowed Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.11 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -82.84 146.75 28.74 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.89 0.876 . . . . 0.0 109.559 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . 0.44 ' CE2' ' HD2' ' A' ' 296' ' ' ARG . 43.5 m95 -74.92 111.76 10.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.869 0.366 . . . . 0.0 111.673 -175.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -119.12 166.24 13.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.377 1.071 . . . . 0.0 110.193 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . 0.525 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 3.8 m-20 -82.45 158.62 23.17 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.931 0.892 . . . . 0.0 109.512 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -151.51 132.26 14.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.904 0.482 . . . . 0.0 109.774 169.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -95.95 117.28 30.32 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 174.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.616 HD12 HD11 ' A' ' 255' ' ' LEU . 25.3 mm -65.4 124.23 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.649 0.593 . . . . 0.0 109.424 -175.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.0 t -108.29 -43.51 4.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.575 0.75 . . . . 0.0 109.58 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.505 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 63.0 mtt180 -139.34 157.48 45.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.457 1.103 . . . . 0.0 110.0 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -154.37 120.22 5.24 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.06 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 45.7 ttt-85 -144.1 115.68 8.14 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -93.65 133.61 36.81 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.366 0.603 . . . . 0.0 110.0 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 39.2 p -107.97 166.71 10.51 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 167.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -71.33 -10.4 59.69 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.5 p -94.04 -28.71 15.59 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.192 0.597 . . . . 0.0 111.515 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -171.27 145.97 2.26 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -80.46 102.68 9.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.168 0.987 . . . . 0.0 109.482 172.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -95.47 140.16 30.71 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.35 0.66 . . . . 0.0 111.674 -173.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.616 HD11 HD12 ' A' ' 243' ' ' ILE . 0.6 OUTLIER -132.57 142.4 49.14 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -176.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . 0.505 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 92.1 m-85 -132.11 122.55 25.56 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.95 46.23 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.176 0.512 . . . . 0.0 111.778 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 39.9 t30 -78.64 95.58 5.29 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.73 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 59.9 t -76.19 107.17 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.26 0.553 . . . . 0.0 110.313 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 39.4 t -86.12 115.17 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.081 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.23 -152.56 0.12 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.013 1.325 . . . . 0.0 110.208 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -48.25 -65.23 2.63 Favored Glycine 0 C--N 1.363 2.056 0 C-N-CA 124.092 0.853 . . . . 0.0 114.266 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -123.09 -22.41 5.19 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.546 0.738 . . . . 0.0 109.575 165.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -76.17 177.35 7.24 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.166 0.987 . . . . 0.0 112.077 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 35.6 p -153.17 154.41 34.69 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.679 0.792 . . . . 0.0 110.44 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 69.8 mt -128.77 89.71 2.93 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.441 1.096 . . . . 0.0 108.783 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 61.6 t30 -71.87 136.55 46.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.759 0.424 . . . . 0.0 111.431 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 14.6 t70 60.35 68.58 0.75 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.24 1.416 . . . . 0.0 111.078 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 79.9 m -113.72 135.39 53.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.919 0.888 . . . . 0.0 109.553 169.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -66.51 116.7 7.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.926 0.49 . . . . 0.0 110.714 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.613 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 43.1 mm -92.49 96.28 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.981 0.912 . . . . 0.0 108.88 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 62.6 mt -76.23 -23.48 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.217 1.007 . . . . 0.0 110.713 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.446 ' HD2' HD12 ' A' ' 225' ' ' LEU . 24.5 m-85 -93.21 32.0 1.39 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.458 1.103 . . . . 0.0 111.214 -166.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.07 -21.45 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.273 1.029 . . . . 0.0 112.003 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.65 -21.72 44.46 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.914 0.886 . . . . 0.0 111.827 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.63 9.42 3.37 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.134 0.574 . . . . 0.0 112.278 -168.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.4 129.16 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 122.985 0.514 . . . . 0.0 110.263 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -92.52 161.33 14.65 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.749 0.82 . . . . 0.0 110.652 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.611 ' HB3' HD11 ' A' ' 212' ' ' ILE . 18.2 ptmt -82.32 158.12 23.54 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.446 0.698 . . . . 0.0 111.087 176.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 42.2 mm -87.65 131.39 35.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 166.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 208' ' ' ALA . 0.0 OUTLIER -72.44 104.79 3.9 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.427 -175.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.706 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 84.6 mtt180 -87.36 159.49 50.26 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 123.466 0.707 . . . . 0.0 111.125 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -55.25 94.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.426 2.751 . . . . 0.0 113.513 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.38 -46.44 1.24 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.294 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.706 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 21.6 tt0 -73.59 -17.88 61.12 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.3 0.64 . . . . 0.0 111.452 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -74.78 98.9 1.09 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.622 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.1 p -75.32 126.15 88.1 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.403 0.681 . . . . 0.0 111.124 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.24 167.1 26.5 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 123.193 2.595 . . . . 0.0 112.379 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . 0.569 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 55.1 ttm -86.26 81.39 8.41 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.4 p -96.21 -28.55 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.35 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -81.88 -172.71 4.06 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.373 1.069 . . . . 0.0 109.143 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -45.14 117.42 3.31 Favored Pre-proline 0 N--CA 1.489 1.49 0 C-N-CA 124.912 1.285 . . . . 0.0 112.742 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.569 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 64.9 Cg_exo -55.96 141.75 85.76 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.656 2.238 . . . . 0.0 113.36 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 24.5 mmt -84.06 -69.57 0.63 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 49.47 62.32 2.69 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 122.006 0.908 . . . . 0.0 109.15 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.491 ' NH1' ' HG3' ' A' ' 153' ' ' GLU . 12.5 ptt180 -58.48 -29.16 66.02 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.092 -166.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.622 ' HA ' ' HA ' ' A' ' 190' ' ' ASP . 38.6 mtmm 54.1 58.04 5.38 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.952 0.901 . . . . 0.0 111.974 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 CA--C 1.538 0.508 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.037 -178.795 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.379 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.19 2.72 8.56 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.674 0.79 . . . . 0.0 110.808 173.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -127.54 137.6 52.66 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.467 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 2.1 mptp? -89.65 175.25 7.34 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.535 1.134 . . . . 0.0 110.256 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.7 m -75.9 8.07 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.035 0.934 . . . . 0.0 112.811 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -124.96 -1.17 7.83 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.622 0.769 . . . . 0.0 110.236 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.467 ' HG2' ' HB2' ' A' ' 136' ' ' LYS . 22.3 mm-40 -91.21 89.98 7.57 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.677 0.751 . . . . 0.0 111.652 -170.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 6.8 p90 -63.48 111.5 2.36 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.346 164.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.2 m -120.89 166.69 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.189 0.995 . . . . 0.0 109.32 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -93.05 104.95 17.12 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.494 ' HB2' HG12 ' A' ' 204' ' ' VAL . . . -109.65 117.56 34.25 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.753 1.221 . . . . 0.0 109.93 -176.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -73.93 112.74 10.35 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.79 127.49 32.68 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.6 m -69.58 -27.8 65.43 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.845 0.858 . . . . 0.0 111.38 -173.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.47 -44.12 13.0 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.459 0.704 . . . . 0.0 110.968 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 51.0 tpp -75.71 -37.62 59.31 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.75 0.82 . . . . 0.0 110.611 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.3 7.79 88.2 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.133 -0.939 . . . . 0.0 113.215 -172.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 239' ' ' TYR . . . -107.03 152.54 23.85 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.607 0.763 . . . . 0.0 110.858 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 238' ' ' TRP . 67.2 m95 -77.65 132.29 38.15 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.496 1.118 . . . . 0.0 109.919 171.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -136.54 130.97 33.23 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.235 1.014 . . . . 0.0 108.702 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.35 96.78 0.51 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.598 0.713 . . . . 0.0 109.218 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.72 128.15 45.83 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.928 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.648 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 56.7 tt0 -84.91 105.69 15.87 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.743 0.817 . . . . 0.0 110.647 -173.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.71 107.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.6 m -107.64 -3.13 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.651 0.781 . . . . 0.0 111.234 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.518 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 79.2 ttt180 -171.28 146.44 2.33 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.157 0.911 . . . . 0.0 108.986 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.0 m -125.78 144.39 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.4 p -131.85 130.44 41.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -73.32 147.99 43.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.668 0.787 . . . . 0.0 109.407 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 61.1 mttm . . . . . 0 N--CA 1.496 1.859 0 C-N-CA 123.179 0.592 . . . . 0.0 111.402 -176.409 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 201' ' ' SER . 1.0 OUTLIER -80.75 67.89 6.79 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.404 1.097 . . . . 0.0 110.67 -178.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.504 ' HA ' ' H ' ' A' ' 201' ' ' SER . 67.9 m-20 -82.89 44.74 0.94 Allowed 'General case' 0 C--O 1.243 0.727 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.537 174.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.1 m -69.58 176.49 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.881 0 C-N-CA 124.472 1.109 . . . . 0.0 108.507 174.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 183' ' ' ILE . 2.6 mp -92.35 106.37 17.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -172.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -89.01 104.03 16.6 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 7.0 m170 -79.7 92.84 5.44 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.31 158.17 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.609 0.764 . . . . 0.0 110.615 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -123.98 119.49 29.71 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -57.83 125.83 24.74 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.74 -31.37 72.52 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.271 0.558 . . . . 0.0 109.974 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.46 -28.94 62.22 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.247 175.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -139.32 71.89 38.84 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.14 0.576 . . . . 0.0 112.022 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.05 -15.86 28.99 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.527 2.151 . . . . 0.0 111.184 165.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.33 -22.89 66.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.315 1.046 . . . . 0.0 111.587 173.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -78.77 -5.37 53.14 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.791 0.836 . . . . 0.0 111.356 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.4 -161.95 53.13 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.555 0.534 . . . . 0.0 111.817 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 25.5 t -86.53 124.09 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 29.2 m -107.49 154.58 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.928 0.891 . . . . 0.0 110.09 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -92.93 131.16 38.18 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.542 0.737 . . . . 0.0 109.472 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 92.9 mmm -131.88 153.58 50.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.514 0.726 . . . . 0.0 109.299 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.551 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 36.9 m-80 -98.96 172.21 7.55 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.574 0.75 . . . . 0.0 109.163 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 10.9 t -67.64 -29.34 68.63 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.139 0.427 . . . . 0.0 110.84 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.551 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 17.2 ptp180 -62.19 -25.56 67.85 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.474 0.71 . . . . 0.0 111.638 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -92.23 -39.87 11.3 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.87 0.868 . . . . 0.0 111.0 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' A' ' 201' ' ' SER . 26.8 m -93.85 117.35 37.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 CA-C-O 122.462 1.125 . . . . 0.0 109.292 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 170.82 7.67 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.906 174.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.82 148.78 27.56 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 167.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.41 ' O ' ' HE3' ' A' ' 289' ' ' MET . 37.7 mtm105 -72.37 109.91 6.42 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.38 113.75 3.84 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.83 0.452 . . . . 0.0 110.638 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' A' ' 289' ' ' MET . 5.8 ptm180 -82.09 9.36 8.66 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.007 0.923 . . . . 0.0 112.23 -177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.9 m -100.91 112.32 24.73 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.028 0.931 . . . . 0.0 110.088 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 277' ' ' VAL . 38.1 mt -85.54 130.75 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 279' ' ' LYS . 30.1 mm -96.77 148.08 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.516 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 1.5 ptpp? -129.52 171.22 12.8 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.97 0.908 . . . . 0.0 109.96 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . 0.43 ' HA ' HD12 ' A' ' 217' ' ' LEU . 72.1 t-105 -53.78 -44.83 70.4 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.535 1.134 . . . . 0.0 112.103 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -71.24 -11.28 60.84 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.668 0.787 . . . . 0.0 112.442 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -109.33 -7.96 15.15 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.221 1.008 . . . . 0.0 110.704 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 213' ' ' LYS . 92.2 mt -72.17 124.11 24.33 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -134.03 146.73 50.64 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 31.6 m -67.44 126.89 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 123.54 0.525 . . . . 0.0 111.322 -174.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 106.1 -16.86 41.99 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.681 -0.511 . . . . 0.0 113.011 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.425 ' HG2' HG13 ' A' ' 223' ' ' VAL . 8.6 tt0 -80.4 122.24 26.72 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.21 0.604 . . . . 0.0 110.472 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 50.8 t -91.39 129.78 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.962 0.905 . . . . 0.0 108.935 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.425 HG13 ' HG2' ' A' ' 221' ' ' GLN . 2.8 m -145.73 149.65 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.676 1.19 . . . . 0.0 110.586 -172.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.523 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 20.0 ptm -100.34 125.51 46.58 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.643 0.777 . . . . 0.0 111.357 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.431 ' HG ' HG13 ' A' ' 277' ' ' VAL . 1.4 mp -127.11 158.7 36.32 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.971 0.908 . . . . 0.0 108.798 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -89.66 106.12 18.25 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.363 0.601 . . . . 0.0 110.232 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -167.4 148.09 5.45 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.749 1.22 . . . . 0.0 108.602 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -90.76 144.82 30.91 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.434 ' HB3' HD21 ' A' ' 261' ' ' LEU . 33.9 Cg_endo -62.29 -37.17 63.4 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.137 2.558 . . . . 0.0 112.373 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -71.03 -19.41 62.51 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.012 0.925 . . . . 0.0 111.721 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -144.23 82.97 10.38 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 122.746 0.419 . . . . 0.0 110.104 174.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.06 -4.48 15.49 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.534 2.156 . . . . 0.0 112.833 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -72.73 -27.51 62.09 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.106 0.963 . . . . 0.0 110.958 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -138.38 161.6 36.55 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.46 0.704 . . . . 0.0 110.376 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -52.81 156.34 2.02 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.575 1.55 . . . . 0.0 112.711 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -161.98 -93.42 0.09 OUTLIER Glycine 0 C--N 1.335 0.515 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.644 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -129.08 167.78 17.03 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.596 0.758 . . . . 0.0 109.354 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 89.9 m95 -79.4 105.75 10.94 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 150' ' ' ALA . 46.6 m-85 -121.65 154.74 36.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.092 0.957 . . . . 0.0 109.726 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . 0.748 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 0.8 OUTLIER -82.07 154.12 25.76 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.555 -177.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -152.19 134.23 14.97 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -100.11 118.45 36.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.466 HD12 HD21 ' A' ' 255' ' ' LEU . 26.5 mm -59.09 110.01 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.9 m -100.25 -25.77 14.14 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.235 0.614 . . . . 0.0 110.352 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 59.8 ttt180 -172.02 149.95 2.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.174 0.99 . . . . 0.0 108.642 -174.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -154.85 147.95 24.77 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -148.49 119.06 7.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.709 0.804 . . . . 0.0 108.873 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -96.89 124.53 40.89 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 54.1 p -124.62 162.61 23.74 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 167.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -60.69 -18.58 54.9 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.693 0.797 . . . . 0.0 112.612 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 53.6 p -93.85 -32.92 13.74 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.45 0.7 . . . . 0.0 112.151 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -174.08 164.54 4.11 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.298 0.57 . . . . 0.0 111.225 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -107.47 114.91 29.22 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.388 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -94.78 97.44 10.05 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.526 ' O ' ' HA ' ' A' ' 270' ' ' ARG . 1.7 tt -102.83 125.58 49.63 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . 0.488 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 43.4 m-85 -118.46 116.98 27.8 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -136.92 143.56 42.98 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.237 0.615 . . . . 0.0 111.095 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -78.13 99.37 6.15 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 94.9 t -64.93 106.64 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.494 0.718 . . . . 0.0 109.37 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.748 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 58.6 t -87.52 98.89 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' A' ' 229' ' ' PRO . 31.9 mt -84.14 -177.94 6.8 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.416 176.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -76.65 -45.05 13.94 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.387 -0.37 . . . . 0.0 112.612 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -107.52 -5.47 17.57 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.959 0.904 . . . . 0.0 111.726 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -155.46 176.12 13.01 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.49 0.716 . . . . 0.0 110.25 -172.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 27.7 p -145.63 115.86 7.49 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.478 0.711 . . . . 0.0 110.404 171.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 66.1 mt -82.53 95.05 7.61 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.688 0.795 . . . . 0.0 109.911 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -70.93 136.28 48.44 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.346 0.258 . . . . 0.0 110.689 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 14.6 t70 60.08 75.7 0.39 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.957 1.303 . . . . 0.0 111.347 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 42.9 t -111.6 129.2 56.15 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.917 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 71.4 ttt-85 -74.73 107.88 7.12 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.435 ' HB ' HD13 ' A' ' 255' ' ' LEU . 43.2 mm -90.81 128.3 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.773 0.829 . . . . 0.0 109.572 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 67.2 mt -96.12 -21.33 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.194 0.998 . . . . 0.0 110.694 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -86.44 45.13 1.21 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.207 1.003 . . . . 0.0 111.471 -173.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.513 HG12 HD12 ' A' ' 255' ' ' LEU . 24.7 m -64.74 -21.84 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 125.11 1.364 . . . . 0.0 113.437 -169.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -110.87 -24.87 10.17 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.157 0.983 . . . . 0.0 110.115 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -89.0 44.26 1.2 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.879 0.872 . . . . 0.0 110.2 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.431 HG13 ' HG ' ' A' ' 225' ' ' LEU . 4.1 t -103.14 150.19 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.026 0.93 . . . . 0.0 109.279 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.523 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 72.9 m-85 -124.91 154.85 40.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 167.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.537 ' HB2' HD11 ' A' ' 212' ' ' ILE . 22.9 ttmm -77.42 144.85 37.54 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 45.9 mm -69.88 127.16 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.96 105.5 2.03 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 174.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 78.8 mtp180 -115.03 147.66 38.84 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 124.574 1.15 . . . . 0.0 109.888 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.79 102.03 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.588 2.192 . . . . 0.0 111.407 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.51 -4.58 54.31 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-O 119.109 -0.828 . . . . 0.0 114.364 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 33.3 tt0 -128.27 -25.14 3.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.157 0.979 . . . . 0.0 112.426 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -75.13 112.14 3.56 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.8 m -64.75 131.44 95.15 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 117.091 0.445 . . . . 0.0 111.186 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.68 135.41 19.69 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.306 2.67 . . . . 0.0 111.341 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . 0.485 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 38.5 ttm -78.97 82.3 5.16 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.836 0.826 . . . . 0.0 109.767 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.2 p -108.68 -23.12 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.293 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -99.52 -153.84 0.45 Allowed 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 293' ' ' PRO . 27.3 t-20 -57.5 127.16 77.14 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-N 119.116 0.871 . . . . 0.0 111.87 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.485 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 12.0 Cg_exo -72.57 111.9 3.34 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.373 2.715 . . . . 0.0 113.673 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 91.7 mmm -77.14 115.96 17.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.143 0.577 . . . . 0.0 110.207 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -100.01 171.7 7.67 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.309 1.044 . . . . 0.0 109.158 171.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.65 -29.06 2.67 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.687 0.795 . . . . 0.0 108.936 164.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -169.64 121.61 0.71 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.777 1.231 . . . . 0.0 109.013 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.544 0.716 0 C-N-CA 123.688 0.795 . . . . 0.0 109.255 178.816 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.226 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -91.81 -13.31 31.67 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.848 0.859 . . . . 0.0 111.207 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.434 ' O ' HG11 ' A' ' 159' ' ' VAL . 25.6 m-85 -94.91 162.64 13.66 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.548 0.739 . . . . 0.0 109.542 171.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.75 -177.41 3.82 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.04 0.936 . . . . 0.0 109.043 171.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.5 m -68.22 2.47 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -173.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -112.94 -9.97 13.57 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.637 0.775 . . . . 0.0 111.377 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.87 84.87 3.44 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.459 0.703 . . . . 0.0 111.562 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.671 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 3.9 p90 -71.93 99.61 2.27 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.079 168.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.98 -178.97 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.476 1.11 . . . . 0.0 109.13 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 5.3 t0 -94.75 163.21 13.45 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.651 0.78 . . . . 0.0 108.922 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.436 ' HB2' HG12 ' A' ' 204' ' ' VAL . . . -152.07 125.35 8.74 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 120.872 0.368 . . . . 0.0 111.833 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -74.83 109.73 8.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.786 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.479 ' HB3' ' SD ' ' A' ' 148' ' ' MET . 9.2 t70 -80.01 117.99 21.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.8 m -66.86 -28.49 68.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.839 0.856 . . . . 0.0 112.333 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -58.05 -54.74 43.49 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.6 0.76 . . . . 0.0 111.948 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.479 ' SD ' ' HB3' ' A' ' 145' ' ' ASP . 1.7 pmm? -103.35 -8.86 19.93 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.575 0.35 . . . . 0.0 111.006 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.12 18.27 80.14 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 123.215 0.322 . . . . 0.0 113.518 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.427 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . . . -93.29 150.14 20.7 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.45 0.643 . . . . 0.0 111.899 -175.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -76.11 139.0 41.14 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.468 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -145.52 124.35 12.67 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 45.4 mt-10 -65.78 93.94 0.19 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.444 0.698 . . . . 0.0 110.993 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -99.44 120.06 39.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.095 0.558 . . . . 0.0 110.894 -176.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 53.4 tt0 -87.39 114.56 24.12 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.833 0.853 . . . . 0.0 110.664 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.428 ' HA ' HG12 ' A' ' 186' ' ' VAL . 50.1 t -59.88 114.74 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.1 m -115.35 -4.41 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.372 0.669 . . . . 0.0 111.264 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.52 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 76.7 ttt180 -164.56 138.86 5.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.836 0.854 . . . . 0.0 109.564 173.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 135' ' ' TYR . 34.4 m -117.19 137.64 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.511 0.724 . . . . 0.0 109.554 173.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.4 m -145.69 137.86 25.49 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.907 0.883 . . . . 0.0 108.857 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.95 135.11 36.33 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.604 ' HB2' HG13 ' A' ' 183' ' ' ILE . 55.3 tttm . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 124.158 0.983 . . . . 0.0 111.132 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 C--O 1.238 0.486 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.24 87.81 0.82 Allowed 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.979 0.895 . . . . 0.0 110.82 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -80.51 73.13 7.44 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.145 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 18.0 m -125.73 172.59 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.338 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.607 HG23 ' HB2' ' A' ' 198' ' ' GLN . 97.5 mt -94.86 110.13 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.619 0.768 . . . . 0.0 110.045 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -103.1 106.93 17.55 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 43.3 m-70 -77.31 92.47 3.91 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 204' ' ' VAL . 35.0 m -108.38 151.02 10.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.336 -175.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.477 ' HD3' HG22 ' A' ' 196' ' ' VAL . 31.6 mmmt -110.92 113.12 25.45 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.217 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -57.43 105.6 0.26 Allowed 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 168.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.7 -24.02 64.45 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.211 0.529 . . . . 0.0 109.814 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -68.91 -31.86 71.07 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.201 1.0 . . . . 0.0 110.733 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -143.8 67.45 15.83 Favored Pre-proline 0 N--CA 1.487 1.381 0 C-N-CA 124.12 0.968 . . . . 0.0 110.667 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.3 -15.82 28.2 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.211 1.94 . . . . 0.0 113.177 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.36 -17.1 61.86 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.483 0.713 . . . . 0.0 111.024 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -87.63 25.17 1.53 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.119 0.967 . . . . 0.0 111.893 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 83.13 174.81 50.65 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.175 0.297 . . . . 0.0 113.84 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.477 HG22 ' HD3' ' A' ' 187' ' ' LYS . 3.1 t -92.2 118.32 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 172.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.32 143.62 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 122.903 0.481 . . . . 0.0 110.019 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.607 ' HB2' HG23 ' A' ' 183' ' ' ILE . 15.3 pt20 -106.92 114.36 28.41 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.31 0.576 . . . . 0.0 110.128 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 55.4 mtp -125.66 162.95 23.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.002 0.921 . . . . 0.0 109.701 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 6.7 m-80 -98.98 170.02 9.02 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.221 0.609 . . . . 0.0 109.55 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 50.9 m -56.42 -39.59 73.29 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.135 0.574 . . . . 0.0 111.634 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.46 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 34.1 ptt180 -54.66 -34.95 62.98 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.204 1.002 . . . . 0.0 112.222 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -86.82 -45.07 11.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.753 0.821 . . . . 0.0 110.534 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 186' ' ' VAL . 13.6 m -96.11 115.08 34.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 CA-C-O 121.797 0.808 . . . . 0.0 109.811 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -118.43 129.23 55.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.786 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.09 126.61 29.73 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.441 ' HE ' ' HB2' ' A' ' 294' ' ' MET . 91.1 mtm-85 -66.03 107.34 1.86 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.268 0.485 . . . . 0.0 111.789 -172.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.61 107.47 0.51 Allowed 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.175 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.441 ' HG2' ' HG3' ' A' ' 294' ' ' MET . 0.1 OUTLIER -75.28 81.04 2.38 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -173.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.5 m -145.54 108.44 4.53 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 54.0 mt -85.19 119.27 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.524 ' HB ' HG13 ' A' ' 277' ' ' VAL . 31.7 mm -91.45 152.86 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 123.911 0.884 . . . . 0.0 109.363 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -127.45 171.68 11.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.578 0.351 . . . . 0.0 110.681 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -48.93 -42.85 38.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.239 1.416 . . . . 0.0 111.874 -177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -62.06 -39.14 91.38 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.044 0.937 . . . . 0.0 111.93 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.438 ' HB2' HG23 ' A' ' 212' ' ' ILE . 61.2 m-20 -77.64 -22.31 50.89 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.077 0.551 . . . . 0.0 110.749 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.516 HD11 HG11 ' A' ' 277' ' ' VAL . 94.8 mt -72.41 109.98 6.49 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -114.14 154.14 28.32 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.161 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 32.0 m -67.97 130.35 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-O 120.754 0.312 . . . . 0.0 111.065 -175.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.05 -6.96 64.34 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.412 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.424 ' NE2' ' HA ' ' A' ' 217' ' ' LEU . 28.4 tt0 -88.55 121.22 30.69 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.236 0.615 . . . . 0.0 111.161 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.5 t -91.83 127.66 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.022 0.929 . . . . 0.0 109.3 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' A' ' 280' ' ' ILE . 3.5 m -142.77 151.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.974 1.31 . . . . 0.0 110.298 -172.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.481 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 16.1 ptm -101.06 128.14 47.26 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.932 0.493 . . . . 0.0 111.378 -177.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.577 ' HB3' HG23 ' A' ' 277' ' ' VAL . 2.3 pt? -145.72 174.72 10.96 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.273 1.029 . . . . 0.0 110.393 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.501 ' HB3' ' CZ3' ' A' ' 238' ' ' TRP . 8.1 p30 -79.03 131.22 36.2 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 167.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -168.91 142.43 2.92 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.498 HD21 ' HB3' ' A' ' 231' ' ' ASN . 6.0 p-10 -136.64 133.56 19.09 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.305 0.642 . . . . 0.0 109.959 172.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.12 -20.92 67.94 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.365 2.043 . . . . 0.0 112.303 170.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.45 -47.74 84.32 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.513 0.725 . . . . 0.0 110.824 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.498 ' HB3' HD21 ' A' ' 228' ' ' ASN . 53.2 t30 -145.35 82.21 9.85 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.668 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.9 -16.51 54.37 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.078 2.519 . . . . 0.0 112.958 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -76.47 -27.7 56.24 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.581 0.753 . . . . 0.0 111.843 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -121.95 165.71 15.55 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.706 0.402 . . . . 0.0 110.389 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -60.58 131.19 49.96 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.929 1.292 . . . . 0.0 112.0 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -127.2 -139.24 4.9 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.088 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -82.23 159.96 23.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.12 0.568 . . . . 0.0 109.912 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . 0.501 ' CZ3' ' HB3' ' A' ' 226' ' ' ASN . 22.9 m95 -82.93 100.4 10.38 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 150' ' ' ALA . 40.8 m-85 -114.87 163.04 16.09 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.834 0.854 . . . . 0.0 111.032 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.35 148.83 27.1 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.512 171.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -147.46 134.7 20.57 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.583 0.753 . . . . 0.0 109.154 172.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.15 119.09 34.99 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.532 HD12 HD21 ' A' ' 255' ' ' LEU . 26.6 mm -61.9 107.92 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.0 t -79.62 -50.68 10.31 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.394 0.616 . . . . 0.0 109.801 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 20.3 mtp180 -151.36 163.24 39.39 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.726 1.61 . . . . 0.0 108.09 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -155.83 143.15 19.3 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.987 0.358 . . . . 0.0 111.025 166.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -149.92 128.23 12.12 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.204 1.002 . . . . 0.0 109.03 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -100.83 125.33 47.33 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 31.4 p -96.02 -175.13 3.3 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 170.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -76.75 -23.09 53.0 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 120.679 0.276 . . . . 0.0 110.849 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 22.8 p -97.76 -29.24 13.48 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.393 0.677 . . . . 0.0 112.7 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -167.39 146.05 4.91 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.773 0.429 . . . . 0.0 111.955 -173.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -90.43 102.02 14.75 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -92.37 99.2 12.0 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.532 HD21 HD12 ' A' ' 243' ' ' ILE . 9.4 tt -100.47 131.39 46.41 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 174.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . 0.488 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 65.0 m-85 -106.51 127.05 53.01 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.253 1.021 . . . . 0.0 108.308 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -142.79 141.16 31.62 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.939 0.336 . . . . 0.0 111.009 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -79.75 96.62 6.32 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 39.7 t -77.54 102.8 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 13.8 m -92.11 111.03 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.655 0.74 . . . . 0.0 110.065 -171.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.576 HD12 ' HB2' ' A' ' 264' ' ' ASP . 12.4 mt -87.48 -165.78 1.4 Allowed 'General case' 0 CA--C 1.557 1.237 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.857 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.06 -35.29 88.85 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 122.395 -0.19 . . . . 0.0 113.34 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -123.2 -51.76 1.87 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.097 0.959 . . . . 0.0 109.482 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.576 ' HB2' HD12 ' A' ' 261' ' ' LEU . 4.7 m-20 -76.26 164.43 26.06 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.317 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 55.9 m -143.46 136.97 28.24 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.654 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 73.7 mt -113.7 82.07 1.63 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.754 0.822 . . . . 0.0 109.394 -171.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.1 125.63 26.11 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.847 0.859 . . . . 0.0 112.737 -170.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 61.46 26.94 16.6 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.855 1.262 . . . . 0.0 112.896 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 96.5 m -68.31 128.18 35.64 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 122.698 0.399 . . . . 0.0 110.061 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 52.3 ttp180 -69.77 111.44 5.53 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 121.645 0.736 . . . . 0.0 110.532 -174.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 225' ' ' LEU . 48.7 mm -82.29 123.88 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.427 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 49.9 mt -90.51 -27.37 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.076 0.951 . . . . 0.0 109.243 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -96.15 36.71 1.3 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.032 1.333 . . . . 0.0 110.06 -166.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 29.0 m -65.82 -20.57 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.794 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -95.27 -27.51 15.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.056 0.943 . . . . 0.0 110.617 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -91.59 4.26 53.06 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.743 0.817 . . . . 0.0 111.807 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.577 HG23 ' HB3' ' A' ' 225' ' ' LEU . 13.3 p -78.92 154.81 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 C-N-CA 123.238 0.615 . . . . 0.0 110.499 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.481 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 54.6 m-85 -128.89 161.07 30.7 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.502 1.121 . . . . 0.0 110.45 -173.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -73.93 140.54 45.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.128 0.971 . . . . 0.0 111.081 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 223' ' ' VAL . 31.3 mm -77.12 122.3 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.817 0.847 . . . . 0.0 109.421 169.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.94 119.78 28.63 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 97.5 mtt180 -101.73 127.52 31.05 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.271 1.028 . . . . 0.0 109.817 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -37.36 131.91 0.59 Allowed 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 123.746 2.964 . . . . 0.0 114.326 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 105.27 -46.67 1.14 Allowed Glycine 0 C--N 1.341 0.823 0 CA-C-O 119.937 -0.368 . . . . 0.0 112.716 -171.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 9.5 pt-20 -84.69 -9.25 58.41 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 117.562 0.681 . . . . 0.0 110.793 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -35.82 83.62 0.0 OUTLIER Glycine 0 C--N 1.351 1.377 0 N-CA-C 117.558 1.783 . . . . 0.0 117.558 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 2.6 m -92.62 138.07 23.98 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 171.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.62 177.67 5.25 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.87 2.38 . . . . 0.0 111.476 -175.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 2.8 tpt -75.1 80.91 2.26 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.92 -37.18 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.082 -173.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.04 179.0 6.5 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -43.82 123.83 3.96 Favored Pre-proline 0 CA--C 1.561 1.388 0 C-N-CA 125.159 1.384 . . . . 0.0 113.319 -168.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.11 109.25 0.25 Allowed 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 123.949 3.099 . . . . 0.0 114.479 -173.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . 0.441 ' HB2' ' HE ' ' A' ' 207' ' ' ARG . 90.2 mtp -74.17 104.0 4.81 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 168.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.72 81.24 1.96 Allowed 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -74.88 -71.34 0.36 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.422 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? 57.26 115.62 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.224 1.81 . . . . 0.0 112.368 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 124.233 1.013 . . . . 0.0 109.193 172.621 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.065 0 N-CA-C 112.222 -0.351 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.85 0.1 37.93 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.212 0.605 . . . . 0.0 111.668 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -115.86 160.95 19.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.853 0.861 . . . . 0.0 108.782 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.12 -178.24 4.24 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.745 0.818 . . . . 0.0 110.115 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 157' ' ' VAL . 13.0 m -55.35 -19.23 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 124.683 1.193 . . . . 0.0 113.869 -175.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -94.86 -31.37 13.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.132 0.973 . . . . 0.0 111.413 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.55 105.97 5.92 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.69 0.757 . . . . 0.0 111.652 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.558 ' HD1' ' HD3' ' A' ' 207' ' ' ARG . 15.3 t80 -70.32 138.11 51.21 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.547 164.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 28.7 m -127.9 179.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.559 1.144 . . . . 0.0 111.311 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -119.46 108.17 14.22 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.51 118.58 33.57 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.59 0.756 . . . . 0.0 110.11 -169.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -69.44 133.27 47.54 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -68.02 127.49 33.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -67.29 -26.61 66.62 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 123.845 0.716 . . . . 0.0 111.602 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -80.36 -52.87 7.18 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.994 0.518 . . . . 0.0 111.095 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 43.0 ttm -83.18 -24.67 32.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.353 0.661 . . . . 0.0 111.05 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.42 -15.92 32.51 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.474 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.481 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . . . -73.68 153.54 40.05 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.98 0.912 . . . . 0.0 111.305 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 238' ' ' TRP . 40.7 m95 -73.74 136.14 43.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -140.27 110.57 6.63 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' A' ' 296' ' ' ARG . 19.4 mt-10 -48.3 137.92 10.48 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.89 0.876 . . . . 0.0 109.908 172.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.12 154.48 32.42 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.086 0.554 . . . . 0.0 110.613 -169.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -105.18 119.66 39.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.843 0.457 . . . . 0.0 110.041 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.6 t -68.25 114.23 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 168.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 137' ' ' VAL . 24.6 m -107.52 -10.36 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.157 0.583 . . . . 0.0 111.113 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -171.51 146.3 2.2 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.536 0.523 . . . . 0.0 110.892 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.59 133.4 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.433 0.693 . . . . 0.0 109.661 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.4 p -142.14 166.39 24.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.93 1.292 . . . . 0.0 108.621 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -119.44 155.19 32.5 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt . . . . . 0 N--CA 1.5 2.047 0 C-N-CA 123.813 0.845 . . . . 0.0 110.396 178.688 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.733 ' HB3' HG22 ' A' ' 182' ' ' VAL . 3.8 mp0 -70.01 101.02 1.7 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.568 -166.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -83.99 16.18 3.0 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.155 164.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.733 HG22 ' HB3' ' A' ' 180' ' ' GLU . 15.3 m -72.5 166.92 2.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-O 121.394 0.616 . . . . 0.0 110.411 172.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' A' ' 198' ' ' GLN . 2.5 mp -95.44 115.87 35.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.178 -172.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -97.52 104.54 16.58 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -79.11 94.66 5.39 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.53 151.06 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.508 ' HG2' HG22 ' A' ' 196' ' ' VAL . 43.2 mtmt -106.37 118.79 37.57 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 170.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -56.53 116.01 2.85 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.35 -36.84 66.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.753 0.821 . . . . 0.0 110.312 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -72.29 -32.07 66.27 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.808 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.54 ' HB3' ' ND2' ' A' ' 194' ' ' ASN . 68.0 m-85 -140.04 61.0 16.35 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 123.58 0.752 . . . . 0.0 111.744 -173.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.59 -20.02 9.65 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.033 1.822 . . . . 0.0 112.905 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.04 -20.21 66.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.933 0.893 . . . . 0.0 111.723 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.54 ' ND2' ' HB3' ' A' ' 191' ' ' TYR . 29.1 m-80 -81.51 -20.17 40.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.64 0.776 . . . . 0.0 111.155 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 110.42 -179.36 20.3 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 116.521 -0.309 . . . . 0.0 113.068 174.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.508 HG22 ' HG2' ' A' ' 187' ' ' LYS . 20.3 t -79.63 122.77 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.857 0.863 . . . . 0.0 109.433 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 33.9 m -104.73 144.13 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.637 0.775 . . . . 0.0 110.634 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.552 ' HB2' HG23 ' A' ' 183' ' ' ILE . 8.7 pt20 -99.62 121.79 41.71 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.631 0.772 . . . . 0.0 110.327 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 67.4 mmm -120.11 170.14 9.58 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.547 1.139 . . . . 0.0 110.554 -169.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -105.86 176.61 5.11 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.707 0.803 . . . . 0.0 109.66 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 180' ' ' GLU . 61.1 p -59.64 -42.81 93.59 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.031 0.932 . . . . 0.0 110.999 174.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? -70.11 -5.12 24.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.958 0.903 . . . . 0.0 113.283 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -105.36 -34.91 7.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.811 0.444 . . . . 0.0 111.351 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.49 126.98 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.735 0.778 . . . . 0.0 110.312 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.453 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 2.1 mpt_? -120.26 172.24 7.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.502 1.121 . . . . 0.0 109.09 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.63 167.24 18.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.999 0.428 . . . . 0.0 109.903 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.558 ' HD3' ' HD1' ' A' ' 140' ' ' TYR . 77.6 mtm180 -78.65 90.24 4.57 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.614 0.766 . . . . 0.0 110.419 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.75 96.59 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.536 0.684 . . . . 0.0 109.545 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -1.78 43.81 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.061 1.344 . . . . 0.0 111.344 -174.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 44.9 m -84.19 112.79 20.59 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 121.681 -0.637 . . . . 0.0 109.339 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.424 HD11 ' SD ' ' A' ' 294' ' ' MET . 41.4 mt -82.21 123.32 38.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 175.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.692 HG23 ' HB2' ' A' ' 216' ' ' ASP . 49.1 mm -97.27 128.09 48.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.364 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 0.0 OUTLIER -117.52 176.92 4.94 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.095 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . 0.433 ' HA ' HD23 ' A' ' 217' ' ' LEU . 69.7 t90 -46.94 -41.63 16.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.578 0.751 . . . . 0.0 111.553 -170.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -53.67 -43.03 68.52 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.002 1.321 . . . . 0.0 111.913 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.692 ' HB2' HG23 ' A' ' 212' ' ' ILE . 20.0 m-20 -77.97 -25.86 48.37 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.084 0.953 . . . . 0.0 112.416 -175.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 214' ' ' TRP . 1.4 mm? -67.7 112.63 4.91 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -115.35 152.2 33.25 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.9 m -67.05 115.76 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-O 121.114 0.483 . . . . 0.0 110.524 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 110.15 -5.09 30.22 Favored Glycine 0 C--N 1.346 1.128 0 C-N-CA 123.412 0.53 . . . . 0.0 112.846 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -86.69 128.72 35.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.614 0.766 . . . . 0.0 110.677 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.63 130.7 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.54 HG23 HD11 ' A' ' 225' ' ' LEU . 3.0 m -145.9 164.2 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.98 1.312 . . . . 0.0 109.74 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.653 ' SD ' ' HB3' ' A' ' 238' ' ' TRP . 9.0 tmm? -105.31 129.84 53.56 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.575 ' HG ' HG13 ' A' ' 277' ' ' VAL . 2.1 mp -129.12 160.41 32.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.24 0.616 . . . . 0.0 110.354 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -90.01 108.42 19.71 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.784 0.834 . . . . 0.0 110.899 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.659 ' HE1' ' HB2' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -168.1 158.6 10.43 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.304 1.041 . . . . 0.0 110.413 177.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.575 HD21 ' HB3' ' A' ' 231' ' ' ASN . 6.6 p30 -111.14 148.61 39.06 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -58.28 -33.17 97.4 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.926 2.417 . . . . 0.0 113.115 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.44 -39.95 77.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.425 0.69 . . . . 0.0 111.025 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.575 ' HB3' HD21 ' A' ' 228' ' ' ASN . 41.6 t-20 -128.64 99.49 23.17 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.273 0.629 . . . . 0.0 109.69 -172.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -84.16 -0.0 9.37 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.941 2.427 . . . . 0.0 112.824 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -92.44 -29.27 16.36 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.379 0.672 . . . . 0.0 110.318 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -124.46 152.74 42.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.673 0.789 . . . . 0.0 109.732 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -55.39 170.19 0.25 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.334 1.453 . . . . 0.0 113.699 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 228' ' ' ASN . . . -171.27 -110.79 0.24 Allowed Glycine 0 C--N 1.337 0.631 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.138 174.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.469 ' HB2' ' CE1' ' A' ' 239' ' ' TYR . 17.8 m-85 -91.85 177.51 6.17 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.757 0.823 . . . . 0.0 109.454 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . 0.653 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 6.8 m95 -99.5 106.46 18.48 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.659 ' HB2' ' HE1' ' A' ' 227' ' ' TYR . 90.3 m-85 -121.84 166.89 13.68 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 118.927 0.785 . . . . 0.0 110.993 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . 0.572 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 3.4 m-20 -83.42 160.61 21.55 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.627 1.171 . . . . 0.0 110.329 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -162.51 138.9 7.61 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.07 0.948 . . . . 0.0 110.77 170.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -103.05 120.14 40.12 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.546 HD12 HD11 ' A' ' 255' ' ' LEU . 25.0 mm -63.89 117.47 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.924 0.89 . . . . 0.0 110.937 -171.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 33.3 t -88.24 -53.07 4.88 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.593 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.403 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 95.9 mtt180 -140.6 164.83 29.13 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.282 1.033 . . . . 0.0 109.873 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -155.95 147.89 23.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.493 0.717 . . . . 0.0 110.05 170.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -146.23 116.21 7.34 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.516 0.727 . . . . 0.0 109.599 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.665 ' HG2' ' HG2' ' A' ' 253' ' ' ARG . 6.0 tm-20 -92.85 123.6 36.23 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 30.6 p -133.47 148.45 51.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 168.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -63.81 -10.58 20.91 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.382 0.673 . . . . 0.0 112.801 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 47.2 p -91.73 -28.98 17.07 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.84 0.856 . . . . 0.0 111.058 175.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.84 130.2 0.8 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.301 0.64 . . . . 0.0 111.409 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.665 ' HG2' ' HG2' ' A' ' 248' ' ' GLU . 53.6 mtm180 -83.63 98.55 9.68 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -92.71 150.42 20.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.341 1.056 . . . . 0.0 110.213 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.811 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.5 OUTLIER -145.87 146.41 31.1 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -174.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 78.9 m-85 -134.06 127.77 32.89 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.206 1.002 . . . . 0.0 108.662 174.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -143.64 141.67 30.68 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.515 0.726 . . . . 0.0 109.805 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 19.4 m-20 -78.64 94.94 5.13 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 269' ' ' CYS . 92.9 t -67.54 105.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.608 0.567 . . . . 0.0 110.371 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 45.1 t -85.79 99.3 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 30.6 mt -84.99 176.78 8.23 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.365 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -56.78 -36.46 72.48 Favored Glycine 0 N--CA 1.475 1.264 0 N-CA-C 114.349 0.5 . . . . 0.0 114.349 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -123.26 -47.75 2.0 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.707 0.803 . . . . 0.0 109.774 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -80.11 166.35 21.58 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.781 -175.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 30.7 p -146.84 110.3 4.86 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.573 0.749 . . . . 0.0 109.187 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 61.9 mt -87.12 87.39 7.44 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.973 0.909 . . . . 0.0 109.439 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 3.2 p-10 -64.38 139.4 58.76 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.792 0.437 . . . . 0.0 110.763 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.92 29.81 19.36 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.065 0.946 . . . . 0.0 112.199 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.481 ' HB3' HG23 ' A' ' 259' ' ' VAL . 38.3 t -72.96 126.97 31.19 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.76 0.424 . . . . 0.0 110.58 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -63.57 133.41 53.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.105 0.562 . . . . 0.0 110.894 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.811 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 46.9 mm -111.97 124.5 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.404 1.081 . . . . 0.0 109.251 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 41.3 mt -106.02 2.04 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.181 0.992 . . . . 0.0 109.312 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -102.87 29.98 5.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.048 1.339 . . . . 0.0 109.712 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 24.0 m -57.82 -29.46 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -165.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 22.5 m-20 -97.13 -23.72 16.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.283 0.633 . . . . 0.0 111.72 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -81.84 6.5 15.49 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.869 0.868 . . . . 0.0 112.208 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.575 HG13 ' HG ' ' A' ' 225' ' ' LEU . 19.4 t -73.94 148.62 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.325 0.65 . . . . 0.0 109.432 178.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -128.18 160.28 32.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.576 1.151 . . . . 0.0 108.313 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -76.16 153.62 36.05 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.105 0.562 . . . . 0.0 111.481 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.525 HG12 ' HA ' ' A' ' 223' ' ' VAL . 46.8 mm -75.6 122.71 30.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 167.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.521 ' HG2' ' HA3' ' A' ' 286' ' ' GLY . 0.1 OUTLIER -84.16 106.11 15.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 165.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -107.81 108.22 61.21 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -11.26 88.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 1 C-N-CA 126.883 5.055 . . . . 0.0 116.687 -158.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 99.69 1.12 56.42 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 115.102 -0.954 . . . . 0.0 114.923 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -93.52 -23.44 18.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.003 0.902 . . . . 0.0 110.801 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . 0.521 ' HA3' ' HG2' ' A' ' 281' ' ' GLU . . . -93.84 -165.94 37.19 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.579 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 38.2 p -117.64 163.98 21.59 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 123.681 0.792 . . . . 0.0 111.438 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -86.62 -154.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.142 2.561 . . . . 0.0 111.308 164.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . 0.517 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 23.3 mmt -115.32 80.51 1.44 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 168.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.91 -35.25 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 168.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -84.11 -168.7 2.26 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.479 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -49.89 115.95 5.74 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.499 1.12 . . . . 0.0 111.849 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.517 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 12.4 Cg_exo -70.81 80.89 1.14 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.267 2.645 . . . . 0.0 111.148 175.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . 0.424 ' SD ' HD11 ' A' ' 211' ' ' ILE . 49.3 mtm -63.26 -55.63 23.21 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.589 -172.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 66.6 144.74 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.858 1.263 . . . . 0.0 111.245 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.404 ' NH2' ' HG3' ' A' ' 153' ' ' GLU . 14.2 mtm180 -91.93 -30.95 15.85 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 173.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.454 ' HB2' ' HZ2' ' A' ' 238' ' ' TRP . 77.1 tttt -141.63 153.04 44.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.248 1.019 . . . . 0.0 108.978 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.0 p . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 123.444 0.697 . . . . 0.0 110.535 -176.451 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.87 8.69 9.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.208 0.603 . . . . 0.0 112.317 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -116.1 161.74 18.46 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.258 0.552 . . . . 0.0 110.938 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.12 161.65 15.72 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.994 1.317 . . . . 0.0 109.153 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 158' ' ' ARG . 92.1 t -70.17 80.38 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 124.188 0.995 . . . . 0.0 110.058 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.3 m120 175.2 -38.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 126.641 1.976 . . . . 0.0 109.18 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -72.17 91.82 1.31 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -159.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 10.5 p90 -72.49 99.88 2.59 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.917 0.865 . . . . 0.0 109.616 168.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.87 -176.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.937 1.295 . . . . 0.0 109.255 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.18 104.15 16.56 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.392 0.615 . . . . 0.0 110.239 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -95.79 102.28 14.06 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 26.2 ttt180 -72.08 109.7 6.06 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.36 109.39 0.99 Allowed 'General case' 0 C--O 1.217 -0.625 0 O-C-N 124.506 1.129 . . . . 0.0 108.07 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.81 -10.94 59.85 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 124.033 0.833 . . . . 0.0 111.282 -170.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -74.03 -56.01 5.44 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.444 0.698 . . . . 0.0 110.258 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 50.5 ttp -92.53 -37.16 12.64 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.902 0.481 . . . . 0.0 109.955 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.434 ' HA3' ' CA ' ' A' ' 262' ' ' GLY . . . 101.44 20.73 12.7 Favored Glycine 0 N--CA 1.469 0.87 0 CA-C-N 115.45 -0.795 . . . . 0.0 113.518 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -101.79 140.31 36.26 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.085 0.554 . . . . 0.0 110.405 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 76.5 m95 -74.76 134.86 41.78 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.811 0.845 . . . . 0.0 109.581 174.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -135.78 136.36 40.66 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.686 ' HB3' HH12 ' A' ' 207' ' ' ARG . 19.9 pt-20 -68.62 103.76 1.8 Allowed 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -108.64 131.27 55.05 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.681 0.792 . . . . 0.0 110.287 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 60.8 tt0 -87.11 109.09 19.2 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.298 0.639 . . . . 0.0 110.444 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 186' ' ' VAL . 70.1 t -61.68 103.87 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 124.197 0.936 . . . . 0.0 109.381 171.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.0 m -106.12 -0.37 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.758 0.423 . . . . 0.0 111.613 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.423 ' HA ' HG22 ' A' ' 137' ' ' VAL . 52.4 ttm-85 -172.73 149.92 2.08 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.617 0.573 . . . . 0.0 110.674 169.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.11 142.47 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.754 0.822 . . . . 0.0 108.955 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.45 ' OG1' ' HB ' ' A' ' 183' ' ' ILE . 8.1 p -145.69 161.95 38.68 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.882 1.273 . . . . 0.0 108.907 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -114.88 178.36 4.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.829 0.852 . . . . 0.0 110.78 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 N--CA 1.485 1.322 0 C-N-CA 123.685 0.794 . . . . 0.0 110.417 -179.807 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 CA--C 1.541 0.603 0 CA-C-O 122.3 1.048 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -88.49 67.37 8.54 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.049 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -85.07 40.31 0.81 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 121.889 0.852 . . . . 0.0 109.707 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 34.9 m -88.61 175.93 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.823 0.849 . . . . 0.0 111.085 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.45 ' HB ' ' OG1' ' A' ' 160' ' ' THR . 20.6 mt -96.72 112.35 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.683 0.793 . . . . 0.0 110.594 -168.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -102.05 109.38 21.09 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.418 1.087 . . . . 0.0 108.961 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -79.26 89.38 4.91 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 156' ' ' VAL . 26.7 m -110.58 161.16 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.762 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.52 ' HG2' HG22 ' A' ' 196' ' ' VAL . 32.0 mtmt -124.97 117.75 24.72 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 173.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -57.52 97.03 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -62.73 -23.92 67.41 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.202 1.001 . . . . 0.0 111.593 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 297' ' ' LYS . 19.9 m-20 -63.34 -30.81 71.88 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.715 0.406 . . . . 0.0 111.711 173.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -146.88 78.04 10.8 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 124.14 0.976 . . . . 0.0 108.89 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.15 -21.2 55.88 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.925 2.417 . . . . 0.0 112.563 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -67.14 -8.19 29.12 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.648 1.179 . . . . 0.0 112.788 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -79.33 -12.76 59.93 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.443 0.697 . . . . 0.0 111.333 173.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 93.88 -178.7 37.88 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.713 0.633 . . . . 0.0 112.915 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.52 HG22 ' HG2' ' A' ' 187' ' ' LYS . 24.6 t -83.95 116.6 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.55 153.64 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.036 0.934 . . . . 0.0 109.663 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -108.32 122.21 46.51 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.437 0.695 . . . . 0.0 109.536 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 84.7 mmm -125.28 164.88 19.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.696 1.198 . . . . 0.0 109.265 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -110.53 172.77 6.67 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.525 ' HA ' HG22 ' A' ' 204' ' ' VAL . 41.7 m -66.29 -30.23 70.61 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 118.159 0.436 . . . . 0.0 111.258 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -10.4 58.86 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.862 176.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -104.25 -39.93 6.31 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.452 1.101 . . . . 0.0 111.014 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.525 HG22 ' HA ' ' A' ' 201' ' ' SER . 32.0 m -95.79 143.47 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -174.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.96 163.47 32.79 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.321 0.648 . . . . 0.0 109.774 -168.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.97 166.64 23.01 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.186 0.594 . . . . 0.0 109.804 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.686 HH12 ' HB3' ' A' ' 153' ' ' GLU . 10.8 ptm180 -136.75 134.11 36.76 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.0 148.32 40.02 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.744 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.63 ' HG3' ' HB3' ' A' ' 291' ' ' ASP . 3.3 tmt_? -75.79 -9.47 58.62 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.942 168.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.8 m -86.94 109.33 19.27 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.869 0.868 . . . . 0.0 111.023 -171.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.4 mt -84.02 136.36 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.676 HD11 ' HB2' ' A' ' 279' ' ' LYS . 39.0 mm -110.98 153.52 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.637 0.775 . . . . 0.0 111.419 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -125.1 171.29 10.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.988 1.315 . . . . 0.0 109.929 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . 0.483 ' HD1' HG11 ' A' ' 274' ' ' VAL . 88.7 t90 -50.01 -49.05 52.05 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.378 1.071 . . . . 0.0 111.662 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -61.23 -35.76 78.12 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.618 -175.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.451 ' HB3' HG23 ' A' ' 212' ' ' ILE . 14.6 t70 -78.78 -23.98 44.94 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.279 0.632 . . . . 0.0 110.978 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.444 HD22 HG21 ' A' ' 223' ' ' VAL . 96.0 mt -72.37 113.18 9.12 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.051 0.54 . . . . 0.0 109.928 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 221' ' ' GLN . 9.3 pt-20 -119.71 154.06 34.68 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.993 0.917 . . . . 0.0 109.961 -176.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.3 m -63.68 123.63 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 120.844 0.354 . . . . 0.0 110.945 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.76 -14.05 56.26 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.177 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.478 ' HG2' HG13 ' A' ' 223' ' ' VAL . 30.5 tt0 -81.29 122.69 27.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.346 0.658 . . . . 0.0 110.767 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 74.1 t -93.58 130.74 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.478 HG13 ' HG2' ' A' ' 221' ' ' GLN . 3.0 m -150.34 147.02 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.268 1.027 . . . . 0.0 110.297 -172.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 26.1 ttp -102.76 130.41 49.71 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.896 0.478 . . . . 0.0 110.986 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.506 HD11 HD12 ' A' ' 271' ' ' ILE . 1.9 pt? -142.43 167.89 21.02 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.283 1.033 . . . . 0.0 110.917 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.545 HD21 ' HB3' ' A' ' 276' ' ' GLU . 4.8 p30 -81.37 126.52 31.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.328 0.651 . . . . 0.0 109.655 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -166.08 152.28 9.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.956 0.902 . . . . 0.0 109.384 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.59 HD21 ' HB3' ' A' ' 231' ' ' ASN . 3.7 p30 -131.34 133.0 23.97 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.442 ' HB3' HD11 ' A' ' 266' ' ' LEU . 27.0 Cg_endo -61.52 -26.02 80.29 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.809 2.339 . . . . 0.0 113.943 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.41 -33.32 71.22 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.114 0.566 . . . . 0.0 111.699 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.59 ' HB3' HD21 ' A' ' 228' ' ' ASN . 35.5 t-20 -133.23 104.33 12.46 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 123.48 0.712 . . . . 0.0 109.116 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.33 -19.48 49.75 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.767 2.311 . . . . 0.0 113.019 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.26 -10.82 40.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.331 0.652 . . . . 0.0 110.944 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -123.81 159.13 30.23 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.484 0.659 . . . . 0.0 111.179 -171.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -80.28 172.24 14.02 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.688 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 228' ' ' ASN . . . -161.55 -101.98 0.17 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.291 172.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -103.46 168.9 8.86 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.77 0.828 . . . . 0.0 109.503 -177.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -83.87 114.73 21.86 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -126.8 141.29 51.87 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.214 1.006 . . . . 0.0 108.387 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.4 p-10 -81.18 152.81 27.54 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -151.09 136.85 18.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.791 0.836 . . . . 0.0 109.058 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -94.54 118.27 31.41 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.558 HD12 HD21 ' A' ' 255' ' ' LEU . 32.3 mm -61.57 116.27 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 124.041 0.838 . . . . 0.0 108.952 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.6 t -97.08 -25.04 15.48 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.332 0.653 . . . . 0.0 110.633 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -170.13 157.34 6.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.859 0.864 . . . . 0.0 110.195 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.406 ' HB3' ' HG ' ' A' ' 255' ' ' LEU . 26.0 pttm -153.13 149.1 27.72 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.659 0.784 . . . . 0.0 109.32 163.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -154.52 120.45 5.24 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.305 0.642 . . . . 0.0 109.449 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 40.0 tt0 -111.24 125.49 53.87 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.179 0.992 . . . . 0.0 109.151 177.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.7 p -83.59 178.78 7.84 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.943 0.897 . . . . 0.0 109.565 171.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -71.62 -0.78 11.56 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.366 0.666 . . . . 0.0 112.634 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 25.4 p -123.4 -29.68 3.77 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.29 0.636 . . . . 0.0 112.607 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.86 166.76 27.96 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.882 0.31 . . . . 0.0 111.457 -172.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 33.1 ptt180 -121.14 140.76 51.55 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.454 0.701 . . . . 0.0 110.661 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.22 154.31 47.7 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.71 0.804 . . . . 0.0 108.876 172.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.558 HD21 HD12 ' A' ' 243' ' ' ILE . 7.1 tt -147.16 143.89 28.57 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -130.21 121.82 26.93 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -131.97 166.72 21.05 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.377 0.671 . . . . 0.0 110.431 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -102.19 98.14 8.33 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.795 HG23 ' SG ' ' A' ' 269' ' ' CYS . 96.6 t -66.57 112.36 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 123.783 0.677 . . . . 0.0 110.374 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.48 101.79 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 73.4 mt -82.81 -158.02 0.25 Allowed 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.642 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.434 ' CA ' ' HA3' ' A' ' 149' ' ' GLY . . . -70.29 -56.61 7.58 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-O 121.088 0.271 . . . . 0.0 113.418 177.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -112.87 -37.32 4.87 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.171 0.988 . . . . 0.0 109.929 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -94.39 176.39 6.32 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.125 0.97 . . . . 0.0 111.713 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 77.0 p -142.89 153.12 42.81 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.28 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 92.8 mt -125.31 92.15 3.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.359 0.663 . . . . 0.0 109.458 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -69.2 140.02 54.56 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 123.606 0.566 . . . . 0.0 110.284 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 12.6 t70 67.08 31.64 6.72 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.452 1.101 . . . . 0.0 111.705 171.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.795 ' SG ' HG23 ' A' ' 259' ' ' VAL . 27.2 p -65.05 124.92 23.35 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 37.6 ttp-105 -76.91 102.46 6.38 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.57 HD11 ' SG ' ' A' ' 269' ' ' CYS . 47.7 mm -77.87 108.29 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.886 -172.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 44.5 mt -82.1 -34.5 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.424 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.448 ' O ' HG23 ' A' ' 277' ' ' VAL . 46.0 m-85 -90.26 37.42 0.9 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.336 1.054 . . . . 0.0 111.14 -168.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.483 HG11 ' HD1' ' A' ' 214' ' ' TRP . 21.0 m -56.75 -34.27 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.799 1.239 . . . . 0.0 112.433 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -92.78 -10.59 36.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.676 1.19 . . . . 0.0 111.983 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.545 ' HB3' HD21 ' A' ' 226' ' ' ASN . 59.4 mm-40 -102.6 21.26 15.64 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.215 1.006 . . . . 0.0 111.148 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.492 HG22 ' HB3' ' A' ' 225' ' ' LEU . 84.2 t -90.44 153.44 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.038 0.935 . . . . 0.0 110.587 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.43 148.66 44.85 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.874 1.27 . . . . 0.0 107.808 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.676 ' HB2' HD11 ' A' ' 212' ' ' ILE . 24.0 ttmt -83.28 141.01 32.15 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 120.841 0.353 . . . . 0.0 111.126 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 36.5 mm -79.13 138.19 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 168.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.506 ' HA ' ' HA3' ' A' ' 286' ' ' GLY . 1.1 mp0 -66.11 103.46 0.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.283 0.563 . . . . 0.0 110.08 -167.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -85.7 155.0 59.14 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.31 1.044 . . . . 0.0 109.524 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.98 94.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 123.402 2.735 . . . . 0.0 112.075 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.9 -48.09 2.49 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.994 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -73.12 -25.61 60.91 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.996 0.519 . . . . 0.0 112.085 -172.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -84.68 82.19 1.7 Allowed Glycine 0 C--N 1.342 0.915 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 174.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 14.8 m -62.8 144.37 96.6 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.418 0.687 . . . . 0.0 111.989 -168.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.15 152.85 79.12 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.103 2.535 . . . . 0.0 111.875 -175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 16.7 ttt -79.76 80.77 6.11 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.26 -28.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.338 1.055 . . . . 0.0 109.963 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.63 ' HB3' ' HG3' ' A' ' 209' ' ' ARG . 10.3 t70 -84.26 -151.68 0.13 Allowed 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.303 1.041 . . . . 0.0 109.135 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.513 ' H ' HD22 ' A' ' 292' ' ' ASN . 0.8 OUTLIER -50.81 115.98 6.51 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.99 0.916 . . . . 0.0 110.533 177.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.75 102.97 0.44 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.218 1.946 . . . . 0.0 111.534 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 25.7 mmt -65.84 136.7 56.51 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.273 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -144.46 148.78 34.99 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -148.0 -175.92 5.08 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.29 0.236 . . . . 0.0 110.847 -167.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 2.1 tppt? -161.02 134.0 6.36 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 111.541 0.201 . . . . 0.0 111.541 173.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 123.579 0.752 . . . . 0.0 110.064 175.292 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.979 -0.449 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.412 HD22 ' OH ' ' A' ' 184' ' ' TYR . 0.5 OUTLIER -81.31 -34.2 32.06 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.178 0.513 . . . . 0.0 110.414 -178.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -90.16 152.42 21.11 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.778 -165.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 139' ' ' GLU . 45.0 mttp -99.35 162.93 12.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.128 -167.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.1 m -71.91 -2.28 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 124.161 0.984 . . . . 0.0 113.116 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -118.34 -21.04 8.27 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.89 0.876 . . . . 0.0 110.425 171.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.457 ' HB3' ' H ' ' A' ' 136' ' ' LYS . 43.6 tt0 -82.12 89.67 6.49 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.77 0.828 . . . . 0.0 110.116 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.702 ' HB3' ' HG2' ' A' ' 155' ' ' GLN . 26.8 p90 -68.16 139.12 56.11 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.202 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.404 HG21 ' HB ' ' A' ' 204' ' ' VAL . 29.0 m -119.5 178.96 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.998 0.919 . . . . 0.0 109.662 176.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.73 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 54.1 t0 -95.01 158.79 15.31 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 166.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.17 110.06 4.52 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 119.436 1.016 . . . . 0.0 111.213 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.411 ' HA ' ' HB3' ' A' ' 151' ' ' TRP . 3.0 tmm_? -73.01 113.69 10.33 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.878 0.871 . . . . 0.0 110.593 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -87.16 114.62 23.93 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.6 m -70.79 -26.57 63.39 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.736 0.814 . . . . 0.0 111.546 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -59.99 -49.93 75.75 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.616 0.766 . . . . 0.0 110.683 -175.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.503 ' HG3' ' H ' ' A' ' 150' ' ' ALA . 23.9 ptm -101.79 -18.99 15.52 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.526 0.331 . . . . 0.0 111.394 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 93.32 -21.56 39.83 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-O 120.021 -0.321 . . . . 0.0 113.141 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.503 ' H ' ' HG3' ' A' ' 148' ' ' MET . . . -72.47 131.18 42.22 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.197 0.599 . . . . 0.0 110.818 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 0.1 OUTLIER -97.65 124.72 42.06 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.18 175.231 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -113.64 137.3 51.8 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.017 0.927 . . . . 0.0 109.464 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.73 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 48.3 mt-10 -64.43 102.21 0.52 Allowed 'General case' 0 C--N 1.346 0.435 0 O-C-N 123.653 0.596 . . . . 0.0 110.802 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -96.61 119.13 34.53 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.78 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.702 ' HG2' ' HB3' ' A' ' 140' ' ' TYR . 15.4 tm0? -84.94 107.91 17.31 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -173.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.527 ' HA ' HG12 ' A' ' 186' ' ' VAL . 47.0 t -61.47 119.61 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 124.229 0.955 . . . . 0.0 109.207 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.408 HG13 ' OE1' ' A' ' 155' ' ' GLN . 1.9 m -115.63 -6.03 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.574 0.749 . . . . 0.0 111.179 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.54 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 44.9 ttt85 -172.23 142.12 1.33 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.966 0.506 . . . . 0.0 110.511 175.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.3 m -126.05 132.09 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.282 1.033 . . . . 0.0 108.832 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.7 p -142.96 145.2 32.77 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.39 0.676 . . . . 0.0 110.099 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -74.93 150.13 39.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.868 0.867 . . . . 0.0 109.053 168.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.0 mttt . . . . . 0 N--CA 1.478 0.964 0 C-N-CA 123.601 0.76 . . . . 0.0 109.951 173.24 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.519 ' HB3' HG22 ' A' ' 182' ' ' VAL . 5.9 mm-40 -70.68 90.76 0.78 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.33 -169.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -85.88 8.85 18.61 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.648 167.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 180' ' ' GLU . 28.6 m -65.69 173.98 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.039 1.336 . . . . 0.0 112.02 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 198' ' ' GLN . 59.0 mt -94.95 110.81 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.549 0.74 . . . . 0.0 110.417 -169.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.412 ' OH ' HD22 ' A' ' 134' ' ' LEU . 58.5 m-85 -93.95 106.48 18.45 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.887 1.275 . . . . 0.0 109.543 173.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 30.5 m-70 -80.54 101.95 9.45 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 156' ' ' VAL . 29.6 m -129.68 165.47 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.832 1.253 . . . . 0.0 110.5 -172.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -133.56 116.33 15.79 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.384 0.674 . . . . 0.0 109.375 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.646 ' HB2' ' HB2' ' A' ' 191' ' ' TYR . 47.0 m-85 -57.2 151.23 16.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 123.167 0.292 . . . . 0.0 111.347 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -60.11 -44.41 94.9 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.062 0.545 . . . . 0.0 110.875 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.47 -13.42 40.38 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.646 0.778 . . . . 0.0 111.268 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.646 ' HB2' ' HB2' ' A' ' 188' ' ' TYR . 58.3 m-85 -129.11 58.65 38.71 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -174.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.38 -23.78 8.38 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 121.71 1.607 . . . . 0.0 110.442 163.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.31 -20.55 62.18 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.687 1.195 . . . . 0.0 111.914 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -81.19 -0.42 40.4 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.057 0.543 . . . . 0.0 110.872 175.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 89.12 -177.48 44.44 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.161 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 23.6 t -82.86 116.89 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.12 153.21 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.027 0.931 . . . . 0.0 110.029 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.409 ' HB2' HG23 ' A' ' 183' ' ' ILE . 12.8 pt20 -103.78 113.88 27.73 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.731 0.777 . . . . 0.0 109.851 178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 77.9 mmm -117.27 169.75 9.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.318 1.447 . . . . 0.0 108.785 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -110.92 173.07 6.51 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.611 ' HA ' HG22 ' A' ' 204' ' ' VAL . 9.7 t -70.56 -26.2 63.43 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 118.369 0.531 . . . . 0.0 110.63 177.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -12.24 60.88 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.745 0.418 . . . . 0.0 111.786 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -94.68 -44.47 7.79 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.51 0.724 . . . . 0.0 110.082 171.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.611 HG22 ' HA ' ' A' ' 201' ' ' SER . 15.3 m -95.76 143.24 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.433 0.635 . . . . 0.0 110.996 -170.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 21.2 tpt180 -150.97 126.64 10.22 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.2 125.48 25.67 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 168.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.427 ' H ' ' NE ' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -73.68 152.02 40.57 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.428 ' N ' ' HB2' ' A' ' 281' ' ' GLU . . . -64.39 135.11 55.8 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.835 0.709 . . . . 0.0 109.398 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.522 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 5.3 ppt_? -78.21 23.06 0.29 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.876 0.87 . . . . 0.0 112.803 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 79.5 m -113.6 119.41 37.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.892 1.277 . . . . 0.0 109.082 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.63 129.03 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.038 0.535 . . . . 0.0 109.77 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 279' ' ' LYS . 28.2 mm -87.37 144.48 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.41 170.14 9.65 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.901 0.881 . . . . 0.0 109.727 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . 0.409 ' CZ3' ' HB2' ' A' ' 255' ' ' LEU . 38.2 t-105 -52.3 -47.78 65.75 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.979 0.912 . . . . 0.0 111.302 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -69.11 -23.03 63.94 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.278 0.631 . . . . 0.0 111.979 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -92.12 -16.57 26.16 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.115 0.566 . . . . 0.0 110.513 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.62 141.21 42.88 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -147.79 155.08 41.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.586 0.755 . . . . 0.0 109.419 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.93 123.39 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-O 121.26 0.552 . . . . 0.0 110.947 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.1 -4.0 48.46 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.744 -174.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.521 ' HG2' HG13 ' A' ' 223' ' ' VAL . 30.1 tt0 -87.21 121.72 30.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.235 0.614 . . . . 0.0 110.233 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 92.9 t -87.15 115.58 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.779 0.832 . . . . 0.0 108.863 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.521 HG13 ' HG2' ' A' ' 221' ' ' GLN . 6.3 m -137.91 157.37 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.311 1.044 . . . . 0.0 110.642 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.701 ' SD ' ' HD3' ' A' ' 296' ' ' ARG . 1.5 ttp -88.24 129.71 35.28 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.592 ' HB3' HG22 ' A' ' 277' ' ' VAL . 2.0 pp -143.79 168.21 20.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.826 0.85 . . . . 0.0 110.304 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.511 HD21 ' HA ' ' A' ' 235' ' ' ARG . 8.8 t30 -90.92 143.13 27.04 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -167.18 144.02 4.5 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 124.227 0.955 . . . . 0.0 109.051 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -109.84 119.09 48.55 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -56.24 -44.87 42.39 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.067 2.512 . . . . 0.0 113.082 172.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.1 -27.74 59.98 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.046 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.56 ' HB3' ' HB2' ' A' ' 234' ' ' GLU . 16.7 m120 -120.37 86.32 38.6 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 123.407 0.683 . . . . 0.0 109.194 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.37 -20.43 70.18 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.984 2.456 . . . . 0.0 113.366 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.589 ' HA ' HD12 ' A' ' 272' ' ' ILE . 61.7 tttm -97.47 -29.5 13.44 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.668 0.787 . . . . 0.0 111.26 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 231' ' ' ASN . 44.0 mt-10 -111.46 172.15 7.06 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.825 0.821 . . . . 0.0 112.665 -170.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.511 ' HA ' HD21 ' A' ' 226' ' ' ASN . 24.3 ptt180 -76.94 164.25 25.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.724 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -171.47 -79.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.694 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.412 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 11.5 m-85 -127.79 173.96 9.52 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.841 0.456 . . . . 0.0 110.268 -170.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -110.51 127.97 55.42 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 94.0 m-85 -133.54 158.34 43.39 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.415 0.686 . . . . 0.0 110.155 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . 0.404 ' HB3' ' CZ2' ' A' ' 151' ' ' TRP . 8.6 p-10 -86.14 147.08 26.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 162.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.449 ' HB3' HD21 ' A' ' 225' ' ' LEU . . . -153.48 139.76 18.51 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 122.957 0.503 . . . . 0.0 110.04 -176.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -95.53 120.11 35.22 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.564 HD12 HD21 ' A' ' 255' ' ' LEU . 35.6 mm -58.3 111.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 123.658 0.599 . . . . 0.0 109.968 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.1 m -83.77 -49.47 9.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.688 0.795 . . . . 0.0 110.303 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 4.8 mmp_? -142.43 159.21 42.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.955 1.302 . . . . 0.0 109.07 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -154.89 116.81 4.16 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.33 0.652 . . . . 0.0 109.373 168.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -123.86 117.85 25.78 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.498 1.119 . . . . 0.0 108.542 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.54 135.48 49.74 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.465 0.706 . . . . 0.0 109.604 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.9 p -133.6 175.0 9.82 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.886 0.875 . . . . 0.0 109.284 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -69.12 -38.16 78.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.815 0.446 . . . . 0.0 110.757 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 46.1 p -88.66 -27.32 21.34 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.489 0.716 . . . . 0.0 112.859 -171.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.57 172.98 17.36 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.084 0.469 . . . . 0.0 111.829 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -128.54 130.36 47.31 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.943 0.897 . . . . 0.0 108.665 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -133.03 98.6 4.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.592 0.757 . . . . 0.0 109.314 -175.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.564 HD21 HD12 ' A' ' 243' ' ' ILE . 8.4 tt -107.72 147.01 31.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 64.2 m-85 -129.14 141.35 51.21 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.886 1.274 . . . . 0.0 107.599 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.96 151.02 35.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.718 0.407 . . . . 0.0 111.091 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -79.8 96.68 6.37 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 39.4 t -79.68 108.98 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.98 0.912 . . . . 0.0 109.96 -173.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 83.2 t -87.03 114.35 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.514 0.673 . . . . 0.0 110.796 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 13.4 mt -90.44 -161.6 0.81 Allowed 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.62 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.3 -42.5 57.1 Favored Glycine 0 C--N 1.35 1.32 0 O-C-N 122.16 -0.337 . . . . 0.0 113.907 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -122.3 -27.07 4.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.213 1.005 . . . . 0.0 111.039 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -114.19 167.17 10.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.924 0.889 . . . . 0.0 110.605 -172.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 67.8 p -137.45 133.22 34.43 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.022 0.929 . . . . 0.0 108.767 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.691 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 75.4 mt -81.56 93.8 6.77 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.061 0.944 . . . . 0.0 108.514 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -59.39 110.67 1.14 Allowed 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.413 1.071 . . . . 0.0 112.151 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 30.1 t70 67.26 29.44 7.62 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.766 0.827 . . . . 0.0 111.636 167.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 98.9 m -75.45 131.42 40.13 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.807 -0.558 . . . . 0.0 111.078 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -65.47 117.04 7.4 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.534 0.734 . . . . 0.0 112.126 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 273' ' ' PHE . 36.5 mm -89.64 112.44 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.925 0.89 . . . . 0.0 109.126 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 233' ' ' LYS . 49.0 mt -97.93 22.98 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 CA-C-O 122.519 1.152 . . . . 0.0 109.061 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.502 ' H ' HG22 ' A' ' 271' ' ' ILE . 83.8 m-85 -135.6 34.86 2.94 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.622 1.169 . . . . 0.0 109.989 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 34.3 m -71.03 -12.5 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.057 -174.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -87.15 -29.01 22.11 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.547 0.739 . . . . 0.0 111.325 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -102.08 22.1 13.71 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.341 0.656 . . . . 0.0 111.356 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.592 HG22 ' HB3' ' A' ' 225' ' ' LEU . 85.2 t -73.14 131.34 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.946 0.898 . . . . 0.0 110.406 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -109.07 160.39 16.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.617 0.767 . . . . 0.0 109.886 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 212' ' ' ILE . 85.3 tttt -75.44 143.35 42.71 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.132 174.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.1 mm -72.2 116.06 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.428 ' HB2' ' N ' ' A' ' 208' ' ' ALA . 0.5 OUTLIER -83.39 105.95 14.76 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -106.47 151.53 40.37 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.512 0.725 . . . . 0.0 110.111 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.11 121.14 9.47 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.009 2.472 . . . . 0.0 113.531 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.16 -49.09 1.08 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.974 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -91.31 -24.27 19.87 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -171.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -83.23 137.15 16.0 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.04 0.212 . . . . 0.0 113.027 -170.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 6.5 m -84.36 146.48 47.74 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.144 0.578 . . . . 0.0 111.789 -173.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.28 -173.61 1.8 Allowed 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 123.731 2.954 . . . . 0.0 111.617 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . 0.522 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 25.5 mmt -82.04 78.83 8.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.102 0.477 . . . . 0.0 109.906 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 13.7 p -87.33 -25.46 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 121.779 0.8 . . . . 0.0 109.022 169.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.66 -166.4 1.57 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.405 1.482 . . . . 0.0 108.22 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.35 154.96 94.41 Favored Pre-proline 0 N--CA 1.483 1.198 0 CA-C-N 118.933 0.788 . . . . 0.0 109.701 172.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.56 102.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.586 2.19 . . . . 0.0 112.292 173.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 89.7 mmm -95.37 135.52 36.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.582 0.753 . . . . 0.0 110.108 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -155.93 165.44 36.47 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.479 0.657 . . . . 0.0 111.397 -172.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.701 ' HD3' ' SD ' ' A' ' 224' ' ' MET . 17.1 mtm180 -88.88 153.07 21.34 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.939 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 82.5 tttt 71.24 166.73 0.3 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.274 1.029 . . . . 0.0 112.397 167.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 CA--C 1.541 0.633 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 159.559 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.487 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.72 10.27 10.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.347 0.659 . . . . 0.0 111.898 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -114.92 149.36 37.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 170.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.452 ' H ' ' HB3' ' A' ' 139' ' ' GLU . 3.9 mppt? -102.94 170.25 8.09 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.019 0.528 . . . . 0.0 111.312 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -68.95 -6.23 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.489 1.116 . . . . 0.0 112.996 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.78 -22.97 9.92 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.139 0.976 . . . . 0.0 110.974 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.452 ' HB3' ' H ' ' A' ' 136' ' ' LYS . 38.3 tt0 -80.88 88.26 5.88 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.377 0.671 . . . . 0.0 110.212 -173.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.424 ' HB3' ' OE1' ' A' ' 155' ' ' GLN . 48.5 p90 -78.56 139.42 38.62 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.121 176.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.9 m -130.98 -166.74 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 126.158 1.783 . . . . 0.0 108.386 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -93.89 159.46 15.17 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 154' ' ' ALA . . . -128.94 101.95 6.3 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 124.338 1.055 . . . . 0.0 108.452 172.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -69.8 96.37 0.98 Allowed 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.652 174.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -78.4 111.02 13.98 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.1 m -71.96 -29.52 64.35 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.76 0.824 . . . . 0.0 111.694 -172.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -65.53 -42.97 91.38 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.819 0.847 . . . . 0.0 110.633 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.4 tpp -82.06 -37.9 25.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.191 0.996 . . . . 0.0 109.664 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.52 18.18 66.85 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.397 -170.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -107.4 161.13 15.09 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 122.029 0.918 . . . . 0.0 112.564 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -91.0 126.26 36.03 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.457 -1.701 . . . . 0.0 107.644 169.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -129.13 123.78 33.05 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.459 ' HB2' ' N ' ' A' ' 190' ' ' ASP . 14.6 mm-40 -43.7 137.78 2.89 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.192 0.933 . . . . 0.0 110.192 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 187' ' ' LYS . . . -134.73 116.07 14.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 122.32 0.248 . . . . 0.0 110.4 -176.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.424 ' OE1' ' HB3' ' A' ' 140' ' ' TYR . 60.6 tp60 -90.35 101.35 14.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.409 HG22 HG12 ' A' ' 186' ' ' VAL . 59.4 t -61.18 117.08 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -116.66 -10.02 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.785 0.434 . . . . 0.0 111.838 -176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 -171.33 148.53 2.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.747 0.819 . . . . 0.0 109.245 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 6.1 m -117.4 142.36 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.511 0.724 . . . . 0.0 109.4 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.473 ' OG1' ' HB ' ' A' ' 183' ' ' ILE . 69.6 p -144.24 159.99 41.74 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.79 1.236 . . . . 0.0 108.099 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -97.35 -179.21 4.42 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.213 0.605 . . . . 0.0 109.732 174.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt . . . . . 0 N--CA 1.491 1.587 0 C-N-CA 124.002 0.921 . . . . 0.0 110.402 169.778 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 CA--C 1.544 0.742 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.19 95.22 0.56 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.442 0.639 . . . . 0.0 109.845 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -75.96 76.72 2.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.073 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.08 152.87 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.39 1.476 . . . . 0.0 107.792 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.505 HG23 ' HB2' ' A' ' 198' ' ' GLN . 39.3 mt -95.19 110.15 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.02 0.528 . . . . 0.0 110.654 -170.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -92.48 112.44 24.38 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 170.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -79.34 93.95 5.41 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.409 HG12 HG22 ' A' ' 156' ' ' VAL . 6.0 m -108.2 163.84 5.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 114.404 -1.271 . . . . 0.0 107.773 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.496 ' HG2' HG22 ' A' ' 196' ' ' VAL . 35.4 mtmt -106.48 135.02 48.71 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 165.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -63.61 89.88 0.05 OUTLIER 'General case' 0 C--O 1.207 -1.148 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 164.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.46 -20.28 65.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.079 0.952 . . . . 0.0 110.639 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.459 ' N ' ' HB2' ' A' ' 153' ' ' GLU . 2.1 t70 -64.52 -32.48 74.14 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.871 0.869 . . . . 0.0 110.078 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -144.6 72.24 15.54 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.11 -16.61 55.94 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.285 2.657 . . . . 0.0 115.582 -165.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.53 -11.22 59.84 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.568 0.347 . . . . 0.0 111.59 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -72.61 -15.71 61.73 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.308 0.643 . . . . 0.0 111.226 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 93.25 -175.47 36.29 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.661 0.624 . . . . 0.0 114.661 167.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.496 HG22 ' HG2' ' A' ' 187' ' ' LYS . 17.9 t -79.16 115.33 21.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.53 154.92 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.643 1.177 . . . . 0.0 110.214 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.505 ' HB2' HG23 ' A' ' 183' ' ' ILE . 10.8 pt20 -98.24 127.41 44.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.072 0.549 . . . . 0.0 110.103 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 82.7 mmm -137.13 142.01 42.26 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.327 1.051 . . . . 0.0 108.968 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.43 ' O ' HG22 ' A' ' 204' ' ' VAL . 27.5 m-80 -86.24 173.6 9.65 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 118.294 0.497 . . . . 0.0 110.228 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 51.6 m -61.0 -37.88 84.07 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.858 0.299 . . . . 0.0 111.488 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -58.88 -27.9 65.63 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.788 0.835 . . . . 0.0 112.158 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -87.96 -41.55 13.07 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.359 0.664 . . . . 0.0 111.309 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 200' ' ' ASN . 4.7 m -93.28 116.66 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.82 0.819 . . . . 0.0 109.233 -175.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -113.43 148.77 35.25 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.59 -165.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.09 153.93 20.55 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.272 0.629 . . . . 0.0 110.275 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.419 ' HG3' ' SD ' ' A' ' 289' ' ' MET . 9.6 ptm85 -117.64 127.17 53.69 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.371 0.668 . . . . 0.0 111.006 -169.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -85.26 136.47 33.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.828 0.851 . . . . 0.0 109.837 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.715 ' HB3' ' HG2' ' A' ' 289' ' ' MET . 6.7 ppt_? -92.77 15.61 14.21 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.125 0.57 . . . . 0.0 110.65 175.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 279' ' ' LYS . 23.0 m -86.62 108.89 18.82 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.391 0.677 . . . . 0.0 110.01 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 mt -86.51 121.98 38.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 172.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.568 HG23 ' HB2' ' A' ' 216' ' ' ASP . 38.5 mm -94.29 142.33 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.502 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 1.3 ptpp? -128.2 -179.73 5.16 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.609 1.164 . . . . 0.0 109.699 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . 0.428 ' CH2' ' HB2' ' A' ' 248' ' ' GLU . 10.5 t90 -56.16 -40.47 73.93 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.064 0.546 . . . . 0.0 110.454 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -59.3 -33.12 70.71 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.718 0.807 . . . . 0.0 111.604 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.568 ' HB2' HG23 ' A' ' 212' ' ' ILE . 66.0 m-20 -80.34 -34.7 36.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.279 0.632 . . . . 0.0 110.536 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.518 HD22 HD11 ' A' ' 243' ' ' ILE . 89.0 mt -67.18 112.86 4.7 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-O 120.99 0.424 . . . . 0.0 110.479 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.51 154.83 51.24 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.519 1.127 . . . . 0.0 108.353 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 36.0 m -64.42 124.15 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.008 0.432 . . . . 0.0 110.49 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.25 -18.88 47.56 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.561 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -79.64 124.36 28.48 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.526 0.663 . . . . 0.0 109.859 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 14.0 p -91.94 141.23 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.535 0.683 . . . . 0.0 109.165 173.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.463 HG11 HG21 ' A' ' 212' ' ' ILE . 11.4 m -139.1 -177.1 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.978 1.311 . . . . 0.0 109.266 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.45 ' HB3' ' HE2' ' A' ' 224' ' ' MET . 3.8 ttp -136.63 125.27 23.75 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.115 0.566 . . . . 0.0 109.609 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.432 HD13 ' HD1' ' A' ' 227' ' ' TYR . 0.4 OUTLIER -146.21 151.62 37.89 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.408 1.083 . . . . 0.0 110.29 -169.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -88.8 108.79 19.7 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.935 0.494 . . . . 0.0 111.064 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.432 ' HD1' HD13 ' A' ' 225' ' ' LEU . 93.5 m-85 -140.61 139.77 34.96 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.913 0.885 . . . . 0.0 108.836 171.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.493 HD22 ' HB2' ' A' ' 230' ' ' ASP . 14.0 p-10 -87.26 134.62 36.07 Favored Pre-proline 0 N--CA 1.474 0.729 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.49 -13.12 36.78 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.116 1.878 . . . . 0.0 112.469 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.493 ' HB2' HD22 ' A' ' 228' ' ' ASN . 6.5 m-20 -67.69 -40.31 84.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.867 0.867 . . . . 0.0 110.133 173.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 234' ' ' GLU . 48.1 t-20 -141.31 104.19 6.04 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.78 -16.96 47.12 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.655 2.236 . . . . 0.0 112.688 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.478 ' HG3' HD11 ' A' ' 272' ' ' ILE . 83.0 tttt -95.55 8.3 43.75 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.989 0.916 . . . . 0.0 110.358 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 231' ' ' ASN . 38.3 tt0 -132.95 148.76 52.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.334 0.654 . . . . 0.0 110.964 -175.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -60.14 150.34 29.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.626 1.17 . . . . 0.0 112.386 172.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -169.6 -115.36 0.33 Allowed Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.493 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -95.62 150.06 20.77 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.347 0.659 . . . . 0.0 110.439 -176.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -77.97 107.45 10.52 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.403 0.681 . . . . 0.0 110.042 -174.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -119.63 164.97 15.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.331 0.652 . . . . 0.0 109.263 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.55 144.23 30.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 174.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.73 133.95 21.68 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 222' ' ' VAL . 34.6 tt0 -105.49 127.06 52.8 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.552 HD12 HD11 ' A' ' 255' ' ' LEU . 14.7 mm -64.95 103.8 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 123.993 0.808 . . . . 0.0 109.666 -172.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.8 p -79.31 -45.57 19.4 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.144 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -143.82 163.6 32.91 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.284 1.034 . . . . 0.0 110.102 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -155.03 149.05 25.8 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.761 0.824 . . . . 0.0 109.427 172.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -146.57 118.87 8.36 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.484 0.659 . . . . 0.0 110.565 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.428 ' HB2' ' CH2' ' A' ' 214' ' ' TRP . 5.0 tm-20 -93.17 124.19 36.97 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 63.6 p -125.61 157.51 37.01 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.44 ' HG3' HG23 ' A' ' 251' ' ' THR . 27.5 ptt180 -60.82 -24.76 66.11 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.349 1.06 . . . . 0.0 112.703 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.44 HG23 ' HG3' ' A' ' 250' ' ' ARG . 55.9 p -97.93 -28.59 13.74 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.828 0.851 . . . . 0.0 112.566 -172.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -166.1 169.24 14.7 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.68 0.392 . . . . 0.0 111.026 -173.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -95.85 155.56 16.7 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.081 0.553 . . . . 0.0 109.747 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -146.28 140.56 26.58 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.552 HD11 HD12 ' A' ' 243' ' ' ILE . 0.3 OUTLIER -148.17 144.35 27.69 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -135.68 134.04 38.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.998 0.919 . . . . 0.0 109.82 176.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.84 143.98 27.82 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.223 0.609 . . . . 0.0 111.087 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -79.52 98.43 6.84 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.022 0.529 . . . . 0.0 109.583 172.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 91.8 t -76.42 103.51 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.273 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.66 122.53 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.966 0.889 . . . . 0.0 110.104 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 32.5 mt -88.17 -151.57 0.2 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.173 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -59.89 -77.04 0.19 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 117.852 0.296 . . . . 0.0 112.579 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -100.49 -25.15 14.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.378 0.671 . . . . 0.0 110.944 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -90.61 173.21 8.17 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.826 0.85 . . . . 0.0 111.435 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 32.8 p -155.56 120.54 4.8 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.553 0.741 . . . . 0.0 110.054 174.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.19 97.51 7.64 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.364 1.066 . . . . 0.0 109.033 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.7 132.92 46.89 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.564 0.746 . . . . 0.0 111.36 -172.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 55.3 35.87 25.85 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.644 1.215 . . . . 0.0 111.818 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 36.8 t -64.0 124.43 21.57 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 54.3 ttt180 -70.63 117.18 11.83 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.788 0.435 . . . . 0.0 110.229 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 34.8 mm -80.36 110.91 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.219 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.478 HD11 ' HG3' ' A' ' 233' ' ' LYS . 25.0 mm -78.12 -66.36 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.796 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -83.63 65.84 8.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.817 1.247 . . . . 0.0 109.948 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.7 m -64.4 -32.53 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.603 0.761 . . . . 0.0 111.999 -173.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 5.3 p-10 -86.05 -13.98 45.76 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.645 1.178 . . . . 0.0 111.917 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -97.65 -0.64 45.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.453 0.701 . . . . 0.0 111.471 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.81 153.87 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.704 0.801 . . . . 0.0 110.637 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -117.4 161.56 19.35 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.899 0.879 . . . . 0.0 108.869 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.417 ' HB3' ' HB ' ' A' ' 210' ' ' THR . 80.1 tttt -91.03 153.09 20.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.867 0.467 . . . . 0.0 112.008 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.2 mm -67.23 120.26 14.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 123.947 0.899 . . . . 0.0 108.802 168.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.36 112.2 8.22 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.527 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 96.1 mtt180 -128.2 141.59 41.79 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 123.883 0.873 . . . . 0.0 109.436 172.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -46.16 108.03 0.14 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.815 3.01 . . . . 0.0 113.265 170.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.36 -39.78 2.9 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.817 -0.628 . . . . 0.0 113.435 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 32.5 tt0 -79.35 -29.19 42.09 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.961 0.381 . . . . 0.0 111.766 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -117.57 151.43 18.07 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 12.5 p -88.91 109.95 34.15 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-N 117.788 0.794 . . . . 0.0 110.114 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.25 155.69 60.31 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 123.198 2.599 . . . . 0.0 110.166 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . 0.715 ' HG2' ' HB3' ' A' ' 209' ' ' ARG . 63.8 mtt -74.78 80.5 2.08 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.61 0.719 . . . . 0.0 112.559 -172.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.02 -28.11 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 165.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.78 -164.42 0.79 Allowed 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.254 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -57.24 111.75 3.78 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 118.774 0.715 . . . . 0.0 111.566 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.544 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 11.9 Cg_exo -72.61 93.89 0.77 Allowed 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.432 2.088 . . . . 0.0 111.094 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.2 mtm -73.36 125.73 28.52 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.02 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.23 121.34 22.77 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -64.59 -30.08 71.1 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.06 0.944 . . . . 0.0 111.179 -175.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -57.06 122.08 11.52 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.383 167.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 50.2 p . . . . . 0 CA--C 1.55 0.948 0 C-N-CA 123.366 0.666 . . . . 0.0 110.804 -177.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.417 0 CA-C-O 119.744 -0.476 . . . . 0.0 111.967 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.31 7.37 4.97 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -79.6 128.47 33.42 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.776 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 58.1 pttt -72.18 174.66 6.88 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.004 0.922 . . . . 0.0 111.657 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -74.51 -2.67 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.206 0.602 . . . . 0.0 111.948 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.511 ' H ' ' HG3' ' A' ' 136' ' ' LYS . 92.0 m-20 -120.99 30.3 6.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.244 1.018 . . . . 0.0 110.96 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.776 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 6.3 mm-40 -88.86 71.21 8.64 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.253 1.025 . . . . 0.0 110.859 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -63.76 99.4 0.23 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.288 169.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 30.1 m -121.77 169.32 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.972 0.909 . . . . 0.0 109.703 -176.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' A' ' 207' ' ' ARG . 1.6 t0 -101.6 110.34 22.32 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -92.75 92.98 8.21 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 122.932 0.493 . . . . 0.0 110.497 -171.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 2.8 tmt_? -72.27 106.13 4.32 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 174.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.62 114.8 3.78 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.47 ' HA ' ' NH1' ' A' ' 144' ' ' ARG . 13.8 t -60.25 -23.89 64.46 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -171.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -83.7 -38.69 21.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.447 0.699 . . . . 0.0 110.174 -174.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 41.9 ttm -92.96 -22.89 18.93 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.491 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.42 12.93 73.66 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.063 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.56 129.98 53.71 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.622 0.769 . . . . 0.0 111.147 -174.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 52.1 m95 -81.89 121.93 27.09 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.077 0.951 . . . . 0.0 110.617 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -131.03 115.18 16.12 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 27.1 mt-10 -58.45 144.86 40.72 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.311 0.505 . . . . 0.0 111.139 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.494 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -158.42 124.78 4.69 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 124.31 1.006 . . . . 0.0 109.613 -176.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -92.48 118.88 31.42 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 63.7 t -61.66 111.72 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 C-N-CA 123.484 0.713 . . . . 0.0 109.315 172.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.7 m -104.48 -6.89 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.138 0.575 . . . . 0.0 111.8 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -170.14 141.28 2.08 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.199 0.599 . . . . 0.0 110.24 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.6 m -119.41 142.09 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.59 0.756 . . . . 0.0 110.672 172.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.2 t -147.14 160.86 41.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.032 0.933 . . . . 0.0 108.833 169.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.2 ptt-85 -101.73 176.39 5.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.061 0.544 . . . . 0.0 110.217 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 N--CA 1.477 0.909 0 C-N-CA 123.474 0.71 . . . . 0.0 110.042 177.039 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.402 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 10.0 mm-40 52.11 29.21 6.15 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 173.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -71.41 63.35 0.38 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.54 168.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.31 -175.51 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.821 1.648 . . . . 0.0 108.645 -170.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.611 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.7 mp -97.5 110.71 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.402 ' OH ' ' HB3' ' A' ' 180' ' ' GLU . 99.6 m-85 -98.61 106.61 18.91 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.193 0.997 . . . . 0.0 108.411 170.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -79.09 97.7 6.23 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.494 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 35.1 m -109.97 163.65 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.241 1.017 . . . . 0.0 111.019 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 154' ' ' ALA . 1.8 mmmp? -121.54 114.01 20.61 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -63.16 115.03 4.12 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.303 0.377 . . . . 0.0 110.254 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.69 -34.77 72.33 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.968 0.413 . . . . 0.0 110.408 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.64 -28.72 61.93 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.898 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -142.17 68.13 22.0 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 122.762 0.425 . . . . 0.0 111.342 -170.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.34 -11.41 24.75 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.264 2.643 . . . . 0.0 113.629 -174.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.44 -17.87 62.36 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.558 0.743 . . . . 0.0 111.17 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -72.5 -10.5 59.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.389 0.675 . . . . 0.0 111.54 173.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.63 -151.78 45.16 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.401 0.438 . . . . 0.0 112.342 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.75 117.88 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 18.5 m -116.6 152.62 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.833 0.853 . . . . 0.0 109.466 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.611 ' HB2' HG23 ' A' ' 183' ' ' ILE . 5.4 pm0 -107.57 123.97 49.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.976 0.51 . . . . 0.0 109.716 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . 0.404 ' HE1' ' HB1' ' A' ' 143' ' ' ALA . 74.9 mtp -131.16 170.13 14.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.58 0.752 . . . . 0.0 110.045 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -109.41 175.4 5.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.922 0.889 . . . . 0.0 109.904 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 45.8 t -63.73 -40.02 95.72 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.884 0.474 . . . . 0.0 110.687 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -65.46 -7.32 13.59 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -101.87 -54.64 2.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.027 0.931 . . . . 0.0 111.345 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 32.6 m -91.72 119.94 39.94 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -168.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.428 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 16.0 mmt180 -123.12 141.4 52.01 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.937 -169.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.81 132.18 51.55 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 168.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.674 ' HB3' ' HB2' ' A' ' 142' ' ' ASP . 4.2 ptm180 -111.71 158.35 19.43 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.772 0.429 . . . . 0.0 111.119 -173.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.64 140.64 29.33 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.858 0.463 . . . . 0.0 109.882 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.515 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 10.9 ptm180 -93.43 18.11 10.32 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.378 0.609 . . . . 0.0 110.537 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 87.8 m -98.91 113.99 26.39 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.304 1.042 . . . . 0.0 109.996 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 30.6 mt -86.94 124.49 40.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 169.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.629 ' HB ' ' HB ' ' A' ' 277' ' ' VAL . 47.9 mm -86.37 127.3 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.755 1.222 . . . . 0.0 109.917 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.87 -178.91 3.6 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.208 1.003 . . . . 0.0 108.625 171.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . 0.401 ' HA ' HD23 ' A' ' 217' ' ' LEU . 64.4 t-105 -54.29 -32.92 57.54 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.128 0.571 . . . . 0.0 112.269 -172.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -61.77 -39.17 90.73 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.529 0.731 . . . . 0.0 111.487 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.593 ' HB2' HG23 ' A' ' 212' ' ' ILE . 7.1 m-20 -84.6 -14.52 48.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.85 0.86 . . . . 0.0 111.67 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.447 HD22 HG22 ' A' ' 212' ' ' ILE . 3.2 mm? -66.7 113.41 4.81 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.7 140.94 34.99 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.129 0.971 . . . . 0.0 108.438 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.1 m -70.0 138.49 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 120.966 0.412 . . . . 0.0 110.899 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 94.06 -13.78 66.66 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.324 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.474 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.1 tt0 -81.68 122.77 28.05 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.344 0.572 . . . . 0.0 110.837 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.83 119.66 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 279' ' ' LYS . 1.9 m -135.27 172.58 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.587 1.155 . . . . 0.0 110.265 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.531 ' HE2' ' HB2' ' A' ' 278' ' ' PHE . 48.4 ttp -110.32 113.98 27.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.257 0.623 . . . . 0.0 110.08 -174.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.527 ' HG ' HG13 ' A' ' 277' ' ' VAL . 0.2 OUTLIER -121.97 147.16 46.41 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.281 0.632 . . . . 0.0 109.502 -173.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -87.44 124.09 33.06 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.575 0.75 . . . . 0.0 110.143 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 225' ' ' LEU . 7.3 p90 -169.07 154.2 5.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.061 0.944 . . . . 0.0 109.357 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -82.11 127.83 70.23 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 162.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.77 -38.89 77.57 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.304 2.003 . . . . 0.0 111.939 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -75.59 -30.1 59.51 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.021 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -132.9 79.87 62.21 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 123.3 0.64 . . . . 0.0 110.643 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.95 -11.96 32.18 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.135 2.557 . . . . 0.0 113.389 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.51 ' HA ' HD12 ' A' ' 272' ' ' ILE . 22.3 tptm -70.99 -24.23 62.35 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.35 0.66 . . . . 0.0 110.931 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.68 164.56 24.75 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.0 0.52 . . . . 0.0 111.033 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -51.49 160.08 0.65 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.335 1.454 . . . . 0.0 112.804 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -166.02 -107.32 0.2 Allowed Glycine 0 C--N 1.344 1.018 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -128.18 173.18 10.33 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.773 0.829 . . . . 0.0 109.11 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -96.65 127.16 42.37 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.452 0.701 . . . . 0.0 110.049 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 224' ' ' MET . 93.7 m-85 -138.95 164.54 29.45 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.371 0.668 . . . . 0.0 110.051 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.4 140.44 34.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -150.95 137.38 18.62 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -95.42 126.42 40.7 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.475 HD12 HD11 ' A' ' 255' ' ' LEU . 19.0 mm -67.65 110.39 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.052 0.453 . . . . 0.0 109.801 -175.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.424 ' H ' ' HA ' ' A' ' 257' ' ' ALA . 17.1 m -79.3 -39.66 32.35 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.823 0.849 . . . . 0.0 110.666 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -161.97 156.08 21.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.79 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -141.69 148.29 38.84 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.524 ' HB3' ' HG3' ' A' ' 254' ' ' GLU . 28.1 tpt180 -149.87 122.15 8.39 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -115.32 123.69 49.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.113 0.565 . . . . 0.0 109.873 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 62.2 p -121.6 162.95 19.73 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' A' ' 250' ' ' ARG . 11.6 tpt180 -67.18 -22.31 65.75 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 120.759 0.314 . . . . 0.0 111.401 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.2 p -86.41 -28.99 23.22 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.375 0.67 . . . . 0.0 111.414 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -165.67 141.41 5.1 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.445 ' O ' ' HD2' ' A' ' 253' ' ' ARG . 4.2 ppt_? -111.18 102.52 10.94 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.675 0.79 . . . . 0.0 109.569 173.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 247' ' ' ARG . 7.6 pt-20 -95.71 122.85 38.92 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.634 0.774 . . . . 0.0 110.722 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 270' ' ' ARG . 1.7 tm? -108.77 147.85 31.41 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . 0.448 ' N ' HD13 ' A' ' 255' ' ' LEU . 99.3 m-85 -135.04 132.31 38.1 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.264 1.026 . . . . 0.0 108.516 175.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.424 ' HA ' ' H ' ' A' ' 244' ' ' SER . . . -144.46 139.94 28.62 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 -177.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 43.5 t30 -75.66 95.54 3.41 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 172.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 34.3 t -68.79 112.16 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.372 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.79 117.92 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 264' ' ' ASP . 59.8 mt -94.5 -165.78 1.37 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.497 0.719 . . . . 0.0 109.423 173.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -62.85 -45.3 95.99 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.01 0.194 . . . . 0.0 113.341 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -123.06 -35.98 2.92 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.546 0.738 . . . . 0.0 110.646 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.571 ' HB2' HD12 ' A' ' 261' ' ' LEU . 8.2 m-20 -91.79 176.55 6.49 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.83 0.852 . . . . 0.0 111.574 -172.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 35.1 t -156.59 118.08 3.82 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.514 0.726 . . . . 0.0 110.201 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 2.0 mm? -96.15 92.11 6.25 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 3.2 p-10 -68.7 138.61 55.07 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.353 0.261 . . . . 0.0 111.289 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 57.88 32.53 22.05 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.291 1.036 . . . . 0.0 111.786 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 44.0 t -65.27 127.27 31.05 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.41 0.684 . . . . 0.0 110.411 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 45.0 ttp180 -70.51 110.49 5.42 Favored 'General case' 0 C--N 1.346 0.456 0 O-C-N 123.436 0.46 . . . . 0.0 110.343 -178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.1 mm -89.43 132.78 33.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.774 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 233' ' ' LYS . 65.0 mt -102.09 -26.31 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.082 1.353 . . . . 0.0 109.932 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -92.38 42.62 1.11 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.124 1.37 . . . . 0.0 111.336 -168.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 16.7 m -69.59 -22.84 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -168.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.85 -25.22 19.07 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.96 9.12 17.9 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.762 0.825 . . . . 0.0 112.332 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.629 ' HB ' ' HB ' ' A' ' 212' ' ' ILE . 32.7 t -80.56 147.05 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.391 0.676 . . . . 0.0 110.836 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.531 ' HB2' ' HE2' ' A' ' 224' ' ' MET . 62.7 m-85 -105.8 156.26 18.49 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 162.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.552 ' HA ' HG12 ' A' ' 223' ' ' VAL . 36.5 ttmt -80.57 146.58 31.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.666 0.386 . . . . 0.0 110.417 173.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.542 HG12 ' HA ' ' A' ' 223' ' ' VAL . 35.1 mm -73.48 114.91 13.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 168.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -76.6 134.06 39.47 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.631 173.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 61.5 mtp180 -108.38 94.2 13.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 168.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -20.17 97.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.386 2.551 1 C-N-CA 126.263 4.642 . . . . 0.0 117.246 -162.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 103.53 -30.84 9.5 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 115.347 -0.842 . . . . 0.0 115.189 169.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 11.6 pt-20 -79.51 -20.21 47.77 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.859 1.33 . . . . 0.0 112.004 -173.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -87.46 -100.57 0.87 Allowed Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . 0.422 ' HB2' ' HG2' ' A' ' 209' ' ' ARG . 14.6 p -127.23 128.52 24.08 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.535 1.134 . . . . 0.0 110.791 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.52 133.66 17.65 Favored 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 123.29 2.66 . . . . 0.0 112.921 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . 0.515 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 98.3 mmm -86.45 82.49 7.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 168.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 11.2 p -128.58 -15.03 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.757 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -103.42 -153.18 0.47 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.701 1.2 . . . . 0.0 108.625 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -55.17 120.19 28.28 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.566 0.747 . . . . 0.0 111.575 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.33 85.12 0.45 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.817 2.345 . . . . 0.0 111.336 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 18.7 ptm -71.05 82.39 0.68 Allowed 'General case' 0 C--O 1.244 0.767 0 CA-C-O 123.037 1.399 . . . . 0.0 109.895 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -94.73 160.03 14.8 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.77 -172.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.455 ' NH2' ' H ' ' A' ' 153' ' ' GLU . 30.6 mtm-85 -87.3 118.79 26.96 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.108 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.6 mttt 64.81 -170.89 0.19 Allowed 'General case' 0 CA--C 1.551 1.002 0 O-C-N 124.565 1.166 . . . . 0.0 111.078 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 C--O 1.24 0.562 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 160.272 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.634 ' N ' ' HH ' ' A' ' 184' ' ' TYR . . . . . . . . 0 N--CA 1.485 1.955 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.432 HD13 ' N ' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -127.29 5.67 6.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.488 0.715 . . . . 0.0 112.323 -173.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.505 ' HB2' HG11 ' A' ' 156' ' ' VAL . 43.0 m-85 -96.93 143.08 28.14 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.475 0.31 . . . . 0.0 110.433 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.551 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 22.6 pttp -86.14 176.8 7.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.037 0.535 . . . . 0.0 111.055 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.65 -10.27 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -173.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -127.44 21.59 6.59 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.747 0.419 . . . . 0.0 110.44 -171.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.551 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 17.9 mm-40 -99.65 88.62 3.88 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 122.038 -0.414 . . . . 0.0 110.798 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 25.6 p90 -76.75 122.87 25.35 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.339 171.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.26 167.42 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.617 0.767 . . . . 0.0 108.968 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -90.72 115.12 27.57 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.79 120.37 36.33 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.588 -167.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.54 128.37 35.39 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.85 112.45 5.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 t -68.02 -14.35 62.9 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.464 0.705 . . . . 0.0 112.702 -172.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -86.76 -54.12 4.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.343 0.657 . . . . 0.0 111.107 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 37.8 ttp -96.34 -27.83 14.77 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.411 0.685 . . . . 0.0 112.084 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.72 18.85 46.35 Favored Glycine 0 N--CA 1.475 1.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.946 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.75 129.37 53.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.119 0.568 . . . . 0.0 111.062 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.673 ' HH2' ' HD2' ' A' ' 205' ' ' ARG . 81.4 m95 -75.22 128.09 34.66 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.64 0.776 . . . . 0.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -131.8 137.66 48.22 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.283 1.033 . . . . 0.0 108.925 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -59.32 114.43 2.65 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -125.54 120.67 31.5 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.199 0.6 . . . . 0.0 109.796 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.734 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 51.6 tt0 -87.19 114.75 24.07 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.605 0.762 . . . . 0.0 110.554 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 135' ' ' TYR . 92.5 t -62.28 98.41 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.7 m -94.88 -10.02 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.912 0.485 . . . . 0.0 111.076 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 27.8 ttt180 -170.25 146.7 2.97 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.975 0.797 . . . . 0.0 109.92 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.0 m -117.17 142.9 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 169.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.3 p -135.21 121.49 20.3 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 172.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -82.18 176.47 9.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.029 0.532 . . . . 0.0 111.051 -175.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 CA--C 1.553 1.081 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.77 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 . . . . . 0 C--O 1.241 0.621 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.23 97.43 1.55 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.025 -171.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -76.66 53.14 0.87 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.823 0.82 . . . . 0.0 110.435 169.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 31.6 m -83.85 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 124.603 1.161 . . . . 0.0 109.624 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.595 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.5 mp -97.3 106.21 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.634 ' HH ' ' N ' ' A' ' 133' ' ' GLY . 36.2 m-85 -93.54 111.17 22.78 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 14.5 m-70 -80.01 90.28 5.38 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 35.0 m -108.97 140.2 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.32 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -105.74 123.45 47.97 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -57.04 96.3 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -62.96 -29.63 70.96 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.006 0.922 . . . . 0.0 109.076 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 298' ' ' SER . 2.0 t0 -61.83 -30.96 71.18 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.086 1.354 . . . . 0.0 111.031 176.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -145.75 81.27 10.1 Favored Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 124.549 1.14 . . . . 0.0 108.624 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -65.05 -16.86 57.36 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.076 2.517 . . . . 0.0 114.618 -170.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.53 -18.7 65.13 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -74.67 -20.9 59.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.206 0.602 . . . . 0.0 111.626 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.41 -144.6 41.04 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.511 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 6.8 t -87.66 129.55 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.217 0.607 . . . . 0.0 110.424 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.7 153.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.045 1.338 . . . . 0.0 108.52 170.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.595 ' HB2' HG23 ' A' ' 183' ' ' ILE . 16.2 pt20 -102.88 128.74 49.54 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.124 0.488 . . . . 0.0 110.305 177.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 84.2 mtp -137.61 159.82 40.9 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.33 1.052 . . . . 0.0 108.73 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -97.81 174.23 6.7 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.6 t -64.21 -34.79 78.89 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 120.827 0.346 . . . . 0.0 110.746 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.46 -14.86 63.3 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -96.5 -45.29 6.81 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.716 0.807 . . . . 0.0 110.344 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 32.6 m -95.41 117.29 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.673 ' HD2' ' HH2' ' A' ' 151' ' ' TRP . 92.7 mtt180 -128.55 171.42 12.15 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.77 -0.582 . . . . 0.0 111.193 -168.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.58 129.4 40.43 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.374 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.58 ' HG3' ' SD ' ' A' ' 289' ' ' MET . 26.4 ptt180 -81.1 142.11 33.64 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.357 1.063 . . . . 0.0 111.229 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.65 ' HB2' ' HB2' ' A' ' 281' ' ' GLU . . . -99.92 145.41 27.84 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.395 0.678 . . . . 0.0 110.339 175.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -2.38 34.81 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.657 0.783 . . . . 0.0 110.558 173.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.5 m -89.49 117.71 28.6 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.473 0.709 . . . . 0.0 111.332 -165.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.3 mt -92.4 136.26 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 166.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.686 HG21 HD13 ' A' ' 217' ' ' LEU . 19.9 mm -107.46 153.55 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.951 0.9 . . . . 0.0 110.372 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -128.26 168.52 15.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.549 0.74 . . . . 0.0 109.066 167.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 35.9 t90 -46.32 -41.86 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.344 1.058 . . . . 0.0 112.096 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -57.68 -46.3 84.48 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.85 0.86 . . . . 0.0 112.637 -173.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -103.65 6.3 36.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.504 0.722 . . . . 0.0 111.023 -175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.686 HD13 HG21 ' A' ' 212' ' ' ILE . 8.0 tp -86.63 110.96 20.2 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 175.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.7 153.35 25.39 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.947 0.34 . . . . 0.0 110.861 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.413 ' HA ' ' HB ' ' A' ' 243' ' ' ILE . 28.0 m -66.13 136.99 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.701 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.0 -23.62 34.89 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.622 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.524 ' HG2' HG13 ' A' ' 223' ' ' VAL . 9.5 tt0 -74.69 123.39 24.81 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.119 0.567 . . . . 0.0 110.373 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 84.5 t -85.8 119.91 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.524 HG13 ' HG2' ' A' ' 221' ' ' GLN . 3.5 m -132.69 164.54 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.226 1.41 . . . . 0.0 109.856 -177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.589 ' HB3' HD11 ' A' ' 280' ' ' ILE . 15.0 ptm -112.28 139.11 48.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.635 0.774 . . . . 0.0 110.353 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.578 HD13 HG23 ' A' ' 271' ' ' ILE . 0.6 OUTLIER -142.69 157.28 44.83 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -89.37 112.23 23.29 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.195 0.598 . . . . 0.0 109.65 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.429 ' OH ' HG13 ' A' ' 259' ' ' VAL . 0.5 OUTLIER -159.89 149.69 18.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.692 0.797 . . . . 0.0 109.321 178.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -92.76 137.37 24.14 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 171.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.82 2.53 5.83 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.733 2.289 . . . . 0.0 113.66 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -96.77 -15.93 21.1 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.869 0.868 . . . . 0.0 110.726 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -160.08 90.48 1.79 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.606 0.762 . . . . 0.0 109.025 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.05 -5.19 15.8 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.067 2.511 . . . . 0.0 112.33 175.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.664 ' HA ' HD12 ' A' ' 272' ' ' ILE . 88.6 tttt -73.45 -28.29 61.88 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.772 0.829 . . . . 0.0 111.171 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -123.84 155.18 38.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.09 0.556 . . . . 0.0 110.263 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -68.75 174.3 4.45 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.263 1.025 . . . . 0.0 112.76 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -178.8 -105.03 0.19 Allowed Glycine 0 C--N 1.338 0.67 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.932 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -110.04 153.03 25.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 0.0 109.408 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . 0.437 ' HA ' ' O ' ' A' ' 225' ' ' LEU . 67.2 m95 -83.58 106.38 15.27 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 122.796 0.438 . . . . 0.0 110.074 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -112.62 166.08 11.67 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . 0.494 ' HB2' HG13 ' A' ' 260' ' ' VAL . 3.8 m-20 -81.32 146.21 30.48 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.223 176.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -146.47 134.51 21.5 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -102.39 117.28 34.38 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.414 HD12 HD21 ' A' ' 255' ' ' LEU . 31.8 mm -61.98 114.8 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 123.352 0.407 . . . . 0.0 110.377 -171.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 20.1 m -98.86 -25.01 14.76 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.463 0.705 . . . . 0.0 110.449 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 23.9 ttm180 -166.89 151.71 7.42 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.726 0.811 . . . . 0.0 109.381 -174.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -156.42 134.3 11.09 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.963 0.505 . . . . 0.0 110.388 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -146.51 116.38 7.27 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 8.9 pt-20 -100.16 152.18 20.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.194 0.521 . . . . 0.0 109.824 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 69.5 p -131.96 168.03 18.62 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -67.93 -15.98 63.86 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 117.829 0.286 . . . . 0.0 111.32 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.6 p -94.01 -29.87 15.0 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.843 0.857 . . . . 0.0 112.027 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -168.62 134.73 1.82 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 122.917 0.487 . . . . 0.0 111.528 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 46.9 mtt180 -90.79 106.88 18.82 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -95.95 143.55 27.03 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.301 0.64 . . . . 0.0 109.643 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.516 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 5.6 tt -150.0 149.84 30.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . 0.476 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 82.4 m-85 -134.72 124.84 25.89 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -134.54 147.88 50.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.11 0.564 . . . . 0.0 110.459 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 35.0 t30 -76.01 92.49 3.16 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 15.7 t -67.96 130.42 33.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.649 174.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 240' ' ' ASP . 4.3 p -122.47 114.26 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 40.4 mt -89.35 -155.63 0.36 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.221 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -81.3 -49.25 5.6 Favored Glycine 0 C--N 1.344 1.0 0 C-N-CA 121.932 -0.175 . . . . 0.0 112.722 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -104.99 -24.22 12.85 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.259 0.624 . . . . 0.0 111.988 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -139.57 175.66 9.38 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.97 0.508 . . . . 0.0 109.899 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 17.6 p -144.76 131.47 20.05 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.158 0.583 . . . . 0.0 111.315 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 14.7 mt -97.87 89.83 4.73 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.699 1.2 . . . . 0.0 109.38 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 18.4 t-20 -69.98 135.15 49.09 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.14 0.576 . . . . 0.0 111.44 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 57.18 29.7 17.1 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.532 1.133 . . . . 0.0 112.825 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 39.3 t -66.43 130.39 43.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.005 0.522 . . . . 0.0 109.968 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -69.58 131.22 44.33 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.032 0.444 . . . . 0.0 111.361 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.578 HG23 HD13 ' A' ' 225' ' ' LEU . 48.8 mm -108.24 114.44 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.838 1.255 . . . . 0.0 109.335 -175.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.664 HD12 ' HA ' ' A' ' 233' ' ' LYS . 11.9 mt -87.94 -21.96 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.579 0.752 . . . . 0.0 109.893 173.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.79 38.54 0.84 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.262 1.025 . . . . 0.0 111.461 -173.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 26.8 m -63.19 -21.33 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.543 0.737 . . . . 0.0 111.861 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.92 -27.62 14.19 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.895 1.278 . . . . 0.0 110.543 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -106.17 10.82 31.81 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.198 0.999 . . . . 0.0 111.434 -170.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.529 HG13 ' HB ' ' A' ' 212' ' ' ILE . 7.4 p -86.17 131.14 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.527 0.731 . . . . 0.0 109.515 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.4 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 7.0 m-30 -101.27 164.21 11.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.478 1.111 . . . . 0.0 109.41 172.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.623 ' HB2' HD11 ' A' ' 212' ' ' ILE . 40.4 ttmt -83.76 142.32 30.77 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.153 0.581 . . . . 0.0 110.994 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.589 HD11 ' HB3' ' A' ' 224' ' ' MET . 21.0 mm -84.04 117.47 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 165.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.65 ' HB2' ' HB2' ' A' ' 208' ' ' ALA . 0.3 OUTLIER -83.63 106.34 15.27 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.407 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 29.4 mtp180 -97.65 92.35 1.3 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -15.33 90.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.474 1 C-N-CA 126.621 4.881 . . . . 0.0 117.037 -161.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.26 6.05 51.7 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.441 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 34.7 tt0 -121.11 -23.06 5.9 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.438 0.695 . . . . 0.0 110.704 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -83.79 -126.88 1.31 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 174.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 23.0 m -127.81 142.36 44.02 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-N 117.62 0.71 . . . . 0.0 110.654 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.71 114.81 4.12 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.81 2.34 . . . . 0.0 111.036 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . 0.58 ' SD ' ' HG3' ' A' ' 207' ' ' ARG . 26.5 ttt -73.94 92.76 2.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.564 0.697 . . . . 0.0 110.055 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 11.1 p -123.19 24.19 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 125.057 1.343 . . . . 0.0 108.687 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.09 -171.28 2.84 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.191 -165.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -47.2 141.71 6.06 Favored Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 125.048 1.339 . . . . 0.0 113.663 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.42 146.84 86.39 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.069 2.512 . . . . 0.0 112.582 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.4 mmt -82.39 -88.03 0.09 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.147 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 56.25 50.6 13.08 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -165.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -59.07 104.03 0.21 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.948 -1.933 . . . . 0.0 111.623 -170.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.54 26.28 14.15 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.13 0.972 . . . . 0.0 110.544 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 190' ' ' ASP . 78.4 p . . . . . 0 C--O 1.244 0.767 0 C-N-CA 123.204 0.601 . . . . 0.0 111.446 -172.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.791 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.607 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -59.09 -32.78 70.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.351 0.66 . . . . 0.0 112.475 -177.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.515 ' N ' HD22 ' A' ' 134' ' ' LEU . 48.8 m-85 -79.62 152.16 30.18 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -114.94 176.83 4.89 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 109.134 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.0 m -71.67 -2.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.479 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -117.66 7.68 12.63 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.877 0.871 . . . . 0.0 111.38 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -86.48 90.92 8.38 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.898 0.479 . . . . 0.0 111.211 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 50.4 p90 -63.81 123.36 18.71 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.612 167.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.19 -170.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.597 0.759 . . . . 0.0 110.154 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 205' ' ' ARG . 47.0 t0 -106.1 158.39 16.85 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 165.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -140.27 111.45 7.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.36 0.527 . . . . 0.0 109.586 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -70.77 93.71 0.98 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -62.03 132.48 53.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.696 1.198 . . . . 0.0 112.1 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.3 p -86.8 -14.11 43.16 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.092 0.957 . . . . 0.0 111.36 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.92 -53.82 7.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.064 0.546 . . . . 0.0 110.479 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 53.8 ttm -100.68 -36.25 9.19 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.437 0.695 . . . . 0.0 111.239 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.61 16.68 48.11 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.443 -172.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -103.96 150.58 24.09 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.768 0.827 . . . . 0.0 110.283 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.446 ' HZ3' ' HG3' ' A' ' 205' ' ' ARG . 18.5 m95 -83.05 118.61 23.65 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -124.06 112.35 17.04 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.127 0.571 . . . . 0.0 109.648 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.637 ' HB2' ' HD2' ' A' ' 295' ' ' ARG . 5.6 pt-20 -58.48 128.96 39.78 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.701 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.461 ' HA ' ' H ' ' A' ' 189' ' ' ASP . . . -144.1 -175.72 4.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.218 1.007 . . . . 0.0 111.136 -168.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.6 tt0 -140.25 125.49 18.76 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.038 0.535 . . . . 0.0 109.906 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.9 t -62.13 115.48 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 124.026 0.93 . . . . 0.0 108.921 169.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.556 HG11 ' HE2' ' A' ' 187' ' ' LYS . 35.5 m -116.99 -3.48 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.238 0.615 . . . . 0.0 112.007 -178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 29.2 ttm180 -162.4 139.39 8.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.186 0.594 . . . . 0.0 109.488 173.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 135' ' ' TYR . 11.6 m -119.2 134.4 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.419 0.688 . . . . 0.0 109.693 176.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.553 HG23 ' HB ' ' A' ' 183' ' ' ILE . 3.2 t -147.09 161.51 40.71 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.885 0.874 . . . . 0.0 109.907 175.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -115.97 149.96 37.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.949 0.9 . . . . 0.0 110.145 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 N--CA 1.483 1.194 0 C-N-CA 123.758 0.823 . . . . 0.0 109.358 173.643 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.96 83.49 2.85 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.195 0.598 . . . . 0.0 109.6 -173.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.418 ' HA ' ' HB3' ' A' ' 200' ' ' ASN . 5.9 m-20 -80.34 63.19 4.73 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.118 0.961 . . . . 0.0 109.364 171.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 160' ' ' THR . 34.7 m -105.54 159.27 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.641 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.553 ' HB ' HG23 ' A' ' 160' ' ' THR . 2.3 mp -93.18 108.97 21.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.979 0.895 . . . . 0.0 108.99 -173.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.42 ' HD2' HG12 ' A' ' 159' ' ' VAL . 68.7 m-85 -92.54 108.3 19.87 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.518 167.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 33.2 m-70 -77.05 100.09 5.55 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.93 142.81 20.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 123.811 0.694 . . . . 0.0 109.223 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.583 ' HG2' HG22 ' A' ' 196' ' ' VAL . 42.9 mtmt -103.59 121.62 43.29 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 170.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -60.7 108.51 0.85 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.461 ' H ' ' HA ' ' A' ' 154' ' ' ALA . 20.9 t70 -57.75 -42.13 83.33 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.905 0.882 . . . . 0.0 110.737 -173.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.94 -19.0 32.84 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.98 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -133.77 64.72 68.52 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 122.907 0.483 . . . . 0.0 110.607 -177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.0 -11.77 32.68 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.635 2.223 . . . . 0.0 112.559 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.85 -30.64 70.08 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.899 0.88 . . . . 0.0 111.229 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -72.24 -16.76 61.94 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.376 0.67 . . . . 0.0 110.512 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 87.31 -166.33 36.46 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.811 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.583 HG22 ' HG2' ' A' ' 187' ' ' LYS . 6.5 t -93.04 125.24 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.65 157.01 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.782 0.833 . . . . 0.0 110.68 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.55 114.59 28.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.582 1.153 . . . . 0.0 109.192 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 77.3 mmm -126.94 138.89 53.35 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.449 0.7 . . . . 0.0 110.065 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 20.6 m-80 -83.18 173.41 11.69 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.307 0.643 . . . . 0.0 109.865 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 29.8 t -56.15 -43.99 78.81 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.567 0.747 . . . . 0.0 111.813 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -54.04 -33.83 58.39 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.548 1.139 . . . . 0.0 111.947 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -88.28 -33.26 18.11 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.998 0.919 . . . . 0.0 111.661 -172.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 10.3 m -92.72 117.1 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 122.275 1.036 . . . . 0.0 108.483 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 22.3 mmm180 -109.66 168.65 9.25 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.836 -165.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.579 ' HA ' ' NH2' ' A' ' 207' ' ' ARG . . . -88.93 144.73 25.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.907 172.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.602 ' HG2' ' HG2' ' A' ' 295' ' ' ARG . 0.0 OUTLIER -80.06 93.25 5.74 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.9 97.08 0.21 Allowed 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.521 ' H ' ' NE ' ' A' ' 209' ' ' ARG . 0.0 OUTLIER -76.75 71.13 3.3 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.639 1.209 . . . . 0.0 110.141 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.9 m -146.09 110.38 5.03 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.937 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 28.7 mt -83.35 134.23 27.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 279' ' ' LYS . 42.6 mm -82.51 139.41 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.308 0.575 . . . . 0.0 110.951 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -124.41 160.03 29.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.12 1.368 . . . . 0.0 109.392 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . 0.583 ' HA ' HD23 ' A' ' 217' ' ' LEU . 31.9 t90 -56.2 -40.48 74.08 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.756 0.823 . . . . 0.0 112.323 -169.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -56.79 -41.77 78.29 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.663 0.785 . . . . 0.0 110.98 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.98 -21.27 51.18 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.881 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 214' ' ' TRP . 2.4 mm? -63.02 115.37 4.36 Favored 'General case' 0 C--N 1.364 1.205 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 221' ' ' GLN . 10.3 pt-20 -143.98 148.93 35.98 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.49 0.716 . . . . 0.0 109.556 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.38 135.02 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 122.781 0.433 . . . . 0.0 110.726 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.64 -9.44 77.0 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.633 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.482 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.7 tt0 -85.77 122.48 29.91 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.975 0.51 . . . . 0.0 110.445 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 72.8 t -93.66 114.47 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.482 HG13 ' HG2' ' A' ' 221' ' ' GLN . 13.1 m -126.91 160.27 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.957 0.903 . . . . 0.0 109.237 176.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.545 ' SD ' ' HB3' ' A' ' 238' ' ' TRP . 44.0 ttp -95.16 111.56 23.37 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.869 0.467 . . . . 0.0 110.604 -176.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.571 HD22 HG13 ' A' ' 271' ' ' ILE . 0.8 OUTLIER -111.24 155.62 22.69 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.62 0.768 . . . . 0.0 109.143 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.51 HD22 ' NE ' ' A' ' 235' ' ' ARG . 9.1 p-10 -97.57 121.27 39.28 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.219 1.008 . . . . 0.0 111.009 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.575 ' HB2' ' HA ' ' A' ' 232' ' ' PRO . 6.9 p90 -168.15 155.89 8.37 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.334 1.053 . . . . 0.0 109.801 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -83.27 137.09 42.67 Favored Pre-proline 0 CA--C 1.555 1.157 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 171.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.75 -28.43 68.41 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.0 1.8 . . . . 0.0 111.917 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.64 -30.27 36.65 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.553 0.741 . . . . 0.0 110.918 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -140.81 90.34 9.66 Favored Pre-proline 0 N--CA 1.489 1.51 0 C-N-CA 123.692 0.797 . . . . 0.0 110.174 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.575 ' HA ' ' HB2' ' A' ' 227' ' ' TYR . 38.8 Cg_endo -66.05 -8.24 19.47 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.453 2.102 . . . . 0.0 112.16 170.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.417 ' O ' HD12 ' A' ' 272' ' ' ILE . 21.3 tptm -74.18 -26.78 60.48 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.607 1.163 . . . . 0.0 110.967 173.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -117.19 147.14 42.74 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.332 0.653 . . . . 0.0 110.877 -172.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.51 ' NE ' HD22 ' A' ' 226' ' ' ASN . 3.3 tmt_? -69.0 117.29 10.47 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.656 1.582 . . . . 0.0 109.764 -176.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -134.26 -130.66 3.03 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 123.31 0.381 . . . . 0.0 112.427 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.427 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 42.0 m-85 -83.92 171.23 13.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.675 0.79 . . . . 0.0 110.819 -173.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . 0.545 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 97.6 m95 -91.38 112.38 24.26 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.254 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 68.3 m-85 -126.09 149.12 49.14 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 174.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.5 p-10 -82.44 157.11 23.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.5 ' HA ' HG23 ' A' ' 260' ' ' VAL . . . -162.93 140.76 8.07 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.216 0.606 . . . . 0.0 110.663 -176.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -90.51 118.6 30.1 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.144 0.578 . . . . 0.0 109.885 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.485 HD12 HD11 ' A' ' 255' ' ' LEU . 32.1 mm -62.8 126.36 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.38 0.672 . . . . 0.0 110.413 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.6 t -105.62 -38.47 6.41 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.466 1.106 . . . . 0.0 111.214 -174.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.55 143.25 11.53 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -135.71 143.48 45.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -155.33 114.94 3.67 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -100.13 121.6 41.67 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.8 p -84.64 -170.97 3.37 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 170.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -67.12 -34.63 78.01 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.01 23.79 3.89 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 120.696 0.284 . . . . 0.0 111.232 -171.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -159.35 129.07 5.52 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.261 0.625 . . . . 0.0 110.658 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.472 ' HD2' HG21 ' A' ' 274' ' ' VAL . 36.5 ttm180 -99.58 102.27 13.73 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.2 139.79 30.27 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.485 HD11 HD12 ' A' ' 243' ' ' ILE . 3.3 tm? -147.41 140.31 24.99 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -176.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -122.3 119.69 31.87 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.315 1.046 . . . . 0.0 108.538 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.77 137.15 54.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.81 0.844 . . . . 0.0 110.254 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -81.63 98.29 8.29 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.704 1.202 . . . . 0.0 108.34 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 58.9 t -63.31 134.16 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.857 0.863 . . . . 0.0 110.915 -173.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 241' ' ' ALA . 38.4 t -117.26 107.05 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.33 -151.45 0.26 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.235 1.014 . . . . 0.0 110.078 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -55.11 -71.83 0.66 Allowed Glycine 0 C--N 1.355 1.629 0 C-N-CA 123.066 0.365 . . . . 0.0 113.779 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -123.34 -16.66 6.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.477 0.711 . . . . 0.0 110.302 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -87.59 174.49 8.42 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.782 0.833 . . . . 0.0 111.006 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 65.8 p -153.43 138.3 17.13 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.181 0.593 . . . . 0.0 110.666 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 20.9 mt -108.72 90.91 3.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.991 0.916 . . . . 0.0 108.636 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -67.32 143.69 56.27 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 117.945 0.338 . . . . 0.0 111.113 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 33.1 t70 58.75 75.8 0.38 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.513 1.125 . . . . 0.0 111.748 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 68.8 m -113.48 126.32 55.2 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.413 0.685 . . . . 0.0 109.298 170.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -71.43 113.27 8.29 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.571 HG13 HD22 ' A' ' 225' ' ' LEU . 39.9 mm -94.3 123.58 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.962 0.505 . . . . 0.0 109.844 -174.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 233' ' ' LYS . 59.4 mt -83.76 -36.38 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.221 1.008 . . . . 0.0 110.5 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -96.14 51.15 1.2 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 122.262 1.03 . . . . 0.0 110.574 -167.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.472 HG21 ' HD2' ' A' ' 253' ' ' ARG . 23.9 m -72.14 -16.69 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.696 -1.593 . . . . 0.0 113.292 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.72 -15.07 33.32 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.936 0.494 . . . . 0.0 110.982 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -96.93 4.55 51.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.369 0.668 . . . . 0.0 111.634 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.418 HG13 ' HG ' ' A' ' 225' ' ' LEU . 43.4 t -76.4 146.15 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.36 0.664 . . . . 0.0 111.455 -175.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -126.65 160.16 31.52 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.045 0.938 . . . . 0.0 109.859 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.501 ' HB2' HD11 ' A' ' 212' ' ' ILE . 22.4 ttmm -84.87 149.21 25.84 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.306 0.643 . . . . 0.0 111.77 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 224' ' ' MET . 50.2 mm -92.29 126.78 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 169.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 105.36 13.55 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.334 0.653 . . . . 0.0 110.559 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -93.18 146.06 31.22 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 123.777 0.831 . . . . 0.0 111.153 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -41.94 119.17 1.11 Allowed 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 124.525 3.484 . . . . 0.0 115.005 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 97.0 -51.88 1.44 Allowed Glycine 0 C--N 1.352 1.425 0 O-C-N 123.333 0.396 . . . . 0.0 112.205 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -71.73 -22.85 61.57 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.663 1.185 . . . . 0.0 110.47 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -77.38 78.39 1.46 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.9 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 14.8 m -71.24 146.97 92.92 Favored Pre-proline 0 C--O 1.246 0.896 0 C-N-CA 123.424 0.69 . . . . 0.0 109.911 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.25 157.03 62.89 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.744 2.296 . . . . 0.0 111.245 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 21.0 ttt -83.25 78.18 9.66 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.724 0.774 . . . . 0.0 109.393 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 10.6 p -92.83 -28.43 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.372 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -74.81 162.33 28.76 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.012 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 293' ' ' PRO . 0.1 OUTLIER -49.45 140.5 13.5 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 124.703 1.201 . . . . 0.0 113.539 -167.201 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 292' ' ' ASN . 26.7 Cg_exo -62.12 109.63 0.86 Allowed 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.257 2.638 . . . . 0.0 112.922 -176.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -140.04 143.42 36.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.707 0.803 . . . . 0.0 109.891 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.637 ' HD2' ' HB2' ' A' ' 153' ' ' GLU . 49.4 mtm180 -129.91 -163.43 1.3 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -18.5 26.93 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.247 0.476 . . . . 0.0 110.738 -173.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -131.33 48.44 2.42 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 122.481 1.134 . . . . 0.0 109.398 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.7 p . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 164.924 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.419 ' HA3' ' CE1' ' A' ' 184' ' ' TYR . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 112.238 -0.345 . . . . 0.0 112.238 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.18 -10.04 14.66 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.262 1.025 . . . . 0.0 111.153 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -79.27 121.12 24.69 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -82.08 178.94 8.0 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.93 0.892 . . . . 0.0 111.407 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.14 29.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.708 1.203 . . . . 0.0 112.985 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -140.18 -50.39 0.47 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.528 1.131 . . . . 0.0 109.176 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -68.99 88.91 0.41 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.742 0.417 . . . . 0.0 111.268 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -75.35 138.35 41.7 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.341 172.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 206' ' ' ALA . 17.4 m -123.89 158.87 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.172 1.389 . . . . 0.0 109.854 -172.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -93.04 109.78 21.24 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.74 120.46 34.03 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.69 0.796 . . . . 0.0 111.396 -168.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -72.78 98.86 2.49 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.658 0.783 . . . . 0.0 110.085 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.78 110.34 10.13 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.4 m -66.04 -27.53 68.17 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.032 0.933 . . . . 0.0 112.049 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -62.12 -50.68 70.94 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.973 0.509 . . . . 0.0 111.688 -171.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -102.27 -18.76 15.32 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 122.304 0.242 . . . . 0.0 111.64 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.44 50.63 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.237 0.336 . . . . 0.0 113.628 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.66 152.06 20.9 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.531 0.681 . . . . 0.0 112.554 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -80.06 120.89 24.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.159 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -127.3 115.84 19.62 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -62.27 137.71 58.3 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.621 0.575 . . . . 0.0 109.678 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.487 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -148.31 129.17 14.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.037 0.535 . . . . 0.0 111.384 -165.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -87.29 114.54 23.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.492 0.717 . . . . 0.0 109.705 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 186' ' ' VAL . 58.6 t -66.96 116.06 5.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.558 HG11 ' HE2' ' A' ' 187' ' ' LYS . 33.5 m -117.73 -9.4 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.171 0.588 . . . . 0.0 111.534 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.588 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 2.5 tpm_? -166.82 147.03 5.74 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.46 136.89 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 124.113 0.965 . . . . 0.0 109.655 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.405 HG23 ' HB ' ' A' ' 183' ' ' ILE . 10.2 t -148.77 163.33 37.68 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.323 1.049 . . . . 0.0 109.68 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 59.6 mtt-85 -122.77 170.4 10.11 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -172.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 94.1 mttt . . . . . 0 N--CA 1.479 0.993 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.002 173.653 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -67.61 85.76 0.19 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.815 0.697 . . . . 0.0 109.909 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -79.56 65.41 4.72 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 122.677 1.227 . . . . 0.0 108.202 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.64 177.35 3.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.838 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.3 mp -95.58 108.63 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.599 0.714 . . . . 0.0 109.342 -171.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.419 ' CE1' ' HA3' ' A' ' 133' ' ' GLY . 95.1 m-85 -97.59 107.2 19.65 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.857 1.263 . . . . 0.0 107.834 170.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.588 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 89.0 m-70 -78.77 102.5 8.16 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.487 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 20.9 m -114.92 150.9 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.125 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.558 ' HE2' HG11 ' A' ' 157' ' ' VAL . 45.0 mtmt -117.87 122.83 44.36 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.455 ' HD2' ' HB2' ' A' ' 154' ' ' ALA . 17.1 m-85 -61.61 109.5 1.22 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.104 0.562 . . . . 0.0 111.329 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.3 -35.58 74.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -63.36 -34.73 78.35 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.815 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -155.02 82.07 4.07 Favored Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 124.655 1.182 . . . . 0.0 109.287 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -65.29 -27.34 55.8 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.807 3.005 . . . . 0.0 114.133 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.52 -1.96 17.89 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -75.13 -14.77 60.59 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.837 0.855 . . . . 0.0 111.436 171.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.86 -175.81 54.22 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.439 -0.346 . . . . 0.0 112.571 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.48 116.54 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.95 144.41 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.746 0.818 . . . . 0.0 109.144 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.563 ' HB2' HG23 ' A' ' 183' ' ' ILE . 28.9 pt20 -96.16 132.46 41.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 86.3 mmm -132.71 160.76 35.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.858 0.863 . . . . 0.0 109.193 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -110.88 175.1 5.55 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.882 0.473 . . . . 0.0 109.751 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 70.1 p -57.58 -45.87 84.69 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.673 0.789 . . . . 0.0 111.04 176.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -66.93 -8.49 29.91 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.082 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.31 -41.06 8.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.661 0.785 . . . . 0.0 110.87 173.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.59 132.91 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 112.773 0.656 . . . . 0.0 112.773 -169.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.609 ' HB3' ' HB3' ' A' ' 281' ' ' GLU . 39.5 mmt180 -112.29 155.72 23.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.827 1.251 . . . . 0.0 107.861 167.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.405 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -63.76 167.33 6.05 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.251 0.478 . . . . 0.0 110.87 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.67 95.82 6.7 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.25 97.86 0.13 Allowed 'General case' 0 C--N 1.36 1.023 0 C-N-CA 123.164 0.586 . . . . 0.0 109.841 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.456 ' NH2' ' HB2' ' A' ' 292' ' ' ASN . 3.5 tmt_? -84.45 76.52 10.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -172.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 73.1 m -147.19 119.06 8.11 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.062 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 58.8 mt -85.05 126.75 40.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 279' ' ' LYS . 38.4 mm -96.12 127.91 47.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 124.015 0.926 . . . . 0.0 108.636 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.456 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 0.0 OUTLIER -111.71 179.14 4.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.119 0.967 . . . . 0.0 109.168 -177.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . 0.509 ' HA ' HD12 ' A' ' 217' ' ' LEU . 59.6 t-105 -60.42 -43.15 97.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.284 0.634 . . . . 0.0 110.899 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . 0.505 ' HA ' HE21 ' A' ' 215' ' ' GLN . 0.0 OUTLIER -62.1 -27.38 68.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.042 0.937 . . . . 0.0 111.888 177.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -90.03 -22.48 21.84 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.898 0.479 . . . . 0.0 110.894 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 214' ' ' TRP . 85.7 mt -67.77 112.6 4.94 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -138.29 151.1 47.28 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.607 0.763 . . . . 0.0 109.632 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.9 m -68.87 123.98 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.045 0.538 . . . . 0.0 111.565 -171.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.56 -15.75 49.1 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.732 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.429 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.5 tt0 -79.67 121.39 25.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.941 0.496 . . . . 0.0 109.979 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 45.8 t -93.07 120.21 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.429 HG13 ' HG2' ' A' ' 221' ' ' GLN . 13.2 m -141.01 148.66 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.32 1.048 . . . . 0.0 110.541 -175.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 20.5 ptm -89.82 136.22 33.16 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.273 0.629 . . . . 0.0 110.847 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.54 ' HB3' HG22 ' A' ' 277' ' ' VAL . 0.7 OUTLIER -144.7 144.1 31.05 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.046 0.939 . . . . 0.0 110.4 -174.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.409 ' HB3' ' CE2' ' A' ' 238' ' ' TRP . 10.5 p-10 -71.17 106.01 3.62 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.349 0.66 . . . . 0.0 109.837 174.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -135.31 132.13 37.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.536 HD22 ' HB2' ' A' ' 231' ' ' ASN . 61.1 t30 -105.41 114.89 62.8 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -62.92 -33.77 73.78 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.82 2.347 . . . . 0.0 111.756 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.26 -36.38 82.85 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.053 0.941 . . . . 0.0 111.213 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.536 ' HB2' HD22 ' A' ' 228' ' ' ASN . 38.4 m-80 -143.97 87.32 8.07 Favored Pre-proline 0 N--CA 1.487 1.413 0 C-N-CA 123.793 0.837 . . . . 0.0 109.382 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.86 -9.87 27.52 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.399 2.733 . . . . 0.0 115.104 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -82.83 -27.7 30.69 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.031 0.532 . . . . 0.0 110.984 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -120.95 154.63 35.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.512 0.725 . . . . 0.0 110.257 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -49.14 154.15 0.84 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.006 1.322 . . . . 0.0 113.053 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.61 -148.17 4.9 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.16 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -83.86 148.82 26.76 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.259 1.023 . . . . 0.0 109.699 -174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . 0.437 ' CE2' ' HD2' ' A' ' 296' ' ' ARG . 67.1 m95 -84.3 107.24 16.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.013 0.525 . . . . 0.0 110.54 -171.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -114.52 151.9 32.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.3 p-10 -83.93 146.2 28.16 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 172.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -146.26 137.17 24.33 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.581 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -91.11 119.48 31.28 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.401 HD12 HD11 ' A' ' 255' ' ' LEU . 29.8 mm -60.41 107.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 124.051 0.844 . . . . 0.0 109.388 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.6 t -82.89 -47.66 11.58 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.452 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 65.9 mtt85 -152.86 164.76 37.26 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 125.345 1.458 . . . . 0.0 109.649 -172.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -151.27 136.78 17.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.804 0.441 . . . . 0.0 110.745 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -150.82 115.49 5.2 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.812 0.845 . . . . 0.0 109.439 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -91.74 153.77 19.4 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 68.7 p -130.15 174.88 9.39 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.948 0.899 . . . . 0.0 108.871 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -65.62 -18.65 65.48 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.528 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 26.5 p -103.99 -31.54 9.67 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 123.426 0.691 . . . . 0.0 112.788 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.23 157.28 6.2 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.23 0.538 . . . . 0.0 112.292 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 253' ' ' ARG . 4.3 mpt_? -94.91 101.68 13.48 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -97.81 102.21 13.91 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.124 0.57 . . . . 0.0 110.736 -173.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 3.4 tm? -95.18 143.65 26.43 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 81.2 m-85 -123.03 116.42 23.5 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.23 144.8 31.68 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.984 0.513 . . . . 0.0 110.421 -174.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -81.55 96.87 7.58 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 92.6 t -81.06 107.23 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.699 1.2 . . . . 0.0 109.619 -176.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 16.9 m -89.11 129.8 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.52 0.676 . . . . 0.0 110.361 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 63.9 mt -93.95 -154.87 0.43 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.814 1.246 . . . . 0.0 108.888 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -64.68 -54.45 28.6 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 122.959 0.162 . . . . 0.0 113.122 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -115.95 -46.27 2.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.463 0.705 . . . . 0.0 110.283 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.68 151.01 37.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.819 0.848 . . . . 0.0 111.424 -173.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 15.5 p -120.3 113.63 20.67 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.863 0.865 . . . . 0.0 109.319 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.654 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 81.5 mt -82.27 102.45 11.18 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.232 1.013 . . . . 0.0 109.86 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -75.02 123.8 25.83 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.102 0.561 . . . . 0.0 112.073 -173.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 54.8 46.59 24.21 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.755 1.222 . . . . 0.0 113.128 169.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 81.6 m -67.96 133.1 48.5 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 122.396 0.278 . . . . 0.0 111.184 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 45.1 ttp180 -70.26 107.29 3.67 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.722 0.638 . . . . 0.0 109.8 173.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.459 HG21 HD22 ' A' ' 225' ' ' LEU . 40.7 mm -95.86 111.3 25.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 82.9 mt -84.76 -13.5 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 124.623 1.169 . . . . 0.0 109.884 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -99.86 39.52 1.32 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.352 1.461 . . . . 0.0 110.072 -161.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.506 HG11 ' HZ3' ' A' ' 214' ' ' TRP . 28.8 m -71.74 -13.74 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 114.553 -1.203 . . . . 0.0 113.29 -167.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -86.87 -27.52 23.39 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.295 0.638 . . . . 0.0 110.996 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -93.26 1.26 57.1 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.694 0.797 . . . . 0.0 112.128 -174.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 225' ' ' LEU . 59.2 t -71.12 139.35 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.198 0.599 . . . . 0.0 110.397 -174.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -120.37 160.92 22.08 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.216 1.007 . . . . 0.0 109.93 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.559 ' HB2' HD11 ' A' ' 212' ' ' ILE . 35.8 ttmt -79.66 151.34 30.58 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.715 0.406 . . . . 0.0 111.184 176.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.9 mm -77.54 132.79 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.8 0.84 . . . . 0.0 109.676 172.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 205' ' ' ARG . 1.0 OUTLIER -79.99 105.85 11.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 59.4 mtp85 -120.19 149.76 50.01 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.907 1.283 . . . . 0.0 109.445 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.93 98.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.413 2.742 . . . . 0.0 113.856 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 86.74 -3.96 86.61 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.494 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -119.4 -23.14 6.77 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.734 0.767 . . . . 0.0 111.827 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -92.89 100.6 2.68 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 175.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 11.6 p -64.45 130.29 94.6 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.003 0.521 . . . . 0.0 111.919 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.37 164.47 34.02 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.104 2.536 . . . . 0.0 111.676 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . 0.476 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 44.1 ttm -80.31 85.44 5.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.669 0.747 . . . . 0.0 109.968 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.85 -29.41 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.9 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -85.89 -158.5 0.4 Allowed 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.828 0.851 . . . . 0.0 109.431 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.456 ' HB2' ' NH2' ' A' ' 209' ' ' ARG . 13.3 m120 -58.93 116.87 17.19 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.851 0.86 . . . . 0.0 110.866 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.476 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 25.1 Cg_exo -64.28 112.33 1.87 Allowed 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 123.263 2.642 . . . . 0.0 112.568 -175.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 22.2 ptm -117.63 129.87 56.02 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.729 0.812 . . . . 0.0 110.105 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -97.27 174.5 6.68 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.319 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.437 ' HD2' ' CE2' ' A' ' 238' ' ' TRP . 0.3 OUTLIER -60.37 -50.57 73.08 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.096 173.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.64 -161.69 1.4 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.469 1.508 . . . . 0.0 108.221 173.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 C--O 1.243 0.727 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.699 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.986 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.28 4.05 4.34 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.433 0.693 . . . . 0.0 111.683 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -78.94 159.32 27.76 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.253 0.549 . . . . 0.0 110.289 172.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.465 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -86.19 172.55 10.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.151 0.98 . . . . 0.0 110.814 -174.46 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.5 m -83.62 6.26 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.272 1.029 . . . . 0.0 112.257 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -127.84 8.4 6.27 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.581 0.753 . . . . 0.0 111.175 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 156' ' ' VAL . 19.6 mm-40 -80.9 74.13 7.89 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.888 0.475 . . . . 0.0 111.864 -173.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 8.7 p90 -77.69 98.8 5.6 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.524 0.678 . . . . 0.0 109.434 168.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.497 ' HA ' ' HD2' ' A' ' 207' ' ' ARG . 27.4 m -115.98 179.51 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.141 1.376 . . . . 0.0 108.772 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.16 109.72 21.22 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -92.9 122.95 35.79 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.805 0.842 . . . . 0.0 110.057 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -71.3 110.42 5.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.69 136.06 57.85 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.064 0.946 . . . . 0.0 110.249 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.5 p -74.26 -28.69 61.33 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.685 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.8 -55.5 4.77 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 120.926 0.393 . . . . 0.0 111.502 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.5 ttp -104.5 -18.16 14.47 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.71 0.804 . . . . 0.0 112.472 -170.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.95 18.24 70.36 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 113.981 0.352 . . . . 0.0 113.981 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -94.08 140.66 29.46 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.993 0.517 . . . . 0.0 111.172 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -75.31 119.94 20.1 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -115.22 148.65 38.84 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.506 ' HG2' HH22 ' A' ' 207' ' ' ARG . 8.1 mt-10 -76.84 89.03 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.97 116.95 30.09 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.653 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 53.8 tt0 -89.57 102.67 15.35 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.084 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 59.8 t -57.88 96.35 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 167.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.2 m -95.41 -13.85 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.443 0.697 . . . . 0.0 110.864 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 50.3 ttt85 -163.53 135.62 5.06 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.62 139.66 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.0 p -133.43 159.3 40.76 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 123.827 0.851 . . . . 0.0 108.713 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -96.43 175.57 6.36 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.622 0.769 . . . . 0.0 110.222 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.503 ' HG3' HG12 ' A' ' 182' ' ' VAL . 7.7 mtpm? . . . . . 0 CA--C 1.55 0.964 0 CA-C-O 121.979 0.895 . . . . 0.0 109.847 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 . . . . . 0 C--O 1.243 0.753 0 CA-C-O 121.694 0.759 . . . . 0.0 108.955 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.711 ' HB3' HG22 ' A' ' 182' ' ' VAL . 2.8 mp0 -69.12 99.01 1.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.688 -162.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.06 20.71 1.49 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.26 165.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.711 HG22 ' HB3' ' A' ' 180' ' ' GLU . 12.5 m -73.6 175.0 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 164.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 183' ' ' ILE . 3.1 mp -95.56 110.93 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 O-C-N 121.882 -0.512 . . . . 0.0 110.22 -165.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -95.62 106.49 18.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.003 0.921 . . . . 0.0 108.65 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 14.0 m-70 -79.79 96.55 6.32 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.409 HG12 HG22 ' A' ' 156' ' ' VAL . 13.3 m -109.01 157.73 9.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.475 0.71 . . . . 0.0 109.55 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -130.16 117.82 20.5 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -67.38 116.22 7.9 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.903 0.481 . . . . 0.0 110.638 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 153' ' ' GLU . 34.3 t70 -67.04 -27.1 67.12 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.368 1.067 . . . . 0.0 109.876 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.12 -29.54 62.97 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.929 0.892 . . . . 0.0 111.566 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -141.57 75.31 22.35 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.775 0.83 . . . . 0.0 110.494 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.42 -15.43 49.74 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.942 2.428 . . . . 0.0 112.455 171.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.5 -26.56 67.23 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.997 0.919 . . . . 0.0 111.282 174.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -77.37 -16.43 58.87 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.332 0.653 . . . . 0.0 110.985 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.83 -130.13 22.24 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.86 0.725 . . . . 0.0 112.503 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 6.2 t -101.17 118.25 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.521 0.729 . . . . 0.0 109.112 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 24.5 m -113.6 155.21 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.422 0.689 . . . . 0.0 109.258 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -97.93 130.13 44.81 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.232 0.613 . . . . 0.0 110.043 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 92.1 mmm -131.63 160.61 34.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.445 1.098 . . . . 0.0 108.891 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -95.69 167.2 11.43 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.451 ' OG ' ' HB2' ' A' ' 180' ' ' GLU . 61.6 m -63.93 -39.47 94.22 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.866 0.466 . . . . 0.0 111.537 176.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -63.15 -23.51 67.47 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.703 0.801 . . . . 0.0 112.031 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -83.78 -37.72 22.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.521 0.728 . . . . 0.0 110.649 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 33.1 m -94.56 144.71 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.518 ' HA ' ' HE ' ' A' ' 205' ' ' ARG . 0.0 OUTLIER -140.69 142.92 34.83 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.8 155.49 7.72 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.024 0.93 . . . . 0.0 111.11 177.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.506 HH22 ' HG2' ' A' ' 153' ' ' GLU . 0.8 OUTLIER -128.85 138.42 52.03 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.078 0.466 . . . . 0.0 110.218 -172.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.09 152.74 18.55 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.11 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.411 ' HG3' ' SD ' ' A' ' 294' ' ' MET . 2.6 ttp180 -86.58 6.29 31.55 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 168.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.2 m -83.5 105.1 14.16 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.708 0.803 . . . . 0.0 108.91 -168.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 19.7 mt -85.69 132.73 31.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 279' ' ' LYS . 10.0 mm -105.48 139.07 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 0.0 OUTLIER -109.81 168.28 9.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.535 0.734 . . . . 0.0 109.757 176.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . 0.412 ' CD1' HD23 ' A' ' 255' ' ' LEU . 55.3 t90 -45.38 -46.38 13.18 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.857 1.263 . . . . 0.0 111.936 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -57.52 -34.61 69.29 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.804 1.242 . . . . 0.0 111.961 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.48 -11.44 32.04 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.133 0.973 . . . . 0.0 113.06 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 243' ' ' ILE . 1.5 mm? -73.84 114.41 12.1 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 169.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 12.6 pt-20 -115.77 165.03 13.52 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.621 0.768 . . . . 0.0 109.053 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.9 m -69.0 119.24 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 121.26 0.552 . . . . 0.0 110.361 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.91 -4.45 49.53 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.738 -0.664 . . . . 0.0 113.246 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -70.67 118.42 13.44 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.537 0.735 . . . . 0.0 110.581 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.78 113.39 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.73 150.13 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.938 1.295 . . . . 0.0 109.403 -172.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.666 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 16.0 ptm -97.95 124.69 42.52 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 120.838 0.351 . . . . 0.0 111.34 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.477 ' HB3' HG13 ' A' ' 277' ' ' VAL . 1.3 pt? -144.53 167.53 22.3 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.9 0.88 . . . . 0.0 110.149 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -80.84 135.38 35.93 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.865 0.364 . . . . 0.0 110.759 -169.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.486 ' HD1' ' HB2' ' A' ' 239' ' ' TYR . 58.0 m-85 -144.66 157.42 44.21 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.815 1.246 . . . . 0.0 110.167 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 42.5 t-20 -129.9 110.93 17.17 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 166.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -71.73 -17.91 29.04 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.431 2.088 . . . . 0.0 112.787 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -87.03 -39.66 15.42 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.261 0.624 . . . . 0.0 110.447 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 10.0 m120 -124.35 81.33 58.91 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.213 1.005 . . . . 0.0 108.482 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.91 -11.34 31.78 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.746 2.297 . . . . 0.0 114.317 -170.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -88.9 -4.17 58.54 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.28 0.632 . . . . 0.0 111.267 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -131.51 163.83 27.12 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.635 -0.665 . . . . 0.0 110.275 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 162.46 29.44 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.801 0.84 . . . . 0.0 111.639 174.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.03 -88.66 0.07 OUTLIER Glycine 0 C--O 1.238 0.361 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.376 171.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -130.23 167.57 18.23 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.495 1.118 . . . . 0.0 109.118 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -87.68 113.61 23.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.771 0.428 . . . . 0.0 110.574 -170.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.486 ' HB2' ' HD1' ' A' ' 227' ' ' TYR . 64.0 m-85 -117.51 142.84 46.69 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . 0.666 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 8.3 p-10 -84.27 158.08 21.34 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -153.54 148.02 26.08 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.882 -173.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -96.01 118.26 32.28 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.464 HG13 HD12 ' A' ' 217' ' ' LEU . 36.1 mm -66.94 107.41 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.356 0.662 . . . . 0.0 109.328 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.2 t -81.16 -45.28 16.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.562 0.745 . . . . 0.0 110.267 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -154.11 167.54 29.5 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.626 1.171 . . . . 0.0 109.978 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.45 146.81 23.91 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.714 0.806 . . . . 0.0 109.898 167.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -142.65 115.93 8.97 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.15 0.98 . . . . 0.0 109.17 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.83 144.05 25.67 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 175.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.6 p -126.9 169.93 12.77 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 169.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -61.26 -34.07 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.883 0.473 . . . . 0.0 110.448 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 75.0 p -87.22 -29.67 21.53 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.449 -171.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -166.66 153.9 9.32 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.891 0.477 . . . . 0.0 111.616 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -104.06 105.78 16.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.738 0.815 . . . . 0.0 109.883 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.03 144.95 25.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.552 0.741 . . . . 0.0 110.099 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.802 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.3 OUTLIER -135.87 146.74 47.75 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -175.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -135.03 120.66 19.39 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.54 ' HB3' HD11 ' A' ' 271' ' ' ILE . . . -136.01 161.27 36.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.497 0.665 . . . . 0.0 111.653 -175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -100.67 94.12 5.93 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 46.4 t -77.34 106.19 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.02 0.928 . . . . 0.0 110.068 -171.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 34.7 m -89.54 118.43 34.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 122.245 1.022 . . . . 0.0 110.201 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.403 HD12 ' HB2' ' A' ' 264' ' ' ASP . 31.2 mt -96.57 -153.08 0.4 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 113.888 -1.505 . . . . 0.0 108.173 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.5 -52.07 32.82 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 117.708 0.231 . . . . 0.0 113.278 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -122.23 -36.21 3.0 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.022 0.929 . . . . 0.0 110.611 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.403 ' HB2' HD12 ' A' ' 261' ' ' LEU . 3.8 m-20 -89.11 157.92 18.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.264 1.025 . . . . 0.0 110.858 -174.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 67.2 p -135.2 113.83 11.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.542 0.737 . . . . 0.0 109.124 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.554 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 23.9 mt -81.73 86.68 6.39 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.773 0.829 . . . . 0.0 108.888 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -69.34 142.4 54.03 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.237 0.615 . . . . 0.0 111.659 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 57.41 17.69 3.95 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.569 1.148 . . . . 0.0 113.823 170.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.554 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 94.5 m -66.73 142.9 57.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.326 0.65 . . . . 0.0 111.04 -176.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -70.03 133.79 47.59 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.948 0.78 . . . . 0.0 110.821 -176.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.802 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 10.3 mm -107.02 128.46 61.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 46.3 mt -98.3 -24.51 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 123.862 0.865 . . . . 0.0 109.025 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.555 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 67.7 m-85 -91.69 47.91 1.41 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.69 1.196 . . . . 0.0 110.14 -176.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 27.5 m -65.35 -26.37 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.518 1.127 . . . . 0.0 112.92 -171.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 52.7 m-20 -110.27 -7.98 14.78 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.174 0.589 . . . . 0.0 110.984 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 15.5 mm-40 -94.09 24.69 4.16 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.907 0.883 . . . . 0.0 110.734 -175.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.56 ' HB ' ' HB ' ' A' ' 212' ' ' ILE . 19.4 t -89.61 153.63 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.155 0.982 . . . . 0.0 110.001 -174.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -129.21 156.19 44.34 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.123 0.969 . . . . 0.0 108.79 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.566 ' HB2' HD11 ' A' ' 212' ' ' ILE . 54.2 tttm -89.76 146.2 24.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.112 0.565 . . . . 0.0 110.925 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 44.3 mm -72.49 122.78 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 168.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -106.17 112.8 25.98 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 285' ' ' GLU . 59.8 mtt85 -103.3 107.26 55.1 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -25.41 94.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.38 2.227 1 C-N-CA 125.307 4.005 . . . . 0.0 117.196 -156.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 104.72 6.99 39.94 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 118.231 -1.316 . . . . 0.0 116.275 172.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 282' ' ' ARG . 0.2 OUTLIER -103.26 -25.04 13.48 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 120.236 2.018 . . . . 0.0 111.452 173.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -106.64 -177.66 23.12 Favored Glycine 0 C--O 1.245 0.821 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 172.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 13.5 m -76.26 144.44 74.84 Favored Pre-proline 0 CA--C 1.554 1.129 0 CA-C-N 116.991 0.396 . . . . 0.0 111.208 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.13 175.93 6.21 Favored 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 123.356 2.704 . . . . 0.0 112.337 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 43.5 ttm -82.8 95.43 7.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 170.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 14.4 p -125.83 19.29 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.944 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -154.42 -167.04 2.5 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.61 -169.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -44.27 121.38 3.99 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 125.597 1.559 . . . . 0.0 113.073 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -45.53 113.0 0.46 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 124.596 3.53 . . . . 0.0 114.784 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . 0.411 ' SD ' ' HG3' ' A' ' 209' ' ' ARG . 88.0 mmm -78.04 97.34 5.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.207 0.603 . . . . 0.0 110.579 -176.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -128.07 113.13 15.39 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 172.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.77 123.09 11.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.336 1.454 . . . . 0.0 110.531 -169.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -101.59 -31.29 10.91 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.9 0.88 . . . . 0.0 109.112 167.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 33.5 p . . . . . 0 CA--C 1.543 0.686 0 C-N-CA 124.247 1.019 . . . . 0.0 110.196 -178.523 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.504 ' HA3' HG21 ' A' ' 159' ' ' VAL . . . . . . . . 0 N--CA 1.476 1.332 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 6.96 0.5 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.655 0.782 . . . . 0.0 112.092 -176.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.575 ' HB2' ' CE1' ' A' ' 184' ' ' TYR . 34.7 m-85 -126.21 149.92 48.71 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.128 0.49 . . . . 0.0 110.924 172.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -94.03 172.69 8.07 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.871 1.268 . . . . 0.0 110.12 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.52 4.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.235 1.014 . . . . 0.0 113.124 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -106.09 -18.04 14.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.1 0.96 . . . . 0.0 110.908 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -75.33 92.63 2.8 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-O 121.579 0.704 . . . . 0.0 111.726 -166.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 8.1 p90 -55.13 105.17 0.15 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.8 165.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 28.0 m -116.01 -174.79 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.903 0.881 . . . . 0.0 109.931 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.733 ' HB3' ' HB3' ' A' ' 205' ' ' ARG . 33.9 t0 -110.73 160.49 16.67 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 171.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -140.72 105.86 5.0 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.638 0.775 . . . . 0.0 109.536 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.97 116.58 11.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.027 1.331 . . . . 0.0 109.33 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -85.59 116.69 24.03 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.7 0.8 . . . . 0.0 110.937 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.4 p -74.14 -33.48 63.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.556 1.142 . . . . 0.0 111.201 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.43 -52.59 57.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.318 0.647 . . . . 0.0 112.008 -171.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.408 ' HG2' ' HE1' ' A' ' 239' ' ' TYR . 38.1 ttp -102.75 -8.32 20.94 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.924 0.49 . . . . 0.0 111.1 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.15 18.86 70.93 Favored Glycine 0 C--N 1.358 1.756 0 CA-C-O 121.385 0.436 . . . . 0.0 112.246 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -96.32 174.7 6.74 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.057 0.943 . . . . 0.0 111.458 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -126.47 119.2 26.6 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -109.81 119.18 38.54 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.69 152.12 31.85 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.427 ' HA ' ' H ' ' A' ' 189' ' ' ASP . . . -153.95 -177.47 6.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.199 0.6 . . . . 0.0 111.57 -167.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 64.8 tt0 -151.64 120.72 6.7 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.152 172.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.49 126.02 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.769 0.828 . . . . 0.0 110.149 171.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.414 HG11 ' HE2' ' A' ' 187' ' ' LYS . 12.8 m -120.74 -6.08 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.121 0.568 . . . . 0.0 110.69 173.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 37.4 ttm180 -169.9 156.2 6.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.775 0.83 . . . . 0.0 110.639 174.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.504 HG21 ' HA3' ' A' ' 133' ' ' GLY . 1.7 p -132.96 127.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.22 1.008 . . . . 0.0 109.862 173.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.3 p -125.86 162.6 24.8 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.345 1.458 . . . . 0.0 109.319 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -107.38 177.21 4.91 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.45 0.7 . . . . 0.0 109.179 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.562 ' HD3' HD11 ' A' ' 183' ' ' ILE . 73.7 mmtt . . . . . 0 N--CA 1.5 2.07 0 C-N-CA 123.31 0.644 . . . . 0.0 112.599 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 C--O 1.237 0.441 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 201' ' ' SER . 26.9 mp0 -76.23 79.69 3.01 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 175.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -110.51 11.93 22.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.507 0.723 . . . . 0.0 109.724 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.27 149.09 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.328 0.651 . . . . 0.0 110.224 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.562 HD11 ' HD3' ' A' ' 162' ' ' LYS . 3.7 mp -95.75 109.59 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.003 0.521 . . . . 0.0 110.119 -167.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 58.3 m-85 -88.76 132.18 34.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.182 0.993 . . . . 0.0 111.033 173.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 30.6 m-70 -92.16 97.0 10.64 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.72 145.5 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.517 0.727 . . . . 0.0 110.447 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.414 ' HE2' HG11 ' A' ' 157' ' ' VAL . 45.2 mtmt -104.64 128.58 52.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -67.62 117.99 10.3 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.175 0.512 . . . . 0.0 111.088 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.427 ' H ' ' HA ' ' A' ' 154' ' ' ALA . 27.6 t70 -60.03 -30.2 69.01 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.846 1.258 . . . . 0.0 110.656 173.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.748 ' HA ' ' HD2' ' A' ' 297' ' ' LYS . 5.6 t70 -81.82 -30.18 32.3 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.209 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -138.48 81.17 25.14 Favored Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 123.082 0.553 . . . . 0.0 110.098 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.33 -21.9 46.78 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.593 2.195 . . . . 0.0 111.589 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.35 -26.48 68.77 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.411 1.084 . . . . 0.0 111.79 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -77.27 -20.11 55.55 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.821 0.449 . . . . 0.0 110.325 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 72.21 -154.23 50.43 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.58 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.3 t -79.46 117.39 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.564 0.746 . . . . 0.0 109.381 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.38 151.87 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.276 1.03 . . . . 0.0 109.38 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -88.48 129.29 35.48 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 90.8 mmm -147.23 126.8 13.28 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.699 1.2 . . . . 0.0 108.383 -174.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -68.18 160.8 28.39 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.631 ' HA ' HG22 ' A' ' 204' ' ' VAL . 20.6 t -69.32 -28.23 66.06 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.969 0.414 . . . . 0.0 111.048 -173.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -67.62 -32.22 72.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.038 0.935 . . . . 0.0 110.022 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.59 -19.84 32.41 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.078 0.951 . . . . 0.0 111.211 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.631 HG22 ' HA ' ' A' ' 201' ' ' SER . 7.8 m -96.68 157.87 3.21 Favored 'Isoleucine or valine' 0 C--N 1.356 0.882 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.733 ' HB3' ' HB3' ' A' ' 142' ' ' ASP . 0.5 OUTLIER -145.66 -178.63 6.19 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -165.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.444 ' HB3' ' HG3' ' A' ' 281' ' ' GLU . . . -98.51 143.82 28.52 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 166.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.43 HH11 ' HB2' ' A' ' 140' ' ' TYR . 57.2 mtp180 -70.32 96.56 1.14 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.164 0.585 . . . . 0.0 109.817 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.44 103.36 0.15 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.72 0.808 . . . . 0.0 110.955 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -82.86 -1.88 53.19 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.813 1.245 . . . . 0.0 111.632 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.0 m -94.46 119.93 33.93 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.843 0.857 . . . . 0.0 110.918 -176.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.4 mt -86.84 130.76 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.308 0.643 . . . . 0.0 109.284 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 39.7 mm -92.32 98.07 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.462 ' HD3' ' H ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -58.05 156.52 9.29 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.151 0.98 . . . . 0.0 111.439 174.21 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . 0.415 ' CZ2' ' HB2' ' A' ' 246' ' ' LYS . 79.9 t90 -57.26 -40.34 77.49 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.714 -167.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -65.39 -29.83 70.58 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.871 0.468 . . . . 0.0 111.297 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.35 -15.49 49.75 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.043 0.937 . . . . 0.0 111.723 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.1 mt -65.84 114.31 4.99 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 169.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . 0.432 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 11.1 pt-20 -119.0 168.03 11.2 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.219 1.007 . . . . 0.0 109.354 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.87 115.95 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-O 121.3 0.571 . . . . 0.0 109.541 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.19 -1.4 56.19 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.585 -174.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.563 ' HG3' HG13 ' A' ' 223' ' ' VAL . 6.2 tp-100 -67.55 120.58 14.21 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.969 0.508 . . . . 0.0 110.856 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.534 HG12 HG13 ' A' ' 280' ' ' ILE . 97.1 t -97.55 111.89 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.563 HG13 ' HG3' ' A' ' 221' ' ' GLN . 12.9 m -132.1 -174.76 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.219 1.408 . . . . 0.0 109.505 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 20.3 ptm -135.15 143.92 46.77 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.46 0.704 . . . . 0.0 109.447 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.51 159.89 42.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.779 0.832 . . . . 0.0 111.336 -169.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -90.31 106.94 18.83 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 173.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -145.48 138.73 26.34 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -172.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 46.4 t-20 -89.16 121.22 69.7 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.6 -19.74 21.19 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.562 2.175 . . . . 0.0 112.394 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -88.88 -39.16 14.01 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.468 0.707 . . . . 0.0 110.282 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 29.4 m-80 -119.97 101.93 47.11 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.443 0.697 . . . . 0.0 110.027 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -61.28 -26.57 82.12 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.803 2.336 . . . . 0.0 113.231 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -78.44 -27.05 46.44 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.764 0.825 . . . . 0.0 111.385 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 231' ' ' ASN . 8.6 tp10 -107.05 151.52 25.23 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.252 0.621 . . . . 0.0 111.144 -170.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -76.26 152.34 36.54 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.572 0.749 . . . . 0.0 109.192 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -139.04 -106.86 0.72 Allowed Glycine 0 N--CA 1.47 0.907 0 C-N-CA 121.674 -0.298 . . . . 0.0 112.77 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -128.35 170.52 12.99 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . 0.437 ' CE2' ' HB3' ' A' ' 296' ' ' ARG . 81.8 m95 -80.2 105.81 11.75 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.36 0.664 . . . . 0.0 110.917 -175.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.408 ' HE1' ' HG2' ' A' ' 148' ' ' MET . 76.1 m-85 -118.42 165.04 14.37 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.64 1.176 . . . . 0.0 108.449 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -97.34 142.92 28.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.0 0.52 . . . . 0.0 110.121 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' A' ' 257' ' ' ALA . . . -137.09 155.07 50.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.328 1.051 . . . . 0.0 111.12 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -110.91 117.53 33.63 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.632 HD12 HD11 ' A' ' 255' ' ' LEU . 33.0 mm -69.86 107.82 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.678 0.791 . . . . 0.0 109.012 -173.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.3 p -84.33 -32.71 24.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.468 0.707 . . . . 0.0 111.944 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -160.33 158.35 29.56 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.692 0.397 . . . . 0.0 110.914 -176.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.415 ' HB2' ' CZ2' ' A' ' 214' ' ' TRP . 60.8 pttt -154.62 148.78 25.9 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.36 0.664 . . . . 0.0 112.076 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -155.8 149.93 25.57 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.483 1.113 . . . . 0.0 108.671 173.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -129.72 139.87 51.23 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 119.564 1.075 . . . . 0.0 112.26 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.4 p -119.67 170.28 9.34 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 165.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -67.92 -32.88 73.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.824 0.449 . . . . 0.0 110.606 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 73.5 p -90.99 -19.71 22.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.246 1.019 . . . . 0.0 112.581 -172.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.69 155.44 21.66 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -171.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -108.53 132.96 53.31 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 173.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -102.25 128.82 48.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.274 1.03 . . . . 0.0 108.427 172.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -149.87 137.08 19.69 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -127.05 136.36 52.08 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' A' ' 241' ' ' ALA . . . -147.24 140.8 25.55 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.197 0.599 . . . . 0.0 110.697 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.47 HD22 ' N ' ' A' ' 258' ' ' ASN . 0.8 OUTLIER -79.51 94.98 5.7 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 49.0 t -78.24 105.66 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 28.8 t -86.35 124.02 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.48 HD12 ' HB2' ' A' ' 264' ' ' ASP . 54.9 mt -103.16 -171.4 1.94 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.031 0.932 . . . . 0.0 109.032 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.08 -39.81 92.93 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 113.953 0.341 . . . . 0.0 113.953 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -121.77 -40.9 2.5 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.984 0.913 . . . . 0.0 109.255 173.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.48 ' HB2' HD12 ' A' ' 261' ' ' LEU . 21.5 m-20 -83.53 167.54 17.28 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.93 -173.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 54.7 p -145.53 114.21 6.81 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.617 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 61.9 mt -78.73 78.21 5.18 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -70.72 124.61 24.7 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.791 -170.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . 0.442 ' H ' ' ND2' ' A' ' 258' ' ' ASN . 36.8 t70 61.66 26.11 15.85 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.07 1.348 . . . . 0.0 111.603 173.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 94.9 m -73.47 133.62 43.71 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.709 -177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 -65.7 130.28 42.75 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.641 0.588 . . . . 0.0 110.493 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.9 mm -103.29 116.9 47.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.318 0.647 . . . . 0.0 109.555 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 61.9 mt -82.5 -45.45 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.685 173.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -89.58 64.44 6.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.951 0.9 . . . . 0.0 110.215 -168.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 30.5 m -78.84 -14.96 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.393 -174.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -90.63 -14.75 31.77 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.551 0.74 . . . . 0.0 111.047 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -96.98 43.6 1.07 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.098 0.959 . . . . 0.0 109.428 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.92 113.45 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.093 0.957 . . . . 0.0 109.737 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.41 ' HE2' ' HG3' ' A' ' 294' ' ' MET . 51.8 m-85 -94.61 164.92 12.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.014 0.926 . . . . 0.0 110.826 170.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -78.26 144.74 35.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.238 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.534 HG13 HG12 ' A' ' 222' ' ' VAL . 31.6 mm -73.42 113.57 11.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 164.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.444 ' HG3' ' HB3' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -78.97 125.52 29.48 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 170.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -109.16 104.92 56.34 Favored Pre-proline 0 N--CA 1.477 0.887 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -23.57 98.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.03 1 C-N-CA 125.751 4.3 . . . . 0.0 116.496 -151.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.23 60.21 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.577 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -78.2 -26.13 47.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.245 0.618 . . . . 0.0 110.24 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -134.79 160.44 24.27 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.838 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 12.4 m -91.04 159.01 40.79 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.552 0.741 . . . . 0.0 110.339 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.91 -155.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.62 2.214 . . . . 0.0 110.632 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . 0.532 ' HB3' ' HB3' ' A' ' 293' ' ' PRO . 24.6 mmt -76.87 78.37 3.46 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 121.538 0.685 . . . . 0.0 109.534 177.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 13.6 p -106.78 -8.87 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.015 0.926 . . . . 0.0 109.933 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -122.32 -153.13 0.54 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.74 112.02 3.57 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.464 1.029 . . . . 0.0 109.709 167.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.532 ' HB3' ' HB3' ' A' ' 289' ' ' MET . 84.6 Cg_endo -76.17 137.21 18.95 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.051 1.834 . . . . 0.0 111.221 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . 0.41 ' HG3' ' HE2' ' A' ' 278' ' ' PHE . 21.0 mmt -80.85 -49.45 11.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.148 0.579 . . . . 0.0 109.661 174.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 55.57 106.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.288 1.435 . . . . 0.0 110.627 -166.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.437 ' HB3' ' CE2' ' A' ' 238' ' ' TRP . 16.9 mtm180 -62.36 -33.41 74.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.989 0.915 . . . . 0.0 111.061 -177.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.748 ' HD2' ' HA ' ' A' ' 190' ' ' ASP . 51.5 tttp -64.26 92.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 37.2 t . . . . . 0 CA--C 1.541 0.625 0 C-N-CA 123.411 0.684 . . . . 0.0 110.48 -172.524 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.443 ' HA3' HG21 ' A' ' 159' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.465 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -109.39 9.78 25.54 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.555 0.742 . . . . 0.0 112.104 -170.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -125.91 144.87 50.5 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.391 0.676 . . . . 0.0 109.623 174.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.45 -177.6 3.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.635 0.774 . . . . 0.0 110.317 176.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.5 m -60.13 -6.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 125.205 1.402 . . . . 0.0 114.712 -173.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -110.63 -3.69 15.77 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.776 0.83 . . . . 0.0 112.032 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -86.39 88.52 7.65 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.352 0.596 . . . . 0.0 112.42 -171.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.657 ' HB3' ' HG2' ' A' ' 155' ' ' GLN . 31.0 p90 -75.86 102.1 5.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.052 0.929 . . . . 0.0 109.325 165.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.1 m -114.07 -165.84 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.526 1.53 . . . . 0.0 107.751 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.21 123.26 42.81 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.345 0.52 . . . . 0.0 111.825 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.23 103.36 16.05 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.555 171.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.8 108.25 8.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -82.38 115.8 21.58 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.5 m -81.54 -15.43 54.88 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.81 0.844 . . . . 0.0 111.846 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -67.71 -51.91 43.9 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 23.1 ptp -96.65 -25.49 15.55 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.917 0.487 . . . . 0.0 110.934 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.55 18.22 33.63 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-O 119.991 -0.339 . . . . 0.0 113.836 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -99.68 168.51 9.89 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.669 0.747 . . . . 0.0 112.491 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -116.01 120.75 40.15 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 125.284 1.434 . . . . 0.0 107.63 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.9 127.18 54.0 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.19 103.5 0.39 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.484 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -101.95 117.42 34.79 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.828 0.851 . . . . 0.0 110.265 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.657 ' HG2' ' HB3' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -87.42 104.92 16.91 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.028 0.931 . . . . 0.0 109.165 -178.162 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.42 HG22 HG12 ' A' ' 186' ' ' VAL . 82.6 t -62.89 102.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.653 0.781 . . . . 0.0 109.501 172.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.0 -10.07 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 122.848 0.459 . . . . 0.0 110.983 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -170.5 143.29 2.23 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.839 0.856 . . . . 0.0 109.269 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.443 HG21 ' HA3' ' A' ' 133' ' ' GLY . 6.8 p -115.09 139.26 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 166.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 20.5 p -131.96 150.68 52.09 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.398 1.079 . . . . 0.0 108.583 172.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -66.97 147.21 53.52 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 171.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.41 ' HA ' HG13 ' A' ' 183' ' ' ILE . 87.5 tttt . . . . . 0 N--CA 1.485 1.31 0 C-N-CA 123.541 0.736 . . . . 0.0 112.74 -171.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 C--O 1.24 0.566 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -86.5 67.93 10.04 Favored 'General case' 0 C--O 1.248 1.015 0 CA-C-O 121.698 0.761 . . . . 0.0 109.235 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -84.37 61.05 6.36 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.2 m -115.45 173.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.449 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.41 HG13 ' HA ' ' A' ' 162' ' ' LYS . 45.2 mt -96.26 108.29 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.218 0.532 . . . . 0.0 109.99 -170.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -93.36 112.08 23.9 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.978 0.911 . . . . 0.0 108.631 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -78.25 89.97 4.32 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 175.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.484 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 29.3 m -110.46 151.68 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.288 -177.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -120.41 148.83 43.27 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 170.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -68.36 107.82 2.99 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -58.38 -34.55 70.83 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.406 0.682 . . . . 0.0 110.635 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -78.15 -23.77 47.61 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.379 0.672 . . . . 0.0 111.525 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -137.22 67.43 54.51 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.758 -0.589 . . . . 0.0 109.957 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.7 -17.57 42.51 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.969 2.446 . . . . 0.0 112.269 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.79 -13.78 62.41 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.58 1.552 . . . . 0.0 112.667 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -85.03 -21.21 29.52 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.748 0.419 . . . . 0.0 111.11 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 90.31 -157.19 25.62 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.545 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.8 t -92.17 118.67 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.894 0.878 . . . . 0.0 110.634 -172.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.6 m -109.41 156.38 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.368 1.067 . . . . 0.0 109.703 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -103.91 134.04 47.87 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.153 0.581 . . . . 0.0 110.919 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 82.7 mmm -136.83 167.05 22.19 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.575 1.15 . . . . 0.0 109.305 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.448 ' O ' HG22 ' A' ' 204' ' ' VAL . 21.1 m-80 -109.83 171.41 7.46 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.722 0.809 . . . . 0.0 109.639 174.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 43.4 m -61.32 -37.03 81.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 118.64 0.655 . . . . 0.0 111.566 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -16.59 61.57 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.453 176.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -96.66 -50.1 4.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.826 0.85 . . . . 0.0 110.681 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 200' ' ' ASN . 7.9 m -96.34 115.77 36.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 CA-C-O 122.004 0.907 . . . . 0.0 109.917 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -125.9 139.22 53.65 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.799 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.4 126.3 26.69 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.504 ' NH1' ' HB2' ' A' ' 296' ' ' ARG . 4.0 ptm180 -74.19 161.53 29.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.561 0.744 . . . . 0.0 112.215 -174.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 287' ' ' SER . . . -83.1 125.56 31.62 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.383 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.36 66.38 4.69 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 164.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.6 m -145.42 109.18 4.74 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.803 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.9 mt -85.93 129.07 38.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 123.077 0.551 . . . . 0.0 110.014 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.611 HD11 ' HE3' ' A' ' 279' ' ' LYS . 26.3 mm -101.51 148.12 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.791 1.237 . . . . 0.0 108.603 174.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 175.72 8.57 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.286 0.634 . . . . 0.0 110.27 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -54.28 -51.92 63.06 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -166.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -72.68 -19.56 61.4 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.24 -21.48 29.05 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.942 0.897 . . . . 0.0 109.954 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.463 HD22 HD11 ' A' ' 243' ' ' ILE . 90.5 mt -71.37 128.76 36.94 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -143.55 158.17 43.86 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.785 0.434 . . . . 0.0 110.572 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.0 127.28 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 123.912 0.757 . . . . 0.0 111.428 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.23 -25.7 25.95 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.013 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -72.95 122.12 21.16 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.32 0.648 . . . . 0.0 110.159 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.505 HG13 ' NH2' ' A' ' 282' ' ' ARG . 1.8 p -108.72 125.15 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.326 0.651 . . . . 0.0 110.308 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 280' ' ' ILE . 3.8 m -135.31 177.27 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 125.422 1.489 . . . . 0.0 109.912 -175.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 16.8 ptm -108.19 120.76 43.28 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.185 0.594 . . . . 0.0 110.702 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.676 ' HG ' HG13 ' A' ' 277' ' ' VAL . 0.4 OUTLIER -127.86 148.88 50.48 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.704 0.802 . . . . 0.0 108.91 -176.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -88.51 116.85 27.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.803 0.841 . . . . 0.0 111.734 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.523 ' HE1' ' HB2' ' A' ' 225' ' ' LEU . 4.9 p90 -163.69 142.45 7.88 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.156 0.982 . . . . 0.0 108.648 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.409 HD22 ' HB3' ' A' ' 230' ' ' ASP . 6.3 p-10 -85.92 131.12 47.93 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 168.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.18 -19.77 66.36 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.25 1.967 . . . . 0.0 113.253 -171.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.409 ' HB3' HD22 ' A' ' 228' ' ' ASN . 17.2 t70 -66.57 -42.89 86.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.245 0.618 . . . . 0.0 110.154 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -130.06 89.1 46.44 Favored Pre-proline 0 N--CA 1.47 0.548 0 C-N-CA 123.608 0.763 . . . . 0.0 109.181 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.21 -6.97 17.51 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.616 2.211 . . . . 0.0 113.072 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.52 -29.35 46.48 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.243 0.617 . . . . 0.0 111.595 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.82 151.62 44.98 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.869 0.467 . . . . 0.0 110.237 -176.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 227' ' ' TYR . 7.0 ppt_? -66.72 161.79 22.74 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.814 0.846 . . . . 0.0 112.639 -175.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -165.57 -84.4 0.05 OUTLIER Glycine 0 C--N 1.338 0.684 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.388 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.454 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 30.1 m-85 -119.27 149.15 42.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.72 0.808 . . . . 0.0 109.224 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -88.36 104.43 16.76 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 95.5 m-85 -108.38 160.85 15.55 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.145 0.578 . . . . 0.0 110.367 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -81.48 119.23 23.48 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.676 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.467 ' HB3' HD13 ' A' ' 225' ' ' LEU . . . -126.82 136.56 52.53 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -99.36 123.17 43.41 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.608 HD12 HD11 ' A' ' 255' ' ' LEU . 19.5 mm -64.84 110.37 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.9 t -78.93 -36.42 41.79 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.278 -177.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -170.22 158.79 6.98 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.782 0.833 . . . . 0.0 109.52 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -143.43 136.21 27.52 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 254' ' ' GLU . 4.0 ptm180 -145.61 125.41 13.44 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -92.15 137.67 32.17 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.9 p -116.0 176.62 5.01 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 170.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -58.7 -39.71 81.52 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.7 p -127.84 13.5 6.86 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.6 159.98 37.62 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.244 0.474 . . . . 0.0 111.314 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -122.35 108.76 13.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.106 0.962 . . . . 0.0 108.825 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . 0.475 ' HB2' ' HG3' ' A' ' 247' ' ' ARG . 3.7 mp0 -90.88 99.1 12.19 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.608 HD11 HD12 ' A' ' 243' ' ' ILE . 2.1 tm? -100.23 121.34 41.31 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 176.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -107.23 132.14 53.4 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.05 122.32 12.28 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.28 0.632 . . . . 0.0 109.948 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -76.35 99.93 4.98 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 94.4 t -69.26 107.12 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.734 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 9.2 m -87.4 104.46 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 36.4 mt -81.93 -160.04 0.33 Allowed 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.684 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.43 -47.8 33.52 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-O 120.994 0.219 . . . . 0.0 112.979 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -122.3 -32.29 3.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.126 0.971 . . . . 0.0 111.044 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -101.44 171.56 7.5 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.666 0.787 . . . . 0.0 110.567 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 58.7 m -144.61 121.97 11.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.779 0.832 . . . . 0.0 109.816 171.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 72.2 mt -80.97 113.18 19.0 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.858 0.863 . . . . 0.0 109.562 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.69 109.47 4.38 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.513 0.725 . . . . 0.0 111.423 -173.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.79 57.69 4.56 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.735 1.214 . . . . 0.0 112.873 171.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 42.7 t -65.03 125.24 24.3 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 36.6 ttt180 -71.82 123.33 22.42 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.6 mm -100.03 122.4 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.32 0.648 . . . . 0.0 109.804 -175.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 65.4 mt -92.06 -14.29 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 124.451 1.1 . . . . 0.0 109.649 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -89.09 20.63 3.56 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.239 1.416 . . . . 0.0 111.494 -168.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 28.9 m -69.09 -4.51 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.757 1.223 . . . . 0.0 114.101 -166.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -94.19 -33.49 13.28 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.687 0.395 . . . . 0.0 111.228 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -128.72 48.62 2.3 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.77 0.795 . . . . 0.0 110.193 -173.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.676 HG13 ' HG ' ' A' ' 225' ' ' LEU . 59.4 t -74.7 154.01 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.426 169.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -119.92 149.8 41.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.611 ' HE3' HD11 ' A' ' 212' ' ' ILE . 26.4 ttmt -80.14 151.4 29.79 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.662 174.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 223' ' ' VAL . 36.1 mm -76.93 126.41 37.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 168.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.669 ' HA ' ' HA3' ' A' ' 286' ' ' GLY . 0.6 OUTLIER -71.26 108.57 4.81 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.671 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 90.2 mtt-85 -123.06 153.69 64.46 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.783 1.233 . . . . 0.0 108.566 -176.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.16 96.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.091 2.527 . . . . 0.0 113.557 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.28 -34.91 5.26 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.229 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 10.5 tp10 -85.97 -27.37 24.92 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.677 0.391 . . . . 0.0 111.902 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -108.93 136.59 13.65 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -175.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 208' ' ' ALA . 3.3 m -96.24 144.98 28.77 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 117.259 0.53 . . . . 0.0 110.093 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -88.23 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.033 2.489 . . . . 0.0 111.765 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 17.4 mmt -80.66 78.92 7.37 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.1 -26.77 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.334 1.054 . . . . 0.0 110.146 -175.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -125.89 -160.08 0.95 Allowed 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -44.73 106.51 0.54 Allowed Pre-proline 0 N--CA 1.489 1.496 0 CA-C-N 119.743 1.156 . . . . 0.0 112.293 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.404 ' HB2' ' OH ' ' A' ' 140' ' ' TYR . 7.0 Cg_exo -73.82 84.52 1.44 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.164 2.576 . . . . 0.0 111.252 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 25.0 ptm -66.2 140.97 58.21 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.14 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -85.16 159.64 20.09 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.504 ' HB2' ' NH1' ' A' ' 207' ' ' ARG . 23.1 ttp-105 -128.12 10.57 6.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.567 0.747 . . . . 0.0 109.837 -175.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -51.8 131.94 31.05 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.791 1.636 . . . . 0.0 111.139 172.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.548 0.871 0 C-N-CA 123.081 0.552 . . . . 0.0 109.902 -177.402 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.401 HD13 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -120.18 -18.57 8.01 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.258 0.623 . . . . 0.0 111.397 175.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -99.78 143.45 29.99 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 136' ' ' LYS . 6.3 mptt -97.87 179.32 4.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.494 1.117 . . . . 0.0 110.472 -170.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -68.74 -17.81 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 124.767 1.227 . . . . 0.0 112.161 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -116.41 16.29 15.68 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.253 0.621 . . . . 0.0 110.976 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.43 ' HG3' HG13 ' A' ' 141' ' ' VAL . 11.3 tp10 -97.21 89.43 4.76 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.341 0.591 . . . . 0.0 110.17 -173.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.624 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 22.8 p90 -82.18 100.23 9.72 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.69 0.757 . . . . 0.0 111.179 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.43 HG13 ' HG3' ' A' ' 139' ' ' GLU . 34.1 m -114.88 169.14 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.721 0.808 . . . . 0.0 109.221 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -87.93 113.88 24.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.136 0.493 . . . . 0.0 111.296 -169.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.38 109.41 19.54 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 170.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.564 HH22 HG12 ' A' ' 260' ' ' VAL . 26.3 ttt180 -74.9 113.68 12.49 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.497 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.89 134.89 35.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.431 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.6 p -77.04 -36.51 56.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.472 0.709 . . . . 0.0 111.494 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -65.03 -45.1 86.84 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.189 0.595 . . . . 0.0 110.847 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 54.0 tpp -85.54 -38.49 18.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.59 0.756 . . . . 0.0 110.127 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.68 9.89 80.35 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.867 -171.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.99 168.42 9.13 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 121.791 0.805 . . . . 0.0 112.243 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.441 ' HZ2' HD12 ' A' ' 280' ' ' ILE . 8.5 m0 -89.35 122.41 32.54 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.512 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.72 111.15 17.25 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 173.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -57.32 98.28 0.03 OUTLIER 'General case' 0 C--N 1.363 1.168 0 O-C-N 124.163 0.915 . . . . 0.0 109.963 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -103.73 133.1 49.29 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.437 1.095 . . . . 0.0 109.818 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 43.6 tt0 -84.01 106.75 15.91 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 122.684 0.394 . . . . 0.0 110.667 -173.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.1 t -58.56 109.23 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.521 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 167.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 m -108.37 -26.2 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 122.861 0.464 . . . . 0.0 111.028 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.425 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 56.5 ttt85 -146.5 122.63 10.81 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 110.788 -0.078 . . . . 0.0 110.788 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.16 117.82 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 123.335 0.654 . . . . 0.0 109.369 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.7 p -127.87 117.63 22.17 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.711 0.804 . . . . 0.0 109.289 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.46 ' HG3' HG12 ' A' ' 182' ' ' VAL . 27.1 ttt180 -76.14 138.19 40.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.376 0.67 . . . . 0.0 109.473 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 N--CA 1.486 1.337 0 C-N-CA 123.201 0.6 . . . . 0.0 111.144 177.734 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.243 0.75 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.89 96.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.367 1.079 . . . . 0.0 111.603 -172.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -88.81 19.71 3.91 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.209 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.46 HG12 ' HG3' ' A' ' 161' ' ' ARG . 6.4 m -78.17 163.4 3.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 124.007 0.923 . . . . 0.0 110.046 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.497 HG23 ' HB2' ' A' ' 198' ' ' GLN . 61.3 mt -97.16 110.31 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.41 0.684 . . . . 0.0 110.117 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -90.6 108.43 19.8 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 169.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 56.0 m-70 -77.14 97.77 4.86 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.49 143.32 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.533 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.539 ' HG2' HG22 ' A' ' 196' ' ' VAL . 25.3 mtmt -104.83 116.81 32.64 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -53.99 111.01 0.67 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.88 -22.99 67.1 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -80.34 -29.12 38.0 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.597 0.759 . . . . 0.0 111.404 173.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.488 ' HB3' ' ND2' ' A' ' 194' ' ' ASN . 79.8 m-85 -129.27 55.05 16.19 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 123.499 0.72 . . . . 0.0 111.321 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.38 -13.58 20.6 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 121.719 1.613 . . . . 0.0 112.73 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -71.83 -27.93 63.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.864 0.866 . . . . 0.0 110.697 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.488 ' ND2' ' HB3' ' A' ' 191' ' ' TYR . 30.4 m-80 -75.82 -1.42 25.1 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.548 0.739 . . . . 0.0 111.905 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 92.48 -172.05 34.14 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-O 121.11 0.283 . . . . 0.0 113.279 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.539 HG22 ' HG2' ' A' ' 187' ' ' LYS . 8.8 t -90.51 116.9 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.11 152.56 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.837 0.855 . . . . 0.0 110.015 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.497 ' HB2' HG23 ' A' ' 183' ' ' ILE . 16.7 pm0 -92.27 126.48 37.37 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 97.0 mmm -141.38 136.44 31.43 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.742 1.217 . . . . 0.0 107.973 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.464 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 20.8 m-80 -89.45 173.12 8.52 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.167 0.44 . . . . 0.0 110.071 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.535 ' HA ' HG22 ' A' ' 204' ' ' VAL . 18.9 t -66.82 -30.0 70.08 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 120.806 0.336 . . . . 0.0 110.496 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.464 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 15.4 ptm180 -67.24 -18.11 65.08 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.585 0.754 . . . . 0.0 111.935 175.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -102.38 -29.32 11.71 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.93 0.892 . . . . 0.0 111.085 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 201' ' ' SER . 31.9 m -99.21 148.78 5.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 CA-C-O 121.599 0.714 . . . . 0.0 110.374 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -128.85 146.14 51.01 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.873 1.269 . . . . 0.0 108.111 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.69 128.93 38.29 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -63.4 137.35 58.13 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.362 0.665 . . . . 0.0 110.814 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 279' ' ' LYS . . . -69.89 113.86 7.52 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -172.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.576 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 1.2 ptm180 -82.24 -31.94 29.96 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.686 169.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.7 m -90.04 123.51 33.98 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.554 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.4 mt -86.29 136.31 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.425 ' HB ' HG12 ' A' ' 277' ' ' VAL . 48.4 mm -107.51 144.2 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.673 0.789 . . . . 0.0 109.619 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.42 168.78 14.4 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.197 0.999 . . . . 0.0 109.296 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -52.22 -38.63 58.55 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.351 1.06 . . . . 0.0 112.953 -170.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.6 -44.31 93.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.358 0.663 . . . . 0.0 112.186 -173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.88 -1.46 32.07 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.609 0.764 . . . . 0.0 110.736 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.522 HD11 HG21 ' A' ' 223' ' ' VAL . 21.0 tp -79.19 121.0 24.49 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -130.69 156.72 44.44 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.496 0.589 . . . . 0.0 111.509 -172.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.4 m -67.93 132.34 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.971 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.8 -11.87 70.31 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.971 -176.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.419 HE21 HD12 ' A' ' 217' ' ' LEU . 29.0 tt0 -86.05 123.99 31.98 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.506 0.722 . . . . 0.0 109.47 177.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.96 133.16 29.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 173.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.522 HG21 HD11 ' A' ' 217' ' ' LEU . 3.3 m -145.19 145.76 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.6 1.16 . . . . 0.0 109.369 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.568 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 12.0 ptm -97.28 131.21 44.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.994 0.518 . . . . 0.0 109.692 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.513 ' HB3' ' HA ' ' A' ' 277' ' ' VAL . 0.8 OUTLIER -143.92 158.54 43.63 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.926 0.491 . . . . 0.0 110.834 -175.225 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 235' ' ' ARG . 16.5 p30 -77.04 117.87 19.04 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -156.6 143.16 18.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.726 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -108.53 120.47 46.29 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 168.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.66 -36.14 11.64 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.62 2.213 . . . . 0.0 111.873 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.31 -29.13 62.49 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.408 0.683 . . . . 0.0 110.774 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -131.18 90.13 39.64 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.41 -17.77 49.29 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.923 2.415 . . . . 0.0 113.473 -176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -76.03 -27.75 57.44 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.069 0.547 . . . . 0.0 111.176 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.09 153.64 37.17 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.407 ' HB2' ' HB2' ' A' ' 226' ' ' ASN . 0.0 OUTLIER -75.4 173.34 11.06 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.933 0.493 . . . . 0.0 111.732 176.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -159.83 -117.53 0.47 Allowed Glycine 0 C--O 1.24 0.522 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.278 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -82.56 171.42 14.1 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.199 0.6 . . . . 0.0 110.102 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -89.01 105.5 17.82 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -114.02 135.3 54.16 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -82.67 129.0 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -136.65 137.04 39.64 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.205 1.002 . . . . 0.0 109.309 -173.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -94.64 118.93 32.48 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.601 HD12 HD11 ' A' ' 255' ' ' LEU . 37.3 mm -62.44 112.79 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.195 0.598 . . . . 0.0 111.192 -173.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.4 t -82.53 -41.62 19.43 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.901 0.88 . . . . 0.0 110.088 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -157.05 155.73 31.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.735 0.814 . . . . 0.0 109.53 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -142.85 144.28 32.45 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.15 0.58 . . . . 0.0 109.893 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 254' ' ' GLU . 33.3 ttm180 -156.54 148.85 23.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.96 0.904 . . . . 0.0 109.786 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.21 139.82 35.72 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 165.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.0 p -114.31 177.65 4.57 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 172.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -78.98 -23.4 44.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 118.434 0.561 . . . . 0.0 110.434 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.1 p -95.16 -21.04 18.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.702 0.801 . . . . 0.0 112.5 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.91 173.86 16.13 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.191 0.596 . . . . 0.0 111.006 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -126.4 151.1 48.12 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 247' ' ' ARG . 10.1 tp10 -138.73 137.1 36.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.11 0.481 . . . . 0.0 110.894 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.648 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.4 OUTLIER -149.96 139.1 21.18 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.242 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -130.75 129.88 43.06 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.79 138.58 24.5 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.238 0.615 . . . . 0.0 109.919 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -76.69 99.22 4.99 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.49 106.14 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.564 HG12 HH22 ' A' ' 144' ' ' ARG . 48.4 t -89.0 114.56 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.225 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 264' ' ' ASP . 87.8 mt -92.28 -170.17 2.44 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.965 0.906 . . . . 0.0 109.907 173.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -61.41 -54.55 35.15 Favored Glycine 0 C--N 1.352 1.438 0 O-C-N 123.156 0.285 . . . . 0.0 112.591 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.05 -49.56 3.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.212 1.005 . . . . 0.0 109.905 172.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.431 ' HB2' HD12 ' A' ' 261' ' ' LEU . 7.4 m-20 -76.18 167.35 22.03 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.703 -171.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 38.0 p -153.95 112.89 3.69 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.422 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 2.6 mm? -81.41 95.86 7.18 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.508 0.723 . . . . 0.0 109.659 -177.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -58.6 111.73 1.36 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.229 0.956 . . . . 0.0 110.662 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 16.0 t70 64.01 83.75 0.16 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.889 1.275 . . . . 0.0 111.783 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 71.4 m -106.9 140.32 39.89 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.051 0.94 . . . . 0.0 109.554 172.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -82.2 107.97 15.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.106 0.562 . . . . 0.0 110.13 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.648 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 42.4 mm -91.76 124.06 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.947 0.899 . . . . 0.0 108.734 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 52.6 mt -88.17 -26.73 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.304 0.642 . . . . 0.0 110.499 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.476 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 38.0 m-85 -95.56 60.91 2.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.876 0.87 . . . . 0.0 111.038 -166.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 255' ' ' LEU . 9.8 m -66.69 -17.15 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.369 1.067 . . . . 0.0 112.246 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -98.65 -24.26 15.14 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.003 0.921 . . . . 0.0 110.98 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 36.5 mt-10 -98.24 28.05 4.29 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.564 0.697 . . . . 0.0 110.799 -176.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.513 ' HA ' ' HB3' ' A' ' 225' ' ' LEU . 72.6 t -82.95 146.36 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.586 1.155 . . . . 0.0 108.88 172.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.568 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 73.0 m-85 -130.78 160.89 33.01 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.179 0.991 . . . . 0.0 109.531 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 208' ' ' ALA . 75.1 tttt -82.04 154.78 25.47 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.34 1.056 . . . . 0.0 111.858 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.441 HD12 ' HZ2' ' A' ' 151' ' ' TRP . 15.9 mm -88.54 111.08 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 164.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' ' 208' ' ' ALA . 46.0 mm-40 -83.97 103.81 13.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -90.06 142.35 28.67 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.72 1.208 . . . . 0.0 109.52 -173.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.88 99.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.441 2.761 . . . . 0.0 113.544 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.28 -49.72 1.9 Allowed Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.906 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -73.36 -24.61 60.35 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.331 0.653 . . . . 0.0 111.728 -174.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -91.13 -159.81 35.94 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 25.2 p -126.99 135.11 26.89 Favored Pre-proline 0 N--CA 1.468 0.435 0 CA-C-N 117.142 0.471 . . . . 0.0 110.895 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.02 -174.67 1.63 Allowed 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.01 2.473 . . . . 0.0 110.616 163.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . 0.576 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 24.6 mmt -74.72 81.33 2.06 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.429 0.633 . . . . 0.0 110.479 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 12.3 p -100.77 -17.36 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.843 1.257 . . . . 0.0 109.627 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -122.75 -160.68 0.9 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -45.87 117.65 3.93 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.56 1.144 . . . . 0.0 112.422 177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.555 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 85.1 Cg_endo -78.36 144.08 20.14 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.585 2.19 . . . . 0.0 111.994 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 97.5 mmm -115.1 145.18 42.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.963 0.905 . . . . 0.0 110.693 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -143.3 91.53 2.28 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 169.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 40.6 mtm-85 -72.57 -17.24 61.73 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.378 -170.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -67.74 98.71 0.73 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 162.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 23.5 p . . . . . 0 CA--C 1.543 0.688 0 C-N-CA 123.944 0.898 . . . . 0.0 110.935 -177.111 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.355 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -102.83 -21.07 14.08 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.585 0.754 . . . . 0.0 110.673 -175.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -108.02 132.56 53.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 169.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 139' ' ' GLU . 17.7 pttp -130.24 -175.74 3.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.944 0.898 . . . . 0.0 110.742 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.8 m -35.47 -32.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -167.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -109.39 -22.18 12.16 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.208 0.603 . . . . 0.0 111.983 -173.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.402 ' HB2' ' H ' ' A' ' 136' ' ' LYS . 5.1 mp0 -77.13 78.83 3.66 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.371 1.068 . . . . 0.0 110.612 -176.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -76.52 130.81 38.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.545 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.2 m -132.69 169.01 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.491 1.516 . . . . 0.0 107.219 172.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.434 ' HB2' ' CE3' ' A' ' 151' ' ' TRP . 4.5 m-20 -92.24 139.51 30.54 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.664 0.665 . . . . 0.0 110.878 -174.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.1 99.4 12.4 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.888 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.435 ' HG2' ' NE1' ' A' ' 151' ' ' TRP . 0.0 OUTLIER -70.8 91.03 0.81 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.129 -1.396 . . . . 0.0 107.407 177.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.69 128.92 37.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.143 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.5 m -81.88 -19.15 41.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.563 0.345 . . . . 0.0 111.722 -172.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -76.69 -52.88 8.81 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.9 ttm -90.26 -39.99 12.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.693 0.797 . . . . 0.0 110.552 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.76 -7.67 59.38 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.199 -173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.3 153.38 35.94 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.598 0.759 . . . . 0.0 111.676 -174.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.547 ' CH2' HD12 ' A' ' 280' ' ' ILE . 12.9 m95 -101.51 116.07 31.93 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -109.0 123.28 48.88 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.03 101.66 0.23 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.757 0.66 . . . . 0.0 110.447 -173.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.9 114.84 26.49 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -85.52 97.6 10.15 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.439 HG22 HG12 ' A' ' 186' ' ' VAL . 44.7 t -65.51 97.84 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -92.14 -12.56 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.012 0.525 . . . . 0.0 111.851 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 21.1 ttm180 -168.72 154.05 6.34 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.525 0.73 . . . . 0.0 110.809 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.0 m -131.43 143.44 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.194 0.998 . . . . 0.0 110.14 172.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.577 HG23 ' HB ' ' A' ' 183' ' ' ILE . 4.5 t -141.69 150.4 41.82 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.896 0.878 . . . . 0.0 109.781 176.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -120.04 158.26 27.19 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.961 0.904 . . . . 0.0 110.791 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 123.372 0.669 . . . . 0.0 110.378 177.03 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 71.59 -15.36 0.44 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.245 1.418 . . . . 0.0 112.346 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.547 ' HA ' ' H ' ' A' ' 201' ' ' SER . 28.7 m-20 -87.62 51.14 2.14 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.641 0.734 . . . . 0.0 110.147 174.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 160' ' ' THR . 35.3 m -81.59 179.56 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.771 169.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' A' ' 160' ' ' THR . 3.6 mp -94.04 107.31 19.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -176.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -85.49 108.92 18.13 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.498 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 22.5 m-70 -78.29 100.71 6.82 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.439 HG12 HG22 ' A' ' 156' ' ' VAL . 12.0 m -118.35 164.0 15.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.237 -176.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -122.18 116.13 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -57.99 111.18 1.09 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 169.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.98 -23.99 61.51 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.653 0.739 . . . . 0.0 110.334 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -82.3 -30.4 30.56 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.29 172.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -137.73 70.31 51.47 Favored Pre-proline 0 N--CA 1.487 1.381 0 C-N-CA 123.101 0.56 . . . . 0.0 110.985 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.83 -18.21 57.48 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.801 2.334 . . . . 0.0 112.173 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.19 -17.12 57.21 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.871 1.268 . . . . 0.0 112.573 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.43 HD22 ' N ' ' A' ' 194' ' ' ASN . 0.8 OUTLIER -75.91 -7.21 54.01 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.751 0.82 . . . . 0.0 112.263 177.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.77 -167.11 52.61 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 40.5 t -81.3 117.02 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 171.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 29.0 m -108.38 141.9 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 122.82 0.448 . . . . 0.0 110.047 -175.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.501 ' HB2' HG23 ' A' ' 183' ' ' ILE . 18.4 pt20 -87.51 130.48 34.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.448 0.699 . . . . 0.0 110.156 -176.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 60.1 mmm -133.3 161.5 34.32 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.335 0.654 . . . . 0.0 109.739 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -111.55 -179.5 3.73 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.099 0.959 . . . . 0.0 109.275 172.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.547 ' H ' ' HA ' ' A' ' 181' ' ' ASP . 42.3 t -62.37 -41.43 98.61 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 118.168 0.44 . . . . 0.0 110.367 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -15.19 62.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.868 0.467 . . . . 0.0 112.157 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -89.19 -57.79 2.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.445 0.698 . . . . 0.0 110.008 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -94.24 117.97 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.69 0.757 . . . . 0.0 109.77 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.428 ' HD2' ' HH2' ' A' ' 151' ' ' TRP . 25.8 ttm180 -111.66 149.89 30.91 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.08 -176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.18 127.72 32.66 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 123.907 0.754 . . . . 0.0 111.625 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -101.27 136.53 40.96 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.191 0.996 . . . . 0.0 109.417 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.75 157.55 15.89 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.037 0.922 . . . . 0.0 110.433 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.431 ' HD3' ' N ' ' A' ' 209' ' ' ARG . 0.0 OUTLIER -114.61 42.89 2.03 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.462 177.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 21.3 m -127.12 118.73 24.95 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.583 -178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 50.4 mt -84.08 127.74 39.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.574 HG23 ' HB2' ' A' ' 216' ' ' ASP . 46.6 mm -92.37 138.96 18.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.379 -178.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -128.31 -178.49 4.58 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.867 1.267 . . . . 0.0 109.415 175.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' A' ' 246' ' ' LYS . 49.7 t-105 -60.99 -28.64 69.17 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.812 0.445 . . . . 0.0 111.87 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -61.91 -41.98 98.55 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.301 0.641 . . . . 0.0 110.564 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.574 ' HB2' HG23 ' A' ' 212' ' ' ILE . 58.8 m-20 -80.58 -14.55 58.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.733 0.813 . . . . 0.0 111.58 -177.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.516 ' HB3' ' HD3' ' A' ' 246' ' ' LYS . 0.5 OUTLIER -63.06 113.49 3.15 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.634 0.773 . . . . 0.0 111.222 -172.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.85 139.53 22.72 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.736 0.814 . . . . 0.0 110.005 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -67.31 139.64 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.161 0.584 . . . . 0.0 110.876 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 96.88 -21.74 44.4 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.696 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.414 ' HG2' HG13 ' A' ' 223' ' ' VAL . 8.0 tt0 -77.83 122.15 25.06 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.937 0.495 . . . . 0.0 109.968 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 10.5 p -91.84 131.45 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.428 HG23 HD11 ' A' ' 225' ' ' LEU . 15.6 m -135.64 156.73 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.741 1.216 . . . . 0.0 110.095 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.505 ' HB2' HD11 ' A' ' 280' ' ' ILE . 39.4 ttp -107.29 127.0 53.16 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.871 0.469 . . . . 0.0 109.988 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.506 ' HG ' HG13 ' A' ' 277' ' ' VAL . 0.1 OUTLIER -131.17 144.98 51.77 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.064 0.946 . . . . 0.0 108.558 -175.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -75.0 106.24 6.41 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -139.94 154.96 47.36 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.672 -169.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 32.6 t-20 -120.44 120.71 29.68 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.18 -29.75 32.36 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.42 2.08 . . . . 0.0 112.688 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -71.48 -53.8 12.72 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.88 0.472 . . . . 0.0 110.281 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 1.0 OUTLIER -117.0 88.59 26.96 Favored Pre-proline 0 N--CA 1.484 1.237 0 C-N-CA 123.823 0.849 . . . . 0.0 109.2 176.232 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.31 -9.85 23.72 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.014 2.476 . . . . 0.0 114.137 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.424 ' HD2' HD11 ' A' ' 272' ' ' ILE . 21.7 tptm -77.61 -15.5 59.18 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.989 0.915 . . . . 0.0 110.916 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -134.66 165.52 25.04 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.52 0.728 . . . . 0.0 110.463 -172.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.7 ppt_? -71.91 163.65 27.47 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.922 0.889 . . . . 0.0 111.023 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -145.52 -84.44 0.06 OUTLIER Glycine 0 C--O 1.239 0.456 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 175.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -128.53 178.09 6.55 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.33 1.052 . . . . 0.0 108.549 173.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . 0.499 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 97.4 m95 -83.21 110.03 17.72 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 122.744 0.418 . . . . 0.0 109.905 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.29 141.29 49.1 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.795 0.838 . . . . 0.0 109.656 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -83.53 123.06 29.37 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.265 0.555 . . . . 0.0 109.709 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -128.62 137.35 51.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.408 1.083 . . . . 0.0 109.59 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 222' ' ' VAL . 33.0 tt0 -94.98 136.43 35.3 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.513 HD12 HD21 ' A' ' 255' ' ' LEU . 33.9 mm -63.96 108.29 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 O-C-N 123.83 0.706 . . . . 0.0 109.46 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.4 t -93.9 -29.16 15.43 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.476 0.711 . . . . 0.0 110.198 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 77.0 ttt180 -167.98 156.26 8.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.355 0.662 . . . . 0.0 109.563 -175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.516 ' HD3' ' HB3' ' A' ' 217' ' ' LEU . 23.8 pttm -148.03 139.84 23.92 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 167.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -134.01 114.84 13.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.791 1.236 . . . . 0.0 107.68 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 9.1 pt-20 -100.23 134.07 43.71 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.014 0.435 . . . . 0.0 109.924 175.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.3 p -118.55 161.76 19.5 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -64.44 -15.08 60.03 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 52.6 p -94.75 -32.06 13.5 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.549 0.74 . . . . 0.0 111.473 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.4 141.38 1.97 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.229 0.612 . . . . 0.0 110.986 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 0.0 OUTLIER -98.18 102.81 14.66 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 121.8 0.81 . . . . 0.0 111.174 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -87.92 116.73 26.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.186 0.994 . . . . 0.0 111.161 -169.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.632 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 3.9 tt -97.84 138.27 35.44 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . 0.513 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 53.2 m-85 -128.44 115.04 17.58 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -132.41 140.0 48.28 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.991 0.516 . . . . 0.0 110.083 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 3.4 p-10 -79.85 96.93 6.47 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.415 0.626 . . . . 0.0 109.551 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 49.6 t -72.83 100.49 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.053 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.2 p -93.74 110.91 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.609 0.718 . . . . 0.0 109.228 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 5.2 mp -83.6 -172.51 4.19 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.247 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.08 -31.45 66.61 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 121.885 -0.197 . . . . 0.0 112.824 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -121.81 -48.62 2.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.141 0.976 . . . . 0.0 109.677 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.74 168.81 18.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.511 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 51.7 p -158.43 112.63 2.5 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.61 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 55.3 mt -94.3 96.9 9.86 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.37 1.068 . . . . 0.0 110.044 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 4.1 p-10 -74.87 137.6 41.9 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.896 0.479 . . . . 0.0 111.439 -174.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 63.58 26.04 14.56 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.835 1.254 . . . . 0.0 113.634 171.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 72.0 m -64.83 133.2 51.44 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.628 0.371 . . . . 0.0 111.296 177.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -68.86 116.46 9.36 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.93 0.768 . . . . 0.0 110.058 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.632 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 45.8 mm -88.74 133.31 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.018 0.527 . . . . 0.0 109.726 177.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.424 HD11 ' HD2' ' A' ' 233' ' ' LYS . 62.3 mt -104.91 -22.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.342 1.057 . . . . 0.0 110.044 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -90.61 41.54 1.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.184 0.993 . . . . 0.0 110.794 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 26.2 m -70.04 -26.07 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.678 1.191 . . . . 0.0 112.686 -169.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -91.92 -3.57 55.79 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.372 0.669 . . . . 0.0 111.724 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.7 25.9 3.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.111 0.564 . . . . 0.0 111.331 -170.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.506 HG13 ' HG ' ' A' ' 225' ' ' LEU . 46.5 t -73.59 153.7 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.885 0.874 . . . . 0.0 110.267 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -116.71 150.26 38.49 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.457 0.703 . . . . 0.0 109.6 169.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.453 ' HE2' HD11 ' A' ' 212' ' ' ILE . 22.2 ttmm -82.97 149.48 26.98 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.227 1.011 . . . . 0.0 110.653 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.547 HD12 ' CH2' ' A' ' 151' ' ' TRP . 32.7 mm -87.1 125.03 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 165.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.52 104.4 6.06 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -173.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 98.0 mtt180 -94.4 103.7 11.75 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 168.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -27.98 118.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 125.25 3.967 . . . . 0.0 116.617 -165.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 106.96 -41.69 2.12 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.922 -0.932 . . . . 0.0 114.612 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 10.5 pt-20 -79.99 -25.23 40.39 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 119.088 1.444 . . . . 0.0 113.338 -170.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -76.84 117.88 5.01 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 17.8 p -63.57 129.8 93.91 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 117.508 0.654 . . . . 0.0 109.65 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.58 153.05 74.23 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.451 2.767 . . . . 0.0 112.85 -172.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . 0.518 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 57.0 ttm -76.91 79.57 3.48 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-O 121.852 0.834 . . . . 0.0 110.167 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.9 -28.9 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -74.33 178.45 5.17 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.748 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -54.02 141.12 50.29 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.131 0.972 . . . . 0.0 111.964 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.518 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 16.0 Cg_exo -67.68 84.82 0.39 Allowed 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.758 2.305 . . . . 0.0 111.679 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.7 mtm -68.11 109.55 3.57 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.692 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -123.37 137.55 54.8 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.105 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 50.25 0.6 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.793 0.837 . . . . 0.0 110.697 -159.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 190' ' ' ASP . 16.8 ptpt -55.68 149.71 13.78 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.411 1.084 . . . . 0.0 113.872 -173.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.681 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.42 ' HA3' ' HB ' ' A' ' 159' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.411 ' N ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -115.61 10.81 15.65 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -169.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -91.74 159.45 15.83 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 166.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 60.0 mttp -79.18 178.64 7.91 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.99 0.516 . . . . 0.0 111.564 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -91.39 17.45 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 123.903 0.881 . . . . 0.0 110.929 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -151.8 9.11 0.51 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.422 0.689 . . . . 0.0 109.715 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 136' ' ' LYS . 9.2 tp10 -75.2 87.56 2.46 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 123.7 0.8 . . . . 0.0 110.133 -170.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.696 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 46.2 p90 -74.71 120.92 20.92 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.071 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.42 -170.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.424 1.09 . . . . 0.0 109.55 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -92.61 147.9 22.5 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -140.01 104.22 4.8 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -70.03 103.61 2.32 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 173.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.34 115.07 3.87 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.457 0.703 . . . . 0.0 109.843 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t -68.8 -16.67 63.86 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.163 0.985 . . . . 0.0 112.849 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -82.46 -49.34 10.05 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 122.914 0.486 . . . . 0.0 110.978 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 22.6 ptm -101.4 -13.61 17.91 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.568 0.747 . . . . 0.0 111.441 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.647 ' HA3' ' HA3' ' A' ' 262' ' ' GLY . . . 79.19 20.55 69.56 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 174.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.429 ' HB2' ' CE1' ' A' ' 239' ' ' TYR . . . -106.19 153.42 22.15 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.25 0.62 . . . . 0.0 111.278 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.425 ' HZ3' ' HG3' ' A' ' 205' ' ' ARG . 57.2 m95 -78.26 144.67 35.98 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 171.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.434 ' HA ' ' HD1' ' A' ' 238' ' ' TRP . 59.2 m-85 -145.56 145.78 31.14 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.397 0.544 . . . . 0.0 111.146 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 189' ' ' ASP . 75.2 mm-40 -63.51 138.07 58.37 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 167.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -146.82 166.69 25.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.408 0.683 . . . . 0.0 110.269 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.696 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 63.1 tt0 -137.08 105.13 5.65 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.346 0.659 . . . . 0.0 110.1 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 186' ' ' VAL . 42.3 t -67.52 100.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.51 -3.02 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.217 0.607 . . . . 0.0 112.453 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 72.4 ttt180 -166.41 135.06 2.93 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.42 ' HB ' ' HA3' ' A' ' 133' ' ' GLY . 27.6 m -118.25 127.62 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.301 0.64 . . . . 0.0 109.48 173.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.3 p -136.26 145.65 45.82 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.835 0.854 . . . . 0.0 109.264 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.51 ' HA ' ' HB ' ' A' ' 182' ' ' VAL . 13.5 ptt180 -94.27 165.85 12.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.304 0.642 . . . . 0.0 110.474 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt . . . . . 0 N--CA 1.477 0.881 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.266 175.777 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.523 ' HB3' HG22 ' A' ' 182' ' ' VAL . 3.6 mp0 -71.86 92.02 1.21 Allowed 'General case' 0 C--O 1.243 0.726 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -80.11 70.29 6.69 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 160.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.523 HG22 ' HB3' ' A' ' 180' ' ' GLU . 18.2 m -126.78 173.94 11.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.507 177.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 183' ' ' ILE . 3.1 mp -96.8 108.87 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.427 0.632 . . . . 0.0 109.748 -166.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -99.77 105.97 17.81 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 17.7 m-70 -78.88 92.88 4.93 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.664 HG12 HG22 ' A' ' 156' ' ' VAL . 2.4 m -108.93 153.55 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -119.19 118.15 30.57 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 191' ' ' TYR . 24.2 m-85 -64.72 127.25 30.75 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.453 0.471 . . . . 0.0 110.378 177.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 153' ' ' GLU . 13.4 t70 -65.85 -37.53 86.45 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.72 -20.32 65.25 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.696 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 188' ' ' TYR . 89.5 m-85 -139.37 66.87 37.76 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 123.568 0.747 . . . . 0.0 109.11 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -71.2 -40.03 3.51 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.331 2.021 . . . . 0.0 112.883 -169.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.68 -2.57 58.7 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.782 0.833 . . . . 0.0 111.982 -176.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.04 -16.4 59.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.205 0.602 . . . . 0.0 110.56 172.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 100.02 -161.13 19.29 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.206 -0.452 . . . . 0.0 113.16 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 7.6 t -96.3 116.96 39.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 22.4 m -101.88 155.2 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.878 0.871 . . . . 0.0 110.204 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.404 ' HB2' HG23 ' A' ' 183' ' ' ILE . 15.1 pm0 -99.4 128.54 45.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.654 0.782 . . . . 0.0 109.563 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 86.3 mmm -130.05 165.05 23.02 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.636 1.175 . . . . 0.0 108.788 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -110.74 172.11 7.06 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 180' ' ' GLU . 56.9 m -58.32 -43.86 88.39 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.137 0.575 . . . . 0.0 111.593 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -22.62 67.0 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.83 0.852 . . . . 0.0 112.219 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -84.16 -40.68 17.89 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.624 0.77 . . . . 0.0 110.423 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 31.3 m -93.38 117.73 37.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 CA-C-O 122.216 1.008 . . . . 0.0 110.011 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.425 ' HG3' ' HZ3' ' A' ' 151' ' ' TRP . 2.0 mmp_? -122.08 -170.27 2.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.971 1.308 . . . . 0.0 109.085 -175.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 289' ' ' MET . . . -101.98 128.58 48.35 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 169.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.67 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -73.95 118.51 16.98 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 167.223 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -69.14 121.93 17.74 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 122.855 0.462 . . . . 0.0 110.446 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -74.41 4.39 6.0 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.217 0.607 . . . . 0.0 111.913 174.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 52.4 m -84.11 105.91 15.34 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.64 114.74 25.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 279' ' ' LYS . 30.8 mm -76.49 133.65 30.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.509 177.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.91 178.04 5.05 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . 0.52 ' HA ' HD12 ' A' ' 217' ' ' LEU . 75.3 t-105 -49.5 -41.87 41.93 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.957 0.903 . . . . 0.0 111.908 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -53.93 -44.18 70.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.466 1.106 . . . . 0.0 112.788 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -115.18 17.15 16.81 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.597 0.759 . . . . 0.0 112.34 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 214' ' ' TRP . 53.1 mt -76.2 113.22 13.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 163.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -126.69 152.71 46.42 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.733 0.413 . . . . 0.0 110.274 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.33 140.58 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.219 0.608 . . . . 0.0 110.798 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.45 -1.39 82.12 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.5 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.53 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.5 tt0 -85.57 120.49 27.08 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.496 0.648 . . . . 0.0 109.818 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 64.8 t -90.05 114.29 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.53 HG13 ' HG2' ' A' ' 221' ' ' GLN . 3.5 m -126.89 163.44 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.501 1.12 . . . . 0.0 109.346 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.434 ' HB3' HD11 ' A' ' 280' ' ' ILE . 0.0 OUTLIER -100.88 139.46 36.53 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.617 ' HG ' HG13 ' A' ' 277' ' ' VAL . 1.1 mp -131.35 167.67 18.86 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.409 ' HB3' ' HZ3' ' A' ' 238' ' ' TRP . 12.2 p-10 -101.36 105.64 16.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.997 0.919 . . . . 0.0 110.434 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -167.71 159.16 11.62 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.485 0.714 . . . . 0.0 110.196 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -103.31 129.15 26.04 Favored Pre-proline 0 C--O 1.217 -0.644 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.82 -7.36 20.97 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 122.405 2.07 . . . . 0.0 113.366 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -70.5 -30.27 67.0 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.116 0.566 . . . . 0.0 109.53 170.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.572 HD22 ' HB2' ' A' ' 234' ' ' GLU . 5.1 t30 -152.45 82.82 5.1 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.754 1.222 . . . . 0.0 107.77 177.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -60.88 -10.9 15.87 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.345 2.696 . . . . 0.0 114.381 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.404 ' O ' HD12 ' A' ' 272' ' ' ILE . 50.6 tttm -72.31 -31.34 65.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.458 0.703 . . . . 0.0 110.826 173.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.572 ' HB2' HD22 ' A' ' 231' ' ' ASN . 0.4 OUTLIER -108.01 156.52 19.15 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.822 0.849 . . . . 0.0 111.149 -173.073 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -65.81 161.37 21.09 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.284 -1.325 . . . . 0.0 112.033 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -171.25 -122.92 0.67 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -104.86 -177.32 3.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.179 0.592 . . . . 0.0 110.645 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . 0.434 ' HD1' ' HA ' ' A' ' 152' ' ' PHE . 14.5 m95 -90.59 105.77 18.04 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -173.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 150' ' ' ALA . 84.5 m-85 -126.63 157.57 38.58 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.77 0.828 . . . . 0.0 111.033 -176.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -88.07 146.77 25.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.3 0.64 . . . . 0.0 110.6 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -155.89 138.5 15.06 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.254 1.022 . . . . 0.0 108.529 170.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.6 125.12 39.05 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.611 HD12 HD11 ' A' ' 255' ' ' LEU . 28.5 mm -64.72 108.94 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.548 0.739 . . . . 0.0 109.218 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.3 m -79.92 -48.43 13.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.667 0.787 . . . . 0.0 110.798 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.96 128.44 2.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -170.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -114.23 145.53 41.6 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -141.29 121.02 13.43 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -104.56 126.54 51.74 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 77.7 p -125.23 172.31 9.65 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.182 0.993 . . . . 0.0 108.869 170.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -78.99 -12.41 60.04 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.971 0.508 . . . . 0.0 111.366 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 65.4 p -96.69 -29.14 13.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.37 0.668 . . . . 0.0 111.085 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.54 163.24 38.58 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.031 0.532 . . . . 0.0 111.336 -173.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -116.6 99.89 7.46 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 165.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.37 100.54 13.09 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.181 0.593 . . . . 0.0 110.439 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.611 HD11 HD12 ' A' ' 243' ' ' ILE . 1.7 tm? -96.24 136.09 37.19 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 175.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -125.17 127.61 47.08 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -142.57 140.31 31.69 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.13 0.572 . . . . 0.0 110.575 -176.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.79 102.54 10.05 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 170.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 49.6 t -65.88 121.85 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.794 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.5 p -121.78 107.82 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 121.976 0.893 . . . . 0.0 109.166 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' A' ' 264' ' ' ASP . 25.4 mt -88.15 -160.01 0.59 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.437 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.647 ' HA3' ' HA3' ' A' ' 149' ' ' GLY . . . -89.23 -25.47 28.6 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -123.04 -43.72 2.21 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.534 0.734 . . . . 0.0 111.084 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.581 ' HB3' HD12 ' A' ' 261' ' ' LEU . 30.1 t70 -113.37 177.08 4.76 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.572 1.149 . . . . 0.0 110.442 -170.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 57.6 p -148.6 143.4 26.55 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.009 0.924 . . . . 0.0 110.159 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 2.8 mm? -114.58 106.37 14.17 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -78.59 125.24 29.09 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.57 0.748 . . . . 0.0 110.493 -177.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 62.39 81.56 0.2 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.854 1.261 . . . . 0.0 112.208 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 61.3 m -111.02 127.4 55.52 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 19.4 ttp180 -80.56 104.14 10.89 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 43.1 mm -74.3 120.19 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.247 1.019 . . . . 0.0 110.335 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 233' ' ' LYS . 54.1 mt -83.52 -20.2 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 125.2 1.4 . . . . 0.0 110.177 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -93.71 37.55 1.07 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.289 1.436 . . . . 0.0 111.902 -167.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 32.9 m -66.9 -28.59 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -169.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -95.77 0.07 51.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.657 0.783 . . . . 0.0 112.293 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -134.72 25.88 3.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.119 0.568 . . . . 0.0 111.3 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.617 HG13 ' HG ' ' A' ' 225' ' ' LEU . 55.5 t -76.11 148.74 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.835 0.854 . . . . 0.0 108.844 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -117.66 150.69 38.63 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.506 ' HB2' HD11 ' A' ' 212' ' ' ILE . 38.8 ttmt -79.45 145.55 33.23 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.952 0.501 . . . . 0.0 111.091 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 224' ' ' MET . 37.0 mm -84.74 139.14 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 166.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.24 147.06 51.92 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 173.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -127.35 144.35 50.45 Favored Pre-proline 0 N--CA 1.473 0.704 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.88 125.48 13.08 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.061 2.508 . . . . 0.0 113.293 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.55 -58.95 0.56 Allowed Glycine 0 C--N 1.345 1.062 0 C-N-CA 123.156 0.408 . . . . 0.0 113.317 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.02 -23.14 26.93 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.249 0.524 . . . . 0.0 111.495 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -125.46 136.51 9.8 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 16.5 m -71.5 148.83 93.38 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 123.314 0.646 . . . . 0.0 110.858 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.8 176.63 9.87 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.133 2.555 . . . . 0.0 111.574 176.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . 0.424 ' HB2' ' HB1' ' A' ' 206' ' ' ALA . 9.5 ttt -95.12 81.14 3.64 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 14.6 p -100.38 -26.73 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.286 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.31 -177.51 4.66 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.138 0.975 . . . . 0.0 109.912 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -47.62 109.63 1.15 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.508 1.123 . . . . 0.0 111.085 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.77 108.53 1.47 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.565 2.177 . . . . 0.0 111.639 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 58.4 ttp -105.69 91.26 3.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.128 0.971 . . . . 0.0 108.639 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -66.49 142.23 57.61 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.144 0.577 . . . . 0.0 110.631 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -59.99 -32.37 70.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.696 0.798 . . . . 0.0 112.138 -173.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.96 -24.34 66.94 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.268 1.027 . . . . 0.0 111.713 -176.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.8 m . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 172.063 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.109 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.487 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -92.35 -6.33 50.4 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.178 0.591 . . . . 0.0 112.167 -176.068 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -98.65 150.07 22.15 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.159 0.504 . . . . 0.0 111.106 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.621 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 48.4 mtpt -84.69 168.83 14.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.564 1.146 . . . . 0.0 110.998 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.2 m -78.75 14.47 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 C-N-CA 124.211 1.004 . . . . 0.0 112.735 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -132.2 0.22 3.75 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.974 0.91 . . . . 0.0 111.412 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.621 ' HG2' ' HB2' ' A' ' 136' ' ' LYS . 27.9 mm-40 -79.9 92.17 5.49 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.62 0.724 . . . . 0.0 112.29 -168.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 12.8 p90 -65.29 100.11 0.44 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.74 165.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.88 -172.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.983 1.313 . . . . 0.0 109.191 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.631 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 15.3 t70 -104.53 157.94 16.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 168.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -133.86 96.07 3.58 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.481 0.312 . . . . 0.0 110.465 169.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -73.41 97.95 2.64 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 169.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.82 128.0 34.11 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.121 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.6 m -68.5 -30.15 68.92 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.22 0.608 . . . . 0.0 111.222 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -74.03 -42.26 60.58 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.347 0.659 . . . . 0.0 111.649 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 54.4 ttm -102.02 -22.8 14.19 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.09 0.556 . . . . 0.0 112.378 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 77.45 0.75 73.58 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-N 116.663 -0.244 . . . . 0.0 113.431 -174.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -93.16 164.83 13.1 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 123.422 0.689 . . . . 0.0 111.342 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.571 ' HB3' ' HB2' ' A' ' 238' ' ' TRP . 2.3 p-90 -77.41 139.59 39.73 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.85 174.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.414 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 89.6 m-85 -147.22 77.26 1.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 171.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 50.9 mt-10 -55.99 134.96 52.68 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.628 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -149.15 135.11 18.96 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.655 0.597 . . . . 0.0 111.796 -164.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.3 tt0 -91.44 109.63 20.92 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.51 113.77 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.524 0.73 . . . . 0.0 109.261 170.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.89 -8.7 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 122.967 0.507 . . . . 0.0 111.497 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.559 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 36.3 ttm180 -169.93 143.83 2.64 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.639 0.776 . . . . 0.0 109.412 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.34 143.47 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.7 0.8 . . . . 0.0 108.866 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.437 HG23 ' HB ' ' A' ' 183' ' ' ILE . 9.5 t -148.79 163.8 36.3 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.122 0.569 . . . . 0.0 111.207 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -87.28 171.78 10.37 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.381 1.072 . . . . 0.0 112.162 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 124.473 1.109 . . . . 0.0 110.086 173.441 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 201' ' ' SER . 7.3 mp0 -77.29 89.05 3.72 Favored 'General case' 0 C--O 1.249 1.026 0 CA-C-O 121.19 0.519 . . . . 0.0 110.764 -172.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.06 79.35 9.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 163.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 16.7 m -129.68 157.24 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.955 0.902 . . . . 0.0 108.768 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.2 mp -95.38 109.39 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -166.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.446 ' HB3' HG13 ' A' ' 186' ' ' VAL . 78.7 m-85 -92.35 111.4 22.95 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.519 1.127 . . . . 0.0 108.973 172.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 17.5 m-70 -77.29 91.59 3.81 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 168.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.628 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 34.9 m -109.02 157.92 9.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.477 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -127.88 115.14 18.14 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.423 ' HD2' ' HB2' ' A' ' 154' ' ' ALA . 17.6 m-30 -60.43 117.51 5.34 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.698 0.624 . . . . 0.0 111.755 -171.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -56.09 -42.7 77.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.034 1.334 . . . . 0.0 111.554 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -86.14 -16.63 37.32 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.263 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -138.61 68.14 44.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 123.115 0.566 . . . . 0.0 110.836 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.14 -17.67 53.67 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.565 2.177 . . . . 0.0 113.514 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.66 -23.08 66.71 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.743 0.817 . . . . 0.0 112.067 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -74.83 -13.34 60.55 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.151 0.58 . . . . 0.0 111.61 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.99 -141.35 34.33 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.81 0.694 . . . . 0.0 112.308 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 25.9 t -93.19 119.25 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 20.2 m -123.59 155.71 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.964 1.306 . . . . 0.0 109.54 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.47 ' HB2' HG23 ' A' ' 183' ' ' ILE . 20.8 pt20 -98.62 132.29 44.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.866 0.467 . . . . 0.0 110.812 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 83.5 mmm -135.24 164.49 27.6 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.998 0.919 . . . . 0.0 108.68 173.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.425 ' O ' HG22 ' A' ' 204' ' ' VAL . 21.4 m-80 -109.71 172.03 7.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 180' ' ' GLU . 40.7 m -61.59 -30.25 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.127 0.421 . . . . 0.0 111.134 175.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -55.94 -42.59 76.4 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.428 1.091 . . . . 0.0 109.246 175.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.68 -40.44 17.38 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.366 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 18.8 m -91.85 116.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 CA-C-O 122.703 1.24 . . . . 0.0 108.33 -173.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -106.96 137.7 44.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.479 -1.691 . . . . 0.0 107.895 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.55 ' HB3' ' HG2' ' A' ' 281' ' ' GLU . . . -62.37 126.31 26.9 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.772 ' HD3' ' H ' ' A' ' 295' ' ' ARG . 42.2 ttm180 -63.38 95.82 0.1 Allowed 'General case' 0 C--O 1.241 0.634 0 O-C-N 123.972 0.795 . . . . 0.0 109.854 -175.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.06 121.52 10.83 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.891 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -91.93 1.92 56.87 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.216 172.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.0 m -97.92 113.94 25.9 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.747 0.819 . . . . 0.0 110.67 -176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.76 136.8 22.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.759 0.824 . . . . 0.0 108.954 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.453 ' HB ' HG12 ' A' ' 277' ' ' VAL . 37.1 mm -90.25 133.79 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -97.92 172.43 7.65 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.21 0.604 . . . . 0.0 110.688 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . 0.433 ' HA ' HD12 ' A' ' 217' ' ' LEU . 73.1 t-105 -56.01 -43.36 77.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.904 0.882 . . . . 0.0 111.47 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -58.22 -37.96 75.89 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.012 0.925 . . . . 0.0 111.645 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -82.62 -20.91 35.45 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.137 0.575 . . . . 0.0 111.282 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 214' ' ' TRP . 96.0 mt -63.22 118.98 8.73 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . 0.408 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 10.6 pt-20 -144.97 155.56 43.47 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.724 0.809 . . . . 0.0 109.729 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 35.9 m -65.4 131.27 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.149 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.71 -12.58 69.01 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 115.782 -0.645 . . . . 0.0 113.641 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -72.76 123.02 22.47 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.255 0.527 . . . . 0.0 110.535 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 51.7 t -91.62 115.72 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.57 -170.12 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.564 1.546 . . . . 0.0 109.56 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.44 ' HB2' HD11 ' A' ' 280' ' ' ILE . 40.1 ttp -141.59 130.45 23.04 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.949 0.5 . . . . 0.0 109.953 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.408 HD13 ' HD1' ' A' ' 227' ' ' TYR . 0.8 OUTLIER -143.29 147.19 34.38 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.857 0.863 . . . . 0.0 109.991 -175.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 235' ' ' ARG . 6.9 p30 -90.92 114.24 26.66 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.392 0.615 . . . . 0.0 111.347 -175.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.408 ' HD1' HD13 ' A' ' 225' ' ' LEU . 26.7 m-85 -137.64 144.54 41.93 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.348 1.059 . . . . 0.0 110.641 174.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -86.11 123.01 72.36 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.77 -9.63 26.13 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.468 2.112 . . . . 0.0 112.703 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.55 -43.57 14.37 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.31 0.644 . . . . 0.0 109.967 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -130.55 89.15 44.76 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.645 0.778 . . . . 0.0 109.967 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.18 -12.23 33.49 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.761 2.308 . . . . 0.0 112.615 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -66.51 -28.65 68.72 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.11 0.564 . . . . 0.0 110.544 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -120.24 161.12 21.63 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.31 0.644 . . . . 0.0 110.068 -173.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.415 ' HB2' ' OD1' ' A' ' 226' ' ' ASN . 1.4 ppt_? -60.47 166.85 2.86 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 124.397 1.079 . . . . 0.0 111.394 175.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -177.37 -113.33 0.35 Allowed Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.302 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -96.73 139.68 32.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.137 0.975 . . . . 0.0 110.178 -172.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . 0.571 ' HB2' ' HB3' ' A' ' 151' ' ' TRP . 79.7 m95 -70.91 123.59 22.37 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.208 0.528 . . . . 0.0 110.548 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -130.92 151.48 51.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.52 137.22 35.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 258' ' ' ASN . . . -134.83 137.71 43.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.804 0.442 . . . . 0.0 110.512 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -96.23 118.56 33.04 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.551 HD12 HD11 ' A' ' 255' ' ' LEU . 44.0 mm -59.64 107.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 123.813 0.696 . . . . 0.0 109.294 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 10.0 m -78.38 -44.19 25.63 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.855 0.862 . . . . 0.0 110.623 -176.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -155.49 155.79 34.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.973 -168.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -149.7 145.58 26.77 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.596 0.56 . . . . 0.0 110.18 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -155.53 117.35 4.05 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.002 0.921 . . . . 0.0 108.535 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -102.98 124.33 48.28 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.1 p -133.25 162.26 32.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.681 0.793 . . . . 0.0 109.598 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.31 -26.73 68.0 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.203 1.001 . . . . 0.0 112.71 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 26.9 p -88.69 -30.24 19.27 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.198 0.599 . . . . 0.0 111.342 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -172.06 151.96 2.8 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.428 0.455 . . . . 0.0 111.462 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -105.86 110.46 22.76 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.901 0.48 . . . . 0.0 109.768 172.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -89.87 129.43 36.23 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.694 1.197 . . . . 0.0 110.825 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.551 HD11 HD12 ' A' ' 243' ' ' ILE . 1.5 tm? -137.34 129.84 29.83 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -118.64 144.26 46.28 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.59 146.04 29.23 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.525 0.73 . . . . 0.0 110.611 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 241' ' ' ALA . 7.3 m-20 -78.19 96.3 5.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.746 0.818 . . . . 0.0 109.233 172.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 51.0 t -76.54 107.57 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 95.8 t -87.52 119.36 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.799 0.84 . . . . 0.0 110.786 -167.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 43.2 mt -107.81 -176.88 3.18 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.356 1.062 . . . . 0.0 108.816 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -76.75 -49.94 7.48 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-O 120.957 0.198 . . . . 0.0 113.247 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.17 -30.73 12.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.445 0.698 . . . . 0.0 109.885 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -112.14 175.34 5.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.571 0.749 . . . . 0.0 111.65 -175.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 14.0 p -155.73 113.24 3.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.504 1.122 . . . . 0.0 108.103 170.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.445 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 31.9 mt -80.87 81.7 7.05 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.239 1.015 . . . . 0.0 108.57 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 4.2 p-10 -76.46 135.81 39.39 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.533 -171.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 13.6 t70 56.89 47.45 17.81 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.399 1.08 . . . . 0.0 110.597 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 91.9 m -99.66 132.67 44.85 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.826 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 24.8 ttp180 -62.93 117.9 7.05 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.598 0.759 . . . . 0.0 112.128 -174.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.51 105.56 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.666 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 34.3 mt -70.74 -36.31 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 125.443 1.497 . . . . 0.0 110.507 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -109.26 69.41 0.7 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.7 0.8 . . . . 0.0 109.881 -171.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 18.3 m -71.4 -14.39 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.516 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.19 -28.78 48.21 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.265 1.026 . . . . 0.0 110.87 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -90.6 26.0 2.14 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.332 0.587 . . . . 0.0 111.289 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.453 HG12 ' HB ' ' A' ' 212' ' ' ILE . 71.5 t -96.36 126.12 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.469 1.108 . . . . 0.0 109.602 175.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -112.28 160.88 17.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.181 0.992 . . . . 0.0 109.985 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.674 ' HD3' ' HA2' ' A' ' 286' ' ' GLY . 17.2 ttmm -78.31 136.61 37.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.488 1.115 . . . . 0.0 111.013 177.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 224' ' ' MET . 41.2 mm -83.05 117.15 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 163.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.55 ' HG2' ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -68.25 105.36 2.1 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.458 0.647 . . . . 0.0 110.564 -178.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -122.02 142.52 36.66 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 123.654 0.781 . . . . 0.0 108.956 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.15 120.4 6.72 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.477 2.784 . . . . 0.0 113.817 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.26 -25.75 26.63 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-N 116.063 -0.517 . . . . 0.0 114.038 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.04 -12.9 4.61 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 117.855 0.828 . . . . 0.0 112.543 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . 0.674 ' HA2' ' HD3' ' A' ' 279' ' ' LYS . . . -98.11 120.46 6.8 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 123.448 0.546 . . . . 0.0 111.785 -173.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.3 m -75.52 142.3 74.13 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 117.092 0.446 . . . . 0.0 111.604 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.09 148.81 24.88 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.828 2.352 . . . . 0.0 111.993 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . 0.548 ' SD ' ' HB3' ' A' ' 207' ' ' ARG . 23.5 ttt -77.81 85.1 4.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.242 0.544 . . . . 0.0 109.609 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 10.8 p -123.14 3.64 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.426 1.091 . . . . 0.0 109.668 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -120.36 -167.81 1.52 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.762 1.225 . . . . 0.0 108.341 -171.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -43.54 115.27 1.91 Allowed Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 124.902 1.281 . . . . 0.0 112.961 -177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.86 115.18 2.94 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.368 2.046 . . . . 0.0 110.915 173.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 22.8 mmt -72.24 -77.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.475 0.71 . . . . 0.0 110.77 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.772 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 6.7 ttt180 66.43 106.58 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.411 1.484 . . . . 0.0 109.752 -176.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.472 ' NH2' ' HB2' ' A' ' 151' ' ' TRP . 7.3 mtm-85 -101.25 22.09 12.98 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.133 1.373 . . . . 0.0 109.688 -167.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -56.44 108.16 0.45 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 125.343 1.457 . . . . 0.0 110.063 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.242 0.699 0 C-N-CA 123.638 0.775 . . . . 0.0 110.028 -176.078 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 CA-C-O 119.807 -0.44 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.67 -58.77 2.25 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.278 0.631 . . . . 0.0 110.087 -172.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -80.92 159.47 24.96 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.754 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -100.04 177.24 5.15 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.73 0.812 . . . . 0.0 111.022 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.7 m -72.4 0.51 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.688 1.195 . . . . 0.0 113.298 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -119.98 6.0 10.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.656 0.782 . . . . 0.0 112.264 -173.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 156' ' ' VAL . 8.2 mm-40 -82.28 94.8 7.41 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.263 0.554 . . . . 0.0 111.588 -171.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -79.21 101.47 8.0 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.938 171.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 35.9 m -120.08 -166.29 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 125.974 1.71 . . . . 0.0 108.995 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 207' ' ' ARG . 1.8 t70 -122.12 165.13 16.58 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 154' ' ' ALA . . . -129.42 140.64 51.26 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.353 0.524 . . . . 0.0 111.418 -175.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.558 HH11 ' HA ' ' A' ' 146' ' ' THR . 1.1 tmt_? -90.74 102.3 15.05 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.401 ' HB2' ' HD1' ' A' ' 152' ' ' PHE . 9.3 t70 -65.25 110.82 2.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.558 ' HA ' HH11 ' A' ' 144' ' ' ARG . 13.1 t -72.58 -26.39 61.69 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 122.97 0.508 . . . . 0.0 111.965 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -80.82 -41.26 23.56 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.695 0.798 . . . . 0.0 111.19 -173.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.5 ttm -94.57 -33.78 12.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.434 0.694 . . . . 0.0 110.767 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.51 14.95 67.14 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.279 -171.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.4 175.23 5.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.133 0.973 . . . . 0.0 110.614 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -115.92 129.79 56.55 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.401 ' HD1' ' HB2' ' A' ' 145' ' ' ASP . 97.1 m-85 -131.9 135.71 46.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 188' ' ' TYR . 23.9 mt-10 -60.52 142.85 54.79 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.748 0.655 . . . . 0.0 109.309 -178.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 143' ' ' ALA . . . -133.49 117.23 16.92 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.818 0.736 . . . . 0.0 111.267 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -94.24 101.88 13.88 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 55.1 t -63.68 108.55 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 172.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.427 HG11 ' HE2' ' A' ' 187' ' ' LYS . 29.0 m -108.45 -10.52 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.331 0.652 . . . . 0.0 111.97 -177.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 34.6 ttm-85 -168.85 148.2 4.19 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.384 0.674 . . . . 0.0 109.892 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.07 130.2 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.213 1.005 . . . . 0.0 109.484 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 38.7 p -130.94 151.84 50.91 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -103.19 178.75 4.47 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp . . . . . 0 N--CA 1.483 1.191 0 C-N-CA 123.099 0.56 . . . . 0.0 110.944 172.77 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 C--O 1.241 0.629 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.0 97.43 2.31 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.287 -172.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.63 19.64 0.48 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.463 171.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.5 m -66.97 162.14 3.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 124.537 1.135 . . . . 0.0 110.382 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.9 mp -94.4 109.7 22.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -174.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.403 ' HB3' HG13 ' A' ' 186' ' ' VAL . 71.1 m-85 -88.41 109.09 19.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.996 0.919 . . . . 0.0 109.165 172.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -80.31 88.94 5.51 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 156' ' ' VAL . 9.9 m -114.0 155.21 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.555 ' HG2' HG22 ' A' ' 196' ' ' VAL . 43.8 mtmt -115.06 131.81 56.8 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' A' ' 153' ' ' GLU . 19.7 m-30 -60.82 97.62 0.06 Allowed 'General case' 0 C--O 1.209 -1.038 0 O-C-N 123.586 0.554 . . . . 0.0 110.031 170.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -68.05 -21.18 65.01 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.687 0.795 . . . . 0.0 111.652 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 25.6 p30 -85.54 -28.77 24.69 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.67 0.788 . . . . 0.0 111.827 173.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -135.13 69.17 69.99 Favored Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 123.364 0.665 . . . . 0.0 109.818 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.61 -7.3 20.59 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.476 2.118 . . . . 0.0 112.902 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.79 -9.67 59.15 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.634 0.773 . . . . 0.0 110.88 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.49 -19.54 52.81 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.749 0.82 . . . . 0.0 110.443 169.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 84.78 -165.45 40.21 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.911 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.555 HG22 ' HG2' ' A' ' 187' ' ' LYS . 42.2 t -79.24 129.6 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 32.1 m -114.67 155.12 15.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 124.328 1.051 . . . . 0.0 109.541 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.551 ' HB2' HG23 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -102.45 117.08 33.95 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.597 0.759 . . . . 0.0 109.574 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 79.8 mmm -120.79 169.67 10.2 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.033 0.933 . . . . 0.0 109.702 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.442 ' H ' ' HB2' ' A' ' 203' ' ' ASP . 19.4 m-80 -109.92 178.58 4.37 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.334 0.654 . . . . 0.0 109.611 172.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 22.7 t -65.36 -39.82 92.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.419 0.688 . . . . 0.0 110.545 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -65.31 -22.87 66.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.546 0.738 . . . . 0.0 111.847 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' A' ' 200' ' ' ASN . 33.9 m-20 -97.85 2.1 48.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.646 0.779 . . . . 0.0 112.339 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.9 m -121.55 134.74 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 171.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 7.2 ptm180 -120.58 166.4 13.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.012 1.325 . . . . 0.0 109.777 -177.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.02 167.62 21.15 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 163.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.66 ' H ' ' HA ' ' A' ' 288' ' ' PRO . 37.8 ttp180 -143.61 125.98 15.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.39 0.541 . . . . 0.0 110.405 169.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -81.82 158.91 23.9 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.671 1.188 . . . . 0.0 111.782 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.51 23.97 1.51 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.584 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 99.3 m -108.05 113.57 26.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.737 0.815 . . . . 0.0 110.473 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 14.8 mt -85.62 125.98 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 162.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.506 HG21 HG11 ' A' ' 223' ' ' VAL . 46.0 mm -75.7 147.03 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 123.297 0.639 . . . . 0.0 110.79 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.03 179.75 5.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.431 1.092 . . . . 0.0 109.54 176.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -59.89 -32.09 70.41 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.865 0.866 . . . . 0.0 111.037 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -68.92 -25.21 64.47 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.472 ' HB2' HG23 ' A' ' 212' ' ' ILE . 26.3 m-20 -77.21 -26.01 52.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.549 0.34 . . . . 0.0 110.937 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.551 HD22 HG13 ' A' ' 243' ' ' ILE . 50.4 mt -73.43 144.01 46.5 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.614 0.721 . . . . 0.0 112.848 -165.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.27 169.94 20.16 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.033 -1.439 . . . . 0.0 107.987 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.9 117.87 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.91 -6.76 57.01 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 116.024 -0.534 . . . . 0.0 113.171 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.474 ' HG2' ' HA ' ' A' ' 217' ' ' LEU . 4.0 tp-100 -64.49 120.64 12.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.547 0.739 . . . . 0.0 109.644 174.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.7 p -102.88 130.08 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 109.9 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.506 HG11 HG21 ' A' ' 212' ' ' ILE . 15.0 m -141.34 179.8 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 124.532 1.133 . . . . 0.0 110.232 -171.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.412 ' HB2' HD11 ' A' ' 280' ' ' ILE . 21.0 ttp -141.72 124.33 15.9 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 118.033 0.378 . . . . 0.0 111.877 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.566 HD12 ' HB2' ' A' ' 273' ' ' PHE . 2.2 pt? -138.69 167.13 22.64 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.143 0.977 . . . . 0.0 110.404 -174.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.81 121.15 26.07 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 170.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -142.98 146.9 34.33 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -122.95 116.06 29.0 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.12 -24.13 66.42 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.229 1.953 . . . . 0.0 112.395 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.57 -44.11 21.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.265 0.626 . . . . 0.0 110.549 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -122.24 80.45 44.62 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.761 0.825 . . . . 0.0 109.798 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.89 -19.92 64.48 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.137 2.558 . . . . 0.0 114.408 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.48 ' HD3' HD13 ' A' ' 272' ' ' ILE . 5.0 tppp? -82.72 -27.14 31.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.943 0.497 . . . . 0.0 111.424 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.526 ' HG2' ' HG2' ' A' ' 235' ' ' ARG . 34.6 tt0 -118.38 160.46 21.63 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 120.913 0.387 . . . . 0.0 110.849 -173.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.526 ' HG2' ' HG2' ' A' ' 234' ' ' GLU . 24.4 ptt-85 -49.09 149.5 1.94 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.442 1.497 . . . . 0.0 113.587 175.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -141.49 -110.53 0.82 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 171.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -117.23 165.17 13.75 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.857 0.863 . . . . 0.0 109.161 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . 0.474 ' CZ2' ' HB3' ' A' ' 296' ' ' ARG . 54.0 m95 -80.32 115.01 19.63 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -127.1 166.6 17.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . 0.447 ' HB2' HG23 ' A' ' 260' ' ' VAL . 5.2 m-20 -82.8 156.62 23.58 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -143.49 138.45 29.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 167.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -111.17 118.54 36.25 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.635 HD12 HD21 ' A' ' 255' ' ' LEU . 29.1 mm -63.9 104.56 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 124.459 1.099 . . . . 0.0 110.364 -169.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.481 ' H ' ' HA ' ' A' ' 257' ' ' ALA . 18.8 m -79.82 -32.36 40.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.8 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.591 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 36.5 ttm180 -164.01 156.19 17.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.05 0.94 . . . . 0.0 109.559 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -155.81 148.78 24.34 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -150.5 135.18 17.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.872 0.469 . . . . 0.0 109.904 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -91.93 122.72 34.72 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 58.4 p -122.64 154.44 38.02 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -62.01 -20.59 64.07 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.6 p -97.94 -29.75 13.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.992 0.517 . . . . 0.0 112.164 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.45 165.09 31.64 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.24 0.543 . . . . 0.0 112.384 -169.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -97.79 103.41 15.35 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -92.23 141.32 28.7 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.962 0.905 . . . . 0.0 110.601 -171.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.635 HD21 HD12 ' A' ' 243' ' ' ILE . 1.2 tt -149.66 138.93 21.35 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.668 0.787 . . . . 0.0 108.985 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . 0.591 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 95.5 m-85 -132.09 131.86 42.77 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.921 0.889 . . . . 0.0 108.602 169.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.481 ' HA ' ' H ' ' A' ' 244' ' ' SER . . . -145.97 148.98 33.33 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.001 0.429 . . . . 0.0 111.223 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 43.9 t30 -79.61 97.02 6.34 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.406 171.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.57 103.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 240' ' ' ASP . 30.9 m -96.44 120.24 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.744 0.783 . . . . 0.0 110.56 -171.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.5 HD12 ' HB2' ' A' ' 264' ' ' ASP . 19.6 mt -92.26 -159.64 0.68 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.816 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.89 -40.62 89.22 Favored Glycine 0 C--N 1.352 1.423 0 N-CA-C 113.524 0.169 . . . . 0.0 113.524 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -123.5 -49.55 1.9 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.82 0.848 . . . . 0.0 109.675 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.5 ' HB2' HD12 ' A' ' 261' ' ' LEU . 3.3 m-20 -75.16 172.39 12.47 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.481 1.112 . . . . 0.0 111.932 -176.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 15.3 p -159.28 114.47 2.47 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.952 0.901 . . . . 0.0 109.37 175.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -82.06 88.93 6.41 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 25.8 t-20 -76.98 139.47 40.12 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.017 -175.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 38.5 t70 68.07 20.0 9.13 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.696 1.198 . . . . 0.0 111.276 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 48.9 t -71.71 122.84 21.33 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 255' ' ' LEU . 41.7 ttp180 -71.04 119.67 15.5 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.484 ' HB ' HD13 ' A' ' 255' ' ' LEU . 51.0 mm -78.71 95.98 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.615 0 CA-C-O 122.018 0.913 . . . . 0.0 110.163 -173.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.48 HD13 ' HD3' ' A' ' 233' ' ' LYS . 73.4 mt -67.5 -29.74 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 113.263 -1.79 . . . . 0.0 110.337 173.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.599 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 15.0 m-85 -95.65 45.47 1.09 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.678 1.191 . . . . 0.0 109.585 -173.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . 0.545 HG23 HD12 ' A' ' 255' ' ' LEU . 7.3 p -67.01 -20.52 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 124.576 1.15 . . . . 0.0 112.45 -175.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.38 -17.86 19.46 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.4 0.68 . . . . 0.0 111.135 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 65.2 mm-40 -93.59 16.63 13.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.408 1.083 . . . . 0.0 112.045 -174.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.81 138.01 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.303 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -125.78 163.89 21.89 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.493 1.517 . . . . 0.0 110.049 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 279' ' ' LYS . 0.6 OUTLIER -63.35 136.39 57.62 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.353 178.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 224' ' ' MET . 18.3 mm -98.8 116.77 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 162.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.18 134.77 40.48 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.473 1.109 . . . . 0.0 108.948 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -82.19 134.99 48.07 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.179 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.12 124.28 15.58 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.852 2.368 . . . . 0.0 111.794 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.98 -46.87 1.21 Allowed Glycine 0 C--N 1.344 0.98 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -75.87 -23.55 55.63 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.616 0.767 . . . . 0.0 110.925 175.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -130.84 159.13 22.88 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 53.5 p -97.32 150.12 36.45 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.217 0.607 . . . . 0.0 110.712 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.66 ' HA ' ' H ' ' A' ' 207' ' ' ARG . 86.3 Cg_endo -74.14 -171.76 0.98 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.856 2.371 . . . . 0.0 111.897 175.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 16.1 mmt -75.21 79.65 2.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.667 0.746 . . . . 0.0 110.285 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 6.8 p -92.7 -29.94 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.869 1.268 . . . . 0.0 108.619 173.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -81.34 161.29 23.88 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.945 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -46.58 99.41 0.21 Allowed Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 124.987 1.315 . . . . 0.0 111.995 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.31 99.85 0.17 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.608 2.872 . . . . 0.0 114.236 -164.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 55.7 mtm -78.21 92.09 4.43 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -83.28 170.14 14.95 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.072 0.463 . . . . 0.0 110.594 -178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.474 ' HB3' ' CZ2' ' A' ' 238' ' ' TRP . 20.9 mtm180 -89.08 91.05 8.66 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.57 0.748 . . . . 0.0 109.21 -169.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 70.17 -107.58 0.06 Allowed 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.27 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--O 1.24 0.561 0 C-N-CA 122.691 0.396 . . . . 0.0 110.13 -169.11 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.85 11.15 9.63 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.528 0.731 . . . . 0.0 111.202 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.464 ' O ' HG11 ' A' ' 159' ' ' VAL . 30.5 m-85 -124.4 163.4 21.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.235 1.014 . . . . 0.0 109.315 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.704 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 10.1 ptpp? -123.62 -179.57 4.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.275 1.03 . . . . 0.0 109.358 176.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.33 11.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.566 ' H ' ' HG3' ' A' ' 136' ' ' LYS . 6.9 t-20 -131.32 -6.64 3.79 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.247 0.619 . . . . 0.0 111.105 -174.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.704 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 29.8 mm-40 -78.22 87.15 4.31 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.59 0.71 . . . . 0.0 110.879 -177.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 11.4 p90 -68.91 100.49 1.2 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.289 169.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.38 177.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.456 0.702 . . . . 0.0 109.814 -177.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.635 ' HB2' ' HB3' ' A' ' 207' ' ' ARG . 16.9 t0 -94.25 152.06 18.97 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -146.89 115.65 6.81 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.401 0.68 . . . . 0.0 110.412 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -72.42 115.02 11.18 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.51 ' HB3' ' SD ' ' A' ' 148' ' ' MET . 9.8 t70 -66.68 110.41 3.21 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.4 p -64.74 -7.68 11.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.415 1.086 . . . . 0.0 113.775 -167.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -75.58 -57.14 4.06 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 117.898 0.317 . . . . 0.0 111.113 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.51 ' SD ' ' HB3' ' A' ' 145' ' ' ASP . 1.8 pmm? -104.5 -19.85 13.89 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.131 0.572 . . . . 0.0 111.38 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.44 9.57 61.51 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.911 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.01 128.62 34.16 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.591 0.357 . . . . 0.0 110.856 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.43 ' O ' ' HB2' ' A' ' 238' ' ' TRP . 97.1 m95 -73.09 133.19 44.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.578 0.751 . . . . 0.0 109.283 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -139.59 133.19 30.39 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.483 ' HG3' ' HG2' ' A' ' 207' ' ' ARG . 33.2 tt0 -70.26 90.12 0.68 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.272 0.558 . . . . 0.0 110.427 -175.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.588 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -96.87 118.69 33.86 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.363 0.665 . . . . 0.0 110.007 -172.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.635 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 65.0 tt0 -86.38 116.09 24.32 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.495 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.422 ' HA ' HG12 ' A' ' 186' ' ' VAL . 61.8 t -61.56 109.04 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 124.359 1.037 . . . . 0.0 108.807 172.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.532 HG11 ' HE2' ' A' ' 187' ' ' LYS . 16.1 m -114.58 -0.98 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.993 0.917 . . . . 0.0 112.012 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.618 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 51.1 ttt85 -167.1 138.04 3.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.271 1.028 . . . . 0.0 108.549 173.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 135' ' ' TYR . 26.0 m -116.19 134.19 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.9 p -142.5 150.82 41.0 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.454 0.702 . . . . 0.0 109.738 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -76.91 164.03 26.18 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.699 0.8 . . . . 0.0 110.424 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.872 0.367 . . . . 0.0 110.39 172.569 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 74.6 -6.48 1.9 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.201 1.401 . . . . 0.0 112.824 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -108.38 23.03 15.11 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 m -81.74 175.71 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 123.657 0.783 . . . . 0.0 109.417 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.526 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.4 mp -97.5 109.39 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.75 0.786 . . . . 0.0 109.964 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 201' ' ' SER . 93.2 m-85 -96.77 113.35 24.9 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.757 1.223 . . . . 0.0 108.211 168.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' HIS . . . . . 0.618 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 12.7 m-70 -78.67 103.87 8.91 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.588 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 35.5 m -117.36 157.31 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.468 1.107 . . . . 0.0 110.776 -172.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.532 ' HE2' HG11 ' A' ' 157' ' ' VAL . 50.6 mtmt -129.15 123.83 33.12 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -64.48 133.56 52.7 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.386 0.674 . . . . 0.0 110.339 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.37 -31.52 62.41 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -66.11 -30.75 71.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.089 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -145.69 71.74 13.93 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.046 0.538 . . . . 0.0 110.465 -174.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.87 -26.73 15.3 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.658 2.239 . . . . 0.0 112.047 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -76.42 -10.9 59.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.089 0.956 . . . . 0.0 110.885 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.73 6.09 19.2 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.259 0.624 . . . . 0.0 110.89 170.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.0 -154.14 49.35 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.393 0.433 . . . . 0.0 113.796 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.24 119.18 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.614 0.766 . . . . 0.0 109.57 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.7 m -109.13 153.55 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.992 0.917 . . . . 0.0 109.098 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.526 ' HB2' HG23 ' A' ' 183' ' ' ILE . 5.1 pm0 -91.1 137.3 32.47 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 80.4 mmm -148.51 158.52 44.17 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.049 0.94 . . . . 0.0 110.706 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -112.36 149.85 31.89 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.274 1.43 . . . . 0.0 110.477 -178.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.72 ' HA ' HG22 ' A' ' 204' ' ' VAL . 33.0 t -64.14 -30.32 71.39 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.071 0.949 . . . . 0.0 112.611 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -67.68 -20.63 65.32 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 122.519 -0.113 . . . . 0.0 111.131 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -115.15 -1.8 12.9 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.652 0.781 . . . . 0.0 111.838 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 201' ' ' SER . 6.0 m -115.71 118.94 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.962 0.887 . . . . 0.0 109.37 169.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -106.07 158.7 16.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -175.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.25 128.12 34.39 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 169.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.635 ' HB3' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -76.28 138.26 40.43 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.127 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -88.57 139.79 30.12 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -90.7 -0.36 57.67 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.479 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 28.0 m -84.29 112.93 20.75 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.51 121.91 37.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.092 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.1 mm -93.41 148.66 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.141 0.977 . . . . 0.0 109.95 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.669 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 16.2 ptpt -123.9 169.02 12.01 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.541 0.736 . . . . 0.0 110.226 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -51.37 -44.12 62.02 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.112 0.965 . . . . 0.0 111.562 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -60.78 -35.21 75.87 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.171 -177.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.11 -7.87 57.6 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.944 0.897 . . . . 0.0 111.372 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.509 ' O ' ' HD3' ' A' ' 246' ' ' LYS . 97.4 mt -84.67 137.55 33.19 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.736 0.814 . . . . 0.0 110.077 175.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . 0.478 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 9.6 pt-20 -151.78 171.64 17.4 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.773 0.829 . . . . 0.0 110.578 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 29.2 m -67.56 116.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 122.834 0.454 . . . . 0.0 111.745 -175.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.07 -15.12 33.64 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.345 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -71.92 122.42 20.77 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.57 1.148 . . . . 0.0 110.981 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.431 ' HB ' ' NH2' ' A' ' 282' ' ' ARG . 60.7 t -103.73 123.69 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 174.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.88 148.95 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 125.105 1.362 . . . . 0.0 109.927 -176.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 15.7 ptm -98.03 122.7 41.49 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.351 0.596 . . . . 0.0 111.22 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.89 141.85 40.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.742 1.217 . . . . 0.0 109.595 -171.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -96.34 107.35 19.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.017 0.913 . . . . 0.0 111.869 -173.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.559 ' HE2' ' HB2' ' A' ' 239' ' ' TYR . 20.4 p90 -136.33 156.83 48.08 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -87.62 125.07 66.38 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.56 -31.75 95.0 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.366 2.044 . . . . 0.0 112.707 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -81.47 -24.63 36.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.538 0.735 . . . . 0.0 110.982 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -134.62 81.81 46.79 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 123.716 0.807 . . . . 0.0 109.636 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.1 -27.14 73.3 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.602 2.201 . . . . 0.0 112.3 -175.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -85.42 15.07 4.71 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.357 1.063 . . . . 0.0 110.649 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -140.4 146.33 38.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.835 0.854 . . . . 0.0 110.061 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -71.37 138.45 49.2 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.437 0.695 . . . . 0.0 109.42 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.27 -114.36 0.52 Allowed Glycine 0 C--N 1.339 0.738 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -100.17 143.4 30.41 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.476 1.111 . . . . 0.0 109.694 -170.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' TRP . . . . . 0.43 ' HB2' ' O ' ' A' ' 151' ' ' TRP . 60.7 m95 -74.34 124.01 25.67 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.77 0.428 . . . . 0.0 110.049 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.559 ' HB2' ' HE2' ' A' ' 227' ' ' TYR . 96.3 m-85 -131.59 147.29 52.51 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -81.67 142.75 32.44 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.495 ' HB2' HG12 ' A' ' 259' ' ' VAL . . . -142.83 135.95 28.27 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 123.461 0.705 . . . . 0.0 110.029 -170.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -95.98 115.72 27.86 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.6 HD12 HD11 ' A' ' 255' ' ' LEU . 20.0 mm -65.1 113.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 123.803 0.841 . . . . 0.0 108.911 -175.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.4 p -90.97 -20.43 22.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.806 0.842 . . . . 0.0 110.954 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -161.81 142.15 10.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.1 0.56 . . . . 0.0 110.859 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 217' ' ' LEU . 23.5 pttm -122.55 129.5 52.01 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 167.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -155.27 150.54 27.02 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.923 0.889 . . . . 0.0 108.772 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -142.79 137.69 29.89 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.279 0.632 . . . . 0.0 109.761 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 32.7 p -99.04 178.04 5.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 161.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -68.14 -26.7 65.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.203 0.601 . . . . 0.0 110.929 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.7 p -86.5 -30.3 22.07 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.096 0.558 . . . . 0.0 112.132 -174.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -167.21 173.29 9.14 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.983 0.513 . . . . 0.0 110.941 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -109.73 113.53 26.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.105 0.962 . . . . 0.0 109.887 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -91.34 92.45 8.6 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.6 HD11 HD12 ' A' ' 243' ' ' ILE . 1.8 tm? -109.51 129.46 55.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.0 130.79 53.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.52 135.34 22.33 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.069 0.948 . . . . 0.0 109.736 -175.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.418 HD22 ' N ' ' A' ' 258' ' ' ASN . 0.8 OUTLIER -76.42 97.96 4.43 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 176.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 266' ' ' LEU . 18.8 m -81.86 107.3 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.488 -175.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.0 p -93.33 131.65 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.377 -175.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.37 -171.6 2.56 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.841 1.256 . . . . 0.0 109.491 174.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -85.9 -17.46 61.42 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-N 116.88 -0.146 . . . . 0.0 113.397 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -122.56 -34.18 3.29 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.368 1.067 . . . . 0.0 110.083 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.46 177.69 5.11 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.758 0.823 . . . . 0.0 109.77 -173.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 33.3 t -150.52 112.96 4.67 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.496 ' HB2' HG23 ' A' ' 259' ' ' VAL . 66.3 mt -80.49 105.83 12.04 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -64.5 122.61 17.19 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.455 0.702 . . . . 0.0 110.952 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 15.1 t70 54.63 74.37 0.35 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.724 1.209 . . . . 0.0 112.325 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 43.6 t -102.2 139.78 37.36 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.495 0.718 . . . . 0.0 109.651 173.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -69.51 134.8 49.31 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.096 0.558 . . . . 0.0 109.639 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 33.1 mm -107.55 130.74 59.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 48.7 mt -98.07 -29.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.39 1.076 . . . . 0.0 110.365 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -95.03 38.03 1.14 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.235 1.014 . . . . 0.0 110.242 -167.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.9 -29.77 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.131 1.372 . . . . 0.0 113.534 -166.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ASP . . . . . 0.669 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 45.6 m-20 -100.05 -0.37 39.27 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.392 0.677 . . . . 0.0 111.674 -175.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.541 ' HB2' ' HE3' ' A' ' 297' ' ' LYS . 11.8 pt-20 -125.07 22.59 7.91 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.567 0.698 . . . . 0.0 110.845 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.76 154.24 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.5 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -108.84 160.36 16.05 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.508 0.671 . . . . 0.0 110.336 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -79.11 145.48 33.73 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.508 1.123 . . . . 0.0 111.239 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.429 HG22 ' HG3' ' A' ' 282' ' ' ARG . 40.2 mm -79.67 114.18 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -76.45 115.51 16.26 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.431 ' NH2' ' HB ' ' A' ' 222' ' ' VAL . 95.2 mtt180 -118.8 148.95 45.56 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.008 0.923 . . . . 0.0 109.836 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -55.66 122.22 11.34 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.12 2.546 . . . . 0.0 112.884 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 98.87 -52.03 1.14 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.368 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.35 -22.47 18.31 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.081 0.552 . . . . 0.0 112.139 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -90.29 98.69 2.48 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 8.4 m -64.52 144.56 98.65 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 122.821 0.448 . . . . 0.0 110.613 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.44 140.43 43.86 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.629 2.22 . . . . 0.0 111.447 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 27.6 ttt -76.39 84.36 3.13 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.819 0.819 . . . . 0.0 110.232 -177.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.65 -27.38 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.321 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.28 178.29 8.38 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.253 1.021 . . . . 0.0 109.935 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -42.92 129.02 3.19 Favored Pre-proline 0 N--CA 1.489 1.481 0 C-N-CA 125.4 1.48 . . . . 0.0 113.304 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -58.73 84.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 123.337 2.691 . . . . 0.0 113.702 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.5 mmm -74.56 78.02 1.97 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.799 1.24 . . . . 0.0 108.292 168.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -56.9 170.65 0.41 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.013 0.925 . . . . 0.0 113.313 -175.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.414 ' HD3' ' HB2' ' A' ' 153' ' ' GLU . 3.4 tpt180 -57.35 155.94 8.41 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.08 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.541 ' HE3' ' HB2' ' A' ' 276' ' ' GLU . 65.3 mttm -82.99 64.71 7.75 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 165.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.5 p . . . . . 0 C--O 1.241 0.655 0 CA-C-N 112.912 -1.949 . . . . 0.0 110.384 -171.702 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 176' ' ' PRO . 1.4 mm? -100.37 -12.25 19.58 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.397 0.679 . . . . 0.0 111.419 -171.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.87 138.78 33.02 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.401 ' H ' ' HB2' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -93.45 176.24 6.45 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 118.532 0.605 . . . . 0.0 112.226 -174.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.68 -14.96 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 124.578 1.151 . . . . 0.0 111.694 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.448 ' HA ' ' NE2' ' A' ' 155' ' ' GLN . 35.2 m-80 -113.01 24.96 11.83 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.34 0.656 . . . . 0.0 111.636 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.503 ' HG3' HG13 ' A' ' 141' ' ' VAL . 8.9 tp10 -98.98 79.77 2.4 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.632 0.73 . . . . 0.0 111.496 -173.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 9.5 p90 -73.55 98.37 2.8 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.172 173.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.503 HG13 ' HG3' ' A' ' 139' ' ' GLU . 15.7 m -114.87 171.56 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.771 0.828 . . . . 0.0 109.196 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 7.1 t0 -90.91 107.74 19.39 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -172.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.74 99.74 12.57 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.956 0.902 . . . . 0.0 109.756 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -76.06 98.91 4.45 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -64.9 123.68 20.06 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 170.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.1 t -79.9 -28.15 39.87 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.741 0.816 . . . . 0.0 110.837 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -68.85 -51.49 39.91 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.065 0.946 . . . . 0.0 111.124 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 43.8 ttp -94.72 -14.1 25.1 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.343 0.657 . . . . 0.0 109.883 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.88 7.08 86.17 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 113.668 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.52 134.52 43.36 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.733 0.413 . . . . 0.0 111.871 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -75.31 135.85 40.89 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.386 1.074 . . . . 0.0 109.34 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -143.14 118.4 10.19 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.491 ' HG3' ' NH1' ' A' ' 296' ' ' ARG . 41.5 mt-10 -59.21 98.58 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.996 0.518 . . . . 0.0 109.889 176.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -103.04 138.82 39.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.432 1.093 . . . . 0.0 112.374 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.4 tp60 -87.2 104.47 16.41 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.921 1.688 . . . . 0.0 110.546 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.651 HG22 HG12 ' A' ' 186' ' ' VAL . 59.2 t -61.99 115.43 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.64 -12.77 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.89 0.876 . . . . 0.0 111.265 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -161.17 144.98 13.16 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.539 0.736 . . . . 0.0 109.549 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.22 137.33 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 166.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.6 p -132.65 150.62 52.13 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.632 HH21 ' HB3' ' A' ' 165' ' ' SER . 77.0 mtm180 -87.37 161.09 18.1 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.998 176.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -76.12 -16.5 59.88 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.87 159.63 81.61 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 124.521 1.128 . . . . 0.0 110.296 164.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.63 91.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.446 2.764 . . . . 0.0 113.631 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.632 ' HB3' HH21 ' A' ' 161' ' ' ARG . 19.9 p -157.46 98.9 1.72 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.07 1.348 . . . . 0.0 108.348 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -103.9 -21.18 13.68 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.837 0.855 . . . . 0.0 110.781 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -103.74 -165.94 1.21 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.959 0.904 . . . . 0.0 110.371 -177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -52.99 127.6 45.74 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 123.558 0.743 . . . . 0.0 110.907 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.85 134.86 45.43 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.746 2.297 . . . . 0.0 113.042 -169.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 28.4 p -158.14 -177.06 6.28 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.889 0.876 . . . . 0.0 109.761 -173.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 30.9 m 58.72 58.03 3.45 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.163 0.985 . . . . 0.0 110.938 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.3 m 55.4 77.02 0.24 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.499 1.119 . . . . 0.0 110.787 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 14.4 t -90.24 7.94 35.67 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.938 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 70.1 m -62.29 97.13 0.08 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 123.342 0.657 . . . . 0.0 110.446 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.407 ' HA ' ' HE ' ' A' ' 175' ' ' ARG . 2.3 tpm_? -140.1 78.26 24.16 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.886 0.874 . . . . 0.0 110.269 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.576 ' HB3' HD11 ' A' ' 134' ' ' LEU . 68.2 Cg_endo -89.52 174.26 3.54 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.419 2.746 . . . . 0.0 112.336 169.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -169.12 -171.33 1.28 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.717 0.807 . . . . 0.0 110.954 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.12 -58.75 2.93 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -120.96 105.51 10.73 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 163.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.462 ' HB3' HG22 ' A' ' 182' ' ' VAL . 2.3 mp0 -68.61 105.31 2.21 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.484 -172.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.31 50.23 0.5 Allowed 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 122.234 1.016 . . . . 0.0 110.283 166.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 180' ' ' GLU . 13.2 m -122.64 160.85 24.59 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 174.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.519 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.3 mp -95.56 110.83 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -166.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -92.59 109.2 20.61 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -78.56 98.68 6.21 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 156' ' ' VAL . 14.7 m -107.98 165.43 4.68 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.358 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -130.43 116.49 18.31 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -54.21 110.26 0.59 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.635 0.652 . . . . 0.0 109.26 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.03 -22.42 62.14 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.738 0.78 . . . . 0.0 109.217 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.622 ' HA ' ' HA ' ' A' ' 297' ' ' LYS . 0.9 OUTLIER -69.3 -28.37 66.21 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.837 1.255 . . . . 0.0 111.899 171.278 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -142.2 78.82 16.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 123.75 0.82 . . . . 0.0 109.862 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.09 -22.33 55.41 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.322 2.682 . . . . 0.0 113.814 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -66.27 -18.85 65.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.178 0.991 . . . . 0.0 112.074 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.11 -21.65 58.76 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.987 0.515 . . . . 0.0 111.241 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 67.24 -148.0 49.63 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.67 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 18.8 t -84.56 114.7 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.3 m -112.2 151.01 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.657 1.183 . . . . 0.0 109.39 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.519 ' HB2' HG23 ' A' ' 183' ' ' ILE . 16.6 pt20 -94.66 123.45 38.1 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.061 0.544 . . . . 0.0 110.568 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 87.8 mmm -139.17 135.6 34.19 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -88.11 176.46 7.27 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 14.0 t -64.96 -39.81 94.05 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.074 0.397 . . . . 0.0 111.188 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -50.97 -29.12 11.41 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.68 0.792 . . . . 0.0 112.388 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -92.92 -39.17 11.3 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.738 0.815 . . . . 0.0 111.34 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.429 HG11 HG11 ' A' ' 186' ' ' VAL . 27.8 m -98.77 114.84 37.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 CA-C-O 121.991 0.9 . . . . 0.0 110.132 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -110.81 165.91 11.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.673 1.189 . . . . 0.0 108.704 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -78.88 124.82 28.61 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 102.41 0.22 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.548 0.739 . . . . 0.0 110.33 172.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 281' ' ' GLU . . . -68.6 99.36 0.98 Allowed 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.704 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -77.06 75.02 3.63 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.752 0.657 . . . . 0.0 110.223 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 92.5 m -147.34 108.54 4.26 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 28.8 mt -82.86 116.5 27.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.611 HD11 ' HB3' ' A' ' 279' ' ' LYS . 41.5 mm -79.25 120.41 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.516 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -76.96 164.99 25.26 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.519 ' HA ' HD12 ' A' ' 217' ' ' LEU . 90.3 t90 -56.04 -43.65 78.06 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.686 0.794 . . . . 0.0 111.029 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -69.48 -18.61 63.72 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.846 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.63 -19.12 22.21 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.769 0.427 . . . . 0.0 110.086 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 214' ' ' TRP . 88.2 mt -69.05 129.22 39.28 Favored 'General case' 0 C--N 1.359 1.005 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.456 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 7.9 pt-20 -147.89 160.59 42.62 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.215 1.006 . . . . 0.0 109.573 -175.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 35.0 m -59.4 134.66 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 123.631 0.582 . . . . 0.0 111.958 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.13 -22.26 30.22 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.835 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -74.62 121.47 21.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.201 0.6 . . . . 0.0 110.912 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 61.3 t -93.63 130.0 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.414 0.686 . . . . 0.0 109.275 177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.1 m -140.87 147.21 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.674 1.19 . . . . 0.0 109.584 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 20.8 ptm -98.64 127.93 44.75 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.343 0.657 . . . . 0.0 111.257 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.577 HD13 HG23 ' A' ' 271' ' ' ILE . 2.2 pt? -134.58 155.58 50.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.267 1.027 . . . . 0.0 110.602 -176.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -71.7 106.78 4.23 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -132.68 128.11 36.29 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.505 0.722 . . . . 0.0 109.964 -169.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.452 HD22 ' HB3' ' A' ' 231' ' ' ASN . 49.3 t30 -89.44 113.07 55.11 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 171.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.95 -5.26 16.73 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.645 2.23 . . . . 0.0 112.582 176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.86 -32.34 23.28 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.22 0.608 . . . . 0.0 110.176 171.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.452 ' HB3' HD22 ' A' ' 228' ' ' ASN . 33.8 t30 -151.52 105.16 2.91 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 123.923 0.889 . . . . 0.0 109.576 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.55 -18.39 63.27 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.27 2.647 . . . . 0.0 113.322 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -84.88 -5.96 59.34 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.049 0.94 . . . . 0.0 110.952 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -126.88 153.35 45.84 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.583 0.753 . . . . 0.0 110.054 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -75.27 162.59 28.3 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.537 0.735 . . . . 0.0 112.002 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -169.47 -124.21 0.72 Allowed Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.11 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -82.84 146.75 28.74 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.89 0.876 . . . . 0.0 109.559 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . 0.44 ' CE2' ' HD2' ' A' ' 296' ' ' ARG . 43.5 m95 -74.92 111.76 10.45 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.869 0.366 . . . . 0.0 111.673 -175.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -119.12 166.24 13.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.377 1.071 . . . . 0.0 110.193 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . 0.525 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 3.8 m-20 -82.45 158.62 23.17 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.931 0.892 . . . . 0.0 109.512 176.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -151.51 132.26 14.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.904 0.482 . . . . 0.0 109.774 169.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -95.95 117.28 30.32 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 174.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.616 HD12 HD11 ' A' ' 255' ' ' LEU . 25.3 mm -65.4 124.23 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 O-C-N 123.649 0.593 . . . . 0.0 109.424 -175.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.0 t -108.29 -43.51 4.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.575 0.75 . . . . 0.0 109.58 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.505 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 63.0 mtt180 -139.34 157.48 45.8 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.457 1.103 . . . . 0.0 110.0 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -154.37 120.22 5.24 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.06 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 45.7 ttt-85 -144.1 115.68 8.14 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -93.65 133.61 36.81 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.366 0.603 . . . . 0.0 110.0 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 39.2 p -107.97 166.71 10.51 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 167.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -71.33 -10.4 59.69 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.5 p -94.04 -28.71 15.59 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.192 0.597 . . . . 0.0 111.515 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -171.27 145.97 2.26 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -80.46 102.68 9.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.168 0.987 . . . . 0.0 109.482 172.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -95.47 140.16 30.71 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.35 0.66 . . . . 0.0 111.674 -173.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.616 HD11 HD12 ' A' ' 243' ' ' ILE . 0.6 OUTLIER -132.57 142.4 49.14 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -176.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . 0.505 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 92.1 m-85 -132.11 122.55 25.56 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.95 46.23 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.176 0.512 . . . . 0.0 111.778 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 39.9 t30 -78.64 95.58 5.29 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.73 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 59.9 t -76.19 107.17 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.26 0.553 . . . . 0.0 110.313 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 39.4 t -86.12 115.17 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.081 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.23 -152.56 0.12 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.013 1.325 . . . . 0.0 110.208 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -48.25 -65.23 2.63 Favored Glycine 0 C--N 1.363 2.056 0 C-N-CA 124.092 0.853 . . . . 0.0 114.266 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -123.09 -22.41 5.19 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.546 0.738 . . . . 0.0 109.575 165.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -76.17 177.35 7.24 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.166 0.987 . . . . 0.0 112.077 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 35.6 p -153.17 154.41 34.69 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.679 0.792 . . . . 0.0 110.44 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 69.8 mt -128.77 89.71 2.93 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.441 1.096 . . . . 0.0 108.783 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 61.6 t30 -71.87 136.55 46.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.759 0.424 . . . . 0.0 111.431 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 14.6 t70 60.35 68.58 0.75 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.24 1.416 . . . . 0.0 111.078 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 79.9 m -113.72 135.39 53.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.919 0.888 . . . . 0.0 109.553 169.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -66.51 116.7 7.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.926 0.49 . . . . 0.0 110.714 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.613 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 43.1 mm -92.49 96.28 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.981 0.912 . . . . 0.0 108.88 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 62.6 mt -76.23 -23.48 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.217 1.007 . . . . 0.0 110.713 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.446 ' HD2' HD12 ' A' ' 225' ' ' LEU . 24.5 m-85 -93.21 32.0 1.39 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.458 1.103 . . . . 0.0 111.214 -166.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.07 -21.45 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.273 1.029 . . . . 0.0 112.003 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.65 -21.72 44.46 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.914 0.886 . . . . 0.0 111.827 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.63 9.42 3.37 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.134 0.574 . . . . 0.0 112.278 -168.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.4 129.16 37.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 122.985 0.514 . . . . 0.0 110.263 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -92.52 161.33 14.65 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.749 0.82 . . . . 0.0 110.652 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.611 ' HB3' HD11 ' A' ' 212' ' ' ILE . 18.2 ptmt -82.32 158.12 23.54 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.446 0.698 . . . . 0.0 111.087 176.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 42.2 mm -87.65 131.39 35.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 166.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 208' ' ' ALA . 0.0 OUTLIER -72.44 104.79 3.9 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.427 -175.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.706 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 84.6 mtt180 -87.36 159.49 50.26 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 123.466 0.707 . . . . 0.0 111.125 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -55.25 94.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.426 2.751 . . . . 0.0 113.513 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.38 -46.44 1.24 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.294 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.706 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 21.6 tt0 -73.59 -17.88 61.12 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.3 0.64 . . . . 0.0 111.452 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -74.78 98.9 1.09 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.622 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.1 p -75.32 126.15 88.1 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.403 0.681 . . . . 0.0 111.124 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.24 167.1 26.5 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 123.193 2.595 . . . . 0.0 112.379 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . 0.569 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 55.1 ttm -86.26 81.39 8.41 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.4 p -96.21 -28.55 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.35 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -81.88 -172.71 4.06 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.373 1.069 . . . . 0.0 109.143 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -45.14 117.42 3.31 Favored Pre-proline 0 N--CA 1.489 1.49 0 C-N-CA 124.912 1.285 . . . . 0.0 112.742 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.569 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 64.9 Cg_exo -55.96 141.75 85.76 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.656 2.238 . . . . 0.0 113.36 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 24.5 mmt -84.06 -69.57 0.63 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 49.47 62.32 2.69 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 122.006 0.908 . . . . 0.0 109.15 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.491 ' NH1' ' HG3' ' A' ' 153' ' ' GLU . 12.5 ptt180 -58.48 -29.16 66.02 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.092 -166.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.622 ' HA ' ' HA ' ' A' ' 190' ' ' ASP . 38.6 mtmm 54.1 58.04 5.38 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.952 0.901 . . . . 0.0 111.974 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 6.6 m -78.3 83.69 4.53 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.037 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -143.97 75.1 0.31 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 176.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--N 1.387 2.578 0 C-N-CA 123.904 3.069 . . . . 0.0 112.936 -176.595 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.599 ' N ' ' HG ' ' A' ' 174' ' ' SER . . . . . . . . 0 N--CA 1.477 1.379 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.19 2.72 8.56 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.674 0.79 . . . . 0.0 110.808 173.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -127.54 137.6 52.66 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.467 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 2.1 mptp? -89.65 175.25 7.34 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.535 1.134 . . . . 0.0 110.256 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.7 m -75.9 8.07 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.035 0.934 . . . . 0.0 112.811 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -124.96 -1.17 7.83 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.622 0.769 . . . . 0.0 110.236 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.467 ' HG2' ' HB2' ' A' ' 136' ' ' LYS . 22.3 mm-40 -91.21 89.98 7.57 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.677 0.751 . . . . 0.0 111.652 -170.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 6.8 p90 -63.48 111.5 2.36 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.346 164.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.2 m -120.89 166.69 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.189 0.995 . . . . 0.0 109.32 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -93.05 104.95 17.12 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.494 ' HB2' HG12 ' A' ' 204' ' ' VAL . . . -109.65 117.56 34.25 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.753 1.221 . . . . 0.0 109.93 -176.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -73.93 112.74 10.35 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.79 127.49 32.68 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.6 m -69.58 -27.8 65.43 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.845 0.858 . . . . 0.0 111.38 -173.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.47 -44.12 13.0 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.459 0.704 . . . . 0.0 110.968 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 51.0 tpp -75.71 -37.62 59.31 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.75 0.82 . . . . 0.0 110.611 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.3 7.79 88.2 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.133 -0.939 . . . . 0.0 113.215 -172.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 239' ' ' TYR . . . -107.03 152.54 23.85 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.607 0.763 . . . . 0.0 110.858 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 238' ' ' TRP . 67.2 m95 -77.65 132.29 38.15 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.496 1.118 . . . . 0.0 109.919 171.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -136.54 130.97 33.23 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.235 1.014 . . . . 0.0 108.702 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.35 96.78 0.51 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.598 0.713 . . . . 0.0 109.218 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.72 128.15 45.83 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.928 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.648 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 56.7 tt0 -84.91 105.69 15.87 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.743 0.817 . . . . 0.0 110.647 -173.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.71 107.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.6 m -107.64 -3.13 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.651 0.781 . . . . 0.0 111.234 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.518 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 79.2 ttt180 -171.28 146.44 2.33 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 124.157 0.911 . . . . 0.0 108.986 176.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.0 m -125.78 144.39 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.4 p -131.85 130.44 41.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -73.32 147.99 43.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.668 0.787 . . . . 0.0 109.407 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -52.63 -56.28 16.53 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.179 0.592 . . . . 0.0 111.402 -176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.69 146.26 93.34 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.419 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -54.54 144.98 60.63 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.312 2.675 . . . . 0.0 113.613 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.9 m -70.12 -67.36 0.5 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.416 0.686 . . . . 0.0 110.136 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -177.28 158.8 1.51 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.712 1.205 . . . . 0.0 108.481 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -50.51 -47.66 57.3 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.081 0.952 . . . . 0.0 111.638 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -91.96 146.65 33.27 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.02 164.01 15.23 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 122.979 2.452 . . . . 0.0 113.097 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 77.9 m 73.03 -171.48 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.032 1.333 . . . . 0.0 111.033 -168.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.0 m 74.37 16.84 3.28 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.849 1.659 . . . . 0.0 112.815 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 30.4 p -76.64 91.9 3.46 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 173.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 37.1 p -86.49 145.8 26.65 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.875 0.87 . . . . 0.0 110.792 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.599 ' HG ' ' N ' ' A' ' 133' ' ' GLY . 16.0 m -92.64 113.06 25.23 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.201 1.0 . . . . 0.0 110.244 -172.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -111.99 107.52 55.97 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 123.68 0.792 . . . . 0.0 109.72 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -70.33 83.98 0.77 Allowed 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.469 2.113 . . . . 0.0 110.945 169.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.82 -71.43 0.47 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.029 0.932 . . . . 0.0 111.199 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 43.3 mt -147.88 -74.83 0.19 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -119.18 102.41 8.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 201' ' ' SER . 1.0 OUTLIER -80.75 67.89 6.79 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.404 1.097 . . . . 0.0 110.67 -178.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.504 ' HA ' ' H ' ' A' ' 201' ' ' SER . 67.9 m-20 -82.89 44.74 0.94 Allowed 'General case' 0 C--O 1.243 0.727 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.537 174.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.1 m -69.58 176.49 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.881 0 C-N-CA 124.472 1.109 . . . . 0.0 108.507 174.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 183' ' ' ILE . 2.6 mp -92.35 106.37 17.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -172.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -89.01 104.03 16.6 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 7.0 m170 -79.7 92.84 5.44 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.31 158.17 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.609 0.764 . . . . 0.0 110.615 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -123.98 119.49 29.71 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -57.83 125.83 24.74 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.74 -31.37 72.52 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.271 0.558 . . . . 0.0 109.974 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.46 -28.94 62.22 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.247 175.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -139.32 71.89 38.84 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.14 0.576 . . . . 0.0 112.022 -174.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.05 -15.86 28.99 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.527 2.151 . . . . 0.0 111.184 165.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.33 -22.89 66.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.315 1.046 . . . . 0.0 111.587 173.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -78.77 -5.37 53.14 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.791 0.836 . . . . 0.0 111.356 175.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.4 -161.95 53.13 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.555 0.534 . . . . 0.0 111.817 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 25.5 t -86.53 124.09 40.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 29.2 m -107.49 154.58 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.928 0.891 . . . . 0.0 110.09 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -92.93 131.16 38.18 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.542 0.737 . . . . 0.0 109.472 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 92.9 mmm -131.88 153.58 50.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.514 0.726 . . . . 0.0 109.299 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.551 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 36.9 m-80 -98.96 172.21 7.55 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.574 0.75 . . . . 0.0 109.163 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 180' ' ' GLU . 10.9 t -67.64 -29.34 68.63 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 118.139 0.427 . . . . 0.0 110.84 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.551 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 17.2 ptp180 -62.19 -25.56 67.85 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.474 0.71 . . . . 0.0 111.638 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -92.23 -39.87 11.3 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.87 0.868 . . . . 0.0 111.0 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' A' ' 201' ' ' SER . 26.8 m -93.85 117.35 37.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 CA-C-O 122.462 1.125 . . . . 0.0 109.292 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 170.82 7.67 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.906 174.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.82 148.78 27.56 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 167.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.41 ' O ' ' HE3' ' A' ' 289' ' ' MET . 37.7 mtm105 -72.37 109.91 6.42 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.38 113.75 3.84 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.83 0.452 . . . . 0.0 110.638 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' A' ' 289' ' ' MET . 5.8 ptm180 -82.09 9.36 8.66 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.007 0.923 . . . . 0.0 112.23 -177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.9 m -100.91 112.32 24.73 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.028 0.931 . . . . 0.0 110.088 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 277' ' ' VAL . 38.1 mt -85.54 130.75 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 279' ' ' LYS . 30.1 mm -96.77 148.08 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.516 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 1.5 ptpp? -129.52 171.22 12.8 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.97 0.908 . . . . 0.0 109.96 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.43 ' HA ' HD12 ' A' ' 217' ' ' LEU . 72.1 t-105 -53.78 -44.83 70.4 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.535 1.134 . . . . 0.0 112.103 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -71.24 -11.28 60.84 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.668 0.787 . . . . 0.0 112.442 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -109.33 -7.96 15.15 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.221 1.008 . . . . 0.0 110.704 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 213' ' ' LYS . 92.2 mt -72.17 124.11 24.33 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -134.03 146.73 50.64 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 31.6 m -67.44 126.89 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 123.54 0.525 . . . . 0.0 111.322 -174.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 106.1 -16.86 41.99 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.681 -0.511 . . . . 0.0 113.011 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.425 ' HG2' HG13 ' A' ' 223' ' ' VAL . 8.6 tt0 -80.4 122.24 26.72 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.21 0.604 . . . . 0.0 110.472 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 50.8 t -91.39 129.78 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.962 0.905 . . . . 0.0 108.935 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.425 HG13 ' HG2' ' A' ' 221' ' ' GLN . 2.8 m -145.73 149.65 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.676 1.19 . . . . 0.0 110.586 -172.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.523 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 20.0 ptm -100.34 125.51 46.58 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.643 0.777 . . . . 0.0 111.357 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.431 ' HG ' HG13 ' A' ' 277' ' ' VAL . 1.4 mp -127.11 158.7 36.32 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.971 0.908 . . . . 0.0 108.798 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -89.66 106.12 18.25 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.363 0.601 . . . . 0.0 110.232 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -167.4 148.09 5.45 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.749 1.22 . . . . 0.0 108.602 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -90.76 144.82 30.91 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.434 ' HB3' HD21 ' A' ' 261' ' ' LEU . 33.9 Cg_endo -62.29 -37.17 63.4 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.137 2.558 . . . . 0.0 112.373 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -71.03 -19.41 62.51 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.012 0.925 . . . . 0.0 111.721 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -144.23 82.97 10.38 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 122.746 0.419 . . . . 0.0 110.104 174.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.06 -4.48 15.49 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.534 2.156 . . . . 0.0 112.833 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -72.73 -27.51 62.09 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.106 0.963 . . . . 0.0 110.958 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -138.38 161.6 36.55 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.46 0.704 . . . . 0.0 110.376 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -52.81 156.34 2.02 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.575 1.55 . . . . 0.0 112.711 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -161.98 -93.42 0.09 OUTLIER Glycine 0 C--N 1.335 0.515 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.644 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -129.08 167.78 17.03 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.596 0.758 . . . . 0.0 109.354 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 151' ' ' TRP . 89.9 m95 -79.4 105.75 10.94 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 150' ' ' ALA . 46.6 m-85 -121.65 154.74 36.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.092 0.957 . . . . 0.0 109.726 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . 0.748 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 0.8 OUTLIER -82.07 154.12 25.76 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.555 -177.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -152.19 134.23 14.97 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -100.11 118.45 36.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.466 HD12 HD21 ' A' ' 255' ' ' LEU . 26.5 mm -59.09 110.01 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.9 m -100.25 -25.77 14.14 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.235 0.614 . . . . 0.0 110.352 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 59.8 ttt180 -172.02 149.95 2.46 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.174 0.99 . . . . 0.0 108.642 -174.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -154.85 147.95 24.77 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -148.49 119.06 7.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.709 0.804 . . . . 0.0 108.873 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -96.89 124.53 40.89 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 54.1 p -124.62 162.61 23.74 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 167.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -60.69 -18.58 54.9 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.693 0.797 . . . . 0.0 112.612 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 53.6 p -93.85 -32.92 13.74 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.45 0.7 . . . . 0.0 112.151 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -174.08 164.54 4.11 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.298 0.57 . . . . 0.0 111.225 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -107.47 114.91 29.22 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.388 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -94.78 97.44 10.05 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.526 ' O ' ' HA ' ' A' ' 270' ' ' ARG . 1.7 tt -102.83 125.58 49.63 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . 0.488 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 43.4 m-85 -118.46 116.98 27.8 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 176.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -136.92 143.56 42.98 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.237 0.615 . . . . 0.0 111.095 -175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -78.13 99.37 6.15 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 94.9 t -64.93 106.64 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.494 0.718 . . . . 0.0 109.37 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.748 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 58.6 t -87.52 98.89 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' A' ' 229' ' ' PRO . 31.9 mt -84.14 -177.94 6.8 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.416 176.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -76.65 -45.05 13.94 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.387 -0.37 . . . . 0.0 112.612 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -107.52 -5.47 17.57 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.959 0.904 . . . . 0.0 111.726 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -155.46 176.12 13.01 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.49 0.716 . . . . 0.0 110.25 -172.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 27.7 p -145.63 115.86 7.49 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.478 0.711 . . . . 0.0 110.404 171.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 66.1 mt -82.53 95.05 7.61 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.688 0.795 . . . . 0.0 109.911 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -70.93 136.28 48.44 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.346 0.258 . . . . 0.0 110.689 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 14.6 t70 60.08 75.7 0.39 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.957 1.303 . . . . 0.0 111.347 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 42.9 t -111.6 129.2 56.15 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.917 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 71.4 ttt-85 -74.73 107.88 7.12 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.435 ' HB ' HD13 ' A' ' 255' ' ' LEU . 43.2 mm -90.81 128.3 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.773 0.829 . . . . 0.0 109.572 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 67.2 mt -96.12 -21.33 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.194 0.998 . . . . 0.0 110.694 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -86.44 45.13 1.21 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.207 1.003 . . . . 0.0 111.471 -173.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.513 HG12 HD12 ' A' ' 255' ' ' LEU . 24.7 m -64.74 -21.84 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 125.11 1.364 . . . . 0.0 113.437 -169.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -110.87 -24.87 10.17 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.157 0.983 . . . . 0.0 110.115 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -89.0 44.26 1.2 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.879 0.872 . . . . 0.0 110.2 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.431 HG13 ' HG ' ' A' ' 225' ' ' LEU . 4.1 t -103.14 150.19 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.026 0.93 . . . . 0.0 109.279 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.523 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 72.9 m-85 -124.91 154.85 40.47 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 167.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.537 ' HB2' HD11 ' A' ' 212' ' ' ILE . 22.9 ttmm -77.42 144.85 37.54 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 45.9 mm -69.88 127.16 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.96 105.5 2.03 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 174.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 78.8 mtp180 -115.03 147.66 38.84 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 124.574 1.15 . . . . 0.0 109.888 -171.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.79 102.03 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.588 2.192 . . . . 0.0 111.407 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.51 -4.58 54.31 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-O 119.109 -0.828 . . . . 0.0 114.364 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 33.3 tt0 -128.27 -25.14 3.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.157 0.979 . . . . 0.0 112.426 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -75.13 112.14 3.56 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.8 m -64.75 131.44 95.15 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 117.091 0.445 . . . . 0.0 111.186 -172.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.68 135.41 19.69 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.306 2.67 . . . . 0.0 111.341 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . 0.485 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 38.5 ttm -78.97 82.3 5.16 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.836 0.826 . . . . 0.0 109.767 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.2 p -108.68 -23.12 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.293 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -99.52 -153.84 0.45 Allowed 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 293' ' ' PRO . 27.3 t-20 -57.5 127.16 77.14 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-N 119.116 0.871 . . . . 0.0 111.87 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.485 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 12.0 Cg_exo -72.57 111.9 3.34 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.373 2.715 . . . . 0.0 113.673 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 91.7 mmm -77.14 115.96 17.37 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.143 0.577 . . . . 0.0 110.207 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -100.01 171.7 7.67 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.309 1.044 . . . . 0.0 109.158 171.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.65 -29.06 2.67 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.687 0.795 . . . . 0.0 108.936 164.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -169.64 121.61 0.71 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.777 1.231 . . . . 0.0 109.013 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 22.9 t -159.16 122.73 3.78 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.688 0.795 . . . . 0.0 109.255 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -151.3 -65.67 0.01 OUTLIER Glycine 0 CA--C 1.543 1.783 0 CA-C-O 118.633 -1.093 . . . . 0.0 113.482 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo . . . . . 0 C--N 1.385 2.466 0 C-N-CA 125.218 3.946 . . . . 0.0 115.038 174.705 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.226 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -91.81 -13.31 31.67 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.848 0.859 . . . . 0.0 111.207 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.434 ' O ' HG11 ' A' ' 159' ' ' VAL . 25.6 m-85 -94.91 162.64 13.66 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.548 0.739 . . . . 0.0 109.542 171.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.75 -177.41 3.82 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.04 0.936 . . . . 0.0 109.043 171.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.5 m -68.22 2.47 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -173.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -112.94 -9.97 13.57 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.637 0.775 . . . . 0.0 111.377 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.87 84.87 3.44 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.459 0.703 . . . . 0.0 111.562 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.671 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 3.9 p90 -71.93 99.61 2.27 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.079 168.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.98 -178.97 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.476 1.11 . . . . 0.0 109.13 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 5.3 t0 -94.75 163.21 13.45 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.651 0.78 . . . . 0.0 108.922 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.436 ' HB2' HG12 ' A' ' 204' ' ' VAL . . . -152.07 125.35 8.74 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 120.872 0.368 . . . . 0.0 111.833 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -74.83 109.73 8.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.786 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.479 ' HB3' ' SD ' ' A' ' 148' ' ' MET . 9.2 t70 -80.01 117.99 21.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.8 m -66.86 -28.49 68.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.839 0.856 . . . . 0.0 112.333 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -58.05 -54.74 43.49 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.6 0.76 . . . . 0.0 111.948 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.479 ' SD ' ' HB3' ' A' ' 145' ' ' ASP . 1.7 pmm? -103.35 -8.86 19.93 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.575 0.35 . . . . 0.0 111.006 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.12 18.27 80.14 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 123.215 0.322 . . . . 0.0 113.518 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.427 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . . . -93.29 150.14 20.7 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.45 0.643 . . . . 0.0 111.899 -175.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -76.11 139.0 41.14 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.468 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -145.52 124.35 12.67 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 45.4 mt-10 -65.78 93.94 0.19 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.444 0.698 . . . . 0.0 110.993 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -99.44 120.06 39.0 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.095 0.558 . . . . 0.0 110.894 -176.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 53.4 tt0 -87.39 114.56 24.12 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.833 0.853 . . . . 0.0 110.664 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.428 ' HA ' HG12 ' A' ' 186' ' ' VAL . 50.1 t -59.88 114.74 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.1 m -115.35 -4.41 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.372 0.669 . . . . 0.0 111.264 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.52 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 76.7 ttt180 -164.56 138.86 5.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.836 0.854 . . . . 0.0 109.564 173.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 135' ' ' TYR . 34.4 m -117.19 137.64 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.511 0.724 . . . . 0.0 109.554 173.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.4 m -145.69 137.86 25.49 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.907 0.883 . . . . 0.0 108.857 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.95 135.11 36.33 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.604 ' HB2' HG13 ' A' ' 183' ' ' ILE . 55.3 tttm -98.05 87.07 3.86 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.158 0.983 . . . . 0.0 111.132 -170.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -173.8 157.38 2.78 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.479 1.112 . . . . 0.0 109.919 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.21 105.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.002 2.468 . . . . 0.0 112.503 169.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 39.7 m -89.74 -28.68 19.23 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.296 1.038 . . . . 0.0 111.301 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? 63.48 43.81 5.72 Favored 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 124.344 1.058 . . . . 0.0 109.294 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 75.0 -48.99 0.65 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.202 1.801 . . . . 0.0 112.331 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 169' ' ' PRO . 27.7 mt-10 -61.46 139.57 94.93 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.506 1.122 . . . . 0.0 112.393 -175.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 168' ' ' GLU . 23.7 Cg_exo -67.2 -162.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 123.457 2.772 . . . . 0.0 112.549 173.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 61.4 m 71.93 136.38 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.943 1.297 . . . . 0.0 111.677 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 39.3 m -79.47 67.39 5.2 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.655 0.782 . . . . 0.0 108.915 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.3 t -71.64 -41.09 69.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.27 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 80.8 p -111.08 161.5 15.85 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.609 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 34.7 t 52.78 86.09 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.807 1.243 . . . . 0.0 113.474 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 73.4 mtm-85 -112.13 97.72 39.92 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.94 -60.42 0.82 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.501 2.801 . . . . 0.0 114.162 -172.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 59.47 17.69 6.24 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.47 1.108 . . . . 0.0 112.96 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 85.2 mt -141.44 -58.46 0.49 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -175.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -148.22 110.08 4.51 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 173.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.24 87.81 0.82 Allowed 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.979 0.895 . . . . 0.0 110.82 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -80.51 73.13 7.44 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.145 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 18.0 m -125.73 172.59 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.338 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.607 HG23 ' HB2' ' A' ' 198' ' ' GLN . 97.5 mt -94.86 110.13 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 123.619 0.768 . . . . 0.0 110.045 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -103.1 106.93 17.55 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 43.3 m-70 -77.31 92.47 3.91 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 204' ' ' VAL . 35.0 m -108.38 151.02 10.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.336 -175.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.477 ' HD3' HG22 ' A' ' 196' ' ' VAL . 31.6 mmmt -110.92 113.12 25.45 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.217 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -57.43 105.6 0.26 Allowed 'General case' 0 C--O 1.206 -1.198 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 168.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.7 -24.02 64.45 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.211 0.529 . . . . 0.0 109.814 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -68.91 -31.86 71.07 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.201 1.0 . . . . 0.0 110.733 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -143.8 67.45 15.83 Favored Pre-proline 0 N--CA 1.487 1.381 0 C-N-CA 124.12 0.968 . . . . 0.0 110.667 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.3 -15.82 28.2 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.211 1.94 . . . . 0.0 113.177 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.36 -17.1 61.86 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.483 0.713 . . . . 0.0 111.024 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -87.63 25.17 1.53 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.119 0.967 . . . . 0.0 111.893 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 83.13 174.81 50.65 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.175 0.297 . . . . 0.0 113.84 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.477 HG22 ' HD3' ' A' ' 187' ' ' LYS . 3.1 t -92.2 118.32 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 172.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.32 143.62 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 122.903 0.481 . . . . 0.0 110.019 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.607 ' HB2' HG23 ' A' ' 183' ' ' ILE . 15.3 pt20 -106.92 114.36 28.41 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.31 0.576 . . . . 0.0 110.128 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 55.4 mtp -125.66 162.95 23.85 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.002 0.921 . . . . 0.0 109.701 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 6.7 m-80 -98.98 170.02 9.02 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.221 0.609 . . . . 0.0 109.55 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 50.9 m -56.42 -39.59 73.29 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.135 0.574 . . . . 0.0 111.634 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.46 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 34.1 ptt180 -54.66 -34.95 62.98 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.204 1.002 . . . . 0.0 112.222 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -86.82 -45.07 11.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.753 0.821 . . . . 0.0 110.534 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 186' ' ' VAL . 13.6 m -96.11 115.08 34.43 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 CA-C-O 121.797 0.808 . . . . 0.0 109.811 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -118.43 129.23 55.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.786 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.09 126.61 29.73 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.441 ' HE ' ' HB2' ' A' ' 294' ' ' MET . 91.1 mtm-85 -66.03 107.34 1.86 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 118.268 0.485 . . . . 0.0 111.789 -172.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.61 107.47 0.51 Allowed 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.175 170.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.441 ' HG2' ' HG3' ' A' ' 294' ' ' MET . 0.1 OUTLIER -75.28 81.04 2.38 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -173.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 33.5 m -145.54 108.44 4.53 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 54.0 mt -85.19 119.27 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.524 ' HB ' HG13 ' A' ' 277' ' ' VAL . 31.7 mm -91.45 152.86 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 123.911 0.884 . . . . 0.0 109.363 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -127.45 171.68 11.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.578 0.351 . . . . 0.0 110.681 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -48.93 -42.85 38.68 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.239 1.416 . . . . 0.0 111.874 -177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -62.06 -39.14 91.38 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.044 0.937 . . . . 0.0 111.93 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.438 ' HB2' HG23 ' A' ' 212' ' ' ILE . 61.2 m-20 -77.64 -22.31 50.89 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.077 0.551 . . . . 0.0 110.749 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.516 HD11 HG11 ' A' ' 277' ' ' VAL . 94.8 mt -72.41 109.98 6.49 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -114.14 154.14 28.32 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.161 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 32.0 m -67.97 130.35 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-O 120.754 0.312 . . . . 0.0 111.065 -175.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.05 -6.96 64.34 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.412 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.424 ' NE2' ' HA ' ' A' ' 217' ' ' LEU . 28.4 tt0 -88.55 121.22 30.69 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.236 0.615 . . . . 0.0 111.161 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.5 t -91.83 127.66 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.022 0.929 . . . . 0.0 109.3 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' A' ' 280' ' ' ILE . 3.5 m -142.77 151.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.974 1.31 . . . . 0.0 110.298 -172.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.481 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 16.1 ptm -101.06 128.14 47.26 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.932 0.493 . . . . 0.0 111.378 -177.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.577 ' HB3' HG23 ' A' ' 277' ' ' VAL . 2.3 pt? -145.72 174.72 10.96 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.273 1.029 . . . . 0.0 110.393 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.501 ' HB3' ' CZ3' ' A' ' 238' ' ' TRP . 8.1 p30 -79.03 131.22 36.2 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 167.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -168.91 142.43 2.92 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.498 HD21 ' HB3' ' A' ' 231' ' ' ASN . 6.0 p-10 -136.64 133.56 19.09 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.305 0.642 . . . . 0.0 109.959 172.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.12 -20.92 67.94 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.365 2.043 . . . . 0.0 112.303 170.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.45 -47.74 84.32 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.513 0.725 . . . . 0.0 110.824 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.498 ' HB3' HD21 ' A' ' 228' ' ' ASN . 53.2 t30 -145.35 82.21 9.85 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.668 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.9 -16.51 54.37 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.078 2.519 . . . . 0.0 112.958 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -76.47 -27.7 56.24 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.581 0.753 . . . . 0.0 111.843 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -121.95 165.71 15.55 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.706 0.402 . . . . 0.0 110.389 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -60.58 131.19 49.96 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.929 1.292 . . . . 0.0 112.0 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -127.2 -139.24 4.9 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.088 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -82.23 159.96 23.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.12 0.568 . . . . 0.0 109.912 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . 0.501 ' CZ3' ' HB3' ' A' ' 226' ' ' ASN . 22.9 m95 -82.93 100.4 10.38 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 150' ' ' ALA . 40.8 m-85 -114.87 163.04 16.09 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.834 0.854 . . . . 0.0 111.032 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.35 148.83 27.1 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.512 171.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -147.46 134.7 20.57 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.583 0.753 . . . . 0.0 109.154 172.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.15 119.09 34.99 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 173.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.532 HD12 HD21 ' A' ' 255' ' ' LEU . 26.6 mm -61.9 107.92 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.0 t -79.62 -50.68 10.31 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.394 0.616 . . . . 0.0 109.801 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 20.3 mtp180 -151.36 163.24 39.39 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.726 1.61 . . . . 0.0 108.09 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -155.83 143.15 19.3 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.987 0.358 . . . . 0.0 111.025 166.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -149.92 128.23 12.12 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.204 1.002 . . . . 0.0 109.03 177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -100.83 125.33 47.33 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 173.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 31.4 p -96.02 -175.13 3.3 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 170.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -76.75 -23.09 53.0 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 120.679 0.276 . . . . 0.0 110.849 174.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 22.8 p -97.76 -29.24 13.48 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.393 0.677 . . . . 0.0 112.7 -173.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -167.39 146.05 4.91 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.773 0.429 . . . . 0.0 111.955 -173.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -90.43 102.02 14.75 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -92.37 99.2 12.0 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.532 HD21 HD12 ' A' ' 243' ' ' ILE . 9.4 tt -100.47 131.39 46.41 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 174.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . 0.488 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 65.0 m-85 -106.51 127.05 53.01 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.253 1.021 . . . . 0.0 108.308 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -142.79 141.16 31.62 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.939 0.336 . . . . 0.0 111.009 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -79.75 96.62 6.32 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 39.7 t -77.54 102.8 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 13.8 m -92.11 111.03 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.655 0.74 . . . . 0.0 110.065 -171.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.576 HD12 ' HB2' ' A' ' 264' ' ' ASP . 12.4 mt -87.48 -165.78 1.4 Allowed 'General case' 0 CA--C 1.557 1.237 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.857 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.06 -35.29 88.85 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 122.395 -0.19 . . . . 0.0 113.34 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -123.2 -51.76 1.87 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.097 0.959 . . . . 0.0 109.482 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.576 ' HB2' HD12 ' A' ' 261' ' ' LEU . 4.7 m-20 -76.26 164.43 26.06 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.317 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 55.9 m -143.46 136.97 28.24 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.654 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 73.7 mt -113.7 82.07 1.63 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.754 0.822 . . . . 0.0 109.394 -171.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.1 125.63 26.11 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.847 0.859 . . . . 0.0 112.737 -170.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 61.46 26.94 16.6 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.855 1.262 . . . . 0.0 112.896 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 96.5 m -68.31 128.18 35.64 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 122.698 0.399 . . . . 0.0 110.061 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 52.3 ttp180 -69.77 111.44 5.53 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 121.645 0.736 . . . . 0.0 110.532 -174.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 225' ' ' LEU . 48.7 mm -82.29 123.88 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.427 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 49.9 mt -90.51 -27.37 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.076 0.951 . . . . 0.0 109.243 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -96.15 36.71 1.3 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.032 1.333 . . . . 0.0 110.06 -166.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 29.0 m -65.82 -20.57 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.794 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -95.27 -27.51 15.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.056 0.943 . . . . 0.0 110.617 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -91.59 4.26 53.06 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.743 0.817 . . . . 0.0 111.807 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.577 HG23 ' HB3' ' A' ' 225' ' ' LEU . 13.3 p -78.92 154.81 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 C-N-CA 123.238 0.615 . . . . 0.0 110.499 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.481 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 54.6 m-85 -128.89 161.07 30.7 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.502 1.121 . . . . 0.0 110.45 -173.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -73.93 140.54 45.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.128 0.971 . . . . 0.0 111.081 177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 223' ' ' VAL . 31.3 mm -77.12 122.3 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.817 0.847 . . . . 0.0 109.421 169.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.94 119.78 28.63 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 97.5 mtt180 -101.73 127.52 31.05 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.271 1.028 . . . . 0.0 109.817 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -37.36 131.91 0.59 Allowed 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 123.746 2.964 . . . . 0.0 114.326 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 105.27 -46.67 1.14 Allowed Glycine 0 C--N 1.341 0.823 0 CA-C-O 119.937 -0.368 . . . . 0.0 112.716 -171.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 9.5 pt-20 -84.69 -9.25 58.41 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 117.562 0.681 . . . . 0.0 110.793 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -35.82 83.62 0.0 OUTLIER Glycine 0 C--N 1.351 1.377 0 N-CA-C 117.558 1.783 . . . . 0.0 117.558 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 2.6 m -92.62 138.07 23.98 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 171.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -69.62 177.67 5.25 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.87 2.38 . . . . 0.0 111.476 -175.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 2.8 tpt -75.1 80.91 2.26 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.92 -37.18 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.082 -173.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.04 179.0 6.5 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -43.82 123.83 3.96 Favored Pre-proline 0 CA--C 1.561 1.388 0 C-N-CA 125.159 1.384 . . . . 0.0 113.319 -168.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.11 109.25 0.25 Allowed 'Trans proline' 0 C--N 1.385 2.482 0 C-N-CA 123.949 3.099 . . . . 0.0 114.479 -173.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.441 ' HB2' ' HE ' ' A' ' 207' ' ' ARG . 90.2 mtp -74.17 104.0 4.81 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 168.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.72 81.24 1.96 Allowed 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -74.88 -71.34 0.36 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.422 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? 57.26 115.62 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 126.224 1.81 . . . . 0.0 112.368 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.4 m -143.31 114.98 8.14 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.233 1.013 . . . . 0.0 109.193 172.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -155.51 -108.67 0.3 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-O 118.511 -1.16 . . . . 0.0 111.64 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo . . . . . 0 C--N 1.382 2.294 0 C-N-CA 123.183 2.589 . . . . 0.0 112.395 178.629 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.065 0 N-CA-C 112.222 -0.351 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -100.85 0.1 37.93 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.212 0.605 . . . . 0.0 111.668 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -115.86 160.95 19.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.853 0.861 . . . . 0.0 108.782 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.12 -178.24 4.24 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.745 0.818 . . . . 0.0 110.115 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 157' ' ' VAL . 13.0 m -55.35 -19.23 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 124.683 1.193 . . . . 0.0 113.869 -175.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -94.86 -31.37 13.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.132 0.973 . . . . 0.0 111.413 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.55 105.97 5.92 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.69 0.757 . . . . 0.0 111.652 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.558 ' HD1' ' HD3' ' A' ' 207' ' ' ARG . 15.3 t80 -70.32 138.11 51.21 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.547 164.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 28.7 m -127.9 179.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.559 1.144 . . . . 0.0 111.311 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -119.46 108.17 14.22 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.51 118.58 33.57 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.59 0.756 . . . . 0.0 110.11 -169.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -69.44 133.27 47.54 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -68.02 127.49 33.07 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -67.29 -26.61 66.62 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 123.845 0.716 . . . . 0.0 111.602 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -80.36 -52.87 7.18 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.994 0.518 . . . . 0.0 111.095 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 43.0 ttm -83.18 -24.67 32.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.353 0.661 . . . . 0.0 111.05 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.42 -15.92 32.51 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.474 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.481 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . . . -73.68 153.54 40.05 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.98 0.912 . . . . 0.0 111.305 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 238' ' ' TRP . 40.7 m95 -73.74 136.14 43.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -140.27 110.57 6.63 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' A' ' 296' ' ' ARG . 19.4 mt-10 -48.3 137.92 10.48 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.89 0.876 . . . . 0.0 109.908 172.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.12 154.48 32.42 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.086 0.554 . . . . 0.0 110.613 -169.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -105.18 119.66 39.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.843 0.457 . . . . 0.0 110.041 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.6 t -68.25 114.23 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 168.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 137' ' ' VAL . 24.6 m -107.52 -10.36 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.157 0.583 . . . . 0.0 111.113 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -171.51 146.3 2.2 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.536 0.523 . . . . 0.0 110.892 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.6 m -120.59 133.4 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.433 0.693 . . . . 0.0 109.661 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.4 p -142.14 166.39 24.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.93 1.292 . . . . 0.0 108.621 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -119.44 155.19 32.5 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -51.85 -43.91 63.42 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 123.813 0.845 . . . . 0.0 110.396 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.88 127.55 59.41 Favored Pre-proline 0 CA--C 1.547 0.832 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 168.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.77 89.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.394 2.729 . . . . 0.0 113.719 -175.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 41.6 t -122.28 147.21 46.5 Favored 'General case' 0 C--O 1.245 0.848 0 C-N-CA 125.149 1.38 . . . . 0.0 107.95 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.72 36.7 19.35 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-O 122.919 1.342 . . . . 0.0 107.908 -166.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -50.8 -49.7 57.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.821 1.648 . . . . 0.0 112.207 -173.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.92 141.75 33.62 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.318 0.647 . . . . 0.0 109.285 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.81 80.16 1.2 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.871 2.381 . . . . 0.0 111.731 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 57.8 m -143.52 168.13 20.57 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.648 -173.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 37.0 t -67.05 103.82 1.26 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.647 0.779 . . . . 0.0 109.667 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 37.6 m -129.43 80.45 1.97 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.718 0.807 . . . . 0.0 109.778 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 51.4 p -99.35 177.65 5.13 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.61 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.4 t 64.65 19.44 11.82 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.137 0.975 . . . . 0.0 112.38 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -87.11 146.79 41.13 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.647 0.779 . . . . 0.0 110.292 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -52.01 97.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 124.021 3.148 . . . . 0.0 113.795 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -126.2 99.19 5.77 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.854 0.861 . . . . 0.0 109.283 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.9 tt -139.4 107.65 5.78 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 56.71 80.61 0.15 Allowed 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.507 1.13 . . . . 0.0 108.761 -171.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.733 ' HB3' HG22 ' A' ' 182' ' ' VAL . 3.8 mp0 -70.01 101.02 1.7 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.568 -166.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -83.99 16.18 3.0 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.155 164.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.733 HG22 ' HB3' ' A' ' 180' ' ' GLU . 15.3 m -72.5 166.92 2.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-O 121.394 0.616 . . . . 0.0 110.411 172.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' A' ' 198' ' ' GLN . 2.5 mp -95.44 115.87 35.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.178 -172.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -97.52 104.54 16.58 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -79.11 94.66 5.39 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.53 151.06 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.508 ' HG2' HG22 ' A' ' 196' ' ' VAL . 43.2 mtmt -106.37 118.79 37.57 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 170.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -56.53 116.01 2.85 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.35 -36.84 66.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.753 0.821 . . . . 0.0 110.312 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -72.29 -32.07 66.27 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.808 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.54 ' HB3' ' ND2' ' A' ' 194' ' ' ASN . 68.0 m-85 -140.04 61.0 16.35 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 123.58 0.752 . . . . 0.0 111.744 -173.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.59 -20.02 9.65 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.033 1.822 . . . . 0.0 112.905 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.04 -20.21 66.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.933 0.893 . . . . 0.0 111.723 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.54 ' ND2' ' HB3' ' A' ' 191' ' ' TYR . 29.1 m-80 -81.51 -20.17 40.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.64 0.776 . . . . 0.0 111.155 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 110.42 -179.36 20.3 Favored Glycine 0 C--N 1.343 0.919 0 CA-C-N 116.521 -0.309 . . . . 0.0 113.068 174.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.508 HG22 ' HG2' ' A' ' 187' ' ' LYS . 20.3 t -79.63 122.77 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.857 0.863 . . . . 0.0 109.433 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 33.9 m -104.73 144.13 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.637 0.775 . . . . 0.0 110.634 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.552 ' HB2' HG23 ' A' ' 183' ' ' ILE . 8.7 pt20 -99.62 121.79 41.71 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.631 0.772 . . . . 0.0 110.327 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 67.4 mmm -120.11 170.14 9.58 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.547 1.139 . . . . 0.0 110.554 -169.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -105.86 176.61 5.11 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.707 0.803 . . . . 0.0 109.66 172.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 180' ' ' GLU . 61.1 p -59.64 -42.81 93.59 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.031 0.932 . . . . 0.0 110.999 174.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? -70.11 -5.12 24.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.958 0.903 . . . . 0.0 113.283 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -105.36 -34.91 7.7 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.811 0.444 . . . . 0.0 111.351 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.49 126.98 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.735 0.778 . . . . 0.0 110.312 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.453 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 2.1 mpt_? -120.26 172.24 7.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.502 1.121 . . . . 0.0 109.09 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -82.63 167.24 18.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.999 0.428 . . . . 0.0 109.903 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.558 ' HD3' ' HD1' ' A' ' 140' ' ' TYR . 77.6 mtm180 -78.65 90.24 4.57 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.614 0.766 . . . . 0.0 110.419 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.75 96.59 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.536 0.684 . . . . 0.0 109.545 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -1.78 43.81 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.061 1.344 . . . . 0.0 111.344 -174.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 44.9 m -84.19 112.79 20.59 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 121.681 -0.637 . . . . 0.0 109.339 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.424 HD11 ' SD ' ' A' ' 294' ' ' MET . 41.4 mt -82.21 123.32 38.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 175.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.692 HG23 ' HB2' ' A' ' 216' ' ' ASP . 49.1 mm -97.27 128.09 48.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.364 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 0.0 OUTLIER -117.52 176.92 4.94 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.095 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.433 ' HA ' HD23 ' A' ' 217' ' ' LEU . 69.7 t90 -46.94 -41.63 16.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.578 0.751 . . . . 0.0 111.553 -170.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -53.67 -43.03 68.52 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.002 1.321 . . . . 0.0 111.913 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.692 ' HB2' HG23 ' A' ' 212' ' ' ILE . 20.0 m-20 -77.97 -25.86 48.37 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.084 0.953 . . . . 0.0 112.416 -175.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 214' ' ' TRP . 1.4 mm? -67.7 112.63 4.91 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -115.35 152.2 33.25 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.9 m -67.05 115.76 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-O 121.114 0.483 . . . . 0.0 110.524 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 110.15 -5.09 30.22 Favored Glycine 0 C--N 1.346 1.128 0 C-N-CA 123.412 0.53 . . . . 0.0 112.846 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -86.69 128.72 35.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.614 0.766 . . . . 0.0 110.677 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.63 130.7 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.54 HG23 HD11 ' A' ' 225' ' ' LEU . 3.0 m -145.9 164.2 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.98 1.312 . . . . 0.0 109.74 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.653 ' SD ' ' HB3' ' A' ' 238' ' ' TRP . 9.0 tmm? -105.31 129.84 53.56 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.575 ' HG ' HG13 ' A' ' 277' ' ' VAL . 2.1 mp -129.12 160.41 32.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.24 0.616 . . . . 0.0 110.354 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -90.01 108.42 19.71 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.784 0.834 . . . . 0.0 110.899 177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.659 ' HE1' ' HB2' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -168.1 158.6 10.43 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.304 1.041 . . . . 0.0 110.413 177.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.575 HD21 ' HB3' ' A' ' 231' ' ' ASN . 6.6 p30 -111.14 148.61 39.06 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -58.28 -33.17 97.4 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.926 2.417 . . . . 0.0 113.115 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.44 -39.95 77.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.425 0.69 . . . . 0.0 111.025 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.575 ' HB3' HD21 ' A' ' 228' ' ' ASN . 41.6 t-20 -128.64 99.49 23.17 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.273 0.629 . . . . 0.0 109.69 -172.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -84.16 -0.0 9.37 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.941 2.427 . . . . 0.0 112.824 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -92.44 -29.27 16.36 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.379 0.672 . . . . 0.0 110.318 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -124.46 152.74 42.96 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.673 0.789 . . . . 0.0 109.732 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -55.39 170.19 0.25 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.334 1.453 . . . . 0.0 113.699 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 228' ' ' ASN . . . -171.27 -110.79 0.24 Allowed Glycine 0 C--N 1.337 0.631 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.138 174.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.469 ' HB2' ' CE1' ' A' ' 239' ' ' TYR . 17.8 m-85 -91.85 177.51 6.17 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.757 0.823 . . . . 0.0 109.454 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . 0.653 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 6.8 m95 -99.5 106.46 18.48 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.659 ' HB2' ' HE1' ' A' ' 227' ' ' TYR . 90.3 m-85 -121.84 166.89 13.68 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 118.927 0.785 . . . . 0.0 110.993 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . 0.572 ' HB2' ' HB ' ' A' ' 260' ' ' VAL . 3.4 m-20 -83.42 160.61 21.55 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.627 1.171 . . . . 0.0 110.329 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -162.51 138.9 7.61 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.07 0.948 . . . . 0.0 110.77 170.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -103.05 120.14 40.12 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.546 HD12 HD11 ' A' ' 255' ' ' LEU . 25.0 mm -63.89 117.47 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.924 0.89 . . . . 0.0 110.937 -171.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 33.3 t -88.24 -53.07 4.88 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.593 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.403 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 95.9 mtt180 -140.6 164.83 29.13 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.282 1.033 . . . . 0.0 109.873 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -155.95 147.89 23.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.493 0.717 . . . . 0.0 110.05 170.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -146.23 116.21 7.34 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.516 0.727 . . . . 0.0 109.599 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.665 ' HG2' ' HG2' ' A' ' 253' ' ' ARG . 6.0 tm-20 -92.85 123.6 36.23 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 30.6 p -133.47 148.45 51.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 168.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -63.81 -10.58 20.91 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.382 0.673 . . . . 0.0 112.801 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 47.2 p -91.73 -28.98 17.07 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.84 0.856 . . . . 0.0 111.058 175.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.84 130.2 0.8 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.301 0.64 . . . . 0.0 111.409 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.665 ' HG2' ' HG2' ' A' ' 248' ' ' GLU . 53.6 mtm180 -83.63 98.55 9.68 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -92.71 150.42 20.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.341 1.056 . . . . 0.0 110.213 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.811 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.5 OUTLIER -145.87 146.41 31.1 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -174.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 78.9 m-85 -134.06 127.77 32.89 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.206 1.002 . . . . 0.0 108.662 174.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -143.64 141.67 30.68 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.515 0.726 . . . . 0.0 109.805 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 19.4 m-20 -78.64 94.94 5.13 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 269' ' ' CYS . 92.9 t -67.54 105.55 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.608 0.567 . . . . 0.0 110.371 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 240' ' ' ASP . 45.1 t -85.79 99.3 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 30.6 mt -84.99 176.78 8.23 Favored 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.365 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -56.78 -36.46 72.48 Favored Glycine 0 N--CA 1.475 1.264 0 N-CA-C 114.349 0.5 . . . . 0.0 114.349 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -123.26 -47.75 2.0 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.707 0.803 . . . . 0.0 109.774 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -80.11 166.35 21.58 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.781 -175.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 30.7 p -146.84 110.3 4.86 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.573 0.749 . . . . 0.0 109.187 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 61.9 mt -87.12 87.39 7.44 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.973 0.909 . . . . 0.0 109.439 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 3.2 p-10 -64.38 139.4 58.76 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.792 0.437 . . . . 0.0 110.763 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.92 29.81 19.36 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.065 0.946 . . . . 0.0 112.199 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.481 ' HB3' HG23 ' A' ' 259' ' ' VAL . 38.3 t -72.96 126.97 31.19 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.76 0.424 . . . . 0.0 110.58 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -63.57 133.41 53.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.105 0.562 . . . . 0.0 110.894 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.811 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 46.9 mm -111.97 124.5 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.404 1.081 . . . . 0.0 109.251 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 41.3 mt -106.02 2.04 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.181 0.992 . . . . 0.0 109.312 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -102.87 29.98 5.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.048 1.339 . . . . 0.0 109.712 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 24.0 m -57.82 -29.46 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -165.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 22.5 m-20 -97.13 -23.72 16.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.283 0.633 . . . . 0.0 111.72 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -81.84 6.5 15.49 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.869 0.868 . . . . 0.0 112.208 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.575 HG13 ' HG ' ' A' ' 225' ' ' LEU . 19.4 t -73.94 148.62 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.325 0.65 . . . . 0.0 109.432 178.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -128.18 160.28 32.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.576 1.151 . . . . 0.0 108.313 173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -76.16 153.62 36.05 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.105 0.562 . . . . 0.0 111.481 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.525 HG12 ' HA ' ' A' ' 223' ' ' VAL . 46.8 mm -75.6 122.71 30.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 167.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.521 ' HG2' ' HA3' ' A' ' 286' ' ' GLY . 0.1 OUTLIER -84.16 106.11 15.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 165.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -107.81 108.22 61.21 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -11.26 88.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 1 C-N-CA 126.883 5.055 . . . . 0.0 116.687 -158.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 99.69 1.12 56.42 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 115.102 -0.954 . . . . 0.0 114.923 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -93.52 -23.44 18.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 118.003 0.902 . . . . 0.0 110.801 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . 0.521 ' HA3' ' HG2' ' A' ' 281' ' ' GLU . . . -93.84 -165.94 37.19 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.579 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 38.2 p -117.64 163.98 21.59 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 123.681 0.792 . . . . 0.0 111.438 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -86.62 -154.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.142 2.561 . . . . 0.0 111.308 164.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . 0.517 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 23.3 mmt -115.32 80.51 1.44 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 168.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.91 -35.25 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 168.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -84.11 -168.7 2.26 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.479 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -49.89 115.95 5.74 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.499 1.12 . . . . 0.0 111.849 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.517 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 12.4 Cg_exo -70.81 80.89 1.14 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.267 2.645 . . . . 0.0 111.148 175.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.424 ' SD ' HD11 ' A' ' 211' ' ' ILE . 49.3 mtm -63.26 -55.63 23.21 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.589 -172.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 66.6 144.74 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.858 1.263 . . . . 0.0 111.245 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.404 ' NH2' ' HG3' ' A' ' 153' ' ' GLU . 14.2 mtm180 -91.93 -30.95 15.85 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 173.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.454 ' HB2' ' HZ2' ' A' ' 238' ' ' TRP . 77.1 tttt -141.63 153.04 44.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.248 1.019 . . . . 0.0 108.978 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.0 p -143.29 113.37 7.21 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.444 0.697 . . . . 0.0 110.535 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -123.3 -89.77 0.92 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 C--N 1.374 1.893 0 C-N-CA 123.627 2.885 . . . . 0.0 112.642 167.774 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.535 HD12 ' HB3' ' A' ' 176' ' ' PRO . 0.0 OUTLIER -122.87 8.69 9.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.208 0.603 . . . . 0.0 112.317 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -116.1 161.74 18.46 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.258 0.552 . . . . 0.0 110.938 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.12 161.65 15.72 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.994 1.317 . . . . 0.0 109.153 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 158' ' ' ARG . 92.1 t -70.17 80.38 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 124.188 0.995 . . . . 0.0 110.058 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.3 m120 175.2 -38.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 126.641 1.976 . . . . 0.0 109.18 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -72.17 91.82 1.31 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -159.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 10.5 p90 -72.49 99.88 2.59 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.917 0.865 . . . . 0.0 109.616 168.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.87 -176.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.937 1.295 . . . . 0.0 109.255 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.18 104.15 16.56 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.392 0.615 . . . . 0.0 110.239 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -95.79 102.28 14.06 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 26.2 ttt180 -72.08 109.7 6.06 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.36 109.39 0.99 Allowed 'General case' 0 C--O 1.217 -0.625 0 O-C-N 124.506 1.129 . . . . 0.0 108.07 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.81 -10.94 59.85 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 124.033 0.833 . . . . 0.0 111.282 -170.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -74.03 -56.01 5.44 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.444 0.698 . . . . 0.0 110.258 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 50.5 ttp -92.53 -37.16 12.64 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.902 0.481 . . . . 0.0 109.955 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.434 ' HA3' ' CA ' ' A' ' 262' ' ' GLY . . . 101.44 20.73 12.7 Favored Glycine 0 N--CA 1.469 0.87 0 CA-C-N 115.45 -0.795 . . . . 0.0 113.518 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -101.79 140.31 36.26 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.085 0.554 . . . . 0.0 110.405 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 76.5 m95 -74.76 134.86 41.78 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.811 0.845 . . . . 0.0 109.581 174.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -135.78 136.36 40.66 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.686 ' HB3' HH12 ' A' ' 207' ' ' ARG . 19.9 pt-20 -68.62 103.76 1.8 Allowed 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -108.64 131.27 55.05 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.681 0.792 . . . . 0.0 110.287 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 60.8 tt0 -87.11 109.09 19.2 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.298 0.639 . . . . 0.0 110.444 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 186' ' ' VAL . 70.1 t -61.68 103.87 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 124.197 0.936 . . . . 0.0 109.381 171.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.0 m -106.12 -0.37 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.758 0.423 . . . . 0.0 111.613 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.485 HH11 ' HG2' ' A' ' 169' ' ' PRO . 52.4 ttm-85 -172.73 149.92 2.08 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.617 0.573 . . . . 0.0 110.674 169.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.11 142.47 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.754 0.822 . . . . 0.0 108.955 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.45 ' OG1' ' HB ' ' A' ' 183' ' ' ILE . 8.1 p -145.69 161.95 38.68 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.882 1.273 . . . . 0.0 108.907 -178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -114.88 178.36 4.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.829 0.852 . . . . 0.0 110.78 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -58.18 -56.98 15.11 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.685 0.794 . . . . 0.0 110.417 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -93.95 162.21 27.58 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.666 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -49.01 127.17 16.6 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.954 2.436 . . . . 0.0 112.066 168.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.4 m -69.96 -56.49 6.86 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.246 0.618 . . . . 0.0 112.599 -171.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -156.19 -40.39 0.08 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -175.12 -63.97 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.74 154.05 39.21 Favored Pre-proline 0 CA--C 1.551 1.007 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.725 170.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.485 ' HG2' HH11 ' A' ' 158' ' ' ARG . 19.2 Cg_endo -57.22 90.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.863 3.042 . . . . 0.0 113.206 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 78.0 m 62.08 175.45 0.13 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.504 1.521 . . . . 0.0 112.297 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.6 t -167.79 148.36 5.18 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 122.884 0.474 . . . . 0.0 110.339 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.8 m 60.78 -163.95 0.24 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 124.563 1.164 . . . . 0.0 111.752 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.1 t -89.33 84.77 6.47 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.057 0.932 . . . . 0.0 108.544 172.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 57.4 p -67.79 115.69 7.63 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.343 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -65.28 124.28 86.55 Favored Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.266 0.626 . . . . 0.0 110.854 -172.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.535 ' HB3' HD12 ' A' ' 134' ' ' LEU . 57.2 Cg_endo -67.99 148.97 77.03 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.881 2.387 . . . . 0.0 112.439 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -87.99 -96.24 0.09 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -135.99 -68.96 0.49 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.95 86.23 7.31 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-O 122.3 1.048 . . . . 0.0 110.286 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -88.49 67.37 8.54 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.049 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -85.07 40.31 0.81 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 121.889 0.852 . . . . 0.0 109.707 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 34.9 m -88.61 175.93 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.823 0.849 . . . . 0.0 111.085 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.45 ' HB ' ' OG1' ' A' ' 160' ' ' THR . 20.6 mt -96.72 112.35 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.683 0.793 . . . . 0.0 110.594 -168.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -102.05 109.38 21.09 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.418 1.087 . . . . 0.0 108.961 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -79.26 89.38 4.91 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 156' ' ' VAL . 26.7 m -110.58 161.16 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.762 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.52 ' HG2' HG22 ' A' ' 196' ' ' VAL . 32.0 mtmt -124.97 117.75 24.72 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 173.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -57.52 97.03 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -62.73 -23.92 67.41 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.202 1.001 . . . . 0.0 111.593 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 297' ' ' LYS . 19.9 m-20 -63.34 -30.81 71.88 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.715 0.406 . . . . 0.0 111.711 173.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -146.88 78.04 10.8 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 124.14 0.976 . . . . 0.0 108.89 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.15 -21.2 55.88 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.925 2.417 . . . . 0.0 112.563 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -67.14 -8.19 29.12 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.648 1.179 . . . . 0.0 112.788 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -79.33 -12.76 59.93 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.443 0.697 . . . . 0.0 111.333 173.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 93.88 -178.7 37.88 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.713 0.633 . . . . 0.0 112.915 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.52 HG22 ' HG2' ' A' ' 187' ' ' LYS . 24.6 t -83.95 116.6 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.55 153.64 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.036 0.934 . . . . 0.0 109.663 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -108.32 122.21 46.51 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.437 0.695 . . . . 0.0 109.536 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 84.7 mmm -125.28 164.88 19.38 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.696 1.198 . . . . 0.0 109.265 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -110.53 172.77 6.67 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.525 ' HA ' HG22 ' A' ' 204' ' ' VAL . 41.7 m -66.29 -30.23 70.61 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 118.159 0.436 . . . . 0.0 111.258 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -10.4 58.86 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.862 176.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -104.25 -39.93 6.31 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.452 1.101 . . . . 0.0 111.014 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.525 HG22 ' HA ' ' A' ' 201' ' ' SER . 32.0 m -95.79 143.47 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -174.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.96 163.47 32.79 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.321 0.648 . . . . 0.0 109.774 -168.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.97 166.64 23.01 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.186 0.594 . . . . 0.0 109.804 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.686 HH12 ' HB3' ' A' ' 153' ' ' GLU . 10.8 ptm180 -136.75 134.11 36.76 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.0 148.32 40.02 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.744 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.63 ' HG3' ' HB3' ' A' ' 291' ' ' ASP . 3.3 tmt_? -75.79 -9.47 58.62 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.942 168.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.8 m -86.94 109.33 19.27 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.869 0.868 . . . . 0.0 111.023 -171.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.4 mt -84.02 136.36 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.676 HD11 ' HB2' ' A' ' 279' ' ' LYS . 39.0 mm -110.98 153.52 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.637 0.775 . . . . 0.0 111.419 -170.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -125.1 171.29 10.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.988 1.315 . . . . 0.0 109.929 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.483 ' HD1' HG11 ' A' ' 274' ' ' VAL . 88.7 t90 -50.01 -49.05 52.05 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.378 1.071 . . . . 0.0 111.662 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -61.23 -35.76 78.12 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.618 -175.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.451 ' HB3' HG23 ' A' ' 212' ' ' ILE . 14.6 t70 -78.78 -23.98 44.94 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.279 0.632 . . . . 0.0 110.978 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.444 HD22 HG21 ' A' ' 223' ' ' VAL . 96.0 mt -72.37 113.18 9.12 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.051 0.54 . . . . 0.0 109.928 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 221' ' ' GLN . 9.3 pt-20 -119.71 154.06 34.68 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.993 0.917 . . . . 0.0 109.961 -176.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.3 m -63.68 123.63 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 120.844 0.354 . . . . 0.0 110.945 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.76 -14.05 56.26 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.177 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.478 ' HG2' HG13 ' A' ' 223' ' ' VAL . 30.5 tt0 -81.29 122.69 27.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.346 0.658 . . . . 0.0 110.767 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 74.1 t -93.58 130.74 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.478 HG13 ' HG2' ' A' ' 221' ' ' GLN . 3.0 m -150.34 147.02 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.268 1.027 . . . . 0.0 110.297 -172.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 26.1 ttp -102.76 130.41 49.71 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.896 0.478 . . . . 0.0 110.986 -175.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.506 HD11 HD12 ' A' ' 271' ' ' ILE . 1.9 pt? -142.43 167.89 21.02 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.283 1.033 . . . . 0.0 110.917 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.545 HD21 ' HB3' ' A' ' 276' ' ' GLU . 4.8 p30 -81.37 126.52 31.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.328 0.651 . . . . 0.0 109.655 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -166.08 152.28 9.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.956 0.902 . . . . 0.0 109.384 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.59 HD21 ' HB3' ' A' ' 231' ' ' ASN . 3.7 p30 -131.34 133.0 23.97 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.442 ' HB3' HD11 ' A' ' 266' ' ' LEU . 27.0 Cg_endo -61.52 -26.02 80.29 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.809 2.339 . . . . 0.0 113.943 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.41 -33.32 71.22 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.114 0.566 . . . . 0.0 111.699 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.59 ' HB3' HD21 ' A' ' 228' ' ' ASN . 35.5 t-20 -133.23 104.33 12.46 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 123.48 0.712 . . . . 0.0 109.116 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.33 -19.48 49.75 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.767 2.311 . . . . 0.0 113.019 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -91.26 -10.82 40.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.331 0.652 . . . . 0.0 110.944 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -123.81 159.13 30.23 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.484 0.659 . . . . 0.0 111.179 -171.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -80.28 172.24 14.02 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.688 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 228' ' ' ASN . . . -161.55 -101.98 0.17 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.291 172.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -103.46 168.9 8.86 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.77 0.828 . . . . 0.0 109.503 -177.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -83.87 114.73 21.86 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -126.8 141.29 51.87 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.214 1.006 . . . . 0.0 108.387 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.4 p-10 -81.18 152.81 27.54 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -151.09 136.85 18.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.791 0.836 . . . . 0.0 109.058 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -94.54 118.27 31.41 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.558 HD12 HD21 ' A' ' 255' ' ' LEU . 32.3 mm -61.57 116.27 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 124.041 0.838 . . . . 0.0 108.952 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.6 t -97.08 -25.04 15.48 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.332 0.653 . . . . 0.0 110.633 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -170.13 157.34 6.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.859 0.864 . . . . 0.0 110.195 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.406 ' HB3' ' HG ' ' A' ' 255' ' ' LEU . 26.0 pttm -153.13 149.1 27.72 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.659 0.784 . . . . 0.0 109.32 163.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -154.52 120.45 5.24 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.305 0.642 . . . . 0.0 109.449 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 40.0 tt0 -111.24 125.49 53.87 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.179 0.992 . . . . 0.0 109.151 177.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.7 p -83.59 178.78 7.84 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.943 0.897 . . . . 0.0 109.565 171.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -71.62 -0.78 11.56 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.366 0.666 . . . . 0.0 112.634 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 25.4 p -123.4 -29.68 3.77 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.29 0.636 . . . . 0.0 112.607 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.86 166.76 27.96 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.882 0.31 . . . . 0.0 111.457 -172.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 33.1 ptt180 -121.14 140.76 51.55 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.454 0.701 . . . . 0.0 110.661 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.22 154.31 47.7 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.71 0.804 . . . . 0.0 108.876 172.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.558 HD21 HD12 ' A' ' 243' ' ' ILE . 7.1 tt -147.16 143.89 28.57 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -130.21 121.82 26.93 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -131.97 166.72 21.05 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.377 0.671 . . . . 0.0 110.431 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -102.19 98.14 8.33 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.795 HG23 ' SG ' ' A' ' 269' ' ' CYS . 96.6 t -66.57 112.36 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 123.783 0.677 . . . . 0.0 110.374 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.48 101.79 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 73.4 mt -82.81 -158.02 0.25 Allowed 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.642 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.434 ' CA ' ' HA3' ' A' ' 149' ' ' GLY . . . -70.29 -56.61 7.58 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-O 121.088 0.271 . . . . 0.0 113.418 177.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -112.87 -37.32 4.87 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.171 0.988 . . . . 0.0 109.929 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -94.39 176.39 6.32 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.125 0.97 . . . . 0.0 111.713 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 77.0 p -142.89 153.12 42.81 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.28 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 92.8 mt -125.31 92.15 3.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.359 0.663 . . . . 0.0 109.458 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -69.2 140.02 54.56 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 123.606 0.566 . . . . 0.0 110.284 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 12.6 t70 67.08 31.64 6.72 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.452 1.101 . . . . 0.0 111.705 171.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.795 ' SG ' HG23 ' A' ' 259' ' ' VAL . 27.2 p -65.05 124.92 23.35 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 37.6 ttp-105 -76.91 102.46 6.38 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.57 HD11 ' SG ' ' A' ' 269' ' ' CYS . 47.7 mm -77.87 108.29 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.886 -172.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 44.5 mt -82.1 -34.5 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.424 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.448 ' O ' HG23 ' A' ' 277' ' ' VAL . 46.0 m-85 -90.26 37.42 0.9 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.336 1.054 . . . . 0.0 111.14 -168.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.483 HG11 ' HD1' ' A' ' 214' ' ' TRP . 21.0 m -56.75 -34.27 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.799 1.239 . . . . 0.0 112.433 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -92.78 -10.59 36.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.676 1.19 . . . . 0.0 111.983 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.545 ' HB3' HD21 ' A' ' 226' ' ' ASN . 59.4 mm-40 -102.6 21.26 15.64 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.215 1.006 . . . . 0.0 111.148 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.492 HG22 ' HB3' ' A' ' 225' ' ' LEU . 84.2 t -90.44 153.44 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.038 0.935 . . . . 0.0 110.587 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.43 148.66 44.85 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.874 1.27 . . . . 0.0 107.808 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.676 ' HB2' HD11 ' A' ' 212' ' ' ILE . 24.0 ttmt -83.28 141.01 32.15 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 120.841 0.353 . . . . 0.0 111.126 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 36.5 mm -79.13 138.19 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 168.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.506 ' HA ' ' HA3' ' A' ' 286' ' ' GLY . 1.1 mp0 -66.11 103.46 0.97 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.283 0.563 . . . . 0.0 110.08 -167.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -85.7 155.0 59.14 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.31 1.044 . . . . 0.0 109.524 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.98 94.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 123.402 2.735 . . . . 0.0 112.075 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.9 -48.09 2.49 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.994 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -73.12 -25.61 60.91 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.996 0.519 . . . . 0.0 112.085 -172.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -84.68 82.19 1.7 Allowed Glycine 0 C--N 1.342 0.915 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 174.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 14.8 m -62.8 144.37 96.6 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.418 0.687 . . . . 0.0 111.989 -168.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.15 152.85 79.12 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.103 2.535 . . . . 0.0 111.875 -175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 16.7 ttt -79.76 80.77 6.11 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.26 -28.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.338 1.055 . . . . 0.0 109.963 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.63 ' HB3' ' HG3' ' A' ' 209' ' ' ARG . 10.3 t70 -84.26 -151.68 0.13 Allowed 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.303 1.041 . . . . 0.0 109.135 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.513 ' H ' HD22 ' A' ' 292' ' ' ASN . 0.8 OUTLIER -50.81 115.98 6.51 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.99 0.916 . . . . 0.0 110.533 177.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.75 102.97 0.44 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.218 1.946 . . . . 0.0 111.534 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 25.7 mmt -65.84 136.7 56.51 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.273 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -144.46 148.78 34.99 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -148.0 -175.92 5.08 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.29 0.236 . . . . 0.0 110.847 -167.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 2.1 tppt? -161.02 134.0 6.36 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 111.541 0.201 . . . . 0.0 111.541 173.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 48.3 m -75.13 79.3 2.28 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.579 0.752 . . . . 0.0 110.064 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -172.08 157.36 27.23 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-O 118.92 -0.933 . . . . 0.0 112.116 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo . . . . . 0 C--N 1.375 1.924 0 C-N-CA 123.468 2.778 . . . . 0.0 111.909 175.03 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.979 -0.449 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.412 HD22 ' OH ' ' A' ' 184' ' ' TYR . 0.5 OUTLIER -81.31 -34.2 32.06 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.178 0.513 . . . . 0.0 110.414 -178.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -90.16 152.42 21.11 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.778 -165.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 139' ' ' GLU . 45.0 mttp -99.35 162.93 12.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.128 -167.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.1 m -71.91 -2.28 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 124.161 0.984 . . . . 0.0 113.116 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -118.34 -21.04 8.27 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.89 0.876 . . . . 0.0 110.425 171.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.457 ' HB3' ' H ' ' A' ' 136' ' ' LYS . 43.6 tt0 -82.12 89.67 6.49 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.77 0.828 . . . . 0.0 110.116 -175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.702 ' HB3' ' HG2' ' A' ' 155' ' ' GLN . 26.8 p90 -68.16 139.12 56.11 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.202 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.404 HG21 ' HB ' ' A' ' 204' ' ' VAL . 29.0 m -119.5 178.96 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.998 0.919 . . . . 0.0 109.662 176.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.73 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 54.1 t0 -95.01 158.79 15.31 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 166.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.17 110.06 4.52 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 119.436 1.016 . . . . 0.0 111.213 -175.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.411 ' HA ' ' HB3' ' A' ' 151' ' ' TRP . 3.0 tmm_? -73.01 113.69 10.33 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.878 0.871 . . . . 0.0 110.593 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -87.16 114.62 23.93 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.6 m -70.79 -26.57 63.39 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.736 0.814 . . . . 0.0 111.546 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -59.99 -49.93 75.75 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.616 0.766 . . . . 0.0 110.683 -175.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.503 ' HG3' ' H ' ' A' ' 150' ' ' ALA . 23.9 ptm -101.79 -18.99 15.52 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.526 0.331 . . . . 0.0 111.394 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 93.32 -21.56 39.83 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-O 120.021 -0.321 . . . . 0.0 113.141 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.503 ' H ' ' HG3' ' A' ' 148' ' ' MET . . . -72.47 131.18 42.22 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.197 0.599 . . . . 0.0 110.818 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 0.1 OUTLIER -97.65 124.72 42.06 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.18 175.231 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -113.64 137.3 51.8 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.017 0.927 . . . . 0.0 109.464 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.73 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 48.3 mt-10 -64.43 102.21 0.52 Allowed 'General case' 0 C--N 1.346 0.435 0 O-C-N 123.653 0.596 . . . . 0.0 110.802 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -96.61 119.13 34.53 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.78 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.702 ' HG2' ' HB3' ' A' ' 140' ' ' TYR . 15.4 tm0? -84.94 107.91 17.31 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -173.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.527 ' HA ' HG12 ' A' ' 186' ' ' VAL . 47.0 t -61.47 119.61 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 124.229 0.955 . . . . 0.0 109.207 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.408 HG13 ' OE1' ' A' ' 155' ' ' GLN . 1.9 m -115.63 -6.03 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.574 0.749 . . . . 0.0 111.179 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.54 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 44.9 ttt85 -172.23 142.12 1.33 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.966 0.506 . . . . 0.0 110.511 175.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.3 m -126.05 132.09 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.282 1.033 . . . . 0.0 108.832 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.7 p -142.96 145.2 32.77 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.39 0.676 . . . . 0.0 110.099 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -74.93 150.13 39.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.868 0.867 . . . . 0.0 109.053 168.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -65.4 78.21 0.06 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.601 0.76 . . . . 0.0 109.951 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 165.88 100.69 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.715 2.006 . . . . 0.0 106.909 -172.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.4 -56.14 1.46 Allowed 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.659 2.24 . . . . 0.0 112.537 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 39.2 p -82.14 -31.0 30.77 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.419 0.688 . . . . 0.0 111.41 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 61.89 104.63 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.936 1.294 . . . . 0.0 110.773 -170.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -58.46 -45.25 88.98 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.21 0.604 . . . . 0.0 109.945 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -110.54 100.26 44.48 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.2 -90.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.424 2.083 . . . . 0.0 113.092 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 85.2 m -148.3 99.64 3.06 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 118.616 0.643 . . . . 0.0 111.287 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 27.1 p -87.41 85.33 7.13 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 39.8 m 68.86 8.93 7.1 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.201 1.401 . . . . 0.0 113.128 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 53.3 p -96.8 141.01 30.53 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.341 0.656 . . . . 0.0 111.116 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.2 m -85.35 -59.14 2.41 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.108 0.963 . . . . 0.0 110.453 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -95.86 152.06 38.78 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.424 0.689 . . . . 0.0 109.815 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.92 -24.51 74.16 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.846 2.364 . . . . 0.0 115.159 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -158.61 165.94 33.27 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.1 mp -93.83 127.2 39.44 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 62.05 90.3 0.07 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.466 1.106 . . . . 0.0 109.242 -169.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.519 ' HB3' HG22 ' A' ' 182' ' ' VAL . 5.9 mm-40 -70.68 90.76 0.78 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.33 -169.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -85.88 8.85 18.61 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.648 167.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 180' ' ' GLU . 28.6 m -65.69 173.98 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.039 1.336 . . . . 0.0 112.02 -178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 198' ' ' GLN . 59.0 mt -94.95 110.81 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 123.549 0.74 . . . . 0.0 110.417 -169.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.412 ' OH ' HD22 ' A' ' 134' ' ' LEU . 58.5 m-85 -93.95 106.48 18.45 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.887 1.275 . . . . 0.0 109.543 173.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 30.5 m-70 -80.54 101.95 9.45 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 172.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 156' ' ' VAL . 29.6 m -129.68 165.47 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.832 1.253 . . . . 0.0 110.5 -172.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -133.56 116.33 15.79 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.384 0.674 . . . . 0.0 109.375 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.646 ' HB2' ' HB2' ' A' ' 191' ' ' TYR . 47.0 m-85 -57.2 151.23 16.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 123.167 0.292 . . . . 0.0 111.347 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -60.11 -44.41 94.9 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.062 0.545 . . . . 0.0 110.875 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.47 -13.42 40.38 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.646 0.778 . . . . 0.0 111.268 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.646 ' HB2' ' HB2' ' A' ' 188' ' ' TYR . 58.3 m-85 -129.11 58.65 38.71 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -174.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.38 -23.78 8.38 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 121.71 1.607 . . . . 0.0 110.442 163.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.31 -20.55 62.18 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.687 1.195 . . . . 0.0 111.914 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -81.19 -0.42 40.4 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.057 0.543 . . . . 0.0 110.872 175.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 89.12 -177.48 44.44 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.161 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 23.6 t -82.86 116.89 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.6 m -97.12 153.21 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.027 0.931 . . . . 0.0 110.029 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.409 ' HB2' HG23 ' A' ' 183' ' ' ILE . 12.8 pt20 -103.78 113.88 27.73 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.731 0.777 . . . . 0.0 109.851 178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 77.9 mmm -117.27 169.75 9.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.318 1.447 . . . . 0.0 108.785 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -110.92 173.07 6.51 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.611 ' HA ' HG22 ' A' ' 204' ' ' VAL . 9.7 t -70.56 -26.2 63.43 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 118.369 0.531 . . . . 0.0 110.63 177.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -12.24 60.88 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.745 0.418 . . . . 0.0 111.786 174.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -94.68 -44.47 7.79 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.51 0.724 . . . . 0.0 110.082 171.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.611 HG22 ' HA ' ' A' ' 201' ' ' SER . 15.3 m -95.76 143.24 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.433 0.635 . . . . 0.0 110.996 -170.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' A' ' 142' ' ' ASP . 21.2 tpt180 -150.97 126.64 10.22 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -66.2 125.48 25.67 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 168.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.427 ' H ' ' NE ' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -73.68 152.02 40.57 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.428 ' N ' ' HB2' ' A' ' 281' ' ' GLU . . . -64.39 135.11 55.8 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.835 0.709 . . . . 0.0 109.398 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.522 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 5.3 ppt_? -78.21 23.06 0.29 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.876 0.87 . . . . 0.0 112.803 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 79.5 m -113.6 119.41 37.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.892 1.277 . . . . 0.0 109.082 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.63 129.03 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.038 0.535 . . . . 0.0 109.77 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 279' ' ' LYS . 28.2 mm -87.37 144.48 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 173.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.41 170.14 9.65 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.901 0.881 . . . . 0.0 109.727 -176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.409 ' CZ3' ' HB2' ' A' ' 255' ' ' LEU . 38.2 t-105 -52.3 -47.78 65.75 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.979 0.912 . . . . 0.0 111.302 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -69.11 -23.03 63.94 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.278 0.631 . . . . 0.0 111.979 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -92.12 -16.57 26.16 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.115 0.566 . . . . 0.0 110.513 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.62 141.21 42.88 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -147.79 155.08 41.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.586 0.755 . . . . 0.0 109.419 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.93 123.39 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-O 121.26 0.552 . . . . 0.0 110.947 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.1 -4.0 48.46 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.744 -174.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.521 ' HG2' HG13 ' A' ' 223' ' ' VAL . 30.1 tt0 -87.21 121.72 30.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.235 0.614 . . . . 0.0 110.233 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 92.9 t -87.15 115.58 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.779 0.832 . . . . 0.0 108.863 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.521 HG13 ' HG2' ' A' ' 221' ' ' GLN . 6.3 m -137.91 157.37 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.311 1.044 . . . . 0.0 110.642 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.701 ' SD ' ' HD3' ' A' ' 296' ' ' ARG . 1.5 ttp -88.24 129.71 35.28 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.592 ' HB3' HG22 ' A' ' 277' ' ' VAL . 2.0 pp -143.79 168.21 20.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.826 0.85 . . . . 0.0 110.304 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.511 HD21 ' HA ' ' A' ' 235' ' ' ARG . 8.8 t30 -90.92 143.13 27.04 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -167.18 144.02 4.5 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 124.227 0.955 . . . . 0.0 109.051 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -109.84 119.09 48.55 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -56.24 -44.87 42.39 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.067 2.512 . . . . 0.0 113.082 172.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.1 -27.74 59.98 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.046 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.56 ' HB3' ' HB2' ' A' ' 234' ' ' GLU . 16.7 m120 -120.37 86.32 38.6 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 123.407 0.683 . . . . 0.0 109.194 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.37 -20.43 70.18 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.984 2.456 . . . . 0.0 113.366 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.589 ' HA ' HD12 ' A' ' 272' ' ' ILE . 61.7 tttm -97.47 -29.5 13.44 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.668 0.787 . . . . 0.0 111.26 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 231' ' ' ASN . 44.0 mt-10 -111.46 172.15 7.06 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.825 0.821 . . . . 0.0 112.665 -170.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.511 ' HA ' HD21 ' A' ' 226' ' ' ASN . 24.3 ptt180 -76.94 164.25 25.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.168 -1.378 . . . . 0.0 111.724 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -171.47 -79.05 0.05 OUTLIER Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.694 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.412 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 11.5 m-85 -127.79 173.96 9.52 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.841 0.456 . . . . 0.0 110.268 -170.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -110.51 127.97 55.42 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 94.0 m-85 -133.54 158.34 43.39 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.415 0.686 . . . . 0.0 110.155 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . 0.404 ' HB3' ' CZ2' ' A' ' 151' ' ' TRP . 8.6 p-10 -86.14 147.08 26.31 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 162.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.449 ' HB3' HD21 ' A' ' 225' ' ' LEU . . . -153.48 139.76 18.51 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 122.957 0.503 . . . . 0.0 110.04 -176.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -95.53 120.11 35.22 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.564 HD12 HD21 ' A' ' 255' ' ' LEU . 35.6 mm -58.3 111.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 123.658 0.599 . . . . 0.0 109.968 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.1 m -83.77 -49.47 9.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.688 0.795 . . . . 0.0 110.303 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 4.8 mmp_? -142.43 159.21 42.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.955 1.302 . . . . 0.0 109.07 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -154.89 116.81 4.16 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.33 0.652 . . . . 0.0 109.373 168.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -123.86 117.85 25.78 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.498 1.119 . . . . 0.0 108.542 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.54 135.48 49.74 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.465 0.706 . . . . 0.0 109.604 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.9 p -133.6 175.0 9.82 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.886 0.875 . . . . 0.0 109.284 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -69.12 -38.16 78.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.815 0.446 . . . . 0.0 110.757 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 46.1 p -88.66 -27.32 21.34 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.489 0.716 . . . . 0.0 112.859 -171.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -155.57 172.98 17.36 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.084 0.469 . . . . 0.0 111.829 -175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -128.54 130.36 47.31 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.943 0.897 . . . . 0.0 108.665 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -133.03 98.6 4.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.592 0.757 . . . . 0.0 109.314 -175.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.564 HD21 HD12 ' A' ' 243' ' ' ILE . 8.4 tt -107.72 147.01 31.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 64.2 m-85 -129.14 141.35 51.21 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.886 1.274 . . . . 0.0 107.599 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.96 151.02 35.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.718 0.407 . . . . 0.0 111.091 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -79.8 96.68 6.37 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 39.4 t -79.68 108.98 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.98 0.912 . . . . 0.0 109.96 -173.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 83.2 t -87.03 114.35 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.514 0.673 . . . . 0.0 110.796 -167.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 13.4 mt -90.44 -161.6 0.81 Allowed 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.62 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.3 -42.5 57.1 Favored Glycine 0 C--N 1.35 1.32 0 O-C-N 122.16 -0.337 . . . . 0.0 113.907 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -122.3 -27.07 4.54 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.213 1.005 . . . . 0.0 111.039 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -114.19 167.17 10.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.924 0.889 . . . . 0.0 110.605 -172.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 67.8 p -137.45 133.22 34.43 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.022 0.929 . . . . 0.0 108.767 172.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.691 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 75.4 mt -81.56 93.8 6.77 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.061 0.944 . . . . 0.0 108.514 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -59.39 110.67 1.14 Allowed 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.413 1.071 . . . . 0.0 112.151 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 30.1 t70 67.26 29.44 7.62 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.766 0.827 . . . . 0.0 111.636 167.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 98.9 m -75.45 131.42 40.13 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.807 -0.558 . . . . 0.0 111.078 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -65.47 117.04 7.4 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.534 0.734 . . . . 0.0 112.126 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 273' ' ' PHE . 36.5 mm -89.64 112.44 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.925 0.89 . . . . 0.0 109.126 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 233' ' ' LYS . 49.0 mt -97.93 22.98 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 CA-C-O 122.519 1.152 . . . . 0.0 109.061 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.502 ' H ' HG22 ' A' ' 271' ' ' ILE . 83.8 m-85 -135.6 34.86 2.94 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.622 1.169 . . . . 0.0 109.989 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 34.3 m -71.03 -12.5 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.057 -174.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -87.15 -29.01 22.11 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.547 0.739 . . . . 0.0 111.325 -178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -102.08 22.1 13.71 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.341 0.656 . . . . 0.0 111.356 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.592 HG22 ' HB3' ' A' ' 225' ' ' LEU . 85.2 t -73.14 131.34 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 123.946 0.898 . . . . 0.0 110.406 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -109.07 160.39 16.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.617 0.767 . . . . 0.0 109.886 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.482 ' HB2' HD11 ' A' ' 212' ' ' ILE . 85.3 tttt -75.44 143.35 42.71 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.132 174.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.1 mm -72.2 116.06 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.428 ' HB2' ' N ' ' A' ' 208' ' ' ALA . 0.5 OUTLIER -83.39 105.95 14.76 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -106.47 151.53 40.37 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.512 0.725 . . . . 0.0 110.111 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.11 121.14 9.47 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.009 2.472 . . . . 0.0 113.531 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.16 -49.09 1.08 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.974 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -91.31 -24.27 19.87 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -171.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -83.23 137.15 16.0 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.04 0.212 . . . . 0.0 113.027 -170.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 6.5 m -84.36 146.48 47.74 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 123.144 0.578 . . . . 0.0 111.789 -173.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.28 -173.61 1.8 Allowed 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 123.731 2.954 . . . . 0.0 111.617 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . 0.522 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 25.5 mmt -82.04 78.83 8.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.102 0.477 . . . . 0.0 109.906 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 13.7 p -87.33 -25.46 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 121.779 0.8 . . . . 0.0 109.022 169.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.66 -166.4 1.57 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.405 1.482 . . . . 0.0 108.22 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.35 154.96 94.41 Favored Pre-proline 0 N--CA 1.483 1.198 0 CA-C-N 118.933 0.788 . . . . 0.0 109.701 172.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.56 102.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.586 2.19 . . . . 0.0 112.292 173.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 89.7 mmm -95.37 135.52 36.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.582 0.753 . . . . 0.0 110.108 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -155.93 165.44 36.47 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.479 0.657 . . . . 0.0 111.397 -172.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.701 ' HD3' ' SD ' ' A' ' 224' ' ' MET . 17.1 mtm180 -88.88 153.07 21.34 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.939 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 82.5 tttt 71.24 166.73 0.3 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.274 1.029 . . . . 0.0 112.397 167.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 40.3 m -74.52 76.9 1.96 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 159.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.42 156.86 29.71 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.451 -174.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo . . . . . 0 C--N 1.37 1.667 0 C-N-CA 123.088 2.525 . . . . 0.0 111.003 175.501 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.491 ' N ' ' HG ' ' A' ' 172' ' ' SER . . . . . . . . 0 N--CA 1.478 1.487 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.72 10.27 10.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.347 0.659 . . . . 0.0 111.898 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -114.92 149.36 37.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 170.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.452 ' H ' ' HB3' ' A' ' 139' ' ' GLU . 3.9 mppt? -102.94 170.25 8.09 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.019 0.528 . . . . 0.0 111.312 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -68.95 -6.23 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 124.489 1.116 . . . . 0.0 112.996 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -113.78 -22.97 9.92 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.139 0.976 . . . . 0.0 110.974 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.452 ' HB3' ' H ' ' A' ' 136' ' ' LYS . 38.3 tt0 -80.88 88.26 5.88 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.377 0.671 . . . . 0.0 110.212 -173.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.424 ' HB3' ' OE1' ' A' ' 155' ' ' GLN . 48.5 p90 -78.56 139.42 38.62 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.121 176.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.9 m -130.98 -166.74 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 126.158 1.783 . . . . 0.0 108.386 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -93.89 159.46 15.17 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 154' ' ' ALA . . . -128.94 101.95 6.3 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 124.338 1.055 . . . . 0.0 108.452 172.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -69.8 96.37 0.98 Allowed 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.652 174.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -78.4 111.02 13.98 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.1 m -71.96 -29.52 64.35 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.76 0.824 . . . . 0.0 111.694 -172.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -65.53 -42.97 91.38 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.819 0.847 . . . . 0.0 110.633 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.4 tpp -82.06 -37.9 25.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.191 0.996 . . . . 0.0 109.664 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.52 18.18 66.85 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.397 -170.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -107.4 161.13 15.09 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 122.029 0.918 . . . . 0.0 112.564 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -91.0 126.26 36.03 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.457 -1.701 . . . . 0.0 107.644 169.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -129.13 123.78 33.05 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.459 ' HB2' ' N ' ' A' ' 190' ' ' ASP . 14.6 mm-40 -43.7 137.78 2.89 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.192 0.933 . . . . 0.0 110.192 173.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 187' ' ' LYS . . . -134.73 116.07 14.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 122.32 0.248 . . . . 0.0 110.4 -176.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.424 ' OE1' ' HB3' ' A' ' 140' ' ' TYR . 60.6 tp60 -90.35 101.35 14.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.409 HG22 HG12 ' A' ' 186' ' ' VAL . 59.4 t -61.18 117.08 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -116.66 -10.02 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.785 0.434 . . . . 0.0 111.838 -176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 -171.33 148.53 2.62 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.747 0.819 . . . . 0.0 109.245 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 6.1 m -117.4 142.36 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.511 0.724 . . . . 0.0 109.4 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 166' ' ' ARG . 69.6 p -144.24 159.99 41.74 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.79 1.236 . . . . 0.0 108.099 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.4 HH22 ' NH2' ' A' ' 175' ' ' ARG . 93.5 mtt180 -97.35 -179.21 4.42 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.213 0.605 . . . . 0.0 109.732 174.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -78.3 40.87 0.36 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.002 0.921 . . . . 0.0 110.402 169.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -141.53 160.23 57.51 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.784 1.634 . . . . 0.0 108.087 -167.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -52.05 151.06 17.21 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.092 2.528 . . . . 0.0 115.077 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.593 ' HB3' ' HD3' ' A' ' 166' ' ' ARG . 55.5 m 61.06 -105.58 0.21 Allowed 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 125.574 1.55 . . . . 0.0 113.608 175.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.593 ' HD3' ' HB3' ' A' ' 165' ' ' SER . 0.0 OUTLIER -152.62 -178.16 6.69 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 118.344 0.52 . . . . 0.0 112.285 -170.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -146.39 160.71 41.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.958 0.903 . . . . 0.0 110.335 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -104.8 154.45 38.58 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.846 0.858 . . . . 0.0 110.652 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.32 152.6 79.12 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.16 1.907 . . . . 0.0 110.768 163.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 25.2 t 68.57 17.92 8.94 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.79 1.236 . . . . 0.0 111.804 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.4 m -109.0 13.83 24.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.808 0.843 . . . . 0.0 110.968 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.491 ' HG ' ' N ' ' A' ' 133' ' ' GLY . 18.8 m -135.35 21.7 3.42 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.955 0.902 . . . . 0.0 109.939 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 24.2 p -69.9 -57.35 5.15 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.067 0.947 . . . . 0.0 111.186 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.5 m -84.85 -9.71 57.86 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.538 0.735 . . . . 0.0 111.581 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.4 ' NH2' HH22 ' A' ' 161' ' ' ARG . 19.7 ptt180 -128.37 85.81 59.47 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.203 0.601 . . . . 0.0 111.283 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -89.8 -148.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 123.179 2.586 . . . . 0.0 110.298 165.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -151.23 -129.31 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 171.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.0 -52.87 4.21 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 165.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -127.31 130.58 49.77 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 165.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.19 95.22 0.56 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.442 0.639 . . . . 0.0 109.845 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -75.96 76.72 2.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.073 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.08 152.87 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.39 1.476 . . . . 0.0 107.792 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.505 HG23 ' HB2' ' A' ' 198' ' ' GLN . 39.3 mt -95.19 110.15 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.02 0.528 . . . . 0.0 110.654 -170.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -92.48 112.44 24.38 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 170.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -79.34 93.95 5.41 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.409 HG12 HG22 ' A' ' 156' ' ' VAL . 6.0 m -108.2 163.84 5.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-N 114.404 -1.271 . . . . 0.0 107.773 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.496 ' HG2' HG22 ' A' ' 196' ' ' VAL . 35.4 mtmt -106.48 135.02 48.71 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 165.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -63.61 89.88 0.05 OUTLIER 'General case' 0 C--O 1.207 -1.148 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 164.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.46 -20.28 65.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.079 0.952 . . . . 0.0 110.639 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.459 ' N ' ' HB2' ' A' ' 153' ' ' GLU . 2.1 t70 -64.52 -32.48 74.14 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.871 0.869 . . . . 0.0 110.078 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -144.6 72.24 15.54 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.11 -16.61 55.94 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.285 2.657 . . . . 0.0 115.582 -165.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.53 -11.22 59.84 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.568 0.347 . . . . 0.0 111.59 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -72.61 -15.71 61.73 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.308 0.643 . . . . 0.0 111.226 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 93.25 -175.47 36.29 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.661 0.624 . . . . 0.0 114.661 167.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.496 HG22 ' HG2' ' A' ' 187' ' ' LYS . 17.9 t -79.16 115.33 21.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.53 154.92 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.643 1.177 . . . . 0.0 110.214 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.505 ' HB2' HG23 ' A' ' 183' ' ' ILE . 10.8 pt20 -98.24 127.41 44.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.072 0.549 . . . . 0.0 110.103 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 82.7 mmm -137.13 142.01 42.26 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.327 1.051 . . . . 0.0 108.968 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.43 ' O ' HG22 ' A' ' 204' ' ' VAL . 27.5 m-80 -86.24 173.6 9.65 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 118.294 0.497 . . . . 0.0 110.228 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 51.6 m -61.0 -37.88 84.07 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 117.858 0.299 . . . . 0.0 111.488 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -58.88 -27.9 65.63 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.788 0.835 . . . . 0.0 112.158 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -87.96 -41.55 13.07 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.359 0.664 . . . . 0.0 111.309 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 200' ' ' ASN . 4.7 m -93.28 116.66 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.82 0.819 . . . . 0.0 109.233 -175.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -113.43 148.77 35.25 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.59 -165.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.09 153.93 20.55 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.272 0.629 . . . . 0.0 110.275 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.419 ' HG3' ' SD ' ' A' ' 289' ' ' MET . 9.6 ptm85 -117.64 127.17 53.69 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.371 0.668 . . . . 0.0 111.006 -169.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -85.26 136.47 33.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.828 0.851 . . . . 0.0 109.837 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.715 ' HB3' ' HG2' ' A' ' 289' ' ' MET . 6.7 ppt_? -92.77 15.61 14.21 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.125 0.57 . . . . 0.0 110.65 175.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 279' ' ' LYS . 23.0 m -86.62 108.89 18.82 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.391 0.677 . . . . 0.0 110.01 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 mt -86.51 121.98 38.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 172.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.568 HG23 ' HB2' ' A' ' 216' ' ' ASP . 38.5 mm -94.29 142.33 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.502 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 1.3 ptpp? -128.2 -179.73 5.16 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.609 1.164 . . . . 0.0 109.699 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.428 ' CH2' ' HB2' ' A' ' 248' ' ' GLU . 10.5 t90 -56.16 -40.47 73.93 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.064 0.546 . . . . 0.0 110.454 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -59.3 -33.12 70.71 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.718 0.807 . . . . 0.0 111.604 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.568 ' HB2' HG23 ' A' ' 212' ' ' ILE . 66.0 m-20 -80.34 -34.7 36.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.279 0.632 . . . . 0.0 110.536 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.518 HD22 HD11 ' A' ' 243' ' ' ILE . 89.0 mt -67.18 112.86 4.7 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-O 120.99 0.424 . . . . 0.0 110.479 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.51 154.83 51.24 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.519 1.127 . . . . 0.0 108.353 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 36.0 m -64.42 124.15 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.008 0.432 . . . . 0.0 110.49 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 103.25 -18.88 47.56 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.561 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -79.64 124.36 28.48 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.526 0.663 . . . . 0.0 109.859 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 14.0 p -91.94 141.23 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.535 0.683 . . . . 0.0 109.165 173.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.463 HG11 HG21 ' A' ' 212' ' ' ILE . 11.4 m -139.1 -177.1 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.978 1.311 . . . . 0.0 109.266 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.45 ' HB3' ' HE2' ' A' ' 224' ' ' MET . 3.8 ttp -136.63 125.27 23.75 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.115 0.566 . . . . 0.0 109.609 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.432 HD13 ' HD1' ' A' ' 227' ' ' TYR . 0.4 OUTLIER -146.21 151.62 37.89 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.408 1.083 . . . . 0.0 110.29 -169.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -88.8 108.79 19.7 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.935 0.494 . . . . 0.0 111.064 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.432 ' HD1' HD13 ' A' ' 225' ' ' LEU . 93.5 m-85 -140.61 139.77 34.96 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.913 0.885 . . . . 0.0 108.836 171.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.493 HD22 ' HB2' ' A' ' 230' ' ' ASP . 14.0 p-10 -87.26 134.62 36.07 Favored Pre-proline 0 N--CA 1.474 0.729 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.49 -13.12 36.78 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.116 1.878 . . . . 0.0 112.469 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.493 ' HB2' HD22 ' A' ' 228' ' ' ASN . 6.5 m-20 -67.69 -40.31 84.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.867 0.867 . . . . 0.0 110.133 173.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 234' ' ' GLU . 48.1 t-20 -141.31 104.19 6.04 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.78 -16.96 47.12 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.655 2.236 . . . . 0.0 112.688 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.478 ' HG3' HD11 ' A' ' 272' ' ' ILE . 83.0 tttt -95.55 8.3 43.75 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.989 0.916 . . . . 0.0 110.358 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 231' ' ' ASN . 38.3 tt0 -132.95 148.76 52.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.334 0.654 . . . . 0.0 110.964 -175.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -60.14 150.34 29.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.626 1.17 . . . . 0.0 112.386 172.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -169.6 -115.36 0.33 Allowed Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.493 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -95.62 150.06 20.77 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.347 0.659 . . . . 0.0 110.439 -176.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -77.97 107.45 10.52 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.403 0.681 . . . . 0.0 110.042 -174.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -119.63 164.97 15.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.331 0.652 . . . . 0.0 109.263 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.55 144.23 30.52 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 174.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.73 133.95 21.68 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 222' ' ' VAL . 34.6 tt0 -105.49 127.06 52.8 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.552 HD12 HD11 ' A' ' 255' ' ' LEU . 14.7 mm -64.95 103.8 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 123.993 0.808 . . . . 0.0 109.666 -172.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.8 p -79.31 -45.57 19.4 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.144 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -143.82 163.6 32.91 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.284 1.034 . . . . 0.0 110.102 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -155.03 149.05 25.8 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.761 0.824 . . . . 0.0 109.427 172.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -146.57 118.87 8.36 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.484 0.659 . . . . 0.0 110.565 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.428 ' HB2' ' CH2' ' A' ' 214' ' ' TRP . 5.0 tm-20 -93.17 124.19 36.97 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 63.6 p -125.61 157.51 37.01 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.44 ' HG3' HG23 ' A' ' 251' ' ' THR . 27.5 ptt180 -60.82 -24.76 66.11 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.349 1.06 . . . . 0.0 112.703 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.44 HG23 ' HG3' ' A' ' 250' ' ' ARG . 55.9 p -97.93 -28.59 13.74 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.828 0.851 . . . . 0.0 112.566 -172.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -166.1 169.24 14.7 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.68 0.392 . . . . 0.0 111.026 -173.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -95.85 155.56 16.7 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.081 0.553 . . . . 0.0 109.747 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -146.28 140.56 26.58 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.552 HD11 HD12 ' A' ' 243' ' ' ILE . 0.3 OUTLIER -148.17 144.35 27.69 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -135.68 134.04 38.75 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.998 0.919 . . . . 0.0 109.82 176.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.84 143.98 27.82 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.223 0.609 . . . . 0.0 111.087 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -79.52 98.43 6.84 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.022 0.529 . . . . 0.0 109.583 172.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 91.8 t -76.42 103.51 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.273 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.66 122.53 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.966 0.889 . . . . 0.0 110.104 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 32.5 mt -88.17 -151.57 0.2 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.173 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -59.89 -77.04 0.19 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 117.852 0.296 . . . . 0.0 112.579 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -100.49 -25.15 14.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.378 0.671 . . . . 0.0 110.944 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -90.61 173.21 8.17 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.826 0.85 . . . . 0.0 111.435 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 32.8 p -155.56 120.54 4.8 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.553 0.741 . . . . 0.0 110.054 174.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.19 97.51 7.64 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.364 1.066 . . . . 0.0 109.033 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.7 132.92 46.89 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.564 0.746 . . . . 0.0 111.36 -172.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 55.3 35.87 25.85 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.644 1.215 . . . . 0.0 111.818 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 36.8 t -64.0 124.43 21.57 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 54.3 ttt180 -70.63 117.18 11.83 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.788 0.435 . . . . 0.0 110.229 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 34.8 mm -80.36 110.91 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.219 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.478 HD11 ' HG3' ' A' ' 233' ' ' LYS . 25.0 mm -78.12 -66.36 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.796 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -83.63 65.84 8.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.817 1.247 . . . . 0.0 109.948 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 22.7 m -64.4 -32.53 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.603 0.761 . . . . 0.0 111.999 -173.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 5.3 p-10 -86.05 -13.98 45.76 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.645 1.178 . . . . 0.0 111.917 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -97.65 -0.64 45.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.453 0.701 . . . . 0.0 111.471 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.81 153.87 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 123.704 0.801 . . . . 0.0 110.637 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -117.4 161.56 19.35 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.899 0.879 . . . . 0.0 108.869 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.417 ' HB3' ' HB ' ' A' ' 210' ' ' THR . 80.1 tttt -91.03 153.09 20.38 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.867 0.467 . . . . 0.0 112.008 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.2 mm -67.23 120.26 14.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 123.947 0.899 . . . . 0.0 108.802 168.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.36 112.2 8.22 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.527 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 96.1 mtt180 -128.2 141.59 41.79 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 123.883 0.873 . . . . 0.0 109.436 172.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -46.16 108.03 0.14 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.815 3.01 . . . . 0.0 113.265 170.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.36 -39.78 2.9 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.817 -0.628 . . . . 0.0 113.435 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 32.5 tt0 -79.35 -29.19 42.09 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.961 0.381 . . . . 0.0 111.766 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -117.57 151.43 18.07 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 12.5 p -88.91 109.95 34.15 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-N 117.788 0.794 . . . . 0.0 110.114 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.25 155.69 60.31 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 123.198 2.599 . . . . 0.0 110.166 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . 0.715 ' HG2' ' HB3' ' A' ' 209' ' ' ARG . 63.8 mtt -74.78 80.5 2.08 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.61 0.719 . . . . 0.0 112.559 -172.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.02 -28.11 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 165.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.78 -164.42 0.79 Allowed 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.254 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -57.24 111.75 3.78 Favored Pre-proline 0 N--CA 1.487 1.402 0 CA-C-N 118.774 0.715 . . . . 0.0 111.566 -177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.544 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 11.9 Cg_exo -72.61 93.89 0.77 Allowed 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.432 2.088 . . . . 0.0 111.094 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.2 mtm -73.36 125.73 28.52 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.02 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.23 121.34 22.77 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -64.59 -30.08 71.1 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.06 0.944 . . . . 0.0 111.179 -175.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -57.06 122.08 11.52 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.383 167.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 50.2 p -77.57 91.98 4.02 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.366 0.666 . . . . 0.0 110.804 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -92.25 167.54 30.35 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.564 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo . . . . . 0 C--N 1.38 2.203 0 C-N-CA 123.214 2.609 . . . . 0.0 111.917 176.472 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.417 0 CA-C-O 119.744 -0.476 . . . . 0.0 111.967 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.31 7.37 4.97 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -79.6 128.47 33.42 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.776 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 58.1 pttt -72.18 174.66 6.88 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.004 0.922 . . . . 0.0 111.657 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -74.51 -2.67 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.206 0.602 . . . . 0.0 111.948 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.511 ' H ' ' HG3' ' A' ' 136' ' ' LYS . 92.0 m-20 -120.99 30.3 6.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.244 1.018 . . . . 0.0 110.96 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.776 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 6.3 mm-40 -88.86 71.21 8.64 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.253 1.025 . . . . 0.0 110.859 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -63.76 99.4 0.23 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.288 169.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 30.1 m -121.77 169.32 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.972 0.909 . . . . 0.0 109.703 -176.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' A' ' 207' ' ' ARG . 1.6 t0 -101.6 110.34 22.32 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -92.75 92.98 8.21 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 122.932 0.493 . . . . 0.0 110.497 -171.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 2.8 tmt_? -72.27 106.13 4.32 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 174.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.62 114.8 3.78 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.47 ' HA ' ' NH1' ' A' ' 144' ' ' ARG . 13.8 t -60.25 -23.89 64.46 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -171.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -83.7 -38.69 21.12 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.447 0.699 . . . . 0.0 110.174 -174.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 41.9 ttm -92.96 -22.89 18.93 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.491 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.42 12.93 73.66 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.063 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.56 129.98 53.71 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.622 0.769 . . . . 0.0 111.147 -174.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 52.1 m95 -81.89 121.93 27.09 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.077 0.951 . . . . 0.0 110.617 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -131.03 115.18 16.12 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 27.1 mt-10 -58.45 144.86 40.72 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.311 0.505 . . . . 0.0 111.139 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.494 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -158.42 124.78 4.69 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 124.31 1.006 . . . . 0.0 109.613 -176.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -92.48 118.88 31.42 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 63.7 t -61.66 111.72 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.485 0 C-N-CA 123.484 0.713 . . . . 0.0 109.315 172.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.7 m -104.48 -6.89 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.138 0.575 . . . . 0.0 111.8 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -170.14 141.28 2.08 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.199 0.599 . . . . 0.0 110.24 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.6 m -119.41 142.09 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.59 0.756 . . . . 0.0 110.672 172.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.2 t -147.14 160.86 41.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.032 0.933 . . . . 0.0 108.833 169.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.588 ' HE ' ' HB3' ' A' ' 163' ' ' ALA . 17.2 ptt-85 -101.73 176.39 5.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.061 0.544 . . . . 0.0 110.217 -177.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -85.78 58.58 5.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.474 0.71 . . . . 0.0 110.042 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.588 ' HB3' ' HE ' ' A' ' 161' ' ' ARG . . . -169.17 148.92 3.75 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.709 1.204 . . . . 0.0 109.224 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.538 ' HB2' ' HB2' ' A' ' 167' ' ' ASP . 42.2 Cg_endo -64.39 92.42 0.19 Allowed 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.95 2.433 . . . . 0.0 112.585 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 16.7 m -86.07 -42.89 13.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.789 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -68.65 -51.57 40.66 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.313 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.538 ' HB2' ' HB2' ' A' ' 164' ' ' PRO . 10.1 m-20 -54.73 -45.67 74.13 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 123.591 0.557 . . . . 0.0 110.456 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.607 ' HG2' ' HB3' ' A' ' 171' ' ' SER . 0.6 OUTLIER 47.4 73.7 0.95 Allowed Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.227 1.411 . . . . 0.0 110.083 -177.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.02 -61.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.37 2.047 . . . . 0.0 110.598 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 85.9 m -134.51 33.04 3.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.501 1.121 . . . . 0.0 109.108 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.607 ' HB3' ' HG2' ' A' ' 168' ' ' GLU . 32.7 t -71.97 171.15 12.33 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.537 1.135 . . . . 0.0 111.071 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.2 m 72.12 8.16 5.86 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.936 1.294 . . . . 0.0 112.809 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.6 t -88.15 -25.77 22.79 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.061 0.545 . . . . 0.0 109.747 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 23.7 p -166.09 154.75 11.11 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 124.794 1.238 . . . . 0.0 109.334 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -146.32 91.74 5.37 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.081 0.553 . . . . 0.0 109.894 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.84 113.5 3.81 Favored 'Trans proline' 0 CA--C 1.554 1.509 0 C-N-CA 122.709 2.273 . . . . 0.0 112.405 174.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -129.66 -33.76 1.82 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.665 0.786 . . . . 0.0 110.299 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.594 ' HG ' ' HG3' ' A' ' 179' ' ' GLU . 43.5 tp 56.61 -83.13 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.117 1.767 . . . . 0.0 112.447 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.594 ' HG3' ' HG ' ' A' ' 178' ' ' LEU . 45.3 mt-10 -126.18 44.48 2.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.408 1.083 . . . . 0.0 109.078 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.402 ' HB3' ' OH ' ' A' ' 184' ' ' TYR . 10.0 mm-40 52.11 29.21 6.15 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 173.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -71.41 63.35 0.38 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.54 168.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.31 -175.51 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.821 1.648 . . . . 0.0 108.645 -170.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.611 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.7 mp -97.5 110.71 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.402 ' OH ' ' HB3' ' A' ' 180' ' ' GLU . 99.6 m-85 -98.61 106.61 18.91 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.193 0.997 . . . . 0.0 108.411 170.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -79.09 97.7 6.23 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.494 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 35.1 m -109.97 163.65 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.241 1.017 . . . . 0.0 111.019 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 154' ' ' ALA . 1.8 mmmp? -121.54 114.01 20.61 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 174.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -63.16 115.03 4.12 Favored 'General case' 0 N--CA 1.483 1.189 0 O-C-N 123.303 0.377 . . . . 0.0 110.254 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.69 -34.77 72.33 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.968 0.413 . . . . 0.0 110.408 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.64 -28.72 61.93 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.898 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -142.17 68.13 22.0 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 122.762 0.425 . . . . 0.0 111.342 -170.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.34 -11.41 24.75 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.264 2.643 . . . . 0.0 113.629 -174.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.44 -17.87 62.36 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.558 0.743 . . . . 0.0 111.17 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -72.5 -10.5 59.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.389 0.675 . . . . 0.0 111.54 173.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.63 -151.78 45.16 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.401 0.438 . . . . 0.0 112.342 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.75 117.88 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 18.5 m -116.6 152.62 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.833 0.853 . . . . 0.0 109.466 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.611 ' HB2' HG23 ' A' ' 183' ' ' ILE . 5.4 pm0 -107.57 123.97 49.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.976 0.51 . . . . 0.0 109.716 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . 0.404 ' HE1' ' HB1' ' A' ' 143' ' ' ALA . 74.9 mtp -131.16 170.13 14.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.58 0.752 . . . . 0.0 110.045 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -109.41 175.4 5.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.922 0.889 . . . . 0.0 109.904 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 45.8 t -63.73 -40.02 95.72 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.884 0.474 . . . . 0.0 110.687 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -65.46 -7.32 13.59 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -101.87 -54.64 2.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.027 0.931 . . . . 0.0 111.345 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 32.6 m -91.72 119.94 39.94 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -168.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.428 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 16.0 mmt180 -123.12 141.4 52.01 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.937 -169.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.81 132.18 51.55 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 168.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.674 ' HB3' ' HB2' ' A' ' 142' ' ' ASP . 4.2 ptm180 -111.71 158.35 19.43 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.772 0.429 . . . . 0.0 111.119 -173.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -92.64 140.64 29.33 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.858 0.463 . . . . 0.0 109.882 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.515 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 10.9 ptm180 -93.43 18.11 10.32 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.378 0.609 . . . . 0.0 110.537 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 87.8 m -98.91 113.99 26.39 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.304 1.042 . . . . 0.0 109.996 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 30.6 mt -86.94 124.49 40.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 169.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.629 ' HB ' ' HB ' ' A' ' 277' ' ' VAL . 47.9 mm -86.37 127.3 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.755 1.222 . . . . 0.0 109.917 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.87 -178.91 3.6 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.208 1.003 . . . . 0.0 108.625 171.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.401 ' HA ' HD23 ' A' ' 217' ' ' LEU . 64.4 t-105 -54.29 -32.92 57.54 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.128 0.571 . . . . 0.0 112.269 -172.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -61.77 -39.17 90.73 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.529 0.731 . . . . 0.0 111.487 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.593 ' HB2' HG23 ' A' ' 212' ' ' ILE . 7.1 m-20 -84.6 -14.52 48.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.85 0.86 . . . . 0.0 111.67 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.447 HD22 HG22 ' A' ' 212' ' ' ILE . 3.2 mm? -66.7 113.41 4.81 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.7 140.94 34.99 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.129 0.971 . . . . 0.0 108.438 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.1 m -70.0 138.49 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 120.966 0.412 . . . . 0.0 110.899 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 94.06 -13.78 66.66 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.324 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.474 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.1 tt0 -81.68 122.77 28.05 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.344 0.572 . . . . 0.0 110.837 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.83 119.66 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 279' ' ' LYS . 1.9 m -135.27 172.58 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.587 1.155 . . . . 0.0 110.265 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.531 ' HE2' ' HB2' ' A' ' 278' ' ' PHE . 48.4 ttp -110.32 113.98 27.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.257 0.623 . . . . 0.0 110.08 -174.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.527 ' HG ' HG13 ' A' ' 277' ' ' VAL . 0.2 OUTLIER -121.97 147.16 46.41 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.281 0.632 . . . . 0.0 109.502 -173.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -87.44 124.09 33.06 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.575 0.75 . . . . 0.0 110.143 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 225' ' ' LEU . 7.3 p90 -169.07 154.2 5.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.061 0.944 . . . . 0.0 109.357 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -82.11 127.83 70.23 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 162.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.77 -38.89 77.57 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.304 2.003 . . . . 0.0 111.939 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -75.59 -30.1 59.51 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.021 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -132.9 79.87 62.21 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 123.3 0.64 . . . . 0.0 110.643 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.95 -11.96 32.18 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 123.135 2.557 . . . . 0.0 113.389 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.51 ' HA ' HD12 ' A' ' 272' ' ' ILE . 22.3 tptm -70.99 -24.23 62.35 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.35 0.66 . . . . 0.0 110.931 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -130.68 164.56 24.75 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.0 0.52 . . . . 0.0 111.033 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -51.49 160.08 0.65 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.335 1.454 . . . . 0.0 112.804 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -166.02 -107.32 0.2 Allowed Glycine 0 C--N 1.344 1.018 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -128.18 173.18 10.33 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.773 0.829 . . . . 0.0 109.11 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -96.65 127.16 42.37 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.452 0.701 . . . . 0.0 110.049 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 224' ' ' MET . 93.7 m-85 -138.95 164.54 29.45 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.371 0.668 . . . . 0.0 110.051 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.4 140.44 34.68 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 173.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -150.95 137.38 18.62 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -95.42 126.42 40.7 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.475 HD12 HD11 ' A' ' 255' ' ' LEU . 19.0 mm -67.65 110.39 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.052 0.453 . . . . 0.0 109.801 -175.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.424 ' H ' ' HA ' ' A' ' 257' ' ' ALA . 17.1 m -79.3 -39.66 32.35 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.823 0.849 . . . . 0.0 110.666 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -161.97 156.08 21.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.79 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -141.69 148.29 38.84 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 169.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.524 ' HB3' ' HG3' ' A' ' 254' ' ' GLU . 28.1 tpt180 -149.87 122.15 8.39 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -115.32 123.69 49.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.113 0.565 . . . . 0.0 109.873 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 62.2 p -121.6 162.95 19.73 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' A' ' 250' ' ' ARG . 11.6 tpt180 -67.18 -22.31 65.75 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 120.759 0.314 . . . . 0.0 111.401 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.2 p -86.41 -28.99 23.22 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.375 0.67 . . . . 0.0 111.414 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -165.67 141.41 5.1 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.445 ' O ' ' HD2' ' A' ' 253' ' ' ARG . 4.2 ppt_? -111.18 102.52 10.94 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.675 0.79 . . . . 0.0 109.569 173.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 247' ' ' ARG . 7.6 pt-20 -95.71 122.85 38.92 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.634 0.774 . . . . 0.0 110.722 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 270' ' ' ARG . 1.7 tm? -108.77 147.85 31.41 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . 0.448 ' N ' HD13 ' A' ' 255' ' ' LEU . 99.3 m-85 -135.04 132.31 38.1 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.264 1.026 . . . . 0.0 108.516 175.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.424 ' HA ' ' H ' ' A' ' 244' ' ' SER . . . -144.46 139.94 28.62 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 -177.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 43.5 t30 -75.66 95.54 3.41 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 172.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 34.3 t -68.79 112.16 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.372 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.79 117.92 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 264' ' ' ASP . 59.8 mt -94.5 -165.78 1.37 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.497 0.719 . . . . 0.0 109.423 173.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -62.85 -45.3 95.99 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.01 0.194 . . . . 0.0 113.341 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -123.06 -35.98 2.92 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.546 0.738 . . . . 0.0 110.646 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.571 ' HB2' HD12 ' A' ' 261' ' ' LEU . 8.2 m-20 -91.79 176.55 6.49 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.83 0.852 . . . . 0.0 111.574 -172.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 35.1 t -156.59 118.08 3.82 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.514 0.726 . . . . 0.0 110.201 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 2.0 mm? -96.15 92.11 6.25 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 3.2 p-10 -68.7 138.61 55.07 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.353 0.261 . . . . 0.0 111.289 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 57.88 32.53 22.05 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.291 1.036 . . . . 0.0 111.786 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 44.0 t -65.27 127.27 31.05 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.41 0.684 . . . . 0.0 110.411 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 45.0 ttp180 -70.51 110.49 5.42 Favored 'General case' 0 C--N 1.346 0.456 0 O-C-N 123.436 0.46 . . . . 0.0 110.343 -178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.1 mm -89.43 132.78 33.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.774 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 233' ' ' LYS . 65.0 mt -102.09 -26.31 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.082 1.353 . . . . 0.0 109.932 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -92.38 42.62 1.11 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.124 1.37 . . . . 0.0 111.336 -168.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 16.7 m -69.59 -22.84 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -168.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.85 -25.22 19.07 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.96 9.12 17.9 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.762 0.825 . . . . 0.0 112.332 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.629 ' HB ' ' HB ' ' A' ' 212' ' ' ILE . 32.7 t -80.56 147.05 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.391 0.676 . . . . 0.0 110.836 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.531 ' HB2' ' HE2' ' A' ' 224' ' ' MET . 62.7 m-85 -105.8 156.26 18.49 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 162.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.552 ' HA ' HG12 ' A' ' 223' ' ' VAL . 36.5 ttmt -80.57 146.58 31.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.666 0.386 . . . . 0.0 110.417 173.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.542 HG12 ' HA ' ' A' ' 223' ' ' VAL . 35.1 mm -73.48 114.91 13.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 168.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -76.6 134.06 39.47 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.631 173.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 61.5 mtp180 -108.38 94.2 13.07 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 168.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -20.17 97.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.386 2.551 1 C-N-CA 126.263 4.642 . . . . 0.0 117.246 -162.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 103.53 -30.84 9.5 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 115.347 -0.842 . . . . 0.0 115.189 169.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 11.6 pt-20 -79.51 -20.21 47.77 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.859 1.33 . . . . 0.0 112.004 -173.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -87.46 -100.57 0.87 Allowed Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . 0.422 ' HB2' ' HG2' ' A' ' 209' ' ' ARG . 14.6 p -127.23 128.52 24.08 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.535 1.134 . . . . 0.0 110.791 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.52 133.66 17.65 Favored 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 123.29 2.66 . . . . 0.0 112.921 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . 0.515 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 98.3 mmm -86.45 82.49 7.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 168.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 11.2 p -128.58 -15.03 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.757 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -103.42 -153.18 0.47 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.701 1.2 . . . . 0.0 108.625 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -55.17 120.19 28.28 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.566 0.747 . . . . 0.0 111.575 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.33 85.12 0.45 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.817 2.345 . . . . 0.0 111.336 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 18.7 ptm -71.05 82.39 0.68 Allowed 'General case' 0 C--O 1.244 0.767 0 CA-C-O 123.037 1.399 . . . . 0.0 109.895 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -94.73 160.03 14.8 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.77 -172.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.455 ' NH2' ' H ' ' A' ' 153' ' ' GLU . 30.6 mtm-85 -87.3 118.79 26.96 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.108 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.6 mttt 64.81 -170.89 0.19 Allowed 'General case' 0 CA--C 1.551 1.002 0 O-C-N 124.565 1.166 . . . . 0.0 111.078 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.5 m -146.32 76.41 1.44 Allowed 'General case' 0 C--O 1.24 0.562 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 160.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 122.22 175.33 14.78 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.891 -171.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo . . . . . 0 C--N 1.375 1.966 0 C-N-CA 123.311 2.674 . . . . 0.0 111.274 178.135 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.634 ' N ' ' HH ' ' A' ' 184' ' ' TYR . . . . . . . . 0 N--CA 1.485 1.955 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.432 HD13 ' N ' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -127.29 5.67 6.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.488 0.715 . . . . 0.0 112.323 -173.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.505 ' HB2' HG11 ' A' ' 156' ' ' VAL . 43.0 m-85 -96.93 143.08 28.14 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.475 0.31 . . . . 0.0 110.433 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.551 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 22.6 pttp -86.14 176.8 7.78 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.037 0.535 . . . . 0.0 111.055 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.65 -10.27 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -173.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -127.44 21.59 6.59 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 122.747 0.419 . . . . 0.0 110.44 -171.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.551 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 17.9 mm-40 -99.65 88.62 3.88 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 122.038 -0.414 . . . . 0.0 110.798 175.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 25.6 p90 -76.75 122.87 25.35 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.339 171.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.26 167.42 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.617 0.767 . . . . 0.0 108.968 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -90.72 115.12 27.57 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.79 120.37 36.33 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.588 -167.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.54 128.37 35.39 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.85 112.45 5.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 t -68.02 -14.35 62.9 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.464 0.705 . . . . 0.0 112.702 -172.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -86.76 -54.12 4.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.343 0.657 . . . . 0.0 111.107 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 37.8 ttp -96.34 -27.83 14.77 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.411 0.685 . . . . 0.0 112.084 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.72 18.85 46.35 Favored Glycine 0 N--CA 1.475 1.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.946 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.75 129.37 53.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.119 0.568 . . . . 0.0 111.062 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.673 ' HH2' ' HD2' ' A' ' 205' ' ' ARG . 81.4 m95 -75.22 128.09 34.66 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.64 0.776 . . . . 0.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -131.8 137.66 48.22 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.283 1.033 . . . . 0.0 108.925 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -59.32 114.43 2.65 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -125.54 120.67 31.5 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.199 0.6 . . . . 0.0 109.796 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.734 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 51.6 tt0 -87.19 114.75 24.07 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.605 0.762 . . . . 0.0 110.554 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 135' ' ' TYR . 92.5 t -62.28 98.41 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.7 m -94.88 -10.02 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.912 0.485 . . . . 0.0 111.076 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 27.8 ttt180 -170.25 146.7 2.97 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.975 0.797 . . . . 0.0 109.92 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.0 m -117.17 142.9 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 169.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 31.3 p -135.21 121.49 20.3 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 172.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -82.18 176.47 9.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.029 0.532 . . . . 0.0 111.051 -175.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -78.29 67.71 4.15 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -171.38 155.02 4.07 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.399 -169.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.54 88.26 0.17 Allowed 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.562 2.175 . . . . 0.0 112.044 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.7 m -81.14 -41.71 22.03 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.057 0.943 . . . . 0.0 110.364 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 73.51 150.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.794 1.638 . . . . 0.0 112.636 173.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -50.54 -55.72 14.86 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.333 1.053 . . . . 0.0 111.199 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -79.44 108.98 9.95 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 163.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.82 139.85 34.25 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.558 2.172 . . . . 0.0 112.601 -166.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 10.0 p -78.37 153.46 31.61 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.732 0.813 . . . . 0.0 109.562 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 31.3 t -58.37 137.15 57.44 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.632 0.773 . . . . 0.0 110.221 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 71.2 p -60.29 104.8 0.35 Allowed 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.997 0.81 . . . . 0.0 111.867 -169.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 19.3 p -75.81 157.78 32.98 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.546 -1.207 . . . . 0.0 111.322 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 10.6 p -88.65 59.26 5.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.159 0.984 . . . . 0.0 110.12 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 64.9 mtt-85 -96.48 105.29 21.76 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.416 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.39 163.54 24.59 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.591 2.194 . . . . 0.0 113.063 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -160.61 -179.18 7.42 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.949 0.9 . . . . 0.0 110.207 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.41 ' H ' HD23 ' A' ' 178' ' ' LEU . 1.2 pt? -120.2 -112.21 0.33 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -74.77 78.22 2.08 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 119.152 0.887 . . . . 0.0 108.658 167.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.23 97.43 1.55 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.025 -171.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -76.66 53.14 0.87 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.823 0.82 . . . . 0.0 110.435 169.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 31.6 m -83.85 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 124.603 1.161 . . . . 0.0 109.624 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.595 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.5 mp -97.3 106.21 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.634 ' HH ' ' N ' ' A' ' 133' ' ' GLY . 36.2 m-85 -93.54 111.17 22.78 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 14.5 m-70 -80.01 90.28 5.38 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 35.0 m -108.97 140.2 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.32 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -105.74 123.45 47.97 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -57.04 96.3 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -62.96 -29.63 70.96 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.006 0.922 . . . . 0.0 109.076 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 298' ' ' SER . 2.0 t0 -61.83 -30.96 71.18 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.086 1.354 . . . . 0.0 111.031 176.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -145.75 81.27 10.1 Favored Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 124.549 1.14 . . . . 0.0 108.624 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -65.05 -16.86 57.36 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.076 2.517 . . . . 0.0 114.618 -170.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.53 -18.7 65.13 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -74.67 -20.9 59.69 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.206 0.602 . . . . 0.0 111.626 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.41 -144.6 41.04 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.511 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 6.8 t -87.66 129.55 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.217 0.607 . . . . 0.0 110.424 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.7 153.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.045 1.338 . . . . 0.0 108.52 170.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.595 ' HB2' HG23 ' A' ' 183' ' ' ILE . 16.2 pt20 -102.88 128.74 49.54 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.124 0.488 . . . . 0.0 110.305 177.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 84.2 mtp -137.61 159.82 40.9 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.33 1.052 . . . . 0.0 108.73 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -97.81 174.23 6.7 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.6 t -64.21 -34.79 78.89 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 120.827 0.346 . . . . 0.0 110.746 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.46 -14.86 63.3 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -96.5 -45.29 6.81 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.716 0.807 . . . . 0.0 110.344 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 32.6 m -95.41 117.29 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.673 ' HD2' ' HH2' ' A' ' 151' ' ' TRP . 92.7 mtt180 -128.55 171.42 12.15 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.77 -0.582 . . . . 0.0 111.193 -168.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.58 129.4 40.43 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.374 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.58 ' HG3' ' SD ' ' A' ' 289' ' ' MET . 26.4 ptt180 -81.1 142.11 33.64 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.357 1.063 . . . . 0.0 111.229 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.65 ' HB2' ' HB2' ' A' ' 281' ' ' GLU . . . -99.92 145.41 27.84 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.395 0.678 . . . . 0.0 110.339 175.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -2.38 34.81 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.657 0.783 . . . . 0.0 110.558 173.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.5 m -89.49 117.71 28.6 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.473 0.709 . . . . 0.0 111.332 -165.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.3 mt -92.4 136.26 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 166.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.686 HG21 HD13 ' A' ' 217' ' ' LEU . 19.9 mm -107.46 153.55 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.951 0.9 . . . . 0.0 110.372 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -128.26 168.52 15.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.549 0.74 . . . . 0.0 109.066 167.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 35.9 t90 -46.32 -41.86 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.344 1.058 . . . . 0.0 112.096 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -57.68 -46.3 84.48 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.85 0.86 . . . . 0.0 112.637 -173.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -103.65 6.3 36.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.504 0.722 . . . . 0.0 111.023 -175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.686 HD13 HG21 ' A' ' 212' ' ' ILE . 8.0 tp -86.63 110.96 20.2 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 175.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.7 153.35 25.39 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.947 0.34 . . . . 0.0 110.861 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.413 ' HA ' ' HB ' ' A' ' 243' ' ' ILE . 28.0 m -66.13 136.99 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.701 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.0 -23.62 34.89 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.622 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.524 ' HG2' HG13 ' A' ' 223' ' ' VAL . 9.5 tt0 -74.69 123.39 24.81 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.119 0.567 . . . . 0.0 110.373 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 84.5 t -85.8 119.91 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.524 HG13 ' HG2' ' A' ' 221' ' ' GLN . 3.5 m -132.69 164.54 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.226 1.41 . . . . 0.0 109.856 -177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.589 ' HB3' HD11 ' A' ' 280' ' ' ILE . 15.0 ptm -112.28 139.11 48.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.635 0.774 . . . . 0.0 110.353 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.578 HD13 HG23 ' A' ' 271' ' ' ILE . 0.6 OUTLIER -142.69 157.28 44.83 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -89.37 112.23 23.29 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.195 0.598 . . . . 0.0 109.65 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.429 ' OH ' HG13 ' A' ' 259' ' ' VAL . 0.5 OUTLIER -159.89 149.69 18.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.692 0.797 . . . . 0.0 109.321 178.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -92.76 137.37 24.14 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 171.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.82 2.53 5.83 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.733 2.289 . . . . 0.0 113.66 -175.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -96.77 -15.93 21.1 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.869 0.868 . . . . 0.0 110.726 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -160.08 90.48 1.79 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.606 0.762 . . . . 0.0 109.025 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.05 -5.19 15.8 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.067 2.511 . . . . 0.0 112.33 175.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.664 ' HA ' HD12 ' A' ' 272' ' ' ILE . 88.6 tttt -73.45 -28.29 61.88 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.772 0.829 . . . . 0.0 111.171 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -123.84 155.18 38.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.09 0.556 . . . . 0.0 110.263 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -68.75 174.3 4.45 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.263 1.025 . . . . 0.0 112.76 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -178.8 -105.03 0.19 Allowed Glycine 0 C--N 1.338 0.67 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.932 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -110.04 153.03 25.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 0.0 109.408 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . 0.437 ' HA ' ' O ' ' A' ' 225' ' ' LEU . 67.2 m95 -83.58 106.38 15.27 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 122.796 0.438 . . . . 0.0 110.074 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -112.62 166.08 11.67 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . 0.494 ' HB2' HG13 ' A' ' 260' ' ' VAL . 3.8 m-20 -81.32 146.21 30.48 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.223 176.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -146.47 134.51 21.5 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 169.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -102.39 117.28 34.38 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.414 HD12 HD21 ' A' ' 255' ' ' LEU . 31.8 mm -61.98 114.8 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 123.352 0.407 . . . . 0.0 110.377 -171.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 20.1 m -98.86 -25.01 14.76 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.463 0.705 . . . . 0.0 110.449 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 23.9 ttm180 -166.89 151.71 7.42 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.726 0.811 . . . . 0.0 109.381 -174.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -156.42 134.3 11.09 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 122.963 0.505 . . . . 0.0 110.388 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -146.51 116.38 7.27 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 169.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 8.9 pt-20 -100.16 152.18 20.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.194 0.521 . . . . 0.0 109.824 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 69.5 p -131.96 168.03 18.62 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -67.93 -15.98 63.86 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 117.829 0.286 . . . . 0.0 111.32 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.6 p -94.01 -29.87 15.0 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.843 0.857 . . . . 0.0 112.027 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -168.62 134.73 1.82 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 122.917 0.487 . . . . 0.0 111.528 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 46.9 mtt180 -90.79 106.88 18.82 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -95.95 143.55 27.03 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.301 0.64 . . . . 0.0 109.643 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.516 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 5.6 tt -150.0 149.84 30.94 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . 0.476 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 82.4 m-85 -134.72 124.84 25.89 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -134.54 147.88 50.39 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.11 0.564 . . . . 0.0 110.459 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 35.0 t30 -76.01 92.49 3.16 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 15.7 t -67.96 130.42 33.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.649 174.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 240' ' ' ASP . 4.3 p -122.47 114.26 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 40.4 mt -89.35 -155.63 0.36 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.221 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -81.3 -49.25 5.6 Favored Glycine 0 C--N 1.344 1.0 0 C-N-CA 121.932 -0.175 . . . . 0.0 112.722 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -104.99 -24.22 12.85 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.259 0.624 . . . . 0.0 111.988 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -139.57 175.66 9.38 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.97 0.508 . . . . 0.0 109.899 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 17.6 p -144.76 131.47 20.05 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.158 0.583 . . . . 0.0 111.315 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 14.7 mt -97.87 89.83 4.73 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.699 1.2 . . . . 0.0 109.38 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 18.4 t-20 -69.98 135.15 49.09 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.14 0.576 . . . . 0.0 111.44 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 57.18 29.7 17.1 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.532 1.133 . . . . 0.0 112.825 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 39.3 t -66.43 130.39 43.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.005 0.522 . . . . 0.0 109.968 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -69.58 131.22 44.33 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.032 0.444 . . . . 0.0 111.361 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.578 HG23 HD13 ' A' ' 225' ' ' LEU . 48.8 mm -108.24 114.44 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.838 1.255 . . . . 0.0 109.335 -175.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.664 HD12 ' HA ' ' A' ' 233' ' ' LYS . 11.9 mt -87.94 -21.96 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.579 0.752 . . . . 0.0 109.893 173.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.79 38.54 0.84 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.262 1.025 . . . . 0.0 111.461 -173.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 26.8 m -63.19 -21.33 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.543 0.737 . . . . 0.0 111.861 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -97.92 -27.62 14.19 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.895 1.278 . . . . 0.0 110.543 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -106.17 10.82 31.81 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.198 0.999 . . . . 0.0 111.434 -170.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.529 HG13 ' HB ' ' A' ' 212' ' ' ILE . 7.4 p -86.17 131.14 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.527 0.731 . . . . 0.0 109.515 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.4 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 7.0 m-30 -101.27 164.21 11.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.478 1.111 . . . . 0.0 109.41 172.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.623 ' HB2' HD11 ' A' ' 212' ' ' ILE . 40.4 ttmt -83.76 142.32 30.77 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.153 0.581 . . . . 0.0 110.994 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.589 HD11 ' HB3' ' A' ' 224' ' ' MET . 21.0 mm -84.04 117.47 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 165.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.65 ' HB2' ' HB2' ' A' ' 208' ' ' ALA . 0.3 OUTLIER -83.63 106.34 15.27 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.407 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 29.4 mtp180 -97.65 92.35 1.3 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -15.33 90.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.474 1 C-N-CA 126.621 4.881 . . . . 0.0 117.037 -161.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.26 6.05 51.7 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.441 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 34.7 tt0 -121.11 -23.06 5.9 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.438 0.695 . . . . 0.0 110.704 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -83.79 -126.88 1.31 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 174.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 23.0 m -127.81 142.36 44.02 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-N 117.62 0.71 . . . . 0.0 110.654 174.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.71 114.81 4.12 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.81 2.34 . . . . 0.0 111.036 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . 0.58 ' SD ' ' HG3' ' A' ' 207' ' ' ARG . 26.5 ttt -73.94 92.76 2.13 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.564 0.697 . . . . 0.0 110.055 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 11.1 p -123.19 24.19 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 125.057 1.343 . . . . 0.0 108.687 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -136.09 -171.28 2.84 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.191 -165.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -47.2 141.71 6.06 Favored Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 125.048 1.339 . . . . 0.0 113.663 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.42 146.84 86.39 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.069 2.512 . . . . 0.0 112.582 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 7.4 mmt -82.39 -88.03 0.09 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.147 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 56.25 50.6 13.08 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -165.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -59.07 104.03 0.21 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 112.948 -1.933 . . . . 0.0 111.623 -170.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.54 26.28 14.15 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.13 0.972 . . . . 0.0 110.544 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 190' ' ' ASP . 78.4 p -89.52 163.3 15.28 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.204 0.601 . . . . 0.0 111.446 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -78.36 -177.45 48.37 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.649 -0.705 . . . . 0.0 113.579 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 CA--C 1.563 1.947 0 C-N-CA 123.143 2.562 . . . . 0.0 112.15 178.013 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.791 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.607 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -59.09 -32.78 70.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.351 0.66 . . . . 0.0 112.475 -177.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.515 ' N ' HD22 ' A' ' 134' ' ' LEU . 48.8 m-85 -79.62 152.16 30.18 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -114.94 176.83 4.89 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 109.134 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 30.0 m -71.67 -2.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.479 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -117.66 7.68 12.63 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.877 0.871 . . . . 0.0 111.38 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -86.48 90.92 8.38 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.898 0.479 . . . . 0.0 111.211 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 50.4 p90 -63.81 123.36 18.71 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.612 167.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.19 -170.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.597 0.759 . . . . 0.0 110.154 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 205' ' ' ARG . 47.0 t0 -106.1 158.39 16.85 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 165.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -140.27 111.45 7.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.36 0.527 . . . . 0.0 109.586 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -70.77 93.71 0.98 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -62.03 132.48 53.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.696 1.198 . . . . 0.0 112.1 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.3 p -86.8 -14.11 43.16 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.092 0.957 . . . . 0.0 111.36 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.92 -53.82 7.37 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.064 0.546 . . . . 0.0 110.479 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 53.8 ttm -100.68 -36.25 9.19 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.437 0.695 . . . . 0.0 111.239 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.61 16.68 48.11 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.443 -172.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -103.96 150.58 24.09 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.768 0.827 . . . . 0.0 110.283 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.446 ' HZ3' ' HG3' ' A' ' 205' ' ' ARG . 18.5 m95 -83.05 118.61 23.65 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -124.06 112.35 17.04 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 123.127 0.571 . . . . 0.0 109.648 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.637 ' HB2' ' HD2' ' A' ' 295' ' ' ARG . 5.6 pt-20 -58.48 128.96 39.78 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.701 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.461 ' HA ' ' H ' ' A' ' 189' ' ' ASP . . . -144.1 -175.72 4.72 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.218 1.007 . . . . 0.0 111.136 -168.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.6 tt0 -140.25 125.49 18.76 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.038 0.535 . . . . 0.0 109.906 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.9 t -62.13 115.48 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 124.026 0.93 . . . . 0.0 108.921 169.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.556 HG11 ' HE2' ' A' ' 187' ' ' LYS . 35.5 m -116.99 -3.48 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.238 0.615 . . . . 0.0 112.007 -178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 29.2 ttm180 -162.4 139.39 8.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.186 0.594 . . . . 0.0 109.488 173.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 135' ' ' TYR . 11.6 m -119.2 134.4 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.419 0.688 . . . . 0.0 109.693 176.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.553 HG23 ' HB ' ' A' ' 183' ' ' ILE . 3.2 t -147.09 161.51 40.71 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.885 0.874 . . . . 0.0 109.907 175.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -115.97 149.96 37.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.949 0.9 . . . . 0.0 110.145 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.44 81.15 0.56 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.758 0.823 . . . . 0.0 109.358 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -166.69 159.55 11.52 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 124.392 1.077 . . . . 0.0 109.014 -171.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -54.33 -31.76 68.84 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.333 2.022 . . . . 0.0 112.07 167.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.8 m -77.65 134.44 38.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.491 0.717 . . . . 0.0 110.144 169.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.445 ' H ' ' HG3' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -89.17 53.62 2.72 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.467 0.707 . . . . 0.0 110.206 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.3 t70 63.06 86.25 0.12 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.86 1.264 . . . . 0.0 109.249 -169.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -133.52 144.84 53.86 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.414 1.086 . . . . 0.0 109.181 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -42.19 110.6 0.15 Allowed 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 124.236 3.291 . . . . 0.0 114.438 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 26.9 p -159.51 -27.89 0.07 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.045 0.938 . . . . 0.0 110.277 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.0 m -105.42 19.05 21.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.288 1.035 . . . . 0.0 111.147 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 37.8 m -63.48 -36.99 85.59 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.695 0.798 . . . . 0.0 112.029 -174.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 61.6 p -115.79 114.93 25.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.911 0.884 . . . . 0.0 108.749 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.2 t 71.85 167.16 0.31 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.67 1.588 . . . . 0.0 111.24 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 38.33 91.82 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 C-N-CA 126.254 1.822 . . . . 0.0 113.878 -172.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.2 0.88 9.29 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.122 2.548 . . . . 0.0 113.627 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 69.46 91.59 0.09 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 124.727 1.211 . . . . 0.0 110.73 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 63.8 mt -78.03 128.68 34.23 Favored 'General case' 0 C--O 1.244 0.807 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 62.66 81.07 0.21 Allowed 'General case' 0 N--CA 1.48 1.07 0 O-C-N 124.652 1.22 . . . . 0.0 109.828 -169.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.96 83.49 2.85 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.195 0.598 . . . . 0.0 109.6 -173.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.418 ' HA ' ' HB3' ' A' ' 200' ' ' ASN . 5.9 m-20 -80.34 63.19 4.73 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.118 0.961 . . . . 0.0 109.364 171.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 160' ' ' THR . 34.7 m -105.54 159.27 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.641 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.553 ' HB ' HG23 ' A' ' 160' ' ' THR . 2.3 mp -93.18 108.97 21.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.979 0.895 . . . . 0.0 108.99 -173.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.42 ' HD2' HG12 ' A' ' 159' ' ' VAL . 68.7 m-85 -92.54 108.3 19.87 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.202 -1.363 . . . . 0.0 107.518 167.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 33.2 m-70 -77.05 100.09 5.55 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.93 142.81 20.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 123.811 0.694 . . . . 0.0 109.223 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.583 ' HG2' HG22 ' A' ' 196' ' ' VAL . 42.9 mtmt -103.59 121.62 43.29 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 170.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -60.7 108.51 0.85 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.461 ' H ' ' HA ' ' A' ' 154' ' ' ALA . 20.9 t70 -57.75 -42.13 83.33 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.905 0.882 . . . . 0.0 110.737 -173.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.94 -19.0 32.84 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.98 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -133.77 64.72 68.52 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 122.907 0.483 . . . . 0.0 110.607 -177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.0 -11.77 32.68 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.635 2.223 . . . . 0.0 112.559 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.85 -30.64 70.08 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.899 0.88 . . . . 0.0 111.229 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -72.24 -16.76 61.94 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.376 0.67 . . . . 0.0 110.512 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 87.31 -166.33 36.46 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.811 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.583 HG22 ' HG2' ' A' ' 187' ' ' LYS . 6.5 t -93.04 125.24 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.5 m -119.65 157.01 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.782 0.833 . . . . 0.0 110.68 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.55 114.59 28.36 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.582 1.153 . . . . 0.0 109.192 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 77.3 mmm -126.94 138.89 53.35 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.449 0.7 . . . . 0.0 110.065 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 20.6 m-80 -83.18 173.41 11.69 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.307 0.643 . . . . 0.0 109.865 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 29.8 t -56.15 -43.99 78.81 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.567 0.747 . . . . 0.0 111.813 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -54.04 -33.83 58.39 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.548 1.139 . . . . 0.0 111.947 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -88.28 -33.26 18.11 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.998 0.919 . . . . 0.0 111.661 -172.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 10.3 m -92.72 117.1 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 122.275 1.036 . . . . 0.0 108.483 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 22.3 mmm180 -109.66 168.65 9.25 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.836 -165.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.579 ' HA ' ' NH2' ' A' ' 207' ' ' ARG . . . -88.93 144.73 25.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.907 172.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.602 ' HG2' ' HG2' ' A' ' 295' ' ' ARG . 0.0 OUTLIER -80.06 93.25 5.74 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 176.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.9 97.08 0.21 Allowed 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.521 ' H ' ' NE ' ' A' ' 209' ' ' ARG . 0.0 OUTLIER -76.75 71.13 3.3 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.639 1.209 . . . . 0.0 110.141 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.9 m -146.09 110.38 5.03 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.937 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 28.7 mt -83.35 134.23 27.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 279' ' ' LYS . 42.6 mm -82.51 139.41 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.308 0.575 . . . . 0.0 110.951 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -124.41 160.03 29.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.12 1.368 . . . . 0.0 109.392 -174.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.583 ' HA ' HD23 ' A' ' 217' ' ' LEU . 31.9 t90 -56.2 -40.48 74.08 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.756 0.823 . . . . 0.0 112.323 -169.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -56.79 -41.77 78.29 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.663 0.785 . . . . 0.0 110.98 174.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.98 -21.27 51.18 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.881 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 214' ' ' TRP . 2.4 mm? -63.02 115.37 4.36 Favored 'General case' 0 C--N 1.364 1.205 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 221' ' ' GLN . 10.3 pt-20 -143.98 148.93 35.98 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.49 0.716 . . . . 0.0 109.556 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.38 135.02 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 122.781 0.433 . . . . 0.0 110.726 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.64 -9.44 77.0 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.633 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.482 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.7 tt0 -85.77 122.48 29.91 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.975 0.51 . . . . 0.0 110.445 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 72.8 t -93.66 114.47 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.482 HG13 ' HG2' ' A' ' 221' ' ' GLN . 13.1 m -126.91 160.27 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.957 0.903 . . . . 0.0 109.237 176.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.545 ' SD ' ' HB3' ' A' ' 238' ' ' TRP . 44.0 ttp -95.16 111.56 23.37 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.869 0.467 . . . . 0.0 110.604 -176.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.571 HD22 HG13 ' A' ' 271' ' ' ILE . 0.8 OUTLIER -111.24 155.62 22.69 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.62 0.768 . . . . 0.0 109.143 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.51 HD22 ' NE ' ' A' ' 235' ' ' ARG . 9.1 p-10 -97.57 121.27 39.28 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.219 1.008 . . . . 0.0 111.009 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.575 ' HB2' ' HA ' ' A' ' 232' ' ' PRO . 6.9 p90 -168.15 155.89 8.37 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.334 1.053 . . . . 0.0 109.801 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -83.27 137.09 42.67 Favored Pre-proline 0 CA--C 1.555 1.157 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 171.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.75 -28.43 68.41 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.0 1.8 . . . . 0.0 111.917 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.64 -30.27 36.65 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.553 0.741 . . . . 0.0 110.918 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -140.81 90.34 9.66 Favored Pre-proline 0 N--CA 1.489 1.51 0 C-N-CA 123.692 0.797 . . . . 0.0 110.174 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.575 ' HA ' ' HB2' ' A' ' 227' ' ' TYR . 38.8 Cg_endo -66.05 -8.24 19.47 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.453 2.102 . . . . 0.0 112.16 170.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.417 ' O ' HD12 ' A' ' 272' ' ' ILE . 21.3 tptm -74.18 -26.78 60.48 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.607 1.163 . . . . 0.0 110.967 173.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -117.19 147.14 42.74 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.332 0.653 . . . . 0.0 110.877 -172.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.51 ' NE ' HD22 ' A' ' 226' ' ' ASN . 3.3 tmt_? -69.0 117.29 10.47 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.656 1.582 . . . . 0.0 109.764 -176.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -134.26 -130.66 3.03 Favored Glycine 0 C--N 1.343 0.935 0 O-C-N 123.31 0.381 . . . . 0.0 112.427 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.427 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 42.0 m-85 -83.92 171.23 13.23 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.675 0.79 . . . . 0.0 110.819 -173.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . 0.545 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 97.6 m95 -91.38 112.38 24.26 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.254 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 68.3 m-85 -126.09 149.12 49.14 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 174.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.5 p-10 -82.44 157.11 23.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.5 ' HA ' HG23 ' A' ' 260' ' ' VAL . . . -162.93 140.76 8.07 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.216 0.606 . . . . 0.0 110.663 -176.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -90.51 118.6 30.1 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.144 0.578 . . . . 0.0 109.885 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.485 HD12 HD11 ' A' ' 255' ' ' LEU . 32.1 mm -62.8 126.36 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 123.38 0.672 . . . . 0.0 110.413 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.6 t -105.62 -38.47 6.41 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.466 1.106 . . . . 0.0 111.214 -174.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.55 143.25 11.53 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -135.71 143.48 45.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -155.33 114.94 3.67 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 169.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -100.13 121.6 41.67 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.8 p -84.64 -170.97 3.37 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 170.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -67.12 -34.63 78.01 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.01 23.79 3.89 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 120.696 0.284 . . . . 0.0 111.232 -171.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -159.35 129.07 5.52 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.261 0.625 . . . . 0.0 110.658 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.472 ' HD2' HG21 ' A' ' 274' ' ' VAL . 36.5 ttm180 -99.58 102.27 13.73 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.2 139.79 30.27 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.485 HD11 HD12 ' A' ' 243' ' ' ILE . 3.3 tm? -147.41 140.31 24.99 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -176.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -122.3 119.69 31.87 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.315 1.046 . . . . 0.0 108.538 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -124.77 137.15 54.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.81 0.844 . . . . 0.0 110.254 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -81.63 98.29 8.29 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.704 1.202 . . . . 0.0 108.34 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 58.9 t -63.31 134.16 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.857 0.863 . . . . 0.0 110.915 -173.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 241' ' ' ALA . 38.4 t -117.26 107.05 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.33 -151.45 0.26 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.235 1.014 . . . . 0.0 110.078 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -55.11 -71.83 0.66 Allowed Glycine 0 C--N 1.355 1.629 0 C-N-CA 123.066 0.365 . . . . 0.0 113.779 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -123.34 -16.66 6.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.477 0.711 . . . . 0.0 110.302 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -87.59 174.49 8.42 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.782 0.833 . . . . 0.0 111.006 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 65.8 p -153.43 138.3 17.13 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.181 0.593 . . . . 0.0 110.666 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 20.9 mt -108.72 90.91 3.44 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.991 0.916 . . . . 0.0 108.636 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -67.32 143.69 56.27 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 117.945 0.338 . . . . 0.0 111.113 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 33.1 t70 58.75 75.8 0.38 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.513 1.125 . . . . 0.0 111.748 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 68.8 m -113.48 126.32 55.2 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.413 0.685 . . . . 0.0 109.298 170.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -71.43 113.27 8.29 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.571 HG13 HD22 ' A' ' 225' ' ' LEU . 39.9 mm -94.3 123.58 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.962 0.505 . . . . 0.0 109.844 -174.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 233' ' ' LYS . 59.4 mt -83.76 -36.38 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.221 1.008 . . . . 0.0 110.5 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -96.14 51.15 1.2 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 122.262 1.03 . . . . 0.0 110.574 -167.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.472 HG21 ' HD2' ' A' ' 253' ' ' ARG . 23.9 m -72.14 -16.69 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.696 -1.593 . . . . 0.0 113.292 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.72 -15.07 33.32 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.936 0.494 . . . . 0.0 110.982 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -96.93 4.55 51.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.369 0.668 . . . . 0.0 111.634 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.418 HG13 ' HG ' ' A' ' 225' ' ' LEU . 43.4 t -76.4 146.15 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.36 0.664 . . . . 0.0 111.455 -175.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -126.65 160.16 31.52 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.045 0.938 . . . . 0.0 109.859 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.501 ' HB2' HD11 ' A' ' 212' ' ' ILE . 22.4 ttmm -84.87 149.21 25.84 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.306 0.643 . . . . 0.0 111.77 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 224' ' ' MET . 50.2 mm -92.29 126.78 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 169.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.56 105.36 13.55 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.334 0.653 . . . . 0.0 110.559 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -93.18 146.06 31.22 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 123.777 0.831 . . . . 0.0 111.153 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -41.94 119.17 1.11 Allowed 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 124.525 3.484 . . . . 0.0 115.005 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 97.0 -51.88 1.44 Allowed Glycine 0 C--N 1.352 1.425 0 O-C-N 123.333 0.396 . . . . 0.0 112.205 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -71.73 -22.85 61.57 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.663 1.185 . . . . 0.0 110.47 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -77.38 78.39 1.46 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.9 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 14.8 m -71.24 146.97 92.92 Favored Pre-proline 0 C--O 1.246 0.896 0 C-N-CA 123.424 0.69 . . . . 0.0 109.911 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.25 157.03 62.89 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.744 2.296 . . . . 0.0 111.245 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 21.0 ttt -83.25 78.18 9.66 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.724 0.774 . . . . 0.0 109.393 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 10.6 p -92.83 -28.43 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.372 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -74.81 162.33 28.76 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.012 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 293' ' ' PRO . 0.1 OUTLIER -49.45 140.5 13.5 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 124.703 1.201 . . . . 0.0 113.539 -167.201 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 292' ' ' ASN . 26.7 Cg_exo -62.12 109.63 0.86 Allowed 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.257 2.638 . . . . 0.0 112.922 -176.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -140.04 143.42 36.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.707 0.803 . . . . 0.0 109.891 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.637 ' HD2' ' HB2' ' A' ' 153' ' ' GLU . 49.4 mtm180 -129.91 -163.43 1.3 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -18.5 26.93 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.247 0.476 . . . . 0.0 110.738 -173.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -131.33 48.44 2.42 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 122.481 1.134 . . . . 0.0 109.398 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.7 p -76.32 96.3 3.95 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 164.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -76.07 -134.36 0.5 Allowed Glycine 0 CA--C 1.534 1.266 0 CA-C-O 119.043 -0.865 . . . . 0.0 113.711 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo . . . . . 0 C--N 1.374 1.875 0 C-N-CA 123.362 2.708 . . . . 0.0 112.63 177.154 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.64 ' N ' ' HG ' ' A' ' 172' ' ' SER . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 112.238 -0.345 . . . . 0.0 112.238 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.18 -10.04 14.66 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.262 1.025 . . . . 0.0 111.153 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -79.27 121.12 24.69 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -82.08 178.94 8.0 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.93 0.892 . . . . 0.0 111.407 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.14 29.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.708 1.203 . . . . 0.0 112.985 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -140.18 -50.39 0.47 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.528 1.131 . . . . 0.0 109.176 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -68.99 88.91 0.41 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.742 0.417 . . . . 0.0 111.268 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -75.35 138.35 41.7 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.341 172.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 206' ' ' ALA . 17.4 m -123.89 158.87 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.172 1.389 . . . . 0.0 109.854 -172.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -93.04 109.78 21.24 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.74 120.46 34.03 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.69 0.796 . . . . 0.0 111.396 -168.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -72.78 98.86 2.49 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.658 0.783 . . . . 0.0 110.085 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.78 110.34 10.13 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.4 m -66.04 -27.53 68.17 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.032 0.933 . . . . 0.0 112.049 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -62.12 -50.68 70.94 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.973 0.509 . . . . 0.0 111.688 -171.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -102.27 -18.76 15.32 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 122.304 0.242 . . . . 0.0 111.64 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.44 50.63 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.237 0.336 . . . . 0.0 113.628 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.66 152.06 20.9 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.531 0.681 . . . . 0.0 112.554 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -80.06 120.89 24.83 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.159 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -127.3 115.84 19.62 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -62.27 137.71 58.3 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.621 0.575 . . . . 0.0 109.678 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.487 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -148.31 129.17 14.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.037 0.535 . . . . 0.0 111.384 -165.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -87.29 114.54 23.99 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.492 0.717 . . . . 0.0 109.705 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 186' ' ' VAL . 58.6 t -66.96 116.06 5.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.558 HG11 ' HE2' ' A' ' 187' ' ' LYS . 33.5 m -117.73 -9.4 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.171 0.588 . . . . 0.0 111.534 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.588 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 2.5 tpm_? -166.82 147.03 5.74 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.46 136.89 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 124.113 0.965 . . . . 0.0 109.655 171.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.405 HG23 ' HB ' ' A' ' 183' ' ' ILE . 10.2 t -148.77 163.33 37.68 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.323 1.049 . . . . 0.0 109.68 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.553 HH22 ' HG3' ' A' ' 176' ' ' PRO . 59.6 mtt-85 -122.77 170.4 10.11 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -172.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -82.03 -22.03 36.66 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.002 173.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.86 159.94 59.03 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.018 0.927 . . . . 0.0 110.257 167.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.96 81.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.212 2.608 . . . . 0.0 112.55 172.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 73.9 m -160.49 91.31 0.91 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.283 1.433 . . . . 0.0 108.246 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 23.3 tpp180 -68.81 -34.68 75.91 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.549 0.74 . . . . 0.0 110.039 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -133.6 112.62 11.61 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -88.8 115.73 64.32 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-O 119.004 -0.522 . . . . 0.0 109.688 177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.25 -60.86 0.15 Allowed 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.223 1.948 . . . . 0.0 111.602 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 28.7 p -168.17 33.63 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.401 0.68 . . . . 0.0 110.489 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.1 m -63.8 -10.86 22.42 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.765 0.826 . . . . 0.0 113.117 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.64 ' HG ' ' N ' ' A' ' 133' ' ' GLY . 41.1 m -81.2 2.11 29.16 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.619 0.768 . . . . 0.0 112.7 176.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.0 t -73.75 106.53 5.53 Favored 'General case' 0 CA--C 1.554 1.123 0 CA-C-O 121.017 0.437 . . . . 0.0 110.113 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.7 m 67.24 -2.71 1.16 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 169.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -86.57 -46.24 0.55 Allowed Pre-proline 0 N--CA 1.484 1.236 0 CA-C-N 119.076 0.853 . . . . 0.0 110.472 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.553 ' HG3' HH22 ' A' ' 161' ' ' ARG . 23.9 Cg_endo -95.97 174.99 0.9 Allowed 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.478 2.119 . . . . 0.0 111.297 159.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -174.88 24.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.114 0.565 . . . . 0.0 111.88 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.55 -86.6 0.52 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -175.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -143.73 98.47 3.24 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 173.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -67.61 85.76 0.19 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.815 0.697 . . . . 0.0 109.909 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -79.56 65.41 4.72 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 122.677 1.227 . . . . 0.0 108.202 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.64 177.35 3.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 113.482 -1.69 . . . . 0.0 108.838 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.3 mp -95.58 108.63 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.599 0.714 . . . . 0.0 109.342 -171.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.419 ' CE1' ' HA3' ' A' ' 133' ' ' GLY . 95.1 m-85 -97.59 107.2 19.65 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.857 1.263 . . . . 0.0 107.834 170.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.588 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 89.0 m-70 -78.77 102.5 8.16 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.487 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 20.9 m -114.92 150.9 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.125 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.558 ' HE2' HG11 ' A' ' 157' ' ' VAL . 45.0 mtmt -117.87 122.83 44.36 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.455 ' HD2' ' HB2' ' A' ' 154' ' ' ALA . 17.1 m-85 -61.61 109.5 1.22 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.104 0.562 . . . . 0.0 111.329 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.3 -35.58 74.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 167.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -63.36 -34.73 78.35 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.815 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -155.02 82.07 4.07 Favored Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 124.655 1.182 . . . . 0.0 109.287 -176.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.479 ' HG3' ' HD3' ' A' ' 300' ' ' PRO . 26.4 Cg_exo -65.29 -27.34 55.8 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.807 3.005 . . . . 0.0 114.133 -173.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.52 -1.96 17.89 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -75.13 -14.77 60.59 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.837 0.855 . . . . 0.0 111.436 171.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.86 -175.81 54.22 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 116.439 -0.346 . . . . 0.0 112.571 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.48 116.54 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.95 144.41 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.746 0.818 . . . . 0.0 109.144 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.563 ' HB2' HG23 ' A' ' 183' ' ' ILE . 28.9 pt20 -96.16 132.46 41.55 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 86.3 mmm -132.71 160.76 35.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.858 0.863 . . . . 0.0 109.193 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -110.88 175.1 5.55 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.882 0.473 . . . . 0.0 109.751 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 70.1 p -57.58 -45.87 84.69 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.673 0.789 . . . . 0.0 111.04 176.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -66.93 -8.49 29.91 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.082 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -97.31 -41.06 8.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.661 0.785 . . . . 0.0 110.87 173.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.59 132.91 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 112.773 0.656 . . . . 0.0 112.773 -169.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.609 ' HB3' ' HB3' ' A' ' 281' ' ' GLU . 39.5 mmt180 -112.29 155.72 23.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.827 1.251 . . . . 0.0 107.861 167.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.405 ' HA ' HG12 ' A' ' 141' ' ' VAL . . . -63.76 167.33 6.05 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.251 0.478 . . . . 0.0 110.87 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.67 95.82 6.7 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.25 97.86 0.13 Allowed 'General case' 0 C--N 1.36 1.023 0 C-N-CA 123.164 0.586 . . . . 0.0 109.841 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.456 ' NH2' ' HB2' ' A' ' 292' ' ' ASN . 3.5 tmt_? -84.45 76.52 10.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -172.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 73.1 m -147.19 119.06 8.11 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.062 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 58.8 mt -85.05 126.75 40.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 279' ' ' LYS . 38.4 mm -96.12 127.91 47.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 124.015 0.926 . . . . 0.0 108.636 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.456 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 0.0 OUTLIER -111.71 179.14 4.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.119 0.967 . . . . 0.0 109.168 -177.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.509 ' HA ' HD12 ' A' ' 217' ' ' LEU . 59.6 t-105 -60.42 -43.15 97.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.284 0.634 . . . . 0.0 110.899 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . 0.505 ' HA ' HE21 ' A' ' 215' ' ' GLN . 0.0 OUTLIER -62.1 -27.38 68.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.042 0.937 . . . . 0.0 111.888 177.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -90.03 -22.48 21.84 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.898 0.479 . . . . 0.0 110.894 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 214' ' ' TRP . 85.7 mt -67.77 112.6 4.94 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -138.29 151.1 47.28 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.607 0.763 . . . . 0.0 109.632 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.9 m -68.87 123.98 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.045 0.538 . . . . 0.0 111.565 -171.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.56 -15.75 49.1 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.732 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.429 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.5 tt0 -79.67 121.39 25.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.941 0.496 . . . . 0.0 109.979 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 45.8 t -93.07 120.21 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.429 HG13 ' HG2' ' A' ' 221' ' ' GLN . 13.2 m -141.01 148.66 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.32 1.048 . . . . 0.0 110.541 -175.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 20.5 ptm -89.82 136.22 33.16 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.273 0.629 . . . . 0.0 110.847 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.54 ' HB3' HG22 ' A' ' 277' ' ' VAL . 0.7 OUTLIER -144.7 144.1 31.05 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.046 0.939 . . . . 0.0 110.4 -174.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.409 ' HB3' ' CE2' ' A' ' 238' ' ' TRP . 10.5 p-10 -71.17 106.01 3.62 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.349 0.66 . . . . 0.0 109.837 174.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -135.31 132.13 37.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.536 HD22 ' HB2' ' A' ' 231' ' ' ASN . 61.1 t30 -105.41 114.89 62.8 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -62.92 -33.77 73.78 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.82 2.347 . . . . 0.0 111.756 172.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -66.26 -36.38 82.85 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.053 0.941 . . . . 0.0 111.213 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.536 ' HB2' HD22 ' A' ' 228' ' ' ASN . 38.4 m-80 -143.97 87.32 8.07 Favored Pre-proline 0 N--CA 1.487 1.413 0 C-N-CA 123.793 0.837 . . . . 0.0 109.382 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.86 -9.87 27.52 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.399 2.733 . . . . 0.0 115.104 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -82.83 -27.7 30.69 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.031 0.532 . . . . 0.0 110.984 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -120.95 154.63 35.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.512 0.725 . . . . 0.0 110.257 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -49.14 154.15 0.84 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.006 1.322 . . . . 0.0 113.053 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.61 -148.17 4.9 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.16 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -83.86 148.82 26.76 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.259 1.023 . . . . 0.0 109.699 -174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . 0.437 ' CE2' ' HD2' ' A' ' 296' ' ' ARG . 67.1 m95 -84.3 107.24 16.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.013 0.525 . . . . 0.0 110.54 -171.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -114.52 151.9 32.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 10.3 p-10 -83.93 146.2 28.16 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 172.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -146.26 137.17 24.33 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.581 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -91.11 119.48 31.28 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.401 HD12 HD11 ' A' ' 255' ' ' LEU . 29.8 mm -60.41 107.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 124.051 0.844 . . . . 0.0 109.388 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.6 t -82.89 -47.66 11.58 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.452 ' HB2' ' HB2' ' A' ' 256' ' ' TYR . 65.9 mtt85 -152.86 164.76 37.26 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 125.345 1.458 . . . . 0.0 109.649 -172.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -151.27 136.78 17.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.804 0.441 . . . . 0.0 110.745 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -150.82 115.49 5.2 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.812 0.845 . . . . 0.0 109.439 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -91.74 153.77 19.4 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 68.7 p -130.15 174.88 9.39 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.948 0.899 . . . . 0.0 108.871 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -65.62 -18.65 65.48 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.528 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 26.5 p -103.99 -31.54 9.67 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 123.426 0.691 . . . . 0.0 112.788 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.23 157.28 6.2 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.23 0.538 . . . . 0.0 112.292 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 253' ' ' ARG . 4.3 mpt_? -94.91 101.68 13.48 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -97.81 102.21 13.91 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.124 0.57 . . . . 0.0 110.736 -173.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 3.4 tm? -95.18 143.65 26.43 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 245' ' ' ARG . 81.2 m-85 -123.03 116.42 23.5 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.23 144.8 31.68 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.984 0.513 . . . . 0.0 110.421 -174.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -81.55 96.87 7.58 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 92.6 t -81.06 107.23 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.699 1.2 . . . . 0.0 109.619 -176.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 16.9 m -89.11 129.8 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.52 0.676 . . . . 0.0 110.361 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 63.9 mt -93.95 -154.87 0.43 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.814 1.246 . . . . 0.0 108.888 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -64.68 -54.45 28.6 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 122.959 0.162 . . . . 0.0 113.122 176.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -115.95 -46.27 2.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.463 0.705 . . . . 0.0 110.283 176.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.68 151.01 37.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.819 0.848 . . . . 0.0 111.424 -173.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 15.5 p -120.3 113.63 20.67 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.863 0.865 . . . . 0.0 109.319 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.654 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 81.5 mt -82.27 102.45 11.18 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.232 1.013 . . . . 0.0 109.86 177.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -75.02 123.8 25.83 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.102 0.561 . . . . 0.0 112.073 -173.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 54.8 46.59 24.21 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.755 1.222 . . . . 0.0 113.128 169.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 81.6 m -67.96 133.1 48.5 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 122.396 0.278 . . . . 0.0 111.184 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 45.1 ttp180 -70.26 107.29 3.67 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.722 0.638 . . . . 0.0 109.8 173.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.459 HG21 HD22 ' A' ' 225' ' ' LEU . 40.7 mm -95.86 111.3 25.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 82.9 mt -84.76 -13.5 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 124.623 1.169 . . . . 0.0 109.884 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -99.86 39.52 1.32 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.352 1.461 . . . . 0.0 110.072 -161.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.506 HG11 ' HZ3' ' A' ' 214' ' ' TRP . 28.8 m -71.74 -13.74 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 114.553 -1.203 . . . . 0.0 113.29 -167.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -86.87 -27.52 23.39 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.295 0.638 . . . . 0.0 110.996 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -93.26 1.26 57.1 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.694 0.797 . . . . 0.0 112.128 -174.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 225' ' ' LEU . 59.2 t -71.12 139.35 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.198 0.599 . . . . 0.0 110.397 -174.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -120.37 160.92 22.08 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.216 1.007 . . . . 0.0 109.93 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.559 ' HB2' HD11 ' A' ' 212' ' ' ILE . 35.8 ttmt -79.66 151.34 30.58 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.715 0.406 . . . . 0.0 111.184 176.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.9 mm -77.54 132.79 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.8 0.84 . . . . 0.0 109.676 172.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 205' ' ' ARG . 1.0 OUTLIER -79.99 105.85 11.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 59.4 mtp85 -120.19 149.76 50.01 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.907 1.283 . . . . 0.0 109.445 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.93 98.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.413 2.742 . . . . 0.0 113.856 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 86.74 -3.96 86.61 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.494 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -119.4 -23.14 6.77 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.734 0.767 . . . . 0.0 111.827 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -92.89 100.6 2.68 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 175.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 11.6 p -64.45 130.29 94.6 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.003 0.521 . . . . 0.0 111.919 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.37 164.47 34.02 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.104 2.536 . . . . 0.0 111.676 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . 0.476 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 44.1 ttm -80.31 85.44 5.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.669 0.747 . . . . 0.0 109.968 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.85 -29.41 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.9 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -85.89 -158.5 0.4 Allowed 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.828 0.851 . . . . 0.0 109.431 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.456 ' HB2' ' NH2' ' A' ' 209' ' ' ARG . 13.3 m120 -58.93 116.87 17.19 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.851 0.86 . . . . 0.0 110.866 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.476 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 25.1 Cg_exo -64.28 112.33 1.87 Allowed 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 123.263 2.642 . . . . 0.0 112.568 -175.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 22.2 ptm -117.63 129.87 56.02 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.729 0.812 . . . . 0.0 110.105 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -97.27 174.5 6.68 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.319 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.437 ' HD2' ' CE2' ' A' ' 238' ' ' TRP . 0.3 OUTLIER -60.37 -50.57 73.08 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.096 173.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.64 -161.69 1.4 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.469 1.508 . . . . 0.0 108.221 173.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 41.1 m -110.14 79.67 1.23 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.0 -96.8 0.7 Allowed Glycine 0 CA--C 1.537 1.412 0 CA-C-N 115.216 -0.902 . . . . 0.0 113.022 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.479 ' HD3' ' HG3' ' A' ' 192' ' ' PRO . 58.9 Cg_endo . . . . . 0 C--N 1.374 1.896 0 C-N-CA 123.107 2.538 . . . . 0.0 112.182 -175.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.986 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.529 ' HB3' ' HD3' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -131.28 4.05 4.34 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.433 0.693 . . . . 0.0 111.683 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -78.94 159.32 27.76 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.253 0.549 . . . . 0.0 110.289 172.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.465 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -86.19 172.55 10.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.151 0.98 . . . . 0.0 110.814 -174.46 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.5 m -83.62 6.26 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.272 1.029 . . . . 0.0 112.257 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -127.84 8.4 6.27 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.581 0.753 . . . . 0.0 111.175 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 156' ' ' VAL . 19.6 mm-40 -80.9 74.13 7.89 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.888 0.475 . . . . 0.0 111.864 -173.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 8.7 p90 -77.69 98.8 5.6 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.524 0.678 . . . . 0.0 109.434 168.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.497 ' HA ' ' HD2' ' A' ' 207' ' ' ARG . 27.4 m -115.98 179.51 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.141 1.376 . . . . 0.0 108.772 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -93.16 109.72 21.22 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -92.9 122.95 35.79 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.805 0.842 . . . . 0.0 110.057 176.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -71.3 110.42 5.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.69 136.06 57.85 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.064 0.946 . . . . 0.0 110.249 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.5 p -74.26 -28.69 61.33 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.685 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.8 -55.5 4.77 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 120.926 0.393 . . . . 0.0 111.502 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.5 ttp -104.5 -18.16 14.47 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.71 0.804 . . . . 0.0 112.472 -170.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.95 18.24 70.36 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 113.981 0.352 . . . . 0.0 113.981 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -94.08 140.66 29.46 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.993 0.517 . . . . 0.0 111.172 -177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -75.31 119.94 20.1 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -115.22 148.65 38.84 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.506 ' HG2' HH22 ' A' ' 207' ' ' ARG . 8.1 mt-10 -76.84 89.03 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.97 116.95 30.09 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.653 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 53.8 tt0 -89.57 102.67 15.35 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.084 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 59.8 t -57.88 96.35 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 167.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.2 m -95.41 -13.85 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.443 0.697 . . . . 0.0 110.864 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 50.3 ttt85 -163.53 135.62 5.06 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.62 139.66 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.0 p -133.43 159.3 40.76 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 123.827 0.851 . . . . 0.0 108.713 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -96.43 175.57 6.36 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.622 0.769 . . . . 0.0 110.222 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.503 ' HG3' HG12 ' A' ' 182' ' ' VAL . 7.7 mtpm? -86.1 58.3 4.97 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.979 0.895 . . . . 0.0 109.847 176.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -157.88 139.55 9.93 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 124.469 1.108 . . . . 0.0 108.818 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -59.68 96.52 0.1 OUTLIER 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.977 2.452 . . . . 0.0 112.126 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.6 m -140.05 -55.13 0.54 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.082 0.953 . . . . 0.0 109.839 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 77.63 -32.38 0.17 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 126.049 1.74 . . . . 0.0 112.976 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.512 ' HA ' ' NH2' ' A' ' 158' ' ' ARG . 3.5 p30 -72.9 178.14 4.45 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.493 0.717 . . . . 0.0 111.223 171.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -77.22 144.91 72.0 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 122.774 0.43 . . . . 0.0 110.142 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.51 77.65 1.33 Allowed 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.03 2.486 . . . . 0.0 112.491 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 38.8 t -102.36 -30.25 11.16 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.121 0.568 . . . . 0.0 110.417 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 28.2 m -103.77 21.81 15.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.293 1.037 . . . . 0.0 110.421 175.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 23.1 t -77.32 -5.37 49.27 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.89 0.876 . . . . 0.0 112.618 -173.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.1 m 74.01 -65.79 0.33 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.638 1.575 . . . . 0.0 110.619 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 26.2 m -132.28 121.66 23.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.06 0.944 . . . . 0.0 109.26 175.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.529 ' HD3' ' HB3' ' A' ' 134' ' ' LEU . 91.8 mtt180 -79.06 119.23 76.46 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.16 86.24 1.56 Allowed 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.543 2.162 . . . . 0.0 112.014 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -74.61 82.13 2.02 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 168.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -152.2 48.12 0.77 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -167.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 62.11 75.04 0.42 Allowed 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.955 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.711 ' HB3' HG22 ' A' ' 182' ' ' VAL . 2.8 mp0 -69.12 99.01 1.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.688 -162.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.06 20.71 1.49 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.26 165.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.711 HG22 ' HB3' ' A' ' 180' ' ' GLU . 12.5 m -73.6 175.0 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 164.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 183' ' ' ILE . 3.1 mp -95.56 110.93 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 O-C-N 121.882 -0.512 . . . . 0.0 110.22 -165.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -95.62 106.49 18.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.003 0.921 . . . . 0.0 108.65 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 14.0 m-70 -79.79 96.55 6.32 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.409 HG12 HG22 ' A' ' 156' ' ' VAL . 13.3 m -109.01 157.73 9.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.475 0.71 . . . . 0.0 109.55 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -130.16 117.82 20.5 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -67.38 116.22 7.9 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.903 0.481 . . . . 0.0 110.638 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 153' ' ' GLU . 34.3 t70 -67.04 -27.1 67.12 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.368 1.067 . . . . 0.0 109.876 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.12 -29.54 62.97 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.929 0.892 . . . . 0.0 111.566 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -141.57 75.31 22.35 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.775 0.83 . . . . 0.0 110.494 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.42 -15.43 49.74 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.942 2.428 . . . . 0.0 112.455 171.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.5 -26.56 67.23 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.997 0.919 . . . . 0.0 111.282 174.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -77.37 -16.43 58.87 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.332 0.653 . . . . 0.0 110.985 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.83 -130.13 22.24 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.86 0.725 . . . . 0.0 112.503 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 6.2 t -101.17 118.25 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.521 0.729 . . . . 0.0 109.112 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 24.5 m -113.6 155.21 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.422 0.689 . . . . 0.0 109.258 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -97.93 130.13 44.81 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.232 0.613 . . . . 0.0 110.043 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 92.1 mmm -131.63 160.61 34.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.445 1.098 . . . . 0.0 108.891 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -95.69 167.2 11.43 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.451 ' OG ' ' HB2' ' A' ' 180' ' ' GLU . 61.6 m -63.93 -39.47 94.22 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.866 0.466 . . . . 0.0 111.537 176.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -63.15 -23.51 67.47 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.703 0.801 . . . . 0.0 112.031 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -83.78 -37.72 22.23 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.521 0.728 . . . . 0.0 110.649 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 33.1 m -94.56 144.71 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.518 ' HA ' ' HE ' ' A' ' 205' ' ' ARG . 0.0 OUTLIER -140.69 142.92 34.83 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -56.8 155.49 7.72 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.024 0.93 . . . . 0.0 111.11 177.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.506 HH22 ' HG2' ' A' ' 153' ' ' GLU . 0.8 OUTLIER -128.85 138.42 52.03 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.078 0.466 . . . . 0.0 110.218 -172.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.09 152.74 18.55 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.11 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.411 ' HG3' ' SD ' ' A' ' 294' ' ' MET . 2.6 ttp180 -86.58 6.29 31.55 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 168.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.2 m -83.5 105.1 14.16 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.708 0.803 . . . . 0.0 108.91 -168.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 19.7 mt -85.69 132.73 31.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 279' ' ' LYS . 10.0 mm -105.48 139.07 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 0.0 OUTLIER -109.81 168.28 9.53 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.535 0.734 . . . . 0.0 109.757 176.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.412 ' CD1' HD23 ' A' ' 255' ' ' LEU . 55.3 t90 -45.38 -46.38 13.18 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.857 1.263 . . . . 0.0 111.936 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -57.52 -34.61 69.29 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.804 1.242 . . . . 0.0 111.961 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -93.48 -11.44 32.04 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.133 0.973 . . . . 0.0 113.06 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 243' ' ' ILE . 1.5 mm? -73.84 114.41 12.1 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 169.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 12.6 pt-20 -115.77 165.03 13.52 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.621 0.768 . . . . 0.0 109.053 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.9 m -69.0 119.24 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 121.26 0.552 . . . . 0.0 110.361 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.91 -4.45 49.53 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.738 -0.664 . . . . 0.0 113.246 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -70.67 118.42 13.44 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.537 0.735 . . . . 0.0 110.581 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.78 113.39 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.73 150.13 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.938 1.295 . . . . 0.0 109.403 -172.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.666 ' HA ' ' HA ' ' A' ' 240' ' ' ASP . 16.0 ptm -97.95 124.69 42.52 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 120.838 0.351 . . . . 0.0 111.34 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.477 ' HB3' HG13 ' A' ' 277' ' ' VAL . 1.3 pt? -144.53 167.53 22.3 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.9 0.88 . . . . 0.0 110.149 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -80.84 135.38 35.93 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.865 0.364 . . . . 0.0 110.759 -169.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.486 ' HD1' ' HB2' ' A' ' 239' ' ' TYR . 58.0 m-85 -144.66 157.42 44.21 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.815 1.246 . . . . 0.0 110.167 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 42.5 t-20 -129.9 110.93 17.17 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 166.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -71.73 -17.91 29.04 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.431 2.088 . . . . 0.0 112.787 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -87.03 -39.66 15.42 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.261 0.624 . . . . 0.0 110.447 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 10.0 m120 -124.35 81.33 58.91 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 124.213 1.005 . . . . 0.0 108.482 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.91 -11.34 31.78 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.746 2.297 . . . . 0.0 114.317 -170.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -88.9 -4.17 58.54 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.28 0.632 . . . . 0.0 111.267 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -131.51 163.83 27.12 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.635 -0.665 . . . . 0.0 110.275 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 162.46 29.44 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.801 0.84 . . . . 0.0 111.639 174.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.03 -88.66 0.07 OUTLIER Glycine 0 C--O 1.238 0.361 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.376 171.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -130.23 167.57 18.23 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.495 1.118 . . . . 0.0 109.118 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -87.68 113.61 23.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.771 0.428 . . . . 0.0 110.574 -170.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.486 ' HB2' ' HD1' ' A' ' 227' ' ' TYR . 64.0 m-85 -117.51 142.84 46.69 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 173.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . 0.666 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 8.3 p-10 -84.27 158.08 21.34 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -153.54 148.02 26.08 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.882 -173.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -96.01 118.26 32.28 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.464 HG13 HD12 ' A' ' 217' ' ' LEU . 36.1 mm -66.94 107.41 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.356 0.662 . . . . 0.0 109.328 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.2 t -81.16 -45.28 16.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.562 0.745 . . . . 0.0 110.267 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -154.11 167.54 29.5 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.626 1.171 . . . . 0.0 109.978 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.45 146.81 23.91 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.714 0.806 . . . . 0.0 109.898 167.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -142.65 115.93 8.97 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.15 0.98 . . . . 0.0 109.17 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -92.83 144.05 25.67 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 175.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.6 p -126.9 169.93 12.77 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 169.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -61.26 -34.07 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.883 0.473 . . . . 0.0 110.448 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 75.0 p -87.22 -29.67 21.53 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.449 -171.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -166.66 153.9 9.32 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.891 0.477 . . . . 0.0 111.616 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -104.06 105.78 16.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.738 0.815 . . . . 0.0 109.883 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.03 144.95 25.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.552 0.741 . . . . 0.0 110.099 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.802 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.3 OUTLIER -135.87 146.74 47.75 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -175.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -135.03 120.66 19.39 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.54 ' HB3' HD11 ' A' ' 271' ' ' ILE . . . -136.01 161.27 36.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.497 0.665 . . . . 0.0 111.653 -175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -100.67 94.12 5.93 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 46.4 t -77.34 106.19 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.02 0.928 . . . . 0.0 110.068 -171.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 34.7 m -89.54 118.43 34.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 122.245 1.022 . . . . 0.0 110.201 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.403 HD12 ' HB2' ' A' ' 264' ' ' ASP . 31.2 mt -96.57 -153.08 0.4 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 113.888 -1.505 . . . . 0.0 108.173 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.5 -52.07 32.82 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 117.708 0.231 . . . . 0.0 113.278 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -122.23 -36.21 3.0 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.022 0.929 . . . . 0.0 110.611 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.403 ' HB2' HD12 ' A' ' 261' ' ' LEU . 3.8 m-20 -89.11 157.92 18.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.264 1.025 . . . . 0.0 110.858 -174.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 67.2 p -135.2 113.83 11.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.542 0.737 . . . . 0.0 109.124 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.554 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 23.9 mt -81.73 86.68 6.39 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.773 0.829 . . . . 0.0 108.888 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -69.34 142.4 54.03 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.237 0.615 . . . . 0.0 111.659 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 57.41 17.69 3.95 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.569 1.148 . . . . 0.0 113.823 170.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.554 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 94.5 m -66.73 142.9 57.24 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.326 0.65 . . . . 0.0 111.04 -176.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -70.03 133.79 47.59 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.948 0.78 . . . . 0.0 110.821 -176.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.802 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 10.3 mm -107.02 128.46 61.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 46.3 mt -98.3 -24.51 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 123.862 0.865 . . . . 0.0 109.025 174.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.555 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 67.7 m-85 -91.69 47.91 1.41 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.69 1.196 . . . . 0.0 110.14 -176.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 27.5 m -65.35 -26.37 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.518 1.127 . . . . 0.0 112.92 -171.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 52.7 m-20 -110.27 -7.98 14.78 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.174 0.589 . . . . 0.0 110.984 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 15.5 mm-40 -94.09 24.69 4.16 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.907 0.883 . . . . 0.0 110.734 -175.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.56 ' HB ' ' HB ' ' A' ' 212' ' ' ILE . 19.4 t -89.61 153.63 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.155 0.982 . . . . 0.0 110.001 -174.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -129.21 156.19 44.34 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.123 0.969 . . . . 0.0 108.79 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.566 ' HB2' HD11 ' A' ' 212' ' ' ILE . 54.2 tttm -89.76 146.2 24.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.112 0.565 . . . . 0.0 110.925 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 44.3 mm -72.49 122.78 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 168.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -106.17 112.8 25.98 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 285' ' ' GLU . 59.8 mtt85 -103.3 107.26 55.1 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -25.41 94.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.38 2.227 1 C-N-CA 125.307 4.005 . . . . 0.0 117.196 -156.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 104.72 6.99 39.94 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-O 118.231 -1.316 . . . . 0.0 116.275 172.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 282' ' ' ARG . 0.2 OUTLIER -103.26 -25.04 13.48 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 120.236 2.018 . . . . 0.0 111.452 173.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -106.64 -177.66 23.12 Favored Glycine 0 C--O 1.245 0.821 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 172.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 13.5 m -76.26 144.44 74.84 Favored Pre-proline 0 CA--C 1.554 1.129 0 CA-C-N 116.991 0.396 . . . . 0.0 111.208 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.13 175.93 6.21 Favored 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 123.356 2.704 . . . . 0.0 112.337 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 43.5 ttm -82.8 95.43 7.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 170.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 14.4 p -125.83 19.29 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.944 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -154.42 -167.04 2.5 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.61 -169.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -44.27 121.38 3.99 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 125.597 1.559 . . . . 0.0 113.073 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -45.53 113.0 0.46 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 124.596 3.53 . . . . 0.0 114.784 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.411 ' SD ' ' HG3' ' A' ' 209' ' ' ARG . 88.0 mmm -78.04 97.34 5.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.207 0.603 . . . . 0.0 110.579 -176.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -128.07 113.13 15.39 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 172.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.77 123.09 11.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.336 1.454 . . . . 0.0 110.531 -169.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -101.59 -31.29 10.91 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.9 0.88 . . . . 0.0 109.112 167.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 33.5 p -161.31 -170.62 2.71 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.247 1.019 . . . . 0.0 110.196 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -59.8 -57.49 19.16 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-O 119.443 -0.643 . . . . 0.0 112.832 169.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo . . . . . 0 C--N 1.383 2.379 0 C-N-CA 123.084 2.523 . . . . 0.0 111.59 171.721 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.504 ' HA3' HG21 ' A' ' 159' ' ' VAL . . . . . . . . 0 N--CA 1.476 1.332 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 6.96 0.5 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.655 0.782 . . . . 0.0 112.092 -176.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.575 ' HB2' ' CE1' ' A' ' 184' ' ' TYR . 34.7 m-85 -126.21 149.92 48.71 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.128 0.49 . . . . 0.0 110.924 172.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -94.03 172.69 8.07 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.871 1.268 . . . . 0.0 110.12 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.52 4.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 124.235 1.014 . . . . 0.0 113.124 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -106.09 -18.04 14.14 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.1 0.96 . . . . 0.0 110.908 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -75.33 92.63 2.8 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-O 121.579 0.704 . . . . 0.0 111.726 -166.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 8.1 p90 -55.13 105.17 0.15 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.8 165.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 28.0 m -116.01 -174.79 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.903 0.881 . . . . 0.0 109.931 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.733 ' HB3' ' HB3' ' A' ' 205' ' ' ARG . 33.9 t0 -110.73 160.49 16.67 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 171.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -140.72 105.86 5.0 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.638 0.775 . . . . 0.0 109.536 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.97 116.58 11.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.027 1.331 . . . . 0.0 109.33 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -85.59 116.69 24.03 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.7 0.8 . . . . 0.0 110.937 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.4 p -74.14 -33.48 63.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.556 1.142 . . . . 0.0 111.201 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.43 -52.59 57.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.318 0.647 . . . . 0.0 112.008 -171.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.408 ' HG2' ' HE1' ' A' ' 239' ' ' TYR . 38.1 ttp -102.75 -8.32 20.94 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.924 0.49 . . . . 0.0 111.1 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.15 18.86 70.93 Favored Glycine 0 C--N 1.358 1.756 0 CA-C-O 121.385 0.436 . . . . 0.0 112.246 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -96.32 174.7 6.74 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.057 0.943 . . . . 0.0 111.458 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -126.47 119.2 26.6 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -109.81 119.18 38.54 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.69 152.12 31.85 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.427 ' HA ' ' H ' ' A' ' 189' ' ' ASP . . . -153.95 -177.47 6.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.199 0.6 . . . . 0.0 111.57 -167.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 64.8 tt0 -151.64 120.72 6.7 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.152 172.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.49 126.02 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.769 0.828 . . . . 0.0 110.149 171.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.414 HG11 ' HE2' ' A' ' 187' ' ' LYS . 12.8 m -120.74 -6.08 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.121 0.568 . . . . 0.0 110.69 173.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 37.4 ttm180 -169.9 156.2 6.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.775 0.83 . . . . 0.0 110.639 174.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.504 HG21 ' HA3' ' A' ' 133' ' ' GLY . 1.7 p -132.96 127.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.22 1.008 . . . . 0.0 109.862 173.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 39.3 p -125.86 162.6 24.8 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.345 1.458 . . . . 0.0 109.319 177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -107.38 177.21 4.91 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.45 0.7 . . . . 0.0 109.179 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.562 ' HD3' HD11 ' A' ' 183' ' ' ILE . 73.7 mmtt -54.57 -33.8 60.81 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 123.31 0.644 . . . . 0.0 112.599 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.41 121.68 49.68 Favored Pre-proline 0 CA--C 1.546 0.799 0 O-C-N 123.856 0.723 . . . . 0.0 109.84 172.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -54.83 -29.51 63.35 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.079 2.519 . . . . 0.0 111.866 178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 61.7 m 62.81 84.84 0.14 Allowed 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.951 1.3 . . . . 0.0 111.633 172.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -68.77 -35.46 77.09 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.645 170.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -79.5 174.47 11.54 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.572 167.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -114.34 94.56 36.07 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.385 0.674 . . . . 0.0 109.324 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -71.52 100.62 1.05 Allowed 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.351 2.701 . . . . 0.0 111.372 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 56.1 m -88.44 -44.49 10.69 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.588 0.755 . . . . 0.0 111.574 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 54.0 m -141.97 25.49 1.94 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.035 0.534 . . . . 0.0 112.123 -174.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 21.3 m -125.43 13.96 8.21 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.188 0.595 . . . . 0.0 110.782 176.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 m -84.14 -20.79 31.88 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.623 0.769 . . . . 0.0 110.52 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 67.1 p -71.91 10.83 0.63 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.061 1.344 . . . . 0.0 114.242 -172.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -57.92 152.24 39.67 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.402 1.081 . . . . 0.0 111.525 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -54.02 127.88 27.5 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.177 2.584 . . . . 0.0 113.995 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -142.37 102.35 4.07 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.424 1.09 . . . . 0.0 108.276 175.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 59.8 tp -57.72 -45.09 86.24 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.701 0.801 . . . . 0.0 110.473 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -103.4 131.95 50.06 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.963 0.905 . . . . 0.0 108.771 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 201' ' ' SER . 26.9 mp0 -76.23 79.69 3.01 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 175.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -110.51 11.93 22.96 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.507 0.723 . . . . 0.0 109.724 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.6 m -67.27 149.09 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.328 0.651 . . . . 0.0 110.224 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.562 HD11 ' HD3' ' A' ' 162' ' ' LYS . 3.7 mp -95.75 109.59 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.003 0.521 . . . . 0.0 110.119 -167.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 135' ' ' TYR . 58.3 m-85 -88.76 132.18 34.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.182 0.993 . . . . 0.0 111.033 173.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 30.6 m-70 -92.16 97.0 10.64 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 172.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.72 145.5 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.517 0.727 . . . . 0.0 110.447 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.414 ' HE2' HG11 ' A' ' 157' ' ' VAL . 45.2 mtmt -104.64 128.58 52.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -67.62 117.99 10.3 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.175 0.512 . . . . 0.0 111.088 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.427 ' H ' ' HA ' ' A' ' 154' ' ' ALA . 27.6 t70 -60.03 -30.2 69.01 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 124.846 1.258 . . . . 0.0 110.656 173.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.748 ' HA ' ' HD2' ' A' ' 297' ' ' LYS . 5.6 t70 -81.82 -30.18 32.3 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.209 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -138.48 81.17 25.14 Favored Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 123.082 0.553 . . . . 0.0 110.098 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.33 -21.9 46.78 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.593 2.195 . . . . 0.0 111.589 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.35 -26.48 68.77 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.411 1.084 . . . . 0.0 111.79 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -77.27 -20.11 55.55 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.821 0.449 . . . . 0.0 110.325 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 72.21 -154.23 50.43 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.58 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.3 t -79.46 117.39 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.564 0.746 . . . . 0.0 109.381 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 31.8 m -117.38 151.87 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.276 1.03 . . . . 0.0 109.38 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -88.48 129.29 35.48 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 90.8 mmm -147.23 126.8 13.28 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.699 1.2 . . . . 0.0 108.383 -174.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -68.18 160.8 28.39 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.631 ' HA ' HG22 ' A' ' 204' ' ' VAL . 20.6 t -69.32 -28.23 66.06 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.969 0.414 . . . . 0.0 111.048 -173.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -67.62 -32.22 72.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.038 0.935 . . . . 0.0 110.022 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.59 -19.84 32.41 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.078 0.951 . . . . 0.0 111.211 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.631 HG22 ' HA ' ' A' ' 201' ' ' SER . 7.8 m -96.68 157.87 3.21 Favored 'Isoleucine or valine' 0 C--N 1.356 0.882 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.733 ' HB3' ' HB3' ' A' ' 142' ' ' ASP . 0.5 OUTLIER -145.66 -178.63 6.19 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -165.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.444 ' HB3' ' HG3' ' A' ' 281' ' ' GLU . . . -98.51 143.82 28.52 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 166.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.43 HH11 ' HB2' ' A' ' 140' ' ' TYR . 57.2 mtp180 -70.32 96.56 1.14 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.164 0.585 . . . . 0.0 109.817 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.44 103.36 0.15 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.72 0.808 . . . . 0.0 110.955 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -82.86 -1.88 53.19 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.813 1.245 . . . . 0.0 111.632 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.0 m -94.46 119.93 33.93 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.843 0.857 . . . . 0.0 110.918 -176.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.4 mt -86.84 130.76 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.308 0.643 . . . . 0.0 109.284 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 39.7 mm -92.32 98.07 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.462 ' HD3' ' H ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -58.05 156.52 9.29 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.151 0.98 . . . . 0.0 111.439 174.21 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.415 ' CZ2' ' HB2' ' A' ' 246' ' ' LYS . 79.9 t90 -57.26 -40.34 77.49 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.714 -167.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -65.39 -29.83 70.58 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.871 0.468 . . . . 0.0 111.297 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.35 -15.49 49.75 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.043 0.937 . . . . 0.0 111.723 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 95.1 mt -65.84 114.31 4.99 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 169.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.432 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 11.1 pt-20 -119.0 168.03 11.2 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.219 1.007 . . . . 0.0 109.354 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.87 115.95 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-O 121.3 0.571 . . . . 0.0 109.541 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.19 -1.4 56.19 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.585 -174.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.563 ' HG3' HG13 ' A' ' 223' ' ' VAL . 6.2 tp-100 -67.55 120.58 14.21 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.969 0.508 . . . . 0.0 110.856 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.534 HG12 HG13 ' A' ' 280' ' ' ILE . 97.1 t -97.55 111.89 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.563 HG13 ' HG3' ' A' ' 221' ' ' GLN . 12.9 m -132.1 -174.76 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.219 1.408 . . . . 0.0 109.505 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 20.3 ptm -135.15 143.92 46.77 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.46 0.704 . . . . 0.0 109.447 174.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.51 159.89 42.83 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.779 0.832 . . . . 0.0 111.336 -169.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -90.31 106.94 18.83 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 173.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -145.48 138.73 26.34 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -172.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 46.4 t-20 -89.16 121.22 69.7 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.6 -19.74 21.19 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.562 2.175 . . . . 0.0 112.394 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -88.88 -39.16 14.01 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.468 0.707 . . . . 0.0 110.282 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.438 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 29.4 m-80 -119.97 101.93 47.11 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 123.443 0.697 . . . . 0.0 110.027 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -61.28 -26.57 82.12 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.803 2.336 . . . . 0.0 113.231 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -78.44 -27.05 46.44 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.764 0.825 . . . . 0.0 111.385 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 231' ' ' ASN . 8.6 tp10 -107.05 151.52 25.23 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.252 0.621 . . . . 0.0 111.144 -170.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -76.26 152.34 36.54 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.572 0.749 . . . . 0.0 109.192 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -139.04 -106.86 0.72 Allowed Glycine 0 N--CA 1.47 0.907 0 C-N-CA 121.674 -0.298 . . . . 0.0 112.77 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -128.35 170.52 12.99 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . 0.437 ' CE2' ' HB3' ' A' ' 296' ' ' ARG . 81.8 m95 -80.2 105.81 11.75 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.36 0.664 . . . . 0.0 110.917 -175.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.408 ' HE1' ' HG2' ' A' ' 148' ' ' MET . 76.1 m-85 -118.42 165.04 14.37 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.64 1.176 . . . . 0.0 108.449 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -97.34 142.92 28.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.0 0.52 . . . . 0.0 110.121 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' A' ' 257' ' ' ALA . . . -137.09 155.07 50.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.328 1.051 . . . . 0.0 111.12 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -110.91 117.53 33.63 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.632 HD12 HD11 ' A' ' 255' ' ' LEU . 33.0 mm -69.86 107.82 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.678 0.791 . . . . 0.0 109.012 -173.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.3 p -84.33 -32.71 24.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.468 0.707 . . . . 0.0 111.944 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -160.33 158.35 29.56 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.692 0.397 . . . . 0.0 110.914 -176.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.415 ' HB2' ' CZ2' ' A' ' 214' ' ' TRP . 60.8 pttt -154.62 148.78 25.9 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.36 0.664 . . . . 0.0 112.076 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -155.8 149.93 25.57 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.483 1.113 . . . . 0.0 108.671 173.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -129.72 139.87 51.23 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 119.564 1.075 . . . . 0.0 112.26 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.4 p -119.67 170.28 9.34 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 165.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -67.92 -32.88 73.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.824 0.449 . . . . 0.0 110.606 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 73.5 p -90.99 -19.71 22.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.246 1.019 . . . . 0.0 112.581 -172.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -161.69 155.44 21.66 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -171.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -108.53 132.96 53.31 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 173.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -102.25 128.82 48.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.274 1.03 . . . . 0.0 108.427 172.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -149.87 137.08 19.69 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -127.05 136.36 52.08 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.408 ' HB1' ' HB1' ' A' ' 241' ' ' ALA . . . -147.24 140.8 25.55 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.197 0.599 . . . . 0.0 110.697 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.47 HD22 ' N ' ' A' ' 258' ' ' ASN . 0.8 OUTLIER -79.51 94.98 5.7 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 171.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 49.0 t -78.24 105.66 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 28.8 t -86.35 124.02 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.48 HD12 ' HB2' ' A' ' 264' ' ' ASP . 54.9 mt -103.16 -171.4 1.94 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.031 0.932 . . . . 0.0 109.032 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.08 -39.81 92.93 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 113.953 0.341 . . . . 0.0 113.953 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -121.77 -40.9 2.5 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.984 0.913 . . . . 0.0 109.255 173.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.48 ' HB2' HD12 ' A' ' 261' ' ' LEU . 21.5 m-20 -83.53 167.54 17.28 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.93 -173.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 54.7 p -145.53 114.21 6.81 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.617 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 61.9 mt -78.73 78.21 5.18 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -70.72 124.61 24.7 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.791 -170.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . 0.442 ' H ' ' ND2' ' A' ' 258' ' ' ASN . 36.8 t70 61.66 26.11 15.85 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.07 1.348 . . . . 0.0 111.603 173.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 94.9 m -73.47 133.62 43.71 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.709 -177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 -65.7 130.28 42.75 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 123.641 0.588 . . . . 0.0 110.493 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.9 mm -103.29 116.9 47.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.318 0.647 . . . . 0.0 109.555 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 61.9 mt -82.5 -45.45 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.685 173.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -89.58 64.44 6.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.951 0.9 . . . . 0.0 110.215 -168.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 30.5 m -78.84 -14.96 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.393 -174.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -90.63 -14.75 31.77 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.551 0.74 . . . . 0.0 111.047 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -96.98 43.6 1.07 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.098 0.959 . . . . 0.0 109.428 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.92 113.45 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.093 0.957 . . . . 0.0 109.737 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.41 ' HE2' ' HG3' ' A' ' 294' ' ' MET . 51.8 m-85 -94.61 164.92 12.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.014 0.926 . . . . 0.0 110.826 170.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -78.26 144.74 35.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.238 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.534 HG13 HG12 ' A' ' 222' ' ' VAL . 31.6 mm -73.42 113.57 11.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 164.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.444 ' HG3' ' HB3' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -78.97 125.52 29.48 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 170.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -109.16 104.92 56.34 Favored Pre-proline 0 N--CA 1.477 0.887 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -23.57 98.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.03 1 C-N-CA 125.751 4.3 . . . . 0.0 116.496 -151.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.23 60.21 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.577 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -78.2 -26.13 47.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.245 0.618 . . . . 0.0 110.24 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -134.79 160.44 24.27 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.838 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 12.4 m -91.04 159.01 40.79 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.552 0.741 . . . . 0.0 110.339 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.91 -155.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.62 2.214 . . . . 0.0 110.632 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . 0.532 ' HB3' ' HB3' ' A' ' 293' ' ' PRO . 24.6 mmt -76.87 78.37 3.46 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 121.538 0.685 . . . . 0.0 109.534 177.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 13.6 p -106.78 -8.87 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.015 0.926 . . . . 0.0 109.933 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -122.32 -153.13 0.54 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.74 112.02 3.57 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.464 1.029 . . . . 0.0 109.709 167.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.532 ' HB3' ' HB3' ' A' ' 289' ' ' MET . 84.6 Cg_endo -76.17 137.21 18.95 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.051 1.834 . . . . 0.0 111.221 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.41 ' HG3' ' HE2' ' A' ' 278' ' ' PHE . 21.0 mmt -80.85 -49.45 11.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.148 0.579 . . . . 0.0 109.661 174.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 55.57 106.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.288 1.435 . . . . 0.0 110.627 -166.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.437 ' HB3' ' CE2' ' A' ' 238' ' ' TRP . 16.9 mtm180 -62.36 -33.41 74.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.989 0.915 . . . . 0.0 111.061 -177.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.748 ' HD2' ' HA ' ' A' ' 190' ' ' ASP . 51.5 tttp -64.26 92.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 37.2 t -152.55 97.9 2.31 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.411 0.684 . . . . 0.0 110.48 -172.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.461 ' N ' ' HD3' ' A' ' 300' ' ' PRO . . . -165.39 54.79 0.26 Allowed Glycine 0 CA--C 1.539 1.569 0 CA-C-O 119.191 -0.783 . . . . 0.0 112.401 170.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 299' ' ' GLY . 19.5 Cg_endo . . . . . 0 C--N 1.389 2.682 0 C-N-CA 123.648 2.899 . . . . 0.0 111.496 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.443 ' HA3' HG21 ' A' ' 159' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.465 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -109.39 9.78 25.54 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.555 0.742 . . . . 0.0 112.104 -170.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -125.91 144.87 50.5 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.391 0.676 . . . . 0.0 109.623 174.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.45 -177.6 3.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.635 0.774 . . . . 0.0 110.317 176.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.5 m -60.13 -6.18 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 125.205 1.402 . . . . 0.0 114.712 -173.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -110.63 -3.69 15.77 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.776 0.83 . . . . 0.0 112.032 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -86.39 88.52 7.65 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.352 0.596 . . . . 0.0 112.42 -171.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.657 ' HB3' ' HG2' ' A' ' 155' ' ' GLN . 31.0 p90 -75.86 102.1 5.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.052 0.929 . . . . 0.0 109.325 165.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.1 m -114.07 -165.84 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.526 1.53 . . . . 0.0 107.751 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.21 123.26 42.81 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.345 0.52 . . . . 0.0 111.825 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.23 103.36 16.05 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.555 171.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.8 108.25 8.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -82.38 115.8 21.58 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.5 m -81.54 -15.43 54.88 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.81 0.844 . . . . 0.0 111.846 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -67.71 -51.91 43.9 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 23.1 ptp -96.65 -25.49 15.55 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.917 0.487 . . . . 0.0 110.934 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.55 18.22 33.63 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-O 119.991 -0.339 . . . . 0.0 113.836 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -99.68 168.51 9.89 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.669 0.747 . . . . 0.0 112.491 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -116.01 120.75 40.15 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 125.284 1.434 . . . . 0.0 107.63 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.9 127.18 54.0 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.19 103.5 0.39 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 172.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.484 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -101.95 117.42 34.79 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.828 0.851 . . . . 0.0 110.265 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.657 ' HG2' ' HB3' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -87.42 104.92 16.91 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.028 0.931 . . . . 0.0 109.165 -178.162 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.42 HG22 HG12 ' A' ' 186' ' ' VAL . 82.6 t -62.89 102.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.653 0.781 . . . . 0.0 109.501 172.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.0 -10.07 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 122.848 0.459 . . . . 0.0 110.983 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -170.5 143.29 2.23 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.839 0.856 . . . . 0.0 109.269 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.443 HG21 ' HA3' ' A' ' 133' ' ' GLY . 6.8 p -115.09 139.26 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 166.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 20.5 p -131.96 150.68 52.09 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.398 1.079 . . . . 0.0 108.583 172.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.418 ' NE ' ' SG ' ' A' ' 170' ' ' CYS . 1.9 tmm_? -66.97 147.21 53.52 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 171.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.41 ' HA ' HG13 ' A' ' 183' ' ' ILE . 87.5 tttt -57.69 90.48 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.541 0.736 . . . . 0.0 112.74 -171.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 164.13 163.39 0.07 OUTLIER Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 127.982 2.513 . . . . 0.0 107.085 172.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.58 -22.6 36.08 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.098 1.865 . . . . 0.0 112.545 167.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 54.8 m 61.32 30.02 18.88 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 124.655 1.182 . . . . 0.0 110.622 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -75.38 -36.63 60.87 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.85 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -74.48 -61.75 1.76 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.989 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.417 ' HG2' ' SG ' ' A' ' 170' ' ' CYS . 0.3 OUTLIER -109.94 125.78 30.42 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 123.951 0.901 . . . . 0.0 109.654 -176.176 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.09 -30.59 89.49 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.069 2.513 . . . . 0.0 113.296 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.418 ' SG ' ' NE ' ' A' ' 161' ' ' ARG . 50.9 m 64.64 28.33 13.19 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.556 1.16 . . . . 0.0 111.034 -176.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 32.6 p -64.06 87.84 0.05 OUTLIER 'General case' 0 C--O 1.244 0.798 0 C-N-CA 124.348 1.059 . . . . 0.0 110.757 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 16.1 m 60.81 32.43 20.13 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.671 1.189 . . . . 0.0 111.842 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -60.55 122.54 14.93 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.777 0.431 . . . . 0.0 110.173 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.1 p -70.7 82.07 0.61 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.75 0.82 . . . . 0.0 111.017 -175.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -136.45 102.35 9.71 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -69.3 114.81 3.75 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.565 2.177 . . . . 0.0 112.075 -171.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -74.82 105.27 5.8 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.692 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 43.2 mt -71.94 -41.19 68.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.876 0.87 . . . . 0.0 108.908 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -132.36 127.11 34.78 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 167.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -86.5 67.93 10.04 Favored 'General case' 0 C--O 1.248 1.015 0 CA-C-O 121.698 0.761 . . . . 0.0 109.235 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -84.37 61.05 6.36 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.2 m -115.45 173.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.449 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.41 HG13 ' HA ' ' A' ' 162' ' ' LYS . 45.2 mt -96.26 108.29 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.218 0.532 . . . . 0.0 109.99 -170.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -93.36 112.08 23.9 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.978 0.911 . . . . 0.0 108.631 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -78.25 89.97 4.32 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 175.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.484 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 29.3 m -110.46 151.68 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.288 -177.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -120.41 148.83 43.27 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 170.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -68.36 107.82 2.99 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 171.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -58.38 -34.55 70.83 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.406 0.682 . . . . 0.0 110.635 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -78.15 -23.77 47.61 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.379 0.672 . . . . 0.0 111.525 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -137.22 67.43 54.51 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.758 -0.589 . . . . 0.0 109.957 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.7 -17.57 42.51 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 122.969 2.446 . . . . 0.0 112.269 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.79 -13.78 62.41 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.58 1.552 . . . . 0.0 112.667 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -85.03 -21.21 29.52 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.748 0.419 . . . . 0.0 111.11 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 90.31 -157.19 25.62 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.545 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.8 t -92.17 118.67 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.894 0.878 . . . . 0.0 110.634 -172.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.6 m -109.41 156.38 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.368 1.067 . . . . 0.0 109.703 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -103.91 134.04 47.87 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.153 0.581 . . . . 0.0 110.919 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 82.7 mmm -136.83 167.05 22.19 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.575 1.15 . . . . 0.0 109.305 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.448 ' O ' HG22 ' A' ' 204' ' ' VAL . 21.1 m-80 -109.83 171.41 7.46 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.722 0.809 . . . . 0.0 109.639 174.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 43.4 m -61.32 -37.03 81.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 118.64 0.655 . . . . 0.0 111.566 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -16.59 61.57 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.453 176.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -96.66 -50.1 4.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.826 0.85 . . . . 0.0 110.681 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 200' ' ' ASN . 7.9 m -96.34 115.77 36.55 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 CA-C-O 122.004 0.907 . . . . 0.0 109.917 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -125.9 139.22 53.65 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.799 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.4 126.3 26.69 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.504 ' NH1' ' HB2' ' A' ' 296' ' ' ARG . 4.0 ptm180 -74.19 161.53 29.86 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.561 0.744 . . . . 0.0 112.215 -174.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 287' ' ' SER . . . -83.1 125.56 31.62 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.383 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.36 66.38 4.69 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 164.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.6 m -145.42 109.18 4.74 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.803 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.9 mt -85.93 129.07 38.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 123.077 0.551 . . . . 0.0 110.014 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.611 HD11 ' HE3' ' A' ' 279' ' ' LYS . 26.3 mm -101.51 148.12 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.791 1.237 . . . . 0.0 108.603 174.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 175.72 8.57 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.286 0.634 . . . . 0.0 110.27 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -54.28 -51.92 63.06 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -166.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -72.68 -19.56 61.4 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 120.861 0.362 . . . . 0.0 110.842 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.24 -21.48 29.05 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.942 0.897 . . . . 0.0 109.954 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.463 HD22 HD11 ' A' ' 243' ' ' ILE . 90.5 mt -71.37 128.76 36.94 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -143.55 158.17 43.86 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.785 0.434 . . . . 0.0 110.572 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.0 127.28 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 123.912 0.757 . . . . 0.0 111.428 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 97.23 -25.7 25.95 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.013 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -72.95 122.12 21.16 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.32 0.648 . . . . 0.0 110.159 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.505 HG13 ' NH2' ' A' ' 282' ' ' ARG . 1.8 p -108.72 125.15 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.326 0.651 . . . . 0.0 110.308 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 280' ' ' ILE . 3.8 m -135.31 177.27 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 125.422 1.489 . . . . 0.0 109.912 -175.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 16.8 ptm -108.19 120.76 43.28 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.185 0.594 . . . . 0.0 110.702 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.676 ' HG ' HG13 ' A' ' 277' ' ' VAL . 0.4 OUTLIER -127.86 148.88 50.48 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.704 0.802 . . . . 0.0 108.91 -176.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -88.51 116.85 27.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.803 0.841 . . . . 0.0 111.734 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.523 ' HE1' ' HB2' ' A' ' 225' ' ' LEU . 4.9 p90 -163.69 142.45 7.88 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.156 0.982 . . . . 0.0 108.648 173.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.409 HD22 ' HB3' ' A' ' 230' ' ' ASP . 6.3 p-10 -85.92 131.12 47.93 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 168.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.18 -19.77 66.36 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.25 1.967 . . . . 0.0 113.253 -171.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.409 ' HB3' HD22 ' A' ' 228' ' ' ASN . 17.2 t70 -66.57 -42.89 86.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.245 0.618 . . . . 0.0 110.154 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -130.06 89.1 46.44 Favored Pre-proline 0 N--CA 1.47 0.548 0 C-N-CA 123.608 0.763 . . . . 0.0 109.181 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.21 -6.97 17.51 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.616 2.211 . . . . 0.0 113.072 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -78.52 -29.35 46.48 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.243 0.617 . . . . 0.0 111.595 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -124.82 151.62 44.98 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.869 0.467 . . . . 0.0 110.237 -176.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 227' ' ' TYR . 7.0 ppt_? -66.72 161.79 22.74 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.814 0.846 . . . . 0.0 112.639 -175.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -165.57 -84.4 0.05 OUTLIER Glycine 0 C--N 1.338 0.684 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.388 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.454 ' HB2' ' CE2' ' A' ' 239' ' ' TYR . 30.1 m-85 -119.27 149.15 42.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.72 0.808 . . . . 0.0 109.224 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -88.36 104.43 16.76 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' A' ' 237' ' ' PHE . 95.5 m-85 -108.38 160.85 15.55 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.145 0.578 . . . . 0.0 110.367 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -81.48 119.23 23.48 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.676 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.467 ' HB3' HD13 ' A' ' 225' ' ' LEU . . . -126.82 136.56 52.53 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 172.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -99.36 123.17 43.41 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.608 HD12 HD11 ' A' ' 255' ' ' LEU . 19.5 mm -64.84 110.37 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.9 t -78.93 -36.42 41.79 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.278 -177.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -170.22 158.79 6.98 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.782 0.833 . . . . 0.0 109.52 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -143.43 136.21 27.52 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 254' ' ' GLU . 4.0 ptm180 -145.61 125.41 13.44 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -92.15 137.67 32.17 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.9 p -116.0 176.62 5.01 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 170.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -58.7 -39.71 81.52 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.7 p -127.84 13.5 6.86 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.6 159.98 37.62 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 118.244 0.474 . . . . 0.0 111.314 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -122.35 108.76 13.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.106 0.962 . . . . 0.0 108.825 176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.475 ' HB2' ' HG3' ' A' ' 247' ' ' ARG . 3.7 mp0 -90.88 99.1 12.19 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.608 HD11 HD12 ' A' ' 243' ' ' ILE . 2.1 tm? -100.23 121.34 41.31 Favored 'General case' 0 C--O 1.216 -0.664 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 176.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -107.23 132.14 53.4 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -144.05 122.32 12.28 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.28 0.632 . . . . 0.0 109.948 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -76.35 99.93 4.98 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 94.4 t -69.26 107.12 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.734 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 9.2 m -87.4 104.46 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 36.4 mt -81.93 -160.04 0.33 Allowed 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.684 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.43 -47.8 33.52 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-O 120.994 0.219 . . . . 0.0 112.979 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -122.3 -32.29 3.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.126 0.971 . . . . 0.0 111.044 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -101.44 171.56 7.5 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.666 0.787 . . . . 0.0 110.567 -176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 259' ' ' VAL . 58.7 m -144.61 121.97 11.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.779 0.832 . . . . 0.0 109.816 171.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 72.2 mt -80.97 113.18 19.0 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.858 0.863 . . . . 0.0 109.562 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.69 109.47 4.38 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.513 0.725 . . . . 0.0 111.423 -173.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.79 57.69 4.56 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.735 1.214 . . . . 0.0 112.873 171.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 42.7 t -65.03 125.24 24.3 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 36.6 ttt180 -71.82 123.33 22.42 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 172.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.6 mm -100.03 122.4 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.32 0.648 . . . . 0.0 109.804 -175.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 65.4 mt -92.06 -14.29 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 124.451 1.1 . . . . 0.0 109.649 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -89.09 20.63 3.56 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.239 1.416 . . . . 0.0 111.494 -168.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 28.9 m -69.09 -4.51 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.757 1.223 . . . . 0.0 114.101 -166.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -94.19 -33.49 13.28 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.687 0.395 . . . . 0.0 111.228 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -128.72 48.62 2.3 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.77 0.795 . . . . 0.0 110.193 -173.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.676 HG13 ' HG ' ' A' ' 225' ' ' LEU . 59.4 t -74.7 154.01 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.426 169.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -119.92 149.8 41.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.611 ' HE3' HD11 ' A' ' 212' ' ' ILE . 26.4 ttmt -80.14 151.4 29.79 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.662 174.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 223' ' ' VAL . 36.1 mm -76.93 126.41 37.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 168.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.669 ' HA ' ' HA3' ' A' ' 286' ' ' GLY . 0.6 OUTLIER -71.26 108.57 4.81 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.671 ' HB2' ' HB3' ' A' ' 285' ' ' GLU . 90.2 mtt-85 -123.06 153.69 64.46 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.783 1.233 . . . . 0.0 108.566 -176.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.16 96.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.091 2.527 . . . . 0.0 113.557 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.28 -34.91 5.26 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.229 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 282' ' ' ARG . 10.5 tp10 -85.97 -27.37 24.92 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.677 0.391 . . . . 0.0 111.902 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 281' ' ' GLU . . . -108.93 136.59 13.65 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -175.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 208' ' ' ALA . 3.3 m -96.24 144.98 28.77 Favored Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 117.259 0.53 . . . . 0.0 110.093 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -88.23 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.033 2.489 . . . . 0.0 111.765 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 17.4 mmt -80.66 78.92 7.37 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 9.1 p -100.1 -26.77 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.334 1.054 . . . . 0.0 110.146 -175.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -125.89 -160.08 0.95 Allowed 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -44.73 106.51 0.54 Allowed Pre-proline 0 N--CA 1.489 1.496 0 CA-C-N 119.743 1.156 . . . . 0.0 112.293 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.404 ' HB2' ' OH ' ' A' ' 140' ' ' TYR . 7.0 Cg_exo -73.82 84.52 1.44 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.164 2.576 . . . . 0.0 111.252 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 25.0 ptm -66.2 140.97 58.21 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.14 176.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -85.16 159.64 20.09 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.504 ' HB2' ' NH1' ' A' ' 207' ' ' ARG . 23.1 ttp-105 -128.12 10.57 6.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.567 0.747 . . . . 0.0 109.837 -175.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -51.8 131.94 31.05 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.791 1.636 . . . . 0.0 111.139 172.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 19.7 m -76.66 89.37 3.35 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.081 0.552 . . . . 0.0 109.902 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -81.38 118.64 4.67 Favored Glycine 0 CA--C 1.537 1.466 0 CA-C-O 119.026 -0.874 . . . . 0.0 113.298 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo . . . . . 0 C--N 1.375 1.926 0 C-N-CA 123.21 2.607 . . . . 0.0 112.16 177.465 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.401 HD13 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -120.18 -18.57 8.01 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.258 0.623 . . . . 0.0 111.397 175.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -99.78 143.45 29.99 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 173.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 136' ' ' LYS . 6.3 mptt -97.87 179.32 4.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.494 1.117 . . . . 0.0 110.472 -170.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -68.74 -17.81 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 124.767 1.227 . . . . 0.0 112.161 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -116.41 16.29 15.68 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.253 0.621 . . . . 0.0 110.976 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.43 ' HG3' HG13 ' A' ' 141' ' ' VAL . 11.3 tp10 -97.21 89.43 4.76 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.341 0.591 . . . . 0.0 110.17 -173.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.624 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 22.8 p90 -82.18 100.23 9.72 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.69 0.757 . . . . 0.0 111.179 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.43 HG13 ' HG3' ' A' ' 139' ' ' GLU . 34.1 m -114.88 169.14 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.721 0.808 . . . . 0.0 109.221 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -87.93 113.88 24.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.136 0.493 . . . . 0.0 111.296 -169.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -87.38 109.41 19.54 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 170.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.564 HH22 HG12 ' A' ' 260' ' ' VAL . 26.3 ttt180 -74.9 113.68 12.49 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.497 -175.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.89 134.89 35.82 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.431 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.6 p -77.04 -36.51 56.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.472 0.709 . . . . 0.0 111.494 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -65.03 -45.1 86.84 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.189 0.595 . . . . 0.0 110.847 -174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 54.0 tpp -85.54 -38.49 18.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.59 0.756 . . . . 0.0 110.127 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.68 9.89 80.35 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.867 -171.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.99 168.42 9.13 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 121.791 0.805 . . . . 0.0 112.243 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.441 ' HZ2' HD12 ' A' ' 280' ' ' ILE . 8.5 m0 -89.35 122.41 32.54 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.512 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.72 111.15 17.25 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 173.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -57.32 98.28 0.03 OUTLIER 'General case' 0 C--N 1.363 1.168 0 O-C-N 124.163 0.915 . . . . 0.0 109.963 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -103.73 133.1 49.29 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.437 1.095 . . . . 0.0 109.818 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 43.6 tt0 -84.01 106.75 15.91 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 122.684 0.394 . . . . 0.0 110.667 -173.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.1 t -58.56 109.23 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.521 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 167.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 m -108.37 -26.2 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 122.861 0.464 . . . . 0.0 111.028 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.425 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 56.5 ttt85 -146.5 122.63 10.81 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 110.788 -0.078 . . . . 0.0 110.788 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.16 117.82 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 123.335 0.654 . . . . 0.0 109.369 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.7 p -127.87 117.63 22.17 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.711 0.804 . . . . 0.0 109.289 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.46 ' HG3' HG12 ' A' ' 182' ' ' VAL . 27.1 ttt180 -76.14 138.19 40.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.376 0.67 . . . . 0.0 109.473 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -63.69 -21.62 66.48 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.201 0.6 . . . . 0.0 111.144 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.18 101.77 1.46 Allowed Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 161.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -63.63 127.01 18.69 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 122.757 2.305 . . . . 0.0 111.499 -174.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.5 m -104.45 28.14 7.22 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.826 0.85 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 65.95 175.27 0.23 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.771 1.228 . . . . 0.0 111.779 -175.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.6 -51.66 68.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.892 0.477 . . . . 0.0 110.155 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -96.58 107.5 36.69 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.01 59.46 6.96 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.584 2.856 . . . . 0.0 112.384 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 61.9 m -70.22 -37.93 75.14 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.868 0.867 . . . . 0.0 111.212 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 45.5 m -73.79 93.76 2.18 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 171.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 27.2 t -144.66 26.74 1.39 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.449 -173.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 41.7 p -67.91 89.86 0.29 Allowed 'General case' 0 C--N 1.358 0.971 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.1 t 65.56 -179.99 0.19 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.624 1.17 . . . . 0.0 111.173 -171.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.8 ptt-85 -158.6 134.27 5.99 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 123.989 0.916 . . . . 0.0 108.901 175.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.48 113.59 2.17 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 123.088 2.525 . . . . 0.0 112.911 -173.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.43 123.9 19.11 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.475 0.71 . . . . 0.0 110.564 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 30.7 tp -154.17 176.19 12.56 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -172.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -70.48 97.98 1.38 Allowed 'General case' 0 C--O 1.243 0.75 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 163.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.89 96.45 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.367 1.079 . . . . 0.0 111.603 -172.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -88.81 19.71 3.91 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.209 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.46 HG12 ' HG3' ' A' ' 161' ' ' ARG . 6.4 m -78.17 163.4 3.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 124.007 0.923 . . . . 0.0 110.046 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.497 HG23 ' HB2' ' A' ' 198' ' ' GLN . 61.3 mt -97.16 110.31 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.41 0.684 . . . . 0.0 110.117 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -90.6 108.43 19.8 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 169.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 56.0 m-70 -77.14 97.77 4.86 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 29.9 m -109.49 143.32 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.533 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.539 ' HG2' HG22 ' A' ' 196' ' ' VAL . 25.3 mtmt -104.83 116.81 32.64 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -53.99 111.01 0.67 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -64.88 -22.99 67.1 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -80.34 -29.12 38.0 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.597 0.759 . . . . 0.0 111.404 173.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.488 ' HB3' ' ND2' ' A' ' 194' ' ' ASN . 79.8 m-85 -129.27 55.05 16.19 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 123.499 0.72 . . . . 0.0 111.321 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.38 -13.58 20.6 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 121.719 1.613 . . . . 0.0 112.73 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -71.83 -27.93 63.23 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.864 0.866 . . . . 0.0 110.697 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.488 ' ND2' ' HB3' ' A' ' 191' ' ' TYR . 30.4 m-80 -75.82 -1.42 25.1 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.548 0.739 . . . . 0.0 111.905 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 92.48 -172.05 34.14 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-O 121.11 0.283 . . . . 0.0 113.279 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.539 HG22 ' HG2' ' A' ' 187' ' ' LYS . 8.8 t -90.51 116.9 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.11 152.56 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.837 0.855 . . . . 0.0 110.015 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.497 ' HB2' HG23 ' A' ' 183' ' ' ILE . 16.7 pm0 -92.27 126.48 37.37 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 97.0 mmm -141.38 136.44 31.43 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.742 1.217 . . . . 0.0 107.973 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.464 ' HB2' ' HG2' ' A' ' 202' ' ' ARG . 20.8 m-80 -89.45 173.12 8.52 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.167 0.44 . . . . 0.0 110.071 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.535 ' HA ' HG22 ' A' ' 204' ' ' VAL . 18.9 t -66.82 -30.0 70.08 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 120.806 0.336 . . . . 0.0 110.496 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.464 ' HG2' ' HB2' ' A' ' 200' ' ' ASN . 15.4 ptm180 -67.24 -18.11 65.08 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.585 0.754 . . . . 0.0 111.935 175.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -102.38 -29.32 11.71 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.93 0.892 . . . . 0.0 111.085 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 201' ' ' SER . 31.9 m -99.21 148.78 5.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 CA-C-O 121.599 0.714 . . . . 0.0 110.374 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -128.85 146.14 51.01 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.873 1.269 . . . . 0.0 108.111 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -67.69 128.93 38.29 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -63.4 137.35 58.13 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.362 0.665 . . . . 0.0 110.814 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 279' ' ' LYS . . . -69.89 113.86 7.52 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -172.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.576 ' HB3' ' SD ' ' A' ' 289' ' ' MET . 1.2 ptm180 -82.24 -31.94 29.96 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.686 169.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.7 m -90.04 123.51 33.98 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.554 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 37.4 mt -86.29 136.31 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.425 ' HB ' HG12 ' A' ' 277' ' ' VAL . 48.4 mm -107.51 144.2 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.673 0.789 . . . . 0.0 109.619 178.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.42 168.78 14.4 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.197 0.999 . . . . 0.0 109.296 178.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -52.22 -38.63 58.55 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.351 1.06 . . . . 0.0 112.953 -170.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.6 -44.31 93.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.358 0.663 . . . . 0.0 112.186 -173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -101.88 -1.46 32.07 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.609 0.764 . . . . 0.0 110.736 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.522 HD11 HG21 ' A' ' 223' ' ' VAL . 21.0 tp -79.19 121.0 24.49 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -130.69 156.72 44.44 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.496 0.589 . . . . 0.0 111.509 -172.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.4 m -67.93 132.34 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.971 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.8 -11.87 70.31 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.971 -176.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.419 HE21 HD12 ' A' ' 217' ' ' LEU . 29.0 tt0 -86.05 123.99 31.98 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.506 0.722 . . . . 0.0 109.47 177.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.96 133.16 29.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 173.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.522 HG21 HD11 ' A' ' 217' ' ' LEU . 3.3 m -145.19 145.76 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.6 1.16 . . . . 0.0 109.369 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.568 ' HG3' ' HB2' ' A' ' 278' ' ' PHE . 12.0 ptm -97.28 131.21 44.2 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.994 0.518 . . . . 0.0 109.692 -178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.513 ' HB3' ' HA ' ' A' ' 277' ' ' VAL . 0.8 OUTLIER -143.92 158.54 43.63 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.926 0.491 . . . . 0.0 110.834 -175.225 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 235' ' ' ARG . 16.5 p30 -77.04 117.87 19.04 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -156.6 143.16 18.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.726 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -108.53 120.47 46.29 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 168.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.66 -36.14 11.64 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.62 2.213 . . . . 0.0 111.873 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.31 -29.13 62.49 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.408 0.683 . . . . 0.0 110.774 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -131.18 90.13 39.64 Favored Pre-proline 0 N--CA 1.48 1.058 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.41 -17.77 49.29 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.923 2.415 . . . . 0.0 113.473 -176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -76.03 -27.75 57.44 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.069 0.547 . . . . 0.0 111.176 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.09 153.64 37.17 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.407 ' HB2' ' HB2' ' A' ' 226' ' ' ASN . 0.0 OUTLIER -75.4 173.34 11.06 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.933 0.493 . . . . 0.0 111.732 176.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -159.83 -117.53 0.47 Allowed Glycine 0 C--O 1.24 0.522 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.278 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -82.56 171.42 14.1 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.199 0.6 . . . . 0.0 110.102 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -89.01 105.5 17.82 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -114.02 135.3 54.16 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -82.67 129.0 34.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -136.65 137.04 39.64 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.205 1.002 . . . . 0.0 109.309 -173.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -94.64 118.93 32.48 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.601 HD12 HD11 ' A' ' 255' ' ' LEU . 37.3 mm -62.44 112.79 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.195 0.598 . . . . 0.0 111.192 -173.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 22.4 t -82.53 -41.62 19.43 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.901 0.88 . . . . 0.0 110.088 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -157.05 155.73 31.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.735 0.814 . . . . 0.0 109.53 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -142.85 144.28 32.45 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.15 0.58 . . . . 0.0 109.893 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 254' ' ' GLU . 33.3 ttm180 -156.54 148.85 23.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.96 0.904 . . . . 0.0 109.786 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.21 139.82 35.72 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 165.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.0 p -114.31 177.65 4.57 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 172.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -78.98 -23.4 44.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 118.434 0.561 . . . . 0.0 110.434 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.1 p -95.16 -21.04 18.76 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.702 0.801 . . . . 0.0 112.5 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.91 173.86 16.13 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.191 0.596 . . . . 0.0 111.006 -175.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -126.4 151.1 48.12 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 247' ' ' ARG . 10.1 tp10 -138.73 137.1 36.45 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.11 0.481 . . . . 0.0 110.894 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.648 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 0.4 OUTLIER -149.96 139.1 21.18 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.242 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -130.75 129.88 43.06 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 173.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.79 138.58 24.5 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.238 0.615 . . . . 0.0 109.919 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -76.69 99.22 4.99 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.49 106.14 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.564 HG12 HH22 ' A' ' 144' ' ' ARG . 48.4 t -89.0 114.56 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.225 -174.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 264' ' ' ASP . 87.8 mt -92.28 -170.17 2.44 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.965 0.906 . . . . 0.0 109.907 173.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -61.41 -54.55 35.15 Favored Glycine 0 C--N 1.352 1.438 0 O-C-N 123.156 0.285 . . . . 0.0 112.591 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.05 -49.56 3.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.212 1.005 . . . . 0.0 109.905 172.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.431 ' HB2' HD12 ' A' ' 261' ' ' LEU . 7.4 m-20 -76.18 167.35 22.03 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.703 -171.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 38.0 p -153.95 112.89 3.69 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.422 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 2.6 mm? -81.41 95.86 7.18 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.508 0.723 . . . . 0.0 109.659 -177.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -58.6 111.73 1.36 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.229 0.956 . . . . 0.0 110.662 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 16.0 t70 64.01 83.75 0.16 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.889 1.275 . . . . 0.0 111.783 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 71.4 m -106.9 140.32 39.89 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.051 0.94 . . . . 0.0 109.554 172.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -82.2 107.97 15.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.106 0.562 . . . . 0.0 110.13 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.648 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 42.4 mm -91.76 124.06 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.947 0.899 . . . . 0.0 108.734 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 52.6 mt -88.17 -26.73 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.304 0.642 . . . . 0.0 110.499 176.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.476 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 38.0 m-85 -95.56 60.91 2.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.876 0.87 . . . . 0.0 111.038 -166.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 255' ' ' LEU . 9.8 m -66.69 -17.15 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.369 1.067 . . . . 0.0 112.246 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -98.65 -24.26 15.14 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.003 0.921 . . . . 0.0 110.98 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 36.5 mt-10 -98.24 28.05 4.29 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.564 0.697 . . . . 0.0 110.799 -176.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.513 ' HA ' ' HB3' ' A' ' 225' ' ' LEU . 72.6 t -82.95 146.36 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 124.586 1.155 . . . . 0.0 108.88 172.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.568 ' HB2' ' HG3' ' A' ' 224' ' ' MET . 73.0 m-85 -130.78 160.89 33.01 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.179 0.991 . . . . 0.0 109.531 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 208' ' ' ALA . 75.1 tttt -82.04 154.78 25.47 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.34 1.056 . . . . 0.0 111.858 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.441 HD12 ' HZ2' ' A' ' 151' ' ' TRP . 15.9 mm -88.54 111.08 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 164.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' ' 208' ' ' ALA . 46.0 mm-40 -83.97 103.81 13.53 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -90.06 142.35 28.67 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.72 1.208 . . . . 0.0 109.52 -173.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.88 99.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.441 2.761 . . . . 0.0 113.544 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.28 -49.72 1.9 Allowed Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.047 -0.978 . . . . 0.0 112.906 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -73.36 -24.61 60.35 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.331 0.653 . . . . 0.0 111.728 -174.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -91.13 -159.81 35.94 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 25.2 p -126.99 135.11 26.89 Favored Pre-proline 0 N--CA 1.468 0.435 0 CA-C-N 117.142 0.471 . . . . 0.0 110.895 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.02 -174.67 1.63 Allowed 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.01 2.473 . . . . 0.0 110.616 163.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . 0.576 ' SD ' ' HB3' ' A' ' 209' ' ' ARG . 24.6 mmt -74.72 81.33 2.06 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.429 0.633 . . . . 0.0 110.479 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 12.3 p -100.77 -17.36 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.843 1.257 . . . . 0.0 109.627 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -122.75 -160.68 0.9 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -45.87 117.65 3.93 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.56 1.144 . . . . 0.0 112.422 177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.555 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 85.1 Cg_endo -78.36 144.08 20.14 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.585 2.19 . . . . 0.0 111.994 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 97.5 mmm -115.1 145.18 42.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.963 0.905 . . . . 0.0 110.693 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -143.3 91.53 2.28 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 169.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 40.6 mtm-85 -72.57 -17.24 61.73 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.378 -170.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -67.74 98.71 0.73 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 162.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 23.5 p -74.56 79.95 1.97 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.944 0.898 . . . . 0.0 110.935 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -172.67 76.23 0.09 OUTLIER Glycine 0 C--N 1.344 0.979 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.185 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo . . . . . 0 CA--C 1.565 2.05 0 C-N-CA 123.317 2.678 . . . . 0.0 111.82 176.168 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.456 ' N ' ' HG ' ' A' ' 174' ' ' SER . . . . . . . . 0 N--CA 1.476 1.355 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -102.83 -21.07 14.08 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.585 0.754 . . . . 0.0 110.673 -175.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -108.02 132.56 53.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 169.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 139' ' ' GLU . 17.7 pttp -130.24 -175.74 3.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.944 0.898 . . . . 0.0 110.742 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.8 m -35.47 -32.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -167.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -109.39 -22.18 12.16 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.208 0.603 . . . . 0.0 111.983 -173.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.402 ' HB2' ' H ' ' A' ' 136' ' ' LYS . 5.1 mp0 -77.13 78.83 3.66 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.371 1.068 . . . . 0.0 110.612 -176.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -76.52 130.81 38.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.545 174.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.2 m -132.69 169.01 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.491 1.516 . . . . 0.0 107.219 172.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.434 ' HB2' ' CE3' ' A' ' 151' ' ' TRP . 4.5 m-20 -92.24 139.51 30.54 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.664 0.665 . . . . 0.0 110.878 -174.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.1 99.4 12.4 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.888 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.435 ' HG2' ' NE1' ' A' ' 151' ' ' TRP . 0.0 OUTLIER -70.8 91.03 0.81 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.129 -1.396 . . . . 0.0 107.407 177.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.69 128.92 37.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.143 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.5 m -81.88 -19.15 41.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.563 0.345 . . . . 0.0 111.722 -172.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -76.69 -52.88 8.81 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.9 ttm -90.26 -39.99 12.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.693 0.797 . . . . 0.0 110.552 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.76 -7.67 59.38 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.199 -173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.3 153.38 35.94 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.598 0.759 . . . . 0.0 111.676 -174.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.547 ' CH2' HD12 ' A' ' 280' ' ' ILE . 12.9 m95 -101.51 116.07 31.93 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -109.0 123.28 48.88 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -62.03 101.66 0.23 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.757 0.66 . . . . 0.0 110.447 -173.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.9 114.84 26.49 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -85.52 97.6 10.15 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.439 HG22 HG12 ' A' ' 186' ' ' VAL . 44.7 t -65.51 97.84 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -92.14 -12.56 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.012 0.525 . . . . 0.0 111.851 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 170' ' ' CYS . 21.1 ttm180 -168.72 154.05 6.34 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.525 0.73 . . . . 0.0 110.809 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.0 m -131.43 143.44 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.194 0.998 . . . . 0.0 110.14 172.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.577 HG23 ' HB ' ' A' ' 183' ' ' ILE . 4.5 t -141.69 150.4 41.82 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.896 0.878 . . . . 0.0 109.781 176.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -120.04 158.26 27.19 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.961 0.904 . . . . 0.0 110.791 -172.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -95.69 86.56 4.44 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.372 0.669 . . . . 0.0 110.378 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -144.21 155.68 58.02 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.979 0.912 . . . . 0.0 109.809 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.94 -42.86 63.23 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.423 2.082 . . . . 0.0 112.335 168.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 46.7 m -87.57 91.17 8.65 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 172.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -144.75 23.06 1.59 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.872 0.869 . . . . 0.0 110.615 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -77.61 124.98 28.63 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 55.9 59.83 9.04 Favored Pre-proline 0 CA--C 1.563 1.477 0 C-N-CA 124.684 1.193 . . . . 0.0 111.856 -173.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -89.0 98.17 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.345 2.697 . . . . 0.0 112.328 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . 0.498 ' HA ' ' HG3' ' A' ' 158' ' ' ARG . 47.6 t -129.04 172.47 11.36 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.622 0.725 . . . . 0.0 111.935 -174.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.8 p -72.73 -22.75 60.83 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.23 173.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 17.7 p -74.37 126.18 30.13 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.3 m 56.92 54.95 6.55 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -167.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.456 ' HG ' ' N ' ' A' ' 133' ' ' GLY . 14.2 t -54.08 101.28 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.246 -170.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -74.49 130.97 80.87 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.512 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.15 143.98 17.61 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.967 3.111 . . . . 0.0 114.54 -172.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.5 146.59 31.27 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.445 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 50.8 mt -73.0 -75.72 0.14 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.194 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -113.83 16.2 18.48 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.111 0.964 . . . . 0.0 109.797 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 71.59 -15.36 0.44 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.245 1.418 . . . . 0.0 112.346 -173.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.547 ' HA ' ' H ' ' A' ' 201' ' ' SER . 28.7 m-20 -87.62 51.14 2.14 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.641 0.734 . . . . 0.0 110.147 174.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 160' ' ' THR . 35.3 m -81.59 179.56 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.771 169.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' A' ' 160' ' ' THR . 3.6 mp -94.04 107.31 19.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -176.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -85.49 108.92 18.13 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.498 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 22.5 m-70 -78.29 100.71 6.82 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.439 HG12 HG22 ' A' ' 156' ' ' VAL . 12.0 m -118.35 164.0 15.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.237 -176.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -122.18 116.13 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -57.99 111.18 1.09 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 169.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -71.98 -23.99 61.51 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.653 0.739 . . . . 0.0 110.334 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -82.3 -30.4 30.56 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.29 172.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -137.73 70.31 51.47 Favored Pre-proline 0 N--CA 1.487 1.381 0 C-N-CA 123.101 0.56 . . . . 0.0 110.985 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.83 -18.21 57.48 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.801 2.334 . . . . 0.0 112.173 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.19 -17.12 57.21 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.871 1.268 . . . . 0.0 112.573 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.43 HD22 ' N ' ' A' ' 194' ' ' ASN . 0.8 OUTLIER -75.91 -7.21 54.01 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.751 0.82 . . . . 0.0 112.263 177.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.77 -167.11 52.61 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 40.5 t -81.3 117.02 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 171.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 29.0 m -108.38 141.9 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 122.82 0.448 . . . . 0.0 110.047 -175.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.501 ' HB2' HG23 ' A' ' 183' ' ' ILE . 18.4 pt20 -87.51 130.48 34.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.448 0.699 . . . . 0.0 110.156 -176.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 60.1 mmm -133.3 161.5 34.32 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.335 0.654 . . . . 0.0 109.739 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -111.55 -179.5 3.73 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.099 0.959 . . . . 0.0 109.275 172.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.547 ' H ' ' HA ' ' A' ' 181' ' ' ASP . 42.3 t -62.37 -41.43 98.61 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 118.168 0.44 . . . . 0.0 110.367 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -15.19 62.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.868 0.467 . . . . 0.0 112.157 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -89.19 -57.79 2.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.445 0.698 . . . . 0.0 110.008 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -94.24 117.97 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.69 0.757 . . . . 0.0 109.77 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.428 ' HD2' ' HH2' ' A' ' 151' ' ' TRP . 25.8 ttm180 -111.66 149.89 30.91 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.08 -176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.18 127.72 32.66 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 123.907 0.754 . . . . 0.0 111.625 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -101.27 136.53 40.96 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.191 0.996 . . . . 0.0 109.417 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -94.75 157.55 15.89 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.037 0.922 . . . . 0.0 110.433 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.431 ' HD3' ' N ' ' A' ' 209' ' ' ARG . 0.0 OUTLIER -114.61 42.89 2.03 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.462 177.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 21.3 m -127.12 118.73 24.95 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.583 -178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 50.4 mt -84.08 127.74 39.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.574 HG23 ' HB2' ' A' ' 216' ' ' ASP . 46.6 mm -92.37 138.96 18.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.379 -178.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -128.31 -178.49 4.58 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.867 1.267 . . . . 0.0 109.415 175.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.491 ' CH2' ' HB2' ' A' ' 246' ' ' LYS . 49.7 t-105 -60.99 -28.64 69.17 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.812 0.445 . . . . 0.0 111.87 -177.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -61.91 -41.98 98.55 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.301 0.641 . . . . 0.0 110.564 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.574 ' HB2' HG23 ' A' ' 212' ' ' ILE . 58.8 m-20 -80.58 -14.55 58.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.733 0.813 . . . . 0.0 111.58 -177.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.516 ' HB3' ' HD3' ' A' ' 246' ' ' LYS . 0.5 OUTLIER -63.06 113.49 3.15 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.634 0.773 . . . . 0.0 111.222 -172.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.85 139.53 22.72 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.736 0.814 . . . . 0.0 110.005 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -67.31 139.64 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.161 0.584 . . . . 0.0 110.876 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 96.88 -21.74 44.4 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.696 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.414 ' HG2' HG13 ' A' ' 223' ' ' VAL . 8.0 tt0 -77.83 122.15 25.06 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.937 0.495 . . . . 0.0 109.968 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 10.5 p -91.84 131.45 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.428 HG23 HD11 ' A' ' 225' ' ' LEU . 15.6 m -135.64 156.73 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.741 1.216 . . . . 0.0 110.095 -176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.505 ' HB2' HD11 ' A' ' 280' ' ' ILE . 39.4 ttp -107.29 127.0 53.16 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.871 0.469 . . . . 0.0 109.988 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.506 ' HG ' HG13 ' A' ' 277' ' ' VAL . 0.1 OUTLIER -131.17 144.98 51.77 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.064 0.946 . . . . 0.0 108.558 -175.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -75.0 106.24 6.41 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 174.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -139.94 154.96 47.36 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.672 -169.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 231' ' ' ASN . 32.6 t-20 -120.44 120.71 29.68 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.18 -29.75 32.36 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.42 2.08 . . . . 0.0 112.688 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -71.48 -53.8 12.72 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.88 0.472 . . . . 0.0 110.281 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 228' ' ' ASN . 1.0 OUTLIER -117.0 88.59 26.96 Favored Pre-proline 0 N--CA 1.484 1.237 0 C-N-CA 123.823 0.849 . . . . 0.0 109.2 176.232 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.31 -9.85 23.72 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.014 2.476 . . . . 0.0 114.137 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.424 ' HD2' HD11 ' A' ' 272' ' ' ILE . 21.7 tptm -77.61 -15.5 59.18 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.989 0.915 . . . . 0.0 110.916 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -134.66 165.52 25.04 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.52 0.728 . . . . 0.0 110.463 -172.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.7 ppt_? -71.91 163.65 27.47 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.922 0.889 . . . . 0.0 111.023 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -145.52 -84.44 0.06 OUTLIER Glycine 0 C--O 1.239 0.456 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 175.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -128.53 178.09 6.55 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.33 1.052 . . . . 0.0 108.549 173.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . 0.499 ' HB3' ' SD ' ' A' ' 224' ' ' MET . 97.4 m95 -83.21 110.03 17.72 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 122.744 0.418 . . . . 0.0 109.905 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.29 141.29 49.1 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.795 0.838 . . . . 0.0 109.656 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -83.53 123.06 29.37 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.265 0.555 . . . . 0.0 109.709 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -128.62 137.35 51.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.408 1.083 . . . . 0.0 109.59 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 222' ' ' VAL . 33.0 tt0 -94.98 136.43 35.3 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.513 HD12 HD21 ' A' ' 255' ' ' LEU . 33.9 mm -63.96 108.29 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 O-C-N 123.83 0.706 . . . . 0.0 109.46 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.4 t -93.9 -29.16 15.43 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.476 0.711 . . . . 0.0 110.198 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 77.0 ttt180 -167.98 156.26 8.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.355 0.662 . . . . 0.0 109.563 -175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.516 ' HD3' ' HB3' ' A' ' 217' ' ' LEU . 23.8 pttm -148.03 139.84 23.92 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 167.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -134.01 114.84 13.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.791 1.236 . . . . 0.0 107.68 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 253' ' ' ARG . 9.1 pt-20 -100.23 134.07 43.71 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.014 0.435 . . . . 0.0 109.924 175.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.3 p -118.55 161.76 19.5 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -64.44 -15.08 60.03 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 52.6 p -94.75 -32.06 13.5 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.549 0.74 . . . . 0.0 111.473 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -170.4 141.38 1.97 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.229 0.612 . . . . 0.0 110.986 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 248' ' ' GLU . 0.0 OUTLIER -98.18 102.81 14.66 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 121.8 0.81 . . . . 0.0 111.174 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -87.92 116.73 26.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.186 0.994 . . . . 0.0 111.161 -169.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.632 ' HB3' ' HB ' ' A' ' 271' ' ' ILE . 3.9 tt -97.84 138.27 35.44 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . 0.513 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 53.2 m-85 -128.44 115.04 17.58 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -132.41 140.0 48.28 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.991 0.516 . . . . 0.0 110.083 -176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 3.4 p-10 -79.85 96.93 6.47 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.415 0.626 . . . . 0.0 109.551 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 49.6 t -72.83 100.49 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.053 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.2 p -93.74 110.91 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.609 0.718 . . . . 0.0 109.228 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 5.2 mp -83.6 -172.51 4.19 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.247 174.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -71.08 -31.45 66.61 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 121.885 -0.197 . . . . 0.0 112.824 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -121.81 -48.62 2.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.141 0.976 . . . . 0.0 109.677 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.74 168.81 18.83 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.511 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 51.7 p -158.43 112.63 2.5 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.61 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 55.3 mt -94.3 96.9 9.86 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.37 1.068 . . . . 0.0 110.044 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 4.1 p-10 -74.87 137.6 41.9 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.896 0.479 . . . . 0.0 111.439 -174.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 63.58 26.04 14.56 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.835 1.254 . . . . 0.0 113.634 171.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 72.0 m -64.83 133.2 51.44 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.628 0.371 . . . . 0.0 111.296 177.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -68.86 116.46 9.36 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.93 0.768 . . . . 0.0 110.058 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.632 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 45.8 mm -88.74 133.31 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.018 0.527 . . . . 0.0 109.726 177.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.424 HD11 ' HD2' ' A' ' 233' ' ' LYS . 62.3 mt -104.91 -22.34 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.342 1.057 . . . . 0.0 110.044 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -90.61 41.54 1.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.184 0.993 . . . . 0.0 110.794 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 26.2 m -70.04 -26.07 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.678 1.191 . . . . 0.0 112.686 -169.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -91.92 -3.57 55.79 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.372 0.669 . . . . 0.0 111.724 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.7 25.9 3.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.111 0.564 . . . . 0.0 111.331 -170.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.506 HG13 ' HG ' ' A' ' 225' ' ' LEU . 46.5 t -73.59 153.7 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.885 0.874 . . . . 0.0 110.267 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -116.71 150.26 38.49 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.457 0.703 . . . . 0.0 109.6 169.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.453 ' HE2' HD11 ' A' ' 212' ' ' ILE . 22.2 ttmm -82.97 149.48 26.98 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.227 1.011 . . . . 0.0 110.653 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.547 HD12 ' CH2' ' A' ' 151' ' ' TRP . 32.7 mm -87.1 125.03 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 165.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.52 104.4 6.06 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -173.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 285' ' ' GLU . 98.0 mtt180 -94.4 103.7 11.75 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 168.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -27.98 118.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 125.25 3.967 . . . . 0.0 116.617 -165.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 106.96 -41.69 2.12 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.922 -0.932 . . . . 0.0 114.612 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 282' ' ' ARG . 10.5 pt-20 -79.99 -25.23 40.39 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 119.088 1.444 . . . . 0.0 113.338 -170.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -76.84 117.88 5.01 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 17.8 p -63.57 129.8 93.91 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 117.508 0.654 . . . . 0.0 109.65 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.58 153.05 74.23 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.451 2.767 . . . . 0.0 112.85 -172.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . 0.518 ' SD ' ' HA ' ' A' ' 293' ' ' PRO . 57.0 ttm -76.91 79.57 3.48 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-O 121.852 0.834 . . . . 0.0 110.167 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.9 -28.9 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -74.33 178.45 5.17 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.748 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -54.02 141.12 50.29 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.131 0.972 . . . . 0.0 111.964 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.518 ' HA ' ' SD ' ' A' ' 289' ' ' MET . 16.0 Cg_exo -67.68 84.82 0.39 Allowed 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.758 2.305 . . . . 0.0 111.679 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.7 mtm -68.11 109.55 3.57 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.692 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -123.37 137.55 54.8 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.105 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.82 50.25 0.6 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.793 0.837 . . . . 0.0 110.697 -159.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 190' ' ' ASP . 16.8 ptpt -55.68 149.71 13.78 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.411 1.084 . . . . 0.0 113.872 -173.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 68.8 m -84.99 76.19 10.3 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -124.59 75.0 0.4 Allowed Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.426 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--N 1.378 2.096 0 C-N-CA 123.153 2.569 . . . . 0.0 112.328 -176.083 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.42 ' HA3' ' HB ' ' A' ' 159' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.411 ' N ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -115.61 10.81 15.65 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -169.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -91.74 159.45 15.83 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 166.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 60.0 mttp -79.18 178.64 7.91 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.99 0.516 . . . . 0.0 111.564 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -91.39 17.45 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 123.903 0.881 . . . . 0.0 110.929 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -151.8 9.11 0.51 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.422 0.689 . . . . 0.0 109.715 175.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 136' ' ' LYS . 9.2 tp10 -75.2 87.56 2.46 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 123.7 0.8 . . . . 0.0 110.133 -170.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.696 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 46.2 p90 -74.71 120.92 20.92 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.071 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.42 -170.13 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.424 1.09 . . . . 0.0 109.55 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -92.61 147.9 22.5 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -140.01 104.22 4.8 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -70.03 103.61 2.32 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 173.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.34 115.07 3.87 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.457 0.703 . . . . 0.0 109.843 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t -68.8 -16.67 63.86 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.163 0.985 . . . . 0.0 112.849 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -82.46 -49.34 10.05 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 122.914 0.486 . . . . 0.0 110.978 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 22.6 ptm -101.4 -13.61 17.91 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.568 0.747 . . . . 0.0 111.441 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.647 ' HA3' ' HA3' ' A' ' 262' ' ' GLY . . . 79.19 20.55 69.56 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 174.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.429 ' HB2' ' CE1' ' A' ' 239' ' ' TYR . . . -106.19 153.42 22.15 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.25 0.62 . . . . 0.0 111.278 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.425 ' HZ3' ' HG3' ' A' ' 205' ' ' ARG . 57.2 m95 -78.26 144.67 35.98 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 171.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.434 ' HA ' ' HD1' ' A' ' 238' ' ' TRP . 59.2 m-85 -145.56 145.78 31.14 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.397 0.544 . . . . 0.0 111.146 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 189' ' ' ASP . 75.2 mm-40 -63.51 138.07 58.37 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 167.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -146.82 166.69 25.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.408 0.683 . . . . 0.0 110.269 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.696 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 63.1 tt0 -137.08 105.13 5.65 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.346 0.659 . . . . 0.0 110.1 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.664 HG22 HG12 ' A' ' 186' ' ' VAL . 42.3 t -67.52 100.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.51 -3.02 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.217 0.607 . . . . 0.0 112.453 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 72.4 ttt180 -166.41 135.06 2.93 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.42 ' HB ' ' HA3' ' A' ' 133' ' ' GLY . 27.6 m -118.25 127.62 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.301 0.64 . . . . 0.0 109.48 173.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 40.3 p -136.26 145.65 45.82 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.835 0.854 . . . . 0.0 109.264 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.565 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 13.5 ptt180 -94.27 165.85 12.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.304 0.642 . . . . 0.0 110.474 175.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -70.21 -35.53 73.97 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.266 175.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.565 ' HB3' ' HD2' ' A' ' 161' ' ' ARG . . . -65.75 142.0 97.98 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.323 0.649 . . . . 0.0 110.628 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.57 140.58 54.75 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.336 2.69 . . . . 0.0 112.807 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.7 m -76.19 115.77 16.23 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.336 0.655 . . . . 0.0 110.581 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -105.73 87.08 2.51 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 169.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 25.7 t70 67.98 -72.72 0.09 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.211 1.404 . . . . 0.0 109.3 -165.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.445 ' H ' ' HD2' ' A' ' 169' ' ' PRO . 0.9 OUTLIER -168.53 -55.87 0.0 OUTLIER Pre-proline 0 CA--C 1.57 1.722 0 C-N-CA 125.053 1.341 . . . . 0.0 108.828 177.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 168' ' ' GLU . 66.0 Cg_endo -75.89 -171.31 1.02 Allowed 'Trans proline' 0 C--N 1.405 3.527 0 C-N-CA 122.518 2.146 . . . . 0.0 113.116 -174.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 51.9 t 66.02 76.58 0.31 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 124.829 1.252 . . . . 0.0 109.585 -173.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.3 m -66.62 103.84 1.16 Allowed 'General case' 0 C--N 1.35 0.59 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.441 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 5.2 m -77.6 78.45 4.11 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.852 0.861 . . . . 0.0 110.353 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 77.0 p 48.15 51.52 14.65 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.4 1.48 . . . . 0.0 111.82 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.7 t -102.55 26.23 8.15 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.565 -166.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -117.65 86.87 24.56 Favored Pre-proline 0 N--CA 1.482 1.148 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 171.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.466 ' HG2' ' HB3' ' A' ' 181' ' ' ASP . 59.5 Cg_exo -54.8 105.63 0.15 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.004 2.47 . . . . 0.0 112.043 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . 65.1 -74.79 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.045 1.338 . . . . 0.0 109.464 -165.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 64.0 tp -149.99 -42.14 0.13 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.621 1.168 . . . . 0.0 108.381 169.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -64.86 128.41 35.63 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.749 0.82 . . . . 0.0 110.083 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.523 ' HB3' HG22 ' A' ' 182' ' ' VAL . 3.6 mp0 -71.86 92.02 1.21 Allowed 'General case' 0 C--O 1.243 0.726 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.466 ' HB3' ' HG2' ' A' ' 176' ' ' PRO . 19.5 t70 -80.11 70.29 6.69 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 160.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.523 HG22 ' HB3' ' A' ' 180' ' ' GLU . 18.2 m -126.78 173.94 11.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.704 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.507 177.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 183' ' ' ILE . 3.1 mp -96.8 108.87 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.427 0.632 . . . . 0.0 109.748 -166.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -99.77 105.97 17.81 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 17.7 m-70 -78.88 92.88 4.93 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.664 HG12 HG22 ' A' ' 156' ' ' VAL . 2.4 m -108.93 153.55 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -119.19 118.15 30.57 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 191' ' ' TYR . 24.2 m-85 -64.72 127.25 30.75 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.453 0.471 . . . . 0.0 110.378 177.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 153' ' ' GLU . 13.4 t70 -65.85 -37.53 86.45 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.72 -20.32 65.25 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.696 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 188' ' ' TYR . 89.5 m-85 -139.37 66.87 37.76 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 123.568 0.747 . . . . 0.0 109.11 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -71.2 -40.03 3.51 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.331 2.021 . . . . 0.0 112.883 -169.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.68 -2.57 58.7 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.782 0.833 . . . . 0.0 111.982 -176.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -77.04 -16.4 59.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.205 0.602 . . . . 0.0 110.56 172.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 100.02 -161.13 19.29 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.206 -0.452 . . . . 0.0 113.16 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 7.6 t -96.3 116.96 39.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 22.4 m -101.88 155.2 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.878 0.871 . . . . 0.0 110.204 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.404 ' HB2' HG23 ' A' ' 183' ' ' ILE . 15.1 pm0 -99.4 128.54 45.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.654 0.782 . . . . 0.0 109.563 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 86.3 mmm -130.05 165.05 23.02 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.636 1.175 . . . . 0.0 108.788 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -110.74 172.11 7.06 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 180' ' ' GLU . 56.9 m -58.32 -43.86 88.39 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.137 0.575 . . . . 0.0 111.593 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -22.62 67.0 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.83 0.852 . . . . 0.0 112.219 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -84.16 -40.68 17.89 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.624 0.77 . . . . 0.0 110.423 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 31.3 m -93.38 117.73 37.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 CA-C-O 122.216 1.008 . . . . 0.0 110.011 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.425 ' HG3' ' HZ3' ' A' ' 151' ' ' TRP . 2.0 mmp_? -122.08 -170.27 2.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.971 1.308 . . . . 0.0 109.085 -175.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' A' ' 289' ' ' MET . . . -101.98 128.58 48.35 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 169.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.67 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 0.0 OUTLIER -73.95 118.51 16.98 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 167.223 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -69.14 121.93 17.74 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 122.855 0.462 . . . . 0.0 110.446 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -74.41 4.39 6.0 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.217 0.607 . . . . 0.0 111.913 174.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 52.4 m -84.11 105.91 15.34 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.64 114.74 25.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 279' ' ' LYS . 30.8 mm -76.49 133.65 30.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.509 177.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.91 178.04 5.05 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.52 ' HA ' HD12 ' A' ' 217' ' ' LEU . 75.3 t-105 -49.5 -41.87 41.93 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.957 0.903 . . . . 0.0 111.908 -177.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -53.93 -44.18 70.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.466 1.106 . . . . 0.0 112.788 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -115.18 17.15 16.81 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.597 0.759 . . . . 0.0 112.34 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 214' ' ' TRP . 53.1 mt -76.2 113.22 13.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 163.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -126.69 152.71 46.42 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.733 0.413 . . . . 0.0 110.274 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.33 140.58 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.219 0.608 . . . . 0.0 110.798 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.45 -1.39 82.12 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.5 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.53 ' HG2' HG13 ' A' ' 223' ' ' VAL . 29.5 tt0 -85.57 120.49 27.08 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.496 0.648 . . . . 0.0 109.818 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 64.8 t -90.05 114.29 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.53 HG13 ' HG2' ' A' ' 221' ' ' GLN . 3.5 m -126.89 163.44 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.501 1.12 . . . . 0.0 109.346 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.434 ' HB3' HD11 ' A' ' 280' ' ' ILE . 0.0 OUTLIER -100.88 139.46 36.53 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 171.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.617 ' HG ' HG13 ' A' ' 277' ' ' VAL . 1.1 mp -131.35 167.67 18.86 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.409 ' HB3' ' HZ3' ' A' ' 238' ' ' TRP . 12.2 p-10 -101.36 105.64 16.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.997 0.919 . . . . 0.0 110.434 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -167.71 159.16 11.62 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.485 0.714 . . . . 0.0 110.196 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -103.31 129.15 26.04 Favored Pre-proline 0 C--O 1.217 -0.644 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.82 -7.36 20.97 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 122.405 2.07 . . . . 0.0 113.366 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -70.5 -30.27 67.0 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.116 0.566 . . . . 0.0 109.53 170.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.572 HD22 ' HB2' ' A' ' 234' ' ' GLU . 5.1 t30 -152.45 82.82 5.1 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.754 1.222 . . . . 0.0 107.77 177.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -60.88 -10.9 15.87 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.345 2.696 . . . . 0.0 114.381 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.404 ' O ' HD12 ' A' ' 272' ' ' ILE . 50.6 tttm -72.31 -31.34 65.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.458 0.703 . . . . 0.0 110.826 173.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.572 ' HB2' HD22 ' A' ' 231' ' ' ASN . 0.4 OUTLIER -108.01 156.52 19.15 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.822 0.849 . . . . 0.0 111.149 -173.073 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -65.81 161.37 21.09 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.284 -1.325 . . . . 0.0 112.033 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -171.25 -122.92 0.67 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -104.86 -177.32 3.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.179 0.592 . . . . 0.0 110.645 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . 0.434 ' HD1' ' HA ' ' A' ' 152' ' ' PHE . 14.5 m95 -90.59 105.77 18.04 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -173.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 150' ' ' ALA . 84.5 m-85 -126.63 157.57 38.58 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.77 0.828 . . . . 0.0 111.033 -176.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -88.07 146.77 25.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.3 0.64 . . . . 0.0 110.6 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -155.89 138.5 15.06 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.254 1.022 . . . . 0.0 108.529 170.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.6 125.12 39.05 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.611 HD12 HD11 ' A' ' 255' ' ' LEU . 28.5 mm -64.72 108.94 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.548 0.739 . . . . 0.0 109.218 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 11.3 m -79.92 -48.43 13.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.667 0.787 . . . . 0.0 110.798 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.96 128.44 2.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -170.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -114.23 145.53 41.6 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -141.29 121.02 13.43 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -104.56 126.54 51.74 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 77.7 p -125.23 172.31 9.65 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.182 0.993 . . . . 0.0 108.869 170.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -78.99 -12.41 60.04 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.971 0.508 . . . . 0.0 111.366 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 65.4 p -96.69 -29.14 13.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.37 0.668 . . . . 0.0 111.085 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -157.54 163.24 38.58 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.031 0.532 . . . . 0.0 111.336 -173.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -116.6 99.89 7.46 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 165.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -92.37 100.54 13.09 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.181 0.593 . . . . 0.0 110.439 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.611 HD11 HD12 ' A' ' 243' ' ' ILE . 1.7 tm? -96.24 136.09 37.19 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 175.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -125.17 127.61 47.08 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -142.57 140.31 31.69 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.13 0.572 . . . . 0.0 110.575 -176.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -80.79 102.54 10.05 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 170.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 49.6 t -65.88 121.85 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.794 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.5 p -121.78 107.82 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 121.976 0.893 . . . . 0.0 109.166 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.581 HD12 ' HB3' ' A' ' 264' ' ' ASP . 25.4 mt -88.15 -160.01 0.59 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.437 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.647 ' HA3' ' HA3' ' A' ' 149' ' ' GLY . . . -89.23 -25.47 28.6 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -123.04 -43.72 2.21 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.534 0.734 . . . . 0.0 111.084 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.581 ' HB3' HD12 ' A' ' 261' ' ' LEU . 30.1 t70 -113.37 177.08 4.76 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.572 1.149 . . . . 0.0 110.442 -170.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 57.6 p -148.6 143.4 26.55 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.009 0.924 . . . . 0.0 110.159 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 259' ' ' VAL . 2.8 mm? -114.58 106.37 14.17 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -78.59 125.24 29.09 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.57 0.748 . . . . 0.0 110.493 -177.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 62.39 81.56 0.2 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.854 1.261 . . . . 0.0 112.208 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 61.3 m -111.02 127.4 55.52 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 19.4 ttp180 -80.56 104.14 10.89 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 255' ' ' LEU . 43.1 mm -74.3 120.19 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.247 1.019 . . . . 0.0 110.335 -174.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 233' ' ' LYS . 54.1 mt -83.52 -20.2 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 125.2 1.4 . . . . 0.0 110.177 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -93.71 37.55 1.07 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.289 1.436 . . . . 0.0 111.902 -167.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 32.9 m -66.9 -28.59 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -169.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -95.77 0.07 51.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.657 0.783 . . . . 0.0 112.293 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -134.72 25.88 3.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.119 0.568 . . . . 0.0 111.3 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.617 HG13 ' HG ' ' A' ' 225' ' ' LEU . 55.5 t -76.11 148.74 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.835 0.854 . . . . 0.0 108.844 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -117.66 150.69 38.63 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.506 ' HB2' HD11 ' A' ' 212' ' ' ILE . 38.8 ttmt -79.45 145.55 33.23 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.952 0.501 . . . . 0.0 111.091 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 224' ' ' MET . 37.0 mm -84.74 139.14 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 166.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.24 147.06 51.92 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 173.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -127.35 144.35 50.45 Favored Pre-proline 0 N--CA 1.473 0.704 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.88 125.48 13.08 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.061 2.508 . . . . 0.0 113.293 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.55 -58.95 0.56 Allowed Glycine 0 C--N 1.345 1.062 0 C-N-CA 123.156 0.408 . . . . 0.0 113.317 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.02 -23.14 26.93 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.249 0.524 . . . . 0.0 111.495 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -125.46 136.51 9.8 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 16.5 m -71.5 148.83 93.38 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 123.314 0.646 . . . . 0.0 110.858 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.8 176.63 9.87 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 123.133 2.555 . . . . 0.0 111.574 176.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . 0.424 ' HB2' ' HB1' ' A' ' 206' ' ' ALA . 9.5 ttt -95.12 81.14 3.64 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 14.6 p -100.38 -26.73 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.286 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.31 -177.51 4.66 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.138 0.975 . . . . 0.0 109.912 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -47.62 109.63 1.15 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.508 1.123 . . . . 0.0 111.085 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.77 108.53 1.47 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.565 2.177 . . . . 0.0 111.639 -172.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 58.4 ttp -105.69 91.26 3.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.128 0.971 . . . . 0.0 108.639 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -66.49 142.23 57.61 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.144 0.577 . . . . 0.0 110.631 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -59.99 -32.37 70.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.696 0.798 . . . . 0.0 112.138 -173.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.96 -24.34 66.94 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.268 1.027 . . . . 0.0 111.713 -176.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 62.8 m -138.81 91.32 2.52 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 172.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -150.08 -63.76 0.01 OUTLIER Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo . . . . . 0 C--N 1.376 2.004 0 C-N-CA 123.046 2.497 . . . . 0.0 111.242 168.889 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.657 ' N ' ' HG ' ' A' ' 174' ' ' SER . . . . . . . . 0 N--CA 1.488 2.109 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.487 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -92.35 -6.33 50.4 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.178 0.591 . . . . 0.0 112.167 -176.068 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -98.65 150.07 22.15 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.159 0.504 . . . . 0.0 111.106 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.621 ' HB2' ' HG2' ' A' ' 139' ' ' GLU . 48.4 mtpt -84.69 168.83 14.89 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.564 1.146 . . . . 0.0 110.998 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.2 m -78.75 14.47 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 C-N-CA 124.211 1.004 . . . . 0.0 112.735 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -132.2 0.22 3.75 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.974 0.91 . . . . 0.0 111.412 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.621 ' HG2' ' HB2' ' A' ' 136' ' ' LYS . 27.9 mm-40 -79.9 92.17 5.49 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.62 0.724 . . . . 0.0 112.29 -168.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 12.8 p90 -65.29 100.11 0.44 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.74 165.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.1 m -115.88 -172.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.983 1.313 . . . . 0.0 109.191 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.631 ' HA ' ' HA ' ' A' ' 153' ' ' GLU . 15.3 t70 -104.53 157.94 16.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 168.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 204' ' ' VAL . . . -133.86 96.07 3.58 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.481 0.312 . . . . 0.0 110.465 169.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -73.41 97.95 2.64 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 169.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -61.82 128.0 34.11 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.121 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.6 m -68.5 -30.15 68.92 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.22 0.608 . . . . 0.0 111.222 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -74.03 -42.26 60.58 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.347 0.659 . . . . 0.0 111.649 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 54.4 ttm -102.02 -22.8 14.19 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.09 0.556 . . . . 0.0 112.378 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 77.45 0.75 73.58 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-N 116.663 -0.244 . . . . 0.0 113.431 -174.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -93.16 164.83 13.1 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 123.422 0.689 . . . . 0.0 111.342 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.571 ' HB3' ' HB2' ' A' ' 238' ' ' TRP . 2.3 p-90 -77.41 139.59 39.73 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.85 174.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.414 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 89.6 m-85 -147.22 77.26 1.44 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 171.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 142' ' ' ASP . 50.9 mt-10 -55.99 134.96 52.68 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.628 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -149.15 135.11 18.96 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.655 0.597 . . . . 0.0 111.796 -164.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 54.3 tt0 -91.44 109.63 20.92 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.51 113.77 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.524 0.73 . . . . 0.0 109.261 170.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.89 -8.7 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 122.967 0.507 . . . . 0.0 111.497 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.559 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 36.3 ttm180 -169.93 143.83 2.64 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.639 0.776 . . . . 0.0 109.412 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.455 ' O ' ' HD2' ' A' ' 169' ' ' PRO . 11.0 m -129.34 143.47 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.7 0.8 . . . . 0.0 108.866 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.437 HG23 ' HB ' ' A' ' 183' ' ' ILE . 9.5 t -148.79 163.8 36.3 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.122 0.569 . . . . 0.0 111.207 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.446 ' NH2' ' HA ' ' A' ' 174' ' ' SER . 17.4 mmt180 -87.28 171.78 10.37 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.381 1.072 . . . . 0.0 112.162 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -68.59 -36.91 79.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.473 1.109 . . . . 0.0 110.086 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.27 152.38 90.21 Favored Pre-proline 0 C--O 1.241 0.645 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.003 172.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.49 91.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.785 2.323 . . . . 0.0 111.377 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.4 m -143.03 40.16 1.49 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.427 1.491 . . . . 0.0 107.739 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -69.38 -27.01 64.94 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.938 -169.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -68.97 79.91 0.31 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.479 0.711 . . . . 0.0 112.319 -171.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 28.07 65.67 0.64 Allowed Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 127.263 2.225 . . . . 0.0 115.117 174.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.455 ' HD2' ' O ' ' A' ' 159' ' ' VAL . 36.8 Cg_exo -60.12 -32.29 94.45 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.057 2.504 . . . . 0.0 113.165 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 65.5 m 61.45 -161.05 0.3 Allowed 'General case' 0 CA--C 1.55 0.977 0 O-C-N 124.699 1.25 . . . . 0.0 110.017 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.0 m -64.04 84.74 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.443 0.639 . . . . 0.0 111.398 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 32.0 t -174.15 178.61 2.06 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 124.9 1.28 . . . . 0.0 109.403 -171.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 14.9 t 43.85 53.74 6.04 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 126.236 1.814 . . . . 0.0 113.213 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.657 ' HG ' ' N ' ' A' ' 133' ' ' GLY . 58.0 m -155.28 22.17 0.42 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.764 0.825 . . . . 0.0 111.526 173.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -61.81 -53.95 55.69 Favored Pre-proline 0 N--CA 1.489 1.514 0 CA-C-O 118.643 -0.694 . . . . 0.0 110.826 172.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -74.9 97.6 1.08 Allowed 'Trans proline' 0 C--N 1.39 2.739 0 C-N-CA 121.722 1.615 . . . . 0.0 110.466 171.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.67 ' HB1' ' HG3' ' A' ' 180' ' ' GLU . . . -160.92 127.38 4.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.204 -173.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.58 -63.06 1.46 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 173.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -112.28 106.98 15.66 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 168.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.67 ' HG3' ' HB1' ' A' ' 177' ' ' ALA . 7.3 mp0 -77.29 89.05 3.72 Favored 'General case' 0 C--O 1.249 1.026 0 CA-C-O 121.19 0.519 . . . . 0.0 110.764 -172.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.06 79.35 9.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 163.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 16.7 m -129.68 157.24 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.955 0.902 . . . . 0.0 108.768 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.2 mp -95.38 109.39 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -166.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.446 ' HB3' HG13 ' A' ' 186' ' ' VAL . 78.7 m-85 -92.35 111.4 22.95 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.519 1.127 . . . . 0.0 108.973 172.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 17.5 m-70 -77.29 91.59 3.81 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 168.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.628 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 34.9 m -109.02 157.92 9.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.477 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -127.88 115.14 18.14 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.423 ' HD2' ' HB2' ' A' ' 154' ' ' ALA . 17.6 m-30 -60.43 117.51 5.34 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.698 0.624 . . . . 0.0 111.755 -171.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -56.09 -42.7 77.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.034 1.334 . . . . 0.0 111.554 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -86.14 -16.63 37.32 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.263 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -138.61 68.14 44.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 123.115 0.566 . . . . 0.0 110.836 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.14 -17.67 53.67 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.565 2.177 . . . . 0.0 113.514 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.66 -23.08 66.71 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.743 0.817 . . . . 0.0 112.067 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -74.83 -13.34 60.55 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.151 0.58 . . . . 0.0 111.61 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.99 -141.35 34.33 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.81 0.694 . . . . 0.0 112.308 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 25.9 t -93.19 119.25 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 20.2 m -123.59 155.71 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.964 1.306 . . . . 0.0 109.54 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.47 ' HB2' HG23 ' A' ' 183' ' ' ILE . 20.8 pt20 -98.62 132.29 44.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.866 0.467 . . . . 0.0 110.812 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 83.5 mmm -135.24 164.49 27.6 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.998 0.919 . . . . 0.0 108.68 173.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.425 ' O ' HG22 ' A' ' 204' ' ' VAL . 21.4 m-80 -109.71 172.03 7.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 180' ' ' GLU . 40.7 m -61.59 -30.25 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.127 0.421 . . . . 0.0 111.134 175.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -55.94 -42.59 76.4 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.428 1.091 . . . . 0.0 109.246 175.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.68 -40.44 17.38 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 113.595 -1.639 . . . . 0.0 110.366 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . 18.8 m -91.85 116.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 CA-C-O 122.703 1.24 . . . . 0.0 108.33 -173.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -106.96 137.7 44.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.479 -1.691 . . . . 0.0 107.895 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.55 ' HB3' ' HG2' ' A' ' 281' ' ' GLU . . . -62.37 126.31 26.9 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.772 ' HD3' ' H ' ' A' ' 295' ' ' ARG . 42.2 ttm180 -63.38 95.82 0.1 Allowed 'General case' 0 C--O 1.241 0.634 0 O-C-N 123.972 0.795 . . . . 0.0 109.854 -175.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -58.06 121.52 10.83 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.891 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -91.93 1.92 56.87 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.216 172.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.0 m -97.92 113.94 25.9 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.747 0.819 . . . . 0.0 110.67 -176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 64.5 mt -85.76 136.8 22.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.759 0.824 . . . . 0.0 108.954 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.453 ' HB ' HG12 ' A' ' 277' ' ' VAL . 37.1 mm -90.25 133.79 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -97.92 172.43 7.65 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.21 0.604 . . . . 0.0 110.688 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . 0.433 ' HA ' HD12 ' A' ' 217' ' ' LEU . 73.1 t-105 -56.01 -43.36 77.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.904 0.882 . . . . 0.0 111.47 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -58.22 -37.96 75.89 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.012 0.925 . . . . 0.0 111.645 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -82.62 -20.91 35.45 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.137 0.575 . . . . 0.0 111.282 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 214' ' ' TRP . 96.0 mt -63.22 118.98 8.73 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.408 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 10.6 pt-20 -144.97 155.56 43.47 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.724 0.809 . . . . 0.0 109.729 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 35.9 m -65.4 131.27 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.149 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.71 -12.58 69.01 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 115.782 -0.645 . . . . 0.0 113.641 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -72.76 123.02 22.47 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.255 0.527 . . . . 0.0 110.535 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 51.7 t -91.62 115.72 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.57 -170.12 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.564 1.546 . . . . 0.0 109.56 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.44 ' HB2' HD11 ' A' ' 280' ' ' ILE . 40.1 ttp -141.59 130.45 23.04 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.949 0.5 . . . . 0.0 109.953 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.408 HD13 ' HD1' ' A' ' 227' ' ' TYR . 0.8 OUTLIER -143.29 147.19 34.38 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.857 0.863 . . . . 0.0 109.991 -175.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 235' ' ' ARG . 6.9 p30 -90.92 114.24 26.66 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.392 0.615 . . . . 0.0 111.347 -175.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.408 ' HD1' HD13 ' A' ' 225' ' ' LEU . 26.7 m-85 -137.64 144.54 41.93 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.348 1.059 . . . . 0.0 110.641 174.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -86.11 123.01 72.36 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.77 -9.63 26.13 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.468 2.112 . . . . 0.0 112.703 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.55 -43.57 14.37 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.31 0.644 . . . . 0.0 109.967 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -130.55 89.15 44.76 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.645 0.778 . . . . 0.0 109.967 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.18 -12.23 33.49 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.761 2.308 . . . . 0.0 112.615 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -66.51 -28.65 68.72 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.11 0.564 . . . . 0.0 110.544 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -120.24 161.12 21.63 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.31 0.644 . . . . 0.0 110.068 -173.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.415 ' HB2' ' OD1' ' A' ' 226' ' ' ASN . 1.4 ppt_? -60.47 166.85 2.86 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 124.397 1.079 . . . . 0.0 111.394 175.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -177.37 -113.33 0.35 Allowed Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.302 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -96.73 139.68 32.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.137 0.975 . . . . 0.0 110.178 -172.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . 0.571 ' HB2' ' HB3' ' A' ' 151' ' ' TRP . 79.7 m95 -70.91 123.59 22.37 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.208 0.528 . . . . 0.0 110.548 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -130.92 151.48 51.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.52 137.22 35.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 258' ' ' ASN . . . -134.83 137.71 43.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.804 0.442 . . . . 0.0 110.512 -177.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -96.23 118.56 33.04 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.551 HD12 HD11 ' A' ' 255' ' ' LEU . 44.0 mm -59.64 107.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 123.813 0.696 . . . . 0.0 109.294 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 10.0 m -78.38 -44.19 25.63 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.855 0.862 . . . . 0.0 110.623 -176.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -155.49 155.79 34.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.973 -168.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -149.7 145.58 26.77 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 123.596 0.56 . . . . 0.0 110.18 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -155.53 117.35 4.05 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.002 0.921 . . . . 0.0 108.535 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -102.98 124.33 48.28 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.1 p -133.25 162.26 32.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.681 0.793 . . . . 0.0 109.598 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.31 -26.73 68.0 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.203 1.001 . . . . 0.0 112.71 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 26.9 p -88.69 -30.24 19.27 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.198 0.599 . . . . 0.0 111.342 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -172.06 151.96 2.8 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.428 0.455 . . . . 0.0 111.462 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -105.86 110.46 22.76 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.901 0.48 . . . . 0.0 109.768 172.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -89.87 129.43 36.23 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.694 1.197 . . . . 0.0 110.825 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.551 HD11 HD12 ' A' ' 243' ' ' ILE . 1.5 tm? -137.34 129.84 29.83 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -118.64 144.26 46.28 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -147.59 146.04 29.23 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.525 0.73 . . . . 0.0 110.611 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 241' ' ' ALA . 7.3 m-20 -78.19 96.3 5.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.746 0.818 . . . . 0.0 109.233 172.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 266' ' ' LEU . 51.0 t -76.54 107.57 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 95.8 t -87.52 119.36 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.799 0.84 . . . . 0.0 110.786 -167.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 43.2 mt -107.81 -176.88 3.18 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.356 1.062 . . . . 0.0 108.816 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -76.75 -49.94 7.48 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-O 120.957 0.198 . . . . 0.0 113.247 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.17 -30.73 12.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.445 0.698 . . . . 0.0 109.885 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -112.14 175.34 5.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.571 0.749 . . . . 0.0 111.65 -175.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 14.0 p -155.73 113.24 3.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.504 1.122 . . . . 0.0 108.103 170.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.445 ' HB3' ' SG ' ' A' ' 269' ' ' CYS . 31.9 mt -80.87 81.7 7.05 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.239 1.015 . . . . 0.0 108.57 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 4.2 p-10 -76.46 135.81 39.39 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.533 -171.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 13.6 t70 56.89 47.45 17.81 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.399 1.08 . . . . 0.0 110.597 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 266' ' ' LEU . 91.9 m -99.66 132.67 44.85 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.826 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 255' ' ' LEU . 24.8 ttp180 -62.93 117.9 7.05 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.598 0.759 . . . . 0.0 112.128 -174.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 42.1 mm -87.51 105.56 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.666 175.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 34.3 mt -70.74 -36.31 64.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 125.443 1.497 . . . . 0.0 110.507 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -109.26 69.41 0.7 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.7 0.8 . . . . 0.0 109.881 -171.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 18.3 m -71.4 -14.39 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.516 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.19 -28.78 48.21 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.265 1.026 . . . . 0.0 110.87 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -90.6 26.0 2.14 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.332 0.587 . . . . 0.0 111.289 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.453 HG12 ' HB ' ' A' ' 212' ' ' ILE . 71.5 t -96.36 126.12 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.469 1.108 . . . . 0.0 109.602 175.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -112.28 160.88 17.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.181 0.992 . . . . 0.0 109.985 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.674 ' HD3' ' HA2' ' A' ' 286' ' ' GLY . 17.2 ttmm -78.31 136.61 37.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.488 1.115 . . . . 0.0 111.013 177.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 224' ' ' MET . 41.2 mm -83.05 117.15 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 163.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.55 ' HG2' ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -68.25 105.36 2.1 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.458 0.647 . . . . 0.0 110.564 -178.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -122.02 142.52 36.66 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 123.654 0.781 . . . . 0.0 108.956 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.15 120.4 6.72 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.477 2.784 . . . . 0.0 113.817 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 102.26 -25.75 26.63 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-N 116.063 -0.517 . . . . 0.0 114.038 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.04 -12.9 4.61 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 117.855 0.828 . . . . 0.0 112.543 -175.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . 0.674 ' HA2' ' HD3' ' A' ' 279' ' ' LYS . . . -98.11 120.46 6.8 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 123.448 0.546 . . . . 0.0 111.785 -173.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 3.3 m -75.52 142.3 74.13 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 117.092 0.446 . . . . 0.0 111.604 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.09 148.81 24.88 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.828 2.352 . . . . 0.0 111.993 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . 0.548 ' SD ' ' HB3' ' A' ' 207' ' ' ARG . 23.5 ttt -77.81 85.1 4.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.242 0.544 . . . . 0.0 109.609 178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 10.8 p -123.14 3.64 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.426 1.091 . . . . 0.0 109.668 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -120.36 -167.81 1.52 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.762 1.225 . . . . 0.0 108.341 -171.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -43.54 115.27 1.91 Allowed Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 124.902 1.281 . . . . 0.0 112.961 -177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.86 115.18 2.94 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.368 2.046 . . . . 0.0 110.915 173.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 22.8 mmt -72.24 -77.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.475 0.71 . . . . 0.0 110.77 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.772 ' H ' ' HD3' ' A' ' 207' ' ' ARG . 6.7 ttt180 66.43 106.58 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.411 1.484 . . . . 0.0 109.752 -176.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.472 ' NH2' ' HB2' ' A' ' 151' ' ' TRP . 7.3 mtm-85 -101.25 22.09 12.98 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.133 1.373 . . . . 0.0 109.688 -167.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -56.44 108.16 0.45 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 125.343 1.457 . . . . 0.0 110.063 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 19.6 m -90.35 118.44 29.84 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.638 0.775 . . . . 0.0 110.028 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -109.27 -118.89 4.14 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-O 118.195 -1.336 . . . . 0.0 111.265 175.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo . . . . . 0 C--N 1.38 2.217 0 C-N-CA 123.298 2.665 . . . . 0.0 112.226 177.704 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 CA-C-O 119.807 -0.44 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -92.67 -58.77 2.25 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.278 0.631 . . . . 0.0 110.087 -172.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -80.92 159.47 24.96 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.754 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -100.04 177.24 5.15 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.73 0.812 . . . . 0.0 111.022 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.7 m -72.4 0.51 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.688 1.195 . . . . 0.0 113.298 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -119.98 6.0 10.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.656 0.782 . . . . 0.0 112.264 -173.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 156' ' ' VAL . 8.2 mm-40 -82.28 94.8 7.41 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.263 0.554 . . . . 0.0 111.588 -171.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -79.21 101.47 8.0 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.938 171.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 205' ' ' ARG . 35.9 m -120.08 -166.29 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 125.974 1.71 . . . . 0.0 108.995 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 207' ' ' ARG . 1.8 t70 -122.12 165.13 16.58 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 154' ' ' ALA . . . -129.42 140.64 51.26 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 118.353 0.524 . . . . 0.0 111.418 -175.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.558 HH11 ' HA ' ' A' ' 146' ' ' THR . 1.1 tmt_? -90.74 102.3 15.05 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.401 ' HB2' ' HD1' ' A' ' 152' ' ' PHE . 9.3 t70 -65.25 110.82 2.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.558 ' HA ' HH11 ' A' ' 144' ' ' ARG . 13.1 t -72.58 -26.39 61.69 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 122.97 0.508 . . . . 0.0 111.965 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -80.82 -41.26 23.56 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.695 0.798 . . . . 0.0 111.19 -173.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.5 ttm -94.57 -33.78 12.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.434 0.694 . . . . 0.0 110.767 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.51 14.95 67.14 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.279 -171.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -100.4 175.23 5.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.133 0.973 . . . . 0.0 110.614 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -115.92 129.79 56.55 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.401 ' HD1' ' HB2' ' A' ' 145' ' ' ASP . 97.1 m-85 -131.9 135.71 46.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 188' ' ' TYR . 23.9 mt-10 -60.52 142.85 54.79 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.748 0.655 . . . . 0.0 109.309 -178.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 143' ' ' ALA . . . -133.49 117.23 16.92 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.818 0.736 . . . . 0.0 111.267 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -94.24 101.88 13.88 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 139' ' ' GLU . 55.1 t -63.68 108.55 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 172.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.427 HG11 ' HE2' ' A' ' 187' ' ' LYS . 29.0 m -108.45 -10.52 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.331 0.652 . . . . 0.0 111.97 -177.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 34.6 ttm-85 -168.85 148.2 4.19 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.384 0.674 . . . . 0.0 109.892 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.07 130.2 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.213 1.005 . . . . 0.0 109.484 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 38.7 p -130.94 151.84 50.91 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 163' ' ' ALA . 53.0 mtp180 -103.19 178.75 4.47 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -61.55 -24.06 66.38 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.099 0.56 . . . . 0.0 110.944 172.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 161' ' ' ARG . . . -108.54 145.58 31.88 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.574 1.15 . . . . 0.0 108.104 163.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -42.7 -36.59 5.05 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 124.288 3.325 . . . . 0.0 115.409 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 49.2 m -138.05 -43.29 0.52 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.485 0.714 . . . . 0.0 110.419 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.595 HH11 ' HB2' ' A' ' 167' ' ' ASP . 0.5 OUTLIER 70.26 141.73 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.563 1.545 . . . . 0.0 110.011 -174.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.595 ' HB2' HH11 ' A' ' 166' ' ' ARG . 29.3 t70 70.81 -168.92 0.16 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.971 0.908 . . . . 0.0 109.688 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -49.05 122.86 11.99 Favored Pre-proline 0 CA--C 1.562 1.427 0 CA-C-N 119.093 0.86 . . . . 0.0 111.478 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.5 13.83 0.68 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.583 2.855 . . . . 0.0 114.902 -173.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 4.2 p -75.98 170.24 16.63 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.548 0.739 . . . . 0.0 111.089 173.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.0 m -70.98 85.0 0.69 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.787 0.835 . . . . 0.0 112.736 -171.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 35.7 m 56.29 93.33 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.441 1.496 . . . . 0.0 112.931 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 68.5 p -72.58 -68.06 0.51 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 122.832 0.453 . . . . 0.0 110.373 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 48.7 m -156.02 -69.92 0.11 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.05 0.94 . . . . 0.0 109.667 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.421 ' HD2' ' N ' ' A' ' 175' ' ' ARG . 1.1 mpt_? 65.14 131.16 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 125.212 1.405 . . . . 0.0 111.89 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.58 117.39 5.12 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.333 2.022 . . . . 0.0 111.89 -174.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.56 81.54 4.88 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.541 0.736 . . . . 0.0 110.212 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 70.7 mt -111.17 -89.73 0.5 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.84 0.856 . . . . 0.0 109.611 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -141.23 78.52 1.65 Allowed 'General case' 0 C--O 1.241 0.629 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.0 97.43 2.31 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.287 -172.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.63 19.64 0.48 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.463 171.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.5 m -66.97 162.14 3.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 124.537 1.135 . . . . 0.0 110.382 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.9 mp -94.4 109.7 22.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -174.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.403 ' HB3' HG13 ' A' ' 186' ' ' VAL . 71.1 m-85 -88.41 109.09 19.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.996 0.919 . . . . 0.0 109.165 172.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -80.31 88.94 5.51 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 156' ' ' VAL . 9.9 m -114.0 155.21 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.555 ' HG2' HG22 ' A' ' 196' ' ' VAL . 43.8 mtmt -115.06 131.81 56.8 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' A' ' 153' ' ' GLU . 19.7 m-30 -60.82 97.62 0.06 Allowed 'General case' 0 C--O 1.209 -1.038 0 O-C-N 123.586 0.554 . . . . 0.0 110.031 170.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.45 ' O ' ' HA3' ' A' ' 299' ' ' GLY . 37.3 t70 -68.05 -21.18 65.01 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.687 0.795 . . . . 0.0 111.652 -173.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 25.6 p30 -85.54 -28.77 24.69 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.67 0.788 . . . . 0.0 111.827 173.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -135.13 69.17 69.99 Favored Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 123.364 0.665 . . . . 0.0 109.818 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.607 ' HD2' ' HD2' ' A' ' 300' ' ' PRO . 74.0 Cg_endo -72.61 -7.3 20.59 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.476 2.118 . . . . 0.0 112.902 -176.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.79 -9.67 59.15 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.634 0.773 . . . . 0.0 110.88 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.49 -19.54 52.81 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.749 0.82 . . . . 0.0 110.443 169.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 84.78 -165.45 40.21 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.911 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.555 HG22 ' HG2' ' A' ' 187' ' ' LYS . 42.2 t -79.24 129.6 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 32.1 m -114.67 155.12 15.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 124.328 1.051 . . . . 0.0 109.541 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.551 ' HB2' HG23 ' A' ' 183' ' ' ILE . 0.0 OUTLIER -102.45 117.08 33.95 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.597 0.759 . . . . 0.0 109.574 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 79.8 mmm -120.79 169.67 10.2 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.033 0.933 . . . . 0.0 109.702 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.442 ' H ' ' HB2' ' A' ' 203' ' ' ASP . 19.4 m-80 -109.92 178.58 4.37 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.334 0.654 . . . . 0.0 109.611 172.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 22.7 t -65.36 -39.82 92.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.419 0.688 . . . . 0.0 110.545 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -65.31 -22.87 66.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.546 0.738 . . . . 0.0 111.847 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' A' ' 200' ' ' ASN . 33.9 m-20 -97.85 2.1 48.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.646 0.779 . . . . 0.0 112.339 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.9 m -121.55 134.74 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 171.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 7.2 ptm180 -120.58 166.4 13.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.012 1.325 . . . . 0.0 109.777 -177.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.02 167.62 21.15 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 163.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.66 ' H ' ' HA ' ' A' ' 288' ' ' PRO . 37.8 ttp180 -143.61 125.98 15.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.39 0.541 . . . . 0.0 110.405 169.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -81.82 158.91 23.9 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.671 1.188 . . . . 0.0 111.782 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.51 23.97 1.51 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.584 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 99.3 m -108.05 113.57 26.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.737 0.815 . . . . 0.0 110.473 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 14.8 mt -85.62 125.98 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 162.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.506 HG21 HG11 ' A' ' 223' ' ' VAL . 46.0 mm -75.7 147.03 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 123.297 0.639 . . . . 0.0 110.79 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.03 179.75 5.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.431 1.092 . . . . 0.0 109.54 176.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -59.89 -32.09 70.41 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.865 0.866 . . . . 0.0 111.037 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -68.92 -25.21 64.47 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.472 ' HB2' HG23 ' A' ' 212' ' ' ILE . 26.3 m-20 -77.21 -26.01 52.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.549 0.34 . . . . 0.0 110.937 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.551 HD22 HG13 ' A' ' 243' ' ' ILE . 50.4 mt -73.43 144.01 46.5 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.614 0.721 . . . . 0.0 112.848 -165.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.27 169.94 20.16 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.033 -1.439 . . . . 0.0 107.987 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.9 117.87 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.91 -6.76 57.01 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 116.024 -0.534 . . . . 0.0 113.171 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.474 ' HG2' ' HA ' ' A' ' 217' ' ' LEU . 4.0 tp-100 -64.49 120.64 12.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.547 0.739 . . . . 0.0 109.644 174.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 5.7 p -102.88 130.08 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 109.9 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.506 HG11 HG21 ' A' ' 212' ' ' ILE . 15.0 m -141.34 179.8 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 124.532 1.133 . . . . 0.0 110.232 -171.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.412 ' HB2' HD11 ' A' ' 280' ' ' ILE . 21.0 ttp -141.72 124.33 15.9 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 118.033 0.378 . . . . 0.0 111.877 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.566 HD12 ' HB2' ' A' ' 273' ' ' PHE . 2.2 pt? -138.69 167.13 22.64 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.143 0.977 . . . . 0.0 110.404 -174.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -81.81 121.15 26.07 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 170.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -142.98 146.9 34.33 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -122.95 116.06 29.0 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.12 -24.13 66.42 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.229 1.953 . . . . 0.0 112.395 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.57 -44.11 21.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.265 0.626 . . . . 0.0 110.549 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -122.24 80.45 44.62 Favored Pre-proline 0 N--CA 1.486 1.36 0 C-N-CA 123.761 0.825 . . . . 0.0 109.798 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.89 -19.92 64.48 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.137 2.558 . . . . 0.0 114.408 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.48 ' HD3' HD13 ' A' ' 272' ' ' ILE . 5.0 tppp? -82.72 -27.14 31.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.943 0.497 . . . . 0.0 111.424 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.526 ' HG2' ' HG2' ' A' ' 235' ' ' ARG . 34.6 tt0 -118.38 160.46 21.63 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 120.913 0.387 . . . . 0.0 110.849 -173.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.526 ' HG2' ' HG2' ' A' ' 234' ' ' GLU . 24.4 ptt-85 -49.09 149.5 1.94 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.442 1.497 . . . . 0.0 113.587 175.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -141.49 -110.53 0.82 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 171.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -117.23 165.17 13.75 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.857 0.863 . . . . 0.0 109.161 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . 0.474 ' CZ2' ' HB3' ' A' ' 296' ' ' ARG . 54.0 m95 -80.32 115.01 19.63 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -127.1 166.6 17.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . 0.447 ' HB2' HG23 ' A' ' 260' ' ' VAL . 5.2 m-20 -82.8 156.62 23.58 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -143.49 138.45 29.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 167.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -111.17 118.54 36.25 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.635 HD12 HD21 ' A' ' 255' ' ' LEU . 29.1 mm -63.9 104.56 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 124.459 1.099 . . . . 0.0 110.364 -169.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.481 ' H ' ' HA ' ' A' ' 257' ' ' ALA . 18.8 m -79.82 -32.36 40.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.8 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.591 ' HB3' ' HB2' ' A' ' 256' ' ' TYR . 36.5 ttm180 -164.01 156.19 17.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.05 0.94 . . . . 0.0 109.559 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -155.81 148.78 24.34 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -150.5 135.18 17.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.872 0.469 . . . . 0.0 109.904 175.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -91.93 122.72 34.72 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 172.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 58.4 p -122.64 154.44 38.02 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -62.01 -20.59 64.07 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.6 p -97.94 -29.75 13.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.992 0.517 . . . . 0.0 112.164 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -160.45 165.09 31.64 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.24 0.543 . . . . 0.0 112.384 -169.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -97.79 103.41 15.35 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -92.23 141.32 28.7 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.962 0.905 . . . . 0.0 110.601 -171.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.635 HD21 HD12 ' A' ' 243' ' ' ILE . 1.2 tt -149.66 138.93 21.35 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.668 0.787 . . . . 0.0 108.985 -175.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . 0.591 ' HB2' ' HB3' ' A' ' 245' ' ' ARG . 95.5 m-85 -132.09 131.86 42.77 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.921 0.889 . . . . 0.0 108.602 169.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.481 ' HA ' ' H ' ' A' ' 244' ' ' SER . . . -145.97 148.98 33.33 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.001 0.429 . . . . 0.0 111.223 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 267' ' ' ASN . 43.9 t30 -79.61 97.02 6.34 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.406 171.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 44.1 t -78.57 103.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 240' ' ' ASP . 30.9 m -96.44 120.24 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.744 0.783 . . . . 0.0 110.56 -171.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.5 HD12 ' HB2' ' A' ' 264' ' ' ASP . 19.6 mt -92.26 -159.64 0.68 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.816 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -67.89 -40.62 89.22 Favored Glycine 0 C--N 1.352 1.423 0 N-CA-C 113.524 0.169 . . . . 0.0 113.524 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -123.5 -49.55 1.9 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.82 0.848 . . . . 0.0 109.675 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.5 ' HB2' HD12 ' A' ' 261' ' ' LEU . 3.3 m-20 -75.16 172.39 12.47 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.481 1.112 . . . . 0.0 111.932 -176.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 15.3 p -159.28 114.47 2.47 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.952 0.901 . . . . 0.0 109.37 175.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -82.06 88.93 6.41 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 258' ' ' ASN . 25.8 t-20 -76.98 139.47 40.12 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.017 -175.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 38.5 t70 68.07 20.0 9.13 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.696 1.198 . . . . 0.0 111.276 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 48.9 t -71.71 122.84 21.33 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 255' ' ' LEU . 41.7 ttp180 -71.04 119.67 15.5 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.484 ' HB ' HD13 ' A' ' 255' ' ' LEU . 51.0 mm -78.71 95.98 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.615 0 CA-C-O 122.018 0.913 . . . . 0.0 110.163 -173.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.48 HD13 ' HD3' ' A' ' 233' ' ' LYS . 73.4 mt -67.5 -29.74 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 113.263 -1.79 . . . . 0.0 110.337 173.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.599 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 15.0 m-85 -95.65 45.47 1.09 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.678 1.191 . . . . 0.0 109.585 -173.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . 0.545 HG23 HD12 ' A' ' 255' ' ' LEU . 7.3 p -67.01 -20.52 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 124.576 1.15 . . . . 0.0 112.45 -175.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.38 -17.86 19.46 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.4 0.68 . . . . 0.0 111.135 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 273' ' ' PHE . 65.2 mm-40 -93.59 16.63 13.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.408 1.083 . . . . 0.0 112.045 -174.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.81 138.01 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.303 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -125.78 163.89 21.89 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.493 1.517 . . . . 0.0 110.049 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 279' ' ' LYS . 0.6 OUTLIER -63.35 136.39 57.62 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.353 178.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 224' ' ' MET . 18.3 mm -98.8 116.77 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 162.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.18 134.77 40.48 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.473 1.109 . . . . 0.0 108.948 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -82.19 134.99 48.07 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.179 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.12 124.28 15.58 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.852 2.368 . . . . 0.0 111.794 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 101.98 -46.87 1.21 Allowed Glycine 0 C--N 1.344 0.98 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -75.87 -23.55 55.63 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.616 0.767 . . . . 0.0 110.925 175.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -130.84 159.13 22.88 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 53.5 p -97.32 150.12 36.45 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.217 0.607 . . . . 0.0 110.712 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.66 ' HA ' ' H ' ' A' ' 207' ' ' ARG . 86.3 Cg_endo -74.14 -171.76 0.98 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.856 2.371 . . . . 0.0 111.897 175.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 16.1 mmt -75.21 79.65 2.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.667 0.746 . . . . 0.0 110.285 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 6.8 p -92.7 -29.94 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.869 1.268 . . . . 0.0 108.619 173.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -81.34 161.29 23.88 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.945 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -46.58 99.41 0.21 Allowed Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 124.987 1.315 . . . . 0.0 111.995 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.31 99.85 0.17 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.608 2.872 . . . . 0.0 114.236 -164.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 55.7 mtm -78.21 92.09 4.43 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -83.28 170.14 14.95 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.072 0.463 . . . . 0.0 110.594 -178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.474 ' HB3' ' CZ2' ' A' ' 238' ' ' TRP . 20.9 mtm180 -89.08 91.05 8.66 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.57 0.748 . . . . 0.0 109.21 -169.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 70.17 -107.58 0.06 Allowed 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.27 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 66.5 m -158.75 108.27 1.98 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 122.691 0.396 . . . . 0.0 110.13 -169.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 189' ' ' ASP . . . -75.39 119.11 5.73 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 117.894 -1.503 . . . . 0.0 110.516 164.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . 0.607 ' HD2' ' HD2' ' A' ' 192' ' ' PRO . 85.0 Cg_exo . . . . . 0 C--N 1.381 2.241 0 C-N-CA 124.059 3.173 . . . . 0.0 114.116 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.85 11.15 9.63 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.528 0.731 . . . . 0.0 111.202 177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.464 ' O ' HG11 ' A' ' 159' ' ' VAL . 30.5 m-85 -124.4 163.4 21.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.235 1.014 . . . . 0.0 109.315 173.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.704 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 10.1 ptpp? -123.62 -179.57 4.4 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.275 1.03 . . . . 0.0 109.358 176.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.33 11.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.566 ' H ' ' HG3' ' A' ' 136' ' ' LYS . 6.9 t-20 -131.32 -6.64 3.79 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.247 0.619 . . . . 0.0 111.105 -174.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.704 ' HG2' ' HG2' ' A' ' 136' ' ' LYS . 29.8 mm-40 -78.22 87.15 4.31 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.59 0.71 . . . . 0.0 110.879 -177.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 155' ' ' GLN . 11.4 p90 -68.91 100.49 1.2 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.289 169.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.38 177.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.456 0.702 . . . . 0.0 109.814 -177.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.635 ' HB2' ' HB3' ' A' ' 207' ' ' ARG . 16.9 t0 -94.25 152.06 18.97 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -146.89 115.65 6.81 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.401 0.68 . . . . 0.0 110.412 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -72.42 115.02 11.18 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 171.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.51 ' HB3' ' SD ' ' A' ' 148' ' ' MET . 9.8 t70 -66.68 110.41 3.21 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.4 p -64.74 -7.68 11.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.415 1.086 . . . . 0.0 113.775 -167.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -75.58 -57.14 4.06 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 117.898 0.317 . . . . 0.0 111.113 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.51 ' SD ' ' HB3' ' A' ' 145' ' ' ASP . 1.8 pmm? -104.5 -19.85 13.89 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.131 0.572 . . . . 0.0 111.38 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 92.44 9.57 61.51 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.911 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.01 128.62 34.16 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.591 0.357 . . . . 0.0 110.856 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.43 ' O ' ' HB2' ' A' ' 238' ' ' TRP . 97.1 m95 -73.09 133.19 44.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.578 0.751 . . . . 0.0 109.283 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -139.59 133.19 30.39 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.483 ' HG3' ' HG2' ' A' ' 207' ' ' ARG . 33.2 tt0 -70.26 90.12 0.68 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.272 0.558 . . . . 0.0 110.427 -175.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.588 ' HB1' ' HB ' ' A' ' 186' ' ' VAL . . . -96.87 118.69 33.86 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.363 0.665 . . . . 0.0 110.007 -172.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.635 ' HA ' ' HA ' ' A' ' 140' ' ' TYR . 65.0 tt0 -86.38 116.09 24.32 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.495 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.422 ' HA ' HG12 ' A' ' 186' ' ' VAL . 61.8 t -61.56 109.04 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 124.359 1.037 . . . . 0.0 108.807 172.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.532 HG11 ' HE2' ' A' ' 187' ' ' LYS . 16.1 m -114.58 -0.98 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.993 0.917 . . . . 0.0 112.012 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.618 ' HB3' ' HB2' ' A' ' 185' ' ' HIS . 51.1 ttt85 -167.1 138.04 3.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.271 1.028 . . . . 0.0 108.549 173.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 135' ' ' TYR . 26.0 m -116.19 134.19 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.9 p -142.5 150.82 41.0 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.454 0.702 . . . . 0.0 109.738 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.498 ' HG2' ' H ' ' A' ' 163' ' ' ALA . 46.0 ttt85 -76.91 164.03 26.18 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.699 0.8 . . . . 0.0 110.424 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -63.46 -28.55 70.04 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 120.872 0.367 . . . . 0.0 110.39 172.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.498 ' H ' ' HG2' ' A' ' 161' ' ' ARG . . . -59.34 143.95 84.53 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 124.034 0.934 . . . . 0.0 110.254 170.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -61.49 87.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.804 3.002 . . . . 0.0 114.192 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 12.1 m -90.94 91.79 8.49 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -93.07 -22.61 19.02 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.376 0.67 . . . . 0.0 111.737 -169.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -151.05 162.16 41.38 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.096 0.558 . . . . 0.0 110.174 -172.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.476 ' HG3' ' NH1' ' A' ' 158' ' ' ARG . 3.2 mp0 -75.24 126.78 87.49 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 174.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.36 69.54 4.11 Favored 'Trans proline' 0 CA--C 1.56 1.792 0 C-N-CA 122.127 1.885 . . . . 0.0 111.935 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' CYS . . . . . . . . . . . . . 80.7 m 59.63 -85.83 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.888 1.675 . . . . 0.0 112.335 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 m -137.09 11.83 3.07 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.343 1.057 . . . . 0.0 110.186 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 25.1 m -91.98 161.76 14.67 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.665 0.786 . . . . 0.0 110.203 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 6.0 t -165.81 100.49 0.67 Allowed 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 122.193 0.997 . . . . 0.0 109.103 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 80.1 p -94.55 156.38 16.47 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.82 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.79 101.11 31.12 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 123.932 0.893 . . . . 0.0 109.199 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.494 ' HG3' ' HB2' ' A' ' 161' ' ' ARG . 59.6 Cg_endo -67.88 168.24 19.25 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.365 2.043 . . . . 0.0 111.558 172.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.6 157.63 26.5 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.766 0.826 . . . . 0.0 111.489 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.4 pp -72.29 155.25 40.39 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.892 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -165.99 -36.43 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 74.6 -6.48 1.9 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.201 1.401 . . . . 0.0 112.824 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -108.38 23.03 15.11 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 m -81.74 175.71 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 123.657 0.783 . . . . 0.0 109.417 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.526 HG23 ' HB2' ' A' ' 198' ' ' GLN . 3.4 mp -97.5 109.39 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.75 0.786 . . . . 0.0 109.964 -175.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 201' ' ' SER . 93.2 m-85 -96.77 113.35 24.9 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.757 1.223 . . . . 0.0 108.211 168.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.618 ' HB2' ' HB3' ' A' ' 158' ' ' ARG . 12.7 m-70 -78.67 103.87 8.91 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.588 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 35.5 m -117.36 157.31 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.468 1.107 . . . . 0.0 110.776 -172.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.532 ' HE2' HG11 ' A' ' 157' ' ' VAL . 50.6 mtmt -129.15 123.83 33.12 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -64.48 133.56 52.7 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.386 0.674 . . . . 0.0 110.339 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -74.37 -31.52 62.41 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -66.11 -30.75 71.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.089 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -145.69 71.74 13.93 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.046 0.538 . . . . 0.0 110.465 -174.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.87 -26.73 15.3 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.658 2.239 . . . . 0.0 112.047 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -76.42 -10.9 59.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.089 0.956 . . . . 0.0 110.885 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.73 6.09 19.2 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.259 0.624 . . . . 0.0 110.89 170.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.0 -154.14 49.35 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.393 0.433 . . . . 0.0 113.796 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.24 119.18 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.614 0.766 . . . . 0.0 109.57 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.7 m -109.13 153.55 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.992 0.917 . . . . 0.0 109.098 174.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.526 ' HB2' HG23 ' A' ' 183' ' ' ILE . 5.1 pm0 -91.1 137.3 32.47 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 177.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' MET . . . . . . . . . . . . . 80.4 mmm -148.51 158.52 44.17 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.049 0.94 . . . . 0.0 110.706 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -112.36 149.85 31.89 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.274 1.43 . . . . 0.0 110.477 -178.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.72 ' HA ' HG22 ' A' ' 204' ' ' VAL . 33.0 t -64.14 -30.32 71.39 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.071 0.949 . . . . 0.0 112.611 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -67.68 -20.63 65.32 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 122.519 -0.113 . . . . 0.0 111.131 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -115.15 -1.8 12.9 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.652 0.781 . . . . 0.0 111.838 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 201' ' ' SER . 6.0 m -115.71 118.94 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 121.962 0.887 . . . . 0.0 109.37 169.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -106.07 158.7 16.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -175.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.25 128.12 34.39 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 169.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.635 ' HB3' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -76.28 138.26 40.43 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.127 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -88.57 139.79 30.12 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -90.7 -0.36 57.67 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.479 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 28.0 m -84.29 112.93 20.75 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.51 121.91 37.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.092 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.1 mm -93.41 148.66 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.141 0.977 . . . . 0.0 109.95 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.669 ' HA ' ' HA ' ' A' ' 275' ' ' ASP . 16.2 ptpt -123.9 169.02 12.01 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.541 0.736 . . . . 0.0 110.226 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -51.37 -44.12 62.02 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.112 0.965 . . . . 0.0 111.562 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -60.78 -35.21 75.87 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.171 -177.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -87.11 -7.87 57.6 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.944 0.897 . . . . 0.0 111.372 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.509 ' O ' ' HD3' ' A' ' 246' ' ' LYS . 97.4 mt -84.67 137.55 33.19 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.736 0.814 . . . . 0.0 110.077 175.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.478 ' O ' ' HB ' ' A' ' 243' ' ' ILE . 9.6 pt-20 -151.78 171.64 17.4 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.773 0.829 . . . . 0.0 110.578 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 243' ' ' ILE . 29.2 m -67.56 116.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 122.834 0.454 . . . . 0.0 111.745 -175.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.07 -15.12 33.64 Favored Glycine 0 CA--C 1.537 1.41 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.345 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -71.92 122.42 20.77 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.57 1.148 . . . . 0.0 110.981 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.431 ' HB ' ' NH2' ' A' ' 282' ' ' ARG . 60.7 t -103.73 123.69 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 174.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.88 148.95 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 125.105 1.362 . . . . 0.0 109.927 -176.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 15.7 ptm -98.03 122.7 41.49 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.351 0.596 . . . . 0.0 111.22 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.89 141.85 40.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.742 1.217 . . . . 0.0 109.595 -171.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -96.34 107.35 19.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.017 0.913 . . . . 0.0 111.869 -173.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.559 ' HE2' ' HB2' ' A' ' 239' ' ' TYR . 20.4 p90 -136.33 156.83 48.08 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 175.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -87.62 125.07 66.38 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.56 -31.75 95.0 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.366 2.044 . . . . 0.0 112.707 176.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -81.47 -24.63 36.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.538 0.735 . . . . 0.0 110.982 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -134.62 81.81 46.79 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 123.716 0.807 . . . . 0.0 109.636 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.1 -27.14 73.3 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.602 2.201 . . . . 0.0 112.3 -175.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -85.42 15.07 4.71 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 124.357 1.063 . . . . 0.0 110.649 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -140.4 146.33 38.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.835 0.854 . . . . 0.0 110.061 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -71.37 138.45 49.2 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.437 0.695 . . . . 0.0 109.42 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -154.27 -114.36 0.52 Allowed Glycine 0 C--N 1.339 0.738 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -100.17 143.4 30.41 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.476 1.111 . . . . 0.0 109.694 -170.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' TRP . . . . . 0.43 ' HB2' ' O ' ' A' ' 151' ' ' TRP . 60.7 m95 -74.34 124.01 25.67 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.77 0.428 . . . . 0.0 110.049 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.559 ' HB2' ' HE2' ' A' ' 227' ' ' TYR . 96.3 m-85 -131.59 147.29 52.51 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -81.67 142.75 32.44 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.495 ' HB2' HG12 ' A' ' 259' ' ' VAL . . . -142.83 135.95 28.27 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 123.461 0.705 . . . . 0.0 110.029 -170.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -95.98 115.72 27.86 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.6 HD12 HD11 ' A' ' 255' ' ' LEU . 20.0 mm -65.1 113.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 123.803 0.841 . . . . 0.0 108.911 -175.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.4 p -90.97 -20.43 22.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.806 0.842 . . . . 0.0 110.954 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -161.81 142.15 10.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.1 0.56 . . . . 0.0 110.859 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 217' ' ' LEU . 23.5 pttm -122.55 129.5 52.01 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 167.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -155.27 150.54 27.02 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.923 0.889 . . . . 0.0 108.772 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -142.79 137.69 29.89 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.279 0.632 . . . . 0.0 109.761 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 32.7 p -99.04 178.04 5.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 161.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -68.14 -26.7 65.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.203 0.601 . . . . 0.0 110.929 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 41.7 p -86.5 -30.3 22.07 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.096 0.558 . . . . 0.0 112.132 -174.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -167.21 173.29 9.14 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.983 0.513 . . . . 0.0 110.941 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -109.73 113.53 26.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.105 0.962 . . . . 0.0 109.887 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -91.34 92.45 8.6 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.6 HD11 HD12 ' A' ' 243' ' ' ILE . 1.8 tm? -109.51 129.46 55.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.969 -1.864 . . . . 0.0 105.969 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -125.0 130.79 53.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -146.52 135.34 22.33 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.069 0.948 . . . . 0.0 109.736 -175.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.418 HD22 ' N ' ' A' ' 258' ' ' ASN . 0.8 OUTLIER -76.42 97.96 4.43 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 176.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 266' ' ' LEU . 18.8 m -81.86 107.3 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.488 -175.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.0 p -93.33 131.65 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.377 -175.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.9 mp -94.37 -171.6 2.56 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.841 1.256 . . . . 0.0 109.491 174.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -85.9 -17.46 61.42 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-N 116.88 -0.146 . . . . 0.0 113.397 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -122.56 -34.18 3.29 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.368 1.067 . . . . 0.0 110.083 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.46 177.69 5.11 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.758 0.823 . . . . 0.0 109.77 -173.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 33.3 t -150.52 112.96 4.67 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.496 ' HB2' HG23 ' A' ' 259' ' ' VAL . 66.3 mt -80.49 105.83 12.04 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -64.5 122.61 17.19 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.455 0.702 . . . . 0.0 110.952 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 15.1 t70 54.63 74.37 0.35 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.724 1.209 . . . . 0.0 112.325 171.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 43.6 t -102.2 139.78 37.36 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.495 0.718 . . . . 0.0 109.651 173.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -69.51 134.8 49.31 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.096 0.558 . . . . 0.0 109.639 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 33.1 mm -107.55 130.74 59.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 48.7 mt -98.07 -29.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.39 1.076 . . . . 0.0 110.365 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -95.03 38.03 1.14 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.235 1.014 . . . . 0.0 110.242 -167.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.9 -29.77 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.131 1.372 . . . . 0.0 113.534 -166.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.669 ' HA ' ' HA ' ' A' ' 213' ' ' LYS . 45.6 m-20 -100.05 -0.37 39.27 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.392 0.677 . . . . 0.0 111.674 -175.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.541 ' HB2' ' HE3' ' A' ' 297' ' ' LYS . 11.8 pt-20 -125.07 22.59 7.91 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.567 0.698 . . . . 0.0 110.845 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.76 154.24 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.5 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -108.84 160.36 16.05 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.508 0.671 . . . . 0.0 110.336 169.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -79.11 145.48 33.73 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.508 1.123 . . . . 0.0 111.239 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.429 HG22 ' HG3' ' A' ' 282' ' ' ARG . 40.2 mm -79.67 114.18 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -76.45 115.51 16.26 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.431 ' NH2' ' HB ' ' A' ' 222' ' ' VAL . 95.2 mtt180 -118.8 148.95 45.56 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.008 0.923 . . . . 0.0 109.836 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -55.66 122.22 11.34 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.12 2.546 . . . . 0.0 112.884 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 98.87 -52.03 1.14 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.368 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.35 -22.47 18.31 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.081 0.552 . . . . 0.0 112.139 -169.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . -90.29 98.69 2.48 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' SER . . . . . . . . . . . . . 8.4 m -64.52 144.56 98.65 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 122.821 0.448 . . . . 0.0 110.613 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -69.44 140.43 43.86 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.629 2.22 . . . . 0.0 111.447 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' MET . . . . . . . . . . . . . 27.6 ttt -76.39 84.36 3.13 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.819 0.819 . . . . 0.0 110.232 -177.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.65 -27.38 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.321 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.28 178.29 8.38 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.253 1.021 . . . . 0.0 109.935 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -42.92 129.02 3.19 Favored Pre-proline 0 N--CA 1.489 1.481 0 C-N-CA 125.4 1.48 . . . . 0.0 113.304 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -58.73 84.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 123.337 2.691 . . . . 0.0 113.702 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 64.5 mmm -74.56 78.02 1.97 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.799 1.24 . . . . 0.0 108.292 168.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -56.9 170.65 0.41 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.013 0.925 . . . . 0.0 113.313 -175.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.414 ' HD3' ' HB2' ' A' ' 153' ' ' GLU . 3.4 tpt180 -57.35 155.94 8.41 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.08 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.541 ' HE3' ' HB2' ' A' ' 276' ' ' GLU . 65.3 mttm -82.99 64.71 7.75 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 165.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 8.5 p -80.08 83.09 6.02 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 112.912 -1.949 . . . . 0.0 110.384 -171.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 163.05 81.12 0.04 OUTLIER Glycine 0 C--N 1.333 0.405 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 C--N 1.376 2.007 0 C-N-CA 123.164 2.576 . . . . 0.0 111.934 178.65 . . . . . . . . 0 0 . 1 stop_ save_